PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Puig, MS; Zapata, LP; Aznar-Casanova, JA; Super, H				Sole Puig, Maria; Perez Zapata, Laura; Antonio Aznar-Casanova, J.; Super, Hans			A Role of Eye Vergence in Covert Attention	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR DISPARITY; SPATIAL ATTENTION; DEPTH-PERCEPTION; MOVEMENTS; MECHANISMS; OVERT; MICROSACCADES; SHIFTS	Covert spatial attention produces biases in perceptual and neural responses in the absence of overt orienting movements. The neural mechanism that gives rise to these effects is poorly understood. Here we report the relation between fixational eye movements, namely eye vergence, and covert attention. Visual stimuli modulate the angle of eye vergence as a function of their ability to capture attention. This illustrates the relation between eye vergence and bottom-up attention. In visual and auditory cue/no-cue paradigms, the angle of vergence is greater in the cue condition than in the no-cue condition. This shows a top-down attention component. In conclusion, observations reveal a close link between covert attention and modulation in eye vergence during eye fixation. Our study suggests a basis for the use of eye vergence as a tool for measuring attention and may provide new insights into attention and perceptual disorders.	[Sole Puig, Maria; Perez Zapata, Laura; Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Antonio Aznar-Casanova, J.; Super, Hans] Univ Barcelona, Inst Brain Cognit & Behav, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain.	hans.super@icrea.es	/B-3900-2011; Aznar-Casanova, J.Antonio/Z-1011-2019	/0000-0002-3084-3135; Aznar-Casanova, J.Antonio/0000-0002-3084-3135; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from the Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Hoecks B., 1993, BEHAV RES METH INSTR, V25, P16; Horowitz TS, 2007, PSYCHOL SCI, V18, P356, DOI 10.1111/j.1467-9280.2007.01903.x; Hunt AR, 2003, COGNITIVE BRAIN RES, V18, P102, DOI 10.1016/j.cogbrainres.2003.08.006; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P776; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Super H, 2004, P NATL ACAD SCI USA, V101, P3230, DOI 10.1073/pnas.0400433101; Thompson KA, 2005, ABA J, V91, P25; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wright R.D, 2008, ORIENTING ATTENTION; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	31	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52955	10.1371/journal.pone.0052955	http://dx.doi.org/10.1371/journal.pone.0052955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23382827	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600009
J	Missbach, S; Weis, BL; Martin, R; Simm, S; Bohnsack, MT; Schleiff, E				Missbach, Sandra; Weis, Benjamin L.; Martin, Roman; Simm, Stefan; Bohnsack, Markus T.; Schleiff, Enrico			40S Ribosome Biogenesis Co-Factors Are Essential for Gametophyte and Embryo Development	PLOS ONE			English	Article							INITIATION-FACTOR 6; FEMALE GAMETOPHYTE; SACCHAROMYCES-CEREVISIAE; DOUBLE FERTILIZATION; POLLEN GERMINATION; RNA BIOGENESIS; PIN DOMAIN; ARABIDOPSIS; PROTEIN; CLEAVAGE	Ribosome biogenesis is well described in Saccharomyces cerevisiae. In contrast only very little information is available on this pathway in plants. This study presents the characterization of five putative protein co-factors of ribosome biogenesis in Arabidopsis thaliana, namely Rrp5, Pwp2, Nob1, Enp1 and Noc4. The characterization of the proteins in respect to localization, enzymatic activity and association with pre-ribosomal complexes is shown. Additionally, analyses of T-DNA insertion mutants aimed to reveal an involvement of the plant co-factors in ribosome biogenesis. The investigated proteins localize mainly to the nucleolus or the nucleus, and atEnp1 and atNob1 co-migrate with 40S pre-ribosomal complexes. The analysis of T-DNA insertion lines revealed that all proteins are essential in Arabidopsis thaliana and mutant plants show alterations of rRNA intermediate abundance already in the heterozygous state. The most significant alteration was observed in the NOB1 T-DNA insertion line where the P-A3 fragment, a 23S-like rRNA precursor, accumulated. The transmission of the T-DNA through the male and female gametophyte was strongly inhibited indicating a high importance of ribosome cofactor genes in the haploid stages of plant development. Additionally impaired embryogenesis was observed in some mutant plant lines. All results support an involvement of the analyzed proteins in ribosome biogenesis but differences in rRNA processing, gametophyte and embryo development suggested an alternative regulation in plants.	[Missbach, Sandra; Weis, Benjamin L.; Martin, Roman; Simm, Stefan; Bohnsack, Markus T.; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci, D-60054 Frankfurt, Germany; [Bohnsack, Markus T.; Schleiff, Enrico] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci, D-60054 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Bohnsack, Markus T./D-3076-2011; Simm, Stefan/AAX-4991-2020; Schleiff, Enrico/C-5105-2017	Bohnsack, Markus T./0000-0001-7063-5456; Schleiff, Enrico/0000-0002-0518-3489	Cluster of Excellence Frankfurt; Goethe University in the Forderfond; SFB 902	Cluster of Excellence Frankfurt; Goethe University in the Forderfond; SFB 902	This project was funded by the Cluster of Excellence Frankfurt "Macromolecular Complexes'' (MTB, ES), the Goethe University in the Forderfond program (MTB, ES), and the SFB 902 "Molecular mechanisms of RNA-based regulation'' (MTB, ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Brown JWS, 1998, PLANT CELL, V10, P649, DOI 10.1105/tpc.10.5.649; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comella P, 2008, NUCLEIC ACIDS RES, V36, P1163, DOI 10.1093/nar/gkm1130; De Boer P, 2006, RNA, V12, P263, DOI 10.1261/rna.2257606; De Storme N, 2011, PLANT PHYSIOL, V155, P1403, DOI 10.1104/pp.110.170415; Devic M, 2008, CR BIOL, V331, P726, DOI 10.1016/j.crvi.2008.07.014; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Faure JE, 2001, CR ACAD SCI III-VIE, V324, P551, DOI 10.1016/S0764-4469(01)01325-7; Feldmann KA, 1997, GENETICS, V147, P1411; Forreiter C, 1997, PLANT CELL, V9, P2171, DOI 10.1105/tpc.9.12.2171; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Guo JJ, 2011, PLANT SIGNAL BEHAV, V6, P766, DOI 10.4161/psb.6.5.15438; Harrison-Lowe NJ, 2008, AUTOPHAGY, V4, P339, DOI 10.4161/auto.5629; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Howden R, 1998, GENETICS, V149, P621; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Im CH, 2011, J BIOL CHEM, V286, P8620, DOI 10.1074/jbc.M110.200816; Ingouff M, 2006, PLANT CELL, V18, P3491, DOI 10.1105/tpc.106.047266; Kato Y, 2010, BIOCHEM BIOPH RES CO, V397, P673, DOI 10.1016/j.bbrc.2010.06.001; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kuhn H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008370; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2011, PLANT J, V68, P51, DOI 10.1111/j.1365-313X.2011.04675.x; Li N, 2009, PLANT PHYSIOL, V151, P1486, DOI 10.1104/pp.109.142414; Liu JJ, 2008, MOL PLANT, V1, P564, DOI 10.1093/mp/ssn033; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Pontvianne F, 2007, MOL BIOL CELL, V18, P369, DOI 10.1091/mbc.E06-08-0751; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Roos J, 1997, GENE, V185, P137, DOI 10.1016/S0378-1119(96)00661-0; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Sommer MS, 2011, P NATL ACAD SCI USA, V108, P13841, DOI 10.1073/pnas.1108626108; Thole V, 2009, NAT PROTOC, V4, P650, DOI 10.1038/nprot.2009.32; Veith T, 2012, NUCLEIC ACIDS RES, V40, P3259, DOI 10.1093/nar/gkr1186; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vicient CM, 1999, ANAL BIOCHEM, V268, P412, DOI 10.1006/abio.1998.3045; Vos HR, 2004, EUKARYOT CELL, V3, P1504, DOI 10.1128/EC.3.6.1504-1512.2004; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1192, DOI 10.1093/pcp/pcg147; Young CL, 2011, RNA, V17, P512, DOI 10.1261/rna.2458811; Zakrzewska-Placzek M, 2010, NUCLEIC ACIDS RES, V38, P4487, DOI 10.1093/nar/gkq172; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x	69	57	60	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54084	10.1371/journal.pone.0054084	http://dx.doi.org/10.1371/journal.pone.0054084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382868	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800031
J	Li, GC; Zhang, Z; Ma, XJ; Zhu, J; Cai, G				Li, Guichao; Zhang, Zhen; Ma, Xuejun; Zhu, Ji; Cai, Gang			Postoperative Chemoradiotherapy Combined with Epirubicin-Based Triplet Chemotherapy for Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction	PLOS ONE			English	Article							PHASE-III TRIAL; RESECTABLE GASTRIC-CANCER; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; PERIOPERATIVE CHEMOTHERAPY; COMPARING CAPECITABINE; D2 GASTRECTOMY; ASIAN PATIENTS; UNITED-STATES; SURGERY	Background: Due to low tolerance to chemotherapy, the maximum number of cycles of postoperative adjuvant chemotherapy is 4 in adjuvant gastric clinical trials. The aim of this study is to retrospectively evaluate the safety and efficacy of adjuvant epirubicin-based triplet chemotherapy and radiotherapy in the treatment of resected locally advanced stomach or gastroesophageal junction adenocarcinoma. Methodology/Principal Findings: From January 2004 to July 2008, ninety-seven consecutive gastric or gastroesophageal junction adenocarcinoma patients in stages T3-4/N+ were treated with postoperative radiotherapy and chemotherapy. The recommended treatment plan was radical resection followed by 1-2 cycles of adjuvant chemotherapy (ACT), postoperative chemoradiotherapy (CRT), and, finally, 4-5 cycles of ACT. The patients were classified into two groups depending on the number of cycles of ACT: group 1 received 4-6 cycles (n = 59), and group 2 received 0-3 cycles (n = 38). The detailed grouping is as follows: RT alone, 2; RT and CT, 18; concurrent RTCT and CT, 41; and CRT, 36. Of the 97 patients, 77 patients received concurrent therapy (CRT, (5-fluorouracil or capecitabine), and 20 received radiotherapy alone because of patient refusal (n = 15) or treatment toxicity (n = 5). After a median follow-up of 44 months, the 3-year disease free survival(DFS) and overall survival (OS) were 66.5% and 69.5% for group 1 and 45.5% and 50% for group 2, respectively (p = 0.005 and p = 0.024). Multivariate analysis revealed that 4-6 cycles of ACT, lymphovascular invasion, or peritoneal metastasis were independent prognostic factors for disease-free survival or overall survival (p < 0.05). Conclusions/Significance: This study demonstrates that concurrent chemoradiation with adjuvant epirubicin-based triplet chemotherapy is feasible and tolerable for gastric or gastroesophageal junction carcinoma patients. Patients can benefit from more cycles of ACT.	[Zhang, Zhen] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Radiat Oncol, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Radiat Oncol, Shanghai 200433, Peoples R China.	zhenzhang6@163.com	zhu, ji/HDM-1538-2022	Zhu, Ji/0000-0001-7134-9419				Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Gill R D, 1992, Math Popul Stud, V3, P259; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; HALLISSEY MT, 1994, LANCET, V343, P1309, DOI 10.1016/S0140-6736(94)92464-3; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Janunger KG, 2001, ACTA ONCOL, V40, P309, DOI 10.1080/02841860151116385; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Leong T, 2011, INT J RADIAT ONCOL, V79, P690, DOI 10.1016/j.ijrobp.2009.11.042; Lim DH, 2004, BRIT J CANCER, V91, P11, DOI 10.1038/sj.bjc.6601896; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; Noguchi Y, 2000, CANCER-AM CANCER SOC, V89, P2237, DOI 10.1002/1097-0142(20001201)89:11<2237::AID-CNCR12>3.3.CO;2-0; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Quero L, 2012, INT J RADIAT ONCOL, V83, P574, DOI 10.1016/j.ijrobp.2011.07.031; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Sumpter K, 2005, BRIT J CANCER, V92, P1976, DOI 10.1038/sj.bjc.6602572; Tepper JE, 2002, SEMIN RADIAT ONCOL, V12, P187, DOI 10.1053/srao.2002.30827; Theuer CP, 2000, CANCER, V89, P1883, DOI 10.1002/1097-0142(20001101)89:9<1883::AID-CNCR3>3.3.CO;2-8; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van de Velde CJH, 1998, ANN CHIR GYNAECOL FE, V87, P89; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54233	10.1371/journal.pone.0054233	http://dx.doi.org/10.1371/journal.pone.0054233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372688	gold, Green Submitted, Green Published			2022-12-27	WOS:000315210400009
J	Melchers, NVSV; van Elsland, SL; Lange, JMA; Borgdorff, MW; van den Hombergh, J				Melchers, Natalie V. S. Vinkeles; van Elsland, Sabine L.; Lange, Joep M. A.; Borgdorff, Martien W.; van den Hombergh, Jan			State of Affairs of Tuberculosis in Prison Facilities: A Systematic Review of Screening Practices and Recommendations for Best TB Control	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; PULMONARY TUBERCULOSIS; PREVALENCE SURVEY; DIAGNOSTIC-TESTS; XPERT MTB/RIF; THAI PRISONS; SOUTH-AFRICA; SAO-PAULO; ROLL-OUT; HIV	Background: Prisoners are at high risk of developing tuberculosis (TB), causing morbidity and mortality. Prison facilities encounter many challenges in TB screening procedures and TB control. This review explores screening practices for detection of TB and describes limitations of TB control in prison facilities worldwide. Methods: A systematic search of online databases (e. g., PubMed and Embase) and conference abstracts was carried out. Research papers describing screening and diagnostic practices among prisoners were included. A total of 52 articles met the inclusion criteria. A meta-analysis of TB prevalence in prison facilities by screening and diagnostic tools was performed. Results: The most common screening tool was symptom questionnaires (63.5%), mostly reporting presence of cough. Microscopy of sputum with Ziehl-Neelsen staining and solid culture were the most frequently combined diagnostic methods (21.2%). Chest X-ray and tuberculin skin tests were used by 73.1% and 50%, respectively, as either a screening and/or diagnostic tool. Median TB prevalence among prisoners of all included studies was 1,913 cases of TB per 100,000 prisoners (interquartile range [IQR]: 332-3,517). The overall annual median TB incidence was 7.0 cases per 1000 person-years (IQR: 2.7-30.0). Major limitations for successful TB control were inaccuracy of diagnostic algorithms and the lack of adequate laboratory facilities reported by 61.5% of studies. The most frequent recommendation for improving TB control and case detection was to increase screening frequency (73.1%). Discussion: TB screening algorithms differ by income area and should be adapted to local contexts. In order to control TB, prison facilities must improve laboratory capacity and frequent use of effective screening and diagnostic tools. Sustainable political will and funding are critical to achieve this.	[Melchers, Natalie V. S. Vinkeles; Lange, Joep M. A.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [van Elsland, Sabine L.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat Infect Dis Immunol & Rheumatol, Amsterdam, Netherlands; [Borgdorff, Martien W.] Publ Hlth Serv GGD Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [van den Hombergh, Jan] PharmAccess Int, Dar Es Salaam, Tanzania	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam	Melchers, NVSV (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	natalie.melchers@gmail.com	Melchers, Natalie Vinkeles/ABF-4364-2020	Vinkeles Melchers, Natalie VS/0000-0002-1494-3101; van Elsland, Sabine L./0000-0003-0775-7463				Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Abrahao RMCM, 2006, INT J TUBERC LUNG D, V10, P203; Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; Aerts A, 2006, INT J TUBERC LUNG D, V10, P1215; Banda HT, 2009, INT J TUBERC LUNG D, V13, P1557; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Bur S, 2003, INT J TUBERC LUNG D, V7, pS417; Butler T, 1999, AUST NZ J PUBL HEAL, V23, P185, DOI 10.1111/j.1467-842X.1999.tb01232.x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P250; Chee CBE, 2005, INT J TUBERC LUNG D, V9, P1248; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; Dara M, 2009, GUIDELINES FOR CONTR; DEAKINS DD, 1956, AM REV TUBERC PULM, V73, P882; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177, DOI 10.1097/00042560-199610010-00009; Getahun H, 2009, PROGRAM AND ABSTRACT, V2; Habeenzu C, 2007, INT J TUBERC LUNG D, V11, P1216; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hatwiinda S, 2011, UNION WORLD CONFEREN; Jittimanee SX, 2007, INT J TUBERC LUNG D, V11, P556; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; KNCV, 2007, STATUS PAPER ON PRIS; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Larouze B, 2008, T ROY SOC TROP MED H, V102, P841, DOI 10.1016/j.trstmh.2008.04.020; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Leung CC, 2005, INT J TUBERC LUNG D, V9, P627; Levy Michael H, 2007, N S W Public Health Bull, V18, P119, DOI 10.1071/NB07051; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Mor Z, 2008, ISR MED ASSOC J, V10, P202; O'Grady J, 2011, SAMJ S AFR MED J, V101, P107, DOI 10.7196/SAMJ.4629; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Porta M, 2008, DICT EPIDEMIOLOGY; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Reid SE, 2012, J INFECT DIS, V205, pS265, DOI 10.1093/infdis/jis029; Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447; Rodrigues C, 2012, CLIN LAB MED, V32, P111, DOI 10.1016/j.cll.2012.03.002; SALIVE ME, 1990, PUBLIC HEALTH REP, V105, P307; Saunders DL, 2001, PUBLIC HEALTH REP, V116, P210, DOI 10.1016/S0033-3549(04)50036-5; Schnippel K, 2012, TROP MED INT HEALTH, V17, P1142, DOI 10.1111/j.1365-3156.2012.03028.x; Shah S A, 2003, East Mediterr Health J, V9, P667; Sretrirutchai S, 2002, INT J TUBERC LUNG D, V6, P208; Todrys KW, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-8; Tulsky JP, 1998, AM J PUBLIC HEALTH, V88, P223, DOI 10.2105/AJPH.88.2.223; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Vieira Amadeu A., 2010, Rev. bras. epidemiol., V13, P641, DOI 10.1590/S1415-790X2010000400009; Walmsley R, 2015, WORLD PRISON POPULAT; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, USE OF TUBERCULOSIS; WHO, 2007, THE USE OF LIQUID TB; WHO, 2007, STRENGTHENING HEALTH; World Bank, 2011, WORLD BANK COUNTRY C; World Health Organization, 2000, Tuberculosis Control in Prisons: a manual for programme managers; Yates S, 2009, THORAX CONFERENCE BR	55	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53644	10.1371/journal.pone.0053644	http://dx.doi.org/10.1371/journal.pone.0053644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372662	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400006
J	Otegui, J; Arino, AH; Encinas, MA; Pando, F				Otegui, Javier; Arino, Arturo H.; Encinas, Maria A.; Pando, Francisco			Assessing the Primary Data Hosted by the Spanish Node of the Global Biodiversity Information Facility (GBIF)	PLOS ONE			English	Article							DIVERSITY; CONSERVATION; PREDICTIONS; INDEX	In order to effectively understand and cope with the current 'biodiversity crisis', having large-enough sets of qualified data is necessary. Information facilitators such as the Global Biodiversity Information Facility (GBIF) are ensuring increasing availability of primary biodiversity records by linking data collections spread over several institutions that have agreed to publish their data in a common access schema. We have assessed the primary records that one such publisher, the Spanish node of GBIF (GBIF. ES), hosts on behalf of a number of institutions, considered to be a highly representative sample of the total mass of available data for a country in order to know the quantity and quality of the information made available. Our results may provide an indication of the overall fitness-for-use in these data. We have found a number of patterns in the availability and accrual of data that seem to arise naturally from the digitization processes. Knowing these patterns and features may help deciding when and how these data can be used. Broadly, the error level seems low. The available data may be of capital importance for the development of biodiversity research, both locally and globally. However, wide swaths of records lack data elements such as georeferencing or taxonomical levels. Although the remaining information is ample and fit for many uses, improving the completeness of the records would likely increase the usability span for these data.	[Otegui, Javier; Arino, Arturo H.] Univ Navarra, Dept Zool & Ecol, Navarra, Spain; [Encinas, Maria A.; Pando, Francisco] Unidad Coordinac Infraestruct Mundial Informac Bi, Madrid, Spain	University of Navarra	Otegui, J (corresponding author), Univ Navarra, Dept Zool & Ecol, Navarra, Spain.	javier.otegui@gmail.com	Otegui, Javier/B-3973-2012; Arino, Arturo H./A-2262-2012	Otegui, Javier/0000-0002-8997-3559; Arino, Arturo H./0000-0003-4620-6445	'Friends of the University of Navarra' Association	'Friends of the University of Navarra' Association	JO has received financial support of the 'Friends of the University of Navarra' Association (http://www.unav.es/servicio/amigos/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, GLOBAL BIODIVERSITY; Arino AH, 2008, P TDWG, P77; Arino AH, 2005, DIGITAL IMAGING BIOL, P87; Arino AH, 2009, METAANALISIS DATOS B; Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Arino AH, 2006, P TDWG 2006, P84; Berendsohn WG, 2010, BIODIVERSITY INFORM, V7, P67, DOI [10.1016/j.ppees.2012.10.002, DOI 10.17161/BI.V7I2.3989]; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; BISBY FA, 2011, SPECIES 2000 ITIS CA; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Canhos V.P., 2004, Biodiversity Informatics, V1, P1; Chapman AD, 2004, ENV DAT QUALITY; Chapman AD, 2006, GLOBAL BIODIVERSITY; Chavan V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S2; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Encinas MA, 2010, ANALISIS COMP DATOS; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Global Biodiversity Information Facility, 2006, TERMS REF PART NOD M; Global Biodiversity Information Facility, 2006, MEM UND; Guralnick R, 2009, BIOINFORMATICS, V25, P421, DOI 10.1093/bioinformatics/btn659; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; Hill AW, 2011, GBIF POSITION PAPER; Ingwersen P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-S3; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson NF, 2007, ANNU REV ENTOMOL, V52, P421, DOI 10.1146/annurev.ento.52.110405.091259; Kent R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025440; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; Lira-Noriega A, 2007, DIVERS DISTRIB, V13, P185, DOI 10.1111/j.1472-4642.2006.00304.x; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Otegui J, 2009, E BIOSPH C BIOD INF; Otegui J, BIODIVERSIT IN PRESS; Otegui J, 2009, P TDWG 2009, P31; Palmer CL, 2007, 3 INT DIG CUR C 11 1; Pando F, 2011, 2011 GBIF SCI S ARG; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Sarkar IN, 2007, BRIEF BIOINFORM, V8, P347, DOI 10.1093/bib/bbm037; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Telenius A, 2011, NORD J BOT, V29, P378, DOI 10.1111/j.1756-1051.2011.01167.x; Valdecasas AG, 2003, BIODIVERS CONSERV, V12, P1113, DOI 10.1023/A:1023082606162; Wieczorek J, 2004, INT J GEOGR INF SCI, V18, P745, DOI 10.1080/13658810412331280211; Wilson E.O., 1988, P3; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124	44	27	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55144	10.1371/journal.pone.0055144	http://dx.doi.org/10.1371/journal.pone.0055144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372828	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400069
J	Welzen-Coppens, JMC; van Helden-Meeuwsen, CG; Leenen, PJM; Drexhage, HA; Versnel, MA				Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Leenen, Pieter J. M.; Drexhage, Hemmo A.; Versnel, Marjan A.			The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis	PLOS ONE			English	Article							NONOBESE DIABETIC MOUSE; T-CELL; INTERFERON-ALPHA; AUTOIMMUNE-DISEASES; CXCR3 LIGANDS; I INTERFERON; SIGLEC-H; MICE; MACROPHAGES; RECEPTOR	In non-obese diabetic (NOD) mice that spontaneously develop autoimmune diabetes, plasmacytoid dendritic cells (pDCs) have a diabetes-promoting role through IFN-alpha production on one hand, while a diabetes-inhibiting role through indoleamine 2,3-dioxygenase (IDO) production on the other. Little is known about the kinetics and phenotype of pDCs in the NOD pancreas during the development of autoimmune diabetes. While para/peri-insular accumulation of conventional dendritic cells (cDCs) could be observed from 4 weeks of age onwards in NOD mice, pDCs only started to accumulate around the islets of Langerhans from 10 weeks onwards, which is concomitant with the influx of lymphocytes. NOD pancreatic pDCs showed a tolerogenic phenotype as assessed by their high expression of IDO and non-detectable levels of IFN-alpha and MxA. Furthermore, expression of the pDC-attracting chemokines CXCL10 and CXCL12 was significantly increased in the NOD pancreas at 10 weeks and the circulating pDC numbers were increased at 4 and 10 weeks. Our data suggest that a simultaneous accumulation of IDO+ pDCs and lymphocytes in the pancreas in 10 weeks old NOD mice, which may reflect both an immunogenic influx of T cells as well as a tolerogenic attempt to control these immunogenic T cells.	[Welzen-Coppens, Jojanneke M. C.; van Helden-Meeuwsen, Cornelia G.; Leenen, Pieter J. M.; Drexhage, Hemmo A.; Versnel, Marjan A.] Erasmus MC Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Welzen-Coppens, JMC (corresponding author), Erasmus MC Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands.	j.coppens@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013	Leenen, Pieter JM/0000-0001-9860-2920	Juvenile Diabetes Research Foundation [5-2006-31]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The authors would like to thank the Juvenile Diabetes Research Foundation for supporting this study, grant number 5-2006-31 (http://www.jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bouma G, 2005, EUR J IMMUNOL, V35, P2386, DOI 10.1002/eji.200526251; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Chen XQ, 2008, CLIN IMMUNOL, V129, P413, DOI 10.1016/j.clim.2008.08.013; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Fox CJ, 1998, DIABETES, V47, P331, DOI 10.2337/diabetes.47.3.331; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Hinkmann C, 2008, HORM METAB RES, V40, P767, DOI 10.1055/s-2008-1080896; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; LEITER EH, 1987, AM J PATHOL, V128, P380; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Nikolic T, 2005, LAB INVEST, V85, P487, DOI 10.1038/labinvest.3700238; Nikolic T, 2009, IMMUNOBIOLOGY, V214, P791, DOI 10.1016/j.imbio.2009.06.002; REDDY S, 1995, PANCREAS, V11, P16, DOI 10.1097/00006676-199507000-00002; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; Rosmalen JGM, 2002, TRENDS ENDOCRIN MET, V13, P209, DOI 10.1016/S1043-2760(02)00600-8; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; SIGNORE A, 1989, DIABETOLOGIA, V32, P282, DOI 10.1007/BF00265543; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Welzen-Coppens JM, 2012, EUR J IMMUNOL; Wildenberg ME, 2008, EUR J IMMUNOL, V38, P2024, DOI 10.1002/eji.200738008; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	36	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55071	10.1371/journal.pone.0055071	http://dx.doi.org/10.1371/journal.pone.0055071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372814	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400057
J	Bi, SD; Meng, J; McLean, S; Wu, WY; Ni, XJ; Ye, J				Bi, Shundong; Meng, Jin; McLean, Sarah; Wu, Wenyu; Ni, Xijun; Ye, Jie			A New Genus of Aplodontid Rodent (Mammalia, Rodentia) from the Late Oligocene of Northern Junggar Basin, China	PLOS ONE			English	Article							PHYLOGENY; MIOCENE	A new genus and species of aplodontid rodent, Proansomys dureensis, from the late Oligocene of the northern Junggar Basin of China is described. The new genus is referred to as Ansomyinae because the ectoloph on the upper cheek teeth, although not fully crested, has attained the same characteristic bucket-handle-shaped configuration as other members of the subfamily. It represents the earliest record of the subfamily yet discovered in Asia and is more plesiomorphic than species of the genus Ansomys in having a partly crested ectoloph, a lower degree of lophodonty, and less complex tooth basins (lacking accessory lophules). Proansomys has transitional features between Prosciurus and Ansomys, suggesting that the Ansomyinae derived from a group of aplodontids related to Prosciurus, as did other advanced aplodontid rodents. This provides new light on the paleobiogeography of the Ansomyinae.	[Bi, Shundong; Wu, Wenyu; Ni, Xijun; Ye, Jie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Bi, Shundong; McLean, Sarah] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; American Museum of Natural History (AMNH)	Bi, SD (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	sbi@iup.edu			Chinese Academy of Sciences (CAS) Key Project [XDB03020500]; National Nature Science Foundation of China [KA212201]; CAS 100-Talent Project; CAS Fossil Excavation and Preparation Fund; American Museum of Natural History	Chinese Academy of Sciences (CAS) Key Project; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS 100-Talent Project; CAS Fossil Excavation and Preparation Fund; American Museum of Natural History	This research has been funded by the Chinese Academy of Sciences (CAS) Key Project (XDB03020500), the National Nature Science Foundation of China (KA212201), the CAS 100-Talent Project, and the CAS Fossil Excavation and Preparation Fund. Meng is also supported by funds from the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hopkins SSB, 2008, ZOOL J LINN SOC-LOND, V153, P769, DOI 10.1111/j.1096-3642.2008.00399.x; Hopkins SSB, 2004, J PALEONTOL, V78, P731, DOI 10.1666/0022-3360(2004)078<0731:PABOTG>2.0.CO;2; Jie Y, 2003, B AM MUS NAT HIST, P568, DOI 10.1206/0003-0090(2003)279<0568:C>2.0.CO;2; Kelly Thomas S., 2005, Paludicola, V5, P85; KORTH W.W, 1989, J VERTEBR PALEONTOL, V9, P400; Korth WW, 2007, J VERTEBR PALEONTOL, V27, P740, DOI 10.1671/0272-4634(2007)27[740:ANSOAR]2.0.CO;2; Lopatin A. V., 1997, PALAEONTOLOGICAL J, V31, P667; Meng Jin, 2006, Vertebrata Palasiatica, V44, P205; QIU ZD, 1988, VERTEBRAT PALASIATIC, V26, P50; QIU ZD, 1987, VERTEBRAT PALASIATIC, V25, P283; RENSBERGER JM, 1986, J PALEONTOL, V60, P763, DOI 10.1017/S0022336000022289; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Tong Yongsheng, 1990, Vertebrata Palasiatica, V28, P59; Wang Ban-Yue, 2005, Vertebrata Palasiatica, V43, P85; Ye Jie, 2001, Journal of Stratigraphy, V25, P283; Ye Jie, 2001, Journal of Stratigraphy, V25, P193	16	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52625	10.1371/journal.pone.0052625	http://dx.doi.org/10.1371/journal.pone.0052625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359629	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600007
J	Corina, DP; Lawyer, LA; Hauser, P; Hirshorn, E				Corina, David P.; Lawyer, Laurel A.; Hauser, Peter; Hirshorn, Elizabeth			Lexical Processing in Deaf Readers: An fMRI Investigation of Reading Proficiency	PLOS ONE			English	Article							WORD FORM AREA; ANTERIOR CINGULATE CORTEX; CEREBRAL ORGANIZATION; CHINESE CHARACTERS; PREFRONTAL CORTEX; RHYMING SKILLS; SIGN-LANGUAGE; BROCAS REGION; DUAL-ROUTE; ACTIVATION	Individuals with significant hearing loss often fail to attain competency in reading orthographic scripts which encode the sound properties of spoken language. Nevertheless, some profoundly deaf individuals do learn to read at age-appropriate levels. The question of what differentiates proficient deaf readers from less-proficient readers is poorly understood but topical, as efforts to develop appropriate and effective interventions are needed. This study uses functional magnetic resonance imaging (fMRI) to examine brain activation in deaf readers (N = 21), comparing proficient (N = 11) and less proficient (N = 10) readers' performance in a widely used test of implicit reading. Proficient deaf readers activated left inferior frontal gyrus and left middle and superior temporal gyrus in a pattern that is consistent with regions reported in hearing readers. In contrast, the less-proficient readers exhibited a pattern of response characterized by inferior and middle frontal lobe activation (right. left) which bears some similarity to areas reported in studies of logographic reading, raising the possibility that these individuals are using a qualitatively different mode of orthographic processing than is traditionally observed in hearing individuals reading sound-based scripts. The evaluation of proficient and less-proficient readers points to different modes of processing printed English words. Importantly, these preliminary findings allow us to begin to establish the impact of linguistic and educational factors on the neural systems that underlie reading achievement in profoundly deaf individuals.	[Corina, David P.; Lawyer, Laurel A.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Hauser, Peter] Rochester Inst Technol, Natl Tech Inst Deaf, Dept Res & Teacher Educ, Rochester, NY 14623 USA; [Hirshorn, Elizabeth] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	University of California System; University of California Davis; Rochester Institute of Technology; University of Rochester	Corina, DP (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.	dpcorina@ucdavis.edu			NSF Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2) [SBE-0541953]	NSF Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2)	This work was supported by NSF SBE-0541953 Gallaudet University Science of Learning Center on Visual Language and Visual Learning (VL2).	Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Allen TE, 2009, AM ANN DEAF, V154, P338, DOI 10.1353/aad.0.0109; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; [Anonymous], 1998, PEAB IND ACH TEST RE; Aparicio M, 2007, NEUROIMAGE, V35, P1303, DOI 10.1016/j.neuroimage.2006.12.046; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; CAMPBELL R, 1988, Q J EXP PSYCHOL-A, V40, P771, DOI 10.1080/14640748808402298; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chamberlain C, 2000, LANGUAGE ACQUISITION BY EYE, P221; Chamberlain C., 2008, APPL PSYCHOLINGUIST, V28, P537; Charlier BL, 2000, Q J EXP PSYCHOL-A, V53, P349, DOI 10.1080/027249800390529; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Coltheart M, 2000, BRAIN LANG, V71, P299, DOI 10.1006/brln.1999.2183; Coltheart M, 1980, DEEP DYSLEXIA, P326; Corina D, 1998, APHASIA IN ATYPICAL POPULATIONS, P261; Corina D, 2007, BRAIN RES, V1152, P111, DOI 10.1016/j.brainres.2007.03.054; Corina DP, 1999, BRAIN LANG, V69, P230, DOI 10.1006/brln.1999.2062; De Carli D, 2007, MAGN RESON IMAGING, V25, P933, DOI 10.1016/j.mri.2007.03.031; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dyer Annabella, 2003, J Deaf Stud Deaf Educ, V8, P215, DOI 10.1093/deafed/eng012; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Gizewski ER, 2005, NEUROREPORT, V16, P1913, DOI 10.1097/01.wnr.0000186592.41587.3e; Goldin-Meadow S., 2001, LEARN DISABIL RES PR, V16, P222, DOI [DOI 10.1111/0938-8982.00022, 10.1111/0938-8982.00022]; Goodman K, 1982, LANGUAGE LIT LEARNIN; HANSON VL, 1989, J SPEECH HEAR RES, V32, P2, DOI 10.1044/jshr.3201.02; HANSON VL, 1987, MEM COGNITION, V15, P199, DOI 10.3758/BF03197717; Harris M, 1998, J Deaf Stud Deaf Educ, V3, P205; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Heim S, 2008, NEUROIMAGE, V40, P1362, DOI 10.1016/j.neuroimage.2008.01.009; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hoffmeister RJ, 2000, LANGUAGE ACQUISITION BY EYE, P143; Horwitz B, 2003, NEUROPSYCHOLOGIA, V41, P1868, DOI 10.1016/S0028-3932(03)00125-8; Jones PO, 2011, CEREB CORTEX; KELLY LP, 1995, EXCEPT CHILDREN, V61, P318, DOI 10.1177/001440299506100402; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kuntze M, 1998, TOP LANG DISORD, V18, P1; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacSweeney M, 2009, BRAIN, V132, P1928, DOI 10.1093/brain/awp129; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Meschyan G, 2006, NEUROIMAGE, V29, P1135, DOI 10.1016/j.neuroimage.2005.08.055; Miller P, 1997, J SPEECH LANG HEAR R, V40, P1151, DOI 10.1044/jslhr.4005.1151; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; National Reading Panel, 2000, REP SUBG; Nelson JR, 2009, HUM BRAIN MAPP, V30, P810, DOI 10.1002/hbm.20551; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; NOLAN KA, 1983, BRAIN LANG, V20, P305, DOI 10.1016/0093-934X(83)90047-0; Olson AC, 2004, Q J EXP PSYCHOL-A, V57, P385, DOI 10.1080/02724980343000396; Padden C, 1988, DEAF AM VOICES CULTU; Patterson K. E., 1982, NORMALITY PATHOLOGY, P77; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Smith Frank, 1994, UNDERSTANDING READIN; Sterne A, 2000, J CHILD PSYCHOL PSYC, V41, P609, DOI 10.1111/1469-7610.00648; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tham WWP, 2005, NEUROIMAGE, V28, P579, DOI 10.1016/j.neuroimage.2005.06.057; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Torgesen JK, 1999, J EDUC PSYCHOL, V91, P579, DOI 10.1037/0022-0663.91.4.579; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner RK, 2006, HDB PSYCHOLINGUISTIC; Wang Y, 2008, AM ANN DEAF, V153, P396; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	86	23	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54696	10.1371/journal.pone.0054696	http://dx.doi.org/10.1371/journal.pone.0054696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359269	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600095
J	Gallet, M; Saidi, S; Hay, E; Photsavang, J; Marty, C; Sailland, J; Carnesecchi, J; Tribollet, V; Barenton, B; Forcet, C; Birling, MC; Sorg, T; Chassande, O; Cohen-Solal, M; Vanacker, JM				Gallet, Marlene; Saidi, Soraya; Hay, Eric; Photsavang, Johann; Marty, Caroline; Sailland, Juliette; Carnesecchi, Julie; Tribollet, Violaine; Barenton, Bruno; Forcet, Christelle; Birling, Marie-Christine; Sorg, Tania; Chassande, Olivier; Cohen-Solal, Martine; Vanacker, Jean-Marc			Repression of Osteoblast Maturation by ERR alpha Accounts for Bone Loss Induced by Estrogen Deficiency	PLOS ONE			English	Article							BREAST-CANCER CELLS; RECEPTOR-ALPHA; DIFFERENTIATION; ORPHAN; EXPRESSION; RISK; PROLIFERATION; OSTEOPOROSIS; ACTIVATION; PROMOTER	ERR alpha is an orphan member of the nuclear receptor family, the complete inactivation of which confers resistance to bone loss induced by ageing and estrogen withdrawal to female mice in correlation with increased bone formation in vivo. Furthermore ERR alpha negatively regulates the commitment of mesenchymal cells to the osteoblast lineage ex vivo as well as later steps of osteoblast maturation. We searched to determine whether the activities of ERR alpha on osteoblast maturation are responsible for one or both types of in vivo induced bone loss. To this end we have generated conditional knock out mice in which the receptor is normally present during early osteoblast differentiation but inactivated upon osteoblast maturation. Bone ageing in these animals was similar to that observed for control animals. In contrast conditional ERR alpha KO mice were completely resistant to bone loss induced by ovariectomy. We conclude that the late (maturation), but not early (commitment), negative effects of ERR alpha on the osteoblast lineage contribute to the reduced bone mineral density observed upon estrogen deficiency.	[Gallet, Marlene; Sailland, Juliette; Carnesecchi, Julie; Tribollet, Violaine; Barenton, Bruno; Forcet, Christelle; Vanacker, Jean-Marc] Univ Lyon, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, Lyon, France; [Saidi, Soraya; Hay, Eric; Marty, Caroline; Cohen-Solal, Martine] Hop Lariboisiere, INSERM, U606, F-75475 Paris, France; [Photsavang, Johann; Chassande, Olivier] INSERM, U1026, Bordeaux, France; [Birling, Marie-Christine; Sorg, Tania] Inst Clin Souris, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanacker, JM (corresponding author), Univ Lyon, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Chassande, Olivier/J-3582-2015; Cohen-Solal, Martine/P-7808-2017	Hay, Eric/0000-0002-0131-9983; Birling, Marie-Christine/0000-0002-3372-8108; Cohen-Solal, Martine/0000-0002-8582-8258; Carnesecchi, Julie/0000-0002-3872-2215	Agence Nationale de la Recherche [ANR-GENOPAT-012]; Ligue contre le Cancer (comite Rhone); Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue contre le Cancer (comite Rhone)(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de la Recherche (grant ANR-GENOPAT-012), Ligue contre le Cancer (comite Rhone) and Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Auld KL, 2012, J MOL ENDOCRINOL, V48, P177, DOI 10.1530/JME-11-0140; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; Collins JA, 2005, HUM REPROD UPDATE, V11, P545, DOI 10.1093/humupd/dmi028; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Gallet M, 2010, TRENDS ENDOCRIN MET, V21, P637, DOI 10.1016/j.tem.2010.06.008; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Horwitz KB, 2008, MOL ENDOCRINOL, V22, P2743, DOI 10.1210/me.2008-0291; Ijichi N, 2007, BIOCHEM BIOPH RES CO, V358, P813, DOI 10.1016/j.bbrc.2007.04.209; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Macari C, 2010, MOL CELL ENDOCRINOL, V330, P33, DOI 10.1016/j.mce.2010.08.003; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Vico L, 2010, OSTEOPOROSIS INT, V21, P365, DOI 10.1007/s00198-009-0963-5; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	36	16	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54837	10.1371/journal.pone.0054837	http://dx.doi.org/10.1371/journal.pone.0054837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359549	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600119
J	Jain, S; Chodisetti, SB; Agrewala, JN				Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.			Combinatorial Signaling through TLR-2 and CD86 Augments Activation and Differentiation of Resting B Cells	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; ANTIGEN RECEPTOR; DENDRITIC CELLS; CUTTING EDGE; T-CELLS; STIMULATION; PROLIFERATION; B7-2; CD40	B cells are an integral component in mounting humoral immune responses and they are also crucial in programming T cell mediated immunity. Usually, B cell activation is initiated by recognition of antigen through B cell receptor (BCR), followed by its processing and presentation to T cells. But very little is known about BCR independent activation of B cells. Now, there is an increasing body of evidence indicating the combinatorial effect of innate and adaptive immune components in modulating the functions of B cells. In this study, we demonstrate the activation of resting B cells (RB) by simultaneous involvement of Toll like Receptor-2 (TLR-2) and costimulatory molecule, CD86. Interestingly, these B cells exhibited significant level of activation and proliferation. Furthermore, this process of activation leads to the differentiation of RB cells, preferably into marginal zone precursors (CD19(+)IgD(hi)IgM(hi)CD21/35(hi)CD23(hi)) in a shorter time window and showed increased secretion of IgG isotype. These RB cells also showed enhanced antigen uptake capacity. These observations were also substantiated by microarray gene expression results, which strengthen the notion that combinatorial signaling through innate and adaptive immune components enhances B cell mediated immune response. Thus, the present study elucidates a novel BCR independent B cell activation mechanism that links TLR-2 and CD86. Hence signaling of TLRs in conjunction with costimulatory molecules will substantially help in bolstering humoral immune response, which can be extrapolated to formulate vaccination strategies for diseases involving B cell-mediated immunity.	[Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.] Council Sci & Ind Research Inst Microbial Technol, Immunol Lab, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Agrewala, JN (corresponding author), Council Sci & Ind Research Inst Microbial Technol, Immunol Lab, Chandigarh, India.	javed@imtech.res.in	Jain, Shweta/I-4139-2019; Chodisetti, Sathi Babu/H-3239-2018; Agrewala, Javed Naim/AAS-8449-2021	Jain, Shweta/0000-0001-6297-0078; Chodisetti, Sathi Babu/0000-0001-7473-9420; 	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This project was supported by Council of Scientific and Industrial Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank K Ganesan for useful discussions concerning microarray experiments. We acknowledge Uthaman Gowthaman and Nargis Khan for helping in the preparation of the manuscript. We are also thankful to animal house facilities of National Institute of Immunology, New Delhi; National Institute of Pharmaceutical Education and Research, Mohali and National Institute of Nutrition, Hyderabad, India for providing the experimental mice. SJ and SBC are recipients of research fellowships from Council of Scientific and Industrial Research (CSIR), New Delhi, India	Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Fillatreau S, 2006, EUR J IMMUNOL, V36, P798, DOI 10.1002/eji.200636040; HAN SH, 1995, J IMMUNOL, V155, P556; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Haxhinasto SA, 2004, J BIOL CHEM, V279, P2575, DOI 10.1074/jbc.M310628200; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020651; Jeannin P, 1997, J BIOL CHEM, V272, P15613, DOI 10.1074/jbc.272.25.15613; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Kasprowicz DJ, 2000, J IMMUNOL, V165, P680, DOI 10.4049/jimmunol.165.2.680; Kin NW, 2007, J IMMUNOL, V179, P1516, DOI 10.4049/jimmunol.179.3.1516; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Lopes-Carvalho T, 2005, CURR OPIN IMMUNOL, V17, P244, DOI 10.1016/j.coi.2005.04.009; Manjarrez-Orduno N, 2007, EUR J IMMUNOL, V37, P358, DOI 10.1002/eji.200636453; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Podojil JR, 2005, TRENDS IMMUNOL, V26, P180, DOI 10.1016/j.it.2005.02.005; Podojil JR, 2004, J BIOL CHEM, V279, P23394, DOI 10.1074/jbc.M313096200; Podojil JR, 2003, J IMMUNOL, V170, P5143, DOI 10.4049/jimmunol.170.10.5143; Poovassery JS, 2009, J IMMUNOL, V183, P2974, DOI 10.4049/jimmunol.0900495; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; Ray A, 2004, MOL IMMUNOL, V41, P1167, DOI 10.1016/j.molimm.2004.06.007; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; SNAPPER CM, 1995, J IMMUNOL, V155, P5582; Sperling AI, 1996, J IMMUNOL, V157, P3909; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Vasilevsky S, 2008, EUR J IMMUNOL, V38, P3316, DOI 10.1002/eji.200838484; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54392	10.1371/journal.pone.0054392	http://dx.doi.org/10.1371/journal.pone.0054392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365665	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600053
J	Mangoni, AA; Zinellu, A; Carru, C; Attia, JR; McEvoy, M				Mangoni, Arduino A.; Zinellu, Angelo; Carru, Ciriaco; Attia, John R.; McEvoy, Mark			Transsulfuration Pathway Thiols and Methylated Arginines: The Hunter Community Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL CYCLE; ASYMMETRIC DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; CAPILLARY-ELECTROPHORESIS; MYOCARDIAL-INFARCTION; CORONARY-ANGIOGRAPHY; OBESE INDIVIDUALS; EMERGING ROLE	Background: Serum homocysteine, when studied singly, has been reported to be positively associated both with the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine [ADMA, via inhibition of dimethylarginine dimethylaminohydrolase (DDAH) activity] and with symmetric dimethylarginine (SDMA). We investigated combined associations between transsulfuration pathway thiols, including homocysteine, and serum ADMA and SDMA concentrations at population level. Methods: Data on clinical and demographic characteristics, medication exposure, C-reactive protein, serum ADMA and SDMA (LC-MS/MS), and thiols (homocysteine, cysteine, taurine, glutamylcysteine, total glutathione, and cysteinylglycine; capillary electrophoresis) were collected from a sample of the Hunter Community Study on human ageing [n = 498, median age (IQR) = 64 (60-70) years]. Results: Regression analysis showed that: a) age (P = 0.001), gender (P = 0.03), lower estimated glomerular filtration rate (eGFR, P = 0.08), body mass index (P = 0.008), treatment with beta-blockers (P = 0.03), homocysteine (P = 0.02), and glutamylcysteine (P = 0.003) were independently associated with higher ADMA concentrations; and b) age (P = 0.001), absence of diabetes (P = 0.001), lower body mass index (P = 0.01), lower eGFR (P < 0.001), cysteine (P = 0.007), and glutamylcysteine (P < 0.001) were independently associated with higher SDMA concentrations. No significant associations were observed between methylated arginines and either glutathione or taurine concentrations. Conclusions: After adjusting for clinical, demographic, biochemical, and pharmacological confounders the combined assessment of transsulfuration pathway thiols shows that glutamylcysteine has the strongest and positive independent associations with ADMA and SDMA. Whether this reflects a direct effect of glutamylcysteine on DDAH activity (for ADMA) and/or cationic amino acid transport requires further investigations.	[Mangoni, Arduino A.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Zinellu, Angelo; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Attia, John R.; McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of Aberdeen; University of Sassari; University of Newcastle	Mangoni, AA (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	a.a.mangoni@abdn.ac.uk	Mangoni, Arduino Aleksander/I-5109-2019; Attia, John R/F-5376-2013; Carru, Ciriaco/AAI-9996-2021	Mangoni, Arduino Aleksander/0000-0001-8699-1412; Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557; Zinellu, Angelo/0000-0002-8396-0968; Carru, Ciriaco/0000-0002-6985-4907	University of Newcastle from Strategic Initiatives Fund; University of Newcastle from Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust	University of Newcastle from Strategic Initiatives Fund; University of Newcastle from Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust	The University of Newcastle provided $300,000 from its Strategic Initiatives Fund, and $600,000 from the Gladys M Brawn Senior Research Fellowship scheme; Vincent Fairfax Family Foundation, a private philanthropic trust, provided $195,000; The Hunter Medical Research Institute provided media support during the initial recruitment of participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEAS STAT, P103; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Can A, 2011, DIABETES RES CLIN PR, V94, pE61, DOI 10.1016/j.diabres.2011.08.008; Cavusoglu E, 2010, ATHEROSCLEROSIS, V210, P226, DOI 10.1016/j.atherosclerosis.2009.10.034; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; Deneva-Koycheva Tanya I, 2011, Folia Med (Plovdiv), V53, P28; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Finkelstein JD, 2000, INT J BIOCHEM CELL B, V32, P385, DOI 10.1016/S1357-2725(99)00138-7; Fratta Pasini A, 2008, AM J HYPERTENS, V21, P1251, DOI 10.1038/ajh.2008.260; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Hong L, 2007, J BIOL CHEM, V282, P34684, DOI 10.1074/jbc.M707231200; Kandavar R, 2011, J AM SOC HYPERTENS, V5, P161, DOI 10.1016/j.jash.2010.11.003; Kelly AS, 2012, J CLIN HYPERTENS, V14, P85, DOI 10.1111/j.1751-7176.2011.00569.x; Koc F, 2010, MED SCI MONITOR, V16, pCR536; Koide S, 2003, J AM COLL CARDIOL, V41, P539, DOI 10.1016/S0735-1097(02)02866-8; Korandji C, 2007, CLIN BIOCHEM, V40, P66, DOI 10.1016/j.clinbiochem.2006.08.004; Krzyzanowska K, 2006, ATHEROSCLEROSIS, V189, P236, DOI 10.1016/j.atherosclerosis.2005.12.007; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mamatha SN, 2011, CLIN CHIM ACTA, V412, P139, DOI 10.1016/j.cca.2010.09.026; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Mangoni AA, 2011, J AM COLL CARDIOL, V58, P1034, DOI 10.1016/j.jacc.2011.05.029; Mangoni AA, 2009, ADV CLIN CHEM, V48, P73, DOI 10.1016/S0065-2423(09)48003-X; Mao DW, 2010, ARCH GYNECOL OBSTET, V282, P371, DOI 10.1007/s00404-009-1234-6; Marliss EB, 2006, DIABETOLOGIA, V49, P351, DOI 10.1007/s00125-005-0066-6; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; MEISTER A, 1974, LIFE SCI, V15, P177, DOI 10.1016/0024-3205(74)90206-9; MILLER DE, 1973, MEAS EVAL GUID, V6, P157, DOI 10.1080/00256307.1973.12022590; Nakamura YK, 2012, LIFE SCI, V90, P116, DOI 10.1016/j.lfs.2011.10.016; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Perna M, 2010, ARTHRITIS RHEUM-US, V62, P1718, DOI 10.1002/art.27392; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schutte AE, 2010, EUR J ENDOCRINOL, V162, P525, DOI 10.1530/EJE-09-0865; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Schwedhelm E, 2011, CLIN CHEM LAB MED, V49, P1907, DOI 10.1515/CCLM.2011.679; Serg M, 2011, BLOOD PRESSURE, V20, P111, DOI 10.3109/08037051.2010.533821; Simmons WW, 1996, J BIOL CHEM, V271, P11694, DOI 10.1074/jbc.271.20.11694; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Tan B, 2007, VASC PHARMACOL, V46, P338, DOI 10.1016/j.vph.2006.11.006; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Varela-Moreiras G, 2001, BIOMED PHARMACOTHER, V55, P448, DOI 10.1016/S0753-3322(01)00126-3; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Yamori Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S6; Yoo JH, 2001, ATHEROSCLEROSIS, V158, P425, DOI 10.1016/S0021-9150(01)00444-0; Zinellu A, 2003, ELECTROPHORESIS, V24, P2796, DOI 10.1002/elps.200305570; Zinellu A, 2009, AMINO ACIDS, V36, P35, DOI 10.1007/s00726-007-0022-5; Zinellu A, 2011, CLIN CHEM LAB MED, V49, P897, DOI 10.1515/CCLM.2011.121; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zsuga J, 2007, METABOLISM, V56, P394, DOI 10.1016/j.metabol.2006.10.023	59	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54870	10.1371/journal.pone.0054870	http://dx.doi.org/10.1371/journal.pone.0054870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365680	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600125
J	Tang, XQ; Fang, HR; Zhou, CF; Zhuang, YY; Zhang, P; Gu, HF; Hu, B				Tang, Xiao-Qing; Fang, Heng-Rong; Zhou, Cheng-Fang; Zhuang, Yuan-Yuan; Zhang, Ping; Gu, Hong-Feng; Hu, Bi			A Novel Mechanism of Formaldehyde Neurotoxicity: Inhibition of Hydrogen Sulfide Generation by Promoting Overproduction of Nitric Oxide	PLOS ONE			English	Article							SENSITIVE AMINE OXIDASE; CYSTATHIONINE-BETA-SYNTHASE; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; INHALED FORMALDEHYDE; PREFRONTAL CORTEX; PROTECTS NEURONS; PC12 CELLS; VITAMIN-E; HOMOCYSTEINE	Background: Formaldehyde (FA) induces neurotoxicity by overproduction of intracellular reactive oxygen species (ROS). Increasing studies have shown that hydrogen sulfide (H2S), an endogenous gastransmitter, protects nerve cells against oxidative stress by its antioxidant effect. It has been shown that overproduction of nitric oxide (NO) inhibits the activity of cystathionine-beta-synthase (CBS), the predominant H2S-generating enzyme in the central nervous system. Objective: We hypothesize that FA-caused neurotoxicity involves the deficiency of this endogenous protective antioxidant gas, which results from excessive generation of NO. The aim of this study is to evaluate whether FA disturbs H2S synthesis in PC12 cells, and whether this disturbance is associated with overproduction of NO. Principal Findings: We showed that exposure of PC12 cells to FA causes reduction of viability, inhibition of CBS expression, decrease of endogenous H2S production, and NO production. CBS silencing deteriorates FA-induced decreases in endogenous H2S generation, neurotoxicity, and intracellular ROS accumulation in PC12 cells; while ADMA, a specific inhibitor of NOS significantly attenuates FA-induced decreases in endogenous H2S generation, neurotoxicity, and intracellular ROS accumulation in PC12 cells. Conclusion/Significance: Our data indicate that FA induces neurotoxicity by inhibiting the generation of H2S through excess of NO and suggest that strategies to manipulate endogenous H2S could open a suitable novel therapeutic avenue for FA-induced neurotoxicity.	[Tang, Xiao-Qing; Fang, Heng-Rong; Zhou, Cheng-Fang; Zhuang, Yuan-Yuan; Gu, Hong-Feng; Hu, Bi] Univ S China, Dept Physiol, Coll Med, Hengyang, Hunan, Peoples R China; [Fang, Heng-Rong] Hengyang Cent Hosp, Dept Pharm, Hengyang, Hunan, Peoples R China; [Zhang, Ping] Univ S China, Dept Neurol, Nanhua Affiliated Hosp, Hengyang, Hunan, Peoples R China	University of South China; University of South China	Tang, XQ (corresponding author), Univ S China, Dept Physiol, Coll Med, Hengyang, Hunan, Peoples R China.	txq01001@gmail.com; bridgeman1025@yahoo.com.cn			National Natural Science Foundation of China [81071005, 81200985]; Natural Science Foundation of Hunan Province, China [11JJ3117]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by National Natural Science Foundation of China (81071005 and 81200985), Natural Science Foundation of Hunan Province, China (11JJ3117) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2010] 508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Ahmed S, 2007, J NEUROIMMUNOL, V186, P104, DOI 10.1016/j.jneuroim.2007.03.010; Aslan H, 2006, BRAIN RES, V1122, P191, DOI 10.1016/j.brainres.2006.09.005; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Dwyer BE, 2004, FREE RADICAL BIO MED, V36, P1471, DOI 10.1016/j.freeradbiomed.2004.03.009; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; GRIEVE A, 1992, J NEUROSCI RES, V32, P60, DOI 10.1002/jnr.490320108; Gurel A, 2005, J CHEM NEUROANAT, V29, P173, DOI 10.1016/j.jchemneu.2005.01.001; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Jiang ZJ, 2008, NEUROPATH APPL NEURO, V34, P194, DOI 10.1111/j.1365-2990.2007.00886.x; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; Kamoun P, 2003, AM J MED GENET A, V116A, P310, DOI 10.1002/ajmg.a.10847; KILBURN KH, 1987, ARCH ENVIRON HEALTH, V42, P117, DOI 10.1080/00039896.1987.9935806; KILBURN KH, 1994, ARCH ENVIRON HEALTH, V49, P37, DOI 10.1080/00039896.1994.9934412; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kovacic P, 2010, REV ENVIRON CONTAM T, V203, P119, DOI 10.1007/978-1-4419-1352-4_4; Kubo A, 2007, TOXICOLOGY, V241, P92, DOI 10.1016/j.tox.2007.08.087; Liu Y, 2010, NEUROSCIENCE, V169, P1248, DOI 10.1016/j.neuroscience.2010.05.061; Lowicka E, 2007, PHARMACOL REP, V59, P4; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; Maiese K, 2010, EXP GERONTOL, V45, P217, DOI 10.1016/j.exger.2010.01.004; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Nilsson JA, 1998, J DENT RES, V77, P1896, DOI 10.1177/00220345980770110601; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Pitten FA, 2000, PATHOL RES PRACT, V196, P193, DOI 10.1016/S0344-0338(00)80100-4; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; Songur A, 2008, TOXICOL MECH METHOD, V18, P569, DOI 10.1080/15376510701555288; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Tang XQ, 2012, NEUROCHEM INT, V61, P16, DOI 10.1016/j.neuint.2012.04.011; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; Tang XQ, 2011, NEUROTOX RES, V19, P403, DOI 10.1007/s12640-010-9180-4; Tang XQ, 2011, J MOL NEUROSCI, V45, P60, DOI 10.1007/s12031-010-9477-z; Tang XQ, 2010, NEUROSCI RES, V68, P241, DOI 10.1016/j.neures.2010.07.2039; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Unzeta M, 2007, J NEURAL TRANSM, V114, P857, DOI 10.1007/s00702-007-0701-0; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yin WL, 2009, LIFE SCI, V85, P269, DOI 10.1016/j.lfs.2009.05.023; Yu PH, 2001, MED HYPOTHESES, V57, P175, DOI 10.1054/mehy.2001.1329; Zararsiz I, 2007, CELL BIOCHEM FUNCT, V25, P413, DOI 10.1002/cbf.1315; Zararsiz I, 2006, CELL BIOCHEM FUNCT, V24, P237, DOI 10.1002/cbf.1204; Zhou DX, 2006, ASIAN J ANDROL, V8, P584, DOI 10.1111/j.1745-7262.2006.00198.x	55	26	29	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54829	10.1371/journal.pone.0054829	http://dx.doi.org/10.1371/journal.pone.0054829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359814	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600118
J	Tay, Z; Eng, RJ; Sajiki, K; Lim, KK; Tang, MY; Yanagida, M; Chen, ES				Tay, Zoey; Eng, Ru Jun; Sajiki, Kenichi; Lim, Kim Kiat; Tang, Ming Yi; Yanagida, Mitsuhiro; Chen, Ee Sin			Cellular Robustness Conferred by Genetic Crosstalk Underlies Resistance against Chemotherapeutic Drug Doxorubicin in Fission Yeast	PLOS ONE			English	Article							STRAND BREAK REPAIR; MULTIDRUG-RESISTANCE; DNA TOPOISOMERASES; COENZYME Q(10); INCREASE; ROLES; ANTICANCER; PROTECTION; COMPLEXES; POMBE	Doxorubicin is an anthracycline antibiotic that is among one of the most commonly used chemotherapeutic agents in the clinical setting. The usage of doxorubicin is faced with many problems including severe side effects and chemoresistance. To overcome these challenges, it is important to gain an understanding of the underlying molecular mechanisms with regards to the mode of action of doxorubicin. To facilitate this aim, we identified the genes that are required for doxorubicin resistance in the fission yeast Schizosaccharomyces pombe. We further demonstrated interplay between factors controlling various aspects of chromosome metabolism, mitochondrial respiration and membrane transport. In the nucleus we observed that the subunits of the Ino80, RSC, and SAGA complexes function in the similar epistatic group that shares significant overlap with the homologous recombination genes. However, these factors generally act in synergistic manner with the chromosome segregation regulator DASH complex proteins, possibly forming two major arms for regulating doxorubicin resistance in the nucleus. Simultaneous disruption of genes function in membrane efflux transport or the mitochondrial respiratory chain integrity in the mutants defective in either Ino80 or HR function resulted in cumulative upregulation of drug-specific growth defects, suggesting a rewiring of pathways that synergize only when the cells is exposed to the cytotoxic stress. Taken together, our work not only identified factors that are required for survival of the cells in the presence of doxorubicin but has further demonstrated that an extensive molecular crosstalk exists between these factors to robustly confer doxorubicin resistance.	[Tay, Zoey; Eng, Ru Jun; Lim, Kim Kiat; Tang, Ming Yi; Chen, Ee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Tay, Zoey; Eng, Ru Jun; Lim, Kim Kiat; Tang, Ming Yi; Chen, Ee Sin] Natl Univ Hlth Syst, Singapore, Singapore; [Sajiki, Kenichi; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan	National University of Singapore; National University of Singapore; Okinawa Institute of Science & Technology Graduate University	Chen, ES (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchces@nus.edu.sg		Tang, Richard Ming Yi/0000-0001-8038-1189; Tay, Zoey/0000-0002-6660-5980; Lim, Kim Kiat/0000-0003-0340-5903	National University of Singapore; Ministry of Education, Tier I	National University of Singapore(National University of Singapore); Ministry of Education, Tier I	Start up grant awarded to ESC from National University of Singapore. Ministry of Education, Tier I fund awarded to ESC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2013, MED RES REV, V33, P33, DOI 10.1002/med.20244; Baguley BC, 2010, METHODS MOL BIOL, V596, P1, DOI 10.1007/978-1-60761-416-6_1; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bilardi RA, 2012, BIOCHEM PHARMACOL, V83, P1241, DOI 10.1016/j.bcp.2012.01.029; Brea-Calvo G, 2006, FREE RADICAL BIO MED, V40, P1293, DOI 10.1016/j.freeradbiomed.2005.11.014; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Cavero S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001138; Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Hanusova V, 2011, DRUG METAB REV, V43, P540, DOI 10.3109/03602532.2011.609174; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Khasanov FK, 1999, GENETICS, V152, P1557; Kitano H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.40; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Raji H, 2006, YEAST, V23, P963, DOI 10.1002/yea.1414; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szalay MS, 2007, FEBS LETT, V581, P3675, DOI 10.1016/j.febslet.2007.03.083; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399	33	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55041	10.1371/journal.pone.0055041	http://dx.doi.org/10.1371/journal.pone.0055041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365689	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600146
J	Wang, L; Hu, XB; Zhang, W; Di Wu, L; Liu, YS; Hu, B; Bi, CL; Chen, YF; Liu, XX; Ge, C; Zhang, Y; Zhang, M				Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei			Dickkopf-1 as a Novel Predictor Is Associated with Risk Stratification by GRACE Risk Scores for Predictive Value in Patients with Acute Coronary Syndrome: A Retrospective Research	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GLOBAL REGISTRY; FOLLOW-UP; ATHEROSCLEROSIS; INFLAMMATION; EVENTS; BIOMARKERS; MORTALITY; DEATH; PERFORMANCE	Objective: Dickkopf-1 (DKK-1), a major regulator of the Wnt pathway, plays an important role in cardiovascular disease. However, no study has evaluated the association of DKK-1 and acute coronary syndrome (ACS). We investigated this association and whether the Global Registry of Acute Coronary Events (GRACE) hospital-discharge risk score predicting major adverse cardiac events (MACE) can be improved by adding the DKK-1 value. Methods: We enrolled 291 patients (46 with ST-segment elevation myocardial infarction [STEMI] and 245 with non-ST elevated ACS [NSTE-ACS]) who were divided into groups by tertiles of baseline plasma DKK-1 level measured by ELISA. The GRACE risk score was calculated and predictive value alone and together with DKK-1 and/or high-sensitivity C-reactive protein (hs-CRP) level were assessed, respectively. Results: Compared with patients with NSTE-ACS, those with STEMI had higher plasma DKK-1 level at baseline (P = 0.006). Plasma DKK-1 level was correlated with hs-CRP level (r = 0.295, P < 0.001) and was greater with high than intermediate or low GRACE scores (P = 0.002 and P < 0.001, respectively). We found 44 (15.1%) MACEs during a median 2-year follow-up. DKK-1 levels were higher for patients with than without events (P < 0.001). The rate of MACE increased with increasing DKK-1 level (P < 0.001). The area under the receiver operating characteristic curve for GRACE score with MACE was 0.524 and improved to 0.791 with the addition of hs-CRP level, 0.775 with the addition of DKK-1 level and 0.847 with both values added. Conclusions: DKK-1 is an independent predictor of long-term MACE of patients with ACS. The long-term predictive ability of post-discharge GRACE score may be enhanced by adding DKK-1 level.	[Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Wang, Lin; Hu, Xiao Bo; Zhang, Wei; Di Wu, Lin; Liu, Yu Sheng; Hu, Bo; Bi, Cheng Long; Chen, Yi Fei; Liu, Xin Xin; Ge, Cheng; Zhang, Yun; Zhang, Mei] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Hu, Xiao Bo; Hu, Bo] Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Liu, Yu Sheng] Shandong Univ, Hosp 2, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China.	daixh@vip.sina.com	Chen, Yi/HIR-2608-2022		National 973 Basic Research Program [2010CB732605, 2011CB503906]; Natural Science Foundation of China [30970709]; National 863 Hi-Tech Research and Development Program [2007AA02Z448]; Key Projects in the National Science and Technology Pillar Program from the Ministry of Science and Technology, China [2006BAI01A02]	National 973 Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program from the Ministry of Science and Technology, China	The work was supported by grants from the National 973 Basic Research Program (2010CB732605 and 2011CB503906), the Natural Science Foundation of China (30970709), National 863 Hi-Tech Research and Development Program (2007AA02Z448) and Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period (2006BAI01A02) from the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Assi E, 2010, REV ESP CARDIOL, V63, P640, DOI 10.1016/S0300-8932(10)70156-1; Beygui F, 2010, AM J CARDIOL, V106, P650, DOI 10.1016/j.amjcard.2010.04.019; D'Ascenzo F, 2012, CONTEMP CLIN TRIALS, V33, P507, DOI 10.1016/j.cct.2012.01.001; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Eggers KM, 2010, AM HEART J, V160, P88, DOI 10.1016/j.ahj.2010.05.002; Goliasch G, 2012, ATHEROSCLEROSIS, V222, P251, DOI 10.1016/j.atherosclerosis.2012.02.017; Gomceli I, 2012, HEPATO-GASTROENTEROL, V59, P1661, DOI 10.5754/hge11516; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hamm CW, 2011, J AM COLL CARDIOL, V57, P1465, DOI 10.1016/j.jacc.2010.10.044; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meune C, 2011, HEART, V97, P1479, DOI 10.1136/hrt.2010.220988; Mohlenkamp S, 2011, J AM COLL CARDIOL, V57, P1455, DOI 10.1016/j.jacc.2010.10.043; Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909; Nakamura M, 2010, J CARDIOL, V55, P69, DOI 10.1016/j.jjcc.2009.08.007; Schiele F, 2010, EUR HEART J, V31, P290, DOI 10.1093/eurheartj/ehp273; Seifert-Held T, 2011, ATHEROSCLEROSIS, V218, P233, DOI 10.1016/j.atherosclerosis.2011.05.015; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P131, DOI 10.1007/s11883-004-0102-x; Siasos G, 2012, CURR TOP MED CHEM, V12, P1132, DOI 10.2174/1568026611208011132; Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004; Trepels T, 2004, HERZ, V29, P769, DOI 10.1007/s00059-004-2637-6; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Wang SY, 2011, J RHEUMATOL, V38, P821, DOI 10.3899/jrheum.100089; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6	28	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54731	10.1371/journal.pone.0054731	http://dx.doi.org/10.1371/journal.pone.0054731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359112	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600098
J	Weigel, KM; Jones, KL; Do, JS; Witt, JM; Chung, JH; Valcke, C; Cangelosi, GA				Weigel, Kris M.; Jones, Kelly L.; Do, Julie S.; Witt, Jody Melton; Chung, Jae-Hyun; Valcke, Christian; Cangelosi, Gerard A.			Molecular Viability Testing of Bacterial Pathogens from a Complex Human Sample Matrix	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TUBERCULOSIS MESSENGER-RNA; BLOOD-STREAM INFECTIONS; REAL-TIME PCR; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; WASTE-WATER; LISTERIA-MONOCYTOGENES; PROPIDIUM MONOAZIDE; QUANTITATIVE PCR	Assays for bacterial ribosomal RNA precursors (pre-rRNA) have been shown to distinguish viable from inactivated bacterial cells in drinking water samples. Because the synthesis of pre-rRNA is rapidly induced by nutritional stimulation, viable bacteria can be distinguished from inactivated cells and free nucleic acids by measuring the production of species-specific pre-rRNA in samples that have been briefly stimulated with nutrients. Here, pre-rRNA analysis was applied to bacteria from serum, a human sample matrix. In contrast to drinking water, serum is rich in nutrients that might be expected to mask the effects of nutritional stimulation. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assays were used to detect pre-rRNA of four bacterial species: Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and the Mycobacterium tuberculosis complex. These species were chosen for their clinical significance and phylogenetic diversity (Proteobacteria, Firmicutes, and Actinobacteria). To maximize resolving power, pre-rRNA was normalized to genomic DNA of each pathogen. When viable cells were shifted from serum to bacteriological culture medium, rapid replenishment of pre-rRNA was always observed. Cells of P. aeruginosa that were inactivated in the presence of serum exhibited no pre-rRNA response to nutritional stimulation, despite strong genomic DNA signals in these samples. When semi-automated methods were used, pre-rRNA analysis detected viable A. baumannii cells in serum at densities of <= 100 CFU/mL in <5.5 hours. Originally developed for rapid microbiological analysis of drinking water, ratiometric pre-rRNA analysis can also assess the viability of bacterial cells derived from human specimens, without requiring bacteriological culture.	[Weigel, Kris M.; Jones, Kelly L.; Cangelosi, Gerard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Do, Julie S.] AttoDx Inc, Seattle, WA USA; [Witt, Jody Melton; Valcke, Christian] Novartis Diagnost, Emeryville, CA USA; [Chung, Jae-Hyun] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Novartis; University of Washington; University of Washington Seattle	Cangelosi, GA (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	gcang@uw.edu		Domesle, Kelly/0000-0003-1873-5091; Weigel, Kris/0000-0003-3199-2148	Novartis Vaccines and Diagnostics; AttoDx, Inc.; Catalysis Foundation for Health; NIDCR [R21DE021510]; NIAID [R01AI093418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021510] Funding Source: NIH RePORTER	Novartis Vaccines and Diagnostics; AttoDx, Inc.; Catalysis Foundation for Health; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by Novartis Vaccines and Diagnostics, AttoDx, Inc., the Catalysis Foundation for Health, NIDCR grant # R21DE021510, and NIAID grant # R01AI093418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Cangelosi GA, 1997, J BACTERIOL, V179, P4457, DOI 10.1128/jb.179.14.4457-4463.1997; Cangelosi GA, 2010, APPL ENVIRON MICROB, V76, P960, DOI 10.1128/AEM.01810-09; Condon C, 2001, RNA, V7, P242, DOI 10.1017/S1355838201002163; Flekna G, 2007, RES MICROBIOL, V158, P405, DOI 10.1016/j.resmic.2007.02.008; Gedalanga PB, 2009, APPL MICROBIOL BIOT, V82, P587, DOI 10.1007/s00253-008-1846-y; Gonzalez-Escalona N, 2009, APPL ENVIRON MICROB, V75, P3714, DOI 10.1128/AEM.02686-08; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kobayashi H, 2009, LETT APPL MICROBIOL, V48, P633, DOI 10.1111/j.1472-765X.2009.02585.x; Kobayashi H, 2010, J ORTHOP RES, V28, P1245, DOI 10.1002/jor.21108; Kobayashi H, 2009, DIAGN MICR INFEC DIS, V64, P445, DOI 10.1016/j.diagmicrobio.2009.04.004; Li L, 2010, J CLIN MICROBIOL, V48, P46, DOI 10.1128/JCM.01526-09; Liu YM, 2010, ANAL CHEM, V82, P2612, DOI 10.1021/ac1003272; Lu T, 2009, APPL ENVIRON MICROB, V75, P4589, DOI 10.1128/AEM.02970-08; MACKOW ER, 1985, FEBS LETT, V182, P407, DOI 10.1016/0014-5793(85)80343-4; Mdivani N, 2009, CLIN CHEM, V55, P1694, DOI 10.1373/clinchem.2009.124396; Milner MG, 2001, MICROBIOL-SGM, V147, P2689, DOI 10.1099/00221287-147-10-2689; Nanassy OZ, 2011, J CLIN MICROBIOL, V49, P1010, DOI 10.1128/JCM.01132-10; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Oerther DB, 2002, WATER SCI TECHNOL, V46, P443, DOI 10.2166/wst.2002.0514; Oerther DB, 2000, APPL ENVIRON MICROB, V66, P2154, DOI 10.1128/AEM.66.5.2154-2165.2000; Pai SR, 2000, MICROB PATHOGENESIS, V28, P335, DOI 10.1006/mpat.2000.0353; PATEL BKR, 1993, J INFECT DIS, V168, P799, DOI 10.1093/infdis/168.3.799; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354, DOI 10.1128/AEM.59.5.1354-1360.1993; Redko Y, 2008, MOL MICROBIOL, V68, P1096, DOI 10.1111/j.1365-2958.2008.06207.x; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; Stroot PG, 2003, WATER SCI TECHNOL, V47, P241, DOI 10.2166/wst.2003.0611	29	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54886	10.1371/journal.pone.0054886	http://dx.doi.org/10.1371/journal.pone.0054886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365682	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600128
J	Xu, XD; Chen, YR; Zhao, Y; Liu, XF; Dong, BT; Jones, IM; Chen, HY				Xu, Xiaodong; Chen, Yuanrong; Zhao, Yu; Liu, Xiaofen; Dong, Beitao; Jones, Ian M.; Chen, Hongying			Baculovirus Superinfection: A Probable Restriction Factor on the Surface Display of Proteins for Library Screening	PLOS ONE			English	Article							INFECTED INSECT CELLS; BINDING; GP64; INTERFERON; RECEPTORS; MIMOTOPES; DYNAMICS; KINETICS; DELIVERY; VECTORS	In addition to the expression of recombinant proteins, baculoviruses have been developed as a platform for the display of complex eukaryotic proteins on the surface of virus particles or infected insect cells. Surface display has been used extensively for antigen presentation and targeted gene delivery but is also a candidate for the display of protein libraries for molecular screening. However, although baculovirus gene libraries can be efficiently expressed and displayed on the surface of insect cells, target gene selection is inefficient probably due to super-infection which gives rise to cells expressing more than one protein. In this report baculovirus superinfection of Sf9 cells has been investigated by the use of two recombinant multiple nucleopolyhedrovirus carrying green or red fluorescent proteins under the control of both early and late promoters (vAcBacGFP and vAcBacDsRed). The reporter gene expression was detected 8 hours after the infection of vAcBacGFP and cells in early and late phases of infection could be distinguished by the fluorescence intensity of the expressed protein. Simultaneous infection with vAcBacGFP and vAcBacDsRed viruses each at 0.5 MOI resulted in 80% of infected cells co-expressing the two fluorescent proteins at 48 hours post infection (hpi), and subsequent infection with the two viruses resulted in similar co-infection rate. Most Sf9 cells were re-infectable within the first several hours post infection, but the reinfection rate then decreased to a very low level by 16 hpi. Our data demonstrate that Sf9 cells were easily super-infectable during baculovirus infection, and super-infection could occur simultaneously at the time of the primary infection or subsequently during secondary infection by progeny viruses. The efficiency of super-infection may explain the difficulties of baculovirus display library screening but would benefit the production of complex proteins requiring co-expression of multiple polypeptides.	[Xu, Xiaodong; Chen, Yuanrong; Zhao, Yu; Liu, Xiaofen; Dong, Beitao; Chen, Hongying] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Hongying] Univ Reading, Sch Biol Sci, Reading, Berks, England	Northwest A&F University - China; University of Reading	Chen, HY (corresponding author), NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	chenhy@nwsuaf.edu.cn		Chen, Hongying/0000-0001-8258-0683; Jones, Ian/0000-0002-7738-2516	Program for New Century Excellent Talents in University [NCET-09-0652]; Northwest A F University; MRC [G1000769] Funding Source: UKRI; Medical Research Council [G1000769] Funding Source: researchfish	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Northwest A F University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project is supported by Program for New Century Excellent Talents in University (NCET-09-0652), and starting research fund from Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Dee KU, 1997, BIOTECHNOL BIOENG, V54, P468, DOI 10.1002/(SICI)1097-0290(19970605)54:5<468::AID-BIT7>3.0.CO;2-C; Enden G, 2005, J THEOR BIOL, V237, P257, DOI 10.1016/j.jtbi.2005.04.013; Ernst W, 1998, NUCLEIC ACIDS RES, V26, P1718, DOI 10.1093/nar/26.7.1718; Gotoh T, 2008, J CHEM ENG JPN, V41, P804, DOI 10.1252/jcej.08we032; Grabherr R, 2001, TRENDS BIOTECHNOL, V19, P231, DOI 10.1016/S0167-7799(01)01610-9; Harel HYM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-64; Hericourt F, 2000, BIOCHEM J, V349, P417, DOI 10.1042/0264-6021:3490417; Hitchman Richard B, 2009, Recent Pat Biotechnol, V3, P46; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Hu YC, 2008, EXPERT REV VACCINES, V7, P363, DOI 10.1586/14760584.7.3.363; JAMES DC, 1995, BIO-TECHNOL, V13, P592, DOI 10.1038/nbt0695-592; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; LICARI P, 1992, BIOTECHNOL BIOENG, V39, P432, DOI 10.1002/bit.260390409; Makela AR, 2008, COMB CHEM HIGH T SCR, V11, P86, DOI 10.2174/138620708783744525; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Mena JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-39; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Sokolenko S, 2012, BIOTECHNOL ADV, V30, P766, DOI 10.1016/j.biotechadv.2012.01.009; VOLKMAN L.E., 1990, SEMIN VIROL, V1, P249; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Westenberg M, 2008, J GEN VIROL, V89, P424, DOI 10.1099/vir.0.83342-0; Westenberg M, 2007, J GEN VIROL, V88, P3302, DOI 10.1099/vir.0.83240-0; WICKHAM TJ, 1990, BIOPHYS J, V58, P1501, DOI 10.1016/S0006-3495(90)82495-4; WU SC, 1994, BIOTECHNOL PROGR, V10, P55, DOI 10.1021/bp00025a006; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	29	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54631	10.1371/journal.pone.0054631	http://dx.doi.org/10.1371/journal.pone.0054631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365677	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000314023600082
J	Bommarius, B; Anyanful, A; Izrayelit, Y; Bhatt, S; Cartwright, E; Wang, W; Swimm, AI; Benian, GM; Schroeder, FC; Kalman, D				Bommarius, Bettina; Anyanful, Akwasi; Izrayelit, Yevgeniy; Bhatt, Shantanu; Cartwright, Emily; Wang, Wei; Swimm, Alyson I.; Benian, Guy M.; Schroeder, Frank C.; Kalman, Daniel			A Family of Indoles Regulate Virulence and Shiga Toxin Production in Pathogenic E. coli	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; FORM ACTIN PEDESTALS; III SECRETION SYSTEM; CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; CITROBACTER-RODENTIUM; INNATE IMMUNITY; EXPRESSION; SIGNAL; 2,3-DIOXYGENASE	Enteropathogenic Escherichia coli (EPEC), enterohemorrhagic E. coli (EHEC) and enteroaggregative E. coli (EAEC) are intestinal pathogens that cause food and water-borne disease in humans. Using biochemical methods and NMR-based comparative metabolomics in conjunction with the nematode Caenorhabditis elegans, we developed a bioassay to identify secreted small molecules produced by these pathogens. We identified indole, indole-3-carboxaldehyde (ICA), and indole-3-acetic acid (IAA), as factors that only in combination are sufficient to kill C. elegans. Importantly, although lethal to C. elegans, these molecules downregulate several bacterial processes important for pathogenesis in mammals. These include motility, biofilm formation and production of Shiga toxins. Some pathogenic E. coli strains are known to contain a Locus of Enterocyte Effacement (LEE), which encodes virulence factors that cause "attaching and effacing" (A/E) lesions in mammals, including formation of actin pedestals. We found that these indole derivatives also downregulate production of LEE virulence factors and inhibit pedestal formation on mammalian cells. Finally, upon oral administration, ICA inhibited virulence and promoted survival in a lethal mouse infection model. In summary, the C. elegans model in conjunction with metabolomics has facilitated identification of a family of indole derivatives that broadly regulate physiology in E. coli, and virulence in pathogenic strains. These molecules may enable development of new therapeutics that interfere with bacterial small-molecule signaling.	[Bommarius, Bettina; Anyanful, Akwasi; Wang, Wei; Swimm, Alyson I.; Benian, Guy M.; Kalman, Daniel] Emory Univ, Dept Lab Med & Pathol, Atlanta, GA 30322 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Bhatt, Shantanu] Emory Univ, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Cartwright, Emily] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	Emory University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Emory University; Emory University	Kalman, D (corresponding author), Emory Univ, Dept Lab Med & Pathol, Atlanta, GA 30322 USA.	dkalman@emory.edu	Bhatt, Shantanu/AAB-9405-2020; Swimm, Alyson/D-1025-2013	Swimm, Alyson/0000-0001-9975-0247; Bommarius, Bettina/0000-0002-1283-0218; Schroeder, Frank/0000-0002-4420-0237	National Institutes of Health [R01-A107246201, R01-AI056067, R01-GM088290, T32GM008500]; Vassar College Mary Landon Sague Fellowship; Bio-Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vassar College Mary Landon Sague Fellowship; Bio-Merieux Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01-A107246201 and R01-AI056067 to D. K., R01-GM088290 to F. S., and T32GM008500 to Y. I.), Vassar College Mary Landon Sague Fellowship (to Y. I.), and a grant from the Bio-Merieux Foundation (to D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bhatt S, 2011, J BACTERIOL, V193, P4516, DOI 10.1128/JB.05197-11; Bhatt S, 2009, INFECT IMMUN, V77, P3552, DOI 10.1128/IAI.00418-09; BRENNER S, 1974, GENETICS, V77, P71; Clarke SC, 2002, BRIT J BIOMED SCI, V59, P123, DOI 10.1080/09674845.2002.11783647; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Denamur E, 2011, CLIN MICROBIOL INFEC, V17, P1124, DOI 10.1111/j.1469-0691.2011.03620.x; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Feng P, 2001, J CLIN MICROBIOL, V39, P24, DOI 10.1128/JCM.39.1.24-28.2001; Forseth RR, 2011, CURR OPIN CHEM BIOL, V15, P38, DOI 10.1016/j.cbpa.2010.10.010; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kuczynska-Wisnik D, 2010, RES MICROBIOL, V161, P847, DOI 10.1016/j.resmic.2010.09.012; Kuczynska-Wisnik D, 2010, MICROBIOL-SGM, V156, P148, DOI 10.1099/mic.0.032334-0; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lambrecht M, 2000, TRENDS MICROBIOL, V8, P298, DOI 10.1016/S0966-842X(00)01732-7; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Mattmann ME, 2010, J ORG CHEM, V75, P6737, DOI 10.1021/jo101237e; McClay K, 2005, APPL ENVIRON MICROB, V71, P5476, DOI 10.1128/AEM.71.9.5476-5483.2005; Mellies JL, 2010, TRENDS MICROBIOL, V18, P448, DOI 10.1016/j.tim.2010.07.002; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Partridge FA, 2010, DEV DYNAM, V239, P1330, DOI 10.1002/dvdy.22232; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Shen DK, 2008, MICROBIOL-SGM, V154, P2195, DOI 10.1099/mic.0.2007/013680-0; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wei OL, 2005, INFECT IMMUN, V73, P1978, DOI 10.1128/IAI.73.4.1978-1985.2005; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	53	61	64	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54456	10.1371/journal.pone.0054456	http://dx.doi.org/10.1371/journal.pone.0054456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372726	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500073
J	Kim, HS; Hwang, YC; Koo, SH; Park, KS; Lee, MS; Kim, KW; Lee, MK				Kim, Hyo-Sup; Hwang, You-Cheol; Koo, Seung-Hoi; Park, Kyong Soo; Lee, Myung-Shik; Kim, Kwang-Won; Lee, Moon-Kyu			PPAR-gamma Activation Increases Insulin Secretion through the Up-regulation of the Free Fatty Acid Receptor GPR40 in Pancreatic beta-Cells	PLOS ONE			English	Article							PEROXISOME-PROLIFERATOR; METABOLIC DISEASE; RESPONSE ELEMENT; GENE-EXPRESSION; PROTEIN-KINASE; DIABETIC MICE; IN-VIVO; ROSIGLITAZONE; TROGLITAZONE; RELEASE	Background: It has been reported that peroxisome proliferator-activated receptor (PPAR)-gamma and their synthetic ligands have direct effects on pancreatic beta-cells. We investigated whether PPAR-gamma activation stimulates insulin secretion through the up-regulation of GPR40 in pancreatic beta-cells. Methods: Rat insulinoma INS-1 cells and primary rat islets were treated with rosiglitazone (RGZ) and/or adenoviral PPAR-gamma overexpression. OLETF rats were treated with RGZ. Results: PPAR-gamma activation with RGZ and/or adenoviral PPAR-gamma overexpression increased free fatty acid (FFA) receptor GPR40 expression, and increased insulin secretion and intracellular calcium mobilization, and was blocked by the PLC inhibitors, GPR40 RNA interference, and GLUT2 RNA interference. As a downstream signaling pathway of intracellular calcium mobilization, the phosphorylated levels of CaMKII and CREB, and the downstream IRS-2 and phospho-Akt were significantly increased. Despite of insulin receptor RNA interference, the levels of IRS-2 and phospho-Akt was still maintained with PPAR-gamma activation. In addition, the beta-cell specific gene expression, including Pdx-1 and FoxA2, increased in a GPR40- and GLUT2-dependent manner. The levels of GPR40, phosphorylated CaMKII and CREB, and beta-cell specific genes induced by RGZ were blocked by GW9662, a PPAR-gamma antagonist. Finally, PPAR-gamma activation up-regulated beta-cell gene expressions through FoxO1 nuclear exclusion, independent of the insulin signaling pathway. Based on immunohistochemical staining, the GLUT2, IRS-2, Pdx-1, and GPR40 were more strongly expressed in islets from RGZ-treated OLETF rats compared to control islets. Conclusion: These observations suggest that PPAR-gamma activation with RGZ and/or adenoviral overexpression increased intracellular calcium mobilization, insulin secretion, and beta-cell gene expression through GPR40 and GLUT2 gene up-regulation.	[Kim, Hyo-Sup] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Endocrinol & Metab, Seoul, South Korea; [Hwang, You-Cheol] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Seoul, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Myung-Shik; Kim, Kwang-Won; Lee, Moon-Kyu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Sungkyunkwan University (SKKU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, MK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	leemk@skku.edu	Hwang, You-Cheol/AAA-4616-2022; Koo, Seung-Hoi/E-2763-2015; Lee, Myung Shik/C-9606-2011; Park, Kyong Soo/C-2265-2008	Koo, Seung-Hoi/0000-0001-8769-2879; Park, Kyong Soo/0000-0003-3597-342X; Hwang, You-Cheol/0000-0003-4033-7874	Ministry of Health and Welfare, Republic of Korea [A080513]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by funds from the Ministry of Health and Welfare, Republic of Korea (A080513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; Bollheimer LC, 2003, J MOL ENDOCRINOL, V31, P61, DOI 10.1677/jme.0.0310061; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Gromada J, 2006, ENDOCRINOLOGY, V147, P672, DOI 10.1210/en.2005-1388; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235; Ito E, 2004, BIOCHEM BIOPH RES CO, V324, P810, DOI 10.1016/j.bbrc.2004.08.238; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kim EK, 2007, INT J BIOCHEM CELL B, V39, P1260, DOI 10.1016/j.biocel.2007.04.005; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2008, BIOCHEM BIOPH RES CO, V367, P623, DOI 10.1016/j.bbrc.2007.12.192; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Nakamichi Y, 2003, BIOCHEM BIOPH RES CO, V306, P832, DOI 10.1016/S0006-291X(03)01045-3; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Richardson H, 2006, DIABETOLOGIA, V49, P685, DOI 10.1007/s00125-006-0155-1; Santini E, 2004, DIABETES, V53, pS79, DOI 10.2337/diabetes.53.suppl_3.S79; Schinner S, 2009, BRIT J PHARMACOL, V157, P736, DOI 10.1111/j.1476-5381.2009.00208.x; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tomita T, 2006, DIABETOLOGIA, V49, P962, DOI 10.1007/s00125-006-0193-8; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Wang X, 2007, LIFE SCI, V81, P160, DOI 10.1016/j.lfs.2007.04.034; Wu PW, 2010, BIOCHEM BIOPH RES CO, V403, P36, DOI 10.1016/j.bbrc.2010.10.105; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Zhao YF, 2008, J ENDOCRINOL, V198, P533, DOI 10.1677/JOE-08-0105	51	71	72	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50128	10.1371/journal.pone.0050128	http://dx.doi.org/10.1371/journal.pone.0050128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372643	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500003
J	Neal, ML; Trister, AD; Cloke, T; Sodt, R; Ahn, S; Baldock, AL; Bridge, CA; Lai, A; Cloughesy, TF; Mrugala, MM; Rockhill, JK; Rockne, RC; Swanson, KR				Neal, Maxwell Lewis; Trister, Andrew D.; Cloke, Tyler; Sodt, Rita; Ahn, Sunyoung; Baldock, Anne L.; Bridge, Carly A.; Lai, Albert; Cloughesy, Timothy F.; Mrugala, Maciej M.; Rockhill, Jason K.; Rockne, Russell C.; Swanson, Kristin R.			Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric	PLOS ONE			English	Article							INDIVIDUAL PATIENTS; GLIOMA GROWTH; CRITERIA; PSEUDOPROGRESSION; PSEUDORESPONSE; PROLIFERATION; RADIOTHERAPY; INVASION; QUANTIFY; TUMORS	Accurate clinical assessment of a patient's response to treatment for glioblastoma multiforme (GBM), the most malignant type of primary brain tumor, is undermined by the wide patient-to-patient variability in GBM dynamics and responsiveness to therapy. Using computational models that account for the unique geometry and kinetics of individual patients' tumors, we developed a method for assessing treatment response that discriminates progression-free and overall survival following therapy for GBM. Applying these models as untreated virtual controls, we generate a patient-specific "Days Gained'' response metric that estimates the number of days a therapy delayed imageable tumor progression. We assessed treatment response in terms of Days Gained scores for 33 patients at the time of their first MRI scan following first-line radiation therapy. Based on Kaplan-Meier analyses, patients with Days Gained scores of 100 or more had improved progression-free survival, and patients with scores of 117 or more had improved overall survival. Our results demonstrate that the Days Gained response metric calculated at the routinely acquired first post-radiation treatment time point provides prognostic information regarding progression and survival outcomes. Applied prospectively, our model-based approach has the potential to improve GBM treatment by accounting for patient-to-patient heterogeneity in GBM dynamics and responses to therapy.	[Neal, Maxwell Lewis; Cloke, Tyler; Sodt, Rita; Ahn, Sunyoung; Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Trister, Andrew D.; Rockhill, Jason K.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA; [Baldock, Anne L.; Bridge, Carly A.; Rockne, Russell C.; Swanson, Kristin R.] NW Brain Tumor Inst, Chicago, IL USA; [Lai, Albert; Cloughesy, Timothy F.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mrugala, Maciej M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Swanson, Kristin R.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Swanson, Kristin R.] Univ Washington, Nancy & Buster Alvord Brain Tumor Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Northwestern University; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Neal, ML (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	mneal@uw.edu; Kristin.swanson@northwestern.edu	Rockne, Russell/T-1549-2017; Cloughesy, Timothy Francis/AGV-1013-2022	Rockne, Russell/0000-0002-1557-159X; Trister, Andrew/0000-0002-7070-0139; Neal, Maxwell/0000-0002-2390-6572	McDonnell Foundation; Brain Tumor Funders Collaborative; National Institutes of Health [R01 CA164371, R01 NS 060752, U54 CA143970]; James D. Murray Endowed Chair; University of Washington Academic Pathology Fund; NATIONAL CANCER INSTITUTE [U54CA143970, R01CA164371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060752] Funding Source: NIH RePORTER	McDonnell Foundation; Brain Tumor Funders Collaborative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. Murray Endowed Chair; University of Washington Academic Pathology Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the McDonnell Foundation, the Brain Tumor Funders Collaborative, the National Institutes of Health (R01 CA164371, R01 NS 060752, U54 CA143970), the James D. Murray Endowed Chair and the University of Washington Academic Pathology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVORD EC, 1995, AM J NEURORADIOL, V16, P1013; Alvord Jr E.C., 1991, PATHOLOGY AGING HUMA, P210; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gu SL, 2012, MATH MED BIOL, V29, P31, DOI 10.1093/imammb/dqr002; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Neal ML, 2011, NEURO-ONCOLOGY, V13, P83; Neal ML, 2010, BRIEF BIOINFORM, V11, P111, DOI 10.1093/bib/bbp049; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Rockne Russell, 2008, Biophysical Reviews and Letters, V3, P111, DOI 10.1142/S1793048008000642; Shaw E. G., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS135, DOI 10.1016/S0360-3016(03)00843-5; Sodt R, COMPUTATION IN PRESS, V2; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Swanson K., 1999, THESIS U WASHINGTON; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson K R, 2002, NEURO-ONCOLOGY, P4340, DOI DOI 10.1093/NEUONC/4.4.308; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson K, 2007, NEURO-ONCOLOGY, V9, P575; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	29	61	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51951	10.1371/journal.pone.0051951	http://dx.doi.org/10.1371/journal.pone.0051951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372647	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500007
J	Puleston, R; Bugg, G; Hoschler, K; Konje, J; Thornton, J; Stephenson, I; Myles, P; Enstone, J; Augustine, G; Davis, Y; Zambon, M; Nicholson, K; Nguyen-Van-Tam, J				Puleston, Richard; Bugg, George; Hoschler, Katja; Konje, Justin; Thornton, James; Stephenson, Iain; Myles, Puja; Enstone, Joanne; Augustine, Glenda; Davis, Yvette; Zambon, Maria; Nicholson, Karl; Nguyen-Van-Tam, Jonathan			Multi-Centre Observational Study of Transplacental Transmission of Influenza Antibodies following Vaccination with AS03(A)-Adjuvanted H1N1 2009 Vaccine	PLOS ONE			English	Article							PASSIVE MEASLES ANTIBODY; PREGNANT-WOMEN; MATERNAL IMMUNIZATION; RESPIRATORY ILLNESS; A(H1N1) VIRUS; INFECTION; INFANTS; HOSPITALIZATIONS; PROTECTION; DECLINE	Illness and death from influenza increase during pregnancy. In the United Kingdom pregnant women were targeted in a national programme for vaccination during the H1N1 2009-10 pandemic. Methods: In this study, pregnant women were recruited in labour from November 9, 2009 to March 10, 2010. Pandemic vaccination status was determined. Venous cord blood collected at delivery was evaluated for transplacental transfer of antibodies by measurement of haemagglutination inhibition and microneutralization titres. Results: Samples were collected from 77 vaccinated and 27 unvaccinated women. Seroprotection (HI titre >= 1:40) was detected in 58 (75.3%, 95% CI 64.2-84.4) cord blood samples from vaccinated women and 5 (18.5%, 95% CI 6.3-38.1) from unvaccinated women (P<0.0001). There was evidence of transplacental seroprotection 8 days after maternal immunization (77.9%, 95 CI 66.2-87.1), maintained in most cases for at least 16 weeks. Discussion: Immunization of pregnant women with AS03(A)-adjuvanted vaccine is followed by transplacental transfer of passive immunity at titres consistent with clinical protection in three-quarters of new-born infants. The findings support national and international pandemic H1N1 2009 recommendations for immunization during pregnancy.	[Puleston, Richard; Myles, Puja; Enstone, Joanne; Augustine, Glenda; Nguyen-Van-Tam, Jonathan] Univ Nottingham, City Hosp, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Bugg, George] Nottingham Univ Hosp Natl Hlth Serv Trust, Queens Med Ctr, Nottingham, England; [Hoschler, Katja; Zambon, Maria] Hlth Protect Agcy, London, England; [Konje, Justin] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Thornton, James; Davis, Yvette] Univ Nottingham, Fac Med & Hlth Sci, Div Human Dev, Nottingham NG7 2RD, England; [Stephenson, Iain; Nicholson, Karl] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; Health Protection Agency; University of Leicester; University of Nottingham; University of Leicester	Puleston, R (corresponding author), Univ Nottingham, City Hosp, Sch Community Hlth Sci, Div Epidemiol & Publ Hlth, Clin Sci Bldg, Nottingham NG7 2RD, England.	Richard.puleston@nottingham.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Thornton, Jim/B-8336-2008	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Thornton, Jim/0000-0001-9764-6876; Myles, Puja/0000-0002-8976-890X	National Institute for Health Research Health Technology Assessment Program [09/84/136]; Sanofi Pasteur; GlaxoSmithKline; Novartis Vaccines; Novartis; GSK; Baxter; Baxter Vaccines; Hoffman-La Roche; CSL Australia Ltd; Berna Biotech; Esteves; European Scientific Working Group on Influenza; MRC; National Institute for Health Research; Roche Products Ltd; Sanofi Pasteur MSD; National Institute for Health Research [09/84/136] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Program; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Novartis Vaccines; Novartis(Novartis); GSK(GlaxoSmithKline); Baxter; Baxter Vaccines; Hoffman-La Roche; CSL Australia Ltd; Berna Biotech; Esteves; European Scientific Working Group on Influenza; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Roche Products Ltd; Sanofi Pasteur MSD; National Institute for Health Research(National Institute for Health Research (NIHR))	This project has been wholly funded by the National Institute for Health Research Health Technology Assessment Program, under grant number 09/84/136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Richard Puleston has received funding from Sanofi Pasteur to attend two influenza-related meetings. He will also be providing UNPAID consultancy advice to Novartis. Richard Puleston, Jonathan Nguyen Van Tam, Iain Stephenson and Karl Nicholson have received funding from GlaxoSmithKline to support virus isolation studies as a subsidiary (ongoing) component of this study. Joanne Enstone has received a one-off consultancy fee from GlaxoSmithKline and funding to attend an educational meeting from Sanofi Pasteur. Iain Stephenson has received funding to attend international scientific meetings (Novartis Vaccines), lecture and consultancy fees (Novartis, GSK and Baxter) and research funding from several pharmaceutical companies including Novartis Vaccines, GSK, Baxter Vaccines and Hoffman-La Roche. Maria Zambon and Katja Hoschler have been investigators of clinical trials sponsored by Novartis, Baxter, Sanofi Pasteur, and CSL Australia Ltd. Katja Hoschler has been sponsored by Sanofi Pasteur to take part and speak at one international meeting. Karl Nicholson has been an ad hoc consultant to GlaxoSmithKline, Merck, Sanofi Pasteur, and Novartis. He has received funding to speak at meetings organised by Novartis, Baxter, Berna Biotech, Esteves, and the European Scientific Working Group on Influenza, and H5 vaccines from Novartis to support an MRC-funded research project, and H1N1 vaccines from Baxter AG and GlaxoSmithKline to support an National Institute for Health Research-funded research project. Jonathan Nguyen Van Tam has received funding to attend influenza-related meetings, ad-hoc lecture and consultancy fees and research funding from several influenza antiviral drug and vaccine manufacturers (including both GlaxoSmithKline and Baxter AG), and is a former employee of SmithKline Beecham PLC (now GlaxoSmithKline), Roche Products Ltd, and Sanofi Pasteur MSD. The other authors have for themselves declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahluwalia IB, 2010, OBSTET GYNECOL, V116, P949, DOI 10.1097/AOG.0b013e3181f1039f; Beigi RH, 2009, J REPROD MED, V54, P341; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Broughton DE, 2009, OBSTET GYNECOL, V114, P981, DOI 10.1097/AOG.0b013e3181bd89c2; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; CHRISTIE CD, 1990, INT J EPIDEMIOL, V19, P698, DOI 10.1093/ije/19.3.698; CLOONAN MJ, 1971, J HYG-CAMB, V69, P435, DOI 10.1017/S0022172400021689; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Department of Health, 2009, SWIN FLU PREGN PROT; Derya A, 2005, AM J TROP MED HYG, V73, P457, DOI 10.4269/ajtmh.2005.73.457; Dinsdale P, 2009, BMJ, P339; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; EMEA, 2010, EMEAHC001202; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; European Agency for the Evaluation of Medicinal Products, 2004, CPMPVEG471703 EUR AG; European Agency for the Evaluation of Medicinal Products (EMEA) CfPMPC, 1997, CPMPBWP21496 EUR AG; European Centre for Disease Prevention and Control, 2009, US SPEC PAND INFL VA; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Gagneur A, 2008, CLIN VACCINE IMMUNOL, V15, P1845, DOI 10.1128/CVI.00229-08; GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994; Gold BD, 1997, PEDIATR RES, V41, P641, DOI 10.1203/00006450-199705000-00007; Hanquet G, 2011, VACCINE, V29, P370, DOI 10.1016/j.vaccine.2010.10.079; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2010, ARCH PEDIAT ADOL MED, V164, P1023, DOI 10.1001/archpediatrics.2010.203; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Madhun AS, 2010, VACCINE, V29, P266, DOI 10.1016/j.vaccine.2010.10.038; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; MALDONADO YA, 1995, PEDIATRICS, V96, P447; Malek A, 1996, AM J REPROD IMMUNOL, V36, P248; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; Nicoara C, 1999, CLIN DIAGN LAB IMMUN, V6, P868, DOI 10.1128/CDLI.6.6.868-871.1999; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Puleston RL, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14550-01; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Stein M, 2010, ARCH PEDIAT ADOL MED, V164, P1015, DOI 10.1001/archpediatrics.2010.195; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Tong A, 2008, J OBSTET GYNAECOL CA, V30, P404, DOI 10.1016/S1701-2163(16)32825-0; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; WHO, 2009, 2 WHO; Wu JA, 2011, VACCINE, V29, P1009, DOI 10.1016/j.vaccine.2010.11.058; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729	56	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e47448	10.1371/journal.pone.0047448	http://dx.doi.org/10.1371/journal.pone.0047448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372640	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500001
J	Ko, HL; Wang, YT; Chiu, TS; Lee, MA; Leu, MY; Chang, KZ; Chen, WY; Shao, KT				Ko, Hui-Ling; Wang, Yu-Tze; Chiu, Tai-Sheng; Lee, Ming-An; Leu, Ming-Yih; Chang, Kuang-Zong; Chen, Wen-Yu; Shao, Kwang-Tsao			Evaluating the Accuracy of Morphological Identification of Larval Fishes by Applying DNA Barcoding	PLOS ONE			English	Article								Due to insufficient morphological diagnostic characters in larval fishes, it is easy to misidentify them and difficult to key to the genus or species level. The identification results from different laboratories are often inconsistent. This experiment aims to find out, by applying DNA barcoding, how inconsistent the identifications can be among larval fish taxonomists. One hundred morphotypes of larval fishes were chosen as test specimens. The fishes were collected with either larval fish nets or light traps in the northern, southern and northwestern waters of Taiwan. After their body lengths (SL) were measured and specimen photos were taken, all specimens were delivered, in turn, to five laboratories (A-E) in Taiwan to be identified independently. When all the results were collected, these specimens were then identified using COI barcoding. Out of a total of 100 specimens, 87 were identified to the family level, 79 to the genus level and 69 to the species level, based on the COI database currently available. The average accuracy rates of the five laboratories were quite low: 80.1% for the family level, 41.1% for the genus level, and 13.5% for the species level. If the results marked as "unidentified'' were excluded from calculations, the rates went up to 75.4% and 43.7% for the genus and species levels, respectively. Thus, we suggest that larval fish identification should be more conservative; i.e., when in doubt, it is better to key only to the family and not to the genus or species level. As to the most misidentified families in our experiment, they were Sparidae, Scorpaenidae, Scombridae, Serranidae and Malacanthidae. On the other hand, Mene maculata and Microcanthus strigatus were all correctly identified to the species level because their larvae have distinct morphology. Nevertheless, barcoding remains one of the best methods to confirm species identification.	[Ko, Hui-Ling; Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Wang, Yu-Tze] Council Agr, Fisheries Res Inst, Keelung, Taiwan; [Chiu, Tai-Sheng; Chang, Kuang-Zong] Natl Taiwan Univ, Coll Life Sci, Inst Zool, Taipei 10764, Taiwan; [Lee, Ming-An; Chen, Wen-Yu] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan; [Leu, Ming-Yih] Natl Museum Marine Biol & Aquarium, Dept Biol, Pingtung, Taiwan	Academia Sinica - Taiwan; Taiwan Fish Research Institute; Academia Sinica - Taiwan; National Taiwan University; National Taiwan Ocean University; National Museum of Marine Biology & Aquarium	Shao, KT (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	zoskt@gate.sinica.edu.tw	Leu, Ming-Yih/AAV-7065-2020	Leu, Ming-Yih/0000-0001-8554-7643	National Science Council, Taiwan [NSC 95-2621-B-001-010-MY2]; Forest Bureau	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Forest Bureau	We wish to thank the National Science Council, Taiwan for financial support to KTS during 2006-2008 (Grant number: NSC 95-2621-B-001-010-MY2). We also thank Forest Bureau for support of the KTS one cryobank and BOL project in Taiwan since 2004-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Baldwin CC, 2011, ZOOTAXA, P1; Hall T, 2004, BIOEDIT VERSION 6 0; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Kim JK, 2010, GENES GENOM, V32, P437, DOI 10.1007/s13258-010-0017-6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Matarese AC, 2011, ICHTHYOL RES, V58, P170, DOI 10.1007/s10228-010-0198-7; Moura T, 2008, MAR FRESHWATER RES, V59, P214, DOI 10.1071/MF07192; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shao KT, 2002, MAR FRESHWATER RES, V53, P355, DOI 10.1071/MF01141; Spies IB, 2006, J FISH BIOL, V69, P283, DOI 10.1111/j.1095-8649.2006.01286.x; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Victor BC, 2009, ZOOTAXA, P24; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	22	130	147	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53451	10.1371/journal.pone.0053451	http://dx.doi.org/10.1371/journal.pone.0053451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382845	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600016
J	Rodriguez-Tornos, FM; San Aniceto, I; Cubelos, B; Nieto, M				Rodriguez-Tornos, Fernanda M.; San Aniceto, Inigo; Cubelos, Beatriz; Nieto, Marta			Enrichment of Conserved Synaptic Activity-Responsive Element in Neuronal Genes Predicts a Coordinated Response of MEF2, CREB and SRF	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; AUTISM; EXPRESSION; MEMORY; HOMER; TRANSCRIPTION; HIPPOCAMPAL; REQUIREMENT; PLASTICITY; SYNAPSES	A unique synaptic activity-responsive element (SARE) sequence, composed of the consensus binding sites for SRF, MEF2 and CREB, is necessary for control of transcriptional upregulation of the Arc gene in response to synaptic activity. We hypothesize that this sequence is a broad mechanism that regulates gene expression in response to synaptic activation and during plasticity; and that analysis of SARE-containing genes could identify molecular mechanisms involved in brain disorders. To search for conserved SARE sequences in the mammalian genome, we used the SynoR in silico tool, and found the SARE cluster predominantly in the regulatory regions of genes expressed specifically in the nervous system; most were related to neural development and homeostatic maintenance. Two of these SARE sequences were tested in luciferase assays and proved to promote transcription in response to neuronal activation. Supporting the predictive capacity of our candidate list, up-regulation of several SARE containing genes in response to neuronal activity was validated using external data and also experimentally using primary cortical neurons and quantitative real time RT-PCR. The list of SARE-containing genes includes several linked to mental retardation and cognitive disorders, and is significantly enriched in genes that encode mRNA targeted by FMRP (fragile X mental retardation protein). Our study thus supports the idea that SARE sequences are relevant transcriptional regulatory elements that participate in plasticity. In addition, it offers a comprehensive view of how activity-responsive transcription factors coordinate their actions and increase the selectivity of their targets. Our data suggest that analysis of SARE-containing genes will reveal yet-undescribed pathways of synaptic plasticity and additional candidate genes disrupted in mental disease.	[Rodriguez-Tornos, Fernanda M.; Nieto, Marta] CSIC, CNB, Madrid, Spain; [San Aniceto, Inigo] Univ Complutense Madrid, Fac Informat, Madrid, Spain; [Cubelos, Beatriz] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Nieto, M (corresponding author), CSIC, CNB, Darwin 3,Campus Cantoblanco, Madrid, Spain.	mnlopez@cnb.csic.es	Nieto, Marta/F-1434-2013	Nieto, Marta/0000-0002-8349-8435; Cubelos Alvarez, Beatriz/0000-0002-2280-8233	Ministerio de Ciencia e Innovacion (MICINN) [SAF2008-00211, PIE- 200820I166]; Spanish Comunidad de Madrid [CCG08-CSIC/SAL-3464]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the Ministerio de Ciencia e Innovacion (MICINN) grants (SAF2008-00211; PIE- 200820I166), and a grant from the Spanish Comunidad de Madrid CCG08-CSIC/SAL-3464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Inoue N, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-7; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ovcharenko I, 2005, NUCLEIC ACIDS RES, V33, pW403, DOI 10.1093/nar/gki466; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Upadhya SC, 2011, NEUROCHEM INT, V59, P787, DOI 10.1016/j.neuint.2011.08.009; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53848	10.1371/journal.pone.0053848	http://dx.doi.org/10.1371/journal.pone.0053848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382855	Green Published, gold			2022-12-27	WOS:000314610600019
J	Johnson, RM; Dahlgren, L; Siegfried, BD; Ellis, MD				Johnson, Reed M.; Dahlgren, Lizette; Siegfried, Blair D.; Ellis, Marion D.			Acaricide, Fungicide and Drug Interactions in Honey Bees (Apis mellifera)	PLOS ONE			English	Article							DEGRADATION-PRODUCTS; PESTICIDE-RESIDUES; VARROA-DESTRUCTOR; OXALIC-ACID; MECHANISM; TOXICITY; HYMENOPTERA; COLONIES; DELTAMETHRIN; COUMAPHOS	Background: Chemical analysis shows that honey bees (Apis mellifera) and hive products contain many pesticides derived from various sources. The most abundant pesticides are acaricides applied by beekeepers to control Varroa destructor. Beekeepers also apply antimicrobial drugs to control bacterial and microsporidial diseases. Fungicides may enter the hive when applied to nearby flowering crops. Acaricides, antimicrobial drugs and fungicides are not highly toxic to bees alone, but in combination there is potential for heightened toxicity due to interactive effects. Methodology/Principal Findings: Laboratory bioassays based on mortality rates in adult worker bees demonstrated interactive effects among acaricides, as well as between acaricides and antimicrobial drugs and between acaricides and fungicides. Toxicity of the acaricide tau-fluvalinate increased in combination with other acaricides and most other compounds tested (15 of 17) while amitraz toxicity was mostly unchanged (1 of 15). The sterol biosynthesis inhibiting (SBI) fungicide prochloraz elevated the toxicity of the acaricides tau-fluvalinate, coumaphos and fenpyroximate, likely through inhibition of detoxicative cytochrome P450 monooxygenase activity. Four other SBI fungicides increased the toxicity of tau-fluvalinate in a dose-dependent manner, although possible evidence of P450 induction was observed at the lowest fungicide doses. Non-transitive interactions between some acaricides were observed. Sublethal amitraz pre-treatment increased the toxicity of the three P450-detoxified acaricides, but amitraz toxicity was not changed by sublethal treatment with the same three acaricides. A two-fold change in the toxicity of tau-fluvalinate was observed between years, suggesting a possible change in the genetic composition of the bees tested. Conclusions/Significance: Interactions with acaricides in honey bees are similar to drug interactions in other animals in that P450-mediated detoxication appears to play an important role. Evidence of non-transivity, year-to-year variation and induction of detoxication enzymes indicates that pesticide interactions in bees may be as complex as drug interactions in mammals.	[Johnson, Reed M.; Dahlgren, Lizette; Siegfried, Blair D.; Ellis, Marion D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Johnson, RM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	johnson.5005@osu.edu	Johnson, Reed M./H-3742-2011	Johnson, Reed M./0000-0002-2431-0180	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2009-85118-05718]	United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	Funding support was provided by the United States Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative, Managed Pollinator Coordinated Agricultural Project 2009-85118-05718 (http://www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2005, J AGR FOOD CHEM, V53, P10085, DOI 10.1021/jf051813f; Aliano NP, 2006, J ECON ENTOMOL, V99, P1579, DOI 10.1603/0022-0493-99.5.1579; ANKE T, 1995, CAN J BOT, V73, pS940, DOI 10.1139/b95-342; Atkins EL, 1992, HIVE HONEY BEE, P1153; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bogdanov S, 2004, BEE WORLD, V85, P46, DOI 10.1080/0005772X.2004.11099623; Bogdanov S, 1998, APIDOLOGIE, V29, P513, DOI 10.1051/apido:19980604; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Corta E, 1999, TALANTA, V48, P189, DOI 10.1016/S0039-9140(98)00237-9; Corta E, 2000, TALANTA, V52, P169, DOI 10.1016/S0039-9140(00)00333-7; Dai PL, 2010, ENVIRON TOXICOL CHEM, V29, P644, DOI 10.1002/etc.67; De-Oliveira ACAX, 1999, TOXICOLOGY, V135, P33, DOI 10.1016/S0300-483X(99)00043-8; Elzen PJ, 2003, SOUTHWEST ENTOMOL, V28, P255; Elzen PJ, 2002, AM BEE J, V142, P291; FINNEY D J, 1971, P333; Fungicide Resistance Action Committee, 2012, FRAC COD LIST 2012; Garcia DA, 2006, NEUROPHARMACOLOGY, V50, P25, DOI 10.1016/j.neuropharm.2005.07.009; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gregorc A, 2000, CELL BIOL INT, V24, P319, DOI 10.1006/cbir.1999.0490; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kale M, 1999, TOXICOL LETT, V105, P197, DOI 10.1016/S0378-4274(98)00399-3; Kubik M, 2000, APIDOLOGIE, V31, P531, DOI 10.1051/apido:2000144; Kuhn P. J., 1984, Mode of action of antifungal agents, P155; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; LIU MY, 1992, PESTIC BIOCHEM PHYS, V43, P134, DOI 10.1016/0048-3575(92)90027-W; LODESANI M, 1995, APIDOLOGIE, V26, P67, DOI 10.1051/apido:19950109; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Medici SK, 2012, J APICULT RES, V51, P164, DOI 10.3896/IBRA.1.51.2.03; Meimaridou E, 2005, FREE RADICAL BIO MED, V38, P1553, DOI 10.1016/j.freeradbiomed.2005.02.020; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P449, DOI 10.1111/1523-1747.ep12285793; MOTOBA K, 1992, PESTIC BIOCHEM PHYS, V43, P37, DOI 10.1016/0048-3575(92)90017-T; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mussen EC, 2004, ENVIRON ENTOMOL, V33, P1151, DOI 10.1603/0046-225X-33.5.1151; ORR GL, 1990, PESTIC SCI, V30, P285, DOI 10.1002/ps.2780300305; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; R Core Team, 2021, R LANGUAGE ENV STAT; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Sokol Rajmund, 1996, Medycyna Weterynaryjna, V52, P718; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SANDERS WE, 1979, ANNU REV PHARMACOL, V19, P53, DOI 10.1146/annurev.pa.19.040179.000413; Savin N. E., 1977, Bulletin of the Entomological Society of America, V23, P257; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sergent T, 2009, TOXICOL LETT, V184, P159, DOI 10.1016/j.toxlet.2008.11.009; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Sparks T, 2012, MOA CLASSIFICATION F; Suzuki T, 2004, TOXICOLOGY, V204, P97, DOI 10.1016/j.tox.2004.06.025; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Thompson Helen, 2003, Bulletin of Insectology, V56, P131; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; USMANI KA, 1995, J ECON ENTOMOL, V88, P1580, DOI 10.1093/jee/88.6.1580; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Willoughby L, 2007, PEST MANAG SCI, V63, P803, DOI 10.1002/ps.1391; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yu S. J., 2014, The toxicology and biochemistry of insecticides; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010	75	250	260	12	275	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54092	10.1371/journal.pone.0054092	http://dx.doi.org/10.1371/journal.pone.0054092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382869	Green Published, gold			2022-12-27	WOS:000315483200004
J	Deloron, P; Milet, J; Badaut, C				Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril			Plasmodium falciparum Variability and Immune Evasion Proceed from Antigenicity of Consensus Sequences from DBL6 epsilon; Generalization to All DBL from VAR2CSA	PLOS ONE			English	Article							LOW-COMPLEXITY REGIONS; B-CELL EPITOPES; MALARIA VACCINE; T-CELL; CHONDROITIN SULFATE; VAR GENE; PLACENTAL MALARIA; ANTIBODIES; BINDING; RECOMBINATION	We studied all consensus sequences within the four least 'variable blocks' (VB) present in the DBL6 epsilon domain of VAR2CSA, the protein involved in the adhesion of infected red blood cells by Plasmodium falciparum that causes the Pregnancy-Associated Malaria (PAM). Characterising consensus sequences with respect to recognition of antibodies and percentage of responders among pregnant women living in areas where P. falciparum is endemic allows the identification of the most antigenic sequences within each VB. When combining these consensus sequences among four serotypes from VB1 or VB5, the most often recognized ones are expected to induce pan-reactive antibodies recognizing VAR2CSA from all plasmodial strains. These sequences are of main interest in the design of an immunogenic molecule. Using a similar approach than for DBL6e, we studied the five other DBL and the CIDRpam from VAR2CSA, and again identified VB segments with highly conserved consensus sequences. In addition, we identified consensus sequences in other var genes expressed by non-PAM parasites. This finding paves the way for vaccine design against other pathologies caused by P. falciparum.	[Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril] Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France; [Deloron, Philippe; Milet, Jacqueline; Badaut, Cyril] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France; [Milet, Jacqueline] Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Badaut, C (corresponding author), Inst Rech Biomed Armees, Dept Expertise, Bretigny Sur Orge, France.	cbadaut@gmail.com	Deloron, Philippe/G-6305-2010	Deloron, Philippe/0000-0003-4705-2484; Badaut, Cyril/0000-0002-0064-6384; MILET, Jacqueline/0000-0003-2710-1517	Institut de Medecine et d'Epidemiologie Appliquee [IMEA-0801]; European 7th Framework Programme (STOPPAM programme) [200889]; French National Agency for Research [ANR-05-MIME-009-01]; Institute of Research for Development (IRD)	Institut de Medecine et d'Epidemiologie Appliquee; European 7th Framework Programme (STOPPAM programme); French National Agency for Research(French National Research Agency (ANR)); Institute of Research for Development (IRD)	This study received financial support from the Institut de Medecine et d'Epidemiologie Appliquee (grant IMEA-0801), from the European 7th Framework Programme (STOPPAM programme, grant 200889), and from the French National Agency for Research (grant ANR-05-MIME-009-01). C. Badaut was supported by the Institute of Research for Development (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Baumann A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-46; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; Brabin BJ, 1999, ANN TROP MED PARASIT, V93, pS43, DOI 10.1080/00034983.1999.11813503; Brolin KJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009230; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DEOLIVEIRA GA, 1994, VACCINE, V12, P1012, DOI 10.1016/0264-410X(94)90337-9; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gnidehou S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013105; Golnitz U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-14; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Kelly-Cirino CD, 2009, INFECT IMMUN, V77, P4859, DOI 10.1128/IAI.00117-09; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; KUMAR A, 1992, J IMMUNOL, V148, P1499; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; LEW AM, 1989, P NATL ACAD SCI USA, V86, P3768, DOI 10.1073/pnas.86.10.3768; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Sanni Latifu A, 2002, Malar J, V1, P7, DOI 10.1186/1475-2875-1-7; Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SNIJDERS A, 1991, J GEN VIROL, V72, P557, DOI 10.1099/0022-1317-72-3-557; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Talundzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031565; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; Vasconcelos NM, 2004, VACCINE, V23, P343, DOI 10.1016/j.vaccine.2004.06.003; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54882	10.1371/journal.pone.0054882	http://dx.doi.org/10.1371/journal.pone.0054882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372786	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400039
J	Ackerman, SH; Gatti, DL				Ackerman, Sharon H.; Gatti, Domenico L.			Biapenem Inactivation by B2 Metallo beta-Lactamases: Energy Landscape of the Hydrolysis Reaction	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ANTIBIOTIC BINDING; CRYSTAL-STRUCTURE; STENOTROPHOMONAS-MALTOPHILIA; ENTROPIC CONTRIBUTIONS; REACTION INTERMEDIATE; CATALYTIC EFFICIENCY; ENZYME; MECHANISM; CPHA	Background: A general mechanism has been proposed for metallo beta-lactamases (M beta Ls), in which deprotonation of a water molecule near the Zn ion(s) results in the formation of a hydroxide ion that attacks the carbonyl oxygen of the beta-lactam ring. However, because of the absence of X-ray structures that show the exact position of the antibiotic in the reactant state (RS) it has been difficult to obtain a definitive validation of this mechanism. Methodology/Principal Findings: We have employed a strategy to identify the RS, which does not rely on substrate docking and/or molecular dynamics. Starting from the X-ray structure of the enzyme: product complex (the product state, PS), a QM/MM scan was used to drive the reaction uphill from product back to reactant. Since in this process also the enzyme changes from PS to RS, we actually generate the enzyme: substrate complex from product and avoid the uncertainties associated with models of the reactant state. We used this strategy to study the reaction of biapenem hydrolysis by B2 M beta L CphA. QM/MM simulations were carried out under 14 different ionization states of the active site, in order to generate potential energy surfaces (PESs) corresponding to a variety of possible reaction paths. Conclusions/Significance: The calculations support a model for biapenem hydrolysis by CphA, in which the nucleophile that attacks the b-lactam ring is not the water molecule located in proximity of the active site Zn, but a second water molecule, hydrogen bonded to the first one, which is used up in the reaction, and thus is not visible in the X-ray structure of the enzyme: product complex.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Wayne State University; Wayne State University	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu			United States Public Health Service [GM69840, GM48157]; Wayne State University Research Enhancement Program in Computational Biology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University Research Enhancement Program in Computational Biology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Public Health Service Grants GM69840 to DLG and GM48157 to SHA, and by a Wayne State University Research Enhancement Program in Computational Biology Grant to DLG. Funding was used for the purchase of computational equipment and software licenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebrone C, 2005, J BIOL CHEM, V280, P28195, DOI 10.1074/jbc.M414052200; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bebrone C, 2009, ANTIMICROB AGENTS CH, V53, P4464, DOI 10.1128/AAC.00288-09; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; Diaz N, 2001, J AM CHEM SOC, V123, P9867, DOI 10.1021/ja0113246; E WN, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2720838; Estiu G, 2006, J COMPUT CHEM, V27, P1240, DOI 10.1002/jcc.20411; Fast W, 2001, BIOCHEMISTRY-US, V40, P1640, DOI 10.1021/bi001860v; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; Gatti DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030079; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; GONZALEZ C, 1991, J CHEM PHYS, V95, P5853, DOI 10.1063/1.461606; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Hamelberg D, 2004, J AM CHEM SOC, V126, P7683, DOI 10.1021/ja0377908; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENSEN A, 1983, THEOR CHIM ACTA, V63, P269, DOI 10.1007/BF01151605; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740, DOI 10.2174/092986709789104957; Leiros HKS, 2012, ANTIMICROB AGENTS CH, V56, P4341, DOI 10.1128/AAC.00448-12; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Oelschlaeger P, 2008, J INORG BIOCHEM, V102, P2043, DOI 10.1016/j.jinorgbio.2008.05.007; Olsen L, 2004, J COMPUT AID MOL DES, V18, P287, DOI 10.1023/B:JCAM.0000046821.15502.71; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Page MGP, 2006, CURR OPIN PHARMACOL, V6, P480, DOI 10.1016/j.coph.2006.06.002; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Parr R. G., 1989, DENSITY FUNCTIONAL T; Queenan AM, 2007, ANTIMICROB AGENTS CH, V51, P3089, DOI 10.1128/AAC.00218-07; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Sgrignani J, 2012, J COMPUT AID MOL DES, V26, P425, DOI 10.1007/s10822-012-9571-0; Sharma N, 2008, J AM CHEM SOC, V130, P8215, DOI 10.1021/ja0774562; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Suarez D, 2001, J AM CHEM SOC, V123, P3759, DOI 10.1021/ja003796a; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Villa J, 2000, P NATL ACAD SCI USA, V97, P11899, DOI 10.1073/pnas.97.22.11899; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Warshel A, 2001, Q REV BIOPHYS, V34, P563, DOI 10.1017/S0033583501003730; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Widmann M, 2012, ANTIMICROB AGENTS CH, V56, P3481, DOI 10.1128/AAC.00255-12; Wu SS, 2010, J AM CHEM SOC, V132, P17986, DOI 10.1021/ja104241g; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112; Xu DG, 2007, J PHYS CHEM A, V111, P5630, DOI 10.1021/jp068746s; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409; [No title captured]	77	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55136	10.1371/journal.pone.0055136	http://dx.doi.org/10.1371/journal.pone.0055136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23372827	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600156
J	Francini, RB; Coni, EOC; Meirelles, PM; Amado, GM; Thompson, FL; Pereira, GH; Bastos, AC; Abrantes, DP; Ferreira, CM; Gibran, FZ; Guth, AZ; Sumida, PYG; Oliveira, NL; Kaufman, L; Minte-Vera, CV; Moura, RL				Francini-Filho, Ronaldo B.; Coni, Ericka O. C.; Meirelles, Pedro M.; Amado-Filho, Gilberto M.; Thompson, Fabiano L.; Pereira-Filho, Guilherme H.; Bastos, Alex C.; Abrantes, Douglas P.; Ferreira, Camilo M.; Gibran, Fernando Z.; Gueth, Arthur Z.; Sumida, Paulo Y. G.; Oliveira, Nara L.; Kaufman, Les; Minte-Vera, Carolina V.; Moura, Rodrigo L.			Dynamics of Coral Reef Benthic Assemblages of the Abrolhos Bank, Eastern Brazil: Inferences on Natural and Anthropogenic Drivers	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHASE-SHIFTS; STABLE STATES; LONG-TERM; COMPETITION; SCARIDAE; DECLINE; COVER; FISH; SEDIMENTATION	The Abrolhos Bank (eastern Brazil) encompasses the largest and richest coral reefs of the South Atlantic. Coral reef benthic assemblages of the region were monitored from 2003 to 2008. Two habitats (pinnacles' tops and walls) were sampled per site with 3-10 sites sampled within different reef areas. Different methodologies were applied in two distinct sampling periods: 2003-2005 and 2006-2008. Spatial coverage and taxonomic resolution were lower in the former than in the latter period. Benthic assemblages differed markedly in the smallest spatial scale, with greater differences recorded between habitats. Management regimes and biomass of fish functional groups (roving and territorial herbivores) had minor influences on benthic assemblages. These results suggest that local environmental factors such as light, depth and substrate inclination exert a stronger influence on the structure of benthic assemblages than protection from fishing. Reef walls of unprotected coastal reefs showed highest coral cover values, with a major contribution of Montastraea cavernosa (a sediment resistant species that may benefit from low light levels). An overall negative relationship between fleshy macroalgae and slow-growing reef-building organisms (i.e. scleractinians and crustose calcareous algae) was recorded, suggesting competition between these organisms. The opposite trend (i.e. positive relationships) was recorded for turf algae and the two reef-building organisms, suggesting beneficial interactions and/or co-occurrence mediated by unexplored factors. Turf algae cover increased across the region between 2006 and 2008, while scleractinian cover showed no change. The need of a continued and standardized monitoring program, aimed at understanding drivers of change in community patterns, as well as to subsidize sound adaptive conservation and management measures, is highlighted.	[Francini-Filho, Ronaldo B.] Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil; [Coni, Ericka O. C.; Ferreira, Camilo M.] Univ Estadual Paraiba, Dept Biol, Campina Grande, Paraiba, Brazil; [Meirelles, Pedro M.; Thompson, Fabiano L.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro, Dept Biol Marinha, Rio De Janeiro, Brazil; [Amado-Filho, Gilberto M.; Abrantes, Douglas P.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Pereira-Filho, Guilherme H.] Univ Fed Rural Rio de Janeiro, Dept Bot, Rio De Janeiro, Brazil; [Bastos, Alex C.] Univ Fed Espirito Santo, Dept Oceanog, Vitoria, ES, Brazil; [Gibran, Fernando Z.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Gueth, Arthur Z.; Sumida, Paulo Y. G.] Univ Sao Paulo, Dept Oceanog Biol, Sao Paulo, Brazil; [Oliveira, Nara L.; Moura, Rodrigo L.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Kaufman, Les] Boston Univ, Marine Program, Boston, MA 02215 USA; [Minte-Vera, Carolina V.] Univ Estadual Maringa, Ctr Ciencias Biol, Maringa, Parana, Brazil	Universidade Federal da Paraiba; Universidade Estadual da Paraiba; Universidade Federal do Rio de Janeiro; Jardim Botanico do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Espirito Santo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Estadual de Santa Cruz; Boston University; Universidade Estadual de Maringa	Francini, RB (corresponding author), Univ Fed Paraiba, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil.	rofilho@yahoo.com	Francini-Filho, Ronaldo/I-5708-2012; Meirelles, Pedro/AAK-5942-2021; Güth, Arthur Z/F-2559-2011; Ferreira, Camilo M/M-9427-2015; Meirelles, Pedro/AAL-4542-2020; Ferreira, Camilo Moitinho/ABA-4883-2021; de Moura, Rodrigo Leao/AAL-5781-2020; Pereira-Filho, Guilherme-Henrique/I-2946-2013; Gibran, Fernando Z/G-5844-2012; Sumida, Paulo Y G/F-2561-2011; Minte-Vera, Carolina/D-6326-2013; Minte-Vera, Carolina V/A-5461-2017; FILHO, GILBERTO M AMADO/I-1324-2012; Bastos, Alex/H-3674-2014	Francini-Filho, Ronaldo/0000-0002-7678-6797; Meirelles, Pedro/0000-0002-1306-0331; Güth, Arthur Z/0000-0001-8388-4187; Ferreira, Camilo M/0000-0001-9022-1963; Ferreira, Camilo Moitinho/0000-0001-9022-1963; de Moura, Rodrigo Leao/0000-0002-5597-6196; Pereira-Filho, Guilherme-Henrique/0000-0001-6078-2241; Gibran, Fernando Z/0000-0002-2812-8976; Sumida, Paulo Y G/0000-0001-7549-4541; Minte-Vera, Carolina V/0000-0002-0537-1519; Bastos, Alex/0000-0002-1272-1134; Thompson, Fabiano/0000-0002-7562-1683	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project [420219/2005-6]; Conservation International (CI); CNPq; FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation International (CI); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Pro-Abrolhos Project (#420219/2005-6) and Conservation International (CI). This is a contribution of the CI's Marine Management Areas Science Program, Brazil Node, and Rede Abrolhos/SISBIOTA (MCT/CNPq/CAPES/FAPES). RLM, FLT and GMAF acknowledge individual grants from CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Castro CBE, 2012, BRAZ J OCEANOGR, V60, P49, DOI 10.1590/S1679-87592012000100006; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; CASTRO C.B., 2006, RAP BULL BIOL ASSESM, V38, P19; Castro CB, 2001, B MAR SCI, V69, P357; Ceccarelli DM, 2007, CORAL REEFS, V26, P853, DOI 10.1007/s00338-007-0275-1; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; Clarke KR, 1994, CHANGE MARINE COMMUN; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Coutinho R., 1993, ACTA BIOL LEOPOLDENS, V15, P133; De Moura RL, 2009, COAST MANAGE, V37, P617, DOI 10.1080/08920750903194165; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Edmunds PJ, 1999, CORAL REEFS, V18, P133, DOI 10.1007/s003380050167; Ferrari R, 2012, MAR ECOL PROG SER, V467, P77, DOI 10.3354/meps09953; Francini-Filho RB, 2008, FISH RES, V93, P346, DOI 10.1016/j.fishres.2008.06.011; Francini RB, 2008, NEOTROP ICHTHYOL, V6, P191, DOI 10.1590/S1679-62252008000200006; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Francini RB, 2010, J MAR BIOL ASSOC UK, V90, P481, DOI 10.1017/S0025315409991147; Francini RB, 2010, BRAZ J OCEANOGR, V58, P77, DOI 10.1590/S1679-87592010000100008; Freitas MO, 2011, SCI MAR, V75, P135, DOI 10.3989/scimar.2011.75n1135; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; HOEKSEMA BW, 1989, NETH J SEA RES, V23, P149, DOI 10.1016/0077-7579(89)90009-4; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2011, CORAL REEFS, V30, P653, DOI 10.1007/s00338-011-0787-6; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kikuchi RKP, 2004, ATOLL RES B, V496, P172; Kikuchi RKP, 2010, REV BIOL TROP, V58, P1; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Leao Z, 1997, P 8 INT COR REEF S, V2, P1767; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; LEAO ZMA, 2003, LATIN AM CORAL REEFS; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leao ZMAN, 2001, ECOL STU AN, V144, P83; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moura R.L., 2002, P917; Moura RL, 2011, ESTUAR COAST SHELF S, V95, P274, DOI 10.1016/j.ecss.2011.08.010; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Neves EG, 2008, GENETICA, V132, P243, DOI 10.1007/s10709-007-9168-z; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Niendonca-Neto JP, 2008, AN ACAD BRAS CIENC, V80, P495, DOI 10.1590/S0001-37652008000300010; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pawlowski-Glahn V, 2012, COMPOSITIONAL DATA A; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Pires DO, 2011, J MAR BIOL ASSOC UK, V91, P1613, DOI 10.1017/S0025315410000767; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rosenberg E, 2004, CORAL HLTH DIS; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; SEBENS KP, 1982, B MAR SCI, V32, P316; Segal B, 2001, B MAR SCI, V69, P487; Segal B, 2008, CONT SHELF RES, V28, P533, DOI 10.1016/j.csr.2007.11.003; Segal B, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000200001; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Suchanek T.H., 1982, Proceedings of the International Coral Reef Symposium, P679; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Suzuki G, 2011, J MAR BIOL ASSOC UK, V91, P677, DOI 10.1017/S0025315410000573; Sweatman H, 2011, CORAL REEFS, V30, P661, DOI 10.1007/s00338-011-0794-7; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; ter Braak, 1996, UNIMODAL MODELS RELA; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Villaca Roberto, 1997, Revista Brasileira de Oceanografia, V45, P35; Wilkinson C, 2008, STATUS CORAL REEFS W; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	85	110	110	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54260	10.1371/journal.pone.0054260	http://dx.doi.org/10.1371/journal.pone.0054260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365655	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600043
J	Jacobson, AL; Booth, W; Vargo, EL; Kennedy, GG				Jacobson, Alana L.; Booth, Warren; Vargo, Edward L.; Kennedy, George G.			Thrips tabaci Population Genetic Structure and Polyploidy in Relation to Competency as a Vector of Tomato Spotted Wilt Virus	PLOS ONE			English	Article							EVOLUTIONARY GENETICS; BEMISIA-TABACI; THYSANOPTERA; TRANSMISSION; TOSPOVIRUS; CONSEQUENCES; SPECIFICITY; SEQUENCES; EPIDEMIC; FORMS	Knowledge of population-level genetic differences can help explain variation among populations of insect vectors in their role in the epidemiology of specific viruses. Variation in competency to transmit Tomato spotted wilt virus (TSWV) that exists among populations of Thrips tabaci has been associated with the presence of cryptic species that exhibit different modes of reproduction and host ranges. However, recent findings suggest that vector competency of T. tabaci at any given location depends on the thrips and virus populations that are present. This study characterizes the population genetic structure of T. tabaci collected from four locations in North Carolina and examines the relationship between population genetic structure and variation in TSWV transmission by T. tabaci. Mitochondrial COI sequence analysis revealed the presence of two genetically distinct groups with one characterized by thelytokous, parthenogenetic reproduction and the other by arrhenotokous, sexual reproduction. Using a set of 11 microsatellite markers that we developed to investigate T. tabaci population genetic structure, we identified 17 clonal groups and found significant genetic structuring among the four NC populations that corresponded to the geographic locations where the populations were collected. Application of microsatellite markers also led to the discovery of polyploidy in this species. All four populations contained tetraploid individuals, and three contained both diploid and tetraploid individuals. Analysis of variation in transmission ofTSWV among isofemale lines initiated with individuals used in this study revealed that 'clone assignment,' 'virus isolate' and their interaction significantly influenced vector competency. These results highlight the importance of interactions between specific T. tabaci clonal types and specific TSWV isolates underlying transmission of TSWV by T. tabaci.	[Jacobson, Alana L.; Booth, Warren; Vargo, Edward L.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Kennedy, GG (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	george_kennedy@ncsu.edu	Buckman, Rebecca/F-4960-2013		North Carolina Tobacco Commission	North Carolina Tobacco Commission	The sources of funding for this work were provided by the North Carolina Tobacco Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Beatty R. A., 1957, PARTHENOGENESIS POLY; BIRD J, 1978, ADV VIRUS RES, V22, P55, DOI 10.1016/S0065-3527(08)60772-1; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chatzivassiliou EK, 2008, PLANT DIS, V92, P1012, DOI 10.1094/PDIS-92-7-1012; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Copren KA, 2005, MOL PHYLOGENET EVOL, V35, P689, DOI 10.1016/j.ympev.2005.03.002; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Diaz-Montano J, 2011, J ECON ENTOMOL, V104, P1, DOI 10.1603/EC10269; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dunham R. A., 2004, Aquaculture and fisheries biotechnology: genetic approaches, DOI 10.1079/9780851995960.0000; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jacobson AL, 2013, PLOS ONE IN PRESS; Jenser G, 2003, J APPL ENTOMOL, V127, P7, DOI 10.1046/j.1439-0418.2003.00704.x; LEMMETTY A, 1993, AGR SCI FINLAND, V2, P189, DOI 10.23986/afsci.72648; Lewis Trevor, 1997, P1; Lundmark M, 2006, HEREDITAS, V143, P23, DOI 10.1111/j.2006.0018-0661.01935.x; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mound LA, 2005, THYSANOPTERA THRIPS; Nagata T, 2004, PLANT PATHOL, V53, P136, DOI 10.1111/j.0032-0862.2004.00984.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; PALIWAL YC, 1974, CAN J BOT, V52, P1177, DOI 10.1139/b74-151; PALIWAL YC, 1976, CAN J BOT, V54, P402, DOI 10.1139/b76-038; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terradot L, 1999, B ENTOMOL RES, V89, P355, DOI 10.1017/S0007485399000498; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; van de Wetering F, 1999, B ENTOMOL RES, V89, P579, DOI 10.1017/S0007485399000735; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wilson CR, 1998, PLANT PATHOL, V47, P171, DOI 10.1046/j.1365-3059.1998.00227.x; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	53	27	29	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54484	10.1371/journal.pone.0054484	http://dx.doi.org/10.1371/journal.pone.0054484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365671	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600059
J	Manikkam, M; Tracey, R; Guerrero-Bosagna, C; Skinner, MK				Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.			Plastics Derived Endocrine Disruptors (BPA, DEHP and DBP) Induce Epigenetic Transgenerational Inheritance of Obesity, Reproductive Disease and Sperm Epimutations	PLOS ONE			English	Article							BISPHENOL-A EXPOSURE; DI-(2-ETHYLHEXYL) PHTHALATE DEHP; POLYCYSTIC-OVARY-SYNDROME; SPRAGUE-DAWLEY RATS; ADULT-ONSET DISEASE; ALTERS SEXUAL-DIFFERENTIATION; MALE OFFSPRING RATS; IN-UTERO EXPOSURE; LACTATIONAL EXPOSURE; PERINATAL EXPOSURE	Environmental compounds are known to promote epigenetic transgenerational inheritance of adult onset disease in subsequent generations (F1-F3) following ancestral exposure during fetal gonadal sex determination. The current study was designed to determine if a mixture of plastic derived endocrine disruptor compounds bisphenol-A (BPA), bis(2-ethylhexyl) phthalate (DEHP) and dibutyl phthalate (DBP) at two different doses promoted epigenetic transgenerational inheritance of adult onset disease and associated DNA methylation epimutations in sperm. Gestating F0 generation females were exposed to either the "plastics" or "lower dose plastics" mixture during embryonic days 8 to 14 of gonadal sex determination and the incidence of adult onset disease was evaluated in F1 and F3 generation rats. There were significant increases in the incidence of total disease/abnormalities in F1 and F3 generation male and female animals from plastics lineages. Pubertal abnormalities, testis disease, obesity, and ovarian disease (primary ovarian insufficiency and polycystic ovaries) were increased in the F3 generation animals. Kidney and prostate disease were only observed in the direct fetally exposed F1 generation plastic lineage animals. Analysis of the plastics lineage F3 generation sperm epigenome previously identified 197 differential DNA methylation regions (DMR) in gene promoters, termed epimutations. A number of these transgenerational DMR form a unique direct connection gene network and have previously been shown to correlate with the pathologies identified. Observations demonstrate that a mixture of plastic derived compounds, BPA and phthalates, can promote epigenetic transgenerational inheritance of adult onset disease. The sperm DMR provide potential epigenetic biomarkers for transgenerational disease and/or ancestral environmental exposures.	[Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	Department of Defense (DOD); National Institues of Health (NIH)	Department of Defense (DOD)(United States Department of Defense); National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Department of Defense (DOD), and National Institues of Health (NIH) grants to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewale HB, 2011, NEUROTOXICOLOGY, V32, P38, DOI 10.1016/j.neuro.2010.07.008; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020; Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093; Astill BD, 1996, FUND APPL TOXICOL, V31, P29, DOI 10.1006/faat.1996.0073; Baudry C, 2012, J PHYSIOL-LONDON, V590, P533, DOI 10.1113/jphysiol.2011.219717; Motta AB, 2012, CURR PHARM DESIGN, V18, P2482, DOI 10.2174/13816128112092482; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Campos KE, 2008, BRAZ J MED BIOL RES, V41, P122, DOI 10.1590/S0100-879X2008005000001; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7; Dunaif A, 2012, NAT REV ENDOCRINOL, V8, P72, DOI 10.1038/nrendo.2011.227; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; Farabollino F, 2002, ENVIRON HEALTH PERSP, V110, P409, DOI 10.1289/ehp.02110s3409; Fiege H., 2002, ULLMANNS ENCY IND CH; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387; Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005; Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035; GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Ishido M, 2004, J NEUROSCI RES, V76, P423, DOI 10.1002/jnr.20050; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Kawai K, 2003, ENVIRON HEALTH PERSP, V111, P175, DOI 10.1289/ehp.5440; Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014; KHALIQ MA, 1993, TOXICOL LETT, V66, P317, DOI 10.1016/0378-4274(93)90013-N; Khurana S, 2000, ENDOCRINOLOGY, V141, P4512, DOI 10.1210/en.141.12.4512; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Koo HJ, 2007, J TOXICOL ENV HEAL A, V70, P383, DOI 10.1080/15287390600882150; Kostka G, 2010, TOXICOL IND HEALTH, V26, P407, DOI 10.1177/0748233710369124; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1; LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Linne Y, 2004, Obes Rev, V5, P137, DOI 10.1111/j.1467-789X.2004.00147.x; LORZ PM, 2002, ULLMANNS ENCY IND CH; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Martino-Andrade AJ, 2009, INT J ANDROL, V32, P704, DOI 10.1111/j.1365-2605.2008.00939.x; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Mizuo K, 2004, NEUROSCI LETT, V356, P95, DOI 10.1016/j.neulet.2003.11.027; Monje L, 2010, REPROD TOXICOL, V30, P625, DOI 10.1016/j.reprotox.2010.08.004; Monje L, 2007, J ENDOCRINOL, V194, P201, DOI 10.1677/JOE-07-0014; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1006/toxs.1998.2436; Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Patisaul HB, 2006, NEUROTOXICOL TERATOL, V28, P111, DOI 10.1016/j.ntt.2005.11.004; Patisaul HB, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.010.2009; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Ramos JG, 2003, ENDOCRINOLOGY, V144, P3206, DOI 10.1210/en.2002-0198; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Ryu JY, 2007, TOXICOLOGY, V234, P103, DOI 10.1016/j.tox.2007.02.003; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Simoneau C, 2012, FOOD ADDIT CONTAM A, V29, P469, DOI 10.1080/19440049.2011.644588; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Slocum N., 2012, EXP TOXICOL PATHOL; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Tian YH, 2011, SYNAPSE, V65, P1032, DOI 10.1002/syn.20934; Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Van Camp JK, 2012, MOL GENET METAB, V105, P489, DOI 10.1016/j.ymgme.2011.11.197; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Vogel Sarah A, 2009, Am J Public Health, V99 Suppl 3, pS559, DOI 10.2105/AJPH.2008.159228; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Zanni MV, 2010, CLIN ENDOCRINOL, V73, P48, DOI 10.1111/j.1365-2265.2009.03741.x	125	542	569	6	282	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55387	10.1371/journal.pone.0055387	http://dx.doi.org/10.1371/journal.pone.0055387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359474	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600164
J	Mohazab, AR; Plotkin, SS				Mohazab, Ali R.; Plotkin, Steven S.			Polymer Uncrossing and Knotting in Protein Folding, and Their Role in Minimal Folding Pathways	PLOS ONE			English	Article							TRANSITION-STATE ENSEMBLE; ENERGY LANDSCAPE THEORY; RELATE 2 SETS; CONTACT ORDER; CONFORMATIONAL TRANSITIONS; ROTATIONAL SUPERPOSITION; MOLECULAR-DYNAMICS; REACTION PATHS; CHAIN-LENGTH; KNOTS	We introduce a method for calculating the extent to which chain non-crossing is important in the most efficient, optimal trajectories or pathways for a protein to fold. This involves recording all unphysical crossing events of a ghost chain, and calculating the minimal uncrossing cost that would have been required to avoid such events. A depth-first tree search algorithm is applied to find minimal transformations to fold alpha, beta, alpha/beta, and knotted proteins. In all cases, the extra uncrossing/non-crossing distance is a small fraction of the total distance travelled by a ghost chain. Different structural classes may be distinguished by the amount of extra uncrossing distance, and the effectiveness of such discrimination is compared with other order parameters. It was seen that non-crossing distance over chain length provided the best discrimination between structural and kinetic classes. The scaling of non-crossing distance with chain length implies an inevitable crossover to entanglement-dominated folding mechanisms for sufficiently long chains. We further quantify the minimal folding pathways by collecting the sequence of uncrossing moves, which generally involve leg, loop, and elbow-like uncrossing moves, and rendering the collection of these moves over the unfolded ensemble as a multiple-transformation "alignment". The consensus minimal pathway is constructed and shown schematically for representative cases of an alpha, beta, and knotted protein. An overlap parameter is defined between pathways; we find that alpha proteins have minimal overlap indicating diverse folding pathways, knotted proteins are highly constrained to follow a dominant pathway, and beta proteins are somewhere in between. Thus we have shown how topological chain constraints can induce dominant pathway mechanisms in protein folding.	[Mohazab, Ali R.; Plotkin, Steven S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Plotkin, SS (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	steve@physics.ubc.ca	Plotkin, Steven/AAO-3257-2020	Plotkin, Steven/0000-0001-8998-877X	Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver; Natural Sciences and Engineering Council	Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge funding from the Faculty of Graduate Studies 4YF Program at the University of British Columbia at Vancouver, and the Natural Sciences and Engineering Council for providing funding to defray publication page fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Adams CC, 1994, THE KNOT BOOK; ANDERSEN KV, 1993, J BIOMOL NMR, V3, P271, DOI 10.1007/BF00212514; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Banavar JR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940059; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Bodenreider C, 2005, J MOL BIOL, V351, P393, DOI 10.1016/j.jmb.2005.05.062; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Byeon IJL, 1998, MOL CELL, V1, P421, DOI 10.1016/S1097-2765(00)80042-8; Cavagnero S, 1999, J MOL BIOL, V285, P269, DOI 10.1006/jmbi.1998.2273; CERJAN CJ, 1981, J CHEM PHYS, V75, P2800, DOI 10.1063/1.442352; CHAN HS, 1990, J CHEM PHYS, V92, P3118, DOI 10.1063/1.458605; CHAN HS, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881371; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2004, PROTEIN SCI, V13, P1750, DOI 10.1110/ps.03580104; Clementi C, 2003, J MOL BIOL, V326, P933, DOI 10.1016/S0022-2836(02)01379-7; CONNOLLY ML, 1980, BIOPOLYMERS, V19, P1167, DOI 10.1002/bip.1980.360190606; Coutsias EA, 2005, J COMPUT CHEM, V26, P1663, DOI 10.1002/jcc.20316; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; Das A, 2012, PROC NATL ACAD SCI U; Dellago C, 1998, J CHEM PHYS, V108, P1964, DOI 10.1063/1.475562; Ding F, 2005, J MOL BIOL, V350, P1035, DOI 10.1016/j.jmb.2005.05.017; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; ELBER R, 1987, CHEM PHYS LETT, V139, P375, DOI 10.1016/0009-2614(87)80576-6; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Favrin G, 2003, BIOPHYS J, V85, P1457, DOI 10.1016/S0006-3495(03)74578-0; Ferguson A, 2009, J MOL BIOL, V389, P619, DOI 10.1016/j.jmb.2009.04.011; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2000, STRUCTURE AND MECHAN; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Flower DR, 1999, J MOL GRAPH MODEL, V17, P238; Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343; Galzitskaya OV, 2001, FEBS LETT, V489, P113, DOI 10.1016/S0014-5793(01)02092-0; Garel T, 1996, NEW DEV THEORETICAL, P197; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Grosberg AY, 2004, COMPUTATIONAL SOFT M, V23, P375; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hummer G, 2003, J CHEM PHYS, V118, P10762, DOI 10.1063/1.1574777; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Istomin AY, 2007, PROTEIN SCI, V16, P2564, DOI 10.1110/ps.073124507; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Kneller G. R., 1991, MOL SIMULAT, V7, P113; Koczyk G, 2008, NUCLEIC ACIDS RES, V36, pW239, DOI 10.1093/nar/gkn326; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Komatsuzaki T, 2003, CHEMICAL REACTION DY, P79; KONIARIS K, 1991, J CHEM PHYS, V95, P2873, DOI 10.1063/1.460889; KONIARIS K, 1991, PHYS REV LETT, V66, P2211, DOI 10.1103/PhysRevLett.66.2211; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LAL M, 1969, MOL PHYS, V17, P57, DOI 10.1080/00268976900100781; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lua RC, 2006, PLOS COMPUT BIOL, V2, P350, DOI 10.1371/journal.pcbi.0020045; MADRAS N, 1988, J STAT PHYS, V50, P109, DOI 10.1007/BF01022990; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; Mansfield ML, 1997, NAT STRUCT BIOL, V4, P166, DOI 10.1038/nsb0397-166; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418; Mezard M, 1986, WORLD SCI LECT NOTES, V9; Mohazab AR, 2009, INT J QUANTUM CHEM, V109, P3217, DOI 10.1002/qua.22347; Mohazab AR, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/24/244133; Mohazab AR, 2008, BIOPHYS J, V95, P5496, DOI 10.1529/biophysj.108.135046; Nechaev SK, 1996, STATISTICS OF KNOTS; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Norcross TS, 2006, J MOL BIOL, V362, P605, DOI 10.1016/j.jmb.2006.07.054; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Nymeyer H, 2000, P NATL ACAD SCI US; Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Oztop B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.208105; Pande VS, 2000, REV MOD PHYS, V72, P259, DOI 10.1103/RevModPhys.72.259; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Plotkin SS, 1998, PHYS REV LETT, V80, P5015, DOI 10.1103/PhysRevLett.80.5015; Plotkin SS, 2002, Q REV BIOPHYS, V35, P205, DOI 10.1017/S0033583502003785; Plotkin SS, 2002, J CHEM PHYS, V116, P5263, DOI 10.1063/1.1449866; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Plotkin SS, 2001, PROTEINS, V45, P337, DOI 10.1002/prot.1154; Plotkin SS, 2007, P NATL ACAD SCI USA, V104, P14899, DOI 10.1073/pnas.0607833104; Potestio R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000864; Prentiss MC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000835; Schuyler AD, 2009, PROTEINS, V74, P760, DOI 10.1002/prot.22200; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Sosnick TR, 2006, CHEM REV, V106, P1862, DOI 10.1021/cr040431q; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Thiruv B, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-12; van der Vaart A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2719697; van Roon AMM, 2008, P NATL ACAD SCI USA, V105, P9621, DOI 10.1073/pnas.0802494105; Virnau P, 2005, J AM CHEM SOC, V127, P15102, DOI 10.1021/ja052438a; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; Wales DJ, 2001, SCIENCE, V293, P2067, DOI 10.1126/science.1062565; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Weinkam P, 2005, P NATL ACAD SCI USA, V102, P12401, DOI 10.1073/pnas.0505274102; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; Wiegel FW, 1986, INTRODUCTION TO PATH; Wolynes P.G., 1992, SPIN GLASSES BIOL, P225; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yang HJ, 2007, J CHEM THEORY COMPUT, V3, P17, DOI 10.1021/ct0502054; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou H, 2009, PROTEIN SCI, V16, P947; Zhou YQ, 1999, J MOL BIOL, V293, P917, DOI 10.1006/jmbi.1999.2936	143	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53642	10.1371/journal.pone.0053642	http://dx.doi.org/10.1371/journal.pone.0053642			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365638	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600017
J	Sahl, JW; Gillece, JD; Schupp, JM; Waddell, VG; Driebe, EM; Engelthaler, DM; Keim, P				Sahl, Jason W.; Gillece, John D.; Schupp, James M.; Waddell, Victor G.; Driebe, Elizabeth M.; Engelthaler, David M.; Keim, Paul			Evolution of a Pathogen: A Comparative Genomics Analysis Identifies a Genetic Pathway to Pathogenesis in Acinetobacter	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; MULTIDRUG-RESISTANCE; BAUMANNII STRAINS; CLINICAL STRAINS; BETA-LACTAMASE; SP-NOV; SEQUENCE; SIDEROPHORE; CALCOACETICUS; ORGANIZATION	Acinetobacter baumannii is an emergent and global nosocomial pathogen. In addition to A. baumannii, other Acinetobacter species, especially those in the Acinetobacter calcoaceticus-baumannii (Acb) complex, have also been associated with serious human infection. Although mechanisms of attachment, persistence on abiotic surfaces, and pathogenesis in A. baumannii have been identified, the genetic mechanisms that explain the emergence of A. baumannii as the most widespread and virulent Acinetobacter species are not fully understood. Recent whole genome sequencing has provided insight into the phylogenetic structure of the genus Acinetobacter. However, a global comparison of genomic features between Acinetobacter spp. has not been described in the literature. In this study, 136 Acinetobacter genomes, including 67 sequenced in this study, were compared to identify the acquisition and loss of genes in the expansion of the Acinetobacter genus. A whole genome phylogeny confirmed that A. baumannii is a monophyletic clade and that the larger Acb complex is also a well-supported monophyletic group. The whole genome phylogeny provided the framework for a global genomic comparison based on a blast score ratio (BSR) analysis. The BSR analysis demonstrated that specific genes have been both lost and acquired in the evolution of A. baumannii. In addition, several genes associated with A. baumannii pathogenesis were found to be more conserved in the Acb complex, and especially in A. baumannii, than in other Acinetobacter genomes; until recently, a global analysis of the distribution and conservation of virulence factors across the genus was not possible. The results demonstrate that the acquisition of specific virulence factors has likely contributed to the widespread persistence and virulence of A. baumannii. The identification of novel features associated with transcriptional regulation and acquired by clades in the Acb complex presents targets for better understanding the evolution of pathogenesis and virulence in the expansion of the genus.	[Sahl, Jason W.; Gillece, John D.; Schupp, James M.; Driebe, Elizabeth M.; Engelthaler, David M.; Keim, Paul] Translat Genom Res Inst, Dept Pathogen Genom, Flagstaff, AZ USA; [Waddell, Victor G.] Arizona Dept Hlth Serv, Bur State Lab Serv, Phoenix, AZ 85007 USA; [Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Gen, Flagstaff, AZ 86011 USA	Translational Genomics Research Institute; Arizona Department of Health Services; Northern Arizona University	Sahl, JW (corresponding author), Translat Genom Res Inst, Dept Pathogen Genom, Flagstaff, AZ USA.	jsahl@tgen.org		, Jason/0000-0002-2497-0138	National Institutes of Health [R01AI090782-03]; NAU Technology and Research Initiative Fund (TRIF); DOD [W81XWH-09-0573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NAU Technology and Research Initiative Fund (TRIF); DOD(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by National Institutes of Health R01 grant R01AI090782-03, the NAU Technology and Research Initiative Fund (TRIF), and DOD grant W81XWH-09-0573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAUMANN P, 1968, J BACTERIOL, V96, P39, DOI 10.1002/path.1700960105; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Brossard KA, 2012, INFECT IMMUN, V80, P228, DOI 10.1128/IAI.05913-11; Brown S, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2004.01016.x; Chan JZM, 2012, BMC MICROBI IN PRESS; Cisneros JM, 1996, CLIN INFECT DIS, V22, P1026, DOI 10.1093/clinids/22.6.1026; Cisneros-Herreros Jose Miguel, 2005, Enferm Infecc Microbiol Clin, V23 Suppl 3, P46; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dijkshoorn Lenie, 2008, P1; Doi Y, 2007, ANTIMICROB AGENTS CH, V51, P4209, DOI 10.1128/AAC.00560-07; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dorsey CW, 2003, MICROBIOL-SGM, V149, P1227, DOI 10.1099/mic.0.26204-0; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Higgins PG, 2010, J CLIN MICROBIOL, V48, P4592, DOI 10.1128/JCM.01765-10; Horii T, 2011, INFECT GENET EVOL, V11, P52, DOI 10.1016/j.meegid.2010.10.011; Hornsey M, 2011, J ANTIMICROB CHEMOTH, V66, P1499, DOI 10.1093/jac/dkr168; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Jawad A, 1996, J CLIN MICROBIOL, V34, P2881, DOI 10.1128/JCM.34.12.2881-2887.1996; Jawad A, 1998, J HOSP INFECT, V39, P235, DOI 10.1016/S0195-6701(98)90263-8; Kang YS, 2011, J MICROBIOL, V49, P29, DOI 10.1007/s12275-011-0315-y; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Koh TH, 2012, EPIDEMIOL INFECT, V140, P535, DOI 10.1017/S0950268811001129; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lolans K, 2006, ANTIMICROB AGENTS CH, V50, P2941, DOI 10.1128/AAC.00116-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Murray CK, 2006, MIL MED, V171, P821, DOI 10.7205/MILMED.171.9.821; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; OKUJO N, 1994, BIOMETALS, V7, P170; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Penwell WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036493; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahl JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-291; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Schafer JJ, 2008, EMERG INFECT DIS, V14, P512, DOI 10.3201/eid1403.070128; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; SEIFERT H, 1993, ZBL BAKT-INT J MED M, V279, P544, DOI 10.1016/S0934-8840(11)80427-5; Seo YS, 2011, J BACTERIOL, V193, P3149, DOI 10.1128/JB.00420-11; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Tien HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-95; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.009; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; Wand ME, 2012, J MED MICROBIOL, V61, P470, DOI 10.1099/jmm.0.037523-0; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11; Zurawski DV, 2012, J BACTERIOL, V194, P1619, DOI 10.1128/JB.06749-11	89	86	91	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54287	10.1371/journal.pone.0054287	http://dx.doi.org/10.1371/journal.pone.0054287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365658	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600046
J	Sasayama, D; Hori, H; Nakamura, S; Miyata, R; Teraishi, T; Hattori, K; Ota, M; Yamamoto, N; Higuchi, T; Amano, N; Kunugi, H				Sasayama, Daimei; Hori, Hiroaki; Nakamura, Seiji; Miyata, Ryo; Teraishi, Toshiya; Hattori, Kotaro; Ota, Miho; Yamamoto, Noriko; Higuchi, Teruhiko; Amano, Naoji; Kunugi, Hiroshi			Identification of Single Nucleotide Polymorphisms Regulating Peripheral Blood mRNA Expression with Genome-Wide Significance: An eQTL Study in the Japanese Population	PLOS ONE			English	Article							GENE-EXPRESSION; TOOL; HAPMAP	Several recent studies have reported that expression quantitative trait loci (eQTLs) may affect gene expression in a cell-dependent manner. In the current study, a genome-wide eQTL analysis was performed in whole blood samples collected from 76 Japanese subjects. RNA microarray analysis was performed for 3 independent sample groups that were genotyped in a genome-wide scan. The correlations between the genotypes of 534,404 autosomal single nucleotide polymorphisms (SNPs) and the expression levels of 30,465 probes were examined for each sample group. The SNP-probe pairs with combined correlation coefficients of all 3 sample groups corresponding to P<3.1x10(-12) (i.e., Bonferroni-corrected P<0.05) were considered significant. SNP-probe pairs with a high likelihood of cross-hybridization and SNP-in-probe effects were excluded to avoid false positive results. We identified 102 cis-acting and 5 trans-acting eQTL regions. The cis-eQTL regions were widely distributed both upstream and downstream of the gene, as well as within the gene. The eQTL SNPs identified were examined for their influence on the expression levels in lymphoblastoid cell lines by using a public database. The results showed that genetic variants affecting expression levels in whole blood may have different effects on gene expression in lymphoblastoid cell lines. Further studies are required to clarify how SNPs function in affecting the expression levels in whole blood as well as in other tissues.	[Sasayama, Daimei; Hori, Hiroaki; Teraishi, Toshiya; Hattori, Kotaro; Ota, Miho; Yamamoto, Noriko; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan; [Sasayama, Daimei; Amano, Naoji] Shinshu Univ, Sch Med, Dept Psychiat, Matsumoto, Nagano 390, Japan; [Nakamura, Seiji; Miyata, Ryo] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Kunugi, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Shinshu University; DNA Chip Research Inc.; Japan Science & Technology Agency (JST)	Kunugi, H (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1870031, Japan.	hkunugi@ncnp.go.jp	Kunugi, Hiroshi/ABC-5260-2021; Miyata, Ryo/J-8804-2012	Miyata, Ryo/0000-0002-7032-994X; Kunugi, Hiroshi/0000-0002-7209-3790; Hori, Hiroaki/0000-0002-4548-7110	Health and Labor Sciences Research Grants; Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry	This study was supported by Health and Labor Sciences Research Grants, the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Understanding of molecular and environmental bases for brain health), Core Research of Evolutional Science & Technology by the Japan Science and Technology Agency, and an Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dobrin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023480; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; FALLER AJ, 1981, J APPL METEOROL, V20, P203, DOI 10.1175/1520-0450(1981)020<0203:AACC>2.0.CO;2; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Mehta D, 2012, EUR J HUM GENET; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Taurines R, 2011, WORLD J BIOL PSYCHIA, V12, P104, DOI 10.3109/15622975.2011.600297; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	23	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54967	10.1371/journal.pone.0054967	http://dx.doi.org/10.1371/journal.pone.0054967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359819	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600139
J	Brown, J; Machen, H; Kawaza, K; Mwanza, Z; Iniguez, S; Lang, H; Gest, A; Kennedy, N; Miros, R; Richards-Kortum, R; Molyneux, E; Oden, M				Brown, Jocelyn; Machen, Heather; Kawaza, Kondwani; Mwanza, Zondiwe; Iniguez, Suzanne; Lang, Hans; Gest, Alfred; Kennedy, Neil; Miros, Robert; Richards-Kortum, Rebecca; Molyneux, Elizabeth; Oden, Maria			A High-Value, Low-Cost Bubble Continuous Positive Airway Pressure System for Low-Resource Settings: Technical Assessment and Initial Case Reports	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SUPPORT; CPAP	Acute respiratory infections are the leading cause of global child mortality. In the developing world, nasal oxygen therapy is often the only treatment option for babies who are suffering from respiratory distress. Without the added pressure of bubble Continuous Positive Airway Pressure (bCPAP) which helps maintain alveoli open, babies struggle to breathe and can suffer serious complications, and frequently death. A stand-alone bCPAP device can cost $6,000, too expensive for most developing world hospitals. Here, we describe the design and technical evaluation of a new, rugged bCPAP system that can be made in small volume for a cost-of-goods of approximately $350. Moreover, because of its simple design-consumer-grade pumps, medical tubing, and regulators-it requires only the simple replacement of a <$1 diaphragm approximately every 2 years for maintenance. The low-cost bCPAP device delivers pressure and flow equivalent to those of a reference bCPAP system used in the developed world. We describe the initial clinical cases of a child with bronchiolitis and a neonate with respiratory distress who were treated successfully with the new bCPAP device.	[Brown, Jocelyn; Richards-Kortum, Rebecca; Oden, Maria] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Machen, Heather] Baylor Coll Med, Dept Pediat Emergency Med, Houston, TX 77030 USA; [Kawaza, Kondwani; Mwanza, Zondiwe; Kennedy, Neil; Molyneux, Elizabeth] Coll Med, Dept Pediat, Blantyre, Malawi; [Kawaza, Kondwani; Mwanza, Zondiwe; Kennedy, Neil; Molyneux, Elizabeth] Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Iniguez, Suzanne] Texas Childrens Hosp, Dept Resp Care, Houston, TX 77030 USA; [Lang, Hans] Coll Med, Dept Pediat, Lilongwe, Malawi; [Lang, Hans] Kamuzu Cent Hosp, Lilongwe, Malawi; [Gest, Alfred] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Miros, Robert] 3rd Stone Design, San Rafael, CA USA	Rice University; Baylor College of Medicine; University of Malawi; University of Malawi; Baylor College of Medicine; University of Malawi; Baylor College of Medicine	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467; Kennedy, Neil/0000-0002-6262-2679				Bonner Krista M, 2008, Adv Neonatal Care, V8, P78, DOI 10.1097/01.ANC.0000317256.76201.72; Diblasi RM, 2010, PEDIATR RES, V68, P526, DOI 10.1203/PDR.0b013e3181f985f0; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; Enarson P, 2008, B WORLD HEALTH ORGAN, V86, P344, DOI 10.2471/BLT.07.048017; Howson CP, 2012, BORN TOO SOON GLOBAL, P2; Kamath BD, 2011, PEDIATRICS, V127, P1139, DOI 10.1542/peds.2010-3212; Kaur C, 2008, INDIAN PEDIATR, V45, P312; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Madhi SA, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P149; Nowadzky T, 2009, PEDIATRICS, V123, P1534, DOI 10.1542/peds.2008-1279; Urs PS, 2009, INDIAN PEDIATR, V46, P409; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Watson AD., 2010, PREMARKET NOTIFICATI; World Health Organization, 2006, NEON PER MORT COUNTR, P22	15	48	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53622	10.1371/journal.pone.0053622	http://dx.doi.org/10.1371/journal.pone.0053622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372661	Green Published, gold			2022-12-27	WOS:000314021500017
J	Euler, Z; van Gils, MJ; Boeser-Nunnink, BD; Schuitemaker, H; van Manen, D				Euler, Zelda; van Gils, Marit J.; Boeser-Nunnink, Brigitte D.; Schuitemaker, Hanneke; van Manen, Danielle			Genome-Wide Association Study on the Development of Cross-Reactive Neutralizing Antibodies in HIV-1 Infected Individuals	PLOS ONE			English	Article							HIV-1 INFECTION; DISEASE PROGRESSION; CLINICAL-COURSE; T-CELLS; VIRUS; NK; DETERMINANTS; EXPRESSION; ANTIGENS; BROAD	Broadly neutralizing antibodies may protect against HIV-1 acquisition. In natural infection, only 10-30% of patients have cross-reactive neutralizing humoral immunity which may relate to viral and or host factors. To explore the role of host genetic markers in the formation of cross-reactive neutralizing activity (CrNA) in HIV-1 infected individuals, we performed a genome-wide association study (GWAS), in participants of the Amsterdam Cohort Studies with known CrNA in their sera. Single-nucleotide polymorphisms (SNPs) with the strongest P-values are located in the major histocompatibility complex (MHC) region, close to MICA (P = 7.68 x 10(-7)), HLA-B (P = 6.96 x 10(-6)) and in the coding region of HCP5 (P = 1.34 x 10(-5)). However, none of the signals reached genome-wide significance. Our findings underline the potential involvement of genes close or within the MHC region with the development of CrNA.	Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Schuitemaker, H (corresponding author), Crucell Holland BV, Leiden, Netherlands.	h.schuitemaker@amc.uva.nl	van Gils, Marit J./H-4791-2019	van Gils, Marit J./0000-0003-3422-8161	Netherlands Organization for Scientific Research [918.66.628, 912.06.046]; European Community [037611, 201433]; Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment	This study was financially supported by The Netherlands Organization for Scientific Research (grant 918.66.628 and 912.06.046), the European Community's Six Framework Program European HIV Enterprise (EUROPRISE; FP6/2007-2012) under grant agreement 037611 and the European Community's Seventh Framework Program Next Generation HIV-1 Immunogens inducing broadly reactive Neutralizing antibodies (NGIN) (FP7/2007-2013) under grant agreement 201433. The ACS are financially supported by the Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR RECOMM REP, V41, P1; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Maloy KJ, 1998, P NATL ACAD SCI USA, V95, P1160, DOI 10.1073/pnas.95.3.1160; Mbow ML, 2001, INFECT IMMUN, V69, P2407, DOI 10.1128/IAI.69.4.2407-2415.2001; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Nolting A, 2010, VIROLOGY, V406, P12, DOI 10.1016/j.virol.2010.05.014; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Paul P, 2011, CELL IN PRESS; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; VANGRIENSVEN GJP, 1989, BMJ-BRIT MED J, V298, P218, DOI 10.1136/bmj.298.6668.218	35	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54684	10.1371/journal.pone.0054684	http://dx.doi.org/10.1371/journal.pone.0054684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372753	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500106
J	Banigan, MG; Kao, PF; Kozubek, JA; Winslow, AR; Medina, J; Costa, J; Schmitt, A; Schneider, A; Cabral, H; Cagsal-Getkin, O; Vanderburg, CR; Delalle, I				Banigan, Meredith G.; Kao, Patricia F.; Kozubek, James A.; Winslow, Ashley R.; Medina, Juan; Costa, Joan; Schmitt, Andrea; Schneider, Anja; Cabral, Howard; Cagsal-Getkin, Ozge; Vanderburg, Charles R.; Delalle, Ivana			Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SHRUNKEN CENTROIDS; DENDRITIC SPINES; GENE-EXPRESSION; AMYLOID-BETA; BRAIN; PATHWAY; SECRETION; RNA; MICROARRAYS	Exosomes are cellular secretory vesicles containing microRNAs (miRNAs). Once secreted, exosomes are able to attach to recipient cells and release miRNAs potentially modulating the function of the recipient cell. We hypothesized that exosomal miRNA expression in brains of patients diagnosed with schizophrenia (SZ) and bipolar disorder (BD) might differ from controls, reflecting either disease-specific or common aberrations in SZ and BD patients. The sources of the analyzed samples included McLean 66 Cohort Collection (Harvard Brain Tissue Resource Center), BrainNet Europe II (BNE, a consortium of 18 brain banks across Europe) and Boston Medical Center (BMC). Exosomal miRNAs from frozen postmortem prefrontal cortices with well-preserved RNA were isolated and submitted to profiling by Luminex FLEXMAP 3D microfluidic device. Multiple statistical analyses of microarray data suggested that certain exosomal miRNAs were differentially expressed in SZ and BD subjects in comparison to controls. RT-PCR validation confirmed that two miRNAs, miR-497 in SZ samples and miR-29c in BD samples, have significantly increased expression when compared to control samples. These results warrant future studies to evaluate the potential of exosome-derived miRNAs to serve as biomarkers of SZ and BD.	[Banigan, Meredith G.; Kao, Patricia F.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Banigan, Meredith G.; Cagsal-Getkin, Ozge; Vanderburg, Charles R.] Harvard NeuroDiscovery Ctr, Adv Tissue Resource Ctr, Charlestown, MA USA; [Kozubek, James A.] Boston Univ, Sch Med, Dept Biomed Genet, Boston, MA 02118 USA; [Winslow, Ashley R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Medina, Juan; Costa, Joan] Neurol Tissue Bank, Barcelona, Spain; [Schmitt, Andrea] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Schmitt, Andrea] Univ Sao Paulo, Fac Med, Dept Psychiat, Neurosci Lab, Sao Paulo, Brazil; [Schmitt, Andrea] Univ Sao Paulo, Fac Med, Inst Psychiat, Sao Paulo, Brazil; [Schneider, Anja] Univ Med Goettingen, Dept Psychiat, Gottingen, Germany; [Schneider, Anja] German Res Ctr Neurodegenerat Dis, Gottingen, Germany; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cabral, Howard] Boston Univ, Clin & Translat Sci Inst, Boston, MA 02118 USA	Boston University; Harvard University; Boston University; Harvard University; Massachusetts General Hospital; University of Munich; Universidade de Sao Paulo; Universidade de Sao Paulo; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Boston University; Boston University	Delalle, I (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	idelalle@bu.edu	Schmitt, Andrea/V-3003-2018; Vanderburg, Charles/C-4516-2013	Schmitt, Andrea/0000-0002-5426-4023; Vanderburg, Charles/0000-0001-8979-5054; Delalle, Ivana/0000-0002-1873-3064; Cabral, Howard/0000-0002-1185-8331; Schneider, Anja/0000-0001-9540-8700	National Institute of Mental Health [R21 MH086079]; National Institute of Aging [T32 AG00015-21]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023480] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Mental Health (R21 MH086079; ID and CRV) and National Institute of Aging (T32 AG00015-21; PFK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barbato C, 2010, J NEUROCHEM, V113, P591, DOI 10.1111/j.1471-4159.2009.06560.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2012, NEUROBIOL DIS, V46, P263, DOI 10.1016/j.nbd.2011.12.029; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Gallego JA, 2012, J MOL NEUROSCI, V47, P243, DOI 10.1007/s12031-012-9731-7; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Ghosh Debashis, 2005, Functional & Integrative Genomics, V5, P18, DOI 10.1007/s10142-004-0120-3; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HOLM S, 1979, SCAND J STAT, V6, P65; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lakhal S, 2011, BIOESSAYS, V33, P737, DOI 10.1002/bies.201100076; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Okabayashi S, 2010, NEUROREPORT, V21, P606, DOI 10.1097/WNR.0b013e3283383467; Owen MJ, 2005, BRIT MED J, V330, P158, DOI 10.1136/bmj.330.7484.158; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Presutti C, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S5; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Suedof Thomas C., 2008, V184, P1; TARRANT SB, 1977, TISSUE CELL, V9, P461, DOI 10.1016/0040-8166(77)90006-4; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 2003, STAT SCI, V18, P104, DOI 10.1214/ss/1056397488; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vawter MP, 2000, BIOL PSYCHIAT, V48, P486, DOI 10.1016/S0006-3223(00)00978-1; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	67	150	160	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e48814	10.1371/journal.pone.0048814	http://dx.doi.org/10.1371/journal.pone.0048814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382797	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800002
J	Zhao, YH; Larson-Rabin, Z; Wang, GY; Moller, M; Li, CY; Zhang, JP; Li, HT; Li, DZ				Zhao, Yin-He; Larson-Rabin, Zachary; Wang, Guo-Ying; Moeller, Michael; Li, Cheng-Yun; Zhang, Jin-Peng; Li, Hong-Tao; Li, De-Zhu			Developmental Genetics of the Perianthless Flowers and Bracts of a Paleoherb Species, Saururus chinensis	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; HOMEOTIC GENES; EXPRESSION; EVOLUTION; APETALA3; SEQUENCE; PROTEINS; PISTILLATA; LEAVES	Saururus chinensis is a core member of Saururaceae, a perianthless (lacking petals or sepals) family. Due to its basal phylogenetic position and unusual floral composition, study of this plant family is important for understanding the origin and evolution of perianthless flowers and petaloid bracts among angiosperm species. To isolate genes involved in S. chinensis flower development, subtracted floral cDNA libraries were constructed by using suppression subtractive hybridization (SSH) on transcripts isolated from developing inflorescences and seedling leaves. The subtracted cDNA libraries contained a total of 1,141 ESTs and were used to create cDNA microarrays to analyze transcript profiles of developing inflorescence tissues. Subsequently, qRT-PCR analyses of eight MADS-box transcription factors and in situ hybridizations of two B-class MADS-box transcription factors were performed to verify and extend the cDNA microarray results. Finally, putative phylogenetic relationships within the B-class MADS-box gene family were determined using the discovered S. chinensis B-class genes to compare K-domain sequences with B genes from other basal angiosperms. Two hundred seventy-seven of the 1,141 genes were found to be expressed differentially between S. chinensis inflorescence tissues and seedling leaves, 176 of which were grouped into at least one functional category, including transcription (14.75%), energy (12.59%), metabolism (9.12%), protein-related function (8.99%), and cellular transport (5.76%). qRT-PCR and in situ hybridization of selected MADS-box genes supported our microarray data. Phylogenetic analysis indicated that a total of six B-class MADS-box genes were isolated from S. chinensis. The differential regulation of S. chinensis B-class MADSbox transcription factors likely plays a role during the development of subtending bracts and perianthless flowers. This study contributes to our understanding of inflorescence development in Saururus, and represents an initial step toward understanding the formation of petaloid bracts in this species.	[Zhao, Yin-He; Larson-Rabin, Zachary; Li, Hong-Tao; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China; [Zhao, Yin-He; Li, Cheng-Yun] Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China; [Zhao, Yin-He; Li, Cheng-Yun] Yunnan Agr Univ, Key Lab Plant Pathol Yunnan Prov, Kunming, Peoples R China; [Wang, Guo-Ying; Zhang, Jin-Peng] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Moeller, Michael] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; Yunnan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China.	dzl@mail.kib.ac.cn	Moeller, Michael/O-9748-2015; Li, De-Zhu/G-8203-2011	Moeller, Michael/0000-0002-2819-0323; Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Ministry of Science and Technology of China [2004DKA30430]; National Natural Science Foundation of China [NSFC30860130, NSFC31060166]; Yunnan Natural Science Foundation [2007C209M]; Large-scale Scientific Facilities of the Chinese Academy of Sciences program [2009-LSFGBOWS-01]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Large-scale Scientific Facilities of the Chinese Academy of Sciences program	This work was supported by the Ministry of Science and Technology of China [2004DKA30430]; the National Natural Science Foundation of China [NSFC30860130 and NSFC31060166]; the Yunnan Natural Science Foundation [2007C209M]; and the Large-scale Scientific Facilities of the Chinese Academy of Sciences program [2009-LSFGBOWS-01]. Z.L.R. was supported by a Chinese Academy of Sciences Young International Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Bowman JL, 1997, J BIOSCIENCE, V22, P515, DOI 10.1007/BF02703197; Buzgo M, 2004, INT J PLANT SCI, V165, P925, DOI 10.1086/424024; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; De Craene Louis P. Ronse, 2004, Annals of Botany (London), V94, P741; Di Stilio VS, 2005, PLANT J, V41, P755, DOI 10.1111/j.1365-313X.2005.02336.x; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Fernandes J, 2002, PLANT PHYSIOL, V128, P896, DOI 10.1104/pp.010681; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Furutani I, 2006, PLANT J, V46, P503, DOI 10.1111/j.1365-313X.2006.02703.x; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hu W, 2003, PLANT MOL BIOL, V53, P545, DOI 10.1023/B:PLAN.0000019063.18097.62; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jaramillo MA, 2007, MOL PHYLOGENET EVOL, V44, P598, DOI 10.1016/j.ympev.2007.03.015; Jaramillo MA, 2004, EVOL DEV, V6, P449, DOI 10.1111/j.1525-142X.2004.04053.x; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Johansen B, 2002, MOL PHYLOGENET EVOL, V23, P458, DOI 10.1016/S1055-7903(02)00032-5; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim S, 2005, INT J PLANT SCI, V166, P185, DOI 10.1086/427479; Koo SC, 2010, PLANT J, V62, P807, DOI 10.1111/j.1365-313X.2010.04192.x; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Kramer EM, 2000, INT J PLANT SCI, V161, pS29, DOI 10.1086/317576; Liang HX, 1996, ACTA PHYTOTAXONOMICA, V34, P565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mouradov A, 1999, DEV GENET, V25, P245, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;245::AID-DVG7&gt;3.0.CO;2-N; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Shindo S, 1999, EVOL DEV, V1, P180, DOI 10.1046/j.1525-142x.1999.99024.x; Soltis PS, 2009, AM J BOT, V96, P110, DOI 10.3732/ajb.0800182; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUCKER SC, 1993, SYST BOT, V18, P614, DOI 10.2307/2419537; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Whipple CJ, 2010, PLANT CELL, V22, P565, DOI 10.1105/tpc.109.073536; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yang YZ, 2003, PLANT J, V33, P47, DOI 10.1046/j.0960-7412.2003.01473.x; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang XH, 2005, PLANT MOL BIOL, V58, P401, DOI 10.1007/s11103-005-5434-6; Zhao DL, 1999, PHOTOSYNTHETICA, V36, P279, DOI 10.1023/A:1007059930011; Zhao YH, 2010, PLANTA, V231, P265, DOI 10.1007/s00425-009-1048-6; Zhao YH, 2006, ANN BOT-LONDON, V98, P157, DOI 10.1093/aob/mcl081	55	10	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53019	10.1371/journal.pone.0053019	http://dx.doi.org/10.1371/journal.pone.0053019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382831	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800017
J	Alexandru, N; Popov, D; Dragan, E; Andrei, E; Georgescu, A				Alexandru, Nicoleta; Popov, Doina; Dragan, Emanuel; Andrei, Eugen; Georgescu, Adriana			Circulating Endothelial Progenitor Cell and Platelet Microparticle Impact on Platelet Activation in Hypertension Associated with Hypercholesterolemia	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCE DIFFERENTIATION; POTENTIAL ROLE; ATHEROSCLEROSIS; INFLAMMATION; STENT; CAPACITY; RECRUIT; CAPTURE; DISEASE	Aim: The purpose of this project was to evaluate the influence of circulating endothelial progenitor cells (EPCs) and platelet microparticles (PMPs) on blood platelet function in experimental hypertension associated with hypercholesterolemia. Methods: Golden Syrian hamsters were divided in six groups: (i) control, C; (ii) hypertensive-hypercholesterolemic, HH; (iii) 'prevention', HHin-EPCs, HH animals fed a HH diet and treated with EPCs; (iv) 'regression', HHfin-EPCs, HH treated with EPCs after HH feeding; (v) HH treated with PMPs, HH-PMPs, and (vi) HH treated with EPCs and PMPs, HH-EPCs-PMPs. Results: Compared to HH group, the platelets from HHin-EPCs and HHfin-EPCs groups showed a reduction of: (i) activation, reflected by decreased integrin 3b, FAK, PI3K, src protein expression; (ii) secreted molecules as: SDF-1, MCP-1, RANTES, VEGF, PF4, PDGF and (iii) expression of pro-inflammatory molecules as: SDF-1, MCP-1, RANTES, IL-6, IL-1 beta; TFPI secretion was increased. Compared to HH group, platelets of HH-PMPs group showed increased activation, molecules release and proteins expression. Compared to HH-PMPs group the combination EPCs with PMPs treatment induced a decrease of all investigated platelet molecules, however not comparable with that recorded when EPC individual treatment was applied. Conclusion: EPCs have the ability to reduce platelet activation and to modulate their pro-inflammatory and anti-thrombogenic properties in hypertension associated with hypercholesterolemia. Although, PMPs have several beneficial effects in combination with EPCs, these did not improve the EPC effects. These findings reveal a new biological role of circulating EPCs in platelet function regulation, and may contribute to understand their cross talk, and the mechanisms of atherosclerosis.	[Alexandru, Nicoleta; Georgescu, Adriana] Petru Poni Inst Macromol Chem, R-6600 Iasi, Romania; [Alexandru, Nicoleta; Popov, Doina; Dragan, Emanuel; Andrei, Eugen; Georgescu, Adriana] Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Bucharest, Romania	Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology	Alexandru, N (corresponding author), Petru Poni Inst Macromol Chem, R-6600 Iasi, Romania.	nicoleta.alexandru@icbp.ro; adriana.georgescu@icbp.ro	Georgescu, Adriana/B-9185-2011; L, Popov Doina/AAY-5640-2020; Alexandru, Nicoleta/E-5689-2011	Georgescu, Adriana/0000-0003-4945-1745; 	Romanian National Authority for Scientific Research; CNCS - UEFISCDI, project [PNII-CT-ERC-2012-1, PN-II-RU-TE-2012-3-0020, PN-II-ID-PCE-2012-4-0124]; European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme [POSDRU/89/1.5/S/55216]; Sectoral Operational Programme Human Resources Development; Romanian Academy	Romanian National Authority for Scientific Research; CNCS - UEFISCDI, project(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme; Sectoral Operational Programme Human Resources Development; Romanian Academy(Romanian Academy of Sciences)	This research was financially supported by grants of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project ID PNII-CT-ERC-2012-1 (6ERC-like/July 18, 2012), project ID PN-II-RU-TE-2012-3-0020, project ID PN-II-ID-PCE-2012-4-0124 and by European Social Fund - 'Cristofor I. Simionescu' Postdoctoral Fellowship Programme (ID POSDRU/89/1.5/S/55216), Sectoral Operational Programme Human Resources Development 2007-2013, and by Romanian Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Saleh H, 2009, CIRCULATION, V120, P2230, DOI 10.1161/CIRCULATIONAHA.109.894642; Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Alexandru N, 2011, J THROMB HAEMOST, V9, P173, DOI 10.1111/j.1538-7836.2010.04122.x; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Boulanger CM, 2005, CARDIOVASC RES, V67, P1, DOI 10.1016/j.cardiores.2005.05.001; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Co M, 2008, AM HEART J, V155, P128, DOI 10.1016/j.ahj.2007.08.031; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Fadini GP, 2010, CARDIOVASC RES, V87, P12, DOI 10.1093/cvr/cvq119; Flaumenhaft R, 2006, BLOOD CELL MOL DIS, V36, P182, DOI 10.1016/j.bcmd.2005.12.019; Foteinos G, 2008, CIRCULATION, V117, P1856, DOI 10.1161/CIRCULATIONAHA.107.746008; Gawaz M, 2008, J THROMB HAEMOST, V6, P235, DOI 10.1111/j.1538-7836.2007.02867.x; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Georgescu A, 2012, J THROMB HAEMOST, V10, P680, DOI 10.1111/j.1538-7836.2012.04650.x; Georgescu A, 2009, J THROMB HAEMOST, V7, P1566, DOI 10.1111/j.1538-7836.2009.03525.x; Georgescu A, 2011, WORLD J DIABETES, V2, P92, DOI 10.4239/wjd.v2.i6.92; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2008, BASIC RES CARDIOL, V103, P299, DOI 10.1007/s00395-008-0721-4; Larsen K, 2012, EUR HEART J, V33, P120, DOI 10.1093/eurheartj/ehr196; Leshem-Lev D, 2010, J THROMB THROMBOLYS, V30, P398, DOI 10.1007/s11239-010-0514-0; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Lievens D, 2011, THROMB HAEMOSTASIS, V106, P827, DOI 10.1160/TH11-08-0592; Lindemann S, 2007, CURR OPIN LIPIDOL, V18, P566, DOI 10.1097/MOL.0b013e3282ef7c1e; LUPU C, 1993, THROMB HAEMOSTASIS, V70, P579; Maroney SA, 2011, ARTERIOSCL THROM VAS, V31, P821, DOI 10.1161/ATVBAHA.110.220293; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Miglionico M, 2008, CATHETER CARDIO INTE, V71, P600, DOI 10.1002/ccd.21437; Nagy B, 2012, CURR MED CHEM, V19, P518, DOI 10.2174/092986712798918770; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2007, THROMB HAEMOSTASIS, V98, P922, DOI 10.1160/TH07-02-0147; Theiss HD, 2007, EUR HEART J, V28, P1258, DOI 10.1093/eurheartj/ehm011; Tsoumani ME, 2012, CURR VASC PHARMACOL, V10, P539; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Werner N, 2006, J CELL MOL MED, V10, P318, DOI 10.1111/j.1582-4934.2006.tb00402.x; Xu QB, 2003, CIRC RES, V93, pE76, DOI 10.1161/01.RES.0000097864.24725.60; Xu QB, 2007, CURR OPIN LIPIDOL, V18, P534, DOI 10.1097/MOL.0b013e3282a66082; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	54	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52058	10.1371/journal.pone.0052058	http://dx.doi.org/10.1371/journal.pone.0052058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372649	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400002
J	Chung, KY; Day, PW; Velez-Ruiz, G; Sunahara, RK; Kobilka, BK				Chung, Ka Young; Day, Peter W.; Velez-Ruiz, Gisselle; Sunahara, Roger K.; Kobilka, Brian K.			Identification of GPCR-Interacting Cytosolic Proteins Using HDL Particles and Mass Spectrometry-Based Proteomic Approach	PLOS ONE			English	Article							COUPLED-RECEPTORS; 5-HT2C RECEPTORS; COMPLEXES; PURIFICATION; TRANSDUCTION; ARRESTINS; HEART	G protein-coupled receptors (GPCRs) have critical roles in various physiological and pathophysiological processes, and more than 40% of marketed drugs target GPCRs. Although the canonical downstream target of an agonist-activated GPCR is a G protein heterotrimer; there is a growing body of evidence suggesting that other signaling molecules interact, directly or indirectly, with GPCRs. However, due to the low abundance in the intact cell system and poor solubility of GPCRs, identification of these GPCR-interacting molecules remains challenging. Here, we establish a strategy to overcome these difficulties by using high-density lipoprotein (HDL) particles. We used the beta(2)-adrenergic receptor (beta(2)AR), a GPCR involved in regulating cardiovascular physiology, as a model system. We reconstituted purified beta(2)AR in HDL particles, to mimic the plasma membrane environment, and used the reconstituted receptor as bait to pull-down binding partners from rat heart cytosol. A total of 293 proteins were identified in the full agonist-activated beta(2)AR pull-down, 242 proteins in the inverse agonist-activated beta(2)AR pull-down, and 210 proteins were commonly identified in both pull-downs. A small subset of the beta(2)AR-interacting proteins isolated was confirmed by Western blot; three known beta(2)AR-interacting proteins (Gs alpha, NHERF-2, and Grb2) and 3 newly identified known beta(2)AR-interacting proteins (AMPK alpha, acetyl-CoA carboxylase, and UBC-13). Profiling of the identified proteins showed a clear bias toward intracellular signal transduction pathways, which is consistent with the role of beta(2)AR as a cell signaling molecule. This study suggests that HDL particle-reconstituted GPCRs can provide an effective platform method for the identification of GPCR binding partners coupled with a mass spectrometry-based proteomic analysis.	[Chung, Ka Young; Day, Peter W.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Day, Peter W.] Genentech Inc, Roche Grp, Biol Technol, San Francisco, CA USA; [Velez-Ruiz, Gisselle; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; Sungkyunkwan University (SKKU); Roche Holding; Genentech; University of Michigan System; University of Michigan	Chung, KY (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kychung2@skku.edu; kobilka@stanford.edu	Sunahara, Roger/AAJ-8667-2020; Chung, Ka Young/AAO-7984-2020	Kobilka, Brian/0000-0001-5958-3990; Chung, Ka Young/0000-0001-9038-9571	NIH [R01 HL071078, GM083118]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A1039220]; National Center For Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R01GM083118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants R01 HL071078 and GM083118 and National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1039220). The mass spectrometry described in this publication was supported by Award Number S10RR027425 from the National Center For Research Resources. KYC is supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1039220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Capelo JL, 2009, ANAL CHIM ACTA, V650, P151, DOI 10.1016/j.aca.2009.07.034; Daaka Y, 2012, BBA-GEN SUBJECTS, V1820, P743, DOI 10.1016/j.bbagen.2011.03.007; Daulat AM, 2009, TRENDS PHARMACOL SCI, V30, P72, DOI 10.1016/j.tips.2008.10.009; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Farr CD, 2004, J NEUROCHEM, V91, P438, DOI 10.1111/j.1471-4159.2004.02735.x; Free R Benjamin, 2009, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0528s46; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Helbig AO, 2010, J PROTEOMICS, V73, P868, DOI 10.1016/j.jprot.2010.01.005; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Kabbani N, 2007, EUR J PHARMACOL, V572, P83, DOI 10.1016/j.ejphar.2007.06.059; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physiol.00051.2006; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Maurice P, 2008, MOL CELL PROTEOMICS, V7, P1556, DOI 10.1074/mcp.M700435-MCP200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pluder F, 2006, PHARMACOL THERAPEUT, V112, P1, DOI 10.1016/j.pharmthera.2006.03.001; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206	31	19	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54942	10.1371/journal.pone.0054942	http://dx.doi.org/10.1371/journal.pone.0054942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372797	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400043
J	Reale, ME; Webb, IC; Wang, X; Baltazar, RM; Coolen, LM; Lehman, MN				Reale, Meghan E.; Webb, Ian C.; Wang, Xu; Baltazar, Ricardo M.; Coolen, Lique M.; Lehman, Michael N.			The Transcription Factor Runx2 Is under Circadian Control in the Suprachiasmatic Nucleus and Functions in the Control of Rhythmic Behavior	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EFFERENT PROJECTIONS; OSTEOCALCIN GENE; BONE-DEVELOPMENT; OLFACTORY-BULB; TGF-BETA; IN-VIVO; PERIOD	Runx2, a member of the family of runt-related transcription factors, is rhythmically expressed in bone and may be involved in circadian rhythms in bone homeostasis and osteogenesis. Runx2 is also expressed in the brain, but its function is unknown. We tested the hypothesis that in the brain, Runx2 may interact with clock-controlled genes to regulate circadian rhythms in behavior. First, we demonstrated diurnal and circadian rhythms in the expression of Runx2 in the mouse brain. Expression of Runx2 mRNA and protein mirrored that of the core clock genes, Period1 and Period2, in the suprachiasmatic nucleus (SCN), the paraventricular nucleus and the olfactory bulb. The rhythm of Runx2 expression was eliminated in the SCN of Bmal1(-/-) mice. Moreover, by crossbreeding mPer2(Luc) mice with Runx2(+/-) mice and recording bioluminescence rhythms, a significant lengthening of the period of rhythms was detected in cultured SCN of Runx2(-/-) animals compared to either Runx2(+/-) or Runx2(+/+) mice. Behavioral analyses of Runx2 mutant mice revealed that Runx2(+/-) animals displayed a significantly lengthened free-running period of running wheel activity compared to Runx2(+/+) littermates. Taken together, these findings provide evidence for clock gene-mediated rhythmic expression of Runx2, and its functional role in regulating circadian period at the level of the SCN and behavior.	[Reale, Meghan E.; Wang, Xu; Baltazar, Ricardo M.; Coolen, Lique M.; Lehman, Michael N.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA	Western University (University of Western Ontario); University of Mississippi; University of Mississippi Medical Center	Lehman, MN (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.	mlehman@umc.edu	Lehman, Michael/ABC-9076-2020	Lehman, Michael/0000-0002-9076-5108; Coolen, Lique/0000-0003-2920-1116	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada to MNL and MER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Barski A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh097; BERK ML, 1981, BRAIN RES, V226, P1, DOI 10.1016/0006-8993(81)91079-9; Beynon AL, 2009, NEUROIMMUNOMODULAT, V16, P392, DOI 10.1159/000228914; Breen KM, 2010, ENDOCRINOLOGY, V151, P2669, DOI 10.1210/en.2009-0949; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Dai JP, 1997, J COMP NEUROL, V383, P397, DOI 10.1002/(SICI)1096-9861(19970714)383:4<397::AID-CNE1>3.0.CO;2-Y; DUCY P, 1995, MOL CELL BIOL, V15, P1858; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; GERGEN JP, 1986, CELL, V45, P289, DOI 10.1016/0092-8674(86)90393-4; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Gutierrez S, 2004, J BIOL CHEM, V279, P43581, DOI 10.1074/jbc.M408335200; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Luppen CA, 2003, J BIOL CHEM, V278, P44995, DOI 10.1074/jbc.M306730200; Maronde E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011527; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mickman CT, 2008, AM J PHYSIOL-REG I, V295, pR1688, DOI 10.1152/ajpregu.90510.2008; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NIELSEN HK, 1994, DAN MED BULL, V41, P216; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Smith BJ, 2011, OSTEOPOROSIS INT, V22, P1633, DOI 10.1007/s00198-010-1325-z; Stock M, 2005, J CELL BIOCHEM, V95, P506, DOI 10.1002/jcb.20471; Takarada T, 2009, NEUROSCI LETT, V451, P99, DOI 10.1016/j.neulet.2008.12.037; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; VRANG N, 1995, J COMP NEUROL, V353, P585, DOI 10.1002/cne.903530409; Wang CH, 2006, MOL CELL BIOCHEM, V292, P79, DOI 10.1007/s11010-006-9220-9; Ward SM, 2010, J BIOL CHEM, V285, P38987, DOI 10.1074/jbc.M110.175182; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2003, BLOOD CELL MOL DIS, V30, P184, DOI 10.1016/S1079-9796(03)00020-2; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	68	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54317	10.1371/journal.pone.0054317	http://dx.doi.org/10.1371/journal.pone.0054317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372705	gold, Green Submitted, Green Published			2022-12-27	WOS:000315210400011
J	Thompson, ER; Rowley, SM; Sawyer, S; Eccles, DM; Trainer, AH; Mitchell, G; James, PA; Campbell, IG				Thompson, Ella R.; Rowley, Simone M.; Sawyer, Sarah; Eccles, Diana M.; Trainer, Alison H.; Mitchell, Gillian; James, Paul A.; Campbell, Ian G.		KConFab	Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer	PLOS ONE			English	Article							GERMLINE MUTATIONS; DISEASE; GENE; SUSCEPTIBILITY; TOOL	Mutations in RAD51D have been associated with an increased risk of hereditary ovarian cancer and although they have been observed in the context of breast and ovarian cancer families, the association with breast cancer is unclear. The aim of this current study was to validate the reported association of RAD51D with ovarian cancer and assess for an association with breast cancer. We screened for RAD51D mutations in BRCA1/2 mutation-negative index cases from 1,060 familial breast and/or ovarian cancer families (including 741 affected by breast cancer only) and in 245 unselected ovarian cancer cases. Exons containing novel non-synonymous variants were screened in 466 controls. Two overtly deleterious RAD51D mutations were identified among the unselected ovarian cancers cases (0.82%) but none were detected among the 1,060 families. Our data provide additional evidence that RAD51D mutations are enriched among ovarian cancer patients, but are extremely rare among familial breast cancer patients.	[Thompson, Ella R.; Rowley, Simone M.; Trainer, Alison H.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia; [Sawyer, Sarah; Trainer, Alison H.; Mitchell, Gillian; James, Paul A.] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia; [KConFab] Kathleen Cuningham Fdn Res Familial Breast Canc K, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Eccles, Diana M.] Univ Southampton, Fac Med, Princess Anne Hosp, Canc Sci Div, Southampton SO9 5NH, Hants, England; [Trainer, Alison H.; Mitchell, Gillian; James, Paul A.; Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Campbell, Ian G.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Southampton; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Thompson, ER (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia.	ella.thompson@petermac.org	James, Paul/G-2943-2014; campbell, Ian G/F-6006-2011; Eccles, Diana/K-6327-2019	Eccles, Diana/0000-0002-9935-3169; Thompson, Ella/0000-0001-5206-5111; Campbell, Ian/0000-0002-7773-4155; Thorne, Heather/0000-0003-3610-2511; James, Paul/0000-0002-4361-4657; Rowley, Simone/0000-0002-5897-7979	National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; Cancer Australia (NBCF) [628333]; Victorian Cancer Agency; Cancer Australia; NBCF (Priority-driven Collaborative Cancer Research Scheme grant) [628610]; Wessex Cancer Trust; National Breast Cancer Foundation [IF-12-06, PF-13-10] Funding Source: researchfish	National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Australia (NBCF); Victorian Cancer Agency; Cancer Australia; NBCF (Priority-driven Collaborative Cancer Research Scheme grant); Wessex Cancer Trust; National Breast Cancer Foundation	kConFab is supported by grants from the National Breast Cancer Foundation and the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund; the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia; and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up study was funded between 2001-2009 by NHMRC and currently by the National Breast Cancer Foundation and Cancer Australia (NBCF) (ID 628333). This study was supported by the Victorian Cancer Agency, Cancer Australia, and the NBCF (Priority-driven Collaborative Cancer Research Scheme grant, ID 628610), and the Wessex Cancer Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alsop K, 2012, J CLIN ONCOLOGY; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; Bryan EJ, 1996, CANCER RES, V56, P719; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Osher DJ, 2012, BRIT J CANCER, V106, P1460, DOI 10.1038/bjc.2012.87; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Pelttari LM, 2012, J MED GENET; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smiraldo PG, 2005, CANCER RES, V65, P2089, DOI 10.1158/0008-5472.CAN-04-2079; Thompson ER, 2012, HUM MUTAT, V33, P95, DOI 10.1002/humu.21625; Wickramanyake A, 2012, GYNECOL ONCOL, V127, P552, DOI 10.1016/j.ygyno.2012.09.009; Zhang SY, 2011, GYNECOL ONCOL, V121, P353, DOI 10.1016/j.ygyno.2011.01.020	22	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54772	10.1371/journal.pone.0054772	http://dx.doi.org/10.1371/journal.pone.0054772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372765	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000315210400028
J	van de Bunt, M; Gaulton, KJ; Parts, L; Moran, I; Johnson, PR; Lindgren, CM; Ferrer, J; Gloyn, AL; McCarthy, MI				van de Bunt, Martijn; Gaulton, Kyle J.; Parts, Leopold; Moran, Ignasi; Johnson, Paul R.; Lindgren, Cecilia M.; Ferrer, Jorge; Gloyn, Anna L.; McCarthy, Mark I.			The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENOME-WIDE ASSOCIATION; INSULIN SENSITIVITY; SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; MICRORNAS; TARGET; RNAS	Recent advances in the understanding of the genetics of type 2 diabetes (T2D) susceptibility have focused attention on the regulation of transcriptional activity within the pancreatic beta-cell. MicroRNAs (miRNAs) represent an important component of regulatory control, and have proven roles in the development of human disease and control of glucose homeostasis. We set out to establish the miRNA profile of human pancreatic islets and of enriched beta-cell populations, and to explore their potential involvement in T2D susceptibility. We used Illumina small RNA sequencing to profile the miRNA fraction in three preparations each of primary human islets and of enriched beta-cells generated by fluorescence-activated cell sorting. In total, 366 miRNAs were found to be expressed (i.e. >100 cumulative reads) in islets and 346 in beta-cells; of the total of 384 unique miRNAs, 328 were shared. A comparison of the islet-cell miRNA profile with those of 15 other human tissues identified 40 miRNAs predominantly expressed (i.e. >50% of all reads seen across the tissues) in islets. Several highly-expressed islet miRNAs, such as miR-375, have established roles in the regulation of islet function, but others (e.g. miR-27b-3p, miR-192-5p) have not previously been described in the context of islet biology. As a first step towards exploring the role of islet-expressed miRNAs and their predicted mRNA targets in T2D pathogenesis, we looked at published T2D association signals across these sites. We found evidence that predicted mRNA targets of islet-expressed miRNAs were globally enriched for signals of T2D association (p-values <0.01, q-values <0.1). At six loci with genome-wide evidence for T2D association (AP3S2, KCNK16, NOTCH2, SCL30A8, VPS26A, and WFS1) predicted mRNA target sites for islet-expressed miRNAs overlapped potentially causal variants. In conclusion, we have described the miRNA profile of human islets and beta-cells and provide evidence linking islet miRNAs to T2D pathogenesis.	[McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; Johnson, Paul R.; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; Gaulton, Kyle J.; Lindgren, Cecilia M.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Parts, Leopold] Wellcome Trust Sanger Inst, Hinxton, England; [Parts, Leopold] Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Moran, Ignasi; Ferrer, Jorge] Inst Invest August Pi I Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Johnson, Paul R.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Johnson, Paul R.; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Toronto; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oxford; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	Mark.McCarthy@drl.ox.ac.uk	Ferrer, Jorge/A-3176-2012; Moran, Ignasi/AAA-6417-2020; Duarte, Graziela Biude Silva/Q-7728-2016; McCarthy, Mark/M-3763-2015	Ferrer, Jorge/0000-0002-5959-5729; Moran, Ignasi/0000-0002-3307-7106; Gloyn, Anna/0000-0003-1205-1844; Gaulton, Kyle/0000-0003-1318-7161; McCarthy, Mark/0000-0002-4393-0510; Lindgren, Cecilia/0000-0002-4903-9374; Parts, Leopold/0000-0002-2618-670X; van de Bunt, Martijn/0000-0002-6744-6125	Oxford NIHR Biomedical Research Centre, NIDDK [R01 DK073490]; Wellcome Trust [090532/Z/09/Z]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073490] Funding Source: NIH RePORTER	Oxford NIHR Biomedical Research Centre, NIDDK; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MvdB is a Nuffield Department of Medicine Prize Student. LP is a Canadian Institute for Advanced Research Junior Fellow. CML is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). ALG is a Wellcome Trust Senior Research Fellow in Basic & Biomedical Science (095101/2/10/Z). The work was funded by the Oxford NIHR Biomedical Research Centre, NIDDK (R01 DK073490), and the Wellcome Trust (090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Nieto M, 2011, CELL TRANSPLANT; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Parts L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002704; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; van de Bunt M, 2012, DIABETOLOGIA; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	46	113	114	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55272	10.1371/journal.pone.0055272	http://dx.doi.org/10.1371/journal.pone.0055272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372846	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400086
J	Bell, JR; Aralimarad, P; Lim, KS; Chapman, JW				Bell, James R.; Aralimarad, Prabhuraj; Lim, Ka-Sing; Chapman, Jason W.			Predicting Insect Migration Density and Speed in the Daytime Convective Boundary Layer	PLOS ONE			English	Article							VERTICAL-LOOKING RADAR; HIGH-ALTITUDE; BALLOONING DISPERSAL; AERIAL MIGRATION; FLIGHT; DISTRIBUTIONS; COMPLEXITY; ABUNDANCE; SPECIFICITY; POPULATIONS	Insect migration needs to be quantified if spatial and temporal patterns in populations are to be resolved. Yet so little ecology is understood above the flight boundary layer (i.e. > 10 m) where in north-west Europe an estimated 3 billion insects km(-1) month(-1) comprising pests, beneficial insects and other species that contribute to biodiversity use the atmosphere to migrate. Consequently, we elucidate meteorological mechanisms principally related to wind speed and temperature that drive variation in daytime aerial density and insect displacements speeds with increasing altitude (150-1200 m above ground level). We derived average aerial densities and displacement speeds of 1.7 million insects in the daytime convective atmospheric boundary layer using vertical-looking entomological radars. We first studied patterns of insect aerial densities and displacements speeds over a decade and linked these with average temperatures and wind velocities from a numerical weather prediction model. Generalized linear mixed models showed that average insect densities decline with increasing wind speed and increase with increasing temperatures and that the relationship between displacement speed and density was negative. We then sought to derive how general these patterns were over space using a paired site approach in which the relationship between sites was examined using simple linear regression. Both average speeds and densities were predicted remotely from a site over 100 km away, although insect densities were much noisier due to local 'spiking'. By late morning and afternoon when insects are migrating in a well-developed convective atmosphere at high altitude, they become much more difficult to predict remotely than during the early morning and at lower altitudes. Overall, our findings suggest that predicting migrating insects at altitude at distances of approximate to 100 km is promising, but additional radars are needed to parameterise spatial covariance.	[Bell, James R.; Lim, Ka-Sing; Chapman, Jason W.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England; [Aralimarad, Prabhuraj] Univ Agr Sci, Dept Entomol, Raichur, Karnataka, India; [Chapman, Jason W.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Bell, JR (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	james.bell@rothamsted.ac.uk	Lim, Ka Sing/B-4480-2012; Bell, James/C-2247-2009	Lim, Ka Sing/0000-0002-9166-2928; Bell, James/0000-0003-1640-6120; Aralimarad, Prabhuraj/0000-0001-7703-4266; Chapman, Jason/0000-0002-7475-4441	UK Biotechnology and Biological Sciences Research Council (BBSRC); University of Agricultural Sciences, Raichur; BBSRC [BBS/E/C/00005195, BBS/E/C/00005191] Funding Source: UKRI; NERC [cfaarr010001, NE/I011471/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00006003, BBS/E/C/00005191, BBS/E/C/00005195] Funding Source: researchfish; Natural Environment Research Council [cfaarr010001, NE/I011471/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Agricultural Sciences, Raichur; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). PA's sabbatical at Rothamsted was funded by the University of Agricultural Sciences, Raichur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTEMEIER GL, 1991, J ATMOS OCEAN TECH, V8, P746, DOI 10.1175/1520-0426(1991)008<0746:TUOIAT>2.0.CO;2; Ahrens CD, 2000, METEOROLOGY TODAY; BASCOMPTE J, 1995, TRENDS ECOL EVOL, V10, P361, DOI 10.1016/S0169-5347(00)89134-X; Bell JR, 2012, GLOBAL ECOL BIOGEOGR, V21, P405, DOI 10.1111/j.1466-8238.2011.00685.x; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Betts AK, 1996, J GEOPHYS RES-ATMOS, V101, P7209, DOI 10.1029/95JD02135; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Byers JA, 2011, ENVIRON ENTOMOL, V40, P1210, DOI 10.1603/EN11043; Chandra AS, 2010, J CLIMATE, V23, P5699, DOI 10.1175/2010JCLI3395.1; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2005, ECOL ENTOMOL, V30, P264, DOI 10.1111/j.0307-6946.2005.00702.x; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Chapman JW, 2003, BIOSCIENCE, V53, P503, DOI 10.1641/0006-3568(2003)053[0503:VRANTF]2.0.CO;2; Chapman JW, 2002, COMPUT ELECTRON AGR, V35, P95, DOI 10.1016/S0168-1699(02)00013-3; Cleugh HA, 2001, BOUND-LAY METEOROL, V98, P1, DOI 10.1023/A:1018798928158; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; DeAngelis DL, 2011, AM NAT, V178, P15, DOI 10.1086/660280; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; DRAKE VA, 1984, BOUND-LAY METEOROL, V28, P353, DOI 10.1007/BF00121314; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geerts B, 2005, ENVIRON ENTOMOL, V34, P361, DOI 10.1603/0046-225X-34.2.361; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Johnson C.G., 1969, MIGRATION DISPERSAL; KITCHEN M, 1981, Q J ROY METEOR SOC, V107, P853, DOI 10.1256/smsqj.45406; Letzel MO, 2003, J ATMOS SCI, V60, P2328, DOI 10.1175/1520-0469(2003)060<2328:LESOTI>2.0.CO;2; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; MOORES WH, 1979, Q J ROY METEOR SOC, V105, P397, DOI 10.1002/qj.49710544406; Nathan R, 2005, DIVERS DISTRIB, V11, P131, DOI 10.1111/j.1366-9516.2005.00146.x; Palutikof J, 1997, CLIMATES BRIT ISLES, P220; Reynolds AM, 2007, BIOL LETTERS, V3, P237, DOI 10.1098/rsbl.2007.0109; Reynolds AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015758; Reynolds AM, 2010, P R SOC B, V277, P765, DOI 10.1098/rspb.2009.1221; Reynolds AM, 2009, P R SOC B, V276, P137, DOI 10.1098/rspb.2008.0880; Reynolds DR, 2008, B ENTOMOL RES, V98, P35, DOI 10.1017/S0007485307005470; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Rotach MW, 1996, Q J ROY METEOR SOC, V122, P367, DOI 10.1002/qj; SCHALL R, 1991, BIOMETRIKA, V78, P719; Shortall CR, 2009, INSECT CONSERV DIVER, V2, P251, DOI 10.1111/j.1752-4598.2009.00062.x; Smith AD, 2000, B ENTOMOL RES, V90, P265, DOI 10.1017/S0007485300000389; SMITH AD, 1993, PHILOS T R SOC B, V340, P393, DOI 10.1098/rstb.1993.0081; Storch D, 2004, BASIC APPL ECOL, V5, P389, DOI 10.1016/j.baae.2004.08.001; TAYLOR LR, 1960, J ANIM ECOL, V29, P45, DOI 10.2307/2270; TAYLOR LR, 1980, J ANIM ECOL, V49, P831, DOI 10.2307/4230; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1988, NATURE, V332, P721, DOI 10.1038/332721a0; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Ward SA, 1998, J ANIM ECOL, V67, P763, DOI 10.1046/j.1365-2656.1998.00238.x; Weaver CP, 2001, B AM METEOROL SOC, V82, P269, DOI 10.1175/1520-0477(2001)082<0269:ADCBHM>2.3.CO;2; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2009, METEOROL APPL, V16, P491, DOI 10.1002/met.146; Zuur Alain F., 2009, P1	58	15	16	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54202	10.1371/journal.pone.0054202	http://dx.doi.org/10.1371/journal.pone.0054202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359799	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600038
J	Chong, Y; Shimoda, S; Yakushiji, H; Ito, Y; Miyamoto, T; Kamimura, T; Shimono, N; Akashi, K				Chong, Yong; Shimoda, Shinji; Yakushiji, Hiroko; Ito, Yoshikiyo; Miyamoto, Toshihiro; Kamimura, Tomohiko; Shimono, Nobuyuki; Akashi, Koichi			Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL AGENTS; CEPHALOSPORIN USE; ESCHERICHIA-COLI; RESISTANCE; IMPACT; CANCER; KLEBSIELLA; SUSCEPTIBILITIES	Background: Our unit adopted the single administration of cefepime as the initial treatment for febrile episodes in neutropenic patients with hematological malignancies. However, recently, cefepime-resistant gram-negative bacteremia, including those with extended-spectrum beta-lactamase (ESBL)-producers, was frequently observed in these patients. Therefore, we instituted a rotation of primary antibiotics for febrile neutropenic patients in an attempt to control antibiotic resistance. Methods: This prospective trial was performed from August 2008 through March 2011 at our unit. After a pre-intervention period, in which cefepime was used as the initial agent for febrile neutropenia, 4 primary antibiotics, namely, piperacillin-tazobactam, ciprofloxacin, meropenem, and cefepime, were rotated at 1-month intervals over 20 months. Blood and surveillance cultures were conducted for febrile episodes, in order to assess the etiology, the resistance pattern (particularly to cefepime), and the prognosis. Results: In this trial, 219 patients were registered. A 65.9% reduction in the use of cefepime occurred after the antibiotic rotation. In the surveillance stool cultures, the detection rate of cefepime-resistant gram-negative isolates, of which ESBL-producers were predominant, declined significantly after the intervention (8.5 vs 0.9 episodes per 1000 patient days before and after intervention respectively, P<0.01). Interestingly, ESBL-related bacteremia was not detected after the initiation of the trial (1.7 vs 0.0 episodes per 1000 patient days before and after intervention respectively, P<0.01). Infection-related mortality was comparable between the 2 periods. Conclusions: We implemented a monthly rotation of primary antibiotics for febrile neutropenic patients. An antibiotic heterogeneity strategy, mainly performed as a cycling regimen, would be useful for controlling antimicrobial resistance among patients treated for febrile neutropenia.	[Chong, Yong; Shimoda, Shinji; Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Yakushiji, Hiroko] Hara Sanshin Hosp, Dept Clin Lab, Fukuoka, Japan; [Ito, Yoshikiyo; Kamimura, Tomohiko] Hara Sanshin Hosp, Dept Blood & Marrow Transplantat, Fukuoka, Japan; [Shimono, Nobuyuki] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 812, Japan	Kyushu University; Kyushu University	Chong, Y (corresponding author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 812, Japan.	ychong@gj9.so-net.ne.jp						Bal AM, 2010, ANN NY ACAD SCI, V1213, P81, DOI 10.1111/j.1749-6632.2010.05867.x; Barie Philip S, 2005, Surg Infect (Larchmt), V6, P41, DOI 10.1089/sur.2005.6.41; Bennett KM, 2007, J TRAUMA, V63, P307, DOI 10.1097/TA.0b013e318120595e; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bradley SJ, 1999, J ANTIMICROB CHEMOTH, V43, P261, DOI 10.1093/jac/43.2.261; Brahmi Nozha, 2006, Journal of Infection and Chemotherapy, V12, P190, DOI 10.1007/s10156-006-0452-0; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; Chong Y, 2011, INT J INFECT DIS, V15, pE277, DOI 10.1016/j.ijid.2010.12.010; Chong Y, 2010, INT J INFECT DIS, V14, pE171, DOI 10.1016/j.ijid.2010.01.004; Craig M, 2007, BONE MARROW TRANSPL, V39, P477, DOI 10.1038/sj.bmt.1705591; Dominguez EA, 2000, INFECT CONT HOSP EP, V21, pS4, DOI 10.1086/503166; Evans Heather L, 2005, Surg Infect (Larchmt), V6, P223, DOI 10.1089/sur.2005.6.223; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gruson D, 2003, CRIT CARE MED, V31, P1908, DOI 10.1097/01.CCM.0000069729.06687.DE; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Hashino S, 2012, EUR J CLIN MICROBIOL, V31, P173, DOI 10.1007/s10096-011-1290-2; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Kim JY, 2008, J ANTIMICROB CHEMOTH, V62, P416, DOI 10.1093/jac/dkn164; Kollef MH, 2006, CLIN INFECT DIS, V43, pS82, DOI 10.1086/504484; Kollef NH, 2000, CRIT CARE MED, V28, P3456, DOI 10.1097/00003246-200010000-00014; Lee SO, 2004, INFECT CONT HOSP EP, V25, P832, DOI 10.1086/502304; Link H, 2003, ANN HEMATOL, V82, pS105, DOI 10.1007/s00277-003-0764-4; *NAT COMM CLIN LAB, 2004, PERF STAND ANT SUSC; Puzniak LA, 2001, CLIN INFECT DIS, V33, P151, DOI 10.1086/321807; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Raineri E, 2010, EUR J CLIN MICROBIOL, V29, P1015, DOI 10.1007/s10096-010-0964-5; Ramphal R, 2006, CLIN INFECT DIS, V42, pS164, DOI 10.1086/500663; Ramphal R, 2004, CLIN INFECT DIS, V39, pS25, DOI 10.1086/383048; Raymond DP, 2001, CRIT CARE MED, V29, P1101, DOI 10.1097/00003246-200106000-00001; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Takesue Y, 2010, J HOSP INFECT, V75, P28, DOI 10.1016/j.jhin.2009.11.022; Warren DK, 2004, CRIT CARE MED, V32, P2450, DOI 10.1097/01.CCM.0000147685.79487.28	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54190	10.1371/journal.pone.0054190	http://dx.doi.org/10.1371/journal.pone.0054190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372683	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500037
J	Schroder, A; Vulink, N; Denys, D				Schroder, Arjan; Vulink, Nienke; Denys, Damiaan			Misophonia: Diagnostic Criteria for a New Psychiatric Disorder	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SCALE; RATING-SCALE; VALIDITY; RELIABILITY	Background: Some patients report a preoccupation with a specific aversive human sound that triggers impulsive aggression. This condition is relatively unknown and has hitherto never been described, although the phenomenon has anecdotally been named misophonia. Methodology and Principal Findings: 42 patients who reported misophonia were recruited by our hospital website. All patients were interviewed by an experienced psychiatrist and were screened with an adapted version of the Y-BOCS, HAM-D, HAM-A, SCL-90 and SCID II. The misophonia patients shared a similar pattern of symptoms in which an auditory or visual stimulus provoked an immediate aversive physical reaction with anger, disgust and impulsive aggression. The intensity of these emotions caused subsequent obsessions with the cue, avoidance and social dysfunctioning with intense suffering. The symptoms cannot be classified in the current nosological DSM-IV TR or ICD-10 systems. Conclusions: We suggest that misophonia should be classified as a discrete psychiatric disorder. Diagnostic criteria could help to officially recognize the patients and the disorder, improve its identification by professional health carers, and encourage scientific research.	[Schroder, Arjan; Vulink, Nienke; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Denys, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ddenys@gmail.com		Vulink, Nienke/0000-0001-8991-9627				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Dunn W., 1999, SENSORY PROFILE EXAM; First M. B., 1997, STRUCTURED CLIN INTE; Goodman W., 1989, ARCH GEN PSYCHIAT, V48, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Hadjipavlou G, 2008, PSYCHOSOM MED, V70, P739, DOI 10.1097/PSY.0b013e318180edc2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HOLLANDER E, 1995, J CLIN PSYCHIAT, V56, P3; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Jastreboff PJ, 2000, TINNITUS HDB, P357; LeDoux, 2000, ANNU REV NEUROSCI, P155; Marks IM, 1987, FEARS PHOBIAS RITUAL, P396; McArdle R, 2009, HDB CLIN AUDIOLOGY, P64; McElroy SL, 1999, J CLIN PSYCHIAT, V60, P12; Pallanti S, 2005, J GAMBL STUD, V21, P431, DOI 10.1007/s10899-005-5557-3; Phillips KA, 1997, PSYCHOPHARMACOL BULL, V33, P17; Rogers SJ, 2005, J CHILD PSYCHOL PSYC, V46, P1255, DOI 10.1111/j.1469-7610.2005.01431.x; Schlauch RS, 2009, HDB CLIN AUDIOLOGY, V6, P30; Schwartz Paula, 2011, Minn Med, V94, P42; Villemarette-Pittman NR, 2004, J PSYCHOL, V138, P5, DOI 10.3200/JRLP.138.1.5-22; World Health Organization, 1994, INT STAT CLASS DIS R	24	125	131	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54706	10.1371/journal.pone.0054706	http://dx.doi.org/10.1371/journal.pone.0054706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372758	Green Published, gold			2022-12-27	WOS:000314021500112
J	Wu, JJ; Meng, ZF; Xu, JQ; Lei, YH; Jin, L; Zhong, P; Han, RZ; Su, B				Wu, Jianjun; Meng, Zhefeng; Xu, Jianqing; Lei, Yanhua; Jin, Lin; Zhong, Ping; Han, Renzhi; Su, Bin			New Emerging Recombinant HIV-1 Strains and Close Transmission Linkage of HIV-1 Strains in the Chinese MSM Population Indicate a New Epidemic Risk	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; SUBTYPES; MEN; SEX; PROVINCE; DONORS	In recent years, the population of men who have sex with men (MSM) have become the most significant increasing group of HIV-1 transmission in China. To identify new recombinant strains and transmission patterns of HIV-1 in Chinese MSM population, a cross-sectional investigation of MSM in Anhui Province (in south-eastern China) was performed in 2011. The diagnosed AIDS case rate, CD4 T-cell counts, HIV subtypes, and origin of the recombinant strains were investigated in 138 collected samples. The phylogenetic and bootscan analyses demonstrated that, apart from three previously reported circulating strains (CRF07_BC, CRF01_AE, subtype B), various recombinant strains among subtype B, subtype C, CRF01_AE, and CRF07_BC were simultaneously identified in Chinese MSM for the first time. The introducing time of B subtype in Chinese MSM populations was estimated in 1985, CRF01_AE in 2000, and CRF07_ BC in 2003; the latter two account for more than 85% of MSM infections. Notably, in comparison with B subtype infections in Anhui MSM, CRF01_AE, with the highest prevalence rate, may accelerate AIDS progression. Over half of patients (56%) infected with new recombinant strains infection are diagnosed as progression into AIDS. Both Bayes and phylogenetic analyses indicated that there was active HIV transmission among MSM nationwide, which may facilitate the transmission of the new 01B recombinant strains in MSM. In conclusion, new recombinant strains and active transmission were identified in the Chinese MSM population, which may lead to a new alarming HIV pandemic in this population due to the increased pathogenesis of the newly emerging strains.	[Wu, Jianjun; Jin, Lin; Su, Bin] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Meng, Zhefeng; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS STD, Shanghai, Peoples R China; [Lei, Yanhua] Hefei Ctr Dis Control & Prevent, Hefei, Peoples R China; [Han, Renzhi] Loyola Univ, Dept Cell & Mol Physiol, Chicago Hlth Sci Div, Maywood, IL 60153 USA	Fudan University; Shanghai Center for Disease Control & Prevention; Loyola University Chicago	Meng, ZF (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Key Lab Med Mol Virol, Minist Educ Hlth,Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhefengm@hotmail.com; sub@ahcdc.com.cn	YANHUA, LEI/AAW-7873-2021; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Han, Renzhi/0000-0002-8202-9186; Wu, Jian/0000-0002-3394-1507; meng, zhefeng/0000-0001-9396-0673	Anhui provincial Program of Prevent medicinePublic Health [2011Y0102]; China Ministry of Health & China ministry of Science and Technology [2012ZX10001-002-001-002, 2012ZX10001-006]	Anhui provincial Program of Prevent medicinePublic Health; China Ministry of Health & China ministry of Science and Technology	This work was supported by Anhui provincial Program of Prevent medicine&Public Health (Grant#2011Y0102) and National Grand Program on Key Infectious Disease Control (Grant#2012ZX10001-002-001-002, 2012ZX10001-006), China Ministry of Health & China ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Ministry of Health Joint United Nations Programme on HIV/AIDS World Health Organization, 2008, 2007 UPDATE ON THE H, V2008, P6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; KALISH ML, 1995, AIDS, V9, P851, DOI 10.1097/00002030-199508000-00004; Lau KA, 2007, AIDS REV, V9, P218; Lemey P., 2009, PLOS CURR-TREE LIFE, V1, DOI [10.1371/currents.rrn1031, 10.1371/currents.RRN1031, DOI 10.1371/CURRENTS.RRN1031]; Li L, 2012, AIDS RES HUM RETROV, V201, P27; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li N, 2010, JAIDS-J ACQ IMM DEF, V53, pS41, DOI 10.1097/QAI.0b013e3181c7d717; Liu J, 2011, PLOS ONE, V8; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Meng ZF, 2011, CHINESE MED J-PEKING, V124, P304, DOI 10.3760/cma.j.issn.0366-6999.2011.02.028; Meng ZF, 2007, AIDS RES HUM RETROV, V23, P1049, DOI 10.1089/aid.2007.0058; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Sanchez-Merino V, 2003, AIDS RES HUM RETROV, V19, P49, DOI 10.1089/08892220360473961; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Wang W, 2011, AIDS RES HUM RETROV, V27, P1089; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; WENIGER BG, 1994, AIDS, V8, pS13; WHO, 2000, AIDS EPIDEMIC UPDATE; World Health Organization, 2012, 2012 JOINT MON PROGR, P1; Xin Ruo-lei, 2009, Zhonghua Yi Xue Za Zhi, V89, P876; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	26	47	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54322	10.1371/journal.pone.0054322	http://dx.doi.org/10.1371/journal.pone.0054322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372706	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500057
J	Cheallaigh, CN; Fitzgeral, I; Grace, J; Singh, GJ; El-Eraki, N; Gibbons, N; Keane, J; Rogers, TR; Clarke, S; Bergin, C				Cheallaigh, Cliona Ni; Fitzgeral, Ian; Grace, Jacinta; Singh, Gurmit Jagjit; El-Eraki, Nahla; Gibbons, Noel; Keane, Joseph; Rogers, Thomas R.; Clarke, Susan; Bergin, Colm			Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; TUBERCULIN SKIN-TEST; ACTIVE TUBERCULOSIS; SOUTH-AFRICA; OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY; DRUG-USERS; RISK; SENSITIVITY; RESPONSES	Background: Interferon gamma release assays (IGRAs) are used to diagnose latent tuberculosis infection. Two IGRAs are commercially available: the Quantiferon TB Gold In Tube (QFT-IT) and the T-SPOT. TB. There is debate as to which test to use in HIV+ individuals. Previous publications from high TB burden countries have raised concerns that the sensitivity of the QFT-IT assay, but not the T-SPOT. TB, may be impaired in HIV+ individuals with low CD4+ T-cell counts. We sought to compare the tests in a low TB burden setting. Methodology/Principal Findings: T-SPOT. TB, QFT-IT, and tuberculin skin tests (TST) were performed in HIV infected individuals. Results were related to patient characteristics. McNemar's test, multivariate regression and correlation analysis were carried out using SPSS (SPSS Inc). 256 HIV infected patients were enrolled in the study. The median CD4+ T-cell count was 338 cells/mu L (range 1-1328). 37 (14%) patients had a CD4+ T-cell count of,100 cells/mu L. 46/256 (18%) of QFT-IT results and 28/256 (11%) of T-SPOT. TB results were positive. 6 (2%) of QFT-IT and 18 (7%) of T-SPOT. TB results were indeterminate. An additional 9 (4%) of T-SPOT. TB results were unavailable as tests were not performed due to insufficient cells or clotting of the sample. We found a statistically significant association between lower CD4+ T-cell count and negative QFT-IT results (OR 1.055, p = 0.03), and indeterminate/unavailable T-SPOT. TB results (OR 1.079, p = 0.02). Conclusions/Significance: In low TB prevalence settings, the QFT-IT yields more positive and fewer indeterminate results than T-SPOT. TB. Negative results on the QFT-IT and indeterminate/unavailable results on the T-SPOT. TB were more common in individuals with low CD4+ T-cell counts.	[Cheallaigh, Cliona Ni; Grace, Jacinta; Singh, Gurmit Jagjit; El-Eraki, Nahla; Clarke, Susan; Bergin, Colm] St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin, Ireland; [Fitzgeral, Ian; Rogers, Thomas R.] St James Hosp, Dept Clin Microbiol, Dublin, Ireland; [Cheallaigh, Cliona Ni; Keane, Joseph] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Cheallaigh, Cliona Ni; Keane, Joseph] St James Hosp, Dublin, Ireland; [Gibbons, Noel] St James Hosp, Irish Mycobacterial Reference Lab, Cent Pathol Lab, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Cheallaigh, CN (corresponding author), St James Hosp, Dept Genitourinary Med & Infect Dis, Dublin, Ireland.	nicheacm@tcd.ie; cbergin@stjames.ie	Keane, Joseph/AAX-6658-2021; Cheallaigh, Cliona Ni/C-5482-2017	Keane, Joseph/0000-0001-5313-385X; Cheallaigh, Cliona Ni/0000-0002-0842-425X; Rogers, Thomas/0000-0003-4336-7729; Clarke, Susie/0000-0001-7251-0040	Health Protection Surveillance Centre, Ireland; Health Research Board, Ireland; Health Services Executive, Ireland	Health Protection Surveillance Centre, Ireland; Health Research Board, Ireland; Health Services Executive, Ireland	This work was supported by the Health Protection Surveillance Centre, Ireland. CNC was funded by the Health Research Board, Ireland and the Health Services Executive, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; BROCK I, 2006, RESP RES, V7, pNIL_0001, DOI DOI 10.1186/1465-9921-7-56; CAIAFFA WT, 1995, ARCH INTERN MED, V155, P2111, DOI 10.1001/archinte.155.19.2111; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Chaisson RE, 1996, J ACQ IMMUN DEF SYND, V11, P455, DOI 10.1097/00042560-199604150-00005; Christopher A, 2010, COCHRANE DATABASE SY; Clark SA, 2007, CLIN EXP IMMUNOL, V150, P238, DOI 10.1111/j.1365-2249.2007.03477.x; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Elzi L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-319; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Health Protection Surveillance Centre, 2009, REP EP TUB IR 2007; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Laurie ED, 1995, T ROY SOC TROP MED H, V89, P37; Lee SSJ, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P133; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Oxford Immunotec, 2010, T SPOT TB PACK INS; Quantiferon, 2011, QUANTIFERON CMI PACK; Rangaka MX, 2007, CLIN INFECT DIS, V44, P1639, DOI 10.1086/518234; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; World Health Organization, 2011, TUB COUNTR PROF	38	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53330	10.1371/journal.pone.0053330	http://dx.doi.org/10.1371/journal.pone.0053330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382842	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800021
J	Nilsson, D; Andiappan, AK; Hallden, C; Chew, FT; Sall, T; Wang, DY; Cardell, LO				Nilsson, Daniel; Andiappan, Anand Kumar; Hallden, Christer; Chew, Fook Tim; Sall, Torbjorn; Wang, De Yun; Cardell, Lars-Olaf			Poor Reproducibility of Allergic Rhinitis SNP Associations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; JAPANESE CEDAR POLLINOSIS; GENE POLYMORPHISMS; EOSINOPHIL PEROXIDASE; CHINESE POPULATION; SINGAPORE CHINESE; KOREAN POPULATION; REPORTED ASTHMA; HAY-FEVER; SENSITIZATION	Replication of reported associations is crucial to the investigation of complex disease. More than 100 SNPs have previously been reported as associated with allergic rhinitis (AR), but few of these have been replicated successfully. To investigate the general reproducibility of reported AR-associations in candidate gene studies, one Swedish (352 AR-cases, 709 controls) and one Singapore Chinese population (948 AR-cases, 580 controls) were analyzed using 49 AR-associated SNPs. The overall pattern of P-values indicated that very few of the investigated SNPs were associated with AR. Given published odds ratios (ORs) most SNPs showed high power to detect an association, but no correlations were found between the ORs of the two study populations or with published ORs. None of the association signals were in common to the two genome-wide association studies published in AR, indicating that the associations represent false positives or have much lower effect-sizes than reported.	[Nilsson, Daniel; Cardell, Lars-Olaf] Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Nilsson, Daniel; Hallden, Christer] Kristianstad Univ, Kristianstad, Sweden; [Andiappan, Anand Kumar; Chew, Fook Tim] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Andiappan, Anand Kumar] Singapore Immunol Network SIgN, Singapore, Singapore; [Sall, Torbjorn] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Wang, De Yun] Natl Univ Singapore, Dept Otolaryngol, Singapore 117548, Singapore	Karolinska Institutet; Kristianstad University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Lund University; National University of Singapore	Cardell, LO (corresponding author), Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	lars-olaf.cardell@ki.se	Andiappan, Anand Kumar/AAT-2336-2021; Chew, Fook Tim/E-7259-2010	Chew, Fook Tim/0000-0003-1337-5146; Andiappan, Anand Kumar/0000-0002-8442-1544; Carlberg, Daniel/0000-0002-8098-6396	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiappan AK, 2011, CYTOKINE, V56, P218, DOI 10.1016/j.cyto.2011.05.008; Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Andiappan AK, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-39; Andiappan AK, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-36; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Bryborn M, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-29; Chae SC, 2005, IMMUNOGENETICS, V56, P760, DOI 10.1007/s00251-004-0746-2; Chae SC, 2004, HUM IMMUNOL, V65, P1427, DOI 10.1016/j.humimm.2004.07.002; Chae SC, 2006, EXP MOL MED, V38, P302, DOI 10.1038/emm.2006.36; Cheng L, 2004, CLIN EXP ALLERGY, V34, P1192, DOI 10.1111/j.1365-2222.2004.02008.x; Gulen F, 2007, CLIN BIOCHEM, V40, P392, DOI 10.1016/j.clinbiochem.2006.11.014; Hrdlickova B, 2009, INT ARCH ALLERGY IMM, V150, P184, DOI 10.1159/000218122; Imboden M, 2006, Clin Mol Allergy, V4, P9, DOI 10.1186/1476-7961-4-9; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kang I, 2010, EUR ARCH OTO-RHINO-L, V267, P391, DOI 10.1007/s00405-009-1103-8; Kawai T, 2009, CLIN EXP ALLERGY, V39, P1508, DOI 10.1111/j.1365-2222.2009.03316.x; Kim JJ, 2004, LARYNGOSCOPE, V114, P666, DOI 10.1097/00005537-200404000-00013; Klein RJ, 2012, EUR UROL, V61, P471, DOI 10.1016/j.eururo.2011.10.047; Kruse S, 2003, J ALLERGY CLIN IMMUN, V111, P117, DOI 10.1067/mai.2003.43; Li CS, 2006, J HUM GENET, V51, P292, DOI 10.1007/s10038-006-0359-8; Llanes E, 2009, INT ARCH ALLERGY IMM, V148, P228, DOI 10.1159/000161583; Murk W, 2011, HUM HERED, V71, P97, DOI 10.1159/000319536; Nagata H, 2001, HUM GENET, V109, P262, DOI 10.1007/s004390100561; Nakamura H, 2003, J ALLERGY CLIN IMMUN, V112, P1127, DOI 10.1016/j.jaci.2003.08.051; Nakamura H, 2007, INT ARCH ALLERGY IMM, V142, P329, DOI 10.1159/000097502; Nieters A, 2004, CLIN EXP ALLERGY, V34, P346, DOI 10.1111/j.1365-2222.2004.01889.x; Nilsson D, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-66; R Core Team, 2020, R LANG ENV STAT COMP; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rasanen M, 1998, ALLERGY, V53, P885, DOI 10.1111/j.1398-9995.1998.tb03996.x; Rogers AJ, 2009, AM J RESP CRIT CARE, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su DJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-82; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; van Beijsterveldt CEM, 2007, EUR RESPIR J, V29, P516, DOI 10.1183/09031936.00065706; Warnes G., 2008, GENETICS POPULATION; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Zhang L, 2009, ACTA OTO-LARYNGOL, V129, P190, DOI 10.1080/00016480802139846	42	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53975	10.1371/journal.pone.0053975	http://dx.doi.org/10.1371/journal.pone.0053975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382861	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800027
J	Di Milia, L; Waage, S; Pallesen, S; Bjorvatn, B				Di Milia, Lee; Waage, Siri; Pallesen, Stale; Bjorvatn, Bjorn			Shift Work Disorder in a Random Population Sample - Prevalence and Comorbidities	PLOS ONE			English	Article							SLEEP DURATION; HORDALAND HEALTH; INSOMNIA SCALE; NORTH-SEA; OIL RIG; VALIDATION; MANAGEMENT; PERMANENT; WORKHOURS	Few studies have investigated the presence of shift work disorder (SWD) in the general community. We addressed many of the limitations in this literature and present new findings. SWD has been treated as an 'all or none' construct but we propose the need to consider the 'severity' of the disorder. Using random digit dialling, we randomly recruited 1163 participants. Participants completed an extensive battery of scales and questions concerning work, health and individual differences. Three questions based on the criteria from the International Classification for Sleep Disorders were used to categorise participants with SWD (n = 176). In addition, we asked participants whether SWD interfered with aspects of their life and high ratings were used to define severe shift work disorder (SSWD). The prevalence of SWD was 32.1% among night workers and 10.1% in day workers (p<.001). SSWD was present in 9.1% of night workers and 1.3% of day workers (p<.001). Adjusted logistic regression analyses found significant associations between SWD and night work (OR = 3.35, CI 2.19-5.12), weekly work hours (OR = 1.02, CI 1.00-1.04), short sleep (<= 6 h; OR = 2.93, CI 1.94-4.41), languidity (OR = 1.11, CI 1.06-1.16) and resilience (OR = 0.56, CI 0.43-0.81). Night work, short sleep, languidity, and hypertension were significantly associated with SSWD. Overall, participants with SSWD slept 0.80 h less than other participants (p<.001). Night work, short sleep and languidity were associated with both SWD and SSWD. Day workers with SWD symptoms reported significantly shorter sleep duration, higher levels of languidity and worked longer working hours compared to day workers without SWD.	[Di Milia, Lee] Cent Queensland Univ, Sch Management, Rockhampton, Qld 4702, Australia; [Di Milia, Lee] Cent Queensland Univ, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Waage, Siri; Pallesen, Stale; Bjorvatn, Bjorn] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway; [Waage, Siri; Bjorvatn, Bjorn] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway	Central Queensland University; Central Queensland University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Di Milia, L (corresponding author), Cent Queensland Univ, Sch Management, Rockhampton, Qld 4702, Australia.	v.dimilia@cqu.edu.au	Di Milia, Lee/A-6810-2008	Di Milia, Lee/0000-0001-7681-5589	Institute for Health and Social Science Research at Central Queensland University	Institute for Health and Social Science Research at Central Queensland University	The study was funded by an internal grant from the Institute for Health and Social Science Research at Central Queensland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2010, CHRONOBIOL INT, V27, P975, DOI 10.3109/07420528.2010.489001; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Australian Bureau of Statistics, 2009, WORK TIM ARR; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bin YS, 2012, SLEEP MED REV, V16, P223, DOI 10.1016/j.smrv.2011.07.003; Bjorvatn B, 2006, SLEEP, V29, P821, DOI 10.1093/sleep/29.6.821; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Costa G, 2008, CHRONOBIOL INT, V25, P165, DOI 10.1080/07420520802103410; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Di Milia L, 2005, PERS INDIV DIFFER, V39, P1293, DOI 10.1016/j.paid.2005.04.012; Di Milia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045856; Di Milia L, 2012, PERS INDIV DIFFER, V52, P702, DOI 10.1016/j.paid.2011.12.033; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Flo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033981; FOLKARD S, 1993, ERGONOMICS, V36, P85, DOI 10.1080/00140139308967858; Folkard S, 2008, CHRONOBIOL INT, V25, P215, DOI 10.1080/07420520802106835; Francis A, 1994, DIAGNOSTIC STAT MANU; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Harma M, 2006, SCAND J WORK ENV HEA, V32, P502; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Marquie JC, 2012, SLEEP, V35, P1115, DOI 10.5665/sleep.2000; Natvik S, 2011, APPL ERGON, V42, P719, DOI 10.1016/j.apergo.2010.11.006; Pallesen S, 2008, PERCEPT MOTOR SKILL, V107, P691, DOI 10.2466/PMS.107.3.691-706; Pilcher JJ, 2000, SLEEP, V23, P155; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Puttonen S, 2012, SCAND J WORK ENV HEA, V38, P343, DOI 10.5271/sjweh.3267; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Roth T, 2012, SLEEP MED, V13, P335, DOI 10.1016/j.sleep.2011.11.006; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Schwartz JRL, 2006, DRUGS, V66, P2357, DOI 10.2165/00003495-200666180-00007; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Ursin R, 2009, SCAND J WORK ENV HEA, V35, P193, DOI 10.5271/sjweh.1325; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001	42	60	62	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55306	10.1371/journal.pone.0055306	http://dx.doi.org/10.1371/journal.pone.0055306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372847	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400087
J	Harter, TS; Verreth, JAJ; Heinsbroek, LTN; Schrama, JW				Harter, Till S.; Verreth, Johan A. J.; Heinsbroek, Leon T. N.; Schrama, Johan W.			Isoenergetic Replacement of Fat by Starch in Diets for African Catfish (Clarias gariepinus): Effect on Water Fluxes in the Gastro Intestinal Tract	PLOS ONE			English	Article							RAINBOW-TROUT; IN-VIVO; ABSORPTION; DRINKING; DRY	The effect of an isoenergetic replacement of dietary fat by starch, on chyme characteristics and water fluxes in the gastro intestinal tract (GIT) was assessed. Adult African catfish (Clarias gariepinus) were fed a starch (SD) or fat (FD) diet and groups of fish were dissected at 2, 5 and 8 h after the consumption of a single meal. Chyme was collected quantitatively and was analysed for osmolality and dry matter (DM) content. Postprandial water fluxes were calculated, while using yttrium oxide (Y2O3) as an inert marker to account for the absorption of DM along the GIT. The largest differences in chyme characteristics between diets were observed in the stomach and decreased towards subsequent compartments. A high initial osmotic pressure was measured in the stomach for both diets (up to 498 +/- 2 mOsm kg(-1)) and was likely the driver for the endogeneous water influx to this compartment. Large additions of water were recorded to the stomach and proximal intestine for both diets and absorption of water took place in the mid-and distal intestine. Interestingly, the dietary treatment had an impact on water balance in the stomach and proximal intestine of the fish, but not in the mid-and distal intestine. A strong complementary relationship suggested that 59% of the water fluxes in the proximal intestine could be explained by previous additions to the stomach. Therefore, a higher dietary inclusion of starch led to a shift in water additions from the proximal intestine to the stomach. However, the sum of water additions to the GIT was not different between diets and was on average 6.52 +/- 0.85 ml water g(-1) DM. The interactions between osmoregulation and digestion, in the GIT of fed freshwater fish, deserve further attention in future research.	[Harter, Till S.; Verreth, Johan A. J.; Heinsbroek, Leon T. N.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Schrama, JW (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	Johan.Schrama@wur.nl	Verreth, Johan/ABD-7198-2020	Verreth, Johan/0000-0001-7277-5129; Schrama, Johan/0000-0001-7156-8806	Wageningen University, The Netherlands	Wageningen University, The Netherlands(Netherlands Government)	This research project has been funded by Wageningen University, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Amirkolaie AK, 2006, AQUACULTURE, V260, P194, DOI 10.1016/j.aquaculture.2006.06.039; Anguita M, 2006, ANIM FEED SCI TECH, V129, P99, DOI 10.1016/j.anifeedsci.2005.12.004; Bakke AM, 2010, FISH PHYSL MULTIFUNC, P56; BOGE G, 1988, COMP BIOCHEM PHYS A, V91, P9, DOI 10.1016/0300-9629(88)91584-8; Bucking C, 2006, J EXP BIOL, V209, P1883, DOI 10.1242/jeb.02205; Bucking C, 2006, AM J PHYSIOL-REG I, V291, pR1764, DOI 10.1152/ajpregu.00224.2006; Buddington RK, 1997, ACTA PHYSL SCANDINAV, V161; FAICHNEY GA, 1988, AUST J AGR RES, V39, P481; FAICHNEY GJ, 1981, AGR SYST, V6, P261, DOI 10.1016/0308-521X(81)90062-7; Fuentes J., 1997, P135; Grosell M, 2000, AM J PHYSIOL-REG I, V278, pR1674, DOI 10.1152/ajpregu.2000.278.6.R1674; HEISLER N, 1984, FISH PHYSIOL, V10, P315; Kristiansen HR, 2001, AQUAT LIVING RESOUR, V14, P359, DOI 10.1016/S0990-7440(01)01131-7; Marshall William S., 2006, P177; Nobata S, 2011, AM J PHYSIOL-REG I, V300, P1569, DOI 10.1152/ajpregu.00056.2011; Owens F. N., 1988, RUMINANT ANIMAL DIGE; Ruohonen K, 1997, J FISH BIOL, V51, P93, DOI 10.1111/j.1095-8649.1997.tb02516.x; Smith HW, 1930, AM J PHYSIOL, V93, P480, DOI 10.1152/ajplegacy.1930.93.2.480; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; Takei Y, 2002, EXPTL BIOL REV, P61; TAKEI Y, 1979, GEN COMP ENDOCR, V38, P466, DOI 10.1016/0016-6480(79)90155-2; Takei Y, 2008, FISH NEUROENDOCRINOL, P365; van Bussel W, 2010, ATOM SPECTROSC, V31, P81; van de Nieuwegiessen PG, 2009, AQUACULTURE, V288, P69, DOI 10.1016/j.aquaculture.2008.11.009; WINDELL JT, 1969, J FISH RES BOARD CAN, V26, P1801, DOI 10.1139/f69-164; Wood CM, 2012, J EXP BIOL, V215, P508, DOI 10.1242/jeb.060004; Wood CM, 2011, FISH PHYSIOL, V30, P165, DOI 10.1016/S1546-5098(10)03005-0	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55245	10.1371/journal.pone.0055245	http://dx.doi.org/10.1371/journal.pone.0055245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372842	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400082
J	Xu, F; Li, J; Ni, W; Shen, YW; Zhang, XP				Xu, Feng; Li, Jian; Ni, Wei; Shen, Yi-wen; Zhang, Xiao-ping			Peroxisome Proliferator-Activated Receptor-gamma Agonist 15d-Prostaglandin J(2) Mediates Neuronal Autophagy after Cerebral Ischemia-Reperfusion Injury	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; PPAR-GAMMA; OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; MECHANISMS; TRANSIENT; PROTEIN; LIGAND; BRAIN	Peroxisome proliferator-activated receptor-c (PPAR-c) has recently emerged as potential therapeutic agents for cerebral ischemia-reperfusion (I/R) injury because of anti-neuronal apoptotic actions. However, whether PPAR-c activation mediates neuronal autophagy in such conditions remains unclear. Therefore, in this study, we investigated the role of PPAR-gamma agonist 15-PGJ(2) on neuronal autophagy induced by I/R. The expression of autophagic-related protein in ischemic cortex such as LC3-II, Beclin 1, cathepsin-B and LAMP1 increased significantly after cerebral I/R injury. Furthermore, increased punctate LC3 labeling and cathepsin-B staining occurred in neurons. Treatment with PPAR-gamma agonist 15d-PGJ(2) decreased not only autophagic-related protein expression in ischemic cortex, but also immunoreactivity of LC3 and cathepsin-B in neurons. Autophagic inhibitor 3-methyladenine (3-MA) decreased LC3-II levels, reduced the infarct volume, and mimicked some protective effect of 15d-PGJ(2) against cerebral I/R injury. These results indicate that PPAR-c agonist 15d-PGJ(2) exerts neuroprotection by inhibiting neuronal autophagy after cerebral I/R injury. Although the molecular mechanisms underlying PPAR-c agonist in mediating neuronal autophagy remain to be determined, neuronal autophagy may be a new target for PPAR-c agonist treatment in cerebral I/R injury.	[Xu, Feng; Ni, Wei; Shen, Yi-wen] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Li, Jian] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Xiao-ping] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Tongji University	Xu, F (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	fengxu.dr@gmail.com			National Nature Science Foundation of China [81000488]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (No. 81000488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Clark WM, 1997, NEUROL RES, V19, P641; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marino G., 2010, CURR OPIN CELL BIOL, V23, P1; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; NITATORI T, 1995, J NEUROSCI, V15, P1001; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	39	46	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55080	10.1371/journal.pone.0055080	http://dx.doi.org/10.1371/journal.pone.0055080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372817	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400060
J	Basso, D; Fogar, P; Falconi, M; Fadi, E; Sperti, C; Frasson, C; Greco, E; Tamburrino, D; Teolato, S; Moz, S; Bozzato, D; Pelloso, M; Padoan, A; De Franchis, G; Gnatta, E; Facco, M; Zambon, CF; Navaglia, F; Pasquali, C; Basso, G; Semenzato, G; Pedrazzoli, S; Pederzoli, P; Plebani, M				Basso, Daniela; Fogar, Paola; Falconi, Massimo; Fadi, Elisa; Sperti, Cosimo; Frasson, Chiara; Greco, Eliana; Tamburrino, Domenico; Teolato, Sara; Moz, Stefania; Bozzato, Dania; Pelloso, Michela; Padoan, Andrea; De Franchis, Giuseppe; Gnatta, Elisa; Facco, Monica; Zambon, Carlo-Federico; Navaglia, Filippo; Pasquali, Claudio; Basso, Giuseppe; Semenzato, Gianpietro; Pedrazzoli, Sergio; Pederzoli, Paolo; Plebani, Mario			Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study	PLOS ONE			English	Article							REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE EVASION; CLINICAL-SIGNIFICANCE; CANCER; CARCINOMA; DIFFERENTIATION; EXPRESSION; ACCUMULATION	Background: Blood and spleen expansion of immature myeloid cells (IMCs) might compromise the immune response to cancer. We studied in vivo circulating and splenic T lymphocyte and IMC subsets in patients with benign and malignant pancreatic diseases. We ascertained in vitro whether pancreatic adenocarcinoma (PDAC)-associated IMC subsets are induced by tumor-derived soluble factors and whether they are immunosuppressive focusing on the inhibitory co-stimulatory molecules PDL1 and CTLA4. Methodology and Principal Findings: 103 pancreatic and/or splenic surgical patients were enrolled including 52 PDAC, 10 borderline and 10 neuroendocrine tumors (NETs). Lymphocytes and IMCs were analysed by flow cytometry in blood, in spleen and in three PDAC cell conditioned (CM) or non conditioned PBMC. PDL1 and CTLA4 were studied in 30 splenic samples, in control and conditioned PBMC. IMCs were FACS sorted and co-coltured with allogenic T lymphocytes. In PDAC a reduction was found in circulating CD8(+) lymphocytes (p = 0.004) and dendritic cells (p = 0.01), which were reduced in vitro by one PDAC CM (Capan1; p = 0.03). Blood myeloid derived suppressive cells (MDSCs) CD33(+) CD14(-) HLA-DR- were increased in PDAC (p = 0.022) and were induced in vitro by BxPC3 CM. Splenic dendritic cells had a higher PDL1 expression (p = 0.007), while CD33(+) CD14(+) HLA-DR- IMCs had a lower CTLA4 expression (p = 0.029) in PDAC patients. In vitro S100A8/A9 complex, one of the possible inflammatory mediators of immune suppression in PDAC, induced PDL1 (p = 0.018) and reduced CTLA4 expression (p = 0.028) among IMCs. IMCs not expressing CTLA4 were demonstrated to be immune suppressive. Conclusion: In PDAC circulating dendritic and cytotoxic T cells are reduced, while MDSCs are increased and this might favour tumoral growth and progression. The reduced CTLA4 expression found among splenic IMCs of PDAC patients was demonstrated to characterize an immune suppressive phenotype and to be consequent to the direct exposure of myeloid cells to pancreatic cancer derived products, S100A8/A9 complex in particular.	[Basso, Daniela; Fogar, Paola; Fadi, Elisa; Greco, Eliana; Teolato, Sara; Moz, Stefania; Bozzato, Dania; Pelloso, Michela; Padoan, Andrea; De Franchis, Giuseppe; Gnatta, Elisa; Facco, Monica; Zambon, Carlo-Federico; Navaglia, Filippo; Semenzato, Gianpietro; Plebani, Mario] Univ Padua, Dept Med, Padua, Italy; [Falconi, Massimo; Tamburrino, Domenico; Pederzoli, Paolo] Univ Verona, Dept Surg, I-37100 Verona, Italy; [Sperti, Cosimo; Pasquali, Claudio; Pedrazzoli, Sergio] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Womens & Childrens Hlth, Lab Pediat Hematooncol, Padua, Italy	University of Padua; University of Verona; University of Padua; University of Padua	Basso, D (corresponding author), Univ Padua, Dept Med, Padua, Italy.	daniela.basso@sanita.padova.it	Basso, Daniela/J-7855-2016; Facco, Monica/F-7732-2017; Teolato, Sara/J-8642-2016; pelloso, michela/K-5615-2018; Tamburrino, Domenico/AAA-6894-2019; Plebani, Mario/AAF-4953-2020; SEMENZATO, GIANPIETRO C/J-7727-2016; Zambon, Carlo Federico/J-8187-2016; Bozzato, Dania/AAA-5142-2019; Falconi, Massimo/K-2194-2016; Padoan, Andrea/J-7869-2016	Basso, Daniela/0000-0001-8745-6171; Facco, Monica/0000-0003-0100-5789; Teolato, Sara/0000-0002-0327-9858; Tamburrino, Domenico/0000-0003-1435-3651; SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; Zambon, Carlo Federico/0000-0002-4244-879X; Falconi, Massimo/0000-0001-9654-7243; Padoan, Andrea/0000-0003-1284-7885; Pelloso, Michela/0000-0002-2853-4499; BASSO, GIUSEPPE/0000-0002-2634-9302; moz, stefania/0000-0002-7485-520X	"Associazione Wirsung-Onlus," Padova, Italy	"Associazione Wirsung-Onlus," Padova, Italy	Supported in part by "Associazione Wirsung-Onlus," Via Giustiniani 2, 35128 Padova, Italy. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Almog N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044001; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Basso D, 2011, J CELL PHYSIOL, V226, P456, DOI 10.1002/jcp.22355; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clark CE, 2009, CANCER LETT, V279, P1, DOI 10.1016/j.canlet.2008.09.037; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Durgan K, 2011, CANCER IMMUNOL IMMUN, V60, P547, DOI 10.1007/s00262-010-0963-5; Fogar P, 2011, PANCREAS, V40, P1131, DOI 10.1097/MPA.0b013e31822077b8; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Ishizaki H, 2011, CANCER IMMUNOL IMMUN, V60, P99, DOI 10.1007/s00262-010-0923-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Kim MS, 2012, J PROTEOME RES, V11, P5556, DOI 10.1021/pr300483r; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Loos M, 2008, CANCER LETT, V268, P98, DOI 10.1016/j.canlet.2008.03.056; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Ryschich E, 2005, CLIN CANCER RES, V11, P498; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Sheikh AA, 2007, PROTEOMICS, V7, P1929, DOI 10.1002/pmic.200700072; Shevach EM, 2008, SCIENCE, V322, P202, DOI 10.1126/science.1164872; Takahashi K, 2006, CANCER IMMUNOL IMMUN, V55, P775, DOI 10.1007/s00262-005-0079-5; Tjomsland V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013441; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Wang XB, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-21; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	63	35	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54824	10.1371/journal.pone.0054824	http://dx.doi.org/10.1371/journal.pone.0054824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359812	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600116
J	Delacote, F; Perez, C; Guyot, V; Duhamel, M; Rochon, C; Ollivier, N; Macmaster, R; Silva, GH; Paques, F; Daboussi, F; Duchateau, P				Delacote, Fabien; Perez, Christophe; Guyot, Valerie; Duhamel, Marianne; Rochon, Christelle; Ollivier, Nathalie; Macmaster, Rachel; Silva, George H.; Paques, Frederic; Daboussi, Fayza; Duchateau, Philippe			High Frequency Targeted Mutagenesis Using Engineered Endonucleases and DNA-End Processing Enzymes	PLOS ONE			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; HOMING ENDONUCLEASE; GENE DISRUPTION; KNOCKOUT RATS; BINDING; GENERATION; CLEAVAGE; SEQUENCES; REPAIR	Targeting DNA double-strand breaks is a powerful strategy for gene inactivation applications. Without the use of a repair plasmid, targeted mutagenesis can be achieved through Non-Homologous End joining (NHEJ) pathways. However, many of the DNA breaks produced by engineered nucleases may be subject to precise re-ligation without loss of genetic information and thus are likely to be unproductive. In this study, we combined engineered endonucleases and DNA-end processing enzymes to increase the efficiency of targeted mutagenesis, providing a robust and efficient method to (i) greatly improve targeted mutagenesis frequency up to 30-fold, and; (ii) control the nature of mutagenic events using meganucleases in conjunction with DNA-end processing enzymes in human primary cells.	[Delacote, Fabien; Perez, Christophe; Guyot, Valerie; Macmaster, Rachel; Silva, George H.; Paques, Frederic; Daboussi, Fayza; Duchateau, Philippe] Cellectis SA, Paris, France; [Duhamel, Marianne; Rochon, Christelle; Ollivier, Nathalie] Genopole, Cellectis Stem Cells, Evry, France	Genopole; UDICE-French Research Universities; Universite Paris Saclay	Duchateau, P (corresponding author), Cellectis SA, Paris, France.	duchateau@cellectis.com		Daboussi, Fayza/0000-0001-7689-7975				Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Baxter S, 2012, NUCL ACIDS RES; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Daboussi F, 2012, NUCL ACIDS RES; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Grabarz A, 2012, AM J CANCER RES, V2, P249; Grizot S, 2011, NUCL ACIDS RES; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Grosse S, 2011, MOL THER, V19, P694, DOI 10.1038/mt.2010.302; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Komori K, 1999, NUCLEIC ACIDS RES, V27, P4175, DOI 10.1093/nar/27.21.4175; Liu Y, 2010, METHODS MOL BIOL, V584, P229, DOI 10.1007/978-1-60761-369-5_13; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sandor Z, 2004, NUCLEIC ACIDS RES, V32, P1866, DOI 10.1093/nar/gkh502; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Volna P, 2007, NUCLEIC ACIDS RES, V35, P2748, DOI 10.1093/nar/gkm182; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53217	10.1371/journal.pone.0053217	http://dx.doi.org/10.1371/journal.pone.0053217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359797	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600012
J	Voorberg-van der Wel, A; Zeeman, AM; van Amsterdam, SM; van den Berg, A; Klooster, EJ; Iwanaga, S; Janse, CJ; van Gemert, GJ; Sauerwein, R; Beenhakker, N; Koopman, G; Thomas, AW; Kocken, CHM				Voorberg-van der Wel, Annemarie; Zeeman, Anne-Marie; van Amsterdam, Sandra M.; van den Berg, Alexander; Klooster, Els J.; Iwanaga, Shiroh; Janse, Chris J.; van Gemert, Geert-Jan; Sauerwein, Robert; Beenhakker, Niels; Koopman, Gerrit; Thomas, Alan W.; Kocken, Clemens H. M.			Transgenic Fluorescent Plasmodium cynomolgi Liver Stages Enable Live Imaging and Purification of Malaria Hypnozoite-Forms	PLOS ONE			English	Article							MAMMALIAN HOST; LIFE-CYCLE; PARASITES; VIVAX; FALCIPARUM; BERGHEI; TRANSFECTION; PROTEIN; SEGREGATION; EXPRESSION	A major challenge for strategies to combat the human malaria parasite Plasmodium vivax is the presence of hypnozoites in the liver. These dormant forms can cause renewed clinical disease after reactivation through unknown mechanisms. The closely related non-human primate malaria P. cynomolgi is a frequently used model for studying hypnozoite-induced relapses. Here we report the generation of the first transgenic P. cynomolgi parasites that stably express fluorescent markers in liver stages by transfection with novel DNA-constructs containing a P. cynomolgi centromere. Analysis of fluorescent liver stages in culture identified, in addition to developing liver-schizonts, uninucleate persisting parasites that were atovaquone resistant but primaquine sensitive, features associated with hypnozoites. We demonstrate that these hypnozoite-forms could be isolated by fluorescence-activated cell sorting. The fluorescently-tagged parasites in combination with FACS-purification open new avenues for a wide range of studies for analysing hypnozoite biology and reactivation.	[Voorberg-van der Wel, Annemarie; Zeeman, Anne-Marie; van Amsterdam, Sandra M.; van den Berg, Alexander; Klooster, Els J.; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Iwanaga, Shiroh] Mie Univ, Sch Med, Tsu, Mie 514, Japan; [Janse, Chris J.] Leiden Univ Med, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands; [van Gemert, Geert-Jan; Sauerwein, Robert] Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Beenhakker, Niels; Koopman, Gerrit] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	Mie University; Radboud University Nijmegen	Kocken, CHM (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	kocken@bprc.nl	Sauerwein, Robert/C-8519-2013	Iwanaga, Shiroh/0000-0002-4394-7267; Kocken, Clemens/0000-0002-4784-1734; Janse, Chris J/0000-0002-6410-6205; Voorberg - van der Wel, Annemarie/0000-0001-9403-0515; Zeeman, Anne-Marie/0000-0002-0157-4669	Medicines for Malaria Venture; Wellcome Trust [WT078285]; EU [223044]; EVIMALAR [242095]	Medicines for Malaria Venture; Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); EVIMALAR	This work was supported by a grant from the Medicines for Malaria Venture, a translational research grant (WT078285) from the Wellcome Trust, and FP7 EU grants MALSIG (contract number 223044) and EVIMALAR (contract number 242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bassat Q, 2011, NAT MED, V17, P48, DOI 10.1038/nm0111-48; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; CLYDE DF, 1981, B WORLD HEALTH ORGAN, V59, P391; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Gueirard P, 2010, P NATL ACAD SCI USA, V107, P18640, DOI 10.1073/pnas.1009346107; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Iwanaga S, 2012, GENOME RES; Iwanaga S, 2010, CELL HOST MICROBE, V7, P245, DOI 10.1016/j.chom.2010.02.010; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kocken CHM, 1999, EXP PARASITOL, V93, P58, DOI 10.1006/expr.1999.4430; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Kocken CHM, 2009, TRENDS PARASITOL, V25, P370, DOI 10.1016/j.pt.2009.05.009; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; MAL ERA, 2011, PLOS MED, V8; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; O'Donnell RA, 2001, NUCLEIC ACIDS RES, V29, P716, DOI 10.1093/nar/29.3.716; Pfahler JM, 2006, MOL BIOCHEM PARASIT, V149, P99, DOI 10.1016/j.molbiopara.2006.03.018; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Prudencio M, 2011, TRENDS PARASITOL, V27, P565, DOI 10.1016/j.pt.2011.09.004; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; vanDijk MR, 1997, MOL BIOCHEM PARASIT, V86, P155, DOI 10.1016/S0166-6851(97)02843-0; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	46	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54888	10.1371/journal.pone.0054888	http://dx.doi.org/10.1371/journal.pone.0054888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359816	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600129
J	Wells, JW; Evans, CH; Scott, MC; Rutgen, BC; O'Brien, TD; Modiano, JF; Cvetkovic, G; Tepic, S				Wells, James W.; Evans, Christopher H.; Scott, Milcah C.; Ruetgen, Barbara C.; O'Brien, Timothy D.; Modiano, Jaime F.; Cvetkovic, Goran; Tepic, Slobodan			Arginase Treatment Prevents the Recovery of Canine Lymphoma and Osteosarcoma Cells Resistant to the Toxic Effects of Prolonged Arginine Deprivation	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RECOMBINANT HUMAN ARGINASE; L-ASPARAGINASE THERAPY; AMINO-ACID; B-CELL; MALIGNANT-LYMPHOMA; GROWTH-INHIBITION; IN-VITRO; LINE; ESTABLISHMENT	Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast, become quiescent and remain viable under arginine restriction, displaying full recovery upon return to arginine-rich conditions. The use of arginase therapy to restrict available arginine for selectively targeting malignant cells is currently under investigation in human clinical trials. However, the suitability of this approach for veterinary uses is unexplored. As a prelude to in vivo studies in canine malignancies, we examined the in vitro effects of arginine-deprivation on canine lymphoid and osteosarcoma cell lines. Two lymphoid and 2 osteosarcoma cell lines were unable to recover following 6 days of arginine deprivation, but all remaining cell lines displayed full recovery upon return to arginine-rich culture conditions. These remaining cell lines all proved susceptible to cell death following the addition of arginase to the cultures. The lymphoid lines were particularly sensitive to arginase, becoming unrecoverable after just 3 days of treatment. Two of the osteosarcoma lines were also susceptible over this time-frame; however the other 3 lines required 6-8 days of arginase treatment to prevent recovery. In contrast, adult progenitor cells from the bone marrow of a healthy dog were able to recover fully following 9 days of culture in arginase. Over 3 days in culture, arginase was more effective than asparaginase in inducing the death of lymphoid lines. These results strongly suggest that short-term arginase treatment warrants further investigation as a therapy for lymphoid malignancies and osteosarcomas in dogs.	[Wells, James W.; Evans, Christopher H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Sch Med, Boston, MA 02215 USA; [Scott, Milcah C.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Ruetgen, Barbara C.] Univ Vet Med Vienna, Dept Pathobiol, Cent Lab, Vienna, Austria; [O'Brien, Timothy D.] Univ Minnesota, Vet Populat Med Dept, St Paul, MN 55108 USA; [O'Brien, Timothy D.] Univ Minnesota, Stem Cell Inst, St Paul, MN 55108 USA; [Cvetkovic, Goran; Tepic, Slobodan] Kyon AG, Zurich, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Veterinary Medicine Vienna; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wells, JW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Sch Med, Boston, MA 02215 USA.	j.wells3@uq.edu.au	MODIANO, JAIME/K-3583-2019; Rütgen, Barbara/ADM-6510-2022; Wells, James W./C-7480-2011	MODIANO, JAIME/0000-0001-6398-7648; Wells, James W./0000-0002-9618-6940; O'Brien, Timothy/0000-0001-9742-0930	Kyon AG	Kyon AG	This study was funded by Kyon AG. The funders were involved in study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Bobak YP, 2010, CELL BIOL INT, V34, P1085, DOI 10.1042/CBI20100451; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Garrett LD, 2002, J VET INTERN MED, V16, P704, DOI 10.1111/j.1939-1676.2002.tb02411.x; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Hsueh EC, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-17; Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120; Jorck C, 2011, PEDIATR HEMAT ONCOL, V28, P3, DOI 10.3109/08880018.2010.484852; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; Lam TL, 2011, PIGM CELL MELANOMA R, V24, P366, DOI 10.1111/j.1755-148X.2010.00798.x; Lamb J, 2000, EXP CELL RES, V255, P238, DOI 10.1006/excr.1999.4779; Modiano JF, 2006, GENE THER MOL BIOL, V10A, P31; Modiano JF, 2006, COLD SPRING HARB MON, V44, P439; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Momoi Y, 1997, VET IMMUNOL IMMUNOP, V59, P11, DOI 10.1016/S0165-2427(97)00053-6; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; MORRIS JG, 1978, J NUTR, V108, P1944, DOI 10.1093/jn/108.12.1944; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; ONIONS DE, 1984, JNCI-J NATL CANCER I, V72, P909; Philip R, 2003, BRIT J CANCER, V88, P613, DOI 10.1038/sj.bjc.6600681; Phillips JC, 2007, GENOMICS, V90, P354, DOI 10.1016/j.ygeno.2007.05.001; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Priester W A, 1980, Natl Cancer Inst Monogr, P1; Raetz EA, 2010, J PEDIAT HEMATOL ONC, V32, P554, DOI 10.1097/MPH.0b013e3181e6f003; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; STEPLEWSKI Z, 1987, CANCER IMMUNOL IMMUN, V24, P197; TESKE E, 1994, VET QUART, V16, P134, DOI 10.1080/01652176.1994.9694435; Wheatley Denys N., 2002, Pathology and Oncology Research, V8, P18; Wheatley DN, 2005, SEMIN CANCER BIOL, V15, P247, DOI 10.1016/j.semcancer.2005.04.002; Wheatley DN, 2003, BRIT J CANCER, V89, P573, DOI 10.1038/sj.bjc.6601134; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; Yau T, 2012, INVESTIGATIONAL NEW	35	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54464	10.1371/journal.pone.0054464	http://dx.doi.org/10.1371/journal.pone.0054464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365669	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600057
J	Zhao, J; Wang, SY; Bao, JQ; Sun, XJ; Zhang, XC; Zhang, XL; Ye, DX; Wei, J; Liu, CS; Jiang, XQ; Shen, G; Zhang, ZY				Zhao, Jun; Wang, Shaoyi; Bao, Jianqiang; Sun, Xiaojuan; Zhang, Xiaochen; Zhang, Xiuli; Ye, Dongxia; Wei, Jie; Liu, Changsheng; Jiang, Xinquan; Shen, Gang; Zhang, Zhiyuan			Trehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENTS; BETA-TRICALCIUM PHOSPHATE; GROWTH-FACTOR RELEASE; BONE MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY SYSTEMS; GELATIN MICROPARTICLES; DEFECT MODEL; RHBMP-2; ANHYDROBIOSIS; BIOMATERIALS	Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25 degrees C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% +/- 5.32%) and area (40.71% +/- 7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% +/- 0.44%, calcein: 6.08% +/- 1.37%) and mineral apposition rate (4.13 +/- 0.62 mu m/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17 +/- 15.02 Mpa) and load of fracture (144.67 +/- 16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.	[Zhao, Jun; Shen, Gang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthodont,Coll Stomatol, Shanghai 200030, Peoples R China; [Wang, Shaoyi; Zhang, Xiaochen; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg,Coll Stomatol, Shanghai 200030, Peoples R China; [Zhang, Xiuli; Ye, Dongxia; Jiang, Xinquan; Shen, Gang; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Bao, Jianqiang] Univ Nevada, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Sun, Xiaojuan] Ningxia Med Univ, Gen Hosp, Dept Oral & Maxillofacial Surg, Ningxia, Peoples R China; [Wei, Jie; Liu, Changsheng] E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Ningxia Medical University; East China University of Science & Technology	Shen, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthodont,Coll Stomatol, Shanghai 200030, Peoples R China.	gangshen@orthosh.com; zhzhy@omschina.org.cn	zhang, zhiyuan/GRS-2141-2022; Ye, Dongxia/AAF-2877-2019; Bao, Jianqiang/G-9184-2016; Ye, Dongxia/S-4804-2018; Bao, Jianqiang/T-7299-2019	Bao, Jianqiang/0000-0003-1248-2687; Ye, Dongxia/0000-0001-8260-4569; 	National Natural Science Foundation of China [81200815, 81271182, 30973363, 81000420]; Science and technology fund, Shanghai Jiao Tong University, School of Medicine [11XJ21024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology fund, Shanghai Jiao Tong University, School of Medicine	This work is supported by the National Natural Science Foundation of China (81200815, 81271182, 30973363, 81000420), Science and technology fund, Shanghai Jiao Tong University, School of Medicine 11XJ21024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229; Abdelwahed W, 2006, ADV DRUG DELIVER REV, V58, P1688, DOI 10.1016/j.addr.2006.09.017; Arakawa T, 2001, ADV DRUG DELIVER REV, V46, P307, DOI 10.1016/S0169-409X(00)00144-7; Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830; Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11; Choi S, 2011, J VET MED SCI, V73, P1547, DOI 10.1292/jvms.11-0016; Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; de Castro AG, 2000, NAT BIOTECHNOL, V18, P473, DOI 10.1038/75237; Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026; Dohzono S, 2009, CLIN ORTHOP RELAT R, V467, P3206, DOI 10.1007/s11999-009-0960-1; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007; GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969; Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018; Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263; Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008; Hertz A, 2007, NANOMEDICINE-UK, V2, P899, DOI 10.2217/17435889.2.6.899; Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940; Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005; Kasper JC, 2011, J CONTROL RELEASE, V151, P246, DOI 10.1016/j.jconrel.2011.01.003; Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kim JW, 2011, ORAL SURG ORAL MED O, V112, P298, DOI 10.1016/j.tripleo.2010.10.025; Klijn RJ, 2012, TISSUE ENG PT A, V18, P1171, DOI [10.1089/ten.tea.2011.0444, 10.1089/ten.TEA.2011.0444]; Le Nihouannen D, 2008, EUR J PHARM BIOPHARM, V70, P813, DOI 10.1016/j.ejpb.2008.07.018; Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038; Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9; Lins RD, 2004, PROTEINS, V55, P177, DOI 10.1002/prot.10632; Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003; Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004; Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076; Magazu S, 2007, EUR BIOPHYS J BIOPHY, V36, P163, DOI 10.1007/s00249-006-0108-0; Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081; Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H; MOZHAEV VV, 1993, TRENDS BIOTECHNOL, V11, P88, DOI 10.1016/0167-7799(93)90057-G; Niemeyer P, 2010, ACTA BIOMATER, V6, P900, DOI 10.1016/j.actbio.2009.09.007; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1; PRESTRELSKI SJ, 1993, BIOPHYS J, V65, P661, DOI 10.1016/S0006-3495(93)81120-2; Randall R, 1990, ANAL BIOCHEM, V191, P31; Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z; Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007; Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75; Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Sciadini MF, 2000, J ORTHOP RES, V18, P289, DOI 10.1002/jor.1100180218; Sohier J, 2010, J BIOMED MATER RES A, V92A, P1105, DOI 10.1002/jbm.a.32467; Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003; Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0; Xu LL, 2010, TISSUE ENG A, V16, P2927; Zhao J, 2010, ORAL DIS, V16, P46, DOI 10.1111/j.1601-0825.2009.01602.x; Zhao J, 2012, TISSUE ENG PT A, V18, P185, DOI [10.1089/ten.tea.2011.0297, 10.1089/ten.TEA.2011.0297]; Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026; Zhao L, 2011, TISSUE ENG PT A, V17, P969, DOI [10.1089/ten.tea.2010.0521, 10.1089/ten.TEA.2010.0521]; Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]	61	22	24	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54645	10.1371/journal.pone.0054645	http://dx.doi.org/10.1371/journal.pone.0054645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359400	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600084
J	Bansal, A; Lee, IH; Hong, X; Mathur, SC; Tawfik, O; Rastogi, A; Buttar, N; Visvanathan, M; Sharma, P; Christenson, LK				Bansal, Ajay; Lee, In-Hee; Hong, Xiaoman; Mathur, Sharad C.; Tawfik, Ossama; Rastogi, Amit; Buttar, Navtej; Visvanathan, Mahesh; Sharma, Prateek; Christenson, Lane K.			Discovery and Validation of Barrett's Esophagus MicroRNA Transcriptome by Next Generation Sequencing	PLOS ONE			English	Article							EXPRESSION PROFILES; SMALL RNAS; ADENOCARCINOMA; IDENTIFICATION; LIMITATIONS; PROGRESSION; METAPLASIA; DYSPLASIA; PHENOTYPE; TARGETS	Objective: Barrett's esophagus (BE) is transition from squamous to columnar mucosa as a result of gastroesophageal reflux disease (GERD). The role of microRNA during this transition has not been systematically studied. Design: For initial screening, total RNA from 5 GERD and 6 BE patients was size fractionated. RNA <70 nucleotides was subjected to SOLiD 3 library preparation and next generation sequencing (NGS). Bioinformatics analysis was performed using R package "DEseq". A p value <0.05 adjusted for a false discovery rate of 5% was considered significant. NGS-identified miRNA were validated using qRT-PCR in an independent group of 40 GERD and 27 BE patients. MicroRNA expression of human BE tissues was also compared with three BE cell lines. Results: NGS detected 19.6 million raw reads per sample. 53.1% of filtered reads mapped to miRBase version 18. NGS analysis followed by qRT-PCR validation found 10 differentially expressed miRNA; several are novel (-708-5p, -944, -224-5p and -3065-5p). Up-or down-regulation predicted by NGS was matched by qRT-PCR in every case. Human BE tissues and BE cell lines showed a high degree of concordance (70-80%) in miRNA expression. Prediction analysis identified targets that mapped to developmental signaling pathways such as TGF beta and Notch and inflammatory pathways such as toll-like receptor signaling and TGF beta. Cluster analysis found similarly regulated (up or down) miRNA to share common targets suggesting coordination between miRNA. Conclusion: Using highly sensitive next-generation sequencing, we have performed a comprehensive genome wide analysis of microRNA in BE and GERD patients. Differentially expressed miRNA between BE and GERD have been further validated. Expression of miRNA between BE human tissues and BE cell lines are highly correlated. These miRNA should be studied in biological models to further understand BE development.	[Bansal, Ajay; Rastogi, Amit; Sharma, Prateek] Vet Affairs Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS USA; [Bansal, Ajay; Tawfik, Ossama; Rastogi, Amit; Sharma, Prateek; Christenson, Lane K.] Univ Kansas, Med Ctr, Kansas Canc Inst, Kansas City, KS 66103 USA; [Lee, In-Hee; Visvanathan, Mahesh] Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA; [Hong, Xiaoman; Christenson, Lane K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Mathur, Sharad C.] Vet Affairs Med Ctr, Dept Pathol, Kansas City, KS USA; [Buttar, Navtej] Mayo Clin, Dept Gastroenterol, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Mayo Clinic	Bansal, A (corresponding author), Vet Affairs Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS USA.	abansal@kumc.edu	Christenson, Lane K/G-6435-2013	Lee, In-Hee/0000-0002-8857-1355	American Cancer Society; American College of Gastroenterology; VISN 15 Research Award; Hall Family Foundation;  [K-INBRE P20 RR016475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American College of Gastroenterology(General Electric); VISN 15 Research Award; Hall Family Foundation; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a pilot grant from the American Cancer Society (A. B.) and Junior Faculty Development Award from the American College of Gastroenterology (A. B.), VISN 15 Research Award (A. B.), K-INBRE P20 RR016475 (L. K. C., A. B. and M. V.) and Hall Family Foundation (L. K. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bansal A, 2011, AM J GASTROENTEROL; Barrett MT, 2003, CANCER RES, V63, P4211; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Buermans HPJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-716; Carletti MZ, 2010, BIOL REPROD, V83, P286, DOI 10.1095/biolreprod.109.081448; di Pietro M, 2012, P NATL ACAD SCI US; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Fassan M, 2010, INT J CANC; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Fiedler SD, 2010, METHODS MOL BIOL, V630, P49, DOI 10.1007/978-1-60761-629-0_4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2012, CARCINOGENESIS; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kadri SR, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4372; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kawaji H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040022; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koshiol J, 2010, CANCER EPIDEM BIOMAR, V19, P907, DOI 10.1158/1055-9965.EPI-10-0071; Kosoff RE, 2012, J CELL PHYSIOL, V227, P2654, DOI 10.1002/jcp.23007; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krishnadath KK, 2007, CURR OPIN GASTROEN, V23, P440, DOI 10.1097/MOG.0b013e32814e6b4f; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leidner RS, 2012, GENE CHROMOSOME CANC, V51, P473, DOI 10.1002/gcc.21934; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Ness-Jensen E, 2011, GUT; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Shu M, 2011, MOL PHARM; Souza RF, 2008, AM J PHYSIOL-GASTR L, V295, pG211, DOI 10.1152/ajpgi.90250.2008; Souza RF, 2011, ANN NY ACAD SCI, V1232, P18, DOI 10.1111/j.1749-6632.2011.06043.x; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; van Baal JW, 2012, GUT; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wijnhoven BPL, 2010, BRIT J SURG, V97, P853, DOI 10.1002/bjs.7000; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385	61	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54240	10.1371/journal.pone.0054240	http://dx.doi.org/10.1371/journal.pone.0054240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372692	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500045
J	Crnogorac-Jurcevic, T; Chelala, C; Barry, S; Harada, T; Bhakta, V; Lattimore, S; Jurcevic, S; Bronner, M; Lemoine, NR; Brentnall, TA				Crnogorac-Jurcevic, Tatjana; Chelala, Claude; Barry, Sayka; Harada, Tomohiko; Bhakta, Vipul; Lattimore, Sam; Jurcevic, Stipo; Bronner, Mary; Lemoine, Nicholas R.; Brentnall, Teresa A.			Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; TRANSCRIPTOME ANALYSIS; STELLATE CELLS; MAST-CELLS; EXPRESSION; INFLAMMATION; PROGRESSION; CARCINOMA; PROMOTES; GENES	Background: With less than a 5% survival rate pancreatic adenocarcinoma (PDAC) is almost uniformly lethal. In order to make a significant impact on survival of patients with this malignancy, it is necessary to diagnose the disease early, when curative surgery is still possible. Detailed knowledge of the natural history of the disease and molecular events leading to its progression is therefore critical. Methods and Findings: We have analysed the precursor lesions, PanINs, from prophylactic pancreatectomy specimens of patients from four different kindreds with high risk of familial pancreatic cancer who were treated for histologically proven PanIN-2/3. Thus, the material was procured before pancreatic cancer has developed, rather than from PanINs in a tissue field that already contains cancer. Genome-wide transcriptional profiling using such unique specimens was performed. Bulk frozen sections displaying the most extensive but not microdissected PanIN-2/3 lesions were used in order to obtain the holistic view of both the precursor lesions and their microenvironment. A panel of 76 commonly dysregulated genes that underlie neoplastic progression from normal pancreas to PanINs and PDAC were identified. In addition to shared genes some differences between the PanINs of individual families as well as between the PanINs and PDACs were also seen. This was particularly pronounced in the stromal and immune responses. Conclusions: Our comprehensive analysis of precursor lesions without the invasive component provides the definitive molecular proof that PanIN lesions beget cancer from a molecular standpoint. We demonstrate the need for accumulation of transcriptomic changes during the progression of PanIN to PDAC, both in the epithelium and in the surrounding stroma. An identified 76-gene signature of PDAC progression presents a rich candidate pool for the development of early diagnostic and/or surveillance markers as well as potential novel preventive/therapeutic targets for both familial and sporadic pancreatic adenocarcinoma.	[Crnogorac-Jurcevic, Tatjana; Chelala, Claude; Barry, Sayka; Harada, Tomohiko; Bhakta, Vipul; Lattimore, Sam; Lemoine, Nicholas R.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Jurcevic, Stipo] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England; [Bronner, Mary] Univ Utah, Dept Anat Pathol, Salt Lake City, UT USA; [Brentnall, Teresa A.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA USA	University of London; Queen Mary University London; University of London; King's College London; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle	Crnogorac-Jurcevic, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England.	T.C.Jurcevic@qmul.ac.uk		Lemoine, Nick/0000-0001-8675-058X; chelala, claude/0000-0002-2488-0669	CRUK; Higher Education Funding Council for England (HEFCE); Cancer Research UK [12008] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish	CRUK(Cancer Research UK); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by CRUK (http://www.cancerresearchuk.org/). TCJ is funded by Higher Education Funding Council for England (HEFCE); http://www.hefce.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Arumugam T, 2011, PANCREAS, V40, P815, DOI 10.1097/MPA.0b013e31821f6927; Bartsch DK, 2012, NAT REV GASTRO HEPAT, V9, P445, DOI 10.1038/nrgastro.2012.111; Baumgart M, 2010, PANCREAS, V39, P1093, DOI 10.1097/MPA.0b013e3181dc62f6; Brat DJ, 1998, AM J SURG PATHOL, V22, P163, DOI 10.1097/00000478-199802000-00003; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Buchholz M, 2005, J MOL MED, V83, P795, DOI 10.1007/s00109-005-0680-2; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Chung HW, 2012, CANCER SCI, V103, P1714, DOI 10.1111/j.1349-7006.2012.02358.x; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; CUBILLA AL, 1976, CANCER RES, V36, P2690; Cutts RJ, 2011, NUCLEIC ACIDS RES, V39, pD1023, DOI 10.1093/nar/gkq937; Dowen SE, 2005, AM J PATHOL, V166, P81, DOI 10.1016/S0002-9440(10)62234-1; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; EVANS JP, 1995, J MED GENET, V32, P330, DOI 10.1136/jmg.32.5.330; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lynch HT, 1996, SEMIN ONCOL, V23, P251; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Meckler KA, 2001, AM J SURG PATHOL, V25, P1047, DOI 10.1097/00000478-200108000-00009; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Pan S, 2009, ELECTROPHORESIS, V30, P1132, DOI 10.1002/elps.200800752; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Real FX, 2008, GASTROENTEROLOGY, V135, P724, DOI 10.1053/j.gastro.2008.07.033; Rulyak SJ, 2004, INT J BIOCHEM CELL B, V36, P1386, DOI 10.1016/j.biocel.2004.02.010; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwartz AM, 2007, AM J SURG PATHOL, V31, P645, DOI 10.1097/PAS.0b013e31802d6d42; Shi CJ, 2009, CLIN CANCER RES, V15, P7737, DOI 10.1158/1078-0432.CCR-09-0004; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Shioya M, 2008, PANCREAS, V36, P197, DOI 10.1097/MPA.0b013e3181594258; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sitek B, 2005, PROTEOMICS, V5, P2665, DOI 10.1002/pmic.200401298; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SOMMERS SC, 1954, GASTROENTEROLOGY, V27, P629, DOI 10.1016/S0016-5085(19)36105-0; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; TAKEUCHI Y, 1993, AM J GASTROENTEROL, V88, P1928; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Theoharides TC, 2008, NEW ENGL J MED, V358, P1860, DOI 10.1056/NEJMcibr0801519; Tobita K, 2002, INT J ONCOL, V21, P1189; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Zhang LZ, 2007, AM J SURG PATHOL, V31, P1191, DOI 10.1097/PAS.0b013e31806841e1; Zhang YW, 2003, WORLD J GASTROENTERO, V9, P2635	61	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54830	10.1371/journal.pone.0054830	http://dx.doi.org/10.1371/journal.pone.0054830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372777	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500134
J	Manevski, N; Troberg, J; Svaluto-Moreolo, P; Dziedzic, K; Yli-Kauhaluoma, J; Finel, M				Manevski, Nenad; Troberg, Johanna; Svaluto-Moreolo, Paolo; Dziedzic, Klaudyna; Yli-Kauhaluoma, Jari; Finel, Moshe			Albumin Stimulates the Activity of the Human UDP-Glucuronosyltransferases 1A7, 1A8, 1A10, 2A1 and 2B15, but the Effects Are Enzyme and Substrate Dependent	PLOS ONE			English	Article							IN VIVO EXTRAPOLATION; HUMAN LIVER-MICROSOMES; BOVINE SERUM-ALBUMIN; UNSATURATED FATTY-ACIDS; ZIDOVUDINE GLUCURONIDATION; DRUG CLEARANCE; VITRO DATA; UGT 1A4; ALAMETHICIN; BINDING	Human UDP-glucuronosyltransferases (UGTs) are important enzymes in metabolic elimination of endo-and xenobiotics. It was recently shown that addition of fatty acid free bovine serum albumin (BSA) significantly enhances in vitro activities of UGTs, a limiting factor in in vitro-in vivo extrapolation. Nevertheless, since only few human UGT enzymes were tested for this phenomenon, we have now performed detailed enzyme kinetic analysis on the BSA effects in six previously untested UGTs, using 2-4 suitable substrates for each enzyme. We also examined some of the previously tested UGTs, but using additional substrates and a lower BSA concentration, only 0.1%. The latter concentration allows the use of important but more lipophilic substrates, such as estradiol and 17-epiestradiol. In five newly tested UGTs, 1A7, 1A8, 1A10, 2A1, and 2B15, the addition of BSA enhanced, to a different degree, the in vitro activity by either decreasing reaction's K-m, increasing its V-max, or both. In contrast, the activities of UGT2B17, another previously untested enzyme, were almost unaffected. The results of the assays with the previously tested UGTs, 1A1, 1A6, 2B4, and 2B7, were similar to the published BSA only as far as the BSA effects on the reactions' K-m are concerned. In the cases of V-max values, however, our results differ significantly from the previously published ones, at least with some of the substrates. Hence, the magnitude of the BSA effects appears to be substrate dependent, especially with respect to V-max increases. Additionally, the BSA effects may be UGT subfamily dependent since K-m decreases were observed in members of subfamilies 1A, 2A and 2B, whereas large V-max increases were only found in several UGT1A members. The results shed new light on the complexity of the BSA effects on the activity and enzyme kinetics of the human UGTs.	[Manevski, Nenad; Troberg, Johanna; Svaluto-Moreolo, Paolo; Dziedzic, Klaudyna; Finel, Moshe] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Manevski, Nenad; Troberg, Johanna; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland	University of Helsinki; University of Helsinki	Finel, M (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland.	Moshe.Finel@helsinki.fi		Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Troberg, Johanna Maaria/0000-0003-3886-4771	Sigrid Juselius Foundation; Graduate School in Pharmaceutical Research; Academy of Finland [120975, 1260010]; University of Helsinki Research Foundation; European Erasmus programme	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Graduate School in Pharmaceutical Research; Academy of Finland(Academy of Finland); University of Helsinki Research Foundation; European Erasmus programme	This study was supported by the Sigrid Juselius Foundation, the Graduate School in Pharmaceutical Research, the Academy of Finland (project numbers 120975 and 1260010), the University of Helsinki Research Foundation grant for young researchers, and the European Erasmus programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Guillemette C, 2010, DRUG METAB REV, V42, P24, DOI 10.3109/03602530903210682; Houston JB, 2000, DRUG METAB DISPOS, V28, P246; Itaaho K, 2008, DRUG METAB DISPOS, V36, P2307, DOI 10.1124/dmd.108.022731; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Kaivosaari S, 2008, DRUG METAB DISPOS, V36, P1529, DOI 10.1124/dmd.108.021709; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Knights KM, 2010, DRUG METAB DISPOS, V38, P1011, DOI 10.1124/dmd.110.032870; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Kurkela M, 2004, BIOCHEM PHARMACOL, V68, P2443, DOI 10.1016/j.bcp.2004.08.019; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; Lautala P, 2000, DRUG METAB DISPOS, V28, P1385; Little JM, 1997, DRUG METAB DISPOS, V25, P5; Loureiro AI, 2011, DRUG METAB DISPOS, V39, P1486, DOI 10.1124/dmd.111.038620; Luukkanen L, 1999, BIOCONJUGATE CHEM, V10, P150, DOI 10.1021/bc980064n; Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093; Manevski N, 2012, DRUG METAB DISPOS, V40, P2192, DOI 10.1124/dmd.112.047746; Manevski N, 2011, DRUG METAB DISPOS, V39, P2117, DOI 10.1124/dmd.111.041418; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Miners JO, 2010, DRUG METAB REV, V42, P189; Miners JO, 2011, DRUG METAB DISPOS, V39, P644, DOI 10.1124/dmd.110.037036; Raungrut P, 2010, J PHARMACOL EXP THER, V334, P609, DOI 10.1124/jpet.110.167916; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Rowland A, 2008, DRUG METAB DISPOS, V36, P870, DOI 10.1124/dmd.107.019885; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1124/jpet.106.118216; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Rowland A, 2009, DRUG METAB DISPOS, V37, P1395, DOI 10.1124/dmd.109.027656; Shareef A, 2006, J CHEM ENG DATA, V51, P879, DOI 10.1021/je050318c; Shiraga T, 2012, DRUG METAB DISPOS, V40, P276, DOI 10.1124/dmd.111.042614; Sneitz N, 2009, PHARMACOGENET GENOM, V19, P923, DOI 10.1097/FPC.0b013e3283330767; Taylor J., 1996, INTRO ERROR ANAL STU; Tsoutsikos P, 2004, BIOCHEM PHARMACOL, V67, P191, DOI 10.1016/j.bcp.2003.08.025; Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200; Uchaipichat V, 2006, BRIT J CLIN PHARMACO, V61, P427, DOI 10.1111/j.1365-2125.2006.02588.x; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; Uchaipichat V, 2008, MOL PHARMACOL, V74, P1152, DOI 10.1124/mol.108.048645; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1051, DOI 10.1124/dmd.111.043117; Wattanachai N, 2012, DRUG METAB DISPOS, V40, P982, DOI 10.1124/dmd.111.044057; Zhang HB, 2011, DRUG METAB DISPOS, V39, P456, DOI 10.1124/dmd.110.036582; Zhou J, 2011, DRUG METAB DISPOS, V39, P322, DOI 10.1124/dmd.110.035030; Zhou J, 2010, DRUG METAB DISPOS, V38, P431, DOI 10.1124/dmd.109.028712	43	29	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54767	10.1371/journal.pone.0054767	http://dx.doi.org/10.1371/journal.pone.0054767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372764	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500122
J	Zhang, CL; Zhang, CS; Chen, SP; Yin, XY; Pan, XY; Lin, G; Tan, YQ; Tan, K; Xu, ZF; Hu, P; Li, XC; Chen, F; Xu, X; Li, YR; Zhang, XQ; Jiang, H; Wang, W				Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Lin, Ge; Tan, Yueqiu; Tan, Ke; Xu, Zhengfeng; Hu, Ping; Li, Xuchao; Chen, Fang; Xu, Xun; Li, Yingrui; Zhang, Xiuqing; Jiang, Hui; Wang, Wei			A Single Cell Level Based Method for Copy Number Variation Analysis by Low Coverage Massively Parallel Sequencing	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; CHROMOSOME; EVOLUTION; DELETION; MAPS; DNA	Copy number variations (CNVs), a common genomic mutation associated with various diseases, are important in research and clinical applications. Whole genome amplification (WGA) and massively parallel sequencing have been applied to single cell CNVs analysis, which provides new insight for the fields of biology and medicine. However, the WGA-induced bias significantly limits sensitivity and specificity for CNVs detection. Addressing these limitations, we developed a practical bioinformatic methodology for CNVs detection at the single cell level using low coverage massively parallel sequencing. This method consists of GC correction for WGA-induced bias removal, binary segmentation algorithm for locating CNVs breakpoints, and dynamic threshold determination for final signals filtering. Afterwards, we evaluated our method with seven test samples using low coverage sequencing (4 similar to 9.5%). Four single-cell samples from peripheral blood, whose karyotypes were confirmed by whole genome sequencing analysis, were acquired. Three other test samples derived from blastocysts whose karyotypes were confirmed by SNP-array analysis were also recruited. The detection results for CNVs of larger than 1 Mb were highly consistent with confirmed results reaching 99.63% sensitivity and 97.71% specificity at base-pair level. Our study demonstrates the potential to overcome WGA-bias and to detect CNVs (>1 Mb) at the single cell level through low coverage massively parallel sequencing. It highlights the potential for CNVs research on single cells or limited DNA samples and may prove as a promising tool for research and clinical applications, such as pre-implantation genetic diagnosis/screening, fetal nucleated red blood cells research and cancer heterogeneity analysis.	[Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Xu, Xun; Li, Yingrui; Zhang, Xiuqing; Jiang, Hui; Wang, Wei] BGI Shenzhen, Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Lin, Ge; Tan, Yueqiu] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Xu, Zhengfeng; Hu, Ping] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Ctr Prenatal Diag, Nanjing, Peoples R China; [Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Jiang, Hui; Wang, Wei] BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen, Guangdong, Peoples R China; [Zhang, Chunlei; Zhang, Chunsheng; Chen, Shengpei; Yin, Xuyang; Pan, Xiaoyu; Li, Xuchao; Chen, Fang; Zhang, Xiuqing; Jiang, Hui] BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen, Guangdong, Peoples R China; [Lin, Ge; Tan, Ke] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Lin, Ge; Tan, Yueqiu] Minist Hlth, Key Lab Stem Cell & Reprod Engn, Changsha, Hunan, Peoples R China; [Chen, Shengpei] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Pan, Xiaoyu] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Chen, Fang; Jiang, Hui] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Beijing Genomics Institute (BGI); Central South University; Nanjing Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Central South University; Southeast University - China; South China University of Technology; University of Copenhagen	Jiang, H (corresponding author), BGI Shenzhen, Sci & Technol, Shenzhen, Guangdong, Peoples R China.	jianghui@genomics.cn; wangw@genomics.cn	Pan, Xiaoyu/AAT-9002-2021; Li, Yingrui/K-1064-2015; Xu, Xun/AAI-6763-2020	Pan, Xiaoyu/0000-0002-0282-6047; Xu, Xun/0000-0002-5338-5173	Key Laboratory Project in Guangdong Province [2011A060906007]; Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform [861]	Key Laboratory Project in Guangdong Province; Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform	This project is supported by Key Laboratory Project in Guangdong Province, (2011A060906007) and Key laboratory Project in Shenzhen (Shenzhen Municipal Commission of development and Reform [2011] No. 861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; Bredel M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Corneveaux JJ, 2007, BIOTECHNIQUES, V42, P77, DOI 10.2144/000112308; Dan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027835; DOKRAS A, 1990, HUM REPROD, V5, P821, DOI 10.1093/oxfordjournals.humrep.a137191; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; GRIFFIN DK, 1991, HUM REPROD, V6, P101, DOI 10.1093/oxfordjournals.humrep.a137241; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang R, 2008, PRENATAL DIAG, V28, P892, DOI 10.1002/pd.2079; Krumm N, 2012, GENOME RES; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; STROM CM, 1990, LANCET, V336, P306, DOI 10.1016/0140-6736(90)91835-X; Uum van CMJ, 2010, HUMAN REPROD, V25, pi61; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	30	20	47	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54236	10.1371/journal.pone.0054236	http://dx.doi.org/10.1371/journal.pone.0054236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372689	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500042
J	Thornton, PDJ; Gwynne, RM; McMillan, DJ; Bornstein, JC				Thornton, Peter D. J.; Gwynne, Rachel M.; McMillan, Darren J.; Bornstein, Joel C.			Transmission to Interneurons Is via Slow Excitatory Synaptic Potentials Mediated by P2Y(1) Receptors during Descending Inhibition in Guinea-Pig Ileum	PLOS ONE			English	Article							NEURO-NEURONAL TRANSMISSION; MYENTERIC NEURONS; POSTSYNAPTIC POTENTIALS; MOTOR-NEURONS; NEUROMUSCULAR-TRANSMISSION; MUCOSAL STIMULATION; MOTILITY REFLEXES; ATP; PERISTALSIS; DISTENSION	Background: The nature of synaptic transmission at functionally distinct synapses in intestinal reflex pathways has not been fully identified. In this study, we investigated whether transmission between interneurons in the descending inhibitory pathway is mediated by a purine acting at P2Y receptors to produce slow excitatory synaptic potentials (EPSPs). Methodology/Principal findings: Myenteric neurons from guinea-pig ileum in vitro were impaled with intracellular microelectrodes. Responses to distension 15 mm oral to the recording site, in a separately perfused stimulation chamber and to electrical stimulation of local nerve trunks were recorded. A subset of neurons, previously identified as nitric oxide synthase immunoreactive descending interneurons, responded to both stimuli with slow EPSPs that were reversibly abolished by a high concentration of PPADS (30 mu M, P2 receptor antagonist). When added to the central chamber of a three chambered organ bath, PPADS concentration-dependently depressed transmission through that chamber of descending inhibitory reflexes, measured as inhibitory junction potentials in the circular muscle of the anal chamber. Reflexes evoked by distension in the central chamber were unaffected. A similar depression of transmission was seen when the specific P2Y(1) receptor antagonist MRS 2179 (10 mu M) was in the central chamber. Blocking either nicotinic receptors (hexamethonium 200 mM) or 5-HT3 receptors (granisetron 1 mu M) together with P2 receptors had no greater effect than blocking P2 receptors alone. Conclusions/Significance: Slow EPSPs mediated by P2Y(1) receptors, play a primary role in transmission between descending interneurons of the inhibitory reflexes in the guinea-pig ileum. This is the first demonstration for a primary role of excitatory metabotropic receptors in physiological transmission at a functionally identified synapse.	[Thornton, Peter D. J.; Gwynne, Rachel M.; McMillan, Darren J.; Bornstein, Joel C.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia	University of Melbourne	Bornstein, JC (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	j.bornstein@unimelb.edu.au	Bornstein, Joel/I-3322-2019; Gwynne, Rachel/A-6039-2019	Bornstein, Joel/0000-0002-7518-7717; Gwynne, Rachel/0000-0002-3545-2045	National Health and Medical Research Project [566642]	National Health and Medical Research Project	This work was supported by National Health and Medical Research Project grants (566642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex G, 2002, NEUROSCIENCE, V110, P361, DOI 10.1016/S0306-4522(01)00583-8; Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Aoyama T, 2010, BRAIN RES, V1340, P10, DOI 10.1016/j.brainres.2010.04.053; Bayliss W M, 1899, J Physiol, V24, P99; Bertrand PP, 2006, J PHYSIOL-LONDON, V577, P689, DOI 10.1113/jphysiol.2006.117804; Bian XC, 2000, J PHYSIOL-LONDON, V528, P551, DOI 10.1111/j.1469-7793.2000.00551.x; BORNSTEIN JC, 1986, J PHYSIOL-LONDON, V370, P61, DOI 10.1113/jphysiol.1986.sp015922; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; BROOKES SJH, 1991, NEUROSCIENCE, V42, P863, DOI 10.1016/0306-4522(91)90050-X; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Foong JPP, 2009, FRONT NEUROSCI, DOI [10.3389/neuro.3321.3001.2009, DOI 10.3389/NEURO.3321.3001.2009]; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P159, DOI 10.1111/j.1365-2982.2007.01004.x; Gallego D, 2008, AM J PHYSIOL-GASTR L, V295, pG522, DOI 10.1152/ajpgi.00510.2007; Gallego D, 2006, AM J PHYSIOL-GASTR L, V291, pG584, DOI 10.1152/ajpgi.00474.2005; Grider JR, 1998, GASTROENTEROLOGY, V115, P370, DOI 10.1016/S0016-5085(98)70203-3; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1660, DOI 10.1152/ajpgi.00580.2006; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1162, DOI 10.1152/ajpgi.00441.2006; Gwynne RM, 2007, CURR NEUROPHARMACOL, V5, P1, DOI 10.2174/157015907780077141; Gwynne RM, 2009, AM J PHYSIOL-GASTR L, V297, pG179, DOI 10.1152/ajpgi.90700.2008; Hu HZ, 2003, J PHYSIOL-LONDON, V550, P493, DOI 10.1113/jphysiol.2003.041731; Hwang SJ, 2011, GASTROENTEROLOGY, V140, P608, DOI 10.1053/j.gastro.2010.09.039; Johnson PJ, 2004, NEUROSCIENCE, V126, P137, DOI 10.1016/j.neuroscience.2004.03.021; Johnson PJ, 1998, BRIT J PHARMACOL, V124, P1375, DOI 10.1038/sj.bjp.0701967; Johnson PJ, 1996, BRIT J PHARMACOL, V118, P973, DOI 10.1111/j.1476-5381.1996.tb15495.x; Johnson PJ, 1999, NEUROSCI LETT, V266, P169, DOI 10.1016/S0304-3940(99)00275-X; Katayama Y, 1989, J PHYSL, V408, P1; Kunze WAA, 1998, J PHYSIOL-LONDON, V506, P827, DOI 10.1111/j.1469-7793.1998.827bv.x; LePard KJ, 1997, GASTROENTEROLOGY, V113, P1522, DOI 10.1053/gast.1997.v113.pm9352854; Monro RL, 2005, NEUROSCIENCE, V134, P975, DOI 10.1016/j.neuroscience.2005.05.006; Monro RL, 2004, J PHYSIOL-LONDON, V556, P571, DOI 10.1113/jphysiol.2004.060848; Monro RL, 2002, NEUROGASTROENT MOTIL, V14, P255, DOI 10.1046/j.1365-2982.2002.00325.x; Mutafova-Yambolieva VN, 2007, P NATL ACAD SCI USA, V104, P16359, DOI 10.1073/pnas.0705510104; Neunlist M, 1999, J PHYSIOL-LONDON, V517, P533, DOI 10.1111/j.1469-7793.1999.0533t.x; Pin JP, 1998, NATURE, V394, P19, DOI 10.1038/27771; Ralevic V, 1998, PHARMACOL REV, V50, P413; Riedel G, 1996, PROG NEURO-PSYCHOPH, V20, P761, DOI 10.1016/0278-5846(96)00058-9; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; SMITH TK, 1991, J AUTONOM NERV SYST, V34, P69, DOI 10.1016/0165-1838(91)90009-R; Spencer N, 1999, J PHYSIOL-LONDON, V517, P889, DOI 10.1111/j.1469-7793.1999.0889s.x; Spencer NJ, 2000, J PHYSIOL-LONDON, V522, P321, DOI 10.1111/j.1469-7793.2000.t01-1-00321.x; Spencer NJ, 2001, J PHYSIOL-LONDON, V530, P295, DOI 10.1111/j.1469-7793.2001.0295l.x; Thornton PDJ, 2002, J PHYSIOL-LONDON, V539, P589, DOI 10.1113/jphysiol.2001.013399; Tonini M, 2005, GASTROENTEROLOGY, V129, P1557, DOI 10.1053/j.gastro.2005.08.005	44	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e40840	10.1371/journal.pone.0040840	http://dx.doi.org/10.1371/journal.pone.0040840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23382795	gold, Green Published			2022-12-27	WOS:000315157200001
J	He, S; Chen, XP				He, Sen; Chen, Xiaoping			Could the New Body Shape Index Predict the New Onset of Diabetes Mellitus in the Chinese Population?	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; RISK; TYPE-2; EPIDEMIOLOGY; ASSOCIATION; OBESITY; RATIO	Background: Anthropometric measures could predict the new onset of diabetes mellitus (DM). Recently, a new anthropometric measure (a body shape index, ABSI) was developed, and ABSI could predict premature mortality, even better than WC and BMI. The main aims of the study were to assess the DM predictive power of ABSI based on the follow-up data over 15 years collected from a general Chinese population. Methods and Findings: The data were collected in 1992 and then again in 2007 from the same group of 711 individuals. Because 24 of them were diagnosed with DM in 1992, our analysis was eventually based on the usable data collected from the remaining 687 individuals (male: 58.1%). ABSI was defined as WC/(BMI (2/3) height (1/2)), expressing WC and height in m. After adjusting for confounders, increasing the population ABSI by one standard deviation would result in an increased HR of 41% (95% CI: 12%-77%), compared to 73% (95% CI: 37%-118%) for BMI and 96% (95% CI: 53%-150%) for WC. WC had the best discriminatory power for DM (AROC: 0.701, 95% CI: 0.641-0.760), followed by BMI (AROC: 0.668, 95% CI: 0.601-0.734) and ABSI (AROC: 0.647, 95% CI: 0.581-0.713). Conclusions: ABSI could predict the new onset of DM in the Chinese population independently. Since the confidence intervals for the HR coefficients and AROCs overlapped, the predictive ability of ABSI for DM was not better than WC and BMI. The three measures had similar predictive abilities for DM. Further studies about ethnic specificities of ABSI are needed and warranted.	[He, Sen; Chen, Xiaoping] Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China	Sichuan University	Chen, XP (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiovasc Med, Chengdu 610064, Peoples R China.	happensky@163.com			National Eighth Five-Year Research Plan, China [85-915-01-02]; Mega-projects of Science Research for the 11th Five-Year Plan, China [2006BAI01A01]	National Eighth Five-Year Research Plan, China; Mega-projects of Science Research for the 11th Five-Year Plan, China(National Key Technology R&D Program)	This study was supported by a project from the National Eighth Five-Year Research Plan, China (grant no: 85-915-01-02), and by Mega-projects of Science Research for the 11th Five-Year Plan, China (grant no: 2006BAI01A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berentzen TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023104; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Ren J, 2010, ATHEROSCLEROSIS, V211, P327, DOI 10.1016/j.atherosclerosis.2010.02.020; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	15	66	73	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e50573	10.1371/journal.pone.0050573	http://dx.doi.org/10.1371/journal.pone.0050573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382801	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800004
J	Krag, CL; Fillon, G; Gysbers, A; Hansen, HD; Neumann, M; Richter-Landsberg, C; Haass, C; Zalc, B; Lubetzki, C; Gai, WP; Halliday, GM; Kahle, PJ; Jensen, PH				Krag, Christine L.; Fillon, Gwenaelle; Gysbers, Amanda; Hansen, Hanne D.; Neumann, Manuela; Richter-Landsberg, Christiane; Haass, Christian; Zalc, Bernard; Lubetzki, Catherine; Gai, Wei-Ping; Halliday, Glenda M.; Kahle, Philipp J.; Jensen, Poul H.			FAS-Dependent Cell Death in alpha-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; GLIAL CYTOPLASMIC INCLUSIONS; MOUSE MODEL; PARKINSONS-DISEASE; RAT-BRAIN; NEURONAL DEGENERATION; PROTEIN TPPP/P25; EXPRESSION; APOPTOSIS; OVEREXPRESSION	Multiple system atrophy is a parkinsonian neurodegenerative disorder. It is cytopathologically characterized by accumulation of the protein p25 alpha in cell bodies of oligodendrocytes followed by accumulation of aggregated alpha-synuclein in so-called glial cytoplasmic inclusions. p25 alpha is a stimulator of alpha-synuclein aggregation, and coexpression of alpha-synuclein and p25 alpha in the oligodendroglial OLN-t40-AS cell line causes alpha-synuclein aggregate-dependent toxicity. In this study, we investigated whether the FAS system is involved in alpha-synuclein aggregate dependent degeneration in oligodendrocytes and may play a role in multiple system atrophy. Using rat oligodendroglial OLN-t40-AS cells we demonstrate that the cytotoxicity caused by coexpressing alpha-synuclein and p25 alpha relies on stimulation of the death domain receptor FAS and caspase-8 activation. Using primary oligodendrocytes derived from PLP-alpha-synuclein transgenic mice we demonstrate that they exist in a sensitized state expressing pro-apoptotic FAS receptor, which makes them sensitive to FAS ligand-mediated apoptosis. Immunoblot analysis shows an increase in FAS in brain extracts from multiple system atrophy cases. Immunohistochemical analysis demonstrated enhanced FAS expression in multiple system atrophy brains notably in oligodendrocytes harboring the earliest stages of glial cytoplasmic inclusion formation. Oligodendroglial FAS expression is an early hallmark of oligodendroglial pathology in multiple system atrophy that mechanistically may be coupled to alpha-synuclein dependent degeneration and thus represent a potential target for protective intervention.	[Krag, Christine L.; Jensen, Poul H.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Fillon, Gwenaelle; Haass, Christian] Univ Munich, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, Munich, Germany; [Gysbers, Amanda; Halliday, Glenda M.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Hansen, Hanne D.; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Neumann, Manuela] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany; [Zalc, Bernard; Lubetzki, Catherine] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Dept Human Physiol, Bedford Pk, SA 5042, Australia; [Gai, Wei-Ping] Flinders Univ S Australia, Sch Med, Ctr Neurosci, Bedford Pk, SA 5042, Australia; [Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Tubingen, Germany	Aarhus University; University of Munich; Neuroscience Research Australia; University of New South Wales Sydney; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; Carl von Ossietzky Universitat Oldenburg; UDICE-French Research Universities; Sorbonne Universite; Flinders University South Australia; Flinders University South Australia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany.	Philipp.Kahle@uni-tuebingen.de; phj@biokemi.au.dk	Halliday, Glenda M/E-8555-2011; Gai, Wei-Ping/A-3700-2008; Hansen, Hanne Demant/C-9029-2013; Neumann, Manuela/F-6558-2011	Halliday, Glenda M/0000-0003-0422-8398; Hansen, Hanne Demant/0000-0001-5564-7627; Neumann, Manuela/0000-0002-6232-4057; Jensen, Poul Henning/0000-0002-4439-9020	European Community's Seventh Framework Programme [241791 (MEFOPA), 238316 (Neurasync)]; Lundbeck Foundation; Deutsche Forschungsgemeinschaft [SFB 596, A1]; European consortium to develop PD gene therapy (NEUROPARK); Fondation pour la Recherche Medicale; Danish Medical Research Council, Aarhus University; Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research [01GI0299]; NHMRC Research Fellowships [630434, 535014]; National Health and Medical Research Council of Australia (NHMRC); Neuroscience Research Australia; University of New South Wales; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R24AA012725]; University of Sydney; Flinders Medical Centre Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme(European Commission); Lundbeck Foundation(Lundbeckfonden); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European consortium to develop PD gene therapy (NEUROPARK); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Danish Medical Research Council, Aarhus University(Danish Medical Research Council); Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research; NHMRC Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Research Australia; University of New South Wales; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Sydney(University of Sydney); Flinders Medical Centre Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241791 (MEFOPA), no 238316 (Neurasync), the Lundbeck Foundation, the Deutsche Forschungsgemeinschaft (SFB 596, project A1), the European consortium to develop PD gene therapy (NEUROPARK), the Fondation pour la Recherche Medicale, The Danish Medical Research Council, Aarhus University, the Foundation of 1984 for treatment of Parkinson disease, Federal Ministry of Education and Research (Project-No. 01GI0299). GMH and WPG have NHMRC Research Fellowships (630434 & 535014). Human brain samples were received thanks to support from the National Health and Medical Research Council of Australia (NHMRC), Neuroscience Research Australia, the University of New South Wales, the Schizophrenia Research Institute, the National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725, University of Sydney and the Flinders Medical Centre Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery A, 2006, J NEUROTRAUM, V23, P604, DOI 10.1089/neu.2006.23.604; Ahmed Z, 2012, BRAIN PATHOL; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Fehlings M, 2012, J NEUROTRAUMA; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Jodo S, 2001, J BIOL CHEM, V276, P39938, DOI 10.1074/jbc.M107005200; Kahle PJ, 2002, J NEUROCHEM, V82, P449, DOI 10.1046/j.1471-4159.2002.01020.x; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kholodilov NG, 1999, J NEUROCHEM, V73, P2586, DOI 10.1046/j.1471-4159.1999.0732586.x; Kovacs GG, 2007, ACTA NEUROPATHOL, V113, P153, DOI 10.1007/s00401-006-0167-4; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; Nakayama K, 2009, AM J PATHOL, V174, P1471, DOI 10.2353/ajpath.2009.080503; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Wakabayashi K, 2006, NEUROPATHOLOGY, V26, P338, DOI 10.1111/j.1440-1789.2006.00713.x; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x	40	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55243	10.1371/journal.pone.0055243	http://dx.doi.org/10.1371/journal.pone.0055243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372841	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400081
J	Li, XM; Yuan, DJ; Zhang, JF; Lin, ZX; Zhang, XL				Li, Ximei; Yuan, Daojun; Zhang, Jinfa; Lin, Zhongxu; Zhang, Xianlong			Genetic Mapping and Characteristics of Genes Specifically or Preferentially Expressed during Fiber Development in Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; BC1 POPULATION; EST-SSRS; BIOSYNTHESIS; ANNOTATION; ELONGATION; BLAST2GO; CLONING; GROWTH	Cotton fiber is an ideal model to study cell elongation and cell wall construction in plants. During fiber development, some genes and proteins have been reported to be specifically or preferentially expressed. Mapping of them will reveal the genomic distribution of these genes, and will facilitate selection in cotton breeding. Based on previous reports, we designed 331 gene primers and 164 protein primers, and used single-strand conformation polymorphism (SSCP) to map and integrate them into our interspecific BC1 linkage map. This resulted in the mapping of 57 loci representing 51 genes or proteins on 22 chromosomes. For those three markers which were tightly linked with quantitative trait loci (QTLs), the QTL functions obtained in this study and gene functions reported in previous reports were consistent. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of 52 polymorphic functional primers showed that 21 gene primers and 17 protein primers had differential expression between Emian22 (Gossypium hirsutum) and 3-79 (G. barbadense). Both RT-PCR and quantitative real-time PCR (qRT-PCR) analyses of the three markers tightly linked with QTLs were consistent with QTL analysis and field experiments. Gene Ontology (GO) categorization revealed that almost all 51 mapped genes belonged to multiple categories that contribute to fiber development, indicating that fiber development is a complex process regulated by various genes. These 51 genes were all specifically or preferentially expressed during fiber cell elongation and secondary wall biosynthesis. Therefore, these functional gene-related markers would be beneficial for the genetic improvement of cotton fiber length and strength.	[Li, Ximei; Yuan, Daojun; Lin, Zhongxu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hubei, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Huazhong Agricultural University; New Mexico State University	Lin, ZX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hubei, Peoples R China.	linzhongxu@mail.hzau.edu.cn	Yuan, Daojun/D-5555-2011; Yuan, Daojun/R-6048-2016	Yuan, Daojun/0000-0001-6007-5571	National Basic Research Program [2010CB126001]; Fundamental Research Funds for the Central Universities [2012MBDX007]	National Basic Research Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Basic Research Program (No. 2010CB126001) and the Fundamental Research Funds for the Central Universities (Program No. 2012MBDX007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fan L, 2006, PLANT PHYSIOL, V140, P603, DOI 10.1104/pp.105.073130; Fan L, 2009, J INTEGR PLANT BIOL, V51, P626, DOI 10.1111/j.1744-7909.2009.00840.x; Fang Dong, 2008, Acta Agronomica Sinica, V34, P207, DOI 10.3724/SP.J.1006.2008.00207; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabber JH, 2004, CR BIOL, V327, P455, DOI 10.1016/j.crvi.2004.02.009; Guo WZ, 2006, THEOR APPL GENET, V112, P1573, DOI 10.1007/s00122-006-0261-y; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Han ZhiGuo, 2006, Journal of Agricultural Biotechnology, V14, P360; He YJ, 2008, PLANTA, V228, P473, DOI 10.1007/s00425-008-0751-z; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; Ju Ming, 2009, Acta Agronomica Sinica, V35, P1217, DOI 10.3724/SP.J.1006.2009.01217; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Li XM, 2012, GENOME, V55, P459, DOI [10.1139/G2012-032, 10.1139/g2012-032]; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu CX, 2012, PLANT CELL TISS ORG, V108, P529, DOI 10.1007/s11240-011-0059-8; Lu YZ, 2009, CROP SCI, V49, P1695, DOI 10.2135/cropsci2008.12.0693; Luo M, 2007, PLANT J, V51, P419, DOI 10.1111/j.1365-313X.2007.03144.x; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Varshney RK, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P119, DOI 10.1007/978-90-481-2967-6_5; Wang XQ, 2012, PLANT MOL BIOL REP, V30, P605, DOI 10.1007/s11105-011-0369-3; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang YanJie, 2008, Scientia Agricultura Sinica, V41, P2581; Zhang YX, 2008, GENOME, V51, P534, DOI 10.1139/G08-033; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	40	17	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54444	10.1371/journal.pone.0054444	http://dx.doi.org/10.1371/journal.pone.0054444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372723	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400015
J	Wulaningsih, W; Holmberg, L; Garmo, H; Zethelius, B; Wigertz, A; Carroll, P; Lambe, M; Hammar, N; Walldius, G; Jungner, I; Van Hemelrijck, M				Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Zethelius, Bjoern; Wigertz, Annette; Carroll, Paul; Lambe, Mats; Hammar, Niklas; Walldius, Goeran; Jungner, Ingmar; Van Hemelrijck, Mieke			Serum Glucose and Fructosamine in Relation to Risk of Cancer	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BREAST-CANCER; DIABETES-MELLITUS; COLORECTAL-CANCER; SOLUBLE RECEPTOR; APOLIPOPROTEIN-B; INSULIN; MORTALITY; COHORT; WOMEN	Background: Impaired glucose metabolism has been linked with increased cancer risk, but the association between serum glucose and cancer risk remains unclear. We used repeated measurements of glucose and fructosamine to get more insight into the association between the glucose metabolism and risk of cancer. Methods: We selected 11,998 persons (>20 years old) with four prospectively collected serum glucose and fructosamine measurements from the Apolipoprotein Mortality Risk (AMORIS) study. Multivariate Cox proportional hazards regression was used to assess standardized log of overall mean glucose and fructosamine in relation to cancer risk. Similar analyses were performed for tertiles of glucose and fructosamine and for different types of cancer. Results: A positive trend was observed between standardized log overall mean glucose and overall cancer risk (HR = 1.08; 95% CI: 1.02-1.14). Including standardized log fructosamine in the model resulted in a stronger association between glucose and cancer risk and aninverse association between fructosamine and cancer risk (HR = 1.17; 95% CI: 1.08-1.26 and HR: 0.89; 95% CI: 0.82-0.96, respectively). Cancer risks were highest among those in the highest tertile of glucose and lowest tertile of fructosamine. Similar findings were observed for prostate, lung, and colorectal cancer while none observed for breast cancer. Conclusion: The contrasting effect between glucose, fructosamine, and cancer risk suggests the existence of distinct groups among those with impaired glucose metabolism, resulting in different cancer risks based on individual metabolic profiles. Further studies are needed to clarify whether glucose is a proxy of other lifestyle-related or metabolic factors.	[Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Van Hemelrijck, Mieke] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Holmberg, Lars] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars; Garmo, Hans; Wigertz, Annette; Lambe, Mats] Reg Canc Ctr, Uppsala, Sweden; [Zethelius, Bjoern] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Zethelius, Bjoern] Med Prod Agcy Epidemiol, Uppsala, Sweden; [Carroll, Paul] St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, Dept Endocrinol, London, England; [Lambe, Mats] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hammar, Niklas] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Stockholm, Sweden; [Hammar, Niklas] AstraZeneca Sverige, Sodertalje, Sweden; [Walldius, Goeran] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden; [Jungner, Ingmar] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Jungner, Ingmar] CALAB Res, Stockholm, Sweden	University of London; King's College London; Uppsala University; Uppsala University Hospital; Uppsala University; Medical Products Agency; Guy's & St Thomas' NHS Foundation Trust; Karolinska Institutet; Karolinska Institutet; AstraZeneca; Karolinska Institutet; Karolinska Institutet	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England.	mieke.vanhemelrijck@kcl.ac.uk	Wulaningsih, Wahyu/AAW-4307-2020	Van Hemelrijck, Mieke/0000-0002-7317-0858; Wulaningsih, Wahyu/0000-0002-3822-1648; Lambe, Mats/0000-0002-4624-3767	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London(National Institute for Health Research (NIHR))	This research was supported by the Experimental Cancer Medicine Centre at King's College London and also by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1983, BRIT MED J, V287, P863, DOI 10.1136/bmj.287.6396.863; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; De Michele G, 2008, IMMUNOPHARM IMMUNOT, V30, P925, DOI [10.1080/08923970802337718, 10.1080/08923970802337718 ]; DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group, 1998, BMJ, V317, P371; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Holme I, 2009, J INTERN MED, V266, P558, DOI 10.1111/j.1365-2796.2009.02133.x; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Jungner I, 2006, AM J CARDIOL, V97, P943, DOI 10.1016/j.amjcard.2005.10.062; Jungner I, 1998, CLIN CHEM, V44, P1641; Kabat GC, 2012, BRIT J CANCER, V106, P227, DOI 10.1038/bjc.2011.512; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; LAMB E, 1991, CLIN CHEM, V37, P2138; Lambe M, 2011, CANCER CAUSE CONTROL, V22, P1163, DOI 10.1007/s10552-011-9794-8; Misciagna G, 2004, EUR J EPIDEMIOL, V19, P425, DOI 10.1023/B:EJEP.0000027359.95727.24; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Platek M, 2005, CANCER EPIDEM BIOMAR, V14, P271; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rojas A, 2011, WORLD J DIABETES, V2, P108, DOI 10.4239/wjd.v2.i7.108; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stocks T, 2008, INT J OBESITY, V32, P304, DOI 10.1038/sj.ijo.0803713; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Stopper H, 2003, CANCER LETT, V190, P151, DOI 10.1016/S0304-3835(02)00626-2; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Van Hemelrijck M, 2010, THESIS KINGS COLL LO; Walker K, 2011, BRIT J CANCER, V105, P1451, DOI 10.1038/bjc.2011.358; 1997, LANCET, V350, P1047	41	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54944	10.1371/journal.pone.0054944	http://dx.doi.org/10.1371/journal.pone.0054944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372798	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400044
J	Argyropoulos, C; Wang, K; McClarty, S; Huang, D; Bernardo, J; Ellis, D; Orchard, T; Galas, D; Johnson, J				Argyropoulos, Christos; Wang, Kai; McClarty, Sara; Huang, David; Bernardo, Jose; Ellis, Demetrius; Orchard, Trevor; Galas, David; Johnson, John			Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes	PLOS ONE			English	Article							GROWTH-FACTOR NGF; HIGH GLUCOSE; TGF-BETA; EXPRESSION; KIDNEY; TARGETS; MIR-17; CELLS; MICROALBUMINURIA; QUANTIFICATION	Background: Patients with Type 1 Diabetes (T1D) are particularly vulnerable to development of Diabetic nephropathy (DN) leading to End Stage Renal Disease. Hence a better understanding of the factors affecting kidney disease progression in T1D is urgently needed. In recent years microRNAs have emerged as important post-transcriptional regulators of gene expression in many different health conditions. We hypothesized that urinary microRNA profile of patients will differ in the different stages of diabetic renal disease. Methods and Findings: We studied urine microRNA profiles with qPCR in 40 T1D with >20 year follow up 10 who never developed renal disease (N) matched against 10 patients who went on to develop overt nephropathy (DN), 10 patients with intermittent microalbuminuria (IMA) matched against 10 patients with persistent (PMA) microalbuminuria. A Bayesian procedure was used to normalize and convert raw signals to expression ratios. We applied formal statistical techniques to translate fold changes to profiles of microRNA targets which were then used to make inferences about biological pathways in the Gene Ontology and REACTOME structured vocabularies. A total of 27 microRNAs were found to be present at significantly different levels in different stages of untreated nephropathy. These microRNAs mapped to overlapping pathways pertaining to growth factor signaling and renal fibrosis known to be targeted in diabetic kidney disease. Conclusions: Urinary microRNA profiles differ across the different stages of diabetic nephropathy. Previous work using experimental, clinical chemistry or biopsy samples has demonstrated differential expression of many of these microRNAs in a variety of chronic renal conditions and diabetes. Combining expression ratios of microRNAs with formal inferences about their predicted mRNA targets and associated biological pathways may yield useful markers for early diagnosis and risk stratification of DN in T1D by inferring the alteration of renal molecular processes.	[Argyropoulos, Christos; Bernardo, Jose; Johnson, John] Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15260 USA; [Wang, Kai; McClarty, Sara; Huang, David] Inst Syst Biol, Seattle, WA USA; [Huang, David; Galas, David] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Orchard, Trevor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Ellis, Demetrius; Galas, David] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Galas, David] Pacific NW Diabet Res Inst, Seattle, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Institute for Systems Biology (ISB); University of Luxembourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pacific Northwest Diabetes Research Institute (PNDRI)	Johnson, J (corresponding author), Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15260 USA.	johnsonj@pitt.edu	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805; orchard, trevor/0000-0001-9552-3215	NIH [DK34818]; ISB University of Luxemburg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034818, R37DK034818, R01DK047874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISB University of Luxemburg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grant #DK34818 and the ISB University of Luxemburg program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XY, 2011, J AM SOC NEPHROL, V22, P1252, DOI 10.1681/ASN.2010040367; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bonofiglio R, 2007, J NEPHROL, V20, P186; Box GEP, 1973, NATURE BAYESIAN INFE, P1; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chamorro-Jorganes A, 2011, ARTERIOSCLEROSIS THR; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Heese K, 2003, BIOCHEM PHARMACOL, V65, P293, DOI 10.1016/S0006-2952(02)01487-9; Held L, 2004, J COMPUT GRAPH STAT, V13, P20, DOI 10.1198/1061860043083; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Lorenzen JM, 2011, AM J TRANSPLANTATION; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Neal CS, 2011, NEPHROLOGY DIALYSIS; Ostendorf T, 2011, PEDIAT NEPHROL; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips AO, 1997, KIDNEY INT, V52, P973, DOI 10.1038/ki.1997.419; Roweis S, 1998, ADV NEUR IN, V10, P626; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Scian MJ, 2011, AM J TRANSPLANTATION; Shan D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006800.pub2; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Sun H, 2010, MOL BIOL REP, V37, P2951, DOI 10.1007/s11033-009-9861-3; The Case for Objective Bayesian Analysis, 2006, BAYESIAN ANAL, V1, P385, DOI [10.1214/06-BA115, DOI 10.1214/06-BA115]; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Togliatto G, 2011, DIABETOLOGIA, V54, P1930, DOI 10.1007/s00125-011-2125-5; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang G, 2010, DIS MARKERS, V28, P79, DOI [10.1155/2010/396328, 10.3233/DMA-2010-0687]; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367	64	128	135	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54662	10.1371/journal.pone.0054662	http://dx.doi.org/10.1371/journal.pone.0054662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358711	gold, Green Published			2022-12-27	WOS:000314023600088
J	Bay-Jensen, AC; Wichuk, S; Byrjalsen, I; Leeming, DJ; Morency, N; Christiansen, C; Karsdal, MA; Maksymowych, WP				Bay-Jensen, Anne C.; Wichuk, Stephanie; Byrjalsen, Inger; Leeming, Diana J.; Morency, Nathalie; Christiansen, Claus; Karsdal, Morten A.; Maksymowych, Walter P.			Circulating Protein Fragments of Cartilage and Connective Tissue Degradation Are Diagnostic and Prognostic Markers of Rheumatoid Arthritis and Ankylosing Spondylitis	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; C-REACTIVE PROTEIN; DAMAGE END-POINTS; PSORIATIC-ARTHRITIS; DISEASE-ACTIVITY; VALIDATION; SPONDYLOARTHRITIS; PATHOPHYSIOLOGY; PATHOGENESIS; INFLAMMATION	Inflammation driven connective tissue turnover is key in rheumatic diseases, such as ankylosing spondylitis (AS). Few biomarkers are available for measuring disease prognosis or the efficacy of interventions applied in these tissue-related conditions. Type II collagen is the primary structural protein of cartilage and type III collagen of connective tissues, and obvious targets for the collagenalytic, which increase during tissue inflammation. The objective of the study was to investigate the diagnostic and prognostic utility of cartilage, C2M, and synovial, C3M, turnover biomarkers in AS. Serum samples were retrieved from patients suffering from AS (n = 103), RA (n = 47) and healthy controls (n = 56). AS progressors were defined as having new vertebral syndesmophytes or more that 3 unit change in mSASSS over a two-year period. Type II collagen degradation markers in serum were measured by the C2M ELISA, and type III collagen degradation by the C3M ELISA. Logistic regression and dichotomized decision tree were used to analyze the prognostic value of the markers individually or in combination. Both C2M and C3M levels were significantly higher in RA patients than in healthy controls (p<0.0001). Diagnostic utility was analyzed by ROC and areas under the curve (AUCs) were 72% and 89% for C2M and C3M, respectively. Both C2M and C3M, were significantly higher in serum samples from AS patient than from healthy controls (p<0.0001). The AUCs of C2M and C3M, respectively, were 70% and 81% for AS. A combination of C2M and C3M, dichotomized according to best cut-offs for individual markers, could correctly identify 80% of the progressors and 61% of the non-progressors. The present study is the first to show that specific biomarkers of cartilage and connective tissue degradation facilitate both diagnosis and prediction of progression of RA and AS.	[Bay-Jensen, Anne C.; Byrjalsen, Inger; Leeming, Diana J.; Christiansen, Claus; Karsdal, Morten A.] Nord Biosci, Rheumatol, Herlev, Denmark; [Wichuk, Stephanie; Morency, Nathalie; Maksymowych, Walter P.] Univ Alberta, Div Rheumatol, Edmonton, AB, Canada	Nordic Bioscience; University of Alberta	Bay-Jensen, AC (corresponding author), Nord Biosci, Rheumatol, Herlev, Denmark.	acbj@nordicbioscience.com	Bay-Jensen, Anne-Christine/AEQ-7281-2022	Bay-Jensen, Anne-Christine/0000-0001-7952-9297; Karsdal, Morten/0000-0001-5026-8740; Maksymowych, Walter/0000-0002-1291-1755	Danish Research Foundation; department of ACBJ at Nordic Bioscience; University of Alberta; department of WP at Nordic Bioscience	Danish Research Foundation; department of ACBJ at Nordic Bioscience; University of Alberta(University of Alberta); department of WP at Nordic Bioscience	The study was partly supported by the Danish Research Foundation and partly by the research budgets of the departments of ACBJ and WP at Nordic Bioscience and University of Alberta, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ACBJ, IB, DJL and MK are full time employees at, and CC and MK hold stocks in, Nordic Bioscience. This study was partly funded by Nordic Bioscience. Nordic Bioscience is a privately-owned; small-medium size enterprise partly focused the development of biomarkers for rheumatic and fibrotic diseases. The two biomarkers described in the manuscript are patented by Nordic Bioscience (C2M, "ASSAY FOR A TYPE II COLLAGEN BIOMARKER" Patent Application WO/2012/038331; C3M, "FIBROSIS BIOMARKER ASSAY" Patent Application WO/2010/115749 & United States Patent Application 20100209940). Further research on the markers will be conducted which may lead to commercialization. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. WP, SW and NM have no financial or competing interest to declare. WP is a Medical Scientist of the Alberta Heritage Foundation for Medical Research.	Barascuk N, 2010, CLIN BIOCH IN PRESS; Bay-Jensen AC, 2011, RHEUMATOL INT; Bay-Jensen AC, 2011, CLIN BIOCHEM, V44, P423, DOI 10.1016/j.clinbiochem.2011.01.001; Braun J, 2002, CLIN EXP RHEUMATOL, V20, pS16; Colbert Robert A, 2009, J Rheumatol, V36, P1527, DOI 10.3899/jrheum.090122; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; de Vlam K, 2010, BEST PRACT RES CL RH, V24, P671, DOI 10.1016/j.berh.2010.05.009; de Vries MK, 2009, ARTHRIT RHEUM-ARTHR, V61, P1484, DOI 10.1002/art.24838; Garnero P, 2005, ARTHRITIS RHEUM-US, V52, pS56; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Karsdal MA, 2009, BIOMARKERS, V14, P181, DOI 10.1080/13547500902777608; Lories RJ, 2009, CLIN EXP RHEUMATOL, V27, pS10; Lukas C, 2007, J RHEUMATOL, V34, P862; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Maksymowych WP, 2007, ARTHRIT RHEUM-ARTHR, V57, P501, DOI 10.1002/art.22627; Maksymowych WP, 2009, J RHEUMATOL, V36, P1792, DOI 10.3899/jrheum090347; Maksymowych WP, 2009, J RHEUMATOL, V36, P1785, DOI 10.3899/jrheum.090346; Ruof J, 1999, J RHEUMATOL, V26, P966; Schaller S, 2005, ASSAY DRUG DEV TECHN, V3, P553, DOI 10.1089/adt.2005.3.553; Schett G, 2009, CLIN EXP RHEUMATOL, V27, pS33; Schett G, 2007, ANN RHEUM DIS, V66, P42, DOI 10.1136/ard.2007.078972; Segovia-Silvestre Toni, 2011, BMC Res Notes, V4, P407, DOI 10.1186/1756-0500-4-407; Spoorenberg A, 1999, J RHEUMATOL, V26, P980; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vassiliadis E, 2011, BIOMARKERS; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Wanders AJB, 2004, ARTHRIT RHEUM-ARTHR, V51, P1, DOI 10.1002/art.20075	31	57	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54504	10.1371/journal.pone.0054504	http://dx.doi.org/10.1371/journal.pone.0054504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365672	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600062
J	Harboe, ZB; Valentiner-Branth, P; Ingels, H; Rasmussen, JN; Andersen, PHS; Bjerre, CC; Goldblatt, D; Ashton, L; Haston, M; Konradsen, HB; Lambertsen, L				Harboe, Zitta B.; Valentiner-Branth, Palle; Ingels, Helene; Rasmussen, Jeppe N.; Andersen, Peter H. S.; Bjerre, Catherine C.; Goldblatt, David; Ashton, Lindsey; Haston, Mitch; Konradsen, Helle B.; Lambertsen, Lotte		Danish Pneumococcal Surveillance	Pediatric Invasive Pneumococcal Disease Caused by Vaccine Serotypes following the Introduction of Conjugate Vaccination in Denmark	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; IMMUNOGENICITY; MENINGITIS; ANTIBODIES; SCHEDULE; CHILDREN; INFANTS; PROGRAM; SAFETY; ERA	A seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the Danish childhood immunization program (2+1 schedule) in October 2007, followed by PCV13 starting from April 2010. The nationwide incidence of IPD among children younger than 5 years nearly halved after the introduction of PCV7 in the program, mainly due to a decline in IPD caused by PCV7-serotypes. We report the results from a nationwide population-based cohort study of laboratory confirmed IPD cases in children younger than 5 years during October 1, 2007 to December 31, 2010 and describe the characteristics of children suspected to present with a vaccine failure. The period between April 19 and December 31, 2010 was considered a PCV7/PCV13 transitional period, where both vaccines were offered. We identified 45 episodes of IPD caused by a PCV7 serotype (23% of the total number) and 105 (55%) caused by one of the 6 additional serotypes in PCV13. Ten children had received at least one PCV7 dose before the onset of IPD caused by a PCV7 serotype. Seven children were considered to be incompletely vaccinated before IPD, but only three cases fulfilled the criteria of vaccine failure (caused by serotypes 14, 19F and 23F). One case of vaccine failure was observed in a severely immunosuppressed child following three PCV7 doses, and two cases were observed in immunocompetent children following two infant doses before they were eligible for their booster. None of the IPD cases caused by the additional PCV13 serotypes had been vaccinated by PCV13 and there were therefore no PCV13-vaccine failures in the first 8-months after PCV13 introduction in Denmark.	[Harboe, Zitta B.; Ingels, Helene; Konradsen, Helle B.; Lambertsen, Lotte] Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Ctr, DK-2300 Copenhagen, Denmark; [Valentiner-Branth, Palle; Rasmussen, Jeppe N.; Andersen, Peter H. S.; Bjerre, Catherine C.] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Goldblatt, David; Ashton, Lindsey; Haston, Mitch] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Statens Serum Institut; Statens Serum Institut; University of London; University College London	Harboe, ZB (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, Neisseria & Streptococcus Reference Ctr, DK-2300 Copenhagen, Denmark.	zit@ssi.dk	Harboe, Zitta Barrella/AAZ-2569-2020; Skov, Robert/ABB-3105-2020; Goldblatt, David/C-5972-2008	Harboe, Zitta Barrella/0000-0001-5552-0095; Skov, Robert/0000-0002-6079-5381; Goldblatt, David/0000-0002-0769-5242; Christensen, Jens Jorgen/0000-0001-6721-4917; Lambertsen, Lotte/0000-0001-6409-6337; Dessau, Ram/0000-0002-1497-6309	Statens Serum Institut; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Statens Serum Institut; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by Statens Serum Institut, since data were collected routinely for national surveillance purposes through funding allocated to national surveillance. The funding entity did not have any influence in the study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Angoulvant FO, 2005, CLIN INFECT DIS, V40, P494; [Anonymous], 2007, BEK NR 1102 AF 20 09, V20; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Changed Pneumococcal Vaccine for Children, 2010, EPI NEWS, V2010, P15; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; De Carvalho GH, 2009, EURO SURVEILL, V14, P19159; Deceuninck G, 2010, PEDIATR INFECT DIS J, V29, P546, DOI 10.1097/INF.0b013e3181cffa2a; DTaP-IPV/Hib vaccination coverage, 2011, EPI NEWS, V2011, P20; Ekstrom N, 2005, INFECT IMMUN, V73, P369, DOI 10.1128/IAI.73.1.369-377.2005; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; Harboe ZB, 2008, VACCINE, V26, P3765, DOI 10.1016/j.vaccine.2008.04.040; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hsu K, 2005, PEDIATR INFECT DIS J, V24, P17, DOI 10.1097/01.inf.0000148891.32134.36; Isapof A, 2009, ARCH PEDIATRIE, V16, P1133, DOI 10.1016/j.arcped.2009.04.014; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Lambertsen L, 2010, ABSTRACT PRESENTED A; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; O'Brien KL, 2009, VACCINE, V27, P1863, DOI 10.1016/j.vaccine.2008.12.060; Park SY, 2010, J PEDIATR-US, V156, P478, DOI 10.1016/j.jpeds.2009.10.008; PCV 7 coverage & Invasive Pneumococcal Disease (IPD), 2010, EPI NEWS, V2010, P7; Pneumokokvaccine i det Danske Bornevaccinationsprgram, 2008, EPI NEWS, V2008, P38; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Rose CE, 2011, CLIN VACCINE IMMUNOL, V18, P135, DOI 10.1128/CVI.00370-10; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Vestrheim DF, 2008, VACCINE, V26, P3277, DOI 10.1016/j.vaccine.2008.03.087; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	35	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e51460	10.1371/journal.pone.0051460	http://dx.doi.org/10.1371/journal.pone.0051460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365635	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600002
J	Ju, RT; Gao, L; Zhou, XH; Li, B				Ju, Rui-Ting; Gao, Lei; Zhou, Xu-Hui; Li, Bo			Tolerance to High Temperature Extremes in an Invasive Lace Bug, Corythucha ciliata (Hemiptera: Tingidae), in Subtropical China	PLOS ONE			English	Article							SIMULATED CLIMATE-CHANGE; LIFE-HISTORY RESPONSES; GREEN STINK BUG; NEZARA-VIRIDULA; HEAT-SHOCK; PHENOTYPIC PLASTICITY; HYMENOPTERA; EXPOSURE; EVENTS; ADULTS	Biological invasions are predicted to be more frequent as climate change is increasing its positive impact on the prevalence of invasive exotic species. Success of insect invaders in different temperature zones is closely related to their tolerance to temperature extremes. In this study, we used an exotic lace bug (Corythucha ciliata) as the study organism to address the hypotheses that an insect species invading a subtropical zone from temperate regions has a high capacity to survive and adapt to high temperatures, and that its thermal tolerance plays an important role in determining its seasonal abundance and geographic distribution. To test these hypotheses, the effects of heat shock on the survival and reproduction of C. ciliata adults were assessed in the laboratory. Adults were exposed to 26 (control), 35, 37, 39, 41, 43, and 45 degrees C for 2 h, and then were transferred to 26 degrees C. Heat-shock temperatures ranging from 35 to 41 degrees C did not significantly affect survival pattern, longevity, and fecundity of adults, but heat shock at 43 and 45 degrees C significantly reduced these traits. Exposing parent females to heat-shock treatments from 35 to 41 degrees C did not significantly affect the hatching rate of their eggs, survival of the nymphs, and the proportion of female F-1 progeny, while no progeny were produced with treatments of 43 and 45 degrees C. The results indicate that C. ciliata can tolerate high temperatures less than 41 degrees C, which may contribute to its expansion into the lower latitudes in China where its hosts (Platanus trees) are widely planted. Our findings have important implications for predicting seasonal abundance and understanding invasion mechanisms of this important urban invader under climate change.	[Ju, Rui-Ting; Gao, Lei] Shanghai Inst Landscape Gardening Sci, Dept Plant Protect, Shanghai, Peoples R China; [Ju, Rui-Ting; Zhou, Xu-Hui; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China	Fudan University	Li, B (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Coastal Ecosyst Res Stn Yangtze River, Shanghai 200433, Peoples R China.	bool@fudan.edu.cn	Zhou, Xuhui/H-4332-2011; Ju, Rui-Ting/E-7538-2016; Li, Bo/AAA-8968-2020; Ju, Rui-Ting/AAD-2444-2019; Zhou, Xuhui/O-5727-2019; Li, Bo/B-8016-2010	Li, Bo/0000-0002-7294-6888; Ju, Rui-Ting/0000-0001-9265-8245; Zhou, Xuhui/0000-0002-2038-9901; Li, Bo/0000-0002-0439-5666	National Basic Research Program of China [2009CB119200]; Shanghai Key Project of Science and Technology [10JC1414100]; Shanghai Rising-Star Program (A type) [11QA1406000]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Key Project of Science and Technology; Shanghai Rising-Star Program (A type)	This research was financially supported by the National Basic Research Program of China (No. 2009CB119200), the Shanghai Key Project of Science and Technology (No. 10JC1414100), and the Shanghai Rising-Star Program (A type) (No. 11QA1406000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam HR, 2009, ANN ENTOMOL SOC AM, V102, P233, DOI 10.1603/008.102.0205; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barthell JF, 2002, PAN-PAC ENTOMOL, V78, P235; Benoit JB, 2010, J INSECT PHYSIOL, V56, P1366, DOI 10.1016/j.jinsphys.2010.02.014; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Carlton James T., 2000, P31; Chihrane J, 1997, CAN J ZOOL, V75, P484, DOI 10.1139/z97-059; CHIHRANE J, 1994, ENTOMOPHAGA, V39, P11, DOI 10.1007/BF02373490; Chown SL, 2008, J EXP BIOL, V211, P3353, DOI 10.1242/jeb.019349; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Cui XH, 2008, J INSECT SCI, V8; Cui YD, 2011, J THERM BIOL, V36, P292, DOI 10.1016/j.jtherbio.2011.04.003; Denlinger D. L., 1998, TEMPERATURE SENSITIV, P6; Donat MG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052459; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; Halbert S. E., 1998, ENTOMOL CIRCULAR, V387, P1; HOROWITZ AR, 1992, ENVIRON ENTOMOL, V21, P556, DOI 10.1093/ee/21.3.556; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, P9; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Ju RT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0116; Ju RT, 2011, ENTOMOL EXP APPL, V141, P168, DOI 10.1111/j.1570-7458.2011.01180.x; Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012; Ju RT, 2010, CRYOLETTERS, V31, P445; Ju RT, 2009, ENTOMOL NEWS, V120, P409, DOI 10.3157/021.120.0410; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Knop E, 2012, P ROY SOC B-BIOL SCI, V279, P4668, DOI 10.1098/rspb.2012.1564; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Liu Ya-Jun, 2009, Chinese Bulletin of Entomology, V46, P898; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; Mitchell KA, 2011, FUNCT ECOL, V25, P661, DOI 10.1111/j.1365-2435.2010.01821.x; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Musolin DL, 2010, GLOBAL CHANGE BIOL, V16, P73, DOI 10.1111/j.1365-2486.2009.01914.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scott M, 1997, ENTOMOL EXP APPL, V85, P211, DOI 10.1023/A:1003173612155; [史军 SHI Jun], 2009, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V18, P1143; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Speight R. M., 1999, ECOLOGY INSECTS CONC; SPSS, 2006, SPSS BAS 15 0 ED WIN; Takeda K, 2010, PHYSIOL ENTOMOL, V35, P343, DOI 10.1111/j.1365-3032.2010.00748.x; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tougou D, 2009, ENTOMOL EXP APPL, V130, P249, DOI 10.1111/j.1570-7458.2008.00818.x; Wan FH, 2009, RES BIOL INVASIONS C; West-Eberhard Mary Jane, 2003, pi; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Xie Q, 2008, J ECON ENTOMOL, V101, P736, DOI 10.1603/0022-0493(2008)101[736:TROOFF]2.0.CO;2; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	60	28	33	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54372	10.1371/journal.pone.0054372	http://dx.doi.org/10.1371/journal.pone.0054372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365664	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600052
J	Sanders, JM; Wampole, ME; Thakur, ML; Wickstrom, E				Sanders, Jeffrey M.; Wampole, Matthew E.; Thakur, Mathew L.; Wickstrom, Eric			Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RECEPTOR EXTRACELLULAR DOMAINS; FREE-ENERGY; CRYSTAL-STRUCTURE; TYROSINE KINASES; LIGAND-BINDING; ERBB RECEPTORS; EGF RECEPTOR; FORCE-FIELD; RAS-RAF	The epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase family that plays a role in multiple cellular processes. Activation of EGFR requires binding of a ligand on the extracellular domain to promote conformational changes leading to dimerization and transphosphorylation of intracellular kinase domains. Seven ligands are known to bind EGFR with affinities ranging from sub-nanomolar to near micromolar dissociation constants. In the case of EGFR, distinct conformational states assumed upon binding a ligand is thought to be a determining factor in activation of a downstream signaling network. Previous biochemical studies suggest the existence of both low affinity and high affinity EGFR ligands. While these studies have identified functional effects of ligand binding, high-resolution structural data are lacking. To gain a better understanding of the molecular basis of EGFR binding affinities, we docked each EGFR ligand to the putative active state extracellular domain dimer and 25.0 ns molecular dynamics simulations were performed. MM-PBSA/GBSA are efficient computational approaches to approximate free energies of protein-protein interactions and decompose the free energy at the amino acid level. We applied these methods to the last 6.0 ns of each ligand-receptor simulation. MM-PBSA calculations were able to successfully rank all seven of the EGFR ligands based on the two affinity classes: EGF>HB-EGF>TGF-alpha>BTC>EPR>EPG>AR. Results from energy decomposition identified several interactions that are common among binding ligands. These findings reveal that while several residues are conserved among the EGFR ligand family, no single set of residues determines the affinity class. Instead we found heterogeneous sets of interactions that were driven primarily by electrostatic and Van der Waals forces. These results not only illustrate the complexity of EGFR dynamics but also pave the way for structure-based design of therapeutics targeting EGF ligands or the receptor itself.	[Sanders, Jeffrey M.; Wampole, Matthew E.; Wickstrom, Eric] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Thakur, Mathew L.] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Thakur, Mathew L.; Wickstrom, Eric] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Wickstrom, E (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	eric@tesla.jci.tju.edu	wampole, matthew/AAF-9443-2019	Thakur, Mathew/0000-0003-2409-039X	US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-09-1-0577]; National Institutes of Health (NIH) [CA148565]; NIH [5P41RR006009]; NATIONAL CANCER INSTITUTE [R01CA148565] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER	US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by US Army Medical Research and Materiel Command (USAMRMC) grant W81XWH-09-1-0577 and National Institutes of Health (NIH) grant CA148565 to EW. Computations were performed on the HPC Blacklight of the Pittsburgh Supercomputer Center, supported by NIH grant 5P41RR006009, and on the HPC Harold of the USAMRMC Aberdeen Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blundell TL, 2000, BIOL CHEM, V381, P955, DOI 10.1515/BC.2000.117; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isayev O, 2007, J COMPUT CHEM, V28, P1598, DOI 10.1002/jcc.20696; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Louie GV, 1997, MOL CELL, V1, P67, DOI 10.1016/S1097-2765(00)80008-8; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Miura K, 2002, BIOCHEM BIOPH RES CO, V294, P1040, DOI 10.1016/S0006-291X(02)00585-5; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sato K, 2003, FEBS LETT, V553, P232, DOI 10.1016/S0014-5793(03)01005-6; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Weis A, 2006, J MED CHEM, V49, P6596, DOI 10.1021/jm0608210; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Wereszczynski J, 2012, Q REV BIOPHYS, V45, P1, DOI 10.1017/S0033583511000096; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zhao SL, 2011, J PHYS CHEM B, V115, P6971, DOI 10.1021/jp201949k	53	62	64	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54136	10.1371/journal.pone.0054136	http://dx.doi.org/10.1371/journal.pone.0054136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23382875	Green Published, gold			2022-12-27	WOS:000314023600033
J	Sun, YP; Wang, FW; Wang, N; Dong, YY; Liu, Q; Zhao, L; Chen, H; Liu, WC; Yin, HL; Zhang, XM; Yuan, YX; Li, HY				Sun, Yepeng; Wang, Fawei; Wang, Nan; Dong, Yuanyuan; Liu, Qi; Zhao, Lei; Chen, Huan; Liu, Weican; Yin, Hailong; Zhang, Xiaomei; Yuan, Yanxi; Li, Haiyan			Transcriptome Exploration in Leymus chinensis under Saline-Alkaline Treatment Using 454 Pyrosequencing	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL DISPLAY; LIPID-PEROXIDATION; INNER-MONGOLIA; MESSENGER-RNA; CALCIUM; HYBRIDIZATION; GENOTYPES; PROTEINS; GENOME	Background: Leymus chinensis (Trin.) Tzvel. is a high saline-alkaline tolerant forage grass genus of the tribe Gramineae family, which also plays an important role in protection of natural environment. To date, little is known about the saline-alkaline tolerance of L. chinensis on the molecular level. To better understand the molecular mechanism of saline-alkaline tolerance in L. chinensis, 454 pyrosequencing was used for the transcriptome study. Results: We used Roche-454 massive parallel pyrosequencing technology to sequence two different cDNA libraries that were built from the two samples of control and under saline-alkaline treatment (optimal stress concentration-Hoagland solution with 100 mM NaCl and 200 mM NaHCO3). A total of 363,734 reads in control group and 526,267 reads in treatment group with an average length of 489 bp and 493 bp were obtained, respectively. The reads were assembled into 104,105 unigenes with MIRA sequence assemable software, among which, 73,665 unigenes were in control group, 88,016 unigenes in treatment group and 57,576 unigenes in both groups. According to the comparative expression analysis between the two groups with the threshold of "log2 Ratio >= 1", there were 36,497 up-regulated unegenes and 18,218 down-regulated unigenes predicted to be the differentially expressed genes. After gene annotation and pathway enrichment analysis, most of them were involved in stress and tolerant function, signal transduction, energy production and conversion, and inorganic ion transport. Furthermore, 16 of these differentially expressed genes were selected for real-time PCR validation, and they were successfully confirmed with the results of 454 pyrosequencing. Conclusions: This work is the first time to study the transcriptome of L. chinensis under saline-alkaline treatment based on the 454-FLX massively parallel DNA sequencing platform. It also deepened studies on molecular mechanisms of saline-alkaline in L. chinensis, and constituted a database for future studies.	[Sun, Yepeng; Wang, Fawei; Wang, Nan; Dong, Yuanyuan; Chen, Huan; Liu, Weican; Yin, Hailong; Li, Haiyan] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Sun, Yepeng; Chen, Huan; Liu, Weican; Yin, Hailong; Zhang, Xiaomei; Yuan, Yanxi; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Liu, Qi] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Zhao, Lei] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species GBOWS, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Wenzhou Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, HY (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	hyli99@163.com			Program for New Century Excellent Talents in University [NCET-08-0693]; Special Program for Research of Transgenic Plants [2011ZX08010-002]; National Natural Science Foundation of China [30971804]; State Key Laboratory of Crop Biology at Shandong Agricultural University, China [2010KF02]; Program for Young Scientific and Technological Talents and Outstanding Innovation Team [20111815]; National High Technology Research and Development Program of China (863 Program) [2010AA1000691008]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Program for Research of Transgenic Plants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Crop Biology at Shandong Agricultural University, China; Program for Young Scientific and Technological Talents and Outstanding Innovation Team; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for New Century Excellent Talents in University (grant number NCET-08-0693), the Special Program for Research of Transgenic Plants (2011ZX08010-002), the National Natural Science Foundation of China (grant number 30971804), the State Key Laboratory of Crop Biology at Shandong Agricultural University, China (grant number 2010KF02), the Program for Young Scientific and Technological Talents and Outstanding Innovation Team (grant number 20111815) and the National High Technology Research and Development Program of China (863 Program) (grant number 2010AA1000691008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1995, NATURE, V377, P3; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALLEN GJ, 1995, PLANT CELL ENVIRON, V18, P105, DOI 10.1111/j.1365-3040.1995.tb00344.x; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Chen M., 1988, RES GRASSLAND ECOSYS, V2, P193; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Christensen C. M., 2001, INNOVATORS DILEMMA N; Clayton WD, 1999, KEW B ADDITIONAL SER, V13; DEBOUCK C, 1995, CURR OPIN BIOTECH, V6, P597, DOI 10.1016/0958-1669(95)80098-0; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Jin H, 2006, PLANT SCI, V170, P1081, DOI 10.1016/j.plantsci.2006.01.002; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Leopold A.C., 1983, PLANT IMPROVEMENT IR, P678; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MENNEN H, 1990, J PLANT PHYSIOL, V137, P180, DOI 10.1016/S0176-1617(11)80078-7; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi De-Cheng, 1992, Acta Botanica Sinica, V34, P386; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; SUSSMAN MR, 1994, ANNU REV PLANT PHYS, V45, P211, DOI 10.1146/annurev.pp.45.060194.001235; Valentina M, 2000, PLANT PHYSIOL, V123, P65; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang KP, 1984, GRASSLAND CHINA, V6, P32; WATAD AEA, 1986, PLANT PHYSIOL, V81, P454, DOI 10.1104/pp.81.2.454; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wu FB, 2003, ENVIRON EXP BOT, V50, P67, DOI 10.1016/S0098-8472(02)00113-2; Xia GM, 1996, PLANT SCI, V120, P197, DOI 10.1016/S0168-9452(96)04492-5; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Yan H., 2006, ACTA PRATACULT SIN, V15, P19; Yin Li-Juan, 1993, Acta Botanica Sinica, V35, P619; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379	46	36	39	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53632	10.1371/journal.pone.0053632	http://dx.doi.org/10.1371/journal.pone.0053632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365637	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600016
J	Barutchu, A; Freestone, DR; Innes-Brown, H; Crewther, DP; Crewther, SG				Barutchu, Ayla; Freestone, Dean R.; Innes-Brown, Hamish; Crewther, David P.; Crewther, Sheila G.			Evidence for Enhanced Multisensory Facilitation with Stimulus Relevance: An Electrophysiological Investigation	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; AUDITORY-VISUAL INTERACTIONS; FINGER MOVEMENTS; MOTOR CORTEX; HUMAN BRAIN; NEURONAL OSCILLATIONS; SELECTIVE ATTENTION; OBJECT RECOGNITION; SPECTRAL DYNAMICS; SPATIAL ATTENTION	Currently debate exists relating to the interplay between multisensory processes and bottom-up and top-down influences. However, few studies have looked at neural responses to newly paired audiovisual stimuli that differ in their prescribed relevance. For such newly associated audiovisual stimuli, optimal facilitation of motor actions was observed only when both components of the audiovisual stimuli were targets. Relevant auditory stimuli were found to significantly increase the amplitudes of the event-related potentials at the occipital pole during the first 100 ms post-stimulus onset, though this early integration was not predictive of multisensory facilitation. Activity related to multisensory behavioral facilitation was observed approximately 166 ms post-stimulus, at left central and occipital sites. Furthermore, optimal multisensory facilitation was found to be associated with a latency shift of induced oscillations in the beta range (14-30 Hz) at right hemisphere parietal scalp regions. These findings demonstrate the importance of stimulus relevance to multisensory processing by providing the first evidence that the neural processes underlying multisensory integration are modulated by the relevance of the stimuli being combined. We also provide evidence that such facilitation may be mediated by changes in neural synchronization in occipital and centro-parietal neural populations at early and late stages of neural processing that coincided with stimulus selection, and the preparation and initiation of motor action.	[Barutchu, Ayla; Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Barutchu, Ayla; Freestone, Dean R.; Innes-Brown, Hamish] Bion Inst, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ, Brain Sci Inst, Melbourne, Vic, Australia; [Freestone, Dean R.] Univ Melbourne, NeuroEngn Lab, Melbourne, Vic, Australia; [Barutchu, Ayla] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	La Trobe University; Bionics Institute; Swinburne University of Technology; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Barutchu, A (corresponding author), La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	aylab@unimelb.edu.au	Innes-Brown, Hamish/H-3298-2019; Crewther, Sheila G/A-2165-2008	Innes-Brown, Hamish/0000-0002-1512-2823; Freestone, Dean/0000-0003-2411-5358	School of Psychological Science, La Trobe University; Victorian Government	School of Psychological Science, La Trobe University; Victorian Government	This study was financially supported by the School of Psychological Science, La Trobe University. The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANIBAR A, 1978, ELECTROEN CLIN NEURO, V44, P307, DOI 10.1016/0013-4694(78)90306-1; Baraldi P, 1999, NEUROSCI LETT, V269, P95, DOI 10.1016/S0304-3940(99)00433-4; Barutchu A, 2003, J VISION, V3, p775a; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Bolognini N, 2011, NEUROPSYCHOLOGIA, V49, P231, DOI 10.1016/j.neuropsychologia.2010.11.015; Cacace AT, 2003, HEARING RES, V176, P25, DOI 10.1016/S0378-5955(02)00715-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Corbetta S, 2000, CLIN ENDOCRINOL, V52, P339, DOI 10.1046/j.1365-2265.2000.00933.x; Czigler I, 2001, NEUROREPORT, V12, P223, DOI 10.1097/00001756-200102120-00009; DERAMBURE P, 1993, ELECTROEN CLIN NEURO, V89, P197, DOI 10.1016/0168-5597(93)90133-A; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eimer M, 1998, PSYCHOPHYSIOLOGY, V35, P313, DOI 10.1017/S004857729897086X; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; Graimann B, 2002, CLIN NEUROPHYSIOL, V113, P43, DOI 10.1016/S1388-2457(01)00697-6; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hoshiyama M, 1997, EXP BRAIN RES, V115, P6, DOI 10.1007/PL00005685; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Kanayama N, 2011, NEUROIMAGE; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; Knosche TR, 2002, CLIN NEUROPHYSIOL, V113, P754, DOI 10.1016/S1388-2457(02)00055-X; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Lebib R, 2003, NEUROSCI LETT, V341, P185, DOI 10.1016/S0304-3940(03)00131-9; Mazaheri A, 2005, COGNITIVE BRAIN RES, V24, P81, DOI 10.1016/j.cogbrainres.2004.12.013; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Puce A, 2007, NEUROPSYCHOLOGIA, V45, P93, DOI 10.1016/j.neuropsychologia.2006.04.017; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Sakowitz OW, 2001, COGNITIVE BRAIN RES, V11, P267, DOI 10.1016/S0926-6410(00)00081-1; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Senkowski D, 2005, EXP BRAIN RES, V166, P411, DOI 10.1007/s00221-005-2381-z; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Sinnett S, 2008, ACTA PSYCHOL, V128, P153, DOI 10.1016/j.actpsy.2007.12.002; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; van Atteveldt NM, 2007, NEUROIMAGE, V36, P1345, DOI 10.1016/j.neuroimage.2007.03.065; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vidal J, 2008, CLIN NEUROPHYSIOL, V119, P763, DOI 10.1016/j.clinph.2007.11.178; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079	69	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e52978	10.1371/journal.pone.0052978	http://dx.doi.org/10.1371/journal.pone.0052978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372652	Green Published, gold			2022-12-27	WOS:000314021500009
J	Cetz-Navarro, NP; Espinoza-Avalos, J; Hernandez-Arana, HA; Carricart-Ganivet, JP				Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio; Hernandez-Arana, Hector A.; Carricart-Ganivet, Juan P.			Biological Responses of the Coral Montastraea annularis to the Removal of Filamentous Turf Algae	PLOS ONE			English	Article							REGION-WIDE DECLINES; REEF CORALS; ZOOXANTHELLAE DENSITY; SCLERACTINIAN CORALS; ANTILLARUM PHILIPPI; HERMATYPIC CORALS; BENTHIC ALGAE; WATER-QUALITY; COMPETITION; MACROALGAE	Coral reef degradation increases coral interactions with filamentous turf algae (FTA) and macroalgae, which may result in chronic stress for the corals. We evaluated the effects of short (2.5 month) and long (10 month) periods of FTA removal on tissue thickness (TT), zooxanthellae density (ZD), mitotic index (MI), and concentration of chlorophyll a (Chl a) in Montastraea annularis at the beginning and end of gametogenesis. Ramets (individual lobes within a colony) consistently surrounded by FTA and ramets surrounded by crustose coralline algae (CCA) were used as controls. FTA removal reduced coral stress, indicated by increased TT and ZD and lower MI. The measured effects were similar in magnitude for the short and long periods of algal removal. Ramets were more stressed at the end of gametogenesis compared with the beginning, with lower ZD and Chl a cm(-2), and higher MI. However, it was not possible to distinguish the stress caused by the presence of FTA from that caused by seasonal changes in seawater temperature. Ramets surrounded by CCA showed less stress in comparison with ramets surrounded by FTA: with higher TT, Chl a cm(-2) and ZD, and lower MI values. Coral responses indicated that ramets with FTA suffered the most deleterious effects and contrasted with those measured in ramets surrounded by CCA. According to published studies and our observations, there could be at least six mechanisms associated to FTA in the stress caused to M. annularis by FTA. Owing to the high cover of FTA (in contrast to macroalgae and CCA) in the Caribbean, the chronic stress, the overgrowth and mortality that this functional algal group can cause on M. annularis species complex, a further decline of this important reef-building coral in the Caribbean is expected.	[Cetz-Navarro, Neidy P.; Espinoza-Avalos, Julio; Hernandez-Arana, Hector A.] Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico; [Carricart-Ganivet, Juan P.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Nacional Autonoma de Mexico	Espinoza-Avalos, J (corresponding author), Colegio Frontera Sur, Chetmal, Quintana Roo, Mexico.	jespino@ecosur.mx	Espinoza-Avalos, Julio/H-9189-2013; Hernandez-Arana, Hector A./AAL-2400-2020	Espinoza-Avalos, Julio/0000-0001-5697-446X; Hernandez-Arana, Hector A./0000-0001-9769-3349	PADI Foundation [64]; federal funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [32985]; EU	PADI Foundation; federal funds; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EU(European Commission)	Funding for this study was provided by PADI Foundation (Req. number 64, 2009; NPCN) and federal funds given to ECOSUR (JEA). NPCN was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) through Graduate Research Scholarship (32985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff at Parque Nacional Arrecifes de Xcalak for providing facilities; H. Bahena-Basave for taking most of the photos for this study; J.A. Batun Catzin, R. Herrera-Pavon and D. I. de la Cruz-Gaitan for their field assistance; A. Zavala-Mendoza and A. U. Beltran-Torres for laboratory training; D. I. de la Cruz-Gaitan for assistance in the laboratory; Mark Eakin (NOAA) for providing the temperature data of the EU-funded FORCE Project; and P. Ramsay for correcting the English. Special thanks to the academic editor, S. C. A. Ferse, and two anonymous reviewers for their valuable comments that greatly improved the final version of the manuscript.	Alvarado JJ, 2009, B MAR SCI, V84, P137; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andersen SB, 2010, AQUAT BIOL, V10, P99, DOI 10.3354/ab00270; Barnes DJ, 1999, CORAL REEFS, V18, P213, DOI 10.1007/s003380050185; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; CARPENTER RC, 1981, J MAR RES, V39, P749; Cervino JM, 2003, MAR POLLUT BULL, V46, P573, DOI 10.1016/S0025-326X(03)00071-7; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; CORTES J, 1985, B MAR SCI, V36, P339; Cruz-Pinon G, 2003, MAR BIOL, V143, P491, DOI 10.1007/s00227-003-1127-3; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; Edmunds PJ, 2011, CORAL REEFS, V30, P123, DOI 10.1007/s00338-010-0676-4; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hauri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012685; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Jorgensen P, 2008, HIDROBIOLOGICA, V18, P257; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kramarsky-Winter E, 2000, MAR BIOL, V137, P867, DOI 10.1007/s002270000416; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; McClanahan TR, 2011, MAR ECOL PROG SER, V437, P89, DOI 10.3354/meps09285; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mumby PJ, 2005, CORAL REEFS, V24, P681, DOI 10.1007/s00338-005-0058-5; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; Obura DO, 2009, MAR POLLUT BULL, V58, P206, DOI 10.1016/j.marpolbul.2008.10.002; Okubo N, 2007, MAR BIOL, V151, P353, DOI 10.1007/s00227-006-0490-2; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Ravindran J, 2006, MAR BIOL, V149, P347, DOI 10.1007/s00227-005-0192-1; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; Rogers CS, 2008, P 11 INT COR REEF S, V7, P226; Roy RE, 2004, REV BIOL TROP, V52, P869; Ruiz-Zarate Miguel A., 2003, Atoll Research Bulletin, V496, P318; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Strychar KB, 2005, J EXP MAR BIOL ECOL, V320, P159, DOI 10.1016/j.jembe.2004.12.039; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Titlyanov E, 2006, P 10 INT COR REEF S, V1, P1931; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P229, DOI 10.3354/meps109229; Venera-Ponton DE, 2011, MAR ECOL PROG SER, V421, P109, DOI 10.3354/meps08869; Vermeij MJA, 2011, MAR ECOL PROG SER, V422, P1, DOI 10.3354/meps08964; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103	76	6	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54810	10.1371/journal.pone.0054810	http://dx.doi.org/10.1371/journal.pone.0054810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372774	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500132
J	Ehrentraut, S; Nagel, S; Scherr, ME; Schneider, B; Quentmeier, H; Geffers, R; Kaufmann, M; Meyer, C; Prochorec-Sobieszek, M; Ketterling, RP; Knudson, RA; Feldman, AL; Kadin, ME; Drexler, HG; MacLeod, RAF				Ehrentraut, Stefan; Nagel, Stefan; Scherr, Michaela E.; Schneider, Bjoern; Quentmeier, Hilmar; Geffers, Robert; Kaufmann, Maren; Meyer, Corinna; Prochorec-Sobieszek, Monika; Ketterling, Rhett P.; Knudson, Ryan A.; Feldman, Andrew L.; Kadin, Marshall E.; Drexler, Hans G.; MacLeod, Roderick A. F.			t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5	PLOS ONE			English	Article							T-CELL LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; KINASE-ACTIVITY; IN-VITRO; JAK2; EXPRESSION; FUSION; INHIBITION; SUPPRESSOR; LEUKEMIA	Fusions of the tyrosine kinase domain of JAK2 with multiple partners occur in leukemia/lymphoma where they reportedly promote JAK2-oligomerization and autonomous signalling, Affected entities are promising candidates for therapy with JAK2 signalling inhibitors. While JAK2-translocations occur in myeloid, B-cell and T-cell lymphoid neoplasms, our findings suggest their incidence among the last group is low. Here we describe the genomic, transcriptional and signalling characteristics of PCM1-JAK2 formed by t(8;9)(p22;p24) in a trio of cell lines established at indolent (MAC-1) and aggressive (MAC-2A/2B) phases of a cutaneous T-cell lymphoma (CTCL). To investigate signalling, PCM1-JAK2 was subjected to lentiviral knockdown which inhibited 7 top upregulated genes in t(8;9) cells, notably SOCS2/3. SOCS3, but not SOCS2, was also upregulated in a chronic eosinophilic leukemia bearing PCM1-JAK2, highlighting its role as a central signalling target of JAK2 translocation neoplasia. Conversely, expression of GATA3, a key T-cell developmental gene silenced in aggressive lymphoma cells, was partially restored by PCM1-JAK2 knockdown. Treatment with a selective JAK2 inhibitor (TG101348) to which MAC-1/2A/2B cells were conspicuously sensitive confirmed knockdown results and highlighted JAK2 as the active moiety. PCM1-JAK2 signalling required pSTAT5, supporting a general paradigm of STAT5 activation by JAK2 alterations in lymphoid malignancies. MAC-1/2A/2B - the first JAK2-translocation leukemia/lymphoma cell lines described - display conspicuous JAK/STAT signalling accompanied by T-cell developmental and autoimmune disease gene expression signatures, confirming their fitness as CTCL disease models. Our data support further investigation of SOCS2/3 as signalling effectors, prognostic indicators and potential therapeutic targets in cancers with JAK2 rearrangements.	[Ehrentraut, Stefan; Nagel, Stefan; Quentmeier, Hilmar; Kaufmann, Maren; Meyer, Corinna; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst, DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Cultures, Braunschweig, Germany; [Scherr, Michaela E.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Schneider, Bjoern] Univ Rostock, Inst Pathol & Mol Pathol, D-18055 Rostock, Germany; [Geffers, Robert] HZI Helmholtz Ctr Infect Res, Dept Genome Anal, Braunschweig, Germany; [Prochorec-Sobieszek, Monika] Inst Hematol & Transfus Med, Dept Diagnost Hematol, Warsaw, Poland; [Ketterling, Rhett P.; Knudson, Ryan A.; Feldman, Andrew L.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Kadin, Marshall E.] Boston Univ, Sch Med, Dept Dermatol & Skin Surg, Roger Williams Med Ctr, Providence, RI USA	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Hannover Medical School; University of Rostock; Helmholtz Association; Helmholtz-Center for Infection Research; Mayo Clinic; Boston University; Roger Williams Medical Center	MacLeod, RAF (corresponding author), Leibniz Inst, DSMZ German Collect Microorganisms & Cell Culture, Dept Human & Anim Cell Cultures, Braunschweig, Germany.	rml@dsmz.de	Prochorec-Sobieszek, Monika/AAD-5065-2020	Prochorec-Sobieszek, Monika/0000-0002-8109-9553; Feldman, Andrew/0000-0001-5009-4808; Ketterling, Rhett/0000-0001-6479-7897	National Institutes of Health [P20GM103414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grant P20GM103414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RM, 2011, CANC BIOL THER, V12; Adelaide J, 2006, LEUKEMIA, V20, P536, DOI 10.1038/sj.leu.2404104; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Bochtler T, 2012, LEUKEMIA, V26, P728, DOI 10.1038/leu.2011.283; Brender C, 2005, LEUKEMIA, V19, P209, DOI 10.1038/sj.leu.2403610; Brender C, 2001, BLOOD, V97, P1056, DOI 10.1182/blood.V97.4.1056; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; DAVIS TH, 1992, NEW ENGL J MED, V326, P1115, DOI 10.1056/NEJM199204233261704; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Drexler HG, 2000, LEUKEMIA LYMPHOMA CE; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Fridman JS, 2011, J INVEST DERMATOL, V131, P1838, DOI 10.1038/jid.2011.140; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hansen N, 2012, LEUKEMIA IN PRESS; Harrison C, 2012, BRIT J HAEMATOL, V157, P426, DOI 10.1111/j.1365-2141.2012.09108.x; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hoeller S, 2011, EXPERT OPIN THER TAR, V15, P53, DOI 10.1517/14728222.2011.538683; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Irino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022148; KADIN ME, 1994, P NATL ACAD SCI USA, V91, P6002, DOI 10.1073/pnas.91.13.6002; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Krejsgaard T, 2011, J INVEST DERMATOL, V131, P1331, DOI 10.1038/jid.2011.27; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lejeune D, 2001, BIOCHEM J, V353, P109, DOI 10.1042/bj3530109; Lierman E, 2012, BLOOD, V120, P1529, DOI 10.1182/blood-2012-06-433821; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Prochorec-Sobieszek M, 2012, LEUKEMIA LYMPHOMA, V53; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quentmeier H, 2008, LEUKEMIA, V22, P2169, DOI 10.1038/leu.2008.226; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Scherr M, 2002, BLOOD, V99, P709, DOI 10.1182/blood.V99.2.709; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096	50	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53767	10.1371/journal.pone.0053767	http://dx.doi.org/10.1371/journal.pone.0053767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372669	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500024
J	Hirose, N; Shimazu, A; Watanabe, M; Tanimoto, K; Koyota, S; Sugiyama, T; Uchida, T; Tanne, K				Hirose, Naoto; Shimazu, Atsushi; Watanabe, Mineo; Tanimoto, Kotaro; Koyota, Souichi; Sugiyama, Toshihiro; Uchida, Takashi; Tanne, Kazuo			Ameloblastin in Hertwig's Epithelial Root Sheath Regulates Tooth Root Formation and Development	PLOS ONE			English	Article							ENAMEL; DIFFERENTIATION; EXPRESSION; PROTEINS; STAGE; CELLS	Tooth root formation begins after the completion of crown morphogenesis. At the end edge of the tooth crown, inner and outer enamel epithelia form Hertwig's epithelial root sheath (HERS). HERS extends along with dental follicular tissue for root formation. Ameloblastin (AMBN) is an enamel matrix protein secreted by ameloblasts and HERS derived cells. A number of enamel proteins are eliminated in root formation, except for AMBN. AMBN may be related to tooth root formation; however, its role in this process remains unclear. In this study, we found AMBN in the basal portion of HERS of lower first molar in mice, but not at the tip. We designed and synthesized small interfering RNA (siRNA) targeting AMBN based on the mouse sequence. When AMBN siRNA was injected into a prospective mandibular first molar of postnatal day 10 mice, the root became shorter 10 days later. Furthermore, HERS in these mice revealed a multilayered appearance and 5-bromo-2'-deoxyuridine (BrdU) positive cells increased in the outer layers. In vitro experiments, when cells were compared with and without transiently expressing AMBN mRNA, expression of growth suppressor genes such as p21(Cip1) and p27(Kip1) was enhanced without AMBN and BrdU incorporation increased. Thus, AMBN may regulate differentiation state of HERS derived cells. Moreover, our results suggest that the expression of AMBN in HERS functions as a trigger for normal root formation.	[Hirose, Naoto; Tanimoto, Kotaro; Tanne, Kazuo] Hiroshima Univ, Dept Orthodont, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Shimazu, Atsushi] Hiroshima Univ, Dept Publ Oral Hlth, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Watanabe, Mineo; Uchida, Takashi] Hiroshima Univ, Dept Oral Biol, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan; [Koyota, Souichi; Sugiyama, Toshihiro] Akita Univ, Grad Sch Med, Dept Biochem, Akita 010, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Akita University	Hirose, N (corresponding author), Hiroshima Univ, Dept Orthodont, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	hirose@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science [24792286]	Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan society for the promotion of science, grant number 24792286 (elucidation of promoted mechanism of root dentin formation by ameloblastin and application to treatment of root resorption) (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Broderick KE, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.1; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; DenBesten PK, 2005, ARCH ORAL BIOL, V50, P689, DOI 10.1016/j.archoralbio.2004.12.008; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Hao JJ, 2005, BONE, V37, P578, DOI 10.1016/j.bone.2005.05.013; Hatakeyama J, 2009, J DENT RES, V88, P318, DOI 10.1177/0022034509334749; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Huang XF, 2009, DEV BIOL, V334, P22, DOI 10.1016/j.ydbio.2009.06.034; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kitagawa M, 2011, ARCH ORAL BIOL, V56, P374, DOI 10.1016/j.archoralbio.2010.10.012; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nakata A, 2003, BIOCHEM BIOPH RES CO, V308, P834, DOI 10.1016/S0006-291X(03)01467-0; Nguyen T, 2008, CURR OPIN MOL THER, V10, P158; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Spahr A, 2006, EUR J ORAL SCI, V114, P504, DOI 10.1111/j.1600-0722.2006.00403.x; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; Torres-Quintana Maria Angelica, 2005, J Oral Sci, V47, P27, DOI 10.2334/josnusd.47.27; Turchinovich A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-25; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404	27	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54449	10.1371/journal.pone.0054449	http://dx.doi.org/10.1371/journal.pone.0054449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372724	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500071
J	Larson, DW; Currie, PJ				Larson, Derek W.; Currie, Philip J.			Multivariate Analyses of Small Theropod Dinosaur Teeth and Implications for Paleoecological Turnover through Time	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; HELL CREEK FORMATION; DENTAL MORPHOLOGY; NORTH-DAKOTA; BIG-BEND; DIVERSITY; ALBERTA; TOOTH; DROMAEOSAURIDAE; IDENTIFICATION	Isolated small theropod teeth are abundant in vertebrate microfossil assemblages, and are frequently used in studies of species diversity in ancient ecosystems. However, determining the taxonomic affinities of these teeth is problematic due to an absence of associated diagnostic skeletal material. Species such as Dromaeosaurus albertensis, Richardoestesia gilmorei, and Saurornitholestes langstoni are known from skeletal remains that have been recovered exclusively from the Dinosaur Park Formation (Campanian). It is therefore likely that teeth from different formations widely disparate in age or geographic position are not referable to these species. Tooth taxa without any associated skeletal material, such as Paronychodon lacustris and Richardoestesia isosceles, have also been identified from multiple localities of disparate ages throughout the Late Cretaceous. To address this problem, a dataset of measurements of 1183 small theropod teeth (the most specimen-rich theropod tooth dataset ever constructed) from North America ranging in age from Santonian through Maastrichtian were analyzed using multivariate statistical methods: canonical variate analysis, pairwise discriminant function analysis, and multivariate analysis of variance. The results indicate that teeth referred to the same taxon from different formations are often quantitatively distinct. In contrast, isolated teeth found in time equivalent formations are not quantitatively distinguishable from each other. These results support the hypothesis that small theropod taxa, like other dinosaurs in the Late Cretaceous, tend to be exclusive to discrete host formations. The methods outlined have great potential for future studies of isolated teeth worldwide, and may be the most useful non-destructive technique known of extracting the most data possible from isolated and fragmentary specimens. The ability to accurately assess species diversity and turnover through time based on isolated teeth will help illuminate patterns of evolution and extinction in these groups and potentially others in greater detail than has previously been thought possible without more complete skeletal material.	[Larson, Derek W.; Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Larson, DW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	derek.larson@mail.utoronto.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161	Dinosaur Research Institute; Queen Elizabeth II Scholarship; Natural Sciences and Engineering Research Council of Canada [203091-06, 203091-2011]	Dinosaur Research Institute; Queen Elizabeth II Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this study included a student research grant from the Dinosaur Research Institute (www.dinosaurresearch.com) and a Queen Elizabeth II Scholarship to DWL. Also, Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) Grants #203091-06 and # 203091-2011 were provided to PJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Archibald JD, 1997, ENCY DINOSAURS, P221; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Brinkman DB, 2001, PALAEOGEOGR PALAEOCL, V213, P295; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E., 1986, Revue de Paleobiologie, V5, P217; Burnham DA, 2004, LIFE O PAST, P67; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Candeiro CRA, 2004, J S AM EARTH SCI, V18, P1, DOI 10.1016/j.jsames.2004.08.004; CARPENTER K, 1982, Contributions to Geology University of Wyoming, V20, P123; Christiansen P, 2003, NEUES JAHRB GEOL P-A, V227, P287; Cope E.D., 1876, P ACAD NAT SCI PHILA, V28, P340; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; De Valais S, 2001, AMEGHINIANA, V38, P6; Eaton JG, 2006, J VERTEBR PALEONTOL, V26, P446, DOI 10.1671/0272-4634(2006)26[446:SLCMFT]2.0.CO;2; Estes R., 1964, University of California Publications in Geological Sciences, V49, P1; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Fanti F, 2009, PALAEOGEOGR PALAEOCL, V275, P37, DOI 10.1016/j.palaeo.2009.02.007; Farlow J.O., 1991, Modern Geology, V16, P161; Fastovsky DE, 2004, GEOLOGY, V32, P877, DOI 10.1130/G20695.1; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Godefroit P, 2008, J VERTEBR PALEONTOL, V28, P432, DOI 10.1671/0272-4634(2008)28[432:ANSOVD]2.0.CO;2; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Han FL, 2011, J VERTEBR PALEONTOL, V31, P111, DOI 10.1080/02724634.2011.546291; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; HUTCHISON JH, 1986, PALAEOGEOGR PALAEOCL, V55, P1, DOI 10.1016/0031-0182(86)90133-1; JMP, 2002, JMP VERS 5; Larson DW, 2010, CAN J EARTH SCI, V47, P1159, DOI 10.1139/E10-005; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Lehman Thomas M., 2001, P310; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P72; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Lloyd GT, 2012, BIOL LETTERS, V8, P123, DOI 10.1098/rsbl.2011.0210; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Longrich Nick, 2008, P135; Lyson TR, 2010, J VERTEBR PALEONTOL, V30, P394, DOI 10.1080/02724631003618389; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Park EJ, 2000, THESIS KYUNGPOOK NAT; Pearson DA, 2002, GEOL S AM S, P145; Poblete F, 2003, 19 JORN ARG PAL VERT, P24; Prieto-Marquez A, 2000, ECLOGAE GEOL HELV, V93, P497; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; Rauhut OWM, 2002, CRETACEOUS RES, V23, P255, DOI 10.1006/cres.2002.1003; Ruiz-Omenaca J.I., 1996, MAS MATAS, V15, P59; Russell DA, 2002, GEOL S AM S, P169; Ryan MJ, 2005, LIFE O PAST, P312; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; Sankey JT, 2005, LIFE O PAST, P127; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Sankey Julia T., 2008, P117; SANZ J L, 1987, Estudios Geologicos (Madrid), P45; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Sweetman SC, 2004, CRETACEOUS RES, V25, P353, DOI 10.1016/j.cretres.2004.01.004; Telles Antunes M., 1991, Comptes Rendus de l'Academie des Sciences Serie II Mecanique-Physique-Chimie Sciences de l'Univers Sciences de la Terre, V313, P113; Torices A., 2004, GEOTEMAS, V6, P71; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Venables WN., 2002, MODERN APPL STAT S 4; Vilas Boas I., 1999, AN ACAD BRAS CIENC, V71, P846; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Weigert Andrea, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V9, P562; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	73	66	67	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54329	10.1371/journal.pone.0054329	http://dx.doi.org/10.1371/journal.pone.0054329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372708	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500059
J	Reinius, LE; Gref, A; Saaf, A; Acevedo, N; Joerink, M; Kupczyk, M; D'Amato, M; Bergstrom, A; Melen, E; Scheynius, A; Dahlen, SE; Pershagen, G; Soderhall, C; Kere, J				Reinius, Lovisa E.; Gref, Anna; Saaf, Annika; Acevedo, Nathalie; Joerink, Maaike; Kupczyk, Maciej; D'Amato, Mauro; Bergstroem, Anna; Melen, Erik; Scheynius, Annika; Dahlen, Sven-Erik; Pershagen, Goran; Soderhall, Cilla; Kere, Juha		BIOAIR Study Grp	DNA Methylation in the Neuropeptide S Receptor 1 (NPSR1) Promoter in Relation to Asthma and Environmental Factors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR-154; AIR-POLLUTION; SUSCEPTIBILITY LOCUS; GENE POLYMORPHISM; CHILDHOOD ASTHMA; SMOKE EXPOSURE; TOBACCO-SMOKE; BIRTH COHORT; DISEASE; POPULATION	Asthma and allergy are complex disorders influenced by both inheritance and environment, a relationship that might be further clarified by epigenetics. Neuropeptide S Receptor 1 (NPSR1) has been associated with asthma and allergy and a study suggested modulation of the genetic risk by environmental factors. We aimed to study DNA methylation in the promoter region of NPSR1 in relation to asthma and environmental exposures. Electrophoretic Mobility Shift Assay (EMSA) was used to investigate potential functional roles of both genotypes and methylation status in the NPSR1 promoter. DNA methylation was analysed using EpiTYPER in blood samples from two well-characterized cohorts; the BIOAIR study of severe asthma in adults and the Swedish birth cohort BAMSE. We observed that DNA methylation and genetic variants in the promoter influenced the binding of nuclear proteins to DNA, suggesting functional relevance. Significant, although small, differences in methylation were related to both adult severe asthma (p = 0.0001) and childhood allergic asthma (p = 0.01). Furthermore, DNA methylation was associated with exposures such as current smoking in adults for two CpG sites (p = 0.005 and 0.04), parental smoking during infancy in the children (p = 0.02) and in which month the sample was taken (p = 0.01). In summary, DNA methylation levels in the promoter of NPSR1 showed small but significant associations with asthma, both in adults and in children, and to related traits such as allergy and certain environmental exposures. Both genetic variation and the methylated state of CpG sites seem to have an effect on the binding of nuclear proteins in the regulatory region of NPSR1 suggesting complex regulation of this gene in asthma and allergy.	[Reinius, Lovisa E.; D'Amato, Mauro; Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gref, Anna; Saaf, Annika; Kupczyk, Maciej; Bergstroem, Anna; Melen, Erik; Dahlen, Sven-Erik; Pershagen, Goran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Acevedo, Nathalie; Joerink, Maaike; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Translat Immunol Unit, Stockholm, Sweden; [Melen, Erik] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Biomedicum, Res Programs Unit, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Reinius, Lovisa E.; Gref, Anna; Saaf, Annika; Acevedo, Nathalie; Joerink, Maaike; Kupczyk, Maciej; D'Amato, Mauro; Bergstroem, Anna; Melen, Erik; Scheynius, Annika; Dahlen, Sven-Erik; Pershagen, Goran; Soderhall, Cilla; Kere, Juha] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	juha.kere@ki.se	Kere, Juha/A-9179-2008; D'Amato, Mauro/B-5050-2019; Reinius, Lovisa/C-4555-2014; Vachier, Isabelle/AAV-5731-2020; D'Amato, Mauro/F-2450-2010; Söderhäll, Cilla/E-3940-2012; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Reinius, Lovisa/0000-0001-5029-0120; Vachier, Isabelle/0000-0003-2730-5165; D'Amato, Mauro/0000-0003-2743-5197; Söderhäll, Cilla/0000-0002-8397-3080; Kere, Juha/0000-0003-1974-0271; Johnston, Sebastian/0000-0003-3009-9200; Acevedo, Nathalie/0000-0002-5154-2964; PAPI, ALBERTO/0000-0002-6924-4500; chanez, pascal/0000-0003-4059-0917; Gaga, Mina/0000-0002-9949-6012; Pershagen, Goran/0000-0002-9701-1130	Swedish Foundation for Strategic Research (the Epigene study); Swedish Research Council; Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet; Marie Curie Intra-European Fellowship; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Stockholm County Council; Swedish Foundation for Health Care Sciences and Allergy Research; European Union [QLG1-CT-2000-01185, FOOD-CT-2004-506378]; Sweden: Heart-Lung Foundation; Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education	Swedish Foundation for Strategic Research (the Epigene study)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Osher Initiative for Research on Severe Asthma at Karolinska Institutet; Karolinska Institutet(Karolinska Institutet); Marie Curie Intra-European Fellowship(European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Swedish Foundation for Health Care Sciences and Allergy Research; European Union(European Commission); Sweden: Heart-Lung Foundation; Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education	The study was supported by grants from the Swedish Foundation for Strategic Research (the Epigene study) and the Swedish Research Council. LER and MK were supported by the Osher Initiative for Research on Severe Asthma at Karolinska Institutet, AG and NA were supported by a PhD grant from Karolinska Institutet, and MJ was supported by a Marie Curie Intra-European Fellowship. The BAMSE birth cohort was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council, Swedish Heart-Lung Foundation, the Stockholm County Council and the Swedish Foundation for Health Care Sciences and Allergy Research, and the European Union. The BIOAIR study was supported by the Fifth and Sixth Framework Programs of the European Union, contract numbers: QLG1-CT-2000-01185 (BIOAIR) and FOOD-CT-2004-506378 (GA2LEN), and several national funding bodies (Sweden: Heart-Lung Foundation and Asthma and Allergy Foundation; Greece: unrestricted competitive research grant "The Herakleitos project 2002'', from the Hellenic Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Allen IC, 2006, AM J PHYSIOL-LUNG C, V291, pL1005, DOI 10.1152/ajplung.00174.2006; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Bruce S, 2009, J MED GENET, V46, P159, DOI 10.1136/jmg.2007.055137; Castro-Giner F, 2010, THORAX, V65, P124, DOI 10.1136/thx.2009.119628; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Flom JD, 2011, CANCER EPIDEM BIOMAR, V20, P2518, DOI 10.1158/1055-9965.EPI-11-0553; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Melen E, 2008, ENVIRON HEALTH PERSP, V116, P1077, DOI 10.1289/ehp.11117; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Neuman A, 2011, ALLERGY, V66, P643; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sood A, 2012, CHEST, V142, P425, DOI 10.1378/chest.11-2519; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, P79, DOI 10.1111/j.1365-2982.2009.01366.x; Suter M, 2011, EPIGENETICS, V6; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhu HY, 2011, PEPTIDES, V32, P818, DOI 10.1016/j.peptides.2010.12.002	53	31	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53877	10.1371/journal.pone.0053877	http://dx.doi.org/10.1371/journal.pone.0053877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372674	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500028
J	Willett, BJ; Kraase, M; Logan, N; McMonagle, E; Varela, M; Hosie, MJ				Willett, Brian J.; Kraase, Martin; Logan, Nicola; McMonagle, Elizabeth; Varela, Mariana; Hosie, Margaret J.			Selective Expansion of Viral Variants following Experimental Transmission of a Reconstituted Feline Immunodeficiency Virus Quasispecies	PLOS ONE			English	Article							BROAD NEUTRALIZATION RESISTANCE; EXPERIMENTAL VACCINE PROTECTION; IN-VIVO; T-CELLS; FUNCTIONAL RECEPTOR; IMMUNE-RESPONSES; V5 LOOP; INFECTION; CD134; CATS	Following long-term infection with virus derived from the pathogenic GL8 molecular clone of feline immunodeficiency virus (FIV), a range of viral variants emerged with distinct modes of interaction with the viral receptors CD134 and CXCR4, and sensitivities to neutralizing antibodies. In order to assess whether this viral diversity would be maintained following subsequent transmission, a synthetic quasispecies was reconstituted comprising molecular clones bearing envs from six viral variants and its replicative capacity compared in vivo with a clonal preparation of the parent virus. Infection with either clonal (Group 1) or diverse (Group 2) challenge viruses, resulted in a reduction in CD4+ lymphocytes and an increase in CD8+ lymphocytes. Proviral loads were similar in both study groups, peaking by 10 weeks post-infection, a higher plateau (set-point) being achieved and maintained in study Group 1. Marked differences in the ability of individual viral variants to replicate were noted in Group 2; those most similar to GL8 achieved higher viral loads while variants such as the chimaeras bearing the B14 and B28 Envs grew less well. The defective replication of these variants was not due to suppression by the humoral immune response as virus neutralising antibodies were not elicited within the study period. Similarly, although potent cellular immune responses were detected against determinants in Env, no qualitative differences were revealed between animals infected with either the clonal or the diverse inocula. However, in vitro studies indicated that the reduced replicative capacity of variants B14 and B28 in vivo was associated with altered interactions between the viruses and the viral receptor and co-receptor. The data suggest that viral variants with GL8-like characteristics have an early, replicative advantage and should provide the focus for future vaccine development.	[Willett, Brian J.; Logan, Nicola; McMonagle, Elizabeth; Varela, Mariana; Hosie, Margaret J.] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [Kraase, Martin] Vet Med Univ Wien, Inst Virol, Vienna, Austria	University of Glasgow; University of Veterinary Medicine Vienna	Willett, BJ (corresponding author), Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.	brian.willett@glasgow.ac.uk	Willett, Brian J/F-3396-2011		Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/D008425/1] Funding Source: UKRI; MRC [G0300387, G0801822] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D008425/1] Funding Source: researchfish; Medical Research Council [G0801822, G0300387] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and The Wellcome Trust (www.wellcome.ac.uk) to MJH and BJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmal M, 2011, PLOS ONE, P6; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bendinelli M, 2001, J VIROL, V75, P4584, DOI 10.1128/JVI.75.10.4584-4593.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; CALLANAN JJ, 1992, VET REC, V130, P293, DOI 10.1136/vr.130.14.293; CALLANAN JJ, 1992, VET IMMUNOL IMMUNOP, V35, P3, DOI 10.1016/0165-2427(92)90116-8; Callanan JJ, 1996, VET PATHOL, V33, P264, DOI 10.1177/030098589603300302; Callanan John J., 1993, P115; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; Dean GA, 1999, J VIROL, V73, P2596, DOI 10.1128/JVI.73.4.2596-2603.1999; Dean GA, 2004, VET IMMUNOL IMMUNOP, V100, P49, DOI 10.1016/j.vetimm.2004.03.001; Dean GA, 1996, J VIROL, V70, P5165, DOI 10.1128/JVI.70.8.5165-5169.1996; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Dunham SP, 2006, VET REC, V158, P561, DOI 10.1136/vr.158.16.561; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; FLYNN JN, 1994, IMMUNOLOGY, V81, P626; Giannecchini S, 2001, J VIROL, V75, P8868, DOI 10.1128/JVI.75.18.8868-8873.2001; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Hosie MJ, 2011, VIRUSES-BASEL, V3, P1870, DOI 10.3390/v3101870; Hosie MJ, 2002, J VIROL, V76, P6062, DOI 10.1128/JVI.76.12.6062-6072.2002; HOSIE MJ, 1995, J VIROL, V69, P1253, DOI 10.1128/JVI.69.2.1253-1255.1995; Inoshima Y, 1996, J VIROL, V70, P8518, DOI 10.1128/JVI.70.12.8518-8526.1996; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kraase M, 2010, VET IMMUNOL IMMUNOP, V134, P96, DOI 10.1016/j.vetimm.2009.10.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CE, 1995, IMMUNOLOGY, V85, P568; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marozsan AJ, 2005, J VIROL, V79, P7121, DOI 10.1128/JVI.79.11.7121-7134.2005; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Nishimura Y, 2004, J GEN VIROL, V85, P2585, DOI 10.1099/vir.0.80102-0; Paillot R, 2005, VET IMMUNOL IMMUNOP, V106, P1, DOI 10.1016/j.vetimm.2004.12.023; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Pistello M, 2002, VIROLOGY, V298, P84, DOI 10.1006/viro.2002.1442; Pu RY, 2005, J FELINE MED SURG, V7, P65, DOI 10.1016/j.jfms.2004.08.005; Pu RY, 2001, AIDS, V15, P1225, DOI 10.1097/00002030-200107060-00004; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; Ryan G, 2003, J VIROL, V77, P7477, DOI 10.1128/JVI.77.13.7477-7485.2003; Samman A, 2010, J GEN VIROL, V91, P242, DOI 10.1099/vir.0.015404-0; Shimojima M, 2003, MICROBES INFECT, V5, P1171, DOI 10.1016/j.micinf.2003.08.004; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; SIEBELINK KHJ, 1995, VET IMMUNOL IMMUNOP, V46, P51, DOI 10.1016/0165-2427(94)07005-R; SIEBELINK KHJ, 1995, J VIROL, V69, P5124, DOI 10.1128/JVI.69.8.5124-5127.1995; Willett BJ, 2006, J VIROL, V80, P3386, DOI 10.1128/JVI.80.7.3386-3394.2006; Willett BJ, 1997, NATURE, V385, P587, DOI 10.1038/385587a0; WILLETT BJ, 1993, IMMUNOLOGY, V78, P1; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Willett BJ, 2008, VET IMMUNOL IMMUNOP, V123, P56, DOI 10.1016/j.vetimm.2008.01.012; Willett BJ, 2007, J VIROL, V81, P9665, DOI 10.1128/JVI.01020-07; Willett BJ, 2006, J VIROL, V80, P7744, DOI 10.1128/JVI.00722-06; Willett BJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-38; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; YAMAMOTO JK, 1991, AIDS RES HUM RETROV, V7, P911, DOI 10.1089/aid.1991.7.911; YAMAMOTO JK, 1993, J VIROL, V67, P601, DOI 10.1128/JVI.67.1.601-605.1993	55	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54871	10.1371/journal.pone.0054871	http://dx.doi.org/10.1371/journal.pone.0054871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372784	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000314021500138
J	Kumala, S; Fujarewicz, K; Jayaraju, D; Rzeszowska-Wolny, J; Hancock, R				Kumala, Slawomir; Fujarewicz, Krzysztof; Jayaraju, Dheekollu; Rzeszowska-Wolny, Joanna; Hancock, Ronald			Repair of DNA Strand Breaks in a Minichromosome In Vivo: Kinetics, Modeling, and Effects of Inhibitors	PLOS ONE			English	Article							BASE EXCISION-REPAIR; FIELD GEL-ELECTROPHORESIS; DEPENDENT PROTEIN-KINASE; ADP-RIBOSE POLYMERASE-1; BARR-VIRUS GENOMES; TOPOISOMERASE-II; SINGLE-STRAND; POLY(ADP-RIBOSE) POLYMERASE-1; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS	To obtain an overall picture of the repair of DNA single and double strand breaks in a defined region of chromatin in vivo, we studied their repair in a similar to 170 kb circular minichromosome whose length and topology are analogous to those of the closed loops in genomic chromatin. The rate of repair of single strand breaks in cells irradiated with c photons was quantitated by determining the sensitivity of the minichromosome DNA to nuclease S1, and that of double strand breaks by assaying the reformation of supercoiled DNA using pulsed field electrophoresis. Reformation of supercoiled DNA, which requires that all single strand breaks have been repaired, was not slowed detectably by the inhibitors of poly(ADP-ribose) polymerase-1 NU1025 or 1,5-IQD. Repair of double strand breaks was slowed by 20-30% when homologous recombination was supressed by KU55933, caffeine, or siRNA-mediated depletion of Rad51 but was completely arrested by the inhibitors of nonhomologous end-joining wortmannin or NU7441, responses interpreted as reflecting competition between these repair pathways similar to that seen in genomic DNA. The reformation of supercoiled DNA was unaffected when topoisomerases I or II, whose participation in repair of strand breaks has been controversial, were inhibited by the catalytic inhibitors ICRF-193 or F11782. Modeling of the kinetics of repair provided rate constants and showed that repair of single strand breaks in minichromosome DNA proceeded independently of repair of double strand breaks. The simplicity of quantitating strand breaks in this minichromosome provides a usefull system for testing the efficiency of new inhibitors of their repair, and since the sequence and structural features of its DNA and its transcription pattern have been studied extensively it offers a good model for examining other aspects of DNA breakage and repair.	[Kumala, Slawomir; Jayaraju, Dheekollu; Hancock, Ronald] Univ Laval, Canc Res Ctr, Hotel Dieu Hosp, Quebec City, PQ, Canada; [Fujarewicz, Krzysztof] Silesian Tech Univ, Bioinformat Grp, Inst Automat Control, Gliwice, Poland; [Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland	Laval University; Silesian University of Technology; Silesian University of Technology	Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hotel Dieu Hosp, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016; Fujarewicz, Krzysztof/B-9667-2013	Fujarewicz, Krzysztof/0000-0002-1837-6466; Rzeszowska-Wolny, Joanna/0000-0002-5804-4757	Polish Ministry of Education and Science [N N518 4976 39]	Polish Ministry of Education and Science(Ministry of Science and Higher Education, Poland)	This work was supported partially by the Polish Ministry of Education and Science (Grant N N518 4976 39 to K.F. and J.R-W.).No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1987, J VIROL, V61, P1743, DOI 10.1128/JVI.61.5.1743-1746.1987; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; AHN SY, 1991, INT J RADIAT BIOL, V59, P661, DOI 10.1080/09553009114550591; ALAOUIJAMALI MA, 1992, RADIAT RES, V129, P37, DOI 10.2307/3577900; Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; Aneja RK, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-3; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Banath JP, 1998, INT J RADIAT BIOL, V73, P649, DOI 10.1080/095530098141906; Bandstra JZ, 2005, J MATH CHEM, V37, P409, DOI 10.1007/s10910-004-1107-y; BENYAJATI C, 1976, CELL, V9, P393, DOI 10.1016/0092-8674(76)90084-2; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Bowman KJ, 1998, BRIT J CANCER, V78, P1269, DOI 10.1038/bjc.1998.670; Caldecott KW, 2009, DNA DAMAGE RESPONSE: IMPLICATIONS ON CANCER FORMATION AND TREATMENT, P261, DOI 10.1007/978-90-481-2561-6_12; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Deutsch MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Etievant C, 2000, CANCER CHEMOTH PHARM, V46, P101, DOI 10.1007/s002800000133; Falk M, 2008, J PHYS CONF SER, V101, DOI 10.1088/1742-6596/101/1/012018; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Foray N, 1996, INT J RADIAT BIOL, V69, P241, DOI 10.1080/095530096146084; Foray N, 2005, J THEOR BIOL, V236, P448, DOI 10.1016/j.jtbi.2005.03.027; Fowler JF, 1999, RADIAT RES, V152, P124, DOI 10.2307/3580085; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Gaffney DK, 2000, RADIAT RES, V154, P461, DOI 10.1667/0033-7587(2000)154[0461:EOMTIL]2.0.CO;2; Gao HL, 2000, CANCER RES, V60, P5937; GEIGL EM, 1990, MOL MICROBIOL, V4, P801, DOI 10.1111/j.1365-2958.1990.tb00650.x; GIOCANTI N, 1993, CANCER RES, V53, P2105; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; GRIFFIN RJ, 1995, ANTI-CANCER DRUG DES, V10, P507; GUSSANDER E, 1984, J VIROL, V52, P549, DOI 10.1128/JVI.52.2.549-556.1984; Hancock R, 2012, GENOME ORGANIZATION AND FUNCTION IN THE CELL NUCLEUS, P169; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HSIANG YH, 1989, J BIOL CHEM, V264, P9713; ISHIDA R, 1991, CANCER RES, V51, P4909; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Jacob S, 2005, NUCLEIC ACIDS RES, V33, P106, DOI 10.1093/nar/gki154; Jensen LH, 2003, BIOCHEM PHARMACOL, V66, P623, DOI 10.1016/S0006-2952(03)00342-3; Johnson M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp480; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kumala S, 2012, NUCLEIC ACIDS RES, V40, P9417, DOI 10.1093/nar/gks723; Leach TJ, 1998, NUCLEIC ACIDS RES, V26, P4787, DOI 10.1093/nar/26.20.4787; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Legault J, 1997, MOL CELL BIOL, V17, P5437, DOI 10.1128/MCB.17.9.5437; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; LUCHNIK AN, 1988, NUCLEIC ACIDS RES, V16, P5175, DOI 10.1093/nar/16.11.5175; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Maleszka R., 1993, Applied and Theoretical Electrophoresis, V3, P259; Mateos S, 2006, MUTAT RES-FUND MOL M, V599, P105, DOI 10.1016/j.mrfmmm.2006.02.002; MAYER PJ, 1986, EXP CELL RES, V166, P497, DOI 10.1016/0014-4827(86)90494-5; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; NELSON SJ, 1982, RADIAT RES, V92, P120, DOI 10.2307/3575849; Nevaldine B, 1999, RADIAT RES, V152, P154, DOI 10.2307/3580088; NG CE, 1994, INT J RADIAT BIOL, V66, P49, DOI 10.1080/09553009414550941; Noel G, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-7; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okayasu R, 1998, RADIAT RES, V149, P440, DOI 10.2307/3579783; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Pachkowski BF, 2009, MUTAT RES-FUND MOL M, V671, P93, DOI 10.1016/j.mrfmmm.2009.09.006; Perrin D, 2000, BIOCHEM PHARMACOL, V59, P807, DOI 10.1016/S0006-2952(99)00382-2; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; RYDBERG B, 1994, RADIAT RES, V139, P133, DOI 10.2307/3578657; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sato M, 1997, BIOCHEM PHARMACOL, V54, P545, DOI 10.1016/S0006-2952(97)00201-3; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; SHAW JE, 1979, J VIROL, V29, P657, DOI 10.1128/JVI.29.2.657-665.1979; SHIN CG, 1990, TERATOGEN CARCIN MUT, V10, P41, DOI 10.1002/tcm.1770100106; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Strom CE, 2011, NUCLEIC ACIDS RES, V39, P3166, DOI 10.1093/nar/gkq1241; Sugden B, 2001, CURR TOP MICROBIOL, V258, P3; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tambini CE, 2010, DNA REPAIR, V9, P517, DOI 10.1016/j.dnarep.2010.01.016; Terry SYA, 2009, MUTAT RES-FUND MOL M, V663, P40, DOI 10.1016/j.mrfmmm.2009.01.003; TRIVEDI P, 1993, J GEN VIROL, V74, P1393, DOI 10.1099/0022-1317-74-7-1393; Trzeciak AR, 2008, FREE RADICAL BIO MED, V45, P1631, DOI 10.1016/j.freeradbiomed.2008.08.031; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; WANG M, 1995, ELECTROPHORESIS, V16, P1, DOI 10.1002/elps.1150160102; Whitaker SJ, 1992, PULSED FIELD GEL ELE; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Windhofer F, 2007, J CELL PHYSIOL, V213, P475, DOI 10.1002/jcp.21120; WLODEK D, 1987, RADIAT RES, V112, P146, DOI 10.2307/3577085; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017	105	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52966	10.1371/journal.pone.0052966	http://dx.doi.org/10.1371/journal.pone.0052966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382828	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800014
J	Qian, AR; Gao, X; Zhang, W; Li, JB; Wang, Y; Di, SM; Hu, LF; Shang, P				Qian, Ai-Rong; Gao, Xiang; Zhang, Wei; Li, Jing-Bao; Wang, Yang; Di, Sheng-Meng; Hu, Li-Fang; Shang, Peng			Large Gradient High Magnetic Fields Affect Osteoblast Ultrastructure and Function by Disrupting Collagen I or Fibronectin/alpha beta 1 Integrin	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPACE-FLIGHT; DIFFERENTIATION; LEVITATION; GRAVITY; EXPRESSION; GROWTH; PROLIFERATION; OSTEOCALCIN; SPACEFLIGHT	The superconducting magnet generates a field and field gradient product that can levitate diamagnetic materials. In this study a specially designed superconducting magnet with a large gradient high magnetic field (LG-HMF), which can provide three apparent gravity levels (mu-g, 1-g, and 2-g), was used to simulate a space-like gravity environment. The effects of LG-HMF on the ultrastructure and function of osteoblast-like cells (MG-63 and MC3T3-E1) and the underlying mechanism were investigated by transmission electromicroscopy (TEM), MTT, and cell western (ICW) assays. Under LG-HMF significant morphologic changes in osteoblast-like cells occurred, including expansion of endoplasmic reticulum and mitochondria, an increased number of lysosomes, distorted microvilli, and aggregates of actin filaments. Compared to controls, cell viability and alkaline phosphatase (ALP) secretion were significantly increased, and collagen I (col I), fibronectin (FN), vinculin, integrin alpha 3, alpha v, and beta 1 expression were changed under LG-HMF conditions. In conclusion, LG-HMF affects osteoblast ultrastructure, cell viability, and ALP secretion, and the changes caused by LG-HMF may be related to disrupting col I or FN/alpha beta 1 integrin.	[Qian, Ai-Rong; Gao, Xiang; Zhang, Wei; Li, Jing-Bao; Wang, Yang; Di, Sheng-Meng; Hu, Li-Fang; Shang, Peng] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn	Hu, Lifang/W-8020-2019		National Basic Research Program of China [2011CB710903]; National Natural Science Foundation of China [30970706]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB710903) and National Natural Science Foundation of China (No. 30970706). The funders had a role in study design and data collection and analysis.	Babbick M, 2007, ADV SPACE RES, V39, P1182, DOI 10.1016/j.asr.2007.01.001; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Brooks JS, 2000, J APPL PHYS, V87, P6194, DOI 10.1063/1.372653; Caillot-Augusseau A, 2000, CLIN CHEM, V46, P1136; Candeliere GA, 1999, NUCLEIC ACIDS RES, V27, P1079, DOI 10.1093/nar/27.4.1079; Carmeliet G, 1998, BONE, V22, p139S, DOI 10.1016/S8756-3282(98)00007-6; Collet P, 1997, BONE, V20, P547, DOI 10.1016/S8756-3282(97)00052-5; Di S, 2012, INT J RAD BIOL; Garcia-Ovejero D, 2001, DEV BRAIN RES, V130, P191, DOI 10.1016/S0165-3806(01)00236-X; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hammer BE, 2009, MICROGRAVITY SCI TEC, V21, P311, DOI 10.1007/s12217-008-9092-6; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Hughes-Fulford M, 1999, FASEB J, V13, pS121; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Kawakami S, 2006, JPN J APPL PHYS 1, V45, P6055, DOI 10.1143/JJAP.45.6055; Kondrachuk AV, 2001, ADV SPACE RES, V27, P1001, DOI 10.1016/S0273-1177(01)00167-3; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Kuznetsov OA, 1997, J EXP BOT, V48, P1951, DOI 10.1093/jexbot/48.316.1951; Kuznetsov OA, 1996, PLANTA, V198, P87; Landis WJ, 2000, J BONE MINER RES, V15, P1099, DOI 10.1359/jbmr.2000.15.6.1099; Li J, 2011, INT J MICROGRAVITY S, V28, pS36; Li JB, 2010, ANAL BIOCHEM, V398, P254, DOI 10.1016/j.ab.2009.12.013; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; Meng R, 2011, ACTA BIOCH BIOPH SIN, V43, P133, DOI 10.1093/abbs/gmq121; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Research Council Committee on Opportunities in High Magnetic Field Science Solid State Sciences Committee, 2005, OPP HIGH MAGN FIELD; Qian AR, 2012, IEEE T BIO-MED ENG, V59, P68, DOI 10.1109/TBME.2010.2103377; Qian AR, 2010, ADV SPACE RES, V46, P687, DOI 10.1016/j.asr.2010.04.012; Qian AR, 2009, BIOELECTROMAGNETICS, V30, P545, DOI 10.1002/bem.20511; Qian AR, 2008, ACTA ASTRONAUT, V63, P929, DOI 10.1016/j.actaastro.2008.03.005; Qian AR, 2009, ACTA BIOCH BIOPH SIN, V41, P561, DOI 10.1093/abbs/gmp041; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Sakata T, 2004, J BONE MINER RES, V19, P436, DOI 10.1359/JBMR.0301241; Shi DY, 2010, STEM CELL REV REP, V6, P567, DOI 10.1007/s12015-010-9182-x; Simon MD, 2000, J APPL PHYS, V87, P6200, DOI 10.1063/1.372654; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tian ZC, 2010, MICROGRAVITY SCI TEC, V22, P163, DOI 10.1007/s12217-009-9170-4; Valiron O, 2005, J MAGN RESON IMAGING, V22, P334, DOI 10.1002/jmri.20398; Valles JM, 2005, ADV SPACE RES, V36, P114, DOI 10.1016/j.asr.2005.01.081; Valles JM, 2002, BIOPHYS J, V82, P1260, DOI 10.1016/S0006-3495(02)75482-9; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; Wang J, 2008, J DENT RES, V87, P650, DOI 10.1177/154405910808700713; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamaguchi M, 2006, SPRINGER SER MATER S, V89, P41	49	27	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e51036	10.1371/journal.pone.0051036	http://dx.doi.org/10.1371/journal.pone.0051036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382804	gold, Green Submitted, Green Published			2022-12-27	WOS:000315483200040
J	Huang, JW; Lien, YC; Wu, HY; Yen, CJ; Pan, CC; Hung, TW; Su, CT; Chiang, CK; Cheng, HT; Hung, KY				Huang, Jenq-Wen; Lien, Yu-Chung; Wu, Hon-Yen; Yen, Chung-Jen; Pan, Chun-Chun; Hung, Tsai-Wei; Su, Chi-Ting; Chiang, Chih-Kang; Cheng, Hui-Teng; Hung, Kuan-Yu			Lean Body Mass Predicts Long-Term Survival in Chinese Patients on Peritoneal Dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; CREATININE KINETICS; MORTALITY; FAT	Background: Reduced lean body mass (LBM) is one of the main indicators in malnutrition inflammation syndrome among patients on dialysis. However, the influence of LBM on peritoneal dialysis (PD) patients' outcomes and the factors related to increasing LBM are seldom reported. Methods: We enrolled 103 incident PD patients between 2002 and 2003, and followed them until December 2011. Clinical characteristics, PD-associated parameters, residual renal function, and serum chemistry profiles of each patient were collected at 1 month and 1 year after initiating PD. LBM was estimated using creatinine index corrected with body weight. Multiple linear regression analysis, Kaplan-Meier survival analysis, and Cox regression proportional hazard analysis were used to define independent variables and compare survival between groups. Results: Using the median LBM value (70% for men and 64% for women), patients were divided into group 1 (n = 52; low LBM) and group 2 (n = 51; high LBM). Group 1 patients had higher rates of peritonitis (1.6 vs. 1.1/100 patient months; p<0.05) and hospitalization (14.6 vs. 9.7/100 patient months; p<0.05). Group 1 patients also had shorter overall survival and technique survival (p<0.01). Each percentage point increase in LBM reduced the hazard ratio for mortality by 8% after adjustment for diabetes, age, sex, and body mass index (BMI). Changes in residual renal function and protein catabolic rate were independently associated with changes in LBM in the first year of PD. Conclusions: LBM serves as a good parameter in addition to BMI to predict the survival of patients on PD. Preserving residual renal function and increasing protein intake can increase LBM.	[Huang, Jenq-Wen; Wu, Hon-Yen; Yen, Chung-Jen; Chiang, Chih-Kang; Hung, Kuan-Yu] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei 10764, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ, Coll Med & Hosp, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan; [Pan, Chun-Chun; Hung, Tsai-Wei] Natl Taiwan Univ, Coll Med & Hosp, Dept Nursing, Taipei 10764, Taiwan; [Lien, Yu-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, New Taipei City, Taiwan; [Wu, Hon-Yen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Su, Chi-Ting] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Yun Lin Branch, Yunlin Cty, Taiwan; [Cheng, Hui-Teng] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Far Eastern Memorial Hospital; National Taiwan University	Cheng, HT (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan.	cheng78@hotmail.com; kyhung@ntu.edu.tw	CHENG, HUI-TENG/AAD-9899-2020	CHENG, HUI-TENG/0000-0003-1544-7473; HUNG, KUAN-YU/0000-0003-3472-5512; YEN, CHUNG-JEN/0000-0001-5372-3657; HUANG, JENQ-WEN/0000-0001-8011-2317; CHIANG, CHIH-KANG/0000-0001-9021-4616				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; Borovnicar DJ, 1996, EUR J CLIN NUTR, V50, P607; DELIMA JJG, 1995, NEPHROL DIAL TRANSPL, V10, P1708; Dong J, 2008, KIDNEY INT, V73, P334, DOI 10.1038/sj.ki.5002644; Dong J, 2011, NEPHROL DIAL TRANSPL, V26, P3715, DOI 10.1093/ndt/gfr142; FORBES GB, 1976, AM J CLIN NUTR, V29, P1359, DOI 10.1093/ajcn/29.12.1359; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Huang CX, 2010, KIDNEY INT, V77, P624, DOI 10.1038/ki.2009.524; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Majchrzak KM, 2007, J RENAL NUTR, V17, P196, DOI 10.1053/j.jrn.2007.01.003; MITCH WE, 1980, CLIN SCI, V58, P327, DOI 10.1042/cs0580327; Moreau-Gaudry X, 2011, J RENAL NUTR, V21, P369, DOI 10.1053/j.jrn.2010.08.005; Noori N, 2010, AM J CLIN NUTR, V92, P1060, DOI 10.3945/ajcn.2010.29188; Rambod M, 2009, AM J KIDNEY DIS, V53, P298, DOI 10.1053/j.ajkd.2008.09.018; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Trivedi H, 2005, AM J NEPHROL, V25, P466, DOI 10.1159/000087876; Tzamaloukas AH, 2010, J RENAL NUTR, V20, P91, DOI 10.1053/j.jrn.2009.08.004	20	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54976	10.1371/journal.pone.0054976	http://dx.doi.org/10.1371/journal.pone.0054976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372806	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400049
J	Kim, DH; Kim, M; Kim, H; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Kim, YS; Lee, JP				Kim, Do Hyoung; Kim, Myounghee; Kim, Ho; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Yon Su; Lee, Jung Pyo			Early Referral to a Nephrologist Improved Patient Survival: Prospective Cohort Study for End-Stage Renal Disease in Korea	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; ACCESS; CARE; HEMODIALYSIS; DETERMINANTS; PREDICTION; MORTALITY; COMORBIDITY; IMPACT	The timing of referral to a nephrologist may influence the outcome of chronic kidney disease patients, but its impact has not been evaluated thoroughly. The results of a recent study showing an association between early referral and patient survival are still being debated. A total of 1028 patients newly diagnosed as end-stage renal disease (ESRD) from July 2008 to October 2011 were enrolled. Early referral (ER) was defined as patients meeting with a nephrologist more than a year before dialysis and dialysis education were provided, and all others were considered late referral (LR). The relationship of referral pattern with mortality in ESRD patients was explored using a Cox proportional hazards regression models. Time from referral to dialysis was significantly longer in 599 ER patients than in 429 LR patients (62.3 +/- 58.9 versus 2.9 +/- 3.4 months, P<0.001). Emergency HD using a temporary vascular catheter was required in 485 (47.2%) out of all patients and in 262 (43.7%) of ER compared with 223 (52.0%) of LR (P = 0.009). After 2 years of follow-up, the survival rate in ER was better than that in LR (hazard ratio [HR] 2.38, 95% confidence interval [CI] 1.27-4.45, P = 0.007). In patients with diabetes nephropathy, patient survival was also significantly higher in ER than in LR (HR 4.74, 95% CI 1.73-13.00, P = 0.002). With increasing age, HR also increased. Timely referral to a nephrologist in the predialytic stage is associated with reduced mortality.	[Kim, Do Hyoung; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Myounghee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Songnam, South Korea; [Kim, Ho] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Do Hyoung; Kim, Myounghee; Kim, Ho; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kim, Yon Su; Lee, Jung Pyo] Clin Res Ctr End Stage Renal Dis Korea, Taegu, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Kyungpook National University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Seoul National University (SNU); Seoul National University Hospital	Lee, JP (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	nephrolee@gmail.com	Kim, Ho/AAS-2402-2021; Kim, Do Hyoung/AAE-7557-2022	Kim, Ho/0000-0001-7472-3752; Kim, Do Hyoung/0000-0002-8664-8830	Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea [A102065]	Korea Healthcare Technology RD Project; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, COMPR PROSP STUD CLI; Astor BC, 2001, AM J KIDNEY DIS, V38, P494, DOI 10.1053/ajkd.2001.26833; Avorn J, 2002, J CLIN EPIDEMIOL, V55, P711, DOI 10.1016/S0895-4356(02)00415-8; Cass A, 2003, AM J KIDNEY DIS, V42, P1043, DOI 10.1016/j.ajkd.2003.07.006; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins AJ, 2010, AM J KIDNEY DIS, V55, p[1, A426], DOI DOI 10.1053/J.AJKD.2009.10.009; Curtis BM, 2002, CLIN NEPHROL, V58, P282; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; Di Napoli A, 2010, J NEPHROL, V23, P603; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Herget-Rosenthal S, 2010, INT J CLIN PRACT, V64, P1784, DOI 10.1111/j.1742-1241.2010.02535.x; Inaguma Daijo, 2006, Clin Exp Nephrol, V10, P274, DOI 10.1007/s10157-006-0439-2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Lemaire X, 2009, BLOOD PURIFICAT, V28, P21, DOI 10.1159/000210034; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; NHIC, 2004, NAT HLTH INS STAT YB; Quaglia M, 2011, ARCH INTERN MED, V171, P2065, DOI 10.1001/archinternmed.2011.585; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Winkelmayer WC, 2007, AM J TRANSPLANT, V7, P872, DOI 10.1111/j.1600-6143.2006.01689.x; Winkelmayer WC, 2001, KIDNEY INT, V60, P1547, DOI 10.1046/j.1523-1755.2001.00958.x; Winkelmayer WC, 2011, ARCH INTERN MED, V171, P1371, DOI 10.1001/archinternmed.2011.360	29	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55323	10.1371/journal.pone.0055323	http://dx.doi.org/10.1371/journal.pone.0055323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372849	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400089
J	Zheng, HX; Guo, JH; Jin, Y; Yang, F; He, JJ; Lv, L; Zhang, KS; Wu, Q; Liu, XT; Cai, XP				Zheng, Haixue; Guo, Jianhong; Jin, Ye; Yang, Fan; He, Jijun; Lv, Lv; Zhang, Kesan; Wu, Qiong; Liu, Xiangtao; Cai, Xuepeng			Engineering Foot-and-Mouth Disease Viruses with Improved Growth Properties for Vaccine Development	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SEROTYPE-A; REAL-TIME; DETERMINANTS; REPLICATION; PROTECTION; ARGENTINA; RESPONSES; STRAINS; REGION	Background: No licensed vaccine is currently available against serotype A foot-and-mouth disease (FMD) in China, despite the isolation of A/WH/CHA/09 in 2009, partly because this strain does not replicate well in baby hamster kidney (BHK) cells. Methodology/Principal Findings: A novel plasmid-based reverse genetics system was used to construct a chimeric strain by replacing the P1 gene in the vaccine strain O/CHA/99 with that from the epidemic stain A/WH/CHA/09. The chimeric virus displayed growth kinetics similar to those of O/CHA/99 and was selected for use as a candidate vaccine strain after 12 passages in BHK cells. Cattle were vaccinated with the inactivated vaccine and humoral immune responses were induced in most of the animals on day 7. A challenge infection with A/WH/CHA/09 on day 28 indicated that the group given a 4-mu g dose was fully protected and neither developed viremia nor seroconverted to a 3ABC antigen. Conclusions/Significance: Our data demonstrate that the chimeric virus not only propagates well in BHK cells and has excellent antigenic matching against serotype A FMD, but is also a potential marker vaccine to distinguish infection from vaccination. These results suggest that reverse genetics technology is a useful tool for engineering vaccines for the prevention and control of FMD.	[Zheng, Haixue; Guo, Jianhong; Jin, Ye; Yang, Fan; He, Jijun; Lv, Lv; Zhang, Kesan; Wu, Qiong; Liu, Xiangtao; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, XT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol,Minist Agr, Natl Foot & Mouth Dis Reference Lab,Key Lab Anim, Lanzhou, Peoples R China.	hnxiangtao@hotmail.com		zheng, hai xue/0000-0001-6850-1379	National High Technology Research and Development Program of China (863 Program) [2011AA10A211-1]; High-level Technological Talent Program of Gansu province [1013JHTA008]; China Agriculture Research System [CARS-39]; International Atomic Energy Agency [16025/R0]; EPIZONE project [FOOD-CT-2006-016236]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); High-level Technological Talent Program of Gansu province; China Agriculture Research System; International Atomic Energy Agency(International Atomic Energy Agency); EPIZONE project	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2011AA10A211-1), the High-level Technological Talent Program of Gansu province (1013JHTA008), the China Agriculture Research System (CARS-39), the International Atomic Energy Agency (16025/R0), and the EPIZONE (FOOD-CT-2006-016236) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Barnett PV, 2004, VACCINE, V22, P1221, DOI 10.1016/j.vaccine.2003.09.024; Barnett PV, 2002, VACCINE, V20, P3197, DOI 10.1016/S0264-410X(02)00242-6; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Blignaut B, 2011, J GEN VIROL, V92, P849, DOI 10.1099/vir.0.027151-0; Bronsvoort BMD, 2004, J CLIN MICROBIOL, V42, P2186, DOI 10.1128/JCM.42.5.2186-2196.2004; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; Cox SJ, 2003, VACCINE, V21, P1336, DOI 10.1016/S0264-410X(02)00691-6; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; Fowler VL, 2008, VACCINE, V26, P1982, DOI 10.1016/j.vaccine.2008.02.012; Guzman E, 2010, J VIROL, V84, P12375, DOI 10.1128/JVI.01545-10; Islam MA, 2001, VIRUS GENES, V23, P203, DOI 10.1023/A:1011821027235; Kitching RP, 2005, CURR TOP MICROBIOL, V288, P133; KITCHING RP, 1988, VACCINE, V6, P403, DOI 10.1016/0264-410X(88)90139-9; Klein Joern, 2006, BMC Vet Res, V2, P35, DOI 10.1186/1746-6148-2-35; Knowles NJ, 2009, TRANSBOUND EMERG DIS, V56, P157, DOI 10.1111/j.1865-1682.2009.01074.x; Konig GA, 2007, VET MICROBIOL, V124, P1, DOI 10.1016/j.vetmic.2007.03.015; Le VP, VET MICROBIOL; Lu ZJ, 2007, VET MICROBIOL, V125, P157, DOI 10.1016/j.vetmic.2007.05.017; Mattion N, 2004, VACCINE, V22, P4149, DOI 10.1016/j.vaccine.2004.06.040; Mohapatra JK, 2009, INFECT GENET EVOL, V9, P483, DOI 10.1016/j.meegid.2009.01.009; Muthuchelvan D, 2001, ACTA VIROL, V45, P159; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Reed L. J., 1988, J HYG, V27, P493; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993; Pulido MR, 2009, J VIROL, V83, P3475, DOI 10.1128/JVI.01836-08; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Schumann KR, 2008, VIRUS GENES, V36, P401, DOI 10.1007/s11262-008-0206-4; Shaw AE, 2007, J VIROL METHODS, V143, P81, DOI 10.1016/j.jviromet.2007.02.009; Tosh C, 2002, J GEN VIROL, V83, P2455, DOI 10.1099/0022-1317-83-10-2455; Tosh C, 2002, ARCH VIROL, V147, P493, DOI 10.1007/s007050200002; van Rensburg HG, 2004, J GEN VIROL, V85, P61, DOI 10.1099/vir.0.19509-0	36	46	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55228	10.1371/journal.pone.0055228	http://dx.doi.org/10.1371/journal.pone.0055228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372840	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400080
J	Al-Gayyar, MMH; Mysona, BA; Matragoon, S; Abdelsaid, MA; El-Azab, MF; Shanab, AY; Ha, YJ; Smith, SB; Bollinger, KE; El-Remessy, AB				Al-Gayyar, Mohammed M. H.; Mysona, Barbara A.; Matragoon, Suraporn; Abdelsaid, Mohammed A.; El-Azab, Mona F.; Shanab, Ahmed Y.; Ha, Yonju; Smith, Sylvia B.; Bollinger, Kathryn E.; El-Remessy, Azza B.			RETRACTED: Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway(Retracted article. See vol 12,art no e0186748, 2017)	PLOS ONE			English	Article; Retracted Publication							NERVE GROWTH-FACTOR; GANGLION-CELLS; KINASE INHIBITOR; PROTEIN-KINASE; FAMILY GTPASES; RAT MODEL; DEATH; APOPTOSIS; EXPRESSION; RECEPTOR	Our previous studies showed positive correlation between accumulation of proNGF, activation of RhoA and neuronal death in diabetic models. Here, we examined the neuroprotective effects of selective inhibition of RhoA kinase in the diabetic rat retina and in a model that stably overexpressed the cleavage-resistance proNGF plasmid in the retina. Male Sprague-Dawley rats were rendered diabetic using streptozotosin or stably express cleavage-resistant proNGF plasmid. The neuroprotective effects of the intravitreal injection of RhoA kinase inhibitor Y27632 were examined in vivo. Effects of proNGF were examined in freshly isolated primary retinal ganglion cell (RGC) cultures and RGC-5 cell line. Retinal neurodegeneration was assessed by counting TUNEL-positive and Brn-3a positive retinal ganglion cells. Expression of proNGF, p75(NTR), cleaved-PARP, caspase-3 and p38MAPK/JNK were examined by Western-blot. Activation of RhoA was assessed by pull-down assay and G-LISA. Diabetes and overexpression of proNGF resulted in retinal neurodegeneration as indicated by 9- and 6-fold increase in TUNEL-positive cells, respectively. In vitro, proNGF induced 5-fold cell death in RGC-5 cell line, and it induced >10-fold cell death in primary RGC cultures. These effects were associated with significant upregulation of p75(NTR) and activation of RhoA. While proNGF induced TNF-alpha expression in vivo, it selectively activated RhoA in primary RGC cultures and RGC-5 cell line. Inhibiting RhoA kinase with Y27632 significantly reduced diabetes- and proNGF-induced activation of proapoptotic p38MAPK/JNK, expression of cleaved-PARP and caspase-3 and prevented retinal neurodegeneration in vivo and in vitro. Taken together, these results provide compelling evidence for a causal role of proNGF in diabetes-induced retinal neurodegeneration through enhancing p75(NTR) expression and direct activation of RhoA and p38MAPK/JNK apoptotic pathways.	[Al-Gayyar, Mohammed M. H.; Mysona, Barbara A.; Matragoon, Suraporn; Abdelsaid, Mohammed A.; El-Azab, Mona F.; Shanab, Ahmed Y.; El-Remessy, Azza B.] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Athens, GA 30602 USA; [El-Remessy, Azza B.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Ha, Yonju; Smith, Sylvia B.] Georgia Hlth Sci Univ, Dept Cell Biol & Anat, Augusta, GA USA; [Smith, Sylvia B.; El-Remessy, Azza B.] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Al-Gayyar, Mohammed M. H.; Mysona, Barbara A.; Matragoon, Suraporn; Abdelsaid, Mohammed A.; El-Azab, Mona F.; Shanab, Ahmed Y.; Ha, Yonju; Smith, Sylvia B.; Bollinger, Kathryn E.; El-Remessy, Azza B.] Georgia Hlth Sci Univ, Vis Discovery Inst, Augusta, GA USA; [Al-Gayyar, Mohammed M. H.; Mysona, Barbara A.; Matragoon, Suraporn; Abdelsaid, Mohammed A.; El-Azab, Mona F.; Shanab, Ahmed Y.; El-Remessy, Azza B.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	El-Remessy, AB (corresponding author), Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Athens, GA 30602 USA.	aelremessy@georgiahealth.edu	Al-Gayyar, Mohammed M H/E-8250-2014; El-Azab, Mona F./M-9420-2014; El-Remessy, Azza B./AAA-3771-2020	Al-Gayyar, Mohammed M H/0000-0003-4777-3919; El-Azab, Mona F./0000-0003-4982-445X; El-Remessy, Azza B./0000-0003-4386-1989	Juvenile Diabetes Research Foundation [2-2008-149]; NIH [RO1 EY022408, R01 EY014560]; Vision Discovery Institute, Georgia Health Science University; AHA; Islamic Development Bank; NATIONAL EYE INSTITUTE [R01EY022408, R01EY014560] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Discovery Institute, Georgia Health Science University; AHA(American Heart Association); Islamic Development Bank(Islamic Development Bank); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a career development award from Juvenile Diabetes Research Foundation grant (2-2008-149) to ABE and NIH RO1 EY022408 to ABE and a Grant from Vision Discovery Institute, Georgia Health Science University to ABE and KEB, NIH R01 EY014560 to SBS and post-doctoral fellowship from AHA to BAM and a post-doctoral fellowship from Islamic Development Bank to MFE. Funding entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gayyar MMH, 2011, DIABETOLOGIA; Al-Gayyar MMH, 2010, AM J PATHOL, V177, P1187, DOI 10.2353/ajpath.2010.091289; Ali TK, 2011, DIABETOLOGIA, V54, P657, DOI 10.1007/s00125-010-1935-1; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Coassin M, 2008, GRAEF ARCH CLIN EXP, V246, P1743, DOI 10.1007/s00417-008-0913-5; Dong M, 2010, DRUG DISCOV TODAY, V15, P622, DOI 10.1016/j.drudis.2010.06.011; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Dun Y, 2007, INVEST OPHTH VIS SCI, V48, P4785, DOI 10.1167/iovs.07-0343; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fujimura M, 2011, TOXICOL APPL PHARM, V250, P1, DOI 10.1016/j.taap.2010.09.011; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; He Y, 2008, ARTHRITIS RHEUM-US, V58, P3366, DOI 10.1002/art.23986; Hirata A, 2008, GRAEF ARCH CLIN EXP, V246, P51, DOI 10.1007/s00417-007-0666-6; Hu B, 1999, NEUROREPORT, V10, P1293, DOI 10.1097/00001756-199904260-00026; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Ito T, 2007, SPINE, V32, P2070, DOI 10.1097/BRS.0b013e318145a502; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Matragoon S, 2012, MOL VIS, V18, P2993; Mielke K, 2000, MOL BRAIN RES, V75, P128, DOI 10.1016/S0169-328X(99)00308-3; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Mysona BA, 2012, INVEST OPHTH VIS SCI, V53, P2003; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; Suzuki A, 1998, J NEUROSCI RES, V54, P27, DOI 10.1002/(SICI)1097-4547(19981001)54:1<27::AID-JNR4>3.0.CO;2-J; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu FF, 2009, NEUROSCI LETT, V454, P81, DOI 10.1016/j.neulet.2009.02.036; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	45	30	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54692	10.1371/journal.pone.0054692	http://dx.doi.org/10.1371/journal.pone.0054692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365678	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600094
J	Colacino, JA; Dolinoy, DC; Duffy, SA; Sartor, MA; Chepeha, DB; Bradford, CR; McHugh, JB; Patel, DA; Virani, S; Walline, HM; Bellile, E; Terrell, JE; Stoerker, JA; Taylor, JMG; Carey, TE; Wolf, GT; Rozek, LS				Colacino, Justin A.; Dolinoy, Dana C.; Duffy, Sonia A.; Sartor, Maureen A.; Chepeha, Douglas B.; Bradford, Carol R.; McHugh, Jonathan B.; Patel, Divya A.; Virani, Shama; Walline, Heather M.; Bellile, Emily; Terrell, Jeffrey E.; Stoerker, Jay A.; Taylor, Jeremy M. G.; Carey, Thomas E.; Wolf, Gregory T.; Rozek, Laura S.			Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PAPILLOMAVIRUS-POSITIVE HEAD; ADVANCED OROPHARYNX CANCER; TUMOR-SUPPRESSOR GENE; EPIGENETIC INACTIVATION; GLOBAL HYPOMETHYLATION; COPY-NUMBER; P53; EXPRESSION; REVEALS	Head and neck squamous cell carcinoma (HNSCC) is the eighth most commonly diagnosed cancer in the United States. The risk of developing HNSCC increases with exposure to tobacco, alcohol and infection with human papilloma virus (HPV). HPV-associated HNSCCs have a distinct risk profile and improved prognosis compared to cancers associated with tobacco and alcohol exposure. Epigenetic changes are an important mechanism in carcinogenic progression, but how these changes differ between viral-and chemical-induced cancers remains unknown. CpG methylation at 1505 CpG sites across 807 genes in 68 well-annotated HNSCC tumor samples from the University of Michigan Head and Neck SPORE patient population were quantified using the Illumina Goldengate Methylation Cancer Panel. Unsupervised hierarchical clustering based on methylation identified 6 distinct tumor clusters, which significantly differed by age, HPV status, and three year survival. Weighted linear modeling was used to identify differentially methylated genes based on epidemiological characteristics. Consistent with previous in vitro findings by our group, methylation of sites in the CCNA1 promoter was found to be higher in HPV(+) tumors, which was validated in an additional sample set of 128 tumors. After adjusting for cancer site, stage, age, gender, alcohol consumption, and smoking status, HPV status was found to be a significant predictor for DNA methylation at an additional 11 genes, including CASP8 and SYBL1. These findings provide insight into the epigenetic regulation of viral vs. chemical carcinogenesis and could provide novel targets for development of individualized therapeutic and prevention regimens based on environmental exposures.	[Colacino, Justin A.; Dolinoy, Dana C.; Virani, Shama; Rozek, Laura S.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Duffy, Sonia A.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Duffy, Sonia A.; Chepeha, Douglas B.; Bradford, Carol R.; Walline, Heather M.; Terrell, Jeffrey E.; Carey, Thomas E.; Wolf, Gregory T.; Rozek, Laura S.] Univ Michigan, Sch Med, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [McHugh, Jonathan B.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Patel, Divya A.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Bellile, Emily] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Stoerker, Jay A.] Sequenom Ctr Mol Med, San Diego, CA USA; [Taylor, Jeremy M. G.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; University of Michigan System; University of Michigan; Sequenom; University of Michigan System; University of Michigan	Rozek, LS (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	rozekl@umich.edu	Virani, Shama/AAX-3943-2020; Sartor, Maureen/L-2902-2019	Virani, Shama/0000-0002-1163-432X; Carey, Thomas/0000-0002-5202-7518; Chepeha, Douglas/0000-0001-9062-3719	University of Michigan Head and Neck Specialized Program of Research Excellence [NIH/NCI CA097248, NIH/NCI R01CA158286]; National Institute of Environmental Health Sciences (NIEHS) [T32 ES007062]; National Human Genome Research Institute (NHGRI) [T32 HG00040]; NATIONAL CANCER INSTITUTE [P50CA097248, T32CA009676, R01CA158286] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062, P30ES017885] Funding Source: NIH RePORTER	University of Michigan Head and Neck Specialized Program of Research Excellence; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded as a part of the University of Michigan Head and Neck Specialized Program of Research Excellence, NIH/NCI CA097248, as well as through NIH/NCI R01CA158286. Support for JAC was provided by Institutional Training Grants from the National Institute of Environmental Health Sciences (NIEHS) (T32 ES007062) and the National Human Genome Research Institute (NHGRI) (T32 HG00040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arthur AE, 2011, NUTR CANCER, V63, P734, DOI 10.1080/01635581.2011.570894; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boyer SN, 1996, CANCER RES, V56, P4620; Califano J, 1996, CANCER RES, V56, P2488; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Duffy SA, 2009, J CLIN ONCOL, V27, P1969, DOI 10.1200/JCO.2008.18.2188; ElNaggar AK, 1997, AM J PATHOL, V151, P1767; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Kuan PF, 2010, BIOINFORMATICS, V26, P2849, DOI 10.1093/bioinformatics/btq553; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lee SH, 2011, OTOLARYNG HEAD NECK, V145, P64, DOI 10.1177/0194599811401327; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Maxwell JH, 2010, CLIN CANCER RES, V16, P1226, DOI 10.1158/1078-0432.CCR-09-2350; Maxwell JH, 2010, HEAD NECK-J SCI SPEC, V32, P562, DOI 10.1002/hed.21216; Monk D, 2008, GENOME RES, V18, P1270, DOI 10.1101/gr.077115.108; Paluszczak J, 2011, ORAL ONCOL, V47, P104, DOI 10.1016/j.oraloncology.2010.11.006; Poage GM, 2011, CLIN CANCER RES, V17, P3579, DOI 10.1158/1078-0432.CCR-11-0044; Ribarska Teodora, 2010, Cancer Genomics & Proteomics, V7, P51; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Sartor MA, 2011, EPIGENETICS-US, V6, P777, DOI 10.4161/epi.6.6.16216; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOMERS KD, 1992, CANCER RES, V52, P5997; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Tang AL, 2012, HEAD NECK-J SCI SPEC, V34, P1480, DOI 10.1002/hed.21962; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsunematsu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005892; Uesugi H, 2005, INT J MOL MED, V15, P597; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Wang SJ, 2008, BIOMETRICS, V64, P440, DOI 10.1111/j.1541-0420.2007.00922.x; Weiss D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-259; Weiss D, 2011, MOL CARCINOGEN, V50, P680, DOI 10.1002/mc.20798; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Wilop S, 2011, BRIT J HAEMATOL, V155, P65, DOI 10.1111/j.1365-2141.2011.08801.x; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597	52	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54742	10.1371/journal.pone.0054742	http://dx.doi.org/10.1371/journal.pone.0054742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358896	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600102
J	de Souza, BM; Brondani, LA; Boucas, AP; Sortica, DA; Kramer, CK; Canani, LH; Leitao, CB; Crispim, D				de Souza, Bianca M.; Brondani, Leticia A.; Boucas, Ana P.; Sortica, Denise A.; Kramer, Caroline K.; Canani, Luis H.; Leitao, Cristiane B.; Crispim, Daisy			Associations between UCP1-3826A/G, UCP2-866G/A, Ala55Val and Ins/Del, and UCP3-55C/T Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus: Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 GENE; 5' FLANKING REGION; PROMOTER REGION; UCP2 GENE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; OBESITY; VARIANTS; RISK; EXPRESSION	Background: Some studies have reported associations between five uncoupling protein (UCP) 1-3 polymorphisms and type 2 diabetes mellitus (T2DM). However, other studies have failed to confirm the associations. This paper describes a case-control study and a meta-analysis conducted to attempt to determine whether the following polymorphisms are associated with T2DM: -3826A/G (UCP1); -866G/A, Ala55Val and Ins/Del (UCP2) and -55C/T (UCP3). Methods: The case-control study enrolled 981 T2DM patients and 534 nondiabetic subjects, all of European ancestry. A literature search was run to identify all studies that investigated associations between UCP1-3 polymorphisms and T2DM. Pooled odds ratios (OR) were calculated for allele contrast, additive, recessive, dominant and co-dominant inheritance models. Sensitivity analyses were performed after stratification by ethnicity. Results: In the case-control study the frequencies of the UCP polymorphisms did not differ significantly between T2DM and nondiabetic groups (P > 0.05). Twenty-three studies were eligible for the meta-analysis. Meta-analysis results showed that the Ala55Val polymorphism was associated with T2DM under a dominant model (OR = 1.27, 95% CI 1.03-1.57); while the 55C/T polymorphism was associated with this disease in almost all genetic models: allele contrast (OR = 1.17, 95% CI 1.02-1.34), additive (OR = 1.32, 95% CI 1.01-1.72) and dominant (OR = 1.18, 95% CI 1.02-1.37). However, after stratification by ethnicity, the UCP2 55Val and UCP3 -55C/T alleles remained associated with T2DM only in Asians (OR = 1.25, 95% CI 1.02-1.51 and OR = 1.22, 95% CI 1.04-1.44, respectively; allele contrast model). No significant association of the -3826A/G, -866G/A and Ins/Del polymorphisms with T2DM was observed. Conclusions: In our case-control study of people with European ancestry we were not able to demonstrate any association between the UCP polymorphisms and T2DM; however, our meta-analysis detected a significant association between the UCP2 Ala55Val and UCP3 -55C/T polymorphisms and increased susceptibility for T2DM in Asians.	[de Souza, Bianca M.; Brondani, Leticia A.; Boucas, Ana P.; Sortica, Denise A.; Kramer, Caroline K.; Canani, Luis H.; Leitao, Cristiane B.; Crispim, Daisy] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil; [de Souza, Bianca M.; Brondani, Leticia A.; Boucas, Ana P.; Sortica, Denise A.; Canani, Luis H.; Leitao, Cristiane B.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil.	daisy_crispim@hotmail.com	Crispim, Daisy/R-5170-2019; Crispim, Daisy/C-9144-2013; Canani, Luis H/G-9686-2012	Crispim, Daisy/0000-0001-5095-9269; Crispim, Daisy/0000-0001-6822-3014; Canani, Luis H/0000-0002-1813-4491; Boucas, Ana Paula/0000-0002-1563-1513; Leitao, Cristiane/0000-0002-2106-309X	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre	This study was partially supported by grants from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin A, 1999, BIOCHEM BIOPH RES CO, V258, P278, DOI 10.1006/bbrc.1999.0530; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Astrup A, 1999, INT J OBESITY, V23, P1030, DOI 10.1038/sj.ijo.0801040; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Beitelshees AL, 2010, PHARMACOGENET GENOM, V20, P231, DOI 10.1097/FPC.0b013e3283377abc; Berentzen T, 2005, INT J OBESITY, V29, P93, DOI 10.1038/sj.ijo.0802841; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Buemann B, 2001, INT J OBESITY, V25, P467, DOI 10.1038/sj.ijo.0801564; Bulotta A, 2005, J CLIN ENDOCR METAB, V90, P1176, DOI 10.1210/jc.2004-1072; Canani LH, 2005, DIABETES, V54, P3326, DOI 10.2337/diabetes.54.11.3326; Chen HH, 2007, OBES SURG, V17, P926, DOI 10.1007/s11695-007-9171-6; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Crispim D, 2010, CLIN ENDOCRINOL, V72, P612, DOI 10.1111/j.1365-2265.2009.03684.x; Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Dalgaard LT, 2001, DIABETOLOGIA, V44, P1065; Dalgaard LT, 2003, OBES RES, V11, P1420, DOI 10.1038/oby.2003.191; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erlanson-Albertsson C, 2002, NUTR NEUROSCI, V5, P1, DOI 10.1080/10284150290007038; Esterbauer H, 2000, J BIOL CHEM, V275, P36394, DOI 10.1074/jbc.M005713200; Fisler JS, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-38; Franco-Hincapie L, 2009, BIOMEDICA, V29, P108, DOI 10.7705/biomedica.v29i1.46; Gable DR, 2006, DIABETES, V55, P1504, DOI 10.2337/db05-1645; Hamada T, 2008, METABOLISM, V57, P410, DOI 10.1016/j.metabol.2007.10.019; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Heilbronn LK, 2000, DIABETOLOGIA, V43, P242, DOI 10.1007/s001250050036; Herrmann SM, 2003, J MOL MED, V81, P327, DOI 10.1007/s00109-003-0431-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu YH, 2008, DIABETES, V57, P1101, DOI 10.2337/db07-1269; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ji QH, 2004, J HYPERTENS, V22, P97, DOI 10.1097/00004872-200401000-00018; Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Krempler F, 2002, DIABETES, V51, P3331, DOI 10.2337/diabetes.51.11.3331; Kubota T, 1998, J CLIN ENDOCR METAB, V83, P2800, DOI 10.1210/jc.83.8.2800; Lee YH, 2008, BIOCHEM BIOPH RES CO, V371, P767, DOI 10.1016/j.bbrc.2008.04.144; Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9; Liu YJ, 2005, PHYSIOL GENOMICS, V22, P197, DOI 10.1152/physiolgenomics.00031.2005; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; Meirhaeghe A, 2000, DIABETOLOGIA, V43, P1424, DOI 10.1007/s001250051549; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mori H, 2001, DIABETOLOGIA, V44, P373, DOI 10.1007/s001250051629; Ochoa MC, 2007, MOL GENET METAB, V92, P351, DOI 10.1016/j.ymgme.2007.07.011; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Pinelli M, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-85; Rosmond R, 2002, BBA-MOL BASIS DIS, V1588, P103, DOI 10.1016/S0925-4439(02)00152-7; Sale Michele M, 2007, BMC Endocr Disord, V7, P1, DOI 10.1186/1472-6823-7-1; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Schrauwen P, 1999, DIABETES, V48, P146, DOI 10.2337/diabetes.48.1.146; Shiinoki T, 1999, METABOLISM, V48, P581, DOI 10.1016/S0026-0495(99)90054-9; Sivenius K, 2000, INT J OBESITY, V24, P514, DOI 10.1038/sj.ijo.0801194; Solanes G, 2000, FASEB J, V14, P2141; Sramkova D, 2007, EXP CLIN ENDOCR DIAB, V115, P303, DOI 10.1055/s-2007-977732; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stolerman ES, 2009, NAT REV ENDOCRINOL, V5, P429, DOI 10.1038/nrendo.2009.129; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Vimaleswaran KS, 2011, DIABETES TECHNOL THE, V13, P19, DOI 10.1089/dia.2010.0091; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; Vimaleswaran KS, 2010, METAB SYNDR RELAT D, V8, P63, DOI 10.1089/met.2009.0039; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003; Wells G.A., NEWCASTLE OTTAWA SCA; Xiu Ling-ling, 2004, Zhonghua Yi Xue Za Zhi, V84, P375; Xu K, 2011, DIABETOLOGIA, V54, P2315, DOI 10.1007/s00125-011-2245-y; Yu XH, 2005, CLIN CHEM, V51, P1451, DOI 10.1373/clinchem.2004.044859; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	73	50	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54259	10.1371/journal.pone.0054259	http://dx.doi.org/10.1371/journal.pone.0054259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365654	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600042
J	Denis, MC; Furtos, A; Dudonne, S; Montoudis, A; Garofalo, C; Desjardins, Y; Delvin, E; Levy, E				Denis, Marie Claude; Furtos, Alexandra; Dudonne, Stephanie; Montoudis, Alain; Garofalo, Carole; Desjardins, Yves; Delvin, Edgard; Levy, Emile			RETRACTED: Apple Peel Polyphenols and Their Beneficial Actions on Oxidative Stress and Inflammation (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							SMOOTH-MUSCLE-CELLS; BOWEL-DISEASE; ANTIOXIDANT CAPACITY; ANALYSIS REVEALS; OXYGEN RADICALS; GASTRIC-MUCOSA; CACO-2 CELLS; MODEL; METABOLISM; ACTIVATION	Since gastrointestinal mucosa is constantly exposed to reactive oxygen species from various sources, the presence of antioxidants may contribute to the body's natural defenses against inflammatory diseases. Hypothesis: To define the polyphenols extracted from dried apple peels (DAPP) and determine their antioxidant and anti-inflammatory potential in the intestine. Caco-2/15 cells were used to study the role of DAPP preventive actions against oxidative stress (OxS) and inflammation induced by iron-ascorbate (Fe/Asc) and lipopolysaccharide (LPS), respectively. Results: The combination of HPLC with fluorescence detection, HPLC-ESI-MS TOF and UPLC-ESI-MS/MS QQQ allowed us to characterize the phenolic compounds present in the DAPP (phenolic acids, flavonol glycosides, flavan-3-ols, procyanidins). The addition of Fe/Asc to Caco-2/15 cells induced OxS as demonstrated by the rise in malondialdehyde, depletion of n-3 polyunsaturated fatty acids, and alterations in the activity of endogenous antioxidants (SOD, GPx, G-Red). However, preincubation with DAPP prevented Fe/Asc-mediated lipid peroxidation and counteracted LPS-mediated inflammation as evidenced by the down-regulation of cytokines (TNF-alpha and IL-6), and prostaglandin E2. The mechanisms of action triggered by DAPP induced also a down-regulation of cyclooxygenase-2 and nuclear factor-kappa B, respectively. These actions were accompanied by the induction of Nrf2 (orchestrating cellular antioxidant defenses and maintaining redox homeostasis), and PGC-1 alpha (the "master controller" of mitochondrial biogenesis). Conclusion: Our findings provide evidence of the capacity of DAPP to reduce OxS and inflammation, two pivotal processes involved in inflammatory bowel diseases.	[Denis, Marie Claude; Montoudis, Alain; Garofalo, Carole; Delvin, Edgard; Levy, Emile] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Denis, Marie Claude; Levy, Emile] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Furtos, Alexandra; Delvin, Edgard] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Dudonne, Stephanie; Desjardins, Yves; Levy, Emile] Univ Laval, Inst Nutraceut & Funct foods, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University	Levy, E (corresponding author), Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	emile.levy@recherche-ste-justine.qc.ca	Desjardins, Yves/F-1222-2013	Desjardins, Yves/0000-0002-0398-2797; Dudonne, Stephanie/0000-0001-6581-4070	J.A. DeSeve Research Chair in Nutrition; Leader Canadian Foundation of Innovation; Fonds de recherche du Quebec-Nature et technologies; Leahy Orchards Inc.; Appleboost Products Inc.	J.A. DeSeve Research Chair in Nutrition; Leader Canadian Foundation of Innovation; Fonds de recherche du Quebec-Nature et technologies; Leahy Orchards Inc.; Appleboost Products Inc.	This study was supported by the J.A. DeSeve Research Chair in Nutrition, the Leader Canadian Foundation of Innovation (EL) and scholarship award from Fonds de recherche du Quebec-Nature et technologies (MCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from Leahy Orchards Inc. and Appleboost Products Inc. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BABBS CF, 1992, FREE RADICAL BIO MED, V13, P169, DOI 10.1016/0891-5849(92)90079-V; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brownmiller C, 2009, J AGR FOOD CHEM, V57, P1896, DOI 10.1021/jf803015s; Brunet S, 2000, FREE RADICAL BIO MED, V28, P46, DOI 10.1016/S0891-5849(99)00197-5; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Carrasco-Pozo C, 2011, J AGR FOOD CHEM, V59, P6459, DOI 10.1021/jf200553s; Courtois F, 2003, AM J CLIN NUTR, V77, P744, DOI 10.1093/ajcn/77.3.744; Courtois F, 2002, J NUTR, V132, P1289, DOI 10.1093/jn/132.6.1289; Crespy V, 2001, J NUTR, V131, P3227, DOI 10.1093/jn/131.12.3227; D'Argenio G, 2008, BRIT J NUTR, V100, P1228, DOI 10.1017/S0007114508988747; D'Argenio G, 2012, DIGEST LIVER DIS, V44, P555, DOI 10.1016/j.dld.2012.01.009; Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Graziani G, 2005, GUT, V54, P193, DOI 10.1136/gut.2004.046292; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kang NJ, 2011, PHARMACOL THERAPEUT, V130, P310, DOI 10.1016/j.pharmthera.2011.02.004; Kevers C, 2011, J AGR FOOD CHEM, V59, P6165, DOI 10.1021/jf201013k; Kim DO, 2002, J AGR FOOD CHEM, V50, P3713, DOI 10.1021/jf020071c; KORYCKADAHL MB, 1978, CRC CR REV FOOD SCI, V10, P209, DOI 10.1080/10408397809527250; Kosinska A, 2012, FOOD CHEM, V135, P999, DOI 10.1016/j.foodchem.2012.05.101; Kruidenier L, 2002, ALIMENT PHARM THER, V16, P1997, DOI 10.1046/j.1365-2036.2002.01378.x; Lavelli V, 1999, J AGR FOOD CHEM, V47, P3826, DOI 10.1021/jf981372i; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Li J, 2002, J BIOL CHEM, V277, P388, DOI 10.1074/jbc.M109380200; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Martinez-Jimenez CP, 2006, J BIOL CHEM, V281, P29840, DOI 10.1074/jbc.M604046200; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Moon SK, 2003, BIOCHEM BIOPH RES CO, V301, P1069, DOI 10.1016/S0006-291X(03)00091-3; Natarajan R, 2001, J INTERF CYTOK RES, V21, P349, DOI 10.1089/107999001750277826; Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664; PARKS DA, 1989, GUT, V30, P293, DOI 10.1136/gut.30.3.293; PARKS DA, 1988, AM J PHYSIOL, V254, pG768, DOI 10.1152/ajpgi.1988.254.5.G768; Pravda J, 2005, WORLD J GASTROENTERO, V11, P2371, DOI 10.3748/wjg.v11.i16.2371; Precourt LP, 2009, INT J BIOCHEM CELL B, V41, P1628, DOI 10.1016/j.biocel.2009.02.013; Precourt LP, 2012, AM J PHYSL GASTROINT; Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Sanchez S, 2002, DIGEST DIS SCI, V47, P1389, DOI 10.1023/A:1015395103160; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Scalbert A, 2000, BIOFACTORS, V13, P115, DOI 10.1002/biof.5520130119; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shapiro H, 2007, GUT, V56, P426, DOI 10.1136/gut.2006.094599; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; Taha R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011817; Tang YC, 2009, ENDOCRINOLOGY, V150, P3011, DOI 10.1210/en.2008-1601; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; WELLS CL, 1993, CIRC SHOCK, V40, P276; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	63	90	93	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53725	10.1371/journal.pone.0053725	http://dx.doi.org/10.1371/journal.pone.0053725			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372666	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500021
J	Gorlich, D; Dittrich, P				Goerlich, Dennis; Dittrich, Peter			Molecular Codes in Biological and Chemical Reaction Networks	PLOS ONE			English	Article							MITOCHONDRIAL GENETIC-CODE; GENOME ORGANIZATION; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; STOP CODONS; EVOLUTION; ORIGIN; BIOSEMIOTICS; EXAMPLES; SUBUNIT	Shannon's theory of communication has been very successfully applied for the analysis of biological information. However, the theory neglects semantic and pragmatic aspects and thus cannot directly be applied to distinguish between (bio-) chemical systems able to process "meaningful" information from those that do not. Here, we present a formal method to assess a system's semantic capacity by analyzing a reaction network's capability to implement molecular codes. We analyzed models of chemical systems (martian atmosphere chemistry and various combustion chemistries), biochemical systems (gene expression, gene translation, and phosphorylation signaling cascades), an artificial chemistry, and random reaction networks. Our study suggests that different chemical systems posses different semantic capacities. No semantic capacity was found in the model of the martian atmosphere chemistry, the studied combustion chemistries, and highly connected random networks, i.e. with these chemistries molecular codes cannot be implemented. High semantic capacity was found in the studied biochemical systems and in random reaction networks where the number of second order reactions is twice the number of species. We conclude that our approach can be applied to evaluate the information processing capabilities of a chemical system and may thus be a useful tool to understand the origin and evolution of meaningful information, e. g. in the context of the origin of life.	[Goerlich, Dennis; Dittrich, Peter] Jena Ctr Bioinformat, Inst Comp Sci, Bio Syst Anal Grp, Jena, Germany; [Goerlich, Dennis; Dittrich, Peter] Univ Jena, Jena, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, Munster, Germany	Friedrich Schiller University of Jena; University of Munster	Dittrich, P (corresponding author), Jena Ctr Bioinformat, Inst Comp Sci, Bio Syst Anal Grp, Jena, Germany.	peter.dittrich@uni-jena.de	Görlich, Dennis/C-8950-2012	Görlich, Dennis/0000-0002-2574-9419	Jena School for Microbial Communication; German Research Foundation	Jena School for Microbial Communication; German Research Foundation(German Research Foundation (DFG))	DG has been funded by the Jena School for Microbial Communication (www.jsmc.uni-jena.de). The authors acknowledge funding by the German Research Foundation (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANZHAF W, 1993, COMPUT MATH APPL, V26, P1, DOI 10.1016/0898-1221(93)90046-X; Barbieri M, 2008, NATURWISSENSCHAFTEN, V95, P577, DOI 10.1007/s00114-008-0368-x; BATUECAS B, 1988, NUCLEIC ACIDS RES, V16, P6515, DOI 10.1093/nar/16.14.6515; BOORE JL, 1994, GENETICS, V138, P423; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; CLARKWALKER GD, 1994, J MOL EVOL, V38, P593; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; De Beule J, 2011, BIOSEMIOTICS-NETH, V4, P5, DOI 10.1007/s12304-010-9101-1; DURRHEIM GA, 1993, NUCLEIC ACIDS RES, V21, P3587, DOI 10.1093/nar/21.15.3587; Elzanowski A, 2010, GENETIC CODE VERSION; FONTANA W, 1994, B MATH BIOL, V56, P1; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Gorlich Dennis, 2011, Advances in Artificial Life. Darwin Meets von Neumann. 10th European Conference, ECAL 2009. Revised Selected Papers, P305, DOI 10.1007/978-3-642-21283-3_38; HayashiIshimaru Y, 1996, CURR GENET, V30, P29, DOI 10.1007/s002940050096; HIMENO H, 1987, GENE, V56, P219; HOFFMANN RJ, 1992, GENETICS, V131, P397; Hughes KJ, 2001, INT J CHEM KINET, V33, P513, DOI 10.1002/kin.1048; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; JUKES TH, 1993, COMP BIOCHEM PHYS B, V106, P489, DOI 10.1016/0305-0491(93)90122-L; Kaiser EW, 2000, J PHYS CHEM A, V104, P8194, DOI 10.1021/jp994074c; Kaufmann A, 2011, METHODS MOL BIOL, V765, P275, DOI 10.1007/978-1-61779-197-0_16; Keeling PJ, 1996, EMBO J, V15, P2285, DOI 10.1002/j.1460-2075.1996.tb00581.x; Kondow A, 1999, NUCLEIC ACIDS RES, V27, P2554, DOI 10.1093/nar/27.12.2554; Koonin EV, 2009, IUBMB LIFE, V61, P99, DOI 10.1002/iub.146; Krauss G., 2008, BIOCH SIGNAL TRANSDU, V4th; Kuappers B-O., 1990, INFORM ORIGIN LIFE; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; LIANG A, 1993, NATURWISSENSCHAFTEN, V80, P225, DOI 10.1007/BF01175738; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Marinov NM, 1999, INT J CHEM KINET, V31, P183, DOI 10.1002/(SICI)1097-4601(1999)31:3<183::AID-KIN3>3.0.CO;2-X; Martins EQV, 2003, 4OR-Q J OPER RES, V1, P121, DOI 10.1007/s10288-002-0010-2; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Monod J., 1971, CHANCE NECESSITY; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NAIR H, 1994, ICARUS, V111, P124, DOI 10.1006/icar.1994.1137; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; O Conaire M, 2004, INT J CHEM KINET, V36, P603, DOI 10.1002/kin.20036; OHAMA T, 1990, J MOL EVOL, V30, P329, DOI 10.1007/BF02101887; OSAWA S, 1989, J MOL EVOL, V29, P202, DOI 10.1007/BF02100203; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pattee HH, 2008, BIOSEMIOTICS-NETH, V1, P147, DOI 10.1007/s12304-008-9012-6; SCHNEIDER SU, 1991, CURR GENET, V20, P173, DOI 10.1007/BF00312782; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Speroni di Fenizio P, 2000, GERM WORKSH ART LIF; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Tlusty T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048101; Tlusty T, 2008, P NATL ACAD SCI USA, V105, P8238, DOI 10.1073/pnas.0710274105; Tsuda S., 2009, ARTIFICIAL LIFE MODE, P213; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9	57	10	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54694	10.1371/journal.pone.0054694	http://dx.doi.org/10.1371/journal.pone.0054694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372756	Green Published, gold			2022-12-27	WOS:000314021500109
J	Juengel, E; Makarevic, J; Tsaur, I; Bartsch, G; Nelson, K; Haferkamp, A; Blaheta, RA				Juengel, Eva; Makarevic, Jasmina; Tsaur, Igor; Bartsch, Georg; Nelson, Karen; Haferkamp, Axel; Blaheta, Roman A.			Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PHASE-II; THERAPY; ACETYLATION; COMBINATION; VORINOSTAT; EXPRESSION; PATHWAY; TARGET; TRIAL	Targeted drugs have significantly improved the therapeutic options for advanced renal cell carcinoma (RCC). However, resistance often develops, negating the benefit of these agents. In the present study, the molecular mechanisms of acquired resistance towards the histone deacetylase (HDAC) inhibitor valproic acid (VPA) in a RCC in vivo model were investigated. NMRI:nu/nu mice were transplanted with Caki-1 RCC cells and then treated with VPA (200 mg/kg/day). Controls remained untreated. Based on tumor growth dynamics, the mice were divided into "responders'' and "non-responders'' to VPA. Histone H3 and H4 acetylation and expression of cell signaling and cell cycle regulating proteins in the RCC mouse tumors were evaluated by Western blotting. Tumor growth of VPA responders was significantly diminished, whereas that of VPA non-responders even exceeded control values. Cdk1, 2 and 4 proteins were strongly enhanced in the non-responders. Importantly, Akt expression and activity were massively up-regulated in the tumors of the VPA non-responders. Chronic application (12 weeks) of VPA to Caki-1 cells in vitro evoked a distinct elevation of Akt activity and cancer cells no longer responded with cell growth reduction, compared to the short 2 week treatment. We assume that chronic use of an HDAC-inhibitor is associated with (re)-activation of Akt, which may be involved in resistance development. Consequently, combined blockade of both HDAC and Akt may delay or prevent drug resistance in RCC.	[Juengel, Eva; Makarevic, Jasmina; Tsaur, Igor; Bartsch, Georg; Haferkamp, Axel; Blaheta, Roman A.] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany; [Nelson, Karen] Goethe Univ Frankfurt, Dept Vasc & Endovasc Surg, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Blaheta, RA (corresponding author), Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany.	Blaheta@em.uni-frankfurt.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523	Gisela Stadelmann-Stiftung; Ellinore and Herbert Vogel-Stiftung	Gisela Stadelmann-Stiftung; Ellinore and Herbert Vogel-Stiftung	This work was supported by the Gisela Stadelmann-Stiftung and the Ellinore and Herbert Vogel-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins DJ, 2005, VIRCHOWS ARCH, V447, P634, DOI 10.1007/s00428-005-1262-y; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Coronel J, 2011, MED ONCOL, V28, pS540, DOI 10.1007/s12032-010-9700-3; Fedier A, 2007, INT J ONCOL, V31, P633; Hainsworth JD, 2011, CANCER INVEST, V29, P451, DOI 10.3109/07357907.2011.590568; Ikuerowo SO, 2006, INT J CANCER, V119, P867, DOI 10.1002/ijc.21869; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones J, 2009, J CELL MOL MED, V13, P2342, DOI 10.1111/j.1582-4934.2008.00603.x; Jones J, 2009, J CELL MOL MED, V13, P2376, DOI 10.1111/j.1582-4934.2008.00436.x; Juengel E, 2012, CANC LETT IN PRESS; Kanao K, 2008, J UROLOGY, V180, P1131, DOI 10.1016/j.juro.2008.04.136; Kato Y, 2007, CLIN CANCER RES, V13, P4538, DOI 10.1158/1078-0432.CCR-07-0014; Kodani M, 2005, ONCOL REP, V13, P477; Migita T, 2002, CANCER-AM CANCER SOC, V94, P973, DOI 10.1002/cncr.10338.abs; Mosashvilli D, 2010, CANCER SCI, V101, P2664, DOI 10.1111/j.1349-7006.2010.01717.x; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Pertia A, 2009, INT UROL NEPHROL, V41, P243, DOI 10.1007/s11255-008-9442-8; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Porta C, 2009, J UROLOGY, V182, P2569, DOI 10.1016/j.juro.2009.08.085; Qian C, 2012, CLIN CANC R IN PRESS; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stadler WM, 2006, CLIN GENITOURIN CANC, V5, P57, DOI 10.3816/CGC.2006.n.018; Strickler JH, 2012, CANC CHEMOT IN PRESS	24	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53100	10.1371/journal.pone.0053100	http://dx.doi.org/10.1371/journal.pone.0053100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372654	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500011
J	Lopez-Lopez, P; Benavent-Corai, J; Garcia-Ripolles, C; Urios, V				Lopez-Lopez, Pascual; Benavent-Corai, Jose; Garcia-Ripolles, Clara; Urios, Vicente			Scavengers on the Move: Behavioural Changes in Foraging Search Patterns during the Annual Cycle	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; LEVY WALKS EVOLVE; SCALING LAWS; FLIGHT; MOVEMENTS; SANITARY; TRACKING; ECOLOGY; SUCCESS; CONTEXT	Background: Optimal foraging theory predicts that animals will tend to maximize foraging success by optimizing search strategies. However, how organisms detect sparsely distributed food resources remains an open question. When targets are sparse and unpredictably distributed, a Levy strategy should maximize foraging success. By contrast, when resources are abundant and regularly distributed, simple Brownian random movement should be sufficient. Although very different groups of organisms exhibit Levy motion, the shift from a Levy to a Brownian search strategy has been suggested to depend on internal and external factors such as sex, prey density, or environmental context. However, animal response at the individual level has received little attention. Methodology/Principal Findings: We used GPS satellite-telemetry data of Egyptian vultures Neophron percnopterus to examine movement patterns at the individual level during consecutive years, with particular interest in the variations in foraging search patterns during the different periods of the annual cycle (i.e. breeding vs. non-breeding). Our results show that vultures followed a Brownian search strategy in their wintering sojourn in Africa, whereas they exhibited a more complex foraging search pattern at breeding grounds in Europe, including Levy motion. Interestingly, our results showed that individuals shifted between search strategies within the same period of the annual cycle in successive years. Conclusions/Significance: Results could be primarily explained by the different environmental conditions in which foraging activities occur. However, the high degree of behavioural flexibility exhibited during the breeding period in contrast to the non-breeding period is challenging, suggesting that not only environmental conditions explain individuals' behaviour but also individuals' cognitive abilities (e. g., memory effects) could play an important role. Our results support the growing awareness about the role of behavioural flexibility at the individual level, adding new empirical evidence about how animals in general, and particularly scavengers, solve the problem of efficiently finding food resources.	[Lopez-Lopez, Pascual; Garcia-Ripolles, Clara; Urios, Vicente] Univ Alicante, Vertebrates Zool Res Grp, CIBIO Res Inst, E-03080 Alicante, Spain; [Benavent-Corai, Jose] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain	Universitat d'Alacant; University of Valencia	Lopez-Lopez, P (corresponding author), Univ Alicante, Vertebrates Zool Res Grp, CIBIO Res Inst, E-03080 Alicante, Spain.	Pascual.Lopez@uv.es	López-López, Pascual/C-1039-2011; Urios, Vicente/AAD-4800-2022	López-López, Pascual/0000-0001-5269-652X; 	Terra Natura Foundation (Spain); Spanish Regional Administration (Generalitat Valenciana ); Spanish Regional Administration (Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Economy and Competitiveness [JCI-2011-09588]	Terra Natura Foundation (Spain); Spanish Regional Administration (Generalitat Valenciana )(Center for Forestry Research & Experimentation (CIEF)); Spanish Regional Administration (Junta de Comunidades de Castilla-La Mancha)(Junta de Comunidades de Castilla-La Mancha); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Satellite tracking devices were supported by the Terra Natura Foundation (Spain) and two Spanish Regional Administrations (Generalitat Valenciana and Junta de Comunidades de Castilla-La Mancha). PLL is supported by a "Juan de la Cierva" postdoctoral grant of the Spanish Ministry of Economy and Competitiveness (reference JCI-2011-09588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadon JD, 2010, ANIM CONSERV, V13, P495, DOI 10.1111/j.1469-1795.2010.00369.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; [Anonymous], 2008, MATLAB 2008 VERS 7 7; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; BirdLife International, 2012, SPEC FACTSH NEOPHR P; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CEBALLOS O, 1990, Journal of Raptor Research, V24, P19; Christie D ., 2001, RAPTORS BIRDS PREY W; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Cortes-Avizanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021016; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; de Jager M, 2012, SCIENCE, V335, DOI 10.1126/science.1215903; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Garcia-Ripolles C, 2010, BIRD STUDY, V57, P261, DOI 10.1080/00063650903505762; Gotelli NJ, 2013, ECOSIMR 1 00; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jasen VAA, 2012, SCIENCE, V335, P918; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kenward RE., 2000, MANUAL WILDLIFE RADI; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Margalida A, 2012, SCIENCE, V335, P284, DOI 10.1126/science.335.6066.284-a; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; Mundy P., 1992, VULTURES AFRICA; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; SOKAL RR, 1994, BIOMETRY; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zwarts L., 2009, LIVING EDGE WETLANDS	65	41	41	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54352	10.1371/journal.pone.0054352	http://dx.doi.org/10.1371/journal.pone.0054352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372712	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500063
J	Lyra, C; Sinkko, H; Rantanen, M; Paulin, L; Kotilainen, A				Lyra, Christina; Sinkko, Hanna; Rantanen, Matias; Paulin, Lars; Kotilainen, Aarno			Sediment Bacterial Communities Reflect the History of a Sea Basin	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BALTIC SEA; MARINE-SEDIMENTS; MICROBIAL COMMUNITIES; ENVIRONMENTAL-CHANGE; HOLOCENE HISTORY; GOTLAND BASIN; HUMAN IMPACT; METHANE; DIVERSITY	How entire microbial communities are structured across stratified sediments from the historical standpoint is unknown. The Baltic Sea is an ideal research object for historical reconstruction, since it has experienced many fresh-and brackish water periods and is depleted of dissolved oxygen, which increases the sediment's preservation potential. We investigated the bacterial communities, chemical elements (e. g. Cr, Pb Na, P, Sr and U) and sediment composition in a stratified sediment core dated by radiocarbon and spanning 8000 years of Baltic Sea history, using up-to-date multivariate statistics. The communities were analysed by 16S rRNA gene terminal restriction fragment length polymorphism. The communities of the deep Early Litorina and surface Late Litorina Sea laminae were separated from the communities of the middle Litorina Sea laminae, which were associated with elevated concentrations of U and Sr trace elements, palaeo-oxygen and palaeosalinity proxies. Thus, the Litorina Sea laminae were characterized by past oxygen deficiency and salinity increase. The communities of the laminae, bioturbated and homogeneous sediments were differentiated, based on the same historical sea phases, with correct classifications of 90%. Palaeosalinity was one of the major parameters that separated the bacterial communities of the stratified sediments. A discontinuous spatial structure with a surprising increase in community heterogeneity was detected in Litorina Sea sediments from 388 to 422 cm deep, which suggests that a salinity maximum occurred in the central Gulf of Finland app. 6200-6600 years ago. The community heterogeneity decreased from the surface down to 306 cm, which reflected downcore mineralization. The plateau of the decrease was in the app. 2000-year-old sediment layers. Bacterial community data may be used as an additional tool in ocean-drilling projects, in which it is important to detect mineralization plateaus both to determine historically comparable portions of sediment samples and historical events, such as sea-level rise culminations.	[Lyra, Christina; Sinkko, Hanna] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kotilainen, Aarno] Geol Survey Finland, FIN-02150 Espoo, Finland	University of Helsinki; University of Helsinki; Geological Survey of Finland (GTK)	Lyra, C (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	christina.lyra@helsinki.fi		Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling foundation; Centre of Excellence [53305, 118637]; Academy of Finland [214457, 115400]	Maj and Tor Nessling foundation; Centre of Excellence; Academy of Finland(Academy of Finland)	The authors' work was supported by Maj and Tor Nessling foundation, the Centre of Excellence (53305, 118637), and the grants of the Academy of Finland (214457, 115400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Andren E, 2000, HOLOCENE, V10, P687, DOI 10.1191/09596830094944; Aquilina A, 2010, ORG GEOCHEM, V41, P414, DOI 10.1016/j.orggeochem.2009.09.009; Berglund BE, 2005, QUATERN INT, V130, P111, DOI 10.1016/j.quaint.2004.04.036; Bocard D., 1992, ECOLOGY, V73, P1045, DOI DOI 10.2307/1940179; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Brenner WW, 2005, PALAEOGEOGR PALAEOCL, V220, P227, DOI 10.1016/j.palaeo.2004.12.010; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coolen MJL, 2008, ENVIRON MICROBIOL, V10, P1783, DOI 10.1111/j.1462-2920.2008.01601.x; Coolen MJL, 2009, EARTH PLANET SC LETT, V284, P610, DOI 10.1016/j.epsl.2009.05.029; Coolen MJL, 2004, ORG GEOCHEM, V35, P1151, DOI 10.1016/j.orggeochem.2004.06.009; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Emeis KC, 2003, HOLOCENE, V13, P411, DOI 10.1191/0959683603hl634rp; Eronen M, 1988, GEOLOGICAL SURVEY FI, V6, P11; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Kemp A.E.S, 1996, GEOLOGICAL SOC SPECI, V116, P258; Kindt R., 2005, WORLD; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lopez-Buendia AM, 1999, CHEM GEOL, V157, P235, DOI 10.1016/S0009-2541(98)00207-1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Miettinen A, 2004, QUATERN INT, V120, P91, DOI 10.1016/j.quaint.2004.01.009; MILLER U, 1986, P 8 INT DIAT S PAR 1, P601; Nath BN, 1997, GEOCHIM COSMOCHIM AC, V61, P2375; Oksanen J., 2008, VEGAN COMMUNITY ECOL; R Development Core Team, 2007, R LANG ENV STAT COMP; Sandgren P, 2004, GFF, V126, P363, DOI 10.1080/11035890401264363; Sohlenius G, 1998, BOREAS, V27, P101; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Westman P, 2003, ESTUARIES, V26, P680, DOI 10.1007/BF02711979; Widerlund A, 2011, GEOLOGY, V39, P187, DOI 10.1130/G31524.1; Wu L, 2008, APPL ENVIRON MICROB, V74, P4516, DOI 10.1128/AEM.02751-07; Zheng Y, 2003, APPL GEOCHEM, V18, P539, DOI 10.1016/S0883-2927(02)00119-1; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001	51	18	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54326	10.1371/journal.pone.0054326	http://dx.doi.org/10.1371/journal.pone.0054326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372707	gold, Green Submitted, Green Published			2022-12-27	WOS:000314021500058
J	Santl-Temkiv, T; Finster, K; Dittmar, T; Hansen, BM; Thyrhaug, R; Nielsen, NW; Karlson, UG				Santl-Temkiv, Tina; Finster, Kai; Dittmar, Thorsten; Hansen, Bjarne Munk; Thyrhaug, Runar; Nielsen, Niels Woetmann; Karlson, Ulrich Gosewinkel			Hailstones: A Window into the Microbial and Chemical Inventory of a Storm Cloud	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; MOLECULAR CHARACTERIZATION; WATER; MASS; CARBON; ENUMERATION; CHEMISTRY; BACTERIA; COMMUNITIES; VARIABILITY	Storm clouds frequently form in the summer period in temperate climate zones. Studies on these inaccessible and short-lived atmospheric habitats have been scarce. We report here on the first comprehensive biogeochemical investigation of a storm cloud using hailstones as a natural stochastic sampling tool. A detailed molecular analysis of the dissolved organic matter in individual hailstones via ultra-high resolution mass spectrometry revealed the molecular formulae of almost 3000 different compounds. Only a small fraction of these compounds were rapidly biodegradable carbohydrates and lipids, suitable for microbial consumption during the lifetime of cloud droplets. However, as the cloud environment was characterized by a low bacterial density (Me = 1973 cells/ml) as well as high concentrations of both dissolved organic carbon (Me = 179 mu M) and total dissolved nitrogen (Me = 30 mu M), already trace amounts of easily degradable organic compounds suffice to support bacterial growth. The molecular fingerprints revealed a mainly soil origin of dissolved organic matter and a minor contribution of plant-surface compounds. In contrast, both the total and the cultivable bacterial community were skewed by bacterial groups (gamma-Proteobacteria, Sphingobacteriales and Methylobacterium) that indicated the dominance of plant-surface bacteria. The enrichment of plant-associated bacterial groups points at a selection process of microbial genera in the course of cloud formation, which could affect the long-distance transport and spatial distribution of bacteria on Earth. Based on our results we hypothesize that plant-associated bacteria were more likely than soil bacteria (i) to survive the airborne state due to adaptations to life in the phyllosphere, which in many respects matches the demands encountered in the atmosphere and (ii) to grow on the suitable fraction of dissolved organic matter in clouds due to their ecological strategy. We conclude that storm clouds are among the most extreme habitats on Earth, where microbial life exists.	[Santl-Temkiv, Tina; Hansen, Bjarne Munk; Karlson, Ulrich Gosewinkel] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Santl-Temkiv, Tina; Finster, Kai] Aarhus Univ, Dept Biosci, Microbiol Sect, Aarhus, Denmark; [Santl-Temkiv, Tina; Finster, Kai] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, Aarhus, Denmark; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Max Planck Res Grp Marine Geochem, D-26111 Oldenburg, Germany; [Thyrhaug, Runar] Univ Bergen, Dept Biol, Bergen, Norway; [Nielsen, Niels Woetmann] Danish Meteorol Inst, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Bergen; Danish Meteorological Institute DMI	Karlson, UG (corresponding author), Aarhus Univ, Dept Environm Sci, Roskilde, Denmark.	uka@dmu.dk	Finster, Kai W/I-7475-2013; Dittmar, Thorsten/L-7796-2013	Finster, Kai W/0000-0002-9132-5542; Dittmar, Thorsten/0000-0002-3462-0107; Santl-Temkiv, Tina/0000-0002-3446-5813	Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen); Danish National Research Foundation; ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council [267864]	Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council(European Research Council (ERC)European Commission)	TST was supported by a Ph.D. fellowship granted by the Danish Agency for Science, Technology and Innovation (Forsknings- og Innovationsstyrelsen). Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation. The research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (Grant agreement no.: 267864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C.D., 2009, METEOROLOGY TODAY IN; Amato P, 2007, ATMOS CHEM PHYS, V7, P4159, DOI 10.5194/acp-7-4159-2007; Amato P, 2005, ATMOS ENVIRON, V39, P4143, DOI 10.1016/j.atmosenv.2005.04.002; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Burrows S.M., 2009, ATMOS CHEM PHYS DISC, V9, P10777, DOI DOI 10.5194/ACPD-9-10829-2009; Cornell SE, 2003, ATMOS ENVIRON, V37, P2173, DOI 10.1016/S1352-2310(03)00133-X; Delort AM, 2010, ATMOS RES, V98, P249, DOI 10.1016/j.atmosres.2010.07.004; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Garland JL, 2001, MICROBIAL ECOL, V42, P150; GOVINDARAJAN AG, 1988, P NATL ACAD SCI USA, V85, P1334, DOI 10.1073/pnas.85.5.1334; HERLIHY LJ, 1987, ATMOS ENVIRON, V21, P2397, DOI 10.1016/0004-6981(87)90374-X; Hill KA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008002; Jacob JL, 2004, MICROB ECOL, V49, P104; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Kourtev PS, 2011, ATMOS ENVIRON, V45, P5399, DOI 10.1016/j.atmosenv.2011.06.041; MAITA Y, 1990, GEOCHEM J, V24, P245, DOI 10.2343/geochemj.24.245; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marinoni A, 2004, ATMOS CHEM PHYS, V4, P715, DOI 10.5194/acp-4-715-2004; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Niwa R, 2011, CAN J MICROBIOL, V57, P62, DOI [10.1139/W10-101, 10.1139/w10-101]; Oliver JD, 2005, J MICROBIOL, V43, P93; PERDUE EM, 1984, GEOCHIM COSMOCHIM AC, V48, P1435, DOI 10.1016/0016-7037(84)90400-9; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Stenson AC, 2003, ANAL CHEM, V75, P1275, DOI 10.1021/ac026106p; Stubbins A, 2012, LIMNOL OCEANOGR-METH, V10, P347, DOI 10.4319/lom.2012.10.347; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Sun JM, 2006, ATMOS ENVIRON, V40, P795, DOI 10.1016/j.atmosenv.2005.05.052; Temkiv TS, 2012, FEMS MICROBIOL ECOL, V81, P684, DOI 10.1111/j.1574-6941.2012.01402.x; Tremblay LB, 2007, MAR CHEM, V105, P15, DOI 10.1016/j.marchem.2006.12.015; Vaitilingom M, 2010, APPL ENVIRON MICROB, V76, P23, DOI 10.1128/AEM.01127-09; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willey JD, 2000, GLOBAL BIOGEOCHEM CY, V14, P139, DOI 10.1029/1999GB900036; Wozniak AS, 2008, ATMOS CHEM PHYS, V8, P5099, DOI 10.5194/acp-8-5099-2008	38	136	139	18	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53550	10.1371/journal.pone.0053550	http://dx.doi.org/10.1371/journal.pone.0053550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372660	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500016
J	Strohmaier, S; Edlinger, M; Manjer, J; Stocks, T; Bjorge, T; Borena, W; Haggstrom, C; Engeland, A; Nagel, G; Almquist, M; Selmer, R; Tretli, S; Concin, H; Hallmans, G; Jonsson, H; Stattin, P; Ulmer, H				Strohmaier, Susanne; Edlinger, Michael; Manjer, Jonas; Stocks, Tanja; Bjorge, Tone; Borena, Wegene; Haggstrom, Christel; Engeland, Anders; Nagel, Gabriele; Almquist, Martin; Selmer, Randi; Tretli, Steinar; Concin, Hans; Hallmans, Goran; Jonsson, Hakan; Stattin, Par; Ulmer, Hanno			Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can)	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR RISK-FACTORS; CORONARY HEART-DISEASE; FOLLOW-UP; PLASMA-CHOLESTEROL; BREAST-CANCER; PANCREATIC-CANCER; PROSTATE-CANCER; REGRESSION DILUTION; BETA-LIPOPROTEIN	Objective: To investigate the association between total serum cholesterol (TSC) and cancer incidence in the Metabolic syndrome and Cancer project (Me-Can). Methods: Me-Can consists of seven cohorts from Norway, Austria, and Sweden including 289,273 male and 288,057 female participants prospectively followed up for cancer incidence (n = 38,978) with a mean follow-up of 11.7 years. Cox regression models with age as the underlying time metric were used to estimate hazard ratios (HR) and their 95% confidence intervals (CI) for quintiles of cholesterol levels and per 1 mmol/l, adjusting for age at first measurement, body mass index (BMI), and smoking status. Estimates were corrected for regression dilution bias. Furthermore, we performed lag time analyses, excluding different times of follow-up, in order to check for reverse causation. Results: In men, compared with the 1st quintile, TSC concentrations in the 5th quintile were borderline significantly associated with decreasing risk of total cancer (HR = 0.94; 95% CI: 0.88, 1.00). Significant inverse associations were observed for cancers of the liver/intrahepatic bile duct (HR = 0.14; 95% CI: 0.07, 0.29), pancreas cancer (HR = 0.52, 95% CI: 0.33, 0.81), non-melanoma of skin (HR = 0.67; 95% CI: 0.46, 0.95), and cancers of the lymph-/hematopoietic tissue (HR = 0.68, 95% CI: 0.54, 0.87). In women, hazard ratios for the 5th quintile were associated with decreasing risk of total cancer (HR = 0.86, 95% CI: 0.79, 0.93) and for cancers of the gallbladder (HR = 0.23, 95% CI: 0.08, 0.62), breast (HR = 0.70, 95% CI: 0.61, 0.81), melanoma of skin (HR = 0.61, 95% CI: 0.42, 0.88), and cancers of the lymph-/hematopoietic tissue (HR = 0.61, 95% CI: 0.44, 0.83). Conclusion: TSC was negatively associated with risk of cancer overall in females and risk of cancer at several sites in both males and females. In lag time analyses some associations persisted, suggesting that for these cancer sites reverse causation did not apply.	[Strohmaier, Susanne; Edlinger, Michael; Borena, Wegene; Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Manjer, Jonas] Lund Univ, Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [Stocks, Tanja; Haggstrom, Christel; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Stocks, Tanja] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Bjorge, Tone; Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Bjorge, Tone; Engeland, Anders; Selmer, Randi] Norwegian Inst Publ Hlth, Oslo, Norway; [Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Almquist, Martin] Skane Univ Hosp Lund, Dept Surg, Lund, Sweden; [Almquist, Martin] Lund Univ, Lund, Sweden; [Tretli, Steinar] Canc Registry Norway, Inst Population Based Canc Res, Oslo, Norway; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jonsson, Hakan] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	Medical University of Innsbruck; Lund University; Skane University Hospital; Umea University; University of Copenhagen; University of Bergen; Norwegian Institute of Public Health (NIPH); Ulm University; Lund University; Skane University Hospital; Lund University; University of Oslo; Umea University; Umea University; Memorial Sloan Kettering Cancer Center	Ulmer, H (corresponding author), Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria.	hanno.ulmer@i-med.ac.at	Nagel, Gabriele/C-3635-2012; Almquist, Martin/H-7209-2019; vhmpp, aks/F-9756-2012; Engeland, Anders/AAG-7437-2021; Ulmer, Hanno/S-6615-2019	Nagel, Gabriele/0000-0001-6185-8535; Almquist, Martin/0000-0002-0953-1188; Ulmer, Hanno/0000-0001-5911-1002; Bjorge, Tone/0000-0002-9096-5257; Edlinger, Michael/0000-0001-8801-3268	World Cancer Research Fond International [2007/09, 2010/247]; Medical University of Innsbruck (MUI START)	World Cancer Research Fond International; Medical University of Innsbruck (MUI START)	This work was supported by World Cancer Research Fond International (2007/09 and 2010/247 to P. S.); and Medical University of Innsbruck (MUI START). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; Andreotti G, 2008, INT J CANCER, V122, P2322, DOI 10.1002/ijc.23307; Batty GD, 2009, CANCER EPIDEM BIOMAR, V18, P673, DOI 10.1158/1055-9965.EPI-08-1032; Bjorge T, 2010, CANCER EPIDEM BIOMAR, V19, P1737, DOI 10.1158/1055-9965.EPI-10-0230; Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338; CAMBIEN F, 1980, AM J EPIDEMIOL, V112, P388, DOI 10.1093/oxfordjournals.aje.a113004; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clarke R, 2002, EUR HEART J, V23, P286, DOI 10.1053/euhj.2001.2781; de Gonzalez AB, 2008, CANCER EPIDEM BIOMAR, V17, P359, DOI 10.1158/1055-9965.EPI-07-0507; Dellavalle RP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003697.pub2; Fagherazzi G, 2010, EUR J CANCER PREV, V19, P120, DOI 10.1097/CEJ.0b013e3283354918; HIATT RA, 1986, J CHRON DIS, V39, P861, DOI 10.1016/0021-9681(86)90034-2; HIATT RA, 1982, J NATL CANCER I, V68, P885; ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; Jagtap D, 2012, CANCER-AM CANCER SOC, V118, P5124, DOI 10.1002/cncr.27497; Jiang Jing-ting, 2007, Journal of Zhejiang University-Science B, V8, P398, DOI 10.1631/jzus.2007.B0398; Johansen D, 2010, CANCER EPIDEM BIOMAR, V19, P2307, DOI 10.1158/1055-9965.EPI-10-0234; KAGAN A, 1981, AM J EPIDEMIOL, V114, P11, DOI 10.1093/oxfordjournals.aje.a113157; KARK JD, 1982, BRIT MED J, V284, P152, DOI 10.1136/bmj.284.6310.152; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; KREGER BE, 1992, CANCER-AM CANCER SOC, V70, P1038, DOI 10.1002/1097-0142(19920901)70:5<1038::AID-CNCR2820700505>3.0.CO;2-M; Kritz H, 1996, J CLIN ONCOL, V14, P3043, DOI 10.1200/JCO.1996.14.11.3043; LAW MR, 1991, CANCER CAUSE CONTROL, V2, P253, DOI 10.1007/BF00052142; Lim U, 2007, CANCER RES, V67, P5569, DOI 10.1158/0008-5472.CAN-07-0212; Mondul AM, 2011, CANCER CAUSE CONTROL, V22, P1545, DOI 10.1007/s10552-011-9831-7; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; MORRIS DL, 1983, CANCER-AM CANCER SOC, V52, P1754, DOI 10.1002/1097-0142(19831101)52:9<1754::AID-CNCR2820520933>3.0.CO;2-J; PEDERSEN TR, 1994, LANCET, V344, P1383; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; ROSE G, 1980, LANCET, V1, P523; SALONEN JT, 1982, AM J EPIDEMIOL, V116, P622, DOI 10.1093/oxfordjournals.aje.a113445; SCHATZKIN A, 1988, CANCER RES, V48, P452; SCHATZKIN A, 1987, LANCET, V2, P298; SHERWIN RW, 1987, JAMA-J AM MED ASSOC, V257, P943; STEMMERMANN GN, 1991, ARCH INTERN MED, V151, P969, DOI 10.1001/archinte.151.5.969; Stocks T, 2010, INT J EPIDEMIOL, V39, P660, DOI 10.1093/ije/dyp186; Strasak AM, 2009, ANN ONCOL, V20, P1113, DOI 10.1093/annonc/mdn736; TORNBERG SA, 1988, ACTA ONCOL, V27, P31; TORNBERG SA, 1986, NEW ENGL J MED, V315, P1629, DOI 10.1056/NEJM198612253152601; TORNBERG SA, 1989, JNCI-J NATL CANCER I, V81, P1917, DOI 10.1093/jnci/81.24.1917; Trompet S, 2009, AM J EPIDEMIOL, V170, P1415, DOI 10.1093/aje/kwp294; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; VITOLS S, 1985, LANCET, V2, P1150; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194; WILLIAMS RR, 1981, JAMA-J AM MED ASSOC, V245, P247, DOI 10.1001/jama.245.3.247; WINGARD DL, 1984, J CHRON DIS, V37, P401, DOI 10.1016/0021-9681(84)90107-3; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; YAARI S, 1981, LANCET, V1, P1011	48	88	90	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54242	10.1371/journal.pone.0054242	http://dx.doi.org/10.1371/journal.pone.0054242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372693	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500046
J	van Wilgenburg, E; Elgar, MA				van Wilgenburg, Ellen; Elgar, Mark A.			Confirmation Bias in Studies of Nestmate Recognition: A Cautionary Note for Research into the Behaviour of Animals	PLOS ONE			English	Article							ANT APHAENOGASTER-SENILIS; COLONY-MATE RECOGNITION; FUNGUS-GROWING ANT; IMPORTED FIRE ANTS; CUTICULAR HYDROCARBONS; INTRASPECIFIC AGGRESSION; POLYGYNOUS ANT; CHEMICAL RECOGNITION; SOCIAL-ISOLATION; OBSERVER BIAS	Confirmation bias is a tendency of people to interpret information in a way that confirms their expectations. A long recognized phenomenon in human psychology, confirmation bias can distort the results of a study and thus reduce its reliability. While confirmation bias can be avoided by conducting studies blind to treatment groups, this practice is not always used. Surprisingly, this is true of research in animal behaviour, and the extent to which confirmation bias influences research outcomes in this field is rarely investigated. Here we conducted a meta-analysis, using studies on nestmate recognition in ants, to compare the outcomes of studies that were conducted blind with those that were not. Nestmate recognition studies typically perform intra-and inter colony aggression assays, with the a priori expectation that there should be little or no aggression among nestmates. Aggressive interactions between ants can include subtle behaviours such as mandible flaring and recoil, which can be hard to quantify, making these types of assays prone to confirmation bias. Our survey revealed that only 29% of our sample of 79 studies were conducted blind. These studies were more likely to report aggression among nestmates if they were conducted blind (73%) than if they were not (21%). Moreover, we found that the effect size between nestmate and non-nestmate treatment means is significantly lower in experiments conducted blind than those in which colony identity is known (1.38 versus 2.76). We discuss the implications of the impact of confirmation bias for research that attempts to obtain quantitative synthesises of data from different studies.	[van Wilgenburg, Ellen; Elgar, Mark A.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Melbourne	van Wilgenburg, E (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	ellenvw@gmail.com		Elgar, Mark/0000-0003-0861-6064	Australian Research Council	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; [Anonymous], 1999, METAWIN STAT SOFTWAR; Astruc C, 2001, J CHEM ECOL, V27, P1229, DOI 10.1023/A:1010324230982; Balas MT, 1996, ANIM BEHAV, V51, P49, DOI 10.1006/anbe.1996.0004; BALPH DF, 1983, AUK, V100, P755, DOI 10.1093/auk/100.3.755; Bernard C., 1957, INTRO LIT CORRES TON; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; Bjorkman-Chiswell BT, 2008, INSECT SOC, V55, P207, DOI 10.1007/s00040-008-0990-9; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Bos N, 2010, ANIM BEHAV, V80, P839, DOI 10.1016/j.anbehav.2010.08.001; Boulay R, 2001, BEHAV PROCESS, V55, P67, DOI 10.1016/S0376-6357(01)00163-2; Boulay R, 2007, ANIM BEHAV, V74, P985, DOI 10.1016/j.anbehav.2007.02.013; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; BREED MD, 1991, BIOTROPICA, V23, P301, DOI 10.2307/2388208; Breed MD, 2003, J KANSAS ENTOMOL SOC, V76, P539; BREED MD, 1992, ANIM BEHAV, V44, P519, DOI 10.1016/0003-3472(92)90060-M; Caldera EJ, 2004, INSECT SOC, V51, P109, DOI 10.1007/s00040-003-0716-y; CORDARO L, 1963, PSYCHOL REP, V13, P787, DOI 10.2466/pr0.1963.13.3.787; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dahbi A, 1998, BEHAV ECOL SOCIOBIOL, V42, P349, DOI 10.1007/s002650050447; Debout G, 2003, OECOLOGIA, V137, P195, DOI 10.1007/s00442-003-1330-4; Dimarco RD, 2010, BEHAV ECOL, V21, P304, DOI 10.1093/beheco/arp190; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fadamiro HY, 2009, ECOL ENTOMOL, V34, P427, DOI 10.1111/j.1365-2311.2009.01102.x; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Foitzik S, 2007, ANIM BEHAV, V73, P999, DOI 10.1016/j.anbehav.2006.07.017; FOSTER GG, 1975, EXCEPT CHILDREN, V41, P469; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; Furst M, 2011, P ROY SOC B; GAMBOA GJ, 1991, ETHOLOGY, V88, P109; Garnas JR, 2007, ENVIRON ENTOMOL, V36, P105, DOI 10.1603/0046-225X(2007)36[105:IAWAAL]2.0.CO;2; Glass D.J., 2007, EXPT DESIGN BIOL; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; HENDERSON G, 1990, J CHEM ECOL, V16, P2217, DOI 10.1007/BF01026932; Hergovich A, 2010, CURR PSYCHOL, V29, P188, DOI 10.1007/s12144-010-9087-5; Hsu YY, 1999, ANIM BEHAV, V57, P903, DOI 10.1006/anbe.1998.1049; Hsu YY, 2001, ANIM BEHAV, V61, P777, DOI 10.1006/anbe.2000.1650; Ichinose K, 2005, J INSECT BEHAV, V18, P633, DOI 10.1007/s10905-005-7016-5; JAFFE K, 1984, Insectes Sociaux, V31, P302, DOI 10.1007/BF02223614; JAFFE K, 1983, INSECT SOC, V30, P466, DOI 10.1007/BF02223978; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Katzav-Gozansky T, 2004, NATURWISSENSCHAFTEN, V91, P186, DOI 10.1007/s00114-004-0513-0; Katzav-Gozansky T, 2008, J INSECT PHYSIOL, V54, P378, DOI 10.1016/j.jinsphys.2007.10.008; Katzerke A, 2006, BEHAV ECOL SOCIOBIOL, V61, P143, DOI 10.1007/s00265-006-0245-6; Krauth Joachim, 2000, EXPT DESIGN HDB DICT; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lenoir A, 2001, INSECT SOC, V48, P101, DOI 10.1007/PL00001751; Liu ZB, 1998, J ETHOL, V16, P57, DOI 10.1007/BF02769283; Lucas C, 2005, J INSECT PHYSIOL, V51, P1148, DOI 10.1016/j.jinsphys.2005.06.003; MacCoun RJ, 1998, ANNU REV PSYCHOL, V49, P259, DOI 10.1146/annurev.psych.49.1.259; Marsh DM, 2007, ETHOLOGY, V113, P1089, DOI 10.1111/j.1439-0310.2007.01406.x; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Menzel F, 2009, INSECT SOC, V56, P251, DOI 10.1007/s00040-009-0018-0; MINTZER A, 1982, BEHAV ECOL SOCIOBIOL, V10, P165, DOI 10.1007/BF00299680; Moore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P1011, DOI 10.1007/s00265-010-0916-1; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; MOREL L, 1988, BEHAV ECOL SOCIOBIOL, V22, P175, DOI 10.1007/BF00300567; Newey PS, 2008, ANIM BEHAV, V76, P1727, DOI 10.1016/j.anbehav.2008.07.025; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; NOWBAHARI E, 1990, BIOCHEM SYST ECOL, V18, P63, DOI 10.1016/0305-1978(90)90036-F; NOWBAHARI E, 1989, BEHAV PROCESS, V18, P173, DOI 10.1016/S0376-6357(89)80014-2; OBIN MS, 1986, J CHEM ECOL, V12, P1965, DOI 10.1007/BF01041858; OBIN MS, 1993, J INSECT BEHAV, V6, P579, DOI 10.1007/BF01048124; Pirk CWW, 2001, BEHAV ECOL SOCIOBIOL, V49, P366, DOI 10.1007/s002650000315; Popper K., 2002, LOGIC SCI DISCOVERY; Popper K.R., 2002, CONJECTURES REFUTATI; Raudenbush SW, 1994, HDB RES SYNTHESIS, P302; Richard FJ, 2004, CHEMOECOLOGY, V14, P9, DOI 10.1007/s00049-003-0251-3; Romesburg HC, 2009, BEST RES PRACTICES; Rosenthal, 1976, EXPT EFFECTS BEHAV R; ROSENTHAL R, 1963, BEHAV SCI, V8, P183; Rosenthal R, 1969, ARTIFACTS BEHAV RES; Rosset H, 2007, ANIM BEHAV, V74, P951, DOI 10.1016/j.anbehav.2006.11.028; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; SALVIA JA, 1980, J SPEC EDUC, V14, P261, DOI 10.1177/002246698001400213; Sani R., 2006, EXPT DESIGN STAT PSY; Satoh T, 2005, ENTOMOL SCI, V8, P277, DOI 10.1111/j.1479-8298.2005.00126.x; Schmidt AM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-20; Singer TL, 1998, ETHOLOGY, V104, P929, DOI 10.1111/j.1439-0310.1998.tb00042.x; Starks PT, 1998, ETHOLOGY, V104, P573, DOI 10.1111/j.1439-0310.1998.tb00092.x; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; STUART RJ, 1991, ANIM BEHAV, V42, P277, DOI 10.1016/S0003-3472(05)80559-7; STUART RJ, 1993, ANIM BEHAV, V46, P809, DOI 10.1006/anbe.1993.1259; STUART RJ, 1992, BEHAV ECOL SOCIOBIOL, V30, P403; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Sunamura E, 2009, BIOL INVASIONS, V11, P2329, DOI 10.1007/s10530-008-9419-7; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; Thurin N, 2008, ANIM BEHAV, V75, P1023, DOI 10.1016/j.anbehav.2007.08.013; Tillberg CV, 2007, FIELD LAB EXERCISES; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van Wilgenburg E, 2006, NATURWISSENSCHAFTEN, V93, P309, DOI 10.1007/s00114-006-0109-y; van Wilgenburg E, 2005, BEHAVIOUR, V142, P701, DOI 10.1163/1568539054729150; van Wilgenburg E, 2007, ETHOLOGY, V113, P1185, DOI 10.1111/j.1439-0310.2007.01431.x; van Wilgenburg E, 2007, NATURWISSENSCHAFTEN, V94, P787, DOI 10.1007/s00114-007-0255-x; Van Wilgenburg E, 2010, BIOL LETTERS, V6, P152, DOI 10.1098/rsbl.2009.0616; van Zweden JS, 2010, J EVOLUTION BIOL, V23, P1498, DOI 10.1111/j.1420-9101.2010.02020.x; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; Vasquez GM, 2008, ANIM BEHAV, V75, P583, DOI 10.1016/j.anbehav.2007.06.019; Vasquez GM, 2008, BEHAV ECOL SOCIOBIOL, V62, P537, DOI 10.1007/s00265-007-0478-z; Hernandez JV, 2010, SOCIOBIOLOGY, V56, P775; Zinck L, 2008, ENTOMOL EXP APPL, V126, P211, DOI 10.1111/j.1570-7458.2007.00654.x; Zuk Marlene, 2003, SEXUAL SELECTIONS WH	108	44	46	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53548	10.1371/journal.pone.0053548	http://dx.doi.org/10.1371/journal.pone.0053548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372659	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500015
J	Vandenhoudt, HM; Langat, L; Menten, J; Odongo, F; Oswago, S; Luttah, G; Zeh, C; Crucitti, T; Laserson, K; Vulule, J; Buve, A				Vandenhoudt, Hilde M.; Langat, Lilian; Menten, Joris; Odongo, Fredrick; Oswago, Simon; Luttah, Geoffrey; Zeh, Clement; Crucitti, Tania; Laserson, Kayla; Vulule, John; Buve, Anne			Prevalence of HIV and Other Sexually Transmitted Infections among Female Sex Workers in Kisumu, Western Kenya, 1997 and 2008	PLOS ONE			English	Article							COMMERCIAL SEX; UNSAFE SEX; REGULAR PARTNERS; RISK BEHAVIORS; CONDOM USE; TRANSMISSION; PROSTITUTES; AFRICA; VIRUS; EPIDEMIC	Background: In 1997, a survey in Kisumu found a prevalence of HIV infection among female sex workers (FSW) of 75%. Only 50% reported using a condom with the last client. In 2008, we conducted another survey to collect data to inform an intervention targeting FSW in Kisumu. Methods: In 2008 FSW were recruited by respondent-driven sampling. Women completed a questionnaire and were tested for HIV and other sexually transmitted infections (STIs). Multiple logistic regression analysis was done to explore factors associated with HIV-infection, and with condom use. Prevalence of HIV infection was compared in the two surveys from 1997 and 2008. Multivariate analysis was used to assess whether a change in HIV prevalence between the two surveys could be explained by changes in socio-demographic characteristics and/or behavioral factors. Results: 481 FSW participated in the 2008 study. HIV prevalence was 56.5% (95% CI 52.0-61.6). Factors independently associated with HIV were age older than 29 years; being a widow; STI treatment in the past year; herpes simplex virus Type-2 infection; bacterial vaginosis; and trichomoniasis. Condom use with last client was reported by 75.0% (95% CI 70.9-78.9). Predictors of condom use with the last client were age older than 29 years; higher price paid by last client; ever having been tested for HIV. Predictors of unprotected sex were being drunk during last sex act; usually having sex during menses; and STI treatment in the past year. The odds ratio of HIV infection associated with year of survey was 0.49 (95% CI 0.33-0.75) after adjusting for socio-demographic and behavioral factors. Conclusions: The prevalence of HIV among FSW in Kisumu was found to be lower in 2008 than in 1997, while reported condom use was higher. However, access to HIV/STI prevention and care services needs to improve to further decrease HIV transmission between FSW and their clients.	[Vandenhoudt, Hilde M.; Langat, Lilian; Menten, Joris; Crucitti, Tania; Buve, Anne] Inst Trop Med, B-2000 Antwerp, Belgium; [Odongo, Fredrick; Oswago, Simon; Vulule, John] Kenya Govt Med Res Ctr, Kisian, Kenya; [Luttah, Geoffrey] Family Hlth Opt, Kisumu, Kenya; [Zeh, Clement; Laserson, Kayla] Ctr Dis Control & Prevent, Kisian, Kenya	Institute of Tropical Medicine (ITM); Kenya Medical Research Institute	Buve, A (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	abuve@itg.be	Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; 	Presidential Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention [5U62PSO24444-05]	Presidential Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention	This work was funded by the Presidential Emergency Plan for AIDS Relief through a cooperative agreement with the Centers for Disease Control and Prevention (grant number 5U62PSO24444-05). PEPFAR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Centers for Disease Control and Prevention in Atlanta reviewed the protocol and the manuscript. The IRB of the Centers for Disease Control and Prevention gave approval for the study.	[Anonymous], 2009, SAMPLING DESIGN ANAL; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Colvin M, 2008, ANAL HIV RESPONSES M; DCOSTA LJ, 1985, SEX TRANSM DIS, V12, P64, DOI 10.1097/00007435-198504000-00002; Diallo BL, 2010, REV EPIDEMIOL SANTE, V58, P245, DOI 10.1016/j.respe.2010.03.003; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Kenya National AIDS Control Council, 2009, KEN AN HIV PREV RESP; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; Lau JTF, 2007, AIDS CARE, V19, P721, DOI 10.1080/09540120601084373; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Maleta K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-243; Ministry of Health Kenya, 2005, KEN NAT GUID RES DEV; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; PIOT P, 1987, J INFECT DIS, V155, P1108, DOI 10.1093/infdis/155.6.1108; PLUMMER FA, 1991, AIDS, V5, pS169; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; SIMONSEN JN, 1990, AIDS, V4, P139, DOI 10.1097/00002030-199002000-00007; StataCorp, 2007, STAT STAT SOFTW REL; Stoebenau K, 2009, AM J PUBLIC HEALTH, V99, P811, DOI 10.2105/AJPH.2007.118422; Uganda National AIDS Commission, 2009, UG HIV MOD TRANSM PR; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Volz E, 2007, RESPONDENT DRIVEN SA; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151	37	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54953	10.1371/journal.pone.0054953	http://dx.doi.org/10.1371/journal.pone.0054953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372801	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500149
J	Kim, BJ; Hong, SH; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Hong, Seok-Hyun; Kook, Yoon-Hoh; Kim, Bum-Joon			Molecular Evidence of Lateral Gene Transfer in rpoB Gene of Mycobacterium yongonense Strains via Multilocus Sequence Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; AVIUM COMPLEX; RESTRICTION ANALYSIS; DIFFERENTIATION; HSP65; DNA; IDENTIFICATION	Recently, a novel species, Mycobacterium yongonense (DSM 45126(T)), was introduced and while it is phylogenetically related to Mycobacterium intracellulare, it has a distinct RNA polymerase beta-subunit gene (rpoB) sequence that is identical to that of Mycobacterium parascrofulaceum, which is a distantly related scotochromogen, which suggests the acquisition of the rpoB gene via a potential lateral gene transfer (LGT) event. The aims of this study are to prove the presence of the LGT event in the rpoB gene of the M. yongonense strains via multilocus sequence analysis (MLSA). In order to determine the potential of an LGT event in the rpoB gene of the M. yongonense, the MLSA based on full rpoB sequences (3447 or 3450 bp) and on partial sequences of five other targets [16S rRNA (1383 or 1395 bp), hsp65 (603 bp), dnaJ (192 bp), recA (1053 bp), and sodA (501 bp)] were conducted. Incongruences between the phylogenetic analysis of the full rpoB and the five other genes in a total of three M. yongonense strains [two clinical strains (MOTT-12 and MOTT-27) and one type strain (DSM 45126(T))] were observed, suggesting that rpoB gene of three M. yongonense strains may have been acquired very recently via an LGT event from M. parascrofulaceum, which is a distantly related scotochromogen.	[Kim, Byoung-Jun; Hong, Seok-Hyun; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, SNUMRC, Dept Microbiol & Immunol, Canc Res Inst,Coll Med,Inst Endem Dis, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kim, BJ (corresponding author), Seoul Natl Univ, SNUMRC, Dept Microbiol & Immunol, Canc Res Inst,Coll Med,Inst Endem Dis, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/J-2739-2012; Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A101205]	Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by grant A101205 from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; FROTHINGHAM R, 1993, J BACTERIOL, V175, P2818, DOI 10.1128/JB.175.10.2818-2825.1993; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2004, J CLIN MICROBIOL, V42, P1308, DOI 10.1128/JCM.42.3.1308-1312.2004; Kim BJ, 2001, J CLIN MICROBIOL, V39, P2102, DOI 10.1128/JCM.39.6.2102-2109.2001; Kim BJ, 2012, INT J SYST EVOL MICR; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HJ, 2006, J CLIN MICROBIOL, V44, P3855, DOI 10.1128/JCM.01214-06; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Morita Y, 2004, J MED MICROBIOL, V53, P813, DOI 10.1099/jmm.0.45601-0; Mun HS, 2007, MICROBIOL IMMUNOL, V51, P105, DOI 10.1111/j.1348-0421.2007.tb03880.x; Park JH, 2010, J MED MICROBIOL, V59, P1037, DOI 10.1099/jmm.0.020727-0; ROGALL T, 1990, J GEN MICROBIOL, V136, P1915, DOI 10.1099/00221287-136-9-1915; Ryoo SW, 2008, J CLIN LAB ANAL, V22, P415, DOI 10.1002/jcla.20278; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmon KE, 2011, EMERG INFECT DIS, V17, P1692, DOI 10.3201/eid1709.101667; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Turenne CY, 2004, INT J SYST EVOL MICR, V54, P1543, DOI 10.1099/ijs.0.02940-0	25	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e51846	10.1371/journal.pone.0051846	http://dx.doi.org/10.1371/journal.pone.0051846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382812	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600005
J	Li, NF; Li, HJ; Zhang, DL; Zhang, JH; Yao, XG; Wang, HM; Abulikemu, S; Zhou, KM; Zhang, XY				Li, Nan-Fang; Li, Hong-Jian; Zhang, De-Lian; Zhang, Ju-Hong; Yao, Xiao-Guang; Wang, Hong-Mei; Abulikemu, Suofeiya; Zhou, Ke-Ming; Zhang, Xiang-Yang			Genetic Variations in the KCNJ5 Gene in Primary Aldosteronism Patients from Xinjiang, China	PLOS ONE			English	Article							K+-CHANNEL; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; MESSENGER-RNA; MUTATIONS; POLYMORPHISMS; HYPERALDOSTERONISM; HYPERTENSION; ASSOCIATION; EXPRESSION	Background: Primary aldosteronism (PA) is the most common endocrine form of secondary hypertension, and one of the most common subtypes of sporadic PA is aldosterone-producing adenoma (APA). Recently, two somatic mutations of the KCNJ5 gene were implicated in APA, and two germline mutations were associated with familial hyperaldosteronism III. Objectives: This case-control study was designed to investigate the relationship between genetic variations in the KCNJ5 gene and sporadic PA patients in Xinjiang, China. Methods: Five common single nucleotide polymorphisms (SNPs) of the KCNJ5 gene (rs6590357, rs4937391, rs3740835, rs2604204, and rs11221497) were detected in patients with sporadic PA (n=235) and essential hypertension (EH; n=913) by the TaqMan polymerase chain reaction method. Results: The EH group and the PA group showed significant differences in the distributions of genotypes and alleles of rs4937391 and rs2604204 in total and male subjects (P<0.05), as well as rs3740835 in male subjects (P<0.05). However, only the association between the rs2604204 genotype and male sporadic PA remained significant after Bonferroni's correction (P<0.01). Furthermore, logistic regression analysis demonstrated that the CC genotype of rs2604204 was a risk factor for male patients with sporadic PA, after adjusting for age and body mass index (odds ratio=2.228, 95% CI: 1.300-3.819, P=0.004). Conclusion: The genetic variant rs2604204 of KCNJ5 is associated with sporadic PA in Chinese males, suggesting that KCNJ5 may be involved in the pathogenesis of sporadic PA in these particular patients	[Li, Nan-Fang; Zhang, De-Lian; Zhang, Ju-Hong; Yao, Xiao-Guang; Wang, Hong-Mei; Abulikemu, Suofeiya; Zhou, Ke-Ming] Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Ctr Diag Treatment & Res Hypertens Xinjiang, Urumqi, Peoples R China; [Li, Hong-Jian; Zhang, Xiang-Yang] Xinjiang Med Univ, Urumqi, Peoples R China	Xinjiang Medical University	Li, NF (corresponding author), Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Ctr Diag Treatment & Res Hypertens Xinjiang, Urumqi, Peoples R China.	lnanfang@yahoo.com.cn			National Natural Science Foundation of China [81160109, 81260129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81160109 and No. 81260129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Azizan EAB, 2012, HYPERTENSION, V59, P587, DOI 10.1161/HYPERTENSIONAHA.111.186239; Born-Frontsberg E, 2009, J CLIN ENDOCR METAB, V94, P1125, DOI 10.1210/jc.2008-2116; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Catena C, 2008, ARCH INTERN MED, V168, P80, DOI 10.1001/archinternmed.2007.33; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Gomez-Benito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025449; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jabbari J, 2011, CARDIOLOGY, V118, P116, DOI 10.1159/000323840; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li NF, 2012, ANN CLIN BIOCHEM, V49, P369, DOI 10.1258/acb.2011.011129; Li NF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-124; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Murthy M, 2012, J HYPERTENS, V30, P1827, DOI 10.1097/HJH.0b013e328356139f; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; Sechi LA, 2006, JAMA-J AM MED ASSOC, V295, P2638, DOI 10.1001/jama.295.22.2638; Shimodaira M, 2010, EUR J ENDOCRINOL, V163, P671, DOI 10.1530/EJE-10-0428; Stowasser M, 2005, J CLIN ENDOCR METAB, V90, P5070, DOI 10.1210/jc.2005-0681; Taguchi R, 2012, J CLIN ENDOCR METAB, V97, P1311, DOI 10.1210/jc.2011-2885; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; Zhang C, 2009, HEART LUNG CIRC, V18, P257, DOI 10.1016/j.hlc.2008.12.002	31	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54051	10.1371/journal.pone.0054051	http://dx.doi.org/10.1371/journal.pone.0054051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382865	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600022
J	Yajima, I; Colombo, S; Puig, I; Champeval, D; Kumasaka, M; Belloir, E; Bonaventure, J; Mark, M; Yamamoto, H; Taketo, MM; Choquet, P; Etchevers, HC; Beermann, F; Delmas, V; Monassier, L; Larue, L				Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Mark, Manuel; Yamamoto, Hiroaki; Taketo, Mark M.; Choquet, Philippe; Etchevers, Heather C.; Beermann, Friedrich; Delmas, Veronique; Monassier, Laurent; Larue, Lionel			A Subpopulation of Smooth Muscle Cells, Derived from Melanocyte-Competent Precursors, Prevents Patent Ductus Arteriosus	PLOS ONE			English	Article							CARDIAC NEURAL CREST; BETA-CATENIN GENE; MOUSE HEART; MICE; EXPRESSION; RECEPTOR; SYSTEM; CYCLOOXYGENASE-2; MUTATIONS; MYOSIN	Background: Patent ductus arteriosus is a life-threatening condition frequent in premature newborns but also present in some term infants. Current mouse models of this malformation generally lead to perinatal death, not reproducing the full phenotypic spectrum in humans, in whom genetic inheritance appears complex. The ductus arteriosus (DA), a temporary fetal vessel that bypasses the lungs by shunting the aortic arch to the pulmonary artery, is constituted by smooth muscle cells of distinct origins (SMC1 and SMC2) and many fewer melanocytes. To understand novel mechanisms preventing DA closure at birth, we evaluated the importance of cell fate specification in SMC that form the DA during embryonic development. Upon specific Tyr::Cre-driven activation of Wnt/beta-catenin signaling at the time of cell fate specification, melanocytes replaced the SMC2 population of the DA, suggesting that SMC2 and melanocytes have a common precursor. The number of SMC1 in the DA remained similar to that in controls, but insufficient to allow full DA closure at birth. Thus, there was no cellular compensation by SMC1 for the loss of SMC2. Mice in which only melanocytes were genetically ablated after specification from their potential common precursor with SMC2, demonstrated that differentiated melanocytes themselves do not affect DA closure. Loss of the SMC2 population, independent of the presence of melanocytes, is therefore a cause of patent ductus arteriosus and premature death in the first months of life. Our results indicate that patent ductus arteriosus can result from the insufficient differentiation, proliferation, or contractility of a specific smooth muscle subpopulation that shares a common neural crest precursor with cardiovascular melanocytes.	[Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] Inst Curie, F-91405 Orsay, France; [Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] CNRS, UMR 3347, F-91405 Orsay, France; [Yajima, Ichiro; Colombo, Sophie; Puig, Isabel; Champeval, Delphine; Kumasaka, Mayuko; Belloir, Elodie; Bonaventure, Jacky; Delmas, Veronique; Larue, Lionel] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Mark, Manuel] IGBMC, Illkirch Graffenstaden, France; [Yamamoto, Hiroaki] Nagahama Univ, Inst Biosci & Technol, Nagahama, Japan; [Taketo, Mark M.] Kyoto Univ, Dept Pharmacol, Kyoto, Japan; [Choquet, Philippe] Univ Strasbourg, CNRS, Inst Mecan Fluides & Solides, Strasbourg, France; [Etchevers, Heather C.] INSERM, UMR S910, F-13258 Marseille, France; [Etchevers, Heather C.] Aix Marseille Univ, Fac Med, Marseille, France; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Monassier, Laurent] Fac Med, EA4438, Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Larue, L (corresponding author), Inst Curie, F-91405 Orsay, France.	lionel.larue@curie.fr	YAJIMA, Ichiro/I-7467-2014; Etchevers, Heather C./B-5813-2012; Colombo, Sophie/AAD-1030-2019; CHOQUET, Philippe/H-5868-2019; Larue, Lionel/I-6532-2016; Larue, Lionel/F-7355-2013	Etchevers, Heather C./0000-0003-0201-3799; Colombo, Sophie/0000-0001-8945-5631; CHOQUET, Philippe/0000-0003-0514-0726; Puig Borreil, Isabel/0000-0001-5614-4298; Delmas, veronique/0000-0001-7368-3664	Region Ile-de-France; Fondation pour la Recherche Medicale; Ligue contre le Cancer (Comite de l'Oise); Nevus Outreach, Inc.; Naevus France-Europe; Ligue Nationale Contre le Cancer (Equipe labellisee) [EL2012.LNCC/LL]; INCa [2011-1-PL BIO-03-IC-1]; Canceropole IdF	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue contre le Cancer (Comite de l'Oise); Nevus Outreach, Inc.; Naevus France-Europe; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole IdF(Region Ile-de-France)	We warmly thank Prof. Constantinesco for his help, and Drs. Stephane Zaffran and Gaelle Odelin for their constructive criticism. IY, SC and MK were supported by Region Ile-de-France, the Fondation pour la Recherche Medicale and the Ligue contre le Cancer (Comite de l'Oise), respectively. HCE was supported by Nevus Outreach, Inc. and Naevus 2000 France-Europe. We thank members of the animal colony and imaging facilities of the Institut Curie. We dedicate this manuscript to the memory of Christine Larue.; This work was supported grants from the Ligue Nationale Contre le Cancer (Equipe labellisee) # EL2012.LNCC/LL (http://www.ligue-cancer.net/), INCa #2011-1-PL BIO-03-IC-1 (http://www.e-cancer.fr/), and Canceropole IdF (http://www.canceropole-idf.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2003, CANCER RES, V63, P728; Balani K, 2009, J R SOC INTERFACE, V6, P1097, DOI 10.1098/rsif.2009.0174; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1998, CIRC RES, V82, P221; Brault V, 2001, DEVELOPMENT, V128, P1253; Brito FC, 2008, PIGM CELL MELANOMA R, V21, P464, DOI 10.1111/j.1755-148X.2008.00459.x; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Choquet P, 2007, CR BIOL, V330, P821, DOI 10.1016/j.crvi.2007.08.002; COCEANI F, 1973, CAN J PHYSIOL PHARM, V51, P220, DOI 10.1139/y73-031; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Colombo S, 2007, PIGM CELL RES, V20, P305, DOI 10.1111/j.1600-0749.2007.00387.x; COTTON RB, 1978, J PEDIATR-US, V92, P467, DOI 10.1016/S0022-3476(78)80451-X; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Echtler K, 2010, NAT MED, V16, P75, DOI 10.1038/nm.2060; GERSONY WM, 1983, J PEDIATR-US, V102, P895, DOI 10.1016/S0022-3476(83)80022-5; Guyonneau L, 2002, PIGM CELL RES, V15, P305, DOI 10.1034/j.1600-0749.2002.02039.x; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HEYMANN MA, 1975, PHYSIOL REV, V55, P62, DOI 10.1152/physrev.1975.55.1.62; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Jaffre F, 2004, CIRCULATION, V110, P969, DOI 10.1161/01.CIR.0000139856.20505.57; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lei TC, 2002, PIGM CELL RES, V15, P426, DOI 10.1034/j.1600-0749.2002.02044.x; Levin MD, 2009, J CLIN INVEST, V119, P3420, DOI 10.1172/JCI39109; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MARMON LM, 1984, ANN THORAC SURG, V38, P146, DOI 10.1016/S0003-4975(10)62223-0; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Miano JM, 2006, ZEBRAFISH, V3, P455, DOI 10.1089/zeb.2006.3.455; Mjaatvedt CH, 2005, ANAT REC PART A, V285A, P748, DOI 10.1002/ar.a.20210; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; PORTER SD, 1994, DEVELOPMENT, V120, P2103; Puig I, 2009, J CLIN INVEST, V119, P3586, DOI 10.1172/JCI39929; Puig I, 2009, PIGM CELL MELANOMA R, V22, P331, DOI 10.1111/j.1755-148X.2009.00546.x; Quasnichka H, 2006, CIRC RES, V99, P1329, DOI 10.1161/01.RES.0000253533.65446.33; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schneider DJ, 2006, CIRCULATION, V114, P1873, DOI 10.1161/CIRCULATIONAHA.105.592063; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tshori S, 2006, J CLIN INVEST, V116, P2673, DOI 10.1172/JCI27643; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	57	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53183	10.1371/journal.pone.0053183	http://dx.doi.org/10.1371/journal.pone.0053183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382837	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600011
J	Banky, D; Ivan, G; Grolmusz, V				Banky, Daniel; Ivan, Gabor; Grolmusz, Vince			Equal Opportunity for Low-Degree Network Nodes: A PageRank-Based Method for Protein Target Identification in Metabolic Graphs	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MYCOBACTERIUM-TUBERCULOSIS; INHIBITORS; SYNTHASE; BIOSYNTHESIS; DATABASE; SUSCEPTIBILITY; PATHWAY; MODELS; GROWTH	Biological network data, such as metabolic-, signaling- or physical interaction graphs of proteins are increasingly available in public repositories for important species. Tools for the quantitative analysis of these networks are being developed today. Protein network-based drug target identification methods usually return protein hubs with large degrees in the networks as potentially important targets. Some known, important protein targets, however, are not hubs at all, and perturbing protein hubs in these networks may have several unwanted physiological effects, due to their interaction with numerous partners. Here, we show a novel method applicable in networks with directed edges (such as metabolic networks) that compensates for the low degree (non-hub) vertices in the network, and identifies important nodes, regardless of their hub properties. Our method computes the PageRank for the nodes of the network, and divides the PageRank by the in-degree (i.e., the number of incoming edges) of the node. This quotient is the same in all nodes in an undirected graph (even for large- and low-degree nodes, that is, for hubs and non-hubs as well), but may differ significantly from node to node in directed graphs. We suggest to assign importance to non-hub nodes with large PageRank/in-degree quotient. Consequently, our method gives high scores to nodes with large PageRank, relative to their degrees: therefore non-hub important nodes can easily be identified in large networks. We demonstrate that these relatively high PageRank scores have biological relevance: the method correctly finds numerous already validated drug targets in distinct organisms (Mycobacterium tuberculosis, Plasmodium falciparum and MRSA Staphylococcus aureus), and consequently, it may suggest new possible protein targets as well. Additionally, our scoring method was not chosen arbitrarily: its value for all nodes of all undirected graphs is constant; therefore its high value captures importance in the directed edge structure of the graph.	[Banky, Daniel; Ivan, Gabor; Grolmusz, Vince] Eotvos Lorand Univ, Prot Informat Technol Grp, Budapest, Hungary; [Banky, Daniel; Ivan, Gabor; Grolmusz, Vince] Uratim Ltd, Budapest, Hungary	Eotvos Lorand University	Grolmusz, V (corresponding author), Eotvos Lorand Univ, Prot Informat Technol Grp, Pazmany Peter Stny 1-C, Budapest, Hungary.	grolmusz@cs.elte.hu		Grolmusz, Vince/0000-0001-9456-8876	NKTH TB-INTER; OTKA [CNK 77780]; TAMOP [4.2.1./B-09/KMR-2010-0003]	NKTH TB-INTER(National Office for Research and Technology); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP	This work was supported by NKTH TB-INTER (www.nih.gov.hu), OTKA CNK 77780 (www.otka.hu), and the TAMOP 4.2.1./B-09/KMR-2010-0003 (http://kp.elte.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Agren D, 2009, FEBS LETT, V583, P330, DOI 10.1016/j.febslet.2008.12.019; Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Aparicio IM, 2010, MOL BIOCHEM PARASIT, V172, P152, DOI 10.1016/j.molbiopara.2010.04.002; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Bange FC, 1996, INFECT IMMUN, V64, P1794, DOI 10.1128/IAI.64.5.1794-1799.1996; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brown AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006306; Choi KH, 2000, J BIOL CHEM, V275, P28201; Choubey V, 2007, ANTIMICROB AGENTS CH, V51, P696, DOI 10.1128/AAC.00919-06; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; De Las Rivas J, 2004, COMP FUNCT GENOM, V5, P173, DOI 10.1002/cfg.377; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Fortunato S, 2008, LECT NOTES COMPUT SC, V4936, P59, DOI 10.1007/978-3-540-78808-9_6; Gonzalez-Bulnes P, 2011, J BIOL CHEM, V286, P28940, DOI 10.1074/jbc.M111.268946; Grandoni JA, 1998, J ANTIMICROB CHEMOTH, V42, P475, DOI 10.1093/jac/42.4.475; Grolmusz V, 2012, ABS12051960 ARXIV CO; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; Holme P, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034801; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Hwang WC, 2008, CLIN PHARMACOL THER, V84, P563, DOI 10.1038/clpt.2008.129; Ideker T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100145; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lei T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046836; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Manhani KK, 2005, J MOL MODEL, V12, P42, DOI 10.1007/s00894-005-0002-1; McMillan PJ, 2005, MOL MICROBIOL, V55, P27, DOI 10.1111/j.1365-2958.2004.04398.x; McNamara PJ, 2000, INT J ANTIMICROB AG, V14, P117, DOI 10.1016/S0924-8579(99)00170-3; Muller IB, 2010, TRENDS PARASITOL, V26, P35, DOI 10.1016/j.pt.2009.10.006; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007656; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004406; OLAFSSON P, 1992, MOL BIOCHEM PARASIT, V56, P89, DOI 10.1016/0166-6851(92)90157-F; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Perra N, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036107; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Russell RB, 2008, NAT CHEM BIOL, V4, P666, DOI 10.1038/nchembio.119; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh V, 2011, MICROBIOL-SGM, V157, P38, DOI 10.1099/mic.0.042358-0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tonge PJ, 2007, CURR TOP MED CHEM, V7, P489, DOI 10.2174/156802607780059781; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2008, MOL MICROBIOL, V69, P1316, DOI 10.1111/j.1365-2958.2008.06365.x; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	53	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54204	10.1371/journal.pone.0054204	http://dx.doi.org/10.1371/journal.pone.0054204			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382878	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200051
J	Kang, M; Zhong, HJ; He, JF; Rutherford, S; Yang, F				Kang, Min; Zhong, Haojie; He, Jianfeng; Rutherford, Shannon; Yang, Fen			Using Google Trends for Influenza Surveillance in South China	PLOS ONE			English	Article								Background: Google Flu Trends was developed to estimate influenza activity in many countries; however there is currently no Google Flu Trends or other Internet search data used for influenza surveillance in China. Methods and Findings: Influenza surveillance data from 2008 through 2011 were obtained from provincial CDC influenza-like illness and virological surveillance systems of Guangdong, a province in south China. Internet search data were downloaded from the website of Google Trends. Pearson's correlation coefficients with 95% confidence intervals (95% CI) were calculated to compare surveillance data and internet search trends. The correlation between CDC ILI surveillance and CDC virus surveillance was 0.56 (95% CI: 0.43, 0.66). The strongest correlation was between the Google Trends term of Fever and ILI surveillance with a correlation coefficient of 0.73 (95% CI: 0.66, 0.79). When compared with influenza virological surveillance, the Google Trends term of Influenza A had the strongest correlation with a correlation coefficient of 0.64 (95% CI: 0.43, 0.79) in the 2009 H1N1 influenza pandemic period. Conclusions: This study shows that Google Trends in Chinese can be used as a complementary source of data for influenza surveillance in south China. More research in the future should develop new models using search trends in Chinese language to estimate local disease activity and detect early signals of outbreaks.	[Kang, Min; Zhong, Haojie; He, Jianfeng; Yang, Fen] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Griffith University	Kang, M (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	kangmin@yeah.net			key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province [A2010067]	key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province	This study was supported by the key medical specialty program-Field Epidemiology and Medical Scientific Research Foundation of Guangdong Province Grant A2010067 (Research on patterns of transmission and intensity of epidemic of Pandemic Influenza H1N1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; [China internet Network information Center Center CiNi], 2011, CHINESE SEARCH ENGIN, P5; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Eurosurveillance editorial team, 2009, EURO SURVEILL, V14; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google org, 2011, GOOGLE FLU TRENDS; Google Trends Labs, 2009, ABOUT GOOGLE TRENDS; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Kelly H, 2009, EUROSURVEILLANCE, V14, P6; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Valdivia A, 2010, EUROSURVEILLANCE, V15, P2; Valdivia A, 2010, EMERG INFECT DIS, V16, P168, DOI 10.3201/eid1601.091308; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Orgnization, 2003, INFLUENZA FACT SHEET; Yang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038768; Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023034	21	84	90	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55205	10.1371/journal.pone.0055205	http://dx.doi.org/10.1371/journal.pone.0055205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372837	gold, Green Published			2022-12-27	WOS:000315210400077
J	Opiyo, N; Shepperd, S; Musila, N; Allen, E; Nyamai, R; Fretheim, A; English, M				Opiyo, Newton; Shepperd, Sasha; Musila, Nyokabi; Allen, Elizabeth; Nyamai, Rachel; Fretheim, Atle; English, Mike			Comparison of Alternative Evidence Summary and Presentation Formats in Clinical Guideline Development: A Mixed-Method Study	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; HEALTH; MAKERS; GRADE	Background: Best formats for summarising and presenting evidence for use in clinical guideline development remain less well defined. We aimed to assess the effectiveness of different evidence summary formats to address this gap. Methods: Healthcare professionals attending a one-week Kenyan, national guideline development workshop were randomly allocated to receive evidence packaged in three different formats: systematic reviews (SRs) alone, systematic reviews with summary-of-findings tables, and 'graded-entry' formats (a 'front-end' summary and a contextually framed narrative report plus the SR). The influence of format on the proportion of correct responses to key clinical questions, the primary outcome, was assessed using a written test. The secondary outcome was a composite endpoint, measured on a 5-point scale, of the clarity of presentation and ease of locating the quality of evidence for critical neonatal outcomes. Interviews conducted within two months following completion of trial data collection explored panel members' views on the evidence summary formats and experiences with appraisal and use of research information. Results: 65 (93%) of 70 participants completed questions on the prespecified outcome measures. There were no differences between groups in the odds of correct responses to key clinical questions. 'Graded-entry' formats were associated with a higher mean composite score for clarity and accessibility of information about the quality of evidence for critical neonatal outcomes compared to systematic reviews alone (adjusted mean difference 0.52, 95% CI 0.06 to 0.99). There was no difference in the mean composite score between SR with SoF tables and SR alone. Findings from interviews with 16 panelists indicated that short narrative evidence reports were preferred for the improved clarity of information presentation and ease of use. Conclusions: Our findings suggest that 'graded-entry' evidence summary formats may improve clarity and accessibility of research evidence in clinical guideline development.	[Opiyo, Newton; Musila, Nyokabi; English, Mike] KEMRI Wellcome Trust Res Programme, Hlth Serv, Res Grp, Nairobi, Kenya; [Opiyo, Newton; Fretheim, Atle] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Shepperd, Sasha] Univ Oxford, Dept Publ Hlth, Oxford, England; [Allen, Elizabeth] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [Nyamai, Rachel] Minist Med Serv, Div Paediat, Nairobi, Kenya; [Fretheim, Atle] Norwegian Knowledge Ctr Hlth Serv, Global Hlth Unit, Oslo, Norway; [English, Mike] Univ Oxford, Dept Paediat, Oxford, England	University of Oslo; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Norwegian Knowledge Centre for Health Services; University of Oxford	Opiyo, N (corresponding author), KEMRI Wellcome Trust Res Programme, Hlth Serv, Res Grp, Nairobi, Kenya.	nopiyo@nairobi.kemri-wellcome.org		Shepperd, Sasha/0000-0001-6384-8322; English, Michael/0000-0002-7427-0826; Fretheim, Atle/0000-0002-6268-7966	Wellcome Trust [084538, 076827]; National Institute for Health Research [RSES/PDA/C2/017, 10/4001/03] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NO and NM were supported by funds from a Wellcome Trust Strategic Award (#084538). ME is supported by a Wellcome Trust Senior Fellowship (#076827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors carried out this research independently of the funding body.	[Anonymous], COMM NOT READ FRIEND; Chambers D, 2011, MILBANK Q, V89, P131, DOI 10.1111/j.1468-0009.2011.00622.x; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Garcia CAC, 2011, ARCH DIS CHILD, V96, P723, DOI 10.1136/adc.2010.199307; Dobbins M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-20; Duke T, 2006, B WORLD HEALTH ORGAN, V84, P922, DOI 10.2471/BLT.06.037515; Edmond K, 2006, OPTIMAL FEEDING LOW; English M, 2011, J CLIN EPIDEMIOL, V64, P708, DOI 10.1016/j.jclinepi.2010.07.016; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2010, INT J TECHNOL ASSESS, V26, P405, DOI 10.1017/S026646231000108X; Morville P, 2004, USER EXPERIENCE DESI; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; National Institute for Health and Care Excellence, 2009, GUID MAN; Opiyo N, 2012, J CLIN EPIDEMIOL, V65, P962, DOI 10.1016/j.jclinepi.2012.03.004; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rosenbaum SE, 2010, J CLIN EPIDEMIOL, V63, P620, DOI 10.1016/j.jclinepi.2009.12.014; Rosenbaum SE, 2011, B WORLD HEALTH ORGAN, V89, P54, DOI 10.2471/BLT.10.075481; Rosenbaum SE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-34; Tugwell P, 2006, B WORLD HEALTH ORGAN, V84, P643, DOI 10.2471/BLT.05.026658; World Health Organisation (WHO), 2008, WHO HDB GUID DEV; World Health Organization, 2009, WHO GUID HAND HYG HL	24	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55067	10.1371/journal.pone.0055067	http://dx.doi.org/10.1371/journal.pone.0055067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372813	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000315210400056
J	Renga, B; Mencarelli, A; Cipriani, S; D'Amore, C; Carino, A; Bruno, A; Francisci, D; Zampella, A; Distrutti, E; Fiorucci, S				Renga, Barbara; Mencarelli, Andrea; Cipriani, Sabrina; D'Amore, Claudio; Carino, Adriana; Bruno, Angela; Francisci, Daniela; Zampella, Angela; Distrutti, Eleonora; Fiorucci, Stefano			The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation	PLOS ONE			English	Article							FARNESOID-X RECEPTOR; TOLL-LIKE RECEPTORS; NUCLEAR HORMONE-RECEPTORS; INNATE IMMUNITY; PPAR-GAMMA; COLITIS; IRF-7; LIVER; MACROPHAGES; METABOLISM	Background: Toll like receptors (TLRs) sense the intestinal microbiota and regulate the innate immune response. A dysregulation of TLRs function participates into intestinal inflammation. Farnesoid X Receptor (FXR) is a nuclear receptor and bile acid sensor highly expressed in entero-hepatic tissues. FXR regulates lipid metabolism and innate immunity. Methodology/Principal Findings: In this study we have investigated whether FXR gene expression/function in the intestine is modulated by TLRs. We found that in human monocytes activation of membrane TLRs (i.e. TLR2, 4, 5 and 6) downregulates, while activation of intracellular TLRs (i.e. TLR3, 7, 8 and 9) upregulates the expression of FXR and its target gene SHP, small heterodimer partner. This effect was TLR9-dependent and TNF alpha independent. Intestinal inflammation induced in mice by TNBS downregulates the intestinal expression of FXR in a TLR9-dependent manner. Protection against TNBS colitis by CpG, a TLR-9 ligand, was lost in FXR-/- mice. In contrast, activation of FXR rescued TLR9(-/-) and MyD88(-/-) mice from colitis. A putative IRF7 response element was detected in the FXR promoter and its functional characterization revealed that IRF7 is recruited on the FXR promoter under TLR9 stimulation. Conclusions/Significance: Intestinal expression of FXR is selectively modulated by TLR9. In addition to its role in regulating type-I interferons and innate antiviral immunity, IRF-7 a TLR9-dependent factor, regulates the expression of FXR, linking microbiota-sensing receptors to host's immune and metabolic signaling.	[Renga, Barbara; Mencarelli, Andrea; D'Amore, Claudio; Carino, Adriana; Bruno, Angela; Fiorucci, Stefano] Univ Perugia, Dipartimento Med & Clin Sperimentale, I-06100 Perugia, Italy; [Cipriani, Sabrina; Francisci, Daniela] Univ Perugia, Dipartimento Med Clin & Sci Biochim, I-06100 Perugia, Italy; [Zampella, Angela] Univ Naples Federico II, Dipartimento Chim Sostanze Nat, Naples, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Osped Santa Maria della Misericordia, Perugia, Italy	University of Perugia; University of Perugia; University of Naples Federico II; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Dipartimento Med & Clin Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it		Carino, Adriana/0000-0003-2341-9528; Zampella, Angela/0000-0002-6170-279X; D'Amore, Claudio/0000-0001-9217-9404				Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guarner F, 2006, J NUTR, V136, P2269, DOI 10.1093/jn/136.8.2269; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim MS, 2003, J BIOL CHEM, V278, P8988, DOI 10.1074/jbc.M212633200; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Renga B, 2012, FASEB J, V26, P3021, DOI 10.1096/fj.11-195701; Renga B, 2011, BBA-GENE REGUL MECH, V1809, P157, DOI 10.1016/j.bbagrm.2011.01.008; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; SANTUCCI L, 1995, GASTROENTEROLOGY, V108, P393, DOI 10.1016/0016-5085(95)90065-9; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sepe V, 2012, J MED CHEM, V55, P84, DOI 10.1021/jm201004p; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Szanto A, 2008, FEBS LETT, V582, P106, DOI 10.1016/j.febslet.2007.11.020; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wildenberg ME, 2011, GUT, V60, P432, DOI 10.1136/gut.2010.233304; Wu GD, 2007, GASTROENTEROLOGY, V133, P1068, DOI 10.1053/j.gastro.2007.08.052; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	35	64	69	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54472	10.1371/journal.pone.0054472	http://dx.doi.org/10.1371/journal.pone.0054472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372731	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400017
J	Gao, XR; Huang, ML; Liu, LM; He, Y; Yu, Q; Zhao, H; Zhou, CX; Zhang, JK; Zhu, ZS; Wan, J; Jiang, XH; Gao, YZ				Gao, Xueren; Huang, Moli; Liu, Limin; He, Yan; Yu, Qiang; Zhao, Hua; Zhou, Chunxiao; Zhang, Jinkun; Zhu, Zhansheng; Wan, Jiao; Jiang, Xinghong; Gao, Yuzhen			Insertion/Deletion Polymorphisms in the Promoter Region of BRM Contribute to Risk of Hepatocellular Carcinoma in Chinese Populations	PLOS ONE			English	Article							CHROMATIN-REMODELING FACTORS; CANCER CELL-LINES; LUNG-CANCER; LINKAGE DISEQUILIBRIUM; SWI/SNF COMPLEX; BREAST-CANCER; HEPATITIS-B; EXPRESSION; CARCINOGENESIS; GENOME	Background: BRM (Brahma homologue) is well known for its critical role in tumor suppression and cancer development. Genetic variations in the promoter region of BRM have been suggested to be associated with loss of BRM expression and lung cancer risk. To the authors' knowledge, no study on the role of BRM genetic polymorphisms in hepatocellular carcinoma (HCC) risk has been performed. Methodology/Principal Findings: In two independent case-control studies containing 796 HCC cases and 806 cancer-free individuals, we genotyped two putative functional insertion/deletion (indel) polymorphisms [BRM-1321 (rs3832613) and BRM-741 (rs34480940)] within promoter region of BRM in Chinese populations using a PCR-based method. Real-time RT-PCR analysis was used to explore the genotype-phenotype correlation between these polymorphisms and BRM expression in both tissue samples and HCC cell lines. Logistic regression analysis showed that compared to BRM-1321del/del genotype, the ins/del and ins/ins variant genotypes had an increased HCC risk [adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.19-1.82; adjusted OR = 2.55, 95% CI = 1.75-3.72, respectively]. No significant association between BRM-741 and HCC incidence was observed. However, stratification analysis revealed a significant association between ins/ins genotype of BRM-741 and increased HCC susceptibility in smokers (adjusted OR = 2.07, 95% CI = 1.33-3.22). Quantitative PCR analyses demonstrated that the genotypes of BRM-1321 and the corresponding haplotypes were significantly correlated with BRM expression in vivo. Compared with ins/ins genotype, subjects carrying ins/del and del/del genotype had 2.30 and 4.99 fold higher BRM expression in HCC tissue samples, respectively. Similar trends were observed in western blot analysis at protein level. Conclusions/Significance: Our findings suggest that BRM promoter polymorphism (BRM-1321) could regulate BRM expression and may serve as a potential marker for genetic susceptibility to HCC.	[Gao, Xueren; He, Yan; Zhu, Zhansheng; Wan, Jiao; Gao, Yuzhen] Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China; [Huang, Moli] Soochow Univ, Coll Med, Dept Bioinformat, Suzhou, Jiangsu, Peoples R China; [Liu, Limin] Soochow Univ, Coll Med, Dept Pathophysiol, Suzhou, Jiangsu, Peoples R China; [Yu, Qiang; Zhou, Chunxiao; Zhang, Jinkun] Nanjing Med Univ, Affiliated Hosp, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Zhao, Hua] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Jiangsu, Peoples R China; [Jiang, Xinghong] Soochow Univ, Coll Med, Dept Neurobiol & Psychol, Key Lab Pain Res & Therapy, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Soochow University - China; Soochow University - China	Gao, YZ (corresponding author), Soochow Univ, Coll Med, Dept Forens Med, Suzhou, Jiangsu, Peoples R China.	yuzhengao@suda.edu.cn	liu, li/HGC-0900-2022	Huang, Moli/0000-0001-5543-9334	National Natural Science Foundation of China [81171893, 81201574, 31000630, 11101300]; Natural Science Foundation of Jiangsu Province [BK2011290]; Natural Science Foundation for Colleges and Universities of Jiangsu Province [09KJB180007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Colleges and Universities of Jiangsu Province	This study is supported by grants from National Natural Science Foundation of China (No. 81171893, No. 81201574, No. 31000630 and No. 11101300), Natural Science Foundation of Jiangsu Province (No. BK2011290) and Natural Science Foundation for Colleges and Universities of Jiangsu Province (09KJB180007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Casper Markus, 2011, Hepatology, V53, P1390, DOI 10.1002/hep.24241; Chen CJ, 2002, HEPATOLOGY, V36, P1046, DOI 10.1053/jhep.2002.37084; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; McClune AC, 2010, CLIN LIVER DIS, V14, P461, DOI 10.1016/j.cld.2010.05.009; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Momi N, 2012, CARCINOGENESIS, V33, P1617, DOI 10.1093/carcin/bgs186; Okabe H, 2001, CANCER RES, V61, P2129; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yu Q, 2012, WORLD J GASTROENTERO, V18, P383, DOI 10.3748/wjg.v18.i4.383	33	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55169	10.1371/journal.pone.0055169	http://dx.doi.org/10.1371/journal.pone.0055169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359823	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600158
J	Li, BD; Zaveri, T; Ziegler, GR; Hayes, JE				Li, Bangde; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.			User Preferences in a Carrageenan-Based Vaginal Drug Delivery System	PLOS ONE			English	Article							MICROBICIDE ACCEPTABILITY; WOMEN; HIV; CHALLENGES; CARRAGUARD; ATTITUDES; TRIALS; CONDOM	Topical microbicides are a promising solution to address the global threat of HIV and other sexually transmitted infections. To be successful, a microbicide not only needs to be biologically functional but also highly acceptable to users. User acceptability of microbicides can be incorporated early in the product formulation and design process. Previous qualitative research revealed women had strong preferences regarding product shape, while preferences related to size and firmness were less clear. Here, we explored the effect of size and firmness on the acceptability of semisolid ovoid microbicide prototypes intended for vaginal use. Sexually active women (n = 74) were randomized to one of two conditions: with and without applicator. Nine different prototypes were evaluated; they were formulated to low, medium and high firmness using mixtures of kappa and iota carrageenan and potassium chloride. Three sizes were produced at each firmness level. Women manipulated all nine prototypes, rating them for perceived effectiveness, imagined ease-of-insertion and willingness-to-try on visual analog scales. The influence of size and firmness on these three outcome measures were assessed using ANOVA and response surface models. Results indicated size and firmness both influenced the outcome measures, but firmess was more influential than size. Also, the specific effects of size and firmness depended strongly on presence or absence of an applicator. Generally, women in the without applicator condition wanted a larger, firmer product. Collectively, these data suggest efforts to rationally design of microbicides for enhanced user acceptability must consider factors like size and firmness. Also, the decision to include or forego an applicator should be addressed early in the design process, as it strongly influences other design decisions.	[Li, Bangde; Zaveri, Toral; Hayes, John E.] Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA; [Li, Bangde; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.] Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayes, JE (corresponding author), Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA.	jeh40@psu.edu	Hayes, John E/A-5893-2008	Hayes, John E/0000-0001-9065-6326; Ziegler, Gregory/0000-0002-3881-649X; Zaveri, Toral/0000-0003-0059-9212	National Institutes of Health from the National Institute Of Allergy And Infectious Diseases [R21AI094514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094514, R33AI094514] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute Of Allergy And Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant number R21AI094514 from the National Institute Of Allergy And Infectious Diseases to JEH and GRZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMD, 2009, MICR PIP SUMM REP; Beksinska ME, 2001, S AFR MED J, V91, P672; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; CDC, 1993, SEXUALLY TRANSMITTED; Centers for Disease Control, 2012, HIV US GLANC; Coggins C, 2000, REPROD HEALTH MATTER, V8, P132, DOI 10.1016/S0968-8080(00)90015-6; Darroch JE, 1999, FAM PLANN PERSPECT, V31, P16, DOI 10.2307/2991552; Elias C, 2001, J WOMEN HEALTH GEN-B, V10, P163, DOI 10.1089/152460901300039502; FRANK ML, 1995, WOMEN HEALTH, V23, P31, DOI 10.1300/J013v23n02_03; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Han L, 2009, J WOMENS HEALTH, V18, P1377, DOI 10.1089/jwh.2008.1239; Hardy E, 2003, CONTRACEPTION, V67, P391, DOI 10.1016/S0010-7824(03)00026-X; HIRA SK, 1995, AM J PUBLIC HEALTH, V85, P1098, DOI 10.2105/AJPH.85.8_Pt_1.1098; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Mahan ED, 2011, CONTRACEPTION, V84, P184, DOI 10.1016/j.contraception.2010.11.012; Mantell JE, 2005, SOC SCI MED, V60, P319, DOI 10.1016/j.socscimed.2004.05.011; Mason TH, 2003, AIDS BEHAV, V7, P339, DOI 10.1023/B:AIBE.0000004726.61630.96; Menon S, 2007, J WOMENS HEALTH, V16, P703, DOI 10.1089/jwh.2006.0163; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Morrow KM, 2007, HEALTH PSYCHOL, V26, P777, DOI 10.1037/0278-6133.26.6.777; Morrow KM, 2010, ANTIVIR RES, V88, pS40, DOI 10.1016/j.antiviral.2010.09.008; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Nnorom J, 2008, W AFRICA HIV AIDS EP; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Piot P, 2001, J Am Med Womens Assoc (1972), V56, P90; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Tasoglu S, 2011, J NON-NEWTON FLUID, V166, P1116, DOI 10.1016/j.jnnfm.2011.06.007; Tolley EE, 2006, AM J PUBLIC HEALTH, V96, P79, DOI 10.2105/AJPH.2004.043471; UNAIDS, 2011, EP UPD HLTH SECT PRO; UNAIDS, 2007, JOINT ASS HIV AIDS P; van de Wijgert Janneke, 2002, BETA, V15, P23; Verguet S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015501; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Whitehead SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014831; Zaveri T, 2012, 19 INT AIDS C JUL 22	39	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54975	10.1371/journal.pone.0054975	http://dx.doi.org/10.1371/journal.pone.0054975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23358688	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600140
J	Mai, ZX; Liu, HY				Mai, Zhongxing; Liu, Haiyan			Random Parameter Sampling of a Generic Three-Tier MAPK Cascade Model Reveals Major Factors Affecting Its Versatile Dynamics	PLOS ONE			English	Article							PROTEIN-KINASE CASCADES; KINETIC-MODELS; REGULATORY NETWORKS; NEGATIVE FEEDBACK; SIGNALING CASCADE; CELL FATE; BISTABILITY; ULTRASENSITIVITY; PHOSPHORYLATION; IDENTIFICATION	The mitogen-activated protein kinase (MAPK) pathway is considered to be a central block in many biological signaling networks. Despite the common core cascade structure, the activation of MAPK in different biological systems can exhibit different types of dynamic behaviors. Computer modeling may help to reveal the mechanisms underlying such variations. However, so far most computational models of the MAPK cascade have been system-specific, or to reflect a particular type among the wide spectrum of possible dynamics. To obtain a general and integrated view of the relationship between the dynamics of MAPK activation and the structures and parameters of the MAPK cascade, we constructed a generic model by comparing previous models covering different specific biological systems. We assumed that reliable qualitative results could be predicted through a qualitative model with pseudo parameters. We used randomly sampled parameters instead of a specific set of "best-fit" parameters to avoid biases towards any particular systems. A range of dynamics behaviors for MAPK activation, including ultrasensitivity, bistability, transient activation and oscillation, were successfully predicted by the generic model. The results indicated that the steady state dynamics (ultrasensitivity and bistability) was jointly determined by the three-tiered structure of the MAPK cascade and the competitive substrate binding in the dual-phosphorylation processes of the central components, while the temporal dynamics (transient activation and oscillation) was mainly affected by the upstream signaling pathway and feedbacks. Moreover, MAPK kinase (MAPKK) played more important roles than the other two components in determining the dynamics of MAPK activation. We hypothesize that this is an important and advantageous property for the regulation and for the functional diversity of MAPK pathways in real cells. Finally, to assist developing generic models for signaling motifs through model comparisons, we proposed a reaction-based database to make the model data more flexible and interoperable.	[Liu, Haiyan] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liu, HY (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	hyliu@ustc.edu.cn	Liu, Haiyan/O-9637-2014	Liu, Haiyan/0000-0002-5926-820X	Chinese Ministry of Science and Technology [2011CBA00801]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work is financially supported by the Chinese Ministry of Science and Technology (grant number 2011CBA00801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Campagne Fabien, 2004, Sci STKE, V2004, ppl11; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; HarshaRani GV, 2005, J BIOCHEM, V137, P653, DOI 10.1093/jb/mvi083; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Nakakuki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001782; Nikolaev EV, 2007, J THEOR BIOL, V247, P442, DOI 10.1016/j.jtbi.2007.02.013; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sivakumaran S, 2003, BIOINFORMATICS, V19, P408, DOI 10.1093/bioinformatics/btf860; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	34	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54441	10.1371/journal.pone.0054441	http://dx.doi.org/10.1371/journal.pone.0054441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365667	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600055
J	Salomonnson, E; Stacer, AC; Ehrlich, A; Luker, KE; Luker, GD				Salomonnson, Emma; Stacer, Amanda C.; Ehrlich, Anna; Luker, Kathryn E.; Luker, Gary D.			Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy	PLOS ONE			English	Article							CHEMOKINE CXCL12; CXCR4; CELLS; EXPRESSION; MICROENVIRONMENT; CHEMOTHERAPY; INHIBITION; ARRESTINS; SURVIVAL; LEUKEMIA	Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer, a disease that continues to have a dismal prognosis. CXCL12-CXCR4 signaling drives proliferation, survival, and invasion of ovarian cancer cells, leading to tumor growth and metastasis. Pleiotropic effects of CXCR4 in multiple key steps in ovarian cancer suggest that blocking this pathway will improve outcomes for patients with this disease. To quantify CXCL12-CXCR4 signaling in cell-based assays and living mouse models of ovarian cancer, we developed a click beetle red luciferase complementation reporter that detects activation of CXCR4 based on recruitment of the cytosolic adapter protein beta-arrestin 2. Both in two-dimensional and three-dimensional cell cultures, we established that bioluminescence from this reporter measures CXCL12-dependent activation of CXCR4 and inhibition of this pathway with AMD3100, a clinically-approved small molecule that blocks CXCL12-CXCR4 binding. We used this imaging system to quantify CXCL12-CXCR4 signaling in a mouse model of metastatic ovarian cancer and showed that treatment with AMD3100 interrupted this pathway in vivo. Combination therapy with AMD3100 and cisplatin significantly decreased tumor burden in mice, although differences in overall survival were not significantly greater than treatment with either agent as monotherapy. These studies establish a molecular imaging reporter system for analyzing CXCL12-CXCR4 signaling in ovarian cancer, which can be used to investigate biology and therapeutic targeting of this pathway in cell-based assays and living mice.	[Salomonnson, Emma; Stacer, Amanda C.; Ehrlich, Anna; Luker, Kathryn E.; Luker, Gary D.] Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Sch Med, Dept Biomed Engn, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Dept Radiol, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	gluker@umich.edu		luker, gary/0000-0001-6832-2581; Luker, Kathryn/0000-0001-8314-3370	National Institutes of Health [NIH R01CA136553, NIH R01CA136829, NIH P50CA093990]; Department of Defense [W81XWH-09-1-0128]; NATIONAL CANCER INSTITUTE [R01CA136553, P50CA093990, R01CA136829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grants from the National Institutes of Health (NIH R01CA136553, R01CA136829, and P50CA093990) and the Department of Defense (W81XWH-09-1-0128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald K, 2012, ONCOGENE, DOI [10.1038/onc.2011.1653, DOI 10.1038/ONC.2011.1653]; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Barbieri F, 2010, J ONCOL, V2010, DOI 10.1155/2010/426956; Barbolina MV, 2010, MOL CANCER RES, V8, P653, DOI 10.1158/1541-7786.MCR-09-0463; Burger JA, 2009, LEUKEMIA, V23, P43, DOI 10.1038/leu.2008.299; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; D'Alterio C, 2012, CANC IMMUNOL IMMUNOT; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dillmann F, 2009, LEUKEMIA LYMPHOMA, V50, P1676, DOI 10.1080/10428190903150847; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kryczek I, 2005, CANCER RES, V65, P465; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lau BW, 2010, ANTICANCER RES, V30, P2153; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; Mehta G, 2012, J CONTROL RELEASE; Moore DH, 1997, GYNECOL ONCOL, V65, P78, DOI 10.1006/gyno.1997.4628; National Cancer Institute, 2012, SEER STAT FACT SHEET; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Scotton C, 2001, CANCER RES, V61, P3; Scotton CJ, 2002, CANCER RES, V62, P5930; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Yu LF, 2010, LAB CHIP, V10, P2424, DOI 10.1039/c004590j; Yu M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.13; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	42	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51500	10.1371/journal.pone.0051500	http://dx.doi.org/10.1371/journal.pone.0051500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372646	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500006
J	Yuen, HF; McCrudden, CM; Huang, YH; Tham, JM; Zhang, XQ; Zeng, Q; Zhang, SD; Hong, WJ				Yuen, Hiu-Fung; McCrudden, Cian M.; Huang, Yu-Han; Tham, Jill M.; Zhang, Xiaoqian; Zeng, Qi; Zhang, Shu-Dong; Hong, WanJin			TAZ Expression as a Prognostic Indicator in Colorectal Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; YES-ASSOCIATED PROTEIN; TEAD TRANSCRIPTION FACTORS; SQUAMOUS-CELL CARCINOMA; HIPPO PATHWAY; GENE-EXPRESSION; RETINOIC ACID; ONCOGENIC TRANSFORMATION; ACTIN CYTOSKELETON; CANDIDATE ONCOGENE	The Hippo pathway restricts the activity of transcriptional coactivators TAZ (WWTR1) and YAP. TAZ and YAP are reported to be overexpressed in various cancers, however, their prognostic significance in colorectal cancers remains unstudied. The expression levels of TAZ and YAP, and their downstream transcriptional targets, AXL and CTGF, were extracted from two independent colon cancer patient datasets available in the Gene Expression Omnibus database, totaling 522 patients. We found that mRNA expressions of both TAZ and YAP were positively correlated with those of AXL and CTGF (p<0.05). High level mRNA expression of TAZ, AXL or CTGF significantly correlated with shorter survival. Importantly, patients co-overexpressing all 3 genes had a significantly shorter survival time, and combinatorial expression of these 3 genes was an independent predictor for survival. The downstream target genes for TAZ-AXL-CTGF overexpression were identified by Java application MyStats. Interestingly, genes that are associated with colon cancer progression (ANTXR1, EFEMP2, SULF1, TAGLN, VCAN, ZEB1 and ZEB2) were upregulated in patients co-overexpressing TAZ-AXL-CTGF. This TAZ-AXL-CTGF gene expression signature (GES) was then applied to Connectivity Map to identify small molecules that could potentially be utilized to reverse this GES. Of the top 20 small molecules identified by connectivity map, amiloride (a potassium sparing diuretic,) and tretinoin (all-trans retinoic acid) have shown therapeutic promise in inhibition of colon cancer cell growth. Using MyStats, we found that low level expression of either ANO1 or SQLE were associated with a better prognosis in patients who co-overexpressed TAZ-AXL-CTGF, and that ANO1 was an independent predictor of survival together with TAZ-AXL-CTGF. Finally, we confirmed that TAZ regulates Axl, and plays an important role in clonogenicity and non-adherent growth in vitro and tumor formation in vivo. These data suggest that TAZ could be a therapeutic target for the treatment of colon cancer.	[Yuen, Hiu-Fung; Huang, Yu-Han; Tham, Jill M.; Zhang, Xiaoqian; Zeng, Qi; Hong, WanJin] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [McCrudden, Cian M.; Zhang, Shu-Dong] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland; [Zeng, Qi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Hong, WanJin] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Queens University Belfast; National University of Singapore; Xiamen University	Zhang, SD (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk; mcbhwj@imcb.a-star.edu.sg	Zhang, Shu-Dong/G-1269-2010; HONG, Wanjin/E-9927-2010	Zhang, Shu-Dong/0000-0002-7721-0167; 	Agency of Science, Technology, and Research (A*STAR), Singapore	Agency of Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This study is funded by The Agency of Science, Technology, and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus L, 2012, ONCOGENE, V31, P238, DOI 10.1038/onc.2011.224; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Babel I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001784; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; Duvvuri U, 2012, CANC RES; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Farzaneh-Far A, 2000, BIOCHEM BIOPH RES CO, V277, P736, DOI 10.1006/bbrc.2000.3747; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harada T, 2009, PANCREATOLOGY, V9, P13, DOI 10.1159/000178871; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Helias-Rodzewicz Z, 2010, GENE CHROMOSOME CANC, V49, P1161, DOI 10.1002/gcc.20825; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOOSEIN NM, 1988, CANCER LETT, V40, P219, DOI 10.1016/0304-3835(88)90014-6; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Kim EJ, 2002, J CELL PHYSIOL, V190, P92, DOI 10.1002/jcp.10045; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; Matusiewicz M, 2008, INT J COLORECTAL DIS, V23, P383, DOI 10.1007/s00384-007-0434-4; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Narahara H, 2000, INT J CANCER, V88, P157, DOI 10.1002/1097-0215(20001015)88:2<157::AID-IJC2>3.0.CO;2-B; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pannocchia A, 1996, CELL BIOCHEM FUNCT, V14, P11, DOI 10.1002/cbf.641; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; SZOLGAYDANIEL E, 1991, CANCER RES, V51, P1039; TATSUTA M, 1995, CARCINOGENESIS, V16, P941, DOI 10.1093/carcin/16.4.941; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Xie M, 2012, J THORAC ONCOL; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yao L, 2012, J PROTEOME RES; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao H, 2010, PROSTATE CANCER P D, V13, P252, DOI 10.1038/pcan.2010.9; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	89	111	122	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54211	10.1371/journal.pone.0054211	http://dx.doi.org/10.1371/journal.pone.0054211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372686	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500040
J	Hirsch, M; Wareham, RJ; Martin-Fernandez, ML; Hobson, MP; Rolfe, DJ				Hirsch, Michael; Wareham, Richard J.; Martin-Fernandez, Marisa L.; Hobson, Michael P.; Rolfe, Daniel J.			A Stochastic Model for Electron Multiplication Charge-Coupled Devices - From Theory to Practice	PLOS ONE			English	Article							LOCATION; SIGNALS	Electron multiplication charge-coupled devices (EMCCD) are widely used for photon counting experiments and measurements of low intensity light sources, and are extensively employed in biological fluorescence imaging applications. These devices have a complex statistical behaviour that is often not fully considered in the analysis of EMCCD data. Robust and optimal analysis of EMCCD images requires an understanding of their noise properties, in particular to exploit fully the advantages of Bayesian and maximum-likelihood analysis techniques, whose value is increasingly recognised in biological imaging for obtaining robust quantitative measurements from challenging data. To improve our own EMCCD analysis and as an effort to aid that of the wider bioimaging community, we present, explain and discuss a detailed physical model for EMCCD noise properties, giving a likelihood function for image counts in each pixel for a given incident intensity, and we explain how to measure the parameters for this model from various calibration images.	[Hirsch, Michael; Martin-Fernandez, Marisa L.; Rolfe, Daniel J.] STFC Rutherford Appleton Lab, Cent Laser Facil, Didcot, Oxon, England; [Wareham, Richard J.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Hobson, Michael P.] Univ Cambridge, Dept Phys, Cambridge, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Cambridge; University of Cambridge	Hirsch, M (corresponding author), STFC Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	Michael.Hirsch@stfc.ac.uk		martin-fernandez, marisa/0000-0001-5496-6300; Hirsch, Michael/0000-0001-6183-6256; Rolfe, Daniel/0000-0002-8394-8395	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; BBSRC [BB/G006911/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) through grant BB/G006911/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Andor Technology, UNR SENS SIGN NOIS D; Andor Technology, LONG EMCCDS; Barrett HH, 2009, IEEE T NUCL SCI, V56, P725, DOI 10.1109/TNS.2009.2015308; Basden AG, 2003, MON NOT R ASTRON SOC, V345, P985, DOI 10.1046/j.1365-8711.2003.07020.x; Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536; Daigle O, 2009, P SPIE, V5499; Daigle O, 2004, P SPIE, V5499; Diakonis P, 1983, SCI AM, V248; Feroz F, 2009, MON NOT R ASTRON SOC, V398; Hamamatsu Photonics, EL MULT CHARG COUPL; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Hughes J, 2010, ANN APPL STAT, V4, P830, DOI 10.1214/09-AOAS299; Korevaar MAN, 2011, PHYS MED BIOL, V56, P4785, DOI 10.1088/0031-9155/56/15/010; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Mullikin J, 1994, P SPIE, V2173; O'Grady A, 2006, P SOC PHOTO-OPT INS, V6093; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Plakhotnik T, 2006, IEEE T ELECTRON DEV, V53, P618, DOI 10.1109/TED.2006.870572; Robbins MS, 2003, IEEE T ELECT DEVICES, V50; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sharma D, 2006, IMAGING MICROSCOPY, V4; Tubbs RN, 2004, OBSERVATORY, V124; Tulloch S, 2004, P SPIE, V5492; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Zhang L, 2009, J PHYS B, V42	27	61	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53671	10.1371/journal.pone.0053671	http://dx.doi.org/10.1371/journal.pone.0053671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382848	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600017
J	Huang, TS; Shyu, YC; Chen, HY; Lin, LM; Lo, CY; Yuan, SS; Chen, PJ				Huang, Ting-Shuo; Shyu, Yu-Chiau; Chen, Huang-Yang; Lin, Li-Mei; Lo, Chia-Ying; Yuan, Shin-Sheng; Chen, Pei-Jer			Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; SODIUM SELENITE; DOUBLE-BLIND; SEPSIS; PHARMACONUTRITION; HETEROGENEITY; THERAPY; EPIDEMIOLOGY; NUTRITION	Background: It is currently unclear whether parenteral selenium supplementation should be recommended in the management of critically ill patients. Here we conducted a systematic review and meta-analysis to assess the efficacy of parenteral selenium supplementation on clinical outcomes. Methods/Principal Findings: Randomized trials investigating parenteral selenium supplementation administered in addition to standard of care to critically ill patients were included. CENTRAL, Medline, EMBASE, the Science Citation Index, and CINAHL were searched with complementary manual searches. The primary outcome was all-cause mortality. Trials published in any language were included. Two authors independently extracted data and assessed trial quality. A third author was consulted to resolve disagreements and for quality assurance. Twelve trials were included and meta-analysis was performed on nine trials that recruited critically ill septic patients. These comprised 965 participants in total. Of these, 148 patients (30.7%) in the treatment groups, and 180 patients (37.3%) in control groups died. Parenteral selenium treatment significantly reduced all-cause mortality in critically ill patients with sepsis (relative risk [RR] 0.83, 95% CI 0.70-0.99, p = 0.04, I-2 = 0%). Subgroup analyses demonstrated that the administration schedule employing longer duration (RR 0.77, 95% CI 0.63-0.94, p = 0.01, I-2 = 0%), loading boluses (RR 0.73, 95% CI 0.58-0.94, p = 0.01, I-2 = 0%) or high-dose selenium treatment (RR 0.77, 95% CI 0.61-0.99, p = 0.04, I-2 = 0%) might be associated with a lower mortality risk. There was no evidence of adverse events. Conclusions/Significance: Parenteral selenium supplementation reduces risk of mortality among critically ill patients with sepsis. Owing to the varied methodological quality of the studies, future high-quality randomized trials that directly focus on the effect of adequate-duration of parenteral selenium supplementation for severe septic patients are needed to confirm our results. Clinicians should consider these findings when treating this high-risk population.	[Huang, Ting-Shuo; Chen, Huang-Yang] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Keelung Branch, Keelung, Taiwan; [Shyu, Yu-Chiau] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Shyu, Yu-Chiau] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Lin, Li-Mei; Lo, Chia-Ying] Chang Gung Mem Hosp, Dept Pharm, Keelung Branch, Keelung, Taiwan; [Yuan, Shin-Sheng] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; National Taiwan University	Yuan, SS (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	syuan@stat.sinica.edu.tw; peijerchen@ntu.edu.tw	Yuan, Shinsheng/AAP-4855-2021; Huang, Ting-Shuo/ABD-3205-2021	Huang, Ting-Shuo/0000-0002-2932-6878; Shyu, Yu-Chiau/0000-0003-1747-2226; Chen, Pei-Jer/0000-0001-8316-3785	Chang Gung Memorial Hospital, Keelung Branch [CMRPG2B0311]	Chang Gung Memorial Hospital, Keelung Branch	This research was supported by an institutional grant (CMRPG2B0311) of Chang Gung Memorial Hospital, Keelung Branch to TS Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Angstwurm MWA, 1999, CRIT CARE MED, V27, P1807, DOI 10.1097/00003246-199909000-00017; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Avenell A, 2004, COCHRANE DATABASE SY; Berger MM, 2001, INTENS CARE MED, V27, P91, DOI 10.1007/s001340000757; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupertuis YM, 2009, CURR OPIN CLIN NUTR, V12, P398, DOI 10.1097/MCO.0b013e32832c4ce1; Fletcher J, 2007, BMJ-BRIT MED J, V334, P94, DOI 10.1136/bmj.39057.406644.68; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Forceville X, 2007, J TRACE ELEM MED BIO, V21, P62, DOI 10.1016/j.jtemb.2007.09.021; Forceville X, 2007, CRIT CARE, V11, DOI 10.1186/cc5960; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Hardy G, 2011, NUTRITION, V27, P1090, DOI 10.1016/j.nut.2011.01.009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Huang TS, 2011, EFFECT PARENTERAL SE, V2011; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jones NE, 2008, CURR OPIN GASTROEN, V24, P215, DOI 10.1097/MOG.0b013e3282f4cdd8; Kuklinski B, 1991, Z Gesamte Inn Med, V46, P145; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Lindner D, 2004, MED KLIN, V99, P708, DOI 10.1007/s00063-004-1104-8; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Manzanares W, 2012, CRIT CARE, V16, DOI 10.1186/cc11316; Manzanares W, 2011, INTENS CARE MED, V37, P1120, DOI 10.1007/s00134-011-2212-6; Manzanares W, 2009, CURR OPIN CLIN NUTR, V12, P273, DOI 10.1097/MCO.0b013e32832a0cc2; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Mishra V, 2007, CLIN NUTR, V26, P41, DOI 10.1016/j.clnu.2006.10.003; Montoya Gonzalez C., 2009, MED CR TICA, V23, P199; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sakr Y, 2007, BRIT J ANAESTH, V98, P775, DOI 10.1093/bja/aem091; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Valenta J, 2011, INTENS CARE MED, V37, P808, DOI 10.1007/s00134-011-2153-0; Vincent JL, 2004, CHEST, V126, P592, DOI 10.1378/chest.126.2.592; Zimmermann T, 1997, Med Klin (Munich), V92 Suppl 3, P3	46	91	94	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54431	10.1371/journal.pone.0054431	http://dx.doi.org/10.1371/journal.pone.0054431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372722	gold, Green Published			2022-12-27	WOS:000315210400014
J	Li, D; Long, Y; Wang, TC; Xiao, D; Zhang, JX; Guo, ZW; Wang, B; Yan, YP				Li, Duan; Long, Yong; Wang, Tingcai; Xiao, Dan; Zhang, Jingxia; Guo, Zhiwen; Wang, Bo; Yan, Yongping			Epidemiology of Hepatitis C Virus Infection in Highly Endemic HBV Areas in China	PLOS ONE			English	Article							DRUG-USERS; METAANALYSIS; INSIGHTS; DONORS	Background: Wuwei City has the highest prevalence of hepatitis B virus (HBV) in China. From 2007 to 2011, the average reported incidence rate of hepatitis B was 634.56/100,000 people. However, studies assessing the epidemic features and risk factors of HCV in the general population of Wuwei City are limited. Methods: A total of 7189 people were interviewed and screened for HCV antibodies. HCV RNA and HCV genotypes were analyzed by PCR. Relevant information was obtained from the general population using a standardized questionnaire, and association and logistic regression analyses were conducted. Results: The anti-HCV prevalence was 1.64% (118/7189), and HCV-RNA was detected in 37.29% (44/118) of the anti-HCV positive samples. The current HCV infection rate was 0.61% (44/7189) in the Wuwei general population. Hepatitis C infection rate was generally higher in the plains regions (chi(2)=27.54, P<0.05), and the most predominant HCV genotypes were 2a (59.1%) and 1b (34.1%). The concurrent HCV and HBV infection rate was 1.37%, and a history of blood transfusion (OR=17.9, 95% CI: 6.1 to 52.6, p, 0.001) was an independent risk factor for HCV positivity. Conclusions: Although Wuwei is a highly endemic area for HBV, the anti-HCV positive rate in the general population is low. More than one-third of HCV-infected people were unaware of their infection; this may become an important risk factor for hepatitis C prevalence in the general population. Maintaining blood safety is important in order to help reduce the burden of HCV infection in developing regions of China.	[Li, Duan; Long, Yong; Xiao, Dan; Zhang, Jingxia; Wang, Bo; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Li, Duan; Long, Yong; Xiao, Dan; Zhang, Jingxia; Wang, Bo; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Wang, Tingcai; Guo, Zhiwen] Wuwei Municipal Ctr Dis Control & Prevent, Wuwei City, Gansu, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yangyping@fmmu.edu.cn	Yan, Yongping/K-9634-2019		Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); China Special Grant for the Prevention and Control of Infectious Diseases [2012ZX10004907]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Special Grant for the Prevention and Control of Infectious Diseases	This study was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) and the China Special Grant for the Prevention and Control of Infectious Diseases (2012ZX10004907): Infectious disease prevention and control in demonstration areas and the field epidemiological study of viral hepatitis B in Wuwei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadalla HI, 2011, CENT EUR J PUBL HEAL, V19, P217, DOI 10.21101/cejph.a3628; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P131, DOI 10.1111/j.1440-1746.2010.06544.x; Cheng KC, 2011, J PHARM PHARMACOL, V63, P883, DOI 10.1111/j.2042-7158.2011.01267.x; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Forrester JE, 2009, HIV MED, V10, P555, DOI 10.1111/j.1468-1293.2009.00722.x; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Julia U, 2012, J HEPATOL, V54, P736; Li J., 2012, CHIN HEPATOL, V17, P2, DOI [10.3969/j.issn.1672-5069.2012.05.002, DOI 10.3969/J.ISSN.1672-5069.2012.05.002]; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Shi S, 2011, J CLIN VIROL, V51, P110, DOI 10.1016/j.jcv.2011.03.005; Sun JH, 2009, RENAL FAILURE, V31, P610, DOI 10.1080/08860220903003446; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; 刘志英, 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P148	17	17	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54815	10.1371/journal.pone.0054815	http://dx.doi.org/10.1371/journal.pone.0054815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372775	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400032
J	Accordino, SR; Fris, JAR; Appignanesi, GA				Accordino, Sebastian R.; Rodriguez Fris, J. Ariel; Appignanesi, Gustavo A.			Wrapping Effects within a Proposed Function-Rescue Strategy for the Y220C Oncogenic Mutation of Protein p53	PLOS ONE			English	Article							GENERALIZED BORN; CORE DOMAIN; MUTANT; AGGREGATION; MECHANISM; ENERGIES; SURFACE	Soluble proteins must protect their structural integrity from water attack by wrapping interactions which imply the clustering of nonpolar residues around the backbone hydrogen bonds. Thus, poorly wrapped hydrogen bonds constitute defects which have been identified as promoters of protein associations since they favor the removal of hydrating molecules. More specifically, a recent study of our group has shown that wrapping interactions allow the successful identification of protein binding hot spots. Additionally, we have also shown that drugs disruptive of protein-protein interfaces tend to mimic the wrapping behavior of the protein they replace. Within this context, in this work we study wrapping three body interactions related to the oncogenic Y220C mutation of the tumor suppressor protein p53. Our computational results rationalize the oncogenic nature of the Y220C mutation, explain the binding of a drug-like molecule already designed to restore the function of p53 and provide clues to help improve this function-rescue strategy and to apply in other drug design or re-engineering techniques.	[Appignanesi, Gustavo A.] Univ Nacl Sur, Secc Fisicoquim, INQUISUR UNS CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina; Univ Nacl Sur, Dept Quim, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Appignanesi, GA (corresponding author), Univ Nacl Sur, Secc Fisicoquim, INQUISUR UNS CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	appignan@criba.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PME 2006-1581]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support from Agencia Nacional de Promocion Cientifica y Tecnologica (PME 2006-1581) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) is gratefully acknowledged. GAA and JAR-F are research fellows of CONICET. SRA thanks CONICET for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordino SR, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12059-0; Accordino SR, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031503; Accordino SR, 2012, PROTEINS, V80, P1755, DOI 10.1002/prot.24069; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case D.A., 2022, AMBER 2020; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fernandez A, 2004, NAT BIOTECHNOL, V22, P1081, DOI 10.1038/nbt0904-1081; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2010, TRANSFORMATIVE CONCEPTS FOR DRUG DESIGN: TARGET WRAPPING, P1, DOI 10.1007/978-3-642-11792-3_1; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Lee MR, 2000, PROTEINS, V39, P309, DOI 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Schulz E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012844; Wang GZ, 2012, P NATL ACAD SCI USA, V109, P13590, DOI 10.1073/pnas.1211557109; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a	26	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55123	10.1371/journal.pone.0055123	http://dx.doi.org/10.1371/journal.pone.0055123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365691	Green Published, gold			2022-12-27	WOS:000314023600155
J	Donate, PB; Fornari, TA; Macedo, C; Cunha, TM; Nascimento, DCB; Sakamoto-Hojo, ET; Donadi, EA; Cunha, FQ; Passos, GA				Donate, Paula B.; Fornari, Thais A.; Macedo, Claudia; Cunha, Thiago M.; Nascimento, Daniele C. B.; Sakamoto-Hojo, Elza T.; Donadi, Eduardo A.; Cunha, Fernando Q.; Passos, Geraldo A.			T Cell Post-Transcriptional miRNA-mRNA Interaction Networks Identify Targets Associated with Susceptibility/Resistance to Collagen-induced Arthritis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; PROTEIN EXPRESSION; MICRORNA; REGULATORS; AUTOIMMUNITY; PREDICTION; EFFECTOR; MICE	Background: Due to recent studies indicating that the deregulation of microRNAs (miRNAs) in T cells contributes to increased severity of rheumatoid arthritis, we hypothesized that deregulated miRNAs may interact with key mRNA targets controlling the function or differentiation of these cells in this disease. Methodology/Principal Findings: To test our hypothesis, we used microarrays to survey, for the first time, the expression of all known mouse miRNAs in parallel with genome-wide mRNAs in thymocytes and naive and activated peripheral CD3(+) T cells from two mouse strains the DBA-1/J strain (MHC-H2q), which is susceptible to collagen induced arthritis (CIA), and the DBA-2/J strain (MHC-H2d), which is resistant. Hierarchical clustering of data showed the several T cell miRNAs and mRNAs differentially expressed between the mouse strains in different stages of immunization with collagen. Bayesian statistics using the GenMir(++) algorithm allowed reconstruction of post-transcriptional miRNA-mRNA interaction networks for target prediction. We revealed the participation of miR-500, miR-202-3p and miR-30b*, which established interactions with at least one of the following mRNAs: Rorc, Fas, Fasl, Il-10 and Foxo3. Among the interactions that were validated by calculating the minimal free-energy of base pairing between the miRNA and the 3'UTR of the mRNA target and luciferase assay, we highlight the interaction of miR-30b*-Rorc mRNA because the mRNA encodes a protein implicated in pro-inflammatory Th17 cell differentiation (Rorct). FACS analysis revealed that Rorct protein levels and Th17 cell counts were comparatively reduced in the DBA-2/J strain. Conclusions/Significance: This result showed that the miRNAs and mRNAs identified in this study represent new candidates regulating T cell function and controlling susceptibility and resistance to CIA.	[Donate, Paula B.; Fornari, Thais A.; Macedo, Claudia; Passos, Geraldo A.] Univ Sao Paulo, Mol Immunogenet Grp, Dept Genet, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Cunha, Thiago M.; Nascimento, Daniele C. B.; Cunha, Fernando Q.] Fac Med Ribeirao Preto, Inflammat & Pain Grp, Dept Pharmacol, Ribeirao Preto, Brazil; [Sakamoto-Hojo, Elza T.] Fac Philosophy Sci & Letters Ribeirao Preto, Dept Biol, Ribeirao Preto, Brazil; [Donadi, Eduardo A.] Fac Med Ribeirao Preto, Div Clin Immunol, Dept Med, Ribeirao Preto, Brazil; [Passos, Geraldo A.] Fac Dent Ribeirao Preto, Discipline Genet, Dept Morphol, Ribeirao Preto, Brazil; [Passos, Geraldo A.] Fac Dent Ribeirao Preto, Discipline Mol Biol, Dept Morphol, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Passos, GA (corresponding author), Univ Sao Paulo, Mol Immunogenet Grp, Dept Genet, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	passos@usp.br	Passos, Geraldo Aleixo/ABE-3251-2020; Cunha, Thiago M/B-7729-2012; Passos, Geraldo A/A-2899-2008; donadi, eduardo A/H-7080-2013; Sakamoto-Hojo, Elza Tiemi/C-3959-2012; Cunha, Fernando Q/M-3090-2014	Passos, Geraldo Aleixo/0000-0002-4408-140X; Cunha, Thiago M/0000-0003-1084-0065; Passos, Geraldo A/0000-0002-4408-140X; donadi, eduardo A/0000-0002-9457-9601; Sakamoto-Hojo, Elza Tiemi/0000-0002-1383-3314; Cunha, Fernando Queiroz/0000-0003-4755-1670	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/56594-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant number 08/56594-8), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2001, J CLIN INVEST, V107, P519, DOI 10.1172/JCI8027; Alzabin S, 2011, FEBS LETT, V585, P3649, DOI 10.1016/j.febslet.2011.04.034; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Donate PB, 2011, IMMUNOBIOLOGY, V216, P591, DOI 10.1016/j.imbio.2010.09.007; Ehinger M, 2001, IMMUNOLOGY, V103, P291, DOI 10.1046/j.1365-2567.2001.01257.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Fulci V, 2010, HUM IMMUNOL, V71, P206, DOI 10.1016/j.humimm.2009.11.008; GRIFFITHS MM, 1994, J IMMUNOL, V153, P2758; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Junta CM, 2009, IMMUNOLOGY, V127, P365, DOI 10.1111/j.1365-2567.2008.03005.x; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Magalhaes DAR, 2006, CLIN DEV IMMUNOL, V13, P81, DOI 10.1080/17402520600877091; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silva GL, 2007, ANN NY ACAD SCI, V1110, P33, DOI 10.1196/annals.1423.005; Silva GL, 2009, ANN NY ACAD SCI, V1173, P521, DOI 10.1111/j.1749-6632.2009.04629.x; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Turrel-Davin F, 2010, ANN RHEUM DIS, V69, P755, DOI 10.1136/ard.2009.109991; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Wu G, 2010, PLOS ONE, V16; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xue Q, 2011, MOL IMMUNOL, V48, P592, DOI 10.1016/j.molimm.2010.10.021; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128	54	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54803	10.1371/journal.pone.0054803	http://dx.doi.org/10.1371/journal.pone.0054803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359619	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600114
J	Huijskens, EGW; Reimerink, J; Mulder, PGH; van Beek, J; Meijer, A; de Bruin, E; Friesema, I; de Jong, MD; Rimmelzwaan, GF; Peeters, MF; Rossen, JWA; Koopmans, M				Huijskens, Elisabeth G. W.; Reimerink, Johan; Mulder, Paul G. H.; van Beek, Janko; Meijer, Adam; de Bruin, Erwin; Friesema, Ingrid; de Jong, Menno D.; Rimmelzwaan, Guus F.; Peeters, Marcel F.; Rossen, John W. A.; Koopmans, Marion			Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; PANDEMIC H1N1 INFLUENZA; A VIRUS; AVIAN INFLUENZA; ANTIBODY; SEVERITY; AGE	Background: The influence of prior seasonal influenza vaccination on the antibody response produced by natural infection or vaccination is not well understood. Methods: We compared the profiles of antibody responses of 32 naturally infected subjects and 98 subjects vaccinated with a 2009 influenza A(H1N1) monovalent MF59-adjuvanted vaccine (Focetria (R), Novartis), with and without a history of seasonal influenza vaccination. Antibodies were measured by hemagglutination inhibition (HI) assay for influenza A(H1N1)pdm09 and by protein microarray (PA) using the HA1 subunit for seven recent and historic H1, H2 and H3 influenza viruses, and three avian influenza viruses. Serum samples for the infection group were taken at the moment of collection of the diagnostic sample, 10 days and 30 days after onset of influenza symptoms. For the vaccination group, samples were drawn at baseline, 3 weeks after the first vaccination and 5 weeks after the second vaccination. Results: We showed that subjects with a history of seasonal vaccination generally exhibited higher baseline titers for the various HA1 antigens than subjects without a seasonal vaccination history. Infection and pandemic influenza vaccination responses in persons with a history of seasonal vaccination were skewed towards historic antigens. Conclusions: Seasonal vaccination is of significant influence on the antibody response to subsequent infection and vaccination, and further research is needed to understand the effect of annual vaccination on protective immunity.	[Huijskens, Elisabeth G. W.; Peeters, Marcel F.; Rossen, John W. A.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Reimerink, Johan; van Beek, Janko; Meijer, Adam; de Bruin, Erwin; Friesema, Ingrid; Koopmans, Marion] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Mulder, Paul G. H.] Amphia Hosp, Amphia Acad, Breda, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Rimmelzwaan, Guus F.; Koopmans, Marion] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands National Institute for Public Health & the Environment; Amphia Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Huijskens, EGW (corresponding author), St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	i.huijskens@gmail.com	Friesema, Ingrid HM/H-6601-2019; Koopmans, Marion/Y-9170-2019; Rossen, John W/G-7564-2011	Friesema, Ingrid HM/0000-0001-9943-0518; Koopmans, Marion/0000-0002-5204-2312; Rossen, John W/0000-0002-7167-8623				Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2011, J VIROL, V85, P11995, DOI 10.1128/JVI.05213-11; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Couch RB, 2012, CLIN INFECT DIS, V54, P311, DOI 10.1093/cid/cir809; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017821; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fange Y, 2012, J VIROL, V86, P2229, DOI 10.1128/JVI.05540-11; Friesema IHM, 2012, INFLUENZA OTHER RESP, V6, pe16, DOI 10.1111/j.1750-2659.2012.00347.x; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Jefferies S, 2011, EURO SURVEILL, V16; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; RUSSELL RJ, 1979, J IMMUNOL, V123, P825; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Steens A, 2011, AM J EPIDEMIOL, V174, P1307, DOI 10.1093/aje/kwr245; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	30	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54890	10.1371/journal.pone.0054890	http://dx.doi.org/10.1371/journal.pone.0054890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365683	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600130
J	Kang, HW; Crawford, M; Fabbri, M; Nuovo, G; Garofalo, M; Nana-Sinkam, SP; Friedman, A				Kang, Hye-Won; Crawford, Melissa; Fabbri, Muller; Nuovo, Gerard; Garofalo, Michela; Nana-Sinkam, S. Patrick; Friedman, Avner			A Mathematical Model for MicroRNA in Lung Cancer	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; C-MYC; MESSENGER-RNA; CELL; PROTEIN; METASTASIS; MMP-9; AMPLIFICATION; MUTATIONS; INDUCTION	Lung cancer is the leading cause of cancer-related deaths worldwide. Lack of early detection and limited options for targeted therapies are both contributing factors to the dismal statistics observed in lung cancer. Thus, advances in both of these areas are likely to lead to improved outcomes. MicroRNAs (miRs or miRNAs) represent a class of non-coding RNAs that have the capacity for gene regulation and may serve as both diagnostic and prognostic biomarkers in lung cancer. Abnormal expression patterns for several miRNAs have been identified in lung cancers. Specifically, let-7 and miR-9 are deregulated in both lung cancers and other solid malignancies. In this paper, we construct a mathematical model that integrates let-7 and miR-9 expression into a signaling pathway to generate an in silico model for the process of epithelial mesenchymal transition (EMT). Simulations of the model demonstrate that EGFR and Ras mutations in non-small cell lung cancers (NSCLC), which lead to the process of EMT, result in miR-9 upregulation and let-7 suppression, and this process is somewhat robust against random input into miR-9 and more strongly robust against random input into let-7. We elected to validate our model in vitro by testing the effects of EGFR inhibition on downstream MYC, miR-9 and let-7a expression. Interestingly, in an EGFR mutated lung cancer cell line, treatment with an EGFR inhibitor (Gefitinib) resulted in a concentration specific reduction in c-MYC and miR-9 expression while not changing let-7a expression. Our mathematical model explains the signaling link among EGFR, MYC, and miR-9, but not let-7. However, very little is presently known about factors that regulate let-7. It is quite possible that when such regulating factors become known and integrated into our model, they will further support our mathematical model.	[Kang, Hye-Won; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Crawford, Melissa; Nuovo, Gerard; Nana-Sinkam, S. Patrick] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Fabbri, Muller; Garofalo, Michela] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Nana-Sinkam, SP (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Patrick.Nana-Sinkam@osumc.edu		Garofalo, Michela/0000-0002-1741-0415	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; National Cancer Institute [CA 150297]; NATIONAL CANCER INSTITUTE [R21CA150297] Funding Source: NIH RePORTER	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 0931642 and by the National Cancer Institute under grant CA 150297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Chaplain MAJ, 2011, IMA J APPL MATH, V76, P371, DOI 10.1093/imamat/hxr025; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inamura K, 2007, LUNG CANCER, V58, P392, DOI 10.1016/j.lungcan.2007.07.013; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Mitselou A, 2010, HISTOL HISTOPATHOL, V25, P1257, DOI 10.14670/HH-25.1257; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Orton RJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-100; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Saad AG, 2008, CANCER-AM CANCER SOC, V113, P2129, DOI 10.1002/cncr.23826; Safranek J, 2009, ANTICANCER RES, V29, P2513; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Siegel R, 2012, CANCER STATISTICS 20; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Sulzer MA, 1998, AM J RESP CRIT CARE, V157, P1319, DOI 10.1164/ajrccm.157.4.9703099; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vosa U, 2011, GENES CHROMOSOMES AN; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; YOKOTA J, 1988, ONCOGENE, V2, P607; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zheng SQ, 2010, ANTICANCER RES, V30, P713	51	38	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53663	10.1371/journal.pone.0053663	http://dx.doi.org/10.1371/journal.pone.0053663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365639	Green Published, gold			2022-12-27	WOS:000314023600018
J	Vu, AA; Nadaraja, GS; Huth, ME; Luk, L; Kim, J; Chai, RJ; Ricci, AJ; Cheng, AG				Vu, Andrew A.; Nadaraja, Garani S.; Huth, Markus E.; Luk, Lauren; Kim, John; Chai, Renjie; Ricci, Anthony J.; Cheng, Alan G.			Integrity and Regeneration of Mechanotransduction Machinery Regulate Aminoglycoside Entry and Sensory Cell Death	PLOS ONE			English	Article							OUTER HAIR-CELLS; TIP-LINK INTEGRITY; MECHANICAL TRANSDUCTION; FUNCTIONAL INTERACTION; LATERAL-LINE; MYOSIN VIIA; CADHERIN-23; STEREOCILIA; PROTOCADHERIN-15; EXPOSURE	Sound perception requires functional hair cell mechanotransduction (MET) machinery, including the MET channels and tip-link proteins. Prior work showed that uptake of ototoxic aminoglycosides (AG) into hair cells requires functional MET channels. In this study, we examined whether tip-link proteins, including Cadherin 23 (Cdh23), regulate AG entry into hair cells. Using time-lapse microscopy on cochlear explants, we found rapid uptake of gentamicin-conjugated Texas Red (GTTR) into hair cells from three-day-old Cdh23(+/+) and Cdh23(v2J/+) mice, but failed to detect GTTR uptake in Cdh23(v2J/v2J) hair cells. Pre-treatment of wildtype cochleae with the calcium chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (BAPTA) to disrupt tip-links also effectively reduced GTTR uptake into hair cells. Both Cdh23(v2J/v2J) and BAPTA-treated hair cells were protected from degeneration caused by gentamicin. Six hours after BAPTA treatment, GTTR uptake remained reduced in comparison to controls; by 24 hours, drug uptake was comparable between untreated and BAPTA-treated hair cells, which again became susceptible to cell death induced by gentamicin. Together, these results provide genetic and pharmacologic evidence that tip-links are required for AG uptake and toxicity in hair cells. Because tip-links can spontaneously regenerate, their temporary breakage offers a limited time window when hair cells are protected from AG toxicity.	[Vu, Andrew A.; Nadaraja, Garani S.; Huth, Markus E.; Luk, Lauren; Kim, John; Chai, Renjie; Ricci, Anthony J.; Cheng, Alan G.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Ricci, Anthony J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Ricci, AJ (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	aricci@stanford.edu; aglcheng@stanford.edu		Cheng, Alan/0000-0002-4702-8401; ricci, anthony/0000-0002-1706-8904	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [P30 DC010363]; American Society of Pediatric Otolaryngology Grant; Swiss National Science Foundation [PBSKP3_130635/1]; Stanford Dean's fellowship; Stanford SPARK program [R21 DC012183, RO1 DC003896]; Herbert Silverstein Award [K08 DC011043]; Akiko Yamazaki and Jerry Yang Faculty Scholar Fund; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010363, R01DC003896, K08DC011043, R21DC012183] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Society of Pediatric Otolaryngology Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stanford Dean's fellowship; Stanford SPARK program; Herbert Silverstein Award; Akiko Yamazaki and Jerry Yang Faculty Scholar Fund; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders P30 DC010363, American Society of Pediatric Otolaryngology Grant (G.S.N.), Swiss National Science Foundation PBSKP3_130635/1 (M.E.H.), Stanford Dean's fellowship, Hearing Health Foundation (R.C.), Stanford SPARK program, R21 DC012183 (A.J.R. and A.G.C.), RO1 DC003896 (A.J.R.), Herbert Silverstein Award, K08 DC011043, and Akiko Yamazaki and Jerry Yang Faculty Scholar Fund (A.G.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; HIEL H, 1992, HEARING RES, V57, P157, DOI 10.1016/0378-5955(92)90148-G; Husbands JM, 1999, HEARING RES, V135, P135, DOI 10.1016/S0378-5955(99)00101-X; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kurian R, 2003, HEARING RES, V181, P40, DOI 10.1016/S0378-5955(03)00165-5; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; OSBORNE MP, 1984, CELL TISSUE RES, V237, P43; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Richardson GP, 1997, J NEUROSCI, V17, P9506; RICHARDSON GP, 1991, HEARING RES, V53, P293, DOI 10.1016/0378-5955(91)90062-E; Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d; RYAN AF, 1982, AM J OTOLARYNG, V3, P264, DOI 10.1016/S0196-0709(82)80065-3; Rzadzinska AK, 2009, NEUROSCIENCE, V158, P365, DOI 10.1016/j.neuroscience.2008.10.012; Rzadzinska AK, 2005, HEARING RES, V208, P114, DOI 10.1016/j.heares.2005.05.008; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Suzuki M, 2002, HEARING RES, V164, P12, DOI 10.1016/S0378-5955(01)00397-5; Tiede LM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714777; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	46	44	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54794	10.1371/journal.pone.0054794	http://dx.doi.org/10.1371/journal.pone.0054794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359017	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600111
J	Zhang, DL; Liu, B; Chen, J; Peng, XL; Liu, X; Fan, YY; Liu, M; Huang, RW				Zhang, Delong; Liu, Bo; Chen, Jun; Peng, Xiaoling; Liu, Xian; Fan, Yuanyuan; Liu, Ming; Huang, Ruiwang			Determination of Vascular Dementia Brain in Distinct Frequency Bands with Whole Brain Functional Connectivity Patterns	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; MILD COGNITIVE IMPAIRMENT; VISUAL WORKING-MEMORY; MEDIAL TEMPORAL-LOBE; AGE-RELATED-CHANGES; RESTING STATE FMRI; ALZHEIMERS-DISEASE; RECOGNITION MEMORY; TOPOLOGICAL PATTERNS; MAGNETIC-RESONANCE	Recent studies have shown that multivariate pattern analysis (MVPA) can be useful for distinguishing brain disorders into categories. Such analyses can substantially enrich and facilitate clinical diagnoses. Using MPVA methods, whole brain functional networks, especially those derived using different frequency windows, can be applied to detect brain states. We constructed whole brain functional networks for groups of vascular dementia (VaD) patients and controls using resting state BOLD-fMRI (rsfMRI) data from three frequency bands - slow-5 (0.01 similar to 0.027 Hz), slow-4 (0.027 similar to 0.073 Hz), and whole-band (0.01 similar to 0.073 Hz). Then we used the support vector machine (SVM), a type of MVPA classifier, to determine the patterns of functional connectivity. Our results showed that the brain functional networks derived from rsfMRI data (19 VaD patients and 20 controls) in these three frequency bands appear to reflect neurobiological changes in VaD patients. Such differences could be used to differentiate the brain states of VaD patients from those of healthy individuals. We also found that the functional connectivity patterns of the human brain in the three frequency bands differed, as did their ability to differentiate brain states. Specifically, the ability of the functional connectivity pattern to differentiate VaD brains from healthy ones was more efficient in the slow-5 (0.01 similar to 0.027 Hz) band than in the other two frequency bands. Our findings suggest that the MVPA approach could be used to detect abnormalities in the functional connectivity of VaD patients in distinct frequency bands. Identifying such abnormalities may contribute to our understanding of the pathogenesis of VaD.	[Zhang, Delong; Peng, Xiaoling; Fan, Yuanyuan; Liu, Ming; Huang, Ruiwang] S China Normal Univ, Ctr Studies Psychol Applicat, Guangdong Key Lab Mental Hlth & Cognit Sci, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Liu, Bo; Chen, Jun; Liu, Xian] Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China	South China Normal University; Guangzhou University of Chinese Medicine	Liu, B (corresponding author), Guangdong Prov Hosp Tradit Chinese Med, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	lbgdhtcm@163.com; lium@scnu.edu.cn; ruiwang.hang@gmail.com	Chen, Jun/AAD-7667-2020	CHEN, JUN/0000-0001-5049-5759	Guangdong Province Hospital of Traditional Chinese; National Natural Science Foundation of China [81071149, 31140052, 81271548]	Guangdong Province Hospital of Traditional Chinese; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The data collection was supported by the Guangdong Province Hospital of Traditional Chinese. The study design, data analysis, decision to publish, or preparation of the manuscript was supported by the funding of National Natural Science Foundation of China under Grant numbers: 81071149, 31140052, and 81271548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Cui Y, 2012, NEUROIMAGE, V60, P894, DOI 10.1016/j.neuroimage.2012.01.084; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P2494, DOI 10.1016/j.clinph.2008.08.010; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gainotti G, 2004, NEUROL SCI, V25, P192, DOI 10.1007/s10072-004-0321-5; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Grinberg LT, 2010, J NEUROL SCI, V299, P136, DOI 10.1016/j.jns.2010.08.055; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jellinger KA, 2008, J NEUROL SCI, V270, P1, DOI 10.1016/j.jns.2008.03.006; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li LL, 2010, MAGN RESON IMAGING, V28, P380, DOI 10.1016/j.mri.2009.11.009; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 2003, BRAIN, V126, P1511, DOI 10.1093/brain/awg157; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Meppelink AM, 2010, J NEUROL NEUROSUR PS, V81, P1295, DOI 10.1136/jnnp.2009.183087; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tak S, 2011, NEUROIMAGE, V55, P176, DOI 10.1016/j.neuroimage.2010.11.046; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Wang J., 2012, BIOL PSYCHIAT; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54512	10.1371/journal.pone.0054512	http://dx.doi.org/10.1371/journal.pone.0054512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359801	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600063
J	Miyamoto, N; Shinozaki, A; Fujiwara, Y				Miyamoto, Norio; Shinozaki, Ayuta; Fujiwara, Yoshihiro			Neuroanatomy of the Vestimentiferan Tubeworm Lamellibrachia satsuma Provides Insights into the Evolution of the Polychaete Nervous System	PLOS ONE			English	Article							NEREIS-DIVERSICOLOR; MOLECULAR EVIDENCE; MUSHROOM BODIES; COMMON ORIGIN; SIBOGLINIDAE; ANNELIDA; POGONOPHORANS; PHYLOGENY; IMMUNOHISTOCHEMISTRY; COMPLEXITY	Vestimentiferan tubeworms are marine invertebrates that inhabit chemosynthetic environments, and although recent molecular phylogenetic analyses have suggested that vestimentiferan tubeworms are derived from polychaete annelids, they show some morphological features that are different from other polychaetes. For example, vestimentiferans lack a digestive tract and have less body segments and comparative neuroanatomy can provide essential insight into the vestimentiferan body plan and its evolution. In the present study, we investigated the adult nervous system in the vestimentiferan Lamellibrachia satsuma using antibodies against synapsin, serotonin, FMRMamide and acetylated a-tubulin. We also examined the expressions of neural marker genes, elav and synaptotagmin to reveal the distribution of neuronal cell bodies. Brain anatomy shows simple organization in Lamellibrachia compared to other polychaetes. This simplification is probably due to the loss of the digestive tract, passing through the body between the brain and the subesophageal ganglion. In contrast, the ventral nerve cord shows a repeated organizational structure as in the other polychaetes, despite the absence of the multiple segmentation of the trunk. These results suggest that the brain anatomy is variable depending on the function and the condition of surrounding tissues, and that the formation of the rope ladder-like nervous system of the ventral nerve cord is independent from segmentation in polychaetes.	[Miyamoto, Norio; Shinozaki, Ayuta; Fujiwara, Yoshihiro] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Shinozaki, Ayuta; Fujiwara, Yoshihiro] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Hiroshima University	Miyamoto, N (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	nmiyamoto621@gmail.com		Miyamoto, Norio/0000-0002-3051-3945	JSPS [23870044]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a JSPS Grant-in-Aid for Research Activity Start-up (http://www.jsps.go.jp/; grant 23870044 to N. Miyamoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black MB, 1997, MAR BIOL, V130, P141, DOI 10.1007/s002270050233; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Bullock TH, 2002, INTEGR COMP BIOL, V42, P757, DOI 10.1093/icb/42.4.757; Cavanaugh C.M., 1985, Bulletin of the Biological Society of Washington, P373; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Gardiner Stephen L., 1993, P371; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Hessling R, 2003, HYDROBIOLOGIA, V496, P225, DOI 10.1023/A:1026153016913; Heuer CM, 2008, CELL TISSUE RES, V331, P713, DOI 10.1007/s00441-007-0535-y; Heuer CM, 2009, ZOOMORPHOLOGY, V128, P219, DOI 10.1007/s00435-008-0063-7; Heuer CM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-13; Ivanov AV, 1963, POHONOPHORA; Jennings RM, 2005, MOL BIOL EVOL, V22, P210, DOI 10.1093/molbev/msi008; Jones M., 1985, B BIOL SOC WASH, V6, P117; JONES ML, 1989, BIOL BULL, V177, P254, DOI 10.2307/1541941; JONES ML, 1988, P BIOL SOC WASH, V101, P423; Karaseva NP, 2012, RUSS J MAR BIOL+, V38, P10, DOI 10.1134/S1063074012010075; Kaufman ZS, 2008, BIOL BULL+, V35, P318, DOI 10.1134/S106235900803014X; KOJIMA S, 1993, J MOL EVOL, V37, P66; Kojima S, 1998, MOL PHYLOGENET EVOL, V9, P255, DOI 10.1006/mpev.1997.0472; Kristof A, 2008, CURR BIOL, V18, P1129, DOI 10.1016/j.cub.2008.06.066; Loesel R, 2010, ACTA ZOOL-STOCKHOLM, V91, P29, DOI 10.1111/j.1463-6395.2009.00422.x; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Muller MC, 2000, J MORPHOL, V245, P87; Muller MCM, 2006, INTEGR COMP BIOL, V46, P125, DOI 10.1093/icb/icj017; Pleijel F, 2009, CR BIOL, V332, P140, DOI 10.1016/j.crvi.2008.10.007; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 1995, ZOOL SCR, V24, P269, DOI 10.1111/j.1463-6409.1995.tb00476.x; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Rousset V, 2004, CLADISTICS, V20, P518, DOI 10.1111/j.1096-0031.2004.00039.x; Schulze A, 2003, HYDROBIOLOGIA, V496, P199, DOI 10.1023/A:1026192715095; Schulze A, 2003, ZOOL SCR, V32, P321, DOI 10.1046/j.1463-6409.2003.00119.x; Shinozaki A, 2010, CAH BIOL MAR, V51, P467; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; VANDERLAND J, 1977, BIOL SKR DAN VID SEL, V21, P1; WEBB M, 1969, B MAR SCI, V19, P18	44	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55151	10.1371/journal.pone.0055151	http://dx.doi.org/10.1371/journal.pone.0055151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372830	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500157
J	Stone, K; Woods, E; Szmania, SM; Stephens, OW; Garg, TK; Barlogie, B; Shaughnessy, JD; Hall, B; Reddy, M; Hoering, A; Hansen, E; van Rhee, F				Stone, Katie; Woods, Emily; Szmania, Susann M.; Stephens, Owen W.; Garg, Tarun K.; Barlogie, Bart; Shaughnessy, John D., Jr.; Hall, Brett; Reddy, Manjula; Hoering, Antje; Hansen, Emily; van Rhee, Frits			Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels	PLOS ONE			English	Article							MULTIPLE-MYELOMA; IL-6 RECEPTOR; GROWTH-FACTOR; SERUM-LEVELS; GENE; ARTHRITIS; GENOTYPES; PROMOTER; ANTIBODY; CANCER	Multicentric Castleman Disease is largely driven by increased signaling in the pathway for the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 receptor/gp130 polymorphisms contribute to increased interleukin-6 and/or other components of the interleukin-6 signaling pathway in HIV-negative Castleman Disease patients. The study group was composed of 58 patients and 50 healthy donors of a similar racial/ethnic profile. Of seven polymorphisms chosen for analysis, we observed an increased frequency between patients and controls of the minor allele of interleukin-6 receptor polymorphism rs4537545, which is in linkage disequilibrium with interleukin-6 receptor polymorphism rs2228145. Further, individuals possessing at least one copy of the minor allele of either polymorphism expressed higher levels of soluble interleukin-6 receptor. These elevated interleukin-6 receptor levels may contribute to increased interleukin-6 activity through the trans-signaling pathway. These data suggest that interleukin-6 receptor polymorphism may be a contributing factor in Castleman Disease, and further research is warranted.	[Stone, Katie; Woods, Emily; Szmania, Susann M.; Stephens, Owen W.; Garg, Tarun K.; Barlogie, Bart; van Rhee, Frits] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; [Shaughnessy, John D., Jr.] Signal Genet LLC, New York, NY USA; [Hall, Brett; Reddy, Manjula] Janssen Res & Dev, Radnor, PA USA; [Hoering, Antje; Hansen, Emily] Canc Res & Biostat, Seattle, WA USA	University of Arkansas System; University of Arkansas Medical Sciences; Cancer Research & Biostatistics	van Rhee, F (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA.	vanrheefrits@uams.edu	Garg, Tarun K/C-8613-2009		Janssen Research and Development, a Johnson and Johnson Company	Janssen Research and Development, a Johnson and Johnson Company	This work was supported by Janssen Research and Development, a Johnson and Johnson Company. The funders developed the panoptic interleukin-6 assay and performed this testing. The funders had no role in study design, decision to publish, or preparation of the manuscript.	BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; CASTLEMAN B, 1954, N Engl J Med, V251, P396; CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4; Cozen W, 2006, CANCER EPIDEM BIOMAR, V15, P2285, DOI 10.1158/1055-9965.EPI-06-0446; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Galicia JC, 2004, GENES IMMUN, V5, P513, DOI 10.1038/sj.gene.6364120; Guerreiro CS, 2009, AM J GASTROENTEROL, V104, P2241, DOI 10.1038/ajg.2009.313; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Krakauer T, 1998, J IMMUNOL METHODS, V219, P161, DOI 10.1016/S0022-1759(98)00138-0; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; LEDUR A, 1995, J IMMUNOL METHODS, V186, P171, DOI 10.1016/0022-1759(95)00184-C; MAY LT, 1991, J BIOL CHEM, V266, P9950; Mazur G, 2005, IMMUNOL LETT, V96, P241, DOI 10.1016/j.imlet.2004.08.015; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Peake NJ, 2006, RHEUMATOLOGY, V45, P1485, DOI 10.1093/rheumatology/kel154; PETERSON BA, 1993, SEMIN ONCOL, V20, P636; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Sehgal PB, 1996, P SOC EXP BIOL MED, V213, P238; Slattery ML, 2007, CANCER CAUSE CONTROL, V18, P1095, DOI 10.1007/s10552-007-9049-x; Stephens OW, 2012, BLOOD, V119, P503, DOI 10.1182/blood-2011-07-367052; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377	27	35	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54610	10.1371/journal.pone.0054610	http://dx.doi.org/10.1371/journal.pone.0054610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372742	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500096
J	Su, LX; Cao, LC; Zhou, R; Jiang, ZX; Xiao, K; Kong, WJ; Wang, HJ; Deng, J; Wen, B; Tan, FJ; Zhang, Y; Xie, LX				Su, Longxiang; Cao, Lichao; Zhou, Ruo; Jiang, Zhaoxu; Xiao, Kun; Kong, Weijing; Wang, Huijuan; Deng, Jie; Wen, Bo; Tan, Fengji; Zhang, Yong; Xie, Lixin			Identification of Novel Biomarkers for Sepsis Prognosis via Urinary Proteomic Analysis Using iTRAQ Labeling and 2D-LC-MS/MS	PLOS ONE			English	Article							SELENIUM-BINDING PROTEIN-1; ACUTE KIDNEY INJURY; SEPTIC SHOCK; CD107A; EXPRESSION; DISCOVERY; LAMP-1; DEFINITIONS; GUIDELINES; SURVIVAL	Objectives: Sepsis is the major cause of death for critically ill patients. Recent progress in proteomics permits a thorough characterization of the mechanisms associated with critical illness. The purpose of this study was to screen potential biomarkers for early prognostic assessment of patients with sepsis. Methods: For the discovery stage, 30 sepsis patients with different prognoses were selected. Urinary proteins were identified using isobaric tags for relative and absolute quantitation (iTRAQ) coupled with LC-MS/ MS. Mass spec instrument analysis were performed with Mascot software and the International Protein Index (IPI); bioinformatic analyses were used by the algorithm of set and the Gene Ontology (GO) Database. For the verification stage, the study involved another 54 sepsis-hospitalized patients, with equal numbers of patients in survivor and non-survivor groups based on 28-day survival. Differentially expressed proteins were verified by Western Blot. Results: A total of 232 unique proteins were identified. Proteins that were differentially expressed were further analyzed based on the pathophysiology of sepsis and biomathematics. For sepsis prognosis, five proteins were significantly up-regulated: selenium binding protein-1, heparan sulfate proteoglycan-2, alpha-1-B glycoprotein, haptoglobin, and lipocalin; two proteins were significantly down-regulated: lysosome-associated membrane proteins-1 and dipeptidyl peptidase-4. Based on gene ontology clustering, these proteins were associated with the biological processes of lipid homeostasis, cartilage development, iron ion transport, and certain metabolic processes. Urinary LAMP-1 was down-regulated, consistent with the Western Blot validation. Conclusion: This study provides the proteomic analysis of urine to identify prognostic biomarkers of sepsis. The seven identified proteins provide insight into the mechanism of sepsis. Low urinary LAMP-1 levels may be useful for early prognostic assessment of sepsis.	[Su, Longxiang; Jiang, Zhaoxu; Xiao, Kun; Wang, Huijuan; Deng, Jie; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China; [Su, Longxiang; Jiang, Zhaoxu; Wang, Huijuan] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Cao, Lichao; Zhou, Ruo; Wen, Bo; Tan, Fengji; Zhang, Yong] BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China; [Kong, Weijing] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Su, Longxiang; Jiang, Zhaoxu; Xiao, Kun; Wang, Huijuan; Deng, Jie; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Beijing Genomics Institute (BGI); Peking University; Chinese People's Liberation Army General Hospital	Zhang, Y (corresponding author), BGI Shenzhen, Shenzhen Proteome Engn Lab, Shenzhen, Peoples R China.	zhangy@genomics.org.cn; xielx@263.net	Su, Longxiang/I-6788-2019; Xie, li/HGE-6052-2022; Wen, Bo/I-1259-2019	Su, Longxiang/0000-0002-0942-2870; Wen, Bo/0000-0003-2261-3150; cao, lichao/0000-0002-6563-1140; Ruo, Zhou/0000-0002-3747-6147	Chinese National Science and Technology Pillar Program [2009BAI86B03]	Chinese National Science and Technology Pillar Program	This work was supported by the Chinese National Science and Technology Pillar Program [NO: 2009BAI86B03]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Bergmann A, 2002, CLIN CHIM ACTA, V321, P123, DOI 10.1016/S0009-8981(02)00042-6; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Caubet C, 2010, PEDIATR NEPHROL, V25, P27, DOI 10.1007/s00467-009-1251-5; Chang MHY, 2002, J BIOL REG HOMEOS AG, V16, P147; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Hartwig Sonja, 2009, Archives of Physiology and Biochemistry, V115, P155, DOI 10.1080/13813450903154224; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Kalenka A, 2006, ANESTH ANALG, V103, P1522, DOI 10.1213/01.ane.0000242533.59457.70; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Kunzli BM, 2002, CANCER-AM CANCER SOC, V94, P228, DOI 10.1002/cncr.10162; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Liu Jian-xin, 2008, Zhonghua Yi Xue Za Zhi, V88, P1929; Maddens B, 2012, MOL CELL PROTEOMICS; Oragui EE, 2000, CRIT CARE MED, V28, P3002, DOI 10.1097/00003246-200008000-00054; Piyaphanee N, 2011, PROTEOM CLIN APPL, V5, P334, DOI 10.1002/prca.201000110; Quintana LF, 2009, MOL CELL PROTEOMICS, V8, P1658, DOI 10.1074/mcp.M900059-MCP200; Ricci Z, 2009, CURR DRUG TARGETS, V10, P1179, DOI 10.2174/138945009789753192; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Thongboonkerd V, 2008, MOL BIOSYST, V4, P810, DOI 10.1039/b802534g; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Vanhoutte KJA, 2007, NEPHROL DIAL TRANSPL, V22, P2932, DOI 10.1093/ndt/gfm170; Vincent JL, 2011, CONTRIB NEPHROL, V174, P71, DOI 10.1159/000329238; Xia YJ, 2011, HUM PATHOL, V42, P1620, DOI 10.1016/j.humpath.2011.01.008; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x; Zeng Ji-zhang, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P455; Zhang J, 2011, MED ONCOL, V28, P481, DOI 10.1007/s12032-010-9482-7	43	47	49	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54237	10.1371/journal.pone.0054237	http://dx.doi.org/10.1371/journal.pone.0054237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372690	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500043
J	Zha, WB; Wang, GJ; Xu, WR; Liu, XY; Wang, Y; Zha, BS; Shi, J; Zhao, QJ; Gerk, PM; Studer, E; Hylemon, PB; Pandak, WM; Zhou, HP				Zha, Weibin; Wang, Guangji; Xu, Weiren; Liu, Xuyuan; Wang, Yun; Zha, Beth S.; Shi, Jian; Zhao, Qijin; Gerk, Phillip M.; Studer, Elaine; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping			Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages	PLOS ONE			English	Article							CACO-2 CELL MONOLAYERS; IN-VITRO; SIGNALING PATHWAYS; MEDIATED TRANSPORT; ENDOTHELIAL-CELLS; ABC TRANSPORTERS; TNF-ALPHA; EXPRESSION; MODULATION; ABSORPTION	Background: HIV protease inhibitor (PI)-induced inflammatory response in macrophages is a major risk factor for cardiovascular diseases. We have previously reported that berberine (BBR), a traditional herbal medicine, prevents HIV PI-induced inflammatory response through inhibiting endoplasmic reticulum (ER) stress in macrophages. We also found that HIV PIs significantly increased the intracellular concentrations of BBR in macrophages. However, the underlying mechanisms of HIV PI-induced BBR accumulation are unknown. This study examined the role of P-glycoprotein (P-gp) in HIV PI-mediated accumulation of BBR in macrophages. Methodology and Principal Findings: Cultured mouse RAW264.7 macrophages, human THP-1-derived macrophages, Wild type MDCK (MDCK/WT) and human P-gp transfected (MDCK/P-gp) cells were used in this study. The intracellular concentration of BBR was determined by HPLC. The activity of P-gp was assessed by measuring digoxin and rhodamine 123 (Rh123) efflux. The interaction between P-gp and BBR or HIV PIs was predicated by Glide docking using Schrodinger program. The results indicate that P-gp contributed to the efflux of BBR in macrophages. HIV PIs significantly increased BBR concentrations in macrophages; however, BBR did not alter cellular HIV PI concentrations. Although HIV PIs did not affect P-gp expression, P-gp transport activities were significantly inhibited in HIV PI-treated macrophages. Furthermore, the molecular docking study suggests that both HIV PIs and BBR fit the binding pocket of P-gp, and HIV PIs may compete with BBR to bind P-gp. Conclusion and Significance: HIV PIs increase the concentration of BBR by modulating the transport activity of P-gp in macrophages. Understanding the cellular mechanisms of potential drug-drug interactions is critical prior to applying successful combinational therapy in the clinic.	[Zha, Weibin; Wang, Yun; Zha, Beth S.; Studer, Elaine; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zha, Weibin; Wang, Guangji; Shi, Jian; Zhao, Qijin] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Xu, Weiren; Liu, Xuyuan] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin, Peoples R China; [Liu, Xuyuan] Tianjin Med Univ, Basic Med Coll, Tianjin, Peoples R China; [Gerk, Phillip M.] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zhou, Huiping] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China	Virginia Commonwealth University; China Pharmaceutical University; Tianjin Medical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Wenzhou Medical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/J-3639-2015; Shi, Jian/Q-1667-2018; Zhou, Huiping/H-6875-2019; Shi, Jian/Y-9055-2019	Shi, Jian/0000-0003-2609-0094; Zhou, Huiping/0000-0002-0050-372X; Shi, Jian/0000-0003-2609-0094; Gerk, Phillip M./0000-0001-9861-1018	National Institutes of Health (NIH) [R01AT004148, R21AI068432]; VA Merit Award [1I01BX001390]; VCU Presidential Research Incentive Program Award; Merck Research Grant, School of Medicine; VCU Bridge funding; National Science Foundation of China [81070245]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); VCU Presidential Research Incentive Program Award; Merck Research Grant, School of Medicine; VCU Bridge funding; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants R01AT004148 (H.Z.), R21AI068432 (H.Z.), VA Merit Award 1I01BX001390 (H.Z.), The VCU Presidential Research Incentive Program Award (H.Z.), Merck Research Grant, School of Medicine, VCU Bridge funding (H.Z.), and National Science Foundation of China (Grant 81070245 to H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Bierman WFW, 2010, J ANTIMICROB CHEMOTH, V65, P1672, DOI 10.1093/jac/dkq209; Bousquet L, 2008, AIDS RES HUM RETROV, V24, P1147, DOI 10.1089/aid.2007.0022; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Duggan J, 2001, AIDS PATIENT CARE ST, V15, P159, DOI 10.1089/108729101750123661; Fujimoto H, 2009, BIOL PHARM BULL, V32, P1588, DOI 10.1248/bpb.32.1588; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; He SM, 2010, CURR MED CHEM, V17, P4072, DOI 10.2174/092986710793205336; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lei BK, 2010, MOL PHARMACEUT, V7, P844, DOI 10.1021/mp100003r; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Maeng HJ, 2002, J PHARM SCI, V91, P2614, DOI 10.1002/jps.10268; Moreau A, 2011, FUNDAM CLIN PHARM, DOI 0.1111/j.1472-8206.2010.00913.x; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Patel Jignesh, 2004, Am J Ther, V11, P262, DOI 10.1097/01.mjt.0000101827.94820.22; Penzak SR, 2004, THER DRUG MONIT, V26, P322, DOI 10.1097/00007691-200406000-00018; Perloff ES, 2005, DRUG METAB DISPOS, V33, P764, DOI 10.1124/dmd.104.002931; Perloff MD, 2000, AIDS, V14, P1287, DOI 10.1097/00002030-200006160-00034; Perloff MD, 2007, J PHARM PHARMACOL, V59, P947, DOI 10.1211/jpp.59.7.0006; Polli JW, 1999, PHARM RES-DORDR, V16, P1206, DOI 10.1023/A:1018941328702; Profit L, 1999, AIDS, V13, P1623, DOI 10.1097/00002030-199909100-00004; Richter M, 2004, PHARM RES-DORDR, V21, P1862, DOI 10.1023/B:PHAM.0000045240.81664.be; Roy KR, 2007, ARCH BIOCHEM BIOPHYS, V459, P169, DOI 10.1016/j.abb.2007.01.006; Shen Z F, 1993, Yao Xue Xue Bao, V28, P532; Shitan N, 2007, BIOSCI BIOTECH BIOCH, V71, P242, DOI 10.1271/bbb.60441; Storch CH, 2007, BIOCHEM PHARMACOL, V73, P1573, DOI 10.1016/j.bcp.2007.01.027; van Heeswijk RPG, 2006, J CLIN PHARMACOL, V46, P758, DOI 10.1177/0091270006288733; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025436; Wang Y, 2011, J MED CHEM, V54, P3768, DOI 10.1021/jm200017g; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898; Zha W, 2012, CURR DRUG METAB; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793; Zhang YC, 1998, PHARMACEUT RES, V15, P1520, DOI 10.1023/A:1011990730230; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhu XZ, 2004, EUR J PHARMACOL, V500, P221, DOI 10.1016/j.ejphar.2004.07.027	48	25	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54349	10.1371/journal.pone.0054349	http://dx.doi.org/10.1371/journal.pone.0054349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372711	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500062
J	Zhao, ZJ; Zhu, QX; Chen, KX; Wang, YK; Cao, J				Zhao, Zhi-Jun; Zhu, Qiao-Xia; Chen, Ke-Xin; Wang, Yu-Kun; Cao, Jing			Energy Budget, Behavior and Leptin in Striped Hamsters Subjected to Food Restriction and Refeeding	PLOS ONE			English	Article							DEPRIVATION-INDUCED INCREASES; BODY-WEIGHT; SHORT PHOTOPERIOD; CALORIC RESTRICTION; ACOMYS-RUSSATUS; OBESE; THERMOGENESIS; METABOLISM; RATS; MASS	Food restriction induces a loss of body mass that is often followed by rapid regaining of the lost weight when the restriction ends, consequently increasing a risk of development of obesity. To determine the physiological and behavioral mechanisms underlining the regaining, striped hamsters were restricted to 85% of initial food intake for 4 weeks and refed ad libitum for another 4 weeks. Changes in body mass, energy budget, activity, body composition and serum leptin level were measured. Body mass, body fat mass and serum leptin level significantly decreased in food-restricted hamsters, and increased when the restriction ended, showing a short "compensatory growth" rather than over-weight or obesity compared with ad libitum controls. During restriction, the time spent on activity increased significantly, which was opposite to the changes in serum leptin level. Food intake increased shortly during refeeding, which perhaps contributed to the rapid regaining of body mass. No correlation was observed between serum leptin and energy intake, while negative correlations were found in hamsters that were refed for 7 and 28 days. Exogenous leptin significantly decreased the time spent on activity during food restriction and attenuated the increase in food intake during refeeding. This suggests that low leptin in restricted animals may function as a starvation signal to induce an increase in activity behavior, and high leptin likely serves as a satiety signal to prevent activity during refeeding. Leptin may play a crucial role in controlling food intake when the restriction ends, and consequently preventing overweight.	[Zhao, Zhi-Jun; Cao, Jing] Wenzhou Univ, Sch Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Zhao, Zhi-Jun; Zhu, Qiao-Xia; Chen, Ke-Xin; Wang, Yu-Kun; Cao, Jing] Liaocheng Univ, Sch Agr Sci, Liaocheng, Shandong, Peoples R China	Wenzhou University; Liaocheng University	Zhao, ZJ (corresponding author), Wenzhou Univ, Sch Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China.	zhaozj73@yahoo.com.cn			National Natural Science Foundation of China [30800130, 31070367]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was supported by grants (no. 30800130 and 31070367) from the National Natural Science Foundation of China to ZJZ, and was also funded by The State Key Laboratory of Integrated Management of Pest Insects and Rodents (no. ChineseIPM1209) to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda M, 2003, J THERM BIOL, V28, P525, DOI 10.1016/S0306-4565(03)00053-6; Ahima RS, 2005, TRENDS ENDOCRIN MET, V16, P307, DOI 10.1016/j.tem.2005.07.010; Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Alvarenga TAF, 2005, BRAIN RES, V1057, P49, DOI 10.1016/j.brainres.2005.07.024; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; BARTNESS TJ, 1994, AM J PHYSIOL, V266, pR1111, DOI 10.1152/ajpregu.1994.266.4.R1111; Bartness TJ, 1997, AM J PHYSIOL-REG I, V272, pR118, DOI 10.1152/ajpregu.1997.272.1.R118; BLANK JL, 1985, AM J PHYSIOL, V248, pR181, DOI 10.1152/ajpregu.1985.248.2.R181; Cameron KM, 2011, J NUTR, V141, P182, DOI 10.3945/jn.110.129056; Cao J, 2009, J THERM BIOL, V34, P290, DOI 10.1016/j.jtherbio.2009.03.006; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; CLEARY MP, 1986, J NUTR, V116, P290, DOI 10.1093/jn/116.2.290; CLEARY MP, 1986, J NUTR, V116, P1489, DOI 10.1093/jn/116.8.1489; CORNISH ER, 1965, ANIM BEHAV, V13, P242, DOI 10.1016/0003-3472(65)90042-4; Day DE, 2003, PHYSIOL BEHAV, V78, P655, DOI 10.1016/S0031-9384(03)00052-0; Ehrhardt N, 2005, J COMP PHYSIOL B, V175, P193, DOI 10.1007/s00360-005-0475-3; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; Fernandez-Galaz C, 2002, DIABETOLOGIA, V45, P997, DOI 10.1007/s00125-002-0851-4; Forbes G, 1987, HUMAN BODY COMPOSITI; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GRAY DS, 1988, AM J CLIN NUTR, V47, P393, DOI 10.1093/ajcn/47.3.393; Grodzinski W., 1975, International biol Progm, V5, P173; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Gutman R, 2007, PHYSIOL BEHAV, V90, P95, DOI 10.1016/j.physbeh.2006.08.033; Hambly C, 2005, OBES RES, V13, P1548, DOI 10.1038/oby.2005.190; Hambly C, 2012, DIS MODEL MECH, V5, P83, DOI 10.1242/dmm.007781; HARRIS RBS, 1984, J NUTR, V114, P1143, DOI 10.1093/jn/114.6.1143; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; HILL JO, 1985, AM J PHYSIOL, V248, pR549, DOI 10.1152/ajpregu.1985.248.5.R549; Kastin AJ, 2000, REGUL PEPTIDES, V92, P37, DOI 10.1016/S0167-0115(00)00147-6; Keen-Rhinehart E, 2008, AM J PHYSIOL-REG I, V295, pR1737, DOI 10.1152/ajpregu.90512.2008; Klingenspor M, 2000, J COMP PHYSIOL B, V170, P37, DOI 10.1007/s003600050005; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; Li XS, 2005, J COMP PHYSIOL B, V175, P593, DOI 10.1007/s00360-005-0022-2; Liu H, 2003, J MAMMAL, V84, P1410, DOI 10.1644/BRG-030; LU H, 1987, Acta Theriologica Sinica, V7, P28; Mercer JG, 1998, COMP BIOCHEM PHYS C, V119, P295, DOI 10.1016/S0742-8413(98)00018-8; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; ROZEN R, 1994, AM J CLIN NUTR, V59, P560, DOI 10.1093/ajcn/59.3.560; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Song ZG, 2003, J THERM BIOL, V28, P509, DOI 10.1016/S0306-4565(03)00051-2; Song ZG, 2002, ACTA THERIOL, V47, P417, DOI 10.1007/BF03192466; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Speakman JR, 2001, J EXP BIOL, V204, P1957; Speakman JR, 1999, FUNCT ECOL, V13, P373, DOI 10.1046/j.1365-2435.1999.00322.x; SZEPESI B, 1977, AM J CLIN NUTR, V30, P1692, DOI 10.1093/ajcn/30.10.1692; VANITALLIE TB, 1985, AM J CLIN NUTR, V42, P914, DOI 10.1093/ajcn/42.5.914; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P274, DOI 10.1016/j.euroneuro.2010.11.006; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Wisse BE, 1999, AM J CLIN NUTR, V70, P321; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wood AD, 1996, PHYSIOL BEHAV, V60, P1137, DOI 10.1016/0031-9384(96)00173-4; Yang H, 2007, PEPTIDES, V28, P1931, DOI 10.1016/j.peptides.2007.07.030; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao ZJ, 2007, COMP BIOCHEM PHYS A, V148, P168, DOI 10.1016/j.cbpa.2007.04.001; Zhao ZJ, 2011, ACTA THERIOL, V56, P129, DOI 10.1007/s13364-010-0004-y; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008; Zhao ZJ, 2009, COMP BIOCHEM PHYS A, V154, P84, DOI 10.1016/j.cbpa.2009.05.004; Zhao ZJ, 2006, HORM BEHAV, V49, P463, DOI 10.1016/j.yhbeh.2005.10.003	64	9	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54244	10.1371/journal.pone.0054244	http://dx.doi.org/10.1371/journal.pone.0054244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372694	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500047
J	Lamy, E; Herz, C; Lutz-Bonengel, S; Hertrampf, A; Marton, MR; Mersch-Sundermann, V				Lamy, Evelyn; Herz, Corinna; Lutz-Bonengel, Sabine; Hertrampf, Anke; Marton, Melinda-Rita; Mersch-Sundermann, Volker			The MAPK Pathway Signals Telomerase Modulation in Response to Isothiocyanate-Induced DNA Damage of Human Liver Cancer Cells	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; PROTEIN-KINASE-C; INHIBITS TELOMERASE; UP-REGULATION; HTERT GENE; APOPTOSIS; CHEMOPREVENTION; EXPRESSION; BETA; GROWTH	4-methylthiobutyl isothiocyanate (MTBITC), an aliphatic, sulphuric compound from Brassica vegetables, possesses in vitro and in vivo antitumor activity. Recently we demonstrated the potent growth inhibitory potential of the DNA damaging agent MTBITC in human liver cancer cells. Here we now show that MTBITC down regulates telomerase which sensitizes cells to apoptosis induction. This is mediated by MAPK activation but independent from production of reactive oxygen species (ROS). Within one hour, MTBITC induced DNA damage in cancer cells correlating to a transient increase in hTERT mRNA expression which then turned into telomerase suppression, evident at mRNA as well as enzyme activity level. To clarify the role of MAPK for telomerase regulation, liver cancer cells were pre-treated with MAPK-specific inhibitors prior to MTBITC exposure. This clearly showed that transient elevation of hTERT mRNA expression was predominantly mediated by the MAPK family member JNK. In contrast, activated ERK1/2 and P38, but not JNK, signalled to telomerase abrogation and consequent apoptosis induction. DNA damage by MTBITC was also strongly abolished by MAPK inhibition. Oxidative stress, as analysed by DCF fluorescence assay, electron spin resonance spectroscopy and formation of 4-hydroxynonenal was found as not relevant for this process. Furthermore, N-acetylcysteine pre-treatment did not impact MTBITC-induced telomerase suppression or depolarization of the mitochondrial membrane potential as marker for apoptosis. Our data therefore imply that upon DNA damage by MTBITC, MAPK are essential for telomerase regulation and consequent growth impairment in liver tumor cells and this detail probably plays an important role in understanding the potential chemotherapeutic efficacy of ITC.	[Lamy, Evelyn; Herz, Corinna; Hertrampf, Anke; Marton, Melinda-Rita; Mersch-Sundermann, Volker] Univ Med Ctr Freiburg, Dept Environm Hlth Sci, Freiburg, Germany; [Lutz-Bonengel, Sabine] Univ Med Ctr Freiburg, Inst Legal Med, Freiburg, Germany; [Hertrampf, Anke] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Marton, Melinda-Rita] Univ Politehn Bucuresti, Dept Chem Engn, Bucharest, Romania	University of Freiburg; University of Freiburg; University of Freiburg; Polytechnic University of Bucharest	Lamy, E (corresponding author), Univ Med Ctr Freiburg, Dept Environm Hlth Sci, Freiburg, Germany.	evelyn.lamy@uniklinik-freiburg.de		Herz, Corinna/0000-0003-3837-0544	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Sectorial Operational Programme "Human Resources Development" of the Romanian Ministry of Labour, Family and Social Protection [POSDRU/88/1.5/S/60203]; Mattern Foundation, Germany	European Social Fond; Ministry of Science, Research and Arts Baden-Wurttemberg, Germany; Sectorial Operational Programme "Human Resources Development" of the Romanian Ministry of Labour, Family and Social Protection; Mattern Foundation, Germany	E.L. is funded by an academic grant from the European Social Fond and the Ministry of Science, Research and Arts Baden-Wurttemberg, Germany. M-R.M. was partly funded for this project by the Sectorial Operational Programme "Human Resources Development 2007-2013'' of the Romanian Ministry of Labour, Family and Social Protection through the Financial Agreement POSDRU/88/1.5/S/60203. The study was partly supported by a grant from Mattern Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Alfonso-De Matte MY, 2002, CANCER RES, V62, P4575; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Bianchini F, 2004, DRUG METAB REV, V36, P655, DOI 10.1081/DMR-200033468; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GUGUENGUILLOUZO C, 1986, PROG LIVER DIS, V8, P33; Gunes C, 2000, CANCER RES, V60, P2116; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Hsin IL, MUTAT RES, V688, P72; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Klapper W, 2003, LEUKEMIA, V17, P2007, DOI 10.1038/sj.leu.2403086; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy E, 2004, TOXICOL LETT, V146, P103, DOI 10.1016/j.toxlet.2003.07.001; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P190, DOI 10.1002/em.20448; Lamy E, 2009, ENVIRON MOL MUTAGEN, V50, P164, DOI 10.1002/em.20470; Li H, 2007, ANN NY ACAD SCI, V1114, P56, DOI 10.1196/annals.1396.016; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Moon DO, 2010, CANCER LETT, V295, P260, DOI 10.1016/j.canlet.2010.03.009; Moriarty TJ, 2002, LEUKEMIA, V16, P1112, DOI 10.1038/sj.leu.2402522; Mukherjee S, 2009, J ENVIRON PATHOL TOX, V28, P269, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.30; Mukherjee S, 2009, MOL CELL BIOCHEM, V330, P9, DOI 10.1007/s11010-009-0095-4; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura Y, 2009, FORUM NUTR, V61, P170, DOI 10.1159/000212749; Pizzimenti S, 2006, FREE RADICAL BIO MED, V40, P1578, DOI 10.1016/j.freeradbiomed.2005.12.024; Pizzimenti S, 2010, J NUTR BIOCHEM, V21, P818, DOI 10.1016/j.jnutbio.2009.06.005; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Rose P, 2003, CELL MOL LIFE SCI, V60, P1489, DOI 10.1007/s00018-003-3150-4; Sato N, 2000, BRIT J CANCER, V82, P1819, DOI 10.1054/bjoc.2000.1117; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; STROM S, 1982, CANCER RES, V42, P4519; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50; Xi L, 2006, APOPTOSIS, V11, P789, DOI 10.1007/s10495-006-5701-2; Zanichelli F, 2012, APOPTOSIS, V17, P964, DOI 10.1007/s10495-012-0740-3; Zanichelli F, 2012, AGE, V34, P281, DOI 10.1007/s11357-011-9231-7; Zhang PS, 2003, FASEB J, V17, P767, DOI 10.1096/fj.02-0603fje	55	37	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53240	10.1371/journal.pone.0053240	http://dx.doi.org/10.1371/journal.pone.0053240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382840	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600014
J	Danhier, P; Copetti, T; De Preter, G; Leveque, P; Feron, O; Jordan, BF; Sonveaux, P; Gallez, B				Danhier, Pierre; Copetti, Tamara; De Preter, Geraldine; Leveque, Philippe; Feron, Olivier; Jordan, Benedicte F.; Sonveaux, Pierre; Gallez, Bernard			Influence of Cell Detachment on the Respiration Rate of Tumor and Endothelial Cells	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; OXYGEN-CONSUMPTION; MAMMALIAN-CELLS; IN-VITRO; MECHANISM; CANCER; SPECTROSCOPY; ADHERENT; DECREASE; ANOIKIS	Cell detachment is a procedure routinely performed in cell culture and a necessary step in many biochemical assays including the determination of oxygen consumption rates (OCR) in vitro. In vivo, cell detachment has been shown to exert profound metabolic influences notably in cancer but also in other pathologies, such as retinal detachment for example. In the present study, we developed and validated a new technique combining electron paramagnetic resonance (EPR) oximetry and the use of cytodex 1 and collagen-coated cytodex 3 dextran microbeads, which allowed the unprecedented comparison of the OCR of adherent and detached cells with high sensitivity. Hence, we demonstrated that both B16F10 melanoma cells and human umbilical vein endothelial cells (HUVEC) experience strong OCR decrease upon trypsin or collagenase treatments. The reduction of cell oxygen consumption was more pronounced with a trypsin compared to a collagenase treatment. Cells remaining in suspension also encounter a marked intracellular ATP depletion and an increase in the lactate production/glucose uptake ratio. These findings highlight the important influence exerted by cell adhesion/ detachment on cell respiration, which can be probed with the unprecedented experimental assay that was developed and validated in this study.	[Danhier, Pierre; De Preter, Geraldine; Leveque, Philippe; Jordan, Benedicte F.; Gallez, Bernard] Univ Catholique Louvain UCL, Biomed Magnet Resonance Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Copetti, Tamara; Feron, Olivier; Sonveaux, Pierre] Univ Catholique Louvain UCL, Inst Rech Expt & Clin IREC, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Gallez, B (corresponding author), Univ Catholique Louvain UCL, Biomed Magnet Resonance Res Grp, Louvain Drug Res Inst, Brussels, Belgium.	bernard.gallez@uclouvain.be	FERON, Olivier/AAM-6395-2020	FERON, Olivier/0000-0001-5360-0286; Sonveaux, Pierre/0000-0001-6484-8834; Danhier, Pierre/0000-0002-9028-8399	Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds Joseph Maisin; Saint-Luc Foundation; Fondation contre le Cancer the "Actions de Recherches Concerte ' es-Communaute ' Franc [Belgique-ARC 09/14-020]; European Research Council [FP7/2007-2013]; ERC Independent Researcher Starting [243188]	Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Joseph Maisin; Saint-Luc Foundation; Fondation contre le Cancer the "Actions de Recherches Concerte ' es-Communaute ' Franc; European Research Council(European Research Council (ERC)European Commission); ERC Independent Researcher Starting	This work is supported by grants from the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds Joseph Maisin, the Saint-Luc Foundation, the Fondation contre le Cancer, the "Actions de Recherches Concerte ' es-Communaute ' Franc, aise de Belgique-ARC 09/14-020'', and the European Research Council (FP7/2007-2013 ERC Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux). B. F. Jordan and P. Sonveaux are Research Associates and P. Danhier is a Research Fellow of the FRS-FNRS. G. De Preter is a Televie Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1985, IN VITRO CELL DEV B, V21, P254; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Ansiaux R, 2006, CANCER RES, V66, P9698, DOI 10.1158/0008-5472.CAN-06-1854; BAUMANN H, 1979, J BIOL CHEM, V254, P3935; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cichon MA, 2010, J MOL CELL BIOL, V2, P113, DOI 10.1093/jmcb/mjp050; Clementi E, 1999, P NATL ACAD SCI USA, V96, P1559, DOI 10.1073/pnas.96.4.1559; Crokart N, 2005, CANCER RES, V65, P7911, DOI 10.1158/0008-5472.CAN-05-1288; Crokart N, 2007, CLIN CANCER RES, V13, P630, DOI 10.1158/1078-0432.CCR-06-0802; Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gallez B, 2004, NMR BIOMED, V17, P240, DOI 10.1002/nbm.900; Gottlieb E, 2009, NATURE, V461, P44, DOI 10.1038/461044a; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; HONDA BD, 1991, BIOCHEM CELL BIOL, V69, P728, DOI 10.1139/o91-109; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Jordan BF, 2002, CANCER RES, V62, P3555; Lahdesmaki I, 1999, ANAL CHEM, V71, P5248, DOI 10.1021/ac990712b; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Lindskog U, 1987, Dev Biol Stand, V66, P307; Mamchaoui K, 2000, AM J PHYSIOL-LUNG C, V278, P63; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MUKUNDAN NE, 1995, BIOCHEM BIOPH RES CO, V210, P113, DOI 10.1006/bbrc.1995.1634; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Song YL, 2005, J PHYS D APPL PHYS, V38, P2682, DOI 10.1088/0022-3727/38/15/021; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Territo PR, 2000, ANAL BIOCHEM, V286, P156, DOI 10.1006/abio.2000.4774; Vaupel P, 1998, INT J RADIAT ONCOL, V42, P843, DOI 10.1016/S0360-3016(98)00324-1; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wang SF, 2007, INVEST OPHTH VIS SCI, V48, P1335, DOI 10.1167/iovs.06-0842; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, P36; ZECHEL K, 1980, ANAL BIOCHEM, V102, P203, DOI 10.1016/0003-2697(80)90339-5	40	27	27	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53324	10.1371/journal.pone.0053324	http://dx.doi.org/10.1371/journal.pone.0053324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382841	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800020
J	Vandenberghe, LH; Bell, P; Maguire, AM; Xiao, R; Hopkins, TB; Grant, R; Bennett, J; Wilson, JM				Vandenberghe, Luk H.; Bell, Peter; Maguire, Albert M.; Xiao, Ru; Hopkins, Tim B.; Grant, Rebecca; Bennett, Jean; Wilson, James M.			AAV9 Targets Cone Photoreceptors in the Nonhuman Primate Retina	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; GENE-TRANSFER; THERAPY; VECTOR; TRANSDUCTION; ROD; PIGMENTOSA; BINDING; ACHROMATOPSIA; DYSTROPHIES	Transduction of retinal pigment epithelial cells with an adeno-associated viral vector (AAV) based on serotype 2 has partially corrected retinal blindness in Leber congenital amaurosis type 2. However, many applications of gene therapy for retinal blindness rely on the efficient transduction of rod and cone photoreceptor which is difficult to achieve with first generation vector technology. To address this translational need, we evaluated rod and cone photoreceptor targeting of 4 novel AAV capsids (AAV7, AAV9, rh. 64R1 and rh. 8R) versus AAV2 and AAV8 in a foveated retina. Eyes of 20 nonhuman primates were injected subretinally in the proximity of the fovea. While numerous vectors efficiently transduced rods, only AAV9 targeted cones both centrally and peripherally efficiently at low doses, likely due to the abundance of galactosylated glycans, the primary receptor for AAV9, on cone photoreceptors. We conclude AAV9 is an ideal candidate for strategies that require restoration of cone photoreceptor function.	[Vandenberghe, Luk H.; Bell, Peter; Xiao, Ru; Grant, Rebecca; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA USA; [Maguire, Albert M.; Hopkins, Tim B.; Bennett, Jean] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Vandenberghe, LH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA.	luk_vandenberghe@meei.harvard.edu; wilsonjm@mail.med.upenn.edu	VANDENBERGHE, LUC H./ABH-1765-2020; Vandenberghe, Luk H./J-6395-2014; Wilson, James M/F-9220-2011	VANDENBERGHE, LUC H./0000-0002-3508-4924; Vandenberghe, Luk H./0000-0002-3508-4924; Wilson, James M/0000-0002-9630-3131	GlaxoSmithKline [NIH P30 DK47757]; Foundation Fighting Blindness; CHOP-PENN Pediatric Center for Retinal Degenerations; University of Pennsylvania; Evanina Mackall Foundation Trust at Scheie Eye Institute; Kirby Foundation; NATIONAL EYE INSTITUTE [DP1EY023177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008267] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Foundation Fighting Blindness(European Commission); CHOP-PENN Pediatric Center for Retinal Degenerations; University of Pennsylvania; Evanina Mackall Foundation Trust at Scheie Eye Institute; Kirby Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the support of GlaxoSmithKline for a research grant and NIH P30 DK47757 (JMW). This work was also supported by the Foundation Fighting Blindness (LHV, JB), its CHOP-PENN Pediatric Center for Retinal Degenerations (JB), Transdisciplinary Award Program in Translational Medicine and Therapeutics (TAPITMAT) from the University of Pennsylvania (LHV, JB), Research to Prevent Blindness, the Paul and Evanina Mackall Foundation Trust at Scheie Eye Institute, and the F.M. Kirby Foundation (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bainbridge JWB, 2003, GENE THER, V10, P1336, DOI 10.1038/sj.gt.3301990; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2010, NEW ENGL J MED, V363, P1669, DOI 10.1056/NEJMcibr1007685; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Pang JJ, 2010, ADV EXP MED BIOL, V664, P639, DOI 10.1007/978-1-4419-1399-9_73; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Vandenberghe LH, 2009, GENE THER, V16, P1416, DOI 10.1038/gt.2009.101; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06	29	71	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53463	10.1371/journal.pone.0053463	http://dx.doi.org/10.1371/journal.pone.0053463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382846	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800022
J	Ain, QU; Seemab, U; Rashid, S; Nawaz, MS; Kamal, MA				Ain, Qurrat U.; Seemab, Umair; Rashid, Sajid; Nawaz, Muhammad Sulaman; Kamal, Mohammad A.			Prediction of Structure of Human WNT-CRD (FZD) Complex for Computational Drug Repurposing	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; CATENIN PATHWAY; DOCKING; RECEPTOR; REFINEMENT; EXPRESSION; MUTATIONS; ACTIVATE; BINDING; DOMAIN	The observed genetic alterations of various extracellular and intracellular WNT (Wingless, Int-1 proto-oncogene) signaling components can result in an increase or decrease in gene expression, and hence can be obstructed proficiently. These genetics target sites may include the prevention of WNT-FZD (Frizzled) binding, destruction of beta-catenin and formation of Axin, APC and GSK-3 beta complex. Hence, the localized targeting of these interacting partners can help in devising novel inhibitors against WNT signaling. Our present study is an extension of our previous work, in which we proposed the coregulated expression pattern of the WNT gene cluster (WNT-1, WNT-6, WNT-10A and WNT-10B) in human breast carcinoma. We present here the computationally modeled three dimensional structure of human WNT-1 in complex with the FZD-1 CRD (Cysteine Rich Domain) receptor. The dimeric cysteine-rich domain was found to fit into the evolutionarily conserved U-shaped groove of WNT protein. The two ends of the U-shaped cleft contain N-terminal and C-terminal hydrophobic residues, thus providing a strong hydrophobic moiety for the frizzled receptor and serving as the largest binding pocket for WNT-FZD interaction. Detailed structural analysis of this cleft revealed a maximum atomic distance of similar to 28 angstrom at the surface, narrowing down to similar to 17 angstrom and again increasing up to similar to 27 angstrom at the bottom. Altogether, structural prediction analysis of WNT proteins was performed to reveal newer details about post-translational modification sites and to map the novel pharmacophore models for potent WNT inhibitors.	[Ain, Qurrat U.; Nawaz, Muhammad Sulaman] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Seemab, Umair] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan; [Kamal, Mohammad A.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Ain, Qurrat U.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Informat, Cambridge CB2 1EW, England	COMSATS University Islamabad (CUI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Quaid I Azam University; King Abdulaziz University; University of Cambridge	Kamal, MA (corresponding author), King Abdulaziz Univ, Jeddah 21413, Saudi Arabia.	meu.fabg@hotmail.com	Kamal, Mohammad Amjad/J-2918-2014; Kamal, Mohammad A/J-4622-2013; Rashid, Sajid/K-8640-2019	Kamal, Mohammad Amjad/0000-0003-0088-0565; 				AIN Q, 2011, BIOINFORMATION, V7, P339; Akiyama T, 2000, CYTOKINE GROWTH F R, V11, P273, DOI 10.1016/S1359-6101(00)00011-3; [Anonymous], 2002, CURR PROTOC BIOINFOR; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bienz M, 2012, SCIENCE, V337, P44, DOI 10.1126/science.1224468; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gopalakrishnan K, 2007, PROTEIN PEPTIDE LETT, V14, P669; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IOZZO RV, 1995, CANCER RES, V55, P3495; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036770; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malinauskas T, 2008, LIPIDS, V43, P227, DOI 10.1007/s11745-007-3144-3; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Millar JBA, 2002, GENOME BIOL, V3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Voronkov AE, 2008, DOKL BIOCHEM BIOPHYS, V419, P75, DOI 10.1134/S1607672908020087	35	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54630	10.1371/journal.pone.0054630	http://dx.doi.org/10.1371/journal.pone.0054630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372744	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400019
J	Amar, J; Lange, C; Payros, G; Garret, C; Chabo, C; Lantieri, O; Courtney, M; Marre, M; Charles, MA; Balkau, B; Burcelin, R				Amar, Jacques; Lange, Celine; Payros, Gaelle; Garret, Celine; Chabo, Chantal; Lantieri, Olivier; Courtney, Michael; Marre, Michel; Charles, Marie Aline; Balkau, Beverley; Burcelin, Remy		DESIR Study Grp	Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The DESIR Study	PLOS ONE			English	Article							GUT MICROBIOME; MYOCARDIAL-INFARCTION; DISEASE; RISK; BACTERIA; INFLAMMATION; ENDOTOXEMIA; STIFFNESS; OUTCOMES; ENOLASE	Aim: We recently described a human blood microbiome and a connection between this microbiome and the onset of diabetes. The aim of the current study was to assess the association between blood microbiota and incident cardiovascular disease. Methods and Results: D. E. S. I. R. is a longitudinal study with the primary aim of describing the natural history of the metabolic syndrome and its complications. Participants were evaluated at inclusion and at 3-, 6-, and 9-yearly follow-up visits. The 16S ribosomal DNA bacterial gene sequence, that is common to the vast majority of bacteria (Eubac) and a sequence that mostly represents Proteobacteria (Pbac), were measured in blood collected at baseline from 3936 participants. 73 incident cases of acute cardiovascular events, including 30 myocardial infarctions were recorded. Eubac was positively correlated with Pbac (r = 0.59; P<0.0001). In those destined to have cardiovascular complications, Eubac was lower (0.14 +/- 0.26 vs 0.12 +/- 0.29 ng/mu l; P = 0.02) whereas a non significant increase in Pbac was observed. In multivariate Cox analysis, Eubac was inversely correlated with the onset of cardiovascular complications, (hazards ratio 0.50 95% CI 0.35-0.70) whereas Pbac (1.56, 95% CI 1.12-2.15) was directly correlated. Conclusion: Pbac and Eubac were shown to be independent markers of the risk of cardiovascular disease. This finding is evidence for the new concept of the role played by blood microbiota dysbiosis on atherothrombotic disease. This concept may help to elucidate the relation between bacteria and cardiovascular disease.	[Amar, Jacques; Chabo, Chantal; Burcelin, Remy] CHU Toulouse, Inst Res Metab & Cardiovasc Dis, INSERM U1048, Toulouse, France; [Lange, Celine; Charles, Marie Aline; Balkau, Beverley] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, U1018, Villejuif, France; [Lange, Celine; Charles, Marie Aline; Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Payros, Gaelle; Garret, Celine; Chabo, Chantal; Burcelin, Remy] Biomed Res Federat Inst Toulouse, Toulouse, France; [Lantieri, Olivier; DESIR Study Grp] IRSA, La Riche, France; [Courtney, Michael] VAIOMER SAS, Toulouse, France; [Marre, Michel] Grp Hosp Bichat Claude Bernard, AP HP, Serv Endocrinol Diabet Nutr, Paris, France; [Marre, Michel] Univ Paris 07, INSERM U695, Paris, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Amar, J (corresponding author), CHU Toulouse, Inst Res Metab & Cardiovasc Dis, INSERM U1048, Toulouse, France.	amar.j@chu-toulouse.fr	Fumeron, Frederic/AAC-6882-2019; burcelin, remy/M-6013-2014; Charles, Marie Aline/S-1866-2019; FROGUEL, Philippe/O-6799-2017; Charles, Marie Aline/F-8567-2017; Alhenc-Gelas, Francois/F-9511-2017	Fumeron, Frederic/0000-0002-7916-4619; Charles, Marie Aline/0000-0003-4025-4390; FROGUEL, Philippe/0000-0003-2972-0784; Charles, Marie Aline/0000-0003-4025-4390; Marre, Michel/0000-0002-3071-1837; Chabo, Chantal/0000-0002-5131-0880	INSERM; CNAMTS; Lilly; Novartis; Pharma; Sanofi-Aventis; INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; Novartis Pharma	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis(Novartis); Pharma; Sanofi-Aventis(Sanofi-Aventis); INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; Novartis Pharma	The D.E.S.I.R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis; by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR 2008), the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Societe Francophone du Diabete, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from commercial sources: Lilly, Novartis Pharma and Sanofi-Aventis, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon. The authors also declare that Remy Burcelin, Chantal Chabo, Beverley Balkau and Jacques Amar are listed as coinventors on patents held by the National Institute for Health and Medical Research (INSERM) that relate to the use of bacterial DNA in metabolic diseases. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2003, J HYPERTENS, V21, P1869, DOI 10.1097/00004872-200310000-00014; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Blacher J, 2004, J HYPERTENS, V22, P415, DOI 10.1097/00004872-200402000-00028; Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Espinola-Klein C, 2002, CIRCULATION, V105, P15, DOI 10.1161/hc0102.101362; Fumeron F, 2004, DIABETES, V53, P1150, DOI 10.2337/diabetes.53.4.1150; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gilbert A., 1889, C R HEBD SEANCES SOC, V41, P583; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Katz JT, 2006, CIRCULATION, V113, P920, DOI 10.1161/CIRCULATIONAHA.105.607358; Kinloch AJ, 2011, ARTHRITIS RHEUM-US, V63, P3818, DOI 10.1002/art.30639; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Maass M, 1998, J AM COLL CARDIOL, V31, P827, DOI 10.1016/S0735-1097(98)00016-3; Madjid M, 2003, CIRCULATION, V108, P2730, DOI 10.1161/01.CIR.0000102380.47012.92; Marcadet A, 1987, HISTOCOMPATIBILITY T, V1, P553; Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhu JH, 2001, CIRCULATION, V103, P45	44	123	130	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54461	10.1371/journal.pone.0054461	http://dx.doi.org/10.1371/journal.pone.0054461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372728	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400016
J	Sun, YL; Huang, LQ; Pelosi, P; Wang, CZ				Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu			A Lysine at the C-Terminus of an Odorant-Binding Protein is Involved in Binding Aldehyde Pheromone Components in Two Helicoverpa Species	PLOS ONE			English	Article							SWISS-MODEL; OLFACTORY RECEPTOR; SENSITIVE NEURONS; SEXUAL ATTRACTION; CRYSTAL-STRUCTURE; NMR STRUCTURE; RELEASE; MOTH; MECHANISM; INSECTS	Odorant-binding proteins (OBPs) are soluble proteins, whose role in olfaction of insects is being recognized as more and more important. We have cloned, expressed and purified an OBP (HarmOBP7) from the antennae of the moth Helicoverpa armigera. Western blot experiments indicate specific expression of this protein in the antennae of adults. HarmOBP7 binds both pheromone components Z-11-hexadecenal and Z-9-hexadecenal with good affinity. We have also performed a series of binding experiments with linear aldehydes, alcohols and esters, as well as with other compounds and found a requirement of medium size for best affinity. The affinity of OBP7, as well as that of a mutant lacking the last 6 residues does not substantially decrease in acidic conditions, but increases at basic pH values with no significant differences between wild-type and mutant. Binding to both pheromone components, instead, is negatively affected by the lack of the C-terminus. A second mutant, where one of the three lysine residues in the C-terminus (Lys123) was replaced by methionine showed reduced affinity to both pheromone components, as well as to their analogues, thus indicating that Lys123 is involved in binding these compounds, likely forming hydrogen bonds with the functional groups of the ligands.	[Sun, Ya-Lan; Huang, Ling-Qiao; Pelosi, Paolo; Wang, Chen-Zhu] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, CZ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	czwang@ioz.ac.cn	Rocco, Patricia/I-7460-2012	Rocco, Patricia/0000-0003-1412-7136; Sun, Ya-Lan/0000-0002-4468-1333	National Basic Research Program of China [2012CB114105]; National Natural Science Foundation of China [31130050, 30925026]; Key Technologies R&D Program of China [2012BAD19B05]; Chinese Academy of Sciences visiting professorship for senior international scientists [2009S2-32]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of China(National Key Technology R&D Program); Chinese Academy of Sciences visiting professorship for senior international scientists	This work was supported by National Basic Research Program of China (Grant No. 2012CB114105) and the National Natural Science Foundation of China (Grant No. 31130050; Grant No. 30925026), Key Technologies R&D Program of China (Grant No. 2012BAD19B05), and the Chinese Academy of Sciences visiting professorship for senior international scientists (Grant No. 2009S2-32), that supported a nine-month visit of PP at the Institute of Zoology, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo F, 2012, INSECT BIOCHEM MOLEC, V42, P708, DOI 10.1016/j.ibmb.2012.06.004; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; PELOSI P, 1982, BIOCHEM J, V201, P245, DOI 10.1042/bj2010245; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1990, CHEM SENSES, V15, P205, DOI 10.1093/chemse/15.2.205; PELOSI P, 1981, CHEM SENSES, V6, P77, DOI 10.1093/chemse/6.2.77; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tcatchoff L, 2006, FEBS LETT, V580, P2102, DOI 10.1016/j.febslet.2006.03.017; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015	37	20	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55132	10.1371/journal.pone.0055132	http://dx.doi.org/10.1371/journal.pone.0055132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372826	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400068
J	Zhang, WZ; Wang, RJ; Yang, FK; Zhang, LX; Cao, JP; Zhang, XL; Ling, H; Liu, AQ; Shen, YJ				Zhang, Weizhe; Wang, Rongjun; Yang, Fengkun; Zhang, Longxian; Cao, Jianping; Zhang, Xiaoli; Ling, Hong; Liu, Aiqin; Shen, Yujuan			Distribution and Genetic Characterizations of Cryptosporidium spp. in Pre-Weaned Dairy Calves in Northeastern China's Heilongjiang Province	PLOS ONE			English	Article							DEER-LIKE GENOTYPE; MOLECULAR CHARACTERIZATION; SUBTYPE ANALYSIS; BOVINE CRYPTOSPORIDIUM; PARVUM SUBTYPES; CATTLE; PREVALENCE; HUMANS; GIARDIA; WATER	Background: Cryptosporidium spp. are common parasites of humans and animals. Farm animals, especially pre-weaned calves, are considered to be one of main animal reservoir hosts of Cryptosporidium in the transmission of human cryptosporidiosis. The aim of this study was to determine the distribution and genotypes of Cryptosporidium spp. in pre-weaned calves using molecular tools and to assess zoonotic transmission and elucidate the public health significance in northeastern China. Methodology/Principal Findings: A total of 151 fecal specimens from pre-weaned calves were collected in Heilongjiang Province and were screened for Cryptosporidium by PCR. The average prevalence of Cryptosporidium was 47.68% (72/151). Cryptosporidium spp. were characterized by DNA sequencing of the small subunit (SSU) rRNA gene and the 60-kDa glycoprotein (gp60) gene. Based on the SSU rRNA gene, five Cryptosporidium spp. were identified, including C. bovis (n=34), C. andersoni (n=26), C. ryanae (n=5), C. meleagridis (n=5) and C. parvum (n=2). The SSU rRNA nucleotide sequences were identical to each other, respectively, within C. ryanae, C. parvum, C. meleagridis and C. andersoni. Four types of C. bovis were found in the SSU rRNA gene, with two novel types. The gp60 gene was successfully sequenced in one C. parvum isolate and three C. meleagridis isolates, with IIdA19G1 for C. parvum and IIIeA22G2R1 for C. meleagridis. Conclusion/Significance: Molecular analysis indicates that Cryptosporidium spp. are endemic in pre-weaned calves in Heilongjiang Province. The findings of C. parvum and C. meleagridis suggested the possibility of zoonotic transmission and public health significance. The transmission dynamics of C. parvum and C. meleagridis needed to be clarified by further molecular epidemiologic studies from humans and animals. Whether calves could act as the natural reservoirs of C. meleagridis needed to be confirmed by more systematic experimental infection studies.	[Zhang, Weizhe; Yang, Fengkun; Zhang, Xiaoli; Ling, Hong; Liu, Aiqin] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Cao, Jianping; Shen, Yujuan] WHO Collaborating Ctr Malaria Schistosomiasis & F, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China	Harbin Medical University; Henan Agricultural University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Liu, AQ (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; shyj12@yahoo.com.cn	Cao, Jianping/AFL-5468-2022; Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019; Zhang, Longxian/R-7799-2019	Cao, Jianping/0000-0002-1974-0047; Zhang, Longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242	Natural Science Foundation of Heilongjiang Province, China [D200628]; Chinese Special Program for Scientific Research of Public Health [200802012]	Natural Science Foundation of Heilongjiang Province, China(Natural Science Foundation of Heilongjiang Province); Chinese Special Program for Scientific Research of Public Health	AL was supported by the Natural Science Foundation of Heilongjiang Province, China (No. D200628) and YS was supported by the Chinese Special Program for Scientific Research of Public Health (No. 200802012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2007, ANN TROP MED PARASIT, V101, P539, DOI 10.1179/136485907X193798; Akiyoshi DE, 2003, INFECT IMMUN, V71, P1828, DOI 10.1128/IAI.71.4.1828-1832.2003; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Amer Said, 2010, Journal of the Egyptian Society of Parasitology, V40, P349; Blackburn BG, 2006, EMERG INFECT DIS, V12, P684, DOI 10.3201/eid1204.050796; Broglia A, 2008, VET PARASITOL, V154, P8, DOI 10.1016/j.vetpar.2008.02.029; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Darabus Gh., 2003, Polish Journal of Veterinary Sciences, V6, P225; Diaz P, 2010, PARASITOLOGY, V137, P1187, DOI 10.1017/S0031182010000181; Elwin K, 2012, EPIDEMIOL INFECT, V140, P673, DOI 10.1017/S0950268811000860; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2010, VET PARASITOL, V170, P187, DOI 10.1016/j.vetpar.2010.02.040; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2012, VET PARASITOL, V185, P309, DOI 10.1016/j.vetpar.2011.09.025; Feng YY, 2012, EMERG INFECT DIS, V18, P312, DOI 10.3201/eid1802.110666; Feng YY, 2011, APPL ENVIRON MICROB, V77, P3609, DOI 10.1128/AEM.00146-11; Feng YY, 2009, J CLIN MICROBIOL, V47, P153, DOI 10.1128/JCM.01777-08; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Geurden T, 2006, VET PARASITOL, V138, P217, DOI 10.1016/j.vetpar.2006.02.009; Glaberman S, 2001, J EUKARYOT MICROBIOL, p19S; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Halim NA, 2008, VET PARASITOL, V152, P325, DOI 10.1016/j.vetpar.2007.12.035; Hijjawi N, 2010, EXP PARASITOL, V125, P161, DOI 10.1016/j.exppara.2010.01.011; Jex AR, 2007, ELECTROPHORESIS, V28, P2818, DOI 10.1002/elps.200600772; Karanis P, 2010, VET PARASITOL, V169, P387, DOI 10.1016/j.vetpar.2010.01.014; Keshavarz A, 2009, VET PARASITOL, V160, P316, DOI 10.1016/j.vetpar.2008.11.008; Kvac M, 2006, VET PARASITOL, V137, P202, DOI 10.1016/j.vetpar.2006.01.027; Kvac M, 2011, VET PARASITOL, V177, P378, DOI 10.1016/j.vetpar.2010.11.048; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Lv CC, 2009, APPL ENVIRON MICROB, V75, P7692, DOI 10.1128/AEM.01386-09; Meamar AR, 2007, APPL ENVIRON MICROB, V73, P1033, DOI 10.1128/AEM.00964-06; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Muhid A, 2011, EXP PARASITOL, V127, P534, DOI 10.1016/j.exppara.2010.10.015; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Ng J, 2011, VET PARASITOL, V176, P145, DOI 10.1016/j.vetpar.2010.10.056; Ng J, 2010, EXP PARASITOL, V125, P348, DOI 10.1016/j.exppara.2010.02.017; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Paul S, 2008, VET PARASITOL, V153, P143, DOI 10.1016/j.vetpar.2008.01.044; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Qi M, 2011, EXP PARASITOL, V128, P336, DOI 10.1016/j.exppara.2011.04.003; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Reed C, 2002, APPL ENVIRON MICROB, V68, P427, DOI 10.1128/AEM.68.1.427-429.2002; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Wang RJ, 2012, VET PARASITOL, V187, P534, DOI 10.1016/j.vetpar.2012.02.002; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wang RJ, 2010, AVIAN PATHOL, V39, P447, DOI 10.1080/03079457.2010.518314; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2009, VET PARASITOL, V161, P19, DOI 10.1016/j.vetpar.2008.12.021; Zhou RQ, 2007, PARASITOL RES, V100, P1135, DOI 10.1007/s00436-006-0358-x; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	67	64	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54857	10.1371/journal.pone.0054857	http://dx.doi.org/10.1371/journal.pone.0054857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372782	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400035
J	Zhao, SH; Zhou, Y; Wang, CH; Yang, Y; Wu, XB; Wei, Y; Zhu, L; Zhao, W; Zhang, QW; Wan, CS				Zhao, Suhui; Zhou, Ying; Wang, Chunhui; Yang, Yu; Wu, Xianbo; Wei, Yao; Zhu, Li; Zhao, Wei; Zhang, Qiwei; Wan, Chengsong			The N-Terminal Domain of EspF Induces Host Cell Apoptosis after Infection with Enterohaemorrhagic Escherichia coli O157:H7	PLOS ONE			English	Article							EFFECTOR; PROTEIN; MITOCHONDRIA; OPERON	Enterohemorrhagic Escherichia coli (EHEC) employs a type III secretion system (TTSS) to export the translocator and effector proteins required for mucosal colonization. As an important bacterial effector protein in locus of enterocyte effacement four, the EspF protein causes F-actin filament aggregations to form attaching and effacing (A/E) lesions, and induces the destruction of brush-border microvilli and cytoskeletal rearrangements to form pedestals. However, the molecular pathogenesis of A/E lesions due to EHEC O157:H7 infection is unclear. In this study, we constructed an espF-deficient mutant (Delta espF) with a 162-bp deletion in the N-terminal domain by using overlap extension PCR. The results showed that EHEC EspF translocated into intestinal epithelial cells, targeted mitochondria and induced apoptosis. The Delta espF mutant, compared to EHEC prototype Guangzhou strain, had lower cell attachment and effacement abilities, lower caspase-9/3 and lactate dehydrogenase levels, lower bacterial adhesion, weaker mitochondria apoptosis, and a higher mouse survival rate. Our results demonstrate the probable function of the EspF N-terminal domain, which targets mitochondria and binds mitochondria heat shock protein 70 to induce cell apoptosis via A/E lesions. These findings may be invaluable in clarifying the molecular pathogenesis of EspF of EHEC O157:H7.	[Zhao, Suhui; Zhou, Ying; Wang, Chunhui; Yang, Yu; Wu, Xianbo; Wei, Yao; Zhu, Li; Zhao, Wei; Zhang, Qiwei; Wan, Chengsong] So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zhang, QW (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.	zhang.qiwei@yahoo.com; gzwcs@126.com	Zhao, Suhui/AAW-3259-2021; Zhang, Qiwei/D-9110-2012; Wu, Xianbo/AAL-2948-2020; Zhang, Qiwei/AAX-1977-2020	Zhao, Suhui/0000-0001-9170-9071; Zhang, Qiwei/0000-0002-2770-111X; 	Natural Science Foundation of Guangdong Province project [2010B031000005]; Guangdong Province 211 project [GWXY2010]	Natural Science Foundation of Guangdong Province project; Guangdong Province 211 project	This study was supported by the Natural Science Foundation of Guangdong Province project (2010B031000005) and Guangdong Province 211 project (GWXY2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitio O, 2012, STRUCTURE; ALJUMAILI I, 1992, FEMS MICROBIOL LETT, V93, P121; Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Campellone KG, 2012, J BIOL CHEM, V287, P20613, DOI 10.1074/jbc.M112.363473; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 2009, CURR OPIN MICROBIOL, V12, P1, DOI 10.1016/j.mib.2009.01.002; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lodato PB, 2009, MOL MICROBIOL, V71, P273, DOI 10.1111/j.1365-2958.2008.06530.x; MACLEOD DL, 1989, CAN J MICROBIOL, V35, P623, DOI 10.1139/m89-100; Marches O, 2006, J BACTERIOL, V188, P3110, DOI 10.1128/JB.188.8.3110-3115.2006; Mayer BJ, 2001, J CELL SCI, V114, P1253; McNamara BP, 1998, FEMS MICROBIOL LETT, V166, P71, DOI 10.1016/S0378-1097(98)00313-9; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ni XiaoPing, 2002, Chinese Journal of Zoonoses, V18, P74; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Weflen AW, 2010, CELL MICROBIOL, V12, P919, DOI 10.1111/j.1462-5822.2010.01440.x; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; [苑丽霞 YUAN Lixia], 2008, [山西农业科学, Journal of Shanxi Agricultural Sciences], V36, P15; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	41	15	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55164	10.1371/journal.pone.0055164	http://dx.doi.org/10.1371/journal.pone.0055164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372831	Green Published, gold			2022-12-27	WOS:000315210400071
J	Currao, M; Balduini, CL; Balduini, A				Currao, Manuela; Balduini, Carlo L.; Balduini, Alessandra			High Doses of Romiplostim Induce Proliferation and Reduce Proplatelet Formation by Human Megakaryocytes	PLOS ONE			English	Article							CHRONIC ITP; IN-VITRO; THROMBOPOIETIN; PLATELETS; EFFICACY; PROTEINS; THROMBOCYTOPENIA; DIFFERENTIATION; RECEPTORS; BIOLOGY	Background: Romiplostim (AMG531) is a Thrombopoietin (TPO) receptor agonist with no homology with the endogenous TPO that has been used to treat patients affected by immune thrombocytopenia (ITP). Despite the use of TPO mimetics in the clinical practice, the mechanisms underlying their impact on megakaryocyte function is still unknown. Methodology/Principal Findings: In this project we took advantage of an in vitro human model, that we have established in our laboratory for long time to study megakaryocyte development from human cord blood-derived progenitor cells, and we demonstrated that increasing doses of AMG531 (100 to 2000 ng/mL) determine a progressive increase of megakaryocyte proliferation with a parallel decrease in megakaryocyte ploidy and capacity of extending proplatelets. Most importantly, these differences in megakaryocyte function seemed to be correlated to modulation of AKT phosphorylation. Conclusions/Significance: Overall our results shed new light on the mechanisms and on the relevance of dosage related to AMG531 impact on megakaryocyte function.	[Currao, Manuela; Balduini, Alessandra] IRCCS Policlin San Matteo Fdn, Dept Mol Med, Biotechnol Labs, Pavia, Italy; [Currao, Manuela; Balduini, Carlo L.; Balduini, Alessandra] Univ Pavia, I-27100 Pavia, Italy; [Balduini, Carlo L.] IRCCS Policlin San Matteo Fdn, Dept Internal Med, Pavia, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA USA	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Tufts University	Balduini, A (corresponding author), IRCCS Policlin San Matteo Fdn, Dept Mol Med, Biotechnol Labs, Pavia, Italy.	alessandra.balduini@unipv.it	Balduini, Carlo L/D-9299-2015; Balduini, Alessandra/K-6802-2016; BALDUINI, ALESSANDRA/AAC-3363-2022	Balduini, Carlo L/0000-0001-6121-9311; Balduini, Alessandra/0000-0003-3145-1245; BALDUINI, ALESSANDRA/0000-0003-3145-1245	PRIN [A.0MC62.PRIN110]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by PRIN 2008 (A.0MC62.PRIN110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2012, HAEMATOLOGI IN PRESS; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Broudy VC, 2004, CYTOKINE, V25, P52, DOI 10.1016/j.cyto.2003.05.001; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Bussel JB, 2011, BLOOD, V118, P28, DOI 10.1182/blood-2010-10-313908; Bussel JB, 2009, BLOOD, V113, P2161, DOI 10.1182/blood-2008-04-150078; Dusheiko G, 2009, CLIN LIVER DIS, V13, P487, DOI 10.1016/j.cld.2009.05.012; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2010, SEMIN HEMATOL, V47, P243, DOI 10.1053/j.seminhematol.2010.02.005; Majka M, 2002, EXP HEMATOL, V30, P751, DOI 10.1016/S0301-472X(02)00810-X; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Severin S, 2010, J THROMB HAEMOST, V8, P17, DOI 10.1111/j.1538-7836.2009.03658.x	21	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54723	10.1371/journal.pone.0054723	http://dx.doi.org/10.1371/journal.pone.0054723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359807	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600097
J	Glas, J; Seiderer, J; Bues, S; Stallhofer, J; Fries, C; Olszak, T; Tsekeri, E; Wetzke, M; Beigel, F; Steib, C; Friedrich, M; Goke, B; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Bues, Stephanie; Stallhofer, Johannes; Fries, Christoph; Olszak, Torsten; Tsekeri, Eleni; Wetzke, Martin; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Goeke, Burkhard; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTOPHAGY GENE ATG16L1; CROHNS-DISEASE; ULCERATIVE-COLITIS; LOCI; RISK; IL23R; CARD15; PATHOGENESIS; EXPRESSION	Background & Aims: Genome-wide association studies identified the autophagy gene IRGM to be strongly associated with Crohn's disease (CD) but its impact in ulcerative colitis (UC), its phenotypic effects and potential epistatic interactions with other IBD susceptibility genes are less clear which we therefore analyzed in this study. Methodology/Principal Findings: Genomic DNA from 2060 individuals including 817 CD patients, 283 UC patients, and 961 healthy, unrelated controls (all of Caucasian origin) was analyzed for six IRGM single nucleotide polymorphisms (SNPs) (rs13371189, rs10065172 = p.Leu105Leu, rs4958847, rs1000113, rs11747270, rs931058). In all patients, a detailed genotype-phenotype analysis and testing for epistasis with the three major CD susceptibility genes NOD2, IL23R and ATG16L1 were performed. Our analysis revealed an association of the IRGM SNPs rs13371189 (p = 0.02, OR 1.31 [95% CI 1.05-1.65]), rs10065172 = p.Leu105Leu (p = 0.016, OR 1.33 [95% CI 1.06-1.66]) and rs1000113 (p = 0.047, OR 1.27 [95% CI 1.01-1.61]) with CD susceptibility. There was linkage disequilibrium between these three IRGM SNPs. In UC, several IRGM haplotypes were weakly associated with UC susceptibility (p<0.05). Genotype-phenotype analysis revealed no significant associations with a specific IBD phenotype or ileal CD involvement. There was evidence for weak gene-gene-interaction between several SNPs of the autophagy genes IRGM and ATG16L1 (p<0.05), which, however, did not remain significant after Bonferroni correction. Conclusions/Significance: Our results confirm IRGM as susceptibility gene for CD in the German population, supporting a role for the autophagy genes IRGM and ATG16L1 in the pathogenesis of CD.	[Glas, Juergen; Seiderer, Julia; Bues, Stephanie; Stallhofer, Johannes; Fries, Christoph; Olszak, Torsten; Beigel, Florian; Steib, Christian; Friedrich, Matthias; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Fries, Christoph; Tsekeri, Eleni; Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, Hannover, Germany; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Hannover Medical School; Max Planck Society	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Wetzke, Martin/HDM-2614-2022	Stallhofer, Johannes/0000-0001-8698-6103	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich (FoFoLe) [422]; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01]; German Research Foundation [BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds)	Broad Medical Foundation; Ludwig-Maximilians-University Munich (FoFoLe); Else Kroner-Fresenius-Stiftung; German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds)	JG was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and JD were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J. Seiderer and Promotionsstipendium to JD); J. Seiderer was also supported by the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the German Research Foundation (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, INFLAMM BOWEL DIS, V17, P1917, DOI 10.1002/ibd.21562; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014466; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Huett A, 2009, AUTOPHAGY, V5, P96, DOI 10.4161/auto.5.1.7263; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roberts RL, 2008, GENES IMMUN, V9, P561, DOI 10.1038/gene.2008.49; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Van Limbergen J, 2009, GUT, V58, P610, DOI 10.1136/gut.2008.160721; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	47	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54338	10.1371/journal.pone.0054338	http://dx.doi.org/10.1371/journal.pone.0054338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365659	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600047
J	Kanan, C				Kanan, Christopher			Recognizing Sights, Smells, and Sounds with Gnostic Fields	PLOS ONE			English	Article							TEMPORAL CORTEX; SINGLE NEURONS; SPARSE; REPRESENTATION; RESPONSES; CELLS	Mammals rely on vision, audition, and olfaction to remotely sense stimuli in their environment. Determining how the mammalian brain uses this sensory information to recognize objects has been one of the major goals of psychology and neuroscience. Likewise, researchers in computer vision, machine audition, and machine olfaction have endeavored to discover good algorithms for stimulus classification. Almost 50 years ago, the neuroscientist Jerzy Konorski proposed a theoretical model in his final monograph in which competing sets of "gnostic'' neurons sitting atop sensory processing hierarchies enabled stimuli to be robustly categorized, despite variations in their presentation. Much of what Konorski hypothesized has been remarkably accurate, and neurons with gnostic-like properties have been discovered in visual, aural, and olfactory brain regions. Surprisingly, there have not been any attempts to directly transform his theoretical model into a computational one. Here, I describe the first computational implementation of Konorski's theory. The model is not domain specific, and it surpasses the best machine learning algorithms on challenging image, music, and olfactory classification tasks, while also being simpler. My results suggest that criticisms of exemplar-based models of object recognition as being computationally intractable due to limited neural resources are unfounded.	Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kanan, C (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	ckanan@ucsd.edu			National Science Foundation (NSF) [SBE 0542013, SMA 1041755]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported in part by National Science Foundation (NSF) grant SBE 0542013 and SMA 1041755 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Averbeck BB, 2006, J NEUROSCI, V26, P11023, DOI 10.1523/JNEUROSCI.3466-06.2006; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bowers JS, 2009, PSYCHOL REV, V116, P220, DOI 10.1037/a0014462; Bowman NE, 2012, NEURON, V75, P916, DOI 10.1016/j.neuron.2012.06.035; BROWN GJ, 1994, COMPUT SPEECH LANG, V8, P297, DOI 10.1006/csla.1994.1016; Chai YN, 2011, IEEE I CONF COMP VIS, P2579, DOI 10.1109/ICCV.2011.6126546; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Dhillon IS, 2001, MACH LEARN, V42, P143, DOI 10.1023/A:1007612920971; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Ellis DPW., 2007, ISMIR, V7, P339; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Frisby JP, 2010, SEEING COMPUTATIONAL; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Griffin G., 2007, CNSTR2007001 CALT; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; Grove AJ, 2001, MACH LEARN, V43, P173, DOI 10.1023/A:1010844028087; Haddad R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000740; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Kanan C, 2012, PLOS ONE, V7, P133, DOI 10.1371/journal.pone.0029740; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; Khan F.S., 2011, ADV NEURAL INFORM PR, P1323; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Loewenstein Y, 2011, J NEUROSCI, V31, P9481, DOI 10.1523/JNEUROSCI.6130-10.2011; Ma N., 2008, COCHLEAGRAM REPRESEN; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; MUSAVI MT, 1992, NEURAL NETWORKS, V5, P595, DOI 10.1016/S0893-6080(05)80038-3; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; O'Connor KN, 2005, J NEUROPHYSIOL, V94, P4051, DOI 10.1152/jn.00046.2005; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Raina R, 2007, 24 ANN INT C MACH LE, V227, P759, DOI [10.1145/1273496.1273592, DOI 10.1145/1273496.1273592]; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rolls ET, 2003, J NEUROSCI, V23, P339; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Shirali-Shahreza S, 2009, IEEE T CONSUM ELECTR, V55, P1731, DOI 10.1109/TCE.2009.5278049; Trincavelli M, 2010, IEEE T BIO-MED ENG, V57, P2884, DOI 10.1109/TBME.2010.2049492; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493	52	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54088	10.1371/journal.pone.0054088	http://dx.doi.org/10.1371/journal.pone.0054088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365648	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600030
J	Stockman, LJ; Brooks, WA; Streatfield, PK; Rahman, M; Goswami, D; Nahar, K; Rahman, MZ; Luby, SP; Anderson, LJ				Stockman, Lauren J.; Brooks, W. Abdullah; Streatfield, Peter K.; Rahman, Mustafizur; Goswami, Doli; Nahar, Kamrun; Rahman, Mohammed Z.; Luby, Stephen P.; Anderson, Larry J.			Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004-2008	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; YOUNG-CHILDREN; ETIOLOGY; INFECTIONS; INFLUENZA; BURDEN; INFANTS; SEASON; URBAN	Background: Acute lower respiratory illness is the most common cause of death among children, globally. Data are not available to make accurate estimates on the global mortality from respiratory syncytial virus (RSV), specifically. Methods: Respiratory samples collected from children under 5 years of age during 2004 to 2008 as part of population-based respiratory disease surveillance in an urban community in Dhaka, Bangladesh were tested for RSV, human metapneumovirus (HMPV), human parainfluenza virus (PIV) types 1, 2, and 3, influenza and adenovirus by RT-PCR. Verbal autopsy data were used to identify children who died from respiratory illness in a nearby rural community. Significance of the correlation between detections and community respiratory deaths was determined using Spearman's coefficient. Results: RSV activity occurred during defined periods lasting approximately three months but with no clear seasonal pattern. There was no significant correlation between respiratory deaths and detection of any of the respiratory viruses studied. Conclusion: Outbreaks of respiratory viruses may not be associated with deaths in children in the study site; however, the few respiratory deaths observed and community-to-community variation in the timing of outbreaks may have obscured an association. An accurate assessment of respiratory virus-associated deaths will require detections and death data to come from the same location and a larger study population.	[Stockman, Lauren J.; Anderson, Larry J.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Brooks, W. Abdullah; Streatfield, Peter K.; Rahman, Mustafizur; Goswami, Doli; Nahar, Kamrun; Rahman, Mohammed Z.; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	Centers for Disease Control & Prevention - USA; International Centre for Diarrhoeal Disease Research (ICDDR)	Stockman, LJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	lstockman@cdc.gov	rahman, mustafizur/E-6918-2010; Brooks, W. Abdullah/AAD-3876-2021	Brooks, W. Abdullah/0000-0001-9871-5546; Nahar, Dr.Kamrun/0000-0003-3867-9920	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a grant from the Bill & Melinda Gates Foundation to the International Center for Diarrheal Diseases Research, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Anker M, 2012, STANDARD VERBAL AUTO; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; HUQ F, 1990, REV INFECT DIS, V12, pS982; International Center for Diarrheal Diseases Research Bangladesh, 2009, 114 INT CTR DIARR DI, V43; Kabir A Luthful, 2009, Mymensingh Med J, V18, pS50; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Panozzo CA, 2010, PEDIATRICS, V126, pE116, DOI 10.1542/peds.2009-3221; Reina J, 1997, J CLIN MICROBIOL, V35, P1900, DOI 10.1128/JCM.35.7.1900-1901.1997; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Zachariah P, 2009, PEDIATR INFECT DIS J, V28, P772, DOI 10.1097/INF.0b013e3181a3e5b6	26	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53857	10.1371/journal.pone.0053857	http://dx.doi.org/10.1371/journal.pone.0053857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365643	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600023
J	Zhang, JF; Wang, Y; Zhen, PP; Luo, X; Zhang, C; Zhou, L; Lu, YX; Yang, Y; Zhang, W; Wan, J				Zhang, Jufeng; Wang, Ying; Zhen, Pingping; Luo, Xia; Zhang, Chao; Zhou, Lin; Lu, Yanxin; Yang, Yang; Zhang, Wei; Wan, Jun			Genome-Wide Analysis of miRNA Signature Differentially Expressed in Doxorubicin-Resistant and Parental Human Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							MICRORNA EXPRESSION; MALIGNANT-TRANSFORMATION; SIGNALING PATHWAY; DRUG-RESISTANCE; MESSENGER-RNA; CANCER-CELLS; MECHANISMS; ACTIVATION; IDENTIFICATION; SENSITIVITY	Chemotherapy regiments have been widely used in the treatment of a variety of human malignancies including hepatocellular carcinoma (HCC). A major cause of failure in chemotherapy is drug resistance of cancer cells. Resistance to doxorubicin (DOX) is a common and representative obstacle to treat cancer effectively. Individual microRNA (miRNA) has been introduced in the evolution of DOX resistance in HCC in recent studies. However, a global and systematic assessment of the miRNA expression profiles contributing to DOX resistance is still lacking. In the present study, we applied high-throughput Illumina sequencing to comprehensively characterize miRNA expression profiles in both human HCC cell line (HepG2) and its DOX-resistant counterpart (HepG2/DOX). A total of 269 known miRNAs were significantly differentially expressed, of which 23 were up-regulated and 246 were down-regulated in HepG2/DOX cells, indicating that part of them might be involved in the development of DOX resistance. In addition, we have identified 9 and 13 novel miRNAs up- and down-expressed significantly in HepG2/DOX cells, respectively. miRNA profiling was then validated by quantitative real-time PCR for selected miRNAs, including 22 known miRNAs and 6 novel miRNAs. Furthermore, we predicted the putative target genes for the deregulated miRNAs in the samples. Function annotation implied that these selected miRNAs affected many target genes mainly involved in MAPK signaling pathway. This study provides us a general description of miRNA expression profiling, which is helpful to find potential miRNAs for adjunct treatment to overcome DOX resistance in future HCC chemotherapy.	[Zhang, Jufeng; Wang, Ying; Zhang, Chao; Lu, Yanxin; Yang, Yang; Zhang, Wei; Wan, Jun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China; [Zhang, Jufeng; Zhou, Lin] Guangdong Pharmaceut Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhen, Pingping] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Luo, Xia] S China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China; [Wan, Jun] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Guangdong Pharmaceutical University; Chinese Academy of Sciences; Institute of Zoology, CAS; South China Agricultural University; Hong Kong University of Science & Technology	Zhang, JF (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Peoples R China.	jfzhang111@163.com; zhangweispace@gmail.com; wanj@ust.hk	Zhou, Lin/G-6524-2016	Zhou, Lin/0000-0003-4318-5132; Zheng, Pingping/0000-0002-6059-8919; Wan, Jun/0000-0001-7308-0150	National Natural Scientific Foundation of China [81171447]; Natural Science Foundation of Guangdong Province, China [104518036002006310]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Scientific Foundation of China (Grant No. 81171447), and the Natural Science Foundation of Guangdong Province, China (Grant No. 104518036002006310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bonnas C, 2012, INT J CANCER, V131, P1621, DOI 10.1002/ijc.27422; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; HARRISON DJ, 1995, J PATHOL, V175, P7, DOI 10.1002/path.1711750103; Ho R, 2002, CANCER RES, V62, P6462; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Negrini M, 2008, ANTI-CANCER AGENT ME, V11, P500; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Roberti A, 2006, J CELL PHYSIOL, V207, P571, DOI 10.1002/jcp.20515; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Sterpetti P, 2006, AM J PHYSIOL-GASTR L, V290, pG624, DOI 10.1152/ajpgi.00128.2005; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Tomokuni A, 2011, BIOCHEM BIOPH RES CO, V414, P675, DOI 10.1016/j.bbrc.2011.09.124; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Xu YM, 2011, CANCER LETT, V310, P160, DOI 10.1016/j.canlet.2011.06.027; Yang XY, 2012, ONCOL REP, V27, P250, DOI 10.3892/or.2011.1472; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; Yoon A, 2011, NUCLEIC ACIDS RES, V39, P8078, DOI 10.1093/nar/gkr492; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	63	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54111	10.1371/journal.pone.0054111	http://dx.doi.org/10.1371/journal.pone.0054111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359607	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600032
J	Fukuda, T; Kino, Y; Abe, Y; Yamashiro, H; Kuwahara, Y; Nihei, H; Sano, Y; Irisawa, A; Shimura, T; Fukumoto, M; Shinoda, H; Obata, Y; Saigusa, S; Sekine, T; Isogai, E; Fukumoto, M				Fukuda, Tomokazu; Kino, Yasushi; Abe, Yasuyuki; Yamashiro, Hideaki; Kuwahara, Yoshikazu; Nihei, Hidekazu; Sano, Yosuke; Irisawa, Ayumi; Shimura, Tsutomu; Fukumoto, Motoi; Shinoda, Hisashi; Obata, Yuichi; Saigusa, Shin; Sekine, Tsutomu; Isogai, Emiko; Fukumoto, Manabu			Distribution of Artificial Radionuclides in Abandoned Cattle in the Evacuation Zone of the Fukushima Daiichi Nuclear Power Plant	PLOS ONE			English	Article							SILVER; CS-137	The Fukushima Daiichi Nuclear Power Plant (FNPP) accident released large amounts of radioactive substances into the environment. In order to provide basic information for biokinetics of radionuclides and for dose assessment of internal exposure brought by the FNPP accident, we determined the activity concentration of radionuclides in the organs of 79 cattle within a 20-km radius around the FNPP. In all the specimens examined, deposition of Cesium-134 (Cs-134, half-life: 2.065 y) and Cs-137 (30.07 y) was observed. Furthermore, organ-specific deposition of radionuclides with relatively short half-lives was detected, such as silver-110m (Ag-110m, 249.8 d) in the liver and tellurium-129m ((129)mTe, 33.6 d) in the kidney. Regression analysis showed a linear correlation between the radiocesium activity concentration in whole peripheral blood (PB) and that in each organ. The resulting slopes were organ dependent with the maximum value of 21.3 being obtained for skeletal muscles (R-2 = 0.83, standard error (SE) = 0.76). Thus, the activity concentration of Cs-134 and Cs-137 in an organ can be estimated from that in PB. The level of radioactive cesium in the organs of fetus and infants were 1.19-fold (R-2 = 0.62, SE = 0.12), and 1.51-fold (R-2 = 0.70, SE = 0.09) higher than that of the corresponding maternal organ, respectively. Furthermore, radiocesium activity concentration in organs was found to be dependent on the feeding conditions and the geographic location of the cattle. This study is the first to reveal the detailed systemic distribution of radionuclides in cattle attributed to the FNPP accident.	[Fukuda, Tomokazu; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Kino, Yasushi; Nihei, Hidekazu; Sano, Yosuke; Irisawa, Ayumi] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 980, Japan; [Abe, Yasuyuki] Yamagata Univ, Grad Sch Sci & Engn, Tsuruoka, Yamagata, Japan; [Yamashiro, Hideaki] Niigata Univ, Fac Agr, Niigata 95021, Japan; [Kuwahara, Yoshikazu; Shimura, Tsutomu; Fukumoto, Motoi; Fukumoto, Manabu] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Shinoda, Hisashi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Obata, Yuichi] RIKEN BioResource Ctr BRC, Tsukuba, Ibaraki, Japan; [Saigusa, Shin] Natl Inst Radiol Sci, Chiba 260, Japan; [Sekine, Tsutomu] Tohoku Univ, Ctr Adv Higher Educ, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Yamagata University; Niigata University; Tohoku University; Tohoku University; RIKEN; National Institutes for Quantum Science & Technology; Tohoku University	Fukumoto, M (corresponding author), Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	fukumoto@idac.tohoku.ac.jp	Kino, Yasushi/U-3909-2017; Fukumoto, Manabu/L-1444-2019; Obata, Yuichi/A-5300-2016; Kino, Yasushi/ABB-8627-2021; Fukuda, Tomokazu/O-1257-2018	Kino, Yasushi/0000-0002-8359-9383; Obata, Yuichi/0000-0003-1839-4709; Fukuda, Tomokazu/0000-0001-8456-0483	Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Tohoku University; National Cancer Center Research and Development Fund, Japan; Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan	Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Tohoku University; National Cancer Center Research and Development Fund, Japan; Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan	This study was supported by an Emergency Budget for the Reconstruction of Northeastern Japan, MEXT, Japan; Discretionary Expense of the President of Tohoku University; National Cancer Center Research and Development Fund, Japan; The Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fishers, MAFF, Japan; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, BRAIN, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW W F, 1972, Experientia (Basel), V28, P1444, DOI 10.1007/BF01957840; AGNEW WF, 1972, TERATOLOGY, V6, P331, DOI 10.1002/tera.1420060311; Bandazhevsky YI, 2003, SWISS MED WKLY, V133, P488; BERESFORD NA, 1989, SCI TOTAL ENVIRON, V85, P81, DOI 10.1016/0048-9697(89)90307-0; Bowyer TW, 2011, J ENVIRON RADIOACTIV, V102, P681, DOI 10.1016/j.jenvrad.2011.04.009; Calabrese E, 2011, P NATL ACAD SCI USA, V108, P19447, DOI 10.1073/pnas.1117296108; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P177, DOI 10.1007/BF00507822; Danscher G, 2010, HISTOCHEM CELL BIOL, V133, P359, DOI 10.1007/s00418-009-0670-5; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; *ICRP, 1994, ANN ICRP, V23; ICRP, 2002, ICRP PUBL, V88; Inaba J, 1967, J Radiat Res, V8, P132, DOI 10.1269/jrr.8.132; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; MULLEN AA, 1974, HEALTH PHYS, V27, P279, DOI 10.1097/00004032-197409000-00006; POLACHEK AA, 1960, J LAB CLIN MED, V56, P499; Romanenko A, 2009, CARCINOGENESIS, V30, P1821, DOI 10.1093/carcin/bgp193; Sinclair LE, 2011, J ENVIRON RADIOACTIV, V102, P1018, DOI 10.1016/j.jenvrad.2011.06.008; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	19	63	64	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54312	10.1371/journal.pone.0054312	http://dx.doi.org/10.1371/journal.pone.0054312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372703	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500055
J	Guess, AJ; Ayoob, R; Chanley, M; Manley, J; Cajaiba, MM; Agrawal, S; Pengal, R; Pyle, AL; Becknell, B; Kopp, JB; Ronkina, N; Gaestel, M; Benndorf, R; Smoyer, WE				Guess, Adam J.; Ayoob, Rose; Chanley, Melinda; Manley, Joshua; Cajaiba, Mariana M.; Agrawal, Shipra; Pengal, Ruma; Pyle, Amy L.; Becknell, Brian; Kopp, Jeffrey B.; Ronkina, Natalia; Gaestel, Matthias; Benndorf, Rainer; Smoyer, William E.			Crucial Roles of the Protein Kinases MK2 and MK3 in a Mouse Model of Glomerulonephritis	PLOS ONE			English	Article							SMALL HSP PHOSPHORYLATION; CRESCENTIC GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PODOCYTE INJURY; MAPKAP KINASES; CELLULAR STRESS; RENAL INJURY; P38 MAPK; IN-VITRO; ACTIVATION	Elevated mitogen-activated protein kinase p38 (p38 MAPK) signaling has been implicated in various experimental and human glomerulopathies, and its inhibition has proven beneficial in animal models of these diseases. p38 MAPK signaling is partially mediated through MK2 and MK3, two phylogenetically related protein kinases that are its direct substrates. The current study was designed to determine the specific roles of MK2 and MK3 in a mouse model of acute proliferative glomerulonephritis, using mice with disrupted MK2 and/or MK3 genes. We found that the absence of MK3 alone worsened the disease course and increased mortality slightly compared to wild-type mice, whereas the absence of MK2 alone exhibited no significant effect. However, in an MK3-free background, the disease course depended on the presence of MK2 in a gene dosage-dependent manner, with double knock-out mice being most susceptible to disease induction. Histological and renal functional analyses confirmed kidney damage following disease induction. Because the renal stress response plays a crucial role in kidney physiology and disease, we analyzed the stress response pattern in this disease model. We found that renal cortices of diseased mice exhibited a pronounced and specific pattern of expression and/or phosphorylation of stress proteins and other indicators of the stress response (HSPB1, HSPB6, HSPB8, CHOP, eIF2 alpha), partially in a MK2/MK3 genotype-specific manner, and without induction of a general stress response. Similarly, the expression and activation patterns of other protein kinases downstream of p38 MAPK (MNK1, MSK1) depended partially on the MK2/MK3 genotype in this disease model. In conclusion, MK2 and MK3 together play crucial roles in the regulation of the renal stress response and in the development of glomerulonephritis, which can potentially be exploited to develop novel therapeutic approaches to treat glomerular disease.	[Guess, Adam J.; Ayoob, Rose; Chanley, Melinda; Manley, Joshua; Agrawal, Shipra; Pengal, Ruma; Becknell, Brian; Benndorf, Rainer; Smoyer, William E.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Cajaiba, Mariana M.; Pyle, Amy L.] Nationwide Childrens Hosp, Dept Pathol, Columbus, OH USA; [Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Ronkina, Natalia; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany; [Benndorf, Rainer; Smoyer, William E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Hannover Medical School; University System of Ohio; Ohio State University	Benndorf, R (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA.	rainer.benndorf@nationwidechildrens.org	Kopp, Jeffrey B/O-2681-2015; Ayoob, Rose/D-2123-2013; Gaestel, Matthias/A-6560-2013; Becknell, Michael/E-6995-2014	Kopp, Jeffrey B/0000-0001-9052-186X; Ayoob, Rose/0000-0003-1890-4094; Gaestel, Matthias/0000-0002-4944-4652; 	NIH/NIDDK [RO1 DK077283]; NIDDK Intramural Research Program; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077283] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK grant RO1 DK077283 to WES, by the NIDDK Intramural Research Program to JBK, and by the Deutsche Forschungsgemeinschaft to MG and NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. web sites: http://www2.niddk.nih.gov http://www.dfg.de/index.jsp	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Benndorf R, 2000, METH MOL B, V99, P431; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cybulsky AV, 2011, J SIGNAL TRANSDUCT, V2011; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Gaestel M, 2008, FRONT BIOSCI, V13, P6050, DOI 10.2741/3136; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hirano S, 2005, AM J PHYSIOL-RENAL, V288, pF1133, DOI 10.1152/ajprenal.00210.2004; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; IWATA J, 1979, CLIN CHEM, V25, P1317; Kampinga HH, 2006, HANDB EXP PHARM, V172, P1; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Milovanceva-Popovska M, 2005, KIDNEY INT, V67, P1362, DOI 10.1111/j.1523-1755.2005.00213.x; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Musial K, 2011, PEDIATR NEPHROL, V26, P1031, DOI 10.1007/s00467-010-1709-5; Park JK, 2008, NEPHROL DIAL TRANSPL, V23, P1844, DOI 10.1093/ndt/gfm917; Pengal R, 2011, AM J PHYSIOL-RENAL, V301, pF509, DOI 10.1152/ajprenal.00661.2010; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Polzer K, 2008, ANN RHEUM DIS, V67, P602, DOI 10.1136/ard.2007.077263; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Shiryaev Alexey, 2011, J Mol Signal, V6, P4, DOI 10.1186/1750-2187-6-4; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Smoyer WE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0681com; Smoyer WE, 2000, J AM SOC NEPHROL, V11, P211, DOI 10.1681/ASN.V112211; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Stambe C, 2003, KIDNEY INT, V64, P2121, DOI 10.1046/j.1523-1755.2003.00324.x; Stambe C, 2003, J AM SOC NEPHROL, V14, P338, DOI 10.1097/01.ASN.0000048715.12315.FD; Yo Y, 2003, NEPHRON EXP NEPHROL, V93, P92, DOI 10.1159/000069551; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; Yu DH, 2005, J AM SOC NEPHROL, V16, P1733, DOI 10.1681/ASN.2005020159	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54239	10.1371/journal.pone.0054239	http://dx.doi.org/10.1371/journal.pone.0054239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372691	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500044
J	Suzuki, S; Shishido, T; Funayama, A; Netsu, S; Ishino, M; Kitahara, T; Sasaki, T; Katoh, S; Otaki, Y; Watanabe, T; Shibata, Y; Mantovani, A; Takeishi, Y; Kubota, I				Suzuki, Satoshi; Shishido, Tetsuro; Funayama, Akira; Netsu, Shunsuke; Ishino, Mitsunori; Kitahara, Tatsuro; Sasaki, Toshiki; Katoh, Shigehiko; Otaki, Yoichiro; Watanabe, Tetsu; Shibata, Yoko; Mantovani, Alberto; Takeishi, Yasuchika; Kubota, Isao			Long Pentraxin PTX3 Exacerbates Pressure Overload-Induced Left Ventricular Dysfunction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDUCED CARDIAC-HYPERTROPHY; CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; ACUTE MYOCARDIAL-INFARCTION; ADVERSE CLINICAL-OUTCOMES; CAMP EARLY REPRESSOR; NF-KAPPA B; INNATE IMMUNITY; ANGIOTENSIN-II	Background: Left ventricular hypertrophy is enhanced by an inflammatory state and stimulation of various cytokines. Pentraxin 3 (PTX3) is rapidly produced in response to inflammatory signals, and high plasma PTX3 levels are seen in patients with heart failure. This study aimed to examine the influence of PTX3 on cardiac hypertrophy and left ventricular dysfunction with respect to pressure overload. Methods and Results: PTX3 systemic knockout (PTX3-KO) mice, transgenic mice with cardiac-specific overexpression of PTX3 (PTX3-TG), and the respective wild-type (WT) littermate mice were subjected to transverse aortic constriction (TAC) or a sham operation. Cardiac PTX3 expression increased after TAC in WT mice. In vitro, hydrogen peroxide induced the expression of PTX3 in both cardiac myocytes and cardiac fibroblasts. Recombinant PTX3 phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) in cardiac fibroblasts. Phosphorylation of cardiac ERK1/2 and nuclear factor kappa-B after TAC was attenuated in the PTX3-KO mice but was enhanced in the PTX3-TG mice compared with WT mice. Interleukin-6 and connective tissue growth factor production was lower in the PTX3-KO mice than in the WT mice, but this was augmented in the PTX3-TG mice than in the WT mice. Echocardiography revealed that adverse remodeling with left ventricular dysfunction, as well as with increased interstitial fibrosis, was enhanced in PTX3-TG mice, while these responses were suppressed in PTX3-KO mice. Conclusion: The local inflammatory mediator PTX3 directly modulates the hypertrophic response and ventricular dysfunction following an increased afterload.	[Suzuki, Satoshi; Shishido, Tetsuro; Funayama, Akira; Netsu, Shunsuke; Ishino, Mitsunori; Kitahara, Tatsuro; Sasaki, Toshiki; Katoh, Shigehiko; Otaki, Yoichiro; Watanabe, Tetsu; Shibata, Yoko; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy	Yamagata University; Fukushima Medical University; University of Milan	Shishido, T (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	tshishid@med.id.yamagata-u.ac.jp	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X	Ministry of Education, Science, Sports, and Culture, Japan [19590804, 21590935, 21590923, 21790701, 23790830]; 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science; Italian Ministry of Health; European Commission; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Fukuda Foundation for Medical Technology; Japan Heart Foundation Research Grant	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science; Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Japan Heart Foundation Research Grant	This study was supported in part by a grant-in-aid for Scientific Research (Nos. 19590804 and 21590935 to Y.T., 21590923 to I.K., and 21790701 and 23790830 to T.S.) from the Ministry of Education, Science, Sports, and Culture, Japan, and a grant-in-aid from the 21st Global Century Center of Excellence (COE) program of the Japan Society for the Promotion of Science. A.M. was supported by the Italian Ministry of Health and by the European Commission, Project Tolerage. Y.T. was supported by the Mitsubishi Pharma Research Foundation, Takeda Science Foundation, the Uehara Memorial Foundation, and Fukuda Foundation for Medical Technology. T.S. was supported by the Japan Heart Foundation Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; Bilim O, 2010, J CARD FAIL, V16, P873, DOI 10.1016/j.cardfail.2010.05.029; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Cirillo P, 2005, CARDIOVASC RES, V68, P47, DOI 10.1016/j.cardiores.2005.05.010; Devaraj S, 2005, ARTERIOSCL THROM VAS, V25, P1359, DOI 10.1161/01.ATV.0000168573.10844.ae; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Harada M, 2007, CIRC J, V71, P276, DOI 10.1253/circj.71.276; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Introna M, 1996, BLOOD, V87, P1862; Katoh S, 2010, ANN NUCL MED, V24, P679, DOI 10.1007/s12149-010-0409-3; Kitahara T, 2010, J CARD FAIL, V16, P308, DOI 10.1016/j.cardfail.2009.12.014; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sasaki T, 2010, INT J CARDIOL; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Shishido T, 2008, CIRC RES, V102, P1416, DOI 10.1161/CIRCRESAHA.107.168138; Shishido T, 2011, CLIN EXP HYPERTENS, V33, P117, DOI 10.3109/10641963.2010.531837; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Wenzel S, 2010, BASIC RES CARDIOL, V105, P621, DOI 10.1007/s00395-010-0108-1; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Yan C, 2007, CIRC RES, V100, P510, DOI 10.1161/01.RES.0000259045.49371.9c; Yin WH, 2004, AM HEART J, V147, P931, DOI 10.1016/j.ahj.2003.11.021; Yokoyama T, 1999, AM J PHYSIOL-HEART C, V276, pH1968, DOI 10.1152/ajpheart.1999.276.6.H1968	40	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53133	10.1371/journal.pone.0053133	http://dx.doi.org/10.1371/journal.pone.0053133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372656	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500012
J	Phipps, WL; Willis, SG; Wolter, K; Naidoo, V				Phipps, W. Louis; Willis, Stephen G.; Wolter, Kerri; Naidoo, Vinny			Foraging Ranges of Immature African White-Backed Vultures (Gyps africanus) and Their Use of Protected Areas in Southern Africa	PLOS ONE			English	Article							CAPE VULTURES; GRIFFON VULTURES; LAND-USE; RANGING BEHAVIOR; POPULATION; CONSERVATION; COPROTHERES; PROVINCE; PERFORMANCE; PREDATION	Vultures in the Gyps genus are declining globally. Multiple threats related to human activity have caused widespread declines of vulture populations in Africa, especially outside protected areas. Addressing such threats requires the estimation of foraging ranges yet such estimates are lacking, even for widespread (but declining) species such as the African whitebacked vulture (Gyps africanus). We tracked six immature African white-backed vultures in South Africa using GPS-GSM units to study their movement patterns, their use of protected areas and the time they spent in the vicinity of supplementary feeding sites. All individuals foraged widely; their combined foraging ranges extended into six countries in southern Africa (mean (+/- SE) minimum convex polygon area = 269,103 +/- 187,187 km(2)) and three of the vultures travelled more than 900 km from the capture site. All six vultures spent the majority of their tracking periods outside protected areas. South African protected areas were very rarely visited whereas protected areas in northern Botswana and Zimbabwe were used more frequently. Two of the vultures visited supplementary feeding sites regularly, with consequent reduced ranging behaviour, suggesting that individuals could alter their foraging behaviour in response to such sites. We show that immature African white-backed vultures are capable of travelling throughout southern Africa, yet use protected areas to only a limited extent, making them susceptible to the full range of threats in the region. The standard approach of designating protected areas to conserve species is unlikely to ensure the protection of such wide-ranging species against threats in the wider landscape.	[Phipps, W. Louis] Univ Pretoria, Dept Paraclin Sci, Onderstepoort, Guateng, South Africa; [Phipps, W. Louis; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Wolter, Kerri] Vulture Programme, Brits Dist, North West Prov, South Africa; [Naidoo, Vinny] Univ Pretoria, Biomed Res Ctr, Onderstepoort, Guateng, South Africa	University of Pretoria; Durham University; University of Pretoria	Willis, SG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	s.g.willis@durham.ac.uk	Willis, Stephen G/F-8503-2015; Naidoo, Vinny/A-1508-2008	Willis, Stephen G/0000-0002-8656-5808; Naidoo, Vinny/0000-0003-2740-5983; Phipps, Louis/0000-0003-0400-2014	Leverhulme Trus; University of Pretoria; Mankwe Wildlife Reserve	Leverhulme Trus(Leverhulme Trust); University of Pretoria; Mankwe Wildlife Reserve	The Leverhulme Trust funded the project and WLP with a Study Abroad Studentship. The project was also funded in part by the Faculty of Veterinary Science at the University of Pretoria and Mankwe Wildlife Reserve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MD, 2000, OSTRICH, V71, P25, DOI 10.1080/00306525.2000.9639859; Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; Bamford AJ, 2009, S AFR J WILDL RES, V39, P202, DOI 10.3957/056.039.0201; Benson PC, 2004, OSTRICH, V75, P118, DOI 10.2989/00306520409485423; Beyer H, 2009, HAWTHS ANAL TOOLS AR; BirdLife International, 2013, SPEC FACTSH GYPS AFR; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN CJ, 1988, OSTRICH, V59, P126, DOI 10.1080/00306525.1988.9633714; Brown L.H., 1982, BIRDS AFRICA, V1; Cronje H. P., 2002, Koedoe, V45, P79; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Diekmann M., 2004, VULTURE NEWS, V51, P34; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Garcia-Ripolles C, 2011, ACTA ORNITHOL, V46, P127, DOI 10.3161/000164511X625892; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Herremans M, 2000, BIOL CONSERV, V94, P31, DOI 10.1016/S0006-3207(99)00166-4; HORNER MA, 1990, J MAMMAL, V71, P402, DOI 10.2307/1381953; HOUSTON D C, 1974, East African Wildlife Journal, V12, P63; HOUSTON DC, 1974, J ZOOL, V172, P35; HOUSTON DC, 1976, IBIS, V118, P14, DOI 10.1111/j.1474-919X.1976.tb02008.x; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; IUCN UNEP, 2003, UN LIST PROT AR 2003; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lindsey PA, 2009, J ZOOL, V277, P99, DOI 10.1111/j.1469-7998.2008.00529.x; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; Mapiye C, 2009, J ARID ENVIRON, V73, P529, DOI 10.1016/j.jaridenv.2009.01.003; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Mundy P., 1992, VULTURES AFRICA; Mundy PJ, 1997, ATLAS SO AFRICAN BIR, P160; Murn C, 2008, OSTRICH, V79, P191, DOI 10.2989/OSTRICH.2008.79.2.9.583; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Oschadleus Dieter, 2002, Vulture News, V46, P16; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; PARRY D, 1992, ENVIRON CONSERV, V19, P245, DOI 10.1017/S0376892900031040; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Piper SE, 1999, BIRD STUDY, V46, P230; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; ROBERTSON AS, 1986, BIOL CONSERV, V35, P63, DOI 10.1016/0006-3207(86)90027-3; Rodgers A.R., 2007, HOME RANGE TOOLS HRT; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; Schultz P, 2007, THESIS U CAPE TOWN; Simmons Robert E., 2007, Vulture News, V56, P41; South A. B., 2008, RANGES7 ANAL TRACKIN; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Tambling CJ, 2005, J APPL ECOL, V42, P431, DOI 10.1111/j.1365-2664.2005.01039.x; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; van der Waal C, 2000, S AFR J WILDL RES, V30, P151; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	60	53	54	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52813	10.1371/journal.pone.0052813	http://dx.doi.org/10.1371/journal.pone.0052813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382824	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800012
J	Xu, C; Aragam, N; Li, X; Villla, EC; Wang, L; Briones, D; Petty, L; Posada, Y; Arana, TB; Cruz, G; Mao, CX; Camarillo, C; Bin Su, B; Escamilla, MA; Wang, KS				Xu, Chun; Aragam, Nagesh; Li, Xia; Villla, Erika Cynthia; Wang, Liang; Briones, David; Petty, Leonora; Posada, Yolanda; Arana, Tania Bedard; Cruz, Grace; Mao, ChunXiang; Camarillo, Cynthia; Bin Su, Brenda; Escamilla, Michael A.; Wang, KeSheng			BCL9 and C9orf5 Are Associated with Negative Symptoms in Schizophrenia: Meta-Analysis of Two Genome-Wide Association Studies	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; FAMILY-BASED ASSOCIATION; BIPOLAR DISORDER; CANDIDATE GENES; PSYCHIATRIC GENETICS; MENTAL-DISORDERS; COMMON VARIANTS; LINKAGE; CANCER; ENDOPHENOTYPES	Schizophrenia is a chronic and debilitating psychiatric condition affecting slightly more than 1% of the population worldwide and it is a multifactorial disorder with a high degree of heritability (80%) based on family and twin studies. Increasing lines of evidence suggest intermediate phenotypes/endophenotypes are more associated with causes of the disease and are less genetically complex than the broader disease spectrum. Negative symptoms in schizophrenia are attractive intermediate phenotypes based on their clinical and treatment response features. Therefore, our objective was to identify genetic variants underlying the negative symptoms of schizophrenia by analyzing two genome-wide association (GWA) data sets consisting of a total of 1,774 European-American patients and 2,726 controls. Logistic regression analysis of negative symptoms as a binary trait (adjusted for age and sex) was performed using PLINK. For meta-analysis of two datasets, the fixed-effect model in PLINK was applied. Through meta-analysis we identified 25 single nucleotide polymorphisms (SNPs) associated with negative symptoms with p<5x10(-5). Especially we detected five SNPs in the first two genes/loci strongly associated with negative symptoms of schizophrenia (Pmeta-analysis<6.22x10(-6)), which included three SNPs in the BCL9 gene: rs583583 showed the strongest association at a Pmeta-analysis of 6.00x10(-7) and two SNPs in the C9orf5 (the top SNP is rs643410 with a p = 1.29 x 10(-6)). Through meta-analysis, we identified several additional negative symptoms associated genes (ST3GAL1, RNF144, CTNNA3 and ZNF385D). This is the first report of the common variants influencing negative symptoms of schizophrenia. These results provide direct evidence of using of negative symptoms as an intermediate phenotype to dissect the complex genetics of schizophrenia. However, additional studies are warranted to examine the underlying mechanisms of these disease-associated SNPs in these genes.	[Xu, Chun; Briones, David; Petty, Leonora; Arana, Tania Bedard; Cruz, Grace; Camarillo, Cynthia; Escamilla, Michael A.] Texas Tech Univ Hlth Sci Ctr, Paul L Foster Sch Med, Dept Psychiat, El Paso, TX 79905 USA; [Xu, Chun; Briones, David; Petty, Leonora; Arana, Tania Bedard; Cruz, Grace; Camarillo, Cynthia; Escamilla, Michael A.] Texas Tech Univ Hlth Sci Ctr, Paul L Foster Sch Med, Dept Neurol, El Paso, TX USA; [Xu, Chun; Briones, David; Petty, Leonora; Arana, Tania Bedard; Cruz, Grace; Camarillo, Cynthia; Escamilla, Michael A.] Ctr Excellence Neurosci, El Paso, TX USA; [Aragam, Nagesh; Wang, Liang; Wang, KeSheng] E Tennessee State Univ, Coll Publ Hlth, Dept Biostat & Epidemiol, Johnson City, TN 37614 USA; [Aragam, Nagesh] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Div Infect Dis, Chapel Hill, NC 27599 USA; [Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Villla, Erika Cynthia] Univ Texas El Paso, El Paso, TX 79968 USA; [Posada, Yolanda] Walden Univ, Minneapolis, MN USA; [Mao, ChunXiang; Bin Su, Brenda] Univ Toronto, Toronto, ON, Canada	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; East Tennessee State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harbin Medical University; University of Texas System; University of Texas El Paso; Walden University; University of Toronto	Xu, C (corresponding author), Texas Tech Univ Hlth Sci Ctr, Paul L Foster Sch Med, Dept Psychiat, El Paso, TX 79905 USA.	chun.xu@ttuhsc.edu; wangk@etsu.edu	li, xia/HHZ-7468-2022	Arana, Tania/0000-0002-8121-2085	Genomics Research Branch at NIMH; MGS [U01s: MH79469, MH79470]; NIMH Schizophrenia Genetics Initiative [U01s: MH46276, MH46289, MH46318, R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059587, U01MH079469, R01MH059566, R01MH059565, R01MH061675, U01MH046276, R01MH059586, R01MH059588, U01MH079470, R01MH060870, R01MH060879, R01MH067257, U01MH046318, U01MH046289, R01MH059571] Funding Source: NIH RePORTER	Genomics Research Branch at NIMH; MGS; NIMH Schizophrenia Genetics Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The genotyping of samples was provided through the Genetic Association Information Network (GAIN). The dataset used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000021.v2.p1. Samples and associated phenotype data for the Genome-Wide Association Study of Schizophrenia were provided by Dr. PV Gejman. Funding support for the companion studies, Genome-Wide Association Study of Schizophrenia (GAIN) and Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_ non-GAIN), was provided by Genomics Research Branch at NIMH and the genotyping and analysis of samples was provided through the Genetic Association Information Network (GAIN) and under the MGS U01s: MH79469 and MH79470. Assistance with data cleaning was provided by the National Center for Biotechnology Information. The MGS dataset(s) used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession numbers phs000021.v2.p1 (GAIN) and phs000167.v1.p1 (nonGAIN). Samples and associated phenotype data for the MGS GWAS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH46276 (CR Cloninger), MH46289 (C Kaufmann), and MH46318 (MT Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (NG Buccola), MH59588 (BJ Mowry), MH59571 (PV Gejman), MH59565 (Robert Freedman), MH59587 (F Amin), MH60870 (WF Byerley), MH59566 (DW Black), MH59586 (JM Silverman), MH61675 (DF Levinson), and MH60879 (CR Cloninger). Further details of collection sites, individuals, and institutions may be found in data supplement Table 1 of Sanders et al. (2008). This study was approved by Internal Review Board (IRB), East Tennessee State University.	ADDINGTON J, 1991, SCHIZOPHR RES, V5, P123, DOI 10.1016/0920-9964(91)90039-T; Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Berman I, 1997, SCHIZOPHR RES, V25, P1, DOI 10.1016/S0920-9964(96)00098-9; Bishop JR, 2005, SCHIZOPHR RES, V77, P253, DOI 10.1016/j.schres.2005.04.001; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Chadwick BP, 1999, GENE, V240, P67, DOI 10.1016/S0378-1119(99)00432-1; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Duan JB, 2010, BRAIN RES BULL, V83, P93, DOI 10.1016/j.brainresbull.2010.04.009; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gejman PV, 2010, PSYCHIAT CLIN N AM, V33, P35, DOI 10.1016/j.psc.2009.12.003; Gould TD, 2003, PHARMACOL RES, V48, P49, DOI 10.1016/S0143-6618(03)00096-3; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Itokawa M, 2010, J PHARMACOL SCI, V114, P1, DOI 10.1254/jphs.10R07FM; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; Lane HY, 2004, INT J NEUROPSYCHOPH, V7, P461, DOI 10.1017/S1461145704004389; Lecrubier Y, 2008, EUR ARCH PSY CLIN N, V258, P6, DOI 10.1007/s00406-007-1003-0; Li JY, 2011, ARCH GEN PSYCHIAT, V68, P232, DOI 10.1001/archgenpsychiatry.2011.1; Luciano M, 2011, BIOL PSYCHOL, V86, P193, DOI 10.1016/j.biopsycho.2010.11.008; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Meencke H J, 1999, Adv Neurol, V79, P123; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Montgomery SA, 2007, EUR NEUROPSYCHOPHARM, V17, pS223, DOI 10.1016/S0924-977X(07)70295-X; Morgan AR, 2008, AM J MED GENET B, V147B, P727, DOI 10.1002/ajmg.b.30670; Narayan S, 2009, J NEUROSCI RES, V87, P278, DOI 10.1002/jnr.21822; Nieratschker Vanessa, 2010, Front Behav Neurosci, V4, P23, DOI 10.3389/fnbeh.2010.00023; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; Potkin SG, 2010, NEUROIMAGE, V53, P839, DOI 10.1016/j.neuroimage.2010.06.036; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Simpson EH, 2011, BIOL PSYCHIAT, V69, P928, DOI 10.1016/j.biopsych.2011.01.012; Smith JD, 2011, CELL MOL LIFE SCI, V68, P2493, DOI 10.1007/s00018-011-0728-0; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Velligan DI, 2008, PSYCHIAT TIME, V25; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881; Zandi PP, 2008, AM J MED GENET B, V147B, P612, DOI 10.1002/ajmg.b.30651; Zandi PP, 2008, ARCH GEN PSYCHIAT, V65, P785, DOI 10.1001/archpsyc.65.7.785; Zhang P, 2010, BIPOLAR DISORD, V12, P786, DOI 10.1111/j.1399-5618.2010.00883.x	54	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e51674	10.1371/journal.pone.0051674	http://dx.doi.org/10.1371/journal.pone.0051674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382809	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200009
J	He, DM; Zhang, YQ; Liu, XF; Guo, SM; Zhao, DH; Zhu, YJ; Li, HD; Kong, L				He, Dengming; Zhang, Yuqi; Liu, Xiaofeng; Guo, Shimin; Zhao, Donghong; Zhu, Yunjie; Li, Huaidong; Kong, Li			Epidemiological and Clinical Features of Plasmodium falciparum Malaria in United Nations Personnel in Western Bahr el Ghazal State, South Sudan	PLOS ONE			English	Article							TRAVELERS	Western Bahr el Ghazal State is located in northwestern South Sudan, which is a tropical area subject to Plasmodium falciparum malaria epidemics. The aim of this study is to explore the epidemiological and clinical features of Plasmodium falciparum malaria in United Nations personnel stationed in this area. From July 2006 to June 2009, epidemiological data and medical records of 678 patients with Plasmodium falciparum malaria at the U.N. level 2 hospital were analyzed. The U.N. personnel were divided into individuals not immune to Plasmodium falciparum and individuals semi-immune to Plasmodium falciparum. The patients were divided into a chemoprophylaxis group (non-immune individuals who complied with the chemoprophylaxis regimen, 582 cases) and a no/incomplete chemoprophylaxis group (non-immune individuals who either did not fully comply with chemoprophylaxis or did not use it at all and semi-immune individuals who did not use chemoprophylaxis, 96 cases). Overall morbidity was about 11.3%. There was a significant difference in the morbidity of semi-immune and non-immune individuals (1.3% vs. 15.1%, P<0.001). Out of the total, 82.9% of cases occurred during the rainy season. The incidence of fever in the chemoprophylaxis group was significantly lower than in the no/incomplete chemoprophylaxis group (36.8% vs. 96.9%, P<0.001). Significant differences were observed between the two groups with respect to all other malaria-like symptoms except gastrointestinal symptoms, serum glucose level, platelet count, and alanine aminotransferase level. The incidence of complications was 1.2% (chemoprophylaxis group) and 44.8% (no/incomplete chemoprophylaxis group). The most common complication was thrombocytopenia, which was seen in 40.6% of the no/incomplete chemoprophylaxis group. In summary, Plasmodium falciparum malaria mainly occurred in rainy season. Gastrointestinal symptoms are an important precursor of malaria. Blood smears and rapid diagnostic tests should be performed after the onset of gastrointestinal symptoms. Appropriate chemoprophylaxis is necessary for reducing the severity of malaria.	[He, Dengming; Zhang, Yuqi; Zhu, Yunjie; Li, Huaidong; Kong, Li] 88th Hosp Chinese PLA, Dept Infect Dis, Tai An, Shandong, Peoples R China; [Liu, Xiaofeng; Zhao, Donghong] Gen Hosp Jinan Mil Command, Dept Gastroenterol Dis, Jinan, Shandong, Peoples R China; [Guo, Shimin] 150th Hosp Chinese PLA, Dept Infect Dis, Luoyang, Henan Province, Peoples R China; [He, Dengming; Zhang, Yuqi; Liu, Xiaofeng; Guo, Shimin; Zhao, Donghong; Zhu, Yunjie; Li, Huaidong; Kong, Li] Level 2 Hosp United Nations Mission Sudan UNMIS, Wau City, Western Bahr El, Sudan		He, DM (corresponding author), 88th Hosp Chinese PLA, Dept Infect Dis, Tai An, Shandong, Peoples R China.	hedengming@gmail.com						A-Elbasit IE, 2006, TROP MED INT HEALTH, V11, P604, DOI 10.1111/j.1365-3156.2006.01616.x; [Anonymous], 2010, WORLD MAL REP 2010, P54; [Anonymous], 2010, GUID TREATM MAL, P13; Beg MA, 2008, INT J INFECT DIS, V12, P37, DOI 10.1016/j.ijid.2007.04.006; Ciminera P, 2007, AM J TROP MED HYG, V76, P275, DOI 10.4269/ajtmh.2007.76.275; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; GENTON B, 2001, TRAVELERS MALARIA, P371; Guthmann JP, 2002, T ROYAL SOC TROPICAL, V96; Kamya MR, 2007, PLOS CLIN TRIALS, V2; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Moody A, 2002, CLIN MICROBIOLOGY RE, V15; Sadanand Saheli, 2010, Yale Journal of Biology and Medicine, V83, P185	13	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55220	10.1371/journal.pone.0055220	http://dx.doi.org/10.1371/journal.pone.0055220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372839	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400079
J	Lim, JY; Choi, BH; Lee, S; Jang, YH; Choi, JS; Kim, YM				Lim, Jae-Yol; Choi, Byung Hyune; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo			Regulation of Wound Healing by Granulocyte-Macrophage Colony-Stimulating Factor after Vocal Fold Injury	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EXTRACELLULAR-MATRIX PRODUCTION; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAR FORMATION; RABBIT MODEL; FIBROBLASTS; INJECTION; RAT; CULTURE; REPAIR	Objectives: Vocal fold (VF) scarring remains a therapeutic challenge. Granulocyte-macrophage colony-stimulating factor (GM-CSF) facilitates epithelial wound healing, and recently, growth factor therapy has been applied to promote tissue repair. This study was undertaken to investigate the effect of GM-CSF on VF wound healing in vivo and in vitro. Methods: VF scarring was induced in New Zealand white rabbits by direct injury. Immediately thereafter, either GM-CSF or PBS was injected into the VFs of rabbits. Endoscopic, histopathological, immunohistochemical, and biomechanical evaluations of VFs were performed at 3 months post-injury. Human vocal fold fibroblasts (hVFFs) were cultured with GMCSF. Production of type I and III collagen was examined immunocytochemically, and the synthesis of elastin and hyaluronic acids was evaluated by ELISA. The mRNA levels of genes related to ECM components and ECM production-related growth factors, such as HGF and TGF-beta 1, were examined by real time RT-PCR. Results: The GM-CSF-treated VFs showed reduced collagen deposition in comparison to the PBS-injected controls (P<0.05). Immunohistochemical staining revealed lower amounts of type I collagen and fibronectin in the GM-CSF-treated VFs (P<0.05 and P<0.01, respectively). Viscous and elastic shear moduli of VF samples were significantly lower in the GM-CSF group than in the PBS-injected group (P<0.001 and P<0.01, respectively). Mucosal waves in the GM-CSF group showed significant improvement when compared to the PBS group (P = 0.0446). GM-CSF inhibited TGF-beta 1-induced collagen synthesis by hVFFs (P<0.05) and the production of hyaluronic acids increased at 72 hours post-treatment (P<0.05). The expressions of HAS-2, tropoelastin, MMP-1, HGF, and c-Met mRNA were significantly increased by GM-CSF, although at different time points (P<0.05). Conclusion: The present study shows that GM-CSF offers therapeutic potential for the remodeling of VF wounds and the promotion of VF regeneration.	[Lim, Jae-Yol; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo] Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea; [Lim, Jae-Yol; Lee, Songyi; Jang, Yun Ho; Choi, Jeong-Seok; Kim, Young-Mo] Inha Univ, Sch Med, Translat Res Ctr, Inchon, South Korea; [Choi, Byung Hyune] Inha Univ, Sch Med, Div Biomed & Bioengn Sci, Inchon, South Korea	Inha University; Inha University; Inha University	Lim, JY (corresponding author), Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Inchon, South Korea.	jylim@inha.ac.kr		im, jaeyeol/0000-0002-9757-6414	National Research Foundation (NRF); Korean Ministry of Education, Science and Technology [2011-0005812, 2009-0079196]; Inha University Research Grant, Republic of Korea	National Research Foundation (NRF); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Inha University Research Grant, Republic of Korea	This research was supported by the Basic Science Research Program of the National Research Foundation (NRF) funded by the Korean Ministry of Education, Science and Technology (#2011-0005812), the grant of Korean Ministry of Education, Science and Technology (#2009-0079196), and the Inha University Research Grant, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6; Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906; Chen X, 2010, LARYNGOSCOPE, V120, P1819, DOI 10.1002/lary.21037; Gauglitz GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029942; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Hirano S, 2004, LARYNGOSCOPE, V114, P548, DOI 10.1097/00005537-200403000-00030; Hirano S, 2002, ANN OTO RHINOL LARYN, V111, P661, DOI 10.1177/000348940211100801; Hu XL, 2011, BURNS, V37, P729, DOI 10.1016/j.burns.2010.08.016; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Jorgensen LN, 2002, ANN SURG, V236, P684, DOI 10.1097/00000658-200211000-00020; JYUNG RW, 1994, SURGERY, V115, P325; Lim XH, 2008, ANN OTO RHINOL LARYN, V117, P227, DOI 10.1177/000348940811700311; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365; Mann A, 2006, J INVEST DERM SYMP P, V11, P87, DOI 10.1038/sj.jidsymp.5650013; Ohno T, 2009, LARYNGOSCOPE, V119, P806, DOI 10.1002/lary.20174; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303; Thibeault SL, 2003, J VOICE, V17, P377, DOI 10.1067/S0892-1997(03)00064-X; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Thibeault SL, 2008, OTOLARYNG HEAD NECK, V139, P816, DOI 10.1016/j.otohns.2008.09.009; VAILLANT P, 1993, BIOCHEM BIOPH RES CO, V192, P879, DOI 10.1006/bbrc.1993.1497; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yamashita M, 2010, CELLS TISSUES ORGANS, V192, P262, DOI 10.1159/000315476; Zhou H, 2011, LARYNGOSCOPE, V121, P1261, DOI 10.1002/lary.21795	33	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54256	10.1371/journal.pone.0054256	http://dx.doi.org/10.1371/journal.pone.0054256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372696	gold, Green Submitted, Green Published			2022-12-27	WOS:000315210400010
J	Mosoyan, G; Nagi, C; Marukian, S; Teixeira, A; Simonian, A; Resnick-Silverman, L; DiFeo, A; Johnston, D; Reynolds, SR; Roses, DF; Mosoian, A				Mosoyan, Goar; Nagi, Chandandeep; Marukian, Svetlana; Teixeira, Avelino; Simonian, Anait; Resnick-Silverman, Lois; DiFeo, Analisa; Johnston, Dean; Reynolds, Sandra R.; Roses, Daniel F.; Mosoian, Arevik			Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; TP53 MUTATIONS; P53 EXPRESSION; LUNG-CANCER; PROTEIN; GENE; GROWTH; ASSOCIATION; RISK; SUSCEPTIBILITY	Background: Breast cancer cell lines are widely used tools to investigate breast cancer biology and to develop new therapies. Breast cancer tissue contains molecularly heterogeneous cell populations. Thus, it is important to understand which cell lines best represent the primary tumor and have similarly diverse phenotype. Here, we describe the development of five breast cancer cell lines from a single patient's breast cancer tissue. We characterize the molecular profiles, tumorigenicity and metastatic ability in vivo of all five cell lines and compare their responsiveness to 4-hydroxytamoxifen (4-OHT) treatment. Methods: Five breast cancer cell lines were derived from a single patient's primary breast cancer tissue. Expression of different antigens including HER2, estrogen receptor (ER), CK8/18, CD44 and CD24 was determined by flow cytometry, western blotting and immunohistochemistry (IHC). In addition, a Fuorescent In Situ Hybridization (FISH) assay for HER2 gene amplification and p53 genotyping was performed on all cell lines. A xenograft model in nude mice was utilized to assess the tumorigenic and metastatic abilities of the breast cancer cells. Results: We have isolated, cloned and established five new breast cancer cell lines with different tumorigenicity and metastatic abilities from a single primary breast cancer. Although all the cell lines expressed low levels of ER, their growth was estrogen-independent and all had high-levels of expression of mutated non-functional p53. The HER2 gene was rearranged in all cell lines. Low doses of 4-OHT induced proliferation of these breast cancer cell lines. Conclusions: All five breast cancer cell lines have different antigenic expression profiles, tumorigenicity and organ specific metastatic abilities although they derive from a single tumor. None of the studied markers correlated with tumorigenic potential. These new cell lines could serve as a model for detailed genomic and proteomic analyses to identify mechanisms of organ-specific metastasis of breast cancer.	[Mosoyan, Goar; Teixeira, Avelino; Simonian, Anait; Mosoian, Arevik] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Nagi, Chandandeep] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Marukian, Svetlana] HemoShear, Charlottesville, VA USA; [Resnick-Silverman, Lois] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [DiFeo, Analisa] Case Western Reserve Univ, Dept Case, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Johnston, Dean] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Reynolds, Sandra R.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Roses, Daniel F.] NYU, Sch Med, Dept Surg, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Case Western Reserve University; City University of New York (CUNY) System; Hunter College (CUNY); New York University; New York University	Mosoian, A (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	arevik.mosoian@mssm.edu		DiFeo, Analisa/0000-0001-8319-6763	Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund; Dorothy Rodbell Cohen Cancer Research Program; Lehman Brothers Foundation	Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund; Dorothy Rodbell Cohen Cancer Research Program; Lehman Brothers Foundation	This work was supported by the Dr. Leo A. Shifrin and Roslyn Myers Breast Cancer Discovery Fund (to JCB) and the Dorothy Rodbell Cohen Cancer Research Program and Lehman Brothers Foundation (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Bailey ST, 2012, P NATL ACAD SCI USA, V109, P18060, DOI 10.1073/pnas.1018858109; Birnbaum D, 2004, INT J ONCOL, V25, P249; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; D'Assoro AB, 2010, INT J ONCOL, V37, P1167, DOI 10.3892/ijo_00000768; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Endo K, 2000, J HEPATOL, V32, P78, DOI 10.1016/S0168-8278(00)80192-0; Fernandez-Cuesta L, 2010, BREAST CANC RES TREA; FERNANDEZCUESTA L, 2010, INT J CANC; Gaudet MM, 2008, BREAST CANCER RES TR, V108, P93, DOI 10.1007/s10549-007-9573-0; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Hayashi N., 2011, INT J CLIN ONCOL; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Ignatiadis M, 2007, J CLIN ONCOL, V25, P5194, DOI 10.1200/JCO.2007.11.7762; Jha P, 2011, EXP MOL PATHOL, V90, P167, DOI 10.1016/j.yexmp.2010.11.002; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kerstens HMJ, 2000, J HISTOCHEM CYTOCHEM, V48, P709, DOI 10.1177/002215540004800515; Konduri SD, 2010, P NATL ACAD SCI USA, V107, P15081, DOI 10.1073/pnas.1009575107; Korkaya H, 2008, ONCOGENE; Lee EB, 2010, J KOREAN MED SCI, V25, P698, DOI 10.3346/jkms.2010.25.5.698; LESOONWOOD LA, 1995, HUM GENE THER, V6, P395, DOI 10.1089/hum.1995.6.4-395; Li Y, 2010, MOL ENDOCRINOL, V24, P969, DOI 10.1210/me.2009-0148; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Lyon E, 2001, CLIN CHEM, V47, P844; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Ozeki C, 2011, J BIOL CHEM, V286, P18251, DOI 10.1074/jbc.M110.208587; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; REDDEL RR, 1985, CANCER RES, V45, P1525; Ricks-Santi L, 2010, PROSTATE, V70, P1739, DOI 10.1002/pros.21209; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Sangha N, 2008, NEOPLASIA, V10, P1362, DOI 10.1593/neo.08784; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wei FX, 2010, CELL SIGNAL, V22, P1783, DOI 10.1016/j.cellsig.2010.07.007; Weigelt B, 2009, BREAST CANC RES TREA; Xiao Y, 2009, CLIN CHEM, V55, P1307, DOI 10.1373/clinchem.2008.120576; Zolota V, 2002, UROL ONCOL, V7, P13, DOI 10.1016/S1078-1439(01)00129-6	45	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55145	10.1371/journal.pone.0055145	http://dx.doi.org/10.1371/journal.pone.0055145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372829	gold, Green Published			2022-12-27	WOS:000315210400070
J	Ryu, WS; Kim, CK; Kim, BJ; Lee, SH				Ryu, Wi-Sun; Kim, Chi Kyung; Kim, Beom Joon; Lee, Seung-Hoon			Serum Uric Acid Levels and Cerebral Microbleeds in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							BLOOD-PRESSURE; BRAIN-INJURY; RISK-FACTOR; ASSOCIATION; PREVALENCE; HEMORRHAGE; DEMENTIA; DEATH	Unlike experimental studies indicating a neuroprotective property of uric acid, clinical studies have shown that elevated levels of uric acid are associated with a risk of ischemic stroke. However, the association of uric acid with cerebral hemorrhage has seldom been tested. We aimed to elucidate the association between uric acid and cerebral microbleeds (CMBs), a hemorrhage-prone cerebral microangiopathy. Seven hundred twenty-four patients with ischemic stroke who were consecutively admitted to our hospital were included in this study. We collected demographic, clinical, and laboratory data, including uric acid level, and examined the presence of CMBs using T2*-weighted gradient-echo MRI. We used logistic regression analysis to examine an independent association between uric acid and CMBs. Two-hundred twenty-six patients had CMBs (31.2%). After adjusting for possible confounders, elevated uric acid was independently associated with the presence of CMBs (the highest quartile vs. lowest quartile, adjusted odd ratio [OR], 1.98; 95% confidence interval [CI], 1.16-3.39). This association retained in patients with deep or infratentorial CMBs (with or without lobar CMBs) but not among those with lobar CMBs. In addition, this association was robust among patients with hypertension (the highest quartile vs. lowest quartile, adjusted OR, 2.74; 95% CI, 1.43-5.24). In contrast, we did not find the association in patients without hypertension. We demonstrated that serum uric acid is independently associated with the presence of CMBs. In particular, the relation between uric acid and CMBs was robust in hypertensive patients.	[Ryu, Wi-Sun; Kim, Chi Kyung; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Ryu, Wi-Sun; Kim, Chi Kyung; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Clin Res Inst, Clin Res Ctr Stroke, Seoul 110744, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	sb0516@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Kim, Beom Joon/C-2904-2011	Kim, Beom Joon/0000-0002-2719-3012; Ryu, Wi-Sun/0000-0002-2823-5253; Kim, Beom Joon/0000-0003-2320-7621	Korea Health 21 R&D Project, Ministry of Health and Welfare [A111014]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2011-0026315]	Korea Health 21 R&D Project, Ministry of Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare (A111014), and by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology (2011-0026315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro Sergio, 2008, Expert Rev Neurother, V8, P259, DOI 10.1586/14737175.8.2.259; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Benavente Oscar, 2005, Curr Cardiol Rep, V7, P23, DOI 10.1007/s11886-005-0006-6; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; BRITTON M, 1986, STROKE, V17, P861, DOI 10.1161/01.STR.17.5.861; Chamorro A, 2004, MED HYPOTHESES, V62, P173, DOI 10.1016/S0306-9877(03)00324-4; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Christensen H, 2002, ACTA NEUROL SCAND, V106, P142, DOI 10.1034/j.1600-0404.2002.01356.x; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Dimitroula HV, 2008, NEUROLOGIST, V14, P238, DOI 10.1097/NRL.0b013e31815c666b; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fito M, 1997, EUR J CLIN CHEM CLIN, V35, P787; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Jeon SB, 2009, NEUROLOGY, V73, P1638, DOI 10.1212/WNL.0b013e3181bd110f; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kim DE, 2002, ARCH NEUROL-CHICAGO, V59, P425, DOI 10.1001/archneur.59.3.425; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Langlois M, 2003, ATHEROSCLEROSIS, V168, P163, DOI 10.1016/S0021-9150(03)00093-5; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Lee SH, 2006, NEUROLOGY, V66, P430, DOI 10.1212/01.wnl.0000196471.04165.2b; Lee SH, 2004, NEUROLOGY, V63, P16, DOI 10.1212/01.WNL.0000132525.36804.A1; Lee SH, 2004, NEUROLOGY, V62, P72, DOI 10.1212/01.WNL.0000101463.50798.0D; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Patetsios P, 2001, AM J CARDIOL, V88, P188, DOI 10.1016/S0002-9149(01)01621-6; Pipkin FB, 2004, J HYPERTENS, V22, P237, DOI 10.1097/00004872-200402000-00002; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; RAO GN, 1991, J BIOL CHEM, V266, P8604; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Ueno H, 2008, AM J NEURORADIOL, V29, P1483, DOI 10.3174/ajnr.A1120; van den Boom R, 2005, NEUROLOGY, V64, P1288, DOI 10.1212/01.WNL.0000156946.44593.24; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2004, J NEUROL, V251, P584, DOI 10.1007/s00415-004-0371-x; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1	41	12	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55210	10.1371/journal.pone.0055210	http://dx.doi.org/10.1371/journal.pone.0055210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372838	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400078
J	Ferrington, DA; Roehrich, H; Chang, AA; Huang, CW; Maldonado, M; Bratten, W; Rageh, AA; Heuss, ND; Gregerson, DS; Nelson, EF; Yuan, C				Ferrington, Deborah A.; Roehrich, Heidi; Chang, Angela A.; Huang, Craig W.; Maldonado, Marcela; Bratten, Wendy; Rageh, Abrar A.; Heuss, Neal D.; Gregerson, Dale S.; Nelson, Elizabeth F.; Yuan, Ching			Corneal Wound Healing Is Compromised by Immunoproteasome Deficiency	PLOS ONE			English	Article							NF-KAPPA-B; PROTEASOME SUBUNIT; AUTOINFLAMMATORY DISORDER; OXIDATIVE STRESS; T-CELLS; INTERLEUKIN-6; LIPODYSTROPHY; TRANSPARENCY; MUTATION; COMPLEX	Recent studies have revealed roles for immunoproteasome in regulating cell processes essential for maintaining homeostasis and in responding to stress and injury. The current study investigates how the absence of immunoproteasome affects the corneal epithelium under normal and stressed conditions by comparing corneas from wildtype (WT) mice and those deficient in two immunoproteasome catalytic subunits (lmp7(-/-)/mecl-1(-/-), L7M1). Immunoproteasome expression was confirmed in WT epithelial cells and in cells of the immune system that were present in the cornea. More apoptotic cells were found in both corneal explant cultures and uninjured corneas of L7M1 compared to WT mice. Following mechanical debridement, L7M1 corneas displayed delayed wound healing, including delayed re-epithelialization and re-establishment of the epithelial barrier, as well as altered inflammatory cytokine production compared to WT mice. These results suggest that immunoproteasome plays an important role in corneal homeostasis and wound healing.	[Ferrington, Deborah A.; Roehrich, Heidi; Chang, Angela A.; Huang, Craig W.; Maldonado, Marcela; Bratten, Wendy; Rageh, Abrar A.; Heuss, Neal D.; Gregerson, Dale S.; Nelson, Elizabeth F.; Yuan, Ching] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Yuan, C (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	yuanx019@umn.edu		Ferrington, Deborah/0000-0003-2561-7464; Gregerson, Dale/0000-0001-5769-796X	Minnesota Medical Foundation; Minnesota Lions Club, National Institutes of Health [EY013623, AG032391, EY016376, EY019552, P30-EY11374]; Research to Prevent Blindness, Inc., New York, NY; NATIONAL EYE INSTITUTE [R01EY013623, P30EY011374, R01EY016376, R21EY019552, R01EY021996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796, R21AG032391] Funding Source: NIH RePORTER	Minnesota Medical Foundation; Minnesota Lions Club, National Institutes of Health; Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by: Minnesota Medical Foundation, Minnesota Lions Club, National Institutes of Health (EY013623 and AG032391 to DAF, EY016376 to DSG, EY019552 to CY and a Core Grant for Vision Research, P30-EY11374), and an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences at the University of Minnesota from Research to Prevent Blindness, Inc., New York, NY. No additional external funding recieved for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Alexander G, 2006, EXP EYE RES, V82, P700, DOI 10.1016/j.exer.2005.09.012; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Cai ZP, 2008, FASEB J, V22, P4248, DOI 10.1096/fj.08-105940; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Contreras-Ruiz L, 2012, CURR EYE RES, V37, P971, DOI 10.3109/02713683.2012.700756; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Ebihara N, 2011, INVEST OPHTH VIS SCI, V52, P8549, DOI 10.1167/iovs.11-7956; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Haroon N, 2012, ARTHRITIS RHEUM-US, V64, P1119, DOI 10.1002/art.33430; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kanazawa N, 2012, ALLERGOL INT, V61, P197, DOI 10.2332/allergolint.11-RAI-0416; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kloetzel PM, 1999, BIOL CHEM, V380, P293, DOI 10.1515/BC.1999.040; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Lee EJ, 2010, INVEST OPHTH VIS SCI, V51, P2101, DOI 10.1167/iovs.08-2213; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; Nakamura M, 1999, CORNEA, V18, P452, DOI 10.1097/00003226-199907000-00011; NISHIDA T, 1992, ARCH OPHTHALMOL-CHIC, V110, P1292, DOI 10.1001/archopht.1992.01080210110036; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; Odgren PR, 2003, CRIT REV EUKAR GENE, V13, P181; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ricote M, 2006, APOPTOSIS, V11, P1969, DOI 10.1007/s10495-006-0086-9; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Westra J, 2006, MINI-REV MED CHEM, V6, P867, DOI 10.2174/138955706777934982; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54347	10.1371/journal.pone.0054347	http://dx.doi.org/10.1371/journal.pone.0054347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365662	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600050
J	Johnson, TJ; Danzeisen, JL; Trampel, D; Nolan, LK; Seemann, T; Bager, RJ; Bojesen, AM				Johnson, Timothy J.; Danzeisen, Jessica L.; Trampel, Darrell; Nolan, Lisa K.; Seemann, Torsten; Bager, Ragnhild J.; Bojesen, Anders M.			Genome Analysis and Phylogenetic Relatedness of Gallibacterium anatis Strains from Poultry	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GENETIC DIVERSITY; BIOFILM FORMATION; RTX-TOXIN; SEQUENCE; SUSCEPTIBILITY; IDENTIFICATION; CHICKENS; PROGRAM; GTXA	Peritonitis is the major disease problem of laying hens in commercial table egg and parent stock operations. Despite its importance, the etiology and pathogenesis of this disease have not been completely clarified. Although avian pathogenic Escherichia coli (APEC) isolates have been incriminated as the causative agent of laying hen peritonitis, Gallibacterium anatis are frequently isolated from peritonitis lesions. Despite recent studies suggesting a role for G. anatis in the pathogenesis of peritonitis, little is known about the organism's virulence mechanisms, genomic composition and population dynamics. Here, we compared the genome sequences of three G. anatis isolates in an effort to understand its virulence mechanisms and identify novel antigenic traits. A multilocus sequence typing method was also established for G. anatis and used to characterize the genotypic relatedness of 71 isolates from commercial laying hens in Iowa and 18 international reference isolates. Genomic comparisons suggest that G. anatis is a highly diverse bacterial species, with some strains possessing previously described and potential virulence factors, but with a core genome containing several antigenic candidates. Multilocus sequence typing effectively distinguished 82 sequence types and several clonal complexes of G. anatis, and some clones seemed to predominate among G. anatis populations from commercial layers in Iowa. Biofilm formation and resistance to antimicrobial agents was also observed in several clades. Overall, the genomic diversity of G. anatis suggests that multiple lineages exist with differing pathogenic potential towards birds.	[Johnson, Timothy J.; Danzeisen, Jessica L.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Trampel, Darrell] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Nolan, Lisa K.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Bager, Ragnhild J.; Bojesen, Anders M.] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University; Monash University; University of Copenhagen	Johnson, TJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu	Seemann, Torsten/B-2318-2010; Bager, Ragnhild/K-4459-2014; Bojesen, Anders Miki/CAG-0739-2022	Seemann, Torsten/0000-0001-6046-610X; Bager, Ragnhild/0000-0003-3886-8086; Johnson, Timothy/0000-0001-7556-9347; Bojesen, Anders Miki/0000-0003-4030-0019	Midwest Poultry Research Program, Iowa Egg Council [415-49-09]; Danish Research Council for Technology and Production [09-065909]	Midwest Poultry Research Program, Iowa Egg Council; Danish Research Council for Technology and Production	Funding for this study was provided by the Midwest Poultry Research Program, grant 415-49-09, Iowa Egg Council, and the Danish Research Council for Technology and Production, grant 09-065909. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bisgaard M, 2009, INT J SYST EVOL MICR, V59, P735, DOI 10.1099/ijs.0.005694-0; Bojesen AM, 2007, AVIAN PATHOL, V36, P227, DOI 10.1080/03079450701332352; Bojesen AM, 2004, AVIAN PATHOL, V33, P145, DOI 10.1080/03079450310001652059; Bojesen AM, 2003, J CLIN MICROBIOL, V41, P2737, DOI 10.1128/JCM.41.6.2737-2740.2003; Bojesen AM, 2011, VET MICROBIOL, V148, P105, DOI 10.1016/j.vetmic.2010.08.011; Bojesen AM, 2011, VET MICROBIOL, V149, P497, DOI 10.1016/j.vetmic.2010.11.015; Bojesen AM, 2007, VET MICROBIOL, V123, P262, DOI 10.1016/j.vetmic.2007.02.013; Christensen H, 2003, INT J SYST EVOL MICR, V53, P275, DOI 10.1099/ijs.0.02330-0; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Clinical and Laboratory Standards Institute, 2005, PERFORMANCE STANDARD; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Gomez E, 2005, AVIAN PATHOL, V34, P426, DOI 10.1080/03079450500267866; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Johnson TJ, 2011, J BACTERIOL, V193, P3676, DOI 10.1128/JB.05177-11; Kristensen BM, 2011, VET MICROBIOL; Kristensen BM, 2012, APPL ENVIRON MICROB, V78, P4914, DOI 10.1128/AEM.00412-12; Kristensen BM, 2011, VET MICROBIOL, V153, P116, DOI 10.1016/j.vetmic.2011.05.019; Kristensen BM, 2010, VET RES, V41, DOI 10.1051/vetres/2009073; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lin MY, 2001, AVIAN DIS, V45, P655, DOI 10.2307/1592907; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McClure M A, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P155; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P91, DOI 10.1093/jac/dkr411; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neubauer C, 2009, AVIAN PATHOL, V38, P1, DOI 10.1080/03079450802577848; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pattison M, 2008, POULTRY DIS; Saif Y. M., 2008, DIS POULTRY; Skyberg JA, 2007, J APPL MICROBIOL, V102, P548, DOI 10.1111/j.1365-2672.2006.03076.x; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vaca S, 2011, J ANIM VET ADV, V10, P1688; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Zepeda A, 2009, AVIAN DIS, V53, P115, DOI 10.1637/8375-060908-ResNote.1; Zepeda VA, 2010, AVIAN DIS, V54, P1306, DOI 10.1637/9423-061410-ResNote.1	42	24	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54844	10.1371/journal.pone.0054844	http://dx.doi.org/10.1371/journal.pone.0054844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359626	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600121
J	Kenney, MC; Chwa, M; Atilano, SR; Pavlis, JM; Falatoonzadeh, P; Ramirez, C; Malik, D; Hsu, T; Woo, G; Soe, K; Nesburn, AB; Boyer, DS; Kuppermann, BD; Jazwinski, SM; Miceli, MV; Wallace, DC; Udar, N				Kenney, M. Cristina; Chwa, Marilyn; Atilano, Shari R.; Pavlis, Janelle M.; Falatoonzadeh, Payam; Ramirez, Claudio; Malik, Deepika; Hsu, Tiffany; Woo, Grace; Soe, Kyaw; Nesburn, Anthony B.; Boyer, David S.; Kuppermann, Baruch D.; Jazwinski, S. Michal; Miceli, Michael V.; Wallace, Douglas C.; Udar, Nitin			Mitochondrial DNA Variants Mediate Energy Production and Expression Levels for CFH, C3 and EFEMP1 Genes: Implications for Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MYOSIN VIIA; DRUSEN FORMATION; RISK; HAPLOGROUPS; LONGEVITY; GLAUCOMA; DISEASES; CELLS; VARIABILITY	Background: Mitochondrial dysfunction is associated with the development and progression of age-related macular degeneration (AMD). Recent studies using populations from the United States and Australia have demonstrated that AMD is associated with mitochondrial (mt) DNA haplogroups (as defined by combinations of mtDNA polymorphisms) that represent Northern European Caucasians. The aim of this study was to use the cytoplasmic hybrid (cybrid) model to investigate the molecular and biological functional consequences that occur when comparing the mtDNA H haplogroup (protective for AMD) versus J haplogroup (high risk for AMD). Methodology/Principal Findings: Cybrids were created by introducing mitochondria from individuals with either H or J haplogroups into a human retinal epithelial cell line (ARPE-19) that was devoid of mitochondrial DNA (Rho0). In cybrid lines, all of the cells carry the same nuclear genes but vary in mtDNA content. The J cybrids had significantly lower levels of ATP and reactive oxygen/nitrogen species production, but increased lactate levels and rates of growth. Q-PCR analyses showed J cybrids had decreased expressions for CFH, C3, and EFEMP1 genes, high risk genes for AMD, and higher expression for MYO7A, a gene associated with retinal degeneration in Usher type IB syndrome. The H and J cybrids also have comparatively altered expression of nuclear genes involved in pathways for cell signaling, inflammation, and metabolism. Conclusion/Significance: Our findings demonstrate that mtDNA haplogroup variants mediate not only energy production and cell growth, but also cell signaling for major molecular pathways. These data support the hypothesis that mtDNA variants play important roles in numerous cellular functions and disease processes, including AMD.	[Kenney, M. Cristina; Chwa, Marilyn; Atilano, Shari R.; Pavlis, Janelle M.; Falatoonzadeh, Payam; Ramirez, Claudio; Malik, Deepika; Hsu, Tiffany; Woo, Grace; Soe, Kyaw; Nesburn, Anthony B.; Kuppermann, Baruch D.; Udar, Nitin] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Dept Med, New Orleans, LA 70118 USA; [Wallace, Douglas C.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	University of California System; University of California Irvine; Cedars Sinai Medical Center; Retina Vitreous Associates Medical Group; Tulane University; Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kenney, MC (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92717 USA.	mkenney@uci.edu		Atilano, Shari/0000-0002-7729-7864; Udar, Nitin/0000-0001-8533-9190	Discovery Eye Foundation; Lincy Foundation; Beckman Macular Research Initiative; Henry Guenther Foundation; Polly and Michael Smith Foundation; Research to Prevent Blindness Foundation; National Institute on Aging [AG006168]; NATIONAL INSTITUTE ON AGING [R01AG006168, R37AG006168] Funding Source: NIH RePORTER	Discovery Eye Foundation; Lincy Foundation; Beckman Macular Research Initiative; Henry Guenther Foundation; Polly and Michael Smith Foundation; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by The Discovery Eye Foundation www.discoveryeye.org, Lincy Foundation lincyinstitute.unlv.edu/lincy.html, Beckman Macular Research Initiative www.beckmanmacular.org, The Henry Guenther Foundation, Polly and Michael Smith Foundation, Research to Prevent Blindness Foundation www.rpbusa.org, and the National Institute on Aging (AG006168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2011, MOL VIS, V17, P1468; Abu-Amero KK, 2011, MOL VIS, V17, P543; Arning L, 2010, J MOL MED, V88, P431, DOI 10.1007/s00109-010-0589-2; Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI [10.2217/EPI.11.109, 10.2217/epi.11.109]; Bergeron-Sawitzke J, 2009, EUR J HUM GENET, V17, P1190, DOI 10.1038/ejhg.2009.23; BROWN MD, 1992, AM J HUM GENET, V51, P378; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chomyn A, 1996, PLALTELET MEDIATED T; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Czarnecka AM, 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/136435; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Moreno M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00129; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-264; Ferraresi R, 2008, CYTOM PART A, V73A, P528, DOI 10.1002/cyto.a.20544; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Grassi MA, 2006, HUM MUTAT, V27, P921, DOI 10.1002/humu.20359; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Jazwinski S. M., 2012, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbr.2011.03.031; Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kaur I, 2008, INVEST OPHTH VIS SCI, V49, P1771, DOI 10.1167/iovs.07-0560; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; McFarland R, 2009, J INTERN MED, V265, P210, DOI 10.1111/j.1365-2796.2008.02066.x; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Miceli MV, 2005, INVEST OPHTH VIS SCI, V46, P1765, DOI 10.1167/iovs.04-1327; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Okamoto H, 2006, MOL VIS, V12, P156; Pathak D, 2011, MOL VIS, V17, P1514; Penisson-Besnier I, 2001, REV NEUROL-FRANCE, V157, P537; Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293; Rodley CDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030943; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Wallace DC, 2007, MITOCHONDRIAL GENES, P194; Wang GF, 2009, INVEST OPHTH VIS SCI, V50, P3084, DOI 10.1167/iovs.08-3240; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolf C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-8; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	71	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54339	10.1371/journal.pone.0054339	http://dx.doi.org/10.1371/journal.pone.0054339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365660	Green Published, gold			2022-12-27	WOS:000314023600048
J	Kirby, BS; Bruhl, A; Sullivan, MN; Francis, M; Dinenno, FA; Earley, S				Kirby, Brett S.; Bruhl, Allison; Sullivan, Michelle N.; Francis, Michael; Dinenno, Frank A.; Earley, Scott			Robust Internal Elastic Lamina Fenestration in Skeletal Muscle Arteries	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; MYOENDOTHELIAL GAP-JUNCTIONS; BLOOD-FLOW; SMALL-CONDUCTANCE; MECHANICAL-PROPERTIES; MESENTERIC-ARTERIES; CA2+ RELEASE; ENDOTHELIUM; RECEPTOR; RAT	Holes within the internal elastic lamina (IEL) of blood vessels are sites of fenestration allowing for passage of diffusible vasoactive substances and interface of endothelial cell membrane projections with underlying vascular smooth muscle. Endothelial projections are sites of dynamic Ca2+ events leading to endothelium dependent hyperpolarization (EDH)-mediated relaxations and the activity of these events increase as vessel diameter decreases. We tested the hypothesis that IEL fenestration is greater in distal vs. proximal arteries in skeletal muscle, and is unlike other vascular beds (mesentery). We also determined ion channel protein composition within the endothelium of intramuscular and non-intramuscular skeletal muscle arteries. Popliteal arteries, subsequent gastrocnemius feed arteries, and first and second order intramuscular arterioles from rat hindlimb were isolated, cut longitudinally, fixed, and imaged using confocal microscopy. Quantitative analysis revealed a significantly larger total fenestration area in second and first order arterioles vs. feed and popliteal arteries (58% and 16% vs. 5% and 3%; N = 10 images/artery), due to a noticeably greater average size of holes (9.5 and 3.9 mu m(2) vs 1.5 and 1.9 mu m(2)). Next, we investigated via immunolabeling procedures whether proteins involved in EDH often embedded in endothelial cell projections were disparate between arterial segments. Specific proteins involved in EDH, such as inositol trisphosphate receptors, small and intermediate conductance Ca2+-activated K+ channels, and the canonical (C) transient receptor potential (TRP) channel TRPC3 were present in both popliteal and first order intramuscular arterioles. However due to larger IEL fenestration in first order arterioles, a larger spanning area of EDH proteins is observed proximal to the smooth muscle cell plasma membrane. These observations highlight the robust area of fenestration within intramuscular arterioles and indicate that the anatomical architecture and endothelial cell hyperpolarizing apparatus for distinct vasodilatory signaling is potentially present.	[Kirby, Brett S.; Bruhl, Allison; Sullivan, Michelle N.; Dinenno, Frank A.; Earley, Scott] Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA; [Dinenno, Frank A.] Colorado State Univ, Dept Hlth & Exercise Sci, Human Cardiovasc Physiol Lab, Ft Collins, CO 80523 USA; [Francis, Michael] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA	Colorado State University; Colorado State University; University of South Alabama	Earley, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Vasc Physiol Res Grp, Ft Collins, CO 80523 USA.	Scott.Earley@Colostate.edu	Earley, Scott/A-4059-2008	Earley, Scott/0000-0001-9560-2941	United States National Institutes of Health [HL091905, HL102720, HL095573]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091905, R21HL102720, R01HL095573] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was supported through United States National Institutes of Health grants HL091905 (S.E.), HL102720 (F.A.D.), and HL095573 (F.A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1979, ACTA PHYSIOL SCAND, V107, P309, DOI 10.1111/j.1748-1716.1979.tb06480.x; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Anderson KM, 1991, CIRC RES, V69, P178; AYDIN F, 1991, STROKE, V22, P1592, DOI 10.1161/01.STR.22.12.1592; Behringer EJ, 2012, CIRC RES, V110, P1311, DOI 10.1161/CIRCRESAHA.111.262592; BOURGUIGNON LYW, 1994, J CELL PHYSIOL, V159, P29, DOI 10.1002/jcp.1041590105; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Czaja K, 2002, BIOCHEM BIOPH RES CO, V293, P1138, DOI 10.1016/S0006-291X(02)00335-2; Dees MB, 1923, ANAT REC, V26, P161, DOI 10.1002/ar.1090260211; Domeier TL, 2007, J PHYSIOL-LONDON, V579, P175, DOI 10.1113/jphysiol.2006.124529; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Earley S, 2010, MOL PHARMACOL, V77, P612, DOI 10.1124/mol.109.060715; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; FIXLER DE, 1976, AM J PHYSIOL, V231, P1515, DOI 10.1152/ajplegacy.1976.231.5.1515; Francis M, 2012, AM J PHYSIOL-CELL PH, V303, pC236, DOI 10.1152/ajpcell.00016.2012; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC279, DOI 10.1152/ajpcell.00550.2009; Guo ZY, 2008, CLIN BIOMECH, V23, pS104, DOI 10.1016/j.clinbiomech.2007.08.017; Heberlein KR, 2009, MICROCIRCULATION, V16, P307, DOI 10.1080/10739680902744404; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; Jones S, 2008, BLOOD, V111, P605, DOI 10.1182/blood-2007-07-103424; Joyner MJ, 2004, J PHYSIOL-LONDON, V558, P1, DOI 10.1113/jphysiol.2004.067306; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; MARSHALL RJ, 1961, CIRCULATION, V24, P76, DOI 10.1161/01.CIR.24.1.76; Masuda H, 1999, ARTERIOSCL THROM VAS, V19, P2298, DOI 10.1161/01.ATV.19.10.2298; Milkau M, 2010, FASEB J, V24, P3572, DOI 10.1096/fj.10-158956; MULVANY MJ, 1976, NATURE, V260, P617, DOI 10.1038/260617a0; MUSCH TI, 1987, J APPL PHYSIOL, V63, P2269, DOI 10.1152/jappl.1987.63.6.2269; Roseguini BT, 2010, MICROCIRCULATION, V17, P83, DOI 10.1111/j.1549-8719.2009.00005.x; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Sandow SL, 2004, CLIN EXP PHARMACOL P, V31, P563, DOI 10.1111/j.1440-1681.2004.04048.x; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Segal SS, 2001, J PHYSIOL-LONDON, V536, P937, DOI 10.1111/j.1469-7793.2001.00937.x; SEGAL SS, 1995, MED SCI SPORT EXER, V27, P1158; Senadheera S, 2012, CARDIOVASC RES, V95, P439, DOI 10.1093/cvr/cvs208; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SIMS FH, 1989, ARTERY, V16, P159; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; TAUGNER R, 1984, CELL TISSUE RES, V235, P319; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Tran CHT, 2012, AM J PHYSIOL-CELL PH, V302, pC1226, DOI 10.1152/ajpcell.00418.2011; VanTeeffelen JWGE, 2003, J PHYSIOL-LONDON, V550, P563, DOI 10.1113/jphysiol.2003.038984; WIEDEMAN MP, 1968, CIRC RES, V22, P83, DOI 10.1161/01.RES.22.1.83; Winter P, 2007, J PHYSIOL-LONDON, V582, P335, DOI 10.1113/jphysiol.2007.135202; Wolfle SE, 2011, J PHYSIOL-LONDON, V589, P2607, DOI 10.1113/jphysiol.2010.202580; Wong LCY, 1996, CIRC RES, V78, P799, DOI 10.1161/01.RES.78.5.799; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	56	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54849	10.1371/journal.pone.0054849	http://dx.doi.org/10.1371/journal.pone.0054849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359815	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600122
J	Ku, HC; Chen, WP; Su, MJ				Ku, Hui-Chun; Chen, Wen-Pin; Su, Ming-Jai			DPP4 Deficiency Exerts Protective Effect against H2O2 Induced Oxidative Stress in Isolated Cardiomyocytes	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LEFT-VENTRICULAR DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; PRESERVES CARDIAC-FUNCTION; ACTIVATED PROTEIN-KINASE; MYOCARDIAL-INFARCTION; CELLULAR-RESPONSE; GLUCOSE-UPTAKE; GLP-1; HEART	Apart from the antihyperglycemic effects, DPP4 inhibitors and GLP-1 molecules are involved in the preservation of cardiac functions. We have demonstrated that DPP4-deficient rats possess resistance to endotoxemia and ischemia/reperfusion stress. However, whether the decrease of DPP4 activity simply augmented the GLP-1 signaling or that such decrease resulted in a change of cellular function remain unclear. Accordingly, we investigated the responses of H2O2-induced oxidative stress in adult wild-type and DPP4-deficient rats isolated cardiomyocytes. The coadministration of GLP-1 or DPP4 inhibitor was also performed to define the mechanisms. Cell viability, ROS concentration, catalase activity, glucose uptake, prosurvival, proapoptotic signaling, and contractile function were examined after cells exposed to H2O2. DPP4-deficient cardiomyocytes were found to be resistant to H2O2-induced cell death via activating AKT signaling, enhancing glucose uptake, preserving catalase activity, diminishing ROS level and proapoptotic signaling. GLP-1 concentration-dependently improved cell viability in wild-type cardiomyocyte against ROS stress, and the ceiling response concentration (200 nM) was chosen for studies. GLP-1 was shown to decrease H2O2-induced cell death by its receptor-dependent AKT pathway in wild-type cardiomyocytes, but failed to cause further activation of AKT in DPP4-deficient cardiomyocytes. Acute treatment of DPP4 inhibitor only augmented the protective effect of low dose GLP-1, but failed to alter fuel utilization or ameliorate cell viability in wild-type cardiomyocytes after H2O2 exposure. The improvement of cell viability after H2O2 exposure was correlated with the alleviation of cellular contractile dysfunction in both DPP4-deficient and GLP-1 treated wild-type cardiomyocytes. These findings demonstrated that GLP-1 receptor-dependent pathway is important and exert protective effect in wild-type cardiomyocyte. Long term loss of DPP4 activity increased the capability against ROS stress, which was more than GLP-1 dependent pathway.	[Ku, Hui-Chun; Chen, Wen-Pin; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan	National Taiwan University	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	mingja@ntu.edu.tw		SU, MING-JAI/0000-0001-8887-6899; Chen, Wen-Pin/0000-0002-0143-5642	National Science Council of Taiwan, ROC [NSC-100-2325-B-002-066]	National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	The authors work was supported by the grant from National Science Council of Taiwan, ROC (NSC-100-2325-B-002-066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Ban K, 2010, ENDOCRINOLOGY, V151, P1520, DOI 10.1210/en.2009-1197; Bao WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023570; Bellis A, 2009, ARTERIOSCL THROM VAS, V29, P1207, DOI 10.1161/ATVBAHA.109.184135; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Duez H, 2012, BIOCHEM PHARMACOL, V83, P823, DOI 10.1016/j.bcp.2011.11.028; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Giannocco G, 2012, EUR J PHARM; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Higaki Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE889, DOI 10.1152/ajpendo.00150.2007; Horie T, 2008, J CELL PHYSIOL, V215, P733, DOI 10.1002/jcp.21353; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Kang KA, 2005, BIOL PHARM BULL, V28, P1154, DOI 10.1248/bpb.28.1154; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Maes MB, 2007, CLIN CHIM ACTA, V380, P31, DOI 10.1016/j.cca.2007.01.024; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Michel MC, 2008, N-S ARCH PHARMACOL, V377, P205, DOI 10.1007/s00210-008-0280-0; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Read PA, 2010, CIRC CARDIOVASC IMAG; Read PA, 2011, CIRC-CARDIOVASC INTE, V4, P266, DOI 10.1161/CIRCINTERVENTIONS.110.960476; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhong J, 2012, ATHEROSCLEROSIS	45	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54518	10.1371/journal.pone.0054518	http://dx.doi.org/10.1371/journal.pone.0054518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359639	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600064
J	Aycrigg, JL; Davidson, A; Svancara, LK; Gergely, KJ; McKerrow, A; Scott, JM				Aycrigg, Jocelyn L.; Davidson, Anne; Svancara, Leona K.; Gergely, Kevin J.; McKerrow, Alexa; Scott, J. Michael			Representation of Ecological Systems within the Protected Areas Network of the Continental United States	PLOS ONE			English	Article							GAP ANALYSIS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; VEGETATION; WORLD; FRAMEWORK; COVERAGE; SCIENCE; REGIONS	If conservation of biodiversity is the goal, then the protected areas network of the continental US may be one of our best conservation tools for safeguarding ecological systems (i.e., vegetation communities). We evaluated representation of ecological systems in the current protected areas network and found insufficient representation at three vegetation community levels within lower elevations and moderate to high productivity soils. We used national-level data for ecological systems and a protected areas database to explore alternative ways we might be able to increase representation of ecological systems within the continental US. By following one or more of these alternatives it may be possible to increase the representation of ecological systems in the protected areas network both quantitatively (from 10% up to 39%) and geographically and come closer to meeting the suggested Convention on Biological Diversity target of 17% for terrestrial areas. We used the Landscape Conservation Cooperative framework for regional analysis and found that increased conservation on some private and public lands may be important to the conservation of ecological systems in Western US, while increased public-private partnerships may be important in the conservation of ecological systems in Eastern US. We have not assessed the pros and cons of following the national or regional alternatives, but rather present them as possibilities that may be considered and evaluated as decisions are made to increase the representation of ecological systems in the protected areas network across their range of ecological, geographical, and geophysical occurrence in the continental US into the future.	[Aycrigg, Jocelyn L.; Davidson, Anne] Univ Idaho, Dept Fish & Wildlife Sci, Natl Gap Anal Program, Moscow, ID 83843 USA; [Svancara, Leona K.] Idaho Dept Fish & Game, Moscow, ID USA; [Gergely, Kevin J.] US Geol Survey, Gap Anal Program, Boise, ID USA; [McKerrow, Alexa] US Geol Survey, Gap Anal Program, Raleigh, NC USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Aycrigg, JL (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Natl Gap Anal Program, Moscow, ID 83843 USA.	aycrigg@uidaho.edu	Aycrigg, Jocelyn/AAA-5719-2020	Aycrigg, Jocelyn/0000-0002-6511-7985	United States Geological Society [G08A00047]; Idaho Department of Fish and Game; United States Geological Survey GAP	United States Geological Society; Idaho Department of Fish and Game; United States Geological Survey GAP	The National Gap Analysis Program at the University of Idaho is supported by the United States Geological Society Gap Analysis Program under grant #G08A00047. The url: gapanalysis.usgs.gov. The agreement mentioned above supported JA and AD to do the study design, data collection and analysis as well as the decision to publish and preparation of the manuscript. LS was supported by Idaho Department of Fish and Game to help with the study design, data analysis, and preparation of the manuscript. AM and KG were funded by United States Geological Survey GAP to help with study design, data collection and analysis. KG is the program officer for this agreement and he has been involved with the study design, data collection, and data analysis for this manuscript. JMS is retired and he helped with the study design, decision to publish and preparation of the manuscript. The funders had a role in the study design, data collection, and data analysis, but not in the decision to publish or preparation of the manuscript.	Allred CS, 2007, 7675 TRANSF ADM JUR; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Baron J.S., 2008, PRELIMINARY REV ADAP; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bunce RGH, 2012, ECOL INDIC; CAICCO SL, 1995, CONSERV BIOL, V9, P498, DOI 10.1046/j.1523-1739.1995.09030498.x; Chape S., 2003, 2003 UN LIST PROTECT; Comer P., 2003, ECOLOGICAL SYSTEMS U; Crist PJ, 1996, GAP ANAL B, V5; CRUMPACKER D W, 1988, Conservation Biology, V2, P103, DOI 10.1111/j.1523-1739.1988.tb00339.x; Darst CR, 2009, NAT AREA J, V29, P224, DOI 10.3375/043.029.0304; Dietz RW, 2005, CONSERV BIOL, V19, P1478, DOI 10.1111/j.1523-1739.2005.00114.x; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; ESTES JE, 1994, PHOTOGRAMM ENG REM S, V60, P517; Fairfax S.K., 2005, BUYING NATURE LIMITS; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; GLICKSMAN R. L., 2008, NEB LAW REV, V87, P833; Groves C.R., 2003, DRAFTING CONSERVATIO; Groves CR, 2000, PRECIOUS HERITAGE ST; HARRISON J, 1982, AMBIO, V11, P238; Hazen HD, 2004, PHYS GEOGR, V25, P499, DOI 10.2747/0272-3646.25.6.499; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hogenauer A., 1991, G WRIGHT FORUM, V7, P2; Hogenauer AK, 1991, G WRIGHT FORUM, V8, P26; Kareiva P, 2010, NATURE, V466, P322, DOI 10.1038/466322a; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Langhammer P.F., 2007, IDENTIFICATION GAP A; Lemieux CJ, 2011, LAND USE POLICY, V28, P928, DOI 10.1016/j.landusepol.2011.03.008; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; Loomis J.B., 1993, INTEGRATED PUBLIC LA; Lowry J, 2007, REMOTE SENS ENVIRON, V108, P59, DOI 10.1016/j.rse.2006.11.008; Lowry J.H., 2007, SW REGIONAL GAP ANAL, P14; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Millard MJ, 2012, J FISH WILDL MANAG, V3, P175, DOI 10.3996/052011-JFWM-030; MILLER KR, 1982, AMBIO, V11, P315; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Noss R. F., 1994, SAVING NATURES LEGAC; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PCAST, 2011, SUST ENV CAP PROT SO; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Redford KH, 1999, CONSERV BIOL, V13, P1246, DOI 10.1046/j.1523-1739.1999.97463.x; Retti DR, 1995, OUR NATL PARK SYSTEM; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Sanborn, 2006, GAP ZONE 1 VEGETATIO; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scott D, 2002, GLOBAL ECOL BIOGEOGR, V11, P475, DOI 10.1046/j.1466-822X.2002.00308.x; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Scott JM, 2001, BIODIVERS CONSERV, V10, P1297, DOI 10.1023/A:1016647726583; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Shaffer Mark L., 2000, P301; Shelford VE, 1926, NATURALISTS GUIDE AM; Sodhi NS, 2011, TRENDS ECOL EVOL, V26, P585, DOI 10.1016/j.tree.2011.07.002; Stobaugh J, 2003, NOTICE PROPOSED WITH; Stoms DM, 1998, GREAT BASIN NAT, V58, P199; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Swaty R, 2011, PLOS ONE, V6, P1, DOI [10.1371/journal.-pone.0023002, DOI 10.1371/JOURNAL.-PONE.0023002]; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Thomas JW, 2005, PUBLIC LAND RESOURC, V26, P39; Towns E, 1998, USDA FOREST SERVICE; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; US Department of Interior and US Department of Agriculture, 2005, NAT LAND AC PLAN; *US GEOL SURV, 2006, NAT EL DAT; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, PROT AR DAT US VERS; US Geological Survey Gap Analysis Program (USGS-GAP), 2010, NAT GAP LAND COV VER; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Wright RG, 2001, BIOL CONSERV, V98, P97, DOI 10.1016/S0006-3207(00)00146-4; Zhu Z, 2006, ANDFIRE PROTOTYPE PR; [No title captured]	78	86	87	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54689	10.1371/journal.pone.0054689	http://dx.doi.org/10.1371/journal.pone.0054689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372754	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500107
J	El-Far, M; Isabelle, C; Chomont, N; Bourbonniere, M; Fonseca, S; Ancuta, P; Peretz, Y; Chouikh, Y; Halwani, R; Schwartz, O; Madrenas, J; Freeman, GJ; Routy, JP; Haddad, EK; Sekaly, RP				El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Ancuta, Petronela; Peretz, Yoav; Chouikh, Younes; Halwani, Rabih; Schwartz, Olivier; Madrenas, Joaquin; Freeman, Gordon J.; Routy, Jean-Pierre; Haddad, Elias K.; Sekaly, Rafick-Pierre			Down-Regulation of CTLA-4 by HIV-1 Nef Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; LYMPHOCYTE-ASSOCIATED MOLECULE-4; SURFACE CD4; BETA-COP; PHYSICAL INTERACTION; CYTOPLASMIC DOMAIN; DILEUCINE MOTIF; ADAPTER PROTEIN; UP-REGULATION	HIV-1 Nef protein down-regulates several cell surface receptors through its interference with the cell sorting and trafficking machinery. Here we demonstrate for the first time the ability of Nef to down-regulate cell surface expression of the negative immune modulator CTLA-4. Down-regulation of CTLA-4 required the Nef motifs DD175, EE155 and LL165, all known to be involved in vesicle trafficking. Disruption of the lysosomal functions by pH-neutralizing agents prevented CTLA-4 down-regulation by Nef, demonstrating the implication of the endosomal/lysosomal compartments in this process. Confocal microscopy experiments visualized the co-localization between Nef and CTLA-4 in the early and recycling endosomes but not at the cell surface. Overall, our results provide a novel mechanism by which HIV-1 Nef interferes with the surface expression of the negative regulator of T cell activation CTLA-4. Down-regulation of CTLA-4 may contribute to the mechanisms by which HIV-1 sustains T cell activation, a critical step in viral replication and dissemination.	[El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Ancuta, Petronela; Peretz, Yoav; Chouikh, Younes; Haddad, Elias K.; Sekaly, Rafick-Pierre] Hop St Luc, CRCHUM, Montreal, PQ H2X 1P1, Canada; [El-Far, Mohamed; Isabelle, Catherine; Chomont, Nicolas; Bourbonniere, Martin; Fonseca, Simone; Peretz, Yoav; Chouikh, Younes; Haddad, Elias K.; Sekaly, Rafick-Pierre] Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3C 3J7, Canada; [Chomont, Nicolas; Fonseca, Simone; Haddad, Elias K.; Sekaly, Rafick-Pierre] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Dept Pediat, Riyadh 11461, Saudi Arabia; [Schwartz, Olivier] Inst Pasteur, Dept Virol, Virus & Immun Grp, Paris, France; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ H3A 1A1, Canada; [Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Div Hematol, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	Universite de Montreal; Universite de Montreal; Vaccine & Gene Therapy Institute of Florida; King Saud University; King Saud University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Sekaly, RP (corresponding author), Hop St Luc, CRCHUM, 264 Rene Levesque Blvd E, Montreal, PQ H2X 1P1, Canada.	rpsekaly@vgtifl.org	Halwani, Rabih/AAN-1568-2021; Madrenas, Quim/P-5008-2019; Schwartz, Olivier/AAZ-3765-2021; Chomont, Nicolas/ABG-2545-2020; FONSECA, SIMONE GONÇALVES/U-9278-2019; Freeman, Gordon/AAC-5380-2019	Halwani, Rabih/0000-0002-6516-7771; Schwartz, Olivier/0000-0002-0729-1475; Chomont, Nicolas/0000-0001-9747-5018; Freeman, Gordon/0000-0002-7210-5616; El-Far, Mohamed/0000-0002-6458-4207	Canadian Institute of Health Research (CIHR); Fonds de la recherche en sante du Quebec (FRSQ); US National Institutes of Health (NIH); Canadian Foundation for AIDS Research; Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI); Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028871] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Foundation for AIDS Research; Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI); Canadian Network for Vaccines and Immunotherapeutics; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	M.E. and R.H. are funded by the Canadian Institute of Health Research (CIHR). J-P.R. is clinician scientist supported by Fonds de la recherche en sante du Quebec (FRSQ). This study was supported by funds from the US National Institutes of Health (NIH), the Canadian Institute of Health Research (CIHR), the Canadian Foundation for AIDS Research, the Fonds de la recherche en sante du Quebec AIDS and Infectious Disease Network (SIDA-MI) and the Canadian Network for Vaccines and Immunotherapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alegre ML, 1996, J IMMUNOL, V157, P4762; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Arora VK, 2000, J VIROL, V74, P11081, DOI 10.1128/JVI.74.23.11081-11087.2000; BACHELERIE F, 1990, J VIROL, V64, P3059, DOI 10.1128/JVI.64.6.3059-3062.1990; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chuang E, 1999, J IMMUNOL, V162, P1270; Chun T, 2004, IMMUNOL LETT, V91, P213, DOI 10.1016/j.imlet.2003.12.004; Cluet D, 2005, J VIROL, V79, P8629, DOI 10.1128/JVI.79.13.8629-8636.2005; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; DUPREZ V, 1994, J CELL SCI, V107, P1289; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GARCIA JV, 1993, J VIROL, V67, P1511, DOI 10.1128/JVI.67.3.1511-1516.1993; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Harlin H, 2002, EUR J IMMUNOL, V32, P2095, DOI 10.1002/1521-4141(200208)32:8<2095::AID-IMMU2095>3.0.CO;2-E; HARRIS MPG, 1994, J MOL BIOL, V241, P136; Hua J, 1997, VIROLOGY, V231, P231, DOI 10.1006/viro.1997.8517; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; James CO, 2004, J VIROL, V78, P3099, DOI 10.1128/JVI.78.6.3099-3109.2004; Jeong JY, 2002, IMMUNOLOGY, V105, P83, DOI 10.1046/j.0019-2805.2001.01339.x; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kroczek RA, 2004, CURR OPIN IMMUNOL, V16, P321, DOI 10.1016/j.coi.2004.03.002; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Leng QB, 2002, AIDS, V16, P519, DOI 10.1097/00002030-200203080-00002; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002; Luo TC, 1996, J VIROL, V70, P1527, DOI 10.1128/JVI.70.3.1527-1534.1996; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MANDERS EMM, 1992, J CELL SCI, V103, P857; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 1999, REV MED VIROL, V9, P111, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;111::AID-RMV245&gt;3.0.CO;2-P; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	63	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54295	10.1371/journal.pone.0054295	http://dx.doi.org/10.1371/journal.pone.0054295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372701	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500053
J	Luo, YL; Guo, HM; Zhang, YL; Chen, PX; Zhu, YX; Huang, JH; Zhou, WL				Luo, Yu-Li; Guo, Hong-Mei; Zhang, Yi-Lin; Chen, Peng-Xiao; Zhu, Yun-Xin; Huang, Jie-Hong; Zhou, Wen-Liang			Cellular Mechanism Underlying Formaldehyde-Stimulated Cl- Secretion in Rat Airway Epithelium	PLOS ONE			English	Article							FLUID SECRETION; RECEPTOR; ACTIVATION; CELLS; METHYLATION; TRPV1	Background: Recent studies suggest that formaldehyde (FA) could be synthesized endogeneously and transient receptor potential (TRP) channel might be the sensor of FA. However, the physiological significance is still unclear. Methodology/Principal Findings: The present study investigated the FA induced epithelial Cl- secretion by activation of TRPV-1 channel located in the nerve ending fiber. Exogenously applied FA induced an increase of I-SC in intact rat trachea tissue but not in the primary cultured epithelial cells. Western blot and immunofluorescence analysis identified TRPV-1 expression in rat tracheal nerve ending. Capsazepine (CAZ), a TRPV-1 specific antagonist significantly blocked the I-SC induced by FA. The TRPV-1 agonist capsaicin (Cap) induced an increase of I-SC, which was similar to the I-SC induced by FA. L-703606, an NK-1 specific inhibitor and propranolol, an adrenalin beta receptor inhibitor significantly abolished the I-SC induced by FA or Cap. In the ion substitute analysis, FA could not induce I-SC in the absence of extracelluar Cl-. The I-SC induced by FA could be blocked by the non-specific Cl- channel inhibitor DPC and the CFTR specific inhibitor CFTRi-172, but not by the Ca2+ activated Cl- channel inhibitor DIDS. Furthermore, both forskolin, an agonist of adenylate cyclase (AC) and MDL-12330A, an antagonist of AC could block FA-induced I-SC. Conclusion: Our results suggest that FA-induced epithelial I-SC response is mediated by nerve, involving the activation of TRPV-1 and release of adrenalin as well as substance P.	[Luo, Yu-Li; Guo, Hong-Mei; Zhang, Yi-Lin; Chen, Peng-Xiao; Zhu, Yun-Xin; Huang, Jie-Hong; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, JH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	Grace2400@hotmail.com; lsszwl@yahoo.com.cn		Zhang, Yi-Lin/0000-0001-5350-8279	National Key Basic Research Project of China (973 program) [2009CB522102, 2010CB945403]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2011ZX09307-304]; National Natural Science Foundation of China [31071019, 31271247]	National Key Basic Research Project of China (973 program)(National Basic Research Program of China); National Major Scientific and Technological Special Project for "Significant New Drugs Development"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Key Basic Research Project of China (973 program; No. 2009CB522102 and 2010CB945403), the National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the Twelfth Five-year Plan Period (2011ZX09307-304), and the National Natural Science Foundation of China (No. 31071019 and 31271247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameredes Bill T, 2011, Front Biosci (Schol Ed), V3, P643, DOI 10.2741/s177; BOOR PJ, 1992, TOXICOLOGY, V73, P251, DOI 10.1016/0300-483X(92)90067-O; CHAN HC, 1994, BIOL REPROD, V51, P1040, DOI 10.1095/biolreprod51.5.1040; Chan HC, 1997, J PHYSIOL-LONDON, V501, P517, DOI 10.1111/j.1469-7793.1997.517bm.x; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Dib M, 2009, AM J PHYSIOL-LUNG C, V297, pL687, DOI 10.1152/ajplung.90509.2008; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Heck HD, 2004, REGUL TOXICOL PHARM, V40, P92, DOI 10.1016/j.yrtph.2004.05.001; Hizawa N, 2009, J CLIN PHARM THER, V34, P631, DOI 10.1111/j.1365-2710.2009.01066.x; Ianowski JP, 2008, PFLUG ARCH EUR J PHY, V457, P529, DOI 10.1007/s00424-008-0527-0; Iwasaki Y, 2006, NUTR NEUROSCI, V9, P169, DOI 10.1080/10284150600955164; Kalasz H, 2003, MINI-REV MED CHEM, V3, P175, DOI 10.2174/1389557033488187; Kazani S, 2010, J ALLERGY CLIN IMMUN, V125, P295, DOI 10.1016/j.jaci.2009.12.014; Khansaheb M, 2011, AM J PHYSIOL-LUNG C, V300, pL370, DOI 10.1152/ajplung.00372.2010; KHOKHLOV AP, 1989, ZH NEVROPATOL PSIKH, V89, P45; Lam PMW, 2007, J NEUROCHEM, V102, P801, DOI 10.1111/j.1471-4159.2007.04569.x; LEFKOWITZ RJ, 1982, FED PROC, V41, P2664; Lino-dos-Santos-Franco A, 2010, TOXICOL LETT, V197, P211, DOI 10.1016/j.toxlet.2010.05.022; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; McGwin G, 2010, ENVIRON HEALTH PERSP, V118, P313, DOI 10.1289/ehp.0901143; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; National Toxicology Program, 2010, REP CARCINOG BACKGR, V10-5981, pi; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Persoz C, 2012, TOXICOL LETT, V211, P159, DOI 10.1016/j.toxlet.2012.03.799; Persoz C, 2010, TOXICOL LETT, V195, P99, DOI 10.1016/j.toxlet.2010.03.003; Sakamoto Tatsuo, 2010, Acta Anatomica Nipponica, V85, P35; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; Tanaka Yoshio, 2005, Journal of Smooth Muscle Research, V41, P153, DOI 10.1540/jsmr.41.153; Taylor SJ, 2012, J PHARMACOL EXP THER, V340, P377, DOI 10.1124/jpet.111.187872; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tian Li-Juan, 2009, Shengli Xuebao, V61, P404; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; TREZL L, 1983, BIOCHEM J, V214, P289, DOI 10.1042/bj2140289; Wallace DP, 2004, AM J PHYSIOL-RENAL, V287, pF639, DOI 10.1152/ajprenal.00448.2003; Watanabe N, 2006, NEUROSCIENCE, V141, P1533, DOI 10.1016/j.neuroscience.2006.04.073; Watanabe N, 2009, ENVIRON TOXICOL, V141, P1533; Weisel CP, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110s4527; Wick EC, 2006, AM J PHYSIOL-GASTR L, V290, pG95; Yang ZH, 2008, CELL BIOL INT, V32, P679, DOI 10.1016/j.cellbi.2008.01.294; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348; Yu PH, 1996, ATHEROSCLEROSIS, V120, P189, DOI 10.1016/0021-9150(95)05701-3	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54494	10.1371/journal.pone.0054494	http://dx.doi.org/10.1371/journal.pone.0054494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372735	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500079
J	Sanbonmatsu, DM; Strayer, DL; Medeiros-Ward, N; Watson, JM				Sanbonmatsu, David M.; Strayer, David L.; Medeiros-Ward, Nathan; Watson, Jason M.			Who Multi-Tasks and Why? Multi-Tasking Ability, Perceived Multi-Tasking Ability, Impulsivity, and Sensation Seeking	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; SELF-REPORT; INDIVIDUAL-DIFFERENCES; PERSONALITY; BEHAVIOR; COMPONENTS; ATTENTION; RISKY; AGE	The present study examined the relationship between personality and individual differences in multi-tasking ability. Participants enrolled at the University of Utah completed measures of multi-tasking activity, perceived multi-tasking ability, impulsivity, and sensation seeking. In addition, they performed the Operation Span in order to assess their executive control and actual multi-tasking ability. The findings indicate that the persons who are most capable of multi-tasking effectively are not the persons who are most likely to engage in multiple tasks simultaneously. To the contrary, multi-tasking activity as measured by the Media Multitasking Inventory and self-reported cell phone usage while driving were negatively correlated with actual multi-tasking ability. Multi-tasking was positively correlated with participants' perceived ability to multi-task ability which was found to be significantly inflated. Participants with a strong approach orientation and a weak avoidance orientation - high levels of impulsivity and sensation seeking - reported greater multi-tasking behavior. Finally, the findings suggest that people often engage in multi-tasking because they are less able to block out distractions and focus on a singular task. Participants with less executive control - low scorers on the Operation Span task and persons high in impulsivity - tended to report higher levels of multi-tasking activity.	[Sanbonmatsu, David M.; Strayer, David L.; Medeiros-Ward, Nathan; Watson, Jason M.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Strayer, DL (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	David.Strayer@uah.edu	Ward, Nathan/AAB-5713-2021	Strayer, David/0000-0002-1653-730X	American Automobile Association Foundation for Traffic Safety	American Automobile Association Foundation for Traffic Safety	This research was supported by a grant from the American Automobile Association Foundation for Traffic Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton GS, 2003, SUBST USE MISUSE, V38, P67, DOI 10.1081/JA-120016566; Ajzen I., 1980, UNDERSTANDING ATTITU; Alicke M. D., 2005, SELF SOCIAL JUDGMENT, P85, DOI DOI 10.1111/J.1559-1816.2011.00752.X; BACHOROWSKI JA, 1990, J PERS SOC PSYCHOL, V58, P512, DOI 10.1037/0022-3514.58.3.512; Barratt E.S., 1983, BIOL BASES SENSATION, P77; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Cain MS, 2011, PERCEPTION, V40, P1183, DOI 10.1068/p7017; Carver CS, 2000, PERS SOC PSYCHOL B, V26, P741, DOI 10.1177/0146167200268008; Cheung AM, 2004, J CLIN EXP NEUROPSYC, V26, P393, DOI 10.1080/13803390490510103; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; College Board, 1976, STUD DESCR QUEST; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; EINHORN HJ, 1981, ANNU REV PSYCHOL, V32, P53, DOI 10.1146/annurev.ps.32.020181.000413; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FRANKEN RE, 1992, PERS INDIV DIFFER, V13, P31, DOI 10.1016/0191-8869(92)90214-A; GERBING DW, 1987, MULTIVAR BEHAV RES, V22, P357, DOI 10.1207/s15327906mbr2203_6; Glassbrenner D., 2005, 809967 DOT HS NAT CT; Glicksohn J, 1998, PERS INDIV DIFFER, V25, P1085, DOI 10.1016/S0191-8869(98)00096-8; GRAY JA, 1987, J RES PERS, V21, P493, DOI 10.1016/0092-6566(87)90036-5; HORVATH P, 1993, PERS INDIV DIFFER, V14, P41, DOI 10.1016/0191-8869(93)90173-Z; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; LUENGO MA, 1991, PERS INDIV DIFFER, V12, P657, DOI 10.1016/0191-8869(91)90220-6; Martin LE, 2004, NEUROREPORT, V15, P1519, DOI 10.1097/01.wnr.0000132920.12990.b9; Miller E, 2004, PERS INDIV DIFFER, V37, P349, DOI 10.1016/j.paid.2003.09.008; Newell A., 1969, PROGR OPERATIONS RES, V3, P360; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PFEFFERBAUM B, 1994, J ADOLESCENT HEALTH, V15, P295, DOI 10.1016/1054-139X(94)90602-5; PIVIK RT, 1988, PSYCHOPHYSIOLOGY, V25, P16, DOI 10.1111/j.1469-8986.1988.tb00951.x; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; RHODEWALT F, 1986, J PERS SOC PSYCHOL, V50, P47, DOI 10.1037/0022-3514.50.1.47; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; SANBONMATSU DM, 1990, J PERS SOC PSYCHOL, V59, P614, DOI 10.1037/0022-3514.59.4.614; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stanford MS, 1996, PERS INDIV DIFFER, V21, P1073, DOI 10.1016/S0191-8869(96)00151-1; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Strayer DL, 2010, PSYCHOL LEARNING MOT, V54; Suls J, 2002, J PERS SOC PSYCHOL, V82, P252, DOI 10.1037//0022-3514.82.2.252; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Watson J. M., 2011, HDB LIFESPAN PSYCHOL, P407; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Whitney P, 2004, PERS INDIV DIFFER, V37, P417, DOI 10.1016/j.paid.2003.09.013; Zell E, 2011, J APPL SOC PSYCHOL, V41, P1175, DOI 10.1111/j.1559-1816.2011.00752.x; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; Zuckerman M., 1994, BEHAV EXPRESSIONS BI; Zuckerman M., 2014, SENSATION SEEKING OP; Zuckerman M, 2007, PERS INDIV DIFFER, V43, P1303, DOI 10.1016/j.paid.2007.03.021	52	223	226	4	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54402	10.1371/journal.pone.0054402	http://dx.doi.org/10.1371/journal.pone.0054402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372720	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500069
J	Zhu, J; Murphy, GL				Zhu, Jennifer; Murphy, Gregory L.			Influence of Emotionally Charged Information on Category-Based Induction	PLOS ONE			English	Article							PREDICTIONS; UNCERTAINTY; ATTENTION; PEOPLE	Categories help us make predictions, or inductions, about new objects. However, we cannot always be certain that a novel object belongs to the category we are using to make predictions. In such cases, people should use multiple categories to make inductions. Past research finds that people often use only the most likely category to make inductions, even if it is not certain. In two experiments, subjects read stories and answered questions about items whose categorization was uncertain. In Experiment 1, the less likely category was either emotionally neutral or dangerous (emotionally charged or likely to pose a threat). Subjects used multiple categories in induction when one of the categories was dangerous but not when they were all neutral. In Experiment 2, the most likely category was dangerous. Here, people used multiple categories, but there was also an effect of avoidance, in which people denied that dangerous categories were the most likely. The attention-grabbing power of dangerous categories may be balanced by a higher-level strategy to reject them.	[Zhu, Jennifer; Murphy, Gregory L.] NYU, Dept Psychol, New York, NY 10003 USA	New York University	Murphy, GL (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	gregory.murphy@nyu.edu			National Science Foundation [BCS-1128769]; Direct For Social, Behav & Economic Scie [1128769] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was partially supported by National Science Foundation grant BCS-1128769 (nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; Evans J. S. B., 2007, HYPOTHETICAL THINKIN; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Hayes BK, 2008, PSYCHON B REV, V15, P1002, DOI 10.3758/PBR.15.5.1002; Hayes Brett K, 2009, Mem Cognit, V37, P730, DOI 10.3758/MC.37.6.730; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Koo M, 2012, COGNITION EMOTION, V26, P680, DOI 10.1080/02699931.2011.613920; KUNDA Z, 1987, J PERS SOC PSYCHOL, V53, P636, DOI 10.1037/0022-3514.53.4.636; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lagnado DA, 2003, COGNITION, V89, P157, DOI 10.1016/S0010-0277(03)00099-4; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; MALT BC, 1995, J EXP PSYCHOL LEARN, V21, P646, DOI 10.1037/0278-7393.21.3.646; MURPHY GL, 1994, COGNITIVE PSYCHOL, V27, P148, DOI 10.1006/cogp.1994.1015; Murphy GL, 2012, THINK REASONING, V18, P81, DOI 10.1080/13546783.2011.650506; Murphy GL, 2010, J EXP PSYCHOL LEARN, V36, P263, DOI 10.1037/a0018685; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Ross BH, 1996, J EXP PSYCHOL LEARN, V22, P736, DOI 10.1037/0278-7393.22.3.736; Stanovich K. E., 2009, WHAT INTELLIGENCE TE; Tenenbaum JB, 2000, ADV NEUR IN, V12, P59	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54286	10.1371/journal.pone.0054286	http://dx.doi.org/10.1371/journal.pone.0054286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372700	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500052
J	De Ioris, MA; Prete, A; Cozza, R; Podda, M; Manzitti, C; Pession, A; Schiavello, E; Contoli, B; Balter, R; Fagioli, F; Bisogno, G; Amoroso, L; Locatelli, F; Luksch, R				De Ioris, Maria Antonietta; Prete, Arcangelo; Cozza, Raffaele; Podda, Marta; Manzitti, Carla; Pession, Andrea; Schiavello, Elisabetta; Contoli, Benedetta; Balter, Rita; Fagioli, Franca; Bisogno, Gianni; Amoroso, Loredana; Locatelli, Franco; Luksch, Roberto			Ewing Sarcoma of the Bone in Children under 6 Years of Age	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; FAMILY TUMORS; IFOSFAMIDE; ETOPOSIDE; CYCLOPHOSPHAMIDE; OSTEOSARCOMA; CHEMOTHERAPY; EXPERIENCE; YOUNGER; IMPACT	Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study was to report the clinical characteristics and outcome of children under 6 years of age affected by ESFT of the bone in Italy. Methods: The records of all the children diagnosed with osseous ESFT in centres members of the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) from 1990 to 2008 were reviewed. The Kaplan-Meier method was used for estimating overall and progression-free survival (OS, PFS) curves; multivariate analyses were performed using Cox proportional hazards regression model. Results: This study includes 62 patients. An axial primary localization was present in 66% of patients, with the primary site in the chest wall in 34%. Fourteen (23%) patients presented metastatic disease. The 5-year OS and PFS were 73% (95% confidence interval, CI, 58-83%) and 72% (95% CI 57-83%) for patients with localized disease and 38% (95% CI 17-60%) and 21% (95% CI 5-45%) for patients with metastatic disease. Metastatic spread, skull/pelvis/spine primary localization, progression during treatment and no surgery predicted worse survival (P < 0.01), while patients treated in the last decade had better survival (P = 0.002). In fact, the 5-year OS and PFS for patients diagnosed in the period 2000-2008 were 89% (95% CI 71-96%) and 86% (95% CI 66-94%), respectively. Conclusion: The axial localization is the most common site of ESFT in pre-scholar children. Patients treated in the most recent period have an excellent outcome.	[De Ioris, Maria Antonietta; Cozza, Raffaele; Locatelli, Franco] Osped Pediat Bambino Gesu IRCCS, Haematol Oncol Dept, Rome, Italy; [Prete, Arcangelo; Pession, Andrea] Univ Bologna, Paediat Haematol Oncol Dept, Bologna, Italy; [Podda, Marta; Schiavello, Elisabetta; Luksch, Roberto] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Manzitti, Carla; Amoroso, Loredana] Ist Giannina Gaslini IRCCS, Paediat Haematol Oncol Dept, Genoa, Italy; [Contoli, Benedetta] Osped Pediat Bambino Gesu IRCCS, Epidemiol Unit, Rome, Italy; [Balter, Rita] Univ Verona, Paediat Haematol Oncol Dept, I-37100 Verona, Italy; [Fagioli, Franca] Regina Margherita Hosp, Paediat Haematol Oncol Dept, Turin, Italy; [Bisogno, Gianni] Univ Padua, Paediat Haematol Oncol Dept, Padua, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; University of Bologna; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu; University of Verona; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Padua; University of Pavia	De Ioris, MA (corresponding author), Osped Pediat Bambino Gesu IRCCS, Haematol Oncol Dept, Rome, Italy.	deioris@opbg.net	Schiavello, Elisabetta/K-8091-2016; Podda, Marta Giorgia/I-1921-2017; Contoli, Benedetta/AAB-2696-2022; Manzitti, Carla/K-2080-2018; Amoroso, Loredana/AAB-3000-2020; DE IORIS, MARIA ANTONIETTA/AAA-9588-2022; Luksch, Roberto/K-2206-2016; Fagioli, Franca/AAC-2181-2022; Pession, Andrea/O-3200-2013; Bisogno, Gianni/K-9282-2016	Schiavello, Elisabetta/0000-0002-8049-7445; Podda, Marta Giorgia/0000-0002-0855-2526; Manzitti, Carla/0000-0002-1501-5518; Amoroso, Loredana/0000-0003-1950-4754; DE IORIS, MARIA ANTONIETTA/0000-0002-2113-4505; Luksch, Roberto/0000-0002-7203-4176; Pession, Andrea/0000-0002-0379-9562; Bisogno, Gianni/0000-0003-4462-5523; FAGIOLI, FRANCA/0000-0002-9257-900X; Cozza, Raffaele/0000-0002-8502-3310; Contoli, Benedetta/0000-0003-0479-7822; Prete, Arcangelo/0000-0002-6823-3797				Abate ME, 2010, PEDIATR BLOOD CANCER, V55, P652, DOI 10.1002/pbc.22567; Abudu A, 1999, BRIT J CANCER, V79, P1185, DOI 10.1038/sj.bjc.6690190; Ahrens S, 1999, MED PEDIATR ONCOL, V32, P186, DOI 10.1002/(SICI)1096-911X(199903)32:3<186::AID-MPO5>3.0.CO;2-D; Bacci G, 1999, ONCOL REP, V6, P807; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; de Alava E, 2000, CANCER-AM CANCER SOC, V89, P783, DOI 10.1002/1097-0142(20000815)89:4<783::AID-CNCR10>3.0.CO;2-Q; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Ferrari S, 2011, ANN ONCOL, V22, P1221, DOI 10.1093/annonc/mdq573; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Jenkin RD, 2002, MED PEDIATR ONCOL, V39, P586, DOI 10.1002/mpo.10212; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krasin MJ, 2005, CANCER-AM CANCER SOC, V104, P367, DOI 10.1002/cncr.21160; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Luksch R, 2001, HAEMATOLOGICA, V86, P753; Milano GM, 2006, CANCER, V106, P1838, DOI 10.1002/cncr.21780; Paulussen M, 2001, J CLIN ONCOL, V19, P1818, DOI 10.1200/JCO.2001.19.6.1818; Paulussen M, 2008, J CLIN ONCOL, V26, P4385, DOI 10.1200/JCO.2008.16.5720; Picci P, 1997, J CLIN ONCOL, V15, P1; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Rodriguez-Galindo C, 2007, CANCER-AM CANCER SOC, V110, P375, DOI 10.1002/cncr.22821; Rosito P, 1999, CANCER-AM CANCER SOC, V86, P421, DOI 10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O; Stiller CA, 2006, EUR J CANCER, V42, P2124, DOI 10.1016/j.ejca.2006.05.015; van den Berg H, 2008, J PEDIATR ORTHOPED, V28, P29, DOI 10.1097/BPO.0b013e3181558cb5; van den Berg H, 2008, PEDIATR BLOOD CANCER, V50, P761, DOI 10.1002/pbc.21292; Wei G, 2000, CANCER-AM CANCER SOC, V89, P793, DOI 10.1002/1097-0142(20000815)89:4<793::AID-CNCR11>3.0.CO;2-M; Worch J, 2010, PEDIATR BLOOD CANCER, V55, P285, DOI 10.1002/pbc.22509	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53223	10.1371/journal.pone.0053223	http://dx.doi.org/10.1371/journal.pone.0053223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382839	Green Published, gold			2022-12-27	WOS:000314610600013
J	Liu, H; Chatel, S; Simard, C; Syam, N; Salle, L; Probst, V; Morel, J; Millat, G; Lopez, M; Abriel, H; Schott, JJ; Guinamard, R; Bouvagnet, P				Liu, Hui; Chatel, Stephanie; Simard, Christophe; Syam, Ninda; Salle, Laurent; Probst, Vincent; Morel, Julie; Millat, Gilles; Lopez, Michel; Abriel, Hugues; Schott, Jean-Jacques; Guinamard, Romain; Bouvagnet, Patrice			Molecular Genetics and Functional Anomalies in a Series of 248 Brugada Cases with 11 Mutations in the TRPM4 Channel	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; ST-SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; BUNDLE-BRANCH BLOCK; J-WAVE SYNDROMES; CONDUCTION; DEPOLARIZATION; SUBSTRATE	Brugada syndrome (BrS) is a condition defined by ST-segment alteration in right precordial leads and a risk of sudden death. Because BrS is often associated with right bundle branch block and the TRPM4 gene is involved in conduction blocks, we screened TRPM4 for anomalies in BrS cases. The DNA of 248 BrS cases with no SCN5A mutations were screened for TRPM4 mutations. Among this cohort, 20 patients had 11 TRPM4 mutations. Two mutations were previously associated with cardiac conduction blocks and 9 were new mutations (5 absent from similar to 149000 control alleles and 4 statistically more prevalent in this BrS cohort than in control alleles). In addition to Brugada, three patients had a bifascicular block and 2 had a complete right bundle branch block. Functional and biochemical studies of 4 selected mutants revealed that these mutations resulted in either a decreased expression (p. Pro779Arg and p. Lys914X) or an increased expression (p. Thr873Ile and p.Leu1075Pro) of TRPM4 channel. TRPM4 mutations account for about 6% of BrS. Consequences of these mutations are diverse on channel electrophysiological and cellular expression. Because of its effect on the resting membrane potential, reduction or increase of TRPM4 channel function may both reduce the availability of sodium channel and thus lead to BrS.	[Liu, Hui; Millat, Gilles; Bouvagnet, Patrice] Hosp Civils Lyon, Grp Hosp Est, Lab Cardiogenet, Bron, France; [Liu, Hui; Bouvagnet, Patrice] Univ Lyon 1, Lab Cardiogenet, Equipe Accueil 4173, F-69365 Lyon, France; [Bouvagnet, Patrice] Hosp Civils Lyon, Grp Hosp Est, Serv Cardiol Pediat, Bron, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Inst Natl Sante & Rech Med, Inst Thorax, UMR 915, Nantes, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Ctr Natl Rech Sci, Equipe Rech Labellisee 3147, Inst Thorax, Nantes, France; [Chatel, Stephanie; Probst, Vincent; Schott, Jean-Jacques] Univ Nantes, Inst Thorax, Nantes, France; [Schott, Jean-Jacques] CHU Nantes, Serv Cardiol, Inst Thorax, F-44035 Nantes 01, France; [Simard, Christophe; Salle, Laurent; Morel, Julie; Guinamard, Romain] Univ Caen, Ctr Hosp Univ Caen, Equipe Accueil 4650, Grp Signalisat Elect & Imagerie Les Ischem Reperf, F-14032 Caen, France; [Syam, Ninda; Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Lopez, Michel] Hop St Luc, Serv Cardiol, Lyon, France; [Millat, Gilles] Univ Lyon 1, Lab Neurocardiol, EA 4612, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Bern; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bouvagnet, P (corresponding author), Hosp Civils Lyon, Grp Hosp Est, Lab Cardiogenet, Bron, France.	patrice.bouvagnet@chu-lyon.fr	probst, vincent/D-4996-2015; CHATEL, Stephanie/D-2536-2015; MILLAT, Gilles/GWZ-2688-2022; Abriel, Hugues/B-9800-2009; Schott, jean-Jacques/F-8842-2013	probst, vincent/0000-0002-5492-8619; CHATEL, Stephanie/0000-0003-0677-5627; Abriel, Hugues/0000-0003-0465-5138; Schott, jean-Jacques/0000-0002-9578-9475	Projet Hospitalier de Recherche Clinique; Foundation Renaud Febvre; Etards, France; Swiss National Science Foundation TransCure [310030, 120707]	Projet Hospitalier de Recherche Clinique; Foundation Renaud Febvre; Etards, France; Swiss National Science Foundation TransCure	This work was supported by grants from Projet Hospitalier de Recherche Clinique 2008 and Foundation Renaud Febvre, les Etards, France to PB, and Swiss National Science Foundation TransCure and 310030 120707 grants to HA. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Antzelevitch C, 2003, J AM COLL CARDIOL, V41, P1665, DOI 10.1016/S0735-1097(03)00310-3; Brugada J, 2002, CIRCULATION, V105, P73, DOI 10.1161/hc0102.101354; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guinamard R, 2006, TRENDS CARDIOVAS MED, V16, P245, DOI 10.1016/j.tcm.2006.04.007; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Medeiros-Domingo A, 2010, HEART RHYTHM, V7, P1466, DOI 10.1016/j.hrthm.2010.06.016; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Ohkubo K, 2010, INT HEART J, V51, P17, DOI 10.1536/ihj.51.17; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P1320, DOI 10.1046/j.1540-8167.2000.01320.x; SPEAR JF, 1974, CIRC RES, V35, P782, DOI 10.1161/01.RES.35.5.782; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599	28	92	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54131	10.1371/journal.pone.0054131	http://dx.doi.org/10.1371/journal.pone.0054131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382873	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800033
J	Goller, T; Seibold, UK; Kremmer, E; Voos, W; Kolanus, W				Goller, Tobias; Seibold, Ursula K.; Kremmer, Elisabeth; Voos, Wolfgang; Kolanus, Waldemar			Atad3 Function Is Essential for Early Post-Implantation Development in the Mouse	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; M-AAA PROTEASE; MITOCHONDRIAL FUSION; MAMMALIAN-CELLS; MOLECULAR CHARACTERIZATION; CRISTAE MORPHOGENESIS; ENDOPLASMIC-RETICULUM; ANTIOXIDANT ENZYMES; CANCER-CELLS; C-ELEGANS	The mitochondrial AAA+-ATPase ATAD3 is implicated in the regulation of mitochondrial and ER dynamics and was shown to be necessary for larval development in Caenorhabditis elegans. In order to elucidate the relevance of ATAD3 for mammalian development, the phenotype of an Atad3 deficient mouse line was analyzed. Atad3 deficient embryos die around embryonic day E7.5 due to growth retardation and a defective development of the trophoblast lineage immediately after implantation into the uterus. This indicates an essential function of Atad3 for the progression of the first steps of post-implantation development at a time point when mitochondrial biogenesis and ATP production by oxidative phosphorylation are required. Therefore, murine Atad3 plays an important role in the biogenesis of mitochondria in trophoblast stem cells and in differentiating trophoblasts. At the biochemical level, we report here that ATAD3 is present in five native mitochondrial protein complexes of different sizes, indicating complex roles of the protein in mitochondrial architecture and function.	[Goller, Tobias; Kolanus, Waldemar] Univ Bonn, LIMES Inst, Program Unit Mol Cell & Immune Biol, Bonn, Germany; [Seibold, Ursula K.; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Mol Immunol, Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kolanus, W (corresponding author), Univ Bonn, LIMES Inst, Program Unit Mol Cell & Immune Biol, Bonn, Germany.	wkolanus@uni-bonn.de			Deutsche Forschungsgemeinschaft (DFG) [SFB704]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, SFB704).	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Bavister BD, 2006, REPROD FERT DEVELOP, V18, P829, DOI 10.1071/RD06111; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BROWN GC, 1992, BIOCHEM J, V284, P1; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034; Fisher B, 1993, J REPROD FERTIL, V99, P673; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Geuijen CAW, 2005, EUR J CANCER, V41, P178, DOI 10.1016/j.ejca.2004.10.008; Gilquin B, 2010, MOL CELL BIOL, V30, P2724, DOI 10.1128/MCB.01468-09; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017; Hubstenberger A, 2010, J BIOENERG BIOMEMBR, V42, P143, DOI 10.1007/s10863-010-9269-8; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Merle N, 2012, MITOCHONDRION, V12, P441, DOI 10.1016/j.mito.2012.05.005; Neuwald AF, 1999, GENOME RES, V9, P27; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Van Blerkom J, 2008, REPROD BIOMED ONLINE, V16, P553, DOI 10.1016/S1472-6483(10)60463-4; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	75	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54799	10.1371/journal.pone.0054799	http://dx.doi.org/10.1371/journal.pone.0054799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372768	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400030
J	Harper, AR; Mayosi, BM; Rodriguez, A; Rahman, T; Hall, D; Mamasoula, C; Avery, PJ; Keavney, BD				Harper, Andrew R.; Mayosi, Bongani M.; Rodriguez, Antony; Rahman, Thahira; Hall, Darroch; Mamasoula, Chrysovalanto; Avery, Peter J.; Keavney, Bernard D.			Common Variation Neighbouring Micro-RNA 22 Is Associated with Increased Left Ventricular Mass	PLOS ONE			English	Article							BLOOD-PRESSURE; LIPOTOXIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; MEDIAL THICKNESS; GENE; FAMILY; CARDIOMYOCYTES; POLYMORPHISMS; METAANALYSIS; EXPRESSION	Aims: Previous genome-wide linkage analysis has suggested that chromosomal region 17p13.3 may harbour genes influencing left ventricular mass (LVM) in man. To date, the genetic factors accounting for LVM variability remain largely unknown but a non-coding RNA gene within this region, micro-RNA 22 (miR-22), has been implicated in cardiac hypertrophy and heart failure in animal models. We thus investigated the relationship between common genetic polymorphisms surrounding miR-22 and left ventricular mass in a family-based association study. Methods and Results: We studied a cohort of 255 families comprising 1,425 individuals ascertained via a hypertensive proband. Ten single nucleotide polymorphisms which together tagged common genetic variation surrounding the miR-22 gene were genotyped. There was evidence of association between the rs7223247 polymorphism, which lies within the 3'UTR of a gene of unknown function, TLCD2, immediately downstream from miR-22, and left ventricular mass determined by Sokolow-Lyon voltage (Bonferroni corrected p-value = 0.038). The T allele at rs7223247 was associated with an 0.272 standard deviation higher Sokolow-Lyon voltage. Genotype was responsible for similar to 1% of the population variability in LVM. Conclusions: Genotype at the rs7223247 polymorphism affects left ventricular mass determined by Sokolow-Lyon voltage. The neighbouring genes miR-22 and TLCD2 are strong candidates to account for this observation.	[Harper, Andrew R.] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Harper, Andrew R.; Rahman, Thahira; Hall, Darroch; Mamasoula, Chrysovalanto; Keavney, Bernard D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Rodriguez, Antony] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Avery, Peter J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Cape Town; University of Cape Town; Baylor College of Medicine; Newcastle University - UK	Keavney, BD (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.d.keavney@ncl.ac.uk	Harper, Andrew/B-7044-2017	Harper, Andrew/0000-0001-5327-0328; Keavney, Bernard/0000-0001-9573-0812; Mayosi, Bongani/0000-0001-6641-8950	British Heart Foundation [RG/08/012/25941]	British Heart Foundation(British Heart Foundation)	The study was funded by the British Heart Foundation (Grant: RG/08/012/25941) (URL:http://www.bhf.org.uk/annualreview09/BHF-Grant-Awards-2009.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036694; Baker M, 2005, DIABETES, V54, P2492, DOI 10.2337/diabetes.54.8.2492; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Cunnington MS, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-135; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; Getz GS, 2008, J LIPID RES, V49, P2077, DOI 10.1194/jlr.E800015-JLR200; Gurha P., 2012, CIRCULATION; Hall D, 2011, J HYPERTENS, V29, P690, DOI 10.1097/HJH.0b013e3283440115; Hong KW, 2012, EUR HEART J, V33, P1250, DOI 10.1093/eurheartj/ehr267; Jazbutyte V, 2012, AGE DORDR; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Keavney B, 2000, J HUM HYPERTENS, V14, P361, DOI 10.1038/sj.jhh.1001020; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Mayosi BM, 2005, STROKE, V36, P2215, DOI 10.1161/01.STR.0000182254.47941.96; Mayosi BM, 2003, EUR J HUM GENET, V11, P395, DOI 10.1038/sj.ejhg.5200967; Mayosi BM, 2002, EUR HEART J, V23, P1963, DOI 10.1053/euhj.2002.3288; Mayosi BM, 2008, EUR HEART J, V29, P525, DOI 10.1093/eurheartj/ehn028; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Palomino-Doza J, 2008, HYPERTENSION, V52, P980, DOI 10.1161/HYPERTENSIONAHA.108.113282; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Rahman TJ, 2011, CIRC-CARDIOVASC GENE, V4, P156, DOI 10.1161/CIRCGENETICS.110.958496; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shah S, 2011, CIRC-CARDIOVASC GENE, V4, P626, DOI 10.1161/CIRCGENETICS.111.960203; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852	32	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55061	10.1371/journal.pone.0055061	http://dx.doi.org/10.1371/journal.pone.0055061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372812	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400055
J	Huang, CY; Chen, YM; Zhao, JJ; Chen, YB; Jiang, SS; Yan, SM; Zhao, BW; Pan, K; Wang, DD; Lv, L; Li, YF; Wang, W; Zhou, ZW; Xia, JC				Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan			Decreased Expression of Transcription Elongation Factor A-Like 7 Is Associated with Gastric Adenocarcinoma Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; C-MYC ACTIVITY; EARLY-STAGE; TCEAL7	Background: We sought to investigate the expression levels and prognosis value of TCEAL7 in primary gastric cancer. Methods and Results: We investigated TCEAL7 and other homologous five members of the TCEAL family expression in normal gastricepithelial cell line and gastric cancer cell lines using real-time quantitative PCR. Furthermore, we examined the expression of TCEAL7 in 39 paired cancerous and matched adjacent noncancerous gastric mucosa tissues by real-time quantitative PCR and western blotting. Moreover, we analyzed TCEAL7 expression in 406 gastric cancer patients using immunohistochemistry. The relationships between the TCEAL7 expression levels, the clinicopathological factors, and patient survival were investigated. RT-qPCR data showed that mRNA expression level of TCEAL7 was significantly lower in the gastric cancer cell lines comparing with the levels of other five members of the TCEAL family. Results also revealed decreased TCEAL7 mRNA (P = 0.025) and protein (P = 0.012) expression in tumor tissue samples compared with matched adjacent non-tumor tissue samples. Immunohistochemical staining data showed that TCEAL7 expression was significantly decreased in 43.3% of gastric adenocarcinoma cases. The result also showed that the low TCEAL7 expression was significantly correlated with female, larger tumor size, higher histological grade and worse nodal status. Kaplan-Meier survival curves revealed that the reduced expression of TCEAL7 was associated with a poor prognosis in gastric adenocarcinoma patients (P<0.001). Based on a univariate analysis that included all 406 patients, TCEAL7 expression was found to have statistically significant associations with overall survival (P<0.001). Multivariate analysis also demonstrated that TCEAL7 expression (P = 0.009), age, tumor size, histological grade, lymphovascular invasion, T stage, N stage and M stage were independent risk factors in the prognosis of gastric cancer patients. Conclusions: Our study suggests that TCEAL7 might serve as a candidate tumor suppressor and a potential prognostic biomarker in gastric carcinogenesis.	[Huang, Chun-yu; Chen, Yong-ming; Zhao, Bai-wei; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Chen, Yong-ming; Zhao, Jing-jing; Chen, Yi-bing; Jiang, Shan-shan; Yan, Shu-mei; Zhao, Bai-wei; Pan, Ke; Wang, Dan-dan; Lv, Lin; Li, Yuan-fang; Wang, Wei; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-mei] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, ZW (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China.	zhouzhw@sysucc.org.cn; xiajch@mail.sysu.edu.cn	Chen, Yongming/E-3656-2015; Li, Yuan/GXV-1310-2022	Chen, Yongming/0000-0003-2843-5543; 	National Natural Science Foundation of China [30973398]; Science and Technology Projects of Guangdong Province [2008B030301103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects of Guangdong Province	This work was supported by the National Natural Science Foundation of China Grant 30973398 and Science and Technology Projects of Guangdong Province (2008B030301103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-260; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Chien J, 2005, ONCOGENE, V24, P5089, DOI 10.1038/sj.onc.1208700; Chien J, 2008, ONCOGENE, V27, P7223, DOI 10.1038/onc.2008.360; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lafferty-Whyte K, 2010, NEOPLASIA, V12, P405, DOI 10.1593/neo.10180; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Makino H, 2005, DIS ESOPHAGUS, V18, P37, DOI 10.1111/j.1442-2050.2005.00432.x; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Peedicayil A, 2009, GYNECOL ONCOL, V114, P260, DOI 10.1016/j.ygyno.2009.03.038; Pillutla RC, 1999, GENOMICS, V56, P217, DOI 10.1006/geno.1998.5705; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Shridhar V, 2002, CANCER RES, V62, P262; Shridhar V, 2001, CANCER RES, V61, P5895; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019; Zhao JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026608	21	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54671	10.1371/journal.pone.0054671	http://dx.doi.org/10.1371/journal.pone.0054671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372750	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400023
J	Rink, L; Ochs, MF; Zhou, Y; von Mehren, M; Godwin, AK				Rink, Lori; Ochs, Michael F.; Zhou, Yan; von Mehren, Margaret; Godwin, Andrew K.			ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CANCER-CELL-LINES; INTERSTITIAL-CELLS; OVARIAN-CARCINOMA; AKT/PKB PATHWAY; KIT MUTATIONS; BREAST-CANCER; PHASE-II; CAS-L; EXPRESSION	Although imatinib mesylate (IM) has transformed the treatment of gastrointestinal stromal tumors (GIST), many patients experience primary/secondary drug resistance. In a previous study, we identified a gene signature, consisting mainly of Kruppel-associated box (KRAB) domain containing zinc finger (ZNF) transcriptional repressors that predict short-term response to IM. To determine if these genes have functional significance, a siRNA library targeting these genes was constructed and applied to GIST cells in vitro. These screens identified seventeen "IM sensitizing genes'' in GIST cells (sensitization index (SI) <0.85 ratio of drug/vehicle) with a false discovery rate (FDR) <15%, including twelve ZNF genes, the majority of which are located within the HSA19p12-13.1 locus. These genes were shown to be highly specific to IM and another tyrosine kinase inhibitor (TKI), sunitinib, in GIST cells. In order to determine mechanistically how these ZNFs might be modulating response to IM, RNAi approaches were used to individually silence genes within the predictive signature in GIST cells and expression profiling was performed. Knockdown of the 14 IM-sensitizing genes (10 ZNFs) universally led to downregulation of six genes, including TGFb3, periostin, and NEDD9. These studies implicate a role of KRAB-ZNFs in modulating response to TKIs in GIST.	[Rink, Lori; von Mehren, Margaret] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Johns Hopkins Univ, Sch Med, Dept Hlth Sci Informat, Baltimore, MD USA; [Zhou, Yan] Fox Chase Canc Ctr, Dept Stat, Philadelphia, PA 19111 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA	Fox Chase Cancer Center; Johns Hopkins University; Johns Hopkins University; Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rink, L (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Lori.Rink@fccc.edu			NCI [R01 CA106588, K99 CA158061-01A1]; NIH [UL1 TR000001-02S1]; National Institutes of Health [CA-06927]; Kansas Bioscience Authority Eminent Scholar Program; KUMC; GIST Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA106588, K99CA158065, P30CA006927] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Bioscience Authority Eminent Scholar Program; KUMC; GIST Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the NCI R01 CA106588 (MvM & AKG), and K99 CA158061-01A1 (LR), the NIH UL1 TR000001-02S1 (AKG) and the National Institutes of Health core grant CA-06927. The authors would especially like to thank the GIST Cancer Research Fund for their continued support. The authors would also like to acknowledge support from the Kansas Bioscience Authority Eminent Scholar Program and the Chancellors Distinguished Chair in Biomedical Sciences endowment at KUMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Belinsky MG, 2008, CELL CYCLE, V7, P2949, DOI 10.4161/cc.7.19.6760; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chang MH, 2008, J MOL ENDOCRINOL, V41, P65, DOI 10.1677/JME-08-0051; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Chou A, 2012, MODERN PATHOL, V25, P1307, DOI 10.1038/modpathol.2012.77; Corless CL, 2008, ANNU REV PATHOL-MECH, V3, P557, DOI 10.1146/annurev.pathmechdis.3.121806.151538; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Couch FJ, 2012, CANCER EPIDEM BIOMAR, V21, P645, DOI 10.1158/1055-9965.EPI-11-0888; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Demetri GD, 2002, CANCER INVEST, V20, P853, DOI 10.1081/CNV-120002501; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Dupart JJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-99; El-Rifai W, 2000, CANCER RES, V60, P3899; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Frolov A, 2003, MOL CANCER THER, V2, P699; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gillan L, 2002, CANCER RES, V62, P5358; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Heinrich MC, 2005, J SURG ONCOL, V90, P195, DOI 10.1002/jso.20230; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Italiano A, 2012, EUR J CANC; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; MAZUR MT, 1983, AM J SURG PATHOL, V7, P507, DOI 10.1097/00000478-198309000-00001; Micci F, 2010, GENE CHROMOSOME CANC, V49, P1046, DOI 10.1002/gcc.20813; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Miettinen Markku, 2003, Polish Journal of Pathology, V54, P3; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Pantaleo MA, 2011, J NATL CANCER I, V103, P983, DOI 10.1093/jnci/djr130; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sasaki T, 2005, STROKE, V36, P2457, DOI 10.1161/01.STR.0000185672.10390.30; Seyhan AA, 2012, MOL BIOSYST, V8, P1553, DOI 10.1039/c2mb05512k; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sircar K, 1999, AM J SURG PATHOL, V23, P377, DOI 10.1097/00000478-199904000-00002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Strauss LG, 2012, SCI WORLD J, DOI 10.1100/2012/721313; Streit S, 2009, PANCREATOLOGY, V9, P577, DOI 10.1159/000212084; Subramanian S, 2004, ONCOGENE, V23, P7780, DOI 10.1038/sj.onc.1208056; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tarn C, 2005, CLIN CANCER RES, V11, P3668, DOI 10.1158/1078-0432.CCR-04-2515; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Thao LB, 2009, CANCER BIOL THER, V8, P683, DOI 10.4161/cbt.8.8.7779; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	66	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54477	10.1371/journal.pone.0054477	http://dx.doi.org/10.1371/journal.pone.0054477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372733	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400018
J	Zhao, HE; Jiang, Y; Ma, BA; Guo, MJ; Fan, QY				Zhao Haien; Jiang Yong; Ma Baoan; Guo Mingjun; Fan Qingyu			Post-Operative Auto-Transfusion in Total Hip or Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							FILTERED SHED BLOOD; AUTOLOGOUS TRANSFUSION; ORTHOPEDIC-SURGERY; REPLACEMENT SURGERY; SALVAGED BLOOD; INFECTION; RETRANSFUSION; REINFUSION; DRAINAGE; EFFICACY	Background: Total hip or knee arthroplasty is an elective procedure that is usually accompanied by substantial blood loss, which may lead to acute anemia. As a result, almost half of total joint arthroplasty patients receive allogeneic blood transfusions (ABT). Many studies have shown that post-operative auto-transfusion (PAT) significantly reduces the need for ABT, but other studies have questioned the efficacy of this method. Methods: The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1. To evaluate the efficacy of PAT, we conducted a Cochrane systematic review that combined all available data from randomized controlled trials. Data from the six included trials were pooled for analysis. We then calculated relative risks with 95% confidence intervals (CIs) for dichotomous outcomes and mean differences with 95% CIs for continuous outcomes. Findings and Conclusion: To our knowledge, this is the first meta-analysis to compare the clinical results between PAT and a control in joint replacement patients. This meta-analysis has proven that the use of a PAT reinfusion system reduced significantly the demand for ABT, the number of patients who require ABT and the cost of hospitalization after total knee and hip arthroplasty. This study, together with other previously published data, suggests that PAT drains are beneficial. Larger, sufficiently powered studies are necessary to evaluate the presumed reduction in the incidence of infection as well as DVT after joint arthroplasty with the use of PAT.	[Zhao Haien; Ma Baoan; Guo Mingjun; Fan Qingyu] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China; [Jiang Yong] Xi An Jiao Tong Univ, Coll Med, Dept Orthopaed Surg, Hong Hui Hosp, Xian 710049, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University	Ma, BA (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed Surg, Xian 710032, Peoples R China.	zhe992000@eyou.com; 53383365@qq.com						Abuzakuk T, 2007, INT ORTHOP, V31, P235, DOI 10.1007/s00264-006-0159-y; Amin A, 2008, J BONE JOINT SURG BR, V90B, P451, DOI 10.1302/0301-620X.90B4.20044; Andersson I, 2001, CAN J ANAESTH, V48, P251, DOI 10.1007/BF03019754; [Anonymous], 1989, AM J HEMATOL, V31, P144, DOI 10.1002/ajh.2830310217; Biedler AE, 2002, ANESTHESIOLOGY, V97, P1102, DOI 10.1097/00000542-200211000-00011; Blatsoukas KS, 2010, ARCH ORTHOP TRAUM SU, V130, P733, DOI 10.1007/s00402-010-1062-y; Bursi F, 2009, EUR J VASC ENDOVASC, V37, P311, DOI 10.1016/j.ejvs.2008.12.002; Carless P, 2004, TRANSFUSION MED, V14, P123, DOI 10.1111/j.0958-7578.2004.0489.x; Cuenca J, 2006, TRANSFUSION, V46, P1112, DOI 10.1111/j.1537-2995.2006.00859.x; Dalen T, 2003, VOX SANG, V85, P31, DOI 10.1046/j.1423-0410.2003.00314.x; Engelfriet CP, 2006, VOX SANG, V91, P185, DOI 10.1111/j.1423-0410.2006.00732.x; Esler CNA, 2003, J BONE JOINT SURG BR, V85B, P215, DOI 10.1302/0301-620X.85B2.13357; FARIS PM, 1991, J BONE JOINT SURG AM, V73A, P1169, DOI 10.2106/00004623-199173080-00005; Feagan BG, 2001, TRANSFUSION MED, V11, P87, DOI 10.1046/j.1365-3148.2001.00291.x; FERNANDEZ MC, 1992, TRANSFUSION, V32, P318, DOI 10.1046/j.1537-2995.1992.32492263444.x; Friederichs MG, 2002, J ARTHROPLASTY, V17, P298, DOI 10.1054/arth.2002.30409; Gharehbaghian A, 2004, LANCET, V363, P1025, DOI 10.1016/S0140-6736(04)15837-6; Grover M, 2006, VOX SANG, V90, P105, DOI 10.1111/j.1423-0410.2006.00730.x; Handel M, 2001, ACTA ORTHOP SCAND, V72, P270, DOI 10.1080/00016470152846600; Hansen E, 2004, TRANSFUSION, V44, p45S, DOI 10.1111/j.0041-1132.2004.04179.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holt BT, 1997, ORTHOPEDICS, V20, P1121; Innerhofer P, 2005, TRANSFUSION, V45, P103, DOI 10.1111/j.1537-2995.2005.04149.x; Llewelyn CA, 2004, TRANSFUSION, V44, P489, DOI 10.1111/j.1537-2995.2004.03325.x; del Trujillo MM, 2008, ARCH ORTHOP TRAUM SU, V128, P1031, DOI 10.1007/s00402-007-0440-6; Moonen AFCM, 2007, TRANSFUSION, V47, P379, DOI 10.1111/j.1537-2995.2007.01127.x; Munoz M, 2007, VOX SANG, V92, P136, DOI 10.1111/j.1423-0410.2006.00868.x; Munoz M, 2005, ARCH ORTHOP TRAUM SU, V125, P385, DOI 10.1007/s00402-005-0817-3; Munoz M, 2009, VOX SANG, V96, P1, DOI 10.1111/j.1423-0410.2008.01108.x; MURPHY P, 1991, TRANSFUSION, V31, P212, DOI 10.1046/j.1537-2995.1991.31391165169.x; Newman JH, 1997, J BONE JOINT SURG BR, V79B, P630, DOI 10.1302/0301-620X.79B4.7272; RITTER MA, 1994, J BONE JOINT SURG AM, V76A, P35, DOI 10.2106/00004623-199401000-00005; ROLLO VJ, 1995, J ARTHROPLASTY, V10, P532, DOI 10.1016/S0883-5403(05)80157-3; Rosencher N, 2003, TRANSFUSION, V43, P459, DOI 10.1046/j.1537-2995.2003.00348.x; Shulman G, 2002, CLIN ORTHOP RELAT R, P119; Sinha A, 2001, INT ORTHOP, V25, P257, DOI 10.1007/s002640100250; Smith TO, 2009, KNEE, V16, P317, DOI 10.1016/j.knee.2009.01.004; So-Osman C, 2006, TRANSFUSION MED, V16, P321, DOI 10.1111/j.1365-3148.2006.00705.x; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Steinberg EL, 2004, ARCH ORTHOP TRAUM SU, V124, P114, DOI 10.1007/s00402-003-0629-2; Strumper D, 2004, TRANSFUSION, V44, P1567, DOI 10.1111/j.1537-2995.2004.03233.x; Thomas D, 2001, BRIT J ANAESTH, V86, P669, DOI 10.1093/bja/86.5.669; Tobias JD, 2004, SEMIN HEMATOL, V41, P145, DOI 10.1053/j.seminhematol.2003.11.025; TRIULZI DJ, 1992, TRANSFUSION, V32, P517, DOI 10.1046/j.1537-2995.1992.32692367194.x; Tsumara N, 2006, J BONE JOINT SURG BR, V88B, P49, DOI 10.1302/0301-620X.88B1.16653; Weatherall M, 2004, ANZ J SURG, V74, P1049, DOI 10.1111/j.1445-1433.2004.03265.x; Zacharopoulos A, 2007, INT ORTHOP, V31, P303, DOI 10.1007/s00264-006-0173-0	47	2	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55073	10.1371/journal.pone.0055073	http://dx.doi.org/10.1371/journal.pone.0055073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372816	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400059
J	Aquilina, A; Connelly, DP; Copley, JT; Green, DRH; Hawkes, JA; Hepburn, LE; Huvenne, VAI; Marsh, L; Mills, RA; Tyler, PA				Aquilina, Alfred; Connelly, Douglas P.; Copley, Jon T.; Green, Darryl R. H.; Hawkes, Jeffrey A.; Hepburn, Laura E.; Huvenne, Veerle A. I.; Marsh, Leigh; Mills, Rachel A.; Tyler, Paul A.			Geochemical and Visual Indicators of Hydrothermal Fluid Flow through a Sediment-Hosted Volcanic Ridge in the Central Bransfield Basin (Antarctica)	PLOS ONE			English	Article							SURFACE SEDIMENTS; MARINE-SEDIMENTS; GUAYMAS BASIN; SOUTH KYUSHU; HOOK RIDGE; STRAIT; WATER; OCEAN; VENT; GULF	In the austral summer of 2011 we undertook an investigation of three volcanic highs in the Central Bransfield Basin, Antarctica, in search of hydrothermal activity and associated fauna to assess changes since previous surveys and to evaluate the extent of hydrothermalism in this basin. At Hook Ridge, a submarine volcanic edifice at the eastern end of the basin, anomalies in water column redox potential (E-h) were detected close to the seafloor, unaccompanied by temperature or turbidity anomalies, indicating low-temperature hydrothermal discharge. Seepage was manifested as shimmering water emanating from the sediment and from mineralised structures on the seafloor; recognisable vent endemic fauna were not observed. Pore fluids extracted from Hook Ridge sediment were depleted in chloride, sulfate and magnesium by up to 8% relative to seawater, enriched in lithium, boron and calcium, and had a distinct strontium isotope composition (Sr-87/Sr-86 = 0.708776 at core base) compared with modern seawater (Sr-87/Sr-86 approximate to 0.70918), indicating advection of hydrothermal fluid through sediment at this site. Biogeochemical zonation of redox active species implies significant moderation of the hydrothermal fluid with in situ diagenetic processes. At Middle Sister, the central ridge of the Three Sisters complex located about 100 km southwest of Hook Ridge, small water column E-h anomalies were detected but visual observations of the seafloor and pore fluid profiles provided no evidence of active hydrothermal circulation. At The Axe, located about 50 km southwest of Three Sisters, no water column anomalies in E-h, temperature or turbidity were detected. These observations demonstrate that the temperature anomalies observed in previous surveys are episodic features, and suggest that hydrothermal circulation in the Bransfield Strait is ephemeral in nature and therefore may not support vent biota.	[Aquilina, Alfred; Copley, Jon T.; Hawkes, Jeffrey A.; Hepburn, Laura E.; Marsh, Leigh; Mills, Rachel A.; Tyler, Paul A.] Univ Southampton, Southampton, Hants, England; [Connelly, Douglas P.; Green, Darryl R. H.; Hawkes, Jeffrey A.; Huvenne, Veerle A. I.] Natl Oceanog Ctr, Southampton, Hants, England	University of Southampton; NERC National Oceanography Centre	Aquilina, A (corresponding author), Univ Southampton, Waterfront Campus,European Way, Southampton, Hants, England.	Alfred.Aquilina@noc.soton.ac.uk	Marsh, Leigh/AAT-5597-2020; Copley, Jon/I-7076-2012; Marsh, Leigh/J-6068-2013; Hepburn, Laura/AAW-4324-2021; Mills, Rachel A/A-1150-2011	Marsh, Leigh/0000-0002-4613-1538; Copley, Jon/0000-0003-3333-4325; Marsh, Leigh/0000-0002-4613-1538; Mills, Rachel A/0000-0002-9811-246X; Huvenne, Veerle A.I./0000-0001-7135-6360; Hepburn, Laura/0000-0003-3336-5340	NERC [NE/DO1249X/1, NE/DO1429X/1, NE/H524922]; NERC [NE/D01249X/1, NE/D013437/1] Funding Source: UKRI; Natural Environment Research Council [NE/D013437/1, NE/D01249X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a NERC consortium grant NE/DO1249X/1 and NERC PhD studentships NE/DO1429X/1 (LH and LM) and NE/H524922 (JH). The funders had no role in study design, data collection and analysis, decision to publish, of preparation of the manuscript.	Alt J. C., 1995, GEOPHYS MONOGR SER, V91, P85, DOI DOI 10.1029/GM091P0085; Baker ET, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002028; Baker ET, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000948; Bennett SA, 2011, GEOCHIM COSMOCHIM AC, V75, P5526, DOI 10.1016/j.gca.2011.06.039; BISCHOFF JL, 1978, AM J SCI, V278, P838, DOI 10.2475/ajs.278.6.838; Bohrmann G, 1999, GEO-MAR LETT, V18, P277, DOI 10.1007/s003670050080; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Butterfield DA., 2003, ENERGY MASS TRANSFER, P123; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Dahlmann A, 2001, EARTH PLANET SC LETT, V193, P381, DOI 10.1016/S0012-821X(01)00535-0; DeMaster DJ, 1988, US ANTARC J, V23, P94; German C.R., 2006, TREATISE GEOCHEMISTR, V6, P45, DOI 10.1016/B0-08-043751-6/06109-0; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; Gonzalez-Ferran O., 1991, GEOLOGICAL EVOLUTION, P505; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Howe JA, 2007, DEEP-SEA RES PT II, V54, P1652, DOI 10.1016/j.dsr2.2007.07.007; Ishibashi JI, 2008, J VOLCANOL GEOTH RES, V173, P84, DOI 10.1016/j.jvolgeores.2007.12.041; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; KELLER RA, 1992, EARTH PLANET SC LETT, V111, P287, DOI 10.1016/0012-821X(92)90185-X; Klinkhammer GP, 2001, EARTH PLANET SC LETT, V193, P395, DOI 10.1016/S0012-821X(01)00536-2; Klinkhammer GP, 1996, ANTARCT J US, V31, P92; Laurila TE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004247; Lawver LA, 1996, GSA TODAY, V6, P1; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; MAGENHEIM AJ, 1992, GEOCHIM COSMOCHIM AC, V56, P2329, DOI 10.1016/0016-7037(92)90192-L; MARIS CRP, 1982, SCIENCE, V216, P623, DOI 10.1126/science.216.4546.623; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Mills RA, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003157; Nakaseama M, 2008, RESOUR GEOL, V58, P289, DOI 10.1111/j.1751-3928.2008.00062.x; Petersen S, 2004, MINER DEPOSITA, V39, P358, DOI 10.1007/s00126-004-0414-3; Pontbriand CW, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004187; Prieto MJ, 1998, MAR GEOL, V149, P17, DOI 10.1016/S0025-3227(98)00038-3; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; SCHLOSSER P, 1988, DEEP-SEA RES, V35, P1919, DOI 10.1016/0198-0149(88)90117-3; Solorzano L, 1969, ANAL CHEM, V33, P592; SOUTHWAR.EC, 1972, B MAR SCI, V22, P739; Suess E, 1987, ANTARCT J US, V22, P46; VONBREYMANN MT, 1990, GEOCHIM COSMOCHIM AC, V54, P3295, DOI 10.1016/0016-7037(90)90286-T; VONBREYMANN MT, 1988, CHEM GEOL, V70, P359, DOI 10.1016/0009-2541(88)90125-8; VONDAMM KL, 1985, GEOCHIM COSMOCHIM AC, V49, P2221, DOI 10.1016/0016-7037(85)90223-6; Wang YM, 1998, GEOSTANDARD NEWSLETT, V22, P247, DOI 10.1111/j.1751-908X.1998.tb00697.x; Webb M, 1964, SARSIA, V15, P49; WHITICAR MJ, 1985, NATURE, V314, P87, DOI 10.1038/314087a0; Wilson C, 1999, J PHYS OCEANOGR, V29, P465, DOI 10.1175/1520-0485(1999)029<0465:HWTCAE>2.0.CO;2; Winckler G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042093	48	23	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54686	10.1371/journal.pone.0054686	http://dx.doi.org/10.1371/journal.pone.0054686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359806	Green Published, Green Accepted, gold			2022-12-27	WOS:000314023600093
J	Christensen, L; Joo, J; Lee, S; Wai, D; Triche, TJ; May, WA				Christensen, Laura; Joo, Jay; Lee, Sean; Wai, Daniel; Triche, Timothy J.; May, William A.			FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma	PLOS ONE			English	Article							FORKHEAD BOX M1; PROTEASOME INHIBITOR BORTEZOMIB; TRANSCRIPTION FACTOR FOXM1; CANCER-CELLS; TARGET; EXPRESSION; TUMORS; GLI1; THIOSTREPTON; GENE	Ewing Family Tumors (Ewing Sarcoma and peripheral Primitive Neuroectodermal Tumor) are common bone and soft tissue malignancies of childhood, adolescence and young adulthood. Chromosomal translocation in these tumors produces fusion oncogenes of the EWS/ETS class, with EWS/FLI1 being by far the most common. EWS/ETS chimera are the only well established driver mutations in these tumors and they function as aberrant transcription factors. Understanding the downstream genes whose expression is modified has been a central approach to the study of these tumors. FOXM1 is a proliferation associated transcription factor which has increasingly been found to play a role in the pathogenesis of a wide range of human cancers. Here we demonstrate that FOXM1 is expressed in Ewing primary tumors and cell lines. Reduction in FOXM1 expression in Ewing cell lines results in diminished potential for anchorage independent growth. FOXM1 expression is enhanced by EWS/FLI1, though, unlike other tumor systems, it is not driven by expression of the EWS/FLI1 target GLI1. Thiostrepton is a compound known to inhibit FOXM1 by direct binding. We show that Thiostrepton diminishes FOXM1 expression in Ewing cell lines and this reduction reduces cell viability through an apoptotic mechanism. FOXM1 is involved in Ewing tumor pathogenesis and may prove to be a useful therapeutic target in Ewing tumors.	[Christensen, Laura; Joo, Jay; Lee, Sean; May, William A.] Univ So Calif, Keck Sch Med, Div Hematol Oncol, Dept Pediat,Saban Res Inst,Childrens Hosp Los Ang, Los Angeles, CA 90033 USA; [Wai, Daniel; Triche, Timothy J.] Univ So Calif, Keck Sch Med, Dept Pathol, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California	May, WA (corresponding author), Univ So Calif, Keck Sch Med, Div Hematol Oncol, Dept Pediat,Saban Res Inst,Childrens Hosp Los Ang, Los Angeles, CA 90033 USA.	wmay@chla.usc.edu		Wai, Daniel H/0000-0002-4385-4941	NIH [1R21CA137485]; Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R21CA137485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Sarcoma Foundation of America; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by NIH grant 1R21CA137485. It has also been funded by the Alex's Lemonade Stand Foundation, the Mark Herzlich Research Award from the Sarcoma Foundation of America, and a Research Grant from the St. Baldrick's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Gartel AL, 2011, CELL CYCLE, V10, P4341, DOI 10.4161/cc.10.24.18544; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P37, DOI 10.1002/pbc.21214; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Lu GR, 2008, CANCER BIOL THER, V7, P603, DOI 10.4161/cbt.7.4.5564; Maki RG, 2005, CANCER-AM CANCER SOC, V103, P1431, DOI 10.1002/cncr.20968; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Miser JS, 2004, J CLIN ONCOL, V22, P2873, DOI 10.1200/JCO.2004.01.041; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Teh MT, 2002, CANCER RES, V62, P4773; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xia LM, 2009, J CELL BIOCHEM, V106, P247, DOI 10.1002/jcb.21996; Yau C, 2011, BREAST CANCER RES TR, V126, P803, DOI 10.1007/s10549-011-1345-1; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	40	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54556	10.1371/journal.pone.0054556	http://dx.doi.org/10.1371/journal.pone.0054556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365673	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600069
J	Huang, F; Yang, Z; Xu, BH; Bi, YF; Xu, M; Xu, Y; Lu, JL; Liu, Y; Dai, M; Zhou, WZ; Wang, WQ; Chen, YH				Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong			Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY INTIMA; RISK-FACTORS; ATHEROSCLEROSIS; PREDICTION; MEN; PREVENTION; CLASSIFICATION	Background: Previous studies indicated that apolipoprotein measurements predicted cardiovascular disease (CVD) risk; however, associations between apolipoproteins and carotid intima-media thickness (CIMT) were less explored. Methodology and Principal Findings: The cross-sectional study included 6069 participants aged 40 years or older with NGT from Shanghai, China. Serum fasting traditional lipids (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C] and triglycerides [TG]), apoA-I and apoB were assessed. A high-resolution B-mode ultrasonography was performed to measure CIMT. We found CIMT increased progressively across the quartiles of serum apoB (p for trend <0.0001). In logistic regression, concentrations of apoB (odds ratio [OR] 1.27, 95% confidence interval [CI] 1.18-1.36), TC (OR 1.23, 95% CI 1.14-1.32), LDL-C (OR 1.25, 95% CI 1.16-1.34) and TG (OR 1.11, 95% CI 1.04-1.20) were significantly related to elevated CIMT after adjusted for age and sex. Meanwhile, the apoB/apoA-I ratio (OR 1.25, 95% CI 1.17-1.34) related to elevated CIMT. ApoB (OR 1.23, 95% CI 1.00-1.51) and the apoB/apoA-I ratio (OR 1.19, 95% CI 1.04-1.36) remained significantly associated with elevated CIMT, after adjusted for the traditional CVD risk factors including traditional lipids. Conclusions and Significance: There were significant associations between serum apoB, the apoB/apoA-I ratio and elevated CIMT. Serum apoB and the apoB/apoA-I ratio might be independent predictors of early atherosclerosis in NGT.	[Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,E Inst Shangai Univ, Shanghai 200030, Peoples R China; [Huang, Fei; Yang, Zhi; Xu, Baihui; Bi, Yufang; Xu, Min; Xu, Yu; Lu, Jieli; Liu, Yu; Dai, Meng; Zhou, Wenzhong; Wang, Weiqing; Chen, Yuhong] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, YH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,E Inst Shangai Univ, Shanghai 200030, Peoples R China.	chenyh70@yahoo.com.cn			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Health [201002002]; Ministry of Science and Technology [2012ZX09303006-001]; Creative Research Group of Ministry of Education [IRT0932]; National Nature Science Foundation of China [81170739, 81170719, 81222008, 30911120493]; Shanghai Science and Technology Commission [09411954400, 10XD1403000]; Shanghai Natural Science Foundation [10ZR1426400]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Creative Research Group of Ministry of Education; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the Creative Research Group of Ministry of Education (IRT0932), National Nature Science Foundation of China (81170739, 81170719, 81222008, 30911120493), Shanghai Science and Technology Commission (09411954400), Shanghai Science and Technology Commission (10XD1403000), Shanghai Natural Science Foundation (NO. 10ZR1426400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; Dahlen EM, 2009, DIABETIC MED, V26, P384, DOI 10.1111/j.1464-5491.2009.02693.x; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Genest J, 2003, CAN MED ASSOC J, V169, P921; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Hsia SH, 2006, AM J CARDIOL, V98, P1047, DOI 10.1016/j.amjcard.2006.05.024; Huang Y, 2011, J CLIN ENDOCR METAB, V96, pE1461, DOI 10.1210/jc.2010-2697; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Juonala M, 2008, J AM COLL CARDIOL, V52, P293, DOI 10.1016/j.jacc.2008.03.054; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meisinger C, 2005, EUR HEART J, V26, P271, DOI 10.1093/eurheartj/ehi003; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Olofsson SO, 2007, VASC HEALTH RISK MAN, V3, P491; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Shaw JE, 2000, DIABETES CARE, V23, pB5; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; St-Pierre AC, 2003, AM J CARDIOL, V91, P555, DOI 10.1016/S0002-9149(02)03305-2; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; van Deventer HE, 2011, CLIN CHEM, V57, P490, DOI 10.1373/clinchem.2010.154773; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Williams K, 2003, CIRCULATION, V108, P2312, DOI 10.1161/01.CIR.0000097113.11419.9E	31	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54628	10.1371/journal.pone.0054628	http://dx.doi.org/10.1371/journal.pone.0054628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359805	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600081
J	Steckel, J; Peremans, H				Steckel, Jan; Peremans, Herbert			BatSLAM: Simultaneous Localization and Mapping Using Biomimetic Sonar	PLOS ONE			English	Article							CONTINUOUS ATTRACTOR NETWORKS; ECHOLOCATING BATS; PATH INTEGRATION; MODELS; SLAM; INFORMATION; ROBOTS; MAP	We propose to combine a biomimetic navigation model which solves a simultaneous localization and mapping task with a biomimetic sonar mounted on a mobile robot to address two related questions. First, can robotic sonar sensing lead to intelligent interactions with complex environments? Second, can we model sonar based spatial orientation and the construction of spatial maps by bats? To address these questions we adapt the mapping module of RatSLAM, a previously published navigation system based on computational models of the rodent hippocampus. We analyze the performance of the proposed robotic implementation operating in the real world. We conclude that the biomimetic navigation model operating on the information from the biomimetic sonar allows an autonomous agent to map unmodified (office) environments efficiently and consistently. Furthermore, these results also show that successful navigation does not require the readings of the biomimetic sonar to be interpreted in terms of individual objects/landmarks in the environment. We argue that the system has applications in robotics as well as in the field of biology as a simple, first order, model for sonar based spatial orientation and map building.	[Steckel, Jan; Peremans, Herbert] Univ Antwerp, Fac Appl Econ, Act Percept Lab, B-2020 Antwerp, Belgium	University of Antwerp	Steckel, J (corresponding author), Univ Antwerp, Fac Appl Econ, Act Percept Lab, B-2020 Antwerp, Belgium.	jan.steckel@ua.ac.be		Steckel, Jan/0000-0003-4489-466X	EU CHIROPING (Chiroptera, Robots, Sonar) project; Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics; FWO Recap Project	EU CHIROPING (Chiroptera, Robots, Sonar) project; Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics; FWO Recap Project(FWO)	This work was funded by the EU CHIROPING (Chiroptera, Robots, Sonar) project. This project is funded by the Seventh Framework Programme ICT Challenge 2: Cognitive Systems, Interaction, Robotics and the FWO Recap Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Biber C., 1980, 67 CONV AUD ENG SOC; Blauert J., 1997, SPATIAL HEARING PSYC; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; Choset H, 2001, IEEE T ROBOTIC AUTOM, V17, P125, DOI 10.1109/70.928558; Choset HM., 2005, PRINCIPLES ROBOT MOT; Davison AJ, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1403; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; ELFES A, 1987, IEEE T ROBOTIC AUTOM, V3, P249, DOI 10.1109/JRA.1987.1087096; Fontaine B, 2009, J ACOUST SOC AM, V125, P3052, DOI 10.1121/1.3101485; Glantz S. A., 2005, PRIMER BIOSTATISTICS; Griffin D.R., 1958, LISTENING DARK ACOUS; Jensen ME, 2005, J EXP BIOL, V208, P4399, DOI 10.1242/jeb.01901; Jose E, 2004, IEEE INT CONF ROBOT, P1321, DOI 10.1109/ROBOT.2004.1308007; Leonard J. J., 1991, Proceedings IROS '91. IEEE/RSJ International Workshop on Intelligent Robots and Systems '91. Intelligence for Mechanical Systems (Cat. No.91TH0375-6), P1442, DOI 10.1109/IROS.1991.174711; Milford M, 2011, SPRINGER TRACTS ADV; Milford MJ, 2008, IEEE T ROBOT, V24, P1038, DOI 10.1109/TRO.2008.2004520; Milford MJ, 2004, IEEE INT CONF ROBOT, P403, DOI 10.1109/ROBOT.2004.1307183; Montemerlo M., 2003, P INT JOINT C ART IN, P1151; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Mullane J, 2011, IEEE T ROBOT, V27, P268, DOI 10.1109/TRO.2010.2101370; Neuweiler G., 2000, BIOL BATS; OBRIST MK, 1993, J EXP BIOL, V180, P119; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Patterson R, 1987, 2341 APU; Peremans H, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P195; Pierce A. D., 1989, ACOUSTICS INTRO ITS; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; Reijniers J, 2010, BIOL CYBERN, V102, P311, DOI 10.1007/s00422-010-0368-8; Remolina E, 2004, ARTIF INTELL, V152, P47, DOI 10.1016/S0004-3702(03)00114-0; Schaub A, 2007, J COMP PHYSIOL A, V193, P1185, DOI 10.1007/s00359-007-0269-z; Schillebeeckx F, 2012, IET RADAR SONAR NAV, V6, P516, DOI 10.1049/iet-rsn.2011.0069; Schillebeeckx F, 2011, INT J ROBOT RES, V30, P975, DOI 10.1177/0278364910380474; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Steckel J., 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P2549, DOI 10.1109/CISP.2011.6100671; Steckel J, 2012, IEEE T ULTRASON FERR, V59, P1369, DOI 10.1109/TUFFC.2012.2337; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; Stringer SN, 2002, NETWORK-COMP NEURAL, V13, P429, DOI 10.1088/0954-898X/13/4/301; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Tardos JD, 2002, INT J ROBOT RES, V21, P311, DOI 10.1177/027836402320556340; The MathWorks Inc., 2010, MATLAB; Thomas J, 2002, ECHOLOCATION BAT DOL; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Wyeth G, 2009, IEEE ROBOT AUTOM MAG, V16, P24, DOI 10.1109/MRA.2009.933620; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yovel Y, 2011, J COMP PHYSIOL A, V197, P475, DOI 10.1007/s00359-010-0584-7; Zlot R, 2009, SPR TRA ADV ROBOT, V54, P363	53	64	65	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54076	10.1371/journal.pone.0054076	http://dx.doi.org/10.1371/journal.pone.0054076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365647	Green Published, gold			2022-12-27	WOS:000314023600029
J	Aguero, F; Degano, IR; Subirana, I; Grau, M; Zamora, A; Sala, J; Ramos, R; Treserras, R; Marrugat, J; Elosua, R				Agueero, Fernando; Degano, Irene R.; Subirana, Isaac; Grau, Maria; Zamora, Alberto; Sala, Joan; Ramos, Rafel; Treserras, Ricard; Marrugat, Jaume; Elosua, Roberto			Impact of a Partial Smoke-Free Legislation on Myocardial Infarction Incidence, Mortality and Case-Fatality in a Population-Based Registry: The REGICOR Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SECONDHAND SMOKE; HOSPITAL ADMISSIONS; 2ND-HAND SMOKE; EXPOSURE; SPAIN; LAW; HEALTH; TRENDS; RATES	Background and Objective: Coronary heart disease (CHD) is the leading cause of death, and smoking its strongest modifiable risk factor. Our aim was to determine the impact of the Spanish 2006 partial smoke-free legislation on acute myocardial infarction (AMI) incidence, hospitalization and mortality rates, and 28-day case-fatality in Girona, Spain. Methods: Using a population-based registry (the REGICOR Study), we compared population incidence, hospitalization, and mortality rates, and 28-day case-fatality in the pre- and post-ban periods (2002-2005 and 2006-2008, respectively) by binomial regression analysis adjusted for confounding factors. We also analyzed the ban's impact on the outcomes of interest using the AMI definitions of the American Heart Association (AHA)/European Society of Cardiology (ESC) and the World Health Organization (WHO)-Monitoring trends and determinants in cardiovascular diseases (MONICA). Results: In the post-ban period, AMI incidence and mortality rates significantly decreased (relative risk [RR] = 0.89; 95% confidence interval [CI] = 0.81-0.97 and RR = 0.82; 95% CI = 0.71-0.94, respectively). Incidence and mortality rates decreased in both sexes, especially in women, and in people aged 65-74 years. Former and non-smokers (passive smokers) showed diminished incidence rates. Implementation of the ban was not associated with AMI case-fatality. Models tended to be more significant with the WHO-MONICA than with the AHA/ESC definition. Conclusions: The 2006 Spanish partial smoke-free legislation was associated with a decrease in population AMI incidence and mortality, particularly in women, in people aged 65-74 years, and in passive smokers. These results clarify the association between AMI mortality and the enactment of a partial smoke-free legislation and reinforce the effectiveness of smoking regulations in preventing CHD.	[Agueero, Fernando; Degano, Irene R.; Subirana, Isaac; Grau, Maria; Marrugat, Jaume; Elosua, Roberto] IMIM Hosp Mar Med Res Inst, Dept Res Inflammatory & Cardiovasc Disorders RICA, Barcelona, Spain; [Agueero, Fernando] Parc Salut Mar Pompeu Fabra Univ Publ Hlth Agcy B, Dept Prevent Med & Publ Hlth, Barcelona, Spain; [Subirana, Isaac] Epidemiol & Publ Hlth CIBER Ctr Invest Biomed Red, Barcelona, Spain; [Zamora, Alberto] Hosp Comarcal Blanes, Dept Internal Med, Girona, Spain; [Sala, Joan] Hosp Josep Trueta, Dept Cardiol, Girona, Spain; [Ramos, Rafel] IDIAP JGol, Dept Cardiovasc Res, Girona, Spain; [Treserras, Ricard] Generalitat Catalunya, Dept Salut, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Elosua, R (corresponding author), IMIM Hosp Mar Med Res Inst, Dept Res Inflammatory & Cardiovasc Disorders RICA, Barcelona, Spain.	relosua@imim.es	Degano, Irene/ABG-5341-2020; Ramos, Rafel/P-2083-2019; Degano, Irene Roman/C-1826-2012; Grau, Maria/H-5572-2011; Ramos, Rafel/D-9627-2016; Grau, Maria/AAX-4625-2021	Ramos, Rafel/0000-0001-7970-5537; Grau, Maria/0000-0003-2807-8136; Ramos, Rafel/0000-0001-7970-5537; Grau, Maria/0000-0003-2807-8136; ELOSUA, ROBERTO/0000-0001-8235-0095; Degano, Irene R./0000-0003-1914-6934; Marrugat, Jaume/0000-0003-3320-554X; Zamora Cervantes, Alberto/0000-0001-6907-0654	Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found) [Red HERACLES RD06/0009]; Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica) [2009/SGR/1195]; Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute [CM08/00141]	Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found); Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica); Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute	This work has been supported by the Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute (Ministerio de Economia e Innovacion, Instituto de Salud Carlos III/European Regional Development Found) [Red HERACLES RD06/0009], the Government of Catalunya through the Catalan Research and Technology Innovation Interdepartmental Commission (Consell Interdepartamental de Recerca i Innovacio Tecnologica) [2009/SGR/1195]. Dr. Grau is supported by a research fellowship award from the Government of Spain through the Ministry of Science and Innovation, Carlos III Health Institute [CM08/00141]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, QUALITY ASSESSMENT R; Baena-Diez JM, 2009, GAC SANIT, V23, P519, DOI 10.1016/j.gaceta.2009.01.009; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Barone-Adesi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017419; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Dove MS, 2010, AM J PUBLIC HEALTH, V100, P2206, DOI 10.2105/AJPH.2009.189662; Fernandez E, 2006, TOB CONTROL, V15, P79; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Flores-Mateo G, 2011, REV ESP CARDIOL, V64, P988, DOI [10.1016/j.recesp.2011.05.033, 10.1016/j.rec.2011.05.035]; Galan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-224; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Gil M, 2007, REV ESP CARDIOL, V60, P349, DOI 10.1157/13101638; Glantz SA, 2008, PREV MED, V47, P452, DOI 10.1016/j.ypmed.2008.06.007; Grau M, 2007, EUR J CARDIOV PREV R, V14, P653, DOI 10.1097/HJR.0b013e3281764429; Gupta R, 2011, PREV CHRONIC DIS, V8; Hahn EJ, 2011, PUBLIC HEALTH REP, V126, P826, DOI 10.1177/003335491112600608; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Hurt RD, 2012, ARCH INTERN MED, V172, P1635, DOI 10.1001/2013.jamainternmed.46; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Manzanares-Laya S, 2011, GAC SANIT, V25, P495, DOI 10.1016/j.gaceta.2011.06.006; Marrugat J, 2002, REV ESP CARDIOL, V55, P337, DOI 10.1016/S0300-8932(02)76611-6; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Njolstad I, 1996, CIRCULATION, V93, P450; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Piwowarska W, 1991, Folia Med Cracov, V32, P43; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rodu B, 2012, J COMMUN HEALTH, V37, P468, DOI 10.1007/s10900-011-9464-5; SALA J, 1995, EUR HEART J, V16, P779, DOI 10.1093/oxfordjournals.eurheartj.a060996; Sargent JD, 2012, CLIN RES CARDIOL, V101, P227, DOI 10.1007/s00392-011-0385-1; Sclavo M, 2001, Ital Heart J Suppl, V2, P125; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Villalbi JR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000067; Villalbi JR, 2009, REV ESP CARDIOL, V62, P812, DOI 10.1016/S0300-8932(09)71695-1	46	47	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53722	10.1371/journal.pone.0053722	http://dx.doi.org/10.1371/journal.pone.0053722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372663	Green Published, gold			2022-12-27	WOS:000314021500018
J	Baumbusch, LO; Helland, A; Wang, Y; Liestol, K; Schaner, ME; Holm, R; Etemadmoghadam, D; Alsop, K; Brown, P; Mitchell, G; Fereday, S; DeFazio, A; Bowtell, DDL; Kristensen, GB; Lingjaerde, OC; Borresen-Dale, AL				Baumbusch, Lars O.; Helland, Aslaug; Wang, Yun; Liestol, Knut; Schaner, Marci E.; Holm, Ruth; Etemadmoghadam, Dariush; Alsop, Kathryn; Brown, Pat; Mitchell, Gillian; Fereday, Sian; DeFazio, Anna; Bowtell, David D. L.; Kristensen, Gunnar B.; Lingjaerde, Ole Christian; Borresen-Dale, Anne-Lise		Australian Ovarian Canc Study Grp	High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CHROMOSOMAL INSTABILITY; GENE-EXPRESSION; COPY NUMBER; HYBRIDIZATION; BREAST; SEGREGATION; SENSITIVITY; MECHANISMS; PHENOTYPE	Genomic instability and copy number alterations in cancer are generally associated with poor prognosis; however, recent studies have suggested that extreme levels of genomic aberrations may be beneficial for the survival outcome for patients with specific tumour types. We investigated the extent of genomic instability in predominantly high-grade serous ovarian cancers (SOC) using two independent datasets, generated in Norway (n = 74) and Australia (n = 70), respectively. Genomic instability was quantified by the Total Aberration Index (TAI), a measure of the abundance and genomic size of copy number changes in a tumour. In the Norwegian cohort, patients with TAI above the median revealed significantly prolonged overall survival (p<0.001) and progression-free survival (p<0.05). In the Australian cohort, patients with above median TAI showed prolonged overall survival (p<0.05) and moderately, but not significantly, prolonged progression-free survival. Results were confirmed by univariate and multivariate Cox regression analyses with TAI as a continuous variable. Our results provide further evidence supporting an association between high level of genomic instability and prolonged survival of high-grade SOC patients, possibly as disturbed genome integrity may lead to increased sensitivity to chemotherapeutic agents.	[Baumbusch, Lars O.; Helland, Aslaug; Wang, Yun; Lingjaerde, Ole Christian; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo Univ Hosp, Oslo, Norway; [Helland, Aslaug] Norwegian Radium Hosp, Dept Oncol, Oslo Univ Hosp, Oslo, Norway; [Helland, Aslaug; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Wang, Yun; Kristensen, Gunnar B.] Norwegian Radium Hosp, Dept Gynecol Oncol, Oslo Univ Hosp, Oslo, Norway; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Dept Informat, Biomed Informat Grp, N-0316 Oslo, Norway; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Schaner, Marci E.; Brown, Pat] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Holm, Ruth] Norwegian Radium Hosp, Dept Pathol, Oslo Univ Hosp, Oslo, Norway; [Etemadmoghadam, Dariush; Alsop, Kathryn; Mitchell, Gillian; Fereday, Sian; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Etemadmoghadam, Dariush; Alsop, Kathryn; Mitchell, Gillian; Bowtell, David D. L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Etemadmoghadam, Dariush; Bowtell, David D. L.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [DeFazio, Anna; Australian Ovarian Canc Study Grp] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [DeFazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Kristensen, Gunnar B.] Norwegian Radium Hosp, Inst Med Informat, Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Stanford University; University of Oslo; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; University of Sydney; QIMR Berghofer Medical Research Institute; University of Melbourne; University of Oslo	Baumbusch, LO (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo Univ Hosp, Oslo, Norway.	lars.o.baumbusch@rr-research.no	Bowtell, David/H-1007-2016; deFazio, Anna/D-3939-2013; friedlander, michael l/G-3490-2013; Helland, Åslaug/H-3910-2015; DeFazio, Anna/O-2385-2019; Haviv, Izhak/E-3782-2015; Nicklin, James L/F-8035-2013; Wyld, David/B-8893-2015	Bowtell, David/0000-0001-9089-7525; deFazio, Anna/0000-0003-0057-4744; friedlander, michael l/0000-0002-6488-0604; Helland, Åslaug/0000-0002-5520-0275; DeFazio, Anna/0000-0003-0057-4744; Haviv, Izhak/0000-0002-0837-5005; Nicklin, James L/0000-0001-5857-3723; Wyld, David/0000-0001-9523-4333; Liestol, Knut/0000-0002-7929-582X; Baumbusch, Lars O./0000-0003-1290-312X; Fereday, Sian/0000-0002-8559-8579; Lingjaerde, Ole Christian/0000-0003-3565-4912; Alsop, Kathryn/0000-0002-4107-3041; Chenevix-Trench, Georgia/0000-0002-1878-2587	Norwegian Research Council; National Cancer Institute of Norway; Howard Hughes Medical Institute; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Victoria, Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania; National Health and Medical Research Council of Australia (NHMRC) [ID400413, ID40028]; U.S. Department of Defense [W81XWH-08-1-0684, W81XWH-08-1-0685]; Cancer Australia; National Breast Cancer Foundation; Peter MacCallum Cancer Centre Foundation; NHMRC [ID310670, ID628903]; Marsha Rivkin Center for Ovarian Cancer Research	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Cancer Institute of Norway; Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria, Queensland Cancer Fund(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); U.S. Department of Defense(United States Department of Defense); Cancer Australia; National Breast Cancer Foundation; Peter MacCallum Cancer Centre Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Marsha Rivkin Center for Ovarian Cancer Research	This project was supported by grants from the Norwegian Research Council, the National Cancer Institute of Norway and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further, the authors wish to thank SMD and the Stanford Functional Genomics Facility for data storage support. The Australian Ovarian Cancer Study was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; ID400413, ID40028). The AOCS BRCA genotyping study was supported by Ovarian Cancer Research Program of the U.S. Department of Defense (W81XWH-08-1-0684 and W81XWH-08-1-0685), Cancer Australia and National Breast Cancer Foundation (509303) and the Peter MacCallum Cancer Centre Foundation. The Gynaecological Oncology Biobank at Westmead is a member bank of the Australasian Biospecimens Network-Oncology, which is funded by NHMRC (ID310670, ID628903). YW was a research fellow of The Norwegian Research Council. MES was supported in part by a Scholar Award from the Marsha Rivkin Center for Ovarian Cancer Research.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Bakhoum SF, 2011, CLIN CANCER RES, V17, P7704, DOI 10.1158/1078-0432.CCR-11-2049; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Berwick M, 2005, J NATL CANCER I, V97, P84, DOI 10.1093/jnci/dji038; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Bruchim I, 2009, CANCER GENET CYTOGEN, V190, P66, DOI 10.1016/j.cancergencyto.2008.11.013; Caserta D, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-10; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dimova I, 2009, TUMORI, V95, P357; Eide MB, 2010, BLOOD, V116, P1489, DOI 10.1182/blood-2010-03-272278; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Gorringe KL, 2009, MOL ONCOL, V3, P157, DOI 10.1016/j.molonc.2008.12.005; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Helou K, 2006, CANCER GENET CYTOGEN, V170, P1, DOI 10.1016/j.cancergencyto.2006.04.010; Hyman DM, 2011, CANCER, V118, P3703; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Lawrenson K, 2009, PLOS MED, V6, P126, DOI 10.1371/journal.pmed.1000025; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; M'kacher R, 2010, ANN ONCOL, V21, P826, DOI 10.1093/annonc/mdp375; Martin SA, 2010, J PATHOL, V220, P281, DOI 10.1002/path.2631; Mayr D, 2006, AM J CLIN PATHOL, V126, P101, DOI 10.1309/N6X5MB24BP42KP20; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vollebergh MA, 2012, CELL MOL LIFE SCI, V69, P223, DOI 10.1007/s00018-011-0809-0; Wang Y, 2004, HUM MUTAT, V24, P21, DOI 10.1002/humu.20055; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	48	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54356	10.1371/journal.pone.0054356	http://dx.doi.org/10.1371/journal.pone.0054356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372714	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500064
J	Chen, L; Li, YH; Fu, YB; Peng, J; Mo, MH; Stamatakos, M; Teal, CB; Brem, RF; Stojadinovic, A; Grinkemeyer, M; McCaffrey, TA; Man, YG; Fu, SW				Chen, Liang; Li, Youhuai; Fu, Yebo; Peng, Jin; Mo, Meng-Hsuan; Stamatakos, Michael; Teal, Christine B.; Brem, Rachel F.; Stojadinovic, Alexander; Grinkemeyer, Michael; McCaffrey, Timothy A.; Man, Yan-Gao; Fu, Sidney W.			Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MYOEPITHELIAL CELL LAYER; GENE-EXPRESSION; TUMOR INVASION; MIR-200 FAMILY; REPRESSORS ZEB1; POTENTIAL ROLE; RNA; TARGETS; OPTIMIZATION	MicroRNAs (miRNAs) contribute to cancer initiation and progression by silencing the expression of their target genes, causing either mRNA molecule degradation or translational inhibition. Intraductal epithelial proliferations of the breast are histologically and clinically classified into normal, atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). To better understand the progression of ductal breast cancer development, we attempt to identify deregulated miRNAs in this process using Formalin-Fixed, Paraffin-Embedded (FFPE) tissues from breast cancer patients. Following tissue microdissection, we obtained 8 normal, 4 ADH, 6 DCIS and 7 IDC samples, which were subject to RNA isolation and miRNA expression profiling analysis. We found that miR-21, miR-200b/c, miR-141, and miR-183 were consistently up-regulated in ADH, DCIS and IDC compared to normal, while miR-557 was uniquely down-regulated in DCIS. Interestingly, the most significant miRNA deregulations occurred during the transition from normal to ADH. However, the data did not reveal a step-wise miRNA alteration among discrete steps along tumor progression, which is in accordance with previous reports of mRNA profiling of different stages of breast cancer. Furthermore, the expression of MSH2 and SMAD7, two important molecules involving TGF-beta pathway, was restored following miR-21 knockdown in both MCF-7 and Hs578T breast cancer cells. In this study, we have not only identified a number of potential candidate miRNAs for breast cancer, but also found that deregulation of miRNA expression during breast tumorigenesis might be an early event since it occurred significantly during normal to ADH transition. Consequently, we have demonstrated the feasibility of miRNA expression profiling analysis using archived FFPE tissues, typically with rich clinical information, as a means of miRNA biomarker discovery.	[Chen, Liang; Fu, Yebo; Peng, Jin; Mo, Meng-Hsuan; McCaffrey, Timothy A.; Fu, Sidney W.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Div Genom Med,Dept Med, Washington, DC 20052 USA; [Li, Youhuai] Baoji Cent Hosp, Dept Surg, Breast Canc Div, Baoji, Shaanxi, Peoples R China; [Stamatakos, Michael] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20052 USA; [Teal, Christine B.] George Washington Univ, Sch Med & Hlth Sci, Dept Surg, Washington, DC 20052 USA; [Brem, Rachel F.] George Washington Univ, Sch Med & Hlth Sci, Dept Radiol, Washington, DC 20052 USA; [Stojadinovic, Alexander; Grinkemeyer, Michael] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Man, Yan-Gao] Henry Jackson Fdn, Diagnost & Translat Res Ctr, Gaithersburg, MD USA	George Washington University; George Washington University; George Washington University; George Washington University; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Fu, SW (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Div Genom Med,Dept Med, Washington, DC 20052 USA.	sfu@gwu.edu	Peng, Jin/P-4752-2017; Chen, Liang/J-4277-2017	Chen, Liang/0000-0002-3605-8883; Stojadinovic, Alexander/0000-0002-2829-8967	Wendy Will Case Foundation; Hao Foundation; NCI/NIH [R21CA159103]; NATIONAL CANCER INSTITUTE [R21CA159103] Funding Source: NIH RePORTER	Wendy Will Case Foundation; Hao Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wendy Will Case Foundation, the Hao Foundation and the NCI/NIH awards (R21CA159103) to SWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, RNA BIOL, V8, P71, DOI 10.4161/rna.8.1.14299; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fu SW, 2011, J CANCER, V2, P116, DOI 10.7150/jca.2.116; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hsiao YH, 2011, INT J BIOL SCI, V7, P147, DOI 10.7150/ijbs.7.147; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kluk BJ, 2010, INT J BIOL SCI, V6, P513; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Templin MF, 2003, PROTEOMICS, V3, P2155, DOI 10.1002/pmic.200300600; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Yu Y, 2010, MOL CANCER RES, V8, P1633, DOI 10.1158/1541-7786.MCR-10-0362; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	47	79	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54213	10.1371/journal.pone.0054213	http://dx.doi.org/10.1371/journal.pone.0054213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372687	Green Published, gold			2022-12-27	WOS:000314021500041
J	Corbiere, F; Chauvineau-Perrin, C; Lacroux, C; Lugan, S; Costes, P; Thomas, M; Bremaud, I; Chartier, C; Barillet, F; Schelcher, F; Andreoletti, O				Corbiere, Fabien; Chauvineau-Perrin, Cecile; Lacroux, Caroline; Lugan, Severine; Costes, Pierrette; Thomas, Myriam; Bremaud, Isabelle; Chartier, Christophe; Barillet, Francis; Schelcher, Francois; Andreoletti, Olivier			The Limits of Test-Based Scrapie Eradication Programs in Goats	PLOS ONE			English	Article							CLASSICAL SCRAPIE; PRP GENE; TISSUE DISTRIBUTION; NATURAL SCRAPIE; VARIANT CJD; SHEEP; PRION; RESISTANCE; GENOTYPE; PROTEIN	Small ruminant post-mortem testing programs were initially designed for monitoring the prevalence of prion disease. They are now considered as a potential alternative to genetic selection for eradicating/controlling classical scrapie at population level. If such policy should be implemented, its success would be crucially dependent on the efficiency of the surveillance system used to identify infected flocks. In this study, we first determined the performance of post-mortem classical scrapie detection in eight naturally affected goat herds (total n = 1961 animals) according to the age at culling. These results provided us with necessary parameters to estimate, through a Monte Carlo simulation model, the performance of scrapie detection in a commercial population. According to this model, whatever the number of tests performed, post mortem surveillance will have limited success in identifying infected herds. These data support the contention that scrapie eradication programs relying solely on post mortem testing in goats will probably fail. Considering the epidemiological and pathological similarities of scrapie in sheep and goats, the efficiency of scrapie surveillance in both species is likely to be similar.	[Corbiere, Fabien; Lacroux, Caroline; Lugan, Severine; Costes, Pierrette; Schelcher, Francois; Andreoletti, Olivier] Ecole Natl Vet Toulouse, UMR INRA ENVT Interact Hotes Agents Pathogenes 12, Toulouse, France; [Chauvineau-Perrin, Cecile; Thomas, Myriam; Bremaud, Isabelle; Chartier, Christophe] ANSES, Lab Etud & Rech Caprines, Niort, France; [Barillet, Francis] INRA, UR 631, Stn Ameliorat Genet Anim, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE	Andreoletti, O (corresponding author), Ecole Natl Vet Toulouse, UMR INRA ENVT Interact Hotes Agents Pathogenes 12, Toulouse, France.	o.andreoletti@envt.fr		CORBIERE, Fabien/0000-0003-3006-5561	GIS PRION [31B06134]; INRA [AIP P00297]; Poitou-Charentes region [04/RPC-A-103, 05/RPC-A-13]; EU FP7 'Goat BSE' project [CT-2006-36353]; EU EMIDA 'Goat TSE free' project	GIS PRION; INRA; Poitou-Charentes region(Region Nouvelle-Aquitaine); EU FP7 'Goat BSE' project; EU EMIDA 'Goat TSE free' project	This work was funded by GIS PRION grant 31B06134, by INRA grant AIP P00297, by the Poitou-Charentes region grants 04/RPC-A-103 and 05/RPC-A-13, by the EU FP7 'Goat BSE' project CT-2006-36353 and EMIDA 2012 'Goat TSE free' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acutis PL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-8; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; BAKER HF, 1993, VET REC, V132, P403, DOI 10.1136/vr.132.16.403; Barillet F, 2009, J GEN VIROL, V90, P769, DOI 10.1099/vir.0.006114-0; Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Bellworthy SJ, 2005, VET REC, V156, P197, DOI 10.1136/vr.156.7.197; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Dawson M, 2008, VET RES, V39, DOI 10.1051/vetres:2007064; Fediaevsky A, 2010, VET J, V185, P338, DOI 10.1016/j.tvjl.2009.06.019; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Gonzalez L, 2009, VET RES, V40, DOI 10.1051/vetres/2009048; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Hopp P, 2003, PREV VET MED, V61, P103, DOI 10.1016/S0167-5877(03)00192-2; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Ligios C, 2006, ARCH VIROL, V151, P207, DOI 10.1007/s00705-006-0759-2; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; National Agricultural Statistics Service Agricultural Statistics Board USDA, 2012, TOT SHEEP LAMB INV; National Scrapie Eradication Program, 2011, FISC YEAR 2011 REP; Papasavva-Stylianou P, 2011, VET J, V187, P245, DOI 10.1016/j.tvjl.2009.10.015; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Reckzeh C, 2007, VET MICROBIOL; Vaccari G, 2006, J GEN VIROL, V87, P1395, DOI 10.1099/vir.0.81485-0; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009002; van Keulen LJM, 2000, ARCH VIROL, P57	29	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54911	10.1371/journal.pone.0054911	http://dx.doi.org/10.1371/journal.pone.0054911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372789	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500142
J	Gu, X; Reid, D; Higham, DJ; Gilbert, D				Gu, Xu; Reid, David; Higham, Desmond J.; Gilbert, David			Mathematical Modelling of Polyamine Metabolism in Bloodstream-Form Trypanosoma brucei: An Application to Drug Target Identification	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; DL-ALPHA-DIFLUOROMETHYLORNITHINE; TRYPANOTHIONE SYNTHETASE; ORNITHINE-DECARBOXYLASE; SPERMIDINE SYNTHASE; ALLOSTERIC REGULATION; METHIONINE; ANALOGS; INTERFERENCE; VALIDATION	We present the first computational kinetic model of polyamine metabolism in bloodstream-form Trypanosoma brucei, the causative agent of human African trypanosomiasis. We systematically extracted the polyamine pathway from the complete metabolic network while still maintaining the predictive capability of the pathway. The kinetic model is constructed on the basis of information gleaned from the experimental biology literature and defined as a set of ordinary differential equations. We applied Michaelis-Menten kinetics featuring regulatory factors to describe enzymatic activities that are well defined. Uncharacterised enzyme kinetics were approximated and justified with available physiological properties of the system. Optimisation-based dynamic simulations were performed to train the model with experimental data and inconsistent predictions prompted an iterative procedure of model refinement. Good agreement between simulation results and measured data reported in various experimental conditions shows that the model has good applicability in spite of there being gaps in the required data. With this kinetic model, the relative importance of the individual pathway enzymes was assessed. We observed that, at low-to-moderate levels of inhibition, enzymes catalysing reactions of de novo AdoMet (MAT) and ornithine production (OrnPt) have more efficient inhibitory effect on total trypanothione content in comparison to other enzymes in the pathway. In our model, prozyme and TSHSyn (the production catalyst of total trypanothione) were also found to exhibit potent control on total trypanothione content but only when they were strongly inhibited. Different chemotherapeutic strategies against T. brucei were investigated using this model and interruption of polyamine synthesis via joint inhibition of MAT or OrnPt together with other polyamine enzymes was identified as an optimal therapeutic strategy.	[Gu, Xu] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh, Midlothian, Scotland; [Reid, David] Gold Stand Simulat Ltd, Glasgow, Lanark, Scotland; [Higham, Desmond J.] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Gilbert, David] Brunel Univ, Sch Informat Syst Comp & Math, Uxbridge UB8 3PH, Middx, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Strathclyde; Brunel University	Gu, X (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council,Human Genet Unit, Edinburgh, Midlothian, Scotland.	Xu.Gu@igmm.ed.ac.uk	Gilbert, David/G-1432-2011		School of Computing Science, University of Glasgow	School of Computing Science, University of Glasgow	The work was carried out under a PhD programme partly funded by Prof. Ray Welland, School of Computing Science, University of Glasgow. Further work was unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; Bacchi CJ, 1996, ANTIMICROB AGENTS CH, V40, P1448, DOI 10.1128/AAC.40.6.1448; BACCHI CJ, 1991, ANTIMICROB AGENTS CH, V35, P1315, DOI 10.1128/AAC.35.7.1315; BACCHI CJ, 1995, BIOCHEM J, V309, P737, DOI 10.1042/bj3090737; Bakker BM, 1998, THESIS VRIJE U; BELLOFATTO V, 1987, MOL BIOCHEM PARASIT, V25, P227, DOI 10.1016/0166-6851(87)90086-7; Berger BJ, 1996, P NATL ACAD SCI USA, V93, P4126, DOI 10.1073/pnas.93.9.4126; Beswick TC, 2006, BIOCHEMISTRY-US, V45, P7797, DOI 10.1021/bi0603975; BIRNBAUMER L, 1980, J BIOL CHEM, V255, P3552; BITONTI AJ, 1984, MOL BIOCHEM PARASIT, V13, P21, DOI 10.1016/0166-6851(84)90098-7; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; Checchi F, 2007, PLOS NEGLECT TROP D, V1, P1; CHRISTA L, 1988, BIOCHEM J, V255, P145, DOI 10.1042/bj2550145; DUSZENKO M, 1985, J EXP MED, V162, P1256, DOI 10.1084/jem.162.4.1256; Erez O, 2002, EXP CELL RES, V281, P148, DOI 10.1006/excr.2002.5662; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; GHODA LY, 1988, MOL BIOCHEM PARASIT, V27, P109, DOI 10.1016/0166-6851(88)90030-8; Goldberg B, 2000, ARCH BIOCHEM BIOPHYS, V377, P49, DOI 10.1006/abbi.2000.1740; Gu X, 2010, THESIS U GLASGOW GLA; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; KAUR K, 1986, J PROTOZOOL, V33, P518, DOI 10.1111/j.1550-7408.1986.tb05654.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Ljung L, 2008, PLEN SESS 17 IFAC WO; Ljung L, 2007, TECHNICAL REPORT; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Olin-Sandoval V, 2012, FEBS J, V279, P1811, DOI 10.1111/j.1742-4658.2012.08557.x; Oza SL, 2002, BIOCHEM J, V364, P679, DOI 10.1042/BJ20011370; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; PEGG AE, 1983, BIOCHEM J, V213, P495, DOI 10.1042/bj2130495; Peter S Backlund J, 1982, J BIOL CHEM, V257, P4196; PORTER CW, 1986, ANTICANCER RES, V6, P525; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Reguera RM, 2007, MOL BIOCHEM PARASIT, V152, P1, DOI 10.1016/j.molbiopara.2006.11.013; RISCOE MK, 1989, PARASITOL TODAY, V5, P330, DOI 10.1016/0169-4758(89)90128-2; Rodriguez-Caso C, 2006, J BIOL CHEM, V281, P21799, DOI 10.1074/jbc.M602756200; Soderstrom T., 1989, SYSTEM IDENTIFICATIO; Sontag ED, 2006, OPTIMIZATION CONTROL, P1; Sufrin JR, 2008, ANTIMICROB AGENTS CH, V52, P211, DOI 10.1128/AAC.00480-07; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Taylor MC, 2008, BIOCHEM J, V409, P563, DOI 10.1042/BJ20071185; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; van Riel NAW, 2006, IEE P SYST BIOL, V153, P263, DOI 10.1049/ip-syb:20050076; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Voit E. O., 2000, COMPUTATIONAL ANAL B; Willert EK, 2008, PLOS PATHOG, V4, P1; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; YARLETT N, 1993, BIOCHIM BIOPHYS ACTA, V1181, P68, DOI 10.1016/0925-4439(93)90092-F; YARLETT N, 1988, MOL BIOCHEM PARASIT, V27, P1, DOI 10.1016/0166-6851(88)90019-9; YARLETT N, 1991, J GEN MICROBIOL, V137, P717, DOI 10.1099/00221287-137-3-717	55	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53734	10.1371/journal.pone.0053734	http://dx.doi.org/10.1371/journal.pone.0053734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372667	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500022
J	Meyer, JB; Song-Wilson, Y; Foetzki, A; Luginbuhl, C; Winzeler, M; Kneubuhler, Y; Matasci, C; Mascher-Frutschi, F; Kalinina, O; Boller, T; Keel, C; Maurhofer, M				Meyer, Joana Beatrice; Song-Wilson, Yi; Foetzki, Andrea; Luginbuehl, Carolin; Winzeler, Michael; Kneubuehler, Yvan; Matasci, Caterina; Mascher-Frutschi, Fabio; Kalinina, Olena; Boller, Thomas; Keel, Christoph; Maurhofer, Monika			Does Wheat Genetically Modified for Disease Resistance Affect Root-Colonizing Pseudomonads and Arbuscular Mycorrhizal Fungi?	PLOS ONE			English	Article							ACCUMULATING POTATO PLANTS; ANTIFUNGAL GENE-EXPRESSION; COMMUNITY STRUCTURE; FLUORESCENS CHA0; BIOCONTROL PSEUDOMONADS; BIOLOGICAL-CONTROL; RHIZOSPHERE; GROWTH; CROPS; SOIL	This study aimed to evaluate the impact of genetically modified (GM) wheat with introduced pm3b mildew resistance transgene, on two types of root-colonizing microorganisms, namely pseudomonads and arbuscular mycorrhizal fungi (AMF). Our investigations were carried out in field trials over three field seasons and at two locations. Serial dilution in selective King's B medium and microscopy were used to assess the abundance of cultivable pseudomonads and AMF, respectively. We developed a denaturing gradient gel electrophoresis (DGGE) method to characterize the diversity of the pqqC gene, which is involved in Pseudomonas phosphate solubilization. A major result was that in the first field season Pseudomonas abundances and diversity on roots of GM pm3b lines, but also on non-GM sister lines were different from those of the parental lines and conventional wheat cultivars. This indicates a strong effect of the procedures by which these plants were created, as GM and sister lines were generated via tissue cultures and propagated in the greenhouse. Moreover, Pseudomonas population sizes and DGGE profiles varied considerably between individual GM lines with different genomic locations of the pm3b transgene. At individual time points, differences in Pseudomonas and AMF accumulation between GM and control lines were detected, but they were not consistent and much less pronounced than differences detected between young and old plants, different conventional wheat cultivars or at different locations and field seasons. Thus, we conclude that impacts of GM wheat on plant-beneficial root-colonizing microorganisms are minor and not of ecological importance. The cultivation-independent pqqC-DGGE approach proved to be a useful tool for monitoring the dynamics of Pseudomonas populations in a wheat field and even sensitive enough for detecting population responses to altered plant physiology.	[Meyer, Joana Beatrice; Maurhofer, Monika] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Song-Wilson, Yi; Boller, Thomas] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Foetzki, Andrea; Luginbuehl, Carolin; Winzeler, Michael] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Kneubuehler, Yvan; Matasci, Caterina; Mascher-Frutschi, Fabio] Agroscope Changins Wadenswil Res Stn ACW, Nyon, Switzerland; [Kalinina, Olena] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Keel, Christoph] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Swiss Federal Research Station Agroscope; University of Zurich; University of Lausanne	Keel, C (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	christoph.keel@unil.ch; monika.maurhofer@usys.ethz.ch	Kalinina, Olena/H-6275-2011; Boller, Thomas/G-3500-2012; Keel, Christoph/U-4071-2017; Kalinina, Olena/J-5986-2019	Boller, Thomas/0000-0001-6768-7503; Keel, Christoph/0000-0002-8968-735X; Maurhofer, Monika/0000-0001-5408-6290	Swiss National Science Foundation (National Research Program) [NRP59, 405940-115596]	Swiss National Science Foundation (National Research Program)	This study was supported by the Swiss National Science Foundation (National Research Program NRP59, project 405940-115596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022690; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Becker R, 2008, FEMS MICROBIOL ECOL, V66, P411, DOI 10.1111/j.1574-6941.2008.00562.x; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; de Werra P, 2008, APPL ENVIRON MICROB, V74, P1339, DOI 10.1128/AEM.02126-07; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Dunfield KE, 2004, J ENVIRON QUAL, V33, P806, DOI 10.2134/jeq2004.0806; Fliessbach A, 2009, MICROB ECOL, V57, P611, DOI 10.1007/s00248-009-9489-9; Frapolli M, 2008, FEMS MICROBIOL ECOL, V64, P468, DOI 10.1111/j.1574-6941.2008.00471.x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frapolli M, 2010, SOIL BIOL BIOCHEM, V42, P649, DOI 10.1016/j.soilbio.2010.01.005; Goldstein A., 1986, American Journal of Alternative Agriculture, V1, P51; Gschwendtner S, 2010, PLANT SOIL, V335, P413, DOI 10.1007/s11104-010-0430-2; Gyamfi S, 2002, FEMS MICROBIOL ECOL, V41, P181, DOI 10.1111/j.1574-6941.2002.tb00979.x; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Jousset A, 2011, MOL PLANT MICROBE IN, V24, P352, DOI 10.1094/MPMI-09-10-0208; Kalinina O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028091; KING EO, 1954, J LAB CLIN MED, V44, P301; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Li XG, 2009, TRANSGENIC RES, V18, P757, DOI 10.1007/s11248-009-9264-1; Lindfeld A, 2011, APPL SOIL ECOL, V47, P51, DOI 10.1016/j.apsoil.2010.10.012; Liu WK, 2010, ECOTOXICOLOGY, V19, P229, DOI 10.1007/s10646-009-0423-1; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lottmann J, 1999, FEMS MICROBIOL ECOL, V29, P365; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mascher F, 2003, ENVIRON MICROBIOL, V5, P103, DOI 10.1046/j.1462-2920.2003.00388.x; McCune B., 2002, ANAL ECOLOGICAL COMM; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meyer JB, 2011, APPL ENVIRON MICROB, V77, P7345, DOI 10.1128/AEM.05434-11; Meyer JB, 2010, APPL ENVIRON MICROB, V76, P6196, DOI 10.1128/AEM.00752-10; MILLER HJ, 1990, CAN J MICROBIOL, V36, P254, DOI 10.1139/m90-044; Mulder C, 2006, PLOS COMPUT BIOL, V2, P1165, DOI 10.1371/journal.pcbi.0020128; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Notz R, 2002, APPL ENVIRON MICROB, V68, P2229, DOI 10.1128/AEM.68.5.2229-2235.2002; Peter M, 2010, PEDOBIOLOGIA, V53, P271, DOI 10.1016/j.pedobi.2009.12.006; Ramette A, 2006, FEMS MICROBIOL ECOL, V55, P369, DOI 10.1111/j.1574-6941.2005.00052.x; Rochat L, 2010, MOL PLANT MICROBE IN, V23, P949, DOI 10.1094/MPMI-23-7-0949; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stefani FOP, 2010, ENVIRON REV, V18, P441, DOI 10.1139/A10-022; Svercel M, 2009, FEMS MICROBIOL ECOL, V68, P25, DOI 10.1111/j.1574-6941.2009.00649.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Viebahn M, 2005, ENVIRON MICROBIOL, V7, P1775, DOI 10.1111/j.1462-2920.2005.00783.x; VIERHEILIG H, 1995, APPL ENVIRON MICROB, V61, P3031, DOI 10.1128/AEM.61.8.3031-3034.1995; von Burg S, 2011, BIOL LETTERS, V7, P387, DOI 10.1098/rsbl.2010.1147; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; Wagner H, 2009, VEGAN COMMUNITY ECOL; Walley FL, 1997, BIOL FERT SOILS, V24, P365, DOI 10.1007/s003740050259; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Weinert N, 2010, ENVIRON MICROBIOL, V10, P235; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Widmer F, 1998, APPL ENVIRON MICROB, V64, P2545; Widmer F, 2007, ADV BIOCHEM ENG BIOT, V107, P207, DOI 10.1007/10_2007_047; Wilson Y. S., 2010, IOBC/WPRS Bulletin, V52, P91; Xavier LJC, 2002, SOIL BIOL BIOCHEM, V34, P181, DOI 10.1016/S0038-0717(01)00165-1; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; Zhou J, 2012, METABOLOMICS, V8, P529, DOI 10.1007/s11306-011-0338-8	66	20	21	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53825	10.1371/journal.pone.0053825	http://dx.doi.org/10.1371/journal.pone.0053825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372672	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314021500026
J	Ye, XF; Lian, QQ; Eckenhoff, MF; Eckenhoff, RG; Pan, JZ				Ye, Xuefei; Lian, Qingquan; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Pan, Jonathan Z.			Differential General Anesthetic Effects on Microglial Cytokine Expression	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; INTERFERON-GAMMA; ENDOTOXEMIC RATS; ISOFLURANE; SURGERY; LIPOPOLYSACCHARIDE; INFLAMMATION; DESFLURANE	Post-operative cognitive dysfunction has been widely observed, especially in older patients. An association of postoperative cognitive dysfunction with the neurodegenerative diseases, such as Alzheimer's disease, has been suggested. Neuroinflammation contributes to Alzheimer pathology, through elevated pro-inflammatory cytokines and microglial activation in the CNS leading to neuronal damage, synaptic disruption and ultimately cognitive dysfunction. We compare the effects of three different, clinically-used, anesthetics on microglial activation with, and without, the prototypical inflammatory trigger, lipopolysaccharide (LPS). Microglial BV-2 cell cultures were first exposed to isoflurane, sevoflurane (each at 2 concentrations) or propofol for 6 h, and cytokine levels measured in lysates and media. The same experiments were repeated after 1 h LPS pre-treatment. We found; 1) anesthetics alone have either no or only a small effect on cytokine expression; 2) LPS provoked a large increase in microglia cytokine expression; 3) the inhaled anesthetics either had no effect on LPS-evoked responses or enhanced it; 4) propofol nearly eliminated the LPS pro-inflammatory cytokine response and improved cell survival as reflected by lactate dehydrogenase release. These data suggest that propofol may be a preferred anesthetic when it is desirable to minimize neuroinflammation.	[Ye, Xuefei; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Pan, Jonathan Z.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Ye, Xuefei; Lian, Qingquan] Wenzhou Med Coll, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Wenzhou Medical University	Eckenhoff, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X	Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania	Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania	This work was funded by the Austin Lamont Endowment, Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boost KA, 2006, INT J MOL MED, V17, P1139; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hocker J, 2009, ANESTHESIOLOGY, V110, P1068, DOI 10.1097/ALN.0b013e31819dad92; Hofstetter C, 2007, ACTA ANAESTH SCAND, V51, P893, DOI 10.1111/j.1399-6576.2007.01353.x; Kim JA, 2009, ANESTHESIOLOGY, V111, P566, DOI 10.1097/ALN.0b013e3181af5b3d; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liu Y, 2012, AM J MED SCI; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Rortgen D, 2010, BRIT J ANAESTH, V104, P167, DOI 10.1093/bja/aep369; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Schlachetzki JCM, 2009, CURR ALZHEIMER RES, V6, P554, DOI 10.2174/156720509790147179; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tang JXX, 2011, ANESTHESIOLOGY, V115, P727, DOI 10.1097/ALN.0b013e31822e9306; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Tang JX, 2012, ANN SURG; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xu X, 2008, NEUROSCIENCE, V154, P1002, DOI 10.1016/j.neuroscience.2008.04.013; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664	37	68	71	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52887	10.1371/journal.pone.0052887	http://dx.doi.org/10.1371/journal.pone.0052887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382826	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600008
J	Duce, SL; D'Alessandro, M; Du, YM; Jagpal, B; Gilbert, FJ; Crichton, L; Barker, S; Collinson, JM; Miedzybrodzka, Z				Duce, Suzanne L.; D'Alessandro, Mariella; Du, Yimeng; Jagpal, Baljit; Gilbert, Fiona J.; Crichton, Lena; Barker, Simon; Collinson, J. Martin; Miedzybrodzka, Zosia			3D MRI Analysis of the Lower Legs of Treated Idiopathic Congenital Talipes Equinovarus (Clubfoot)	PLOS ONE			English	Article							3-DIMENSIONAL MRI; PONSETI METHOD; LIMB LENGTH; FOOT; ABNORMALITIES; ANGIOGRAPHY; DISCREPANCY; DEFORMITY	Idiopathic congenital talipes equinovarus (CTEV) is the commonest form of clubfoot. Its exact cause is unknown, although it is related to limb development. The aim of this study was to quantify the anatomy of the muscle, subcutaneous fat, tibia, fibula and arteries in the lower legs of teenagers and young adults with CTEV using 3D magnetic resonance imaging (MRI), and thus to investigate the anatomical differences between CTEV participants and controls. Methodology/Principal Findings: The lower legs of six CTEV (2 bilateral, 4 unilateral) and five control young adults (age 1228) were imaged using a 3T MRI Philips scanner. 5 of the CTEV participants had undergone soft-tissue and capsular release surgery. 3D T1-weighted and 3D magnetic resonance angiography (MRA) images were acquired. Segmentation software was used for volumetric, anatomical and image analysis. Kolmogorov-Smirnov tests were performed. The volumes of the lower affected leg, muscle, tibia and fibula in unilateral CTEV participants were consistently smaller compared to their contralateral unaffected leg, this was most pronounced in muscle. The proportion of muscle in affected CTEV legs was significantly reduced compared with control and unaffected CTEV legs, whilst proportion of muscular fat increased. No spatial abnormalities in the location or branching of arteries were detected, but hypoplastic anomalies were observed. Conclusions/Significance: Combining 3D MRI and MRA is effective for quantitatively characterizing CTEV anatomy. Reduction in leg muscle volume appears to be a sensitive marker. Since 5/6 CTEV cases had soft-tissue surgery, further work is required to confirm that the treatment did not affect the MRI features observed. We propose that the proportion of muscle and intra-muscular fat within the lower leg could provide a valuable addition to current clinical CTEV classification. These measures could be useful for clinical care and guiding treatment pathways, as well as treatment research and clinical audit.	[Duce, Suzanne L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [D'Alessandro, Mariella] Clin Genet Ctr, Aberdeen, Scotland; [Du, Yimeng] Univ Dundee, Div Mech Engn & Mechatron, Dundee, Scotland; [Jagpal, Baljit; Gilbert, Fiona J.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Crichton, Lena] Aberdeen Matern Hosp, Aberdeen, Scotland; [Barker, Simon] Royal Aberdeen Childrens Hosp, Dept Paediat Orthopaed Surg, Aberdeen, Scotland; [Collinson, J. Martin] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Miedzybrodzka, Zosia] Dept Med Genet, Aberdeen, Scotland	University of Dundee; University of Dundee; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Duce, SL (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	s.duce@dundee.ac.uk	Collinson, Jon Martin/I-9997-2019	Gilbert, Fiona/0000-0002-0124-9962	Medical Research Council [G0800901, 87379]; Welcome Trust [WT081039]; Chief Scientist Office, Scotland; MRC [G0800901] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust(Wellcome Trust); Chief Scientist Office, Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Medical Research Council project grant reference G0800901 (Grant ID: 87379). The authors also acknowledge the Welcome Trust (WT081039, SLD) and Chief Scientist Office, Scotland (MDA) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MRI PICTURE PROTON; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Barker SL, 2012, SURG-J R COLL SURG E, V10, P84, DOI 10.1016/j.surge.2011.01.002; Bohm M, 1929, J BONE JOINT SURG, V11, P229; Cahuzac JP, 1999, J BONE JOINT SURG BR, V81B, P97, DOI 10.1302/0301-620X.81B1.9053; Dobbs MB, 2004, J BONE JOINT SURG AM, V86A, P599, DOI 10.2106/00004623-200403000-00022; Duce S, 2010, J ANAT, V216, P108, DOI 10.1111/j.1469-7580.2009.01163.x; Dyer PJ, 2006, J BONE JOINT SURG BR, V88B, P1082, DOI 10.1302/0301-620X.88B8.17482; GREIDER TD, 1982, J BONE JOINT SURG AM, V64, P837, DOI 10.2106/00004623-198264060-00005; Gutzeit A, 2011, EUR RADIOL, V21, P1979, DOI 10.1007/s00330-011-2132-4; HARROLD AJ, 1983, J BONE JOINT SURG BR, V65, P8, DOI 10.1302/0301-620X.65B1.6822607; Ippolito E, 2009, J CHILD ORTHOP, V3, P171, DOI 10.1007/s11832-009-0179-4; Itohara T, 2005, EUR J RADIOL, V53, P78, DOI 10.1016/j.ejrad.2004.03.003; Kamegaya M, 2000, CLIN ORTHOP RELAT R, P218; Katz DA, 2003, J PEDIATR ORTHOPED, V23, P84, DOI 10.1097/00004694-200301000-00017; Kruse L, 2009, CLIN ORTHOP RELAT R, V467, P1250, DOI 10.1007/s11999-008-0673-x; LITTLE DG, 1995, AUST NZ J SURG, V65, P409, DOI 10.1111/j.1445-2197.1995.tb01770.x; Merrill LJ, 2011, CLIN ORTHOP RELAT R, V469, P1442, DOI 10.1007/s11999-010-1657-1; Miedzybrodzka Z, 2003, J ANAT, V202, P37, DOI 10.1046/j.1469-7580.2003.00147.x; Noonan Kenneth J, 2004, Iowa Orthop J, V24, P60; O'Connor PJ, 1998, SKELETAL RADIOL, V27, P440, DOI 10.1007/s002560050414; Pekindil G, 2001, EUR J RADIOL, V37, P123, DOI 10.1016/S0720-048X(00)00275-8; Pirani S, 2001, J PEDIATR ORTHOPED, V21, P719, DOI 10.1097/00004694-200111000-00004; PONSETI IV, 1992, J BONE JOINT SURG AM, V74A, P448, DOI 10.2106/00004623-199274030-00021; Richards BS, 2007, J PEDIATR ORTHOPED, V27, P214, DOI 10.1097/BPO.0b013e31803179c0; Saito S, 2004, J PEDIATR ORTHOP B, V13, P99, DOI 10.1097/00009957-200403000-00007; Sarrafian S, 1993, ANATOMY FOOT ANKLE D; Shimode K, 2005, J PEDIATR ORTHOP B, V14, P280, DOI 10.1097/01202412-200507000-00009; SODRE H, 1990, J PEDIATR ORTHOPED, V10, P101; Staheli L, 2009, GLOBAL HELP, V27; Wang C, 1999, PEDIATR RADIOL, V29, P262, DOI 10.1007/s002470050585; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P464, DOI 10.1302/0301-620X.46B3.464	32	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54100	10.1371/journal.pone.0054100	http://dx.doi.org/10.1371/journal.pone.0054100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382871	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800032
J	Lai, JY; Ma, DHK; Lai, MH; Li, YT; Chang, RJ; Chen, LM				Lai, Jui-Yang; Ma, David Hui-Kang; Lai, Meng-Heng; Li, Ya-Ting; Chang, Ren-Jie; Chen, Li-Mei			Characterization of Cross-Linked Porous Gelatin Carriers and Their Interaction with Corneal Endothelium: Biopolymer Concentration Effect	PLOS ONE			English	Article							HYALURONIC-ACID HYDROGELS; PIGMENT EPITHELIAL-CELLS; SHEET TRANSPLANTATION; DELIVERY CARRIERS; IN-VITRO; SCAFFOLDS; RECONSTRUCTION; SURFACES; FABRICATION; ATTACHMENT	Cell sheet-mediated tissue regeneration is a promising approach for corneal reconstruction. However, the fragility of bioengineered corneal endothelial cell (CEC) monolayers allows us to take advantage of cross-linked porous gelatin hydrogels as cell sheet carriers for intraocular delivery. The aim of this study was to further investigate the effects of biopolymer concentrations (5-15 wt%) on the characteristic and safety of hydrogel discs fabricated by a simple stirring process combined with freeze-drying method. Results of scanning electron microscopy, porosity measurements, and ninhydrin assays showed that, with increasing solid content, the pore size, porosity, and cross-linking index of carbodiimide treated samples significantly decreased from 508 +/- 30 to 292 +/- 42 mu m, 59.8 +/- 1.1 to 33.2 +/- 1.9%, and 56.2 +/- 1.6 to 34.3 +/- 1.8%, respectively. The variation in biopolymer concentrations and degrees of cross-linking greatly affects the Young's modulus and swelling ratio of the gelatin carriers. Differential scanning calorimetry measurements and glucose permeation studies indicated that for the samples with a highest solid content, the highest pore wall thickness and the lowest fraction of mobile water may inhibit solute transport. When the biopolymer concentration is in the range of 5-10 wt%, the hydrogels have high freezable water content (0.89-0.93) and concentration of permeated glucose (591.3-615.5 mu g/ml). These features are beneficial to the in vitro cultivation of CECs without limiting proliferation and changing expression of ion channel and pump genes such as ATP1A1, VDAC2, and AQP1. In vivo studies by analyzing the rabbit CEC morphology and count also demonstrate that the implanted gelatin discs with the highest solid content may cause unfavorable tissue-material interactions. It is concluded that the characteristics of cross-linked porous gelatin hydrogel carriers and their triggered biological responses are in relation to biopolymer concentration effects.	[Lai, Jui-Yang; Lai, Meng-Heng; Li, Ya-Ting; Chang, Ren-Jie; Chen, Li-Mei] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan, Taiwan; [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Ma, David Hui-Kang] Chang Gung Mem Hosp, Dept Ophthalmol, Limbal Stem Cell Lab, Tao Yuan, Taiwan; [Ma, David Hui-Kang] Chang Gung Univ, Dept Chinese Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lai, JY (corresponding author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	jylai@mail.cgu.edu.tw	Lai, Jui-Yang/I-1166-2017	Lai, Jui-Yang/0000-0002-9227-8549	Chang Gung Memorial Hospital [CMRPD190431]; National Science Council of the Republic of China [NSC100-2628-E-182-004-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant CMRPD190431 from the Chang Gung Memorial Hospital and grant NSC100-2628-E-182-004-MY3 from the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2011, MACROMOL BIOSCI, V11, P427, DOI 10.1002/mabi.201000389; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; CRAWFORD KM, 1995, INVEST OPHTH VIS SCI, V36, P1317; Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]; Elbert DL, 2011, ACTA BIOMATER, V7, P31, DOI 10.1016/j.actbio.2010.07.028; Faroongsarng D, 2008, INT J PHARMACEUT, V352, P152, DOI 10.1016/j.ijpharm.2007.10.022; Goh YQ, 2008, J MATER SCI-MATER M, V19, P2445, DOI 10.1007/s10856-008-3366-9; Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093; Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c; Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000; Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005; Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8; Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060; Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441; Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575; Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873; Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a; Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085; Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256; Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024; Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3; Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f; Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980; Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442; Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n; Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39; Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052; Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695; Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034; Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W; Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Nitschke M, 2007, J BIOMED MATER RES A, V80A, P1003, DOI 10.1002/jbm.a.31098; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o; Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012	46	75	77	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54058	10.1371/journal.pone.0054058	http://dx.doi.org/10.1371/journal.pone.0054058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382866	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800030
J	Raterman, EL; Welch, RA				Raterman, Erica L.; Welch, Rodney A.			Chemoreceptors of Escherichia coli CFT073 Play Redundant Roles in Chemotaxis toward Urine	PLOS ONE			English	Article							AMINO-ACIDS; TRACT-INFECTIONS; COLONIZATION; SUGARS; AEROTAXIS; EXCRETION; VIRULENCE; CAFFEINE; MOTILITY; GENES	Community-acquired urinary tract infections (UTIs) are commonly caused by uropathogenic Escherichia coli (UPEC). We hypothesize that chemotaxis toward ligands present in urine could direct UPEC into and up the urinary tract. Wild-type E. coli CFT073 and chemoreceptor mutants with tsr, tar, or aer deletions were tested for chemotaxis toward human urine in the capillary tube assay. Wild-type CFT073 was attracted toward urine, and Tsr and Tar were the chemoreceptors mainly responsible for mediating this response. The individual components of urine including L-amino acids, D-amino acids and various organic compounds were also tested in the capillary assay with wild-type CFT073. Our results indicate that CFT073 is attracted toward some L- amino acids and possibly toward some D-amino acids but not other common compounds found in urine such as urea, creatinine and glucuronic acid. In the murine model of UTI, the loss of any two chemoreceptors did not affect the ability of the bacteria to compete with the wild-type strain. Our data suggest that the presence of any strong attractant and its associated chemoreceptor might be sufficient for colonization of the urinary tract and that amino acids are the main chemoattractants for E. coli strain CFT073 in this niche.	[Raterman, Erica L.; Welch, Rodney A.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Welch, RA (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	rawelch@wisc.edu			National Institutes of Health [R01 DK063250-06]; National Research Service [AI55397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institutes of Health Grant R01 DK063250-06 and by the National Institutes of Health, National Research Service Award AI55397. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; ADLER J, 1974, P NATL ACAD SCI USA, V71, P2895, DOI 10.1073/pnas.71.7.2895; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Alphen LBv, 2008, CELL MICROBIOL, V10, P53; ARMSTRONG D W, 1991, Amino Acids (Vienna), V1, P97, DOI 10.1007/BF00808096; Bacheller CD, 1997, MED CLIN N AM, V81, P719, DOI 10.1016/S0025-7125(05)70542-3; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; BLACK RA, 1983, J BACTERIOL, V153, P1187, DOI 10.1128/JB.153.3.1187-1195.1983; BRAUN P, 1955, Acta Med Acad Sci Hung, V7, P147; BRUCKNER H, 1994, AMINO ACIDS, V6, P205, DOI 10.1007/BF00805848; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Chambaz A, 2001, INT J SPORTS MED, V22, P366, DOI 10.1055/s-2001-15646; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donnenberg M.S., 1996, URINARY TRACT INFECT, P135; Eisenbach M, 2007, J CELL PHYSIOL, V213, P574, DOI 10.1002/jcp.21238; Freter R, 1981, Ciba Found Symp, V80, P36; Gosink KK, 2006, J BACTERIOL, V188, P3487, DOI 10.1128/JB.188.10.3487-3493.2006; Greco FA, 2009, AMINOACIDURIA; Huang Y, 1998, BIOL PHARM BULL, V21, P156, DOI 10.1248/bpb.21.156; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kato S, 2010, J CHROMATOGR B; KUNIN CM, 1994, CLIN INFECT DIS, V18, P1, DOI 10.1093/clinids/18.1.1; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2006, J BACTERIOL, V188, P5618, DOI 10.1128/JB.00449-06; LEE A, 1986, INFECT IMMUN, V51, P536, DOI 10.1128/IAI.51.2.536-546.1986; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lux R, 1999, MOL BIOL CELL, V10, P1133, DOI 10.1091/mbc.10.4.1133; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moran VH, 2001, J ENDOCRINOL, V170, P157, DOI 10.1677/joe.0.1700157; MUNION GL, 1983, J SURG RES, V35, P507, DOI 10.1016/0022-4804(83)90040-9; MURAD F, 1972, NEW ENGL J MED, V286, P1382, DOI 10.1056/NEJM197206292862604; Orenstein R, 1999, AM FAM PHYSICIAN, V59, P1225; Parkinson JS, 2005, CURR OPIN MICROBIOL, V8, P116, DOI 10.1016/j.mib.2005.02.008; PeaceHealth, CAT UR; Putnam D. F., 1971, COMPOSITION CONCENTR; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Slocum RH, 1991, TECHNIQUES DIAGNOSTI, P87; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Weimann A, 2005, J MASS SPECTROM, V40, P307, DOI 10.1002/jms.785; Yamamoto Shingo, 2007, Journal of Infection and Chemotherapy, V13, P68, DOI 10.1007/s10156-007-0506-y; Yao J, 2007, J BACTERIOL, V189, P6415, DOI 10.1128/JB.00398-07; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; YOUNG SE, 1967, CANCER RES, V27, P15; Zhang HW, 1999, ANAL CHEM, V71, P3955, DOI 10.1021/ac990162h	50	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54133	10.1371/journal.pone.0054133	http://dx.doi.org/10.1371/journal.pone.0054133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382874	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800034
J	Ribeiro, HV; Mendes, RS; Lenzi, EK; del Castillo-Mussot, M; Amaral, LAN				Ribeiro, Haroldo V.; Mendes, Renio S.; Lenzi, Ervin K.; del Castillo-Mussot, Marcelo; Amaral, Luis A. N.			Move-by-Move Dynamics of the Advantage in Chess Matches Reveals Population-Level Learning of the Game	PLOS ONE			English	Article								The complexity of chess matches has attracted broad interest since its invention. This complexity and the availability of large number of recorded matches make chess an ideal model systems for the study of population-level learning of a complex system. We systematically investigate the move-by-move dynamics of the white player's advantage from over seventy thousand high level chess matches spanning over 150 years. We find that the average advantage of the white player is positive and that it has been increasing over time. Currently, the average advantage of the white player is 0.17 pawns but it is exponentially approaching a value of 0.23 pawns with a characteristic time scale of 67 years. We also study the diffusion of the move dependence of the white player's advantage and find that it is non-Gaussian, has long-ranged anti-correlations and that after an initial period with no diffusion it becomes super-diffusive. We find that the duration of the non-diffusive period, corresponding to the opening stage of a match, is increasing in length and exponentially approaching a value of 15.6 moves with a characteristic time scale of 130 years. We interpret these two trends as a resulting from learning of the features of the game. Additionally, we find that the exponent a characterizing the super-diffusive regime is increasing toward a value of 1.9, close to the ballistic regime. We suggest that this trend is due to the increased broadening of the range of abilities of chess players participating in major tournaments.	[Ribeiro, Haroldo V.; Mendes, Renio S.; Lenzi, Ervin K.] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Ribeiro, Haroldo V.; Mendes, Renio S.; Lenzi, Ervin K.] Univ Estadual Maringa, Natl Inst Sci & Technol Complex Syst, Maringa, Parana, Brazil; [Ribeiro, Haroldo V.; Amaral, Luis A. N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [del Castillo-Mussot, Marcelo] Univ Nacl Autonoma Mexico, Inst Fis, Dept Estado Solido, Mexico City, DF, Mexico; [Amaral, Luis A. N.] Northwestern Univ, Northwestern Inst Complex Syst NICO, Evanston, IL USA	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Northwestern University; Universidad Nacional Autonoma de Mexico; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	amaral@northwestern.edu	Ribeiro, Haroldo Valentin/C-8614-2012; Mendes, Renio/F-9261-2017; Amaral, Luis N./C-5485-2009; Lenzi, Ervin Kaminski/N-1767-2019; Amaral, LAN/A-4980-2008	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Lenzi, Ervin Kaminski/0000-0003-3853-1790; Amaral, LAN/0000-0002-3762-789X; del Castillo Mussot, Marcelo/0000-0001-5061-2601	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao, de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES [5678-11-0]; DGAPA-UNAM [IN102911]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao, de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao, de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). HVR thanks the financial support of CAPES (Grant 5678-11-0) and MdCM thanks DGAPA-UNAM (Grant IN102911) for partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2004, EUR PHYS J B, V38, P147, DOI 10.1140/epjb/e2004-00110-5; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Blasius B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218701; Elo Arpad E, 1978, RATING CHESSPLAYERS; Fogel DB, 2004, P IEEE, V92, P1947, DOI 10.1109/JPROC.2004.837633; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; Hyatt RM, CRAFTY CHESS V23 3; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; OBRIEN C, 1994, SCIENCE, V265, P1168, DOI 10.1126/science.265.5176.1168-a; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Peruani F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098102; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Saariluoma P., 1995, CHESS PLAYERS THINKI; Shannon Claude, 1950, PHILOS MAG, P314; Siegle P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.100602; Skalski GT, 2000, ECOLOGY, V81, P1685, DOI 10.2307/177317; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683	19	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54165	10.1371/journal.pone.0054165	http://dx.doi.org/10.1371/journal.pone.0054165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382876	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800035
J	Foley, JH; Orfeo, T; Undas, A; McLean, KC; Bernstein, IM; Rivard, GE; Mann, KG; Everse, SJ; Brummel-Ziedins, KE				Foley, Jonathan H.; Orfeo, Thomas; Undas, Anetta; McLean, Kelley C.; Bernstein, Ira M.; Rivard, Georges-Etienne; Mann, Kenneth G.; Everse, Stephen J.; Brummel-Ziedins, Kathleen E.			From Principle to Practice: Bridging the Gap in Patient Profiling	PLOS ONE			English	Article							HEMOSTATIC SYSTEM ACTIVATION; THROMBIN GENERATION; HEMOPHILIA-A; VENOUS THROMBOEMBOLISM; FACTOR-VA; PLASMA; BLOOD; MODEL; HEPARIN; GROWTH	The standard clinical coagulation assays, activated partial thromboplastin time (aPTT) and prothrombin time (PT) cannot predict thrombotic or bleeding risk. Since thrombin generation is central to haemorrhage control and when unregulated, is the likely cause of thrombosis, thrombin generation assays (TGA) have gained acceptance as "global assays'' of haemostasis. These assays generate an enormous amount of data including four key thrombin parameters (lag time, maximum rate, peak and total thrombin) that may change to varying degrees over time in longitudinal studies. Currently, each thrombin parameter is averaged and presented individually in a table, bar graph or box plot; no method exists to visualize comprehensive thrombin generation data over time. To address this need, we have created a method that visualizes all four thrombin parameters simultaneously and can be animated to evaluate how thrombin generation changes over time. This method uses all thrombin parameters to intrinsically rank individuals based on their haemostatic status. The thrombin generation parameters can be derived empirically using TGA or simulated using computational models (CM). To establish the utility and diverse applicability of our method we demonstrate how warfarin therapy (CM), factor VIII prophylaxis for haemophilia A (CM), and pregnancy (TGA) affects thrombin generation over time. The method is especially suited to evaluate an individual's thrombotic and bleeding risk during "normal'' processes (e. g pregnancy or aging) or during therapeutic challenges to the haemostatic system. Ultimately, our method is designed to visualize individualized patient profiles which are becoming evermore important as personalized medicine strategies become routine clinical practice.	[Foley, Jonathan H.; Orfeo, Thomas; Mann, Kenneth G.; Everse, Stephen J.; Brummel-Ziedins, Kathleen E.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Undas, Anetta] Jagiellonian Univ, Sch Med, Inst Cardiol, Krakow, Poland; [McLean, Kelley C.; Bernstein, Ira M.] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Rivard, Georges-Etienne] Ctr Hosp Univ St Justine, Dept Hematol Oncol, Montreal, PQ, Canada	University of Vermont; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Vermont; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Brummel-Ziedins, KE (corresponding author), Univ Vermont, Dept Biochem, Burlington, VT 05405 USA.	Kathleen.brummel@uvm.edu		Foley, Jonathan/0000-0002-4593-0469	National Institutes of Health [HL46703-Project 5, HL 71944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health to KEB-Z (HL46703-Project 5) and IMB (HL 71944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock DM, 2000, BLOOD COAGUL FIBRIN, V11, P583, DOI 10.1097/00001721-200010000-00001; Allen GA, 2004, J THROMB HAEMOST, V2, P402, DOI 10.1111/j.1538-7933.2003.00617.x; [Anonymous], 2012, NAT BIOTECHNOL, V30, P1, DOI 10.1038/nbt.2096; BELLONI PN, 1992, MICROVASC RES, V43, P20, DOI 10.1016/0026-2862(92)90004-9; Besser M, 2008, J THROMB HAEMOST, V6, P1720, DOI 10.1111/j.1538-7836.2008.03117.x; Bravo MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-45; Brodin E, 2009, TRANSL RES, V153, P124, DOI 10.1016/j.trsl.2008.12.004; Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins K, 2009, WINTROBES CLIN HEMAT, P528; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P181, DOI 10.1111/j.1538-7836.2009.03426.x; Brummel-Ziedins KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044378; Brummel-Ziedins KE, 2004, J THROMB HAEMOST, V2, P281, DOI 10.1046/j.1538-7933.2003.00576.x; BUSCH C, 1982, LAB INVEST, V47, P498; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; Butenas S, 2008, THROMB HAEMOSTASIS, V99, P142, DOI 10.1160/TH07-08-0499; CONWAY EM, 1987, J CLIN INVEST, V80, P1535, DOI 10.1172/JCI113239; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Dargaud Y, 2008, J THROMB HAEMOST, V6, P962, DOI 10.1111/j.1538-7836.2008.02964.x; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Dargaud Y, 2010, THROMB HAEMOSTASIS, V103, P469, DOI 10.1160/TH09-10-0679; Eichinger S, 1999, THROMB HAEMOSTASIS, V82, P1232; Eikelboom JW, 2006, THROMB HAEMOSTASIS, V96, P547, DOI 10.1160/TH06-05-0290; Gissel M, 2012, HAEMOPHILIA, V18, P193, DOI 10.1111/j.1365-2516.2011.02638.x; Hale SA, 2009, REPROD SCI, V16, P1091, DOI 10.1177/1933719109341843; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Khor B, 2010, AM J HEMATOL, V85, P440, DOI 10.1002/ajh.21679; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; Manco-Johnson M, 2007, HAEMOPHILIA, V13, P4, DOI 10.1111/j.1365-2516.2007.01499.x; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; McLean KC, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.027; Nair SC, 2010, HAEMOPHILIA, V16, P85, DOI 10.1111/j.1365-2516.2010.02304.x; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Quick AJ, 1935, AM J MED SCI, V190, P501, DOI 10.1097/00000441-193510000-00009; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; SHATOS MA, 1995, ARTERIOSCL THROM VAS, V15, P903, DOI 10.1161/01.ATV.15.7.903; Siegemund T, 2003, THROMB HAEMOSTASIS, V90, P781, DOI 10.1160/TH03-01-0027; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Wulfkuhle KC, 2011, J THROMB HAEMOST, V9, P431	49	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54728	10.1371/journal.pone.0054728	http://dx.doi.org/10.1371/journal.pone.0054728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372761	gold, Green Published			2022-12-27	WOS:000315210400026
J	Gane, S; Georganakis, D; Maniati, K; Vamvakias, M; Ragoussis, N; Skoulakis, EMC; Turin, L				Gane, Simon; Georganakis, Dimitris; Maniati, Klio; Vamvakias, Manolis; Ragoussis, Nikitas; Skoulakis, Efthimios M. C.; Turin, Luca			Molecular Vibration-Sensing Component in Human Olfaction	PLOS ONE			English	Article							ODOR RELATIONSHIP; MUSK; DISCRIMINATION; EXCHANGE	Whether olfaction recognizes odorants by their shape, their molecular vibrations, or both remains an open and controversial question. A convenient way to address it is to test for odor character differences between deuterated and undeuterated odorant isotopomers, since these have identical ground-state conformations but different vibrational modes. In a previous paper (Franco et al. (2011) Proc Natl Acad Sci USA 108: 9, 3797-802) we showed that fruit flies can recognize the presence of deuterium in odorants by a vibrational mechanism. Here we address the question of whether humans too can distinguish deuterated and undeuterated odorants. A previous report (Keller and Vosshall (2004) Nat Neurosci 7:4, 337-8) indicated that naive subjects are incapable of distinguishing acetophenone and d-8 acetophenone. Here we confirm and extend those results to trained subjects and gas-chromatography [GC]-pure odorants. However, we also show that subjects easily distinguish deuterated and undeuterated musk odorants purified to GC-pure standard. These results are consistent with a vibrational component in human olfaction.	[Gane, Simon] UCL, Royal Natl Throat Nose & Ear Hosp, London, England; [Georganakis, Dimitris; Vamvakias, Manolis; Ragoussis, Nikitas] Vioryl SA, Afidnes, Greece; [Maniati, Klio; Skoulakis, Efthimios M. C.; Turin, Luca] Biomed Sci Res Ctr Alexander Fleming, Div Neurobiol, Vari, Greece	University College London Hospitals NHS Foundation Trust; University of London; University College London; Alexander Fleming Biomedical Sciences Research Center	Turin, L (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Neurobiol, Vari, Greece.	turin@fleming.gr	Franco, Maribel/AAE-8375-2019		UCL; NanoIRC; Greek Ministry of Education and Research; National Institute for Health Research [ACF-2008-18-025] Funding Source: researchfish	UCL; NanoIRC; Greek Ministry of Education and Research; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Ian Smith for valuable help and advice with gas chromatography, Christina Koutsoudaki for perfumer evaluations of the deuterated musks, Haido Bardouki for analytical chemistry and Andreas Mores for NMR. SG thanks UCL and the NanoIRC for support.; Funded by the Greek Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS CJ, 1985, J PHYS C SOLID STATE, V18, P1313, DOI 10.1088/0022-3719/18/7/003; AMOORE JE, 1964, ANN NY ACAD SCI, V116, P457, DOI 10.1111/j.1749-6632.1964.tb45075.x; Baur A, 1891, BER DTSCH CHEM GES, V24, P2832; Bedoukian PZ, 1967, BIOCHEMISTRY-US, V24, P5907; BERSUKER IB, 1991, NEW J CHEM, V15, P307; BESTMANN HJ, 1989, NATURWISSENSCHAFTEN, V76, P422, DOI 10.1007/BF00366167; Bittner ER, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767067; Brookes JC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038101; Chang PY, 2012, PHYS CHEM CHEM PHYS; CHASTRETTE M, 1995, EUR J MED CHEM, V30, P679, DOI 10.1016/0223-5234(96)88285-7; Dyson GM., 1938, CHEM IND, V57, P647, DOI [10.1002/jctb.5000572802, DOI 10.1002/JCTB.5000572802]; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Gautschi M, 2001, CHIMIA, V55, P379; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; Haffenden LJW, 2001, FOOD CHEM, V73, P67, DOI 10.1016/S0308-8146(00)00287-9; HARA J, 1977, EXPERIENTIA, V33, P618, DOI 10.1007/BF01946534; Franco MI, 2011, P NATL ACAD SCI USA, V108, pE350, DOI 10.1073/pnas.1107618108; Ishikawa Y, 2000, INT J QUANTUM CHEM, V79, P109, DOI 10.1002/1097-461X(2000)79:2<109::AID-QUA6>3.0.CO;2-G; Junk T, 1997, CHEM SOC REV, V26, P401, DOI 10.1039/cs9972600401; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; KLOPPING HL, 1971, J AGR FOOD CHEM, V19, P999, DOI 10.1021/jf60177a002; Maegawa T, 2008, ANGEW CHEM INT EDIT, V47, P5394, DOI 10.1002/anie.200800941; Mookherjee BD, 1982, FRAGRANCE CHEM; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Nojima S, 2008, J CHEM ECOL, V34, P418, DOI 10.1007/s10886-008-9437-z; Pauling L., 1946, CHEM ENG NEWS, V24, P1064; Rossiter KJ, 1996, CHEM REV, V96, P3201, DOI 10.1021/cr950068a; Sell CS, 2006, ANGEW CHEM INT EDIT, V45, P6254, DOI 10.1002/anie.200600782; Socrates G., 2004, INFRARED RAMAN CHARA; Surburg H., 2016, COMMON FRAGRANCE FLA; Takane SY, 2004, ORG BIOMOL CHEM, V2, P3250, DOI 10.1039/b409802a; Turin L, 2002, J THEOR BIOL, V216, P367, DOI 10.1006/jtbi.2001.2504; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Turin L, 2003, HDB OLFACTION GUSTAT, P275; Turin L, 2009, CHEM TECHNOLOGY FLAV, P261; Wade D, 1999, CHEM-BIOL INTERACT, V117, P191, DOI 10.1016/S0009-2797(98)00097-0; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; Williams AS, 1999, SYNTHESIS-STUTTGART, P1707; WRIGHT RH, 1961, NATURE, V190, P1101, DOI 10.1038/1901101a0; Zarzo M, 2007, BIOL REV, V82, P455, DOI 10.1111/j.1469-185X.2007.00019.x	40	70	71	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55780	10.1371/journal.pone.0055780	http://dx.doi.org/10.1371/journal.pone.0055780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372854	Green Published, gold			2022-12-27	WOS:000315210400094
J	Morgan, AA; Rubenstein, E				Morgan, Alexander A.; Rubenstein, Edward			Proline: The Distribution, Frequency, Positioning, and Common Functional Roles of Proline and Polyproline Sequences in the Human Proteome	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; RICH REGIONS; AMINO-ACIDS; SH3 DOMAIN; II HELIX; RECOGNITION; BINDING; FAMILY; GUEST	Proline is an anomalous amino acid. Its nitrogen atom is covalently locked within a ring, thus it is the only proteinogenic amino acid with a constrained phi angle. Sequences of three consecutive prolines can fold into polyproline helices, structures that join alpha helices and beta pleats as architectural motifs in protein configuration. Triproline helices are participants in protein-protein signaling interactions. Longer spans of repeat prolines also occur, containing as many as 27 consecutive proline residues. Little is known about the frequency, positioning, and functional significance of these proline sequences. Therefore we have undertaken a systematic bioinformatics study of proline residues in proteins. We analyzed the distribution and frequency of 687,434 proline residues among 18,666 human proteins, identifying single residues, dimers, trimers, and longer repeats. Proline accounts for 6.3% of the 10,882,808 protein amino acids. Of all proline residues, 4.4% are in trimers or longer spans. We detected patterns that influence function based on proline location, spacing, and concentration. We propose a classification based on proline-rich, polyproline-rich, and proline-poor status. Whereas singlet proline residues are often found in proteins that display recurring architectural patterns, trimers or longer proline sequences tend be associated with the absence of repetitive structural motifs. Spans of 6 or more are associated with DNA/RNA processing, actin, and developmental processes. We also suggest a role for proline in Kruppel-type zinc finger protein control of DNA expression, and in the nucleation and translocation of actin by the formin complex.	[Morgan, Alexander A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Morgan, Alexander A.] Stanford Univ, Sch Med, Genome Technol Ctr, Stanford, CA 94305 USA; [Rubenstein, Edward] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rubenstein, E (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	exr@stanford.edu			Spark Fund; Stanford University; SPARK Project; DHAEV [1110504, Task 204]; Stanford University School of Medicine	Spark Fund; Stanford University(Stanford University); SPARK Project; DHAEV; Stanford University School of Medicine	This work has been supported in part by the Spark Fund, Stanford University, SPARK Project, DHAEV, Project Number 1110504, Task 204. AAM supported by a Stanford University School of Medicine Dean's Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Avbelj F, 2009, P NATL ACAD SCI USA, V106, P3137, DOI 10.1073/pnas.0813018106; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bessonov K, 2013, J MOL GRAPH MODEL, V39, P118, DOI 10.1016/j.jmgm.2012.11.006; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Gushchina LV, 2011, J BIOMOL STRUCT DYN, V29, P485, DOI 10.1080/07391102.2011.10507400; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Hodonsky CJ, 2012, MOL CELL NEUROSCI, V49, P85, DOI 10.1016/j.mcn.2011.10.004; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kelly MA, 2001, BIOCHEMISTRY-US, V40, P14376, DOI 10.1021/bi011043a; Kemper B, 2004, TOXICOL APPL PHARM, V199, P305, DOI 10.1016/j.taap.2003.11.030; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mansiaux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018401; Martin-Garcia JM, 2012, BIOCHEM J, V442, P443, DOI 10.1042/BJ20111089; McDonald CB, 2009, BIOCHEMISTRY-US, V48, P4074, DOI 10.1021/bi802291y; Moradi M, 2011, J PHYS CHEM B, V115, P8645, DOI 10.1021/jp203874f; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Peterson FC, 2009, FRONT BIOSCI-LANDMRK, V14, P833, DOI 10.2741/3281; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Rubenstein E, 2000, MEDICINE, V79, P80, DOI 10.1097/00005792-200003000-00002; Rubenstein E, 2009, PHYTOCHEMISTRY, V70, P100, DOI 10.1016/j.phytochem.2008.11.007; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Smith FJD, 1999, BRIT J DERMATOL, V141, P1010, DOI 10.1046/j.1365-2133.1999.03198.x; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	40	139	140	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53785	10.1371/journal.pone.0053785	http://dx.doi.org/10.1371/journal.pone.0053785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372670	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400007
J	Ezzikouri, S; Alaoui, R; Rebbani, K; Brahim, I; Fakhir, FZ; Nadir, S; Diepolder, H; Khakoo, SI; Thursz, M; Benjelloun, S				Ezzikouri, Sayeh; Alaoui, Rhimou; Rebbani, Khadija; Brahim, Ikram; Fakhir, Fatima-Zohra; Nadir, Salwa; Diepolder, Helmut; Khakoo, Salim I.; Thursz, Mark; Benjelloun, Soumaya			Genetic Variation in the Interleukin-28B Gene Is Associated with Spontaneous Clearance and Progression of Hepatitis C Virus in Moroccan Patients	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; IL28B; POLYMORPHISM; INFECTION; GENOTYPE; FIBROSIS; INFLAMMATION; VARIANTS	Background: Genetic variation in the IL28B gene has been strongly associated with treatment outcomes, spontaneous clearance and progression of the hepatitis C virus infection (HCV). The aim of the present study was to investigate the role of polymorphisms at this locus with progression and outcome of HCV infection in a Moroccan population. Methods: We analyzed a cohort of 438 individuals among them 232 patients with persistent HCV infection, of whom 115 patients had mild chronic hepatitis and 117 had advanced liver disease (cirrhosis and hepatocellular carcinoma), 68 individuals who had naturally cleared HCV and 138 healthy subjects. The IL28B SNPs rs12979860 and rs8099917 were genotyped using a TaqMan 5' allelic discrimination assay. Results: The protective rs12979860-C and rs8099917-T alleles were more common in subjects with spontaneous clearance (77.9% vs 55.2%; p = 0.00001 and 95.6% vs 83.2%; p = 0.0025, respectively). Individuals with clearance were 4.69 (95% CI, 1.99-11.07) times more likely to have the C/C genotype for rs12979860 polymorphism (p = 0.0017) and 3.55 (95% CI, 0.19-66.89) times more likely to have the T/T genotype at rs8099917. Patients with advanced liver disease carried the rs12979860-T/T genotype more frequently than patients with mild chronic hepatitis C (OR = 1.89; 95% CI, 0.99-3.61; p = 0.0532) and this risk was even more pronounced when we compared them with healthy controls (OR = 4.27; 95% CI, 2.08-8.76; p = 0.0005). The rs8099917-G allele was also associated with advanced liver disease (OR = 2.34; 95% CI, 1.40-3.93; p = 0.0100). Conclusions: In the Moroccan population, polymorphisms near the IL28B gene play a role both in spontaneous clearance and progression of HCV infection.	[Ezzikouri, Sayeh; Rebbani, Khadija; Brahim, Ikram; Fakhir, Fatima-Zohra; Benjelloun, Soumaya] Pasteur Inst Morocco, Viral Hepatitis Lab, Virol Unit, Casablanca, Morocco; [Alaoui, Rhimou; Nadir, Salwa] CHU Ibn Rochd, Serv Med B, Casablanca, Morocco; [Diepolder, Helmut] Univ Munich, Munich, Germany; [Khakoo, Salim I.] Univ Southampton, Southampton, Hants, England; [Thursz, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, Div Med, London, England	Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; University of Munich; University of Southampton; Imperial College London	Ezzikouri, S (corresponding author), Pasteur Inst Morocco, Viral Hepatitis Lab, Virol Unit, Casablanca, Morocco.	sayeh.ezzikouri@pasteur.ma; Soumaya.benjelloun@pasteur.ma	Fakhir, Fatima-Zohra/ABC-5592-2020; Ezzikouri, Sayeh/Q-8116-2019	FAKHIR, Fatima-Zohra/0000-0002-1144-9140; Ezzikouri, Sayeh/0000-0002-3982-6163; Thursz, Mark/0000-0002-8218-192X; Benjelloun, Soumaya/0000-0001-5573-8684; Khakoo, Salim/0000-0002-4057-9091	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project [260844]; Medical Research Council [G1001738] Funding Source: researchfish; MRC [G1001738] Funding Source: UKRI	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme for the Research and Technological Development, HepaCute Project [Grant Agreement no260844, www.hepacute.eu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Benjelloun S, 1996, RES VIROLOGY, V147, P247, DOI 10.1016/0923-2516(96)89656-7; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Brahim I, 2012, ARCH VIROL, V157, P515, DOI 10.1007/s00705-011-1193-7; Clark PJ, 2012, DIG DIS SCI; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Coudray C, 2006, AM J HUM BIOL, V18, P23, DOI 10.1002/ajhb.20465; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Di Marco V, 2012, HAEMATOL-HEMATOL J, V97, P679, DOI 10.3324/haematol.2011.050351; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Joshita S, 2012, HUM IMMUNOL, V73, P298, DOI 10.1016/j.humimm.2011.12.021; Kobayashi M, 2012, J GASTROENTEROL, V47, P596, DOI 10.1007/s00535-012-0531-1; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Pedergnana V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038578; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rivero-Juarez A, 2012, AIDS, V26, P1009, DOI 10.1097/QAD.0b013e3283528b1c; Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647; Shi X, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0037054; Sklan EH, 2009, NAT REV GASTRO HEPAT, V6, P217, DOI 10.1038/nrgastro.2009.32; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005	34	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54793	10.1371/journal.pone.0054793	http://dx.doi.org/10.1371/journal.pone.0054793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358556	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000314023600110
J	Friedlander, SM; Herrmann, AL; Lowry, DP; Mepham, ER; Lek, M; North, KN; Organ, CL				Friedlander, Scott M.; Herrmann, Amanda L.; Lowry, Daniel P.; Mepham, Emily R.; Lek, Monkol; North, Kathryn N.; Organ, Chris L.			ACTN3 Allele Frequency in Humans Covaries with Global Latitudinal Gradient	PLOS ONE			English	Article							R577X POLYMORPHISM; EVOLUTION; PATTERNS; GENE; ALPHA-ACTININ-3; PERFORMANCE; MUSCLE; ASSOCIATION; PHYLOGENIES; POPULATION	A premature stop codon in ACTN3 resulting in alpha-actinin-3 deficiency ( the ACTN3 577XX genotype) is common in humans and reduces strength, muscle mass, and fast-twitch fiber diameter, but increases the metabolic efficiency of skeletal muscle. Linkage disequilibrium data suggest that the ACTN3 R577X allele has undergone positive selection during human evolution. The allele has been hypothesized to be adaptive in environments with scarce resources where efficient muscle metabolism would be selected. Here we test this hypothesis by using recently developed comparative methods that account for evolutionary relatedness and gene flow among populations. We find evidence that the ACTN3 577XX genotype evolved in association with the global latitudinal gradient. Our results suggest that environmental variables related to latitudinal variation, such as species richness and mean annual temperature, may have influenced the adaptive evolution of ACTN3 577XX during recent human history.	[Friedlander, Scott M.; Herrmann, Amanda L.; Lowry, Daniel P.; Mepham, Emily R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Lowry, Daniel P.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Lek, Monkol; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Lek, Monkol; North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Organ, Chris L.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Organ, Chris L.] Univ Utah, Nat Hist Museum Utah, Dept Paleontol, Salt Lake City, UT 84112 USA	Brown University; University of Michigan System; University of Michigan; University of Sydney; University of Sydney; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Organ, CL (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	chris.organ@utah.edu	North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Lowry, Daniel/0000-0002-9668-0850				[Anonymous], 2014, TRACER V1 6; Beerli Peter, 2009, V17, P42; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaston KJ, 2007, CURR BIOL, V17, pR574, DOI 10.1016/j.cub.2007.05.013; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Ginevi V., 2010, ACTA MED LITU, V17, P1, DOI DOI 10.2478/V10140-010-0001-0; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Lek M, 2010, BIOESSAYS, V32, P17, DOI 10.1002/bies.200900110; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paparini A, 2007, MED SCI SPORT EXER, V39, P810, DOI 10.1097/mss.0b013e3180317491; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAFTERY AE, 1996, MARKOV CHAIN MONTE C, P163; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Shang X, 2010, INT J SPORTS MED; Sokal R.R., 2012, BIOMETRY; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	36	26	26	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52282	10.1371/journal.pone.0052282	http://dx.doi.org/10.1371/journal.pone.0052282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359641	Green Published, gold			2022-12-27	WOS:000314023600005
J	Huang, TC; Chang, CK; Liao, CH; Ho, YJ				Huang, Tzung-Chi; Chang, Chih-Kai; Liao, Chun-Han; Ho, Yung-Jen			Quantification of Blood Flow in Internal Cerebral Artery by Optical Flow Method on Digital Subtraction Angiography in Comparison with Time-Of-Flight Magnetic Resonance Angiography	PLOS ONE			English	Article							MR PERFUSION IMAGES; ARTERIOVENOUS-MALFORMATION; TRANSCRANIAL DOPPLER; VELOCITY-MEASUREMENT; STENOSIS; SEGMENTATION	Objective: This study compared data on the blood flow velocity in the internal carotid artery, which was obtained using the optical flow method (OFM) with digital subtraction angiography (DSA) and the time-of-flight (TOF) technique using magnetic resonance angiography (MRA). Materials and Methods: Images were obtained from 12 cerebrovascular patients who underwent both brain DSA and MRA imaging. The OFM was applied on the DSA images to determine the average blood flow velocity. The calculated results were compared with the values obtained from the TOF-MRA data. A linear fit was performed on the data and Bland-Altman plots were analyzed. Results: The blood flow velocity was closely associated with vascular diseases. Color-coding of the OFM measurements were superimposed on to the DSA images, which quantitatively illustrated the relative flow in the vessels. The average blood flow velocity was calculated using OFM and DSA, which demonstrated a high correlation with the MRA measurements in the anterior-posterior (AP) view (R = 0.71). In contrast, the average blood flow velocity was low in the lateral view (R = 0.28). The consistency between the high and low blood velocity in the AP view was better compared to the lateral view. The blood flow velocity distribution in the AP view was statistically closer to the MRA measurement compared to the lateral view. Conclusions: This study evaluated the correlation of blood flow measured using DSA and TOF-MRA in a small heterogeneous group of patients with cerebrovascular lesions. OFM with DSA imaging reveals hemodynamic information and TOF-MRA.	[Huang, Tzung-Chi; Chang, Chih-Kai; Ho, Yung-Jen] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Liao, Chun-Han; Ho, Yung-Jen] China Med Univ, Dept Radiol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		 [CMU101-S-05]		This study was supported by funding CMU101-S-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chien A, 2009, SURG NEUROL, V72, P444, DOI 10.1016/j.surneu.2008.12.013; Derdeyn CP, 1998, AM J NEURORADIOL, V19, P1463; Dumoulin C L, 1995, Magn Reson Imaging Clin N Am, V3, P399; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; GREITZ T, 1956, Acta Radiol Suppl, P1; Ho YJ, 2012, THE SCIENTIFICWORLD, V2012; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huang SP, 1997, MED PHYS, V24, P677, DOI 10.1118/1.597990; Huang TC, 2012, J VASC SURG, V56, P812, DOI 10.1016/j.jvs.2012.02.041; Huang TC, 2010, MICROVASC RES, V80, P477, DOI 10.1016/j.mvr.2010.07.007; Kao YH, 2010, MAGN RESON MED, V64, P743, DOI 10.1002/mrm.22402; Kao YH, 2008, J MAGN RESON IMAGING, V28, P1125, DOI 10.1002/jmri.21537; Langevin F, 2009, IRBM, V30, P273, DOI 10.1016/j.irbm.2009.09.002; Lu CF, 2007, P ANN INT IEEE EMBS, P5547, DOI 10.1109/IEMBS.2007.4353603; Molloi S, 1998, INT J CARDIAC IMAG, V14, P137, DOI 10.1023/A:1006059709539; MONIZ E, 1927, REV NEUROL, V1, P48; Park SH, 2009, J CLIN NEUROSCI, V16, P378, DOI 10.1016/j.jocn.2008.04.025; PETTY GW, 1990, STROKE, V21, P260, DOI 10.1161/01.STR.21.2.260; Seifalian A, 1996, DEV CARDIOVASC MED, V186, P425; Serafin Z, 2012, NEURORADIOLOGY, V54, P1253, DOI 10.1007/s00234-012-1030-z; Shih TC, 2011, MICROVASC RES, V81, P68, DOI 10.1016/j.mvr.2010.10.006; Shpilfoygel SD, 2000, MED PHYS, V27, P2008, DOI 10.1118/1.1288669; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Wagner S, 2004, J MAGN RESON IMAGING, V19, P468, DOI 10.1002/jmri.20025; Wang Y, 2004, J X-RAY SCI TECHNOL, V12, P13; Yu SL, 2012, MAGN RESON IMAGING, V30, P869, DOI 10.1016/j.mri.2012.02.027	27	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54678	10.1371/journal.pone.0054678	http://dx.doi.org/10.1371/journal.pone.0054678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358555	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600090
J	Mantokoudis, G; Dahler, C; Dubach, P; Kompis, M; Caversaccio, MD; Senn, P				Mantokoudis, Georgios; Daehler, Claudia; Dubach, Patrick; Kompis, Martin; Caversaccio, Marco D.; Senn, Pascal			Internet Video Telephony Allows Speech Reading by Deaf Individuals and Improves Speech Perception by Cochlear Implant Users	PLOS ONE			English	Article							HEARING-IMPAIRED INDIVIDUALS; HARD-OF-HEARING; SIGN-LANGUAGE; DIRECTIONAL BENEFIT; OLDER-ADULTS; VISUAL CUES; IMPACT; NOISE; INTELLIGIBILITY; COMMUNICATION	Objective: To analyze speech reading through Internet video calls by profoundly hearing-impaired individuals and cochlear implant (CI) users. Methods: Speech reading skills of 14 deaf adults and 21 CI users were assessed using the Hochmair Schulz Moser (HSM) sentence test. We presented video simulations using different video resolutions (1280x720, 640x480, 320x240, 160x120 px), frame rates (30, 20, 10, 7, 5 frames per second (fps)), speech velocities (three different speakers), webcameras (Logitech Pro9000, C600 and C500) and image/sound delays (0-500 ms). All video simulations were presented with and without sound and in two screen sizes. Additionally, scores for live Skype (TM) video connection and live face-to-face communication were assessed. Results: Higher frame rate (>7 fps), higher camera resolution (>640x480 px) and shorter picture/sound delay (<100 ms) were associated with increased speech perception scores. Scores were strongly dependent on the speaker but were not influenced by physical properties of the camera optics or the full screen mode. There is a significant median gain of +8.5% pts (p = 0.009) in speech perception for all 21 CI-users if visual cues are additionally shown. CI users with poor open set speech perception scores (n = 11) showed the greatest benefit under combined audio-visual presentation (median speech perception +11.8% pts, p = 0.032). Conclusion: Webcameras have the potential to improve telecommunication of hearing-impaired individuals.	[Mantokoudis, Georgios; Daehler, Claudia; Dubach, Patrick; Kompis, Martin; Caversaccio, Marco D.; Senn, Pascal] Univ Bern, Inselspital, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Mantokoudis, G (corresponding author), Univ Bern, Inselspital, Univ Dept Otorhinolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland.	mantokoudis@gmx.ch	Mantokoudis, Georgios/J-6318-2013	Mantokoudis, Georgios/0000-0003-2268-7811; Senn, Pascal/0000-0002-4619-3341	foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern	foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern	This study was supported by a grant of the foundation "Stiftung fur die Erforschung von Hor- und Sprachstorungen'', Bern. Logitech Europe S.A. provided the webcameras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria J, 2005, J DEAF STUD DEAF EDU, V10, P122, DOI 10.1093/deafed/eni013; [Anonymous], 1992, ITU T HDB TEL; Barnett S, 1999, PUBLIC HEALTH REP, V114, P330, DOI 10.1093/phr/114.4.330; Baskent D, 2011, EAR HEARING, V32, P582, DOI 10.1097/AUD.0b013e31820fca23; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bergeson TR, 2005, EAR HEARING, V26, P149, DOI 10.1097/00003446-200504000-00004; Bowe FG, 2002, AM ANN DEAF, V147, P6, DOI 10.1353/aad.2012.0251; Cavender A, 2008, DISABIL REHABIL-ASSI, V3, P93, DOI 10.1080/17483100701343475; Champoux F, 2009, NEUROPSYCHOLOGIA, V47, P17, DOI 10.1016/j.neuropsychologia.2008.08.028; Ciaramello FM, 2011, IEEE T IMAGE PROCESS, V20, P3014, DOI 10.1109/TIP.2011.2132730; Colonius H, 2011, EXP BRAIN RES; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; De Cicco L, 2008, SKYPE VIDEO RESPONSI; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; Farrera Marcos Paredes, 2010, Journal of Communications, V5, P169, DOI 10.4304/jcm.5.2.169-177; Foulds RA, 2004, IEEE T NEUR SYS REH, V12, P65, DOI 10.1109/TNSRE.2003.821371; FROWEIN HW, 1991, IEEE J SEL AREA COMM, V9, P611, DOI 10.1109/49.81956; Hellstrom Delevert Revelius, 1997, QUALITY REQUIREMENTS; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; ITU-T Recommendations, 2009, H SER PACK BAS MULT; ITU-T Recommendations, 1999, H SER APPL PROF SIGN; Lenarz M, 2012, OTOLARYNG HEAD NECK, V147, P112, DOI 10.1177/0194599812438041; Lenarz M, 2012, LARYNGOSCOPE, V122, P1126, DOI 10.1002/lary.23214; Mantokoudis G, 2012, J MED INTERNET RES, V14, P264, DOI 10.2196/jmir.1818; Mantokoudis G, 2010, OTOL NEUROTOL, V31, P1014, DOI 10.1097/MAO.0b013e3181ec1d46; PAVEL M, 1987, J OPT SOC AM A, V4, P2355, DOI 10.1364/JOSAA.4.002355; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Rouger J, 2008, BRAIN RES, V1188, P87, DOI 10.1016/j.brainres.2007.10.049; Saxe DM, 2002, IEEE T INF TECHNOL B, V6, P310, DOI 10.1109/TITB.2002.806094; Skoglund Jan, 2008, SPRINGER HDB SPEECH, P307; Strelnikov K, 2009, SCAND J PSYCHOL, V50, P437, DOI 10.1111/j.1467-9450.2009.00741.x; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; Towards Luettin J., 1997, SPEAKER INDEPENDENT, P1991; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; Tye-Murray N, 2007, EAR HEARING, V28, P656, DOI 10.1097/AUD.0b013e31812f7185; Wu YH, 2010, EAR HEARING, V31, P35, DOI 10.1097/AUD.0b013e3181bc769b; Wu YH, 2010, EAR HEARING, V31, P22, DOI 10.1097/AUD.0b013e3181bc767e	38	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54770	10.1371/journal.pone.0054770	http://dx.doi.org/10.1371/journal.pone.0054770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359119	Green Published, gold			2022-12-27	WOS:000314023600107
J	Nicoletti, A; Luca, A; Raciti, L; Contrafatto, D; Bruno, E; Dibilio, V; Sciacca, G; Mostile, G; Petralia, A; Zappia, M				Nicoletti, Alessandra; Luca, Antonina; Raciti, Loredana; Contrafatto, Donatella; Bruno, Elisa; Dibilio, Valeria; Sciacca, Giorgia; Mostile, Giovanni; Petralia, Antonio; Zappia, Mario			Obsessive Compulsive Personality Disorder and Parkinson's Disease	PLOS ONE			English	Article							DSM-IV; RISK	Objectives: To evaluate the frequency of personality disorders in Parkinson's disease (PD) patients and in a group of healthy controls. Methods: Patients affected by PD diagnosed according to the United Kingdom Parkinson's disease Society Brain Bank diagnostic criteria and a group of healthy controls were enrolled in the study. PD patients with cognitive impairment were excluded from the study. Structured Clinical Interview for Personality Disorders-II (SCID-II) has been performed to evaluate the presence of personality disorders. Presence of personality disorders, diagnosed according to the DSM-IV, was confirmed by a psychiatric interview. Clinical and pharmacological data were also recorded using a standardized questionnaire. Results: 100 PD patients (57 men; mean age 59.0 +/- 10.2 years) and 100 healthy subjects (52 men; mean age 58.1 +/- 11.4 years) were enrolled in the study. The most common personality disorder was the obsessive-compulsive personality disorder diagnosed in 40 PD patients and in 10 controls subjects (p-value<0.0001) followed by the depressive personality disorder recorded in 14 PD patients and 4 control subjects (p-value 0.02). Obsessive-compulsive personality disorder was also found in 8 out of 16 de novo PD patients with a short disease duration. Conclusion: PD patients presented a high frequency of obsessive-compulsive personality disorder that does not seem to be related with both disease duration and dopaminergic therapy.	[Nicoletti, Alessandra; Luca, Antonina; Raciti, Loredana; Contrafatto, Donatella; Bruno, Elisa; Dibilio, Valeria; Sciacca, Giorgia; Mostile, Giovanni; Zappia, Mario] Univ Catania, Dipartimento GF Ingrassia, Sez Neurosci, Catania, Italy; [Petralia, Antonio] Univ Catania, Dipartimento Biomed Clin & Mol, Sez Psichiatria, Catania, Italy	University of Catania; University of Catania	Zappia, M (corresponding author), Univ Catania, Dipartimento GF Ingrassia, Sez Neurosci, Catania, Italy.	m.zappia@unict.it	Luca, Antonina/AAA-6605-2022; Zappia, Mario/AAB-7800-2019; Sciacca, Giorgia/AAA-6704-2022; Nicoletti, Alessandra/K-4486-2018; Luca, Antonina/AAA-6614-2022; Bruno, Elisa/P-4317-2018; Mostile, Giovanni/AAA-9014-2022	Luca, Antonina/0000-0002-8397-3478; Sciacca, Giorgia/0000-0002-1629-1282; Nicoletti, Alessandra/0000-0001-6757-340X; Luca, Antonina/0000-0002-8397-3478; Bruno, Elisa/0000-0001-8166-1190; Mostile, Giovanni/0000-0002-3556-7432	AIFA-Agenzia Italiana del Farmaco; Novartis; Lundbeck; MIUR-Ministero dell'Istruzione; dell'Universita e della Ricerca; Italian Ministry of Foreign Affairs	AIFA-Agenzia Italiana del Farmaco; Novartis(Novartis); Lundbeck(Lundbeck Corporation); MIUR-Ministero dell'Istruzione; dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy))	M. Zappia received compensation for consulting services from Boehringer-Ingelheim, Lundbeck, UCB-Union Chimique Belge and scientific grants from AIFA-Agenzia Italiana del Farmaco, Novartis, Lundbeck; Intellectual Property Rights: Movement Time Analyzer patent number 01277716. A. Nicoletti received honoraria from UCB-Union Chimique Belge for medical education symposia and received scientific grants from MIUR-Ministero dell'Istruzione, dell'Universita e della Ricerca, Italian Ministry of Foreign Affairs and Lundbeck. A. Luca, L. Raciti, D. Contrafatto, E. Bruno, V. Dibilio, G. Sciacca, G. Mostile and A. Petralia have nothing to disclose. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amad A, 2013, ENCEPHALE, V39, P374, DOI 10.1016/j.encep.2012.08.006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arabia G, 2010, NEUROLOGY, V75, P349, DOI 10.1212/WNL.0b013e3181ea15fd; Bower JH, 2010, MOVEMENT DISORD, V25, P2105, DOI 10.1002/mds.23230; Bricaud M, 2012, ENCEPHALE, V38, P288, DOI 10.1016/j.encep.2011.08.001; Castelli L, 2008, J NEUROL, V255, P1515, DOI 10.1007/s00415-008-0955-y; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; de Araujo GM, 2010, PROG NEURO-PSYCHOPH, V34, P516, DOI 10.1016/j.pnpbp.2010.02.009; Fabbrini G, 2012, PARKINSONISM RELAT D, V18, P971, DOI 10.1016/j.parkreldis.2012.05.005; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Farmer RF, 2002, COMPR PSYCHIAT, V43, P285, DOI 10.1053/comp.2002.33494; First M. B., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Grant JE, 2012, J PSYCHIATR RES, V46, P469, DOI 10.1016/j.jpsychires.2012.01.009; Harbishettar V, 2005, PARKINSONISM RELAT D, V11, P85, DOI 10.1016/j.parkreldis.2004.07.006; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ishihara L, 2006, MOVEMENT DISORD, V21, P1066, DOI 10.1002/mds.20980; Kummer A, 2009, CURR PSYCHIATRY REV, V5, P55, DOI 10.2174/157340009787315280; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; MENZA MA, 1995, J NEUROPSYCH CLIN N, V7, P176; PHILLIPS KA, 1993, J PERS DISORD, V7, P30, DOI 10.1521/pedi.1993.7.1.30; PILKONIS PA, 1999, COST EFFECTIVENESS P, P279; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Starcevic V, 2013, AUST NZ J PSYCHIAT, V47, P65, DOI 10.1177/0004867412450645; *STAT, 2007, STATA STAT SOFTW REL; van Alphen S P J, 2010, Tijdschr Gerontol Geriatr, V41, P79	28	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54822	10.1371/journal.pone.0054822	http://dx.doi.org/10.1371/journal.pone.0054822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359811	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600115
J	Asato, R; Yoshida, S; Ogura, A; Nakama, T; Ishikawa, K; Nakao, S; Sassa, Y; Enaida, H; Oshima, Y; Ikeo, K; Gojobori, T; Kono, T; Ishibashi, T				Asato, Ryo; Yoshida, Shigeo; Ogura, Atsushi; Nakama, Takahito; Ishikawa, Keijiro; Nakao, Shintaro; Sassa, Yukio; Enaida, Hiroshi; Oshima, Yuji; Ikeo, Kazuho; Gojobori, Takashi; Kono, Toshihiro; Ishibashi, Tatsuro			Comparison of Gene Expression Profile of Epiretinal Membranes Obtained from Eyes with Proliferative Vitreoretinopathy to That of Secondary Epiretinal Membranes	PLOS ONE			English	Article							FIBROVASCULAR MEMBRANES; CELLS; PATHOBIOLOGY; ANNOTATION; PROTEINS; GENOMICS; MUTATION; NEIBANK; RETINA; KI-67	Background: Proliferative vitreoretinopathy (PVR) is a destructive complication of retinal detachment and vitreoretinal surgery which can lead to severe vision reduction by tractional retinal detachments. The purpose of this study was to determine the gene expression profile of epiretinal membranes (ERMs) associated with a PVR (PVR-ERM) and to compare it to the expression profile of less-aggressive secondary ERMs. Methodology/Principal Findings: A PCR-amplified complementary DNA (cDNA) library was constructed using the RNAs isolated from ERMs obtained during vitrectomy. The sequence from the 59 end was obtained for randomly selected clones and used to generate expressed sequence tags (ESTs). We obtained 1116 nonredundant clusters representing individual genes expressed in PVR-ERMs, and 799 clusters representing the genes expressed in secondary ERMs. The transcriptome of the PVR-ERMs was subdivided by functional subsets of genes related to metabolism, cell adhesion, cytoskeleton, signaling, and other functions, by FatiGo analysis. The genes highly expressed in PVR-ERMs were compared to those expressed in the secondary ERMs, and these were subdivided by cell adhesion, proliferation, and other functions. Querying 10 cell adhesion-related genes against the STRING database yielded 70 possible physical relationships to other genes/proteins, which included an additional 60 genes that were not detected in the PVR-ERM library. Of these, soluble CD44 and soluble vascular cellular adhesion molecule-1 were significantly increased in the vitreous of patients with PVR. Conclusions/Significance: Our results support an earlier hypothesis that a PVR-ERM, even from genomic points of view, is an aberrant form of wound healing response. Genes preferentially expressed in PVR-ERMs may play an important role in the progression of PVR and could be served as therapeutic targets.	[Asato, Ryo; Yoshida, Shigeo; Nakama, Takahito; Ishikawa, Keijiro; Nakao, Shintaro; Sassa, Yukio; Enaida, Hiroshi; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Ogura, Atsushi] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 411, Japan; [Kono, Toshihiro] Fukuoka Univ, Chikushi Hosp, Dept Ophthalmol, Chikusino, Fukuoka, Japan	Kyushu University; Tokushima University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Fukuoka University	Yoshida, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan.	yosida@eye.med.kyushu-u.ac.jp		Nakama, Takahito/0000-0001-8999-3667; Yoshida, Shigeo/0000-0003-1049-8909				Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; APPIAH AP, 1989, OPHTHALMOLOGY, V96, P389, DOI 10.1016/S0161-6420(89)32881-8; Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; Heidenkummer H P, 1992, Ger J Ophthalmol, V1, P170; HEIDENKUMMER HP, 1992, RETINA-J RET VIT DIS, V12, P52, DOI 10.1097/00006982-199212010-00011; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; HISCOTT PS, 1985, BRIT J OPHTHALMOL, V69, P810, DOI 10.1136/bjo.69.11.810; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; Ioachim E, 2005, EUR J OPHTHALMOL, V15, P384, DOI 10.1177/112067210501500312; Kirchhof B, 2004, GRAEF ARCH CLIN EXP, V242, P699, DOI 10.1007/s00417-004-0978-8; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kuo Hsi-Kung, 2012, Invest Ophthalmol Vis Sci, V53, P3167, DOI 10.1167/iovs.11-7972; La Heij EC, 2001, AM J OPHTHALMOL, V132, P544, DOI 10.1016/S0002-9394(01)01125-4; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Leiderman YI, 2009, SEMIN OPHTHALMOL, V24, P62, DOI 10.1080/08820530902800082; Lupien CB, 2007, INVEST OPHTH VIS SCI, V48, P5229, DOI 10.1167/iovs.07-0122; Machemer R, 1977, Trans Am Ophthalmol Soc, V75, P556; Mitamura Y, 2002, JPN J OPHTHALMOL, V46, P218, DOI 10.1016/S0021-5155(01)00497-X; Ogura A, 2004, GENOME RES, V14, P1555, DOI 10.1101/gr.2268104; Rojas J, 2010, OPHTHALMOLOGY, V117, P2417, DOI 10.1016/j.ophtha.2010.03.059; Susko E, 2004, BIOINFORMATICS, V20, P2279, DOI 10.1093/bioinformatics/bth239; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi E, 2009, J BIOL CHEM, V285, P4060; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P14; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wiedemann P, 1998, AM J OPHTHALMOL, V126, P550, DOI 10.1016/S0002-9394(98)00115-9; Wistow G, 2006, PROG RETIN EYE RES, V25, P43, DOI 10.1016/j.preteyeres.2005.05.003; Wistow G, 2008, MOL VIS, V14, P1327; Yamaji Y, 2008, INVEST OPHTH VIS SCI, V49, P3151, DOI 10.1167/iovs.07-1249; Yoshida S, 2006, EYE, V20, P743, DOI 10.1038/sj.eye.6702001; Yoshida S, 2006, MOL VIS, V12, P1552; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Yoshida S, 2010, BRIT J OPHTHALMOL, V94, P795, DOI 10.1136/bjo.2009.167072; Yoshida S, 2010, GRAEF ARCH CLIN EXP, V248, P799, DOI 10.1007/s00417-010-1301-5; Yu JD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r65; Zhang XY, 2005, CURR EYE RES, V30, P395, DOI 10.1080/02713680590956306; Zhou QY, 2012, CURR EYE RES, V37, P318, DOI 10.3109/02713683.2011.635397	41	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54191	10.1371/journal.pone.0054191	http://dx.doi.org/10.1371/journal.pone.0054191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372684	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500038
J	Roderburg, C; Luedde, M; Cardenas, DV; Vucur, M; Scholten, D; Frey, N; Koch, A; Trautwein, C; Tacke, F; Luedde, T				Roderburg, Christoph; Luedde, Mark; Cardenas, David Vargas; Vucur, Mihael; Scholten, David; Frey, Norbert; Koch, Alexander; Trautwein, Christian; Tacke, Frank; Luedde, Tom			Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ILL PATIENTS; MIR-150; MORTALITY; DISEASE; RNAS; INFLAMMATION; BIOMARKERS; CELLS	Background and Aims: Down-regulation of miR-150 was recently linked to inflammation and bacterial infection. Furthermore, reduced serum levels of miR-150 were reported from a small cohort of patients with sepsis. We thus aimed at evaluating the diagnostic and prognostic value of miR-150 serum levels in patients with critically illness and sepsis. Methods: miR-150 serum levels were analyzed in a cohort of 223 critically ill patients of which 138 fulfilled sepsis criteria and compared to 76 healthy controls. Results were correlated with clinical data and extensive sets of routine and experimental biomarkers. Results: Measurements of miR-150 serum concentrations revealed only slightly reduced miR-150 serum levels in critically ill patients compared to healthy controls. Furthermore miR-150 levels did not significantly differ in critically ill patients with our without sepsis, indicating that miR-150 serum levels are not suitable for diagnostic establishment of sepsis. However, serum levels of miR-150 correlated with hepatic or renal dysfunction. Low miR-150 serum levels were associated with an unfavorable prognosis of patients, since low miR-150 serum levels predicted mortality with high diagnostic accuracy compared with established clinical scores and biomarkers. Conclusion: Reduced miR-150 serum concentrations are associated with an unfavorable outcome in patients with critical illness, independent of the presence of sepsis. Besides a possible pathogenic role of miR-150 in critical illness, our study indicates a potential use of circulating miRNAs as a prognostic rather than diagnostic marker in critically ill patients.	[Roderburg, Christoph; Cardenas, David Vargas; Vucur, Mihael; Scholten, David; Koch, Alexander; Trautwein, Christian; Tacke, Frank; Luedde, Tom] Rhein Westfal TH RWTH Aachen, Univ Hosp, Dept Med 3, Aachen, Germany; [Luedde, Mark; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, Kiel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Kiel	Luedde, T (corresponding author), Rhein Westfal TH RWTH Aachen, Univ Hosp, Dept Med 3, Aachen, Germany.	tluedde@ukaachen.de	Roderburg, Christoph/AHC-8101-2022; Roderburg, Christoph/AAR-3051-2021; Luedde, Tom/AAE-9135-2022; Frey, Norbert/A-9695-2010; Tacke, Frank/ABF-2212-2020; Frey, Norbert/M-7749-2019	Roderburg, Christoph/0000-0002-1409-7697; Luedde, Tom/0000-0002-6288-8821; Frey, Norbert/0000-0001-7611-378X	European Research Council [ERC-2007-Stg/208237-Luedde-Med3-Aachen]; German-Research-Foundation [SFB-TRR57, P06/P09, Ta434/2-1]; Ernst-Jung-Foundation Hamburg; START-program of the medical faculty Aachen	European Research Council(European Research Council (ERC)European Commission); German-Research-Foundation(German Research Foundation (DFG)); Ernst-Jung-Foundation Hamburg; START-program of the medical faculty Aachen	This work was supported by a Starting Grant from the European Research Council within the FP 7 (ERC-2007-Stg/208237-Luedde-Med3-Aachen) the German-Research-Foundation (SFB-TRR57, P06/P09, Ta434/2-1), the Ernst-Jung-Foundation Hamburg and grants from the START-program of the medical faculty Aachen. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Archanioti P, 2011, J CROHNS COLITIS, V5, P520, DOI 10.1016/j.crohns.2011.05.007; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Gressner OA, 2008, CLIN BIOCHEM, V41, P974, DOI 10.1016/j.clinbiochem.2008.05.005; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	30	125	140	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54612	10.1371/journal.pone.0054612	http://dx.doi.org/10.1371/journal.pone.0054612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372743	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500097
J	Verma, D; Kawarabayasi, Y; Miyazaki, K; Satyanarayana, T				Verma, Digvijay; Kawarabayasi, Yutaka; Miyazaki, Kentaro; Satyanarayana, Tulasi			Cloning, Expression and Characteristics of a Novel Alkalistable and Thermostable Xylanase Encoding Gene (Mxyl) Retrieved from Compost-Soil Metagenome	PLOS ONE			English	Article							ENVIRONMENTAL DNA; SEQUENCE; XYLOOLIGOSACCHARIDES; BINDING; ENZYME; IDENTIFICATION; PURIFICATION; DOMAINS; STRAIN	Background: The alkalistable and thermostable xylanases are in high demand for pulp bleaching in paper industry and generating xylooligosaccharides by hydrolyzing xylan component of agro-residues. The compost-soil samples, one of the hot environments, are expected to be a rich source of microbes with thermostable enzymes. Methodology/Principal Findings: Metagenomic DNA from hot environmental samples could be a rich source of novel biocatalysts. While screening metagenomic library constructed from DNA extracted from the compost-soil in the p18GFP vector, a clone (TSDV-MX1) was detected that exhibited clear zone of xylan hydrolysis on RBB xylan plate. The sequencing of 6.321 kb DNA insert and its BLAST analysis detected the presence of xylanase gene that comprised 1077 bp. The deduced protein sequence (358 amino acids) displayed homology with glycosyl hydrolase (GH) family 11 xylanases. The gene was subcloned into pET28a vector and expressed in E. coli BL21 (DE3). The recombinant xylanase (rMxyl) exhibited activity over a broad range of pH and temperature with optima at pH 9.0 and 80 degrees C. The recombinant xylanase is highly thermostable having T1/2 of 2 h at 80 degrees C and 15 min at 90 degrees C. Conclusion/Significance: This is the first report on the retrieval of xylanase gene through metagenomic approach that encodes an enzyme with alkalistability and thermostability. The recombinant xylanase has a potential application in paper and pulp industry in pulp bleaching and generating xylooligosaccharides from the abundantly available agro-residues.	[Verma, Digvijay; Satyanarayana, Tulasi] Univ Delhi, Dept Microbiol, New Delhi, India; [Kawarabayasi, Yutaka] Kyushu Univ, Fac Agr, Lab Funct Genom Extremophiles, Fukuoka 812, Japan; [Kawarabayasi, Yutaka] Natl Inst Adv Ind Sci & Technol, Inst Hearth Res, Amagasaki, Hyogo, Japan; [Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Hokkaido 1138654, Japan	University of Delhi; Kyushu University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Satyanarayana, T (corresponding author), Univ Delhi, Dept Microbiol, South Campus, New Delhi, India.	tsnarayana@gmail.com	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X; Verma, Digvijay/0000-0002-6177-8399	Department of Biotechnology, Govt. of India [BT/PR-8492/BCE/08/497/2006]; Grants-in-Aid for Scientific Research [24119515] Funding Source: KAKEN	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Department of Biotechnology, Govt. of India (BT/PR-8492/BCE/08/497/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archana A, 1997, ENZYME MICROB TECH, V21, P12, DOI 10.1016/S0141-0229(96)00207-4; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; COUGHLAN MP, 1993, BIOTECHNOL APPL BIOC, V17, P259; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GRUPPEN H, 1992, J CEREAL SCI, V16, P53, DOI 10.1016/S0733-5210(09)80079-9; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hori H, 1985, BIOSYNTHESIS BIODEGR, P109; Hu Y, 2008, APPL MICROBIOL BIOT, V80, P823, DOI 10.1007/s00253-008-1636-6; Jalal A, 2009, J BIOSCI BIOENG, V107, P360, DOI 10.1016/j.jbiosc.2008.12.005; JunGang Li, 2010, Microb Cell Fact, V9, P83, DOI 10.1186/1475-2859-9-83; Khandeparkar R, 2007, BIORESOURCE TECHNOL, V98, P897, DOI 10.1016/j.biortech.2006.02.037; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; KORMELINK FJM, 1993, APPL MICROBIOL BIOT, V38, P688, DOI 10.1007/BF00182811; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lee CC, 2006, EXTREMOPHILES, V10, P295, DOI 10.1007/s00792-005-0499-3; Li N, 2008, APPL MICROBIOL BIOT, V80, P231, DOI 10.1007/s00253-008-1533-z; Li RP, 2009, WORLD J MICROB BIOT, V25, P2071, DOI 10.1007/s11274-009-0111-6; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu WL, 2010, APPL BIOCHEM BIOTECH, V162, P1, DOI 10.1007/s12010-009-8719-4; Maalej I, 2009, APPL BIOCHEM BIOTECH, V158, P200, DOI 10.1007/s12010-008-8317-x; Mamo G, 2007, EXTREMOPHILES, V11, P169, DOI 10.1007/s00792-006-0023-4; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; MATHRANI IM, 1992, APPL MICROBIOL BIOT, V38, P23, DOI 10.1007/BF00169413; Matteotti C, 2012, PROTEIN EXPRES PURIF, V83, P117, DOI 10.1016/j.pep.2012.03.009; Menon V, 2010, BIORESOURCE TECHNOL, V101, P5366, DOI 10.1016/j.biortech.2010.01.150; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ng IS, 2009, EXTREMOPHILES, V13, P425, DOI 10.1007/s00792-009-0228-4; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Romanowska I, 2006, APPL MICROBIOL BIOT, V69, P665, DOI 10.1007/s00253-005-0011-0; SAKKA K, 1993, BIOSCI BIOTECH BIOCH, V57, P273, DOI 10.1271/bbb.57.273; Sharma A, 2007, WORLD J MICROB BIOT, V23, P483, DOI 10.1007/s11274-006-9250-1; Shi P, 2011, APPL ENVIRON MICROB, V76, P3620; Shibuya H, 2000, BIOCHEM J, V349, P651, DOI 10.1042/0264-6021:3490651; Sun JY, 2007, FOOD CHEM, V104, P1055, DOI 10.1016/j.foodchem.2007.01.028; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Sunna A, 1997, EXTREMOPHILES, V1, P2, DOI 10.1007/s007920050009; UCHINO F, 1983, AGR BIOL CHEM TOKYO, V47, P965, DOI 10.1080/00021369.1983.10865774; Vazquez MJ, 2000, TRENDS FOOD SCI TECH, V11, P387, DOI 10.1016/S0924-2244(01)00031-0; Verma D, 2012, BIORESOURCE TECHNOL, V107, P333, DOI 10.1016/j.biortech.2011.12.055; Verma D, 2011, APPL BIOCHEM BIOTECH, V165, P454, DOI 10.1007/s12010-011-9264-5; Vieira DS, 2009, MOL PHYS, V107, P59, DOI 10.1080/00268970902717959; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Wang YR, 2007, AQUACULTURE, V267, P328, DOI 10.1016/j.aquaculture.2007.03.005; WINTERHALTER C, 1995, APPL ENVIRON MICROB, V61, P1810, DOI 10.1128/AEM.61.5.1810-1815.1995; Woldesenbet F, 2012, APPL BIOCHEM BIOTECH, V167, P100, DOI 10.1007/s12010-012-9663-2; Yamada K, 2008, ENVIRON MICROBIOL, V10, P978, DOI 10.1111/j.1462-2920.2007.01518.x; Yang YL, 2010, AFR J MICROBIOL RES, V4, P2249; Yoon Hyang-Sik, 2004, Agricultural Chemistry and Biotechnology, V47, P157; Yoon KH, 2009, J MICROBIOL BIOTECHN, V19, P1514, DOI 10.4014/jmb.0907.07004; Yu EY, 2011, APPL MICROBIOL BIOT, V90, P573, DOI 10.1007/s00253-011-3132-7; Yuhong Z, 2009, J MICROBIOL BIOTECHN, V158, P200; Zhang GM, 2007, APPL MICROBIOL BIOT, V74, P339, DOI 10.1007/s00253-006-0648-3; Zhao YY, 2011, APPL BIOCHEM BIOTECH, V165, P35, DOI 10.1007/s12010-011-9231-1	58	60	67	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52459	10.1371/journal.pone.0052459	http://dx.doi.org/10.1371/journal.pone.0052459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382818	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600006
J	Bremner, AJ; Hill, EL; Pratt, M; Rigato, S; Spence, C				Bremner, Andrew J.; Hill, Elisabeth L.; Pratt, Michelle; Rigato, Silvia; Spence, Charles			Bodily Illusions in Young Children: Developmental Change in Visual and Proprioceptive Contributions to Perceived Hand Position	PLOS ONE			English	Article							LIMB POSITION; INTERMODAL PERCEPTION; LOCALIZATION; INTEGRATION; INFORMATION; MOVEMENT; INFANCY; MIRROR; SPACE; TOUCH	We examined the visual capture of perceived hand position in forty-five 5-to 7-year-olds and in fifteen young adults, using a mirror illusion task. In this task, participants see their left hand on both the left and right (by virtue of a mirror placed at the midline facing the left arm, and obscuring the right). The accuracy of participants' reaching was measured when proprioceptive and visual cues to the location of the right arm were put into conflict (by placing the arms at different distances from the mirror), and also when only proprioceptive information was available (i.e., when the mirror was covered). Children in all age-groups (and adults) made reaching errors in the mirror condition in accordance with the visually-specified illusory starting position of their hand indicating a visual capture of perceived hand position. Data analysis indicated that visual capture increased substantially up until 6 years of age. These findings are interpreted with respect to the development of the visual guidance of action in early childhood.	[Bremner, Andrew J.; Hill, Elisabeth L.; Pratt, Michelle; Rigato, Silvia] Univ London, Dept Psychol, Sensorimotor Dev Res Unit, London, England; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University of Oxford	Bremner, AJ (corresponding author), Univ London, Dept Psychol, Sensorimotor Dev Res Unit, London, England.	a.bremner@gold.ac.uk	Bremner, Andrew J/G-8500-2014	Bremner, Andrew J/0000-0002-4119-3748; Hill, Elisabeth/0000-0003-3130-1271	British Academy [SG42169]; European Research Council under the European Community's Seventh Framework Programme [FP7/2007-2013]; ERC [241242]	British Academy; European Research Council under the European Community's Seventh Framework Programme(European Commission); ERC(European Research Council (ERC)European Commission)	This research was supported by British Academy grant SG42169 (http://www.britac.ac.uk/) awarded to ELH, AJB and CS, and an award from the European Research Council (http://erc.europa.eu/) under the European Community's Seventh Framework Programme (FP7/2007-2013) (ERC Grant agreement no. 241242) to AJB and ELH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; BIRCH HG, 1967, MONOGR SOC RES CHILD, V32, P1, DOI 10.2307/1165792; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bremner AJ, 2013, HAND ORGAN MIND; Bremner AJ, 2008, TRENDS COGN SCI, V12, P298, DOI 10.1016/j.tics.2008.05.003; Bremner AJ, 2008, J EXP PSYCHOL GEN, V137, P149, DOI 10.1037/0096-3445.137.1.149; Brown LE, 2003, EXP BRAIN RES, V153, P266, DOI 10.1007/s00221-003-1601-7; BUTTERWORTH G, 1988, BRIT J DEV PSYCHOL, V6, P303, DOI 10.1111/j.2044-835X.1988.tb01103.x; Cowie D, 2013, PSYCHOL SCI IN PRESS; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; HAY L, 1979, J MOTOR BEHAV, V11, P189, DOI 10.1080/00222895.1979.10735187; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2005, EXP BRAIN RES, V166, P489, DOI 10.1007/s00221-005-2389-4; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Martin MGF, 1995, BODY SELF, P267; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Nardini M, 2012, MUTISENSORY DEV, P137; Nardini M, 2010, P NATL ACAD SCI USA, V107, P17041, DOI 10.1073/pnas.1001699107; Pagel B, 2009, DEVELOPMENTAL SCI, V12, P929, DOI 10.1111/j.1467-7687.2009.00845.x; POPPEL E, 1973, NATURE, V243, P231, DOI 10.1038/243231a0; Renshaw S, 1930, PEDAGOG SEMIN J GEN, V38, P223; Rochat P, 1997, EARLY DEV PARENTING, V6, P105; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Schmuckler MA, 2001, CHILD DEV, V72, P949, DOI 10.1111/1467-8624.00327; Schmuckler MA, 1996, INFANT BEHAV DEV, V19, P221, DOI 10.1016/S0163-6383(96)90021-1; Smyth MM, 2004, Q J EXP PSYCHOL-A, V57, P269, DOI 10.1080/02724980343000215; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Spence C., 2004, CROSSMODAL SPACE CRO; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van der Meer A L, 1997, Eur J Paediatr Neurol, V1, P103; VONHOFSTEN C, 1988, NEUROPSYCHOLOGIA, V26, P805, DOI 10.1016/0028-3932(88)90051-6; WANN JP, 1992, EXP BRAIN RES, V91, P162; WARREN DH, 1970, PERCEPT PSYCHOPHYS, V8, P430, DOI 10.3758/BF03207040	39	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51887	10.1371/journal.pone.0051887	http://dx.doi.org/10.1371/journal.pone.0051887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382813	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315563800007
J	Guo, FJ; Li, YL; Wang, JJ; Li, YD; Li, YH; Li, GC				Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng			Stanniocalcin1 (STC1) Inhibits Cell Proliferation and Invasion of Cervical Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; REGULATOR; APOPTOSIS; HYPOXIA; PROTEIN; MARKER; MUSCLE; GROWTH	STC1 is a glycoprotein hormone involved in calcium/phosphate (Pi) homeostasis. There is mounting evidence that STC1 is tightly associated with the development of cancer. But the function of STC1 in cancer is not fully understood. Here, we found that STC1 is down-regulated in Clinical tissues of cervical cancer compared to the adjacent normal cervical tissues (15 cases). Subsequently, the expression of STC1 was knocked down by RNA interference in cervical cancer CaSki cells and the low expression promoted cell growth, migration and invasion. We also found that STC1 overexpression inhibited cell proliferation and invasion of cervical cancer cells. Moreover, STC1 overexpression sensitized CaSki cells to drugs. Further, we showed that NF-kappa B p65 protein directly bound to STC1 promoter and activated the expression of STC1 in cervical cancer cells. Thus, these results provided evidence that STC1 inhibited cell proliferation and invasion through NF-kappa B p65 activation in cervical cancer.	[Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Cent S Univ, Xiangya Med Sch, Canc Res Inst, Changsha, Hunan, Peoples R China; [Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Hunan, Peoples R China; [Guo, Fengjie; Li, Yalin; Wang, Jiajia; Li, Yandong; Li, Yuehui; Li, Guancheng] Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Guo, Fengjie] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China	Central South University; Tianjin Medical University	Li, GC (corresponding author), Cent S Univ, Xiangya Med Sch, Canc Res Inst, Changsha, Hunan, Peoples R China.	libsun@163.com			National Natural Science Foundation of China [30672352]; Innovation Project of Postgraduate Education of Central South University [2340-74334000006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Postgraduate Education of Central South University	This work was supported by a grant from the National Natural Science Foundation of China (No. 30672352) and Innovation Project of Postgraduate Education of Central South University (No. 2340-74334000006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chen CY, 2008, ARTERIOSCL THROM VAS, V28, P906, DOI 10.1161/ATVBAHA.108.163667; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Diaz-Padilla I, 2012, CANCER TREAT REV, V38, P767, DOI 10.1016/j.ctrv.2012.02.001; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Fujiwara Y, 2000, INT J ONCOL, V16, P799; Fukasawa M, 2004, J BIOCHEM, V136, P273, DOI 10.1093/jb/mvh137; Gerritsen ME, 2002, PHYSIOL GENOMICS, V10, P13, DOI 10.1152/physiolgenomics.00035.2002; Guo FJ, 2010, ONCOL REP, V23, P1449, DOI 10.3892/or_00000783; Hasilo CP, 2005, AM J PHYSIOL-ENDOC M, V289, pE634, DOI 10.1152/ajpendo.00098.2005; Ismail RS, 2000, CANCER RES, V60, P6744; Jiang WQ, 2000, J ENDOCRINOL, V165, P457, DOI 10.1677/joe.0.1650457; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Law AYS, 2008, EXP CELL RES, V314, P2975, DOI 10.1016/j.yexcr.2008.07.002; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; del Campo JM, 2008, GYNECOL ONCOL, V110, pS72, DOI 10.1016/j.ygyno.2008.04.016; McCudden CR, 2004, MOL CELL ENDOCRINOL, V213, P167, DOI 10.1016/j.mce.2003.10.042; Okabe H, 2001, CANCER RES, V61, P2129; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Tamura S, 2011, ANTICANCER RES, V31, P325; Thompson JS, 2010, APOPTOSIS, V15, P705, DOI 10.1007/s10495-010-0487-7; Tohmiya Y, 2004, TOHOKU J EXP MED, V204, P125, DOI 10.1620/tjem.204.125; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Yoshiko Y, 2004, PEPTIDES, V25, P1663, DOI 10.1016/j.peptides.2004.04.015; Zaidi D, 2006, AM J PHYSIOL-ENDOC M, V291, pE974, DOI 10.1152/ajpendo.00601.2005	33	27	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53989	10.1371/journal.pone.0053989	http://dx.doi.org/10.1371/journal.pone.0053989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382863	Green Submitted, Green Published, gold			2022-12-27	WOS:000315483200056
J	Wu, CL; Lu, J; Wang, MH; Lv, X; Chen, Y; Kung, HF; Zee, B; Cheng, XW; He, ML				Wu, Chun-Li; Lu, Juan; Wang, Maggie Haitian; Lv, Xing; Chen, Ying; Kung, Hsiang-fu; Zee, Benny; Cheng, Xiao-wen; He, Ming-Liang			Cross Sectional Survey of Influenza Antibodies before and during the 2009 Pandemic in Shenzhen, China	PLOS ONE			English	Article							H1N1 INFLUENZA; VIRUS INFECTION; EMERGENCE; RESIDENTS; A(H1N1); TITERS	Much information is available for the 2009 H1N1 influenza immunity response, but little is known about the antibody change in seasonal influenza before and during the novel influenza A pandemic. In this study, we conducted a cross-sectional serological survey of 4 types of major seasonal influenza in March and September 2009 on a full range of age groups, to investigate seasonal influenza immunity response before and during the outbreak of the sH1N1 influenza in Shenzhen - the largest migration city in China. We found that the 0-5 age group had an increased antibody level for all types of seasonal influenza during the pandemic compared to the pre-outbreak level, in contrast with almost all other age groups, in which the antibody level decreased. Also, distinct from the antibodies of A/H3N2, B/Yamagata and B/Victoria that decreased significantly during the 2009 H1N1 pandemic, the antibody of A/H1N1 showed no statistical difference from the pre-outbreak level. The results suggest that the antibodies against the 2009 sH1N1 cross-reacted with seasonal H1N1. Moreover, the 0-5 age group was under attack by both seasonal and 2009 H1N1 influenza during the pandemic, hence vaccination merely against a new strain of flu might not be enough to protect the youngest group.	[Wu, Chun-Li; Lv, Xing; Cheng, Xiao-wen] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Lu, Juan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wang, Maggie Haitian; Zee, Benny] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Biostat, Hong Kong, Hong Kong, Peoples R China; [Lu, Juan; Chen, Ying; Kung, Hsiang-fu; He, Ming-Liang] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [He, Ming-Liang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Southern Medical University - China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	He, ML (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	mlhe7788@gmail.com	Wang, Maggie Haitian/F-5954-2017; Zee, Benny Chung Ying/G-5606-2017; HE, Ming-Liang/AFK-4738-2022; HE, Ming-Liang/AAG-3397-2022	Wang, Maggie Haitian/0000-0003-1223-4595; Zee, Benny Chung Ying/0000-0002-7238-845X; HE, Mingliang/0000-0002-9942-9151; He, Ming-Liang/0000-0002-4317-2836	Chinese University of Hong Kong [2041755]; Food and Health Bureau; government of Hong Kong Special Administrative Region, China [CU-10-01-01]	Chinese University of Hong Kong(Chinese University of Hong Kong); Food and Health Bureau; government of Hong Kong Special Administrative Region, China	This work was supported by the Chinese University of Hong Kong [Direct Grant 2041755] and The Food and Health Bureau, the government of Hong Kong Special Administrative Region, China [Commissioned Grant of Research Fund for Control of Infectious Diseases (CU-10-01-01)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUGH M, 1978, AVIAN DIS, V22, P362, DOI 10.2307/1589552; Cheng XW, 2008, J MED VIROL, V80, P1058, DOI 10.1002/jmv.21130; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kendal AP, 1982, CONCEPTS PROCEDURES; Klein SL, 2010, BIOL SEX DIFFER, V1, P5; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nauta JJP, 2006, VACCINE, V24, P6645, DOI 10.1016/j.vaccine.2006.05.052; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2009, EUROSURVEILLANCE, V14, P1; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Xie X, 2012, EPIDEMIOL INFECT, V140, P788, DOI 10.1017/S0950268811001312; Zhang XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025822; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53847	10.1371/journal.pone.0053847	http://dx.doi.org/10.1371/journal.pone.0053847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382854	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200017
J	Pajevic, S; Basser, PJ				Pajevic, Sinisa; Basser, Peter J.			An Optimum Principle Predicts the Distribution of Axon Diameters in Normal White Matter	PLOS ONE			English	Article							STATISTICAL SOFTWARE; CEREBRAL-CORTEX; NERVE-FIBER; SCALING LAW; GRAY-MATTER; INFORMATION; TRANSMISSION; RELIABILITY; CAPACITY	Many important functional properties affecting nerve conduction are influenced by axon diameter. It is also known that the axon diameter distribution (ADD) in normal nerve fascicles is heterogeneous and skewed. A recent attempt to model and explain the parametric form of these distributions was based on biomechanical principles. Here we explore a neurophysiologically-based hypothesis that the observed ADD can be obtained by optimizing the information flow through a fascicle subject to reasonable anatomical and metabolic constraints. Specifically, we use a variational framework to find an optimal distribution based on the fascicle's channel capacity and informative upper bound (IUB), subject to constraints of fixed available fascicle cross-sectional area and fixed number of axons, to derive two novel probability density functions, which we then compare to other previously used distributions. We show, using experimental histological data, that the distributions based on this optimum principle outperform other distributions. Moreover, the new distribution that optimizes the IUB is extremely robust in fitting ADD data obtained histologically, making it well-suited for use in MRI techniques to measure ADDs in vivo, e.g., AxCaliber MRI.	[Pajevic, Sinisa] NIH, Math & Stat Comp Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Basser, Peter J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Tissue Biophys & Biomimet, Program Pediat Imaging & Tissue Sci, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pajevic, S (corresponding author), NIH, Math & Stat Comp Lab, Div Computat Biosci, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	pajevic@nih.gov			Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000275] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	SP was supported by the Intramural Research Program of the Division of Computational Bioscience in the Center for Information Technology, National Institutes of Health (NIH). PJB was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1975, BIOL CYBERN, V19, P121, DOI 10.1007/BF00337250; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aitchison J., 1963, LOGNORMAL DISTRIBUTI; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Basser Peter J., 2004, Journal of Integrative Neuroscience, V3, P227, DOI 10.1142/S0219635204000427; Blair EA, 1933, AM J PHYSIOL, V106, P524, DOI 10.1152/ajplegacy.1933.106.3.524; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Gov NS, 2009, EUR PHYS J E, V29, P337, DOI 10.1140/epje/i2009-10476-8; He JH, 2006, CHAOS SOLITON FRACT, V27, P864, DOI 10.1016/j.chaos.2005.04.081; HEATH DF, 1967, NATURE, V213, P1159, DOI 10.1038/2131159a0; Hildebrand F.B., 1965, METHODS APPL MATH; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; JACOBSON H, 1950, SCIENCE, V112, P143, DOI 10.1126/science.112.2901.143; JACOBSON H, 1951, SCIENCE, V113, P292, DOI 10.1126/science.113.2933.292; Keeling KB, 2007, COMPUT STAT DATA AN, V51, P3811, DOI 10.1016/j.csda.2006.02.013; LASS Y, 1975, BIOL CYBERN, V19, P61, DOI 10.1007/BF00364102; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MacKAY DONALD M., 1952, BULL MATH BIOPHYS, V14, P127, DOI 10.1007/BF02477711; Odeh OO, 2010, AM J AGR ECON, V92, P1472, DOI 10.1093/ajae/aaq068; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pajevic S, 2008, 2008 NEUR M PLANN SO, P8179; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; PUMPHREY R. J., 1938, JOUR EXP BIOL, V15, P453; RAPOPORT A, 1960, INFORM CONTR, V3, P335; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tasaki I, 1943, JAPANESE J MED SCI 3, V9, P189; Tasaki I, 2008, COMMUNICATION; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	36	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54095	10.1371/journal.pone.0054095	http://dx.doi.org/10.1371/journal.pone.0054095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382870	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500009
J	Robertson, DR				Robertson, D. Ross			Who Resembles Whom? Mimetic and Coincidental Look-Alikes among Tropical Reef Fishes	PLOS ONE			English	Article							CORAL-REEF; AGGRESSIVE MIMICRY; COLOR MORPHS; HYPOPLECTRUS; EVOLUTION; HAMLETS; SOCIOBIOLOGY; POLYMORPHISM; MECHANISMS; SPECIATION	Studies of mimicry among tropical reef-fishes usually give little or no consideration to alternative explanations for behavioral associations between unrelated, look-alike species that benefit the supposed mimic. I propose and assess such an alternative explanation. With mimicry the mimic resembles its model, evolved to do so in response to selection by the mimicry target, and gains evolved benefits from that resemblance. In the alternative, the social-trap hypothesis, a coincidental resemblance of the model to the "mimic" inadvertently attracts the latter to it, and reinforcement of this social trapping by learned benefits leads to the "mimic" regularly associating with the model. I examine three well known cases of supposed aggressive mimicry among reef-fishes in relation to nine predictions from these hypotheses, and assess which hypothesis offers a better explanation for each. One case, involving precise and complex morphological and behavioral resemblance, is strongly consistent with mimicry, one is inconclusive, and one is more consistent with a social-trap based on coincidental, imprecise resemblance. Few cases of supposed interspecific mimicry among tropical reef fishes have been examined in depth, and many such associations may involve social traps arising from generalized, coincidental resemblance. Mimicry may be much less common among these fishes than is generally thought.	Smithsonian Trop Res Inst, Balboa, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Robertson, DR (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	drr@stri.org						Aguilar-Perera A, 2004, CARIBB J SCI, V40, P150; Aguilar-Perera A, 2003, CARIBB J SCI, V39, P147; [Anonymous], REEF FISH IDENTIFICA; [Anonymous], 2011, FIELD GUIDE COASTAL; BARLOW GW, 1975, MAR BIOL, V33, P295, DOI 10.1007/BF00390567; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Bshary A, 2010, ETHOLOGY, V116, P681, DOI 10.1111/j.1439-0310.2010.01781.x; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, P667, DOI 10.1098/rspb.2002.2263; Cheney KL, 2008, CORAL REEFS, V27, P527, DOI 10.1007/s00338-008-0360-0; Cheney KL, 2008, P R SOC B, V275, P117, DOI 10.1098/rspb.2007.0966; Cheney KL, 2012, BIOL LETTERS, V8, P10, DOI 10.1098/rsbl.2011.0687; Cheney KL, 2010, P ROY SOC B-BIOL SCI, V277, P1849, DOI 10.1098/rspb.2009.2218; Cheney KL, 2009, BEHAV ECOL, V20, P459, DOI 10.1093/beheco/arp017; Cheney KL, 2009, P R SOC B, V276, P1565, DOI 10.1098/rspb.2008.1819; Cheney KL, 2005, P ROY SOC B-BIOL SCI, V272, P2635, DOI 10.1098/rspb.2005.3256; CHRISTY JH, 1995, AM NAT, V146, P171, DOI 10.1086/285793; Cote IM, 2007, P ROY SOC B-BIOL SCI, V274, P2445, DOI 10.1098/rspb.2007.0797; Deloach N., 1999, REEF FISH BEHAV FLOR; DOMEIER ML, 1994, B MAR SCI, V54, P103; Eagle JV, 2004, J ZOOL, V264, P33, DOI 10.1017/S0952836904005473; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; Edwards DP, 2007, BEHAV ECOL SOCIOBIOL, V61, P1321, DOI 10.1007/s00265-007-0369-3; FEDDERN HENRY A., 1965, BULL MAR SCI, V15, P896; FISCHER EA, 1980, ANIM BEHAV, V28, P620, DOI 10.1016/S0003-3472(80)80070-4; FISCHER EA, 1980, COPEIA, P649, DOI 10.2307/1444441; FISHELSON L, 1977, ISR J ZOOL, V26, P114; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Hastings PA, 2009, ZOOTAXA, P3, DOI 10.11646/zootaxa.2120.1.2; Holt BG, 2008, MAR ECOL PROG SER, V357, P283, DOI 10.3354/meps07339; Johnstone RA, 2002, NATURE, V418, P524, DOI 10.1038/nature00845; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kuwamura T., 1983, J ETHOL, V1, P22, DOI [10.1007/BF02347828, DOI 10.1007/BF02347828]; Lin HC, 2011, MOL PHYLOGENET EVOL, V60, P236, DOI 10.1016/j.ympev.2011.04.018; Lobel PS, 2011, ZOOTAXA, P1; Longley W. H., 1940, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V32, P223; Lukoschek V, 2000, P 9 INT COR REEF S, P467; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; Marshall N.J., 1999, ADAPTIVE MECH ECOLOG, P285, DOI [10.1016/0042-6989(94)90221-6, DOI 10.1016/0042-6989(94)90221-6]; Marshall N. Justin, 2000, P83; Moland E, 2005, OCEANOGR MAR BIOL, V43, P455; Munday PL, 2003, OECOLOGIA, V137, P519, DOI 10.1007/s00442-003-1356-7; OGDEN JC, 1973, ECOLOGY, V54, P589, DOI 10.2307/1935344; ORMOND RFG, 1980, J ZOOL, V191, P247, DOI 10.1111/j.1469-7998.1980.tb01458.x; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Pfennig DW, 2012, CURR ZOOL, V58, P608, DOI 10.1093/czoolo/58.4.608; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; Rainey MM, 2009, J ZOOL, V279, P78, DOI 10.1111/j.1469-7998.2009.00592.x; Randall JE, 2005, ZOOL STUD, V44, P299; RANDALL JE, 1998, CARIBBEAN REEF FISHE; RANDALL JOHN E., 1960, BULL MAR SCI GULF AND CARIBBEAN, V10, P444; Randall John E., 1993, Revue Francaise d'Aquariologie Herpetologie, V20, P5; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Reefnet Inc, 2007, REEF FISH ID FLOR CA; ROBERTSON DR, 1976, ECOLOGY, V57, P1208, DOI 10.2307/1935045; RUSSELL BC, 1976, J ZOOL, V180, P407; Sazima Cristina, 2005, Neotrop. ichthyol., V3, P445, DOI 10.1590/S1679-62252005000300014; Sazima I, 2002, ENVIRON BIOL FISH, V65, P37, DOI 10.1023/A:1019654721236; Sazima I., 2002, AQUA INT J ICHTHYOLO, V6, P61; Shand J, 1997, ENVIRON BIOL FISH, V49, P307, DOI 10.1023/A:1007353003066; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; SIKKEL PC, 1992, COPEIA, P914; Smith-Vaniz WF., 1976, MONOGR ACAD NAT SCI, V19, P1; SMITHVANIZ WF, 1987, P ACAD NAT SCI PHILA, V139, P1; Springer V.G., 1972, Smithsonian Contributions to Zoology, VNo. 112, P1; STEPHENS JOHN STEWART, 1963, UNIV CALIF PUBLICATIONS ZOOL, V68, P1; THRESHER RE, 1978, B MAR SCI, V28, P345; Vereecken NJ, 2008, P NATL ACAD SCI USA, V105, P7484, DOI 10.1073/pnas.0800194105; VICTOR BC, 2012, J OCEAN SCI FOUND, V5, P2; WALDNER R. E., 1980, B MAR SCI, V30, P171; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; Whiteman EA, 2007, J ZOOL, V272, P305, DOI 10.1111/j.1469-7998.2006.00270.x; Whiteman EA, 2007, J FISH BIOL, V71, P235, DOI 10.1111/j.1095-8649.2007.01485.x; Wickler W., 1968, MIMICRY PLANTS ANIMA	73	23	23	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54939	10.1371/journal.pone.0054939	http://dx.doi.org/10.1371/journal.pone.0054939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372795	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400041
J	Sano, K; Satoh, K; Atarashi, R; Takashima, H; Iwasaki, Y; Yoshida, M; Sanjo, N; Murai, H; Mizusawa, H; Schmitz, M; Zerr, I; Kim, YS; Nishida, N				Sano, Kazunori; Satoh, Katsuya; Atarashi, Ryuichiro; Takashima, Hiroshi; Iwasaki, Yasushi; Yoshida, Mari; Sanjo, Nobuo; Murai, Hiroyuki; Mizusawa, Hidehiro; Schmitz, Matthias; Zerr, Inga; Kim, Yong-Sun; Nishida, Noriyuki			Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HETEROGENEITY	Introduction: The definitive diagnosis of genetic prion diseases (gPrD) requires pathological confirmation. To date, diagnosis has relied upon the finding of the biomarkers 14-3-3 protein and total tau (t-tau) protein in the cerebrospinal fluid (CSF), but many researchers have reported that these markers are not sufficiently elevated in gPrD, especially in Gerstmann-Straussler-Scheinker syndrome (GSS). We recently developed a new in vitro amplification technology, designated "real-time quaking-induced conversion (RT-QUIC)", to detect the abnormal form of prion protein in CSF from sporadic Creutzfeldt-Jakob disease (sCJD) patients. In the present study, we aimed to investigate the presence of biomarkers and evaluate RT-QUIC assay in patients with gPrD, as the utility of RT-QUIC as a diagnostic tool in gPrD has yet to be determined. Method/Principal Findings: 56 CSF samples were obtained from gPrD patients, including 20 cases of GSS with P102L mutation, 12 cases of fatal familial insomnia (FFI; D178N), and 24 cases of genetic CJD (gCJD), comprising 22 cases with E200K mutation and 2 with V203I mutation. We subjected all CSF samples to RT-QUIC assay, analyzed 14-3-3 protein by Western blotting, and measured t-tau protein using an ELISA kit. The detection sensitivities of RT-QUIC were as follows: GSS (78%), FFI (100%), gCJD E200K (87%), and gCJD V203I (100%). On the other hand the detection sensitivities of biomarkers were considerably lower: GSS (11%), FFI (0%), gCJD E200K (73%), and gCJD V203I (67%). Thus, RT-QUIC had a much higher detection sensitivity compared with testing for biomarkers, especially in patients with GSS and FFI. Conclusion/Significance: RT-QUIC assay is more sensitive than testing for biomarkers in gPrD patients. RT-QUIC method would thus be useful as a diagnostic tool when the patient or the patient's family does not agree to genetic testing, or to confirm the diagnosis in the presence of a positive result for genetic testing.	[Sano, Kazunori; Satoh, Katsuya; Atarashi, Ryuichiro; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Takashima, Hiroshi] Kagoshima Univ, Dept Neurol & Geriatr, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Iwasaki, Yasushi; Yoshida, Mari] Aichi Med Univ, Dept Neuropathol, Inst Med Sci Aging, Nagakute, Aichi, Japan; [Sanjo, Nobuo; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Tokyo, Japan; [Murai, Hiroyuki] Iizuka Hosp, Dept Neurol, Fukuoka, Japan; [Schmitz, Matthias; Zerr, Inga] Univ Gottingen, Dementia Res Unit, Natl Reference Ctr TSE, D-37073 Gottingen, Germany; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Gyeonggi Do, South Korea; [Sano, Kazunori; Nishida, Noriyuki] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Atarashi, Ryuichiro] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 852, Japan	Nagasaki University; Kagoshima University; Aichi Medical University; Tokyo Medical & Dental University (TMDU); University of Gottingen; Hallym University; Nagasaki University; Nagasaki University	Satoh, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	satoh-prion@nagasaki-u.ac.jp		Sanjo, Nobuo/0000-0002-1226-2425	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare of Japan; Global COE Program for tropical and emerging diseases, Nagasaki University, Japan; Ministry of Education, Culture, Sports, Science and Technology [24591268]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [23300127, 23790998]; Ministry of Health, Labour, and Welfare; Takeda Science Foundation	Research Committee of Surveillance and Infection Control of Prion Disease; Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global COE Program for tropical and emerging diseases, Nagasaki University, Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grants-in-Aid from the Research Committee of Surveillance and Infection Control of Prion Disease and from the Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labour and Welfare of Japan. Dr. Sano and Professor Nishida are supported by the Global COE Program for tropical and emerging diseases, Nagasaki University, Japan. Dr. Satoh has received research support from Grant-in Aid for Scientific Research (C) (24591268) and from the Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science. This work was supported by Grants-in-Aid from the Research Committee on Surveillance and Infection Control of Prion Disease, the Ministry of Health, Labour and Welfare of Japan. Dr. Atarashi has received research support from Grant-in-Aid for Scientific Research (B) (23300127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labour, and Welfare, and a grant from Takeda Science Foundation. Dr. Sano has received research support from Grant-in-Aid for Young Scientific Research (B) (23790998) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Ladogana A, 2009, J NEUROL, V256, P1620, DOI 10.1007/s00415-009-5163-x; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Popova SN, 2012, ACTA NEUROL SCAND, V126, P315, DOI 10.1111/j.1600-0404.2011.01628.x; Satoh K, 2010, LAB INVEST, V90, P1637, DOI 10.1038/labinvest.2009.68; Webb TEF, 2008, BRAIN, V131, P2632, DOI 10.1093/brain/awn202	7	90	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54915	10.1371/journal.pone.0054915	http://dx.doi.org/10.1371/journal.pone.0054915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372790	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400040
J	Aguirre, CE; Murgan, S; Carrasco, AE; Lopez, SL				Aguirre, Cecilia E.; Murgan, Sabrina; Carrasco, Andres E.; Lopez, Silvia L.			An Intact Brachyury Function Is Necessary to Prevent Spurious Axial Development in Xenopus laevis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BOX TRANSCRIPTION FACTOR; MESODERM FORMATION; HOMEOBOX GENE; SPEMANNS ORGANIZER; NEURAL INDUCTION; BETA-CATENIN; CONJOINED TWINS; FLOOR PLATE; NO-TAIL	We have previously shown that the member of the HES family hairy2 induces the ectopic expression of dorsal markers when it is overexpressed in the ventral side of Xenopus embryos. Intriguingly, hairy2 represses the mesoderm transcription factor brachyury (bra) throughout its domain in the marginal zone. Here we show that in early gastrula, bra and hairy2 are expressed in complementary domains. Overexpression of bra repressed hairy2. Interference of bra function with a dominant-negative construct expanded the hairy2 domain and, like hairy2 overexpression, promoted ectopic expression of dorsal axial markers in the ventral side and induced secondary axes without head and notochord. Hairy2 depletion rescued the ectopic dorsal development induced by interference of bra function. We concluded that an intact bra function is necessary to exclude hairy2 expression from the non-organiser field, to impede the ectopic specification of dorsal axial fates and the appearance of incomplete secondary axes. This evidence supports a previously unrecognised role for bra in maintaining the dorsal fates inhibited in the ventral marginal zone, preventing the appearance of trunk duplications.	[Aguirre, Cecilia E.; Murgan, Sabrina; Carrasco, Andres E.; Lopez, Silvia L.] Univ Buenos Aires, Fac Med, Mol Embryol Lab, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina	University of Buenos Aires	Lopez, SL (corresponding author), Univ Buenos Aires, Fac Med, Mol Embryol Lab, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina.	slopez@fmed.uba.ar		Lopez, Silvia/0000-0002-3760-7549	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 6123/05]; Universidad de Buenos Aires [M803/05]; Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT 767/06, BID PICT 32024/05, PME-2006-00319]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 6123/05), Universidad de Buenos Aires (M803/05), and Agencia Nacional de Promocion Cientifica y Tecnologica (BID PICT 767/06, BID PICT 32024/05, PME-2006-00319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABA ARI, 1992, DEVELOPMENT, V116, P81; Amacher SL, 2002, DEVELOPMENT, V129, P3311; Artinger M, 1997, MECH DEVELOP, V65, P187, DOI 10.1016/S0925-4773(97)00073-7; Barbosky L, 2006, DEV DYNAM, V235, P2592, DOI 10.1002/dvdy.20885; Beck CW, 1999, DEVELOPMENT, V126, P1611; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Brand A, 2004, J PEDIATR SURG, V39, P616, DOI 10.1016/j.jpedsurg.2003.12.029; Carnac G, 1996, DEVELOPMENT, V122, P3055; Cha YR, 2006, DEV BIOL, V290, P246, DOI 10.1016/j.ydbio.2005.10.043; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Conlon FL, 1999, DEV BIOL, V213, P85, DOI 10.1006/dbio.1999.9330; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Cui YZ, 2005, DEV GROWTH DIFFER, V47, P609; CUNLIFFE V, 1994, EMBO J, V13, P349, DOI 10.1002/j.1460-2075.1994.tb06268.x; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Davis RL, 2001, DEV CELL, V1, P553, DOI 10.1016/S1534-5807(01)00054-5; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Escobar MA, 2008, J PEDIATR SURG, V43, P943, DOI 10.1016/j.jpedsurg.2008.01.061; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Franco PG, 1999, DEVELOPMENT, V126, P4257; FRANK D, 1991, DEVELOPMENT, V113, P1387; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gilchrist MJ, 2012, GENESIS, V50, P143, DOI 10.1002/dvg.22008; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gluecksohn-Schoenheimer S, 1938, GENETICS, V23, P573; GONT LK, 1993, DEVELOPMENT, V119, P991; GREEN JBA, 1994, DEVELOPMENT, V120, P2271; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gupta Saurabh Kumar, 2010, J Surg Tech Case Rep, V2, P77, DOI 10.4103/2006-8808.73621; GURDON JB, 1995, NATURE, V376, P520, DOI 10.1038/376520a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hayata T, 1999, DEV GENES EVOL, V209, P560, DOI 10.1007/s004270050289; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heasman J, 1997, DEVELOPMENT, V124, P4179; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Holland PWH, 1995, DEVELOPMENT, V121, P4283; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; HOPWOOD ND, 1991, DEVELOPMENT, V111, P551; Horb ME, 1997, DEVELOPMENT, V124, P1689; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kaufman MH, 2004, CHILD NERV SYST, V20, P508, DOI 10.1007/s00381-004-0985-4; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Kumano G, 2001, DEV BIOL, V236, P465, DOI 10.1006/dbio.2001.0341; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Lopez SL, 2005, DEVELOPMENT, V132, P1035, DOI 10.1242/dev.01659; Luu O, 2008, DEV DYNAM, V237, P1307, DOI 10.1002/dvdy.21522; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Murato Y, 2007, DEV GENES EVOL, V217, P665, DOI 10.1007/s00427-007-0176-x; Murato Y, 2006, INT J DEV BIOL, V50, P463, DOI 10.1387/ijdb.052106ym; Nagatomo KI, 2007, DEV DYNAM, V236, P1475, DOI 10.1002/dvdy.21152; Nelson RW, 1999, J CELL BIOL, V147, P367, DOI 10.1083/jcb.147.2.367; Nichane M, 2008, DEV BIOL, V322, P355, DOI 10.1016/j.ydbio.2008.08.003; Nichane M, 2008, DEV BIOL, V322, P368, DOI 10.1016/j.ydbio.2008.07.026; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Panitz F, 1998, EMBO J, V17, P4414, DOI 10.1093/emboj/17.15.4414; PANNESE M, 1995, DEVELOPMENT, V121, P707; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pizard A, 2004, CURR PROTOC MOL BIOL, V14, p14.9, DOI 10.1002/0471142727.mb1409-66; Revinski DR, 2010, DEV BIOL, V339, P477, DOI 10.1016/j.ydbio.2010.01.010; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Smith JC, 1997, COLD SPRING HARB SYM, V62, P337; Smith JC, 2001, INT J DEV BIOL, V45, P219; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Spencer R, 2000, CLIN ANAT, V13, P36, DOI 10.1002/(SICI)1098-2353(2000)13:1<36::AID-CA5>3.0.CO;2-3; Spencer R, 2001, CLIN ANAT, V14, P428, DOI 10.1002/ca.1079; STEINBEISSER H, 1993, DEVELOPMENT, V118, P499; STEINBEISSER H, 1993, CR ACAD SCI III-VIE, V316, P966; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Tada M, 1997, DEVELOPMENT, V124, P2225; Tsuji S, 2003, DEV GENES EVOL, V213, P407, DOI 10.1007/s00427-003-0338-4; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; VODICKA MA, 1995, DEVELOPMENT, V121, P3505; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILSON V, 1993, DEVELOPMENT, V117, P1321; WILSON V, 1995, DEVELOPMENT, V121, P877; Yamada A, 2010, DEV BIOL, V339, P212, DOI 10.1016/j.ydbio.2009.12.019; Yamaguti M, 2005, DEV DYNAM, V234, P102, DOI 10.1002/dvdy.20523; Zucker RM, 1999, METHODS, V18, P473, DOI 10.1006/meth.1999.0815	120	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54777	10.1371/journal.pone.0054777	http://dx.doi.org/10.1371/journal.pone.0054777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359630	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600108
J	Kou, HJ; Du, XL; Li, YL; Xie, J; Qiu, ZF; Ye, M; Fu, Q; Han, Y; Zhu, Z; Li, TS				Kou, Huijuan; Du, Xiaoli; Li, Yanling; Xie, Jing; Qiu, Zhifeng; Ye, Min; Fu, Qiang; Han, Yang; Zhu, Zhu; Li, Taisheng			Comparison of Nevirapine Plasma Concentrations between Lead-In and Steady-State Periods in Chinese HIV-Infected Patients	PLOS ONE			English	Article							POPULATION PHARMACOKINETICS; DAILY DIDANOSINE; LIVER TOXICITY; STAVUDINE; EFAVIRENZ; THERAPY; SELECTION; EXPOSURE	Objectives: To investigate the potential of nevirapine 200 mg once-daily regimen and evaluate the influence of patient characteristics on nevirapine concentrations. Methods: This was a prospective, multicentre cohort study with 532 HIV-infected patients receiving nevirapine as a part of their initial antiretroviral therapy. Plasma samples were collected at trough or peak time at the end of week 2 (lead-in period) and week 4, 12, 24, 36, and 48 (steady-state period), and nevirapine concentrations were determined using a validated HPLC method. Potential influencing factors associated with nevirapine concentrations were evaluated using univariate and multivariate logistic regression. Results: A total of 2348 nevirapine plasma concentrations were collected, including 1510 trough and 838 peak values. The median nevirapine trough and peak concentration during the lead-in period were 4.26 mu g/mL (IQR 3.05-5.61) and 5.07 mu g/mL (IQR 3.92-6.44) respectively, which both exceeded the recommended thresholds of nevirapine plasma concentrations. Baseline hepatic function had a moderate effect on median nevirapine trough concentrations at week 2 (4.25 mu g/mL v.s. 4.86 mu g/mL, for ALT <1.5 x ULN and >= 1.5 x ULN, respectively, P = 0.045). No significant difference was observed in median nevirapine trough concentration between lead-in and steady-state periods in patients with baseline ALT and AST level >= 1.5 x ULN (P = 0.171, P = 0.769), which was different from the patients with ALT/AST level <1.5ULN. The median trough concentrations were significantly higher in HIV/HCV co-infected patients than those without HCV at week 48 (8.16 mu g/mL v.s. 6.15 mu g/mL, P = 0.004). Conclusions: The 200 mg once-daily regimen of nevirapine might be comparable to twice-daily in plasma pharmacokinetics in Chinese population. Hepatic function prior to nevirapine treatment and HIV/HCV coinfection were significantly associated with nevirapine concentrations.	[Kou, Huijuan; Li, Yanling; Xie, Jing; Qiu, Zhifeng; Han, Yang; Li, Taisheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Kou, Huijuan] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Gerontol, Chengdu, Peoples R China; [Du, Xiaoli; Ye, Min; Fu, Qiang; Zhu, Zhu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pharm, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Sichuan Provincial People's Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, TS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	litsh@263.net	han, yang/GRS-2388-2022; li, yan/GTI-4638-2022		National Natural Science Foundation of China [81071372]; National Key Technologies R&D Program for the 11th Five-year Plan [2008ZX10001-006]; Key Clinical Program of the Ministry of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for the 11th Five-year Plan(National Key Technology R&D Program); Key Clinical Program of the Ministry of Health	This work was supported by the National Natural Science Foundation of China (81071372); the National Key Technologies R&D Program for the 11th Five-year Plan (2008ZX10001-006); and Key Clinical Program of the Ministry of Health 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond LM, 2004, AIDS RES HUM RETROV, V20, P716, DOI 10.1089/0889222041524670; [Anonymous], GUID US ANT AG HIV 1; de Maat MMR, 2003, EUR J CLIN PHARMACOL, V59, P457, DOI 10.1007/s00228-003-0613-3; de Maat MMR, 2002, BRIT J CLIN PHARMACO, V54, P378, DOI 10.1046/j.1365-2125.2002.01657.x; de Requena DG, 2005, ANTIMICROB AGENTS CH, V49, P3966, DOI 10.1128/AAC.49.9.3966-3969.2005; de Requena DG, 2002, AIDS, V16, P290, DOI 10.1097/00002030-200201250-00020; de Vries-Sluijs TEMS, 2003, CLIN PHARMACOKINET, V42, P599, DOI 10.2165/00003088-200342060-00009; Garcia F, 2000, AIDS, V14, P2485, DOI 10.1097/00002030-200011100-00010; Guo F, 2011, CHINESE MED IN PRESS; Guo FP, 2010, JAIDS-J ACQ IMM DEF, V54, P137, DOI 10.1097/QAI.0b013e3181cc5964; Harris M, 2000, REV MED VIROL, V10, P217, DOI 10.1002/1099-1654(200007/08)10:4&lt;217::AID-RMV279&gt;3.0.CO;2-L; Kappelhoff BS, 2005, HIV CLIN TRIALS, V6, P254, DOI 10.1310/B5VU-FU5F-QNWC-UDCK; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Launay O, 2004, CLIN INFECT DIS, V38, pE66, DOI 10.1086/382677; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Mahungu TW, 2009, HIV MED, V10, P310, DOI 10.1111/j.1468-1293.2008.00689.x; Molto J, 2008, J ANTIMICROB CHEMOTH, V62, P784, DOI 10.1093/jac/dkn268; Montaner JSG, 2003, JAIDS-J ACQ IMM DEF, V33, P41, DOI 10.1097/00126334-200305010-00007; MURPHY RL, 1996, EXPERT OPIN INV DRUG, V5, P1183; Negredo E, 2004, ANTIVIR THER, V9, P335; Nunez M, 2003, AIDS RES HUM RETROV, V19, P187, DOI 10.1089/088922203763315687; Raffi F, 2000, ANTIVIR THER, V5, P267; Schipani A, 2011, J ANTIMICROB CHEMOTH, V66, P1332, DOI 10.1093/jac/dkr087; Stohr W, 2008, ANTIVIR THER, V13, P675; Swaminathan S, 2011, J ANTIMICROB CHEMOTH, V66, P1354, DOI 10.1093/jac/dkr075; Tao-ming Huang, 2005, Zhongguo Xinyao yu Linchuang Zazhi, V24, P505; van Heeswijk RPG, 2000, AIDS, V14, pF77, DOI 10.1097/00002030-200005260-00001; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Veldkamp AI, 2001, AIDS, V15, P1089, DOI 10.1097/00002030-200106150-00003; von Hentig N, 2006, BRIT J CLIN PHARMACO, V62, P552, DOI 10.1111/j.1365-2125.2006.02664.x; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026739; [王璐 WANG Lu], 2009, [中国药学杂志, Chinese Pharmaceutical Journal], V44, P310; Wyen C, 2008, J ANTIMICROB CHEMOTH, V61, P914, DOI 10.1093/jac/dkn029	33	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52950	10.1371/journal.pone.0052950	http://dx.doi.org/10.1371/journal.pone.0052950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359265	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600009
J	Schymanski, SJ; Or, D; Zwieniecki, M				Schymanski, Stanislaus J.; Or, Dani; Zwieniecki, Maciej			Stomatal Control and Leaf Thermal and Hydraulic Capacitances under Rapid Environmental Fluctuations	PLOS ONE			English	Article							BOUNDARY-LAYER RESISTANCE; GAS-EXCHANGE; PHOTOSYNTHETIC RESPONSES; RAIN-FOREST; TEMPERATURE DISTRIBUTION; TROPICAL SAVANNA; FLAPPING LEAVES; WATER RELATIONS; DYNAMIC LIGHT; ELEVATED CO2	Leaves within a canopy may experience rapid and extreme fluctuations in ambient conditions. A shaded leaf, for example, may become exposed to an order of magnitude increase in solar radiation within a few seconds, due to sunflecks or canopy motions. Considering typical time scales for stomatal adjustments, (2 to 60 minutes), the gap between these two time scales raised the question whether leaves rely on their hydraulic and thermal capacitances for passive protection from hydraulic failure or over-heating until stomata have adjusted. We employed a physically based model to systematically study effects of short-term fluctuations in irradiance on leaf temperatures and transpiration rates. Considering typical amplitudes and time scales of such fluctuations, the importance of leaf heat and water capacities for avoiding damaging leaf temperatures and hydraulic failure were investigated. The results suggest that common leaf heat capacities are not sufficient to protect a non-transpiring leaf from over-heating during sunflecks of several minutes duration whereas transpirative cooling provides effective protection. A comparison of the simulated time scales for heat damage in the absence of evaporative cooling with observed stomatal response times suggested that stomata must be already open before arrival of a sunfleck to avoid over-heating to critical leaf temperatures. This is consistent with measured stomatal conductances in shaded leaves and has implications for water use efficiency of deep canopy leaves and vulnerability to heat damage during drought. Our results also suggest that typical leaf water contents could sustain several minutes of evaporative cooling during a sunfleck without increasing the xylem water supply and thus risking embolism. We thus submit that shaded leaves rely on hydraulic capacitance and evaporative cooling to avoid over-heating and hydraulic failure during exposure to typical sunflecks, whereas thermal capacitance provides limited protection for very short sunflecks (tens of seconds).	[Schymanski, Stanislaus J.; Or, Dani] ETH, Dept Environm Syst Sci, Zurich, Switzerland; [Zwieniecki, Maciej] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Davis	Schymanski, SJ (corresponding author), ETH, Dept Environm Syst Sci, Zurich, Switzerland.	stanislaus.schymanski@env.ethz.ch	Schymanski, Stan/AAV-3862-2021; Schymanski, Stanislaus J/A-5303-2012; Or, Dani/D-8768-2012	Schymanski, Stan/0000-0002-0950-2942; Schymanski, Stanislaus J/0000-0002-0950-2942; Or, Dani/0000-0002-3236-2933; Zwieniecki, Maciej/0000-0002-3774-4455	ETH Zurich; Harvard University	ETH Zurich(ETH Zurich); Harvard University	The research was funded by ETH Zurich and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerle WL, 2003, TREE PHYSIOL, V23, P841, DOI 10.1093/treephys/23.12.841; Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Chazdon RL, 1988, ADV ECOLOGICAL RES, V18, P1; Chen JW, 2010, TREE PHYSIOL, V30, P876, DOI 10.1093/treephys/tpq043; Chen JW, 2009, PLANTA, V230, P459, DOI 10.1007/s00425-009-0959-6; COLOMBO SJ, 1992, TREE PHYSIOL, V11, P95, DOI 10.1093/treephys/11.1.95; Edwards DS, 1993, TROPICAL RAINFOREST; FAY PA, 1993, AM J BOT, V80, P1369, DOI 10.2307/2445664; FAY PA, 1995, PHYSIOL PLANTARUM, V94, P613, DOI 10.1111/j.1399-3054.1995.tb00975.x; Hao GY, 2008, OECOLOGIA, V155, P405, DOI 10.1007/s00442-007-0918-5; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hartmann H, 2011, GLOBAL CHANGE BIOL, V17, P642, DOI 10.1111/j.1365-2486.2010.02248.x; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; HOLLINGER DY, 1987, J ECOL, V75, P925, DOI 10.2307/2260304; Incropera F.P., 2006, FUNDAMENTALS HEAT MA; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; KNAPP AK, 1990, PHYSIOL PLANTARUM, V78, P160, DOI 10.1111/j.1399-3054.1990.tb08731.x; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Leakey ADB, 2005, J EXP BOT, V56, P469, DOI 10.1093/jxb/eri055; Leakey ADB, 2003, PLANT CELL ENVIRON, V26, P1681, DOI 10.1046/j.1365-3040.2003.01086.x; Leigh A, 2012, NEW PHYTOL, V194, P477, DOI 10.1111/j.1469-8137.2012.04058.x; Monteith J., 2007, PRINCIPLES ENV PHYS; Myers BA, 1997, AUST J BOT, V45, P225, DOI 10.1071/BT96015; Naumburg E, 2000, OECOLOGIA, V122, P163, DOI 10.1007/PL00008844; Okajima Y, 2012, ECOL RES, V27, P333, DOI 10.1007/s11284-011-0905-5; Ortiz C, 2001, J EXP BOT, V52, P1711, DOI 10.1093/jexbot/52.361.1711; PARLANGE JY, 1971, PLANT PHYSIOL, V48, P437, DOI 10.1104/pp.48.4.437; PARLANGE JY, 1972, PLANT PHYSIOL, V50, P60, DOI 10.1104/pp.50.1.60; Pearcy RW, 1987, FUNCT ECOL, V1, P169, DOI 10.2307/2389419; Pearcy R. W., 2004, PHOTOSYNTHESIS ENV, P321; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; Peng Y, 2012, CROP SCI, V52, P807, DOI 10.2135/cropsci2011.06.0327; Pinker RT, 1997, PHOTOSYNTHETICALLY A; Roderick ML, 2005, PLANT PHYSIOL BIOCH, V43, P323, DOI 10.1016/j.plaphy.2005.02.014; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SCHUEPP PH, 1993, NEW PHYTOL, V125, P477, DOI 10.1111/j.1469-8137.1993.tb03898.x; Schultz HR, 1997, OECOLOGIA, V110, P312, DOI 10.1007/s004420050164; Tausz M, 2005, NEW PHYTOL, V165, P143, DOI 10.1111/j.1469-8137.2004.01232.x; THIMIJAN RW, 1983, HORTSCIENCE, V18, P818; Valladares F, 1997, OECOLOGIA, V111, P505, DOI 10.1007/s004420050264; Vico G, 2011, NEW PHYTOL, V192, P640, DOI 10.1111/j.1469-8137.2011.03847.x; Warren JM, 2011, TREE PHYSIOL, V31, P117, DOI 10.1093/treephys/tpr002; Way DA, 2012, TREE PHYSL; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Zeppel MJB, 2011, NEW PHYTOL, V192, P800, DOI 10.1111/j.1469-8137.2011.03960.x; Zimmermann M. H., 1983, Xylem structure and the ascent of sap.; Zweifel R, 2000, TREES-STRUCT FUNCT, V15, P50, DOI 10.1007/s004680000072; Zwieniecki MA, 2000, PLANT CELL ENVIRON, V23, P407, DOI 10.1046/j.1365-3040.2000.00554.x; Zwieniecki MA, 2007, PLANT CELL ENVIRON, V30, P910, DOI 10.1111/j.1365-3040.2007.001681.x	51	104	106	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54231	10.1371/journal.pone.0054231	http://dx.doi.org/10.1371/journal.pone.0054231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359800	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600039
J	Alsallaq, RA; Baeten, JM; Celum, CL; Hughes, JP; Abu-Raddad, LJ; Barnabas, RV; Hallett, TB				Alsallaq, Ramzi A.; Baeten, Jared M.; Celum, Connie L.; Hughes, James P.; Abu-Raddad, Laith J.; Barnabas, Ruanne V.; Hallett, Timothy B.			Understanding the Potential Impact of a Combination HIV Prevention Intervention in a Hyper-Endemic Community	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; SOUTH-AFRICA; SEXUAL TRANSMISSION; TREATMENT PROGRAM; PROJECT ACCEPT; HPTN 043; RISK; SPREAD	Objectives: Despite demonstrating only partial efficacy in preventing new infections, available HIV prevention interventions could offer a powerful strategy when combined. In anticipation of combination HIV prevention programs and research studies we estimated the population-level impact of combining effective scalable interventions at high population coverage, determined the factors that influence this impact, and estimated the synergy between the components. Methods: We used a mathematical model to investigate the effect on HIV incidence of a combination HIV prevention intervention comprised of high coverage of HIV testing and counselling, risk reduction following HIV diagnosis, male circumcision for HIV-uninfected men, and antiretroviral therapy (ART) for HIV-infected persons. The model was calibrated to data for KwaZulu-Natal, South Africa, where adult HIV prevalence is approximately 23%. Results: Compared to current levels of HIV testing, circumcision, and ART, the combined intervention with ART initiation according to current guidelines could reduce HIV incidence by 47%, from 2.3 new infections per 100 person-years (pyar) to 1.2 per 100 pyar within 4 years and by almost 60%, to 1 per 100 pyar, after 25 years. Short-term impact is driven primarily by uptake of testing and reductions in risk behaviour following testing while long-term effects are driven by periodic HIV testing and retention in ART programs. If the combination prevention program incorporated HIV treatment upon diagnosis, incidence could be reduced by 63% after 4 years and by 76% (to about 0.5 per 100 pyar) after 15 years. The full impact of the combination interventions accrues over 10-15 years. Synergy is demonstrated between the intervention components. Conclusion: High coverage combination of evidence-based strategies could generate substantial reductions in population HIV incidence in an African generalized HIV epidemic setting. The full impact could be underestimated by the short assessment duration of typical evaluations.	[Alsallaq, Ramzi A.; Baeten, Jared M.; Celum, Connie L.; Hughes, James P.; Barnabas, Ruanne V.] Univ Washington, Seattle, WA 98195 USA; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Barnabas, Ruanne V.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Abu-Raddad, Laith J.] Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Imperial College London	Alsallaq, RA (corresponding author), Univ Washington, Seattle, WA 98195 USA.	ramzi.alsallaq@gmail.com	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Hallett, Timothy/0000-0002-9681-0424	National Institutes of Health [1R01AI083034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B, G0600719B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by a grant from the National Institutes of Health (1R01AI083034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aids2031, 2010, LONG TERM COSTS HIV; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; Anderson RM, 2000, SEX TRANSM DIS, V27, P636, DOI 10.1097/00007435-200011000-00012; Assefa Y, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60647-4; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2011, NEW ENGL J MED, V365, P1; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Department of Health SA, 2003, DEM HLTH SURV; Department of Health SA, 2009, NAT ANT SENT HIV SYP; Department of Health SA, 2012, HIV AIDS STI STRAT P; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Epstein H, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60643-7; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Hsieh YH, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60645-0; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Jurgens R, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60644-9; Kaldor JM, 2010, AIDS, V24, P2564, DOI 10.1097/QAD.0b013e32833ead96; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; KwaZulu-Natal Department of Health, 2006, POP DAT; Lange JMA, 2011, CLIN INFECT DIS, V52, P801, DOI 10.1093/cid/ciq254; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Mugglin C, 2012, 19 C RETR OPP INF MA; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Naik R, 2010, 18 INT AIDS C 18 23; NICOLOSI A, 1994, J ACQ IMMUN DEF SYND, V7, P296; Nuwaha F, 2009, 16 C RETR OPP INF 8; Over M., 2010, GLOBAL AIDS TRANSITI; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V58, pE23, DOI 10.1097/QAI.0b013e318227af37; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Pearson CR, 2007, AIDS CARE, V19, P594, DOI 10.1080/09540120701203337; Poole D, 2000, INFERENCE DETERMINIS; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Rehle T, 2010, COMMUNICATION; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shisana O, 2009, S AFRICAN NATL HIV P; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; The Epidemiology Unit of KwaZulu-Natal Department of Health, 2005, KWAZULU NAT EP B; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Tumwebaze H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051620; Tumwesigye E, 2008, 15 C RETR OPP INF 3; Tumwesigye E, 2011, 6 IAS C HIV PATH TRE; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2010, ANT THER HIV INF AD; [World Health Organization; WHO UNAIDS UNICEF], 2011, EP UPD HLTH SECT PRO; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	83	33	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54575	10.1371/journal.pone.0054575	http://dx.doi.org/10.1371/journal.pone.0054575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372738	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500087
J	van de Waterbeemd, B; Zomer, G; van den IJssel, J; van Keulen, L; Eppink, MH; van der Ley, P; van der Pol, LA				van de Waterbeemd, Bas; Zomer, Gijsbert; van den IJssel, Jan; van Keulen, Lonneke; Eppink, Michel H.; van der Ley, Peter; van der Pol, Leo A.			Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; SEROGROUP-B; TRANSCRIPTOME ANALYSIS; MENINGOCOCCAL DISEASE; CHELATING-AGENTS; DNA MICROARRAYS; STRAINS; LIPOPOLYSACCHARIDE	Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial pathogens. The first OMV vaccines successfully stopped Neisseria meningitidis serogroup B outbreaks but required detergent-extraction for endotoxin removal. Current vaccines use attenuated endotoxin, to preserve immunological properties and allow a detergent-free process. The preferred process is based on spontaneously released OMV (sOMV), which are most similar to in vivo vesicles and easier to purify. The release mechanism however is poorly understood resulting in low yield. This study with N. meningitidis demonstrates that an external stimulus, cysteine depletion, can trigger growth arrest and sOMV release in sufficient quantities for vaccine production (+/- 1500 human doses per liter cultivation). Transcriptome analysis suggests that cysteine depletion impairs iron-sulfur protein assembly and causes oxidative stress. Involvement of oxidative stress is confirmed by showing that addition of reactive oxygen species during cysteine-rich growth also triggers vesiculation. The sOMV in this study are similar to vesicles from natural infection, therefore cysteine-dependent vesiculation is likely to be relevant for the in vivo pathogenesis of N. meningitidis.	[van de Waterbeemd, Bas; Zomer, Gijsbert; van den IJssel, Jan; van Keulen, Lonneke; van der Ley, Peter; van der Pol, Leo A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Eppink, Michel H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	van de Waterbeemd, B (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	bas.van.de.waterbeemd@rivm.nl	Eppink, Michel/AAB-6866-2022	Eppink, Michel/0000-0001-8297-9985	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport (www.minvws.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baart GJE, 2008, BIOTECHNOL BIOENG, V101, P1022, DOI 10.1002/bit.22016; Baart GJE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r136; Baart GJE, 2007, VACCINE, V25, P6399, DOI 10.1016/j.vaccine.2007.06.008; Baart GJE, 2010, MICROBIOL-SGM, V156, P530, DOI 10.1099/mic.0.031641-0; Bartolini E, 2006, MOL MICROBIOL, V60, P963, DOI 10.1111/j.1365-2958.2006.05163.x; BISHOP DG, 1965, BIOCHEM J, V96, P567, DOI 10.1042/bj0960567; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; CATLIN BW, 1973, J INFECT DIS, V128, P178, DOI 10.1093/infdis/128.2.178; CHATTERJ.SN, 1967, J GEN MICROBIOL, V49, P1; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Grifantini R, 2004, MOL MICROBIOL, V54, P962, DOI 10.1111/j.1365-2958.2004.04315.x; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Guckenberger M, 2002, J BACTERIOL, V184, P2546, DOI 10.1128/JB.184.9.2546-2551.2002; HAQUE H, 1974, ANTIMICROB AGENTS CH, V5, P447, DOI 10.1128/AAC.5.5.447; HAQUE H, 1974, ANTIMICROB AGENTS CH, V6, P200, DOI 10.1128/AAC.6.2.200; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; HOLBEIN BE, 1981, CURR MICROBIOL, V6, P213, DOI 10.1007/BF01566974; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982; Keiser PB, 2010, VACCINE; KLUGMAN KP, 1989, INFECT IMMUN, V57, P2066, DOI 10.1128/IAI.57.7.2066-2071.1989; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; Koeberling O, 2008, CLIN VACCINE IMMUNOL; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; MOSLEN MT, 1994, ADV EXP MED BIOL, V366, P17; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; PORT JL, 1984, CAN J MICROBIOL, V30, P1453, DOI 10.1139/m84-232; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prachayasittikul V, 2007, ACTA BIOCH BIOPH SIN, V39, P901, DOI 10.1111/j.1745-7270.2007.00350.x; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thornton V, 2006, VACCINE, V24, P1395, DOI 10.1016/j.vaccine.2005.09.043; Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y; van de Waterbeemd B, 2012, VACCINE, V30, P3683, DOI 10.1016/j.vaccine.2012.03.028; van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; VANDERLEY P, 1995, VACCINE, V13, P401, DOI 10.1016/0264-410X(95)98264-B; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; WORK E, 1966, ANN NY ACAD SCI, V133, P438, DOI 10.1111/j.1749-6632.1966.tb52382.x; ZOLLINGE.WD, 1972, INFECT IMMUN, V6, P835, DOI 10.1128/IAI.6.5.835-851.1972; Zollinger WD, 2010, VACCINE; ZOLLINGER WD, 2003, Patent No. 6558677; Zollinger WD, 2011, EXPERT REV VACCINES, V10, P559, DOI [10.1586/erv.11.41, 10.1586/ERV.11.41]	63	41	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54314	10.1371/journal.pone.0054314	http://dx.doi.org/10.1371/journal.pone.0054314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372704	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500056
J	Zhao, L; Wang, YH				Zhao, Liang; Wang, Yonghui			Conflict Background Triggered Congruency Sequence Effects in Graphic Judgment Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; SIMON TASK; FLANKER TASK; RESPONSE ACTIVATION; PREFRONTAL CORTEX; STROOP TASK; ADAPTATION; ADJUSTMENTS; INTEGRATION	Congruency sequence effects refer to the reduction of congruency effects when following an incongruent trial than following a congruent trial. The conflict monitoring account, one of the most influential contributions to this effect, assumes that the sequential modulations are evoked by response conflict. The present study aimed at exploring the congruency sequence effects in the absence of response conflict. We found congruency sequence effects occurred in graphic judgment task, in which the conflict stimuli acted as irrelevant information. The findings reveal that processing task-irrelevant conflict stimulus features could also induce sequential modulations of interference. The results do not support the interpretation of conflict monitoring and favor a feature integration account that the congruency sequence effects are attributed to the repetitions of stimulus and response features.	[Zhao, Liang; Wang, Yonghui] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Zhao, Liang; Wang, Yonghui] Shaanxi Prov Key Lab Behav & Cognit Neurosci, Xian, Peoples R China	Shaanxi Normal University	Wang, YH (corresponding author), Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China.	wyonghui@snnu.edu.cn			Program for New Century Excellent Talents in University [NCET-08-0801]; Key Program of the 11th Five year Plan of National Education Science [DBA070070]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Program of the 11th Five year Plan of National Education Science	This study was supported by grants from the Program for New Century Excellent Talents in University (NCET-08-0801) and the Key Program of the 11th Five year Plan of National Education Science (DBA070070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Davelaar EJ, 2009, PSYCHON B REV, V16, P121, DOI 10.3758/PBR.16.1.121; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fischer R, 2008, J EXP PSYCHOL LEARN, V34, P712, DOI 10.1037/0278-7393.34.3.712; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Notebaert W, 2006, PSYCHON B REV, V13, P1078, DOI 10.3758/BF03213929; Spape MM, 2011, BIOL PSYCHOL, V88, P116, DOI 10.1016/j.biopsycho.2011.07.001; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2003, EXP BRAIN RES, V153, P35, DOI 10.1007/s00221-003-1579-1; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Wuhr P, 2005, PSYCHON B REV, V12, P282, DOI 10.3758/BF03196373; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269	30	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54780	10.1371/journal.pone.0054780	http://dx.doi.org/10.1371/journal.pone.0054780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372766	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500124
J	Zhu, YS; Wang, YP; Zhao, B; Wei, SG; Xu, M; Liu, EQ; Lai, JH				Zhu, Yongsheng; Wang, Yunpeng; Zhao, Bin; Wei, Shuguang; Xu, Ming; Liu, Enqi; Lai, Jianghua			Differential Phosphorylation of GluN1-MAPKs in Rat Brain Reward Circuits following Long-Term Alcohol Exposure	PLOS ONE			English	Article							ETHANOL WITHDRAWAL SYNDROME; NMDA RECEPTOR SUBUNITS; ACTIVATED PROTEIN-KINASES; SIGNAL-REGULATED KINASE; NUCLEUS-ACCUMBENS; MEDIATED INHIBITION; PREFRONTAL CORTEX; DRUG-ADDICTION; ERK; STRIATUM	The effects of long-term alcohol consumption on the mitogen-activated protein kinases (MAPKs) pathway and N-methyl-D-aspartate-type glutamate receptor 1 (GluN1) subunits in the mesocorticolimbic system remain unclear. In the present study, rats were allowed to consume 6% (v/v) alcohol solution for 28 consecutive days. Locomotor activity and behavioral signs of withdrawal were observed. Phosphorylation and expression of extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), p38 protein kinase and GluN1 in the nucleus accumbens, caudate putamen, amygdala, hippocampus and prefrontal cortex of these rats were also measured. Phosphorylation of ERK, but not JNK or p38, was decreased in all five brain regions studied in alcohol-drinking rats. The ratio of phospho/total-GluN1 subunit was reduced in all five brain regions studied. Those results suggest that the long-term alcohol consumption can inhibits GluN1 and ERK phosphorylation, but not JNK or p38 in the mesocorticolimbic system, and these changes may be relevant to alcohol dependence. To differentiate alcohol-induced changes in ERK and GluN1 between acute and chronic alcohol exposure, we have determined levels of phospho-ERK, phospho-GluN1 and total levels of GluN1 after acute alcohol exposure. Our data show that 30 min following a 2.5 g/kg dose of alcohol (administered intragastrically), levels of phospho-ERK are decreased while those of phospho-GluN1 are elevated with no change in total GluN1 levels. At 24 h following the single alcohol dose, levels of phospho-ERK are elevated in several brain regions while there are no differences between controls and alcohol treated animals in phospho-GluN1 or total GluN1. Those results suggest that alcohol may differentially regulate GluN1 function and ERK activation depending on alcohol dose and exposure time in the central nervous system.	[Zhu, Yongsheng; Wang, Yunpeng; Zhao, Bin; Wei, Shuguang; Liu, Enqi; Lai, Jianghua] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Key Lab,Minist Publ Hlth Forens Sci, Xian 710049, Peoples R China; [Lai, Jianghua] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Minist Educ, Xian 710049, Peoples R China; [Zhu, Yongsheng] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Yinchuan, Peoples R China; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Ningxia Medical University; University of Chicago	Lai, JH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Key Lab,Minist Publ Hlth Forens Sci, Xian 710049, Peoples R China.	laijh1011@hotmail.com	liu, enqi/S-7771-2019		National Science Foundation of China [NSFC 81172910, NSFC 31100900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (NSFC 81172910 and NSFC 31100900; http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Allgaier C, 2002, NEUROCHEM INT, V41, P377, DOI 10.1016/S0197-0186(02)00046-3; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bertotto ME, 2011, EUR NEUROPSYCHOPHARM; Braconi S, 2010, ALCOHOL CLIN EXP RES, V34, P538, DOI 10.1111/j.1530-0277.2009.01119.x; BURNS LH, 1994, PSYCHOPHARMACOLOGY, V115, P516, DOI 10.1007/BF02245576; Celikyurt IK, 2011, PROG NEURO-PSYCHOPH, V35, P528, DOI 10.1016/j.pnpbp.2010.12.009; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clapp P, 2008, ALCOHOL RES HEALTH, V31, P310; Deadwyler SA, 2004, NEUROSCI BIOBEHAV R, V27, P703, DOI 10.1016/j.neubiorev.2003.11.011; Elberger AJ, 2011, NEUROTOXICOL TERATOL; Erden BF, 1999, PHARMACOL BIOCHEM BE, V62, P537, DOI 10.1016/S0091-3057(98)00175-0; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Floyd DW, 2003, J PHARMACOL EXP THER, V307, P1020, DOI 10.1124/jpet.103.057505; Gorelova N, 1997, NEUROSCIENCE, V76, P689, DOI 10.1016/S0306-4522(96)00380-6; Hatt H, 1999, NATURWISSENSCHAFTEN, V86, P177, DOI 10.1007/s001140050593; Hoffman PL, 2003, INT REV NEUROBIOL, V56, P35, DOI 10.1016/S0074-7742(03)56002-0; HOFFMAN PL, 1989, NEUROPHARMACOLOGY, V28, P1239, DOI 10.1016/0028-3908(89)90217-7; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; Kalluri HSG, 1998, MOL BRAIN RES, V58, P221, DOI 10.1016/S0169-328X(98)00112-0; Kalluri HSG, 2002, EUR J PHARMACOL, V451, P51, DOI 10.1016/S0014-2999(02)02100-3; Kalluri HSG, 2002, EUR J PHARMACOL, V439, P53, DOI 10.1016/S0014-2999(01)01599-0; Kalsi G, 2009, TRENDS GENET, V25, P49, DOI 10.1016/j.tig.2008.10.005; Klann E, 2002, LEARN MEMORY, V9, P153, DOI 10.1101/lm.52802; Klugmann M, 2011, INT J NEUROPSYCHOPH, V14, P505, DOI 10.1017/S1461145710001562; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Leggio L, 2008, PROG NEURO-PSYCHOPH, V32, P1106, DOI 10.1016/j.pnpbp.2007.09.021; Liu Y, 2000, CHINESE MED J-PEKING, V113, P948; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Nagy Jozsef, 2005, Current Neuropharmacology, V3, P281, DOI 10.2174/157015905774322499; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; RAYMOND LA, 1994, J PHYSIOLOGY-PARIS, V88, P181, DOI 10.1016/0928-4257(94)90004-3; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Roh MS, 2011, ALCOHOL ALCOHOLISM, V46, P672, DOI 10.1093/alcalc/agr124; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Sanna PP, 2002, BRAIN RES, V948, P186, DOI 10.1016/S0006-8993(02)03191-8; Snell LD, 1996, MOL BRAIN RES, V40, P71; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Swift RM, 1999, NEW ENGL J MED, V340, P1482, DOI 10.1056/NEJM199905133401907; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Turchan J, 1999, NEUROSCIENCE, V91, P971, DOI 10.1016/S0306-4522(98)00637-X; UZBAY IT, 1994, PHARMACOL BIOCHEM BE, V49, P969, DOI 10.1016/0091-3057(94)90251-8; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang YP, 2012, BRAIN RES BULL, V89, P191, DOI 10.1016/j.brainresbull.2012.08.007; Wu PH, 2010, J NEUROCHEM, V115, P1112, DOI 10.1111/j.1471-4159.2010.06991.x; Xu MF, 2006, J NEUROCHEM, V96, P1760, DOI 10.1111/j.1471-4159.2006.03703.x; Zhai HF, 2008, CELL MOL NEUROBIOL, V28, P157, DOI 10.1007/s10571-007-9240-3; Zhao HWW, 2006, J NEUROSCI RES, V84, P291, DOI 10.1002/jnr.20893; Zhou FC, 2007, BRAIN RES, V1134, P148, DOI 10.1016/j.brainres.2006.11.046	66	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54930	10.1371/journal.pone.0054930	http://dx.doi.org/10.1371/journal.pone.0054930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372792	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500145
J	Tsai, CH; Tung, KY; Su, MW; Chiang, BL; Chew, FT; Kuo, NW; Lee, YL				Tsai, Ching-Hui; Tung, Kuan-Yen; Su, Ming-Wei; Chiang, Bor-Luen; Chew, Fook Tim; Kuo, Nai-Wei; Lee, Yungling Leo			Interleukin-13 Genetic Variants, Household Carpet Use and Childhood Asthma	PLOS ONE			English	Article							MITE ALLERGEN; PROMOTER POLYMORPHISM; BRONCHITIC SYMPTOMS; TOBACCO-SMOKE; TOTAL IGE; CHILDREN; ASSOCIATION; IL-13; IL13; EXPOSURE	Interleukin (IL)-13 genetic polymorphisms have shown adverse effects on respiratory health. However, few studies have explored the interactive effects between IL-13 haplotypes and environmental exposures on childhood asthma. The aims of our study are to evaluate the effects of IL-13 genetic variants on asthma phenotypes, and explore the potential interaction between IL-13 and household environmental exposures among Taiwanese children. We investigated 3,577 children in the Taiwan Children Health Study from 14 Taiwanese communities. Data regarding children's exposure and disease status were obtained from parents using a structured questionnaire. Four SNPs were tagged accounting for 100% of the variations in IL-13. Multiple logistic regression models with false-discovery rate (FDR) adjustments were fitted to estimate the effects of IL-13 variants on asthma phenotypes. SNP rs1800925, SNP rs20541 and SNP rs848 were significantly associated with increased risks on childhood wheeze with FDR of 0.03, 0.04 and 0.04, respectively. Children carrying two copies of h1011 haplotype showed increased susceptibility to wheeze. Compared to those without carpet use and h1011 haplotype, children carrying h1011 haplotype and using carpet at home had significantly synergistic risks of wheeze (OR, 2.5; 95% CI, 1.4-4.4; p for interaction, 0.01) and late-onset asthma (OR, 4.7; 95% CI, 2.0-10.9; p for interaction, 0.02). In conclusions, IL-13 genetic variants showed significant adverse effects on asthma phenotypes among children. The results also suggested that asthma pathogenesis might be mediated by household carpet use.	[Tsai, Ching-Hui; Tung, Kuan-Yen; Su, Ming-Wei; Kuo, Nai-Wei; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Tung, Kuan-Yen; Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chew, Fook Tim] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National University of Singapore	Lee, YL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	leolee@ntu.edu.tw	Lee, Yungling/S-7011-2018; Chew, Fook Tim/E-7259-2010	Lee, Yungling/0000-0002-2234-9479; Chew, Fook Tim/0000-0003-1337-5146; CHIANG, BOR-LUEN/0000-0002-6705-0286; Tsai, Chinghui/0000-0003-0998-8230	National Science Council [96-2314-B-006-053, 98-2314-B-002-138-MY3, 101-2314-B-002-113-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (Grant # 96-2314-B-006-053, # 98-2314-B-002-138-MY3 and # 101-2314-B-002-113-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHANYEUNG M, 1995, AM J RESP CRIT CARE, V152, P1805, DOI 10.1164/ajrccm.152.6.8520740; Chen YC, 2011, INT J HYG E IN PRESS; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DeMeo DL, 2002, GENET EPIDEMIOL, V23, P335, DOI 10.1002/gepi.10182; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Heinzmann A, 2003, J ALLERGY CLIN IMMUN, V112, P735, DOI 10.1016/S0091-6749(03)01887-6; HENDERSON FW, 1995, AM J RESP CRIT CARE, V151, P1786, DOI 10.1164/ajrccm.151.6.7767521; Hummelshoj T, 2003, EUR J IMMUNOGENET, V30, P355, DOI 10.1046/j.1365-2370.2003.00416.x; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Kim HB, 2006, J HUM GENET, V51, P1055, DOI 10.1007/s10038-006-0061-x; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Martinez Fernando D, 2007, Proc Am Thorac Soc, V4, P26, DOI 10.1513/pats.200607-144JG; Maziak W, 2003, ALLERGY, V58, P572, DOI 10.1034/j.1398-9995.2003.00161.x; Mihrshahi S, 2002, ALLERGY, V57, P137, DOI 10.1034/j.1398-9995.2002.5720999.x; Ogbuanu Ikechukwu U, 2010, Allergy Asthma Clin Immunol, V6, P6, DOI 10.1186/1710-1492-6-6; Osborne J., 2006, SAS US GROUP INT P, V190, P1; Park HW, 2009, RESP MED, V103, P284, DOI 10.1016/j.rmed.2008.08.009; Sadeghnejad A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-2; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Sorensen M, 2009, PEDIAT ALLERG IMM-UK, V20, P614, DOI 10.1111/j.1399-3038.2009.00855.x; Spee-van der Wekke J, 1998, J EPIDEMIOL COMMUN H, V52, P359, DOI 10.1136/jech.52.6.359; Spertini F, 2010, ALLERGY, V65, P623, DOI 10.1111/j.1398-9995.2009.02230.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Tranter DC, 2009, J OCCUP ENVIRON HYG, V6, P582, DOI 10.1080/15459620903103454; Tsai CH, 2011, OCCUPATIONAL ENV MED; Tsai CH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-11; Vojta PJ, 2001, ENVIRON HEALTH PERSP, V109, P815, DOI 10.2307/3454824; Wang IJ, 2011, EUR RESPIR J, V37, P1371, DOI 10.1183/09031936.00137210; Weiss K B, 1994, Pediatr Allergy Immunol, V5, P7, DOI 10.1111/j.1399-3038.1994.tb00341.x; Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	47	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51970	10.1371/journal.pone.0051970	http://dx.doi.org/10.1371/journal.pone.0051970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382814	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800008
J	Breitenstein, A; Wyss, CA; Spescha, RD; Franzeck, FC; Hof, D; Riwanto, M; Hasun, M; Akhmedov, A; von Eckardstein, A; Maier, W; Landmesser, U; Luscher, TF; Camici, GG				Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; von Eckardstein, Arnold; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.			Peripheral Blood Monocyte Sirt1 Expression Is Reduced in Patients with Coronary Artery Disease	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; MYOCARDIAL-INFARCTION; THROMBUS FORMATION; ATHEROSCLEROSIS; HDL; OVEREXPRESSION; BIOLOGY; SERUM; RISK; MICE	Background: Inflammation plays a key role in atherosclerosis. Sirt1 regulates transcription factors involved in inflammatory processes and blunts atherosclerosis in mice. However, its role in humans remains to be defined. This study was therefore designed to investigate the role of Sirt1 in the development of atherosclerosis. Methods and Results: 48 male subjects admitted for cardiac catheterization were subdivided into healthy subjects, patients with stable coronary artery disease (CAD), and with acute coronary syndromes (ACS). Monocytes were isolated and Sirt1 mRNA levels were determined. Sirt1 gene expression was higher in healthy subjects as compared to patients with CAD or ACS (P<0.05), respectively. Interestingly, HDL levels correlated positively with Sirt1 expression. Thus, HDL from the three groups was isolated and incubated with THP-1 monocytes to determine the effects of HDL on Sirt1 protein in controlled experimental conditions. HDL from healthy subjects stimulated Sirt1 expression in THP-1 monocytes to a higher degree than HDL from CAD and ACS patients (P<0.05). Paraoxonase-1 (PON-1), a HDL-associated enzyme, showed a reduced activity in HDL isolated from CAD and ACS patients as compared to the controls (P<0.001). Conclusions: Monocytic Sirt1 expression is reduced in patients with stable CAD and ACS. Experiments on THP-1 monocytes suggest that this effect is HDL-dependent and is mediated by a reduced activity of HDL-associated enzyme PON1.	[Breitenstein, Alexander; Wyss, Christophe A.; Hasun, Matthias; Akhmedov, Alexander; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Breitenstein, Alexander; Wyss, Christophe A.; Spescha, Remo D.; Franzeck, Fabian C.; Hof, Danielle; Riwanto, Meliana; Hasun, Matthias; Akhmedov, Alexander; von Eckardstein, Arnold; Maier, Willibald; Landmesser, Ulf; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Integrat Human Physiol ZHIP, Zurich, Switzerland; [von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Camici, GG (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland.	giovannic@access.uzh.ch	Camici, Giovanni/H-1631-2018	Camici, Giovanni/0000-0002-0523-0695	Swiss National Science Foundation; Bonizzi-Theler Foundation; Velux Foundation; Wolfermann Nageli Foundation; MERCATOR Foundation; Swiss Heart Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler Foundation; Velux Foundation(Velux Fonden); Wolfermann Nageli Foundation; MERCATOR Foundation; Swiss Heart Foundation	This study was supported by the Swiss National Science Foundation, Bonizzi-Theler Foundation, Velux Foundation, Wolfermann Nageli Foundation, MERCATOR Foundation, and the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Breitenstein A, 2008, ARTERIOSCL THROM VAS, V28, P2231, DOI 10.1161/ATVBAHA.108.171272; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027081	19	56	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53106	10.1371/journal.pone.0053106	http://dx.doi.org/10.1371/journal.pone.0053106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382833	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315483200046
J	King, M; Vasanthan, M; Petersen, I; Jones, L; Marston, L; Nazareth, I				King, Michael; Vasanthan, Mira; Petersen, Irene; Jones, Louise; Marston, Louise; Nazareth, Irwin			Mortality and Medical Care after Bereavement: A General Practice Cohort Study	PLOS ONE			English	Article							SPECIALIST PALLIATIVE CARE; MARITAL-STATUS; DISTRESS; ADULT; LIFE	Bereaved spouses or partners are thought to be at increased risk of morbidity and mortality. However, there are few large prospective studies and results are inconsistent. We estimated the relative mortality, prescription of psychotropic medication and use of primary medical care services in adults whose cohabitee died of cancer. To do this, we undertook a cohort study using The Health Improvement Network (THIN) UK primary care database. Participants were 1) people aged over 40, who were registered with general practices and had been exposed to the death of a cohabitee from cancer; and 2) a comparison cohort frequency matched on five year age bands and sex who were cohabiting with a living partner. The baseline was chosen as six months before the date of the cancer death for the exposed group and a random date for the unexposed group. Incidence rate ratios (IRR) with 95% confidence intervals (CI) were estimated using random effects Poisson regression to account for clustering within general practices and adjusting for other key variables. 92,129 patients were studied for a median follow up of 4 years. Cohabitees of patients who died of cancer were less likely to die of any cause (IRR 0.71, CI 0.68-0.74) after adjustment for age, gender, number of non-psychotropic prescriptions 6 months before the cancer death/index date, use of psychotropic medication 6 months before the cancer death/index date, smoking, alcohol and area deprivation score. Exposed patients were more likely to receive a prescription for antidepressant or hypnotic medication and to attend their GP both before and after the death of the cohabitee. In conclusion, we did not confirm increased mortality in cohabitees of people dying from cancer.	[King, Michael; Vasanthan, Mira; Jones, Louise] UCL, Sch Med, Fac Brain Sci, Unit Mental Hlth Sci, London W1N 8AA, England; [Vasanthan, Mira; Petersen, Irene; Marston, Louise; Nazareth, Irwin] UCL, Sch Med, Res Dept Primary Care & Populat Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	King, M (corresponding author), UCL, Sch Med, Fac Brain Sci, Unit Mental Hlth Sci, Mortimer St, London W1N 8AA, England.	michael.king@ucl.ac.uk	Petersen, Irene/C-5702-2009; Marston, Louise/A-8535-2012	Petersen, Irene/0000-0002-0037-7524; Marston, Louise/0000-0002-9973-1131; Nazareth, Irwin/0000-0003-2146-9628	Marie Curie Cancer Care	Marie Curie Cancer Care	Louise Jones and Mira Vasanthan were funded by Marie Curie Cancer Care. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew A, 2010, PALLIATIVE MED, V24, P46, DOI 10.1177/0269216309107013; Agnew A, 2011, BRIT J SOC WORK, V41, P111, DOI 10.1093/bjsw/bcq055; Bennett KM, 2010, OMEGA-J DEATH DYING, V61, P315, DOI 10.2190/OM.61.4.d; Blak Betina T, 2011, Inform Prim Care, V19, P251; BLYTH AC, 1990, BRIT MED J, V300, P983, DOI 10.1136/bmj.300.6730.983; Carter PA, 2006, CANCER NURS, V29, P95, DOI 10.1097/00002820-200603000-00003; Cartwright A, 1982, J R Coll Gen Pract, V32, P215; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; Department of Health, 2008, END LIF CAR STRAT PR; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Fardet L, 2012, BMJ, V345; GUNNELL DJ, 1990, BMJ-BRIT MED J, V300, P1400, DOI 10.1136/bmj.300.6736.1400-e; HELSING KJ, 1981, AM J EPIDEMIOL, V114, P41, DOI 10.1093/oxfordjournals.aje.a113172; Horsfall L, 2012, PHARMACOEPI IN PRESS; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Main J, 2000, BRIT J GEN PRACT, V50, P863; Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; National Council for Palliative Care, 2011, NAT SURV PAT ACT DAT; National Institute for Clinical Excellence, 2004, GUID CANC SERV IMPR; National Institute for Clinical Excellence, 2012, QUAL OUTC FRAM; Oksuzyan A, 2011, J AGING RES; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Smith KR, 1996, SOC BIOL, V43, P59; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; THOMPSON LW, 1991, PSYCHOL AGING, V6, P434, DOI 10.1037/0882-7974.6.3.434; Walsh K, 2007, BRIT J PSYCHIAT, V190, P142, DOI 10.1192/bjp.bp.106.023960; Woof WR, 1997, BRIT J GEN PRACT, V47, P443	33	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52561	10.1371/journal.pone.0052561	http://dx.doi.org/10.1371/journal.pone.0052561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372651	Green Published, gold			2022-12-27	WOS:000315210400004
J	Papi, A; Storci, G; Guarnieri, T; De Carolis, S; Bertoni, S; Avenia, N; Sanguinetti, A; Sidoni, A; Santini, D; Ceccarelli, C; Taffurelli, M; Orlandi, M; Bonafe, M				Papi, Alessio; Storci, Gianluca; Guarnieri, Tiziana; De Carolis, Sabrina; Bertoni, Sara; Avenia, Nicola; Sanguinetti, Alessandro; Sidoni, Angelo; Santini, Donatella; Ceccarelli, Claudio; Taffurelli, Mario; Orlandi, Marina; Bonafe, Massimiliano			Peroxisome Proliferator Activated Receptor-alpha/Hypoxia Inducible Factor-1 alpha Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells	PLOS ONE			English	Article							NF-KAPPA-B; PPAR-GAMMA; IN-VITRO; SIGNALING PATHWAYS; SELF-RENEWAL; RXR-GAMMA; TUMOR; PROTEIN; GROWTH; IDENTIFICATION	Aims: Cancer stem cell biology is tightly connected to the regulation of the pro-inflammatory cytokine network. The concept of cancer stem cells "inflammatory addiction'' leads to envisage the potential role of anti-inflammatory molecules as new anti-cancer targets. Here we report on the relationship between nuclear receptors activity and the modulation of the pro-inflammatory phenotype in breast cancer stem cells. Methods: Breast cancer stem cells were expanded as mammospheres from normal and tumor human breast tissues and from tumorigenic (MCF7) and non tumorigenic (MCF10) human breast cell lines. Mammospheres were exposed to the supernatant of breast tumor and normal mammary gland tissue fibroblasts. Results: In mammospheres exposed to the breast tumor fibroblasts supernatant, autocrine tumor necrosis factor-alpha signalling engenders the functional interplay between peroxisome proliferator activated receptor-alpha and hypoxia inducible factor-1 alpha (PPAR alpha/HIF1 alpha). The two proteins promote mammospheres formation and enhance each other expression via miRNA130b/miRNA17-5p-dependent mechanism which is antagonized by PPAR gamma. Further, the PPAR alpha/HIF1 alpha interplay regulates the expression of the pro-inflammatory cytokine interleukin-6, the hypoxia survival factor carbonic anhydrase IX and the plasma lipid carrier apolipoprotein E. Conclusion: Our data demonstrate the importance of exploring the role of nuclear receptors (PPAR alpha/PPAR gamma) in the regulation of pro-inflammatory pathways, with the aim to thwart breast cancer stem cells functioning.	[Papi, Alessio; Guarnieri, Tiziana; Ceccarelli, Claudio; Orlandi, Marina] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Storci, Gianluca; De Carolis, Sabrina; Bonafe, Massimiliano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Storci, Gianluca; Guarnieri, Tiziana; Bertoni, Sara; Bonafe, Massimiliano] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy; [Guarnieri, Tiziana] Natl Biostruct & Biosyst Inst INBB, Rome, Italy; [Avenia, Nicola; Sanguinetti, Alessandro] Univ Perugia, Dept Surg Sci Radiol & Dent, I-06100 Perugia, Italy; [Sidoni, Angelo] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Santini, Donatella] St Orsola Malpighi Univ Hosp, Dept Radiol & Histocytopathol, Bologna, Italy; [Taffurelli, Mario] Univ Bologna, Dept Clin & Surg Sci, Bologna, Italy	University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Perugia; University of Perugia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Papi, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	alessio.papi2@unibo.it; massimiliano.bonafe@unibo.it	ceccarelli, claudio/AAS-6105-2020; PAPI, ALESSIO/AAR-6808-2020; Guarnieri, Tiziana/A-9534-2016; Storci, Gianluca/AED-6195-2022; Avenia, Nicola/AAL-4546-2021; Santini, Donatella/AAO-1490-2021; SIDONI, Angelo/K-8171-2016	ceccarelli, claudio/0000-0003-0743-2087; PAPI, ALESSIO/0000-0002-2490-3090; Guarnieri, Tiziana/0000-0002-5069-5010; Storci, Gianluca/0000-0001-5145-3091; Santini, Donatella/0000-0002-1692-6348; SIDONI, Angelo/0000-0002-8458-5901; DE CAROLIS, SABRINA/0000-0001-5785-2624	Project of National Interest (PRIN) of Ministry of Education (Italy) [2008KTRN38]; Cornelia and Roberts Pallotti legacy; Fundamental Oriented Research of TG	Project of National Interest (PRIN) of Ministry of Education (Italy)(Ministry of Education, Universities and Research (MIUR)); Cornelia and Roberts Pallotti legacy; Fundamental Oriented Research of TG	This work has been supported by grant Project of National Interest (PRIN) of Ministry of Education (Italy), code project: 2008KTRN38 and title project: "Clinical, diagnostic and therapeutic implications of studies on breast cancer stem cells'', Cornelia and Roberts Pallotti legacy to MB and MT and by Fundamental Oriented Research of TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alikhani N, 2012, ONCOGENE; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Bonafe M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104; Bonofiglio D, 2009, AM J PATHOL, V175, P1270, DOI 10.2353/ajpath.2009.081078; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Chang NW, 2009, CLIN CHIM ACTA, V401, P144, DOI 10.1016/j.cca.2008.12.005; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Galzio R, 2012, J CELL BIOCHEM, V113, P3342, DOI 10.1002/jcb.24210; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Ha SA, 2009, J CELL MOL MED, V13, P3868, DOI 10.1111/j.1582-4934.2009.00652.x; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Moysich KB, 2000, MOL CARCINOGEN, V27, P2, DOI 10.1002/(SICI)1098-2744(200001)27:1<2::AID-MC2>3.0.CO;2-W; Nakayama-Ichiyama Shoko, 2011, Br J Haematol, V153, P419, DOI 10.1111/j.1365-2141.2011.08625.x; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Nwankwo JO, 2001, PROSTAG LEUKOTR ESS, V64, P241, DOI 10.1054/plef.2001.0266; Papi A, 2012, CELL DEATH DIFFER, V19, P1208, DOI 10.1038/cdd.2011.207; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Papi A, 2009, J NEUROCHEM, V109, P1779, DOI 10.1111/j.1471-4159.2009.06111.x; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pfaff N, 2011, EMBO REP, V12, P1153, DOI 10.1038/embor.2011.176; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; SOULE HD, 1990, CANCER RES, V50, P6075; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Svastova E, 2012, J BIOL CHEM, V287, P3392, DOI 10.1074/jbc.M111.286062; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Twu YC, 2011, EUR J IMMUNOL, V41, P335, DOI 10.1002/eji.201040639; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072; Zhang JZ, 2010, INT J TOXICOL, V29, P496, DOI 10.1177/1091581810376674; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	62	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54968	10.1371/journal.pone.0054968	http://dx.doi.org/10.1371/journal.pone.0054968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372804	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400047
J	Rioja, C; Van Wees, SC; Charlton, KA; Pieterse, CMJ; Lorenzo, O; Garcia-Sanchez, S				Rioja, Cristina; Van Wees, Saskia C.; Charlton, Keith A.; Pieterse, Corne M. J.; Lorenzo, Oscar; Garcia-Sanchez, Susana			Wide Screening of Phage-Displayed Libraries Identifies Immune Targets in Planta	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; TRANSCRIPTION FACTOR; INNATE IMMUNITY; ARABIDOPSIS-THALIANA; HIGH-THROUGHPUT; TRANSIENT EXPRESSION; DEFENSE RESPONSES; CELL-SURFACE; RESISTANCE; PROTEIN	Microbe-Associated Molecular Patterns and virulence effectors are recognized by plants as a first step to mount a defence response against potential pathogens. This recognition involves a large family of extracellular membrane receptors and other immune proteins located in different sub-cellular compartments. We have used phage-display technology to express and select for Arabidopsis proteins able to bind bacterial pathogens. To rapidly identify microbe-bound phage, we developed a monitoring method based on microarrays. This combined strategy allowed for a genome-wide screening of plant proteins involved in pathogen perception. Two phage libraries for high-throughput selection were constructed from cDNA of plants infected with Pseudomonas aeruginosa PA14, or from combined samples of the virulent isolate DC3000 of Pseudomonas syringae pv. tomato and its avirulent variant avrRpt2. These three pathosystems represent different degrees in the specificity of plant-microbe interactions. Libraries cover up to 2610 7 different plant transcripts that can be displayed as functional proteins on the surface of T7 bacteriophage. A number of these were selected in a bio-panning assay for binding to Pseudomonas cells. Among the selected clones we isolated the ethylene response factor ATERF-1, which was able to bind the three bacterial strains in competition assays. ATERF-1 was rapidly exported from the nucleus upon infiltration of either alive or heat-killed Pseudomonas. Moreover, aterf-1 mutants exhibited enhanced susceptibility to infection. These findings suggest that ATERF-1 contains a microbe-recognition domain with a role in plant defence. To identify other putative pathogen-binding proteins on a genome-wide scale, the copy number of selected-vs.-total clones was compared by hybridizing phage cDNAs with Arabidopsis microarrays. Microarray analysis revealed a set of 472 candidates with significant fold change. Within this set defence-related genes, including well-known targets of bacterial effectors, are over-represented. Other genes non-previously related to defence can be associated through this study with general or strain-specific recognition of Pseudomonas.	[Rioja, Cristina; Lorenzo, Oscar] Univ Salamanca, Dpto Fisiol Vegetal, Ctr Hispanoluso Invest Agr CIALE, E-37008 Salamanca, Spain; [Van Wees, Saskia C.; Pieterse, Corne M. J.] Univ Utrecht, Dept Biol Plant Microbe Interact, Utrecht, Netherlands; [Charlton, Keith A.] Scotia Biol Ltd, Aberdeen, Scotland; [Garcia-Sanchez, Susana] CIC Biogune, Funct Genom Unit, Derio, Spain; [Garcia-Sanchez, Susana] Univ Basque Country IKERBASQUE, Dept Physiol, Leioa, Spain	University of Salamanca; Utrecht University; CIC bioGUNE; Basque Foundation for Science; University of Basque Country	Garcia-Sanchez, S (corresponding author), Inst Vasco Invest & Desarrollo Agrario NEIKER Tec, Vitoria, Spain.	susana.garcias@ehu.es	Pieterse, Corné/A-9326-2011; García-Sánchez, Susana/AAM-5901-2020; Lorenzo, Oscar/K-8170-2014; Garcia-Sanchez, Susana/B-4670-2013; Van Wees, Saskia/B-8595-2011	Pieterse, Corné/0000-0002-5473-4646; Lorenzo, Oscar/0000-0001-9523-0789; Rioja, Cristina/0000-0001-9713-1944; Van Wees, Saskia/0000-0002-2295-7271	Ministerio de Ciencia e Innovacion (MICINN) [BIO2006-01299, BIO2008-04698, BIO2011-26940, CSD2007-00057]; Gobierno Vasco [PI-2006-10]; Junta de Castilla y Leon [SA048A10-2]; FPI fellowship from the MICINN	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno Vasco(Basque Government); Junta de Castilla y Leon(Junta de Castilla y Leon); FPI fellowship from the MICINN	This work was supported by grants BIO2006-01299 from the Ministerio de Ciencia e Innovacion (MICINN, http://www.micinn.es/portal/site/MICINN) and PI-2006-10 from Gobierno Vasco to SG; BIO2008-04698, BIO2011-26940, CSD2007-00057 (TRANSPLANTA) from the MICINN and SA048A10-2 from Junta de Castilla y Leon to OL. CR was supported by a FPI fellowship from the MICINN. The publication of this work was supported by IKERBASQUE, Basque Foundation for Science. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Book AJ, 2010, J BIOL CHEM, V285, P25554, DOI 10.1074/jbc.M110.136622; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gopalan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003891; Goritschnig S, 2007, PLANT J, V49, P540, DOI 10.1111/j.1365-313X.2006.02978.x; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lipes BD, 2008, J MOL BIOL, V379, P261, DOI 10.1016/j.jmb.2008.03.072; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lytle BL, 2006, ACTA CRYSTALLOGR F, V62, P490, DOI 10.1107/S1744309106015946; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; O'Brien PM, 1999, P NATL ACAD SCI USA, V96, P640, DOI 10.1073/pnas.96.2.640; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pieterse CMJ, 1996, PLANT CELL, V8, P1225, DOI 10.1105/tpc.8.8.1225; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Willats WGT, 2002, PLANT MOL BIOL, V50, P837, DOI 10.1023/A:1021215516430; Wu SJ, 2011, MOL PLANT MICROBE IN, V24, P585, DOI 10.1094/MPMI-07-10-0150; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101	76	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54654	10.1371/journal.pone.0054654	http://dx.doi.org/10.1371/journal.pone.0054654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372747	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400022
J	Cao, SR; Li, S; Li, HY; Xiong, LP; Zhou, Y; Fan, JJ; Yu, XQ; Mao, HP				Cao, Shirong; Li, Shu; Li, Huiyang; Xiong, Liping; Zhou, Yi; Fan, Jinjin; Yu, Xueqing; Mao, Haiping			The Potential Role of HMGB1 Release in Peritoneal Dialysis-Related Peritonitis	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; MESOTHELIAL CELL; PROTEIN HMGB1; LATE MEDIATOR; INFLAMMATION; PATHWAY; DISEASE; SEPSIS; MECHANISM; INFECTION	High mobility group box 1 (HMGB1), a DNA-binding nuclear protein, has been implicated as an endogenous danger signal in the pathogenesis of infection diseases. However, the potential role and source of HMGB1 in the peritoneal dialysis (PD) effluence of patients with peritonitis are unknown. First, to evaluate HMDB1 levels in peritoneal dialysis effluence (PDE), a total of 61 PD patients were enrolled in this study, including 42 patients with peritonitis and 19 without peritonitis. Demographic characteristics, symptoms, physical examination findings and laboratory parameters were recorded. HMGB1 levels in PDE were determined by Western blot and ELISA. The concentrations of TNF-alpha and IL-6 in PDE were quantified by ELISA. By animal model, inhibition of HMGB1 with glycyrrhizin was performed to determine the effects of HMGB1 in LPS-induced mice peritonitis. In vitro, a human peritoneal mesothelial cell line (HMrSV5) was stimulated with lipopolysaccharide (LPS), HMGB1 extracellular content in the culture media and intracellular distribution in various cellular fractions were analyzed by Western blot or immunofluorescence. The results showed that the levels of HMGB1 in PDE were higher in patients with peritonitis than those in controls, and gradually declined during the period of effective antibiotic treatments. Furthermore, the levels of HMGB1 in PDE were positively correlated with white blood cells (WBCs) count, TNF-a and IL-6 levels. However, pretreatment with glycyrrhizin attenuated LPS-induced acute peritoneal inflammation and dysfunction in mice. In cultured HMrSV5 cells, LPS actively induced HMGB1 nuclear-cytoplasmic translocation and release in a time and dose-dependent fashion. Moreover, cytosolic HMGB1 was located in lysosomes and secreted via a lysosome-mediated secretory pathway following LPS stimulation. Our study demonstrates that elevated HMGB1 levels in PDE during PD-related peritonitis, at least partially, from peritoneal mesothelial cells, which may be involved in the process of PD-related peritonitis and play a critical role in acute peritoneal dysfunction.	[Cao, Shirong; Li, Shu; Li, Huiyang; Xiong, Liping; Zhou, Yi; Fan, Jinjin; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Li, Shu] Cent S Univ, Xiangya Hosp 2, Dept Rheumatol, Changsha, Hunan, Peoples R China	Sun Yat Sen University; Central South University	Mao, HP (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	haipingmao@126.com	cao, shirong/AAX-5688-2021	Cao, Shirong/0000-0002-6593-4600; Mao, Haiping/0000-0002-3608-3851	National Natural Science Foundation of China [81070553, 81270783]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81070553, 81270783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145; Bruchfeld A, 2008, MOL MED, V14, P109, DOI 10.2119/2007-00107.Bruchfeld; Dehbi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044100; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein; Li PK, 2011, PERITON DIALYSIS INT, V30, P393; Li S, 2011, AM J PATHOL, V179, P2822, DOI 10.1016/j.ajpath.2011.08.013; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maugeri N, 2012, AUTOIMMUNITY, V45, P584, DOI 10.3109/08916934.2012.719946; Nessim SJ, 2011, SEMIN NEPHROL, V31, P199, DOI 10.1016/j.semnephrol.2011.01.008; Ni J, 2010, NEPHROL DIAL TRANSPL, V25, P86, DOI 10.1093/ndt/gfp415; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; TOPLEY N, 1995, PERITON DIALYSIS INT, V15, P116; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang HC, 1999, SURGERY, V126, P389, DOI 10.1016/S0039-6060(99)70182-0; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yung S, 1998, KIDNEY INT, V54, P2160, DOI 10.1046/j.1523-1755.1998.00177.x; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	31	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54647	10.1371/journal.pone.0054647	http://dx.doi.org/10.1371/journal.pone.0054647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359306	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600086
J	Chang, SW; Pan, WS; Beltran, DL; Baldelomar, LO; Solano, MA; Tuero, I; Friedland, JS; Torrico, F; Gilman, RH				Chang, Suzanne W.; Pan, William S.; Lozano Beltran, Daniel; Oleyda Baldelomar, Lizet; Antonio Solano, Marco; Tuero, Iskra; Friedland, Jon S.; Torrico, Faustino; Gilman, Robert H.			Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TB	PLOS ONE			English	Article							PLASMA GHRELIN LEVEL; PEPTIDE YY LEVELS; ANOREXIA-NERVOSA; CANCER CACHEXIA; GASTRIC-CANCER; FOOD-INTAKE; TUBERCULOSIS; LEPTIN; RESISTIN; MALNUTRITION	Background: Cachexia is a hallmark of pulmonary tuberculosis and is associated with poor prognosis. A better understanding of the mechanisms behind such weight loss could reveal targets for therapeutic intervention. The role of appetite-regulatory hormones in tuberculosis is unknown. Methods and Findings: 41 subjects with newly-diagnosed pulmonary TB (cases) were compared to 82 healthy controls. We measured appetite, body mass index (BMI), % body fat (BF), plasma peptide YY (PYY), leptin, ghrelin, and resistin for all subjects. Measurements were taken at baseline for controls and at treatment days 0, 30, and 60 for cases. Baseline appetite, BMI, and BF were lower in cases than in controls and improved during treatment. PYY, ghrelin, and resistin were significantly elevated in cases and fell during treatment. Leptin was lower in cases and rose with treatment. Appetite was inversely related to PYY in cases. High pre-treatment PYY predicted reduced gains in appetite and BF. PYY was the strongest independent predictor of appetite in cases across all time points. Conclusions: Appetite-regulatory hormones are altered in TB patients. As hormones normalize during treatment, appetite is restored and nutritional status improves. High baseline PYY is an indicator of poor prognosis for improvement in appetite and nutrition during treatment. Wasting in TB patients may partly be mediated by upregulation of PYY with resulting appetite suppression.	[Chang, Suzanne W.] George Washington Univ, Dept Med, Washington, DC 20052 USA; [Pan, William S.; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Lozano Beltran, Daniel; Oleyda Baldelomar, Lizet; Antonio Solano, Marco; Torrico, Faustino] CEADES Colect Estudios Aplicados & Desarollo Soci, Cochabamba, Bolivia; [Tuero, Iskra; Gilman, Robert H.] Univ Peruano Cayetano Heredia, Lima, Peru; [Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London, England	George Washington University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Imperial College London; Imperial College London	Chang, SW (corresponding author), George Washington Univ, Dept Med, Washington, DC 20052 USA.	suzannewchang@gmail.com; gilmanbob@gmail.com		Tuero, Iskra/0000-0002-5788-1051; Friedland, Jonathan S/0000-0001-7789-9649; SOLANO, MARCO/0000-0003-1057-8298	RLK NSRA; National Institutes of Health (NIH); Fogarty scholars program; NIHR Biomedical Research Centre; National Institute of Allergy and Infectious Diseases (NIAID), NIH;  [T 35 (AI065385)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI065385] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	RLK NSRA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty scholars program; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the T 35 (AI065385) and the RLK NSRA for partially funding SC, and the National Institutes of Health (NIH), Fogarty scholars program for funding DL and anonymous RG/ER fund for funding a portion of this work. JSF is grateful for support from the NIHR Biomedical Research Centre funding scheme. We also thank for their technical support JB Phu and D Sara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. *RG-ER fund is an anonymous donor who is a person and not a fund. There is no expansion of the name possible. There is no conflict of interest with this fund. It is not an organization or a company. *The T35 refers to Training Grant 35. It is funded by the National Institute of Allergy and Infectious Diseases (NIAID), NIH. *The RLK-NSRA-NIH award to Suzanne Chang is the Ruth L. Kirschstein National Service Research Award, NIH. *No additional external funding received for this study.	ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; [Anonymous], 2007, QUANTUM II AND QUANT; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Beck AL, 2008, J PEDIATR-US, V153, P677, DOI 10.1016/j.jpeds.2008.04.065; Buyukoglan H, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64859; Cakir B, 1999, HORM RES, V52, P279, DOI 10.1159/000023495; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506; Cifani C, 2009, ACTA PHYSIOL, V196, P395, DOI 10.1111/j.1748-1716.2008.01949.x; Eddleston M, 2008, OXFORD HANDBOOK OF T; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Faggioni R, 1998, AM J PHYSIOL-REG I, V274, pR204, DOI 10.1152/ajpregu.1998.274.1.R204; Fauci AS, 2009, HARRISONS PRINCIPLES; Instituto Nacional de Estadistica de Bolivia, 2001, CENSO DE POBLACION Y; Itoh T, 2004, AM J RESP CRIT CARE, V170, P879, DOI 10.1164/rccm.200310-1404OC; Kamiji MM, 2008, CURR OPIN CLIN NUTR, V11, P443, DOI 10.1097/MCO.0b013e328303dee4; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Misra M, 2006, J CLIN ENDOCR METAB, V91, P1027, DOI 10.1210/jc.2005-1878; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moschovi M, 2008, J PEDIAT HEMATOL ONC, V30, P733, DOI 10.1097/MPH.0b013e318179a1d8; Nakahara T, 2007, J PSYCHIATR RES, V41, P814, DOI 10.1016/j.jpsychires.2006.07.021; Nakajima TE, 2010, CANCER SCI, V101, P1286, DOI 10.1111/j.1349-7006.2010.01518.x; Nakajima TE, 2010, J CANCER RES CLIN, V136, P261, DOI 10.1007/s00432-009-0657-6; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Neelemaat F, 2008, CLIN NUTR, V27, P439, DOI 10.1016/j.clnu.2008.02.002; Renshaw D, 2005, CURR DRUG TARGETS, V6, P171, DOI 10.2174/1389450053174523; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Santo AH, 2003, REV SAUDE PUBL, V37, P714, DOI 10.1590/S0034-89102003000600005; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Shimizu Y, 2003, CLIN CANCER RES, V9, P774; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Ukkola O, 2004, J ENDOCRINOL INVEST, V27, P96, DOI 10.1007/BF03350918; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Vincent RP, 2008, J CLIN PATHOL, V61, P548, DOI 10.1136/jcp.2007.048488; Wahab PJ, 2001, DIGEST DIS SCI, V46, P2504, DOI 10.1023/A:1012344424300; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, 2010 GLOBAL REPORT O; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; World Health Organization, 2007, USE OF LIQUID TB CUL; World Health Organization, 2010, GLOBAL TUBERCULOSIS; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	44	161	163	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54564	10.1371/journal.pone.0054564	http://dx.doi.org/10.1371/journal.pone.0054564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358528	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600070
J	Savitz, J; Hodgkinson, CA; Martin-Soelch, C; Shen, PH; Szczepanik, J; Nugent, A; Herscovitch, P; Grace, AA; Goldman, D; Drevets, WC				Savitz, Jonathan; Hodgkinson, Colin A.; Martin-Soelch, Chantal; Shen, Pei-Hong; Szczepanik, Joanna; Nugent, Allison; Herscovitch, Peter; Grace, Anthony A.; Goldman, David; Drevets, Wayne C.			The Functional DRD3 Ser9Gly Polymorphism (rs6280) Is Pleiotropic, Affecting Reward as Well as Movement	PLOS ONE			English	Article							D3 RECEPTOR GENE; STRIATAL DOPAMINE RELEASE; PREDICTS AMYGDALA REACTIVITY; HUMAN VENTRAL STRIATUM; D-3 RECEPTORS; IN-VIVO; NUCLEUS-ACCUMBENS; RAT-BRAIN; INDUCED REINSTATEMENT; PERSONALITY-TRAITS	Abnormalities of motivation and behavior in the context of reward are a fundamental component of addiction and mood disorders. Here we test the effect of a functional missense mutation in the dopamine 3 receptor (DRD3) gene (ser9gly, rs6280) on reward-associated dopamine (DA) release in the striatum. Twenty-six healthy controls (HCs) and 10 unmedicated subjects with major depressive disorder (MDD) completed two positron emission tomography (PET) scans with [C-11] raclopride using the bolus plus constant infusion method. On one occasion subjects completed a sensorimotor task (control condition) and on another occasion subjects completed a gambling task (reward condition). A linear regression analysis controlling for age, sex, diagnosis, and self-reported anhedonia indicated that during receipt of unpredictable monetary reward the glycine allele was associated with a greater reduction in D2/3 receptor binding (i.e., increased reward-related DA release) in the middle (anterior) caudate (p, 0.01) and the ventral striatum (p, 0.05). The possible functional effect of the ser9gly polymorphism on DA release is consistent with previous work demonstrating that the glycine allele yields D3 autoreceptors that have a higher affinity for DA and display more robust intracellular signaling. Preclinical evidence indicates that chronic stress and aversive stimulation induce activation of the DA system, raising the possibility that the glycine allele, by virtue of its facilitatory effect on striatal DA release, increases susceptibility to hyperdopaminergic responses that have previously been associated with stress, addiction, and psychosis.	[Savitz, Jonathan; Drevets, Wayne C.] Univ Oklahoma, Coll Med, Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan; Drevets, Wayne C.] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Savitz, Jonathan] Tulsa Sch Community Med, Dept Med, Tulsa, OK USA; [Savitz, Jonathan; Szczepanik, Joanna; Drevets, Wayne C.] NIMH, Sect Neuroimaging Mood & Anxiety Disorders, Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; [Hodgkinson, Colin A.; Shen, Pei-Hong; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Martin-Soelch, Chantal] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, CH-8091 Zurich, Switzerland; [Nugent, Allison] NIMH, Expt Therapeut Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; [Herscovitch, Peter] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Psychiat & Psychol, Pittsburgh, PA USA	Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Zurich; University Zurich Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Savitz, J (corresponding author), Univ Oklahoma, Coll Med, Laureate Inst Brain Res, Tulsa, OK USA.	jonathansavitz@hotmail.com	Savitz, Jonathan/C-3088-2009; Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020; Martin-Soelch, Chantal/F-2486-2017	Savitz, Jonathan/0000-0001-8143-182X; Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Martin-Soelch, Chantal/0000-0003-3859-9023; Nugent, Allison/0000-0003-2569-2480; Grace, Anthony/0000-0003-1864-5504; Shen, Pei-Hong/0000-0002-8031-9374; Hodgkinson, Colin/0000-0002-5365-8119	intramural program at the National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA); William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	intramural program at the National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); William K. Warren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by the intramural program at the National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Drs. Savitz and Drevets also received support from The William K. Warren Foundation. The Foundation played no role in the writing of the manuscript or in the decision to publish. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, ADDICT BEHAV, V38, P1501, DOI 10.1016/j.addbeh.2012.03.021; Aiken CB, 2007, J CLIN PSYCHIAT, V68, P1230, DOI 10.4088/JCP.v68n0810; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogdan R, 2013, NEUROBIOL DIS, V52, P12, DOI 10.1016/j.nbd.2012.05.007; Bombin I, 2008, AM J MED GENET B, V147B, P873, DOI 10.1002/ajmg.b.30710; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Carson RE, 1997, J CEREBR BLOOD F MET, V17, P437, DOI 10.1097/00004647-199704000-00009; Chernoloz O, 2009, NEUROPSYCHOPHARMACOL, V34, P651, DOI 10.1038/npp.2008.114; Costas J, 2009, HUM GENET, V124, P607, DOI 10.1007/s00439-008-0584-7; Dannlowski U, 2011, INT J NEUROPSYCHOPH, V16, P1; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Diaz J, 2000, J NEUROSCI, V20, P8677; Dikeos DG, 1999, PSYCHIATR GENET, V9, P189, DOI 10.1097/00041444-199912000-00005; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Fisher PM, 2006, NAT NEUROSCI, V9, P1362, DOI 10.1038/nn1780; Goeders NE, 1996, BRAIN RES, V722, P145, DOI 10.1016/0006-8993(96)00206-5; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; HEIMER L, 1991, ADV EXP MED BIOL, V295, P1; Henderson AS, 2000, AM J MED GENET, V96, P102, DOI 10.1002/(SICI)1096-8628(20000207)96:1<102::AID-AJMG20>3.0.CO;2-3; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Hwang R, 2010, PHARMACOGENOMICS J, V10, P200, DOI 10.1038/tpj.2009.65; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Jonsson EG, 2003, AM J MED GENET B, V117B, P61, DOI 10.1002/ajmg.b.10009; Jonsson EG, 2003, PSYCHIAT GENET, V13, P1, DOI 10.1097/01.ypg.0000051094.88669.4b; Joutsa J, 2012, NEUROIMAGE, V60, P1992, DOI 10.1016/j.neuroimage.2012.02.006; Khaled MATM, 2010, INT J NEUROPSYCHOPH, V13, P181, DOI 10.1017/S1461145709991064; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Koenig HN, 2004, PSYCHONEUROENDOCRINO, V29, P999, DOI 10.1016/j.psyneuen.2003.09.004; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Lammers CH, 2000, MOL PSYCHIATR, V5, P378, DOI 10.1038/sj.mp.4000754; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; LASSEN NA, 1992, J CEREBR BLOOD F MET, V12, P709, DOI 10.1038/jcbfm.1992.101; Lerer B, 2002, NEUROPSYCHOPHARMACOL, V27, P105, DOI 10.1016/S0893-133X(02)00293-2; Liu X, 2011, MOL PSYCHIATR, V16, P584, DOI 10.1038/mp.2011.1; Liu YZ, 2009, EUR J CLIN PHARMACOL, V65, P679, DOI 10.1007/s00228-009-0658-z; Maina FK, 2010, ACS CHEM NEUROSCI, V1, P450, DOI 10.1021/cn100003u; Maj J, 1998, EUR J PHARMACOL, V351, P31, DOI 10.1016/S0014-2999(98)00297-0; MALMBERG A, 1994, MOL PHARMACOL, V46, P299; Martin-Soelch C, 2011, EUR J NEUROSCI, V33, P1706, DOI 10.1111/j.1460-9568.2011.07642.x; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Novak G, 2010, ANN HUM GENET, V74, P291, DOI 10.1111/j.1469-1809.2010.00578.x; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; Pappata S, 2002, NEUROIMAGE, V16, P1015, DOI 10.1006/nimg.2002.1121; Pecina M, 2012, CORTEX, DOI [10.1016/j.cortex.2012.01.010, DOI 10.1016/J.COR-TEX.2012.01.010]; Perlis RH, 2010, J CLIN PSYCHIAT, V71, P599, DOI 10.4088/JCP.08m04632gre; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Proitsi P, 2012, NEUROBIOL AGING, V33, P791, DOI 10.1016/j.neurobiolaging.2010.06.011; Rabiner EA, 2009, SYNAPSE, V63, P782, DOI 10.1002/syn.20658; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Ridray S, 1998, EUR J NEUROSCI, V10, P1676, DOI 10.1046/j.1460-9568.1998.00173.x; ROWLANDS GJ, 1980, EUR J PHARMACOL, V62, P241, DOI 10.1016/0014-2999(80)90285-X; Sambataro F, 2011, SCHIZOPHR B, V39, P206; Schosser A, 2011, AM J MED GENET B, V156B, P640, DOI 10.1002/ajmg.b.31204; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Segal DM, 1997, MOL BRAIN RES, V45, P335, DOI 10.1016/S0169-328X(97)00025-9; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Taylor S, 2013, MOL PSYCHIATR, V18, P799, DOI 10.1038/mp.2012.76; Toma C, 2013, WORLD J BIOL PSYCHIA, V14, P516, DOI 10.3109/15622975.2011.602719; Tsuchimine S, 2012, J CLIN PSYCHOPHARM, V32, P724, DOI 10.1097/JCP.0b013e318267b6da; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; Vandenbergh DJ, 2007, ADDICT BIOL, V12, P106, DOI 10.1111/j.1369-1600.2007.00054.x; Vengeliene V, 2006, FASEB J, V20, P2223, DOI 10.1096/fj.06-6110com; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Xi ZX, 2004, PSYCHOPHARMACOLOGY, V176, P57, DOI 10.1007/s00213-004-1858-y; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013; Zhang FQ, 2011, AM J MED GENET B, V156B, P613, DOI 10.1002/ajmg.b.31203	79	39	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54108	10.1371/journal.pone.0054108	http://dx.doi.org/10.1371/journal.pone.0054108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365649	Green Published, Green Accepted, gold			2022-12-27	WOS:000314023600031
J	Shi, HY; Zhang, YH; Zhang, GH; Guo, JL; Zhang, X; Song, HY; Lv, JX; Gao, JM; Wang, YP; Chen, LT; Wang, Y				Shi, Haiyan; Zhang, Yonghui; Zhang, Guohui; Guo, Jinlei; Zhang, Xun; Song, Haiyan; Lv, Jianxin; Gao, Jimin; Wang, Yuepeng; Chen, Litian; Wang, Yue			Systematic Functional Comparative Analysis of Four Single-Stranded DNA-Binding Proteins and Their Affection on Viral RNA Metabolism	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ESCHERICHIA-COLI; THERMUS-AQUATICUS; SSB; POLYMERASE; REPLICATION; CULTURE; GENOME; PCR	The accumulation of single-stranded DNA-binding (SSB) proteins is essential for organisms and has various applications. However, no study has simultaneously and systematically compared the characteristics of SSB proteins. In addition, SSB proteins may bind RNA and play an unknown biological role in RNA metabolism. Here, we expressed a novel species of SSB protein derived from Thermococcus kodakarensis KOD1 (KOD), as well as SSB proteins from Thermus thermophilus (TTH), Escherichia coli, and Sulfolobus Solfataricus P2 (SSOB), abbreviated kod, tth, bl21, and ssob, respectively. These SSB proteins could bind ssDNA and viral RNA. bl21 resisted heat treatment for more than 9 h, Ssob and kod could withstand 95 degrees C for 10 h and retain its ssDNA- and RNA-binding ability. Four SSB proteins promoted the specificity of the DNA polymerase in PCR-based 5- and 9-kb genome fragment amplification. kod also increased the amplification of a 13-kb PCR product, and SSB protein-bound RNA resisted Benzonase digestion. The SSB proteins could also enter the host cell bound to RNA, which resulted in modulation of viral RNA metabolism, particularly ssob and bl21.	[Shi, Haiyan; Zhang, Yonghui; Zhang, Guohui; Guo, Jinlei; Zhang, Xun; Wang, Yue] China Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Shi, Haiyan; Lv, Jianxin; Gao, Jimin] Wenzhou Med Coll, Zhejiang Prov Key Lab Technol & Applicat, Model Organisms Key Lab Lab Med, Minist Educ, Wenzhou, Peoples R China; [Chen, Litian] Shanghai Jiao Tong Univ, Sch Med, Dept Liver Transplantat Surg, Xinhua Hosp, Shanghai 200030, Peoples R China; [Song, Haiyan] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin, Peoples R China; [Wang, Yuepeng] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University; Shanghai Jiao Tong University; Harbin Medical University; Shanghai Jiao Tong University	Gao, JM (corresponding author), Wenzhou Med Coll, Zhejiang Prov Key Lab Technol & Applicat, Model Organisms Key Lab Lab Med, Minist Educ, Wenzhou, Peoples R China.	jimingao64@163.com; litianchen669@126.com; euy-tokyo@umin.ac.jp		zhang, yonghui/0000-0001-7542-5183	Natural Science Foundation of Zhejiang Province [Y2101159]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2101159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockman JM, 1999, J AM CHEM SOC, V121, P8044, DOI 10.1021/ja991608e; Brown TA, 1999, GENOMES; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; KOWALCZYKOWSKI SC, 1981, ENZYMES, P373; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kur J, 2005, ACTA BIOCHIM POL, V52, P569; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MILAVETZ B, 1989, NUCLEIC ACIDS RES, V17, P3322, DOI 10.1093/nar/17.8.3322; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Olszewski M, 2005, MOL CELL PROBE, V19, P203, DOI 10.1016/j.mcp.2004.11.006; Perales C, 2003, NUCLEIC ACIDS RES, V31, P6473, DOI 10.1093/nar/gkg865; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2004, NUCLEIC ACIDS RES, V32, P1065, DOI 10.1093/nar/gkh259; Shamoo Y., 2002, ENCY LIFE SCI, P1; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, P NATL ACAD SCI US, V102, P9294	26	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55076	10.1371/journal.pone.0055076	http://dx.doi.org/10.1371/journal.pone.0055076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365690	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600149
J	Zhang, H; Eisenried, A; Zimmermann, W; Shively, JE				Zhang, Hui; Eisenried, Andreas; Zimmermann, Wolfgang; Shively, John E.			Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; CYTOPLASMIC DOMAIN; CARCINOMA-CELLS; LUMEN FORMATION; 3D CULTURE; CANCER; EXPRESSION; IDENTIFICATION; BINDING; BREAST	CEACAM20, a novel member of the CEACAM1 gene family with expression limited to the lumen of small intestine, testes, and prostate, is co-expressed with CEACAM1 in adult prostate tissue and down-regulated to the same extent as CEACAM1 in prostate cancer. Since prostate cancer often involves loss of epithelial lumen formation, we hypothesized that CEACAM20 and CEACAM1 play important roles in lumen formation of normal prostate epithelium. When prostate cells were grown on Matrigel as a source of extracellular matrix (ECM), they differentiated into acinar structures with single tubules and well-defined lumina closely resembling embryonic prostate organoids. Confocal microscopic analysis revealed restriction of CEACAM20 to acini and CEACAM1 to tubule structures, respectively. Inhibition of CEACAM1 with antibodies or soluble CEACAM1 or antisense oligonucleotides inhibited tubule formation by over 50% while the remaining tubules were stunted. Inhibition of CEACAM20 with antisense oligonucleotides completely inhibited tubule formation and stunted the growth of acini. We conclude that CEACAM20 and CEACAM1 not only mark the lumina of adult prostate tissue but also play a critical role in the vitro generation of prostate organoids.	[Zhang, Hui] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Zhang, Hui; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Eisenried, Andreas] Univ Klinikum Erlangen, Anasthesiol Klin, Erlangen, Germany; [Zimmermann, Wolfgang] LIFE Zentrum, Lab Tumorimmunol, Munich, Germany	City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Erlangen Nuremberg; University of Munich	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA.	JShively@coh.org			National Institutes of Health grant [CA 84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health grant CA 84202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Comegys MM, 1999, ONCOGENE, V18, P3261, DOI 10.1038/sj.onc.1202666; Dellinger DJ, 2004, CURR PROTOC NUCL ACI, V4; Garraway LA, 2003, PROSTATE, V55, P206, DOI 10.1002/pros.10244; Gencheva M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-79; Ghosh S, 2011, DEV BIOL, V360, P329, DOI 10.1016/j.ydbio.2011.09.027; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hawley P, 1992, Antisense Res Dev, V2, P119; Huang J, 1999, J CELL SCI, V112, P4193; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lauke H, 2004, MOL HUM REPROD, V10, P247, DOI 10.1093/molehr/gah020; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Pearson JF, 2009, CELL DEATH DIFFER, V16, P475, DOI 10.1038/cdd.2008.181; Prakash TP, 2007, CURR TOP MED CHEM, V7, P641, DOI 10.2174/156802607780487713; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Schumann D, 2004, BIOCHEM BIOPH RES CO, V318, P227, DOI 10.1016/j.bbrc.2004.04.024; Soifer HS, 2012, METHODS MOL BIOL, V815, P333, DOI 10.1007/978-1-61779-424-7_25; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tilki D, 2006, ONCOGENE, V25, P4965, DOI 10.1038/sj.onc.1209514; Tilki D, 2010, EUR UROL, V57, P648, DOI 10.1016/j.eururo.2009.05.040; Timms BG, 2008, DIFFERENTIATION, V76, P565, DOI 10.1111/j.1432-0436.2008.00278.x; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; You YH, 1998, ANTICANCER RES, V18, P3193; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985	41	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53359	10.1371/journal.pone.0053359	http://dx.doi.org/10.1371/journal.pone.0053359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358633	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600014
J	Caller, G; Brown, C				Caller, Georgina; Brown, Culum			Evolutionary Responses to Invasion: Cane Toad Sympatric Fish Show Enhanced Avoidance Learning	PLOS ONE			English	Article							BUFO-MARINUS ANURA; NATIVE FAUNA; PREDATOR; BUFONIDAE; TADPOLES; AUSTRALIA; LARVAE; POPULATIONS; RAINBOWFISH; COMPETITION	The introduced cane toad (Bufo marinus) poses a major threat to biodiversity due to its lifelong toxicity. Several terrestrial native Australian vertebrates are adapting to the cane toad's presence and lab trials have demonstrated that repeated exposure to B. marinus can result in learnt avoidance behaviour. Here we investigated whether aversion learning is occurring in aquatic ecosystems by comparing cane toad naive and sympatric populations of crimson spotted rainbow fish (Melanotaenia duboulayi). The first experiment indicated that fish from the sympatric population had pre-existing aversion to attacking cane toad tadpoles but also showed reduced attacks on native tadpoles. The second experiment revealed that fish from both naive and sympatric populations learned to avoid cane toad tadpoles following repeated, direct exposure. Allopatric fish also developed a general aversion to tadpoles. The aversion learning abilities of both groups was examined using an experiment involving novel distasteful prey items. While both populations developed a general avoidance of edible pellets in the presence of distasteful pellets, only the sympatric population significantly reduced the number of attacks on the novel distasteful prey item. These results indicate that experience with toxic prey items over multiple generations can enhance avoidance leaning capabilities via natural selection.	[Caller, Georgina; Brown, Culum] Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Brown, C (corresponding author), Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia.	Culum.Brown@mq.edu.au	Brown, Culum/S-9826-2017	Brown, Culum/0000-0002-0210-1820	Macquarei University	Macquarei University	This work was funded by Macquarei University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradshaw CJA, 2007, WILDLIFE RES, V34, P419, DOI 10.1071/WR06056; Brown C, 2003, ECOL FRESHW FISH, V12, P118, DOI 10.1034/j.1600-0633.2003.00007.x; Brown C, 1999, ENVIRON BIOL FISH, V56, P455, DOI 10.1023/A:1007518710790; Brown C, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P46; Brown Culum, 2001, Animal Cognition, V4, P109, DOI 10.1007/s100710100105; Campbell N., 2006, BIOLOGY-BASEL, V7th; Carroll SP, 2007, ECOL RES, V22, P892, DOI 10.1007/s11284-007-0352-5; CASE TJ, 1991, EVOL ECOL, V5, P272, DOI 10.1007/BF02214232; Catling PC, 1999, WILDLIFE RES, V26, P161, DOI 10.1071/WR98025; COVACEVICH J, 1975, Memoirs of the Queensland Museum, V17, P305; Crossland MR, 2008, BIOL CONSERV, V141, P2387, DOI 10.1016/j.biocon.2008.07.005; Crossland MR, 2000, ECOGRAPHY, V23, P283, DOI 10.1034/j.1600-0587.2000.d01-1636.x; Crossland MR, 1998, AUST J ECOL, V23, P129, DOI 10.1111/j.1442-9993.1998.tb00711.x; Crossland MR, 1999, HERPETOLOGICA, V55, P192; Crossland MR, 2001, J FISH BIOL, V59, P319, DOI 10.1111/j.1095-8649.2001.tb00132.x; CROWDER LB, 1986, ENVIRON BIOL FISH, V16, P147, DOI 10.1007/BF00005167; Day T, 1996, OECOLOGIA, V108, P380, DOI 10.1007/BF00334665; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Doody JS, 2006, WILDLIFE RES, V33, P349, DOI 10.1071/WR05042; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; EASTEAL S, 1985, J HERPETOL, V19, P185, DOI 10.2307/1564171; Greenlees MJ, 2011, AUSTRAL ECOL, V36, P53, DOI 10.1111/j.1442-9993.2010.02116.x; Greenlees MJ, 2010, BEHAV ECOL, V21, P966, DOI 10.1093/beheco/arq095; Groves R.H., 1991, BIOGEOGRAPHY MEDITER; Hayes RA, 2009, J CHEM ECOL, V35, P391, DOI 10.1007/s10886-009-9608-6; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Kasumyan AO, 2003, FISH FISH, V4, P289, DOI 10.1046/j.1467-2979.2003.00121.x; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Kiesecker JM, 1997, ECOLOGY, V78, P1752; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; Mitchell David, 1995, Memoirs of the Queensland Museum, V38, P512; Nelson DWM, 2011, AUSTRAL ECOL, V36, P605, DOI 10.1111/j.1442-9993.2010.02187.x; Nelson DWM, 2010, BIOL INVASIONS, V12, P3363, DOI 10.1007/s10530-010-9729-4; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PRIMACK R.B., 1998, ESSENTIALS CONSERVAT; ROBINSON M, 1998, FIELD GUIDE FROGS AU; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; SABATH MD, 1981, COPEIA, P676, DOI 10.2307/1444573; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Tyler MJ, 1989, TOXIC PLANTS ANIMALS; WADEC, 2009, CAN TOADS ARR W AUST; WASSERSUG R, 1971, AM MIDL NAT, V86, P101, DOI 10.2307/2423690; Webb JK, 2008, AUSTRAL ECOL, V33, P821, DOI 10.1111/j.1442-9993.2008.01847.x; Williamson I, 1999, AUST J ECOL, V24, P636, DOI 10.1046/j.1442-9993.1999.00993.x	48	18	18	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54909	10.1371/journal.pone.0054909	http://dx.doi.org/10.1371/journal.pone.0054909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372788	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500141
J	Compagnucci, C; Di Siena, S; Bustamante, MB; Di Giacomo, D; Di Tommaso, M; Maccarrone, M; Grimaldi, P; Sette, C				Compagnucci, Claudia; Di Siena, Sara; Bustamante, Maria Blaire; Di Giacomo, Daniele; Di Tommaso, Monia; Maccarrone, Mauro; Grimaldi, Paola; Sette, Claudio			Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ADULT NEUROGENESIS; PROGENITOR PROLIFERATION; SUBVENTRICULAR ZONE; GENE-EXPRESSION; BRAIN; FATE; IDENTIFICATION; MECHANISMS; PLASTICITY	Neural stem cells (NSCs) are self-renewing cells that can differentiate into multiple neural lineages and repopulate regions of the brain after injury. We have investigated the role of endocannabinoids (eCBs), endogenous cues that modulate neuronal functions including neurogenesis, and their receptors CB1 and CB2 in mouse NSCs. Real-time PCR and Western blot analyses indicated that CB1 is present at higher levels than CB2 in NSCs. The eCB anandamide (AEA) or the CB1-specific agonist ACEA enhanced NSC differentiation into neurons, but not astrocytes and oligodendrocytes, whereas the CB2-specific agonist JWH133 was ineffective. Conversely, the effect of AEA was inhibited by CB1, but not CB2, antagonist, corroborating the specificity of the response. CB1 activation also enhanced maturation of neurons, as indicated by morphometric analysis of neurites. CB1 stimulation caused long-term inhibition of the ERK1/2 pathway. Consistently, pharmacological inhibition of the ERK1/2 pathway recapitulated the effects exerted by CB1 activation on neuronal differentiation and maturation. Lastly, gene array profiling showed that CB1 activation augmented the expression of genes involved in neuronal differentiation while decreasing that of stemness genes. These results highlight the role of CB1 in the regulation of NSC fate and suggest that its activation may represent a pro-neuronal differentiation signal.	[Compagnucci, Claudia; Di Siena, Sara; Bustamante, Maria Blaire; Di Giacomo, Daniele; Grimaldi, Paola; Sette, Claudio] Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Anat, Rome, Italy; [Compagnucci, Claudia; Bustamante, Maria Blaire; Sette, Claudio] Fdn Santa Lucia IRCCS, Lab Neuroembryol, Rome, Italy; [Di Tommaso, Monia; Maccarrone, Mauro] Fdn Santa Lucia IRCCS, Lab Lipid Neurochem, Rome, Italy; [Di Tommaso, Monia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Santa Lucia; University of Teramo	Grimaldi, P (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Anat, Rome, Italy.	p.grimaldi@med.uniroma2.it; claudio.sette@uniroma2.it	Grimaldi, Paola/AAW-8721-2020; GRIMALDI, PAOLA/AAJ-7920-2020; Compagnucci, Claudia/J-3608-2016; Maccarrone, Mauro/K-5398-2012; Sette, Claudio/S-4307-2019	GRIMALDI, PAOLA/0000-0001-6724-7604; Compagnucci, Claudia/0000-0003-0877-6172; Maccarrone, Mauro/0000-0002-3990-2963; Sette, Claudio/0000-0003-2864-8266	Muscular Dystrophy Association [186711]; Telethon [GGP09154]; Fondazione Santa Lucia "Ricerca Corrente"; Fondazione TERCAS	Muscular Dystrophy Association(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Fondazione Santa Lucia "Ricerca Corrente"; Fondazione TERCAS	This work was supported by funds from the Muscular Dystrophy Association (186711) and Telethon (GGP09154), the Fondazione Santa Lucia "Ricerca Corrente" and partly from Fondazione TERCAS (grant 2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bertram B, 2012, J NEUROSCI METH, V209, P420, DOI 10.1016/j.jneumeth.2012.06.024; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Galve-Roperh I, 2009, EUR ARCH PSY CLIN N, V259, P371, DOI 10.1007/s00406-009-0028-y; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Herkenham M, 1991, NIDA Res Monogr, V112, P129; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Moritz S, 2008, STEM CELLS, V26, P2321, DOI 10.1634/stemcells.2007-1095; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Patel KD, 2010, CURR MED CHEM, V17, P1394, DOI 10.2174/092986710790980041; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Radio Nicholas M, 2012, Methods Mol Biol, V846, P247, DOI 10.1007/978-1-61779-536-7_22; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Spires TL, 2007, J NEUROCHEM, V100, P874, DOI 10.1111/j.1471-4159.2006.04275.x; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740	56	60	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54271	10.1371/journal.pone.0054271	http://dx.doi.org/10.1371/journal.pone.0054271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372698	Green Published, gold			2022-12-27	WOS:000314021500050
J	Lanotte, P; Perivier, M; Haguenoer, E; Mereghetti, L; Burucoa, C; Claverol, S; Atanassov, C				Lanotte, Philippe; Perivier, Marylise; Haguenoer, Eve; Mereghetti, Laurent; Burucoa, Christophe; Claverol, Stephane; Atanassov, Christo			Proteomic Biomarkers Associated with Streptococcus agalactiae Invasive Genogroups	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; DESORPTION IONIZATION-TIME; RIBOSOMAL-PROTEIN L7/L12; FLIGHT MASS-SPECTROMETRY; SELDI-TOF-MS; HELICOBACTER-PYLORI; NEONATAL DISEASE; RAPID DETECTION; EF-G; IDENTIFICATION	Group B streptococcus (GBS, Streptococcus agalactiae) is a leading cause of meningitis and sepsis in newborns and an etiological agent of meningitis, endocarditis, osteoarticular and soft tissue infections in adults. GBS isolates are routinely clustered in serotypes and in genotypes. At present one GBS sequence type (i.e. ST17) is considered to be closely associated with bacterial invasiveness and novel proteomic biomarkers could make a valuable contribution to currently available GBS typing data. For that purpose we analyzed the protein profiles of 170 genotyped GBS isolates by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (SELDI). Univariate statistical analysis of the SELDI profiles identified four protein biomarkers significantly discriminating ST17 isolates from those of the other sequence types. Two of these biomarkers (MW of 7878 Da and 12200 Da) were overexpressed and the other two (MW of 6258 Da and 10463 Da) were underexpressed in ST17. The four proteins were isolated by mass spectrometry-assisted purification and their tryptic peptides analyzed by LC-MS/MS. They were thereby identified as the small subunit of exodeoxyribonuclease VII, the 50S ribosomal protein L7/L12, a CsbD-like protein and thioredoxin, respectively. In conclusion, we identified four candidate biomarkers of ST17 by SELDI for high-throughput screening. These markers may serve as a basis for further studies on the pathophysiology of GBS infection, and for the development of novel vaccines.	[Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] Univ Tours, Equipe Bacteries & Risque Maternofoetal, UMR ISP 1282, Tours, France; [Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] INRA, Equipe Bacteries & Risque Maternofoetal, UMR ISP 1282, F-37380 Nouzilly, France; [Lanotte, Philippe; Haguenoer, Eve; Mereghetti, Laurent] CHRU Tours, Serv Bacteriol & Virol, Tours, France; [Perivier, Marylise; Burucoa, Christophe; Atanassov, Christo] CHU Poitiers, Serv Bacteriol Hyg, Poitiers, France; [Burucoa, Christophe; Atanassov, Christo] Univ Poitiers, Equipe Accueil 4331, Lab Inflammat Tissus Epitheliaux & Cytokines, Poitiers, France; [Claverol, Stephane] Univ Bordeaux 2, Pole Prote Ctr Genom Fonct, F-33076 Bordeaux, France	Universite de Tours; INRAE; CHU Tours; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; UDICE-French Research Universities; Universite de Bordeaux	Atanassov, C (corresponding author), CHU Poitiers, Serv Bacteriol Hyg, Poitiers, France.	h.atanassov@chu-poitiers.fr	Burucoa, Christophe/AAG-3664-2021					Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bernarde C, 2009, PROTEOM CLIN APPL, V3, P672, DOI 10.1002/prca.200800158; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; BLUMBERG HM, 1992, J INFECT DIS, V166, P574, DOI 10.1093/infdis/166.3.574; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Chatellier S, 1996, J CLIN MICROBIOL, V34, P2741, DOI 10.1128/JCM.34.11.2741-2747.1996; Chatellier S, 1997, J CLIN MICROBIOL, V35, P2573, DOI 10.1128/JCM.35.10.2573-2579.1997; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Haguenoer E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-171; Herbert MA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-31; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jomaa M, 2005, FEMS IMMUNOL MED MIC, V44, P59, DOI 10.1016/j.femsim.2004.12.001; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kimmel B, 2000, INFECT IMMUN, V68, P915, DOI 10.1128/IAI.68.2.915-920.2000; Kolberg J, 1997, MICROBIOL-UK, V143, P55, DOI 10.1099/00221287-143-1-55; KOTELIANSKY VE, 1978, EUR J BIOCHEM, V90, P319, DOI 10.1111/j.1432-1033.1978.tb12607.x; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; Lartigue MF, 2011, J MICROBIOL METH, V86, P262, DOI 10.1016/j.mimet.2011.05.017; Lartigue MF, 2009, J CLIN MICROBIOL, V47, P2284, DOI 10.1128/JCM.00175-09; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2005, J CLIN MICROBIOL, V43, P6113, DOI 10.1128/JCM.43.12.6113-6116.2005; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mini R, 2006, J CHROMATOGR B, V833, P63, DOI 10.1016/j.jchromb.2005.12.052; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Nanninga N, 1998, MICROBIOL MOL BIOL R, V62, P110, DOI 10.1128/MMBR.62.1.110-129.1998; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; Oliveira SC, 1996, VACCINE, V14, P959, DOI 10.1016/0264-410X(96)00018-7; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; Reder A, 2012, J BACTERIOL, V194, P3601, DOI 10.1128/JB.00528-12; Ribeiro LA, 2002, APPL ENVIRON MICROB, V68, P910, DOI 10.1128/AEM.68.2.910-916.2002; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; Schuchat A, 2001, CLIN INFECT DIS, V33, P751, DOI 10.1086/322697; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Voland P, 2002, ALIMENT PHARM THER, V16, P533, DOI 10.1046/j.1365-2036.2002.01221.x; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009	55	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54393	10.1371/journal.pone.0054393	http://dx.doi.org/10.1371/journal.pone.0054393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372719	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500068
J	Ding, AY; Li, Q; Zhou, IY; Ma, SJ; Tong, GH; McAlonan, GM; Wu, EX				Ding, Abby Y.; Li, Qi; Zhou, Iris Y.; Ma, Samantha J.; Tong, Gehua; McAlonan, Grainne M.; Wu, Ed X.			MR Diffusion Tensor Imaging Detects Rapid Microstructural Changes in Amygdala and Hippocampus Following Fear Conditioning in Mice	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED ANALYSIS; WHITE-MATTER; STRUCTURAL PLASTICITY; ANTERIOR CINGULATE; IMMUNE CHALLENGE; GRAY-MATTER; BRAIN; INTEGRITY; NEUROGENESIS	Background: Following fear conditioning (FC), ex vivo evidence suggests that early dynamics of cellular and molecular plasticity in amygdala and hippocampal circuits mediate responses to fear. Such altered dynamics in fear circuits are thought to be etiologically related to anxiety disorders including posttraumatic stress disorder (PTSD). Consistent with this, neuroimaging studies of individuals with established PTSD in the months after trauma have revealed changes in brain regions responsible for processing fear. However, whether early changes in fear circuits can be captured in vivo is not known. Methods: We hypothesized that in vivo magnetic resonance diffusion tensor imaging (DTI) would be sensitive to rapid microstructural changes elicited by FC in an experimental mouse PTSD model. We employed a repeated measures paired design to compare in vivo DTI measurements before, one hour after, and one day after FC-exposed mice (n = 18). Results: Using voxel-wise repeated measures analysis, fractional anisotropy (FA) significantly increased then decreased in amygdala, decreased then increased in hippocampus, and was increasing in cingulum and adjacent gray matter one hour and one day post-FC respectively. These findings demonstrate that DTI is sensitive to early changes in brain microstructure following FC, and that FC elicits distinct, rapid in vivo responses in amygdala and hippocampus. Conclusions: Our results indicate that DTI can detect rapid microstructural changes in brain regions known to mediate fear conditioning in vivo. DTI indices could be explored as a translational tool to capture potential early biological changes in individuals at risk for developing PTSD.	[Ding, Abby Y.; Zhou, Iris Y.; Ma, Samantha J.; Tong, Gehua; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Ding, Abby Y.; Zhou, Iris Y.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Li, Qi; McAlonan, Grainne M.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Qi; McAlonan, Grainne M.] Univ Hong Kong, Ctr Reprod Growth & Dev, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [McAlonan, Grainne M.] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of London; King's College London	McAlonan, GM (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	grainne.mcalonan@kcl.ac.uk; ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Zhou, Yuwen/D-8009-2013; Wu, Ed Xuekui/C-1579-2009; McAlonan, Grainne/G-1541-2011	Zhou, Iris Yuwen/0000-0002-4351-7398; Wu, Ed Xuekui/0000-0001-5581-1546; McAlonan, Grainne/0000-0002-4466-2343; Ma, Samantha J./0000-0003-3127-455X	Hong Kong Research Grant Council [HKU7837/11M, 7747/10]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was fully supported by Hong Kong Research Grant Council (HKU7837/11M and 7747/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Avery SN, 2012, NEUROIMAGE, V59, P887, DOI 10.1016/j.neuroimage.2011.09.065; Barnes P, 2005, BEHAV BRAIN RES, V157, P107, DOI 10.1016/j.bbr.2004.06.014; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Bremner J Douglas, 2005, J Trauma Dissociation, V6, P51, DOI 10.1300/J229v06n02_06; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chahboune H, 2007, NMR BIOMED, V20, P375, DOI 10.1002/nbm.1130; Chan KC, 2009, J MAGN RESON IMAGING, V29, P1013, DOI 10.1002/jmri.21736; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Groof G, 2010, NMR BIOMED, V23, P873, DOI 10.1002/nbm.1551; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Ding AY, 2012, MAGN RESON IMAGING, V30, P993, DOI 10.1016/j.mri.2012.02.012; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Fatemi SH, 2009, EUR NEUROPSYCHOPHARM, V19, P648, DOI 10.1016/j.euroneuro.2009.03.004; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Hui ES, 2007, P ANN INT IEEE EMBS, P4312, DOI 10.1109/IEMBS.2007.4353290; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; JOB RFS, 1995, BEHAV NEUROSCI, V109, P106, DOI 10.1037/0735-7044.109.1.106; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Johansen-Berg H, 2012, NEURON, V73, P1058, DOI 10.1016/j.neuron.2012.03.001; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Kumar M, 2012, BRAIN RES, V1455, P56, DOI 10.1016/j.brainres.2012.03.041; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2011, NEUROIMAGE; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Q, 2010, NEUROIMAGE, V52, P1, DOI 10.1016/j.neuroimage.2010.04.015; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; McFarlane AC, 2000, J CLIN PSYCHIAT, V61, P15; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mori S, 1999, ANAT REC, V257, P102; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Pham J, 2009, J NEUROSCI METH, V178, P323, DOI 10.1016/j.jneumeth.2008.12.021; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sanchez I, 1996, J NEUROSCI, V16, P5095; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shalev AY, 2011, ARCH GEN PSYCHIAT; SHORT KR, 1993, PHARMACOL BIOCHEM BE, V45, P827, DOI 10.1016/0091-3057(93)90128-G; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P558, DOI 10.1016/j.neubiorev.2007.01.001; Steckler T, 2005, HDB STRESS BRAIN ELS; Su TP, 2009, J PSYCHIATR RES, V43, P1078, DOI 10.1016/j.jpsychires.2009.03.010; Tanev Kaloyan, 2003, Curr Psychiatry Rep, V5, P369; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vermetten E, 2002, DEPRESS ANXIETY, V15, P126, DOI 10.1002/da.10016; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wu EX, 2007, MAGN RESON IMAGING, V25, P1048, DOI 10.1016/j.mri.2006.12.008; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Wu EX, 2003, MAGNET RESON MED, V49, P765, DOI 10.1002/mrm.10425; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang L, 2012, METHODS MOL BIOL, V829, P453, DOI 10.1007/978-1-61779-458-2_29	106	45	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51704	10.1371/journal.pone.0051704	http://dx.doi.org/10.1371/journal.pone.0051704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382811	gold, Green Published			2022-12-27	WOS:000315563800006
J	Kim, M; Grimmig, T; Grimm, M; Lazariotou, M; Meier, E; Rosenwald, A; Tsaur, I; Blaheta, R; Heemann, U; Germer, CT; Waaga-Gasser, AM; Gasser, M				Kim, Mia; Grimmig, Tanja; Grimm, Martin; Lazariotou, Maria; Meier, Eva; Rosenwald, Andreas; Tsaur, Igor; Blaheta, Roman; Heemann, Uwe; Germer, Christoph-Thomas; Waaga-Gasser, Ana Maria; Gasser, Martin			Expression of Foxp3 in Colorectal Cancer but Not in Treg Cells Correlates with Disease Progression in Patients with Colorectal Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; INDUCTION; MECHANISM; CARCINOMA; REJECTION; SURVIVAL; IMMUNITY	Background: Regulatory T cells (Treg) expressing the transcription factor forkhead-box protein P3 (Foxp3) have been identified to counteract anti-tumor immune responses during tumor progression. Besides, Foxp3 presentation by cancer cells itself may also allow them to evade from effector T-cell responses, resulting in a survival benefit of the tumor. For colorectal cancer (CRC) the clinical relevance of Foxp3 has not been evaluated in detail. Therefore the aim of this study was to study its impact in colorectal cancer (CRC). Methods and Findings: Gene and protein analysis of tumor tissues from patients with CRC was performed to quantify the expression of Foxp3 in tumor infiltrating Treg and colon cancer cells. The results were correlated with clinicopathological parameters and patients overall survival. Serial morphological analysis demonstrated Foxp3 to be expressed in cancer cells. High Foxp3 expression of the cancer cells was associated with poor prognosis compared to patients with low Foxp3 expression. In contrast, low and high Foxp3 level in tumor infiltrating Treg cells demonstrated no significant differences in overall patient survival. Conclusions: Our findings strongly suggest that Foxp3 expression mediated by cancer cells rather than by Treg cells contribute to disease progression.	[Kim, Mia; Germer, Christoph-Thomas; Gasser, Martin] Univ Wurzburg, Dept Surg 1, D-97070 Wurzburg, Germany; [Grimmig, Tanja; Lazariotou, Maria; Meier, Eva; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97070 Wurzburg, Germany; [Grimm, Martin] Univ Tubingen, Dept Oral & Maxillofacial Plast Surg, Tubingen, Germany; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Tsaur, Igor; Blaheta, Roman] Goethe Univ Frankfurt, Dept Urol, D-60054 Frankfurt, Germany; [Heemann, Uwe] Univ Munich, Dept Nephrol, Klinikum Rechts Isar, Munich, Germany	University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg; Goethe University Frankfurt; Technical University of Munich; University of Munich	Waaga-Gasser, AM (corresponding author), Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97070 Wurzburg, Germany.	waaga-gasser@chirurgie.uni-wuerzburg.de	Tsaur, Igor/ACG-6445-2022	Tsaur, Igor/0000-0001-5107-3523; Kim, Mia/0000-0002-0706-8281				Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Greene Frederick L, 2003, Semin Surg Oncol, V21, P23, DOI 10.1002/ssu.10018; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ho-Pun-Cheung A, 2009, ANAL BIOCHEM, V388, P348, DOI 10.1016/j.ab.2009.03.001; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Onizuka S, 1999, CANCER RES, V59, P3128; Sack MJ, 1997, DIAGN CYTOPATHOL, V16, P132, DOI 10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Tao H, 2012, LUNG CANCER, V75, P95, DOI 10.1016/j.lungcan.2011.06.002; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wang WH, 2010, WORLD J GASTROENTERO, V16, P5502, DOI 10.3748/wjg.v16.i43.5502; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Whiteside TL, 2006, CANC TREAT, V130, P103; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	33	56	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53630	10.1371/journal.pone.0053630	http://dx.doi.org/10.1371/journal.pone.0053630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382847	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800023
J	Long, Y; Wang, YB; Ji, GX; Yan, LF; Hu, F; Gu, AH				Long, Yan; Wang, Yubang; Ji, Guixiang; Yan, Lifeng; Hu, Fan; Gu, Aihua			Neurotoxicity of Perfluorooctane Sulfonate to Hippocampal Cells in Adult Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; NEONATAL EXPOSURE; MOUSE MODEL; PFOS; MEMORY	Perfluorooctane sulfonate (PFOS) is a ubiquitous pollutant and found in the environment and in biota. The neurotoxicity of PFOS has received much concern among its various toxic effects when given during developing period of brain. However, little is known about the neurotoxic effects and potential mechanisms of PFOS in the mature brain. Our study demonstrated the neurotoxicity and the potential mechanisms of PFOS in the hippocampus of adult mice for the first time. The impairments of spatial learning and memory were observed by water maze studies after exposure to PFOS for three months. Significant apoptosis was found in hippocampal cells after PFOS exposure, accompanied with a increase of glutamate in the hippocampus and decreases of dopamine (DA) and 3,4-dihydrophenylacetic acid (DOPAC) in Caudate Putamen in the 10.75 mg/kg PFOS group. By two-dimensional fluorescence difference in gel electrophoresis (2D-DIGE) analysis, seven related proteins in the hippocampus that responded to PFOS exposure were identified, among which, Mib1 protein (an E3 ubiquitin-protein ligase), Herc5 (hect domain and RLD 5 isoform 2) and Tyro3 (TYRO3 protein tyrosine kinase 3) were found down-regulated, while Sdha (Succinate dehydrogenase flavoprotein subunit), Gzma (Isoform HF1 of Granzyme A precursor), Plau (Urokinase-type plasminogen activator precursor) and Lig4 (DNA ligase 4) were found up-regulated in the 10.75 mg/kg PFOS-treated group compare with control group. Furthermore, we also found that (i) increased expression of caspase-3 protein and decreased expression of Bcl-2, Bcl-XL and survivin proteins, (ii) the increased glutamate release in the hippocampus. All these might contribute to the dysfunction of hippocampus which finally account for the impairments of spatial learning and memory in adult mice.	[Long, Yan] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Wang, Yubang] Nanjing Med Univ, Sch Publ Hlth, Safety Assessment & Res Ctr Drugs Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wang, Yubang; Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Ji, Guixiang] Minist Environm Protect, Nanjing Inst Environm Sci, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China; [Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Gu, AH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China.	aihuagu@njmu.edu.cn			National Science Foundation of China [81172694, 30901210, 81102494]; Natural Science Foundation of Jiangsu Province [BK2010431]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Safety Assessment and Research Center for Drugs of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; Safety Assessment and Research Center for Drugs of Jiangsu Province	This study was supported by the National Science Foundation of China (Grant No. 81172694, No. 30901210 and No. 81102494), the Natural Science Foundation of Jiangsu Province (Grant No. BK2010431). This project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supports and animals feeding provided by the Safety Assessment and Research Center for Drugs of Jiangsu Province are gratefully acknowledged. Thanks also to Shanghai Applied Protein Technology Co. Ltd for technical assistance.	Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P185, DOI 10.1111/j.1530-0277.2001.tb02197.x; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Austin ME, 2003, ENVIRON HEALTH PERSP, V111, P1485, DOI 10.1289/ehp.6128; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calafat AM, 2006, ENVIRON SCI TECHNOL, V40, P2128, DOI 10.1021/es0517973; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Davis MA, 2006, J PHARMACOL EXP THER, V318, P589, DOI 10.1124/jpet.105.100032; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Fuentes S, 2007, TOXICOLOGY, V242, P123, DOI 10.1016/j.tox.2007.09.012; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Johansson N, 2009, TOXICOL SCI, V108, P412, DOI 10.1093/toxsci/kfp029; Kajii Y, 1996, BIOL CELL, V88, P45, DOI 10.1016/S0248-4900(97)86830-X; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Kannan K, 2001, ENVIRON SCI TECHNOL, V35, P1593, DOI 10.1021/es001873w; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Lee YJ, 2013, CHEMOSPHERE, V90, P1597, DOI 10.1016/j.chemosphere.2012.08.033; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Mondal D, 2012, ENVIRON HEALTH PERSP, V120, P752, DOI 10.1289/ehp.1104538; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Olsen GW, 2008, ENVIRON SCI TECHNOL, V42, P4989, DOI 10.1021/es800071x; Raiteri L, 2003, BRIT J PHARMACOL, V138, P1021, DOI 10.1038/sj.bjp.0705142; Renner R, 2001, ENVIRON SCI TECHNOL, V35, p154A, DOI 10.1021/es012317k; Shankaran M, 2006, J PHARMACOL EXP THER, V319, P1172, DOI 10.1124/jpet.106.110510; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Terry AV, 2009, FRONT NEUROSCI, P267; Yasuhara S, 2003, J HISTOCHEM CYTOCHEM, V51, P873, DOI 10.1177/002215540305100703; Zeng HC, 2011, NEUROTOXICOLOGY, V32, P130, DOI 10.1016/j.neuro.2010.10.001	32	51	55	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54176	10.1371/journal.pone.0054176	http://dx.doi.org/10.1371/journal.pone.0054176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382877	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800036
J	Claeyssen, E; Dorion, S; Clendenning, A; He, JZ; Wally, O; Chen, JK; Auslender, EL; Moisan, MC; Jolicoeur, M; Rivoal, J				Claeyssen, Eric; Dorion, Sonia; Clendenning, Audrey; He, Jiang Zhou; Wally, Owen; Chen, Jingkui; Auslender, Evgenia L.; Moisan, Marie-Claude; Jolicoeur, Mario; Rivoal, Jean			The Futile Cycling of Hexose Phosphates Could Account for the Fact That Hexokinase Exerts a High Control on Glucose Phosphorylation but Not on Glycolytic Rate in Transgenic Potato (Solanum tuberosum) Roots	PLOS ONE			English	Article							NIGRA SUSPENSION CELLS; HIGHER-PLANT CELLS; CASTOR-OIL SEEDS; SUCROSE SYNTHASE; FRUCTOSE-6-PHOSPHATE 1-PHOSPHOTRANSFERASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; AGROBACTERIUM-RHIZOGENES; CARBOHYDRATE-METABOLISM; ANTISENSE REPRESSION; MATHEMATICAL-MODEL	The metabolism of potato (Solanum tuberosum) roots constitutively over-and underexpressing hexokinase (HK, EC 2.7.1.1) was examined. An 11-fold variation in HK activity resulted in altered root growth, with antisense roots growing better than sense roots. Quantification of sugars, organic acids and amino acids in transgenic roots demonstrated that the manipulation of HK activity had very little effect on the intracellular pools of these metabolites. However, adenylate and free Pi levels were negatively affected by an increase in HK activity. The flux control coefficient of HK over the phosphorylation of glucose was measured for the first time in plants. Its value varied with HK level. It reached 1.71 at or below normal HK activity value and was much lower (0.32) at very high HK levels. Measurements of glycolytic flux and O-2 uptake rates demonstrated that the differences in glucose phosphorylation did not affect significantly glycolytic and respiratory metabolism. We hypothesized that these results could be explained by the existence of a futile cycle between the pools of hexose-Ps and carbohydrates. This view is supported by several lines of evidence. Firstly, activities of enzymes capable of catalyzing these reactions were detected in roots, including a hexose-P phosphatase. Secondly, metabolic tracer experiments using C-14-glucose as precursor showed the formation of C-14-fructose and C-14-sucrose. We conclude that futile cycling of hexose-P could be partially responsible for the differences in energetic status in roots with high and low HK activity and possibly cause the observed alterations in growth in transgenic roots. The involvement of HK and futile cycles in the control of glucose-6P metabolism is discussed.	[Claeyssen, Eric; Dorion, Sonia; Clendenning, Audrey; He, Jiang Zhou; Wally, Owen; Auslender, Evgenia L.; Moisan, Marie-Claude; Rivoal, Jean] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech Montreal, Dept Chem Engn, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Polytechnique Montreal	Rivoal, J (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada.	jean.rivoal@umontreal.ca	Rivoal, Jean/J-6544-2014	Rivoal, Jean/0000-0002-8991-0566	Natural Science and Engineering Research Council of Canada; China Scholarship Council; Fonds de Bourses en Sciences Biologiques of the Universite de Montreal; Canada Research Chair in Applied Metabolic Engineering	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); China Scholarship Council(China Scholarship Council); Fonds de Bourses en Sciences Biologiques of the Universite de Montreal; Canada Research Chair in Applied Metabolic Engineering(Canada Research Chairs)	This research was supported by a Natural Science and Engineering Research Council of Canada Discovery grant to JR (http://www.nserc-crsng.gc.ca). JZH was supported by a State Scholarship Fund from the China Scholarship Council (www.csc.edu.cn). ELA was supported by an Undergraduate Student Research Award from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). MCM was supported in part by a grant from the Fonds de Bourses en Sciences Biologiques of the Universite de Montreal. MJ is supported by the Canada Research Chair in Applied Metabolic Engineering (http.//www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AP, 2005, PLANT PHYSIOL, V138, P2220, DOI 10.1104/pp.105.062083; Aon MA, 1998, BIOTECHNOL BIOENG, V59, P203, DOI 10.1002/(SICI)1097-0290(19980720)59:2<203::AID-BIT8>3.3.CO;2-T; Baque S, 1998, DIABETES, V47, P1392, DOI 10.2337/diabetes.47.9.1392; BORCHERT S, 1993, PLANT PHYSIOL, V101, P303, DOI 10.1104/pp.101.1.303; Bouny JM, 1996, PLANT PHYSIOL, V111, P187, DOI 10.1104/pp.111.1.187; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carswell C, 1996, PLANT PHYSIOL, V110, P105, DOI 10.1104/pp.110.1.105; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Claeyssen E, 2006, PROTEIN EXPRES PURIF, V47, P329, DOI 10.1016/j.pep.2005.11.003; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; DIEUAIDENOUBHANI M, 1995, J BIOL CHEM, V270, P13147, DOI 10.1074/jbc.270.22.13147; Dorion S, 2005, PLANT SCI, V168, P183, DOI 10.1016/j.plantsci.2004.07.029; Dorion S, 2012, PLANTA IN PRESS; Dorion S, 2009, ACTA PHYSIOL PLANT, V31, P855, DOI 10.1007/s11738-009-0292-5; DUFF SMG, 1989, PLANT PHYSIOL, V90, P734, DOI 10.1104/pp.90.2.734; DUFF SMG, 1989, PLANT PHYSIOL, V90, P1275, DOI 10.1104/pp.90.4.1275; Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Fernie AR, 2002, PLANT CELL ENVIRON, V25, P1219, DOI 10.1046/j.1365-3040.2002.00918.x; Fernie AR, 2001, PLANTA, V212, P250, DOI 10.1007/s004250000386; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Gmati D, 2005, BIOTECHNOL BIOENG, V89, P138, DOI 10.1002/bit.20293; GOUT E, 1992, J BIOL CHEM, V267, P13903; HAWKER JS, 1966, BIOCHEM J, V99, P102, DOI 10.1042/bj0990102; Hodgson RJ, 1998, ARCH BIOCHEM BIOPHYS, V355, P189, DOI 10.1006/abbi.1998.0725; Iynedjian PB, 1998, TRENDS BIOCHEM SCI, V23, P467, DOI 10.1016/S0968-0004(98)01317-6; JOURNET EP, 1986, J BIOL CHEM, V261, P3193; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kelly G, 2012, PLANT PHYSIOL, V159, P47, DOI 10.1104/pp.112.196105; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Klein D, 1998, PLANTA, V205, P223, DOI 10.1007/s004250050315; KLEIN RR, 1993, PLANTA, V190, P498, DOI 10.1007/BF00224789; Kristo P, 1996, EUR J BIOCHEM, V237, P240, DOI 10.1111/j.1432-1033.1996.0240n.x; Kulma A, 2004, PLANT J, V37, P654, DOI 10.1111/j.1365-313X.2003.01992.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELENDEZHEVIA E, 1992, MOL CELL BIOCHEM, V115, P1; Menu T, 2004, PLANT CELL ENVIRON, V27, P89, DOI 10.1046/j.0016-8025.2003.01128.x; Moisan MC, 2011, BOTANY, V89, P289, DOI [10.1139/B11-016, 10.1139/b11-016]; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MOORE L, 1979, PLASMID, V2, P617, DOI 10.1016/0147-619X(79)90059-3; MOORHEAD GBG, 1994, ARCH BIOCHEM BIOPHYS, V312, P326, DOI 10.1006/abbi.1994.1316; Moraes TF, 2000, EUR J BIOCHEM, V267, P4465, DOI 10.1046/j.1432-1327.2000.01495.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; PETIT A, 1983, MOL GEN GENET, V190, P204, DOI 10.1007/BF00330641; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Plaxton WC, 2002, ARCH BIOCHEM BIOPHYS, V400, P54, DOI 10.1006/abbi.2002.2782; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Plaxton WC, 1990, METHODS PLANT BIOCH, P145; Puigjaner J, 1997, FEBS LETT, V418, P47, DOI 10.1016/S0014-5793(97)01347-1; RAPOPORT TA, 1974, EUR J BIOCHEM, V42, P107, DOI 10.1111/j.1432-1033.1974.tb03320.x; RENZ A, 1993, PLANTA, V190, P156; RENZ A, 1993, PLANTA, V190, P166; RIVOAL J, 1989, PLANT PHYSIOL BIOCH, V27, P43; RIVOAL J, 1994, PLANT PHYSIOL, V106, P1179, DOI 10.1104/pp.106.3.1179; RIVOAL J, 1993, PLANT PHYSIOL, V101, P553, DOI 10.1104/pp.101.2.553; Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Salla S, 1996, GRAEF ARCH CLIN EXP, V234, P521, DOI 10.1007/BF00184862; SALON C, 1988, J BIOL CHEM, V263, P12278; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; SWEET IR, 1995, AM J PHYSIOL-ENDOC M, V268, pE775, DOI 10.1152/ajpendo.1995.268.4.E775; Sweetlove LJ, 2002, PLANTA, V214, P741, DOI 10.1007/s004250100666; Sweetlove LJ, 1996, BIOCHEM J, V320, P487, DOI 10.1042/bj3200487; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang GQ, 1999, PLANT MOL BIOL, V41, P465, DOI 10.1023/A:1006327606696; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339, DOI 10.1104/pp.101.2.339; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Toroser D, 2000, PLANT PHYSIOL, V123, P403, DOI 10.1104/pp.123.1.403; TORRES NV, 1988, FEBS LETT, V233, P83, DOI 10.1016/0014-5793(88)81360-7; Trethewey RN, 1998, PLANT J, V15, P109, DOI 10.1046/j.1365-313X.1998.00190.x; Troncoso-Ponce MA, 2011, J PLANT PHYSIOL, V168, P299, DOI 10.1016/j.jplph.2010.07.018; Veramendi J, 1999, PLANT PHYSIOL, V121, P123, DOI 10.1104/pp.121.1.123; Veramendi J, 2002, PLANT MOL BIOL, V49, P491, DOI 10.1023/A:1015528014562; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wood SM, 2002, CAN J BOT, V80, P983, DOI [10.1139/B02-085, 10.1139/b02-085]	85	11	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53898	10.1371/journal.pone.0053898	http://dx.doi.org/10.1371/journal.pone.0053898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382859	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000315211500008
J	Castro, V; Grisdale-Helland, B; Helland, SJ; Torgersen, J; Kristensen, T; Claireaux, G; Farrell, AP; Takle, H				Castro, Vicente; Grisdale-Helland, Barbara; Helland, Stale J.; Torgersen, Jacob; Kristensen, Torstein; Claireaux, Guy; Farrell, Anthony P.; Takle, Harald			Cardiac Molecular-Acclimation Mechanisms in Response to Swimming-Induced Exercise in Atlantic Salmon	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RAINBOW-TROUT; SKELETAL-MUSCLE; ERYTHROPOIETIN RECEPTOR; OXIDATIVE CAPACITY; PROTEIN EXPRESSION; TRAINING IMPROVES; OXYGEN-TRANSPORT	Cardiac muscle is a principal target organ for exercise-induced acclimation mechanisms in fish and mammals, given that sustained aerobic exercise training improves cardiac output. Yet, the molecular mechanisms underlying such cardiac acclimation have been scarcely investigated in teleosts. Consequently, we studied mechanisms related to cardiac growth, contractility, vascularization, energy metabolism and myokine production in Atlantic salmon pre-smolts resulting from 10 weeks exercise-training at three different swimming intensities: 0.32 (control), 0.65 (medium intensity) and 1.31 (high intensity) body lengths s(-1). Cardiac responses were characterized using growth, immunofluorescence and qPCR analysis of a large number of target genes encoding proteins with significant and well-characterized function. The overall stimulatory effect of exercise on cardiac muscle was dependent on training intensity, with changes elicited by high intensity training being of greater magnitude than either medium intensity or control. Higher protein levels of PCNA were indicative of cardiac growth being driven by cardiomyocyte hyperplasia, while elevated cardiac mRNA levels of MEF2C, GATA4 and ACTA1 suggested cardiomyocyte hypertrophy. In addition, up-regulation of EC coupling-related genes suggested that exercised hearts may have improved contractile function, while higher mRNA levels of EPO and VEGF were suggestive of a more efficient oxygen supply network. Furthermore, higher mRNA levels of PPAR alpha, PGC1 alpha and CPT1 all suggested a higher capacity for lipid oxidation, which along with a significant enlargement of mitochondrial size in cardiac myocytes of the compact layer of fish exercised at high intensity, suggested an enhanced energetic support system. Training also elevated transcription of a set of myokines and other gene products related to the inflammatory process, such as TNF alpha, NF kappa B, COX2, IL1RA and TNF decoy receptor. This study provides the first characterization of the underlying molecular acclimation mechanisms in the heart of exercise-trained fish, which resemble those reported for mammalian physiological cardiac growth.	[Castro, Vicente; Torgersen, Jacob; Takle, Harald] Nofima AS, As, Norway; [Castro, Vicente; Helland, Stale J.] Norwegian Univ Life Sci UMB, Inst Anim Sci, As, Norway; [Grisdale-Helland, Barbara; Helland, Stale J.] Aquaculture Prot Ctr, As, Norway; [Grisdale-Helland, Barbara; Helland, Stale J.] Nofima AS, Sunndalsora, Norway; [Kristensen, Torstein] Norwegian Inst Water Res, Bodo, Norway; [Claireaux, Guy] Univ Bretagne Occidentale, Lab Sci Environm Marin LEMAR, Plouzane, France; [Claireaux, Guy] IFREMER, Unite Physiol Fonct Organismes, Plouzane, France; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Takle, Harald] AVS Chile SA, Puerto Varas, Chile	Nofima; Norwegian University of Life Sciences; Nofima; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Ifremer; University of British Columbia; University of British Columbia	Takle, H (corresponding author), Nofima AS, As, Norway.	harald.takle@nofima.no		Kristensen, Torstein/0000-0002-2640-4260	Fishery and Aquaculture Industry Research Fund (FHF); Research Council of Norway [190067]	Fishery and Aquaculture Industry Research Fund (FHF); Research Council of Norway(Research Council of Norway)	This study was funded by the Fishery and Aquaculture Industry Research Fund (FHF) and the Research Council of Norway (Grant number: 190067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Anttila K, 2011, J FISH BIOL, V78, P552, DOI 10.1111/j.1095-8649.2010.02871.x; Anttila K, 2008, J COMP PHYSIOL B, V178, P465, DOI 10.1007/s00360-007-0239-3; Anttila K, 2006, J EXP BIOL, V209, P2971, DOI 10.1242/jeb.02341; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Bailey JR, 1997, COMP BIOCHEM PHYS B, V118, P607, DOI 10.1016/S0305-0491(97)00226-5; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bethke J, 2012, J FISH DIS IN PRESS; BLOOR CM, 1970, LAB INVEST, V22, P160; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Castro V, 2011, COMP BIOCHEM PHYS A, V160, P278, DOI 10.1016/j.cbpa.2011.06.013; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Chou CF, 2004, BLOOD, V104, P1498, DOI 10.1182/blood-2003-10-3404; Clark RJ, 1998, J EXP BIOL, V201, P1541; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; DAVIE PS, 1986, J EXP ZOOL, V237, P159, DOI 10.1002/jez.1402370203; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; Doyama K, 1996, INT J CARDIOL, V54, P217, DOI 10.1016/0167-5273(96)02607-1; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Farrell AP, 2003, J EXP BIOL, V206, P487, DOI 10.1242/jeb.00100; FARRELL AP, 1991, FISH PHYSIOL BIOCHEM, V9, P303, DOI 10.1007/BF02265151; FARRELL AP, 1990, CAN J ZOOL, V68, P1174, DOI 10.1139/z90-174; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gallaugher PE, 2001, J EXP BIOL, V204, P2861; Gamperl AK, 2004, J EXP BIOL, V207, P2539, DOI 10.1242/jeb.01057; Gwechenberger M, 1999, CIRCULATION, V99, P546, DOI 10.1161/01.CIR.99.4.546; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heggelund J, 2011, NORD J PSYCHIAT, V65, P269, DOI 10.3109/08039488.2011.560278; Helgerud J, 2011, INT J SPORTS MED, V32, P677, DOI 10.1055/s-0031-1275742; HOCHACHKA P, 1961, CAN J ZOOLOG, V39, P767, DOI 10.1139/z61-073; Hojman P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005894; HOULIHAN DF, 1987, CAN J FISH AQUAT SCI, V44, P1614, DOI 10.1139/f87-195; Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jobling M., 1993, AQUACULT INT, V1, P95, DOI [10.1007/BF00692614, DOI 10.1007/BF00692614]; KAPADIA S, 1995, J CLIN INVEST, V96, P1042, DOI 10.1172/JCI118090; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Khovanskiy I.Y., 1993, J ICHTHYOL, V33, P36; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; Moran M, 2003, PFLUG ARCH EUR J PHY, V446, P161, DOI 10.1007/s00424-003-1019-x; MOYES CD, 1992, CAN J ZOOL, V70, P1246, DOI 10.1139/z92-172; Moyes CD, 1996, COMP BIOCHEM PHYS A, V113, P69, DOI 10.1016/0300-9629(95)02057-8; Patey CP, 1997, CAN J ZOOL, V75, P324, DOI 10.1139/z97-041; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pelster B, 2003, AM J PHYSIOL-REG I, V285, pR339, DOI 10.1152/ajpregu.00110.2003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Rolim NPL, 2007, PHYSIOL GENOMICS, V29, P246, DOI 10.1152/physiolgenomics.00188.2006; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; SABORIDO A, 1995, PFLUG ARCH EUR J PHY, V429, P364, DOI 10.1007/BF00374151; Sachdev S, 2008, FREE RADICAL BIO MED, V44, P215, DOI 10.1016/j.freeradbiomed.2007.07.019; Sanger A. M., 2000, BASIC APPL MYOL, V10, P297; SANGER AM, 1992, ENVIRON BIOL FISH, V33, P97, DOI 10.1007/BF00002557; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Shiels HA, 2002, J EXP BIOL, V205, P3631; Shiels HA, 2002, COMP BIOCHEM PHYS A, V132, P811, DOI 10.1016/S1095-6433(02)00050-8; Simonot DL, 2009, J FISH BIOL, V75, P1762, DOI 10.1111/j.1095-8649.2009.02427.x; Simonot DL, 2007, J EXP BIOL, V210, P2574, DOI 10.1242/jeb.004028; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; THORARENSEN H, 1993, J EXP BIOL, V179, P115; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; TOMANEK RJ, 1970, ANAT RECORD, V167, P55, DOI 10.1002/ar.1091670106; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; Vornanen M, 2002, COMP BIOCHEM PHYS A, V132, P827, DOI 10.1016/S1095-6433(02)00051-X; WALKER MG, 1978, J FISH BIOL, V13, P475, DOI 10.1111/j.1095-8649.1978.tb03457.x; WEST TG, 1993, J EXP BIOL, V177, P63; YAMAUCHITAKIHARA K, 1995, CIRCULATION, V91, P1520, DOI 10.1161/01.CIR.91.5.1520; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	76	39	40	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55056	10.1371/journal.pone.0055056	http://dx.doi.org/10.1371/journal.pone.0055056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372811	Green Published, gold			2022-12-27	WOS:000315210400054
J	Finley, A; Chen, Z; Esposito, E; Cuzzocrea, S; Sabbadini, R; Salvemini, D				Finley, Amanda; Chen, Zhoumou; Esposito, Emanuela; Cuzzocrea, Salvatore; Sabbadini, Roger; Salvemini, Daniela			Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism	PLOS ONE			English	Article							NF-KAPPA-B; MORPHINE ANTINOCICEPTIVE TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; HUMAN ENDOTHELIAL-CELLS; TUMOR-NECROSIS-FACTOR; RAT SENSORY NEURONS; NERVE GROWTH-FACTOR; S1P(1) ANTAGONIST; SPINAL CERAMIDE; SPHINGOSINE-1-PHOSPHATE RECEPTOR	Novel classes of pain-relieving molecules are needed to fill the void between non-steroidal anti-inflammatory agents and narcotics. We have recently shown that intraplantar administration of sphingosine 1-phosphate (S1P) in rats causes peripheral sensitization and hyperalgesia through the S1P(1) receptor subtype (S1PR(1)): the mechanism(s) involved are largely unknown and were thus explored in the present study. Intraplantar injection of carrageenan in rats led to a time-dependent development of thermal hyperalgesia that was associated with pronounced edema and infiltration of neutrophils in paw tissues. Inhibition of 1) S1P formation with SK-I, a sphingosine kinase inhibitor, 2) S1P bioavailability with the S1P blocking antibody Sphingomab, LT1002 (but not its negative control, LT1017) or 3) S1P actions through S1PR(1) with the selective S1PR1 antagonist, W146 (but not its inactive enantiomer, W140) blocked thermal hyperalgesia and infiltration of neutrophils. Taken together, these findings identify S1P as an important contributor to inflammatory pain acting through S1PR(1) to elicit hyperalgesia in a neutrophil-dependant manner. In addition and in further support, we demonstrate that the development of thermal hyperalgesia following intraplantar injection of S1P or SEW2871 (an S1PR(1) agonist) was also associated with neutrophilic infiltration in paw tissues as these events were attenuated by fucoidan, an inhibitor of neutrophilic infiltration. Importantly, FTY720, an FDA-approved S1P receptor modulator known to block S1P-S1PR(1) signaling, attenuated carrageenan-induced thermal hyperalgesia and associated neutrophil infiltration. Targeting the S1P/S1PR(1) axis opens a therapeutic strategy for the development of novel non-narcotic anti-hyperalgesic agents.	[Finley, Amanda; Chen, Zhoumou; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Sabbadini, Roger] San Diego State Univ, Lpath Inc, San Diego, CA 92182 USA; [Sabbadini, Roger] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	Saint Louis University; University of Messina; California State University System; San Diego State University; California State University System; San Diego State University	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	salvemd@slu.edu		Esposito, Emanuela/0000-0002-2663-6387; Cuzzocrea, Salvatore/0000-0001-6131-3690	National Institutes of Health National Institute on Drug Abuse [R01 DA024074]; National Institutes of Health predoctoral fellowship [5T32GM008306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024074] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institutes of Health National Institute on Drug Abuse (Grant R01 DA024074) to DS and a National Institutes of Health predoctoral fellowship (Grant 5T32GM008306) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Bennett G, 1998, PAIN, V77, P315, DOI 10.1016/S0304-3959(98)00114-6; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Bryant L, 2009, NEUROSCI LETT, V463, P49, DOI 10.1016/j.neulet.2009.07.051; CHI XX, 2010, J NEUROPHYSIOL; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cuzzocrea S, 2000, FASEB J, V14, P1061, DOI 10.1096/fasebj.14.9.1061; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Doyle T, 2011, NEUROSCI LETT, V499, P4, DOI 10.1016/j.neulet.2011.05.018; Doyle T, 2011, PAIN, V152, P643, DOI 10.1016/j.pain.2010.12.011; French KJ, 2003, CANCER RES, V63, P5962; Fujii Y, 2012, J IMMUNOL, V188, P206, DOI 10.4049/jimmunol.1101537; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jia YT, 2007, J IMMUNOL, V179, P7808, DOI 10.4049/jimmunol.179.11.7808; Jongsma M, 2006, BRIT J PHARMACOL, V149, P277, DOI 10.1038/sj.bjp.0706872; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Kress M., 2012, TRENDS PHARMACOL SCI; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Kulms D, 2006, VITAM HORM, V74, P283, DOI 10.1016/S0083-6729(06)74011-0; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Lee HY, 2004, AM J PHYSIOL-CELL PH, V287, pC1657, DOI 10.1152/ajpcell.00172.2004; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEVINE JD, 1985, J NEUROSCI, V5, P3025; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; LEY K, 1993, BLOOD, V81, P177; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Lin CI, 2007, BIOCHEM BIOPH RES CO, V355, P895, DOI 10.1016/j.bbrc.2007.02.043; Mair N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017268; Matsuura M, 2000, INT J IMMUNOPHARMACO, V22, P323, DOI 10.1016/S0192-0561(99)00088-0; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; National CfHS, 2006, HEALTH UNITED STATES; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Russell FA, 2009, PAIN, V142, P264, DOI 10.1016/j.pain.2009.01.021; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Salvemini D, 1998, DRUG NEWS PERSPECT, V11, P204; Salvemini D, 2001, BRIT J PHARMACOL, V132, P815, DOI 10.1038/sj.bjp.0703841; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Semenov AV, 1998, VOP MED KHIM, V44, P135; Shimamura K, 2004, EUR J PHARMACOL, V486, P141, DOI 10.1016/j.ejphar.2003.12.022; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TONNESEN MG, 1989, J INVEST DERMATOL, V93, pS53, DOI 10.1111/1523-1747.ep12581069; Trifilieff A, 2009, N-S ARCH PHARMACOL, V380, P303, DOI 10.1007/s00210-009-0438-4; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xie WR, 2012, NEUROSCI LETT, V515, P61, DOI 10.1016/j.neulet.2012.03.019; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006	67	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55255	10.1371/journal.pone.0055255	http://dx.doi.org/10.1371/journal.pone.0055255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372844	gold, Green Submitted, Green Published			2022-12-27	WOS:000315210400084
J	Lee, H; Lee, J; Hwang, SS; Kim, S; Chin, HJ; Han, JS; Heo, NJ				Lee, Hajeong; Lee, Jeonghwan; Hwang, Seung-sik; Kim, Sejoong; Chin, Ho Jun; Han, Jin Suk; Heo, Nam Ju			Potassium Intake and the Prevalence of Metabolic Syndrome: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; THIAZIDE DIURETICS; DIETARY POTASSIUM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; MAGNESIUM INTAKE; ORAL POTASSIUM; ADULTS; RISK	Lower potassium intake is considered to be correlated with diabetes incidence. However, few studies have investigated the effect of potassium intake on metabolic syndrome (MetS). Data was taken from the Korean National Health and Nutritional Examination Survey (2008-2010) using weighted adjustment. MetS was defined as per the revised National Cholesterol Education Program criteria. Homeostasis model assessment indices were calculated to diagnosis insulin resistance (IR). A total of 16,637 participants (44 +/- 0.25 years) were included. Women ingested lower amounts of potassium (2.71 +/- 0.02 g/day) than men (3.45 +/- 0.03 g/day). A curvilinear association between potassium intake and MetS prevalence was found among women. Women with less than the Adequate Intake (4.7 g/day) of potassium had an 11% risk reduction for MetS (adjusted odds ratio [OR], 0.89; 95% confidence interval [CI], 0.82-0.96; P = 0.004) and a 10% risk reduction for IR (OR, 0.90; 95% CI, 0.82-0.99; P = 0.026) for every 1 g/day potassium increase. Compared with the reference group (3.5-4.5 g/day), potassium intake was inversely associated with an increased risk of MetS (1.5-2.5 g/day; OR, 1.29; 95% CI, 1.02-1.63; P = 0.035; < 1.5 g/day; OR, 1.40; 95% CI, 1.06-1.85; P = 0.017) and IR (< 1.5 g/day; OR, 1.36; 95% CI, 1.05-1.76; P = 0.021). This relationship was more prominent in postmenopausal women, but not observed among men. Higher potassium intake is significantly associated with a lower MetS prevalence in women, and IR is believed to be connected.	[Lee, Hajeong; Lee, Jeonghwan; Han, Jin Suk] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Hwang, Seung-sik] Inha Univ, Sch Med, Dept Social & Prevent Med, Inchon, South Korea; [Kim, Sejoong; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Heo, Nam Ju] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Inha University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Heo, NJ (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea.	julie082007@naver.com	Lee, Jeonghwan/C-5214-2011; Kim, Sejoong/J-5356-2015	Lee, Jeonghwan/0000-0003-3199-635X; Kim, Sejoong/0000-0002-7238-9962				ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Bar-Or, 2004, DIETARY REFERENCE IN; Chatterjee R, 2012, DIABETOLOGIA, V55, P1295, DOI 10.1007/s00125-012-2487-3; Chatterjee R, 2010, ARCH INTERN MED, V170, P1745, DOI 10.1001/archinternmed.2010.362; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; GRIMM RH, 1990, NEW ENGL J MED, V322, P569, DOI 10.1056/NEJM199003013220901; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; He FJ, 2008, PHYSIOL PLANTARUM, V133, P725, DOI 10.1111/j.1399-3054.2007.01033.x; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Hu G, 2005, DIABETOLOGIA, V48, P1477, DOI 10.1007/s00125-005-1824-1; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kannel William B, 2002, J Gend Specif Med, V5, P27; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Kim ES, 2003, TOHOKU J EXP MED, V200, P7, DOI 10.1620/tjem.200.7; Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001; Larsson SC, 2011, AM J EPIDEMIOL, V174, P35, DOI 10.1093/aje/kwr051; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mirmiran P, 2012, PUBLIC HEALTH NUTR, V15, P693, DOI 10.1017/S1368980011002941; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; NORBIATO G, 1984, EUR J CLIN INVEST, V14, P414, DOI 10.1111/j.1365-2362.1984.tb01205.x; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; Reungjui S, 2008, CURR OPIN NEPHROL HY, V17, P470, DOI 10.1097/MNH.0b013e328305b9a5; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Sowers MR, 2005, J CLIN ENDOCR METAB, V90, P6064, DOI 10.1210/jc.2005-0765; Tasevska N, 2006, J NUTR, V136, P1334, DOI 10.1093/jn/136.5.1334; van Mierlo LAJ, 2010, ARCH INTERN MED, V170, P1501, DOI 10.1001/archinternmed.2010.284; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	41	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55106	10.1371/journal.pone.0055106	http://dx.doi.org/10.1371/journal.pone.0055106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372822	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400064
J	Wilson, S; Marra, PP; Sillett, TS				Wilson, Scott; Marra, Peter P.; Sillett, T. Scott			The Effects of Experimental Irrigation on Plant Productivity, Insect Abundance and the Non-Breeding Season Performance of a Migratory Songbird	PLOS ONE			English	Article							TROPICAL DRY FOREST; HABITAT QUALITY; NEOTROPICAL MIGRANT; AMERICAN REDSTARTS; DECIDUOUS FOREST; LEAF PHENOLOGY; RAINFALL; TREES; WATER; BIRD	Migratory bird populations are often limited by food during the non-breeding season. Correlative evidence suggests that food abundance on territories varies among years in relation to rainfall, which affects plant productivity and arthropod biomass. At the Font Hill Nature Preserve in Jamaica, we used an irrigation experiment to test the hypothesis that rainfall affects the condition of wintering American redstarts (Setophaga ruticilla) via intermediate effects on plant productivity and arthropod abundance. Experimental plots were irrigated in late February and early March to simulate a mid-season pulse of 200 mm of rain. Irrigation maintained soil moisture levels near saturation and had immediate effects on plant productivity. Cumulative leaf abscission over the dry season was 50% lower on experimental plots resulting in greater canopy cover, and we observed significantly higher ground level shoot growth and the flushing of new leaves on about 58% of logwood (Haematoxylon campechianum) individuals. Arthropod biomass was 1.5 times higher on irrigated plots, but there was considerable inter-plot variability within a treatment and a strong seasonal decline in biomass. Consequently, we found no significant effect of irrigation on arthropod abundance or redstart condition. We suspect that the lack of an irrigation effect for taxa higher on the trophic chain was due to the small spatial scale of the treatment relative to the scale at which these taxa operate. Although redstart condition was not affected, we did observe turnover from subordinate to dominant territorial individuals on experimental plots suggesting a perceived difference in habitat quality that influenced individual behavior.	[Wilson, Scott; Marra, Peter P.; Sillett, T. Scott] Smithsonian Conservat Biol Inst, Natl Zool Pk, Migratory Bird Ctr, Washington, DC USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Wilson, S (corresponding author), Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada.	scottd.wilson@ec.gc.ca	Sillett, Scott/N-2240-2017; Wilson, Scott/AAC-7144-2021	Sillett, Scott/0000-0002-7486-0076; Marra, Peter/0000-0002-0508-7577	National Science Foundation [DEB 0717243]; Smithsonian Institution; Canadian Natural Sciences and Engineering Research Council; Direct For Biological Sciences [1242584] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation (grant DEB 0717243) to PPM and TSS, the Smithsonian Institution, and a Canadian Natural Sciences and Engineering Research Council grant to SW. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams CD., 1971, FLOWERING PLANTS JAM, V7, P109; Angelier F, 2011, J AVIAN BIOL, V42, P335, DOI 10.1111/j.1600-048X.2011.05369.x; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; BORCHERT R, 1994, TREES-STRUCT FUNCT, V8, P198, DOI 10.1007/BF00196847; Borchert R, 2002, BIOTROPICA, V34, P27, DOI 10.1111/j.1744-7429.2002.tb00239.x; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; CARPENTER FL, 1983, P NATL ACAD SCI-BIOL, V80, P7259, DOI 10.1073/pnas.80.23.7259; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Hannon SJ, 2009, OIKOS, V118, P1035, DOI 10.1111/j.1600-0706.2008.17383.x; Hayden B, 2010, J TROP ECOL, V26, P237, DOI 10.1017/S0266467409990563; Holbrook N. Michele, 1995, P243, DOI 10.1017/CBO9780511753398.010; JANZEN DH, 1967, EVOLUTION, V21, P620, DOI 10.1111/j.1558-5646.1967.tb03416.x; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Kendall C., 1998, ISOTOPE TRACERS CATC, DOI [10.1016/c2009-0-10239-8, DOI 10.1016/C2009-0-10239-8, 10.1016/C2009-0-10239-8]; Latta SC, 2002, ECOLOGY, V83, P2502, DOI 10.1890/0012-9658(2002)083[2502:DAPROC]2.0.CO;2; Latta SC, 2012, J FIELD ORNITHOL, V83, P107, DOI 10.1111/j.1557-9263.2012.00361.x; MARRA PP, 1993, AUK, V110, P565, DOI 10.2307/4088420; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MEDINA E, 1985, MEDIO AMBIENTE, V7, P91; Myers BA, 1998, AUST J ECOL, V23, P329, DOI 10.1111/j.1442-9993.1998.tb00738.x; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Paine CET, 2009, J TROP ECOL, V25, P171, DOI 10.1017/S0266467408005798; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; REICH PB, 1982, ECOLOGY, V63, P294, DOI 10.2307/1938945; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rojas-Jimenez K, 2007, TREE PHYSIOL, V27, P1561, DOI 10.1093/treephys/27.11.1561; Sherry T. W., 1997, BIRDS N AM; Sherry Thomas W., 2005, P414; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; STUTCHBURY BJ, 1994, AUK, V111, P63, DOI 10.2307/4088505; TANAKA LK, 1982, BIOTROPICA, V14, P114, DOI 10.2307/2387740; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; WOLDA H, 1992, P K NED AKAD WETENSC, V95, P535; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; WRIGHT SJ, 1990, ECOLOGY, V71, P1165, DOI 10.2307/1937384; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713	48	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55114	10.1371/journal.pone.0055114	http://dx.doi.org/10.1371/journal.pone.0055114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372825	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400067
J	Drell, T; Lillsaar, T; Tummeleht, L; Simm, J; Aaspollu, A; Vain, E; Saarma, I; Salumets, A; Donders, GGG; Metsis, M				Drell, Tiina; Lillsaar, Triin; Tummeleht, Lea; Simm, Jaak; Aaspollu, Anu; Vaein, Edda; Saarma, Ivo; Salumets, Andres; Donders, Gilbert G. G.; Metsis, Madis			Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BACTERIAL VAGINOSIS; MOLECULAR-IDENTIFICATION; VAGINITIS; FLORA; COMMUNITIES; CANDIDOSIS; TAXONOMY; HEALTH; FUNGI	The application of high-throughput sequencing methods has raised doubt in the concept of the uniform healthy vaginal microbiota consisting predominantly of lactobacilli by revealing the existence of more variable bacterial community composition. As this needs to be analyzed more extensively and there is little straightforward data regarding the vaginal mycobiome of asymptomatic women we aimed to define bacterial and fungal communities in vaginal samples from 494 asymptomatic, reproductive-age Estonian women. The composition of the vaginal microbiota was determined by amplifying bacterial 16S rRNA and fungal internal transcribed spacer-1 (ITS-1) regions and subsequently sequencing them using 454 Life Sciences pyrosequencing. We delineated five major bacterial community groups with distinctive diversity and species composition. Lactobacilli were among the most abundant bacteria in all groups, but also members of genus Gardnerella had high relative abundance in some of the groups. Microbial diversity increased with higher vaginal pH values, and was also higher when a malodorous discharge was present, indicating that some of the women who consider themselves healthy may potentially have asymptomatic bacterial vaginosis (BV). Our study is the first of its kind to analyze the mycobiome that colonizes the healthy vaginal environment using barcoded pyrosequencing technology. We observed 196 fungal operational taxonomic units (OTUs), including 16 OTUs of Candida spp., which is more diverse than previously recognized. However, assessing true fungal diversity was complicated because of the problems regarding the possible airborne contamination and bioinformatics used for identification of fungal taxons as significant proportion of fungal sequences were assigned to unspecified OTUs.	[Drell, Tiina; Lillsaar, Triin; Tummeleht, Lea; Simm, Jaak; Aaspollu, Anu; Metsis, Madis] Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia; [Drell, Tiina; Lillsaar, Triin; Salumets, Andres; Metsis, Madis] Competence Ctr Reprod Med & Biol, Tartu, Estonia; [Vaein, Edda; Saarma, Ivo] Fertilitas Hosp, Haabneeme, Estonia; [Salumets, Andres] Univ Tartu, Dept Obstet & Gynaecol, EE-50090 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Biomed, EE-50090 Tartu, Estonia; [Donders, Gilbert G. G.] Reg Hosp H Hart, Dept Obstet & Gynecol, Tienen, Belgium; [Donders, Gilbert G. G.] Femicare Vzw, Clin Res Women, Tienen, Belgium	Tallinn University of Technology; University of Tartu; University of Tartu	Drell, T (corresponding author), Tallinn Univ Technol, Ctr Biol Integrated Syst, Tallinn, Estonia.	tiinadrell@gmail.com	Salumets, Andres/J-2278-2015; Metsis, Madis/F-7080-2016; Donders, Gilbert/AAA-9004-2021	Salumets, Andres/0000-0002-1251-8160; Metsis, Madis/0000-0003-1667-677X; Donders, Gilbert/0000-0001-9890-6254	BiotaP LCC Laboratories, Tallinn University of Technology PhD program; Estonian Ministry of Education and Research [SF0180044s09]; Enterprise Estonia [EU30200]; BiotaP LCC	BiotaP LCC Laboratories, Tallinn University of Technology PhD program; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Enterprise Estonia; BiotaP LCC	This research was funded by BiotaP LCC Laboratories, Tallinn University of Technology PhD program and Estonian Ministry of Education and Research (SF0180044s09) and Enterprise Estonia (EU30200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study received funding from a commercial source, BiotaP LCC. The company partly financed and provided sequencing service for the project as part of their workflow development for metagenomic sequencing service. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Foster JA, 2008, INTERDISCIP PERSPECT; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Haggerty CL, 2009, SEX TRANSM INFECT, V85, P242, DOI 10.1136/sti.2008.032821; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Jenkinson HF, 2002, POLYMICROBIAL DISEASES, P357; Kennedy Melissa A, 2010, Curr Infect Dis Rep, V12, P465, DOI 10.1007/s11908-010-0137-9; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mikamo H, 2000, J Infect Chemother, V6, P173, DOI 10.1007/s101560070018; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwebke Jane R., 2001, Curr Infect Dis Rep, V3, P152, DOI 10.1007/s11908-996-0040-6; Singh S, 2002, CLIN INFECT DIS, V35, P1066, DOI 10.1086/343826; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2000, CLIN INFECT DIS, V30, P652, DOI 10.1086/313746; SRINIVASAN S, 2008, INTERDISCIP PERSPECT; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Trama JP, 2005, MOL CELL PROBE, V19, P145, DOI 10.1016/j.mcp.2004.10.004; Us E, 2007, MYCOSES, V50, P13, DOI 10.1111/j.1439-0507.2006.01289.x; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	45	153	157	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54379	10.1371/journal.pone.0054379	http://dx.doi.org/10.1371/journal.pone.0054379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372716	gold, Green Submitted, Green Published			2022-12-27	WOS:000314021500066
J	Koiv, V; Andresen, L; Broberg, M; Frolova, J; Somervuo, P; Auvinen, P; Pirhonen, M; Tenson, T; Mae, A				Koiv, Viia; Andresen, Liis; Broberg, Martin; Frolova, Jekaterina; Somervuo, Panu; Auvinen, Petri; Pirhonen, Minna; Tenson, Tanel; Maee, Andres			Lack of RsmA-Mediated Control Results in Constant Hypervirulence, Cell Elongation, and Hyperflagellation in Pectobacterium wasabiae	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; ENTERICA SEROVAR TYPHIMURIUM; SWARMING MOTILITY; ESCHERICHIA-COLI; GENE-EXPRESSION; GLYCOGEN BIOSYNTHESIS; VIRULENCE FACTORS; INNATE IMMUNITY; SENSING SIGNAL; RNA REGULATOR	The posttranscriptional regulator RsmA controls the production of plant cell wall degrading enzymes (PCWDE) and cell motility in the Pectobacterium genus of plant pathogens. In this study the physiological role of gene regulation by RsmA is under investigation. Disruption of rsmA gene of the Pectobacterium wasabiae strain, SCC3193 resulted in 3-fold decrease in growth rate and increased virulence. The comparison of mRNA levels of the rsmA(-) mutant and wild-type using a genome-wide microarray showed, that genes responsible for successful infection, i.e. virulence factors, motility, butanediol fermentation, various secretion systems etc. were up-regulated in the rsmA(-) strain. The rsmA(-) strain exhibited a higher propensity to swarm and produce PCWDE compared to the wild-type strain. Virulence experiments in potato tubers demonstrated that in spite of its more efficient tissue maceration, the rsmA(-) strain's ability to survive within the host is reduced and the infection site is taken over by resident bacteria. Taken together, in the absence of RsmA, cells revert to a constitutively infective phenotype characterized by expression of virulence factors and swarming. We hypothesize that lack of control over these costly energetic processes results in decreased growth rate and fitness. In addition, our findings suggest a relationship between swarming and virulence in plant pathogens.	[Koiv, Viia; Andresen, Liis; Frolova, Jekaterina; Maee, Andres] Univ Tartu, Inst Mol & CellBiol, EE-50090 Tartu, Estonia; [Broberg, Martin] Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; [Somervuo, Panu; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, DNA Sequencing & GenomicsLab, Helsinki, Finland; [Pirhonen, Minna] Univ Helsinki, Dept AgriculturalSci, Helsinki, Finland; [Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu; University of Helsinki; University of Helsinki; University of Helsinki; University of Tartu	Koiv, V (corresponding author), Univ Tartu, Inst Mol & CellBiol, Ulikooli 18, EE-50090 Tartu, Estonia.	pontu55@hot.ee	Auvinen, Petri/AAP-8117-2021; Auvinen, Petri/D-5044-2009; Mäe, Andres/AAE-8876-2021; Andresen, Liis/AAB-2147-2021; Tenson, Tanel/I-6431-2015	Auvinen, Petri/0000-0002-3947-4778; Tenson, Tanel/0000-0002-0260-3601; Broberg, Martin/0000-0002-5419-9479; Pirhonen, Minna/0000-0001-5249-563X	Estonian Ministry of Education and Research [SF0180088s08, SF0180166s08]; EU through the European Regional Development Fund; EU through the Estonian Centre of Excellence in Genomics; EU through the Center of Excellence in Chemical Biology; Academy of Finland [213509, 129628, 136470, 120821, 128566]; University of Helsinki; Biocentrum Helsinki; Biocenter Finland; Finnish Doctoral Program in Plant Science	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); EU through the European Regional Development Fund; EU through the Estonian Centre of Excellence in Genomics; EU through the Center of Excellence in Chemical Biology; Academy of Finland(Academy of Finland); University of Helsinki; Biocentrum Helsinki; Biocenter Finland; Finnish Doctoral Program in Plant Science	This work was funded by grants SF0180088s08 and SF0180166s08 from the Estonian Ministry of Education and Research; by the EU through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology; by Academy of Finland grants (Center of Excellence program 2006-2011 grants 213509, 129628, and grants 136470, 120821 and 128566); by University of Helsinki; by Biocentrum Helsinki; by Biocenter Finland; by Finnish Doctoral Program in Plant Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Andresen L, 2010, MICROBIOL-SGM, V156, P1323, DOI 10.1099/mic.0.033936-0; Ang S, 2001, J BIOMED SCI, V8, P160, DOI 10.1159/000054028; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; CHATTERJEE A, 1995, APPL ENVIRON MICROB, V61, P1959, DOI 10.1128/AEM.61.5.1959-1967.1995; Chatterjee A, 2010, MOL PLANT MICROBE IN, V23, P1316, DOI 10.1094/MPMI-01-10-0017; Chen BG, 2007, J BACTERIOL, V189, P8750, DOI 10.1128/JB.01109-07; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cronan JEJ, 2006, ECOSAL PLUS, P206; Cui Y, 2008, J BACTERIOL, V190, P4610, DOI 10.1128/JB.01828-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Effantin G, 2011, MOL MICROBIOL, V82, P988, DOI 10.1111/j.1365-2958.2011.07881.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; GYGI D, 1995, MOL MICROBIOL, V17, P1167, DOI 10.1111/j.1365-2958.1995.mmi_17061167.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Hyytiainen H, 2001, MOL PLANT MICROBE IN, V14, P931, DOI 10.1094/MPMI.2001.14.8.931; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kania A, 2003, PLANT SOIL, V248, P117, DOI 10.1023/A:1022371115788; KARLSSON MB, 1991, MOL GEN GENET, V226, P353, DOI 10.1007/BF00260646; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Koiv V, 2001, MOL GENET GENOMICS, V265, P287, DOI 10.1007/s004380000413; Koiv V, 2010, MOL GENET GENOMICS, V283, P541, DOI 10.1007/s00438-010-0540-9; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Lindum PW, 1998, J BACTERIOL, V180, P6384; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Liu Y, 1999, J BACTERIOL, V181, P2411, DOI 10.1128/JB.181.8.2411-2421.1999; Liu Y, 1998, MOL MICROBIOL, V29, P219, DOI 10.1046/j.1365-2958.1998.00924.x; MacFaddin J.F., 1980, BIOCH TESTS IDENTIFI, V2nd; Marits R, 2002, MICROBIOL-SGM, V148, P835, DOI 10.1099/00221287-148-3-835; Marquez-Villavicencio MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022974; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Mukherjee A, 1996, MICROBIOL-SGM, V142, P427, DOI 10.1099/13500872-142-2-427; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Nykyri J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003013; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Patrick JE, 2012, MOL MICROBIOL, V83, P14, DOI 10.1111/j.1365-2958.2011.07917.x; Pearson MM, 2010, INFECT IMMUN, V78, P2834, DOI 10.1128/IAI.01222-09; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; PIRHONEN M, 1988, MICROB PATHOGENESIS, V4, P359, DOI 10.1016/0882-4010(88)90063-0; Pollumaa L, 2012, SENSORS-BASEL, V12, P3327, DOI 10.3390/s120303327; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Sambrook J., 2001, MOL CLONING LAB MANU; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Urbany C, 2008, MOL PLANT MICROBE IN, V21, P547, DOI 10.1094/MPMI-21-5-0547; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; WEST M, 1977, J CLIN MICROBIOL, V6, P414	61	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54248	10.1371/journal.pone.0054248	http://dx.doi.org/10.1371/journal.pone.0054248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372695	gold, Green Published			2022-12-27	WOS:000314021500048
J	Li, YP; Fang, LQ; Gao, SQ; Wang, Z; Gao, HW; Liu, P; Wang, ZR; Li, YL; Zhu, XG; Li, XL; Xu, B; Li, YJ; Yang, H; de Vlas, SJ; Shi, TX; Cao, WC				Li, Ya-pin; Fang, Li-qun; Gao, Su-qing; Wang, Zhen; Gao, Hong-wei; Liu, Peng; Wang, Ze-rui; Li, Yan-li; Zhu, Xu-guang; Li, Xin-lou; Xu, Bo; Li, Yin-jun; Yang, Hong; de Vlas, Sake J.; Shi, Tao-xing; Cao, Wu-chun			Decision Support System for the Response to Infectious Disease Emergencies Based on WebGIS and Mobile Services in China	PLOS ONE			English	Article							HEALTH SURVEILLANCE; TECHNOLOGIES; INFORMATION; PHONES; TRENDS	Background: For years, emerging infectious diseases have appeared worldwide and threatened the health of people. The emergence and spread of an infectious-disease outbreak are usually unforeseen, and have the features of suddenness and uncertainty. Timely understanding of basic information in the field, and the collection and analysis of epidemiological information, is helpful in making rapid decisions and responding to an infectious-disease emergency. Therefore, it is necessary to have an unobstructed channel and convenient tool for the collection and analysis of epidemiologic information in the field. Methodology/Principal Findings: Baseline information for each county in mainland China was collected and a database was established by geo-coding information on a digital map of county boundaries throughout the country. Google Maps was used to display geographic information and to conduct calculations related to maps, and the 3G wireless network was used to transmit information collected in the field to the server. This study established a decision support system for the response to infectious-disease emergencies based on WebGIS and mobile services (DSSRIDE). The DSSRIDE provides functions including data collection, communication and analyses in real time, epidemiological detection, the provision of customized epidemiological questionnaires and guides for handling infectious disease emergencies, and the querying of professional knowledge in the field. These functions of the DSSRIDE could be helpful for epidemiological investigations in the field and the handling of infectious-disease emergencies. Conclusions/Significance: The DSSRIDE provides a geographic information platform based on the Google Maps application programming interface to display information of infectious disease emergencies, and transfers information between workers in the field and decision makers through wireless transmission based on personal computers, mobile phones and personal digital assistants. After a 2-year practice and application in infectious disease emergencies, the DSSRIDE is becoming a useful platform and is a useful tool for investigations in the field carried out by response sections and individuals. The system is suitable for use in developing countries and low-income districts.	[Li, Ya-pin; Fang, Li-qun; Gao, Hong-wei; Li, Yan-li; Li, Xin-lou; Li, Yin-jun; Yang, Hong; Shi, Tao-xing; Cao, Wu-chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China; [Gao, Su-qing; Wang, Zhen; Liu, Peng; Wang, Ze-rui; Zhu, Xu-guang; Xu, Bo] PLA Univ Sci & Technol, Inst Command Automat, Nanjing, Jiangsu, Peoples R China; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus Med Ctr MC, Dept Publ Hlth, Rotterdam, Netherlands	Beijing Institute of Microbiology & Epidemiology; Army Engineering University of PLA; Erasmus University Rotterdam; Erasmus MC	Shi, TX (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	shitaoxing@sina.com; caowc@bmi.ac.cn	li, xinlou/ABF-8578-2021; Fang, Li-Qun/GWD-0296-2022; WANG, ZERUI/AAU-3671-2021	WANG, ZERUI/0000-0002-8219-1458; de Vlas, Sake J./0000-0002-1830-5668	Chinese National Science Fund for Distinguished Young Scholars [30725032]; Special Program for Prevention and Control of Infectious Diseases in China [2008ZX10004-012, 2009ZX10004-720]; Natural Science Foundation of China [30590374, 3097252 1]	Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Special Program for Prevention and Control of Infectious Diseases in China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Chinese National Science Fund for Distinguished Young Scholars (grant 30725032), the Special Program for Prevention and Control of Infectious Diseases in China (grants 2008ZX10004-012 and 2009ZX10004-720), and the Natural Science Foundation of China (grants 30590374and 3097252 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All China Data Center, 2010, CHIN DAT ONL; Blaya JA, 2010, HEALTH AFFAIR, V29, P244, DOI 10.1377/hlthaff.2009.0894; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Castillo-Salgado C, 2010, EPIDEMIOL REV, V32, P93, DOI 10.1093/epirev/mxq008; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005; Chanlekha H, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-1; Chib A, 2010, J COMPUT-MEDIAT COMM, V15, P500, DOI 10.1111/j.1083-6101.2010.01515.x; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; de Vlas SJ, 2009, TROP MED INT HEALTH, V14, P1, DOI 10.1111/j.1365-3156.2009.02349.x; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Foley DH, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-11; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Garcia-Perez J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-1; Gow GA, 2009, IEEE P, P366; Johnson LE, 2009, CLIN INFECT DIS, V48, P1585, DOI 10.1086/598974; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Li Ya-pin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1102; Lin YB, 2011, PREV VET MED, V98, P209, DOI 10.1016/j.prevetmed.2010.10.003; Liu DH, 2008, INT J MED INFORM, V77, P630, DOI 10.1016/j.ijmedinf.2007.10.011; Lopez J, 2009, EMERG INFECT DIS, V15, P1674, DOI 10.3201/eid1510.081596; Nelson R, 2008, LANCET INFECT DIS, V8, P596, DOI 10.1016/S1473-3099(08)70219-6; Robertson C, 2010, EMERG INFECT DIS, V16, P1524, DOI 10.3201/eid1610.100249; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; Yang CH, 2009, B WORLD HEALTH ORGAN, V87, P619, DOI 10.2471/BLT.08.060905; Yoo HS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-93; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	30	18	20	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54842	10.1371/journal.pone.0054842	http://dx.doi.org/10.1371/journal.pone.0054842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372780	gold, Green Published			2022-12-27	WOS:000314021500136
J	Cao, ZG; Gao, HY; Qu, XL; Yang, MM; Yang, XG				Cao, Zhigang; Gao, Haoyu; Qu, Xinglong; Yang, Mingmin; Yang, Xiaoguang			Fashion, Cooperation, and Social Interactions	PLOS ONE			English	Article							NETWORK FORMATION; STATISTICAL-MECHANICS; ANTI-COORDINATION; LOCAL INTERACTION; SIMPLE-MODEL; DYNAMICS; EMERGENCE; MINORITY; MAJORITY; AGENTS	Fashion plays such a crucial rule in the evolution of culture and society that it is regarded as a second nature to the human being. Also, its impact on economy is quite nontrivial. On what is fashionable, interestingly, there are two viewpoints that are both extremely widespread but almost opposite: conformists think that what is popular is fashionable, while rebels believe that being different is the essence. Fashion color is fashionable in the first sense, and Lady Gaga in the second. We investigate a model where the population consists of the afore-mentioned two groups of people that are located on social networks (a spatial cellular automata network and small-world networks). This model captures two fundamental kinds of social interactions (coordination and anti-coordination) simultaneously, and also has its own interest to game theory: it is a hybrid model of pure competition and pure cooperation. This is true because when a conformist meets a rebel, they play the zero sum matching pennies game, which is pure competition. When two conformists (rebels) meet, they play the (anti-) coordination game, which is pure cooperation. Simulation shows that simple social interactions greatly promote cooperation: in most cases people can reach an extraordinarily high level of cooperation, through a selfish, myopic, naive, and local interacting dynamic (the best response dynamic). We find that degree of synchronization also plays a critical role, but mostly on the negative side. Four indices, namely cooperation degree, average satisfaction degree, equilibrium ratio and complete ratio, are defined and applied to measure people's cooperation levels from various angles. Phase transition, as well as emergence of many interesting geographic patterns in the cellular automata network, is also observed.	[Cao, Zhigang; Gao, Haoyu; Qu, Xinglong; Yang, Mingmin; Yang, Xiaoguang] Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Management Decis & Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Cao, ZG (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Management Decis & Informat Syst, Beijing, Peoples R China.	zhigangcao@amss.ac.cn	cao, zhigang/AHI-0088-2022	CAO, Zhigang/0000-0001-7106-6734	State Key Development Program for Basic Research of China (973 Program) [2010CB731405]; National Natural Science Foundation of China [71101140]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the State Key Development Program for Basic Research of China (973 Program) under grant number 2010CB731405, and the National Natural Science Foundation of China under grant number of 71101140. The funders had no role in study design, data ollection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, DYN GAMES APPL, V1, P3, DOI 10.1007/s13235-010-0004-1; Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; Anderlini L, 1993, PATH DEPENDENCE LEAR; [Anonymous], 2014, HDB GAME THEORY; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bell D, 1973, COMING POST-IND SOC; Berninghaus SK, 1996, J EVOL ECON, V6, P297, DOI 10.1007/s001910050024; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; BLUME LE, 1995, GAME ECON BEHAV, V11, P111, DOI 10.1006/game.1995.1046; Bramoulle Y, 2004, INT J GAME THEORY, V33, P1, DOI 10.1007/s001820400178; Bramoulle Y, 2007, GAME ECON BEHAV, V58, P30, DOI 10.1016/j.geb.2005.12.006; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Cannings C, 2009, INT C GAM THEOR NETW; Cao Z, 2011, 6 INT C KNOWL INF CR, P29; Cao Z, 2012, FASHION GAME MATCHIN; Cao ZG, 2013, J COMB OPTIM, V26, P811, DOI 10.1007/s10878-012-9486-7; Caporale GM, 2008, P 2008 C EV COMP, P3420; Chai A, 2007, ADV AUSTRIAN ECON, V10, P187, DOI 10.1016/S1529-2134(07)10008-9; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Challet D., 2004, MINORITY GAMES INTER; Challet D, 2008, J ECON DYN CONTROL, V32, P85, DOI 10.1016/j.jedc.2007.01.022; Chen F, 2008, PHYSICA A, V387, P3594, DOI 10.1016/j.physa.2008.02.023; Chen S, 2008, CTR GAME THEORY EC A; de Martino A, 2003, J PHY A, V36, P3935; Eliaz K, 2011, GAME ECON BEHAV, V71, P88, DOI 10.1016/j.geb.2009.05.010; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Euromonitor International, 2011, GLOB LUX GOODS OV; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S, 2008, INT J MOD PHYS C, V19, P409, DOI 10.1142/S0129183108012297; Galeotti A, 2010, REV ECON STUD, V77, P218, DOI 10.1111/j.1467-937X.2009.00570.x; Golub B, 2010, AM ECON J-MICROECON, V2, P112, DOI 10.1257/mic.2.1.112; Gou C, 2006, JASSS-J ARTIF SOC S, V9, P321; Gou CL, 2006, NE ECON WIN, P123, DOI 10.1007/978-88-470-0502-0_12; Gou CL, 2006, PHYSICA A, V371, P633, DOI 10.1016/j.physa.2006.04.050; Goyal S, 2005, GAME ECON BEHAV, V50, P178, DOI 10.1016/j.geb.2004.01.005; Hart S, 2003, AM ECON REV, V93, P1830, DOI 10.1257/000282803322655581; Hong H, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056210; Hong H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046202; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Jackson M, 2012, LECT NOTES GEME THEO; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jackson MO, 2002, GAME ECON BEHAV, V41, P265, DOI 10.1016/S0899-8256(02)00504-3; Kalai A, 2010, GAMES EC BEHAV; Kearns Micheal J., 2001, P 17 C UNC ART INT, P253; Liu F., 2010, 2010 3 INT JOINT C C, P1, DOI DOI 10.1109/ITAPP.2010.5566267; Lopez-Pintado D, 2008, RATION SOC, V20, P399, DOI 10.1177/1043463108096787; Lopez-Pintado D, 2009, INT GAME THEORY REV, V11, P53, DOI 10.1142/S0219198909002145; Marsili M, 2001, PHYSICA A, V299, P93, DOI 10.1016/S0378-4371(01)00285-0; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; PESENDORFER W, 1995, AM ECON REV, V85, P771; Schweitzer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001458; Statista, 2021, LUX FASH; Svendsen L, 2006, FASHION PHILOS; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; van Nes Nicole, 2010, LONGER LASTING PRODU; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wilensky U., 1999, NETLOGO; Young H. P, 2001, INDIVIDUAL STRATEGY	65	15	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e49441	10.1371/journal.pone.0049441	http://dx.doi.org/10.1371/journal.pone.0049441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23382799	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600001
J	Hayata, K; Iwahashi, M; Ojima, T; Katsuda, M; Iida, T; Nakamori, M; Ueda, K; Nakamura, M; Miyazawa, M; Tsuji, T; Yamaue, H				Hayata, Keiji; Iwahashi, Makoto; Ojima, Toshiyasu; Katsuda, Masahiro; Iida, Takeshi; Nakamori, Mikihito; Ueda, Kentaro; Nakamura, Masaki; Miyazawa, Motoki; Tsuji, Toshiaki; Yamaue, Hiroki			Inhibition of IL-17A in Tumor Microenvironment Augments Cytotoxicity of Tumor-Infiltrating Lymphocytes in Tumor-Bearing Mice	PLOS ONE			English	Article							SUPPRESSOR-CELLS; T-CELLS; INTESTINAL INFLAMMATION; HUMAN INTERLEUKIN-17; ENDOGENOUS IL-17; LUNG-CANCER; TH17 CELLS; GROWTH; ANGIOGENESIS; INDUCTION	It remains controversial whether IL-17A promotes or inhibits cancer progression. We hypothesized that IL-17A that is locally produced in the tumor microenvironment has an important role in angiogenesis and tumor immunity. We investigated the effect of inhibiting IL-17A at tumor sites on tumor growth and on local and systemic anti-tumor immunity. MC38 or B16 cells were inoculated subcutaneously into mice, and intratumoral injection of an adenovirus vector expressing siRNA against the mouse IL-17A gene (Ad-si-IL-17) significantly inhibited tumor growth in both tumor models compared with control mice. Inhibition of IL-17A at tumor sites significantly suppressed CD31, MMP9, and VEGF expression in tumor tissue. The cytotoxic activity of CD8(+) T cells from tumor-infiltrating lymphocytes in mice treated with Ad-si-IL-17 was significantly higher than in control mice; however, CD8(+) T cells from splenocytes had similar activity levels. Suppression of IL-17A at tumor sites led to a Th1-dominant environment, and moreover, eliminated myeloid-derived suppressor cells and regulatory T cells at tumor sites but not in splenocytes. In conclusion, blockade of IL-17A at tumor sites helped suppress tumor growth by inhibiting angiogenesis as well as cytotoxic T lymphocytes activation at tumor sites.	[Hayata, Keiji; Iwahashi, Makoto; Ojima, Toshiyasu; Katsuda, Masahiro; Iida, Takeshi; Nakamori, Mikihito; Ueda, Kentaro; Nakamura, Masaki; Miyazawa, Motoki; Tsuji, Toshiaki; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan	Wakayama Medical University	Iwahashi, M (corresponding author), Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan.	makoto@wakayama-med.ac.jp			Japan Society for the Promotion of Science [22591415]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22791296]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science grants 22591415 and Ministry of Education, Culture, Sports, Science and Technology, Japan grants 22791296. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ojima T, 2007, INT J CANCER, V120, P585, DOI 10.1002/ijc.22298; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Reppert S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1609; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Tartour E, 1999, CANCER RES, V59, P3698; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yu P, 2005, J EXP MED, V201, P779, DOI 10.1084/jem.20041684; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhao QY, 2011, EUR J IMMUNOL, V41, P2314, DOI 10.1002/eji.201041282; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	49	42	42	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53131	10.1371/journal.pone.0053131	http://dx.doi.org/10.1371/journal.pone.0053131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372655	Green Submitted, gold, Green Published			2022-12-27	WOS:000315210400005
J	Pollet, TV; Roberts, SGB; Dunbar, RIM				Pollet, Thomas V.; Roberts, Sam G. B.; Dunbar, Robin I. M.			Going That Extra Mile: Individuals Travel Further to Maintain Face-to-Face Contact with Highly Related Kin than with Less Related Kin	PLOS ONE			English	Article							GENETIC RELATEDNESS; EMOTIONAL CLOSENESS; INCLUSIVE FITNESS; SOCIAL NETWORKS; MOBILE PHONE; ALTRUISM; KINSHIP; RESEMBLANCE; COOPERATION; EVOLUTION	The theory of inclusive fitness has transformed our understanding of cooperation and altruism. However, the proximate psychological underpinnings of altruism are less well understood, and it has been argued that emotional closeness mediates the relationship between genetic relatedness and altruism. In this study, we use a real-life costly behaviour (travel time) to dissociate the effects of genetic relatedness from emotional closeness. Participants travelled further to see more closely related kin, as compared to more distantly related kin. For distantly related kin, the level of emotional closeness mediated this relationship - when emotional closeness was controlled for, there was no effect of genetic relatedness on travel time. However, participants were willing to travel further to visit parents, children and siblings as compared to more distantly related kin, even when emotional closeness was controlled for. This suggests that the mediating effect of emotional closeness on altruism varies with levels of genetic relatedness.	[Pollet, Thomas V.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Roberts, Sam G. B.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Dunbar, Robin I. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Vrije Universiteit Amsterdam; University of Chester; University of Oxford	Pollet, TV (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	t.v.pollet@vu.nl	Pollet, Thomas/M-6346-2019; Pollet, Thomas V/H-3397-2012	Pollet, Thomas/0000-0002-4210-935X; Pollet, Thomas V/0000-0002-4210-935X; Roberts, Sam/0000-0003-3986-0254	Netherlands Organisation for Scientific Research [451.10.032]; ERC	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	Thomas Pollet is supported by The Netherlands Organisation for Scientific Research (Veni, 451.10.032). Robin Dunbar is supported by an ERC grant (Psychology of Relationships, Networks and Community Cohesion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JM, 2007, EVOL HUM BEHAV, V28, P365, DOI 10.1016/j.evolhumbehav.2007.04.004; Adams GJ, 1996, J EXP EDUC, V64, P267, DOI 10.1080/00220973.1996.9943807; Allison P.D., 1984, EVENT HIST ANAL REGR; Apicella CL, 2004, EVOL HUM BEHAV, V25, P371, DOI 10.1016/j.evolhumbehav.2004.06.003; Barrett L., 2002, HUMAN EVOLUTIONARY P; BEN-NER A., 2008, J SOCIO-ECON, V37, P1775, DOI [DOI 10.1016/J.SOCEC.2007.11.004, 10.1016/j.socec.2007.11.004]; Bereczkei T, 2004, P ROY SOC B-BIOL SCI, V271, P1129, DOI 10.1098/rspb.2003.2672; Binder JF, 2012, SOC NETWORKS, V34, P206, DOI 10.1016/j.socnet.2011.12.001; Boase J, 2006, STRENGTH INTERNET TI; Bourke AFG, 2011, P ROY SOC B-BIOL SCI, V278, P3313, DOI 10.1098/rspb.2011.1465; Bressan P, 2009, BIOL LETTERS, V5, P336, DOI 10.1098/rsbl.2008.0789; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; BURNSTEIN E, 1994, J PERS SOC PSYCHOL, V67, P773, DOI 10.1037/0022-3514.67.5.773; BUYS CJ, 1979, PSYCHOL REP, V45, P547, DOI 10.2466/pr0.1979.45.2.547; COX DR, 1972, J R STAT SOC B, V34, P187; Curry O, 2013, BRIT J PSYCHOL, V104, P283, DOI 10.1111/j.2044-8295.2012.02119.x; Curry O, 2011, BIOL LETTERS, V7, P651, DOI 10.1098/rsbl.2010.1202; DeBruine LM, 2009, VISION RES, V49, P38, DOI 10.1016/j.visres.2008.09.025; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Fisher RA, 1930, GENETICAL THEORY NAT; Grayson D. K., 1993, EVOLUTIONARY ANTHR, V2, P151, DOI DOI 10.1002/EVAN.1360020502; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Haythornthwaite C, 2005, INFORM COMMUNICATION, V8; Heijkoop M, 2009, EUR J DEV PSYCHOL, V6, P64, DOI 10.1080/17405620802642306; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hogan B, 2007, FIELD METHOD, V19, P116, DOI 10.1177/1525822X06298589; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jeon J, 2007, P R SOC B, V274, P1181, DOI 10.1098/rspb.2006.0366; Jones BC, 2011, OXFORD HDB EVOLUTION, P345; KALBFLEISCH JD, 2002, STAT ANAL FAILURE TI, P95, DOI DOI 10.1002/9781118032985; Kana'Iaupuni SM, 2005, SOC FORCES, V83, P1137, DOI 10.1353/sof.2005.0036; Kim H, 2007, J COMPUT-MEDIAT COMM, V12, P1183, DOI 10.1111/j.1083-6101.2007.00369.x; Korchmaros JD, 2006, J SOC PERS RELAT, V23, P21, DOI 10.1177/0265407506060176; Korchmaros JD, 2001, PSYCHOL SCI, V12, P262, DOI 10.1111/1467-9280.00348; Kraut R., 2006, COMPUTERS PHONES INT, P265, DOI DOI 10.1093/ACPROF:OSO/9780195312805.003.0018; Kruger DJ, 2003, EVOL HUM BEHAV, V24, P118, DOI 10.1016/S1090-5138(02)00156-3; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; LEE TR, 1990, J MARRIAGE FAM, V52, P431, DOI 10.2307/353037; Lieberman D, 2008, EUR J SOC PSYCHOL, V38, P998, DOI 10.1002/ejsp.528; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Madsen EA, 2007, BRIT J PSYCHOL, V98, P339, DOI 10.1348/000712606X129213; Marcinkowska UM, 2012, EVOL PSYCHOL-US, V10, P621, DOI 10.1177/147470491201000318; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; Milinski M, 1998, P NATL ACAD SCI USA, V95, P13755, DOI 10.1073/pnas.95.23.13755; Neyer FJ, 2003, J PERS SOC PSYCHOL, V84, P310, DOI 10.1037/0022-3514.84.2.310; Nie NH, 2001, AM BEHAV SCI, V45, P420, DOI 10.1177/00027640121957277; Noe R, 2006, ANIM BEHAV, V71, P1, DOI 10.1016/j.anbehav.2005.03.037; Parks MR, 1996, J SOC PERS RELAT, V13, P85, DOI 10.1177/0265407596131005; Pollet T. V., 2006, J CULTURAL EVOLUTION, V4, P83; Pollet TV, 2008, J BIOSOC SCI, V40, P761, DOI 10.1017/S0021932007002659; Pollet TV, 2007, EVOL HUM BEHAV, V28, P176, DOI 10.1016/j.evolhumbehav.2006.10.001; Pollet TV, 2011, J INDIVID DIFFER, V32, P161, DOI 10.1027/1614-0001/a000048; Pollet TV., 2007, EVOL PSYCHOL-US, V5, P832, DOI [10.1177/14747049, DOI 10.1177/147470490700500412, 10.1177/147470490700500412]; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; SHAVIT Y, 1994, SOC FORCES, V72, P1197, DOI 10.2307/2580298; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040721; SMITH MS, 1987, ETHOL SOCIOBIOL, V8, P171, DOI 10.1016/0162-3095(87)90042-2; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; SPSS, 2007, SPSS WIND 16 0; SPSS, 2007, SPSS 16 0 US MAN; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Stewart-Williams S, 2007, EVOL HUM BEHAV, V28, P193, DOI 10.1016/j.evolhumbehav.2007.01.002; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Watkins CD, 2011, EVOL HUM BEHAV, V32, P70, DOI 10.1016/j.evolhumbehav.2010.09.001; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WEST SG, 1975, J EXP SOC PSYCHOL, V11, P531, DOI 10.1016/0022-1031(75)90004-9; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	77	28	28	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e53929	10.1371/journal.pone.0053929	http://dx.doi.org/10.1371/journal.pone.0053929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372676	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315210400008
J	Timoneda, O; Balcells, I; Nunez, JI; Egea, R; Vera, G; Castello, A; Tomas, A; Sanchez, A				Timoneda, Oriol; Balcells, Ingrid; Ignacio Nunez, Jose; Egea, Raquel; Vera, Gonzalo; Castello, Anna; Tomas, Anna; Sanchez, Armand			miRNA Expression Profile Analysis in Kidney of Different Porcine Breeds	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; PHYLOGENETIC-RELATIONSHIPS; PIG DOMESTICATION; WEB SERVER; MICRORNA; DNA; IDENTIFICATION; TARGETS; CANCER; GENES	microRNAs (miRNAs) are important post-transcriptional regulators in eukaryotes that target mRNAs repressing their expression. The uncertain process of pig domestication, with different origin focuses, and the selection process that commercial breeds suffered, have generated a wide spectrum of breeds with clear genetic and phenotypic variability. The aim of this work was to define the miRNAs expression profile in kidney of several porcine breeds. Small RNA libraries from kidney were elaborated and high-throughput sequenced with the 454 Genome Sequencer FLX (Roche). Pigs used were classified into three groups: the European origin group (Iberian breed and European Wild Boar ancestor), European commercial breeds (Landrace, Large White and Pietrain breeds) and breeds with Asian origin (Meishan and Vietnamese breeds). A total of 229 miRNAs were described in the pig kidney miRNA profile, including 110 miRNAs out of the 257 previously described pig miRNAs and 119 orthologous miRNAs. The most expressed miRNAs in pig kidney microRNAome were Hsa-miR-200b-3p, Ssc-miR-125b and Ssc-miR-23b. Moreover, 5 novel porcine miRNAs and 3 orthologous miRNAs could be validated through RT-qPCR. miRNA sequence variation was determined in 116 miRNAs, evidencing the presence of isomiRs. 125 miRNAs were differentially expressed between breed groups. The identification of breed-specific miRNAs, which could be potentially associated to certain phenotypes, is becoming a new tool for the study of the genetic variability underlying complex traits and furthermore, it adds a new layer of complexity to the interesting process of pig evolution.	[Timoneda, Oriol; Balcells, Ingrid; Egea, Raquel; Vera, Gonzalo; Castello, Anna; Sanchez, Armand] Univ Autonoma Barcelona, Ctr Recerca AgriGenom CRAG, Dept Genet Anim, Bellaterra, Spain; [Ignacio Nunez, Jose] UAB, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Spain; [Tomas, Anna] FISIB, Program Infect & Immun, Bunyola, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Autonomous University of Barcelona; IRTA	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Ctr Recerca AgriGenom CRAG, Dept Genet Anim, Campus UAB, Bellaterra, Spain.	oriol.timoneda@cragenomica.es	Vera, Gonzalo/L-1895-2014; Egea, Raquel/F-9355-2016; Nuñez, Jose I/M-7141-2018; Farré, Anna Castelló/K-9637-2015; Sanchez, Armand/L-7905-2015	Vera, Gonzalo/0000-0001-6990-0216; Egea, Raquel/0000-0002-6201-4112; Nuñez, Jose I/0000-0001-9890-7695; Farré, Anna Castelló/0000-0001-8497-6251; Sanchez, Armand/0000-0001-9160-1124	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion [CSD2007-00036]; FPI PhD fellowship from Spanish Government;  [AGL2007-66371-C02-01];  [AGL2010-22358-C02-01]	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion; FPI PhD fellowship from Spanish Government; ; 	This work was supported by the projects AGL2007-66371-C02-01 and AGL2010-22358-C02-01 and by the Consolider-Ingenio 2010 program (CSD2007-00036) from Ministerio de Ciencia e Innovacion. OT is recipient of FPI PhD fellowship from Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2003, ANIM GENET, V34, P319, DOI 10.1046/j.1365-2052.2003.01010.x; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bockmeyer CL, 2011, BREAST CANC RES TREA; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Clop A, 2004, GENET SEL EVOL, V36, P97, DOI 10.1051/gse:2003053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gao Y, 2011, GENET MOL RES, V10, P779, DOI 10.4238/vol10-2gmr1170; Giuffra E, 2000, GENETICS, V154, P1785; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HY, 2012, ANIMAL GENETICS; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Li S, 2011, DNA CELL BIOL, V30, P1073, DOI 10.1089/dna.2011.1267; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lian C, 2012, FEBS J; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ojeda A, 2011, HEREDITY, V106, P330, DOI 10.1038/hdy.2010.61; Patel N, 2011, J NUCL ACIDS INVESTI, V2, pe1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Tang XQ, 2011, METHODS MOL BIOL, V732, P69, DOI 10.1007/978-1-61779-083-6_6; Tarver JE, 2012, BIOESSAYS, V34, P857, DOI 10.1002/bies.201200055; Taub MA, 2010, GENOME MED, V2, DOI 10.1186/gm208; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou Y, 2012, REPROD DOMESTIC ANIM; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	24	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55402	10.1371/journal.pone.0055402	http://dx.doi.org/10.1371/journal.pone.0055402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372853	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400093
J	Cheng, L; Jin, XK; Li, WW; Li, S; Guo, XN; Wang, J; Gong, YN; He, L; Wang, Q				Cheng, Lin; Jin, Xing-Kun; Li, Wei-Wei; Li, Shuang; Guo, Xiao-Nv; Wang, Juan; Gong, Ya-Nan; He, Lin; Wang, Qun			Fatty Acid Binding Proteins FABP9 and FABP10 Participate in Antibacterial Responses in Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							C-TYPE LECTIN; DIFFERENTIALLY EXPRESSED GENES; SPOT SYNDROME VIRUS; INNATE IMMUNITY; SHRIMP; INVERTEBRATES; RECOGNITION; CELLS; LIVER; HEPATOPANCREAS	Invertebrates rely solely on the innate immune system for defense against pathogens and other stimuli. Fatty acid binding proteins (FABP), members of the lipid binding proteins superfamily, play a crucial role in fatty acid transport and lipid metabolism and are also involved in gene expression induced by fatty acids. In the vertebrate immune system, FABP is involved in inflammation regulated by fatty acids through its interaction with peroxidase proliferator activate receptors (PPARs). However, the immune functions of FABP in invertebrates are not well characterized. For this reason, we investigated the immune functionality of two fatty acid binding proteins, Es-FABP9 and Es-FABP10, following lipopolysaccharide (LPS) challenge in the Chinese mitten crab (Eriocheir sinensis). An obvious variation in the expression of Es-FABP9 and Es-FABP10 mRNA in E. sinensis was observed in hepatopancreas, gills, and hemocytes post-LPS challenge. Recombinant proteins rEs-FABP9 and rEs-FABP10 exhibited distinct bacterial binding activity and bacterial agglutination activity against Escherichia coli and Staphylococcus aureus. Furthermore, bacterial growth inhibition assays demonstrated that rEs-FABP9 responds positively to the growth inhibition of Vibrio parahaemolyticuss and S. aureus, while rEs-FABP10 responds positively to the growth inhibition of Aeromonas hydrophila and Bacillus subtilis. Coating of agarose beads with recombinant rEs-FABP9 and rEs-FABP10 dramatically enhanced encapsulation of the beads by crab hemocytes in vitro. In conclusion, the data presented here demonstrate the participation of these two lipid metabolism-related proteins in the innate immune system of E. sinensis.	[Li, Shuang; Guo, Xiao-Nv; Wang, Juan; Gong, Ya-Nan; He, Lin; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Jin, Xingkun/H-4366-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; 	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Espino AM, 2001, J PARASITOL, V87, P426, DOI 10.1645/0022-3395(2001)087[0426:IOFAMI]2.0.CO;2; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Fonseca CT, 2006, MICROBES INFECT, V8, P2509, DOI 10.1016/j.micinf.2006.06.008; Gerstner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015890; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gong YN, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-71; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021; Jin XK, 2012, FISH SHELLFISH IMMUN, V33, P1149, DOI 10.1016/j.fsi.2012.08.027; Jin XK, 2011, FISH SHELLFISH IMMUN, V30, P263, DOI 10.1016/j.fsi.2010.10.016; Karanth S, 2008, FEBS J, V275, P3031, DOI 10.1111/j.1742-4658.2008.06455.x; Kitanaka N, 2003, HISTOCHEM CELL BIOL, V120, P465, DOI 10.1007/s00418-003-0590-8; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li WW, 2011, MOL BIOL REP, V38, P5169, DOI 10.1007/s11033-010-0666-1; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Owada Y, 2001, HISTOCHEM J, V33, P453, DOI 10.1023/A:1014420330284; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Smith Valerie J., 1991, Comparative Haematology International, V1, P61, DOI 10.1007/BF00422876; Snedecor G., 1971, STAT METHODS; Soderhall I, 2006, FEBS J, V273, P2902, DOI 10.1111/j.1742-4658.2006.05303.x; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang B, 2008, MAR BIOTECHNOL, V10, P664, DOI 10.1007/s10126-008-9105-x; Wang N, 2008, DEV COMP IMMUNOL, V32, P1034, DOI 10.1016/j.dci.2008.02.001; Wood LG, 2009, PROG LIPID RES, V48, P27, DOI 10.1016/j.plipres.2008.10.001; Yamamoto N, 2008, PROSTAG LEUKOTR ESS, V79, P21, DOI 10.1016/j.plefa.2008.06.003; Yang HJ, 2007, FISH SHELLFISH IMMUN, V22, P88, DOI 10.1016/j.fsi.2006.03.015; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	59	20	20	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54053	10.1371/journal.pone.0054053	http://dx.doi.org/10.1371/journal.pone.0054053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365646	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600027
J	Fockenberg, DA; Koole, SL; Lakens, D; Semin, GR				Fockenberg, Daniel A.; Koole, Sander L.; Lakens, Daniel; Semin, Gun R.			Shifting Evaluation Windows: Predictable Forward Primes with Long SOAs Eliminate the Impact of Backward Primes	PLOS ONE			English	Article							AUTOMATIC ACTIVATION; TASK; CONTRAST; ACCOUNT; CONTEXT	Recent work suggests that people evaluate target stimuli within short and flexible time periods called evaluation windows. Stimuli that briefly precede a target (forward primes) or briefly succeed a target (backward primes) are often included in the target's evaluation. In this article, the authors propose that predictable forward primes act as "go" signals that prepare target processing, such that earlier forward primes pull the evaluation windows forward in time. Earlier forward primes may thus reduce the impact of backward primes. This shifting evaluation windows hypothesis was tested in two experiments using an evaluative decision task with predictable (vs. unpredictable) forward and backward primes. As expected, a longer time interval between a predictable forward prime and a target eliminated backward priming. In contrast, the time interval between an unpredictable forward primes and a target had no effects on backward priming. These findings suggest that predictable features of dynamic stimuli can shape target extraction by determining which information is included (or excluded) in rapid evaluation processes.	[Fockenberg, Daniel A.] Univ Freiburg, Inst Psychol, D-79106 Freiburg, Germany; [Koole, Sander L.] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Lakens, Daniel] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands; [Semin, Gun R.] Univ Utrecht, Royal Netherlands Acad Arts & Sci, Utrecht, Netherlands; [Semin, Gun R.] Koc Univ, Istanbul, Turkey	University of Freiburg; Vrije Universiteit Amsterdam; Eindhoven University of Technology; Utrecht University; Koc University	Fockenberg, DA (corresponding author), Univ Freiburg, Inst Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	Dafockenberg@gmail.com	Lakens, Daniël/K-3831-2015; Semin, Gun/J-4046-2013	Lakens, Daniël/0000-0002-0247-239X; Semin, Gun/0000-0002-5304-5566	Royal Netherlands Academy of Arts and Sciences (KNAW) Academy Professorship grant [ISK/4583/PAH]; European Research Council [ERC-2011-StG_20101124]	Royal Netherlands Academy of Arts and Sciences (KNAW) Academy Professorship grant; European Research Council(European Research Council (ERC)European Commission)	The research reported in this paper was partly supported by the Royal Netherlands Academy of Arts and Sciences (KNAW) Academy Professorship grant (ISK/4583/PAH) to Gun R. Semin and a Consolidator Grant of the European Research Council awarded to Sander L. Koole (ERC-2011-StG_20101124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Clark-Carter D, 2004, PSYCHOL PR; De Houwer J, 2004, COGNITION EMOTION, V18, P251, DOI 10.1080/02699930341000022; De Houwer J, 2002, COGNITION EMOTION, V16, P643, DOI 10.1080/02699930143000419; De Houwer J, 2002, EXP PSYCHOL, V49, P163, DOI 10.1027//1618-3169.49.3.163; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Degner J, 2009, COGNITION EMOTION, V23, P327, DOI 10.1080/02699930801993924; Eder AB, 2009, J EXP PSYCHOL GEN, V138, P218, DOI 10.1037/a0015220; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fockenberg DA, 2006, J EXP SOC PSYCHOL, V42, P799, DOI 10.1016/j.jesp.2005.12.003; Fockenberg DA, 2008, SOC COGNITION, V26, P647, DOI 10.1521/soco.2008.26.6.647; Gawronski B, 2005, PERS SOC PSYCHOL B, V31, P1226, DOI 10.1177/0146167205274689; Glaser J, 1999, J PERS SOC PSYCHOL, V77, P669, DOI 10.1037/0022-3514.77.4.669; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Klauer KC, 2010, J EXP PSYCHOL GEN, V139, P490, DOI 10.1037/a0019746; Klauer KC, 2009, J PERS SOC PSYCHOL, V96, P265, DOI 10.1037/a0013248; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Koole SL, 2011, COGNITION EMOTION, V25, P440, DOI 10.1080/02699931.2010.544891; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; RATCLIFF R, 1988, PSYCHOL REV, V95, P385, DOI 10.1037/0033-295X.95.3.385; RATCLIFF R, 1995, J EXP PSYCHOL LEARN, V21, P1380, DOI 10.1037/0278-7393.21.5.1380; Scherer LD, 2009, J PERS SOC PSYCHOL, V97, P383, DOI 10.1037/a0015844; Schmitz M, 2012, J EXP PSYCHOL LEARN, V38, P984, DOI 10.1037/a0026779; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Spruyt A, 2007, EXP PSYCHOL, V54, P44, DOI 10.1027/1618-3169.54.1.44; Storbeck J, 2004, PERS SOC PSYCHOL B, V30, P81, DOI 10.1177/0146167203258855; Teige-Mocigemba S, 2008, J EXP SOC PSYCHOL, V44, P1414, DOI 10.1016/j.jesp.2008.04.004; Voss A, 2007, BEHAV RES METHODS, V39, P797, DOI 10.3758/BF03192971; Wentura D., 2010, HDB IMPLICIT SOCIAL, P95	32	2	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54739	10.1371/journal.pone.0054739	http://dx.doi.org/10.1371/journal.pone.0054739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359809	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600101
J	Hao, K; Qi, Q; Hao, HP; Wang, GJ; Chen, YC; Liang, Y; Xie, L				Hao, Kun; Qi, Qu; Hao, Haiping; Wang, Guangji; Chen, Yuancheng; Liang, Yan; Xie, Lin			The Pharmacokinetic-Pharmacodynamic Model of Azithromycin for Lipopolysaccharide-Induced Depressive-Like Behavior in Mice	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-ALPHA; QUINOLINIC ACID; CANCER-PATIENTS; BRAIN; TRYPTOPHAN; MECHANISM; BUPRENORPHINE; KYNURENINE; INDUCTION	A mechanism-based model was developed to describe the time course of lipopolysaccharide-induced depressive-like behavior and azithromycin pharmacodynamics in mice. The lipopolysaccharide-induced disease progression was monitored by lipopolysaccharide, proinflammatory cytokines, and kynrenine concentration in plasma. The depressive-like behavior was investigated by forced swimming test and tail suspension test. Azithromycin was selected to inhibit the surge of proinflammatory cytokines induced by lipopolysaccharide. Disease progression model and azithromycin pharmacodynamics were constructed from transduction and indirect response models. A delay in the onset of increased proinflammatory cytokines, kynrenine, and behavior test compared to lipopolysaccharide was successfully characterized by series transduction models. The inhibition of azithromycin on proinflammatory cytokines was described by an indirect response model. After lipopolysaccharide challenging, the proinflammatory cytokines, kynrenine and behavior tests would peak approximately at 3, 12, and 24 h respectively, and then the time courses slowly declined toward a baseline state after peak response. During azithromycin administration, the peak levels of proinflammatory cytokines, kynrenine and behavior indexes decreased. Model parameters indicated that azithromycin significantly inhibited the proinflammatory cytokines level in plasma and improved the depressive-like behavior induced by inflammation. The integrated model for disease progression and drug intervention captures turnovers of proinflammatory cytokines, kynrenine and the behavior results in the different time phases and conditions.	[Hao, Kun; Qi, Qu; Hao, Haiping; Wang, Guangji; Liang, Yan; Xie, Lin] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Chen, Yuancheng] Fudan Univ, Inst Antibiot, Huashan Hosp, Shanghai 200433, Peoples R China	China Pharmaceutical University; Fudan University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	guangjiwang@hotmail.com	Chen, Yuancheng/L-9013-2016; Hao, Haiping/L-8265-2019	Chen, Yuancheng/0000-0002-5731-9114; Hao, Haiping/0000-0003-2522-7546	Project Program of State Key Laboratory of Natural Medicines [02410346]; Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects [BM2012012]; Natural Science Foundation of Jiangsu province [SBK201240220]	Project Program of State Key Laboratory of Natural Medicines; Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	This study was supported by the Project Program of State Key Laboratory of Natural Medicines (No. 02410346), Jiangsu Province Key Lab of Drug Metabolism and Pharmacokinetics Projects (BM2012012) and Natural Science Foundation of Jiangsu province (SBK201240220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Aubert JD, 1998, PULM PHARMACOL THER, V11, P263, DOI 10.1006/pupt.1998.0123; AZOULAYDUPUIS E, 1991, ANTIMICROB AGENTS CH, V35, P1024, DOI 10.1128/AAC.35.6.1024; Barrett B, 2005, ANAL BIOANAL CHEM, V383, P210, DOI 10.1007/s00216-005-0018-5; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Capuron L, 2003, BRAIN BEHAV IMMUN, V17, pS119; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Chen YC, 2009, PHARM RES-DORDR, V26, P1863, DOI 10.1007/s11095-009-9899-x; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; D'Argenio DZ, 1997, ADAPT 2 USERS GUIDE; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; de Lange ECM, 2005, AAPS J, V7, pE532, DOI 10.1208/aapsj070354; FIESE EF, 1990, J ANTIMICROB CHEMOTH, V25, P39, DOI 10.1093/jac/25.suppl_A.39; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Fuller-Thomson E, 2006, INFLAMM BOWEL DIS, V12, P697, DOI 10.1097/00054725-200608000-00005; GAL EM, 1980, NEUROCHEM RES, V5, P223, DOI 10.1007/BF00964611; GIRARD AE, 1987, ANTIMICROB AGENTS CH, V31, P1948, DOI 10.1128/AAC.31.12.1948; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; HEYES MP, 1993, BRAIN, V116, P1425, DOI 10.1093/brain/116.6.1425; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Josa M, 2001, J PHARMACOL EXP THER, V297, P198; Kikuchi T, 2002, J ANTIMICROB CHEMOTH, V49, P745, DOI 10.1093/jac/dkf008; Kronenberg S, 2008, PHARMACOGENOMICS, V9, P1725, DOI 10.2217/14622416.9.11.1725; Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235; Lestage J, 2002, BRAIN BEHAV IMMUN, V16, P596, DOI 10.1016/S0889-1591(02)00014-4; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; Mormede U, 2004, BRAIN BEHAV IMMUN, V18, P186, DOI 10.1016/S0889-1591(03)00133-8; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; OHTANI M, 1995, J PHARMACOL EXP THER, V272, P505; Pechnick RN, 2004, NEUROPSYCHOPHARMACOL, V29, P770, DOI 10.1038/sj.npp.1300402; Pitossi F, 1997, J NEUROSCI RES, V48, P287, DOI 10.1002/(SICI)1097-4547(19970515)48:4<287::AID-JNR1>3.0.CO;2-7; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rajman I, 2008, DRUG DISCOV TODAY, V13, P341, DOI 10.1016/j.drudis.2008.01.003; Scaglione F., 1998, Journal of Antimicrobial Chemotherapy, V41, P47, DOI 10.1093/jac/41.suppl_2.47; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Shapiro L, 1993, New Horiz, V1, P13; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Sun YN, 1998, J PHARM SCI, V87, P732, DOI 10.1021/js970414z; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tkalcevic VI, 2006, EUR J PHARMACOL, V539, P131, DOI 10.1016/j.ejphar.2006.03.074; Watanabe S, 2004, PHYSIOL BEHAV, V81, P605, DOI 10.1016/j.physbeh.2004.02.021; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Yassen A, 2005, J PHARMACOL EXP THER, V313, P1136, DOI 10.1124/jpet.104.082560; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	54	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54981	10.1371/journal.pone.0054981	http://dx.doi.org/10.1371/journal.pone.0054981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358536	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600142
J	Ma, F; Yang, Y; Li, XW; Zhou, F; Gao, C; Li, MF; Gao, L				Ma, Fang; Yang, Yu; Li, Xiangwei; Zhou, Feng; Gao, Cong; Li, Mufei; Gao, Lei			The Association of Sport Performance with ACE and ACTN3 Genetic Polymorphisms: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ELITE ATHLETIC PERFORMANCE; I/D POLYMORPHISM; DELETION POLYMORPHISM; R577X POLYMORPHISM; INSERTION/DELETION POLYMORPHISM; MYOCARDIAL-INFARCTION; PHYSICAL PERFORMANCE; GREEK TRACK; GENOTYPE	Background: Genetic polymorphism is suggested to be associated with human physical performance. The angiotensin I-converting enzyme insertion/deletion (ACE I/D) polymorphism and the alpha-actinin-3 gene (ACTN3) R577X polymorphism have been most widely studied for such association analysis. However, the findings are frequently heterogeneous. We aim to summarize the associations of ACE I/D and ACTN3 R577X with sport performance by means of meta-analysis. Methods: We systematically reviewed and quantitatively summarized published studies, until October 31, 2012, on relationship between ACE/ACTN3 genetic polymorphisms and sports performance, respectively. Results: A total of 366 articles on ACE and 88 articles on ACTN3 were achieved by literature search. A significant association was found for ACE II genotype compared to D allele carriage (DD+ID) with increased possibility of physical performance (OR, 1.23; 95% CI, 1.05-1.45). With respect to sport discipline, the II genotype was found to be associated with performance in endurance athletes (OR, 1.35; 95% CI, 1.17-1.55). On the other hand, no significant association was observed for ACTN3 RR genotype as compared to X allele carriage (XX+RX) (OR, 1.03; 95% CI, 0.92-1.15). However, when restricted the analyses to power events, a significant association was observed (OR, 1.21; 95% CI, 1.03-1.42). Conclusion: Our results provide more solid evidence for the associations between ACE II genotype and endurance events and between ACTN3 R allele and power events. The findings suggest that the genetic profiles might influence human physical performance.	[Ma, Fang] Xinjiang Normal Univ, Phys Educ Inst, Kinesiol Lab, Urumqi, Peoples R China; [Yang, Yu; Li, Xiangwei; Zhou, Feng; Gao, Cong; Li, Mufei; Gao, Lei] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Yang, Yu; Li, Xiangwei; Zhou, Feng; Gao, Cong; Li, Mufei; Gao, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China	Xinjiang Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, L (corresponding author), Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China.	gaolei@ipbcams.ac.cn		Yang, Yu/0000-0002-5611-8951	Chinese Ministry of Education [NCET-01-0288]	Chinese Ministry of Education(Ministry of Education, China)	This study was supported by the New Century Excellent Talents Support Program of the Chinese Ministry of Education (NCET-01-0288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred T., 2011, HUM MUTAT; Amir O, 2007, EXP PHYSIOL, V92, P881, DOI 10.1113/expphysiol.2007.038711; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Chiu LL, 2011, INT J SPORTS MED, V32, P476, DOI 10.1055/s-0030-1263115; Cieszczyk P, 2009, INT J SPORTS MED, V30, P624, DOI 10.1055/s-0029-1202825; Costa AM, 2009, EUR J APPL PHYSIOL, V106, P785, DOI 10.1007/s00421-009-1080-z; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Gayagay G, 1998, HUM GENET, V103, P48, DOI 10.1007/s004390050781; Jones A, 2002, EXERC SPORT SCI REV, V30, P184, DOI 10.1097/00003677-200210000-00008; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; MacArthur D, 2005, HUM GENET, V116, P331, DOI 10.1007/s00439-005-1261-8; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Min SK, 2009, APPL PHYSIOL NUTR ME, V34, P926, DOI 10.1139/H09-097; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Nazarov IB, 2001, EUR J HUM GENET, V9, P797, DOI 10.1038/sj.ejhg.5200711; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Oh SD, 2007, J SPORT MED PHYS FIT, V47, P250; Papadimitriou ID, 2008, INT J SPORTS MED, V29, P352, DOI 10.1055/s-2007-965339; Papadimitriou ID, 2009, J SPORT MED PHYS FIT, V49, P459; Paparini A, 2007, MED SCI SPORT EXER, V39, P810, DOI 10.1097/mss.0b013e3180317491; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Shang X, 2010, INT J SPORTS MED, V31, P913, DOI 10.1055/s-0030-1265176; Shenoy Shweta, 2010, Asian J Sports Med, V1, P143; Thompson WR, 2006, PHYS THER, V86, P585, DOI 10.1093/ptj/86.4.585; TIRET L, 1993, LANCET, V341, P991, DOI 10.1016/0140-6736(93)91075-W; Tobina T, 2010, J PHYSIOL SCI, V60, P325, DOI 10.1007/s12576-010-0100-4; Tsianos G, 2004, EUR J APPL PHYSIOL, V92, P360, DOI 10.1007/s00421-004-1120-7; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Zilberman-Schapira G, 2012, RECENT PAT DNA GENE	39	141	161	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54685	10.1371/journal.pone.0054685	http://dx.doi.org/10.1371/journal.pone.0054685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358679	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600092
J	Martinez, P; Hernandez-Losa, J; Montero, MA; Cedres, S; Castellvi, J; Martinez-Marti, A; Tallada, N; Murtra-Garrell, N; Navarro-Mendivill, A; Rodriguez-Freixinos, V; Canela, M; Cajal, SRY; Felip, E				Martinez, Pablo; Hernandez-Losa, Javier; Angeles Montero, M.; Cedres, Susana; Castellvi, Josep; Martinez-Marti, Alex; Tallada, Natalia; Murtra-Garrell, Nuria; Navarro-Mendivill, Alejandro; Rodriguez-Freixinos, Victor; Canela, Mercedes; Ramon y Cajal, Santiago; Felip, Enriqueta			Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							EML4-ALK FUSION GENE; REARRANGEMENT; ADENOCARCINOMAS; INHIBITOR; MUTATIONS; SURVIVAL; EGFR	Background: Anaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods for ALK positive patients and to describe its prevalence and outcomes in a population of NSCLC patients. Methods: NSCLC patients previously screened for Epidermal Growth Factor Receptor (EGFR) at our institution were selected. ALK positive patients were identified by FISH and the value of IHC (D5F3) was explored. Results: ninety-nine patients were identified. Median age was 61.5 years (range 35-83), all were caucasians, eighty percent were adenocarcinomas, fifty-one percent were male and thirty-eight percent were current smokers. Seven (7.1%) patients were ALK positive by FISH, thirteen (13.1%) were EGFR mutant, and 65 (65.6%) were negative/Wild Type (WT) for both ALK and EGFR. ALK positivity and EGFR mutations were mutually exclusive. ALK positive patients tend to be younger than EGFR mutated or wt patients. ALK positive patients were predominantly never smokers (71.4%) and adenocarcinoma (71.4%). ALK positive and EGFR mutant patients have a better outcome than negative/WT. All patients with ALK FISH negative tumours were negative for ALK IHC. Out of 6 patients positive for ALK FISH with more tissue available, 5 were positive for ALK IHC and 1 negative. Conclusions: ALK positive patients represent 7.1% of a population of selected NSCLC. ALK positive patients have different clinical features and a better outcome than EGFR WT and ALK negative patients. IHC is a promising method for detecting ALK positive NSCLC patients.	[Martinez, Pablo; Cedres, Susana; Martinez-Marti, Alex; Murtra-Garrell, Nuria; Navarro-Mendivill, Alejandro; Rodriguez-Freixinos, Victor; Felip, Enriqueta] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain; [Hernandez-Losa, Javier; Angeles Montero, M.; Castellvi, Josep; Tallada, Natalia; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, E-08193 Barcelona, Spain; [Canela, Mercedes] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Thorac Oncol Dept, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Martinez, P (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain.	pamartinez@vhebron.net	Ramon y Cajal, Santiago/H-4955-2016; Castellvi, Josep/C-5092-2014; Javier, Hernandez Losa/C-1173-2008	Ramon y Cajal, Santiago/0000-0002-3867-1390; Castellvi, Josep/0000-0001-5745-9996; Javier, Hernandez Losa/0000-0003-1526-3201; FELIP, ENRIQUETA/0000-0002-7620-0098; Balmana, Judith/0000-0002-0762-6415; MARTINEZ-MARTI, ALEX/0000-0002-6714-9526				Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lee JK, 2012, CANCER-AM CANCER SOC, V118, P3579, DOI 10.1002/cncr.26668; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mitsudomi T, 2011, P AM SOC CLIN ONCO S, V29; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Park HS, 2012, LUNG CANCER, V77, P288, DOI 10.1016/j.lungcan.2012.03.004; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tong J, 2011, J THORACIC ONCOLOGY, V6; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wong K, 2011, JSCLC J CLIN ONCOL S, V29; Yoshida A, 2011, J THORAC ONCOL, V6, P1677, DOI 10.1097/JTO.0b013e3182286d25	24	53	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52261	10.1371/journal.pone.0052261	http://dx.doi.org/10.1371/journal.pone.0052261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359795	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600004
J	Pagonabarraga, J; Corcuera-Solano, I; Vives-Gilabert, Y; Llebaria, G; Garcia-Sanchez, C; Pascual-Sedano, B; Delfino, M; Kulisevsky, J; Gomez-Anson, B				Pagonabarraga, Javier; Corcuera-Solano, Idoia; Vives-Gilabert, Yolanda; Llebaria, Gisela; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Delfino, Manuel; Kulisevsky, Jaime; Gomez-Anson, Beatriz			Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBRAL ATROPHY; HUMAN BRAIN; VISUAL HALLUCINATIONS; DIAGNOSTIC-CRITERIA; ENTORHINAL CORTEX; RATING-SCALE; DEMENTIA; IMPAIRMENT; THICKNESS	Background: Dementia is a frequent and devastating complication in Parkinson's disease (PD). There is an intensive search for biomarkers that may predict the progression from normal cognition (PD-NC) to dementia (PDD) in PD. Mild cognitive impairment in PD (PD-MCI) seems to represent a transitional state between PD-NC and PDD. Few studies have explored the structural changes that differentiate PD-NC from PD-MCI and PDD patients. Objectives and Methods: We aimed to analyze changes in cortical thickness on 3.0T Magnetic Resonance Imaging (MRI) across stages of cognitive decline in a prospective sample of PD-NC (n = 26), PD-MCI (n = 26) and PDD (n = 20) patients, compared to a group of healthy subjects (HC) (n = 18). Cortical thickness measurements were made using the automatic software Freesurfer. Results: In a sample of 72 PD patients, a pattern of linear and progressive cortical thinning was observed between cognitive groups in cortical areas functionally specialized in declarative memory (entorhinal cortex, anterior temporal pole), semantic knowledge (parahippocampus, fusiform gyrus), and visuoperceptive integration (banks of the superior temporal sulcus, lingual gyrus, cuneus and precuneus). Positive correlation was observed between confrontation naming and thinning in the fusiform gyrus, parahippocampal gyrus and anterior temporal pole; clock copy with thinning of the precuneus, parahippocampal and lingual gyrus; and delayed memory with thinning of the bilateral anteromedial temporal cortex. Conclusions: The pattern of regional decreased cortical thickness that relates to cognitive deterioration is present in PD-MCI patients, involving areas that play a central role in the storage of prior experiences, integration of external perceptions, and semantic processing.	[Pagonabarraga, Javier; Llebaria, Gisela; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Kulisevsky, Jaime] St Pau Hosp, Movement Disorders Unit, Dept Neurol, Barcelona, Spain; [Corcuera-Solano, Idoia; Gomez-Anson, Beatriz] St Pau Hosp, Neuroradiol Unit, Barcelona, Spain; [Corcuera-Solano, Idoia; Vives-Gilabert, Yolanda; Delfino, Manuel; Gomez-Anson, Beatriz] PIC, Barcelona, Spain; [Vives-Gilabert, Yolanda] IFAE, Barcelona, Spain; [Pagonabarraga, Javier; Garcia-Sanchez, Carmen; Pascual-Sedano, Berta; Delfino, Manuel; Kulisevsky, Jaime; Gomez-Anson, Beatriz] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Kulisevsky, Jaime; Gomez-Anson, Beatriz] IIB St Pau, Barcelona, Spain; [Llebaria, Gisela; Kulisevsky, Jaime] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Autonomous University of Barcelona; CIBERNED	Kulisevsky, J (corresponding author), St Pau Hosp, Movement Disorders Unit, Dept Neurol, Barcelona, Spain.	jkulisevsky@santpau.cat	Pascual-Sedano, Berta/AAF-4428-2021; Delfino, Manuel/A-1545-2012; Casals, Jordi/AAB-3249-2019; Kulisevsky, Jaime/AEW-0433-2022; Vives-Gilabert, Yolanda/ABB-7461-2021; Pages, Andres Pacheco/C-5353-2011	Pascual-Sedano, Berta/0000-0002-9298-8241; Delfino, Manuel/0000-0002-9468-4751; Kulisevsky, Jaime/0000-0003-4870-1431; Pages, Andres Pacheco/0000-0001-8210-1734; Vives-Gilabert, Yolanda/0000-0002-3744-5893	Fondo de Investigaciones Sanitarias ISCIII [FIS PI10/01498, FIS PI07/770]; Sociedad Espanola de Radiologia Medica [SERAM 06-09]	Fondo de Investigaciones Sanitarias ISCIII(Instituto de Salud Carlos III); Sociedad Espanola de Radiologia Medica	Granted by Fondo de Investigaciones Sanitarias ISCIII (FIS PI10/01498, FIS PI07/770), and Sociedad Espanola de Radiologia Medica (SERAM 06-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Espeseth T, 2012, NEUROBIOL AGING, V33, P304, DOI 10.1016/j.neurobiolaging.2009.12.027; Ferrer I, 2009, PROG NEUROBIOL, V88, P89, DOI 10.1016/j.pneurobio.2009.02.004; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fortea J, 2011, BIOL PSYCHIAT, V70, P183, DOI 10.1016/j.biopsych.2011.02.017; Galvin JE, 2005, ARCH NEUROL-CHICAGO, V62, P758, DOI 10.1001/archneur.62.5.758; Grosset K, 2004, MOVEMENT DISORD, V19, P1370, DOI 10.1002/mds.20210; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; Insausti R, 2008, J COMP NEUROL, V509, P608, DOI 10.1002/cne.21753; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Mattis S, 1988, DEMENTIA RATING SCAL; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pereira JB, 2011, HUM BRAIN MAPP; Ramirez-Ruiz B, 2007, EUR J NEUROL, V14, P750, DOI 10.1111/j.1468-1331.2007.01768.x; Rockwood K, 2000, J AM GERIATR SOC, V48, P558, DOI 10.1111/j.1532-5415.2000.tb05004.x; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; SCHMIDT R, 1994, NEUROLOGY, V44, P964, DOI 10.1212/WNL.44.5.964; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Shin S, 2012, J NEUROL NEUROSUR PS, V83, P1155, DOI 10.1136/jnnp-2012-303391; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	54	101	105	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54980	10.1371/journal.pone.0054980	http://dx.doi.org/10.1371/journal.pone.0054980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359616	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600141
J	Roubelakis, MG; Tsaknakis, G; Pappa, KI; Anagnou, NP; Watt, SM				Roubelakis, Maria G.; Tsaknakis, Grigorios; Pappa, Kalliopi I.; Anagnou, Nicholas P.; Watt, Suzanne M.			Spindle Shaped Human Mesenchymal Stem/Stromal Cells from Amniotic Fluid Promote Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; COLONY-FORMING CELLS; STEM-CELLS; IN-VITRO; UMBILICAL-CORD; STROMAL CELLS; HUMAN ADULT; BONE-MARROW; MATRIX METALLOPROTEINASES; CHROMOSOMAL-ABERRATIONS	Human amniotic fluid obtained at amniocentesis, when cultured, generates at least two morphologically distinct mesenchymal stem/stromal cell (MSC) subsets. Of these, the spindle shaped amniotic fluid MSCs (SS-AF-MSCs) contain multipotent cells with enhanced adipogenic, osteogenic and chondrogenic capacity. Here, we demonstrate, for the first time, the capacity of these SS-AF-MSCs to support neovascularization by umbilical cord blood (UCB) endothelial colony forming cell (ECFC) derived cells in both in vitro and in vivo models. Interestingly, although the kinetics of vascular tubule formation in vitro were similar when the supporting SS-AF-MSCs were compared with the best vasculogenic supportive batches of bone marrow MSCs (BMSCs) or human dermal fibroblasts (hDFs), SS-AF-MSCs supported vascular tubule formation in vivo more effectively than BMSCs. In NOD/SCID mice, the human vessels inosculated with murine vessels demonstrating their functionality. Proteome profiler array analyses revealed both common and distinct secretion profiles of angiogenic factors by the SS-AF-MSCs as opposed to the hDFs and BMSCs. Thus, SS-AF-MSCs, which are considered to be less mature developmentally than adult BMSCs, and intermediate between adult and embryonic stem cells in their potentiality, have the additional and very interesting potential of supporting increased neovascularisation, further enhancing their promise as vehicles for tissue repair and regeneration.	[Roubelakis, Maria G.; Anagnou, Nicholas P.] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece; [Roubelakis, Maria G.; Anagnou, Nicholas P.] Acad Athens BRFAA, Biomed Res Fdn, Ctr Basic Res, Cell & Gene Therapy Lab, Athens, Greece; [Roubelakis, Maria G.; Tsaknakis, Grigorios; Watt, Suzanne M.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Roubelakis, Maria G.; Tsaknakis, Grigorios; Watt, Suzanne M.] John Radcliffe Hosp, Stem Cell Res Lab, NHS Blood & Transplant, Oxford OX3 9DU, England; [Pappa, Kalliopi I.] Univ Athens, Sch Med, Dept Obstet & Gynecol 1, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; University of Oxford; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens	Watt, SM (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England.	suzanne.watt@nhsbt.nhs.uk	Anagnou, Nicholas/GLR-3609-2022; Watt, Suzanne/AAV-4908-2021; PAPPA, KALLIOPI/K-9345-2018	Roubelakis, Maria G./0000-0001-5790-6581; PAPPA, KALLIOPI/0000-0002-1061-7405; Watt, Suzanne/0000-0001-7684-8022	NHS Blood and Transplant; National Institutes of Health Research; Restore Burns and Wound Healing Trust; EU Framework VII Cascade grant; National Institute for Health Research [RP-PG-0310-1003] Funding Source: researchfish	NHS Blood and Transplant; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Restore Burns and Wound Healing Trust; EU Framework VII Cascade grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by research funding from NHS Blood and Transplant (GT, MGR, SMW), National Institutes of Health Research (SMW, GT), Restore Burns and Wound Healing Trust (SMW) and the EU Framework VII Cascade grant (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2010, J R SOC INTERFACE, V7, pS689, DOI 10.1098/rsif.2010.0347.focus; Athanassopoulos A, 2012, BURNS, V38, P691, DOI 10.1016/j.burns.2011.12.019; Ben-David U, 2011, CELL STEM CELL, V9, P97, DOI 10.1016/j.stem.2011.06.013; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bitsika V, 2012, STEM CELLS DEV, V21, P1097, DOI 10.1089/scd.2011.0151; Campagnoli C, 2002, BJOG-INT J OBSTET GY, V109, P952, DOI 10.1111/j.1471-0528.2002.t01-1-02011.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chan J, 2008, HUM REPROD, V23, P2427, DOI 10.1093/humrep/den302; Coldwell KE, 2011, ANGIOGENESIS, V14, P381, DOI 10.1007/s10456-011-9222-4; Da Sacco S, 2010, J UROLOGY, V183, P1193, DOI 10.1016/j.juro.2009.11.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Spiegelaere W, 2011, CLIN HEMORHEOL MICRO, V48, P15, DOI 10.3233/CH-2011-1393; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Diamanti P, 2012, LEUKEMIA, V26, P376, DOI 10.1038/leu.2011.212; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eddleman KA, 2006, OBSTET GYNECOL, V108, P1067, DOI 10.1097/01.AOG.0000240135.13594.07; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Farace P, 2009, BRIT J CANCER, V100, P1575, DOI 10.1038/sj.bjc.6605041; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Laird AD, 2002, FASEB J, V16, DOI 10.1096/fj.01-0700com; LESCHOT NJ, 1985, BRIT J OBSTET GYNAEC, V92, P804, DOI 10.1111/j.1471-0528.1985.tb03049.x; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Makridalds M, 2010, J PROTEOME RES, V9, P3243, DOI 10.1021/pr100189d; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Rissanen TT, 2002, FASEB J, V16, P100, DOI 10.1096/fj.02-0377fje; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; Roelen DL, 2009, HUM IMMUNOL, V70, P16, DOI 10.1016/j.humimm.2008.10.016; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Walker NG, 2012, TISSUE ENG PART C-ME, V18, P143, DOI [10.1089/ten.tec.2011.0037, 10.1089/ten.TEC.2011.0037]; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Watt SM, 2010, J R SOC INTERFACE, V7, pS731, DOI [10.1098/rsif.2010.0377.focus, 10.1098/rsif.2010.0377.focas]; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908; Zhang DL, 2010, MOL CELL BIOCHEM, V335, P1, DOI 10.1007/s11010-009-0234-y; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zhang YY, 2009, STEM CELLS DEV, V18, P359, DOI 10.1089/scd.2008.0071; Zhou B, 2012, BRIT J HAEMATOL, V157, P299, DOI 10.1111/j.1365-2141.2012.09050.x; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	70	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54747	10.1371/journal.pone.0054747	http://dx.doi.org/10.1371/journal.pone.0054747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359810	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600104
J	Chikovore, J; Nystrom, L; Lindmark, G; Ahlberg, BM				Chikovore, Jeremiah; Nystrom, Lennarth; Lindmark, Gunilla; Ahlberg, Beth Maina			"How Can I Gain Skills if I Don't Practice?'' The Dynamics of Prohibitive Silence against Pre-Marital Pregnancy and Sex in Zimbabwe	PLOS ONE			English	Article							HIV PREVENTION; AIDS; BEHAVIOR; CULTURE; WOMEN	Young people face sexual and reproductive health (SRH) problems including Human immunodeficiency virus (HIV) and Acquired immunodeficiency syndrome (AIDS). It is critical to continue documenting their situation including the contexts they live in. As part of a larger study that explored perspectives of men to SRH and more specifically abortion and contraceptive use, 546 pupils (51% female; age range 9-25 years) from a rural area in Zimbabwe were invited to write anonymously questions about growing up or other questions they could not ask adults for fear or shame. The pupils were included following descriptions by adults of the violence that is unleashed on unmarried young people who engaged in sex, used contraceptives, or simply suggested doing so. The questions by the young people pointed to living in a context of prohibitive silence; their sexuality was silenced and denied. As a consequence they had poor knowledge and their fears and internal conflicts around sexuality and pregnancy were not addressed. Current action suggests concerted effort at the policy level to deal with young people's SRH in Zimbabwe. It nevertheless remains necessary, as a way to provide support to these efforts, to continue examining what lessons can be drawn from the past, and how the past continues to reflect in and shape present dynamics and relations. There is also need to look more critically at life skill education, which has previously been described as having failed to address adequately the practical needs of young people. Life skill education in Zimbabwe has rarely been systematically evaluated. A fuller understanding is also needed of the different factors co-existing in contemporary African societies and how they have been and continue to be constituted within history, and the implications to the promotion of adolescent SRH.	[Chikovore, Jeremiah] Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB Unit, Durban, South Africa; [Chikovore, Jeremiah] Malawi Liverpool Wellcome Trust Res Programme, Blantyre, Malawi; [Nystrom, Lennarth] Umea Univ, Dept Publ Hlth & Clin Med, Div Epidemiol & Publ Hlth Sci, Umea, Sweden; [Lindmark, Gunilla] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Sect Int Maternal & Child Hlth, Uppsala, Sweden; [Ahlberg, Beth Maina] Uppsala Univ, Fac Med, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Ahlberg, Beth Maina] Skaraborg Inst Res & Dev, Skovde, Sweden	Human Sciences Research Council-South Africa; University of Malawi; Umea University; Uppsala University; Uppsala University Hospital; Uppsala University	Chikovore, J (corresponding author), Human Sci Res Council, HIV AIDS Sexually Transmitted Infect & TB Unit, Durban, South Africa.	JChikovore@hsrc.ac.za		Chikovore, Jeremiah/0000-0002-4910-6952	Sida/SAREC of Sweden;  [WT085411MA]	Sida/SAREC of Sweden; 	The study was supported by Sida/SAREC of Sweden. Jeremiah Chikovore is a Wellcome Trust Fellow supported by Grant WT085411MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocates for Youth, 2008, OUT HAND GLOB AIDS P; Agar M., 1996, PROFESSIONAL STRANGE; Ahlberg BM, 2001, REPROD HEALTH MATTER, V9, P26, DOI 10.1016/S0968-8080(01)90005-9; [Anonymous], AD SEX REPR HLTH; Ashcroft B., 1998, KEY CONCEPTS POSTCOL; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bhana D, 2010, EARLY CHILD DEV CARE, V180, P1079, DOI 10.1080/03004430902742633; Birdthistle I, 2012, AIDS 2012 WASH DC 22; Boler T, 2005, LIFE SKILL BASED ED; Campbell C, 2009, J YOUTH STUD, V12, P93, DOI 10.1080/13676260802345757; Chikovore J, 2002, J BIOSOC SCI, V34, P317, DOI 10.1017/S0021932002003176; Chikovore J, 2009, AJAR-AFR J AIDS RES, V8, P503, DOI 10.2989/AJAR.2009.8.4.14.1051; Cowan FM, 2002, AIDS, V16, P1673, DOI 10.1097/00002030-200208160-00013; Dixon-Mueller R, 2009, AIDS BEHAV, V13, P100, DOI 10.1007/s10461-008-9376-2; Erulkar Annabel S, 2005, Afr J Reprod Health, V9, P51; Family Health International, 2010, YOUNG PEOPL MOST RIS; Fielder A, 1999, POLITICS READING POS; Government of Zimbabwe, 1999, NAT HIV AIDS POL; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gurevitz R., 2000, ETHICS ENVIRON, V3, P253, DOI [DOI 10.1080/713665905, 10.1080/713665905]; Gusrang J. L., 2010, THESIS U CONNECTICUT; Hallberg L.R.M., 2006, INT J QUALITATIVE ST, V1, P141, DOI [https://doi.org/10.1080/17482620600858399, 10.1080/17482620600858399, DOI 10.1080/17482620600858399]; Helleve A., 2011, SEX ED, V11, P13, DOI [DOI 10.1080/14681811.2011.538143, DOI 10.1080/14681811.2011]; Hindin MJ, 2009, INT PERSPECT SEX R H, V35, P58, DOI 10.1363/ipsrh.35.058.09; Irvine JM, 2000, CRIT INQUIRY, V27, P58, DOI 10.1086/448998; Kaufman C, 1998, VIEW SCH PREPARATION, P58; Kim YM, 1997, E AFR MED J, V74, P514; Ladner J, 2002, LANCET, V360, P1889, DOI 10.1016/S0140-6736(02)11757-0; Langhaug LF, 2003, AIDS CARE, V15, P147, DOI 10.1080/0954012031000068290; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lupton D, 1998, BODY SOC, V4, P19, DOI DOI 10.1177/1357034X98004002002; Marindo-Ranganayi R, 2003, POLICY RES DIVISION, V170; Nare C, 1997, Afr J Reprod Health, V1, P15, DOI 10.2307/3583373; National AIDS Council Ministry of Health and Child Care UNAIDS, 2006, ZIMBABWE NATL HIV AI; O'Donoghue J, 2002, EVAL PROGRAM PLANN, V25, P387, DOI 10.1016/S0149-7189(02)00050-2; Ottemoller-Gwanzura FP, 2005, CHILDRENS GEOGRAPHIE, V3, P253; Pattman R., 2007, BOYS MEN SOCIAL CONS, P33; Paul-Ebhohimhen VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-4; Pelto PJ, 1997, MED ANTHROPOL Q, V11, P147, DOI 10.1525/maq.1997.11.2.147; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Schoepf BG, 1995, CULTURE SEXUAL RISK, P29; Setel P, 1996, SOC SCI MED, V43, P1169, DOI 10.1016/0277-9536(95)00360-6; Shanahan S, 2007, ANNU REV SOCIOL, V33, P407, DOI 10.1146/annurev.soc.33.040406.131808; Shroufi A, 2012, AIDS 2012 WASH DC 22; UNAIDS, 2010, YOUNG PEOPL AR LEAD; UNICEF, 2011, OPP CRIS PREV HIV EA; Van Eeuwijk BO, 1997, POWER REPROD GENDER, P35; Van Onselen Charles, 1976, CHIBARO AFRICAN MINE	48	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53058	10.1371/journal.pone.0053058	http://dx.doi.org/10.1371/journal.pone.0053058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372653	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500010
J	Liu, MZ; Wang, BX; Osborne, CP; Jiang, GM				Liu, Meizhen; Wang, Bingxue; Osborne, Colin P.; Jiang, Gaoming			Chicken Farming in Grassland Increases Environmental Sustainability and Economic Efficiency	PLOS ONE			English	Article							INNER-MONGOLIA; DESERTIFICATION; SOIL; ROOTS; CHINA; DUST	Background: Grassland degradation caused by overgrazing poses a threat to both animal husbandry and environmental sustainability in most semi-arid areas especially north China. Although the Chinese Government has made huge efforts to restore degraded grasslands, a considerable attempt has unfortunately failed due to an inadequate consideration of economic benefits to local communities. Methodology/Principal Findings: A controlled field experiment was conducted to test our hypothesis that utilizing natural grasslands as both habitat and feed resources for chickens and replacing the traditional husbandry system with chicken farming would increase environmental sustainability and raise income. Aboveground plant biomass elevated from 25 g m 22 for grazing sheep to 84 g m 22 for chicken farming. In contrast to the fenced (unstocked) grassland, chicken farming did not significantly decrease aboveground plant biomass, but did increase the root biomass by 60% (p<0.01). Compared with traditional sheep grazing, chicken farming significantly improved soil surface water content (0-10 cm), from 5% to 15%. Chicken farming did not affect the soil bulk density, while the traditional sheep grazing increased the soil bulk density in the 0-10 cm soil layer by 35% of the control (p<0.05). Most importantly, the economic income of local herdsmen has been raised about six times compared with the traditional practice of raising sheep. Ecologically, such an innovative solution allowed large degraded grasslands to naturally regenerate. Grasslands also provided a high quality organic poultry product which could be marketed in big cities. Conclusion/Significance: Chicken farming is an innovative alternative strategy for increasing environmental sustainability and economic income, rather than a challenge to the traditional nomadic pastoral system. Our approach might be technically applicable to other large degraded grasslands of the world, especially in China.	[Liu, Meizhen; Wang, Bingxue; Jiang, Gaoming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Osborne, Colin P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Chinese Academy of Sciences; Institute of Botany, CAS; University of Sheffield	Liu, MZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	liumzh@ibcas.ac.cn; jianggm@126.com			Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050403]; National Scientific Foundation of China [40501009, 50875007]	Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (XDA05050403), and the National Scientific Foundation of China (No. 40501009, 50875007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; [Anonymous], EREMOLOGY; Boehm W., 1979, METHODS STUDYING ROO; BROWN L, 2001, DYNAMIC AGR BOOK 3; Chen SP, 2009, AGR FOREST METEOROL, V149, P1800, DOI 10.1016/j.agrformet.2009.06.009; China Stock Breeding Year book Edition Committee, 2004, YB CHIN STOCKBR 2004; China's State Environmental Protection Administration, 2003, REP STAT ENV CHIN 20; Curtis JT, 1959, VEGETATION WISCONSIN; Du Q. L., 2006, SUSTAINABLE DEV STRA; Glantz M., 2003, CLIMATE AFFAIRS PRIM; Jiang Gaoming, 2011, Science & Technology Review, V29, P19, DOI 10.3981/j.issn.1000-7857.2011.25.002; Jiang Gaoming, 2007, CHINA DIALOGUE; Jiang GM, 2006, CHINA DIALOGUE; Jing D, 2002, THESIS ROYAL I TECHN; Kawamura Kensuke, 2005, Grassland Science, V51, P33, DOI 10.1111/j.1744-697X.2005.00006.x; Li G, 2007, ENVIRON CONSERV, V34, P95, DOI 10.1017/S0376892907003864; Li WJ, 2009, READING PUZZLEDOM GR; Liu MZ, 2009, RESTOR ECOL, V17, P127, DOI 10.1111/j.1526-100X.2008.00366.x; Liu MZ, 2004, ENVIRON CONSERV, V31, P269, DOI 10.1017/S0376892904001675; MAC (Department of Animal Husbandry and Veterinary & General Station of Animal Husbandry and Veterinary of Ministry of Agriculture of China), 1996, RANG RES CHIN; National Environmental Protection General Agency, 2005, CHIN ENV COND B 2005; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; SMUCKER AJM, 1982, AGRON J, V74, P500, DOI 10.2134/agronj1982.00021962007400030023x; Stubbendieck J, 2008, NAT AREA J, V28, P58, DOI 10.3375/0885-8608(2008)28[58:SYOVDI]2.0.CO;2; Wang B., 2011, ACTA ECOLOGICA SINIC, V31, P14, DOI [10.1016/j.chnaes.2010.11.003., DOI 10.1016/J.CHNAES.2010.11.003]; Wang GX, 2004, J ARID ENVIRON, V58, P373, DOI 10.1016/j.jaridenv.2003.11.001; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wu Jianguo, 1992, P67; [乌云塔娜 Wuyun Tana], 2010, [河北农业大学学报, Journal of Agricultural University of Hebei], V33, P10; [Yale Center for Environmental Law & Policy Center for International Earth Science Information Network at Columbia University], 2010, ENV PERF IND EPI REP; Yang X, 2005, J ARID ENVIRON, V63, P517, DOI 10.1016/j.jaridenv.2005.03.032; Zhao HL, 2006, SOIL TILL RES, V87, P175, DOI 10.1016/j.still.2005.03.009	32	5	8	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53977	10.1371/journal.pone.0053977	http://dx.doi.org/10.1371/journal.pone.0053977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372678	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000314021500032
J	Malmo, J; Sandvig, A; Varum, KM; Strand, SP				Malmo, Jostein; Sandvig, Axel; Varum, Kjell M.; Strand, Sabina P.			Nanoparticle Mediated P-Glycoprotein Silencing for Improved Drug Delivery across the Blood-Brain Barrier: A siRNA-Chitosan Approach	PLOS ONE			English	Article							N-ACETYLATED CHITOSANS; IN-VITRO; ENDOTHELIAL-CELLS; RNA INTERFERENCE; MOLECULAR-WEIGHT; DOWN-REGULATION; GENE; RESISTANCE; EXPRESSION; MDR1	The blood-brain barrier (BBB), composed of tightly organized endothelial cells, limits the availability of drugs to therapeutic targets in the central nervous system. The barrier is maintained by membrane bound efflux pumps efficiently transporting specific xenobiotics back into the blood. The efflux pump P-glycoprotein (P-gp), expressed at high levels in brain endothelial cells, has several drug substrates. Consequently, siRNA mediated silencing of the P-gp gene is one possible strategy how to improve the delivery of drugs to the brain. Herein, we investigated the potential of siRNA-chitosan nanoparticles in silencing P-gp in a BBB model. We show that the transfection of rat brain endothelial cells mediated effective knockdown of P-gp with subsequent decrease in P-gp substrate efflux. This resulted in increased cellular delivery and efficacy of the model drug doxorubicin.	[Malmo, Jostein; Varum, Kjell M.; Strand, Sabina P.] Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway; [Malmo, Jostein; Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, Dept Lab Med, Trondheim, Norway; [Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, MI Lab, Trondheim, Norway; [Sandvig, Axel] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Sandvig, Axel] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Umea University	Malmo, J (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway.	jostein.malmo@ntnu.no			NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology)	NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology)	This work was supported by a Ph.D. grant from NTNU (Norges Teknisk-Naturvitenskapelige Universitet) (Norwegian University of Science and Technology) to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Babakhanian K, 2007, BIOCHEM BIOPH RES CO, V361, P301, DOI 10.1016/j.bbrc.2007.06.176; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Begley DJ, 1996, J NEUROCHEM, V67, P988; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; de Klerk OL, 2010, PSYCHIAT RES-NEUROIM, V183, P151, DOI 10.1016/j.pscychresns.2010.05.002; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Fuest C, 2009, NEUROSCI LETT, V464, P47, DOI 10.1016/j.neulet.2009.08.014; Goralski KB, 2003, BRIT J PHARMACOL, V139, P35, DOI 10.1038/sj.bjp.0705227; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Gupta Y, 2007, J PHARM PHARMACOL, V59, P935, DOI 10.1211/jpp.59.7.0004; Han HD, 2010, CLIN CANCER RES, V16, P3910, DOI 10.1158/1078-0432.CCR-10-0005; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Jeong JH, 2007, BIOMATERIALS, V28, P1912, DOI 10.1016/j.biomaterials.2006.12.019; Kemper EM, 2003, CLIN CANCER RES, V9, P2849; Khoury M, 2006, ARTHRITIS RHEUM, V54, P1867, DOI 10.1002/art.21876; Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004; Malmo J, 2012, J CONTROL RELEASE, V158, P261, DOI 10.1016/j.jconrel.2011.11.012; Malmo J, 2011, BIOMACROMOLECULES, V12, P721, DOI 10.1021/bm1013525; Matsui Y, 2005, PHARM RES-DORDR, V22, P2091, DOI 10.1007/s11095-005-8178-8; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; MULLER C, 1995, J CELL PHYSIOL, V163, P538, DOI 10.1002/jcp.1041630314; Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3; Regina A, 1998, J NEUROCHEM, V71, P705; Rojanarata T, 2008, PHARM RES-DORDR, V25, P2807, DOI 10.1007/s11095-008-9648-6; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Saito Takaya, 2012, Silence, V3, P3, DOI 10.1186/1758-907X-3-3; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Strand SP, 2010, BIOMATERIALS, V31, P975, DOI 10.1016/j.biomaterials.2009.09.102; Susa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010764; Techaarpornkul S, 2010, AAPS PHARMSCITECH, V11, P64, DOI 10.1208/s12249-009-9355-6; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tommeraas K, 2001, CARBOHYD RES, V333, P137, DOI 10.1016/S0008-6215(01)00130-6; Varum K.M., 2005, VERSATILITY, P625; Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu H, 2003, CANCER RES, V63, P1515	49	62	63	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54182	10.1371/journal.pone.0054182	http://dx.doi.org/10.1371/journal.pone.0054182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372682	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500036
J	Rappa, F; Greco, A; Podrini, C; Cappello, F; Foti, M; Bourgoin, L; Peyrou, M; Marino, A; Scibetta, N; Williams, R; Mazzoccoli, G; Federici, M; Pazienza, V; Vinciguerra, M				Rappa, Francesca; Greco, Azzura; Podrini, Christine; Cappello, Francesco; Foti, Michelangelo; Bourgoin, Lucie; Peyrou, Marion; Marino, Arianna; Scibetta, Nunzia; Williams, Roger; Mazzoccoli, Gianluigi; Federici, Massimo; Pazienza, Valerio; Vinciguerra, Manlio			Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							FATTY LIVER; DOWN-REGULATION; KAPPA-B; CANCER; PTEN; INFLAMMATION; PROGRESSION; OBESITY; IL-6	Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in the liver, defined as hepatosteatosis, is an independent and strong risk factor for developing an HCC. MacroH2A1, a histone protein generally associated with the repressed regions of chromosomes, is involved in hepatic lipid metabolism and is present in two alternative spliced isoforms, macroH2A1.1 and macroH2A1.2. These isoforms have been shown to predict lung and colon cancer recurrence but to our knowledge, their role in fatty-liver associated HCC has not been investigated previously. Methods: We examined macroH2A1.1 and macroH2A1.2 protein expression levels in the liver of two murine models of fat-associated HCC, the high fat diet/diethylnistrosamine (DEN) and the phosphatase and tensin homolog (PTEN) liver specific knock-out (KO) mouse, and in human liver samples of subjects with steatosis or HCC, using immunoblotting and immunohistochemistry. Results: Protein levels for both macroH2A1 isoforms were massively upregulated in HCC, whereas macroH2A1.2 was specifically upregulated in steatosis. In addition, examination of human liver samples showed a significant difference (p < 0.01) in number of positive nuclei in HCC (100% of tumor cells positive for either macroH2A1.1 or macroH2A1.2), when compared to steatosis (<2% of hepatocytes positive for either isoform). The steatotic areas flanking the tumors were highly immunopositive for macroH2A1.1 and macroH2A1.2. Conclusions: These data obtained in mice and humans suggest that both macroH2A1 isoforms may play a role in HCC pathogenesis and moreover may be considered as novel diagnostic markers for human HCC.	[Rappa, Francesca; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Rappa, Francesca; Cappello, Francesco; Vinciguerra, Manlio] Euromediterranean Inst Sci & Technol, Palermo, Italy; [Greco, Azzura; Podrini, Christine; Williams, Roger; Vinciguerra, Manlio] Fdn Liver Res, Inst Hepatol, London, England; [Cappello, Francesco] Libera Univ Studi Sci Umane & Tecnol, Ist Paolo Sotgiu, Lugano, Switzerland; [Foti, Michelangelo; Bourgoin, Lucie; Peyrou, Marion] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Marino, Arianna; Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Scibetta, Nunzia] Civ Hosp, Anat Pathol Unit, Palermo, Italy; [Mazzoccoli, Gianluigi] IRCCS Casa Sollievo Sofferenza, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, Italy; [Mazzoccoli, Gianluigi] IRCCS Casa Sollievo Sofferenza, Chronobiol Unit, San Giovanni Rotondo, Italy; [Pazienza, Valerio] IRCCS Casa Sollievo Sofferenza, Div & Lab Gastroenterol, San Giovanni Rotondo, Italy	University of Palermo; University of London; University College London; University of Geneva; University of Rome Tor Vergata; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Vinciguerra, M (corresponding author), UCL, Inst Liver & Digest Hlth, Div Med, London, England.	manliovinciguerra@iemest.eu	Vinciguerra, Manlio/N-1309-2015; Pazienza, Valerio/K-5073-2012; Federici, Massimo/G-9940-2012; Podrini, Christine/K-8621-2016; Mazzoccoli, Gianluigi/H-2447-2016; Francesca, Rappa/ADW-8431-2022; Peyrou, Marion/A-7190-2015; Cappello, Francesco/F-9153-2012	Vinciguerra, Manlio/0000-0002-1768-3894; Pazienza, Valerio/0000-0002-3492-1153; Federici, Massimo/0000-0003-4989-5194; Podrini, Christine/0000-0002-5391-3378; Mazzoccoli, Gianluigi/0000-0003-3535-7635; Peyrou, Marion/0000-0002-1210-6094; rappa, francesca/0000-0001-6610-5268; Cappello, Francesco/0000-0001-9288-1148; Foti, Michelangelo/0000-0001-7199-4135				Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Farina F, 2000, J HISTOCHEM CYTOCHEM, V48, P57, DOI 10.1177/002215540004800106; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Kantartzis K, 2010, DIGEST DIS, V28, P169, DOI 10.1159/000282082; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lou-Bonafonte JM, 2011, CURR OPIN LIPIDOL, V22, P159, DOI 10.1097/MOL.0b013e3283462288; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Myers RP, 2009, ANN HEPATOL, V8, pS25, DOI 10.1016/S1665-2681(19)31823-X; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Salamone F, 2012, TRANSL RES, V159, P477, DOI 10.1016/j.trsl.2011.12.003; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Vinciguerra M, 2012, AGING CELL, V11, P139, DOI 10.1111/j.1474-9726.2011.00766.x; Vinciguerra M, 2010, DIS MODEL MECH, V3, P298, DOI 10.1242/dmm.004655; Vinciguerra M, 2009, J HEPATOL, V50, P1132, DOI 10.1016/j.jhep.2009.01.027; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737	39	52	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54458	10.1371/journal.pone.0054458	http://dx.doi.org/10.1371/journal.pone.0054458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372727	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500074
J	Zhou, YF; Liao, SS; Luo, YY; Tang, JG; Wang, JL; Lei, LF; Chi, JW; Du, J; Jiang, H; Xia, K; Tang, BS; Shen, L				Zhou, Ya-Fang; Liao, Shu-Sheng; Luo, Ying-Ying; Tang, Jian-Guang; Wang, Jun-Ling; Lei, Li-Fang; Chi, Jing-Wei; Du, Juan; Jiang, Hong; Xia, Kun; Tang, Bei-Sha; Shen, Lu			SUMO-1 Modification on K166 of PolyQ-Expanded aTaxin-3 Strengthens Its Stability and Increases Its Cytotoxicity	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; COVALENT MODIFICATION; ANDROGEN RECEPTOR; MUTANT-HUNTINGTIN; PROTEIN; AGGREGATION; SUMOYLATION; RANGAP1; GENE; HETEROGENEITY	Post-translational modification by SUMO was proposed to modulate the pathogenesis of several neurodegenerative diseases. Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is an autosomal dominant neurodegenerative disease caused by polyQ-expanded ataxin-3. We have previously shown that ataxin-3 was a new target of SUMOylation in vitro and in vivo. Here we identified that the major SUMO-1 binding site was located on lysine 166. SUMOylation did not influence the subcellular localization, ubiquitination or aggregates formation of mutant-type ataxin-3, but partially increased its stability and the cell apoptosis. Our findings revealed the role of ataxin-3 SUMOylation in SCA3/MJD pathogenesis.	[Zhou, Ya-Fang; Liao, Shu-Sheng; Luo, Ying-Ying; Wang, Jun-Ling; Lei, Li-Fang; Du, Juan; Jiang, Hong; Tang, Bei-Sha; Shen, Lu] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Jian-Guang] Cent S Univ, Xiangya Hosp 2, Dept Neurol, Changsha, Hunan, Peoples R China; [Chi, Jing-Wei; Jiang, Hong; Xia, Kun; Tang, Bei-Sha] Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; [Tang, Bei-Sha; Shen, Lu] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	shenlu2505@yahoo.com.cn	XIA, KUN/AAO-3525-2020		National Natural Sciences Foundation of China [30470619, 30971034, 81000543]; Distinguished Youth Foundation of Hunan Province [2007JJ1005]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Youth Foundation of Hunan Province	This work was supported by the National Natural Sciences Foundation of China (No: 30470619, 30971034, 81000543), Distinguished Youth Foundation of Hunan Province (No: 2007JJ1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Breuer P, 2010, J BIOL CHEM, V285, P6532, DOI 10.1074/jbc.M109.036335; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CANCEL G, 1995, AM J HUM GENET, V57, P809; Cecchin CR, 2007, COMMUNITY GENET, V10, P19, DOI 10.1159/000096276; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 2005, MOL BIOL CELL, V16, P5115, DOI 10.1091/mbc.E05-06-0536; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hughes RE, 2002, CURR BIOL, V12, pR141, DOI 10.1016/S0960-9822(02)00709-1; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pennuto M, 2009, HUM MOL GENET, V18, pR40, DOI 10.1093/hmg/ddn412; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen Lu, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P242; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; Tang JG, 2006, PROG BIOCHEM BIOPHYS, V33, P1037	42	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54214	10.1371/journal.pone.0054214	http://dx.doi.org/10.1371/journal.pone.0054214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382880	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600025
J	Liu, YL; Tsai, IC; Chang, CW; Liao, YF; Liu, GY; Hung, HC				Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Liao, Ya-Fan; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Roles of the Non-Catalytic Calcium-Binding Sites in the N-Terminal Domain of Human Peptidylarginine Deiminase 4	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ARGININE DEIMINASE; GENE ORGANIZATION; DEVELOPMENTALLY IMMATURE; CITRULLINATED PROTEINS; HISTONE DEIMINATION; EXPRESSION ANALYSIS; MULTIPLE-SCLEROSIS; MOLECULAR-CLONING; CDNA CLONING	This study investigated the functional roles of the N-terminal Ca2+ ion-binding sites, in terms of enzyme catalysis and stability, of peptidylarginine deiminase 4 (PAD4). Amino acid residues located in the N-terminal Ca2+-binding site of PAD4 were mutated to disrupt the binding of Ca2+ ions. Kinetic data suggest that Asp155, Asp157 and Asp179, which directly coordinate Ca3 and Ca4, are essential for catalysis in PAD4. For D155A, D157A and D179A, the k(cat)/K-m,(BAEE) values were 0.02, 0.63 and 0.01 s(-1) mM(-1) (20.8 s(-1) mM(-1) for WT), respectively. Asn153 and Asp176 are directly coordinated with Ca3 and indirectly coordinated with Ca5 via a water molecule. However, N153A displayed low enzymatic activity with a k(cat) value of 0.3 s(-1) (13.3 s(-1) for wild-type), whereas D176A retained some catalytic power with a kcat of 9.7 s(-1). Asp168 is the direct ligand for Ca5, and Ca5 coordination by Glu252 is mediated by two water molecules. However, mutation of these two residues to Ala did not cause a reduction in the kcat/Km, BAEE values, which indicates that the binding of Ca5 may not be required for PAD4 enzymatic activity. The possible conformational changes of these PAD4 mutants were examined. Thermal stability analysis of the PAD4 mutants in the absence or presence of Ca2+ indicated that the conformational stability of the enzyme is highly dependent on Ca2+ ions. In addition, the results of urea-induced denaturation for the N153, D155, D157 and D179 series mutants further suggest that the binding of Ca2+ ions in the N-terminal Ca2+-binding site stabilizes the overall conformational stability of PAD4. Therefore, our data strongly suggest that the N-terminal Ca2+ ions play critical roles in the full activation of the PAD4 enzyme.	[Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yi-Liang; Tsai, I-Chen; Chang, Chia-Wei; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liao, Ya-Fan] Chaoyang Univ Technol, Grad Inst Biochem Sci & Biotechnol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chaoyang University of Technology; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, ROC [NSC-101-2311-B-005-016]; Ministry of Education, Taiwan	National Science Council, ROC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the National Science Council, ROC (NSC-101-2311-B-005-016 to H.-C. H.) (http://web1.nsc.gov.tw/) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 1999, NEUROSCI LETT, V274, P53, DOI 10.1016/S0304-3940(99)00678-3; Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 1998, BIOCHEM BIOPH RES CO, V243, P641, DOI 10.1006/bbrc.1998.8148; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; delPino MMS, 1997, BIOCHEMISTRY-US, V36, P5560, DOI 10.1021/bi963133z; Guerrin M, 2003, BIOCHEM J, V370, P167, DOI 10.1042/BJ20020870; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Ishida-Yamamoto A, 2002, J INVEST DERMATOL, V118, P282, DOI 10.1046/j.0022-202x.2001.01671.x; Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7; Ishigami A, 2010, GERIATR GERONTOL INT, V10, pS53, DOI 10.1111/j.1447-0594.2010.00593.x; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knuckley B, 2007, BIOCHEMISTRY-US, V46, P6578, DOI 10.1021/bi700095s; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liao YF, 2005, ANAL BIOCHEM, V347, P176, DOI 10.1016/j.ab.2005.09.027; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021314; Lu XF, 2004, J AM CHEM SOC, V126, P5374, DOI 10.1021/ja049543p; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mizoguchi M, 1998, J HISTOCHEM CYTOCHEM, V46, P1303, DOI 10.1177/002215549804601110; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Nijenhuis S, 2004, CLIN CHIM ACTA, V350, P17, DOI 10.1016/j.cccn.2004.07.016; Pace C N, 1986, Methods Enzymol, V131, P266; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Suzuki A, 2005, BIOCHEM BIOPH RES CO, V333, P418, DOI 10.1016/j.bbrc.2005.05.137; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Zhang JY, 2004, ACTA BIOCHIM POL, V51, P1051	44	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e51660	10.1371/journal.pone.0051660	http://dx.doi.org/10.1371/journal.pone.0051660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382808	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800005
J	Ting, NC; Jansen, J; Nagappan, J; Ishak, Z; Chin, CW; Tan, SG; Cheah, SC; Singh, R				Ting, Ngoot-Chin; Jansen, Johannes; Nagappan, Jayanthi; Ishak, Zamzuri; Chin, Cheuk-Weng; Tan, Soon-Guan; Cheah, Suan-Choo; Singh, Rajinder			Identification of QTLs Associated with Callogenesis and Embryogenesis in Oil Palm Using Genetic Linkage Maps Improved with SSR Markers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TISSUE-CULTURE RESPONSE; NUCLEAR-DNA CONTENT; INITIATION; CALLUS	Clonal reproduction of oil palm by means of tissue culture is a very inefficient process. Tissue culturability is known to be genotype dependent with some genotypes being more amenable to tissue culture than others. In this study, genetic linkage maps enriched with simple sequence repeat (SSR) markers were developed for dura (ENL48) and pisifera (ML161), the two fruit forms of oil palm, Elaeis guineensis. The SSR markers were mapped onto earlier reported parental maps based on amplified fragment length polymorphism (AFLP) and restriction fragment length polymorphism (RFLP) markers. The new linkage map of ENL48 contains 148 markers (33 AFLPs, 38 RFLPs and 77 SSRs) in 23 linkage groups (LGs), covering a total map length of 798.0 cM. The ML161 map contains 240 markers (50 AFLPs, 71 RFLPs and 119 SSRs) in 24 LGs covering a total of 1,328.1 cM. Using the improved maps, two quantitative trait loci (QTLs) associated with tissue culturability were identified each for callusing rate and embryogenesis rate. A QTL for callogenesis was identified in LGD4b of ENL48 and explained 17.5% of the phenotypic variation. For embryogenesis rate, a QTL was detected on LGP16b in ML161 and explained 20.1% of the variation. This study is the first attempt to identify QTL associated with tissue culture amenity in oil palm which is an important step towards understanding the molecular processes underlying clonal regeneration of oil palm.	[Ting, Ngoot-Chin; Nagappan, Jayanthi; Ishak, Zamzuri; Cheah, Suan-Choo; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Jansen, Johannes] Univ Wageningen & Res Ctr, Ac Wageningen, Netherlands; [Chin, Cheuk-Weng] Fed Land Dev Author Malaysia Agr Serv Sdn Bhd, Fed Land Dev Author Malaysia Biotechnol Ctr, Kuala Lumpur, Malaysia; [Tan, Soon-Guan] Univ Putra Malaysia, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia	Malaysian Palm Oil Board; Wageningen University & Research; Universiti Putra Malaysia	Singh, R (corresponding author), Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia.	rajinder@mpob.gov.my	Tan, S G/B-2448-2010; Tan, Soon Guan/V-1782-2019; Singh, Rajinder/P-9179-2015	Tan, S G/0000-0001-9960-4493; Tan, Soon Guan/0000-0001-9960-4493; Singh, Rajinder/0000-0001-9933-4884; Ting, Ngoot Chin/0000-0002-4910-6020	Ministry of Science, Technology and Innovation (MOSTI), Malaysia [MMBPP 04-03-T0045-TC3.2]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This project is funded by the Ministry of Science, Technology and Innovation (MOSTI), Malaysia under the project code MMBPP 04-03-T0045-TC3.2. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwee SSRS, 2010, PROC ADVANCES IN OIL, P45; BenAmer IM, 1997, THEOR APPL GENET, V94, P1047, DOI 10.1007/s001220050513; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Billotte N, 2010, THEOR APPL GENET, V120, P1673, DOI 10.1007/s00122-010-1284-y; Bolibok H, 2007, CELL MOL BIOL LETT, V12, P523, DOI 10.2478/s11658-007-0023-0; Bolibok H, 2006, EUPHYTICA, V149, P73, DOI 10.1007/s10681-005-9055-6; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Cheah S. C, 1993, 1991 P INT PALM OIL, P144; Chin CW, 1996, PROC OIL PALM PLANTI, P71; Chua KL, 2006, THESIS; Corley R.H.V., 1997, PLANTATION MANAGEMEN, P279; Corley RHV, 1998, PROC INT OIL PALM CO, P1; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hardon J., 1987, IMPROVING VEGETATIVE; Ho YW, 2009, P NAT C OIL PALM, P86; Jansen J, 2005, GENETICS, V170, P2013, DOI 10.1534/genetics.105.041822; KEYES GJ, 1980, THEOR APPL GENET, V58, P265, DOI 10.1007/BF00265178; KOMATSUDA T, 1993, THEOR APPL GENET, V86, P713, DOI 10.1007/BF00222661; Krakowsky MD, 2006, THEOR APPL GENET, V113, P821, DOI 10.1007/s00122-006-0334-y; Kushairi A, 2010, PAPER PRESENTED AT T; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; MacKay JJ, 2006, TREE GENET GENOMES, V2, P1, DOI 10.1007/s11295-005-0020-2; Madon M, 2008, J OIL PALM RES, V20, P447; Mano Y, 2002, THEOR APPL GENET, V105, P708, DOI 10.1007/s00122-002-0992-3; Mohd Basri W, 2009, PAPER PRESENTED AT T; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ong-Abdullah M, 2006, OIL PALM B, V53, P36; SINGH R, 2011, FURTHER ADV OIL PALM, P202; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Soh AC, 2011, J OIL PALM RES, V23, P935; TaguchiShiobara F, 1997, THEOR APPL GENET, V95, P828, DOI 10.1007/s001220050632; Tarmizi AH, 2010, FURTHER ADVANCES IN, P102; Ting NC, 2006, PERTANIKA J TROP AGR, V29, P35; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wooi K. C., 1995, P 1993 ISOPB INT S R, P21; Zaki NM, 2010, SAINS MALAYS, V39, P909	43	30	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53076	10.1371/journal.pone.0053076	http://dx.doi.org/10.1371/journal.pone.0053076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382832	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200036
J	Kateb, F; Perrin, H; Tripsianes, K; Zou, P; Spadaccini, R; Bottomley, M; Franzmann, TM; Buchner, J; Ansieau, S; Sattler, M				Kateb, Fatiha; Perrin, Helene; Tripsianes, Konstantinos; Zou, Peijian; Spadaccini, Roberta; Bottomley, Matthew; Franzmann, Titus M.; Buchner, Johannes; Ansieau, Stephane; Sattler, Michael			Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains	PLOS ONE			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; PROTEIN STRUCTURES; AUTOMATED ASSIGNMENT; DIPOLAR COUPLINGS; N-COR; NMR; TRANSCRIPTION; MACROMOLECULES; REPRESSION	DEAF-1 is an important transcriptional regulator that is required for embryonic development and is linked to clinical depression and suicidal behavior in humans. It comprises various structural domains, including a SAND domain that mediates DNA binding and a MYND domain, a cysteine-rich module organized in a Cys(4)-Cys(2)-His-Cys (C4-C2HC) tandem zinc binding motif. DEAF-1 transcription regulation activity is mediated through interactions with cofactors such as NCoR and SMRT. Despite the important biological role of the DEAF-1 protein, little is known regarding the structure and binding properties of its MYND domain. Here, we report the solution structure, dynamics and ligand binding of the human DEAF-1 MYND domain encompassing residues 501-544 determined by NMR spectroscopy. The structure adopts a beta beta alpha fold that exhibits tandem zinc-binding sites with a cross-brace topology, similar to the MYND domains in AML1/ETO and other proteins. We show that the DEAF-1 MYND domain binds to peptides derived from SMRT and NCoR corepressors. The binding surface mapped by NMR titrations is similar to the one previously reported for AML1/ETO. The ligand binding and molecular functions of the related BS69 MYND domain were studied based on a homology model and mutational analysis. Interestingly, the interaction between BS69 and its binding partners (viral and cellular proteins) seems to require distinct charged residues flanking the predicted MYND domain fold, suggesting a different binding mode. Our findings demonstrate that the MYND domain is a conserved zinc binding fold that plays important roles in transcriptional regulation by mediating distinct molecular interactions with viral and cellular proteins.	[Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany; [Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Franzmann, Titus M.; Buchner, Johannes; Sattler, Michael] Tech Univ Munich, Biomol NMR, Garching, Germany; [Kateb, Fatiha; Tripsianes, Konstantinos; Zou, Peijian; Franzmann, Titus M.; Buchner, Johannes; Sattler, Michael] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany; [Perrin, Helene; Ansieau, Stephane] Univ Lyon 1, Ctr Leon Berard, Inst Natl Sante & Rech Med U590, F-69365 Lyon, France; [Zou, Peijian; Sattler, Michael] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Spadaccini, Roberta] Univ Naples Federico II, Dipartimento Chim, Naples, Italy; [Bottomley, Matthew] Novartis Vaccines & Diagnost, Siena, Italy	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Naples Federico II; Novartis	Sattler, M (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Buchner, Johannes/A-2651-2010; Tripsianes, Konstantinos/I-8382-2014; Ansieau, Stephane/I-6195-2016; Franzmann, Titus M/D-1962-2011	Sattler, Michael/0000-0002-1594-0527; Tripsianes, Konstantinos/0000-0003-0948-813X; Buchner, Johannes/0000-0003-1282-7737; SPADACCINI, Roberta/0000-0002-2262-1065; ANSIEAU, Stephane/0000-0003-0989-2108; Franzmann, Titus/0000-0002-4281-7209	Alexander von Humboldt foundation; long-term EMBO fellowship; Marie-Curie fellowship; Chinese Academy of Science [KSCX2-YW-BR-4]; Deutsche Forschungsgemeinschaft	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); long-term EMBO fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie fellowship(European Commission); Chinese Academy of Science(Chinese Academy of Sciences); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	F.K and K. T. acknowledge support by the Alexander von Humboldt foundation. R. S. and M.J.B. are grateful for long-term EMBO and Marie-Curie fellowships, respectively. P.Z. is supported by the grant (KSCX2-YW-BR-4) from the Chinese Academy of Science. M. S. is supported by the Deutsche Forschungsgemeinschaft. M. S. holds a Visiting Professorship for Senior International Scientists at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2003, PATHOL BIOL, V51, P397, DOI 10.1016/S0369-8114(03)00019-1; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, TENSOR2; Eswar N., 2002, COMP PROTEIN STRUCTU; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foreman KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022290; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Goddard D., 2008, SPARKY 3; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lausen J, 2004, J BIOL CHEM, V279, P49281, DOI 10.1074/jbc.M407239200; Lemonde S, 2003, J NEUROSCI, V23, P8788; Linge J. P, 2001, NEW METHODS AUTOMATE; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu Y, 2007, CANCER CELL, V11, P1; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; PELTON JG, 1993, PROTEIN SCI, V2, P543; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SAVAGE CR, 1973, J BIOL CHEM, V248, P7669; Schwabe JWR, 1994, STRUCT BIOL, V1, P345; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spadaccini R, 2006, J MOL BIOL, V358, P498, DOI 10.1016/j.jmb.2006.01.087; Spadaccini R, 2008, J MOL BIOL, V376, P1523, DOI 10.1016/j.jmb.2008.01.071; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Velasco G, 2006, J BIOL CHEM, V281, P16546, DOI 10.1074/jbc.M600573200; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 1998, J BIOMOL NMR, V12, P325, DOI 10.1023/A:1008223017233	65	18	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54715	10.1371/journal.pone.0054715	http://dx.doi.org/10.1371/journal.pone.0054715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372760	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400025
J	Le, J; Kim, S; Kim, P; Liu, XJ; Lee, T; Kim, KM; Do, IG; Park, JO; Park, SH; Jang, J; Hoe, N; Harvie, G; Kuller, A; Jain, A; Meyer, G; Leesman, G; Park, YS; Choi, MG; Sohn, TS; Bae, JM; Lim, HY; Singh, S; Kang, WK				Le, Jeeyun; Kim, Sung; Kim, Phillip; Liu, Xinjun; Lee, Tani; Kim, Kyoung-Mee; Do, In-Gu; Park, Joon Oh; Park, Se Hoon; Jang, Jiryeon; Hoe, Nicholas; Harvie, Gulia; Kuller, Anne; Jain, Anjali; Meyer, Gary; Leesman, Glen; Park, Young Suk; Choi, Min Gew; Sohn, Tae Sung; Bae, Jae Moon; Lim, Ho Yeong; Singh, Sharat; Kang, Won Ki			A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; INTESTINAL-TYPE; TUMOR-CELLS; HER2 STATUS; HIGH-RISK; EXPRESSION; CARCINOMA; RECEPTOR; REVEALS	Purpose: The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs). Experimental Design: Protein lysates from fresh-frozen 434 advanced stage GCs were analyzed for phosphorylation of HER1, HER2, p95HER2, HER3, cMET, IGF1R and PI3K. The pathway activation patterns were segregated based on the tumor HER2 status. Hierarchical clustering was utilized to determine pathway coactivations in GCs. Prognostic value of pathway activation patterns was determined by correlating disease-free survival times of the various GC subgroups using Kaplan-Meier survival analysis. CEER was also used to determine the presence of tyrosine phosphorylated signaling cascades in circulating tumor cells (CTCs) and ascites tumor cells (ATCs). Results: Utilizing a novel diagnostics immunoassay, CEER, we demonstrate the presence of p95HER2 and concomitantly activated signaling pathways in GC tumor tissues, CTCs and ATCs isolated from GC patients for the first time. p95HER2 is expressed in similar to 77% of HER2(+) GCs. Approximately 54% of GCs have an activated HER1, HER2, HER3, cMET or IGF1R and demonstrate a poorer prognosis than those where these receptor tyrosine kinases (RTKs) are not activated. Hierarchical clustering of RTKs reveals co-clustering of phosphorylated HER1: cMET, HER2: HER3 and IGF1R-PI3K. Coactivation of HER1 with cMET renders GCs with a shorter disease-free survival as compared to only cMET activated GCs. Conclusions: Our study highlights the utility of a novel companion diagnostics technology, CEER that has strong implications for drug development and therapeutic monitoring. CEER is used to provide an increased understanding of activated signaling pathways in advanced GCs that can significantly improve their clinical management through accurate patient selection for targeted therapeutics.	[Le, Jeeyun; Park, Joon Oh; Park, Se Hoon; Jang, Jiryeon; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Kim, Sung; Choi, Min Gew; Sohn, Tae Sung] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea; [Kim, Kyoung-Mee; Do, In-Gu; Bae, Jae Moon] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea; [Kim, Phillip; Liu, Xinjun; Lee, Tani; Hoe, Nicholas; Harvie, Gulia; Kuller, Anne; Jain, Anjali; Meyer, Gary; Leesman, Glen; Singh, Sharat] Prometheus Labs, San Diego, CA USA; [Do, In-Gu] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Canc Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, S (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea.	sungkimm@skku.edu; wkkang@skku.edu	Kim, Sung/G-4114-2014; Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015; Park, Se Hoon/GMX-1199-2022	Park, Se Hoon/0000-0001-5084-9326				Arribas J, 2011, CANCER RES, V71, P1515, DOI 10.1158/0008-5472.CAN-10-3795; Bae Jong Myon, 2002, Cancer Res Treat, V34, P77, DOI 10.4143/crt.2002.34.2.77; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; CORREA P, 1990, CANCER RES, V50, P4731; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2005, ANN ONCOL, V16, P22, DOI 10.1093/annonc/mdi812; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hazra S, 2012, J CLIN ONCOL S, V30; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hoe N, 2011, P 102 ANN M AM ASS C; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Jhawer MP, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4572; Kim P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-75; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Loibl S BJ, 2011, J CLIN ONCOL, V29; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tay ST, 2003, CANCER RES, V63, P3309; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ward TM, 2012, ONCOGENE IN PRESS; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; YOU WC, 1993, CANCER RES, V53, P1317	38	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54644	10.1371/journal.pone.0054644	http://dx.doi.org/10.1371/journal.pone.0054644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372746	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400021
J	Martin, DH; Boro, A; Schafer, BW				Martin, David Herrero; Boro, Aleksandar; Schaefer, Beat W.			Cell-Based Small-Molecule Compound Screen Identifies Fenretinide as Potential Therapeutic for Translocation-Positive Rhabdomyosarcoma	PLOS ONE			English	Article							EWINGS-SARCOMA FAMILY; CHILDRENS ONCOLOGY GROUP; SOFT-TISSUE SARCOMA; IN-VIVO; N-(4-HYDROXYPHENYL) RETINAMIDE; INTERGROUP RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; NEUROBLASTOMA-CELLS; INDUCED APOPTOSIS; DOWN-REGULATION	A subset of paediatric sarcomas are characterized by chromosomal translocations encoding specific oncogenic transcription factors. Such fusion proteins represent tumor specific therapeutic targets although so far it has not been possible to directly inhibit their activity by small-molecule compounds. In this study, we hypothesized that screening a small-molecule library might identify already existing drugs that are able to modulate the transcriptional activity of PAX3/FOXO1, the fusion protein specifically found in the pediatric tumor alveolar rhabdomyosarcoma (aRMS). Towards this end, we established a reporter cell line based on the well characterized PAX3/FOXO1 target gene AP2 beta. A library enriched in mostly FDA approved drugs was screened using specific luciferase activity as read-out and normalized for cell viability. The most effective inhibitor identified from this screen was Fenretinide. Treatment with this compound resulted in down-regulation of PAX3/FOXO1 mRNA and protein levels as well as in reduced expression of several of its direct target genes, but not of wild-type FOXO1, in a dose-and time-dependent manner. Moreover, fenretinide induced reactive oxygen species and apoptosis as shown by caspase 9 and PARP cleavage and upregulated miR-9. Importantly, it demonstrated a significant anti-tumor effect in vivo. These results are similar to earlier reports for two other pediatric tumors, namely neuroblastoma and Ewing sarcoma, where fenretinide is under clinical development. Our results suggest that fenretinide might represent a novel treatment option also for translocation-positive rhabdomyosarcoma.	[Schaefer, Beat W.] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Schafer, BW (corresponding author), Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch		Schafer, Beat/0000-0001-5988-2915	Cancer Research Switzerland [OCS2264-08-2008]; Swiss Foundation Child and Cancer	Cancer Research Switzerland; Swiss Foundation Child and Cancer	This work was supported by grants from Cancer Research Switzerland (OCS2264-08-2008) and the Swiss Foundation Child and Cancer (http://www.kindundkrebs.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Amstutz R, 2008, CANCER RES, V68, P3767, DOI 10.1158/0008-5472.CAN-07-2447; Ayyanathan K, 2000, CANCER RES, V60, P5803; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Brien DO, 2012, HISTOL HISTOPATHOL, V27, P13, DOI 10.14670/HH-27.13; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; CROUCH GD, 1991, CANCER RES, V51, P4882; DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359; Denli AM, 2009, NAT STRUCT MOL BIOL, V16, P346, DOI 10.1038/nsmb0409-346; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Ferrari N, 2003, CLIN CANCER RES, V9, P6020; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; FORMELLI F, 1993, CANCER RES, V53, P5374; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gopal AK, 2004, BLOOD, V103, P3516, DOI 10.1182/blood-2003-08-2795; Goto H, 2003, INT J HEMATOL, V78, P219, DOI 10.1007/BF02983798; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hecker RM, 2010, ONCOGENE, V29, P3942, DOI 10.1038/onc.2010.145; Heerema-McKenney A, 2008, AM J SURG PATHOL, V32, P1513, DOI 10.1097/PAS.0b013e31817a909a; HOUGHTON JA, 1982, J NATL CANCER I, V68, P437; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Karmakar Surajit, 2011, World J Oncol, V2, P53; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Koscielniak E, 1999, J CLIN ONCOL, V17, P3706, DOI 10.1200/JCO.1999.17.12.3706; Kutty RK, 2010, MOL VIS, V16, P1475; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Malone W, 2003, EXPERT OPIN INV DRUG, V12, P1829, DOI 10.1517/eoid.12.11.1829.21882; MARIOTTI A, 1994, J NATL CANCER I, V86, P1245, DOI 10.1093/jnci/86.16.1245; Melguizo C, 2011, ONCOL REP, V26, P755, DOI 10.3892/or.2011.1347; Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001; Myatt SS, 2008, ONCOGENE, V27, P985, DOI 10.1038/sj.onc.1210705; Myatt SS, 2005, CLIN CANCER RES, V11, P3136, DOI 10.1158/1078-0432.CCR-04-2050; Oesch S, 2009, MOL CANCER THER, V8, P1838, DOI 10.1158/1535-7163.MCT-08-1147; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pappo AS, 1999, J CLIN ONCOL, V17, P3487, DOI 10.1200/JCO.1999.17.11.3487; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reynolds CP, 2001, HEMATOL ONCOL CLIN N, V15, P867, DOI 10.1016/S0889-8588(05)70256-2; Ricaud S, 2005, EXP CELL RES, V311, P192, DOI 10.1016/j.yexcr.2005.09.011; Roeb W, 2008, CELL CYCLE, V7, P837, DOI 10.4161/cc.7.7.5652; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Selcuklu SD, 2012, J BIOL CHEM, V287, P29516, DOI 10.1074/jbc.M111.335943; Smith LM, 2001, J CLIN ONCOL, V19, P4058, DOI 10.1200/JCO.2001.19.20.4058; Smith ME, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-34; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tosetti F, 2003, MOL PHARMACOL, V63, P565, DOI 10.1124/mol.63.3.565; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Villablanca JG, 2011, CLIN CANCER RES, V17, P6858, DOI 10.1158/1078-0432.CCR-11-0995; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; White DE, 2010, BRIT J CANCER, V103, P1380, DOI 10.1038/sj.bjc.6605896; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	63	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55072	10.1371/journal.pone.0055072	http://dx.doi.org/10.1371/journal.pone.0055072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372815	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400058
J	Nordentoft, M; Wahlbeck, K; Hallgren, J; Westman, J; Osby, U; Alinaghizadeh, H; Gissler, M; Laursen, TM				Nordentoft, Merete; Wahlbeck, Kristian; Hallgren, Jonas; Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan; Gissler, Mika; Laursen, Thomas Munk			Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden	PLOS ONE			English	Article							AUSTRALIAN PSYCHIATRIC-PATIENTS; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; SCHIZOPHRENIA; SUICIDE; PEOPLE; INDIVIDUALS; BIPOLAR; SMOKING	Background: Excess mortality among patients with severe mental disorders has not previously been investigated in detail in large complete national populations. Objective: To investigate the excess mortality in different diagnostic categories due to suicide and other external causes of death, and due to specific causes in connection with diseases and medical conditions. Methods: In longitudinal national psychiatric case registers from Denmark, Finland, and Sweden, a cohort of 270,770 recent-onset patients, who at least once during the period 2000 to 2006 were admitted due to a psychiatric disorder, were followed until death or the end of 2006. They were followed for 912,279 person years, and 28,088 deaths were analyzed. Life expectancy and standardized cause-specific mortality rates were estimated in each diagnostic group in all three countries. Results: The life expectancy was generally approximately 15 years shorter for women and 20 years shorter for men, compared to the general population. Mortality due to diseases and medical conditions was increased two-to three-fold, while excess mortality from external causes ranged from three-to 77-fold. Mortality due to diseases and medical conditions was generally lowest in patients with affective disorders and highest in patients with substance abuse and personality disorders, while mortality due to suicide was highest in patients with affective disorders and personality disorders, and mortality due to other external causes was highest in patients with substance abuse. Conclusions: These alarming figures call for action in order to prevent the high mortality.	[Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Psychiat Ctr Copenhagen, iPSYCH, Copenhagen, Denmark; [Nordentoft, Merete; Wahlbeck, Kristian; Westman, Jeanette; Gissler, Mika; Laursen, Thomas Munk] Nord Res Acad Mental Hlth, Nord Sch Publ Hlth, Gothenburg, Sweden; [Hallgren, Jonas] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan] Karolinska Inst, Ctr Family Med, Care Sci & Soc, Dept Neurobiol, Stockholm, Sweden; [Osby, Urban] Karolinska Inst, Ctr Mol Med, Neurogenet Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Wahlbeck, Kristian; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Laursen, Thomas Munk] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Nordentoft, M (corresponding author), Univ Copenhagen, Fac Hlth Sci, Psychiat Ctr Copenhagen, iPSYCH, Copenhagen, Denmark.	mn@dadlnet.dk	Laursen, Thomas Munk/AFQ-8066-2022; Wahlbeck, Kristian/F-8394-2011; Nordentoft, Merete/AAH-3253-2019	Wahlbeck, Kristian/0000-0003-3754-3933; Alinaghizadeh, Hassan/0000-0002-9455-0753; Gissler, Mika/0000-0001-8254-7525; Westman, Jeanette/0000-0001-8701-4226; Laursen, Thomas Munk/0000-0001-6934-1784	Nordic Council of Ministers; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Nordic Council of Ministers; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by Nordic Council of Ministers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EUR J EDUC PSYCHOL; Bobes J, 2010, SCHIZOPHR RES, V119, P101, DOI 10.1016/j.schres.2010.02.1030; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; Brown S, 2011, SOC PSYCHIAT PSYCHIA; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Compton MT, 2006, HARVARD REV PSYCHIAT, V14, P212, DOI 10.1080/10673220600889256; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Daumit GL, 2008, SCHIZOPHR RES, V105, P175, DOI 10.1016/j.schres.2008.07.006; Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dixon LB, 2010, SCHIZOPHRENIA BULL, V36, P48, DOI 10.1093/schbul/sbp115; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Dutta R, 2010, SCHIZOPHR RES; Green AI, 2000, GEN HOSP PSYCHIAT, V22, P224, DOI 10.1016/S0163-8343(00)00081-5; Hansen T, 2011, BIOL PSYCHIAT; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Juel K, 1999, DAN MED BULL, V46, P354; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Kisely S, 2005, BRIT J PSYCHIAT, V187, P552, DOI 10.1192/bjp.187.6.552; Kisely S, 2007, CAN MED ASSOC J, V176, P779, DOI 10.1503/cmaj.060482; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Laursen TM, 2011, J PSYCHIATR RES, V45, P29, DOI 10.1016/j.jpsychires.2010.04.027; Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61; Lawrence D, 2000, ACTA PSYCHIAT SCAND, V101, P382, DOI 10.1034/j.1600-0447.2000.101005382.x; Lawrence D, 2000, SOC PSYCH PSYCH EPID, V35, P341, DOI 10.1007/s001270050248; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Lawrence D, 2010, J PSYCHOPHARMACOL, V24, P61, DOI 10.1177/1359786810382058; Lawrence DM, 2003, BRIT J PSYCHIAT, V182, P31, DOI 10.1192/bjp.182.1.31; Lindahl ML, 2010, NORD J PSYCHIAT, V64, P372, DOI 10.3109/08039481003710204; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Newcomer John W, 2007, J Clin Psychiatry, V68, pe17; NOMESCO, 2009, HLTH STAT NORD COUNT; Nordentoft M, 2004, BRIT MED J, V329, P261, DOI 10.1136/bmj.38133.622488.63; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Osborn DPJ, 2007, SOC PSYCH PSYCH EPID, V42, P787, DOI 10.1007/s00127-007-0247-3; Osborn DPJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-61; Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Rantanen H, 2009, SOC PSYCH PSYCH EPID, V44, P135, DOI 10.1007/s00127-008-0414-1; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Socialstyrelsen, 2009, KVAL INN PAT UTSKR F; Wahlbeck K, 2011, BR J PSYCHIAT	53	393	396	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55176	10.1371/journal.pone.0055176	http://dx.doi.org/10.1371/journal.pone.0055176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	23372832	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400072
J	Trung, LQ; Espinoza, JL; Takami, A; Nakao, S				Trung, Ly Quoc; Espinoza, J. Luis; Takami, Akiyoshi; Nakao, Shinji			Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NATURAL-KILLER-CELLS; CONSTITUTIVE ACTIVATION; CARCINOMA-CELLS; L-ASPARAGINASE; NASAL-TYPE; MOLECULAR TARGETS; CANCER CELLS; HUMAN TUMORS; STAT3	Natural killer (NK) cell malignancies, particularly aggressive NK cell leukaemias and lymphomas, have poor prognoses. Although recent regimens with L-asparaginase substantially improved outcomes, novel therapeutic approaches are still needed to enhance clinical response. Resveratrol, a naturally occurring polyphenol, has been extensively studied for its anti-inflammatory, cardioprotective and anti-cancer activities. In this study, we investigated the potential anti-tumour activities of resveratrol against the NK cell lines KHYG-1, NKL, NK-92 and NK-YS. Resveratrol induced robust G0/G1 cell cycle arrest, significantly suppressed cell proliferation and induced apoptosis in a dose-and time-dependent manner for all four cell lines. In addition, resveratrol suppressed constitutively active STAT3 in all the cell lines and inhibited JAK2 phosphorylation but had no effect on other upstream mediators of STAT3 activation, such as PTEN, TYK2, and JAK1. Resveratrol also induced downregulation of the anti-apoptotic proteins MCL1 and survivin, two downstream effectors of the STAT3 pathway. Finally, resveratrol induced synergistic effect on the apoptotic and antiproliferative activities of L-asparaginase against KHYG-1, NKL and NK-92 cells. These results suggest that resveratrol may have therapeutic potential against NK cell malignancies. Furthermore, our finding that resveratrol is a bonafide JAK2 inhibitor extends its potential benefits to other diseases with dysregulated JAK2 signaling.	[Trung, Ly Quoc; Espinoza, J. Luis; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Haematol & Oncol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Espinoza, JL (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan.	luis1.esp2.cd@outlook.com	Espinoza, J. Luis/L-1586-2013	Espinoza, J. Luis/0000-0002-1794-6666; Takami, Akiyoshi/0000-0002-1822-9976	Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports and Technology; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku GanKikin Fund (Kanazawa, Japan)	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku GanKikin Fund (Kanazawa, Japan)	This study was supported by grants from the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports and Technology, as well as funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan), the Japan Leukemia Research Fund (Tokyo, Japan) and the Hokkoku GanKikin Fund (Kanazawa, Japan). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ai WZY, 2012, BRIT J HAEMATOL, V156, P626, DOI 10.1111/j.1365-2141.2011.08982.x; Albani D, 2009, J NEUROCHEM, V110, P1445, DOI 10.1111/j.1471-4159.2009.06228.x; Ando M, 2005, BRIT J HAEMATOL, V130, P860, DOI 10.1111/j.1365-2141.2005.05694.x; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Buettner R, 2002, CLIN CANCER RES, V8, P945; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Chen Y, 2004, SURGERY, V136, P57, DOI 10.1016/j.surg.2004.01.017; Cheung MMC, 2003, SEMIN HEMATOL, V40, P221, DOI 10.1016/S0037-1963(03)00136-7; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coppo P, 2009, LEUKEMIA, V23, P1667, DOI 10.1038/leu.2009.91; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; De Leo A, 2011, MOL CANCER RES, V9, P1346, DOI 10.1158/1541-7786.MCR-11-0145; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Grund EM, 2005, J IMMUNOL METHODS, V296, P31, DOI 10.1016/j.jim.2004.10.008; Gui W, 2011, MED ONCOL, V28, pS367, DOI 10.1007/s12032-010-9756-0; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Ham MF, 2010, INT J HEMATOL, V92, P681, DOI 10.1007/s12185-010-0738-y; Hsieh TC, 2011, INT J CANCER, V129, P2732, DOI 10.1002/ijc.25930; Jaccard A, 2009, ANN ONCOL, V20, P110, DOI 10.1093/annonc/mdn542; Jager R, 2010, HAEMATOL-HEMATOL J, V95, P526, DOI 10.3324/haematol.2009.019570; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Kwong YL, 2011, J CLIN EXP HEMATOP, V51, P21; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Li T, 2010, INT IMMUNOPHARMACOL, V10, P18, DOI 10.1016/j.intimp.2009.09.009; Liu BQ, 2010, BIOCHEM BIOPH RES CO, V391, P778, DOI 10.1016/j.bbrc.2009.11.137; Luzi C, 2004, BIOCHEM PHARMACOL, V68, P2019, DOI 10.1016/j.bcp.2004.07.002; Madan E, 2008, BIOCHEM BIOPH RES CO, V377, P1232, DOI 10.1016/j.bbrc.2008.10.158; Markasz L, 2007, MOL CANCER THER, V6, P644, DOI 10.1158/1535-7163.MCT-06-0358; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mora LB, 2002, CANCER RES, V62, P6659; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Ng SB, 2011, J PATHOL, V223, P496, DOI 10.1002/path.2823; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Podhorecka M, 2011, ANN HEMATOL, V90, P173, DOI 10.1007/s00277-010-1045-7; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sakajiri S, 2001, JPN J CANCER RES, V92, P1048, DOI 10.1111/j.1349-7006.2001.tb01059.x; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Suzuki R, 2010, INT J HEMATOL, V92, P697, DOI 10.1007/s12185-010-0726-2; Trincheri NF, 2008, CARCINOGENESIS, V29, P381, DOI 10.1093/carcin/bgm271; Tsuchiyama J, 1998, BLOOD, V92, P1374, DOI 10.1182/blood.V92.4.1374.416a33_1374_1383; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; Wang Y, 2010, HUM MOL GENET, V19, P4319, DOI 10.1093/hmg/ddq354; Wieczorek M, 2012, CYTOKINE GROWTH FACT; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Yasuda H, 2009, EUR J HAEMATOL, V82, P39, DOI 10.1111/j.1600-0609.2008.01152.x; Yin WH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-15; Yong WB, 2009, ANN HEMATOL, V88, P647, DOI 10.1007/s00277-008-0669-3; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071	64	74	75	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55183	10.1371/journal.pone.0055183	http://dx.doi.org/10.1371/journal.pone.0055183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372833	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400073
J	Dentler, W				Dentler, William			A Role for the Membrane in Regulating Chlamydomonas Flagellar Length	PLOS ONE			English	Article							NIMA-RELATED KINASE; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; PROTEIN; CILIARY; COMPLEX; REGENERATION; ELONGATION; MICROTUBULES; TURNOVER	Flagellar assembly requires coordination between the assembly of axonemal proteins and the assembly of the flagellar membrane and membrane proteins. Fully grown steady-state Chlamydomonas flagella release flagellar vesicles from their tips and failure to resupply membrane should affect flagellar length. To study vesicle release, plasma and flagellar membrane surface proteins were vectorially pulse-labeled and flagella and vesicles were analyzed for biotinylated proteins. Based on the quantity of biotinylated proteins in purified vesicles, steady-state flagella appeared to shed a minimum of 16% of their surface membrane per hour, equivalent to a complete flagellar membrane being released every 6 hrs or less. Brefeldin-A destroyed Chlamydomonas Golgi, inhibited the secretory pathway, inhibited flagellar regeneration, and induced full-length flagella to disassemble within 6 hrs, consistent with flagellar disassembly being induced by a failure to resupply membrane. In contrast to membrane lipids, a pool of biotinylatable membrane proteins was identified that was sufficient to resupply flagella as they released vesicles for 6 hrs in the absence of protein synthesis and to support one and nearly two regenerations of flagella following amputation. These studies reveal the importance of the secretory pathway to assemble and maintain full-length flagella.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Dentler, W (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	wdent@ku.edu			National Center for Research Resources [P20RR016475]; National Institute of General Medical Science from the National Institutes of Health [P20GM133418]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Science from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Portions of this work were supported by a grant from the National Center for Research Resources (P20RR016475) and the National Institute of General Medical Science (P20GM133418) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azencott HR, 2007, ULTRASOUND MED BIOL, V33, P1805, DOI 10.1016/j.ultrasmedbio.2007.05.008; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; BERGMAN K, 1975, J CELL BIOL, V67, P606, DOI 10.1083/jcb.67.3.606; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; BLOODGOOD RA, 1984, EXP CELL RES, V150, P488, DOI 10.1016/0014-4827(84)90594-9; Bloodgood RA, 2012, MOL BIOL CELL, V23, P2407, DOI 10.1091/mbc.E12-01-0073; Bouck G.B., 1990, P65; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; BROWN RM, 1968, J PHYCOL, V4, P100, DOI 10.1111/j.1529-8817.1968.tb04683.x; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Cifuentes F, 2001, CELL SIGNAL, V13, P353, DOI 10.1016/S0898-6568(01)00132-2; COYNE B, 1970, J CELL BIOL, V47, P777, DOI 10.1083/jcb.47.3.777; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dentler W, 2005, J CELL BIOL, V170, P649, DOI 10.1083/jcb.200412021; Dentler W, 2009, METHOD CELL BIOL, V93, P145, DOI 10.1016/S0091-679X(08)93008-9; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1995, METHOD CELL BIOL, V47, P407, DOI 10.1016/S0091-679X(08)60838-9; DENTLER WL, 1980, J CELL SCI, V42, P207; Dentler WL, 2009, CHLAMYDOMONAS SOURCE, P283; Eckmiller MS, 1996, CELL TISSUE RES, V285, P165, DOI 10.1007/s004410050632; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; Ghossoub R, 2011, BIOL CELL, V103, P131, DOI 10.1042/BC20100128; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haller K, 1998, BIOCHEM BIOPH RES CO, V242, P597, DOI 10.1006/bbrc.1997.8015; He Q, 2012, MOL BIOL CELL, V23, P3156, DOI 10.1091/mbc.E12-02-0079; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Hunnicutt GR, 1990, J CELL BIOL, V179, P501; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P13225, DOI 10.1073/pnas.1202509109; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kaplan OI, 2012, CURR BIOL, V22, P451, DOI 10.1016/j.cub.2012.01.060; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Langhans M, 2007, PLANT PHYSIOL, V145, P527, DOI 10.1104/pp.107.104919; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; LEFEBVRE PA, 1995, METHOD CELL BIOL, V47, P3, DOI 10.1016/S0091-679X(08)60782-7; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakamura S, 1996, J CELL SCI, V109, P57; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Quarmby L.M., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition, P43, DOI [10.1016/b978-0-12-370873-1.00040-x, DOI 10.1016/B978-0-12-370873-1.00040-X]; REINHART FD, 1988, J CELL SCI, V89, P521; REMILLARD SP, 1982, J CELL BIOL, V93, P615, DOI 10.1083/jcb.93.3.615; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Song L, 2001, J BIOL CHEM, V276, P29754, DOI 10.1074/jbc.M103184200; STEPHENS RE, 1994, J CELL SCI, V107, P683; Stephens RE, 2001, J EXP ZOOL, V289, P335, DOI 10.1002/jez.1015; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	79	21	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53366	10.1371/journal.pone.0053366	http://dx.doi.org/10.1371/journal.pone.0053366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359798	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600015
J	Tessier, MB; Grant, OC; Heimburg-Molinaro, J; Smith, D; Jadey, S; Gulick, AM; Glushka, J; Deutscher, SL; Rittenhouse-Olson, K; Woods, RJ				Tessier, Matthew B.; Grant, Oliver C.; Heimburg-Molinaro, Jamie; Smith, David; Jadey, Snehal; Gulick, Andrew M.; Glushka, John; Deutscher, Susan L.; Rittenhouse-Olson, Kate; Woods, Robert J.			Computational Screening of the Human TF-Glycome Provides a Structural Definition for the Specificity of Anti-Tumor Antibody JAA-F11	PLOS ONE			English	Article							THOMSEN-FRIEDENREICH; CARBOHYDRATE ANTIGEN; MONOCLONAL-ANTIBODY; BINDING-SITES; FORCE-FIELD; LIGAND; GLYCOBIOLOGY; CONFORMATION; NMR	Recombinant antibodies are of profound clinical significance; yet, anti-carbohydrate antibodies are prone to undesirable cross-reactivity with structurally related-glycans. Here we introduce a new technology called Computational Carbohydrate Grafting (CCG), which enables a virtual library of glycans to be assessed for protein binding specificity, and employ it to define the scope and structural origin of the binding specificity of antibody JAA-F11 for glycans containing the Thomsen-Friedenreich (TF) human tumor antigen. A virtual library of the entire human glycome (GLibrary-3D) was constructed, from which 1,182 TF-containing human glycans were identified and assessed for their ability to fit into the antibody combining site. The glycans were categorized into putative binders, or non-binders, on the basis of steric clashes with the antibody surface. The analysis employed a structure of the immune complex, generated by docking the TF-disaccharide (Gal beta 1-GalNAc alpha) into a crystal structure of the JAA-F11 antigen binding fragment, which was shown to be consistent with saturation transfer difference (STD) NMR data. The specificities predicted by CCG were fully consistent with data from experimental glycan array screening, and confirmed that the antibody is selective for the TF-antigen and certain extended core-2 type mucins. Additionally, the CCG analysis identified a limited number of related putative binding motifs, and provided a structural basis for interpreting the specificity. CCG can be utilized to facilitate clinical applications through the determination of the three-dimensional interaction of glycans with proteins, thus augmenting drug and vaccine development techniques that seek to optimize the specificity and affinity of neutralizing proteins, which target glycans associated with diseases including cancer and HIV.	[Tessier, Matthew B.; Glushka, John; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tessier, Matthew B.; Glushka, John; Woods, Robert J.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Grant, Oliver C.; Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland; [Heimburg-Molinaro, Jamie; Jadey, Snehal; Rittenhouse-Olson, Kate] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Smith, David] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Gulick, Andrew M.] SUNY Buffalo, Hauptman Woodward Inst, Dept Biol Struct, Buffalo, NY 14260 USA; [Deutscher, Susan L.] Univ Missouri, Dept Biochem, Columbia, MO USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Emory University; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Missouri System; University of Missouri Columbia	Rittenhouse-Olson, K (corresponding author), SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA.	krolson@buffalo.edu; rwoods@ccrc.uga.edu		Rittenhouse-Olson, Kate/0000-0001-8905-861X; Gulick, Andrew/0000-0003-4238-7453; Grant, Oliver/0000-0003-4835-5161; Woods, Robert/0000-0002-2400-6293	National Institutes for Health [GM085448, GM062116, GM094919]; Science Foundation of Ireland [08/IN.1/B2070]; European Research Development Fund; National Science Foundation [DMR 0225180]; Department of Defense (CDMRP) [W81XWH-04-1-0342]; National Institutes of Health [RR001646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103390, P41GM103694, R01GM085448, R24GM098791, R01GM094919] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); European Research Development Fund; National Science Foundation(National Science Foundation (NSF)); Department of Defense (CDMRP)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RJW would like to thank the National Institutes for Health (GM085448 to DFS, GM062116, GM094919 (EUREKA), www.nih.gov) as well as the Science Foundation of Ireland (08/IN.1/B2070, www.sfi.ie) and the European Research Development Fund for support. Diffraction data were collected at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation under award DMR 0225180 (www.nsf.gov) and the National Institutes of Health (RR001646). KRO would like to acknowledge the Department of Defense (CDMRP # W81XWH-04-1-0342, www.defense.gov) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2011, BIOPOLYMERS, V96, P193, DOI 10.1002/bip.21427; Almogren Adel, 2012, Front Biosci (Schol Ed), V4, P840; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beenhouwer DO, 2002, J IMMUNOL, V169, P6992, DOI 10.4049/jimmunol.169.12.6992; Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bukowski R, 2001, EUR J ORG CHEM, V2001, P2697; Chaturvedi R, 2008, APPL RADIAT ISOTOPES, V66, P278, DOI 10.1016/j.apradiso.2007.07.029; Cobas C, 2011, MESTRE NOVA; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; GRONENBORN AM, 1985, PROG NUCL MAG RES SP, V17, P1, DOI 10.1016/0079-6565(85)80004-2; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; Henderson G, 2011, GLYCOBIOLOGY, V21, P1277, DOI 10.1093/glycob/cwr058; HOMANS SW, 1993, GLYCOBIOLOGY, V3, P551, DOI 10.1093/glycob/3.6.551; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Irazoqui FJ, 2005, IMMUNOL CELL BIOL, V83, P405, DOI 10.1111/j.1440-1711.2005.01348.x; JEFFREY PD, 1995, NAT STRUCT BIOL, V2, P466, DOI 10.1038/nsb0695-466; Johnson MA, 2008, TOP CURR CHEM, V273, P55, DOI 10.1007/128_2007_18; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kosma P, 2011, ANTICARBOHYDRATE ANT; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Lewallen DM, 2009, CHEMBIOCHEM, V10, P1486, DOI 10.1002/cbic.200900211; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRIS GM, 1999, AUTODOCK; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi T, 2008, PROTEIN SCI, V17, P261, DOI 10.1110/ps.073156708; Orntoft TF, 1999, ELECTROPHORESIS, V20, P362, DOI 10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.3.CO;2-M; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POPPE L, 1992, J BIOMOL NMR, V2, P109, DOI 10.1007/BF01875524; Ranzinger R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-384; Rao V. S. R., 1998, CONFORMATION CARBOHY; Rittenhouse-Diakun K, 1998, HYBRIDOMA, V17, P165, DOI 10.1089/hyb.1998.17.165; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Woods R.J., 2005, GLYCAM WEB; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yarema KJ, 1998, CURR OPIN CHEM BIOL, V2, P49, DOI 10.1016/S1367-5931(98)80035-5; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3	53	29	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54874	10.1371/journal.pone.0054874	http://dx.doi.org/10.1371/journal.pone.0054874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365681	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600126
J	Carmona, FD; Martin, JE; Beretta, L; Simeon, CP; Carreira, PE; Callejas, JL; Fernandez-Castro, M; Saez-Comet, L; Beltran, E; Camps, MT; Egurbide, MV; Airo, P; Scorza, R; Lunardi, C; Hunzelmann, N; Riemekasten, G; Witte, T; Kreuter, A; Distler, JHW; Madhok, R; Shiels, P; van Laar, JM; Fonseca, C; Denton, C; Herrick, A; Worthington, J; Schuerwegh, AJ; Vonk, MC; Voskuyl, AE; Radstake, TRDJ; Martin, J				David Carmona, F.; Martin, Jose-Ezequiel; Beretta, Lorenzo; Simeon, Carmen P.; Carreira, Patricia E.; Luis Callejas, Jose; Fernandez-Castro, Monica; Saez-Comet, Luis; Beltran, Emma; Teresa Camps, Maria; Victoria Egurbide, Maria; Airo, Paolo; Scorza, Raffaella; Lunardi, Claudio; Hunzelmann, Nicolas; Riemekasten, Gabriela; Witte, Torsten; Kreuter, Alexander; Distler, Joerg H. W.; Madhok, Rajan; Shiels, Paul; van Laar, Jacob M.; Fonseca, Carmen; Denton, Christopher; Herrick, Ariane; Worthington, Jane; Schuerwegh, Annemie J.; Vonk, Madelon C.; Voskuyl, Alexandre E.; Radstake, Timothy R. D. J.; Martin, Javier		Spanish Scleroderma Grp	The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERFERON-ALPHA ACTIVITY; FUNCTIONAL POLYMORPHISM; RHEUMATOID-ARTHRITIS; SCLERODERMA; GENE; EXPRESSION; SUBSETS	Systemic sclerosis (SSc) is a fibrotic autoimmune disease in which the genetic component plays an important role. One of the strongest SSc association signals outside the human leukocyte antigen (HLA) region corresponds to interferon (IFN) regulatory factor 5 (IRF5), a major regulator of the type I IFN pathway. In this study we aimed to evaluate whether three different haplotypic blocks within this locus, which have been shown to alter the protein function influencing systemic lupus erythematosus (SLE) susceptibility, are involved in SSc susceptibility and clinical phenotypes. For that purpose, we genotyped one representative single-nucleotide polymorphism (SNP) of each block (rs10488631, rs2004640, and rs4728142) in a total of 3,361 SSc patients and 4,012 unaffected controls of Caucasian origin from Spain, Germany, The Netherlands, Italy and United Kingdom. A meta-analysis of the allele frequencies was performed to analyse the overall effect of these IRF5 genetic variants on SSc. Allelic combination and dependency tests were also carried out. The three SNPs showed strong associations with the global disease (rs4728142: P = 1.34x10(-8), OR = 1.22, CI 95% = 1.14-1.30; rs2004640: P = 4.60x10(-7), OR = 0.84, CI 95% = 0.78-0.90; rs10488631: P = 7.53x10(-20), OR = 1.63, CI 95% = 1.47-1.81). However, the association of rs2004640 with SSc was not independent of rs4728142 (conditioned P = 0.598). The haplotype containing the risk alleles (rs4728142* A-rs2004640* T-rs10488631* C: P = 9.04x10(-22), OR = 1.75, CI 95% = 1.56-1.97) better explained the observed association (likelihood P-value = 1.48x10(-4)), suggesting an additive effect of the three haplotypic blocks. No statistical significance was observed in the comparisons amongst SSc patients with and without the main clinical characteristics. Our data clearly indicate that the SLE risk haplotype also influences SSc predisposition, and that this association is not sub-phenotype-specific.	[David Carmona, F.; Martin, Jose-Ezequiel; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Beretta, Lorenzo; Scorza, Raffaella] Univ Milan, Referral Ctr Syst Autoimmune Dis, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Simeon, Carmen P.] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Carreira, Patricia E.] Hosp 12 Octubre, Dept Rheumatol, E-28041 Madrid, Spain; [Luis Callejas, Jose] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain; [Fernandez-Castro, Monica] Hosp Puerta Hierro Majadahonda, Dept Rheumatol, Madrid, Spain; [Saez-Comet, Luis] Hosp Univ Miguel Servet, Dept Internal Med, Zaragoza, Spain; [Beltran, Emma] Hosp Gen Univ Valencia, Dept Rheumatol, Valencia, Spain; [Teresa Camps, Maria] Hosp Carlos Haya, Dept Internal Med, Malaga, Spain; [Victoria Egurbide, Maria] Hosp Cruces, Dept Internal Med, Baracaldo, Spain; [Airo, Paolo] Clin Spedali Civili, Serv Reumatol & Immunol, Brescia, Italy; [Lunardi, Claudio] Univ Verona, Dept Med, I-37100 Verona, Italy; [Hunzelmann, Nicolas] Univ Cologne, Dept Dermatol, Cologne, Germany; [Riemekasten, Gabriela] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Witte, Torsten] Hannover Med Sch, Hannover, Germany; [Kreuter, Alexander] Ruhr Univ Bochum, Bochum, Germany; [Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol, D-91054 Erlangen, Germany; [Madhok, Rajan; Shiels, Paul] Univ Glasgow, Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G31 2ER, Lanark, Scotland; [van Laar, Jacob M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fonseca, Carmen; Denton, Christopher] Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London WC1E 6BT, England; [Herrick, Ariane; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Schuerwegh, Annemie J.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Vonk, Madelon C.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Voskuyl, Alexandre E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre; Hospital Universitario San Cecilio; Hospital Puerta de Hierro-Majadahonda; Miguel Servet University Hospital; Hospital Carlos Haya; Hospital Universitario Cruces; University of Verona; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Ruhr University Bochum; University of Erlangen Nuremberg; University of Glasgow; Newcastle University - UK; University of London; University College London; University of Manchester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Carmona, FD (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	dcarmona@ipb.csic.es	Witte, Torsten/B-5783-2016; Beretta, Lorenzo/AAB-8605-2019; Espinosa, Gerard/J-2603-2016; Riemekasten, Gabriela/B-5019-2017; González-Gay, Miguel A./B-2306-2008; Narvaez, Javier/AAD-7456-2020; Vonk, M.C./L-4726-2015; Worthington, Jane/M-9770-2014; Martin, Javier/B-8141-2008; Carballeir, Monica Rodriguez/AAQ-8337-2021; Martín, María/HDL-9512-2022; Comet, Luis Sáez/I-7301-2017; Catalán, Emma EBC Beltrán/H-5606-2016; Martin, Jose-Ezequiel/A-6136-2011; Martín, Javier/AAV-5209-2021; IBIS, EPIDEMIOLOGIA/O-8791-2015; Centeno, Norberto Ortego/C-4793-2019; Andreu, José Luis/E-5115-2012; Carmona, F. David/F-9953-2016; Castro, Monica Fernandez/ABH-4410-2020; Carreira, Patricia E/D-4429-2018; Fernandez-Nebro, Antonio/K-7628-2012; Martin, Jose Ezequiel/F-4869-2012	Beretta, Lorenzo/0000-0002-6529-6258; Espinosa, Gerard/0000-0003-1336-0163; González-Gay, Miguel A./0000-0002-7924-7406; Narvaez, Javier/0000-0002-1614-8064; Vonk, M.C./0000-0002-2266-9907; Worthington, Jane/0000-0003-0544-042X; Martin, Javier/0000-0002-2202-0622; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Catalán, Emma EBC Beltrán/0000-0001-8070-6916; Centeno, Norberto Ortego/0000-0003-2325-0937; Andreu, José Luis/0000-0002-6002-1239; Carmona, F. David/0000-0002-1427-7639; Castro, Monica Fernandez/0000-0003-4081-2751; Carreira, Patricia E/0000-0001-8279-3806; Saez Comet, Luis/0000-0002-9868-6498; Fernandez-Nebro, Antonio/0000-0002-2962-9844; callejas, jose luis/0000-0002-1653-0087; Kreuter, Alexander/0000-0003-2275-499X; Herrick, Ariane/0000-0003-4941-7926; Shiels, Paul/0000-0002-7577-9843; Garcia-Hernandez, Francisco Jose/0000-0002-2600-0485; Castellvi, Ivan/0000-0002-5410-5807; Martin, Jose Ezequiel/0000-0002-0051-8868; Voskuyl, Alexandre/0000-0002-9699-1827; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786; Andreu Sanchez, Jose Luis/0000-0001-9126-8819	GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science [SAF2009-11110]; Junta de Andalucia [CTS-4977, CTS-180]; RETICS Program; Instituto de Salud Carlos III (ISCIII), Spain within the VI PN de I+D+i (FEDER); European League Against Rheumatism (EULAR); Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain [PI-0590-2010]; Consejeria de Salud, Junta de Andalucia [PI-0590-2010]; Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC; VIDI laureate from the Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); DFG [WI 1031/6.1]	GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); RETICS Program; Instituto de Salud Carlos III (ISCIII), Spain within the VI PN de I+D+i (FEDER); European League Against Rheumatism (EULAR); Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC; VIDI laureate from the Dutch Association of Research (NWO); Dutch Arthritis Foundation (National Reumafonds); DFG(German Research Foundation (DFG))	This work was supported by the following grants: JM was funded by GEN-FER from the Spanish Society of Rheumatology, SAF2009-11110 from the Spanish Ministry of Science, CTS-4977, and CTS-180 from Junta de Andalucia, RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), Spain, within the VI PN de I+D+i 2008-2011 (FEDER), and is sponsored by the Orphan Disease Program grant from the European League Against Rheumatism (EULAR). This study was also funded by PI-0590-2010, from Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain. NH and JM are funded by Consejeria de Salud, Junta de Andalucia, through PI-0590-2010. FDC was supported by Consejo Superior de Investigaciones Cientificas (CSIC) through the program JAE-DOC. TRDJR was funded by the VIDI laureate from the Dutch Association of Research (NWO) and Dutch Arthritis Foundation (National Reumafonds). TW was granted by DFG WI 1031/6.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2010, CURR OPIN RHEUMATOL, V22, P133, DOI 10.1097/BOR.0b013e3283367c17; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Dieude P, 2010, J RHEUMATOL, V37, P987, DOI 10.3899/jrheum.091163; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han SW, 2009, J RHEUMATOL, V36, P693, DOI 10.3899/jrheum.081054; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Kozyrev SV, 2007, AUTOIMMUNITY, V40, P591, DOI 10.1080/08916930701510905; LEROY EC, 1988, J RHEUMATOL, V15, P202; Martin JE, 2012, HUM MOL GENET, V21, P2825, DOI 10.1093/hmg/dds099; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Niewold TB, 2012, ANN RHEUM DIS, V71, P463, DOI 10.1136/annrheumdis-2011-200463; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sozzani S, 2010, AUTOIMMUNITY, V43, P196, DOI 10.3109/08916930903510872	25	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54419	10.1371/journal.pone.0054419	http://dx.doi.org/10.1371/journal.pone.0054419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372721	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000314021500070
J	Moy, AJ; Wiersma, MP; Choi, B				Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard			Optical Histology: A Method to Visualize Microvasculature in Thick Tissue Sections of Mouse Brain	PLOS ONE			English	Article							NORMALIZATION; MICROENVIRONMENT; ANGIOGENESIS; RESOLUTION; DISEASES; DENSITY; CANCER; SKIN	Background: The microvasculature is the network of blood vessels involved in delivering nutrients and gases necessary for tissue survival. Study of the microvasculature often involves immunohistological methods. While useful for visualizing microvasculature at the mm scale in specific regions of interest, immunohistology is not well suited to visualize the global microvascular architecture in an organ. Hence, use of immunohistology precludes visualization of the entire microvasculature of an organ, and thus impedes study of global changes in the microvasculature that occur in concert with changes in tissue due to various disease states. Therefore, there is a critical need for a simple, relatively rapid technique that will facilitate visualization of the microvascular network of an entire tissue. Methodology/Principal Findings: The systemic vasculature of a mouse is stained with the fluorescent lipophilic dye DiI using a method called "vessel painting". The brain, or other organ of interest, is harvested and fixed in 4% paraformaldehyde. The organ is then sliced into 1 mm sections and optically cleared, or made transparent, using FocusClear, a proprietary optical clearing agent. After optical clearing, the DiI-labeled tissue microvasculature is imaged using confocal fluorescence microscopy and adjacent image stacks tiled together to produce a depth-encoded map of the microvasculature in the tissue slice. We demonstrated that the use of optical clearing enhances both the tissue imaging depth and the estimate of the vascular density. Using our "optical histology" technique, we visualized microvasculature in the mouse brain to a depth of 850 mu m. Conclusions/Significance: Presented here are maps of the microvasculature in 1 mm thick slices of mouse brain. Using combined optical clearing and optical imaging techniques, we devised a methodology to enhance the visualization of the microvasculature in thick tissues. We believe this technique could potentially be used to generate a three-dimensional map of the microvasculature in an entire organ.	[Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA; [Moy, Austin J.; Wiersma, Matthew P.; Choi, Bernard] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Choi, Bernard] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Choi, B (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA.	choib@uci.edu		Choi, Bernard/0000-0002-4380-8291	Arnold and Mabel Beckman Foundation; National Institutes of Health [R01 HD065536]; National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource) [EB015890]; CelExplorer Labs (Hsinchu, Taiwan); University of California, Irvine; Tufts University School of Medicine; Princeton University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015890] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource); CelExplorer Labs (Hsinchu, Taiwan); University of California, Irvine(University of California System); Tufts University School of Medicine; Princeton University(Princeton University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the Arnold and Mabel Beckman Foundation, the National Institutes of Health grant award R01 HD065536, and the National Institutes of Health Laser Microbeam and Medical Program (LAMMP, a P41 Technology Research Resource, grant number EB015890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge CelExplorer Labs (Hsinchu, Taiwan) for generously donating FocusClear, Dr. Tatiana Krasieva (University of California, Irvine), Sean White (University of California, Irvine), Henry Shih (Tufts University School of Medicine), and Lawrence Chang (Princeton University) for their support.	Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Choi B, 2005, LASER SURG MED, V36, P72, DOI 10.1002/lsm.20116; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; Choi B, 2008, J INVEST DERMATOL, V128, P485, DOI 10.1038/sj.jid.5700991; De Silva DA, 2011, NEUROLOGY, V77, P896, DOI 10.1212/WNL.0b013e31822c623b; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fanelli M, 1999, INT J BIOL MARKER, V14, P218, DOI 10.1177/172460089901400405; Fu YY, 2010, MICROVASC RES, V80, P512, DOI 10.1016/j.mvr.2010.06.003; Fu YY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470241; Fu YY, 2009, GASTROENTEROLOGY, V137, P453, DOI 10.1053/j.gastro.2009.05.008; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hoenig MR, 2008, CURR VASC PHARMACOL, V6, P292, DOI 10.2174/157016108785909779; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Khan F, 2003, J PHYSIOL-LONDON, V551, P705, DOI 10.1113/jphysiol.2003.045351; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Malpass Katy, 2011, Nat Rev Neurol, V7, P538, DOI 10.1038/nrneurol.2011.148; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Oldham M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907968; Ravnic DJ, 2005, MICROVASC RES, V70, P90, DOI 10.1016/j.mvr.2005.06.002; Rylander CG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2343208; Tuchin VV, 2005, J PHYS D APPL PHYS, V38, P2497, DOI 10.1088/0022-3727/38/15/001; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Vargas G, 2001, LASER SURG MED, V29, P213, DOI 10.1002/lsm.1110; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; White SM, 2011, MICROVASC RES, V82, P92, DOI 10.1016/j.mvr.2011.03.006; Yeh AT, 2003, J INVEST DERMATOL, V121, P1332, DOI 10.1046/j.1523-1747.2003.12634.x; Zanini A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-132; Zhao L-A, 2002, INVEST OPHTHALMOL VI, V43	36	94	97	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53753	10.1371/journal.pone.0053753	http://dx.doi.org/10.1371/journal.pone.0053753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372668	gold, Green Published			2022-12-27	WOS:000314021500023
J	Ferguson, JL; Chao, WCH; Lee, E; Friedman, KL				Ferguson, Jenifer L.; Chao, William Chong Hang; Lee, Ethan; Friedman, Katherine L.			The Anaphase Promoting Complex Contributes to the Degradation of the S. cerevisiae Telomerase Recruitment Subunit Est1p	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST TELOMERASE; DEPENDENT DEGRADATION; REVERSE-TRANSCRIPTASE; CYCLIN PROTEOLYSIS; CATALYTIC SUBUNIT; DESTRUCTION BOX; MITOTIC EXIT; G1 CYCLINS; AURORA-A	Telomerase is a multi-subunit enzyme that reverse transcribes telomere repeats onto the ends of linear eukaryotic chromosomes and is therefore critical for genome stability. S. cerevisiae telomerase activity is cell-cycle regulated; telomeres are not elongated during G1 phase. Previous work has shown that Est1 protein levels are low during G1 phase, preventing telomerase complex assembly. However, the pathway targeting Est1p for degradation remained uncharacterized. Here, we show that Est1p stability through the cell cycle mirrors that of Clb2p, a known target of the Anaphase Promoting Complex (APC). Indeed, Est1p is stabilized by mutations in both essential and non-essential components of the APC. Mutations of putative Destruction boxes (D-boxes), regions shown to be important for recognition of known APC substrates, stabilize Est1p, suggesting that Est1p is likely to be targeted for degradation directly by the APC. However, we do not detect degradation or ubiquitination of recombinant Est1p by the APC in vitro, suggesting either that the recombinant protein lacks necessary post-translational modification and/or conformation, or that the APC affects Est1p degradation by an indirect mechanism. Together, these studies shed light on the regulation of yeast telomerase assembly and demonstrate a new connection between telomere maintenance and cell cycle regulation pathways.	[Ferguson, Jenifer L.; Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Chao, William Chong Hang] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; [Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Vanderbilt University	Friedman, KL (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	katherine.friedman@vanderbilt.edu			Vanderbilt University; National Institutes of Health (NIH) [GM080393]; ICR; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080393] Funding Source: NIH RePORTER	Vanderbilt University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICR; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Vanderbilt University and a National Institutes of Health (NIH) grant GM080393 to KLF. WCHC was funded by an ICR studentship. Flow Cytometry experiments were performed in the VMC Flow Cytometry Shared Resource and supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Baumer M, 2000, FEBS LETT, V468, P142, DOI 10.1016/S0014-5793(00)01208-4; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; DELANGE T, 2005, TELOMERES; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Irniger S, 1997, J CELL SCI, V110, P1523; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Larose S, 2007, J BIOL CHEM, V282, P4373, DOI 10.1074/jbc.M607145200; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lendvay TS, 1996, GENETICS, V144, P1399; LEW DJ, 1992, CELL, V69, P317, DOI 10.1016/0092-8674(92)90412-6; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lubin JW, 2012, RNA, V18, P1597, DOI 10.1261/rna.034447.112; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Martina M, 2012, MOL CELL BIOL, V32, P1604, DOI 10.1128/MCB.06547-11; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Page AM, 2005, GENETICS, V170, P1045, DOI 10.1534/genetics.104.040105; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Pfleger CM, 2000, GENE DEV, V14, P655; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rose MD., 1990, METHODS YEAST GENETI; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tuzon CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002060; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wu Y, 2011, P NATL ACAD SCI USA, V108, P20362, DOI 10.1073/pnas.1100281108; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	86	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55055	10.1371/journal.pone.0055055	http://dx.doi.org/10.1371/journal.pone.0055055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372810	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400053
J	Prat-Vidal, C; Galvez-Monton, C; Nonell, L; Puigdecanet, E; Astier, L; Sole, F; Bayes-Genis, A				Prat-Vidal, Cristina; Galvez-Monton, Carolina; Nonell, Lara; Puigdecanet, Eulalia; Astier, Laura; Sole, Francesc; Bayes-Genis, Antoni			Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine	PLOS ONE			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; POLYMERASE-CHAIN-REACTION; ASSIST DEVICE SUPPORT; CYTOCHROME-C RELEASE; GUANYLYL CYCLASE-A; HEART-FAILURE; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; NONISCHEMIC CARDIOMYOPATHY; CORONARY-ARTERIES	Molecular mechanisms associated with pathophysiological changes in ventricular remodelling due to myocardial infarction (MI) remain poorly understood. We analyzed changes in gene expression by microarray technology in porcine myocardial tissue at 1, 4, and 6 weeks post-MI. MI was induced by coronary artery ligation in 9 female pigs (30-40 kg). Animals were randomly sacrificed at 1, 4, or 6 weeks post-MI (n = 3 per group) and 3 healthy animals were also included as control group. Total RNA from myocardial samples was hybridized to GeneChip (R) Porcine Genome Arrays. Functional analysis was obtained with the Ingenuity Pathway Analysis (IPA) online tool. Validation of microarray data was performed by quantitative real-time PCR (qRT-PCR). More than 8,000 different probe sets showed altered expression in the remodelling myocardium at 1, 4, or 6 weeks post-MI. Ninety-seven percent of altered transcripts were detected in the infarct core and 255 probe sets were differentially expressed in the remote myocardium. Functional analysis revealed 28 genes de-regulated in the remote myocardial region in at least one of the three temporal analyzed stages, including genes associated with heart failure (HF), systemic sclerosis and coronary artery disease. In the infarct core tissue, eight major time-dependent gene expression patterns were recognized among 4,221 probe sets commonly altered over time. Altered gene expression of ACVR2B, BID, BMP2, BMPR1A, LMNA, NFKBIA, SMAD1, TGFB3, TNFRSF1A, and TP53 were further validated. The clustering of similar expression patterns for gene products with related function revealed molecular footprints, some of them described for the first time, which elucidate changes in biological processes at different stages after MI.	[Prat-Vidal, Cristina; Galvez-Monton, Carolina; Astier, Laura; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol, Imperial Coll Res Ethics Comm Heart Failure & Car, Badalona, Barcelona, Spain; [Nonell, Lara; Puigdecanet, Eulalia; Sole, Francesc] Inst Hosp Mar Invest Med, Serv Anal Microarrays, Barcelona, Spain; [Sole, Francesc] Hosp del Mar, Serv Patol, Lab Citogenet Mol, Barcelona, Spain; [Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain	Hospital Germans Trias i Pujol; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Prat-Vidal, C (corresponding author), Hosp Badalona Germans Trias & Pujol, Serv Cardiol, Hlth Sci Res Inst Germans Trias & Pujol, Imperial Coll Res Ethics Comm Heart Failure & Car, Badalona, Barcelona, Spain.	cprat@igtp.cat; abayes.germanstrias@gencat.cat	Galvez-Monton, Carolina/K-4480-2014; Prat-Vidal, Cristina/AAP-9571-2020; Bayes-Genis, Antoni/C-4002-2015; Solé, Francesc/K-8373-2012; Bayes-Genis, Antonio/AAV-9422-2021; Prat-Vidal, Cristina/C-2726-2013; Puigdecanet, Eulàlia/U-7568-2019	Galvez-Monton, Carolina/0000-0003-2254-9371; Prat-Vidal, Cristina/0000-0002-5621-1101; Bayes-Genis, Antoni/0000-0002-3044-197X; Solé, Francesc/0000-0002-3251-2161; Bayes-Genis, Antonio/0000-0002-3044-197X; Prat-Vidal, Cristina/0000-0002-5621-1101; 	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant [CD07/00163]; Ministerio de Ciencia e Innovacion [SAF2008-05144-C02-01, SAF2011-30067-C02-01]; Fundacio Privada Daniel Bravo Andreu; La Marato de TV3 [080330]	Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Privada Daniel Bravo Andreu; La Marato de TV3	This work was supported by the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Sara Borrell Grant (CD07/00163 to CP-V), Ministerio de Ciencia e Innovacion (SAF2008-05144-C02-01 and SAF2011-30067-C02-01 to AB-G), Fundacio Privada Daniel Bravo Andreu, and La Marato de TV3 (080330 to AB-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SH, 1978, J ANAT, V126, P51; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar S, 2012, METHODS MOL BIOL, V798, P311, DOI 10.1007/978-1-61779-343-1_18; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; FISHBEIN MC, 1978, CHEST, V73, P843, DOI 10.1378/chest.73.6.843; Galvez-Monton C, 2011, CARDIOVASC RES, V91, P659, DOI 10.1093/cvr/cvr136; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Harpster MH, 2006, MAMM GENOME, V17, P701, DOI 10.1007/s00335-005-0120-1; Hochhauser E, 2007, CELL BIOCHEM BIOPHYS, V47, P11, DOI 10.1385/CBB:47:1:11; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; Hwang JJ, 2002, PHYSIOL GENOMICS, V10, P31, DOI 10.1152/physiolgenomics.00122.2001; Icardo JM, 2001, J ANAT, V199, P473, DOI 10.1046/j.1469-7580.2001.19940473.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin H, 2001, CIRCULATION, V103, P736; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kittleson MM, 2004, CIRCULATION, V110, P3444, DOI 10.1161/01.CIR.0000148178.19465.11; Kupfahl C, 2000, CARDIOVASC RES, V46, P463, DOI 10.1016/S0008-6363(00)00037-7; Kuster DWD, 2011, BASIC RES CARDIOL, V106, P1269, DOI 10.1007/s00395-011-0229-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Lu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019251; Lyn D, 2000, PHYSIOL GENOMICS, V2, P93, DOI 10.1152/physiolgenomics.2000.2.3.93; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Panguluri SK, 2012, METHODS MOL BIOL, V815, P131, DOI 10.1007/978-1-61779-424-7_11; Peterson JT, 2000, CARDIOVASC RES, V46, P307, DOI 10.1016/S0008-6363(00)00029-8; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sandmann S, 2001, J AM COLL CARDIOL, V37, P2154, DOI 10.1016/S0735-1097(01)01287-6; Sehl PD, 2000, CIRCULATION, V101, P1990, DOI 10.1161/01.CIR.101.16.1990; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; Steenman M, 2003, PHYSIOL GENOMICS, V12, P97, DOI 10.1152/physiolgenomics.00148.2002; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tschope C, 2000, J HYPERTENS, V18, P223, DOI 10.1097/00004872-200018020-00014; WEAVER ME, 1986, CARDIOVASC RES, V20, P907, DOI 10.1093/cvr/20.12.907; Witt H, 2008, J MOL MED, V86, P1013, DOI 10.1007/s00109-008-0385-4; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	59	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54785	10.1371/journal.pone.0054785	http://dx.doi.org/10.1371/journal.pone.0054785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372767	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400029
J	Chhatbar, PY; Francis, JT				Chhatbar, Pratik Y.; Francis, Joseph T.			Towards a Naturalistic Brain-Machine Interface: Hybrid Torque and Position Control Allows Generalization to Novel Dynamics	PLOS ONE			English	Article							CORTICAL CONTROL; MOTOR CORTEX; ARM; REPRESENTATION; SHOULDER; NEURONS	Realization of reaching and grasping movements by a paralytic person or an amputee would greatly facilitate her/his activities of daily living. Towards this goal, control of a computer cursor or robotic arm using neural signals has been demonstrated in rodents, non-human primates and humans. This technology is commonly referred to as a Brain-Machine Interface (BMI) and is achieved by predictions of kinematic parameters, e. g. position or velocity. However, execution of natural movements, such as swinging baseball bats of different weights at the same speed, requires advanced planning for necessary context-specific forces in addition to kinematic control. Here we show, for the first time, the control of a virtual arm with representative inertial parameters using real-time neural control of torques in non-human primates (M. radiata). We found that neural control of torques leads to ballistic, possibly more naturalistic movements than position control alone, and that adding the influence of position in a hybrid torque-position control changes the feedforward behavior of these BMI movements. In addition, this level of control was achievable utilizing the neural recordings from either contralateral or ipsilateral M1. We also observed changed behavior of hybrid torque-position control under novel external dynamic environments that was comparable to natural movements. Our results demonstrate that inclusion of torque control to drive a neuroprosthetic device gives the user a more direct handle on the movement execution, especially when dealing with novel or changing dynamic environments. We anticipate our results to be a starting point of more sophisticated algorithms for sensorimotor neuroprostheses, eliminating the need of fully automatic kinematic-to-dynamic transformations as currently used by traditional kinematic-based decoders. Thus, we propose that direct control of torques, or other force related variables, should allow for more natural neuroprosthetic movements by the user.	[Chhatbar, Pratik Y.; Francis, Joseph T.] NYU, Polytech Inst, Joint Program Biomed Engn, Brooklyn, NY USA; [Chhatbar, Pratik Y.; Francis, Joseph T.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Francis, Joseph T.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Francis, Joseph T.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Francis, Joseph T.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	New York University; New York University Tandon School of Engineering; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Chhatbar, PY (corresponding author), NYU, Polytech Inst, Joint Program Biomed Engn, Brooklyn, NY USA.	pratikchhatbar@gmail.com		Francis, Joseph/0000-0002-2874-0452	NYS Department of Health SCIRBs [C022048]; DARPA REPAIR Contract [N66001-10-C-2008]; SUNY Downstate Medical School	NYS Department of Health SCIRBs; DARPA REPAIR Contract; SUNY Downstate Medical School	This work is supported by NYS Department of Health SCIRBs # C022048 (http://www.wadsworth.org/extramural/spinalcord/programstaff.htm), DARPA REPAIR Contract# N66001-10-C-2008 (http://www.darpa.mil/Our_Work/DSO/Programs/Reorganization_and_Plasticity_to_Accelerate_Injury_Recovery_%28REPAIR%29.aspx), and SUNY Downstate Medical School (http://www.downstate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROPHYSIOL, V98, P993, DOI 10.1152/jn.00102.2007; Bae J, 2011, IEEE ENG MED BIO, P5662, DOI 10.1109/IEMBS.2011.6091370; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cheng EJ, 2000, J MORPHOL, V245, P206, DOI 10.1002/1097-4687(200009)245:3<206::AID-JMOR3>3.3.CO;2-L; Chhatbar PY, 2010, IEEE ENG MED BIO, P1686, DOI 10.1109/IEMBS.2010.5626832; Chhatbar PY, 2010, J NEUROSCI METH, V188, P187, DOI 10.1016/j.jneumeth.2010.02.006; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; Fishbach A, 2005, EXP BRAIN RES, V164, P442, DOI 10.1007/s00221-005-2264-3; Francis JT, 2006, IEEE T NEUR SYS REH, V14, P172, DOI 10.1109/TNSRE.2006.875553; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; Gilja V, 2010, SOC NEUR 40 ANN C SA; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Sanchez JC, 2011, I IEEE EMBS C NEUR E, P525, DOI 10.1109/NER.2011.5910601; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Tarigoppula A, 2012, IEEE ENG MED BIO, P3284, DOI 10.1109/EMBC.2012.6346666; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2010, SOC NEUR 40 ANN C SA; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	32	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e52286	10.1371/journal.pone.0052286	http://dx.doi.org/10.1371/journal.pone.0052286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359212	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600006
J	Peng, T; Sun, HZ; Du, YX; Zhang, J; Li, JZ; Liu, YX; Zhao, YF; Zhao, QZ				Peng, Ting; Sun, Hongzheng; Du, Yanxiu; Zhang, Jing; Li, Junzhou; Liu, Yanxia; Zhao, Yafan; Zhao, Quanzhi			Characterization and Expression Patterns of microRNAs Involved in Rice Grain Filling	PLOS ONE			English	Article							SMALL RNAS; POSTANTHESIS DEVELOPMENT; INFERIOR SPIKELETS; SUPERIOR SPIKELETS; ABSCISIC-ACID; PLANT; ARABIDOPSIS; AUXIN; MIRNAS; YIELD	MicroRNAs (miRNAs) are upstream gene regulators of plant development and hormone homeostasis through their directed cleavage or translational repression of the target mRNAs, which may play crucial roles in rice grain filling and determining the final grain weight and yield. In this study, high-throughput sequencing was performed to survey the dynamic expressions of miRNAs and their corresponding target genes at five distinct developmental stages of grain filling. In total, 445 known miRNAs and 45 novel miRNAs were detected with most of them expressed in a developmental stage dependent manner, and the majority of known miRNAs, which increased gradually with rice grain filling, showed negatively related to the grain filling rate. Detailed expressional comparisons revealed a clear negative correlation between most miRNAs and their target genes. It was found that specific miRNA cohorts are expressed in a developmental stage dependent manner during grain filling and the known functions of these miRNAs are involved in plant hormone homeostasis and starch accumulation, indicating that the expression dynamics of these miRNAs might play key roles in regulating rice grain filling.	[Zhao, Quanzhi] Henan Agr Univ, Res Ctr Rice Engn, Zhengzhou, Peoples R China; Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Zhao, QZ (corresponding author), Henan Agr Univ, Res Ctr Rice Engn, Zhengzhou, Peoples R China.	qzzhaoh@126.com			National Natural Science Foundation of China [30471018, 31271651, 31200973]; Program for New Century Excellent Talents in University [NCET-08-0663]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [94200510003]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [2010IRTSTHN005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This work was supported by the National Natural Science Foundation of China (30471018, 31271651, 31200973), Program for New Century Excellent Talents in University (NCET-08-0663), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (94200510003), and Program for Innovative Research Team (in Science and Technology) in University of Henan Province (2010IRTSTHN005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Devers EA, 2011, PLANT PHYSIOL, V156, P1990, DOI 10.1104/pp.111.172627; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu Q, 2009, BIOCHEM BIOPH RES CO, V384, P1, DOI 10.1016/j.bbrc.2009.04.028; Lunn JE, 2003, CURR OPIN PLANT BIOL, V6, P208, DOI 10.1016/S1369-5266(03)00033-5; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Meng Y, 2011, RNA BIOL, V8; Meng YJ, 2010, J EXP BOT, V61, P3833, DOI 10.1093/jxb/erq209; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Van Ex F, 2011, CURR OPIN PLANT BIOL, V14, P588, DOI 10.1016/j.pbi.2011.07.003; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang H, 2012, J EXP BOT, V63, P215, DOI 10.1093/jxb/err263; Zhang H, 2010, J EXP BOT, V61, P3719, DOI 10.1093/jxb/erq198; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	68	51	56	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54148	10.1371/journal.pone.0054148	http://dx.doi.org/10.1371/journal.pone.0054148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365650	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600035
J	Say, EAT; Melamud, A; Esserman, DA; Povsic, TJ; Chavala, SH				Say, Emil Anthony T.; Melamud, Alex; Esserman, Denise Ann; Povsic, Thomas J.; Chavala, Sai H.			Comparative Analysis of Circulating Endothelial Progenitor Cells in Age-Related Macular Degeneration Patients Using Automated Rare Cell Analysis (ARCA) and Fluorescence Activated Cell Sorting (FACS)	PLOS ONE			English	Article							TUMOR-CELLS; POPULATIONS; CANCER	Background: Patients with age-related macular degeneration (ARMD) begin with non-neovascular (NNV) phenotypes usually associated with good vision. Approximately 20% of NNV-ARMD patients will convert to vision debilitating neovascular (NV) ARMD, but precise timing of this event is unknown. Developing a clinical test predicting impending conversion to NV-ARMD is necessary to prevent vision loss. Endothelial progenitor cells (EPCs), defined as CD34(+)VEGR2(+) using traditional fluorescence activated cell sorting (FACS), are rare cell populations known to be elevated in patients with NV-ARMD compared to NNV-ARMD. FACS has high inter-observer variability and subjectivity when measuring rare cell populations precluding development into a diagnostic test. We hypothesized that automated rare cell analysis (ARCA), a validated and FDA-approved technology for reproducible rare cell identification, can enumerate EPCs in ARMD patients more reliably. This pilot study serves as the first step in developing methods for reproducibly predicting ARMD phenotype conversion. Methods: We obtained peripheral venous blood samples in 23 subjects with NNV-ARMD or treatment naive NV-ARMD. Strict criteria were used to exclude subjects with known angiogenic diseases to minimize confounding results. Blood samples were analyzed in masked fashion in two separate laboratories. EPCs were independently enumerated using ARCA and FACS within 24 hours of blood sample collection, and p < 0.2 was considered indicative of a trend for this proof of concept study, while statistical significance was established at 0.05. Results: We measured levels of CD34(+)VEGFR2(+) EPCs suggestive of a trend with higher values in patients with NV compared to NNV-ARMD (p = 0.17) using ARCA. Interestingly, CD34(+)VEGR2(+) EPC analysis using FACS did not produce similar results (p = 0.94). Conclusions: CD34(+)VEGR2(+) may have predictive value for EPC enumeration in future ARCA studies. EPC measurements in a small sample size were suggestive of a trend in ARMD using ARCA but not FACS. ARCA could be a helpful tool for developing a predictive test for ARMD phenotype conversion.	[Say, Emil Anthony T.; Chavala, Sai H.] Univ N Carolina Hosp, Kittner Eye Ctr, Chapel Hill, NC 27515 USA; [Melamud, Alex] Retina Grp Washington, Washington, DC USA; [Esserman, Denise Ann] Univ N Carolina, Dept Med, Div Gen Med & Clin Epidemiol & Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Povsic, Thomas J.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Povsic, Thomas J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University North Carolina Hospital; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Chavala, SH (corresponding author), Univ N Carolina Hosp, Kittner Eye Ctr, Chapel Hill, NC 27515 USA.	schavala@med.unc.edu			Adler Foundation; Hope for Vision Career Development Award; Research to Prevent Blindness	Adler Foundation; Hope for Vision Career Development Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	SHC would like to acknowledge the Adler Foundation, Hope for Vision Career Development Award, and Research to Prevent Blindness for unrestricted grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner S, 2009, INVEST OPHTH VIS SCI, V50, P392, DOI 10.1167/iovs.08-1748; Damani S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003451; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P4914, DOI 10.1167/iovs.03-0371; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaur H, 2002, RETINA-J RET VIT DIS, V22, P44, DOI 10.1097/00006982-200202000-00008; Kraan J, 2011, CYTOM PART B-CLIN CY, V80B, P112, DOI 10.1002/cyto.b.20573; Machalinska A, 2011, INVEST OPHTH VIS SCI, V52, P93, DOI 10.1167/iovs.10-5756; Machalinska A, 2010, ARCH OPHTHALMOL-CHIC, V128, P1311, DOI 10.1001/archophthalmol.2010.221; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Scholtens TM, 2012, CYTOM PART A, V81A, P138, DOI 10.1002/cyto.a.22002; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; Strijbos MH, 2009, BLOOD CELL MOL DIS, V43, P63, DOI 10.1016/j.bcmd.2009.02.007; Thill M, 2008, INVEST OPHTH VIS SCI, V49, P2696, DOI 10.1167/iovs.07-0955; Van Craenenbroeck EMF, 2008, J IMMUNOL METHODS, V332, P31, DOI 10.1016/j.jim.2007.12.006	17	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55079	10.1371/journal.pone.0055079	http://dx.doi.org/10.1371/journal.pone.0055079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359346	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600150
J	Andersen, JP; Blosnich, J				Andersen, Judith P.; Blosnich, John			Disparities in Adverse Childhood Experiences among Sexual Minority and Heterosexual Adults: Results from a Multi-State Probability-Based Sample	PLOS ONE			English	Article							PHYSICAL ABUSE; UNITED-STATES; GAY; VICTIMIZATION; HEALTH; ORIENTATION; LESBIANS; RISK; LIFE; MALTREATMENT	Background: Adverse childhood experiences (e. g., physical, sexual and emotional abuse, neglect, exposure to domestic violence, parental discord, familial mental illness, incarceration and substance abuse) constitute a major public health problem in the United States. The Adverse Childhood Experiences (ACE) scale is a standardized measure that captures multiple developmental risk factors beyond sexual, physical and emotional abuse. Lesbian, gay, and bisexual (i.e., sexual minority) individuals may experience disproportionately higher prevalence of adverse childhood experiences. Purpose: To examine, using the ACE scale, prevalence of childhood physical, emotional, and sexual abuse and childhood household dysfunction among sexual minority and heterosexual adults. Methods: Analyses were conducted using a probability-based sample of data pooled from three U. S. states' Behavioral Risk Factor Surveillance System (BRFSS) surveys (Maine, Washington, Wisconsin) that administered the ACE scale and collected information on sexual identity (n = 22,071). Results: Compared with heterosexual respondents, gay/lesbian and bisexual individuals experienced increased odds of six of eight and seven of eight adverse childhood experiences, respectively. Sexual minority persons had higher rates of adverse childhood experiences (IRR = 1.66 gay/lesbian; 1.58 bisexual) compared to their heterosexual peers. Conclusions: Sexual minority individuals have increased exposure to multiple developmental risk factors beyond physical, sexual and emotional abuse. We recommend the use of the Adverse Childhood Experiences scale in future research examining health disparities among this minority population.	[Andersen, Judith P.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Blosnich, John] Univ Rochester, Dept Psychiat, Ctr Study & Prevent Suicide, Rochester, NY USA; [Blosnich, John] VISN 2 Ctr Excellence Suicide Prevent, Dept Vet Affairs, Canandaigua, NY USA	University of Toronto; University Toronto Mississauga; University of Rochester	Andersen, JP (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	judith.andersen@utoronto.ca	Wilson, Gregory/AAA-9035-2021	Andersen, Judith/0000-0001-8477-1432	Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health [5T32MH020061]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020061] Funding Source: NIH RePORTER	Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Blosnich was supported by a Post-Doctoral Fellowship in an Institutional National Research Service Award from the National Institute of Mental Health (5T32MH020061). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Alvy L, 2012, CHILD ABUSE IN PRESS; Anda R. F., 2010, BEHAV RISK FACTOR SU, P1; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; [Anonymous], 2011, CHILD MALTR 2010; [Anonymous], 2011, HLTH LESBIAN GAY BIS; Aveline D, 2006, J FAM ISSUES, V27, P777, DOI 10.1177/0192513X05285613; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Berlan ED, 2010, J ADOLESCENT HEALTH, V46, P366, DOI 10.1016/j.jadohealth.2009.10.015; Blosnich J, 2012, J AM COLL HEALTH, V60, P141, DOI 10.1080/07448481.2011.623332; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169; Corliss HL, 2002, CHILD ABUSE NEGLECT, V26, P1165, DOI 10.1016/S0145-2134(02)00385-X; D'Augelli AR, 2006, J INTERPERS VIOLENCE, V21, P1462, DOI 10.1177/0886260506293482; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Frankowski BL, 2004, PEDIATRICS, V113, P1827, DOI 10.1542/peds.113.6.1827; Fredriksen-Goldsen KI, 2010, AM J PUBLIC HEALTH, V100, P2255, DOI 10.2105/AJPH.2009.177329; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; Gartner R. B., 2000, J GAY LESBIAN PSYCHO, V3, P1, DOI [DOI 10.1300/J236V03N02_01, 10. 1300/J236v03n02_01]; Gates GJ, 2012, 34 GALL POLL; Goodrich KM, 2009, J LGBT ISS COUNS, V3, P37, DOI 10.1080/15538600902754478; Heck JE, 2006, J ASTHMA, V43, P579, DOI 10.1080/02770900600878289; HOLM S, 1979, SCAND J STAT, V6, P65; HUGHES TL, 2000, J GAY LESBIAN SOCIAL, V11, P57, DOI DOI 10.1300/J041V11N01_03; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; Lehavot KM, 2012, SEX ROLES, DOI [10.1007/211199-012-0171-1, DOI 10.1007/211199-012-0171-1]; Lester P, 2003, ADOLESCENT PSYCHIAT, V27, P259; Levitt H. M., 2007, BECOMING VISIBLE COU, P297; Long J.S., 2006, REGRESSION MODELS CA; Martin SL, 2011, WOMEN HEALTH ISS, V21, P199, DOI 10.1016/j.whi.2010.12.002; Marvasti J. A., 2004, PSYCHIAT TREATMENT V, P3; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Roberts AL, 2013, ARCH SEX BEHAV, V42, P161, DOI 10.1007/s10508-012-0021-9; Roberts AL, 2012, PEDIATRICS, V129, P410, DOI 10.1542/peds.2011-1804; Rosario M, 2009, ARCH SEX BEHAV, V38, P34, DOI 10.1007/s10508-007-9221-0; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Saltzburg S, 2004, SOC WORK, V49, P109, DOI 10.1093/sw/49.1.109; Stoddard J, 2009, J HOMOSEXUAL, V56, P407, DOI 10.1080/00918360902821395; Wilsnack SC, 2012, CHILD ABUSE NEGLECT, V36, P260, DOI 10.1016/j.chiabu.2011.10.008	45	50	52	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54691	10.1371/journal.pone.0054691	http://dx.doi.org/10.1371/journal.pone.0054691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372755	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500108
J	Ferenczi, N; Marshall, TC				Ferenczi, Nelli; Marshall, Tara C.			Exploring Attachment to the "Homeland'' and Its Association with Heritage Culture Identification	PLOS ONE			English	Article							EASTERN-EUROPEAN IMMIGRANTS; ADULT ATTACHMENT; WORKING MODELS; PLACE ATTACHMENT; YOUNG-ADULTS; ACCULTURATION; IDENTITY; SELF; MOTHER; NATION	Conceptualisations of attachment to one's nation of origin reflecting a symbolic caregiver can be found cross-culturally in literature, art, and language. Despite its prevalence, the relationship with one's nation has not been investigated empirically in terms of an attachment theory framework. Two studies employed an attachment theory approach to investigate the construct validity of symbolic attachment to one's nation of origin, and its association with acculturation (operationalized as heritage and mainstream culture identification). Results for Study 1 indicated a three-factor structure of nation attachment; the factors were labelled secure-preoccupied, fearful, and dismissive nation attachment. Hierarchical linear modelling was employed to control for differing cultures across participants. Secure-preoccupied nation attachment was a significant predictor of increased heritage culture identification for participants residing in their country of birth, whilst dismissive nation attachment was a significant predictor of decreased heritage culture identification for international migrants. Secure-preoccupied nation attachment was also associated with higher levels of subjective-wellbeing. Study 2 further confirmed the validity of the nation attachment construct through confirmatory factor analysis; the three-factor model adequately fit the data. Similar to the results of Study 1, secure-preoccupied nation attachment was associated with increased levels of heritage culture identification and psychological well-being. Implications of the tripartite model of nation attachment for identity and well-being will be discussed.	[Ferenczi, Nelli; Marshall, Tara C.] Brunel Univ, Dept Psychol, London, England	Brunel University	Ferenczi, N (corresponding author), Brunel Univ, Dept Psychol, London, England.	Nelli.Ferenczi@brunel.ac.uk		Ferenczi, Nelli/0000-0002-3757-6244; Marshall, Tara/0000-0002-1379-5290				AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Baldwin MW, 1996, J PERS SOC PSYCHOL, V71, P94, DOI 10.1037/0022-3514.71.1.94; BALDWIN MW, 1995, PERS RELATIONSHIP, V2, P247, DOI 10.1111/j.1475-6811.1995.tb00090.x; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Beck L, 2008, ANTHROZOOS, V21, P43, DOI 10.2752/089279308X274056; Beck R, 2004, J PSYCHOL THEOL, V32, P92, DOI 10.1177/009164710403200202; Becker TE, 1997, EDUC PSYCHOL MEAS, V57, P477, DOI 10.1177/0013164497057003009; Berry JW, 2010, INT J INTERCULT REL, V34, P191, DOI 10.1016/j.ijintrel.2009.11.007; Berry JW, 2005, INT J INTERCULT REL, V29, P697, DOI 10.1016/j.ijintrel.2005.07.013; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Berry JW, 2001, J SOC ISSUES, V57, P615, DOI 10.1111/0022-4537.00231; Bhugra D, 2010, INT J SOC PSYCHIATR, V56, P540, DOI 10.1177/0020764009358024; Bockstr/m M., 2007, INDIVIDUAL DIFFERENC, V5, P124, DOI 10.1111/1467-9450.00216; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Boym S, 1996, POETICS TODAY, V17, P511, DOI 10.2307/1773211; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Cassibba R, 2008, DEV PSYCHOL, V44, P1753, DOI 10.1037/a0013772; Collins N.L., 1994, ATTACHMENT PROCESSES, P53; COLLINS NL, 1990, J PERS SOC PSYCHOL, V58, P644, DOI 10.1037/0022-3514.58.4.644; DELAMATE.J, 1969, J CONFLICT RESOLUT, V13, P320, DOI 10.1177/002200276901300303; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Dixon J, 2000, BRIT J SOC PSYCHOL, V39, P27, DOI 10.1348/014466600164318; Dove N, 2002, J BLACK STUD, V33, P3, DOI 10.1177/002193470203300101; DUGGAN ES, 1994, J SOC PERS RELAT, V11, P147, DOI 10.1177/0265407594111009; FEENEY JA, 1990, J PERS SOC PSYCHOL, V58, P281, DOI 10.1037/0022-3514.58.2.281; Felonneau ML, 2004, J ENVIRON PSYCHOL, V24, P43, DOI 10.1016/S0272-4944(03)00049-5; Feshbach S, 1991, INTERSECTIONS ATTACH, P207; FOX NA, 1991, CHILD DEV, V62, P210, DOI 10.2307/1130716; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Furman FK, 2005, J PREV INTERV COMMUN, V30, P91, DOI 10.1300/J005v30n01_08; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Hidalgo MC, 2001, J ENVIRON PSYCHOL, V21, P273, DOI 10.1006/jevp.2001.0221; Hjerm M, 2010, SOC SCI RES, V39, P527, DOI 10.1016/j.ssresearch.2010.03.006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huppert FA, 2011, SOCIAL INDICATORS RE, P1; Huynh QL, 2009, J CROSS CULT PSYCHOL, V40, P256, DOI 10.1177/0022022108328919; KEELAN JPR, 1994, J SOC PERS RELAT, V11, P201, DOI 10.1177/0265407594112003; KOBAK RR, 1988, CHILD DEV, V59, P135, DOI 10.2307/1130395; KOSTERMAN R, 1989, POLIT PSYCHOL, V10, P257, DOI 10.2307/3791647; Kurdek LA, 2002, J SOC PERS RELAT, V19, P811, DOI 10.1177/0265407502196005; Kyle GT, 2004, J ENVIRON PSYCHOL, V24, P439, DOI 10.1016/j.jenvp.2004.11.001; LAPONCE J, 1984, SOC SCI INFORM, V23, P977, DOI 10.1177/053901884023006005; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Lewicka M, 2008, J ENVIRON PSYCHOL, V28, P209, DOI 10.1016/j.jenvp.2008.02.001; Losonczy AM, 2009, HIST ANTHROPOL, V20, P265, DOI 10.1080/02757200903112602; Mangold DL, 2007, HISPANIC J BEHAV SCI, V29, P366, DOI 10.1177/0739986307302167; MARKUS HR, 1994, PERS SOC PSYCHOL B, V20, P568, DOI 10.1177/0146167294205013; MIKULINCER M, 1995, J PERS SOC PSYCHOL, V69, P1203, DOI 10.1037/0022-3514.69.6.1203; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P97, DOI 10.1037//0022-3514.81.1.97; Mikulincer M, 2007, PSYCHOL INQ, V18, P139, DOI 10.1080/10478400701512646; Najmabadi A, 1997, COMP STUD SOC HIST, V39, P442, DOI 10.1017/S0010417500020727; NETO F, 1995, SOC INDIC RES, V35, P93, DOI 10.1007/BF01079240; Peeters M.C., 2009, INT J STRESS MANAGE, V16, P1, DOI DOI 10.1037/A0014832; Polek E, 2008, INT J PSYCHOL, V43, P919, DOI 10.1080/00207590701484835; Polek E, 2010, CROSS-CULT RES, V44, P60, DOI 10.1177/1069397109352779; Ravitz P, 2010, J PSYCHOSOM RES, V69, P419, DOI 10.1016/j.jpsychores.2009.08.006; Rothi DM, 2005, POLIT PSYCHOL, V26, P135, DOI 10.1111/j.1467-9221.2005.00412.x; Ryder AG, 2000, J PERS SOC PSYCHOL, V79, P49, DOI 10.1037//0022-3514.79.1.49; Saglia D, 1998, ELH-ENGL LIT HIST, V65, P363, DOI 10.1353/elh.1998.0014; Sato T, 2005, J PSYCHOL, V139, P545, DOI 10.3200/JRLP.139.6.545-552; Schmitt DP, 2004, J CROSS CULT PSYCHOL, V35, P367, DOI 10.1177/0022022104266105; Scottham KM, 2010, IDENTITY, V10, P284, DOI 10.1080/15283488.2010.523587; SEARLE W, 1990, INT J INTERCULT REL, V14, P449, DOI 10.1016/0147-1767(90)90030-Z; Seymour M, 1999, MONIST, V82, P411, DOI 10.5840/monist199982316; Shaver PR, 2010, J SOC PERS RELAT, V27, P163, DOI 10.1177/0265407509360899; SHAVER PR, 1992, PERS SOC PSYCHOL B, V18, P536, DOI 10.1177/0146167292185003; Shetty Sandhya, 1995, DIFFERENCES, V7.3, P50; Sibley CG, 2008, PERS INDIV DIFFER, V44, P238, DOI 10.1016/j.paid.2007.08.003; Simpson JA, 2010, J SOC PERS RELAT, V27, P173, DOI 10.1177/0265407509360909; Smith A. D, 1991, NATL IDENTITY; Smith ER, 1999, J PERS SOC PSYCHOL, V77, P94, DOI 10.1037/0022-3514.77.1.94; Stern P.C., 2000, PERSPECTIVES NATL WA, P99; Swann WB, 2012, PSYCHOL REV, V119, P441, DOI 10.1037/a0028589; Tavakoli-Targhi M, 2002, INT J MIDDLE E STUD, V34, P217; TUAN YF, 1991, ANN ASSOC AM GEOGR, V81, P684, DOI 10.1111/j.1467-8306.1991.tb01715.x; Visvanathan S, 2006, THEOR CULT SOC, V23, P533, DOI 10.1177/0263276406061702; Ward C, 1999, J CROSS CULT PSYCHOL, V30, P422, DOI 10.1177/0022022199030004003; Ward C, 2009, PSYCHOL STUD, V55, P26; Ward C., 1996, HDB INTERCULTURAL TR, P124; Wei MF, 2007, J PERS ASSESS, V88, P187, DOI 10.1080/00223890701268041; Zheng Xp., 2004, J HAPPINESS STUD, V5, P57, DOI DOI 10.1023/B:JOHS.0000021836.43694.02	85	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53872	10.1371/journal.pone.0053872	http://dx.doi.org/10.1371/journal.pone.0053872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372673	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000314021500027
J	Ryder, M; Gild, M; Hohl, TM; Pamer, E; Knauf, J; Ghossein, R; Joyce, JA; Fagin, JA				Ryder, Mabel; Gild, Matti; Hohl, Tobias M.; Pamer, Eric; Knauf, Jeff; Ghossein, Ronald; Joyce, Johanna A.; Fagin, James A.			Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression	PLOS ONE			English	Article							INFLAMMATORY MONOCYTES; PROSTATE-CANCER; MAMMARY-TUMORS; BREAST-CANCER; MOUSE MODEL; EXPRESSION; PAPILLARY; CELLS; CCR2; MUTATIONS	Advanced human thyroid cancers are densely infiltrated with tumor-associated macrophages (TAMs) and this correlates with a poor prognosis. We used BRAF-induced papillary thyroid cancer (PTC) mouse models to examine the role of TAMs in PTC progression. Following conditional activation of BRAF(V600E) in murine thyroids there is an increased expression of the TAM chemoattractants Csf-1 and Ccl-2. This is followed by the development of PTCs that are densely infiltrated with TAMs that express Csf-1r and Ccr2. Targeting CCR2-expressing cells during BRAF-induction reduced TAM density and impaired PTC development. This strategy also induced smaller tumors, decreased proliferation and restored a thyroid follicular architecture in established PTCs. In PTCs from mice that lacked CSF-1 or that received a c-FMS/CSF-1R kinase inhibitor, TAM recruitment and PTC progression was impaired, recapitulating the effects of targeting CCR2-expressing cells. Our data demonstrate that TAMs are pro-tumorigenic in advanced PTCs and that they can be targeted pharmacologically, which may be potentially useful for patients with advanced thyroid cancers.	[Ryder, Mabel; Gild, Matti; Knauf, Jeff; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Ryder, Mabel; Hohl, Tobias M.; Pamer, Eric; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Hohl, Tobias M.; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Dept Infect Dis Serv, New York, NY 10021 USA; [Hohl, Tobias M.; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Ghossein, Ronald] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fagin, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	faginj@mkscc.org		Hohl, Tobias/0000-0002-9097-5412; Gild, Matti/0000-0002-6670-2254; Knauf, Jeffrey/0000-0003-4456-8792	American Thyroid Association THANC; Lefkovsky Family Foundation; Byrne fund;  [K08 CA133183];  [K08 AI071998];  [RO1 CA50706];  [R01 CA72597]; NATIONAL CANCER INSTITUTE [R01CA050706, P30CA008748, R01CA072597, K08CA133183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039031, K08AI071998] Funding Source: NIH RePORTER	American Thyroid Association THANC; Lefkovsky Family Foundation; Byrne fund; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded, in part, by K08 CA133183 and American Thyroid Association THANC award (MR), K08 AI071998 (TMH), RO1 CA50706 and R01 CA72597 (JAF), the Lefkovsky Family Foundation and the Byrne fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ekert JE, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-23; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanna J, 2005, BLOOD, V106, P3465, DOI 10.1182/blood-2005-03-0855; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kimura ET, 2003, CANCER RES, V63, P1454; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; KORNFEHL J, 1994, LARYNGO RHINO OTOL, V73, P183, DOI 10.1055/s-2007-997107; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ohno S, 2003, ANTICANCER RES, V23, P4395; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Phillips Roderick J, 2005, J Inflamm (Lond), V2, P14, DOI 10.1186/1476-9255-2-14; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pyonteck SM, 2012, ONCOGENE, V31, P1459, DOI 10.1038/onc.2011.337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sedliarou I, 2004, INT J ONCOL, V25, P1729; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tsutsui S, 2005, ONCOL REP, V14, P425; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; Wei Q, 2012, THYROID	49	101	109	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54302	10.1371/journal.pone.0054302	http://dx.doi.org/10.1371/journal.pone.0054302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372702	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500054
J	Vieux-Rochas, M; Bouhali, K; Mantero, S; Garaffo, G; Provero, P; Astigiano, S; Barbieri, O; Caratozzolo, MF; Tullo, A; Guerrini, L; Lallemand, Y; Robert, B; Levi, G; Merlo, GR				Vieux-Rochas, Maxence; Bouhali, Kamal; Mantero, Stefano; Garaffo, Giulia; Provero, Paolo; Astigiano, Simonetta; Barbieri, Ottavia; Caratozzolo, Mariano F.; Tullo, Apollonia; Guerrini, Luisa; Lallemand, Yvan; Robert, Benoit; Levi, Giovanni; Merlo, Giorgio R.			BMP-Mediated Functional Cooperation between Dlx5;Dlx6 and Msx1;Msx2 during Mammalian Limb Development	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; EARLY TOOTH DEVELOPMENT; VERTEBRATE LIMB; MOUSE LIMB; HOMEOBOX GENES; CLEFT-PALATE; REGULATORY INTERACTIONS; SIGNALING PATHWAYS; DLX HOMEOPROTEINS; MURINE SKULL	The Dlx and Msx homeodomain transcription factors play important roles in the control of limb development. The combined disruption of Msx1 and Msx2, as well as that of Dlx5 and Dlx6, lead to limb patterning defects with anomalies in digit number and shape. Msx1; Msx2 double mutants are characterized by the loss of derivatives of the anterior limb mesoderm which is not observed in either of the simple mutants. Dlx5; Dlx6 double mutants exhibit hindlimb ectrodactyly. While the morphogenetic action of Msx genes seems to involve the BMP molecules, the mode of action of Dlx genes still remains elusive. Here, examining the limb phenotypes of combined Dlx and Msx mutants we reveal a new Dlx-Msx regulatory loop directly involving BMPs. In Msx1; Dlx5; Dlx6 triple mutant mice (TKO), beside the expected ectrodactyly, we also observe the hallmark morphological anomalies of Msx1; Msx2 double mutants suggesting an epistatic role of Dlx5 and Dlx6 over Msx2. In Msx2; Dlx5; Dlx6 TKO mice we only observe an aggravation of the ectrodactyly defect without changes in the number of the individual components of the limb. Using a combination of qPCR, ChIP and bioinformatic analyses, we identify two Dlx/Msx regulatory pathways: 1) in the anterior limb mesoderm a non-cell autonomous Msx-Dlx regulatory loop involves BMP molecules through the AER and 2) in AER cells and, at later stages, in the limb mesoderm the regulation of Msx2 by Dlx5 and Dlx6 occurs also cell autonomously. These data bring new elements to decipher the complex AER-mesoderm dialogue that takes place during limb development and provide clues to understanding the etiology of congenital limb malformations.	[Vieux-Rochas, Maxence; Bouhali, Kamal; Levi, Giovanni] Museum Natl Hist Nat, CNRS, Evolut Regulat Endocriniennes UMR 7221, Paris, France; [Mantero, Stefano; Garaffo, Giulia; Provero, Paolo; Merlo, Giorgio R.] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Astigiano, Simonetta; Barbieri, Ottavia] Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; [Barbieri, Ottavia] Univ Genoa, Dept Expt Med, Genoa, Italy; [Caratozzolo, Mariano F.; Tullo, Apollonia] CNR, Inst Biomed Technol, Bari, Italy; [Guerrini, Luisa] Univ Milan, Dept Biosci, Milan, Italy; [Lallemand, Yvan; Robert, Benoit] Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, Paris, France; [Merlo, Giorgio R.] Univ Turin, Dulbecco Telethon Inst, Turin, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Turin	Merlo, GR (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	gmerlo@dti.telethon.it	Mantero, Stefano/AAE-5515-2021; Provero, Paolo/AAC-1930-2019; Astigiano, Simonetta/AAG-7766-2019; Tullo, Apollonia/AAX-1079-2020	Astigiano, Simonetta/0000-0002-8200-0666; Tullo, Apollonia/0000-0002-5081-4745; Bouhali, Kamal/0000-0002-3497-5303; Levi, Giovanni/0000-0002-7041-6787; Mantero, Stefano/0000-0003-0608-2724; Caratozzolo, Mariano Francesco/0000-0002-9559-4598	Italian Telethon Foundation [GGP11097, GP0218Y01]; Fondazione per la Ricerca Biomedica (Torino, Italy); Compagnia di San Paolo (Torino, Italy); Institut Pasteur; Centre National de la Recherche Scientifique (France); Agence Nationale de la Recherche (France)	Italian Telethon Foundation(Fondazione Telethon); Fondazione per la Ricerca Biomedica (Torino, Italy); Compagnia di San Paolo (Torino, Italy)(Compagnia di San Paolo); Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (France)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	Giorgio R. Merlo is supported by the Italian Telethon Foundation (GGP11097), the Fondazione per la Ricerca Biomedica (Torino, Italy), and the Compagnia di San Paolo (Torino, Italy). Ottavia Barbieri is supported by the Italian Telethon Foundation (GP0218Y01). Benoit Robert is supported by Institut Pasteur and the Centre National de la Recherche Scientifique (France). Benoit Robert and Giovanni Levi are supported by the Agence Nationale de la Recherche (France) grant "GENDACTYL." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Ahn K, 2001, DEVELOPMENT, V128, P4449; Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; Allard P, 2009, SEMIN CELL DEV BIOL, V20, P479, DOI 10.1016/j.semcdb.2008.10.011; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bastida MF, 2008, CURR OPIN GENET DEV, V18, P374, DOI 10.1016/j.gde.2008.06.009; Bei M, 2000, DEVELOPMENT, V127, P4711; Bei M, 1998, DEVELOPMENT, V125, P4325; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Chen HX, 2002, INT J DEV BIOL, V46, P937; Chen YP, 1996, DEVELOPMENT, V122, P3035; Chung IH, 2010, GENESIS, V48, P645, DOI 10.1002/dvg.20671; Cygan JA, 1997, DEVELOPMENT, V124, P5021; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; FERRARI D, 1995, MECH DEVELOP, V52, P257, DOI 10.1016/0925-4773(95)98113-O; Guerrini L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/864904; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; JONES CM, 1991, DEVELOPMENT, V111, P531; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038; Levi G, 2003, MOL CELL NEUROSCI, V22, P530, DOI 10.1016/S1044-7431(02)00041-6; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Lu PF, 2008, DEVELOPMENT, V135, P1395, DOI 10.1242/dev.018945; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Merlo GR, 2007, J MOL HISTOL, V38, P347, DOI 10.1007/s10735-007-9109-2; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Muraglia A, 2008, EUR J CELL BIOL, V87, P751, DOI 10.1016/j.ejcb.2008.04.004; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Paina S, 2011, J NEUROSCI, V31, P2675, DOI 10.1523/JNEUROSCI.3110-10.2011; Pan ZZ, 2002, BIOCHEM BIOPH RES CO, V290, P955, DOI 10.1006/bbrc.2001.6294; Panganiban G, 2002, DEVELOPMENT, V129, P4371; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Perera M, 2004, MOL CELL NEUROSCI, V25, P153, DOI 10.1016/j.mcn.2003.10.004; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Pizette S, 2001, DEVELOPMENT, V128, P4463; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Qiu Q, 2009, GENESIS, V47, P224, DOI 10.1002/dvg.20430; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Robert B, 2006, DEV DYNAM, V235, P2337, DOI 10.1002/dvdy.20890; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shamseldin HE, 2012, J MED GENET, V49, P16, DOI 10.1136/jmedgenet-2011-100556; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Vieux-Rochas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000510; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; ZELLER R, 2004, SCI STKE, V259, pPE53; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	90	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e51700	10.1371/journal.pone.0051700	http://dx.doi.org/10.1371/journal.pone.0051700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382810	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200011
J	Song, QJ; Hyten, DL; Jia, GF; Quigley, CV; Fickus, EW; Nelson, RL; Cregan, PB				Song, Qijian; Hyten, David L.; Jia, Gaofeng; Quigley, Charles V.; Fickus, Edward W.; Nelson, Randall L.; Cregan, Perry B.			Development and Evaluation of SoySNP50K, a High-Density Genotyping Array for Soybean	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; QUANTITATIVE TRAIT LOCUS; GENETIC-LINKAGE MAP; THROUGHPUT SNP DISCOVERY; GLYCINE-SOJA; HETERODERA-GLYCINES; AGRONOMIC TRAITS; L.-MERR.; GENOME; ASSAY	The objective of this research was to identify single nucleotide polymorphisms (SNPs) and to develop an Illumina Infinium BeadChip that contained over 50,000 SNPs from soybean (Glycine max L. Merr.). A total of 498,921,777 reads 35-45 bp in length were obtained from DNA sequence analysis of reduced representation libraries from several soybean accessions which included six cultivated and two wild soybean (G. soja Sieb. et Zucc.) genotypes. These reads were mapped to the soybean whole genome sequence and 209,903 SNPs were identified. After applying several filters, a total of 146,161 of the 209,903 SNPs were determined to be ideal candidates for Illumina Infinium II BeadChip design. To equalize the distance between selected SNPs, increase assay success rate, and minimize the number of SNPs with low minor allele frequency, an iteration algorithm based on a selection index was developed and used to select 60,800 SNPs for Infinium BeadChip design. Of the 60,800 SNPs, 50,701 were targeted to euchromatic regions and 10,000 to heterochromatic regions of the 20 soybean chromosomes. In addition, 99 SNPs were targeted to unanchored sequence scaffolds. Of the 60,800 SNPs, a total of 52,041 passed Illumina's manufacturing phase to produce the SoySNP50K iSelect BeadChip. Validation of the SoySNP50K chip with 96 landrace genotypes, 96 elite cultivars and 96 wild soybean accessions showed that 47,337 SNPs were polymorphic and generated successful SNP allele calls. In addition, 40,841 of the 47,337 SNPs (86%) had minor allele frequencies >= 10% among the landraces, elite cultivars and the wild soybean accessions. A total of 620 and 42 candidate regions which may be associated with domestication and recent selection were identified, respectively. The SoySNP50K iSelect SNP beadchip will be a powerful tool for characterizing soybean genetic diversity and linkage disequilibrium, and for constructing high resolution linkage maps to improve the soybean whole genome sequence assembly.	[Song, Qijian; Hyten, David L.; Jia, Gaofeng; Quigley, Charles V.; Fickus, Edward W.; Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Nelson, Randall L.] Univ Illinois, Pathol & Genet Res Unit, USDA ARS, Urbana, IL 61801 USA; [Nelson, Randall L.] Univ Illinois, Dept Crop Sci, USDA ARS, Urbana, IL 61801 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Cregan, PB (corresponding author), USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA.	Perry.Cregan@ars.usda.gov		Hyten, David/0000-0001-6324-9389	United Soybean Board [8265]	United Soybean Board	This study was partially funded by the United Soybean Board (http://www.unitedsoybean.org/) as part of Project #8265 entitled: Whole Genome Analysis of the USDA Soybean Germplasm Collection and Applications for New Gene Discovery (50,000 SNPs). The United Soybean Board has read the manuscript and has indicated their approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barreiro LB, 2009, METHODS MOL BIOL, V578, P255, DOI 10.1007/978-1-60327-411-1_17; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chen HF, 2011, EUPHYTICA, V179, P485, DOI 10.1007/s10681-011-0382-5; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; Hao ZF, 2011, J INTEGR PLANT BIOL, V53, P641, DOI 10.1111/j.1744-7909.2011.01051.x; Hoeck JA, 2003, CROP SCI, V43, P68, DOI 10.2135/cropsci2003.0068; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; KLEIN RJ, 2007, BMC GENET, V28, P8; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Luo MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-28; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Matukumalli LK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-4; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Orf JH, 1999, CROP SCI, V39, P1642, DOI 10.2135/cropsci1999.3961642x; Qi ZM, 2011, AGR SCI CHINA, V10, P1681, DOI 10.1016/S1671-2927(11)60166-1; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ricard A., 2011, 37th Journee de la Recherche Equine, Le Pin au Haras, France, 24 February, 2011, P227; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Somers DJ, 2003, GENOME, V46, P431, DOI 10.1139/G03-027; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Vuong TD, 2011, EUPHYTICA, V181, P101, DOI 10.1007/s10681-011-0430-1; Yoon MS, 2007, THEOR APPL GENET, V114, P885, DOI 10.1007/s00122-006-0487-8; Yue P, 2001, THEOR APPL GENET, V102, P921, DOI 10.1007/s001220000453; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao Q, 2002, GENOME RES, V12, P817, DOI 10.1101/gr.48902; Zhu YL, 2003, GENETICS, V163, P1123	51	361	381	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54985	10.1371/journal.pone.0054985	http://dx.doi.org/10.1371/journal.pone.0054985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372807	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400050
J	Ishida, E; Hashimoto, K; Okada, S; Satoh, T; Yamada, M; Mori, M				Ishida, Emi; Hashimoto, Koshi; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo			Crosstalk between Thyroid Hormone Receptor and Liver X Receptor in the Regulation of Selective Alzheimer's Disease Indicator-1 Gene Expression	PLOS ONE			English	Article							TERM CELL-CULTURES; NERVOUS-SYSTEM; RESPONSE ELEMENT; MOUSE MODEL; IN-VIVO; CHOLESTEROL-BIOSYNTHESIS; OXIDATIVE STRESS; CO-REPRESSOR; T-TEST; BETA	Selective Alzheimer's disease (AD) indicator 1 (Seladin-1) has been identified as a gene down-regulated in the degenerated lesions of AD brain. Up-regulation of Seladin-1 reduces the accumulation of beta-amyloid and neuronal death. Thyroid hormone (TH) exerts an important effect on the development and maintenance of central nervous systems. In the current study, we demonstrated that Seladin-1 gene and protein expression in the forebrain was increased in thyrotoxic mice compared with that of euthyroid mice. However, unexpectedly, no significant decrease in the gene and protein expression was observed in hypothyroid mice. Interestingly, an agonist of liver X receptor (LXR), TO901317 (TO) administration in vivo increased Seladin-1 gene and protein expression in the mouse forebrain only in a hypothyroid state and in the presence of mutant TR-beta, suggesting that LXR-alpha would compensate for TR-beta function to maintain Seladin-1 gene expression in hypothyroidism and resistance to TH. TH activated the mouse Seladin-1 gene promoter (-1936/+21 bp) and site 2 including canonical TH response element (TRE) half-site in the region between -159 and -154 bp is responsible for the positive regulation. RXR-alpha/TR-beta heterodimerization was identified on site 2 by gel-shift assay, and chromatin immunoprecipitation assay revealed the recruitment of TR-beta to site 2 and the recruitment was increased upon TH administration. On the other hand, LXR-alpha utilizes a distinct region from site 2 (-120 to -102 bp) to activate the mouse Seladin-1 gene promoter. Taking these findings together, we concluded that TH up-regulates Seladin-1 gene expression at the transcriptional level and LXR-alpha maintains the gene expression.	[Ishida, Emi; Hashimoto, Koshi; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan	Gunma University	Hashimoto, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	khashimo@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Japan Intractable Disease Research Foundation	Japan Intractable Disease Research Foundation	This work was supported by grant from Japan Intractable Disease Research Foundation to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Behl C, 2002, J STEROID BIOCHEM, V83, P195, DOI 10.1016/S0960-0760(02)00271-6; Benvenuti S, 2008, J ENDOCRINOL, V197, P437, DOI 10.1677/JOE-07-0324; Benvenuti S, 2005, J CLIN ENDOCR METAB, V90, P1775, DOI 10.1210/jc.2004-0066; Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BRETELER MMB, 1991, INT J EPIDEMIOL, V20, pS36, DOI 10.1093/ije/20.Supplement_2.S36; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Collingwood TN, 1997, P NATL ACAD SCI USA, V94, P248, DOI 10.1073/pnas.94.1.248; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Davis Jennifer Duncan, 2003, Curr Psychiatry Rep, V5, P384, DOI 10.1007/s11920-003-0073-6; de Jong FJ, 2006, J CLIN ENDOCR METAB, V91, P2569, DOI 10.1210/jc.2006-0449; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9; Fatourechi V, 2009, MAYO CLIN PROC, V84, P65, DOI 10.1016/S0025-6196(11)60809-4; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; FLYNN TR, 1994, J BIOL CHEM, V269, P32713; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Fu AL, 2010, NEUROPHARMACOLOGY, V58, P722, DOI 10.1016/j.neuropharm.2009.12.020; Ganguli M, 1996, BIOL PSYCHIAT, V40, P714, DOI 10.1016/0006-3223(95)00489-0; Greeve I, 2000, J NEUROSCI, V20, P7345; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Hashimoto K, 2005, MOL CELL ENDOCRINOL, V229, P11, DOI 10.1016/j.mce.2004.10.005; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Hashimoto K, 2007, ENDOCRINOLOGY, V148, P4667, DOI 10.1210/en.2007-0150; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Hashimoto K, 2011, ENDOCR J, V58, P921, DOI 10.1507/endocrj.EJ11-0114; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huuskonen J, 2004, BIOCHEMISTRY-US, V43, P1626, DOI 10.1021/bi0301643; Jones I, 2003, THYROID, V13, P1057, DOI 10.1089/105072503770867228; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Konig S, 2002, CELL MOL NEUROBIOL, V22, P517, DOI 10.1023/A:1021828218454; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Luciani P, 2008, ENDOCRINOLOGY, V149, P4256, DOI 10.1210/en.2007-1795; Maggi A, 2004, ANNU REV PHYSIOL, V66, P291, DOI 10.1146/annurev.physiol.66.032802.154945; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339, DOI 10.1210/mend-5-9-1339; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; MOSER BK, 1989, COMMUN STAT THEORY, V18, P3963, DOI 10.1080/03610928908830135; Nunez J, 2008, MOL CELL ENDOCRINOL, V287, P1, DOI 10.1016/j.mce.2008.03.006; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rivas M, 2007, GENES BRAIN BEHAV, V6, P40, DOI 10.1111/j.1601-183X.2007.00321.x; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Safer JD, 1997, MOL ENDOCRINOL, V11, P16, DOI 10.1210/me.11.1.16; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tan XJ, 2010, P NATL ACAD SCI USA, V107, P12305, DOI 10.1073/pnas.1006162107; USALA SJ, 1991, MOL ENDOCRINOL, V5, P327, DOI 10.1210/mend-5-3-327; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Zhang YQ, 2001, J BIOL CHEM, V276, P974, DOI 10.1074/jbc.M005894200	64	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54901	10.1371/journal.pone.0054901	http://dx.doi.org/10.1371/journal.pone.0054901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359226	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600134
J	Li, MF; Sun, HX; Feng, Q; Lu, HM; Zhao, Y; Zhang, H; Xu, X; Jiao, JD; Wang, LY; Hua, YJ				Li, Mingfeng; Sun, Hongxing; Feng, Qiong; Lu, Huiming; Zhao, Ye; Zhang, Hui; Xu, Xin; Jiao, Jiandong; Wang, Liangyan; Hua, Yuejin			Extracellular dGMP Enhances Deinococcus radiodurans Tolerance to Oxidative Stress	PLOS ONE			English	Article							MICROCOCCUS-RADIODURANS; IONIZING-RADIATION; GENE-TRANSFER; EXTREME RADIORESISTANCE; NATURAL TRANSFORMATION; NEISSERIA-GONORRHOEAE; SUPEROXIDE-DISMUTASE; DNA-REPAIR; BACTERIA; ENVIRONMENT	Free extracellular DNA provides nutrition to bacteria and promotes bacterial evolution by inducing excessive mutagenesis of the genome. To understand the influence of extracellular DNA fragments on D. radiodurans, we investigated cell growth and survival after extracellular DNA or dNMPs treatment. The results showed that the extracellular DNA fragments inhibited the growth of D. radiodurans. Interestingly, dGMP, a DNA component, enhanced D. radiodurans tolerance to H2O2 and gamma-radiation significantly. Further experiments indicated that extracellular dGMP stimulated the activity of one catalase (KatA, DR1998), and induced gene transcription including the extracellular nuclease (drb0067). When this only extracellular nuclease gene (drb0067) in D. radiodurans was deleted, the mutant strain showed more sensitive to H2O2 and gamma-radiation than the wild type strain. These results suggest that DRB0067 plays an important role in oxidative stress resistance. Taken together, we proposed a new anti-oxidation mechanism in D. radiodurans. This mechanism acts to increase expression levels of DRB0067 which then secretes active nuclease to degrade extracellular DNA fragments. The extracellular nuclease has a two-fold benefit, creating more free dNTPs for further cell protection and the removal of extracellular DNA fragments.	[Li, Mingfeng; Sun, Hongxing; Feng, Qiong; Lu, Huiming; Zhao, Ye; Zhang, Hui; Xu, Xin; Jiao, Jiandong; Wang, Liangyan; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Hongxing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Sun, Hongxing] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, LY (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr & Zhejiang Prov, Key Lab Nucl Agr Sci, Hangzhou 310003, Zhejiang, Peoples R China.	liangyanwang@zju.edu.cn; yjhua@zju.edu.cn	Sun, Hongxing/AAV-6028-2020; LU, HUIMING/C-1996-2014; Zhao, Ye/I-2936-2014; Lu, Huiming/ABG-1372-2021	Zhao, Ye/0000-0002-5455-2586; Lu, Huiming/0000-0002-2743-7419	National Natural Science Foundation of China [30830006, 31070080]; major project for genetically modified organisms breeding from the Ministry of Agriculture of China [2009ZX08009-075B, 2011ZX08009-003-002]; Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China [201103007]; Fundamental Research Funds for the Central Universities from Zhejiang University [2012FZA6014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); major project for genetically modified organisms breeding from the Ministry of Agriculture of China; Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China; Fundamental Research Funds for the Central Universities from Zhejiang University	This work was supported by grants from National Natural Science Foundation of China (30830006, 31070080), a major project for genetically modified organisms breeding from the Ministry of Agriculture of China (2009ZX08009-075B, 2011ZX08009-003-002), a grant from Special Fund for Agroscientific Research in the Public Interest from the Ministry of Agriculture of China (201103007), and the Fundamental Research Funds for the Central Universities from Zhejiang University (2012FZA6014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Blokesch M, 2008, J BACTERIOL, V190, P7232, DOI 10.1128/JB.00959-08; BOLING ME, 1966, BIOCHIM BIOPHYS ACTA, V123, P26, DOI 10.1016/0005-2787(66)90155-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brnakova Z, 2005, BBA-GEN SUBJECTS, V1721, P116, DOI 10.1016/j.bbagen.2004.10.008; Curatola AM, 2011, ANGIOGENESIS, V14, P267, DOI 10.1007/s10456-011-9211-7; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dodd HN, 1999, FEMS MICROBIOL LETT, V173, P41, DOI 10.1016/S0378-1097(99)00054-3; DREISEIKELMANN B, 1994, MICROBIOL REV, V58, P293, DOI 10.1128/MMBR.58.3.293-316.1994; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; GENTNER NE, 1975, RADIAT RES, V61, P204, DOI 10.2307/3574039; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; ICHIGE A, 1988, J BACTERIOL, V170, P3537, DOI 10.1128/jb.170.8.3537-3542.1988; Kamble VA, 2010, FEMS MICROBIOL LETT, V303, P18, DOI 10.1111/j.1574-6968.2009.01855.x; Linder JU, 2010, MOL CELL BIOCHEM, V334, P215, DOI 10.1007/s11010-009-0321-0; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Meima R, 2000, APPL ENVIRON MICROB, V66, P3856, DOI 10.1128/AEM.66.9.3856-3867.2000; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; MITCHEL REJ, 1975, RADIAT RES, V64, P380, DOI 10.2307/3574274; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tanaka A, 1996, RADIAT ENVIRON BIOPH, V35, P95, DOI 10.1007/BF02434031; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; VUKOVICNAGY B, 1974, INT J RADIAT BIOL, V25, P329, DOI 10.1080/09553007414550401; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yin XM, 1997, ADV APPL MICROBIOL, V45, P153, DOI 10.1016/S0065-2164(08)70263-6; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	45	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54420	10.1371/journal.pone.0054420	http://dx.doi.org/10.1371/journal.pone.0054420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365666	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600054
J	Martin, GE; Gouillou, M; Hearps, AC; Angelovich, TA; Cheng, AC; Lynch, F; Cheng, WJ; Paukovics, G; Palmer, CS; Novak, RM; Jaworowski, A; Landay, AL; Crowe, SM				Martin, Genevieve E.; Gouillou, Maelenn; Hearps, Anna C.; Angelovich, Thomas A.; Cheng, Allen C.; Lynch, Fiona; Cheng, Wan-Jung; Paukovics, Geza; Palmer, Clovis S.; Novak, Richard M.; Jaworowski, Anthony; Landay, Alan L.; Crowe, Suzanne M.			Age-Associated Changes in Monocyte and Innate Immune Activation Markers Occur More Rapidly in HIV Infected Women	PLOS ONE			English	Article							T-CELL-ACTIVATION; CORONARY-HEART-DISEASE; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; RISK; SUBPOPULATIONS; PROGRESSION; GENDER; VIRUS; EXPRESSION	Background: Aging is associated with immune dysfunction and the related development of conditions with an inflammatory pathogenesis. Some of these immune changes are also observed in HIV infection, but the interaction between immune changes with aging and HIV infection are unknown. Whilst sex differences in innate immunity are recognized, little research into innate immune aging has been performed on women. Methods: This cross-sectional study of HIV positive and negative women used whole blood flow cytometric analysis to characterize monocyte and CD8(+) T cell subsets. Plasma markers of innate immune activation were measured using standard ELISA-based assays. Results: HIV positive women exhibited elevated plasma levels of the innate immune activation markers CXCL10 (p<0.001), soluble CD163 (sCD163, p = 0.001), sCD14 (p = 0.022), neopterin (p = 0.029) and an increased proportion of CD16(+) monocytes (p = 0.009) compared to uninfected controls. Levels of the innate immune aging biomarkers sCD163 and the proportion of CD16(+) monocytes were equivalent to those observed in HIV negative women aged 14.5 and 10.6 years older, respectively. CXCL10 increased with age at an accelerated rate in HIV positive women (p = 0.002) suggesting a synergistic effect between HIV and aging on innate immune activation. Multivariable modeling indicated that age-related increases in innate immune biomarkers CXCL10 and sCD163 are independent of senescent changes in CD8(+) T lymphocytes. Conclusions: Quantifying the impact of HIV on immune aging reveals that HIV infection in women confers the equivalent of a 10-14 year increase in the levels of innate immune aging markers. These changes may contribute to the increased risk of inflammatory age-related diseases in HIV positive women.	[Martin, Genevieve E.; Hearps, Anna C.; Angelovich, Thomas A.; Cheng, Wan-Jung; Paukovics, Geza; Palmer, Clovis S.; Jaworowski, Anthony; Crowe, Suzanne M.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Martin, Genevieve E.; Hearps, Anna C.; Cheng, Allen C.; Jaworowski, Anthony; Crowe, Suzanne M.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Gouillou, Maelenn] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Angelovich, Thomas A.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Cheng, Allen C.; Crowe, Suzanne M.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Lynch, Fiona; Novak, Richard M.] Univ Illinois, Dept Med, Chicago, IL USA; [Palmer, Clovis S.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Jaworowski, Anthony] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA	Burnet Institute; Monash University; Burnet Institute; Royal Melbourne Institute of Technology (RMIT); Florey Institute of Neuroscience & Mental Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of New South Wales Sydney; Monash University; Rush University	Crowe, SM (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	crowe@burnet.edu.au	Palmer, Clovis/P-1986-2019; Martin, Genevieve Elizabeth/AGH-1336-2022	Palmer, Clovis/0000-0002-5031-6922; Martin, Genevieve Elizabeth/0000-0001-5142-7440; Angelovich, Thomas/0000-0003-2069-0451; Cheng, Allen/0000-0003-3152-116X; jaworowski, anthony/0000-0002-3844-805X	National Health and Medical Research Council of Australia (NHMRC) [543137]; Centres for AIDS Research [P30-AI082151]; National Institutes of Health [AI082971]; NHMRC Principal Research Fellowship Award; NHMRC Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082971, P30AI082151] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centres for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Principal Research Fellowship Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) [543137 to AJ and SC]. Support was also given by the Centres for AIDS Research [P30-AI082151] and National Institutes of Health P01 [AI082971 to AL]. SC is a recipient of a NHMRC Principal Research Fellowship Award and AC is supported by a NHMRC Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bell RJ, 2008, MENOPAUSE, V15, P978, DOI 10.1097/gme.0b013e318162c487; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brew BJ, 2009, J NEUROIMMUNE PHARM, V4, P163, DOI 10.1007/s11481-008-9143-1; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bukh AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021275; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Cauley JA, 2007, J BONE MINER RES, V22, P1088, DOI 10.1359/JBMR.070409; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Hearps AC, 2011, SEX HEALTH, V8, P453, DOI 10.1071/SH11028; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Heller EA, 2006, CIRCULATION, V113, P2301, DOI 10.1161/CIRCULATIONAHA.105.605121; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Koten K, 2008, CLIN BIOCHEM, V41, P30, DOI 10.1016/j.clinbiochem.2007.10.001; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; MELMED RN, 1989, J ACQ IMMUN DEF SYND, V2, P70; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Olsson J, 2000, MECH AGEING DEV, V121, P187; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Spencer ME, 2010, J GERONTOL A-BIOL, V65, P855, DOI 10.1093/gerona/glq066; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228	40	92	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55279	10.1371/journal.pone.0055279	http://dx.doi.org/10.1371/journal.pone.0055279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365694	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600162
J	Tang, B; Li, ZX; Huang, DD; Zheng, L; Li, QW				Tang, Bo; Li, Zhexu; Huang, Dingde; Zheng, Lei; Li, Qianwei			Screening of a Specific Peptide Binding to VPAC1 Receptor from a Phage Display Peptide Library	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; SIGNAL-TRANSDUCTION; VIP ANALOG; IDENTIFICATION; GROWTH; INHIBIT; PACAP; PROLIFERATION; STIMULATION	Background/Purpose: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies. Recently, phage display has become widely used for many applications, including ligand generation for targeted imaging, drug delivery and therapy. In this work, we developed a panning procedure using a phage display peptide library to select a peptide that specifically binds to the VPAC1 receptor to develop a novel targeted probe for molecular imaging and therapy. Methods: CHO-K1 cells stably expressing VPAC1 receptors (CHO-K1/VPAC1 cells) were used to select a VPAC1-binding peptide from a 12-mer phage peptide library. DNA sequencing and homologous analysis of the randomly selected phage clones were performed. A cellular ELISA was used to determine the most selectively binding peptide for further investigation. Binding specificity to the VPAC1 receptor was analyzed by competitive inhibition ELISA and flow cytometry. The binding ability of the selected peptide to CHO-K1/VPAC1 cells and colorectal cancer (CRC) cell lines was confirmed using fluorescence microscopy and flow cytometry. Results: A significant enrichment of phages that specifically bound to CHO-K1/VPAC1 cells was obtained after four rounds of panning. Of the selected phage clones, 16 out of 60 shared the same peptide sequence, GFRFGALHEYNS, which we termed the VP2 peptide. VP2 and vasoactive intestinal peptide (VIP) competitively bound to the VPAC1 receptor. More importantly, we confirmed that VP2 specifically bound to CHO-K1/VPAC1 cells and several CRC cell lines. Conclusion: Our results demonstrate that the VP2 peptide could specifically bind to VPAC1 receptor and several CRC cell lines. And VP2 peptide may be a potential candidate to be developed as a useful diagnostic molecular imaging probe for early detection of CRC.	[Tang, Bo; Li, Zhexu; Huang, Dingde; Zheng, Lei; Li, Qianwei] Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China	Army Medical University	Li, QW (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China.	lqw_swhospital@163.com			Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation [120204]	Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation	This research was supported by the Key Laboratory of Radiopharmaceuticals of Ministry of Education Open Foundation (Grant No. 120204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; Beck S, 2011, BIOMATERIALS, V32, P8518, DOI 10.1016/j.biomaterials.2011.07.048; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Carrasquillo JA, 2011, J NUCL MED, V52, P1173, DOI 10.2967/jnumed.110.086165; Cheng DF, 2007, J FLUORINE CHEM, V128, P196, DOI 10.1016/j.jfluchem.2006.12.007; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Hamzeh-Mivehroud M, 2012, CHEM BIOL DRUG DES, V79, P246, DOI 10.1111/j.1747-0285.2011.01282.x; Jaggi M, 2008, INVEST NEW DRUG, V26, P489, DOI 10.1007/s10637-008-9117-4; Kothari K, 2007, APPL RADIAT ISOTOPES, V65, P382, DOI 10.1016/j.apradiso.2006.11.001; Kuipers EJ, 2005, J SURG ONCOL, V92, P203, DOI 10.1002/jso.20361; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lelievre V, 1998, J BIOL CHEM, V273, P19685, DOI 10.1074/jbc.273.31.19685; Liang SH, 2006, J MOL MED, V84, P764, DOI 10.1007/s00109-006-0064-2; Moody TW, 2007, PEPTIDES, V28, P1883, DOI 10.1016/j.peptides.2007.04.017; MOODY TW, 1993, P NATL ACAD SCI USA, V90, P4345, DOI 10.1073/pnas.90.10.4345; Moody TW, 2004, REGUL PEPTIDES, V123, P187, DOI 10.1016/j.regpep.2004.03.021; Moody TW, 2002, J MOL NEUROSCI, V18, P29, DOI 10.1385/JMN:18:1-2:29; Moody TW, 2002, LIFE SCI, V71, P1005, DOI 10.1016/S0024-3205(02)01741-1; Muller JM, 2006, REGUL PEPTIDES, V137, P34, DOI 10.1016/j.regpep.2006.06.014; Muller JM, 2007, PEPTIDES, V28, P1655, DOI 10.1016/j.peptides.2007.04.006; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Pan WH, 2004, BRAIN RES REV, V46, P32, DOI 10.1016/j.brainresrev.2004.04.006; Park HY, 2012, MOL BIOTECHNOL, V51, P212, DOI 10.1007/s12033-011-9458-7; Pfau PR, 2001, GASTROENTEROLOGY, V120, P763, DOI 10.1053/gast.2001.22429; Qin X, 2007, J BIOCHEM, V142, P79, DOI 10.1093/jb/mvm109; Raderer M, 1998, BRIT J CANCER, V78, P1, DOI 10.1038/bjc.1998.433; Rao PS, 2001, NUCL MED BIOL, V28, P445, DOI 10.1016/S0969-8051(01)00205-0; Reubi JC, 2004, EUR J NUCL MED MOL I, V31, P803, DOI 10.1007/s00259-004-1476-2; Reubi JC, 2000, CANCER RES, V60, P3105; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Straub SG, 1996, J BIOL CHEM, V271, P1660, DOI 10.1074/jbc.271.3.1660; Thakur ML, 2000, ANN NY ACAD SCI, V921, P37; Torizuka T, 2002, EUR J NUCL MED MOL I, V29, P797, DOI 10.1007/s00259-001-0750-9; Tung CH, 2004, BIOPOLYMERS, V76, P391, DOI 10.1002/bip.20139; Valdehita A, 2007, REGUL PEPTIDES, V144, P101, DOI 10.1016/j.regpep.2007.06.006; Valdehita A, 2012, MOL CELL ENDOCRINOL, V348, P241, DOI 10.1016/j.mce.2011.08.031; Valdehita A, 2009, MOL CELL ENDOCRINOL, V302, P41, DOI 10.1016/j.mce.2008.11.024; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vaudry H, 2006, ANN NY ACAD SCI, V1070, P1; Wang FY, 2006, BIOSCI BIOTECH BIOCH, V70, P2035, DOI 10.1271/bbb.50654; Xu R, 2006, HISTOL HISTOPATHOL, V21, P867, DOI 10.14670/HH-21.867; Zang LQ, 2009, CANCER LETT, V281, P64, DOI 10.1016/j.canlet.2009.02.021; Zhang WJ, 2012, WORLD J GASTROENTERO, V18, P2053, DOI 10.3748/wjg.v18.i17.2053; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022203	46	16	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54264	10.1371/journal.pone.0054264	http://dx.doi.org/10.1371/journal.pone.0054264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365656	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600044
J	Domenyuk, V; Loskutov, A; Johnston, SA; Diehnelt, CW				Domenyuk, Valeriy; Loskutov, Andrey; Johnston, Stephen Albert; Diehnelt, Chris W.			A Technology for Developing Synbodies with Antibacterial Activity	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; ANTIBIOTICS; SELECTIVITY; SEQUENCE; DESIGN	The rise in antibiotic resistance has led to an increased research focus on discovery of new antibacterial candidates. While broad-spectrum antibiotics are widely pursued, there is evidence that resistance arises in part from the wide spread use of these antibiotics. Our group has developed a system to produce protein affinity agents, called synbodies, which have high affinity and specificity for their target. In this report, we describe the adaptation of this system to produce new antibacterial candidates towards a target bacterium. The system functions by screening target bacteria against an array of 10,000 random sequence peptides and, using a combination of membrane labeling and intracellular dyes, we identified peptides with target specific binding or killing functions. Binding and lytic peptides were identified in this manner and in vitro tests confirmed the activity of the lead peptides. A peptide with antibacterial activity was linked to a peptide specifically binding Staphylococcus aureus to create a synbody with increased antibacterial activity. Subsequent tests showed that this peptide could block S. aureus induced killing of HEK293 cells in a co-culture experiment. These results demonstrate the feasibility of using the synbody system to discover new antibacterial candidate agents.	[Domenyuk, Valeriy; Loskutov, Andrey; Johnston, Stephen Albert; Diehnelt, Chris W.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Diehnelt, CW (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	chris.diehnelt@asu.edu	Diehnelt, Chris/AAT-9271-2020	Diehnelt, Chris/0000-0003-4565-9338	DARPA [W911NF-10-1-0299]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a grant from DARPA (http://www.darpa.mil/) under the 7 Day Biodefense Program to SAJ (grant number W911NF-10-1-0299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betanzos CM, 2009, CHEMBIOCHEM, V10, P877, DOI 10.1002/cbic.200800716; Casadevall A, 1996, CLIN INFECT DIS, V23, P790, DOI 10.1093/clinids/23.4.790; Casadevall A, 2009, EXPERT OPIN PHARMACO, V10, P1699, DOI 10.1517/14656560903066837; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; CLSI, 2009, M07A8 CLSI, P26; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Diehnelt CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010728; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P1480, DOI 10.1128/AAC.50.4.1480-1488.2006; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Greving MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015432; Gupta N, 2011, BIOCONJUGATE CHEM, V22, P1473, DOI 10.1021/bc200091c; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; He J, 2010, ANTIMICROB AGENTS CH, V54, P2143, DOI 10.1128/AAC.01391-09; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Loutet SA, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00006; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; Reichert JM, 2006, NAT REV DRUG DISCOV, V5, P191, DOI 10.1038/nrd1987; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Saylor C, 2009, VACCINE, V27, pG38, DOI 10.1016/j.vaccine.2009.09.105; Schneider CR, 2005, TRANSPLANT P, V37, P1243, DOI 10.1016/j.transproceed.2005.01.059; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; SILVER LL, 1993, ANTIMICROB AGENTS CH, V37, P377, DOI 10.1128/AAC.37.3.377; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tencza SB, 1999, J ANTIMICROB CHEMOTH, V44, P33, DOI 10.1093/jac/44.1.33; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wiegand C, 2009, WOUND REPAIR REGEN, V17, P730, DOI 10.1111/j.1524-475X.2009.00536.x; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	35	16	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54162	10.1371/journal.pone.0054162	http://dx.doi.org/10.1371/journal.pone.0054162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372679	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500033
J	Chen, ML; Xiao, JF; Zhang, Z; Liu, JX; Wu, JY; Yu, J				Chen, Meili; Xiao, Jingfa; Zhang, Zhang; Liu, Jingxing; Wu, Jiayan; Yu, Jun			Identification of Human HK Genes and Gene Expression Regulation Study in Cancer from Transcriptomics Data Analysis	PLOS ONE			English	Article							HOUSEKEEPING GENES; TGF-BETA; MICROARRAY; REPRODUCIBILITY; NORMALIZATION; DISCOVERIES; COMPENDIUM; STABILITY; DENSITY	The regulation of gene expression is essential for eukaryotes, as it drives the processes of cellular differentiation and morphogenesis, leading to the creation of different cell types in multicellular organisms. RNA-Sequencing (RNA-Seq) provides researchers with a powerful toolbox for characterization and quantification of transcriptome. Many different human tissue/cell transcriptome datasets coming from RNA-Seq technology are available on public data resource. The fundamental issue here is how to develop an effective analysis method to estimate expression pattern similarities between different tumor tissues and their corresponding normal tissues. We define the gene expression pattern from three directions: 1) expression breadth, which reflects gene expression on/off status, and mainly concerns ubiquitously expressed genes; 2) low/high or constant/variable expression genes, based on gene expression level and variation; and 3) the regulation of gene expression at the gene structure level. The cluster analysis indicates that gene expression pattern is higher related to physiological condition rather than tissue spatial distance. Two sets of human housekeeping (HK) genes are defined according to cell/tissue types, respectively. To characterize the gene expression pattern in gene expression level and variation, we firstly apply improved K-means algorithm and a gene expression variance model. We find that cancer-associated HK genes (a HK gene is specific in cancer group, while not in normal group) are expressed higher and more variable in cancer condition than in normal condition. Cancer-associated HK genes prefer to AT-rich genes, and they are enriched in cell cycle regulation related functions and constitute some cancer signatures. The expression of large genes is also avoided in cancer group. These studies will help us understand which cell type-specific patterns of gene expression differ among different cell types, and particularly for cancer.	[Chen, Meili; Xiao, Jingfa; Zhang, Zhang; Liu, Jingxing; Wu, Jiayan; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Meili; Liu, Jingxing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, JY (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	wujy@big.ac.cn; junyu@big.ac.cn		wu, jia yan/0000-0001-6048-405X	National Programs for High Technology Research and Development [2012AA020409]; Ministry of Science and Technology of the People's Republic of China; National Science Foundation of China [31101063, 31271386, 31000584]	National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant (2012AA020409) from National Programs for High Technology Research and Development (863 Program), the Ministry of Science and Technology of the People's Republic of China; and grants from the National Science Foundation of China (No. 31101063, No. 31271386 and No, 31000584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Howard BE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S6; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Klebanov L, 2006, STAT APPL GENET MOL, V5; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; Martinez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010398; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Qiu X, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-120; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Thellin O, 1999, J BIOTECHNOL, V75, P5; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang DP, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-20; Wang D, 2011, COMPUT BIOL CHEM, V35, P126, DOI 10.1016/j.compbiolchem.2011.04.006; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2003, NAT REV GENET, V4, P741, DOI 10.1038/nrg1160; Warnefors M, 2011, GENOME BIOL EVOL, V3, P667, DOI 10.1093/gbe/evr019; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Xu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013696; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zheng-Bradley X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r124; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010144	57	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54082	10.1371/journal.pone.0054082	http://dx.doi.org/10.1371/journal.pone.0054082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382867	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600023
J	Christen, S; Coppieters, K; Rose, K; Holdener, M; Bayer, M; Pfeilschifter, JM; Hintermann, E; von Herrath, MG; Aurrand-Lions, M; Imhof, BA; Christen, U				Christen, Selina; Coppieters, Ken; Rose, Kerstin; Holdener, Martin; Bayer, Monika; Pfeilschifter, Josef M.; Hintermann, Edith; von Herrath, Matthias G.; Aurrand-Lions, Michel; Imhof, Beat A.; Christen, Urs			Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice	PLOS ONE			English	Article							ISLET-SPECIFIC EXPRESSION; ACUTE-PANCREATITIS; JAM-C; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE ADHESION; TRANSGENIC MODEL; IN-VITRO; INFLAMMATION; CELLS; PATHOGENESIS	Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing beta-cells in the pancreas. Recruitment of inflammatory cells is prerequisite to beta-cell-injury. The junctional adhesion molecule (JAM) family proteins JAM-B and JAM-C are involved in polarized leukocyte transendothelial migration and are expressed by vascular endothelial cells of peripheral tissue and high endothelial venules in lympoid organs. Blocking of JAM-C efficiently attenuated cerulean-induced pancreatitis, rheumatoid arthritis or inflammation induced by ischemia and reperfusion in mice. In order to investigate the influence of JAM-C on trafficking and transmigration of antigen-specific, autoaggressive T-cells, we used transgenic mice that express a protein of the lymphocytic choriomeningitis virus (LCMV) as a target autoantigen in the beta-cells of the islets of Langerhans under the rat insulin promoter (RIP). Such RIP-LCMV mice turn diabetic after infection with LCMV. We found that upon LCMV-infection JAM-C protein was upregulated around the islets in RIP-LCMV mice. JAM-C expression correlated with islet infiltration and functional beta-cell impairment. Blockade with a neutralizing anti-JAM-C antibody reduced the T1D incidence. However, JAM-C overexpression on endothelial cells did not accelerate diabetes in the RIP-LCMV model. In summary, our data suggest that JAM-C might be involved in the final steps of trafficking and transmigration of antigen-specific autoaggressive T-cells to the islets of Langerhans.	[Christen, Selina; Rose, Kerstin; Holdener, Martin; Bayer, Monika; Pfeilschifter, Josef M.; Hintermann, Edith; Christen, Urs] Goethe Univ Hosp, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Coppieters, Ken; von Herrath, Matthias G.] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Aurrand-Lions, Michel] Aix Marseille Univ, CNRS, INSERM, Ctr Rech Cancerol Marseille,UMR 891, Marseille, France; [Imhof, Beat A.] Ctr Med Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; La Jolla Institute for Immunology; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Christen, U (corresponding author), Goethe Univ Hosp, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	christen@med.uni-frankfurt.de	Aurrand-Lions, Michel/O-9953-2016	Aurrand-Lions, Michel/0000-0002-8361-3034; Christen, Urs/0000-0003-4165-7976	University Hospital Frankfurt, Frankfurt am Main, Germany; German Research Foundation (DFG)	University Hospital Frankfurt, Frankfurt am Main, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	This research project was funded by the University Hospital Frankfurt, Frankfurt am Main, Germany and a grant of the German Research Foundation (DFG) to UC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Christen S, 2011, CLIN EXP IMMUNOL, V165, P318, DOI 10.1111/j.1365-2249.2011.04426.x; Christen U, 2004, J CLIN INVEST, V113, P74, DOI 10.1172/JCI200417005; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Christen U, 2001, J IMMUNOL, V166, P7023, DOI 10.4049/jimmunol.166.12.7023; Christen U, 2010, J AUTOIMMUN, V34, P38, DOI 10.1016/j.jaut.2009.08.001; Coppieters K, 2012, FUNCTIONAL RED UNPUB; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Coppieters K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015732; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Frossard JL, 1999, GASTROENTEROLOGY, V116, P694, DOI 10.1016/S0016-5085(99)70192-7; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; Martin S, 2001, J AUTOIMMUN, V17, P109, DOI 10.1006/jaut.2001.0526; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Petri B, 2006, FEBS J, V273, P4399, DOI 10.1111/j.1742-4658.2006.05439.x; Rabquer BJ, 2008, ARTHRITIS RHEUM, V58, P3020, DOI 10.1002/art.23867; Rau B, 2001, PANCREAS, V23, P80, DOI 10.1097/00006676-200107000-00012; Rhode A, 2005, J IMMUNOL, V175, P3516, DOI 10.4049/jimmunol.175.6.3516; Sircar M, 2007, J IMMUNOL, V178, P5879, DOI 10.4049/jimmunol.178.9.5879; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Vonlaufen A, 2007, J PATHOL, V213, P239, DOI 10.1002/path.2231; Vonlaufen A, 2006, J PATHOL, V209, P540, DOI 10.1002/path.2007; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54675	10.1371/journal.pone.0054675	http://dx.doi.org/10.1371/journal.pone.0054675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372751	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400024
J	Contreras, E; Rausell, C; Real, MD				Contreras, Estefania; Rausell, Carolina; Real, M. Dolores			Proteome Response of Tribolium castaneum Larvae to Bacillus thuringiensis Toxin Producing Strains	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; COLORADO POTATO BEETLE; GENE-EXPRESSION; CHORISTONEURA-FUMIFERANA; MAINTENANCE PHASES; DOWN-REGULATION; CRY1AB TOXIN; HEMOLYMPH; IDENTIFICATION; INITIATION	Susceptibility of Tribolium castaneum (Tc) larvae was determined against spore-crystal mixtures of five coleopteran specific and one lepidopteran specific Bacillus thuringiensis Cry toxin producing strains and those containing the structurally unrelated Cry3Ba and Cry23Aa/Cry37Aa proteins were found toxic (LC50 values 13.53 and 6.30 mu g spore-crystal mixture/mu L flour disc, respectively). Using iTRAQ combined with LC-MS/MS allowed the discovery of seven novel differentially expressed proteins in early response of Tc larvae to the two active spore-crystal mixtures. Proteins showing a statistically significant change in treated larvae compared to non-intoxicated larvae fell into two major categories; up-regulated proteins were involved in host defense (odorant binding protein C12, apolipophorin-III and chemosensory protein 18) and down-regulated proteins were linked to metabolic pathways affecting larval metabolism and development (pyruvate dehydrogenase Ea subunit, cuticular protein, ribosomal protein L13a and apolipoprotein LI-II). Among increased proteins, Odorant binding protein C12 showed the highest change, 4-fold increase in both toxin treatments. The protein displayed amino acid sequence and structural homology to Tenebrio molitor 12 kDa hemolymph protein b precursor, a non-olfactory odorant binding protein. Analysis of mRNA expression and mortality assays in Odorant binding protein C12 silenced larvae were consistent with a general immune defense function of non-olfactory odorant binding proteins. Regarding down-regulated proteins, at the transcriptional level, pyruvate dehydrogenase and cuticular genes were decreased in Tc larvae exposed to the Cry3Ba producing strain compared to the Cry23Aa/Cry37Aa producing strain, which may contribute to the developmental arrest that we observed with larvae fed the Cry3Ba producing strain. Results demonstrated a distinct host transcriptional regulation depending upon the Cry toxin treatment. Knowledge on how insects respond to Bt intoxication will allow designing more effective management strategies for pest control.	[Contreras, Estefania; Rausell, Carolina; Real, M. Dolores] Univ Valencia, Fac Ciencias Biol, Dept Genet, Valencia, Spain	University of Valencia	Rausell, C (corresponding author), Univ Valencia, Fac Ciencias Biol, Dept Genet, Valencia, Spain.	carolina.rausell@uv.es	Rausell, Carolina/ABG-4542-2020; Contreras, Estefania/AAZ-4659-2020; Rausell, Carolina/ABG-9554-2020; Real, M. Dolores/ABD-4252-2021	Contreras, Estefania/0000-0002-1822-6839; Rausell, Carolina/0000-0002-5849-9102; Real, M. Dolores/0000-0003-3188-9335	Ministerio de Ciencia e Innovacion [BIO 2007-67860, AGL2010-22300-C03-03]; Conselleria Valenciana d'Educacio i Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Valenciana d'Educacio i Ciencia	This work was supported by "Ministerio de Ciencia e Innovacion'' (BIO 2007-67860, AGL2010-22300-C03-03) and E. Contreras was awarded with a grant from the Conselleria Valenciana d'Educacio i Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Armbruster P, 2009, J MED ENTOMOL, V46, P271, DOI 10.1603/033.046.0211; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Crickmore N, 2012, BACILLUS THURINGIENS; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DONOVAN WP, 2002, Patent No. 549839; Finney DJ, 1947, PROBIT ANAL STAT TRE; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Graham LA, 2001, INSECT BIOCHEM MOLEC, V31, P691, DOI 10.1016/S0965-1748(00)00177-6; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; Levy F, 2004, BIOCHIMIE, V86, P607, DOI 10.1016/j.biochi.2004.07.007; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2009, ARCH INSECT BIOCHEM, V71, P70, DOI 10.1002/arch.20301; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Oppert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034624; Oppert B, 2011, PEST MANAG SCI, V67, P568, DOI 10.1002/ps.2099; Oppert B, 2010, J STORED PROD RES, V46, P143, DOI 10.1016/j.jspr.2010.01.003; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sayed A, 2010, INSECT MOL BIOL, V19, P381, DOI 10.1111/j.1365-2583.2010.00998.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song KH, 2006, COMP BIOCHEM PHYS D, V1, P260, DOI 10.1016/j.cbd.2006.01.001; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K., 2009, BACILLUS THURINGIENS; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wang CT, 2007, J INVERTEBR PATHOL, V96, P230, DOI 10.1016/j.jip.2007.05.012; Xie YS, 1996, CAN ENTOMOL, V128, P865, DOI 10.4039/Ent128865-5; Yocum GD, 2009, EUR J ENTOMOL, V106, P471, DOI 10.14411/eje.2009.059; Yocum GD, 2009, J INSECT PHYSIOL, V55, P32, DOI 10.1016/j.jinsphys.2008.10.003; Yuan C, 2011, BIOCONTROL SCI TECHN, V21, P139, DOI 10.1080/09583157.2010.527318; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029084, 10.1371/journal.pone.0031868]; Zhang X, 2008, COMP BIOCHEM PHYS B, V149, P581, DOI 10.1016/j.cbpb.2007.12.006; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	56	43	44	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55330	10.1371/journal.pone.0055330	http://dx.doi.org/10.1371/journal.pone.0055330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372850	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400090
J	Samson, T; van Buul, JD; Kroon, J; Welch, C; Bakker, EN; Matlung, HL; van den Berg, TK; Sharek, L; Doerschuk, C; Hahn, K; Burridge, K				Samson, Thomas; van Buul, Jaap D.; Kroon, Jeffrey; Welch, Christopher; Bakker, Erik N.; Matlung, Hanke L.; van den Berg, Timo K.; Sharek, Lisa; Doerschuk, Claire; Hahn, Klaus; Burridge, Keith			The Guanine-Nucleotide Exchange Factor SGEF Plays a Crucial Role in the Formation of Atherosclerosis	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; ENDOTHELIAL-CELLS; LEUKOCYTE TRANSMIGRATION; ADHERENT LEUKOCYTES; DOCKING STRUCTURE; DEFICIENCY; MIGRATION; ICAM-1; MICE; INFLAMMATION	The passage of leukocytes across the endothelium and into arterial walls is a critical step in the development of atherosclerosis. Previously, we showed in vitro that the RhoG guanine nucleotide exchange factor SGEF (Arhgef26) contributes to the formation of ICAM-1-induced endothelial docking structures that facilitate leukocyte transendothelial migration. To further explore the in vivo role of this protein during inflammation, we generated SGEF-deficient mice. When crossed with ApoE null mice and fed a Western diet, mice lacking SGEF showed a significant decrease in the formation of atherosclerosis in multiple aortic areas. A fluorescent biosensor revealed local activation of RhoG around bead-clustered ICAM-1 in mouse aortic endothelial cells. Notably, this activation was decreased in cells from SGEF-deficient aortas compared to wild type. In addition, scanning electron microscopy of intimal surfaces of SGEF(-/-) mouse aortas revealed reduced docking structures around beads that were coated with ICAM-1 antibody. Similarly, under conditions of flow, these beads adhered less stably to the luminal surface of carotid arteries from SGEF(-/-) mice. Taken together, these results show for the first time that a Rho-GEF, namely SGEF, contributes to the formation of atherosclerosis by promoting endothelial docking structures and thereby retention of leukocytes at athero-prone sites of inflammation experiencing high shear flow. SGEF may therefore provide a novel therapeutic target for inhibiting the development of atherosclerosis.	[Samson, Thomas; Sharek, Lisa; Burridge, Keith] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Samson, Thomas; Sharek, Lisa; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [van Buul, Jaap D.; Kroon, Jeffrey] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Welch, Christopher; Hahn, Klaus] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Bakker, Erik N.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Matlung, Hanke L.; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Dept Blood Cell Res, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Doerschuk, Claire] Univ N Carolina, Chapel Hill, NC USA; [Burridge, Keith] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl; keith_burridge@med.unc.edu	van Buul, Jaap D/AAJ-4371-2021; Kroon, Jeffrey/AAL-2588-2021; Matlung, Hanke/ABH-5649-2020; van den Berg, Timo K/AAC-2479-2022; Stefanadis, Christodoulos/ABH-2232-2020	van Buul, Jaap D/0000-0003-0054-7949; Kroon, Jeffrey/0000-0001-9983-6614; Bakker, Erik/0000-0003-2819-5818; Hahn, Klaus/0000-0002-1970-7562; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institute of Health [GM029860, HL080166, GM057464, F30HL094020-02, T32-GM-80079]; American Heart Association [0825379E]; Dutch Heart Foundation [2005T039]; Landsteiner Foundation for Blood Transfusion Research [1028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166, F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM057464, R55GM057464, R01GM029860] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Dutch Heart Foundation(Netherlands Heart Foundation); Landsteiner Foundation for Blood Transfusion Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health to KB (GM029860 and HL080166) and KH (GM057464). TS was supported by a fellowship from the American Heart Association (0825379E). Fellowships from the National Institute of Health (F30HL094020-02 and T32-GM-80079) supported CW. JDvB is supported by the Dutch Heart Foundation (grant no. 2005T039) and Landsteiner Foundation for Blood Transfusion Research (project no. 1028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bourdillon MC, 2000, ARTERIOSCL THROM VAS, V20, P2630, DOI 10.1161/01.ATV.20.12.2630; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Chi Z, 2007, CELL ADHES MIGR, V1, P171, DOI 10.4161/cam.1.4.5321; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395	28	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55202	10.1371/journal.pone.0055202	http://dx.doi.org/10.1371/journal.pone.0055202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372835	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400075
J	Stoy, S; Sandahl, TD; Dige, AK; Agnholt, J; Rasmussen, TK; Gronbaek, H; Deleuran, B; Vilstrup, H				Stoy, Sidsel; Sandahl, Thomas Damgaard; Dige, Anders Kirch; Agnholt, Jorgen; Rasmussen, Tue Kruse; Gronbaek, Henning; Deleuran, Bent; Vilstrup, Hendrik			Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course	PLOS ONE			English	Article							INNATE IMMUNITY; IL-22; HEPATOCYTES; SURVIVAL; LIPOPOLYSACCHARIDE; REGENERATION; PATHOGENESIS; CIRRHOSIS; THERAPY	Background: Alcoholic hepatitis (AH) has a severe prognosis due to hepatic inflammatory injury. The cytokine interleukin-22 (IL-22) is reported to exert anti-apoptotic and proliferative effects, but IL-22 has not been studied during the course of AH. IL-22 is mainly produced by CD4(+) (helper) T cells, including Th17 cells. In addition, Th17 cells produce the proinflammatory cytokine IL-17A, which has been implicated in AH. Aims: We aimed to study the levels of circulating IL-22- and IL-17A-producing T helper cells and plasma cytokines in patients with AH and to examine the observations in relation to the short-term disease course. Methods: We collected blood samples from 21 consecutive patients with severe AH on days 0, 14 and 30 after diagnosis, and included 10 stable alcoholic cirrhosis patients and 10 healthy subjects as controls. Analyses were performed using flow cytometry and ELISA. Results: We found higher frequencies of IL-22-producing T helper cells in AH patients (median 1.7%) than in cirrhosis patients (1.0%, p = 0.03) and healthy controls (1.0%, p = 0.01), and a 1.5-fold increase in the plasma concentration of IL-17A in AH compared with healthy controls (p < 0.01). Those patients who markedly improved their Glasgow Alcoholic Hepatitis Score demonstrated a 2-fold higher frequency of IL-22-producing T helper cells at baseline and during follow-up than patients whose condition deteriorated (p = 0.04). Conclusions: The frequency of IL-22-producing T helper cells was increased in AH patients and most so in those whose condition seemed to improve. T cell differentiation toward an IL-22-producing phenotype may thus be favourable in AH.	[Stoy, Sidsel; Sandahl, Thomas Damgaard; Dige, Anders Kirch; Agnholt, Jorgen; Gronbaek, Henning; Vilstrup, Hendrik] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark; [Rasmussen, Tue Kruse; Deleuran, Bent] Aarhus Univ, Inst Biomed, Aarhus, Denmark	Aarhus University; Aarhus University	Stoy, S (corresponding author), Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark.	stoy@studmed.au.dk	Gronbaek, Henning/AAJ-3202-2020	Gronbaek, Henning/0000-0001-8998-7910; Agnholt, Jorgen/0000-0003-2822-6442; Deleuran, Bent/0000-0002-7079-1587; Sandahl, Thomas Damgaard/0000-0001-9807-6852	Novo nordisk foundation; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Novo nordisk foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: The Novo nordisk foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Dudakov JA, 2012, SCIENCE, V1, P1; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Foster RG, 2011, DIGEST DIS SCI, V20, P20; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045625; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kong X, 2012, HEPATOLOGY, V2, P25744; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Mookerjee RP, 2007, HEPATOLOGY, V46, P831, DOI 10.1002/hep.21737; Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rasmussen TK, 2010, J RHEUMATOL, V37, P2014, DOI 10.3899/jrheum.100259; Ren XD, 2010, AM J PHYSIOL-GASTR L, V298, pG74, DOI 10.1152/ajpgi.00075.2009; Sandahl TD, 2011, J HEPATOL, V54, P760, DOI 10.1016/j.jhep.2010.07.016; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; THEODOSSI A, 1982, GUT, V23, P75, DOI 10.1136/gut.23.1.75; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wei CC, 2003, GENES IMMUN, V4, P204, DOI 10.1038/sj.gene.6363947; Whitfield K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007339.pub2; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Xiang X, 2011, IMMUNOL CELL BIOL, V27, P79; Xing WW, 2011, CYTOKINE, V56, P174, DOI 10.1016/j.cyto.2011.07.022; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051; Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909; Ziol M, 2001, J HEPATOL, V34, P254, DOI 10.1016/S0168-8278(00)00047-7	43	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55101	10.1371/journal.pone.0055101	http://dx.doi.org/10.1371/journal.pone.0055101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372820	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400062
J	Yue, JY; Lu, HM; Lan, SJ; Liu, JM; Stein, MN; Haffty, BG; Shen, ZY				Yue, Jingyin; Lu, Huimei; Lan, Shijie; Liu, Jingmei; Stein, Mark N.; Haffty, Bruce G.; Shen, Zhiyuan			Identification of the DNA Repair Defects in a Case of Dubowitz Syndrome	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; LIGASE-IV; MALFORMATION SYNDROMES; APLASTIC-ANEMIA; PROTEIN; DAMAGE; GAMMA-H2AX; IMMUNODEFICIENCY; RECOMBINATION; DEFICIENCY	Dubowitz Syndrome is an autosomal recessive disorder with a unique set of clinical features including microcephaly and susceptibility to tumor formation. Although more than 140 cases of Dubowitz syndrome have been reported since 1965, the genetic defects of this disease has not been identified. In this study, we systematically analyzed the DNA damage response and repair capability of fibroblasts established from a Dubowitz Syndrome patient. Dubowitz syndrome fibroblasts are hypersensitive to ionizing radiation, bleomycin, and doxorubicin. However, they have relatively normal sensitivities to mitomycin-C, cisplatin, and camptothecin. Dubowitz syndrome fibroblasts also have normal DNA damage signaling and cell cycle checkpoint activations after DNA damage. These data implicate a defect in repair of DNA double strand break (DSB) likely due to defective non-homologous end joining (NHEJ). We further sequenced several genes involved in NHEJ, and identified a pair of novel compound mutations in the DNA Ligase IV gene. Furthermore, expression of wild type DNA ligase IV completely complement the DNA repair defects in Dubowitz syndrome fibroblasts, suggesting that the DNA ligase IV mutation is solely responsible for the DNA repair defects. These data suggests that at least subset of Dubowitz syndrome can be attributed to DNA ligase IV mutations.	[Yue, Jingyin; Lu, Huimei; Lan, Shijie; Liu, Jingmei; Stein, Mark N.; Haffty, Bruce G.; Shen, Zhiyuan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Shen, ZY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA.	shenzh@umdnj.edu		Shen, Zhiyuan/0000-0003-2834-0309	National Institute of Health [R21ES19769]; NATIONAL CANCER INSTITUTE [R01CA156706, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019769] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health award R21ES19769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nemri AR, 2000, AM J MED GENET, V92, P107, DOI 10.1002/(SICI)1096-8628(20000515)92:2<107::AID-AJMG5>3.0.CO;2-L; Antoniades K, 1996, EUR J PEDIATR, V155, P390, DOI 10.1007/BF01955268; BERNHARD EJ, 1994, RADIAT RES, V138, pS64, DOI 10.2307/3578764; BERTHOLD F, 1987, EUR J PEDIATR, V146, P605, DOI 10.1007/BF02467366; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chistiakov DA, 2009, EUR J MED GENET, V52, P373, DOI 10.1016/j.ejmg.2009.05.009; DUBOWITZ V, 1965, J Med Genet, V2, P12, DOI 10.1136/jmg.2.1.12; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; GROSSE R, 1971, Z KINDERHEILKD, V110, P175, DOI 10.1007/BF00440382; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Hirano T, 1996, ACTA PAEDIATR JAPON, V38, P267; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Huber Rebekah S, 2011, J Clin Med Res, V3, P147, DOI 10.4021/jocmr581w; Liu JF, 2010, INT J DERMATOL, V49, P684, DOI 10.1111/j.1365-4632.2009.04371.x; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Lu HM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002291; Maas N, 2006, GENET COUNSEL, V17, P477; Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011; Meng XB, 2004, J BIOL CHEM, V279, P6098, DOI 10.1074/jbc.M306794200; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; OPITZ JM, 1973, Z KINDERHEILKD, V116, P1, DOI 10.1007/BF00438824; ORRISON WW, 1980, AM J MED GENET, V7, P155, DOI 10.1002/ajmg.1320070209; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; THURET I, 1991, BRIT J HAEMATOL, V78, P124, DOI 10.1111/j.1365-2141.1991.tb04395.x; Tsukahara M, 1996, AM J MED GENET, V63, P277; Turkbeyler Ibrahim Halil, 2011, Tokai J Exp Clin Med, V36, P29; WALTERS TR, 1985, J PEDIATR-US, V106, P622, DOI 10.1016/S0022-3476(85)80089-5; Yue J, 2011, DNA REPAIR AMST; Yue JY, 2009, CANCER RES, V69, P7978, DOI 10.1158/0008-5472.CAN-09-2177	36	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54389	10.1371/journal.pone.0054389	http://dx.doi.org/10.1371/journal.pone.0054389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372718	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400013
J	Yue, YF; Yang, HY; Wu, K; Yang, LJ; Chen, JY; Huang, XW; Pan, Y; Ruan, YQ; Zhao, YJ; Shi, XA; Sun, QM; Li, QH				Yue, Yaofei; Yang, Hongying; Wu, Kun; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Ruan, Youqing; Zhao, Yujiao; Shi, Xinan; Sun, Qiangming; Li, Qihan			Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; INVASIVE CERVICAL-CANCER; MINOR CAPSID PROTEIN; WORLDWIDE PERSPECTIVE; SEQUENCE ANALYSIS; JAPANESE WOMEN; HIGH-RISK; PREVALENCE; VARIANTS; METAANALYSIS	HPV account for most of the incidence of cervical cancer. Approximately 90% of anal cancers and a smaller subset (<50%) of other cancers (oropharyngeal, penile, vaginal, vulvar) are also attributed to HPV. The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing antibodies and confers type restricted protection. The L2 protein is a promising candidate for a broadly protective HPV vaccine. In our previous study, we found the most prevalent high-risk HPV infectious serotypes were HPV-16 and HPV-58 among women of Southwest China. To explore gene polymorphisms and intratypic variations of HPV-16 and HPV-58 L1/L2 genes originating in Southwest China, HPV-16 (L1: n = 31, L2: n = 28) and HPV-58 (L1: n = 21, L2: n = 21) L1/L2 genes were sequenced and compared to others described and submitted to GenBank. Phylogenetic trees were then constructed by Neighbor-Joining and the Kimura 2-parameters methods (MEGA software), followed by an analysis of the diversity of secondary structure. Then selection pressures acting on the L1/L2 genes were estimated by PAML software. Twenty-nine single nucleotide changes were observed in HPV-16 L1 sequences with 16/29 non-synonymous mutations and 13/29 synonymous mutations (six in alpha helix and two in beta turns). Seventeen single nucleotide changes were observed in HPV-16 L2 sequences with 8/17 non-synonymous mutations (one in beta turn) and 9/17 synonymous mutations. Twenty-four single nucleotide changes were observed in HPV-58 L1 sequences with 10/24 non-synonymous mutations and 14/24 synonymous mutations (eight in alpha helix and four in beta turn). Seven single nucleotide changes were observed in HPV-58 L2 sequences with 4/7 non-synonymous mutations and 3/7 synonymous mutations. The result of selective pressure analysis showed that most of these mutations were of positive selection. This study may help understand the intrinsic geographical relatedness and biological differences of HPV-16/HPV-58 and contributes further to research on their infectivity, pathogenicity, and vaccine strategy.	[Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Peking Union Med Coll, Kunming, Peoples R China; [Yue, Yaofei; Yang, Lijuan; Chen, Junying; Huang, Xinwei; Pan, Yue; Zhao, Yujiao; Sun, Qiangming; Li, Qihan] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Yang, Hongying; Ruan, Youqing] Kunming Med Univ, Affiliated Hosp 3, Yunnan Prov Tumor Hosp, Kunming, Peoples R China; [Wu, Kun] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China; [Shi, Xinan] Southwest Guizhou Vocat & Tech Coll Nationalities, Xingyi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Kunming Medical University; Kunming Medical University; Xingyi Normal University for Nationalities	Sun, QM (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China.	msun08@yahoo.com; imbcams.lq@gmail.com	Sun, Qiangming/GYE-2002-2022	Zhao, Yujiao/0000-0001-9142-4332	National Natural Science Foundation of China [81171946]; Natural Science Foundation of Yunnan Province [2009ZC187M, 2011CA016]; Special Research Fund for the Doctoral Program of Higher Education of China [20111106120055]; Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Special Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This research was supported by the National Natural Science Foundation of China (grant no. 81171946), the Natural Science Foundation of Yunnan Province (grant no. 2009ZC187M and grant no. 2011CA016), the Special Research Fund for the Doctoral Program of Higher Education of China (grant no. 20111106120055) and the Scientific Research Foundation for Returned Overseas Chinese Scholars, Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2008, J MICROBIOL BIOTECHN, V18, P788; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Camara GNL, 2003, MEM I OSWALDO CRUZ, V98, P879, DOI 10.1590/S0074-02762003000700003; Cerqueira DM, 2007, ARCH VIROL, V152, P75, DOI 10.1007/s00705-006-0828-6; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;232::AID-JMV18&gt;3.0.CO;2-7; Chaturvedi AK, 2005, J MED VIROL, V75, P105, DOI 10.1002/jmv.20244; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Ding TA, 2010, GYNECOL ONCOL, V119, P436, DOI 10.1016/j.ygyno.2010.08.032; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Fukui A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-199; Garbuglia AR, 2007, NEW MICROBIOL, V30, P377; Hamza AA, 2012, SYST APPL MICROBIOL, V35, P183, DOI 10.1016/j.syapm.2011.12.005; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Huang SX, 1997, INT J CANCER, V70, P408, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;408::AID-IJC6&gt;3.0.CO;2-#; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Karanam B, 2009, IMMUNOL CELL BIOL, V87, P287, DOI 10.1038/icb.2009.13; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Lai CH, 2008, INT J CANCER, V123, P1685, DOI 10.1002/ijc.23679; Lai HC, 1999, INT J CANCER, V84, P553, DOI 10.1002/(SICI)1097-0215(19991222)84:6&lt;553::AID-IJC2&gt;3.0.CO;2-4; Lin QQ, 1998, INT J CANCER, V75, P484, DOI 10.1002/(SICI)1097-0215(19980130)75:3<484::AID-IJC25>3.0.CO;2-7; Liu JH, 2004, GYNECOL ONCOL, V94, P803, DOI 10.1016/j.ygyno.2004.06.005; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pereira R, 2009, ARCH VIROL, V154, P187, DOI 10.1007/s00705-009-0310-3; Pista A, 2007, J MED VIROL, V79, P1889, DOI 10.1002/jmv.21002; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Sasagawa T, 2001, CANCER EPIDEM BIOMAR, V10, P45; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Sun ZR, 2010, INT J GYNECOL OBSTET, V109, P105, DOI 10.1016/j.ijgo.2009.11.026; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; Wu YP, 2006, J CLIN VIROL, V35, P264, DOI 10.1016/j.jcv.2005.07.011; Xin CY, 2001, CANCER LETT, V170, P19, DOI 10.1016/S0304-3835(01)00570-5; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue YaoFei, 2012, Chinese Journal of Obstetrics and Gynecology and Pediatrics, V8, P467; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	49	20	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55204	10.1371/journal.pone.0055204	http://dx.doi.org/10.1371/journal.pone.0055204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372836	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400076
J	Maes, PJ; Leman, M				Maes, Pieter-Jan; Leman, Marc			The Influence of Body Movements on Children's Perception of Music with an Ambiguous Expressive Character	PLOS ONE			English	Article							EMOTIONAL RESPONSES; INDIVIDUAL-DIFFERENCES; SEEING MUSIC; HEARING; RECOGNITION; CONTEXT; SOUND; BIG-5	The theory of embodied music cognition states that the perception and cognition of music is firmly, although not exclusively, linked to action patterns associated with that music. In this regard, the focus lies mostly on how music promotes certain action tendencies (i.e., dance, entrainment, etc.). Only recently, studies have started to devote attention to the reciprocal effects that people's body movements may exert on how people perceive certain aspects of music and sound (e. g., pitch, meter, musical preference, etc.). The present study positions itself in this line of research. The central research question is whether expressive body movements, which are systematically paired with music, can modulate children's perception of musical expressiveness. We present a behavioral experiment in which different groups of children (7-8 years, N = 46) either repetitively performed a happy or a sad choreography in response to expressively ambiguous music or merely listened to that music. The results of our study show indeed that children's perception of musical expressiveness is modulated in accordance with the expressive character of the dance choreography performed to the music. This finding supports theories that claim a strong connection between action and perception, although further research is needed to uncover the details of this connection.	[Maes, Pieter-Jan; Leman, Marc] Univ Ghent, IPEM Dept Musicol, B-9000 Ghent, Belgium	Ghent University	Maes, PJ (corresponding author), Univ Ghent, IPEM Dept Musicol, B-9000 Ghent, Belgium.	pieterjan.maes@UGent.be		Maes, Pieter-Jan/0000-0002-9237-3298	Flemish government	Flemish government(European Commission)	This work is carried out in context of the EmcoMetecca project funded by the Flemish government (http://www.ipem.ugent.be/EmcoMetecca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Boone RT, 2001, J NONVERBAL BEHAV, V25, P21, DOI 10.1023/A:1006733123708; Boone RT, 1998, DEV PSYCHOL, V34, P1007, DOI 10.1037/0012-1649.34.5.1007; Camurri A, 2003, INT J HUM-COMPUT ST, V59, P213, DOI 10.1016/S1071-5819(03)00050-8; Caramiaux B, 2010, LECT NOTES ARTIF INT, V5934, P158, DOI 10.1007/978-3-642-12553-9_14; Cox Arnie, 2011, MUSIC THEORY, V17; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeBruyn L., 2012, MUSIC MED, V4, P28, DOI [DOI 10.1177/1943862111415116, 10.1177/1943862111415116]; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Denissen JJA, 2008, J PERS ASSESS, V90, P152, DOI 10.1080/00223890701845229; Eerola T., 2006, P 9 INT C MUSIC PERC, P472; FUJIHARA T, 1984, JPN J PSYCHOL, V55, P75, DOI 10.4992/jjpsy.55.75; Glenberg AM, 2010, WIRES COGN SCI, V1, P586, DOI 10.1002/wcs.55; Godoy R.I., 2010, MUSICAL GESTURES SOU, P103; Godoy RI, 2003, LEONARDO, V36, P317, DOI 10.1162/002409403322258781; Gregory AH, 1996, MOTIV EMOTION, V20, P341, DOI 10.1007/BF02856522; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Holochwost SJ, 2008, BEHAV BRAIN SCI, V31, P581, DOI 10.1017/S0140525X08005360; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Juchniewicz J, 2008, PSYCHOL MUSIC, V36, P417, DOI 10.1177/0305735607086046; KASTNER MP, 1990, MUSIC PERCEPT, V8, P189; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Larsen JT, 2011, EMOTION, V11, P1469, DOI 10.1037/a0024081; Lee S., 2006, HDB HUMAN PERFORMANC, P760; Leman M., 2007, EMBODIED MUSIC COGNI, DOI [10.7551/mitpress/7476.001.0001, DOI 10.7551/MITPRESS/7476.001.0001]; Leman M, 2009, MUSIC PERCEPT, V26, P263, DOI 10.1525/MP.2009.26.3.263; Mead A, 1999, J MUSIC THEORY, V43, P1, DOI 10.2307/3090688; MERVIELDE I, 1995, PERS INDIV DIFFER, V18, P525, DOI 10.1016/0191-8869(94)00175-R; Murakami T, 2003, MULTIVAR BEHAV RES, V38, P247, DOI 10.1207/S15327906MBR3802_5; Nielzen S., 1981, PSYCHOL MUSIC, V9, P17; OBRIANT MP, 1978, B PSYCHONOMIC SOC, V12, P441; Osgood C. E., 1957, MEASUREMENT MEANING, V47; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Repp BH, 2009, Q J EXP PSYCHOL, V62, P2156, DOI 10.1080/17470210902745009; Saint-Germier P, 2010, P EUR SOC PHIL PSYCH; Salkind NJ, 2007, ENCY MEMASUREMENT ST; Schutz M, 2007, PERCEPTION, V36, P888, DOI 10.1068/p5635; Sedlmeier P, 2011, MUSIC PERCEPT, V28, P297, DOI 10.1525/MP.2011.28.3.297; SENJU M, 1987, MUSIC PERCEPT, V4, P311; Shapiro L, 2011, NEW PROBL PHILOS, P1; SWANWICK K., 1973, PSYCHOL MUSIC, V1, P7; Terwogt M. M., 1991, PSYCHOL MUSIC, V19, P99, DOI [10.1177/0305735691192001, DOI 10.1177/0305735691192001]; Thompson WF, 2005, SEMIOTICA, V156, P203, DOI 10.1515/semi.2005.2005.156.203; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; WHITE WF, 1968, J PSYCHOL, V70, P261, DOI 10.1080/00223980.1968.10544957; Wong D.L., 1996, HOME HLTH FOCUS, V2, P62; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	57	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54682	10.1371/journal.pone.0054682	http://dx.doi.org/10.1371/journal.pone.0054682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	077JK	23358805	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600091
J	Renaud, E; Rosselli, F				Renaud, Emilie; Rosselli, Filippo			FANC Pathway Promotes UV-Induced Stalled Replication Forks Recovery by Acting Both Upstream and Downstream Pol eta and Rev1	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; NUCLEOTIDE EXCISION-REPAIR; TRANSLESION SYNTHESIS; ANEMIA PROTEINS; ATR ACTIVATION; HISTONE H2AX; DAMAGE; MDC1; MONOUBIQUITINATION; UBIQUITINATION	To cope with ultraviolet C (UVC)-stalled replication forks and restart DNA synthesis, cells either undergo DNA translesion synthesis (TLS) by specialised DNA polymerases or tolerate the lesions using homologous recombination (HR)-based mechanisms. To gain insight into how cells manage UVC-induced stalled replication forks, we analysed the molecular crosstalk between the TLS DNA polymerases Pol eta and Rev1, the double-strand break repair (DSB)-associated protein MDC1 and the FANC pathway. We describe three novel functional interactions that occur in response to UVC-induced DNA lesions. First, Pol eta and Rev1, whose optimal expression and/or relocalisation depend on the FANC core complex, act upstream of FANCD2 and are required for the proper relocalisation of monoubiquitinylated FANCD2 (Ub-FANCD2) to subnuclear foci. Second, during S-phase, Ub-FANCD2 and MDC1 relocalise to UVC-damaged nuclear areas or foci simultaneously but independently of each other. Third, Ub-FANCD2 and MDC1 are independently required for optimal BRCA1 relocalisation. While RPA32 phosphorylation (p-RPA32) and RPA foci formation were reduced in parallel with increasing levels of H2AX phosphorylation and MDC1 foci in UVC-irradiated FANC pathway-depleted cells, MDC1 depletion was associated with increased UVC-induced Ub-FANCD2 and FANCD2 foci as well as p-RPA32 levels and p-RPA32 foci. On the basis of the previous observations, we propose that the FANC pathway participates in the rescue of UVC-stalled replication forks in association with TLS by maintaining the integrity of ssDNA regions and by preserving genome stability and preventing the formation of DSBs, the resolution of which would require the intervention of MDC1.	[Renaud, Emilie; Rosselli, Filippo] Univ Paris 11, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France; [Renaud, Emilie; Rosselli, Filippo] CNRS, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy	Rosselli, F (corresponding author), Univ Paris 11, UMR8200, Equipe Labellisee Ligue Contre Canc, Inst Cancerol Gustave Roussy, Villejuif, France.	rosselli@igr.fr	Filippo, Rosselli/AAO-6393-2020	Filippo, Rosselli/0000-0003-1080-5745	Agence Nationale pour la Recherche (ANR, Genopat); Ligue Nationale contre le Cancer (Equipe Labellisee)	Agence Nationale pour la Recherche (ANR, Genopat)(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer)	ER was supported by a grant from Agence Nationale pour la Recherche (ANR, Genopat 2008). This work was supported by grants from the Ligue Nationale contre le Cancer (Equipe Labellisee 2009 and 2012) and Agence Nationale pour la Recherche (ANR, Genopat 2008) to FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; BILLARDON B, 1986, MUTAT RES, V174, P241, DOI 10.1016/0165-7992(86)90158-2; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 1999, CANCER RES, V59, P1102; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Guervilly JH, 2008, HUM MOL GENET, V17, P679, DOI 10.1093/hmg/ddm340; Guervilly JH, 2011, HUM MOL GENET, V20, P2171, DOI 10.1093/hmg/ddr103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Lehmann AR, 2000, GENE, V253, P1, DOI 10.1016/S0378-1119(00)00250-X; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Naim V, 2009, CELL CYCLE, V8, P2907, DOI 10.4161/cc.8.18.9538; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Pichierri P, 2004, CELL CYCLE, V3, P698; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pichierri P, 2002, HUM MOL GENET, V11, P2531, DOI 10.1093/hmg/11.21.2531; Roques C, 2009, EMBO J, V28, P2400, DOI 10.1038/emboj.2009.193; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; STEINGRIMSDOTTIR H, 1993, MUTAT RES, V294, P29, DOI 10.1016/0921-8777(93)90055-L; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang JD, 2011, J CELL BIOL, V193, P267, DOI 10.1083/jcb.201010026; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	55	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53693	10.1371/journal.pone.0053693	http://dx.doi.org/10.1371/journal.pone.0053693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365640	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600019
J	Bolhuis, DP; Lakemond, CMM; de Wijk, RA; Luning, PA; de Graaf, C				Bolhuis, Dieuwerke P.; Lakemond, Catriona M. M.; de Wijk, Rene A.; Luning, Pieternel A.; de Graaf, Cees			Consumption with Large Sip Sizes Increases Food Intake and Leads to Underestimation of the Amount Consumed	PLOS ONE			English	Article							INCREASED MEAL INTAKE; PORTION SIZE; BITE SIZE; COGNITIVE-FACTORS; ENERGY-INTAKE; FAT; CARBOHYDRATE; INFORMATION; INTENSITY; VISCOSITY	Background: A number of studies have shown that bite and sip sizes influence the amount of food intake. Consuming with small sips instead of large sips means relatively more sips for the same amount of food to be consumed; people may believe that intake is higher which leads to faster satiation. This effect may be disturbed when people are distracted. Objective: The objective of the study is to assess the effects of sip size in a focused state and a distracted state on ad libitum intake and on the estimated amount consumed. Design: In this 3 x 2 cross-over design, 53 healthy subjects consumed ad libitum soup with small sips (5 g, 60 g/min), large sips (15 g, 60 g/min), and free sips (where sip size was determined by subjects themselves), in both a distracted and focused state. Sips were administered via a pump. There were no visual cues toward consumption. Subjects then estimated how much they had consumed by filling soup in soup bowls. Results: Intake in the small-sip condition was similar to 30% lower than in both the large-sip and free-sip conditions (P < 0.001). In addition, subjects underestimated how much they had consumed in the large-sip and free-sip conditions (P < 0.03). Distraction led to a general increase in food intake (P = 0.003), independent of sip size. Distraction did not influence sip size or estimations. Conclusions: Consumption with large sips led to higher food intake, as expected. Large sips, that were either fixed or chosen by subjects themselves led to underestimations of the amount consumed. This may be a risk factor for over-consumption. Reducing sip or bite sizes may successfully lower food intake, even in a distracted state.	[Bolhuis, Dieuwerke P.; Lakemond, Catriona M. M.; Luning, Pieternel A.] Wageningen Univ, Prod Design & Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [de Wijk, Rene A.] Wageningen Univ & Res, Wageningen, Netherlands; [de Graaf, Cees] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Bolhuis, DP (corresponding author), Wageningen Univ, Prod Design & Qual Management Grp, NL-6700 AP Wageningen, Netherlands.	dieuwerke.bolhuis@wur.nl	Luning, Pieternel/H-3318-2013	Bolhuis, Dieuwerke/0000-0001-6734-5191	Science and Technology Foundation of the Netherlands Organization for Scientific Research [07438]; Unilever; Danone Nederland; FrieslandCampina; Top Institute Food and Nutrition	Science and Technology Foundation of the Netherlands Organization for Scientific Research; Unilever(Unilever); Danone Nederland(Danone Nutricia); FrieslandCampina; Top Institute Food and Nutrition	This work was supported by the Science and Technology Foundation of the Netherlands Organization for Scientific Research (grant number 07438) with: Unilever, Danone Nederland, FrieslandCampina, and Top Institute Food and Nutrition. The funders had no role in study design, data collection and analysis, or preparation of the manuscript, or decision to publish.	Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Bailey EF, 2008, AM J PHYSIOL-REG I, V295, pR1048, DOI 10.1152/ajpregu.90701.2008; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bellisle F, 2001, AM J CLIN NUTR, V74, P197; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Bolhuis DP, 2012, APPETITE, V58, P48, DOI 10.1016/j.appet.2011.09.001; Bolhuis DP, 2011, J NUTR, V141, P2242, DOI 10.3945/jn.111.143867; Bolhuis DP, BOTH HIGHER NU UNPUB; Burger KS, 2011, OBESITY, V19, P546, DOI 10.1038/oby.2010.233; CAPUTO FA, 1992, AM J CLIN NUTR, V56, P36, DOI 10.1093/ajcn/56.1.36; Cecil JE, 1999, PHYSIOL BEHAV, V67, P299, DOI 10.1016/S0031-9384(99)00069-4; Cecil JE, 1998, APPETITE, V31, P377, DOI 10.1006/appe.1998.0177; Chandon P, 2002, J MARKETING RES, V39, P321, DOI 10.1509/jmkr.39.3.321.19111; CHAPELOT D, 1995, APPETITE, V25, P155, DOI 10.1006/appe.1995.0052; Davis JD, 2009, PHYSIOL BEHAV, V97, P293, DOI 10.1016/j.physbeh.2009.03.028; de Wijk RA, 2008, PHYSIOL BEHAV, V95, P527, DOI 10.1016/j.physbeh.2008.07.026; Fisher JO, 2003, AM J CLIN NUTR, V77, P1164, DOI 10.1093/ajcn/77.5.1164; French SJ, 2001, PHYSIOL BEHAV, V74, P729, DOI 10.1016/S0031-9384(01)00617-5; HABER GB, 1977, LANCET, V2, P679; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Higgs S, 2008, PHYSIOL BEHAV, V94, P734, DOI 10.1016/j.physbeh.2008.04.012; Hiiemae K, 1996, ARCH ORAL BIOL, V41, P175, DOI 10.1016/0003-9969(95)00112-3; Hogenkamp PS, 2010, AM J CLIN NUTR, V91, P841, DOI 10.3945/ajcn.2009.28360; Hubel R, 2006, APPETITE, V46, P57, DOI 10.1016/j.appet.2005.10.006; Hulshof KFAM, 2003, 3500300022004 RIVM, P28; Kral TVE, 2006, APPETITE, V46, P103, DOI 10.1016/j.appet.2005.05.006; Lavin JH, 2002, INT J OBESITY, V26, P80, DOI 10.1038/sj.ijo.0801828; Lavin JH, 2002, INT J OBESITY, V26, P384, DOI 10.1038/sj.ijo.0801829; Lawless HT, 2003, DYSPHAGIA, V18, P196, DOI 10.1007/s00455-002-0105-0; Maas J, 2012, PSYCHOL HEALTH, V27, P59, DOI 10.1080/08870446.2011.565341; McGee TL, 2012, OBESITY, V20, P126, DOI 10.1038/oby.2011.303; Medicis SW, 1998, J DENT RES, V77, P295; Miller DL, 1998, AM J CLIN NUTR, V68, P282, DOI 10.1093/ajcn/68.2.282; Mitchell GL, 2005, APPETITE, V45, P344, DOI 10.1016/j.appet.2005.06.001; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; Phan VA, 2012, FOOD QUAL PREFER, V26, P119, DOI 10.1016/j.foodqual.2012.04.005; PLINER P, 1990, J EXP SOC PSYCHOL, V26, P240, DOI 10.1016/0022-1031(90)90037-M; Raynor HA, 2007, OBESITY, V15, P2311, DOI 10.1038/oby.2007.274; Rolls ET, 2007, OBES REV, V8, P67, DOI 10.1111/j.1467-789X.2007.00321.x; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Spiegel TA, 2000, NEUROSCI BIOBEHAV R, V24, P229, DOI 10.1016/S0149-7634(99)00076-7; Stroebele N, 2006, APPETITE, V47, P285, DOI 10.1016/j.appet.2006.04.001; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; Ueland O, 2009, J AM DIET ASSOC, V109, P124, DOI 10.1016/j.jada.2008.10.002; Viskaal-van Dongen M, 2011, APPETITE, V56, P25, DOI 10.1016/j.appet.2010.11.141; Walden HM, 2004, OBES RES, V12, P1773, DOI 10.1038/oby.2004.220; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2006, AM J PREV MED, V31, P240, DOI 10.1016/j.amepre.2006.04.003; Weijzen PLG, 2008, APPETITE, V50, P435, DOI 10.1016/j.appet.2007.09.008; Weijzen PLG, 2009, BRIT J NUTR, V102, P1091, DOI 10.1017/S000711450932574X; WHO, 1985, PRINC EST EN REQ EN, P34; WOOLEY SC, 1972, PSYCHOSOM MED, V34, P62, DOI 10.1097/00006842-197201000-00007; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	56	29	29	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53288	10.1371/journal.pone.0053288	http://dx.doi.org/10.1371/journal.pone.0053288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372657	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500013
J	O'Neill, SM; Kearney, PM; Kenny, LC; Khashan, AS; Henriksen, TB; Lutomski, JE; Greene, RA				O'Neill, Sinead M.; Kearney, Patricia M.; Kenny, Louise C.; Khashan, Ali S.; Henriksen, Tine B.; Lutomski, Jennifer E.; Greene, Richard A.			Caesarean Delivery and Subsequent Stillbirth or Miscarriage: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HIGH-INCOME COUNTRIES; RISK-FACTORS; MATERNAL AGE; ANTEPARTUM STILLBIRTH; PERINATAL-MORTALITY; UNEXPLAINED STILLBIRTH; RETROSPECTIVE COHORT; SMOKING-HABITS; SECTION RATES; 2ND PREGNANCY	Objective: To compare the risk of stillbirth and miscarriage in a subsequent pregnancy in women with a previous Caesarean or vaginal delivery. Design: Systematic review of the published literature including seven databases: CINAHL; the Cochrane library; Embase; Medline; PubMed; SCOPUS and Web of Knowledge from 1945 until November 11th 2011, using a detailed search-strategy and cross-checking of reference lists. Study Selection: Cohort, case-control and cross-sectional studies examining the association between previous Caesarean section and subsequent stillbirth or miscarriage risk. Two assessors screened titles to identify eligible studies, using a standardised data abstraction form and assessed study quality. Data synthesis: 11 articles were included for stillbirth, totalling 1,961,829 pregnancies and 7,308 events. Eight eligible articles were included for miscarriage, totalling 147,017 pregnancies and 12,682 events. Pooled estimates across the stillbirth studies were obtained using random-effect models. Among women with a previous Caesarean an increase in odds of 1.23 [95% CI 1.08, 1.40] for stillbirth was yielded. Subgroup analyses including unexplained stillbirths yielded an OR of 1.47 [95% CI 1.20, 1.80], an OR of 2.11 [95% CI 1.16, 3.84] for explained stillbirths and an OR of 1.27 [95% CI 0.95, 1.70] for antepartum stillbirths. Only one study reported adjusted estimates in the miscarriage review, therefore results are presented individually. Conclusions: Given the recent revision of the National Institute for Health and Clinical Excellence guidelines (NICE), providing women the right to request a Caesarean, it is essential to establish whether mode of delivery has an association with subsequent risk of stillbirth or miscarriage. Overall, compared to vaginal delivery, the pooled estimates suggest that Caesarean delivery may increase the risk of stillbirth by 23%. Results for the miscarriage review were inconsistent and lack of adjustment for confounding was a major limitation. Higher methodological quality research is required to reliably assess the risk of miscarriage in subsequent pregnancies.	[O'Neill, Sinead M.; Lutomski, Jennifer E.; Greene, Richard A.] Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Natl Perinatal Epidemiol Ctr, Cork, Ireland; [Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Henriksen, Tine B.] Aarhus Univ Hosp, Dept Paediat, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark	University College Cork; Aarhus University	O'Neill, SM (corresponding author), Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Natl Perinatal Epidemiol Ctr, Cork, Ireland.	sinead.oneill@ucc.ie	Greene, Richard A/J-7051-2014; Kenny, Louise C/G-1112-2011; Kenny, Louise/X-6329-2019; Lutomski, Jennifer E./U-2466-2019	Greene, Richard A/0000-0003-0247-523X; Kenny, Louise C/0000-0002-9011-759X; Kenny, Louise/0000-0002-9011-759X; Kearney, Patricia/0000-0001-9599-3540; O Neill, Sinead/0000-0001-9787-4609				AIHW, 2011, AIHW SER; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 2011, REV MAN REVMAN COMP; Atik RB, 2010, EARLY PREGNANCY, P9; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Bendon RW, 2001, PEDIATR DEVEL PATHOL, V4, P517, DOI 10.1007/s10024001-0084-4; Blohm F, 2008, BJOG-INT J OBSTET GY, V115, P176, DOI 10.1111/j.1471-0528.2007.01426.x; Butler N.R., 1963, PERINATAL MORTALITY; Chaliha C, 2004, BJOG-INT J OBSTET GY, V111, P754, DOI 10.1111/j.1471-0528.2004.00155.x; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Cnattingius S, 2002, SEMIN PERINATOL, V26, P25, DOI 10.1053/sper.2002.29841; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; Collins JH, 2002, SEMIN PERINATOL, V26, P79, DOI 10.1053/sper.2002.29860; Fedorcsak P, 2000, ACTA OBSTET GYN SCAN, V79, P43, DOI 10.1034/j.1600-0412.2000.079001043.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Franz MB, 2009, ARCH GYNECOL OBSTET, V279, P29, DOI 10.1007/s00404-008-0664-x; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Garcia-Enguidanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gherman RB, 2006, AM J OBSTET GYNECOL, V195, P657, DOI 10.1016/j.ajog.2005.09.007; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Gray R, 2007, BJOG-INT J OBSTET GY, V114, P264, DOI 10.1111/j.1471-0528.2006.01249.x; Gupta N, 2011, GENETIC CAUSES RECUR, P76; Hagan R, 1996, BRIT J OBSTET GYNAEC, V103, P230, DOI 10.1111/j.1471-0528.1996.tb09711.x; Hall MH, 1999, LANCET, V354, P776, DOI 10.1016/S0140-6736(05)76016-5; HALL MH, 1989, BRIT J OBSTET GYNAEC, V96, P1297, DOI 10.1111/j.1471-0528.1989.tb03227.x; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; HEMMINKI E, 1991, J EPIDEMIOL COMMUN H, V45, P24, DOI 10.1136/jech.45.1.24; HEMMINKI E, 1985, FERTIL STERIL, V43, P520; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; HEMMINKI E, 1986, J REPROD MED, V31, P620; Hemminki E, 1996, PAEDIATR PERINAT EP, V10, P366, DOI 10.1111/j.1365-3016.1996.tb00062.x; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jolly J, 1999, BRIT J OBSTET GYNAEC, V106, P227, DOI 10.1111/j.1471-0528.1999.tb08235.x; Kady SM, 2004, BEST PRACT RES CL OB, V18, P397, DOI 10.1016/j.bpobgyn.2004.02.009; KEELING JW, 1989, ARCH DIS CHILD, V64, P1345, DOI 10.1136/adc.64.10_Spec_No.1345; Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73; Lahra MM, 2007, AM J OBSTET GYNECOL, V196, P229, DOI 10.1016/j.ajog.2006.10.900; LASALA AP, 1987, AM J OBSTET GYNECOL, V157, P379; Lashen H, 2004, HUM REPROD, V19, P1644, DOI 10.1093/humrep/deh277; Last J.M., 2000, DICT EPIDEMIOLOGY, Vthird; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; Lydon-Rochelle M, 2001, OBSTET GYNECOL, V97, P169, DOI 10.1016/S0029-7844(00)01119-4; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Matthews TG, 2003, BJOG-INT J OBSTET GY, V110, P346, DOI 10.1016/S1470-0328(03)02710-1; McClure EM, 2009, J MATERN-FETAL NEO M, V22, P183, DOI 10.1080/14767050802559129; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; McDonald SD, 2009, EUR J OBSTET GYN R B, V146, P138, DOI 10.1016/j.ejogrb.2009.05.035; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mollison J, 2005, BJOG-INT J OBSTET GY, V112, P1061, DOI 10.1111/j.1471-0528.2005.00651.x; Mukherjee SN, 2006, J OBSTET GYN INDIA, V56, P298; NICE, 2011, CAES SECT FULL GUID, P266; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Ohana O, 2011, J MATERN-FETAL NEO M, V24, P1079, DOI 10.3109/14767058.2010.545918; Olusanya BO, 2009, ACTA OBSTET GYN SCAN, V88, P1243, DOI 10.3109/00016340903287474; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; Reddy UM, 2007, OBSTET GYNECOL, V110, P1151, DOI 10.1097/01.AOG.0000287616.71602.d0; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Regan L, 2000, BEST PRACT RES CL OB, V14, P839, DOI 10.1053/beog.2000.0123; Regan L, 2002, J REPROD IMMUNOL, V55, P163, DOI 10.1016/S0165-0378(01)00144-9; Richter R, 2007, EUR J OBSTET GYN R B, V132, P51, DOI 10.1016/j.ejogrb.2006.06.002; Robson SJ, 2010, J PERINATOL, V30, P305, DOI 10.1038/jp.2009.133; Saastad E, 2009, BMC PREGNANCY CHILDB; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; SANDAHL B, 1989, EUR J OBSTET GYN R B, V31, P23, DOI 10.1016/0028-2243(89)90023-3; Savitz DA, 2002, EPIDEMIOL REV, V24, P91, DOI 10.1093/epirev/mxf006; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Silver RM, 2010, SEMIN PERINATOL, V34, P258, DOI 10.1053/j.semperi.2010.03.006; Simpson LL, 2002, SEMIN PERINATOL, V26, P42, DOI 10.1053/sper.2002.29838; Smith GCS, 2006, FERTIL STERIL, V85, P90, DOI 10.1016/j.fertnstert.2005.07.1289; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2007, AM J EPIDEMIOL, V165, P194, DOI 10.1093/aje/kwj354; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x; Thomas J, 2000, BRIT J OBSTET GYNAEC, V107, P579, DOI 10.1111/j.1471-0528.2000.tb13296.x; Tower C L, 2000, J Obstet Gynaecol, V20, P365; Weiss HB, 2001, JAMA-J AM MED ASSOC, V286, P1863, DOI 10.1001/jama.286.15.1863; WHITFIELD CR, 1986, BRIT J OBSTET GYNAEC, V93, P694, DOI 10.1111/j.1471-0528.1986.tb08054.x; WHO: recommended definitions terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths, 1977, ACTA OBSTET GYNECOL, V56, P247, DOI DOI 10.3109/00016347709162009; WIGGLESWORTH JS, 1980, LANCET, V2, P684; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wood SL, 2008, BJOG-INT J OBSTET GY, V115, P726, DOI 10.1111/j.1471-0528.2008.01705.x; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	96	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54588	10.1371/journal.pone.0054588	http://dx.doi.org/10.1371/journal.pone.0054588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372739	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500090
J	Shiely, F; Hayes, K; Perry, IJ; Kelleher, CC				Shiely, Frances; Hayes, Kevin; Perry, Ivan J.; Kelleher, C. Cecily			Height and Weight Bias: The Influence of Time	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; BODY-MASS INDEX; VALIDITY; OBESITY; BMI; HEALTH	Background: We have previously identified in a study of both self-reported body mass index (BMI) and clinically measured BMI that the sensitivity score in the obese category has declined over a 10-year period. It is known that self-reported weight is significantly lower that measured weight and that self-reported height is significantly higher than measured height. The purpose of this study is to establish if self-reported height bias or weight bias, or both, is responsible for the declining sensitivity in the obese category between self-reported and clinically measured BMI. Methods: We report on self-reported and clinically measured height and weight from three waves of the Surveys of Lifestyle Attitudes and Nutrition (SLAN) involving a nationally representative sample of Irish adults. Data were available from 66 men and 142 women in 1998, 147 men and 184 women in 2002 and 909 men and 1128 women in 2007. Respondents were classified into BMI categories normal (<25 kg/m(2)), overweight (25-<30 kg/m(2)) and obese (>= 30 kg/m(2)). Results: Self-reported height bias has remained stable over time regardless of gender, age or clinical BMI category. Self-reported weight bias increases over time for both genders and in all age groups. The increased weight bias is most notable in the obese category. Conclusions: BMI underestimation is increasing across time. Knowledge that the widening gap between self-reported BMI and measured BMI is attributable to an increased weight bias brings us one step closer to accurately estimating true obesity levels in the population using self-reported data.	[Shiely, Frances; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Hayes, Kevin] Univ Limerick, Dept Math & Stat, Limerick, Ireland; [Kelleher, C. Cecily] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	University College Cork; University of Limerick; University College Dublin	Shiely, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	f.shiely@ucc.ie	kelleher, cecily c/A-4233-2013	kelleher, cecily c/0000-0001-9548-4914; Perry, Ivan/0000-0002-4965-9792	HRB Centre for Diet and Health Research	HRB Centre for Diet and Health Research	This work was not funded but was conducted under the auspices of the HRB Centre for Diet and Health Research. The HRB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZTORICES JC, 1993, INT J OBESITY, V17, P663; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bopp M, 2008, BMJ-BRIT MED J, V337, P1463; Dauphinot V, 2009, J EPIDEMIOL COMMUN H, V63, P128, DOI 10.1136/jech.2008.077800; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Faeh D, 2008, SWISS MED WKLY, V138, P204, DOI 2008/13/smw-12065; Friel S, 1999, MAIN RESULTS NATL HL; Giacchi M, 1998, INT J OBESITY, V22, P673, DOI 10.1038/sj.ijo.0800646; Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gorber SC, 2010, OBESITY, V18, P354, DOI 10.1038/oby.2009.206; Hayes AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-53; Hayes K, 2004, P NUTR SOC, V63, p137A; International Obesity Task Force, 2005, OB EUR; Johnson F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a494; Johnson WD, 2009, OBESITY, V17, P571, DOI 10.1038/oby.2008.582; Kelleher C, 2003, NATL HLTH LIFESTYLE; Krul AJ, 2011, EUR J PUBLIC HEALTH, V21, P414, DOI 10.1093/eurpub/ckp228; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lee DH, 2011, J EPIDEMIOL, V21, P30, DOI 10.2188/jea.JE20100058; Morgan K, 2008, SLAN 2007 SURVEY LIF; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Oliveira A, 2009, EUR J PUBLIC HEALTH, V19, P548, DOI 10.1093/eurpub/ckp022; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Plankey MW, 1997, OBES RES, V5, P308, DOI 10.1002/j.1550-8528.1997.tb00556.x; R Development Core Team,, 2003, R LANG ENV STAT COMP; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; STEWART AL, 1982, J CHRON DIS, V35, P295, DOI 10.1016/0021-9681(82)90085-6; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Stommel M, 2013, INT J OBESITY, V37, P461, DOI 10.1038/ijo.2012.67; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Vailas LI, 1998, J GERONTOL A-BIOL, V53, pM481, DOI 10.1093/gerona/53A.6.M481; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; Yong V, 2012, GERIATR GERONTOL INT, V12, P247, DOI 10.1111/j.1447-0594.2011.00759.x	37	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54386	10.1371/journal.pone.0054386	http://dx.doi.org/10.1371/journal.pone.0054386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372717	Green Published, gold			2022-12-27	WOS:000314021500067
J	Hoshino, D; Nagano, M; Saitoh, A; Koshikawa, N; Suzuki, T; Seiki, M				Hoshino, Daisuke; Nagano, Makoto; Saitoh, Anri; Koshikawa, Naohiko; Suzuki, Takashi; Seiki, Motoharu			The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; TUMOR-CELL INVASION; FOCAL ADHESION KINASE; CANCER METASTASIS; MIGRATION; MT1-MMP; PHOSPHORYLATION; MOTILITY; DOMAIN; MICROENVIRONMENT	During the process of tumor invasion, cells require footholds on extracellular matrices (ECM) that are created by forming focal adhesions (FAs) using integrins. On the other hand, cells must degrade the ECM barrier using extracellular proteases including MMPs in the direction of cell movement. Degradation occurs at the leading edges or invadopodia of cells, which are enriched in proteases and adhesion molecules. Recently, we showed that the phosphoinositide-binding protein ZF21 regulates FA disassembly. ZF21 increased cell migration by promoting the turnover of FAs. In addition, ZF21 promotes experimental tumor metastasis to lung in mice and its depletion suppresses it. However, it is not known whether ZF21 regulates cancer cell invasion in addition to its activity on FAs. In this study, we demonstrate that ZF21 also regulates invasion of tumor cells, whereas it does not affect the overall production of MMP-2, MMP-9, and MT1-MMP by the cells. Also, we observe that the ECM-degrading activity specifically at the invadopodia is severely abrogated. In the ZF21 depleted cells MT1-MMP cannot accumulate to the invadopodia and thereby cannot contribute to the ECM degradation. Thus, this study demonstrates that ZF21 is a key player regulating multiple aspects of cancer cell migration and invasion. Possible mechanisms regulating ECM degradation at the invadopodia are discussed.	[Hoshino, Daisuke; Saitoh, Anri; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo, Japan; [Nagano, Makoto] Setsunan Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Hirakata, Osaka 57301, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Div Math Sci, Toyonaka, Osaka 560, Japan	University of Tokyo; Setsunan University; Osaka University	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo, Japan.	mseiki@ims.u-tokyo.ac.jp	Nagano, Makoto/J-7050-2015; Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Nagano, Makoto/0000-0002-1948-1591; Koshikawa, Naohiko/0000-0002-4539-888X	CREST project from JST; MEXT [22220014, 23790109]	CREST project from JST; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a CREST project (to T.S., and M.S.) from JST, by a Grant-in-Aid for Scientific Research (S) (to M.S., number 22220014) from MEXT, and by a Grant-in-Aid for Young Scientists (B) (to M.N., number 23790109) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoshino D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002964; Hoshino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002479; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Liu SC, 2000, J CELL SCI, V113, P3563; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Nagano M, 2011, J BIOL CHEM, V286, P31598, DOI 10.1074/jbc.M110.199430; Nagano Makoto, 2011, Cell Adh Migr, V5, P23, DOI 10.4161/cam.5.1.13492; Nagano M, 2010, J BIOL CHEM, V285, P21013, DOI 10.1074/jbc.M110.106443; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e50825	10.1371/journal.pone.0050825	http://dx.doi.org/10.1371/journal.pone.0050825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382803	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600003
J	Schelleman, H; Bilker, WB; Kimmel, SE; Daniel, GW; Newcomb, C; Guevara, JP; Cziraky, MJ; Strom, BL; Hennessy, S				Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Daniel, Gregory W.; Newcomb, Craig; Guevara, James P.; Cziraky, Mark J.; Strom, Brian L.; Hennessy, Sean			Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; POSITIVE PREDICTIVE-VALUE; MIDDLE-AGED ADULTS; DIAGNOSTIC CODES; ADHD MEDICATIONS; STROKE; VALIDATION; ACCURACY; 1ST-EVER; DEATH	Main Objective: To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in non-users. Methods: This was a retrospective cohort study of new amphetamines (n = 38,586) or atomoxetine (n = 20,995) users. Each medication user was matched to up to four non-users on age, gender, data source, and state (n = 238,183). The following events were primary outcomes of interest 1) sudden death or ventricular arrhythmia, 2) stroke, 3) myocardial infarction, 4) a composite endpoint of stroke or myocardial infarction. Cox proportional hazard regression was used to calculate propensity-adjusted hazard ratios for amphetamines versus matched non-users and atomoxetine versus matched non-users, with intracluster dependence within matched sets accounted for using a robust sandwich estimator. Results: The propensity-score adjusted hazard ratio for amphetamines use versus non-use was 1.18 (95% CI: 0.55-2.54) for sudden death/ventricular arrhythmia, 0.80 (95% CI: 0.44-1.47) for stroke, 0.75 (95% CI: 0.42-1.35) for myocardial infarction, and 0.78 (95% CI: 0.51-1.19) for stroke/myocardial infarction. The propensity-score adjusted hazard ratio for atomoxetine use versus non-use was 0.41 (95% CI: 0.10-1.75) for sudden death/ventricular arrhythmia, 1.30 (95% CI: 0.52-3.29) for stroke, 0.56 (95% CI: 0.16-2.00) for myocardial infarction, and 0.92 (95% CI: 0.44-1.92) for stroke/myocardial infarction. Conclusions: Initiation of amphetamines or atomoxetine was not associated with an elevated risk of serious cardiovascular events. However, some of the confidence intervals do not exclude modest elevated risks, e.g. for sudden death/ventricular arrhythmia.	[Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Newcomb, Craig; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schelleman, Hedi; Bilker, Warren B.; Kimmel, Stephen E.; Newcomb, Craig; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Bilker, Warren B.; Kimmel, Stephen E.; Guevara, James P.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiololgy Res & Training, Philadelphia, PA 19104 USA; [Kimmel, Stephen E.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kimmel, Stephen E.; Strom, Brian L.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Therapeut Effectiveness Res, Philadelphia, PA 19104 USA; [Daniel, Gregory W.] Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Guevara, James P.] Childrens Hosp Philadelphia, PolicyLab, Ctr Bridge Res Practice & Policy, Philadelphia, PA 19104 USA; [Cziraky, Mark J.] HealthCore Inc, Wilmington, DE USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Brookings Institution; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; HealthCore, Inc	Hennessy, S (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	hennessy@upenn.edu	Bilker, Warren/AAS-3515-2021	Guevara, James/0000-0003-1665-4503	Shire Development Inc.; National Institutes of Health [CTSA UL1RR024134]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	Shire Development Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded through a sponsored research agreement with Shire Development Inc., with infrastructure support provided by the National Institutes of Health (CTSA UL1RR024134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were responsible for all aspects of the study and independently performed and analyzed the study, and wrote the manuscript. The authors had the right to publish the results and determine the paper's final wording. Shire approved the protocol and was given the opportunity to provide nonbinding written comments on a draft of this manuscript.	Abildstrom S. Z., 1999, CARDIAC ELECTROPHYSI, V3, P177, DOI DOI 10.1023/A:1009971104937; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; COX DR, 1972, J R STAT SOC B, V34, P187; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Hammerness PG, 2011, CURR PSYCHIAT REP, V13, P357, DOI 10.1007/s11920-011-0213-3; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P934, DOI 10.1002/pds.1992; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pladevall M, 1996, INT J EPIDEMIOL, V25, P948, DOI 10.1093/ije/25.5.948; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schelleman H, 2012, AM J PSYCHIAT, V169, P178, DOI 10.1176/appi.ajp.2011.11010125; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Wahl PM, 2010, THROMB HAEMOSTASIS, V103, P1203, DOI 10.1160/TH09-08-0595; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523	23	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52991	10.1371/journal.pone.0052991	http://dx.doi.org/10.1371/journal.pone.0052991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382829	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800015
J	Fetter-Pruneda, I; Geovannini-Acuna, H; Santiago, C; Ibarraran-Viniegra, AS; Martinez-Martinez, E; Sandoval-Velasco, M; Uribe-Figueroa, L; Padilla-Cortes, P; Mercado-Celis, G; Gutierrez-Ospina, G				Fetter-Pruneda, Ingrid; Geovannini-Acuna, Helga; Santiago, Cecilia; Sofia Ibarraran-Viniegra, Ana; Martinez-Martinez, Eduardo; Sandoval-Velasco, Marcela; Uribe-Figueroa, Laura; Padilla-Cortes, Patricia; Mercado-Celis, Gabriela; Gutierrez-Ospina, Gabriel			Shifts in Developmental Timing, and Not Increased Levels of Experience-Dependent Neuronal Activity, Promote Barrel Expansion in the Primary Somatosensory Cortex of Rats Enucleated at Birth	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; SOMATIC SENSORY CORTEX; ALTERING THALAMOCORTICAL PROJECTIONS; VIBRISSA-RELATED PATTERNS; DEVELOPING VISUAL-CORTEX; DNA METHYLATION; HISTONE MODIFICATIONS; ELECTRICAL-ACTIVITY; CEREBRAL-CORTEX; CRITICAL-PERIOD	Birth-enucleated rodents display enlarged representations of whiskers (i.e., barrels of the posteromedial subfield) in the primary somatosensory cortex. Although the historical view maintains that barrel expansion is due to incremental increases in neuronal activity along the trigeminal pathway during postnatal development, recent evidence obtained in experimental models of intramodal plasticity challenges this view. Here, we re-evaluate the role of experience-dependent neuronal activity on barrel expansion in birth-enucleated rats by combining various anatomical methods and sensory deprivation paradigms. We show that barrels in birth-enucleated rats were already enlarged by the end of the first week of life and had levels of metabolic activity comparable to those in control rats at different ages. Dewhiskering after the postnatal period of barrel formation did not prevent barrel expansion in adult, birth-enucleated rats. Further, dark rearing and enucleation after barrel formation did not lead to expanded barrels in adult brains. Because incremental increases of somatosensory experience did not promote barrel expansion in birth-enucleated rats, we explored whether shifts of the developmental timing could better explain barrel expansion during the first week of life. Accordingly, birth-enucleated rats show earlier formation of barrels, accelerated growth of somatosensory thalamocortical afferents, and an earlier H4 deacetylation. Interestingly, when H4 deacetylation was prevented with a histone deacetylases inhibitor (valproic acid), barrel specification timing returned to normal and barrel expansion did not occur. Thus, we provide evidence supporting that shifts in developmental timing modulated through epigenetic mechanisms, and not increased levels of experience dependent neuronal activity, promote barrel expansion in the primary somatosensory cortex of rats enucleated at birth.	[Fetter-Pruneda, Ingrid; Geovannini-Acuna, Helga; Santiago, Cecilia; Sofia Ibarraran-Viniegra, Ana; Martinez-Martinez, Eduardo; Sandoval-Velasco, Marcela; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Programa Posgrad Ciencias Bil, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico; [Mercado-Celis, Gabriela] Inst Nacl Med Genom, Direcc Invest Med, Lab Oncogenom, Mexico City, DF, Mexico; [Uribe-Figueroa, Laura] Inst Nacl Med Genom, Unidad Genotipificac & Anal Expres Affymetrix, Mexico City, DF, Mexico; [Padilla-Cortes, Patricia] Inst Nacl Med Genom, Inst Invest Biomed, Unidad HPLC, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Fetter-Pruneda, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Programa Posgrad Ciencias Bil, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico.	ifetter@rockefeller.edu; gabo@biomedicas.unam.mx	Sandoval-Velasco, Marcela/AAS-6478-2021; Martínez, Eduardo Martínez/A-2558-2009; Mercado-Celis, Gabriela E./AAR-7836-2020	Sandoval-Velasco, Marcela/0000-0002-4635-6171; Martínez, Eduardo Martínez/0000-0002-9020-559X; Mercado-Celis, Gabriela E./0000-0003-3113-0687; Gutierrez Ospina, Gabriel/0000-0002-6286-8281; Geovannini Acuna, Helga/0000-0002-0345-9787; Fetter-Pruneda, Ingrid/0000-0002-9122-3159	CONACyT [J28035N, 38615N, P45872-M]; PAPIIT; DGAPA [IN203702, IN232604]; The Ricardo Zevada Foundation; The Miguel Aleman Foundation; Roche-Syntex	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); DGAPA; The Ricardo Zevada Foundation; The Miguel Aleman Foundation; Roche-Syntex	Financial aid came from CONACyT (J28035N, 38615N, P45872-M to GGO), PAPIIT, DGAPA (IN203702, IN232604 to GGO). The Ricardo Zevada and Miguel Aleman Foundations, Roche-Syntex provided additional funds. IFP and EMM were fellows of the National Council of Science and Technology (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: Roche-Syntex provided additional funds for this study. Their research group received a national award from Roche-Syntex that they used for purchasing lab equipment. Roche-Syntex is not subsidizing the authors' research and they have no interests on the results and experiments. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1995, J NEUROSCI, V15, P549; Allis C. D., 2006, EPIGENETICS; ANTONINI A, 1993, J NEUROSCI, V13, P3549; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; Baird DH, 1996, J NEUROSCI, V16, P2642; Barber PR, 2007, P SOC PHOTO-OPT INS, V6441, P1; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Boylan CB, 2001, DEV BRAIN RES, V129, P95, DOI 10.1016/S0165-3806(01)00163-8; BRONCHTI G, 1992, NEUROREPORT, V3, P489, DOI 10.1097/00001756-199206000-00008; Burton H, 2003, J NEUROSCI, V23, P4005; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; CATALANO SM, 1995, P NATL ACAD SCI USA, V92, P2549, DOI 10.1073/pnas.92.7.2549; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; Chubb JR, 2006, DEV BIOL, V292, P519, DOI 10.1016/j.ydbio.2005.12.054; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Davis CD, 2007, NUTR REV, V65, P88, DOI [10.1111/j.1753-4887.2007.tb00285.x, 10.1301/nr.2007.feb.88-94]; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; DUNNMEYNELL AA, 1992, J COMP NEUROL, V315, P160, DOI 10.1002/cne.903150204; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gao WJ, 1999, J NEUROSCI, V19, P7940; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Gutierrez-Ospina G, 1998, NEUROSCI LETT, V247, P5, DOI 10.1016/S0304-3940(98)00218-3; GutierrezOspina G, 1996, ENDOCRINOLOGY, V137, P5484, DOI 10.1210/en.137.12.5484; HARRIS WA, 1984, J NEUROSCI, V4, P1153; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 2008, NEURON, V59, P355, DOI 10.1016/j.neuron.2008.07.029; JENSEN KF, 1987, J NEUROSCI, V7, P3544; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Keyes MK, 2007, J NUTR, V137, P1713, DOI 10.1093/jn/137.7.1713; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; KILLACKEY HP, 1989, EUR J NEUROSCI, V1, P210, DOI 10.1111/j.1460-9568.1989.tb00790.x; KORALEK KA, 1990, P NATL ACAD SCI USA, V87, P1396, DOI 10.1073/pnas.87.4.1396; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Lane RD, 2006, NEUROSCI LETT, V395, P165, DOI 10.1016/j.neulet.2005.10.063; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Mah L-J, 2010, J VIS EXP; Mann F, 2002, DEVELOPMENT, V129, P3945; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Maurer D, 2005, TRENDS COGN SCI, V9, P144, DOI 10.1016/j.tics.2005.01.006; MCCANDLISH CA, 1993, EXP BRAIN RES, V92, P369; MCCASLAND JS, 1992, P NATL ACAD SCI USA, V89, P1832, DOI 10.1073/pnas.89.5.1832; McIlvain VA, 2003, J COMP NEUROL, V462, P252, DOI 10.1002/cne.10725; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McNamara K. J., 1997, SHAPES TIME EVOLUTIO; Merabet LB, 2005, NAT REV NEUROSCI, V6, P71, DOI 10.1038/nrn1586; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mire E, 2012, NAT NEUROSCI; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Pallas SL, 1999, P NATL ACAD SCI USA, V96, P8751, DOI 10.1073/pnas.96.15.8751; PASCUALLEONE A, 1993, ANN NEUROL, V34, P33, DOI 10.1002/ana.410340108; Penschuck S, 1999, DEV BRAIN RES, V112, P117, DOI 10.1016/S0165-3806(98)00171-0; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PINA B, 1988, EUR J BIOCHEM, V174, P311, DOI 10.1111/j.1432-1033.1988.tb14099.x; RAUSCHECKER JP, 1992, P NATL ACAD SCI USA, V89, P5063, DOI 10.1073/pnas.89.11.5063; REBILLARD G, 1977, BRAIN RES, V129, P162, DOI 10.1016/0006-8993(77)90980-5; Rhoades RW, 1997, J COMP NEUROL, V389, P185, DOI 10.1002/(SICI)1096-9861(19971208)389:1<185::AID-CNE14>3.0.CO;2-K; RIDDLE D, 1992, J NEUROSCI, V12, P3509; RIDDLE DR, 1993, J NEUROSCI, V13, P4193; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sathian K, 2000, NEUROLOGY, V54, P2203, DOI 10.1212/WNL.54.12.2203; Seelke AMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032322; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Smith KK, 2003, INT J DEV BIOL, V47, P613; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tang MM, 2010, J VIS EXP; Toscano-Marquez B, 2008, P NATL ACAD SCI USA, V105, P15973, DOI 10.1073/pnas.0808431105; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Wang ZP, 2010, ANAT REC, V293, P1947, DOI 10.1002/ar.21232; Weeks R, 2000, J NEUROSCI, V20, P2664; WELKER E, 1992, J NEUROSCI, V12, P153; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; White EL, 1997, SOMATOSENS MOT RES, V14, P34, DOI 10.1080/08990229771204; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhang SY, 2006, NAT PROTOC, V1, P3101, DOI 10.1038/nprot.2006.445; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHENG D, 1995, P NATL ACAD SCI USA, V92, P1802, DOI 10.1073/pnas.92.6.1802	109	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54940	10.1371/journal.pone.0054940	http://dx.doi.org/10.1371/journal.pone.0054940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372796	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400042
J	van Dijk, JH; Sutcliffe, CG; Hamangaba, F; Bositis, C; Watson, DC; Moss, WJ				van Dijk, Janneke H.; Sutcliffe, Catherine G.; Hamangaba, Francis; Bositis, Christopher; Watson, Douglas C.; Moss, William J.			Effectiveness of Efavirenz-Based Regimens in Young HIV-Infected Children Treated for Tuberculosis: A Treatment Option for Resource-Limited Settings	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ANTITUBERCULAR THERAPY; PLASMA-CONCENTRATIONS; EQUIVALENCE TRIAL; INITIAL TREATMENT; AFRICAN CHILDREN; HIGH PREVALENCE; NEVIRAPINE; RIFAMPICIN; EFFICACY	Background: Antiretroviral treatment (ART) options for young children co-infected with HIV and tuberculosis are limited in resource-poor settings due to limited data on the use of efavirenz (EFV). Using available pharmacokinetic data, an EFV dosing schedule was developed for young co-infected children and implemented as the standard of care at Macha Hospital in Southern Province, Zambia. Treatment outcomes in children younger than 3 years of age or weighing less than 10 kg receiving either EFV-based ART plus anti-tuberculous treatment or nevirapine-based (NVP) ART were compared. Methods: Treatment outcomes were measured in a cohort of HIV-infected children seeking care at Macha Hospital in rural Zambia from 2007 to 2010. Informationon the diagnosis and treatment of tuberculosis was abstracted from medical records. Results: Forty-five children treated for tuberculosis initiated an EFV-based regimen and 69 children initiated a NVP-based regimen, 7 of whom also were treated for tuberculosis. Children receiving both regimens were comparable in age, but children receiving EFV started ART with a lower CD4(+) T-cell percentage and weight-for-age z-score. Children receiving EFV experienced increases in both CD4(+) T-cell percentage and weight-for-age z-score during follow-up, such that levels were comparable to children receiving NVP after two years of ART. Cumulative survival after 12 months of ART did not differ between groups (NVP:87%; EFV:80%; p = 0.25). Eleven children experienced virologic failure during follow-up. The adjusted hazard ratio of virologic failure comparing EFV to NVP was 0.25 (95% CI:0.05,1.24) and 0.13 (95% CI:0.03,0.62) using thresholds of 5000 and 400 copies/mL, respectively. Five children receiving EFV were reported to have had convulsions after ART initiation compared to only one child receiving NVP (p = 0.04). Conclusions: Despite poorer health at ART initiation, children treated for tuberculosis and receiving EFV-based regimens showed significant improvements comparable to children receiving NVP-based regimens. EFV-based regimens should be considered for young HIV-infected children co-infected with tuberculosis in resource-limited settings.	[van Dijk, Janneke H.; Hamangaba, Francis] Macha Hosp, Macha Res Trust, Choma, Zambia; [van Dijk, Janneke H.] Erasmus Univ, Dept Immunol & Infect Dis, Rotterdam, Netherlands; [Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Bositis, Christopher] Greater Lawrence Family Hlth Ctr, Lawrence, MA USA; [Watson, Douglas C.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	Erasmus University Rotterdam; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	wmoss@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [U62/CCU322428]; Global AIDS Program	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global AIDS Program	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement U62/CCU322428 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihingsanon A, 2008, ANTIVIR THER, V13, P529; Barlow-Mosha L, 2009, 16 C RETR OPP INF 8; Bobat R, 2008, 4 IAS C HIV PATH TRE; Bolton C, 2012, C RETR OPP INF 2012; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Capparelli E, 2009, 16 C RETR OPP INF 8; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Coutinho AB, 2005, J OCUL PHARMACOL TH, V21, P166, DOI 10.1089/jop.2005.21.166; FDA, 2012, SUST PRESCR INF; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08; Jeena PM, 1998, AIDS, V12, P1185, DOI 10.1097/00002030-199810000-00011; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lapphra K, 2008, INT J INFECT DIS, V12, pE33, DOI 10.1016/j.ijid.2007.10.008; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; Manosuthi W, 2006, CLIN INFECT DIS, V43, P253, DOI 10.1086/505210; McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757; McKinney RE, 2007, PEDIATRICS, V120, pE416, DOI 10.1542/peds.2006-0925; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Oudijk JM, 2009, 5 IAS C HIV PATH TRE; Puthanakit T, 2007, PEDIATR INFECT DIS J, V26, P953, DOI 10.1097/INF.0b013e318125720a; Ramachandran G, 2006, JAIDS-J ACQ IMM DEF, V42, P36; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Ren Y, 2007, JAIDS-J ACQ IMM DEF, V45, P133, DOI 10.1097/QAI.0b013e31805c9d52; Scherpbier HJ, 2007, PEDIATRICS, V119, pE705, DOI 10.1542/peds.2006-1367; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; Strehlau R, 2011, PEDIATR INFECT DIS J, V30, P1001, DOI 10.1097/INF.0b013e318223b680; Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447; Teglas JP, 2001, AIDS, V15, P241, DOI 10.1097/00002030-200101260-00014; The HIV-CAUSAL Collaboration, 2012, EFF EF VERS NEV CONT; UNAIDS, 2012, TOG WE WILL END AIDS; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Vibhagool A, 2004, CURR MED RES OPIN, V20, P1103, DOI 10.1185/030079904125004006; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; von Hentig N, 2006, EUR J MED RES, V11, P377; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; WHO, WHO CHILD GROWTH STA; *WHO, 2008, WHO TECHN REF GROUP; WHO, 2001, IRON DEFICIENCY ANAE; Wintergerst U, 2008, J ANTIMICROB CHEMOTH, V61, P1336, DOI 10.1093/jac/dkn112; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, ANT THER HIV INF INF; Yotebieng M, 2010, AIDS, V24, P1341, DOI 10.1097/QAD.0b013e328339e576	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55111	10.1371/journal.pone.0055111	http://dx.doi.org/10.1371/journal.pone.0055111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372824	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400066
J	De La Fuente, GN; Murray, SC; Isakeit, T; Park, YS; Yan, Y; Warburton, ML; Kolomiets, MV				De La Fuente, Gerald N.; Murray, Seth C.; Isakeit, Thomas; Park, Yong-Soon; Yan, Yuanxin; Warburton, Marilyn L.; Kolomiets, Michael V.			Characterization of Genetic Diversity and Linkage Disequilibrium of ZmLOX4 and ZmLOX5 Loci in Maize	PLOS ONE			English	Article							DNA POLYMORPHISM; JASMONIC ACID; ZEA-MAYS; POPULATIONS; GENOME; LIPOXYGENASE; DISRUPTION; RESISTANCE; AFLATOXIN; PATTERNS	Maize (Zea mays L.) lipoxygenases (ZmLOXs) are well recognized as important players in plant defense against pathogens, especially in cross kingdom lipid communication with pathogenic fungi. This study is among the first to investigate genetic diversity at important gene paralogs ZmLOX4 and ZmLOX5. Sequencing of these genes in 400 diverse maize lines showed little genetic diversity and low linkage disequilibrium in the two genes. Importantly, we identified one inbred line in which ZmLOX5 has a disrupted open reading frame, a line missing ZmLOX5, and five lines with a duplication of ZmLOX5. Tajima's D test suggests that both ZmLOX4 and ZmLOX5 have been under neutral selection. Further investigation of haplotype data revealed that within the ZmLOX family members only ZmLOX12, a monocot specific ZmLOX, showed strong linkage disequilibrium that extends further than expected in maize. Linkage disequilibrium patterns at these loci of interest are crucial for future candidate gene association mapping studies. ZmLOX4 and ZmLOX5 mutations and copy number variants are under further investigation for crop improvement.	[De La Fuente, Gerald N.; Murray, Seth C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Isakeit, Thomas; Park, Yong-Soon; Yan, Yuanxin; Kolomiets, Michael V.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Jackson, MS USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Murray, SC (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	sethmurray@tamu.edu	Warburton, Marilyn/J-2250-2017	Warburton, Marilyn/0000-0002-9542-9912; Murray, Seth/0000-0002-2960-8226	USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) Plant Breeding and Education grant [2010-85117-20539]; National Science Foundation [IOS-0951272]; Texas Corn Producers Board	USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) Plant Breeding and Education grant; National Science Foundation(National Science Foundation (NSF)); Texas Corn Producers Board	This study was funded by the USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) (http://www.nifa.usda.gov/funding/rfas/afri.html) Plant Breeding and Education grant #2010-85117-20539, the National Science Foundation (www.nsf.gov) grant # IOS-0951272, and the Texas Corn Producers Board (www.texascorn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Castegnaro M, 1998, REV MED VET-TOULOUSE, V149, P671; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; DOEBLEY J, 1990, ECON BOT, V44, P6, DOI 10.1007/BF02860472; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Kim J, 2011, PHYTOCHEMISTRY, V72, P1624, DOI 10.1016/j.phytochem.2011.03.026; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Mayfield KL, 2011, CROP SCI, V51, P2489, DOI 10.2135/cropsci2011.02.0112; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; NEI M, 1990, GENETICS, V125, P873; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; Park YS, 2010, PLANTA, V231, P1425, DOI 10.1007/s00425-010-1143-8; Paul C, 2003, THEOR APPL GENET, V107, P263, DOI 10.1007/s00122-003-1241-0; Pingali P.L., 2001, CIMMYT 1999 2000 WOR; Pollak LM, 2003, ADV AGRON, V78, P45, DOI 10.1016/S0065-2113(02)78002-4; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stitz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025925; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; USDA-FAS, 2011, CURR WORLD PROD MARK; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Zhang JL, 2005, PLANT MOL BIOL, V59, P323, DOI 10.1007/s11103-005-8883-z; Zhang PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022378	42	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53973	10.1371/journal.pone.0053973	http://dx.doi.org/10.1371/journal.pone.0053973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365644	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600024
J	Du, MR; Qiu, Q; Gruslin, A; Gordon, J; He, M; Chan, CC; Li, DJ; Tsang, BK				Du, Meirong; Qiu, Qing; Gruslin, Andree; Gordon, John; He, Miao; Chan, Chi Chung; Li, Dajin; Tsang, Benjamin K.			SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro	PLOS ONE			English	Article							NONPEPTIDE CXCR2 ANTAGONIST; CISPLATIN RESISTANCE; INHIBITORY PROTEIN; CHECKPOINT; APOPTOSIS; PATHWAY; DEATH; CHEMORESISTANCE; RECEPTORS; UCN-01	Recent evidence indicates that CXCR2 signaling is crucial for cancer progression, and its antagonist SB225002 induces apoptosis in Wilms' tumor cells. Here, we investigated the effect of SB225002 on cell cycle progression and apoptosis induction in vitro, using CDDP-sensitive and -resistant OVCA cell lines with different p53 status (wild type, mutant or null). Adenovirus infection of wild-type p53 or transfection of p53 siRNA was used to over-express or knock-down p53. Cell cycle and apoptosis were determined by flow cytometry or Hoechst staining and observation of nuclear morphology. Our data demonstrated that SB225002 induced apoptosis in both wild-type and p53-deficient ovarian cancer (OVCA) cells through alternative mechanisms. SB225002 promoted mitotic catastrophe, as evidenced by the accumulation of mitotic cells with spindle abnormalities, chromosome mis-segregation, multi-polar cell division, multiple nuclei, aneuploidy/polyploidy and subsequent extensive apoptosis. SB225002-induced mitotic catastrophe appeared to be mediated by down-regulation of checkpoint kinase Chk1 and Cdk1-cyclin B activation. In cells expressing wild-type p53 (OV2008 and C13*), SB225002 increased total and phospho-Ser p53 levels, and p53 knock-down decreased SB225002-induced apoptosis, without affecting premature mitosis. These results suggest that SB225002 induces p53-dependent apoptosis, and provokes mitotic catastrophe in p53-independent manner in p53 wild-type cells. Reconstitution with wild-type P53 in P53-null SKOV3 cell attenuated SB225002-induced mitotic catastrophe, suggesting p53 prevented mitotic catastrophe induced by SB225002 in p53-deficient OVCA cells. Finally, the effect of SB225002 could not be prevented by pretreatment with CXCR2 ligand or its neutralizing antibody. The present studies demonstrate for the first time that SB225002 has dual actions in OVCA cells, inducing classic apoptosis through p53 activation and provoking mitotic catastrophe in both p53 wild-type and deficient cells by Chk1 inhibition and Cdk activation. These findings raise the possibility of SB225002 as a new candidate molecule for OVCA therapy independent of the p53 status.	[Du, Meirong; Li, Dajin] Fudan Univ, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol, Inst Biomed Sci,Med Coll, Shanghai 200433, Peoples R China; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Du, Meirong; Qiu, Qing; Gruslin, Andree; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Gordon, John] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [He, Miao; Chan, Chi Chung] WuXi AppTech Co Ltd, Shanghai, Peoples R China; [Li, Dajin; Tsang, Benjamin K.] Hainan Med Coll Affiliated Hosp, Dept Obstet & Gynecol, Haikou, Peoples R China; [Tsang, Benjamin K.] Seoul Natl Univ, World Class Univ WCU Biomodulat Major, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151, South Korea	Fudan University; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Saskatchewan; Hainan Medical University; Seoul National University (SNU)	Li, DJ (corresponding author), Fudan Univ, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol, Inst Biomed Sci,Med Coll, Shanghai 200433, Peoples R China.	djli@shmu.edu.cn; btsang@ohri.ca		Gordon, John/0000-0003-3830-8070; Tsang, Benjamin K./0000-0003-1213-3946	National Natural Science Foundation of China [30910103909, 81070537, 31171437]; National and Shanghai Leading Academic Discipline Project [211XK22]; Program for Outstanding Medical Academic Leader of Shanghai; Shanghai PuJiang Talent Program [10PJ1401600]; Canadian Institutes of Health Research [MOP-15691]; World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea [R31-10056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National and Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Program for Outstanding Medical Academic Leader of Shanghai; Shanghai PuJiang Talent Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Major International Joint Research Project of National Natural Science Foundation of China (30910103909 to DJ Li), National and Shanghai Leading Academic Discipline Project (211XK22 to DJL), Program for Outstanding Medical Academic Leader of Shanghai (to DJL), and National Natural Science Foundation of China (81070537 to MRD), National Natural Science Foundation of China (31171437 to MRD), and Shanghai PuJiang Talent Program (10PJ1401600 to MRD), and grants from the Canadian Institutes of Health Research (MOP-15691 to BKT) and the World Class University (WCU) program through the Ministry of Education, Science and Technology of Korea and funded by the National Research Foundation of Korea (R31-10056 to BKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bakshi P, 2009, BIOORGAN MED CHEM, V17, P8102, DOI 10.1016/j.bmc.2009.09.051; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Berghuis D, 2011, J PATHOL, V223, P347, DOI 10.1002/path.2819; Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779; Buhmann R, 2002, BRIT J HAEMATOL, V118, P968, DOI 10.1046/j.1365-2141.2002.03719.x; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Hirose Y, 2001, CANCER RES, V61, P5843; Hoskins P, 2010, J NATL CANCER I, V102, P1547, DOI 10.1093/jnci/djq362; Husain A, 1997, CLIN CANCER RES, V3, P2089; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Li F, 2002, BIOCHEM BIOPH RES CO, V293, P939, DOI 10.1016/S0006-291X(02)00318-2; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Matsuo Y, 2009, MOL CANCER RES, V7, P799, DOI 10.1158/1541-7786.MCR-08-0577; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Romano G, 2010, CELL CYCLE, V9, P4262, DOI 10.4161/cc.9.21.13605; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Wang GD, 2004, ONCOL REP, V12, P955; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zenvirt S, 2010, ONCOGENE, V29, P6149, DOI 10.1038/onc.2010.343	45	16	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54572	10.1371/journal.pone.0054572	http://dx.doi.org/10.1371/journal.pone.0054572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359652	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600073
J	Nagasaka, K; Seiki, T; Yamashita, A; Massimi, P; Subbaiah, VK; Thomas, M; Kranjec, C; Kawana, K; Nakagawa, S; Yano, T; Taketani, Y; Fujii, T; Kozuma, S; Banks, L				Nagasaka, Kazunori; Seiki, Takayuki; Yamashita, Aki; Massimi, Paola; Subbaiah, Vanitha Krishna; Thomas, Miranda; Kranjec, Christian; Kawana, Kei; Nakagawa, Shunsuke; Yano, Tetsu; Taketani, Yuji; Fujii, Tomoyuki; Kozuma, Shiro; Banks, Lawrence			A Novel Interaction between hScrib and PP1 gamma Downregulates ERK Signaling and Suppresses Oncogene-Induced Cell Transformation	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASES; DISCS-LARGE; MAP KINASE; IN-VIVO; POLARITY; DROSOPHILA; SCRIBBLE; DEPHOSPHORYLATION; ACTIVATION; EXPRESSION	Previous studies have shown that the cell polarity regulator hScrib interacts with, and consequently controls, the ERK signaling pathway. This interaction occurs through two well-conserved Kinase Interacting Motifs, which allow hScrib to bind ERK1 directly, resulting in a reduction in the levels of phospho-ERK. This suggests that hScrib might recruit a phosphatase to regulate this signaling pathway. Using a proteomic approach we now show that Protein Phosphatase 1 gamma (PP1 gamma) is a major interacting partner of hScrib. This interaction is direct and occurs through a conserved PP1 gamma interaction motif on the hScrib protein, and this interaction appears to be required for hScrib's ability to downregulate ERK phosphorylation. In addition, hScrib also controls the pattern of PP1 gamma localization, where loss of hScrib enhances the nuclear translocation of PP1 gamma. Furthermore, we also show that the ability of hScrib to interact with PP1 gamma is important for the ability of hScrib to suppress oncogene-induced transformation of primary rodent cells. Taken together, these results demonstrate that hScrib acts as a scaffold to integrate the control of the PP1 gamma and ERK signaling pathways and explains how disruption of hScrib localisation can contribute towards the development of human malignancy.	[Nagasaka, Kazunori; Seiki, Takayuki; Yamashita, Aki; Kawana, Kei; Yano, Tetsu; Taketani, Yuji; Fujii, Tomoyuki; Kozuma, Shiro] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Massimi, Paola; Subbaiah, Vanitha Krishna; Thomas, Miranda; Kranjec, Christian; Banks, Lawrence] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Nakagawa, Shunsuke] Teikyo Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 173, Japan	University of Tokyo; International Center for Genetic Engineering & Biotechnology (ICGEB); Teikyo University	Banks, L (corresponding author), Int Ctr Genet Engn & Biotechnol, Area Sci Pk, Trieste, Italy.	banks@icgeb.org	, Subbaiah/AAB-9747-2021; Nagasaka, Kazunori/AAM-4311-2020; Kranjec, Christian/ABA-9194-2021	Nagasaka, Kazunori/0000-0002-0696-5175; Kranjec, Christian/0000-0001-9713-7406; Krishna, Vanitha/0000-0002-0444-531X	Okinaka Memorial Institute for Medical Research; Ministry of Education, Science and Culture, Japan [24592506]; Associazione Italiana per la Ricerca sul Cancro; Wellcome Trust	Okinaka Memorial Institute for Medical Research; Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by research grants from the Okinaka Memorial Institute for Medical Research (to K.N.) and by a Grant-in-Aid for Scientific Research (no. 24592506, to K.N.) from the Ministry of Education, Science and Culture, Japan, and by research grants from the Associazione Italiana per la Ricerca sul Cancro and the Wellcome Trust (to L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Bilder D, 2003, CURR BIOL, V13, pR661, DOI 10.1016/S0960-9822(03)00599-2; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Cohen PTW, 2002, J CELL SCI, V115, P241; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2003, ONCOGENE, V22, P9225, DOI 10.1038/sj.onc.1207154; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Shimada M, 2010, EMBO REP, V11, P883, DOI 10.1038/embor.2010.152; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Vieira V, 2008, MOL VIS, V14, P2390; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Watson RA, 2002, CARCINOGENESIS, V23, P1791, DOI 10.1093/carcin/23.11.1791; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	52	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53752	10.1371/journal.pone.0053752	http://dx.doi.org/10.1371/journal.pone.0053752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359326	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600021
J	Rodriguez-Rubio, L; Martinez, B; Donovan, DM; Garcia, P; Rodriguez, A				Rodriguez-Rubio, Lorena; Martinez, Beatriz; Donovan, David M.; Garcia, Pilar; Rodriguez, Ana			Potential of the Virion-Associated Peptidoglycan Hydrolase HydH5 and Its Derivative Fusion Proteins in Milk Biopreservation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; LYTIC ACTIVITY; LISTERIA-MONOCYTOGENES; BIOCONTROL AGENTS; MAMMARY-GLANDS; ENTEROTOXIN-A; BOVINE-MILK; PHAGE-K; BACTERIOPHAGE; MASTITIS	Bacteriophage lytic enzymes have recently attracted considerable interest as novel antimicrobials against Gram-positive bacteria. In this work, antimicrobial activity in milk of HydH5 [a virion-associated peptidoglycan hydrolase (VAPGH) encoded by the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88], and three different fusion proteins created between HydH5 and lysostaphin has been assessed. The lytic activity of the five proteins (HydH5, HydH5Lyso, HydH5SH3b, CHAPSH3b and lysostaphin) was confirmed using commercial whole extended shelf-life milk (ESL) in challenge assays with 10(4) CFU/mL of the strain S. aureus Sa9. HydH5, HydH5Lyso and HydH5SH3b (3.5 mu M) kept the staphylococcal viable counts below the control cultures for 6 h at 37 degrees C. The effect is apparent just 15 minutes after the addition of the lytic enzyme. Of note, lysostaphin and CHAPSH3b showed the highest staphylolytic protection as they were able to eradicate the initial staphylococcal challenge immediately or 15 min after addition, respectively, at lower concentration (1 mu M) at 37 degrees C. CHAPSH3b showed the same antistaphyloccal effect at room temperature (1.65 mu M). No re-growth was observed for the remainder of the experiment (up to 6 h). CHAPSH3b activity (1.65 mu M) was also assayed in raw (whole and skim) and pasteurized (whole and skim) milk. Pasteurization of milk clearly enhanced CHAPSH3b staphylolytic activity in both whole and skim milk at both temperatures. This effect was most dramatic at room temperature as this protein was able to reduce S. aureus viable counts to undetectable levels immediately after addition with no re-growth detected for the duration of the experiment (360 min). Furthermore, CHAPSH3b protein is known to be heat tolerant and retained some lytic activity after pasteurization treatment and after storage at 4 degrees C for 3 days. These results might facilitate the use of the peptidoglycan hydrolase HydH5 and its derivative fusions, particularly CHAPSH3b, as biocontrol agents for controlling undesirable bacteria in dairy products.	[Rodriguez-Rubio, Lorena; Martinez, Beatriz; Garcia, Pilar; Rodriguez, Ana] CSIC, DairySafe Grp, Dept Technol & Biotechnol Dairy Prod, IPLA, Villaviciosa, Asturias, Spain; [Donovan, David M.] ARS, Anim Biosci & Biotechnol Lab, Anim & Nat Resources Inst, BARC,USDA, Beltsville, MD USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); United States Department of Agriculture (USDA)	Rodriguez, A (corresponding author), CSIC, DairySafe Grp, Dept Technol & Biotechnol Dairy Prod, IPLA, Villaviciosa, Asturias, Spain.	anarguez@ipla.csic.es	Suárez, Pilar García/H-2544-2012; Rodríguez, Ana/GQR-0554-2022; Garcia, Pilar/AAP-3768-2020; Rodriguez-Rubio, Lorena/D-2888-2017; Rodriguez, Ana/GLQ-7829-2022; Rodriguez, Ana/H-4846-2012; Martinez, Beatriz/H-2953-2012	Suárez, Pilar García/0000-0003-1213-8165; Garcia, Pilar/0000-0003-1213-8165; Rodriguez-Rubio, Lorena/0000-0002-7846-4791; Rodriguez, Ana/0000-0002-1577-9905; Rodriguez, Ana/0000-0002-1577-9905; Martinez, Beatriz/0000-0001-7692-1963	Ministerio de Ciencia e Innovacion, Spain [AGL2009-13144-C02-01, BFU2010-10469-E]; CSIC, Spain [PIE200970I090]; Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain [IB08-052, COF07-006]; National Institutes of Health [1RO1AI075077-01A1]; National Research Initiative [2007-35204-18395]; US State Dept funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075077] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC, Spain; Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Initiative(United States Department of Agriculture (USDA)); US State Dept funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants AGL2009-13144-C02-01 and BFU2010-10469-E (Ministerio de Ciencia e Innovacion, Spain), PIE200970I090 (CSIC, Spain), IB08-052 and COF07-006 (Programa de Ciencia, Tecnologia e Investigacion, Principado de Asturias, Spain), National Institutes of Health, grant 1RO1AI075077-01A1 (to DMD); National Research Initiative grant 2007-35204-18395 (to DMD) and US State Dept funds (to DMD). LR-R is a fellow of the Programa de Ciencia, Tecnologia e Investigacion (Principado de Asturias, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 152 IDF; ANUNCIACAO LLC, 1995, INT J FOOD MICROBIOL, V26, P259; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Becker SC, 2008, FEMS MICROBIOL LETT, V287, P185, DOI 10.1111/j.1574-6968.2008.01308.x; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Belay N, 2002, J FOOD PROTECT, V65, P199, DOI 10.4315/0362-028X-65.1.199; Bernard D, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P971; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Coffey B, 2010, ANNU REV FOOD SCI T, V1, P449, DOI 10.1146/annurev.food.102308.124046; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643; Devlieghere F, 2004, J FOOD PROTECT, V67, P1977, DOI 10.4315/0362-028X-67.9.1977; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P2988, DOI 10.1128/AEM.72.4.2988-2996.2006; Fenton Mark, 2010, Bioeng Bugs, V1, P404, DOI 10.4161/bbug.1.6.13422; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Galvez A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI [10.1080/07388550802107202, 10.1080/07388550802107202 ]; Garcia P, 2009, J DAIRY SCI, V92, P3019, DOI 10.3168/jds.2008-1744; Garcia P, 2011, NATURAL ANTIMICROBIALS IN FOOD SAFETY AND QUALITY, P10, DOI 10.1079/9781845937690.0010; Garcia P, 2010, TRENDS FOOD SCI TECH, V21, P373, DOI 10.1016/j.tifs.2010.04.010; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; IDF, 1982, 4A IDF; International Dairy Federation (IDF), 1993, 20B IDF; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Korhonen H, 2000, BRIT J NUTR, V84, pS75; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Montville TJ, 2008, FOOD MICROBIOLOGY IN, P189; Mork T, 2005, J CLIN MICROBIOL, V43, P3979, DOI 10.1128/JCM.43.8.3979-3984.2005; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P274, DOI 10.1111/j.1472-765X.2005.01762.x; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Paul VD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-226; Rashel M, 2008, FEMS MICROBIOL LETT, V284, P9, DOI 10.1111/j.1574-6968.2008.01152.x; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-138; Rodriguez-Rubio L, 2012, CRIT REV MICROBIOL, DOI [10.3109/1040841X.2012.723675, DOI 10.3109/1040841X.2012.723675)]; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P2241, DOI 10.1128/AEM.07621-11; Rosengren A, 2010, INT J FOOD MICROBIOL, V144, P263, DOI 10.1016/j.ijfoodmicro.2010.10.004; Schmelcher M, 2012, APPL ENVIRON MICROB, V78, P2297, DOI 10.1128/AEM.07050-11; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Takac M, 2005, ANTIMICROB AGENTS CH, V49, P2934, DOI 10.1128/AAC.49.7.2934-2940.2005; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Walstra P., 1984, DAIRY CHEM PHYS; Zhang H, 2012, FOOD MICROBIOL, V31, P133, DOI 10.1016/j.fm.2012.01.005	61	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54828	10.1371/journal.pone.0054828	http://dx.doi.org/10.1371/journal.pone.0054828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359813	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600117
J	Welsch, MA; Blalock, P; Credeur, DP; Parish, TR				Welsch, Michael A.; Blalock, Paul; Credeur, Daniel P.; Parish, Tracie R.			Comparison of Brachial Artery Vasoreactivity in Elite Power Athletes and Age-Matched Controls	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; FLOW-MEDIATED DILATION; BLOOD-PRESSURE; SHEAR-STRESS; EXERCISE; HUMANS; VASOCONSTRICTION; MEN; DIAMETER; VASODILATION	Elite endurance athletes typically have larger arteries contributing to greater skeletal muscle blood flow, oxygen and nutrient delivery and improved physical performance. Few studies have examined structural and functional properties of arteries in power athletes. Purpose: To compare the size and vasoreactivity of the brachial artery of elite power athletes to age-matched controls. It was hypothesized brachial artery diameters of athletes would be larger, have less vasodilation in response to cuff occlusion, but more constriction after a cold pressor test than age-matched controls. Methods: Eight elite power athletes (age = 23 +/- 2 years) and ten controls (age = 22 +/- 1 yrs) were studied. High-resolution ultrasonography was used to assess brachial artery diameters at rest and following 5 minutes of forearm occlusion (Brachial Artery Flow Mediated Dilation = BAFMD) and a cold pressor test (CPT). Basic fitness measures included a handgrip test and 3-minute step test. Results: Brachial arteries of athletes were larger (Athletes 5.39 +/- 1.51 vs. Controls: 3.73 +/- 0.71 mm, p < 0.05), had greater vasodilatory (BAFMD%: Athletes: 8.21 +/- 1.78 vs. Controls: 5.69 +/- 1.56%) and constrictor (CPT %: Athletes: -2.95 +/- 1.07 vs. Controls: -21.20 +/- 0.48%) responses, compared to controls. Vascular operating range (VOR = Peak dilation+Peak Constriction) was also greater in athletes (VOR: Athletes: 0.55 +/- 0.15 vs. Controls: 0.25 +/- 0.18 mm, p < 0.05). Athletes had superior handgrip strength (Athletes: 55.92 +/- 17.06 vs. Controls: 36.77 +/- 17.06 kg, p < 0.05) but similar heart rate responses at peak (Athletes: 123 +/- 16 vs. Controls: 130 +/- 25 bpm, p > 0.05) and 1 minute recovery (Athletes: 88 +/- 21 vs. Controls: 98 +/- 26 bpm, p > 0.05) following the step test. Conclusion: Elite power athletes have larger brachial arteries, and greater vasoreactivity (greater vasodilatory and constrictor responses) than age-matched controls, contributing to a significantly greater VOR. These data extend the existence of an 'athlete's artery' as previously shown for elite endurance athletes to elite power athletes, and presents a hypothetical explanation for the functional significance of the 'power athlete's artery'.	[Welsch, Michael A.; Blalock, Paul] Louisiana State Univ, Dept Kinesiol, Baton Rouge, LA 70803 USA; [Credeur, Daniel P.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Parish, Tracie R.] SE Louisiana Univ, Dept Kinesiol & Hlth Studies, Hammond, LA 70402 USA	Louisiana State University System; Louisiana State University; University of Missouri System; University of Missouri Columbia; University of Louisiana System; Southeastern Louisiana University	Welsch, MA (corresponding author), Louisiana State Univ, Dept Kinesiol, Baton Rouge, LA 70803 USA.	mwelsch@lsu.edu	Welsch, Michael/AAM-2582-2020					Allen JD, 2003, MED SCI SPORT EXER, V35, P847, DOI 10.1249/01.MSS.0000064931.62916.8A; Bigi MAB, 2007, AM J CARDIOL, V100, P528, DOI 10.1016/j.amjcard.2007.02.108; BARCLAY JK, 1986, J APPL PHYSIOL, V61, P1084, DOI 10.1152/jappl.1986.61.3.1084; Calbet JAL, 2010, ACTA PHYSIOL, V199, P393, DOI 10.1111/j.1748-1716.2010.02125.x; Credeur DP, 2012, ATHEROSCLEROSIS, V225, P154, DOI 10.1016/j.atherosclerosis.2012.08.013; de Groot PC, 2006, ARCH PHYS MED REHAB, V87, P688, DOI 10.1016/j.apmr.2006.01.022; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Dishman RK, 2003, PSYCHOPHYSIOLOGY, V40, P370, DOI 10.1111/1469-8986.00040; Dobrosielski DA, 2006, DYNAMIC MED, V5, P1; Dobrosielski DA, 2009, MED SCI SPORT EXER, V41, P1429, DOI 10.1249/MSS.0b013e318199bef4; Golding L.A., 1989, YS WAY PHYS FITNESS; Green DJ, 2012, EXP PHYSIOL, V97, P295, DOI 10.1113/expphysiol.2011.058826; Hassellund SS, 2010, HYPERTENSION, V55, P131, DOI 10.1161/HYPERTENSIONAHA.109.143164; Hopkins ND, 2009, AM J PHYSIOL-HEART C, V297, pH2182, DOI 10.1152/ajpheart.00228.2009; Huonker M, 2003, J APPL PHYSIOL, V95, P685, DOI 10.1152/japplphysiol.00710.2001; Jazuli F, 2011, AM J PHYSIOL-HEART C, V301, pH1667, DOI 10.1152/ajpheart.00487.2011; Joyner MJ, 2003, J PHYSIOL-LONDON, V550, P333, DOI 10.1113/jphysiol.2003.044628; Kasikcioglu E, 2005, TOHOKU J EXP MED, V205, P45, DOI 10.1620/tjem.205.45; Koch DW, 2003, J PHYSIOL-LONDON, V551, P337, DOI 10.1113/jphysiol.2003.042747; Laughlin MH, 2008, J APPL PHYSIOL, V104, P588, DOI 10.1152/japplphysiol.01096.2007; Lestage R, 2006, EXAMINATION BLOOD FL; MACDOUGALL JD, 1992, J APPL PHYSIOL, V73, P1590, DOI 10.1152/jappl.1992.73.4.1590; Maiorana A, 2003, SPORTS MED, V33, P1013, DOI 10.2165/00007256-200333140-00001; Naylor LH, 2006, MED SCI SPORT EXER, V38, P86, DOI 10.1249/01.mss.0000181220.03855.1c; NG AV, 1994, J APPL PHYSIOL, V77, P1366, DOI 10.1152/jappl.1994.77.3.1366; Otsuki T, 2007, AM J PHYSIOL-HEART C, V292, pH786, DOI 10.1152/ajpheart.00678.2006; SEALS DR, 1991, HYPERTENSION, V17, P36, DOI 10.1161/01.HYP.17.1.36; Stein CM, 2000, HYPERTENSION, V36, P945, DOI 10.1161/01.HYP.36.6.945; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Wray DW, 2007, J APPL PHYSIOL, V102, P704, DOI 10.1152/japplphysiol.00984.2006	32	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54718	10.1371/journal.pone.0054718	http://dx.doi.org/10.1371/journal.pone.0054718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359214	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600096
J	Yoshimi, A; Sano, M; Inaba, A; Kokubun, Y; Fujioka, T; Mizutani, O; Hagiwara, D; Fujikawa, T; Nishimura, M; Yano, S; Kasahara, S; Shimizu, K; Yamaguchi, M; Kawakami, K; Abe, K				Yoshimi, Akira; Sano, Motoaki; Inaba, Azusa; Kokubun, Yuko; Fujioka, Tomonori; Mizutani, Osamu; Hagiwara, Daisuke; Fujikawa, Takashi; Nishimura, Marie; Yano, Shigekazu; Kasahara, Shin; Shimizu, Kiminori; Yamaguchi, Masashi; Kawakami, Kazuyoshi; Abe, Keietsu			Functional Analysis of the alpha-1,3-Glucan Synthase Genes agsA and agsB in Aspergillus nidulans: AgsB Is the Major alpha-1,3-Glucan Synthase in This Fungus	PLOS ONE			English	Article							FUMIGATUS CELL-WALL; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; HISTOPLASMA-CAPSULATUM; FISSION YEAST; EXPRESSION; VIRULENCE; NIGER; POLYSACCHARIDES; MORPHOGENESIS	Although alpha-1,3-glucan is one of the major cell wall polysaccharides in filamentous fungi, the physiological roles of alpha-1,3-glucan remain unclear. The model fungus Aspergillus nidulans possesses two alpha-1,3-glucan synthase (AGS) genes, agsA and agsB. For functional analysis of these genes, we constructed several mutant strains in A. nidulans: agsA disruption, agsB disruption, and double-disruption strains. We also constructed several CagsB strains in which agsB expression was controlled by the inducible alcA promoter, with or without the agsA-disrupting mutation. The agsA disruption strains did not show markedly different phenotypes from those of the wild-type strain. The agsB disruption strains formed dispersed hyphal cells under liquid culture conditions, regardless of the agsA genetic background. Dispersed hyphal cells were also observed in liquid culture of the CagsB strains when agsB expression was repressed, whereas these strains grew normally in plate culture even under the agsB-repressed conditions. Fractionation of the cell wall based on the alkali solubility of its components, quantification of sugars, and C-13-NMR spectroscopic analysis revealed that alpha-1,3-glucan was the main component of the alkali-soluble fraction in the wild-type and agsA disruption strains, but almost no alpha-1,3-glucan was found in the alkali-soluble fraction derived from either the agsB disruption strain or the CagsB strain under the agsB-repressed conditions, regardless of the agsA genetic background. Taken together, our data demonstrate that the two AGS genes are dispensable in A. nidulans, but that AgsB is required for normal growth characteristics under liquid culture conditions and is the major AGS in this species.	[Yoshimi, Akira; Abe, Keietsu] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan; [Sano, Motoaki] Kanazawa Inst Technol, Genome Biotechnol Lab, Kanazawa, Ishikawa, Japan; [Inaba, Azusa; Kokubun, Yuko; Abe, Keietsu] Tohoku Univ, Dept Microbial Biotechnol, Sendai, Miyagi, Japan; [Fujioka, Tomonori] Kumiai Chem Ind Co Ltd, Tokyo, Japan; [Mizutani, Osamu] Natl Res Inst Brewing, Higashihiroshima, Japan; [Hagiwara, Daisuke; Shimizu, Kiminori; Yamaguchi, Masashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Fujikawa, Takashi; Nishimura, Marie] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Yano, Shigekazu] Ritsumeikan Univ, Dept Biotechnol, Kusatsu, Japan; [Kasahara, Shin] Miyagi Univ, Dept Environm Sci, Sendai, Miyagi, Japan; [Kawakami, Kazuyoshi] Tohoku Univ, Natl Dept Med Microbiol, Sendai, Miyagi 980, Japan	Tohoku University; Kanazawa Institute of Technology; Tohoku University; Chiba University; National Institute of Agrobiological Sciences - Japan; Ritsumeikan University; Miyagi University; Tohoku University	Abe, K (corresponding author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan.	kabe@niche.tohoku.ac.jp	Hagiwara, Daisuke/A-3488-2016; Fujikawa, Takashi/V-8150-2019	Hagiwara, Daisuke/0000-0003-1382-3914; Fujikawa, Takashi/0000-0001-5659-0407; YOSHIMI, Akira/0000-0003-4331-2744; Mizutani, Osamu/0000-0001-5372-1782	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Science and Technology Agency (JST); Tohoku Bureau of Economy, Trade and Industry	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Tohoku Bureau of Economy, Trade and Industry	This study was supported in part by grants from the Bio-oriented Technology Research Advancement Institution (BRAIN), from the Japan Science and Technology Agency (JST), and from the Tohoku Bureau of Economy, Trade and Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Denning DW, 2002, J ANTIMICROB CHEMOTH, V49, P889, DOI 10.1093/jac/dkf045; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2010, FUNGAL GENET BIOL, V47, P707, DOI 10.1016/j.fgb.2010.04.006; Fujikawa T, 2009, MOL MICROBIOL, V73, P553, DOI 10.1111/j.1365-2958.2009.06786.x; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; Hochstenbach F, 1998, P NATL ACAD SCI USA, V95, P9161, DOI 10.1073/pnas.95.16.9161; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Izumitsu K, 2009, CURR GENET, V55, P439, DOI 10.1007/s00294-009-0257-7; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KANETSUNA F, 1974, MYCOPATH MYCOL APPL, V54, P1, DOI 10.1007/BF02055967; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Sugawara T, 2004, CARBOHYD RES, V339, P2255, DOI 10.1016/j.carres.2004.05.033; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Yamaguchi M., 2005, PLANT MORPHOL, V17, P57; Yamaguchi M, 2009, J ELECTRON MICROSC, V58, P261, DOI 10.1093/jmicro/dfp013; Yano S, 2006, BIOSCI BIOTECH BIOCH, V70, P1754, DOI 10.1271/bbb.60095	40	65	89	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54893	10.1371/journal.pone.0054893	http://dx.doi.org/10.1371/journal.pone.0054893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365684	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600131
J	Liu, LB; Chu, KK; Houser, GH; Diephuis, BJ; Li, Y; Wilsterman, EJ; Shastry, S; Dierksen, G; Birket, SE; Mazur, M; Byan-Parker, S; Grizzle, WE; Sorscher, EJ; Rowe, SM; Tearney, GJ				Liu, Linbo; Chu, Kengyeh K.; Houser, Grace H.; Diephuis, Bradford J.; Li, Yao; Wilsterman, Eric J.; Shastry, Suresh; Dierksen, Gregory; Birket, Susan E.; Mazur, Marina; Byan-Parker, Suzanne; Grizzle, William E.; Sorscher, Eric J.; Rowe, Steven M.; Tearney, Guillermo J.			Method for Quantitative Study of Airway Functional Microanatomy Using Micro-Optical Coherence Tomography	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; PERICILIARY LIQUID; MUCUS; SECRETION; TRANSPORT; CLEARANCE; TRACHEAL; STIMULATION; EPITHELIUM	We demonstrate the use of a high resolution form of optical coherence tomography, termed micro-OCT (mu OCT), for investigating the functional microanatomy of airway epithelia. mu OCT captures several key parameters governing the function of the airway surface (airway surface liquid depth, periciliary liquid depth, ciliary function including beat frequency, and mucociliary transport rate) from the same series of images and without exogenous particles or labels, enabling non-invasive study of dynamic phenomena. Additionally, the high resolution of mu OCT reveals distinguishable phases of the ciliary stroke pattern and glandular extrusion. Images and functional measurements from primary human bronchial epithelial cell cultures and excised tissue are presented and compared with measurements using existing gold standard methods. Active secretion from mucus glands in tissue, a key parameter of epithelial function, was also observed and quantified.	[Liu, Linbo; Chu, Kengyeh K.; Diephuis, Bradford J.; Wilsterman, Eric J.; Dierksen, Gregory; Tearney, Guillermo J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Liu, Linbo; Chu, Kengyeh K.; Wilsterman, Eric J.; Dierksen, Gregory] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Houser, Grace H.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Diephuis, Bradford J.; Tearney, Guillermo J.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Diephuis, Bradford J.] Harvard Univ, Sch Med, Boston, MA USA; [Li, Yao; Shastry, Suresh; Mazur, Marina; Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Birket, Susan E.; Sorscher, Eric J.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Byan-Parker, Suzanne; Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital	Rowe, SM (corresponding author), Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL USA.	smrowe@uab.edu; gtearney@partners.org	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253; Sorscher, Eric J./0000-0001-9341-3354	US National Institute of Health [P30 DK072482, R01 HL105487, R01 HL076398]; Cystic Fibrosis Foundation [R464-CF, SORSCH05XX0, ROWE10XX0, CLANCY09Y2, TEARNE07XX0]; Massachusetts General Hospital ECOR Postdoctoral fellowship [2011A052538]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116213, R01HL076398, R01HL105487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Massachusetts General Hospital ECOR Postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institute of Health (http://www.nih.gov/; Contracts P30 DK072482 to EJS, R01 HL105487 to SMR, and R01 HL076398 to GJT), Cystic Fibrosis Foundation (http://www.cff.org/; Contracts R464-CF and SORSCH05XX0 to EJS, ROWE10XX0 and CLANCY09Y2 to SMR, and TEARNE07XX0 to GJT), and Massachusetts General Hospital ECOR Postdoctoral fellowship (http://www.massgeneral.org/; Award 2011A052538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Ballard ST, 2002, AM J PHYSIOL-LUNG C, V283, pL329, DOI 10.1152/ajplung.00277.2001; Barnes PJ, 2004, NEW ENGL J MED, V350, P2635, DOI 10.1056/NEJMp048102; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Crews A, 2001, J APPL PHYSIOL, V91, P797, DOI 10.1152/jappl.2001.91.2.797; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; DIBENEDETTO G, 1991, J PHYSIOL-LONDON, V439, P103, DOI 10.1113/jphysiol.1991.sp018659; Donaldson Scott H, 2007, Proc Am Thorac Soc, V4, P399, DOI 10.1513/pats.200703-042BR; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; FOSTER WM, 1980, J APPL PHYSIOL, V48, P965, DOI 10.1152/jappl.1980.48.6.965; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; Hayashi S, 2008, J CELL SCI, V121, P2833, DOI 10.1242/jcs.031195; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lansley AB, 1999, BIOPHYS J, V77, P629, DOI 10.1016/S0006-3495(99)76919-5; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Li DC, 2000, AM J RESP CELL MOL, V23, P175, DOI 10.1165/ajrcmb.23.2.4022; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Martens CJ, 2011, AM J PHYSIOL-LUNG C, V301, pL236, DOI 10.1152/ajplung.00388.2010; Martens CJ, 2010, AM J PHYSIOL-LUNG C, V298, pL270, DOI 10.1152/ajplung.00253.2009; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Michel RG, 2010, CHEST, V138, P984, DOI 10.1378/chest.10-0753; Oldenburg AL, 2012, BIOMED OPT EXPRESS, V3, P1978, DOI 10.1364/BOE.3.001978; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1981, J CELL SCI, V47, P331; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SLEIGH MA, 1989, COMP BIOCHEM PHYS A, V94, P359, DOI 10.1016/0300-9629(89)90559-8; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5	44	33	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54473	10.1371/journal.pone.0054473	http://dx.doi.org/10.1371/journal.pone.0054473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372732	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500077
J	Mirshahvalad, A; Beauchesne, OH; Archambault, E; Rosvall, M				Mirshahvalad, Atieh; Beauchesne, Olivier H.; Archambault, Eric; Rosvall, Martin			Resampling Effects on Significance Analysis of Network Clustering and Ranking	PLOS ONE			English	Article							COMMUNITY STRUCTURE; COMPLEX NETWORKS; ORGANIZATION	Community detection helps us simplify the complex configuration of networks, but communities are reliable only if they are statistically significant. To detect statistically significant communities, a common approach is to resample the original network and analyze the communities. But resampling assumes independence between samples, while the components of a network are inherently dependent. Therefore, we must understand how breaking dependencies between resampled components affects the results of the significance analysis. Here we use scientific communication as a model system to analyze this effect. Our dataset includes citations among articles published in journals in the years 1984-2010. We compare parametric resampling of citations with non-parametric article resampling. While citation resampling breaks link dependencies, article resampling maintains such dependencies. We find that citation resampling underestimates the variance of link weights. Moreover, this underestimation explains most of the differences in the significance analysis of ranking and clustering. Therefore, when only link weights are available and article resampling is not an option, we suggest a simple parametric resampling scheme that generates link-weight variances close to the link-weight variances of article resampling. Nevertheless, when we highlight and summarize important structural changes in science, the more dependencies we can maintain in the resampling scheme, the earlier we can predict structural change.	[Mirshahvalad, Atieh; Rosvall, Martin] Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden; [Beauchesne, Olivier H.; Archambault, Eric] Sci Metrix, Montreal, PQ, Canada	Umea University	Mirshahvalad, A (corresponding author), Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden.	atieh.mirshahvalad@physics.umu.se	Archambault, Eric JA/G-5808-2019; Rosvall, Martin/A-9488-2015; Rosvall, Martin/ABD-6411-2020	Archambault, Eric JA/0000-0002-4422-1054; Rosvall, Martin/0000-0002-7181-9940; 	Swedish Research Council [2009-5344]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	MR was supported by the Swedish Research Council grant 2009-5344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Blondel VB, 2008, STAT MECH, V2008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Danon L, 2006, STAT MECH, V2006; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hastings MB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.035102; Hu YQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066106; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mirshahvalad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033721; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Vinh NX, 2010, J MACH LEARN RES, V11, P2837	32	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53943	10.1371/journal.pone.0053943	http://dx.doi.org/10.1371/journal.pone.0053943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372677	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500031
J	Hand, D; Wallis, C; Colyer, A; Penn, CW				Hand, Daniel; Wallis, Corrin; Colyer, Alison; Penn, Charles W.			Pyrosequencing the Canine Faecal Microbiota: Breadth and Depth of Biodiversity	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL DIVERSITY; CETOBACTERIUM-SOMERAE; ILYOBACTER-POLYTROPUS; SP-NOV; DOGS; COMMUNITIES; HEALTH; DNA; DEGRADATION	Mammalian intestinal microbiota remain poorly understood despite decades of interest and investigation by culture-based and other long-established methodologies. Using high-throughput sequencing technology we now report a detailed analysis of canine faecal microbiota. The study group of animals comprised eleven healthy adult miniature Schnauzer dogs of mixed sex and age, some closely related and all housed in kennel and pen accommodation on the same premises with similar feeding and exercise regimes. DNA was extracted from faecal specimens and subjected to PCR amplification of 16S rDNA, followed by sequencing of the 59 region that included variable regions V1 and V2. Barcoded amplicons were sequenced by Roche-454 FLX high-throughput pyrosequencing. Sequences were assigned to taxa using the Ribosomal Database Project Bayesian classifier and revealed dominance of Fusobacterium and Bacteroidetes phyla. Differences between animals in the proportions of different taxa, among 10,000 reads per animal, were clear and not supportive of the concept of a "core microbiota''. Despite this variability in prominent genera, littermates were shown to have a more similar faecal microbial composition than unrelated dogs. Diversity of the microbiota was also assessed by assignment of sequence reads into operational taxonomic units (OTUs) at the level of 97% sequence identity. The OTU data were then subjected to rarefaction analysis and determination of Chao1 richness estimates. The data indicated that faecal microbiota comprised possibly as many as 500 to 1500 OTUs.	[Hand, Daniel; Penn, Charles W.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wallis, Corrin; Colyer, Alison] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	University of Birmingham; Mars; WALTHAM Petcare Science Institute	Penn, CW (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	c.w.penn@bham.ac.uk			UK Biotechnology and Biological Sciences Research Council; WALTHAM Centre for Pet Nutrition	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); WALTHAM Centre for Pet Nutrition	This work was co-funded by the UK Biotechnology and Biological Sciences Research Council and the WALTHAM Centre for Pet Nutrition. The study was undertaken to support the development of a fundamental understanding of the canine gastrointestinal microbiota using 454-pyrosequencing. Scientists at the WALTHAM Centre for Pet Nutrition including co-authors Corrin Wallis and Alison Colyer contributed to the study design, data collection and analysis, the decision to publish and preparation of the manuscript. The work has no direct commercial value and is submitted in good faith within the conventions of scientific integrity and peer review. http://www.bbsrc.ac.uk/ http://www.waltham.com/.	BALISH E, 1977, APPL ENVIRON MICROB, V34, P207, DOI 10.1128/AEM.34.2.207-221.1977; Beasley SS, 2006, J APPL MICROBIOL, V101, P131, DOI 10.1111/j.1365-2672.2006.02884.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Callaway TR, 2010, J ANIM SCI; CHAO A, 1984, SCAND J STAT, V11, P265; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Finegold SM, 2003, SYST APPL MICROBIOL, V26, P177, DOI 10.1078/072320203322346010; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Green BD, 2006, CURR OPIN BIOTECH, V17, P236, DOI 10.1016/j.copbio.2006.05.004; Greetham HL, 2002, J APPL MICROBIOL, V93, P640, DOI 10.1046/j.1365-2672.2002.01724.x; Greetham HL, 2003, THESIS READING U SCH; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hughes JB, 2005, METHOD ENZYMOL, V397, P292, DOI 10.1016/S0076-6879(05)97017-1; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martin-Orue SM, 2002, BRIT J NUTR, V87, P533, DOI [10.1079/BJNBJN2002573, 10.1079/BJN2002573]; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Probert H M, 2002, Curr Issues Intest Microbiol, V3, P23; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; Sikorski J, 2010, STAND GENOMIC SCI, V3, P304, DOI 10.4056/sigs.1273360; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; STIEB M, 1984, ARCH MICROBIOL, V140, P139, DOI 10.1007/BF00454916; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2009, VET MICROBIOL; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walter Jens, 2002, Microbial Ecology in Health and Disease, V14, P129, DOI 10.1080/089106002320644294; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Wiedemann S, 2006, J ANIM SCI, V84, P135, DOI 10.2527/2006.841135x; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Youssef NH, 2008, J MICROBIOL METH, V75, P86, DOI 10.1016/j.mimet.2008.05.009; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	70	49	50	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53115	10.1371/journal.pone.0053115	http://dx.doi.org/10.1371/journal.pone.0053115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382835	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600010
J	Kolbert, CP; Feddersen, RM; Rakhshan, F; Grill, DE; Simon, G; Middha, S; Jang, JS; Simon, V; Schultz, DA; Zschunke, M; Lingle, W; Carr, JM; Thompson, EA; Oberg, AL; Eckloff, BW; Wieben, ED; Li, P; Yang, P; Jen, J				Kolbert, Christopher P.; Feddersen, Rod M.; Rakhshan, Fariborz; Grill, Diane E.; Simon, Gyorgy; Middha, Sumit; Jang, Jin Sung; Simon, Vernadette; Schultz, Debra A.; Zschunke, Michael; Lingle, Wilma; Carr, Jennifer M.; Thompson, E. Aubrey; Oberg, Ann L.; Eckloff, Bruce W.; Wieben, Eric D.; Li, Peter; Yang, Ping; Jen, Jin			Multi-Platform Analysis of MicroRNA Expression Measurements in RNA from Fresh Frozen and FFPE Tissues	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; HEART-FAILURE; LUNG-CANCER; C-ELEGANS; TRANSLATION; LIN-14; TRANSCRIPTOME; TECHNOLOGY; INITIATION	MicroRNAs play a role in regulating diverse biological processes and have considerable utility as molecular markers for diagnosis and monitoring of human disease. Several technologies are available commercially for measuring microRNA expression. However, cross-platform comparisons do not necessarily correlate well, making it difficult to determine which platform most closely represents the true microRNA expression level in a tissue. To address this issue, we have analyzed RNA derived from cell lines, as well as fresh frozen and formalin-fixed paraffin embedded tissues, using Affymetrix, Agilent, and Illumina microRNA arrays, NanoString counting, and Illumina Next Generation Sequencing. We compared the performance within-and between the different platforms, and then verified these results with those of quantitative PCR data. Our results demonstrate that the within-platform reproducibility for each method is consistently high and although the gene expression profiles from each platform show unique traits, comparison of genes that were commonly detectable showed that detection of microRNA transcripts was similar across multiple platforms.	[Kolbert, Christopher P.; Feddersen, Rod M.; Rakhshan, Fariborz; Jang, Jin Sung; Simon, Vernadette; Schultz, Debra A.; Jen, Jin] Mayo Clin, Med Genome Facil Gene Express Core, Rochester, MN 55905 USA; [Grill, Diane E.; Simon, Gyorgy; Middha, Sumit; Oberg, Ann L.; Li, Peter] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zschunke, Michael; Lingle, Wilma] Mayo Clin, Rochester, MN USA; [Carr, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Jacksonville, FL 32224 USA; [Eckloff, Bruce W.; Wieben, Eric D.] Mayo Clin, Med Genome Facil Sequencing Core, Rochester, MN USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kolbert, CP (corresponding author), Mayo Clin, Med Genome Facil Gene Express Core, Rochester, MN 55905 USA.	Kolbert.christopher@mayo.edu; jen.jin@mayo.edu		Middha, Sumit/0000-0003-4135-6268	Mayo Clinic Cancer Center; Center for Individualized Medicine; Research Core Oversight Subcommittee	Mayo Clinic Cancer Center; Center for Individualized Medicine; Research Core Oversight Subcommittee	We thank the Mayo Clinic Cancer Center, Center for Individualized Medicine, and the Research Core Oversight Subcommittee for support of this work. We thank Dr. Don Baldwin for helpful technical discussions.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hasemeier B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-90; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lau NC., 2001, SCIENCE, V294, P858, DOI [DOI 10.1126/SCIENCE.1065062, 10.1126/science.1065062, DOI 10.1126/science.1065062]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	37	76	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e52517	10.1371/journal.pone.0052517	http://dx.doi.org/10.1371/journal.pone.0052517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382819	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600007
J	Ansarullah; Lu, Y; Holstein, M; DeRuyter, B; Rabinovitch, A; Guo, ZG				Ansarullah; Lu, Yan; Holstein, Martha; DeRuyter, Brittany; Rabinovitch, Alex; Guo, Zhiguang			Stimulating beta-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; NONOBESE DIABETIC MICE; GLYCEMIC CONTROL; GLUCOSE-TOLERANCE; SITAGLIPTIN; REPLICATION; INCRETIN; BIOLOGY	Background: Activating G-protein coupled receptor 119 (GPR119) by its agonists can stimulate glucagon like peptide-1 (GLP-1) release. GLP-1 is rapidly degraded and inactivated by dipeptidylpeptidase-IV (DPP-IV). We studied the efficiency of combining PSN632408, a GPR119 agonist, with sitagliptin, a DPP-IV inhibitor, on beta-cell regeneration in diabetic mice. Materials & Methods: Diabetes in C57BL/6 mice was induced by streptozotocin. PSN632408 and sitagliptin alone or in combination were administered to diabetic mice for 7 weeks along with BrdU daily. Nonfasting blood glucose levels were monitored. After treatment, oral glucose tolerance test (OGTT), plasma active GLP-1 levels, beta-cell mass along with alpha- and beta-cell replication, and beta-cell neogenesis were evaluated. Results: Normoglycemia was not achieved in vehicle-treated mice. By contrast, 32% (6 of 19) of PSN632408-treated diabetic mice, 36% (5 of 14) sitagliptin-treated diabetic mice, and 59% (13 of 22) diabetic mice treated with PSN632408 and sitagliptin combination achieved normoglycemia after 7 weeks treatment. Combination therapy significantly increased plasma active GLP-1 levels, improved glucose clearance, stimulated both alpha- and beta-cell replication, and augmented beta-cell mass. Furthermore, treatment with combination therapy induced beta-cell neogenesis from pancreatic duct-derived cells. Conclusion: Our results demonstrate that combining a GPR119 agonist with a DPP-IV inhibitor may offer a novel therapeutic strategy for stimulating beta-cell regeneration and reversing diabetes.	[Ansarullah; Lu, Yan; Holstein, Martha; DeRuyter, Brittany; Rabinovitch, Alex; Guo, Zhiguang] Sanford Res USD, Children Hlth Res Ctr, Sanford Project, Sioux Falls, SD 57105 USA; [Rabinovitch, Alex; Guo, Zhiguang] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Guo, Zhiguang] Univ S Dakota, Sanford Sch Med, Dept Surg, Sioux Falls, SD USA	Sanford Health; University of South Dakota; University of South Dakota	Guo, ZG (corresponding author), Sanford Res USD, Children Hlth Res Ctr, Sanford Project, Sioux Falls, SD 57105 USA.	zhiguang.guo@sanfordhealth.org	Ansarullah, ./CAH-0894-2022	, Ansarullah/0000-0002-3415-7319				Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Brubaker PL, 2010, ENDOCRINOLOGY, V151, P1984, DOI 10.1210/en.2010-0115; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Drucker D, 2007, NAT REV DRUG DISCOV, V6, P109, DOI 10.1038/nrd2245; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Furuta Y, 2010, DIABETES OBES METAB, V12, P421, DOI 10.1111/j.1463-1326.2009.01180.x; Gao J, 2011, TRANSPL INT; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Herman GA, 2006, J CLIN PHARMACOL, V46, P876, DOI 10.1177/0091270006289850; Idris I, 2007, DIABETES OBES METAB, V9, P153, DOI 10.1111/j.1463-1326.2007.00705.x; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Karasik A, 2008, CURR MED RES OPIN, V24, P489, DOI 10.1185/030079908X261069 ; Lee SH, 2011, ISLETS, V3, P358, DOI 10.4161/isl.3.6.17923; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Prasadan K, 2002, DIABETES, V51, P3229, DOI 10.2337/diabetes.51.11.3229; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; Rosenstock Julio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P98, DOI 10.1097/MED.0b013e3280a02f65; Sakamoto Y, 2006, BIOCHEM BIOPH RES CO, V351, P474, DOI 10.1016/j.bbrc.2006.10.076; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Suarez-Pinzon WL, 2009, DIABETOLOGIA, V52, P1680, DOI 10.1007/s00125-009-1390-z; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tian L, 2011, TRANSPL INT, V24, P856, DOI 10.1111/j.1432-2277.2011.01275.x; Tian L, 2010, ENDOCRINOLOGY, V151, P3049, DOI 10.1210/en.2010-0068; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670	41	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53345	10.1371/journal.pone.0053345	http://dx.doi.org/10.1371/journal.pone.0053345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382843	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200058
J	Sakkiah, S; Arooj, M; Kumar, MR; Eom, SH; Lee, KW				Sakkiah, Sugunadevi; Arooj, Mahreen; Kumar, Manian Rajesh; Eom, Soo Hyun; Lee, Keun Woo			Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; INCREASED DOSAGE; SIR2; ACETYLATION; ACTIVATION; STRESS; GENE	The ability to identify the site of a protein that can bind with high affinity to small, drug-like compounds has been an important goal in drug design. Sirtuin 2 (SIRT2), histone deacetylase protein family, plays a central role in the regulation of various pathways. Hence, identification of drug for SIRT2 has attracted great interest in the drug discovery community. To elucidate the molecular basis of the small molecules interactions to inhibit the SIRT2 function we employed the molecular docking, molecular dynamics simulations, and the molecular mechanism Poisson-Boltzmann/ surface area (MM-PBSA) calculations. Five well know inhibitors such as suramin, mol-6, sirtinol, 67, and nf675 were selected to establish the nature of the binding mode of the inhibitors in the SIRT2 active site. The molecular docking and dynamics simulations results revealed that the hydrogen bonds between Arg97 and Gln167 are crucial to inhibit the function of SIRT2. In addition, the MM-PBSA calculations revealed that binding of inhibitors to SIRT2 is mainly driven by van der Waals/non-polar interactions. Although the five inhibitors are very different in structure, shape, and electrostatic potential, they are able to fit in the same binding pocket. These findings from this study provide insights to elucidate the binding pattern of SIRT2 inhibitors and help in the rational structure-based design of novel SIRT2 inhibitors with improved potency and better resistance profile.	[Sakkiah, Sugunadevi; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Sakkiah, Sugunadevi; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Kwangju, South Korea; [Sakkiah, Sugunadevi; Kumar, Manian Rajesh] Chonnam Natl Univ, Dept Chem, Kwangju, South Korea; [Sakkiah, Sugunadevi; Kumar, Manian Rajesh] Chonnam Natl Univ, Inst Basic Sci, Kwangju, South Korea; [Arooj, Mahreen; Lee, Keun Woo] Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Gyeongsang National University	Lee, KW (corresponding author), Gyeongsang Natl Univ, Res Inst Nat Sci, Plant Mol Biol & Biotechnol Res Ctr, Syst & Synthet Agrobiotech Ctr,Div Appl Life Sci, Jinju, South Korea.	kwlee@gnu.ac.kr	Arooj, Mahreen/AAC-7565-2020	Sakkiah, Suguna Devi/0000-0002-8337-9348; Arooj, Mahreen/0000-0003-1975-5289	Basic Science Research Program [2012R1A1A4A01013657]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of the Republic of Korea; Rural Development Administration (RDA) of the Republic of Korea [PJ008038]	Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of the Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of the Republic of Korea. This work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arguelho MLPM, 2010, QUIM NOVA, V33, P1291, DOI 10.1590/S0100-40422010000600014; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Choi SH, 2012, BIOORG MED CHEM LETT, V22, P2789, DOI 10.1016/j.bmcl.2012.02.089; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Eroglu E, 2007, INT J MOL SCI, V8, P145, DOI 10.3390/i8020145; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gaussian, 2004, REV C 03; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Sakkiah S, 2012, CHEM BIOL DRUG DES, V80, P315, DOI 10.1111/j.1747-0285.2012.01406.x; Sakkiah S, 2012, J BIOMOL STRUCT DYN, V30, P235, DOI 10.1080/07391102.2012.680026; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Singh R.K., 2011, INT J CHEMTECH RES, V3, P1571; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tervo AJ, 2004, J MED CHEM, V47, P6292, DOI 10.1021/jm049933m; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x	41	28	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e51429	10.1371/journal.pone.0051429	http://dx.doi.org/10.1371/journal.pone.0051429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382805	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500002
J	Aggarwal, AK; Kumar, P; Pandit, S; Kumar, R				Aggarwal, Arun K.; Kumar, Praveen; Pandit, Sadbhawna; Kumar, Rajesh			Accuracy of WHO Verbal Autopsy Tool in Determining Major Causes of Neonatal Deaths in India	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; VALIDATION; STILLBIRTHS; MORTALITY; CLASSIFICATION; ALGORITHMS; INTERVIEWS; COMMUNITY	Objectives: This study was conducted to evaluate the performance of World Health Organisation (WHO) verbal autopsy tool in determining major causes of neonatal deaths. Methods: From a tertiary care hospital and a government multispecialty hospital, the attending paediatricians ascertained a clinical cause of death for 371 neonatal deaths. Trained field workers conducted verbal autopsy (VA) interviews. Two independent paediatricians, who had no access to the clinical information, assigned cause of death as per verbal autopsy. Analysis was based on 313 cases in which both clinical diagnosis and VA diagnosis was obtained. Findings: As per the clinical diagnosis, four most common causes of neonatal deaths were sepsis (29.1%), preterm birth (27.8%), birth asphyxia (27.2%), and congenital anomalies (11.5%). Cause specific mortality fractions by VA diagnosis were statistically similar to those obtained by clinical diagnosis except for birth asphyxia (16.3%). Diagnostic accuracy of verbal autopsy diagnosis against clinical diagnosis ranged from 78% to 92% in ascertaining different underlying causes of death. Area under the Receiver-Operator Characteristics curve (95% confidence interval) was 0.75 (0.69-0.80) for sepsis, 0.74 (0.68-0.80) for preterm birth, 0.73 (0.65-0.82) for congenital anomaly and 0.70 (0.64-0.75) for birth asphyxia. Kappa for all four causes was moderate (0.46-0.55). Interpretation: The WHO verbal autopsy tools can provide reasonably good estimates of predominant causes of neonatal deaths in countries where neonatal mortality is high. Caution is required to interpret cause specific mortality fraction (CSMF) for birth asphyxia by VA because it is likely to be an underestimate.	[Aggarwal, Arun K.; Kumar, Rajesh] PGIMER, Sch Publ Hlth, Chandigarh, India; [Kumar, Praveen] PGIMER, Neonatal Unit, Dept Pediat, Adv Pediat Ctr, Chandigarh, India; [Pandit, Sadbhawna] Govt Multispecialty Hosp, Dept Pediat, Sect 16, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Aggarwal, AK (corresponding author), PGIMER, Sch Publ Hlth, Chandigarh, India.	aggak63@gmail.com			Department of Child and Adolescent Health and Development, World Health Organization, Geneva, through a grant from United States Agency for International Development	Department of Child and Adolescent Health and Development, World Health Organization, Geneva, through a grant from United States Agency for International Development(United States Agency for International Development (USAID))	Study was funded by the Department of Child and Adolescent Health and Development, World Health Organization, Geneva, through a grant from United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, one staff member provided technical assistance in quality assurance at all stages of the project.	Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; ANKER M, 1999, WHOCDSCSRISR994; [Anonymous], 2007, SRS BULLETIN, V42; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Kalter HD, 1999, PAEDIATR PERINAT EP, V13, P99; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lee ACC, 2008, PEDIATRICS, V121, pE1372, DOI 10.1542/peds.2007-2644; Marsh DR, 2003, PAEDIATR PERINAT EP, V17, P132, DOI 10.1046/j.1365-3016.2003.00475.x; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Thatte N, 2009, J PERINATOL, V29, P187, DOI 10.1038/jp.2008.138; Winbo IGB, 1998, INT J EPIDEMIOL, V27, P499, DOI 10.1093/ije/27.3.499; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; World Health Organisation, 2007, VERBAL AUTOPSY STAND; World Health Organisation, 2005, INTERNATIONAL STATIS; World Health Organization (WHO), 2005, IHR EB	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54865	10.1371/journal.pone.0054865	http://dx.doi.org/10.1371/journal.pone.0054865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372783	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400037
J	Kimani, J; McKinnon, LR; Wachihi, C; Kusimba, J; Gakii, G; Birir, S; Muthui, M; Kariri, A; Muriuki, FK; Muraguri, N; Musyoki, H; Ball, TB; Kaul, R; Gelmon, L				Kimani, Joshua; McKinnon, Lyle R.; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Birir, Sarah; Muthui, Mercy; Kariri, Anthony; Muriuki, Festus K.; Muraguri, Nicholas; Musyoki, Helgar; Ball, T. Blake; Kaul, Rupert; Gelmon, Lawrence			Enumeration of Sex Workers in the Central Business District of Nairobi, Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANS-AFRICA HIGHWAY; HIV TRANSMISSION; FEMALE; PREVENTION; UGANDA	Accurate program planning for populations most at risk for HIV/STI acquisition requires knowledge of the size and location where these populations can best be reached. To obtain this information for sex workers operating at 137 hotspots in the central business district (CBD) in Nairobi, Kenya, we utilized a combined mapping and capture-recapture enumeration exercise. The majority of identified hotspots in this study were bars. Based on this exercise, we estimate that 6,904 male and female sex workers (95% confidence intervals, 6690 and 7118) were working nightly in the Nairobi CBD in April 2009. Wide ranges of captures per spot were obtained, suggesting that relatively few hot spots (18%) contain a relatively high proportion of the area's sex workers (65%). We provide geographic data including relatively short distances from hotspots to our dedicated sex worker outreach program in the CBD (mean<1 km), and clustering of hotspots within a relatively small area. Given the size covered and areas where sex work is likely taking place in Nairobi, the estimate is several times lower than what would be obtained if the entire metropolitan area was enumerated. These results have important practical and policy implications for enhancing HIV/STI prevention efforts.	[Kimani, Joshua; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Kariri, Anthony; Muriuki, Festus K.; Ball, T. Blake; Gelmon, Lawrence] Univ Manitoba, Kenya AIDS Control Project, Nairobi, Kenya; [Kimani, Joshua; Wachihi, Charles; Kusimba, Judith; Gakii, Gloria; Kariri, Anthony; Muriuki, Festus K.; Ball, T. Blake; Gelmon, Lawrence] Univ Nairobi, Kenya AIDS Control Project, Nairobi, Kenya; [Kimani, Joshua; McKinnon, Lyle R.; Ball, T. Blake; Kaul, Rupert; Gelmon, Lawrence] Univ Nairobi, Nairobi, Kenya; [McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Toronto, ON, Canada; [Birir, Sarah; Muraguri, Nicholas; Musyoki, Helgar] CDC, Global AIDS Program, Nairobi, Kenya; [Muthui, Mercy] Minist Publ Hlth & Sanitat, Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Ball, T. Blake] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Nairobi; University of Nairobi; University of Toronto; Public Health Agency of Canada	Kimani, J (corresponding author), Univ Manitoba, Kenya AIDS Control Project, Nairobi, Kenya.	jkimani@csrtkenya.org		McKinnon, Lyle/0000-0002-7157-0700; Kaul, Rupert/0000-0002-1586-4093	Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR)	Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR)	This enumeration was made possible by a grant from the Center for Disease Control-United States President's Emergency Plan for AIDS Relief (CDC-PEPFAR). The funders had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. The funders participated in the study design since this was a part of HIV prevention programming.	[Anonymous], 2003, UNAID WHO EST SIZ PO; [Anonymous], 2000, APNSW STAT MAK SEX W; [Anonymous], 2005, MAP REPORT SEX WORK; [Anonymous], 2009, HIV AIDS SITUATIONAL; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Family Health International, 2002, MAPP CENS FEM SEX WO; Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; Morse T, 2001, AM J IND MED, V39, P636, DOI 10.1002/ajim.1063; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; Rollinson SW, 2004, ESTIMATING POPULATIO; *UNAIDS WHO WORK G, 2003, EST SIZ POP RISK HIV; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Wariki WM, COCHRANE DATABASE SY, V2	17	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54354	10.1371/journal.pone.0054354	http://dx.doi.org/10.1371/journal.pone.0054354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372713	Green Published, gold			2022-12-27	WOS:000315210400012
J	Noto, H; Goto, A; Tsujimoto, T; Noda, M				Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko			Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; MAJOR CHRONIC DISEASE; CARDIOVASCULAR RISK-FACTORS; GUIDELINES-FOR-AMERICANS; HIGH-PROTEIN-DIET; LOW-FAT DIET; GLYCEMIC INDEX; WEIGHT-LOSS; HEALTH; LOAD	Objective: Low-carbohydrate diets and their combination with high-protein diets have been gaining widespread popularity to control weight. In addition to weight loss, they may have favorable short-term effects on the risk factors of cardiovascular disease (CVD). Our objective was to elucidate their long-term effects on mortality and CVD incidence. Data sources: MEDLINE, EMBASE, ISI Web of Science, Cochrane Library, and ClinicalTrials.gov for relevant articles published as of September 2012. Cohort studies of at least one year's follow-up period were included. Review methods: Identified articles were systematically reviewed and those with pertinent data were selected for meta-analysis. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) for all-cause mortality, CVD mortality and CVD incidence were calculated using the random-effects model with inverse-variance weighting. Results: We included 17 studies for a systematic review, followed by a meta-analysis using pertinent data. Of the 272,216 people in 4 cohort studies using the low-carbohydrate score, 15,981 (5.9%) cases of death from all-cause were reported. The risk of all-cause mortality among those with high low-carbohydrate score was significantly elevated: the pooled RR (95% CI) was 1.31 (1.07-1.59). A total of 3,214 (1.3%) cases of CVD death among 249,272 subjects in 3 cohort studies and 5,081 (2.3%) incident CVD cases among 220,691 people in different 4 cohort studies were reported. The risks of CVD mortality and incidence were not statistically increased: the pooled RRs (95% CIs) were 1.10 (0.98-1.24) and 0.98 (0.78-1.24), respectively. Analyses using low-carbohydrate/high-protein score yielded similar results. Conclusion: Low-carbohydrate diets were associated with a significantly higher risk of all-cause mortality and they were not significantly associated with a risk of CVD mortality and incidence. However, this analysis is based on limited observational studies and large-scale trials on the complex interactions between low-carbohydrate diets and long-term outcomes are needed.	[Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet & Metab Med, Tokyo, Japan; [Noto, Hiroshi; Goto, Atsushi; Tsujimoto, Tetsuro; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Res Inst, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Noto, H (corresponding author), Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet & Metab Med, Tokyo, Japan.	noto-tky@umin.net	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631; Goto, Atsushi/0000-0003-0669-654X	Health Sciences Research Grant (Comprehensive Research on Diabetes/Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare of Japan [H22-019]	Health Sciences Research Grant (Comprehensive Research on Diabetes/Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labour and Welfare of Japan	This study was supported by a Health Sciences Research Grant (Comprehensive Research on Diabetes/Cardiovascular and Life-Style Related Diseases H22-019) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Diehr P, 2003, J CLIN EPIDEMIOL, V56, P1224, DOI 10.1016/S0895-4356(03)00202-6; Floegel A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3801; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; GARCIAPALMIERI MR, 1980, AM J CLIN NUTR, V33, P1818, DOI 10.1093/ajcn/33.8.1818; Gogebakan O, 2011, CIRCULATION, V124, P2829, DOI 10.1161/CIRCULATIONAHA.111.033274; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Johnson JA, 2010, DIABETES, V59, P1129, DOI 10.2337/db10-0334; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Massimino FC, 2007, CAD SAUDE PUBLICA, V23, P2145, DOI 10.1590/S0102-311X2007000900022; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; McCullough ML, 2000, AM J CLIN NUTR, V72, P1214; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; MCGEE DL, 1984, AM J EPIDEMIOL, V119, P667, DOI 10.1093/oxfordjournals.aje.a113788; Nilsson LM, 2012, EUR J CLIN NUTR, V66, P694, DOI 10.1038/ejcn.2012.9; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sjogren P, 2010, AM J CLIN NUTR, V92, P967, DOI 10.3945/ajcn.2010.29345; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wells G.A., NEWCASTLE OTTAWA SCA; Willett WC, 2007, J INTERN MED, V261, P363, DOI 10.1111/j.1365-2796.2007.01804.x; Yang YX, 2009, GASTROENTEROLOGY, V137, P412, DOI 10.1053/j.gastro.2009.06.022	39	120	124	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55030	10.1371/journal.pone.0055030	http://dx.doi.org/10.1371/journal.pone.0055030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372809	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400052
J	Zhu, P; Zhu, Q; Zhang, YL; Ma, XJ; Li, ZZ; Li, J; Chen, JZ; Luo, L; Ring, HJZ; Ring, BZ; Su, L				Zhu, Peng; Zhu, Qian; Zhang, Yilei; Ma, Xuejun; Li, Zizhao; Li, Jie; Chen, Jiazhong; Luo, Le; Ring, Huijun Z.; Ring, Brian Z.; Su, Li			ABCB1 Variation and Treatment Response in AIDS Patients: Initial Results of the Henan Cohort	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; P-GLYCOPROTEIN; ANTIRETROVIRAL TREATMENT; PLASMA-CONCENTRATIONS; POLYMORPHISMS; METABOLISM; CYP2B6; PHARMACOGENETICS; VARIANTS; BLOOD	HIV/AIDS has the highest mortality among infectious diseases in China. In ongoing efforts to alleviate this crisis, the national government has placed great emphasis on efforts in Henan province where HIV-infected former plasma donors in the 1990s contributed to AIDS becoming a public health crisis. Concomitant with a national initiative focusing the use of phamacogenetics for the better prediction of treatment response, we studied genetic variants with known pharmacokinetic phenotypes in a set of 298 HAART-treated (highly active antiretroviral therapy) patients infected with HIV from the Henan cohort. We measured the association of response to treatment, assessed as changes in CD4+ T cell counts after antiretroviral therapy, of five polymorphisms in four genes (CYP2B6, ABCB1/MDR1, ABCG2, and ABCC4) in which variation has been suggested to affect the pharmacokinetics of drugs commonly employed to treat HIV/AIDS. We show that genotyping for ABCB1 variations (rs1045642 and rs2032582) may help predict HIV treatment response. We found variations in this gene have a significant association with outcome as measured by CD4+ T cell counts in a discovery subset (N=197; odds ratio (OR)=1.58; 95% CI 1.02-2.45), these results were confirmed in a validation subset of the cohort (N=78; OR=2.81; 95% CI 1.32-5.96). Exploratory analysis suggests that this effect may be specific to NVP (nevirapine) or 3TC (lamivudine) response. This publication represents the first genetic analysis in a continuing effort to study and assist the patients in a very large, unique, and historically significant HIV-AIDS cohort. Genotyping of AIDS patients for ABCB1 variation may help predict outcome and potentially could help guide treatment strategies.	[Zhu, Peng; Zhang, Yilei; Su, Li] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ring, Huijun Z.; Ring, Brian Z.] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China; [Chen, Jiazhong] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China; [Zhu, Qian; Li, Jie] Henan Ctr Dis Prevent & Control, Inst AIDS STD Prevent & Control, Zhengzhou, Peoples R China; [Ma, Xuejun; Luo, Le] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Li, Zizhao] Hlth Dept Henan Prov, Zhengzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Inst Genom & Personalized Med, Wuhan 430074, Peoples R China.	bzring@mail.hust.edu.cn; lisu@mail.hust.edu.cn	Zhang, Yilei/I-8997-2014	Zhang, Yilei/0000-0003-1407-0301	China Mega-Project for Infectious Diseases [2009ZX10017-016, 2011ZX10004-001, 2012ZX10004-215]	China Mega-Project for Infectious Diseases	This study was funded by grants from the China Mega-Project for Infectious Diseases (2009ZX10017-016, 2011ZX10004-001 and 2012ZX10004-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; [Anonymous], 2011, MIN HLTH AIDS PREV C; Chen CL, 2002, DRUG METAB DISPOS, V30, P1523, DOI 10.1124/dmd.30.12.1523; Chen J, 2010, THER DRUG MONIT, V32, P573, DOI 10.1097/FTD.0b013e3181ea953c; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gisslen M, 1997, J INFECT DIS, V175, P434, DOI 10.1093/infdis/175.2.434; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Kim HS, 2007, BRIT J CLIN PHARMACO, V64, P645, DOI 10.1111/j.1365-2125.2007.02944.x; Koralage Nadeeja, 2004, BMJ, V328, P975, DOI 10.1136/bmj.328.7446.975-a; Kwara A, 2009, AIDS, V23, P2101, DOI 10.1097/QAD.0b013e3283319908; Kwara A, 2009, BRIT J CLIN PHARMACO, V67, P427, DOI 10.1111/j.1365-2125.2009.03368.x; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Li JY, 2005, CELL RES, V15, P843, DOI 10.1038/sj.cr.7290356; PILERI SA, 1991, HISTOPATHOLOGY, V19, P131, DOI 10.1111/j.1365-2559.1991.tb00003.x; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Smith MZ, 2012, CURR HIV-AIDS REP, V9, P5, DOI 10.1007/s11904-011-0108-2; Stormer E, 2002, PHARMACEUT RES, V19, P1038, DOI 10.1023/A:1016430825740; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; UNAIDS, 2011, HIV AS PAC GETT ZER, P27; Veal GJ, 1995, GEN PHARMACOL, V26, P1469, DOI 10.1016/0306-3623(95)00047-X; Weinberg Jennifer L, 2010, Virtual Mentor, V12, P202, DOI 10.1001/virtualmentor.2010.12.3.cprl1-1003; WHO, 2010, ANT THER HIV INF AD; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhou ZX, 2006, ANTIMICROB AGENTS CH, V50, P2686, DOI 10.1128/AAC.01637-05	31	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55197	10.1371/journal.pone.0055197	http://dx.doi.org/10.1371/journal.pone.0055197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372834	Green Submitted, gold, Green Published			2022-12-27	WOS:000315210400074
J	Brennan, GP; Jimenez-Mateos, EM; McKiernan, RC; Engel, T; Tzivion, G; Henshall, DC				Brennan, Gary P.; Jimenez-Mateos, Eva M.; McKiernan, Ross C.; Engel, Tobias; Tzivion, Guri; Henshall, David C.			Transgenic Overexpression of 14-3-3 Zeta Protects Hippocampus against Endoplasmic Reticulum Stress and Status Epilepticus In Vivo	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INDUCED NEURONAL DEATH; EXPERIMENTALLY EVOKED SEIZURES; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; ER STRESS; MISFOLDED PROTEINS; CELL-DEATH; APOPTOSIS; MICE	14-3-3 proteins are ubiquitous molecular chaperones that are abundantly expressed in the brain where they regulate cell functions including metabolism, the cell cycle and apoptosis. Brain levels of several 14-3-3 isoforms are altered in diseases of the nervous system, including epilepsy. The 14-3-3 zeta (zeta) isoform has been linked to endoplasmic reticulum (ER) function in neurons, with reduced levels provoking ER stress and increasing vulnerability to excitotoxic injury. Here we report that transgenic overexpression of 14-3-3 zeta in mice results in selective changes to the unfolded protein response pathway in the hippocampus, including down-regulation of glucose-regulated proteins 78 and 94, activating transcription factors 4 and 6, and Xbp1 splicing. No differences were found between wild-type mice and transgenic mice for levels of other 14-3-3 isoforms or various other 14-3-3 binding proteins. 14-3-3 zeta overexpressing mice were potently protected against cell death caused by intracerebroventricular injection of the ER stressor tunicamycin. 14-3-3 zeta overexpressing mice were also potently protected against neuronal death caused by prolonged seizures. These studies demonstrate that increased 14-3-3 zeta levels protect against ER stress and seizure-damage despite down-regulation of the unfolded protein response. Delivery of 14-3-3 zeta may protect against pathologic changes resulting from prolonged or repeated seizures or where injuries provoke ER stress.	[Brennan, Gary P.; Jimenez-Mateos, Eva M.; McKiernan, Ross C.; Engel, Tobias; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Tzivion, Guri] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Royal College of Surgeons - Ireland; University of Mississippi; University of Mississippi Medical Center	Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Jimenez-Mateos, Eva/AAG-8072-2019; Brennan, Gary/K-4009-2019	Brennan, Gary/0000-0002-4262-0481; Engel, Tobias/0000-0001-9137-0637; Jimenez-Mateos, Eva/0000-0001-6417-6580; Henshall, David/0000-0001-6237-9632	Science Foundation Ireland [08/IN.1/B1875, 08/RFP/1745]; Health Research Board award [HRA-POR/2011/41]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board award	This study was funded by Science Foundation Ireland awards 08/IN.1/B1875 and 08/RFP/1745 and by Health Research Board award HRA-POR/2011/41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Concannon CG, 2008, J NEUROCHEM, V105, P891, DOI 10.1111/j.1471-4159.2007.05187.x; Dunleavy M, 2010, AM J PATHOL, V176, P330, DOI 10.2353/ajpath.2010.090119; Engel T, 2012, FASEB J, V26, P1616, DOI 10.1096/fj.11-196089; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Engel T, 2010, J NEUROCHEM, V115, P92, DOI 10.1111/j.1471-4159.2010.06909.x; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Fujikawa DG, 2006, STATUS EPILEPTICUS M, V36, P463; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Henshall DC, 2002, J NEUROSCI, V22, P8458; Henshall DC, 2012, JASPERS BASIC MECH E, P262; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Lin JH, 2007, ANN REV PATHOL; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu GL, 2012, NEUROL SCI; Liu GL, 2011, BRAIN RES BULL, V84, P94, DOI 10.1016/j.brainresbull.2010.10.004; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Maruo K, 2003, BRAIN RES, V977, P294, DOI 10.1016/S0006-8993(03)02838-5; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Murphy N, 2008, BIOMARKERS, V13, P377, DOI 10.1080/13547500802027971 ; Murphy N, 2008, J NEUROCHEM, V106, P978, DOI 10.1111/j.1471-4159.2008.05447.x; Nellist M, 2002, J BIOL CHEM, V277, P39417, DOI 10.1074/jbc.M204802200; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Olney J W, 1986, Adv Neurol, V44, P857; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Ramser EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013462; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tanaka K, 2010, EPILEPSY RES, V88, P151, DOI 10.1016/j.eplepsyres.2009.10.012; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Umahara T, 2011, BRAIN RES, V1410, P1, DOI 10.1016/j.brainres.2011.06.036; van der Brug MP, 2002, BRAIN RES, V956, P110, DOI 10.1016/S0006-8993(02)03487-X; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; WANG S, 1993, NEUROCHEM INT, V23, P575, DOI 10.1016/0197-0186(93)90106-F; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	55	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54491	10.1371/journal.pone.0054491	http://dx.doi.org/10.1371/journal.pone.0054491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359526	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600061
J	Galic, N; Hengeveld, GM; Van den Brink, PJ; Schmolke, A; Thorbek, P; Bruns, E; Baveco, HM				Galic, Nika; Hengeveld, Geerten M.; Van den Brink, Paul J.; Schmolke, Amelie; Thorbek, Pernille; Bruns, Eric; Baveco, Hans M.			Persistence of Aquatic Insects across Managed Landscapes: Effects of Landscape Permeability on Re-Colonization and Population Recovery	PLOS ONE			English	Article							MIDGE CHIRONOMUS-RIPARIUS; FRESH-WATER BIODIVERSITY; CORRELATED RANDOM-WALKS; DIPTERA-CHIRONOMIDAE; DISPERSAL STRATEGIES; PATCHY LANDSCAPES; FOOD AVAILABILITY; MODELING APPROACH; SPATIAL DYNAMICS; STREAM INSECTS	Human practices in managed landscapes may often adversely affect aquatic biota, such as aquatic insects. Dispersal is often the limiting factor for successful re-colonization and recovery of stressed habitats. Therefore, in this study, we evaluated the effects of landscape permeability, assuming a combination of riparian vegetation (edge permeability) and other vegetation (landscape matrix permeability), and distance between waterbodies on the colonization and recovery potential of weakly flying insects. For this purpose, we developed two models, a movement and a population model of the non-biting midge, Chironomus riparius, an aquatic insect with weak flying abilities. With the movement model we predicted the outcome of dispersal in a landscape with several linear water bodies (ditches) under different assumptions regarding landscape-dependent movement. Output from the movement model constituted the probabilities of encountering another ditch and of staying in the natal ditch or perishing in the landscape matrix, and was used in the second model. With this individual-based model of midge populations, we assessed the implications for population persistence and for recovery potential after an extreme stress event. We showed that a combination of landscape attributes from the movement model determines the fate of dispersing individuals and, once extrapolated to the population level, has a big impact on the persistence and recovery of populations. Population persistence benefited from low edge permeability as it reduced the dispersal mortality which was the main factor determining population persistence and viability. However, population recovery benefited from higher edge permeability, but this was conditional on the low effective distance that ensured fewer losses in the landscape matrix. We discuss these findings with respect to possible landscape management scenarios.	[Galic, Nika; Van den Brink, Paul J.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [Hengeveld, Geerten M.; Van den Brink, Paul J.; Baveco, Hans M.] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [Hengeveld, Geerten M.] NIOO KNAW, Workgrp Movement Ecol, Netherlands Inst Ecol, Wageningen, Netherlands; [Schmolke, Amelie] UFZ, Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Thorbek, Pernille] Syngenta Ltd, Bracknell, Berks, England; [Bruns, Eric] Bayer CropSci, Monheim, Germany	Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Syngenta; Bayer AG; Bayer CropScience	Galic, N (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	ngalic@gmail.com	van den brink, Paul/AAT-7144-2020; van den Brink, Paul J/E-8315-2013; Thorbek, Pernille/HGV-0078-2022; Hengeveld, Geerten/O-8943-2019; Schmolke, Amelie/AAX-1810-2021; KNAW, NIOO-KNAW/A-4320-2012	van den brink, Paul/0000-0002-7241-4347; KNAW, NIOO-KNAW/0000-0002-3835-159X; Galic, Nika/0000-0002-4344-3464; Schmolke, Amelie/0000-0002-8114-7287; Hengeveld, Geerten/0000-0002-9592-3080	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Wageningen University and Research centre; Syngenta LtD.; Bayer CropScience	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Wageningen University and Research centre; Syngenta LtD.; Bayer CropScience(Bayer AG)	This study was supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation, Wageningen University and Research centre, Syngenta LtD. and Bayer CropScience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2007, AM NAT, V170, P819, DOI 10.1086/522837; Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Barton KA, 2009, OIKOS, V118, P309, DOI 10.1111/j.1600-0706.2008.16936.x; BERG M, 1992, AQUATIC ECOLOGY, V26, P471; Best D. J., 1979, J R STAT SOC C, V28, P152, DOI DOI 10.2307/2346732); Blakely TJ, 2006, FRESHWATER BIOL, V51, P1634, DOI 10.1111/j.1365-2427.2006.01601.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bond N. R., 2003, Ecological Management & Restoration, V4, P193, DOI 10.1046/j.1442-8903.2003.00156.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Briers RA, 2004, HYDROL EARTH SYST SC, V8, P545, DOI 10.5194/hess-8-545-2004; Briers RA, 2004, FRESHWATER BIOL, V49, P425, DOI 10.1111/j.1365-2427.2004.01198.x; Briers RA, 2002, ARCH HYDROBIOL, V155, P627; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Caquet T, 2007, ENVIRON TOXICOL CHEM, V26, P1280, DOI 10.1897/06-250R.1; Chan EKW, 2007, MAR FRESHWATER RES, V58, P725, DOI 10.1071/MF07033; Chaput-Bardy A, 2009, ECOL MODEL, V220, P3589, DOI 10.1016/j.ecolmodel.2009.06.027; Charles S, 2004, ECOL MODEL, V175, P217, DOI 10.1016/j.ecolmodel.2003.10.016; DELETTRE Y, 1992, LANDSCAPE ECOL, V6, P175; Delettre YR, 2000, FRESHWATER BIOL, V44, P399, DOI 10.1046/j.1365-2427.2000.00578.x; Delettre YR, 2005, PEDOBIOLOGIA, V49, P15, DOI 10.1016/j.pedobi.2004.06.010; Didham RK, 2012, FUND APPL LIMNOL, V180, P27, DOI 10.1127/1863-9135/2012/0243; DOWNE AER, 1973, CAN ENTOMOL, V105, P291, DOI 10.4039/Ent105291-2; Ducrot V, 2004, ENVIRON TOXICOL CHEM, V23, P225, DOI 10.1897/03-52; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dudgeon D, 2010, CURR OPIN ENV SUST, V2, P422, DOI 10.1016/j.cosust.2010.09.001; Eggermont H, 2011, BIOL REV; Elkin CM, 2008, AM NAT, V172, P563, DOI 10.1086/590962; Galic N, 2012, ENVIRON POLLUT, V163, P91, DOI 10.1016/j.envpol.2011.12.024; Greenwood MJ, 2011, J APPL ECOL, P213; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Hladyz S, 2011, ADV ECOL RES, V44, P211, DOI 10.1016/B978-0-12-374794-5.00004-3; JACKSON JK, 1989, ENVIRON ENTOMOL, V18, P278, DOI 10.1093/ee/18.2.278; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Macneale KH, 2005, FRESHWATER BIOL, V50, P1117, DOI 10.1111/j.1365-2427.2005.01387.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Moreno-Mateos D, 2012, NATURE, V482, P8; OLIVER DR, 1971, ANNU REV ENTOMOL, V16, P211, DOI 10.1146/annurev.en.16.010171.001235; Pery ARR, 2004, ECOTOXICOLOGY, V13, P647, DOI 10.1007/s10646-003-4425-0; Pery ARR, 2002, ENVIRON TOXICOL CHEM, V21, P2507, DOI [10.1897/1551-5028(2002)021<2507:AMATLF>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2507:AMATLF&gt;2.0.CO;2]; Petersen I, 2004, J APPL ECOL, V41, P934, DOI 10.1111/j.0021-8901.2004.00942.x; Petersen I, 1999, FRESHWATER BIOL, V42, P401, DOI 10.1046/j.1365-2427.1999.00466.x; Reynolds AM, 2010, J R SOC INTERFACE, V7, P1753, DOI 10.1098/rsif.2010.0292; Silver P, 2000, OECOLOGIA, V124, P216, DOI 10.1007/s004420050009; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Spanhoff B, 2007, RESTOR ECOL, V15, P317, DOI 10.1111/j.1526-100X.2007.00216.x; Tokeshi M, 1996, J ZOOL, V240, P103, DOI 10.1111/j.1469-7998.1996.tb05488.x; Trekels H, 2011, J APPL ECOL, V48, P1480, DOI 10.1111/j.1365-2664.2011.02053.x; Veraart AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018508; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wesner JS, 2010, OIKOS, V119, P170, DOI 10.1111/j.1600-0706.2009.17687.x; Whitaker DM, 2000, CAN J ZOOL, V78, P740, DOI 10.1139/cjz-78-5-740; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	60	24	24	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54584	10.1371/journal.pone.0054584	http://dx.doi.org/10.1371/journal.pone.0054584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365675	gold, Green Published			2022-12-27	WOS:000314023600076
J	Golic, A; Vaneechoutte, M; Nemec, A; Viale, AM; Actis, LA; Mussi, MA				Golic, Adrian; Vaneechoutte, Mario; Nemec, Alexandr; Viale, Alejandro M.; Actis, Luis A.; Alejandra Mussi, Maria			Staring at the Cold Sun: Blue Light Regulation Is Distributed within the Genus Acinetobacter	PLOS ONE			English	Article							SP NOV.; BIOFILM FORMATION; ABIOTIC SURFACES; GENOME SEQUENCE; BAUMANNII; CALCOACETICUS; IDENTIFICATION; PATHOGEN; MOTILITY	We previously showed that the opportunistic nosocomial pathogen Acinetobacter baumannii is able to sense and respond to light via BlsA, a BLUF (Blue-Light-sensing Using FAD)-domain photoreceptor protein. Here, we extend our previous studies showing that light regulation is not restricted to A. baumannii, but rather widespread within the genus Acinetobacter. First, we found that blue light modulates motility and biofilm formation in many species of the genus, including members of the Acinetobacter calcoaceticus-A. baumannii complex. In many of these species blue light acts as a key factor guiding the decision between motility or sessility at 24 degrees C, whereas in A. baumannii, light inhibits both motility and biofilm formation. We also show that light regulation of motility occurred not only at 24 degrees C but also at 37 degrees C in non-A. baumannii species, contrasting the situation of A. baumannii which only shows photoregulation at 24 degrees C. Second, we show that Acinetobacter baylyi (strain ADP1) BLUF-photoreceptors can functionally replace in vivo the A. baumannii 17978 BlsA protein and that the pathways leading to biofilm formation are inversely regulated at 24 degrees C between these two microorganisms. Finally, we found the presence of predicted genes coding BLUF-containing proteins in all Acinetobacter sequenced genomes, even though the copy number is variable among them. Phylogenetic analysis suggests a common origin for all BLUF domains present in members of this genus, and could distinguish well-differentiated clusters that group together BLUF homologs from different species, a situation particularly clear for members of the ACB complex. Despite a role played by these BLUF domain-containing proteins in the photoregulation observed in the members of the genus Acinetobacter is a likely scenario given our findings in A. baumannii and A. baylyi, further research will contribute to confirm this possibility.	[Golic, Adrian; Viale, Alejandro M.; Alejandra Mussi, Maria] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Vaneechoutte, Mario] Univ Ghent, Ghent Univ Hosp, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Nemec, Alexandr] Natl Inst Publ Hlth, Lab Bacterial Genet, Prague, Czech Republic	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University System of Ohio; Miami University; Ghent University; Ghent University Hospital; National Institute of Public Health (SZU) - Czech Republic	Mussi, MA (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Microbiol, Inst Biol Mol & Celular Rosario IBR CONICET, RA-2000 Rosario, Santa Fe, Argentina.	mussi@ibr.gov.ar	Vaneechoutte, Mario/A-6189-2009; Nemec, Alexandr/C-4447-2008	Vaneechoutte, Mario/0000-0002-4586-203X; Nemec, Alexandr/0000-0003-0608-9598	CONICET [PIP 326 2011-2013, PIP 114-200801-00469]; ANPCyT [PICT 25972]; Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe	CONICET PIP 326 2011-2013 (www.conicet.gov.ar), PIP 114-200801-00469 (www.conicet.gov.ar), ANPCyT PICT 25972 (www.agencia.gov.ar), Secretaria de Estado de Ciencia, Tecnologia e Innovacion de la Provincia de Santa Fe, Grant 2012 (www.santafe.gov.ar/index.php/web/content/view/full/93773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2010, J MICROBIOL, V48, P36, DOI 10.1007/s12275-009-0132-8; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Carr EL, 2003, INT J SYST EVOL MICR, V53, P953, DOI 10.1099/ijs.0.02486-0; Clinical and Laboratory Standards Institute, 2006, PERFORMANCE STANDARD; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Malhotra J, 2012, INT J SYST EVOL MICR; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Mussi MA, 2011, J BACTERIOL, V193, P4736, DOI 10.1128/JB.01533-10; Nemec A, 2003, INT J SYST EVOL MICR, V53, P1563, DOI 10.1099/ijs.0.02631-0; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nemec A, 2010, INT J SYST EVOL MICR, V60, P896, DOI 10.1099/ijs.0.013656-0; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; NISHIMURA Y, 1981, Z ALLG MIKROBIOL, V21, P125, DOI 10.1002/jobm.3630210208; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Sambrook J., 2001, MOL CLONING LAB MANU; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Soslau G, 2011, FEMS MICROBIOL LETT, V322, P166, DOI 10.1111/j.1574-6968.2011.02346.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; TOWNER KJ, 1991, FEMS SYMP, V57, P1; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006; Vaneechoutte M., 2011, MANUAL CLIN MICROBIO, P714; Vaneechoutte M, 2009, INT J SYST EVOL MICR, V59, P1376, DOI 10.1099/ijs.0.003541-0; Vaz-Moreira I, 2011, INT J SYST EVOL MICR, V61, P2837, DOI 10.1099/ijs.0.027045-0; Zan J, 2012, MOL MICROBIOL IN PRE; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11	41	29	31	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55059	10.1371/journal.pone.0055059	http://dx.doi.org/10.1371/journal.pone.0055059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358859	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600147
J	Huang, ZYX; de Boer, WF; van Langevelde, F; Olson, V; Blackburn, TM; Prins, HHT				Huang, Zheng Y. X.; de Boer, Willem F.; van Langevelde, Frank; Olson, Valerie; Blackburn, Tim M.; Prins, Herbert H. T.			Species' Life-History Traits Explain Interspecific Variation in Reservoir Competence: A Possible Mechanism Underlying the Dilution Effect	PLOS ONE			English	Article							WEST-NILE-VIRUS; IMMUNE DEFENSES; BODY-SIZE; DISEASE; DIVERSITY; BIODIVERSITY; INFECTION; BIRDS; TRANSMISSION; COMMUNITY	Hosts species for multi-host pathogens show considerable variation in the species' reservoir competence, which is usually used to measure species' potential to maintain and transmit these pathogens. Although accumulating research has proposed a trade-off between life-history strategies and immune defences, only a few studies extended this to host species' reservoir competence. Using a phylogenetic comparative approach, we studied the relationships between some species' life-history traits and reservoir competence in three emerging infectious vector-borne disease systems, namely Lyme disease, West Nile Encephalitis (WNE) and Eastern Equine Encephalitis (EEE). The results showed that interspecific variation in reservoir competence could be partly explained by the species' life histories. Species with larger body mass (for hosts of Lyme disease and WNE) or smaller clutch size (for hosts of EEE) had a higher reservoir competence. Given that both larger body mass and smaller clutch size were linked to higher extinction risk of local populations, our study suggests that with decreasing biodiversity, species with a higher reservoir competence are more likely to remain in the community, and thereby increase the risk of transmitting these pathogens, which might be a possible mechanism underlying the dilution effect.	[Huang, Zheng Y. X.; de Boer, Willem F.; van Langevelde, Frank; Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Olson, Valerie] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Olson, Valerie; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Blackburn, Tim M.] King Saud Univ, Distinguished Scientist Fellowship Program, Riyadh, Saudi Arabia	Wageningen University & Research; University of Bath; Zoological Society of London; King Saud University	Huang, ZYX (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	zheng.huang@wur.nl	Blackburn, Tim/AAC-3144-2019; Blackburn, Tim M/A-7685-2011	Blackburn, Tim/0000-0003-0152-2663; Van Langevelde, Frank/0000-0001-8870-0797; Prins, Herbert/0000-0003-1131-5107	Chinese Scholarship Council	Chinese Scholarship Council(China Scholarship Council)	This work is funded by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cunningham AA, 2012, PHILOS T R SOC B, V367, P2804, DOI 10.1098/rstb.2012.0331; Eisen L, 2003, J MED ENTOMOL, V40, P311, DOI 10.1603/0022-2585-40.3.311; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2009, P ROY SOC B-BIOL SCI, V276, P1657, DOI 10.1098/rspb.2008.1718; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Martin II LB, 2006, OECOLOGIA, V147, P565, DOI 10.1007/s00442-005-0314-y; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; ROBINSON JG, 1986, AM NAT, V128, P665, DOI 10.1086/284596; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011	41	89	91	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54341	10.1371/journal.pone.0054341	http://dx.doi.org/10.1371/journal.pone.0054341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365661	gold, Green Published			2022-12-27	WOS:000314023600049
J	Jin, Y; Qiu, MZ; Wang, DS; Zhang, DS; Ren, C; Bai, L; Luo, HY; Wang, ZQ; Wang, FH; Li, YH; Xu, RH				Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy	PLOS ONE			English	Article							CURATIVE RESECTION; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; METAANALYSIS; THERAPY; SURGERY; ADENOCARCINOMA; STOMACH; AGE	Background: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly. This study aims to investigate the use of adjuvant chemotherapy for gastric cancer after D2 gastrectomy among the elderly and identify its impact on survival. Methods: We retrospectively reviewed 360 patients who had undergone D2 gastrectomy, aged 65 years or older, with non-metastatic gastric cancer in a single institution. We analyzed the predictors and survival benefits of adjuvant chemotherapy use in the elderly. Further, we analyzed the survival benefits of adjuvant chemotherapy by dividing the patients into groups according to disease stages and chemotherapeutic regimens. Results: Among the 360 patients, only 34.7% of patients received adjuvant chemotherapy. Age, tumor location, lymph node involvement and tumor invasion were associated with the receipt of adjuvant chemotherapy. Adjuvant chemotherapy improved the overall survival for non-metastatic elderly patients (HR 0.60, 95%CI 0.42-0.83, P = 0.003). Significant survival benefits were found with adjuvant chemotherapy in stage III patients (HR 0.67, 95%CI 0.47-0.97, P = 0.033), but not in stage I patients or in stage II patients (HR 0.52, 95%CI 0.21-1.30 P = 0.161). Compared to adjuvant chemotherapy without platinum, no significant survival benefits were observed with platinum-containing chemotherapy (HR 0.84, 95%CI 0.49-1.45, P = 0.530). Besides adjuvant chemotherapy, other independent prognostic factors of survival included tumor location, tumor size, histologic grade, depth of tumor invasion, and lymph node status. Conclusions: This study demonstrated the survival benefits of adjuvant fluoropyrimidine-based chemotherapy among the elderly patients with non-metastatic gastric cancer after D2 gastrectomy. However, due to the limitations of this study, further well-designed prospective studies with large populations are needed to confirm these findings and identify the patients that can tolerate and benefit from adjuvant chemotherapy.	[Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Jin, Ying; Qiu, Miao-zhen; Wang, De-shen; Zhang, Dong-sheng; Ren, Chao; Bai, Long; Luo, Hui-yan; Wang, Zhi-qiang; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, RH (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	骆, 卉妍/GWR-3383-2022; Xu, Rui-Hua/AAW-4766-2021; xu, rui/GRX-5734-2022	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534; 				Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Barthelemy P, 2011, CRIT REV ONCOL HEMAT, V79, P196, DOI 10.1016/j.critrevonc.2010.06.005; Bouvier AM, 2008, CANCER, V113, P879, DOI 10.1002/cncr.23629; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen SM, 2004, DRUG AGING, V21, P437, DOI 10.2165/00002512-200421070-00003; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dittmar Y, 2012, WORLD J SURG, V36, P338, DOI 10.1007/s00268-011-1395-x; Dudeja V, 2011, ANN SURG ONCOL, V18, P26, DOI 10.1245/s10434-010-1215-9; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Hoffman KE, 2012, CANCER-AM CANCER SOC, V118, P248, DOI 10.1002/cncr.26248; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Liu TS, 2008, EJSO-EUR J SURG ONC, V34, P1208, DOI 10.1016/j.ejso.2008.02.002; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; Msika S, 2000, EUR J CANCER, V36, P390, DOI 10.1016/S0959-8049(99)00308-1; Panzini I, 2002, TUMORI J, V88, P21; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Sakuramoto S, 2009, WORLD J GASTRO ONCOL, V1, P47, DOI 10.4251/wjgo.v1.i1.47; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Strauss J, 2010, INT J RADIAT ONCOL, V76, P1404, DOI 10.1016/j.ijrobp.2009.03.050; YU CCW, 1995, BRIT J CANCER, V71, P1106, DOI 10.1038/bjc.1995.214; Zhao SL, 2008, CANCER INVEST, V26, P317, DOI 10.1080/07357900701834686	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53149	10.1371/journal.pone.0053149	http://dx.doi.org/10.1371/journal.pone.0053149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359796	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600010
J	Qureshi, A; Thakur, N; Kumar, M				Qureshi, Abid; Thakur, Nishant; Kumar, Manoj			HIPdb: A Database of Experimentally Validated HIV Inhibiting Peptides	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; CONSTRAINED PEPTIDES; DESIGN; INTEGRASE; LIBRARIES; REPLICATION; PREDICTION; DISCOVERY; ENTRY	Background: Besides antiretroviral drugs, peptides have also demonstrated potential to inhibit the Human immunodeficiency virus (HIV). For example, T20 has been discovered to effectively block the HIV entry and was approved by the FDA as a novel anti-HIV peptide (AHP). We have collated all experimental information on AHPs at a single platform. Descriptions: HIPdb is a manually curated database of experimentally verified HIV inhibiting peptides targeting various steps or proteins involved in the life cycle of HIV e.g. fusion, integration, reverse transcription etc. This database provides experimental information of 981 peptides. These are of varying length obtained from natural as well as synthetic sources and tested on different cell lines. Important fields included are peptide sequence, length, source, target, cell line, inhibition/IC50, assay and reference. The database provides user friendly browse, search, sort and filter options. It also contains useful services like BLAST and 'Map' for alignment with user provided sequences. In addition, predicted structure and physicochemical properties of the peptides are also included. Conclusion: HIPdb database is freely available at http://crdd.osdd.net/servers/hipdb. Comprehensive information of this database will be helpful in selecting/designing effective anti-HIV peptides. Thus it may prove a useful resource to researchers for peptide based therapeutics development.	[Qureshi, Abid; Thakur, Nishant; Kumar, Manoj] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumar, M (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	manojk@imtech.res.in	Thakur, Nishant/L-7590-2016; Qureshi, Abid/AAA-1511-2021; Kumar, Manoj/G-1274-2010	Qureshi, Abid/0000-0002-1140-1649; Kumar, Manoj/0000-0003-3769-052X	Council of Scientific and Industrial Research (CSIR), India, CSIR-Institute of Microbial Technology	Council of Scientific and Industrial Research (CSIR), India, CSIR-Institute of Microbial Technology	This work was supported by the Council of Scientific and Industrial Research (CSIR), India, CSIR-Institute of Microbial Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian A, 2009, J BIOL CHEM, V284, P254, DOI 10.1074/jbc.M802199200; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Boussard C, 2002, EUR J MED CHEM, V37, P883, DOI 10.1016/S0223-5234(02)01412-5; Castel G, 2011, MOLECULES, V16, P3499, DOI 10.3390/molecules16053499; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; Gleenberg IO, 2005, J BIOL CHEM, V280, P21987, DOI 10.1074/jbc.M414679200; Gleenberg IO, 2007, J MOL BIOL, V369, P1230, DOI 10.1016/j.jmb.2007.03.073; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Huther A, 2007, AIDS REV, V9, P208; Jiang Hongbing, 2011, Antiviral Chemistry & Chemotherapy, V22, P119, DOI 10.3851/IMP1902; Jin BS, 2000, AIDS RES HUM RETROV, V16, P1797, DOI 10.1089/08892220050195757; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kaushik-Basu N, 2008, BIODRUGS, V22, P161, DOI 10.2165/00063030-200822030-00003; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; RAUSCH DM, 1990, ANN NY ACAD SCI, V616, P125; Real E, 2004, J VIROL, V78, P7410, DOI 10.1128/JVI.78.14.7410-7417.2004; Schramm HJ, 1996, ANTIVIR RES, V30, P155, DOI 10.1016/0166-3542(96)00940-0; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; STEFANO KA, 1993, J VIROL, V67, P6707, DOI 10.1128/JVI.67.11.6707-6715.1993; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pD230, DOI 10.1093/nar/gkr1147; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tyagi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025917; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Yao XJ, 2002, J BIOL CHEM, V277, P48816, DOI 10.1074/jbc.M207982200	34	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54908	10.1371/journal.pone.0054908	http://dx.doi.org/10.1371/journal.pone.0054908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359817	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600135
J	Ye, XF; Wang, HZ; Zhou, JX; Li, HQ; Liu, J; Wang, Z; Chen, AQ; Zhao, Q				Ye, Xiaofeng; Wang, Haozhe; Zhou, Jingxin; Li, Haiqing; Liu, Jun; Wang, Zhe; Chen, Anqing; Zhao, Qiang			The Effect of Heparin-VEGF Multilayer on the Biocompatibility of Decellularized Aortic Valve with Platelet and Endothelial Progenitor Cells	PLOS ONE			English	Article							OUTFLOW TRACT RECONSTRUCTION; CONGENITAL HEART-DISEASE; IN-VITRO; TISSUE; SURFACE; MATRIX; GROWTH; BLOOD; FILMS; RECELLULARIZATION	The application of polyelectrolyte multilayer films is a new, versatile approach to surface modification of decellularized tissue, which has the potential to greatly enhance the functionality of engineered tissue constructs derived from decellularized organs. In the present study, we test the hypothesis that Heparin-vascular endothelial growth factor (VEGF) multilayer film can not only act as an antithrombotic coating reagent, but also induce proliferation of endothelial progenitor cells (EPCs) on the decellularized aortic heart valve. SEM demonstrated the adhesion and geometric deformation of platelets. The quantitative assay of platelet activation was determined by measuring the production of soluble P-selectin. Binding and subsequent release of heparin and VEGF from valve leaflets were assessed qualitatively by laser confocal scanning microscopy and quantitatively by ELISA methods. Human blood derived EPCs were cultured and the adhesion and growth of EPCs on the surface modified valvular scaffolds were assessed. The results showed that Heparin-VEGF multilayer film improved decellularized valve haemocompatibility with respect to a substantial reduction of platelet adhesion. Release of VEGF from the decellularized heart valve leaflets at physiological conditions was sustained over 5 days. In vitro biological tests demonstrated that EPCs achieved better adhesion, proliferation and migration on the coatings with Heparin-VEGF multilayer film. Combined, these results indicate that Heparin-VEGF multilayer film could be used to cover the decellularized porcine aortic valve to decrease platelet adhesion while exhibiting excellent EPCs biocompatibility.	[Ye, Xiaofeng; Wang, Haozhe; Zhou, Jingxin; Li, Haiqing; Liu, Jun; Wang, Zhe; Chen, Anqing; Zhao, Qiang] Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiac Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.	zq11607@rjh.com.cn		Zhou, Jingxin/0000-0003-0471-1961	National Natural Science Foundation of China [81000096]; Shanghai Municipal Science and Technology Commission of Natural Science Foundation [11ZR1422500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission of Natural Science Foundation	The research was partially financially supported by the National Natural Science Foundation of China (81000096) and Shanghai Municipal Science and Technology Commission of Natural Science Foundation (11ZR1422500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X; Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161; Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; De Cock LJ, 2010, BIOMACROMOLECULES, V11, P1002, DOI 10.1021/bm9014649; Kasimir MT, 2006, J HEART VALVE DIS, V15, P278; Konertz W, 2011, J HEART VALVE DIS, V20, P341; Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010; Perri G, 2012, EUR J CARDIO-THORAC, V41, P1320, DOI 10.1093/ejcts/ezr221; Richard D, 2010, SMALL, V6, P2405, DOI 10.1002/smll.201000228; Rippel RA, 2012, WORLD J SURG, V36, P1581, DOI 10.1007/s00268-012-1535-y; Ruel M, 2007, CIRCULATION, V116, pI294, DOI 10.1161/CIRCULATIONAHA.106.681429; Schopka S, 2009, J BIOMED MATER RES B, V88B, P130, DOI 10.1002/jbm.b.31159; Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027; Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Stamm C, 2004, ANN THORAC SURG, V78, P2084, DOI 10.1016/j.athoracsur.2004.03.106; Tan QG, 2005, J MATER SCI-MATER M, V16, P687, DOI 10.1007/s10856-005-2541-5; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Wilcox HE, 2005, J HEART VALVE DIS, V14, P228; Ye XF, 2012, ACTA BIOMATER, V8, P1057, DOI 10.1016/j.actbio.2011.11.011; Ye XF, 2009, TISSUE ENG PT A, V15, P1, DOI 10.1089/ten.tea.2008.0001; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	27	33	37	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54622	10.1371/journal.pone.0054622	http://dx.doi.org/10.1371/journal.pone.0054622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359625	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600079
J	Araripe, J; do Rego, PS; Queiroz, H; Sampaio, I; Schneider, H				Araripe, Juliana; do Rego, Pericles Sena; Queiroz, Helder; Sampaio, Iracilda; Schneider, Horacio			Dispersal Capacity and Genetic Structure of Arapaima gigas on Different Geographic Scales Using Microsatellite Markers	PLOS ONE			English	Article							SOFTWARE; SCHINZ	Despite the ecological and economic importance of the Arapaima gigas (Cuvier 1817), few data about its dispersal capacity are available. The present study was based on the analysis of microsatellite markers in order to estimate the dispersal capacity of the species on fine, meso, and large geographic scales. For this, 561 specimens obtained from stocks separated by distances of up to 25 km (fine scale), 100 km (meso scale), and 1300-2300 km (large scale) were analyzed. The fine scale analysis indicated a marked genetic similarity between lakes, with low genetic differentiation, and significant differences between only a few pairs of sites. Low to moderate genetic differentiation was observed between pairs of sites on a meso scale (100 km), which could be explained by the distances between sites. By contrast, major genetic differentiation was recorded in the large scale analysis, that is, between stocks separated by distances of over 1300 km, with the analysis indicating that differentiation was not related solely to distance. The genetic structuring analysis indicated the presence of two stocks, one represented by the arapaimas of the Mamiraua Reserve, and the other by those of Santarem and Tucurui. The dispersal of arapaimas over short distances indicates a process of lateral migration within the varzea floodplains, which may be the principal factor determining the considerable homogeneity observed among the varzea lakes. The populations separated by distances of approximately 100 km were characterized by reduced genetic differentiation, which was associated with the geographic distances between sites. Populations separated by distances of over 1300 km were characterized by a high degree of genetic differentiation, which may be related primarily to historical bottlenecks in population size and the sedentary behavior of the species. Evidence was found of asymmetric gene flow, resulting in increasing genetic variability in the population of the Mamiraua Reserve.	[Araripe, Juliana; do Rego, Pericles Sena; Sampaio, Iracilda; Schneider, Horacio] Fed Univ Para, Inst Estudos Costeiros, Braganca, Para, Brazil; [Queiroz, Helder] Inst Desenvolvimento Sustentavel Mamiraua, Tefe, Amazonas, Brazil	Universidade Federal do Para	Araripe, J (corresponding author), Fed Univ Para, Inst Estudos Costeiros, Campus Braganca, Braganca, Para, Brazil.	araripe@ufpa.br	Schneider, Horacio/J-7131-2012; Araripe, Juliana/J-3248-2012; Queiroz, Helder/M-3049-2019; Queiroz, Helder/A-4199-2010; Rêgo, Péricles S/J-2620-2012; Araripe, Juliana/N-9071-2019; SAMPAIO, IRACILDA/J-6514-2012; Araripe, Juliana/U-4665-2018	Schneider, Horacio/0000-0002-5987-6395; Queiroz, Helder/0000-0002-4425-3208; Queiroz, Helder/0000-0002-4425-3208; Rêgo, Péricles S/0000-0002-4537-946X; Araripe, Juliana/0000-0002-8014-3081; SAMPAIO, IRACILDA/0000-0002-2137-4656; Araripe, Juliana/0000-0002-8014-3081	MCT/CNPq/PPG-7 [556893/2005-0, 48/2005 - Phase II SPC T]; PROPESP/UFPA; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FADESP	MCT/CNPq/PPG-7(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPESP/UFPA; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FADESP	This research was supported by grant 556893/2005-0 (MCT/CNPq/PPG-7 edital No. 48/2005 - Phase II SPC & T) and PROPESP/UFPA, CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br); PROPESP/UFPA (www.propesp.ufpa.br); FADESP (www.fadesp.org.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOL CONSERVACAO MAN; Arantes CC, 2010, ECOL FRESHW FISH, V19, P455, DOI 10.1111/j.1600-0633.2010.00431.x; ARANTES CC, 2006, UAKARI, V2, P37; Ayres J.M., 1995, MATAS VARZEA MAMIRAU; Barthem R., 1997, CATFISH CONNECTION E; Barthem RB, 2004, PESCA RECURSOS PESQU, P272; Buil-Aranda C, 2011, LECT NOTES COMPUT SC, V6644, P1, DOI 10.1007/978-3-642-21064-8_1; Castello L, 2008, J FISH BIOL, V72, P1520, DOI 10.1111/j.1095-8649.2007.01778.x; Castello L, 2008, ECOL FRESHW FISH, V17, P38, DOI 10.1111/j.1600-0633.2007.00255.x; Castello L, 2010, J APPL ICHTHYOL, V26, P49, DOI 10.1111/j.1439-0426.2009.01355.x; Castello L, 2009, ENVIRON MANAGE, V43, P197, DOI 10.1007/s00267-008-9220-5; Environmental Systems Research Institute [ESRI], 2008, SOFTW GEOGR INF SYST; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FabrU N.N., 2005, MANEJO PESCA GRANDES; Farias IP, 2003, MOL ECOL NOTES, V3, P128, DOI 10.1046/j.1471-8286.2003.00375.x; Goudet G. J., 2002, FSTAT PROGRAM WINDOW; Goulding M, 1980, FISHES FOREST EXPLOI; Goulding M., 1996, FLOODS FORTUNE ECOLO; Henderson PA, 1999, ESTRATEGIAS MANEJO R, P1; Hrbek T., 2007, Braz. J. Biol., V67, P909, DOI 10.1590/S1519-69842007000500015; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Isaac V.J., 1993, POVOS AGUAS REALIDAD, P188; Martinelli NMC, 1999, FISHERIES MANAG ECOL, V6, P233, DOI 10.1046/j.1365-2400.1999.00135.x; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Pritchard JK, 2000, GENETICS, V155, P945; Queiroz HL, 1999, ESTRATEGIAS MANEJO R, P108; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrook J., 2001, MOL CLONING LAB MANU; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verissimo J., 1895, PESCA AMAZONIA; Viana J.P., 2007, AREAS AQUATICAS PROT, P239; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060	33	36	36	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54470	10.1371/journal.pone.0054470	http://dx.doi.org/10.1371/journal.pone.0054470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372730	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500076
J	Baldanzi, S; McQuaid, CD; Cannicci, S; Porri, F				Baldanzi, Simone; McQuaid, Christopher D.; Cannicci, Stefano; Porri, Francesca			Environmental Domains and Range-Limiting Mechanisms: Testing the Abundant Centre Hypothesis Using Southern African Sandhoppers	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CRAB EMERITA-BRASILIENSIS; LIMPET COLLISELLA-SCABRA; POPULATION-DYNAMICS; CONSERVATION BIOGEOGRAPHY; TALITRUS-SALTATOR; CLIMATE-CHANGE; NEW-ZEALAND; FOOD SOURCE; SAND BEACH	Predicting shifts of species geographical ranges is a fundamental challenge for conservation ecologists given the great complexity of factors involved in setting range limits. Distributional patterns are frequently modelled to "simplify" species responses to the environment, yet the central mechanisms that drive a particular pattern are rarely understood. We evaluated the distributions of two sandhopper species (Crustacea, Amphipoda, Talitridae), Talorchestia capensis and Africorchestia quadrispinosa along the Namibian and South African coasts, encompassing three biogeographic regions influenced by two different oceanographic systems, the Benguela and Agulhas currents. We aimed to test whether the Abundant Centre Hypothesis (ACH) can explain the distributions of these species' abundances, sizes and sex ratios and examined which environmental parameters influence/drive these distributions. Animals were collected during a once-off survey at 29 sites over c. 3500 km of coastline. The ACH was tested using a non-parametric constraint space analysis of the goodness of fit of five hypothetical models. Distance Based Linear Modelling (DistLM) was performed to evaluate which environmental traits influenced the distribution data. Abundance, size and sex ratio showed different patterns of distribution. A ramped model fitted the abundance (Ramped North) and size (Ramped South) distribution for A. quadrispinosa. The Inverse Quadratic model fitted the size distribution of T. capensis. Beach slope, salinity, sand temperature and percentage of detritus found on the shore at the time of collection played important roles in driving the abundance of A. quadrispinosa. T. capensis was mainly affected by salinity and the morphodynamic state of the beach. Our results provided only some support for the ACH predictions. The DistLM confirmed that the physical state of the beach is an important factor for sandy beach organisms. The effect of salinity and temperature suggest metabolic responses to local conditions and a role in small to mesoscale shifts in the range of these populations.	[Baldanzi, Simone; McQuaid, Christopher D.; Porri, Francesca] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Cannicci, Stefano] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy	Rhodes University; University of Florence	Baldanzi, S (corresponding author), Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa.	baldanzi.simone@gmail.com	Porri, Francesca/M-4258-2017; McQuaid, Christopher/AAT-3725-2020; Cannicci, Stefano/L-7136-2015; Cannicci, Stefano/N-8512-2019	Porri, Francesca/0000-0001-8247-4506; McQuaid, Christopher/0000-0002-3473-8308; Cannicci, Stefano/0000-0002-6544-0213; Cannicci, Stefano/0000-0002-6544-0213; Baldanzi, Simone/0000-0002-7153-4734	National Research Foundation - NRF; EU IRSES [247514]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF)	National Research Foundation - NRF; EU IRSES; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF)	Funding came from the National Research Foundation - NRF http://www.nrf.ac.za/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to two anonymous reviewers, which contributed with highly constructive criticisms. S. B. thank Pamela Cramb, Linda Johnson, Lukholo Macala, Jennifer Booth, Adam Ludford, Rachel Tintswalo Ndhlovu, Madison Hall, Dr Charles von der Meden, Dr Marco Fusi, Dr Riccardo Simoni, Simone Babbini, Dr Irene Ortolani, Leandro Bergamino and Eleonora Puccinelli for field assistance. Thanks to Prof. Charles Griffiths and Dr Jim Lowry for the precious taxonomic support. Particular thanks to Dr Marco Fusi for help on data analysis. The author thanks Prof. Glyn Armstrong from the Department of Geography at Rhodes University, for the logistic support and help on sedimentology analysis. This paper was written under the framework of the project "CREC" (EU IRSES #247514) and is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF).	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Adin R, 2003, ESTUAR COAST SHELF S, V56, P91, DOI 10.1016/S0272-7714(02)00124-5; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; [Anonymous], 1988, CRUSTACEANA, V55; Booth DT, 2006, CORAL REEFS, V25, P629, DOI 10.1007/s00338-006-0135-4; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cardoso RS, 2003, J COASTAL RES, P392; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Cardoso RS, 2002, MAR BIOL, V141, P167, DOI 10.1007/s00227-002-0784-y; Chelazzi L, 2005, VIE MILIEU, V55, P127; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crawley KR, 2009, MAR ECOL PROG SER, V376, P33, DOI 10.3354/meps07810; Defeo O, 2004, DIVERS DISTRIB, V10, P89, DOI 10.1111/j.1366-9516.2004.00070.x; Defeo O, 2002, MAR ECOL PROG SER, V239, P169, DOI 10.3354/meps239169; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo O, 2011, MAR ECOL PROG SER, V433, P29, DOI 10.3354/meps09206; Duarte C, 2010, HYDROBIOLOGIA, V651, P291, DOI 10.1007/s10750-010-0309-5; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; ENQUIST BJ, 1995, EVOL ECOL, V9, P586, DOI 10.1007/BF01237657; Fenberg PB, 2011, J BIOGEOGR, V38, P2286, DOI 10.1111/j.1365-2699.2011.02572.x; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gilman S, 2005, J BIOGEOGR, V32, P1583, DOI 10.1111/j.1365-2699.2005.01274.x; Gilman SE, 2006, ECOGRAPHY, V29, P709, DOI 10.1111/j.0906-7590.2006.04572.x; Gilman SE, 2006, OECOLOGIA, V148, P270, DOI 10.1007/s00442-006-0372-9; Goltsman M, 2005, J ZOOL, V267, P405, DOI 10.1017/S0952836905007557; Gomez J, 2012, ESTUAR COAST SHELF S, V98, P84, DOI 10.1016/j.ecss.2011.12.008; Gorley C.K., 2006, GETTING STARTED PRIM; GRIFFITHS C L, 1976, P106; Harris L, 2011, ESTUAR COAST SHELF S, V92, P78, DOI 10.1016/j.ecss.2010.12.013; Johnston M, 2005, COMP BIOCHEM PHYS B, V140, P251, DOI 10.1016/j.cbpc.2004.10.007; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lercari D, 2006, ESTUAR COAST SHELF S, V68, P27, DOI 10.1016/j.ecss.2005.12.017; Lester SE, 2007, ECOLOGY, V88, P2229, DOI 10.1890/06-1784.1; Lima M, 2000, MAR ECOL PROG SER, V207, P97, DOI 10.3354/meps207097; Lincoln RJ, 1979, BRIT AMPHIOPODA GAMM; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; MARSDEN ID, 1991, J EXP MAR BIOL ECOL, V152, P75, DOI 10.1016/0022-0981(91)90136-K; MARSDEN ID, 1991, J EXP MAR BIOL ECOL, V152, P61, DOI 10.1016/0022-0981(91)90135-J; MCARDLE SB, 1991, MAR ECOL PROG SER, V76, P91, DOI 10.3354/meps076091; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A., 1993, J COASTAL RES, V15, P27, DOI DOI 10.2307/25735721; Meiri S, 2009, P ROY SOC B-BIOL SCI, V276, P1469, DOI 10.1098/rspb.2008.1318; Morritt D, 1998, J CRUSTACEAN BIOL, V18, P25, DOI 10.2307/1549517; Morritt D, 1988, FUNC ECOL, V12, P351; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Pavesi L, 2009, HYDROBIOLOGIA, V635, P171, DOI 10.1007/s10750-009-9909-3; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Porri F, 2011, MAR ECOL PROG SER, V426, P253, DOI 10.3354/meps08951; Poulin R, 2002, ANIM BEHAV, V63, P269, DOI 10.1006/anbe.2001.1938; R Development Core Team, 2007, R LANG ENV STAT COMP; Rivadeneira MM, 2010, J BIOGEOGR, V37, P486, DOI 10.1111/j.1365-2699.2009.02224.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Samis KE, 2007, ECOLOGY, V88, P1747, DOI 10.1890/06-1153.1; Schoeman DS, 2002, J EXP MAR BIOL ECOL, V276, P67, DOI 10.1016/S0022-0981(02)00239-3; Short AD, 1996, REV CHIL HIST NAT, V69, P589; Soares AG, 2003, THESIS U PORT ELIZAB; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tam JC, 2011, J BIOGEOGR, V38, P1536, DOI 10.1111/j.1365-2699.2011.02498.x; Tolley KA, 2008, DIVERS DISTRIB, V14, P400, DOI 10.1111/j.1472-4642.2007.00428.x; Tsubokura T, 1997, J CRUSTACEAN BIOL, V17, P674, DOI 10.2307/1549370; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; Tuya F, 2008, MAR ECOL PROG SER, V372, P225, DOI 10.3354/meps07718; Virgos E, 2011, J BIOGEOGR, V38, P1546, DOI 10.1111/j.1365-2699.2011.02512.x; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886; Ward DF, 2005, SOCIOBIOL, V45; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; WILLIAMS JA, 1995, J CRUSTACEAN BIOL, V15, P466, DOI 10.2307/1548768; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	76	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54598	10.1371/journal.pone.0054598	http://dx.doi.org/10.1371/journal.pone.0054598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372740	Green Published, gold			2022-12-27	WOS:000314021500093
J	Cheng, JC; Klausen, C; Leung, PCK				Cheng, Jung-Chien; Klausen, Christian; Leung, Peter C. K.			Overexpression of Wild-Type but Not C134W Mutant FOXL2 Enhances GnRH-Induced Cell Apoptosis by Increasing GnRH Receptor Expression in Human Granulosa Cell Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; EPICANTHUS INVERSUS SYNDROME; HORMONE (GNRH)-I; FOLLICULAR DEVELOPMENT; GROWTH INHIBITION; CANCER-CELLS; OVARY; GENE; BLEPHAROPHIMOSIS; INTERACTS	The etiology of granulosa cell tumors (GCTs) is largely unknown. The primary mode of treatment is surgical, however not all women are cured by surgery alone. Thus, it is important to develop improved treatments through a greater understanding of the molecular mechanisms that contribute to this disease. Recently, it has been shown that a FOXL2 402C>G (C134W) mutation is present in 97% of human adult-type GCTs, suggesting an important role for this mutation in the development of GCTs. We have shown previously that gonadotropin-releasing hormone (GnRH)-I and -II induce apoptosis in cultured normal human granulosa cells. Moreover, it has been reported that FOXL2 can bind to the promoter of the mouse GnRH receptor gene and regulate its transcription. Thus, we hypothesized that C134W mutant FOXL2 could modulate the pro-apoptotic effects of GnRH via aberrant regulation of GnRH receptor levels. Using KGN cells, a human GCT-derived cell line which harbors the FOXL2 402C>G mutation, we show that treatment with GnRH-I and -II induces cell apoptosis, and that small interfering RNA-mediated depletion of GnRH receptor abolishes these effects. Overexpression of wild-type FOXL2 increases both mRNA and protein levels of GnRH receptor and consequently enhances GnRH-induced apoptosis. Importantly, neither the expression levels of GnRH receptor nor GnRH-induced apoptosis were affected by overexpression of the C134W mutant FOXL2. Interestingly, knockdown of endogenous FOXL2 down-regulates GnRHR expression in normal human granulosa cells with wild-type FOXL2, but not in KGN cells. These results suggest that the FOXL2 402C>G mutation may contribute to the development of human adult-type GCTs by reducing the expression of GnRH receptor, thus conferring resistance to GnRH-induced cell apoptosis.	[Cheng, Jung-Chien; Klausen, Christian; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	peter.leung@ubc.ca	Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research; Child & Family Research Institute; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	This work was supported by an operating grant from the Canadian Institutes of Health Research to PCKL. PCKL is the recipient of a Child & Family Research Institute Senior Investigator Award. JCC is the recipient of BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Cheng CK, 2002, MOL ENDOCRINOL, V16, P1552, DOI 10.1210/me.16.7.1552; Choi JH, 2006, J CLIN ENDOCR METAB, V91, P4562, DOI 10.1210/jc.2006-1147; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Hong IS, 2008, J CLIN ENDOCR METAB, V93, P3179, DOI 10.1210/jc.2008-0127; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim KY, 2006, ENDOCR-RELAT CANCER, V13, P211, DOI 10.1677/erc.1.01033; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Ngan ESW, 1999, ENDOCRINOLOGY, V140, P2452, DOI 10.1210/endo.140.6.6759; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Park DW, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-81; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Poon SL, 2009, MOL ENDOCRINOL, V23, P1646, DOI 10.1210/me.2009-0147; Rosario R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046270; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stromme PS, 1996, ACTA OPHTHALMOL SCAN, V74, P45; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	30	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e55099	10.1371/journal.pone.0055099	http://dx.doi.org/10.1371/journal.pone.0055099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372819	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500154
J	Cizkova, J; Hribova, E; Humplikova, L; Christelova, P; Suchankova, P; Dolezel, J				Cizkova, Jana; Hribova, Eva; Humplikova, Lenka; Christelova, Pavla; Suchankova, Pavla; Dolezel, Jaroslav			Molecular Analysis and Genomic Organization of Major DNA Satellites in Banana (Musa spp.)	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; RIBOSOMAL-RNA GENES; REPETITIVE DNA; CHROMOSOMAL LOCALIZATION; CENTROMERIC REGIONS; SEQUENCE-ANALYSIS; ACUMINATA GENOME; L. GENOME; EVOLUTION; REPEATS	Satellite DNA sequences consist of tandemly arranged repetitive units up to thousands nucleotides long in head-to-tail orientation. The evolutionary processes by which satellites arise and evolve include unequal crossing over, gene conversion, transposition and extra chromosomal circular DNA formation. Large blocks of satellite DNA are often observed in heterochromatic regions of chromosomes and are a typical component of centromeric and telomeric regions. Satellite-rich loci may show specific banding patterns and facilitate chromosome identification and analysis of structural chromosome changes. Unlike many other genomes, nuclear genomes of banana (Musa spp.) are poor in satellite DNA and the information on this class of DNA remains limited. The banana cultivars are seed sterile clones originating mostly from natural intra-specific crosses within M. acuminata (A genome) and inter-specific crosses between M. acuminata and M. balbisiana (B genome). Previous studies revealed the closely related nature of the A and B genomes, including similarities in repetitive DNA. In this study we focused on two main banana DNA satellites, which were previously identified in silico. Their genomic organization and molecular diversity was analyzed in a set of nineteen Musa accessions, including representatives of A, B and S (M. schizocarpa) genomes and their inter-specific hybrids. The two DNA satellites showed a high level of sequence conservation within, and a high homology between Musa species. FISH with probes for the satellite DNA sequences, rRNA genes and a single-copy BAC clone 2G17 resulted in characteristic chromosome banding patterns in M. acuminata and M. balbisiana which may aid in determining genomic constitution in interspecific hybrids. In addition to improving the knowledge on Musa satellite DNA, our study increases the number of cytogenetic markers and the number of individual chromosomes, which can be identified in Musa.	[Cizkova, Jana; Hribova, Eva; Humplikova, Lenka; Christelova, Pavla; Suchankova, Pavla; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Dolezel, J (corresponding author), Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic.	dolezel@ueb.cas.cz	Cizkova, Jana/F-7673-2014; hribova, eva/F-7291-2014; Dolezel, Jaroslav/B-7716-2008	Dolezel, Jaroslav/0000-0002-6263-0492; Cizkova, Jana/0000-0001-7787-1849; Hribova, Eva/0000-0002-6868-4344	Academy of Sciences of the Czech Republic [KJB500380901]; Bioversity International [LoA CfL 2011/51]; Ministry of Education, Youth and Sports of the Czech Republic [LG12021]; European Regional Development Fund (Operational Programme Research and Development for Innovations) [ED0007/01/01]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Bioversity International; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (Operational Programme Research and Development for Innovations)	This work was supported by the Academy of Sciences of the Czech Republic (award KJB500380901), by the Bioversity International (LoA CfL 2011/51), Ministry of Education, Youth and Sports of the Czech Republic (award LG12021) and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bao WD, 2006, MOL GENET GENOMICS, V275, P421, DOI 10.1007/s00438-006-0103-2; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; Dechyeva D, 2003, CHROMOSOME RES, V11, P3, DOI 10.1023/A:1022005514470; DODDS KS, 1948, HEREDITY, V2, P101, DOI 10.1038/hdy.1948.6; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezelova M, 1998, BIOL PLANTARUM, V41, P497, DOI 10.1023/A:1001880030275; Dover G, 2002, TRENDS GENET, V18, P587, DOI 10.1016/S0168-9525(02)02789-0; DOVER GA, 1982, SCIENCE, V218, P1069, DOI 10.1126/science.7146895; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; GALASSO I, 1995, THEOR APPL GENET, V91, P928, DOI 10.1007/BF00223902; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Hribova E, 2008, BIOL PLANTARUM, V52, P445, DOI 10.1007/s10535-008-0089-1; Hribova E, 2007, CYTOGENET GENOME RES, V119, P268, DOI 10.1159/000112073; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; INGHAM LD, 1993, MOL GEN GENET, V238, P350, DOI 10.1007/BF00291993; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King K, 1995, J MOL EVOL, V41, P996; Kopecky D, 2008, CYTOGENET GENOME RES, V120, P370, DOI 10.1159/000121086; Kopecky D, 2010, CYTOGENET GENOME RES, V129, P162, DOI 10.1159/000313379; Kubis S, 1998, ANN BOT-LONDON, V82, P45, DOI 10.1006/anbo.1998.0779; Kubis SE, 1998, PLANT MOL BIOL, V36, P821, DOI 10.1023/A:1005973932556; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumekawa N, 2001, MOL GENET GENOMICS, V265, P480, DOI 10.1007/s004380000436; Lysak MA, 1999, THEOR APPL GENET, V98, P1344, DOI 10.1007/s001220051201; Macas J, 2000, MOL GEN GENET, V263, P741, DOI 10.1007/s004380000245; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2006, CHROMOSOMA, V115, P437, DOI 10.1007/s00412-006-0070-8; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Macas J, 2010, BIOINFORMATICS, V26, P2101, DOI 10.1093/bioinformatics/btq343; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Navratilova A, 2003, ANN BOT-LONDON, V91, P921, DOI 10.1093/aob/mcg099; Navratilova A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-90; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Osuji JO, 1997, ANN BOT-LONDON, V80, P787, DOI 10.1006/anbo.1997.0516; Otto F, 1990, Methods Cell Biol, V33, P105; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Schmidt T, 1998, TRENDS PLANT SCI, V3, P195, DOI 10.1016/S1360-1385(98)01223-0; SCHMIDT T, 1995, CHROMOSOME RES, V3, P335, DOI 10.1007/BF00710014; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Sharma S, 2005, CYTOGENET GENOME RES, V109, P15, DOI 10.1159/000082377; Shepherd K, 1999, CYTOGENETICS GENUS M; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tek AL, 2004, CHROMOSOMA, V113, P77, DOI 10.1007/s00412-004-0297-1; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; Torres GA, 2011, G3-GENES GENOM GENET, V1, P85, DOI 10.1534/g3.111.000125; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; Valarik M, 2002, CHROMOSOME RES, V10, P89, DOI 10.1023/A:1014945730035; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Willard HF, 1991, CURR OPIN GENET DEV, V1, P509, DOI 10.1016/S0959-437X(05)80200-X; WILSON GB, 1946, GENETICS, V31, P475; Zatloukalova P, 2011, CHROMOSOME RES, V19, P729, DOI 10.1007/s10577-011-9235-2; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	74	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54808	10.1371/journal.pone.0054808	http://dx.doi.org/10.1371/journal.pone.0054808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372772	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500130
J	Alvarez-Arguelles, ME; Melon, S; Junquera, ML; Boga, JA; Villa, L; Perez-Castro, S; de Ona, M				Elena Alvarez-Argueelles, Marta; Melon, Santiago; Luisa Junquera, Maria; Antonio Boga, Jose; Villa, Laura; Perez-Castro, Sonia; de Ona, Maria			Human Papillomavirus Infection in a Male Population Attending a Sexually Transmitted Infection Service	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; MALE ANOGENITAL SITES; HPV DETECTION; PREVALENCE; MEN; RISK; EPIDEMIOLOGY; WOMEN; DNA; DETERMINANTS	Objective: Human Papillomavirus (HPV) infection in men may produce cancer and other major disorders. Men play an important role in the transmission of the virus and act as a reservoir. The aim of this study was to determine the HPV-genotypes and their prevalence in a group of men attending a Sexually Transmitted Infection service. Patients and Samples: Between July 2002 and June 2011, 1392 balanopreputial, 435 urethral, 123 anal, and 67 condyloma lesions from 1551 men with a mean age of 35.8 +/- 11.3 years old (range: 17-87) were collected for HPV-DNA testing. Methods: A fragment of the L1-gene and a fragment of the E6/E7-genes were amplified by PCR. Positive samples were typed by hybridization. Results: The HPV genome was detected in 36.9% (486/1318) balanopreputial and in 24.9% (101/405) urethral (p<0.0001) swabs from 38.1% (538) of 1469 men. Co-infections were present in 5.4% (80/1469) of cases. HPV was found in 43.9% (373/850) of men younger than 35 vs. 31.7% (187/589) of men aged >35. HPV was found in 59.4% (104) of 165 men with lesions (macroscopic or positive peniscopy), and in 22.8% (61/267) without clinical alterations. HPV was also detected in 71.4% (40/56) men with condylomata and in 58.7% (64/109) of men with positive peniscopy. Conclusions: HPV prevalence in men was high and decreased with age. HPV was found more frequently in balanopreputial than in urethral swabs. There was a low rate of co-infections. Low-risk HPV vaccine genotypes were the most recurrent especially in younger. Although HPV has been associated with clinical alterations, it was also found in men without any clinical presentation. Inclusion of men in the national HPV vaccination program may reduce their burden of HPV-related disease and reduce transmission of the virus to non-vaccinated women.	[Elena Alvarez-Argueelles, Marta; Melon, Santiago; Antonio Boga, Jose; Villa, Laura; de Ona, Maria] Hosp Univ Cent Asturias, Microbiol Serv, Oviedo, Spain; [Luisa Junquera, Maria] Hosp Monte Naranco, Unidad ITS, Oviedo, Spain; [Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Microbiol Serv, Vigo, Spain	Central University Hospital Asturias; Complexo Hospitalario Universitario de Vigo	Alvarez-Arguelles, ME (corresponding author), Hosp Univ Cent Asturias, Microbiol Serv, Oviedo, Spain.	martaealvarez@gmail.com	Boga, Jose Antonio/ABA-2719-2021; Melón, Santiago/AAY-1466-2021; Villa, Laura/AAF-3395-2021; Melón García, Santiago/AHE-7360-2022	Boga, Jose Antonio/0000-0002-5500-9972; Melón, Santiago/0000-0001-5770-7902; Villa, Laura/0000-0002-4228-7041; Melón García, Santiago/0000-0001-5770-7902; PEREZ CASTRO, SONIA/0000-0003-1734-1904				Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; Barzon L, 2010, J MED VIROL, V82, P1424, DOI 10.1002/jmv.21733; Benevolo M, 2008, J MED VIROL, V80, P1275, DOI 10.1002/jmv.21189; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Burchell A, 2006, VACCINE S3, P54; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castellsague X, 1997, J INFECT DIS, V176, P353, DOI 10.1086/514052; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Costa FAM, 2009, J MED VIROL, V81, P2007, DOI 10.1002/jmv.21624; Rocha MGD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040988; de Ona M, 2010, J MED VIROL, V82, P597, DOI 10.1002/jmv.21697; Deza J, 2007, 19 C AN AS ESP PAT C; DICKENS P, 1991, J PATHOL, V165, P243, DOI 10.1002/path.1711650308; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; Flores R, 2008, J VIROL METHODS, V149, P136, DOI 10.1016/j.jviromet.2007.12.010; Foresta C, 2010, FERTIL STERIL, V94, P1723, DOI 10.1016/j.fertnstert.2009.11.012; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Georgieva S, 2009, J BUON, V14, P391; Georgousakis M, 2012, LANCET INFECT DIS, V12, P627, DOI 10.1016/S1473-3099(12)70031-2; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2008, J INFECT DIS, V198, P827, DOI 10.1086/591095; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Grulich AE, 2010, SEX HEALTH, V7, P244, DOI 10.1071/SH10020; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Lajous M, 2005, CANCER EPIDEM BIOMAR, V14, P1710, DOI 10.1158/1055-9965.EPI-04-0926; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; MANOS MM, 1989, CANCER CEL, V7, P209; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moscicki AB, 1988, J PEDIAT, V132, P277; Nielson CM, 2007, CANCER EPIDEM BIOMAR, V16, P1107, DOI 10.1158/1055-9965.EPI-06-0997; Nielson CM, 2009, CANCER EPIDEM BIOMAR, V18, P1077, DOI 10.1158/1055-9965.EPI-08-0447; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Schiffman M, 2012, LANCET ONCOL, V13, P10, DOI 10.1016/S1470-2045(11)70324-2; Shukla S, 2009, INDIAN J MED RES, V130, P222; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2010, INT J CANCER, V126, P572, DOI 10.1002/ijc.24770; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Vaccarella S, 2006, INT J CANCER, V119, P1934, DOI 10.1002/ijc.21992; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; Wong AK, 2010, MODERN PATHOL, V23, P144, DOI 10.1038/modpathol.2009.143	47	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54375	10.1371/journal.pone.0054375	http://dx.doi.org/10.1371/journal.pone.0054375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372715	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500065
J	Liu, LD; Zhang, Y; Wang, JJ; Zhao, HL; Jiang, L; Che, YC; Shi, HJ; Li, RC; Mo, ZJ; Huang, T; Liang, ZL; Mao, QY; Wang, LC; Dong, CH; Liao, Y; Guo, L; Yang, EX; Pu, J; Yue, L; Zhou, ZX; Li, QH				Liu, Longding; Zhang, Ying; Wang, Jingjing; Zhao, Hongling; Jiang, Li; Che, Yanchun; Shi, Haijin; Li, Rongcheng; Mo, Zhaojun; Huang, Teng; Liang, Zhenglun; Mao, Qunying; Wang, Lichun; Dong, Chenghong; Liao, Yun; Guo, Lei; Yang, Erxia; Pu, Jing; Yue, Lei; Zhou, Zhenxin; Li, Qihan			Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; BRAIN-STEM ENCEPHALITIS; GENE-EXPRESSION; RHESUS-MONKEYS; MICROARRAY ANALYSIS; TAIWAN; IMMUNOGENICITY; PATHOGENESIS; CYTOKINES; CELLS	Enterovirus 71 (EV71), a major causative agent of hand-foot-and-mouth disease (HFMD), causes outbreaks among children in the Asia-Pacific region. A vaccine is urgently needed. Based on successful pre-clinical work, phase I and II clinical trials of an inactivated EV71 vaccine, which included the participants of 288 and 660 respectively, have been conducted. In the present study, the immune response and the correlated modulation of gene expression in the peripheral blood mononuclear cells (PBMCs) of 30 infants (6 to 11 months) immunized with this vaccine or placebo and consented to join this study in the phase II clinical trial were analyzed. The results showed significantly greater neutralizing antibody and specific T cell responses in vaccine group after two inoculations on days 0 and 28. Additionally, more than 600 functional genes that were up-or down-regulated in PBMCs were identified by the microarray assay, and these genes included 68 genes associated with the immune response in vaccine group. These results emphasize the gene expression profile of the immune system in response to an inactivated EV71 vaccine in humans and confirmed that such an immune response was generated as the result of the positive mobilization of the immune system. Furthermore, the immune response was not accompanied by the development of a remarkable inflammatory response. Clinical Trial Registration: NCT01391494 and NCT01512706.	[Liu, Longding; Zhang, Ying; Wang, Jingjing; Zhao, Hongling; Jiang, Li; Che, Yanchun; Shi, Haijin; Wang, Lichun; Dong, Chenghong; Liao, Yun; Guo, Lei; Yang, Erxia; Pu, Jing; Yue, Lei; Zhou, Zhenxin; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China; [Li, Rongcheng; Mo, Zhaojun; Huang, Teng] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Peoples R China; [Liang, Zhenglun; Mao, Qunying] Natl Inst Food & Drug Control, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; National Institute of Food & Drug Control - China	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China.	imbcams.lq@gmail.com	Guo, Lei/AEU-0178-2022		National Basic Research Program [2011CB504903, 2012CB518901]; National High-Tech RD Program [2012AA02404]; National Natural Sciences Foundation of China [81171573, 31100127]; Yunnan Natural Science Foundation [2011FB116]; Youth Foundation of Peking Union Medical College [2012J23]	National Basic Research Program(National Basic Research Program of China); National High-Tech RD Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Youth Foundation of Peking Union Medical College	This work was supported by the National Basic Research Program (2011CB504903 and 2012CB518901), National High-Tech R&D Program (2012AA02404), National Natural Sciences Foundation of China (81171573 and 31100127), the Yunnan Natural Science Foundation (2011FB116) and Youth Foundation of Peking Union Medical College (2012J23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALE AJ, 1990, LANCET, V335, P839, DOI 10.1016/0140-6736(90)90945-2; Bedognetti D, 2010, EXPERT REV VACCINES, V9, P555, DOI [10.1586/erv.10.55, 10.1586/ERV.10.55]; CAMS IMB, 2012, PHAS 2 SAF EFF STUD; Chen HC, 2012, VIROLOGY, V432, P417, DOI 10.1016/j.virol.2012.06.026; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen R, 1999, CLIN CHEM, V45, P1693; CLEMENS R, 1995, J INFECT DIS, V171, pS44, DOI 10.1093/infdis/171.Supplement_1.S44; Dhiman N, 2001, VACCINE, V20, P22, DOI 10.1016/S0264-410X(01)00319-X; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Dong CH, 2010, HUM VACCINES, V6, P1028, DOI 10.4161/hv.6.12.12982; FADEN H, 1993, J INFECT DIS, V168, P25, DOI 10.1093/infdis/168.1.25; FLEHMIG B, 1987, J MED VIROL, V22, P7, DOI 10.1002/jmv.1890220103; Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Jones JO, 2003, J VIROL, V77, P1268, DOI 10.1128/JVI.77.2.1268-1280.2003; JSPCDCP BVBC, 2011, PHAS 2 CLIN TRIAL IN; JSPCDCP BVBC, 2010, CLIN TRIAL IN VACC V; Liang Y, 2012, J CLIN IMMUNOL, V32, P1048, DOI 10.1007/s10875-012-9690-3; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Liu L, 2011, SAFETY STUDY INACTIV; Liu LD, 2011, VIROLOGY, V412, P91, DOI 10.1016/j.virol.2010.12.058; Ma Shao-hui, 2009, Virologica Sinica, V24, P162, DOI 10.1007/s12250-009-3033-4; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nakaya HI, 2011, WILEY INTERDISCIP RE, V4, P193, DOI DOI 10.1002/WSBM.163; Pallansch M, 2006, FIELDS VIROLOGY, P839; SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3; Switula D, 2000, SCI ENG ETHICS, V6, P71, DOI 10.1007/s11948-000-0025-z; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Xie Z, 2010, J MED RES, V39, P50; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82	36	38	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54451	10.1371/journal.pone.0054451	http://dx.doi.org/10.1371/journal.pone.0054451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372725	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500072
J	Nakashima, H; Ogawa, Y; Shono, S; Kinoshita, M; Nakashima, M; Sato, A; Ikarashi, M; Seki, S				Nakashima, Hiroyuki; Ogawa, Yoshiko; Shono, Satoshi; Kinoshita, Manabu; Nakashima, Masahiro; Sato, Atsushi; Ikarashi, Masami; Seki, Shuhji			Activation of CD11b(+) Kupffer Cells/Macrophages as a Common Cause for Exacerbation of TNF/Fas-Ligand-Dependent Hepatitis in Hypercholesterolemic Mice	PLOS ONE			English	Article							LIVER INNATE IMMUNITY; AG+ T-CELLS; ALPHA-GALACTOSYLCERAMIDE; BACTERIAL-DNA; MEDIATED FUNCTION; CPG MOTIFS; ATHEROSCLEROSIS; INJURY; MACROPHAGES; MECHANISMS	We have reported that the mouse hepatic injury induced by either alpha-galactosylceramide (alpha-GalCer) or bacterial DNA motifs (CpG-ODN) is mediated by the TNF/NKT cell/Fas-ligand (FasL) pathway. In addition, F4/80(+) Kupffer cells can be subclassified into CD68(+) subset with a phagocytosing capacity and CD11b(+) subset with a TNF-producing capacity. CD11b(+) subset increase if mice are fed high-fat and cholesterol diet (HFCD). The present study examined how a HFCD affects the function of NKT cells and F4/80(+) CD11b(+) subset and these hepatitis models. After the C57BL/6 mice received a HFCD, high-cholesterol diet (HCD), high-fat diet (HFD) and control diet (CD) for four weeks, the HFCD mice increased surface CD1d and intracellular TLR-9 expression by the CD11b(+) population compared to CD mice. Hepatic injury induced either by alpha-GalCer or CpG-ODN was more severe in HCD and HFCD mice compared to CD mice, which was in proportion to the serum TNF levels. In addition, liver cholesterol levels but not serum cholesterol levels nor liver triglyceride levels were involved in the aggravation of hepatitis. The FasL expression of NKT cells induced by both reagents was upregulated in HFCD mice. Furthermore, the liver mononuclear cells and purified F4/80(+) CD11b(+) subset from HFCD mice stimulated with either reagent in vitro produced a larger amount of TNF than did those from CD mice. Intracellular TNF production in F4/80(+) CD11b(+) cells was confirmed. The increased number of F4/80(+) CD11b(+) Kupffer cells/macrophages by HFCD and their enhanced TNF production thus play a pivotal role in TNF/NKT cell/FasL dependent hepatic injury.	[Nakashima, Hiroyuki; Ogawa, Yoshiko; Shono, Satoshi; Kinoshita, Manabu; Nakashima, Masahiro; Sato, Atsushi; Ikarashi, Masami; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan	Seki, S (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan.	btraums@ndmc.ac.jp						Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Fuji N, 2000, CLIN CANCER RES, V6, P3380; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Habu Y, 2004, IMMUNOLOGY, V113, P35, DOI 10.1111/j.1365-2567.2004.01932.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hong SM, 1999, IMMUNOL REV, V169, P31, DOI 10.1111/j.1600-065X.1999.tb01304.x; Inatsu A, 2009, HEPATOLOGY, V49, P2044, DOI 10.1002/hep.22888; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kawarabayashi N, 2000, HEPATOLOGY, V32, P962, DOI 10.1053/jhep.2000.19362; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Motoki K, 1996, ONCOL RES, V8, P155; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakagawa R, 2004, J IMMUNOL, V172, P6550, DOI 10.4049/jimmunol.172.11.6550; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Schramm C, 2008, Z GASTROENTEROL, V46, P1369, DOI 10.1055/s-2008-1027411; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; Takayama E, 2003, IMMUNOLOGY, V108, P211, DOI 10.1046/j.1365-2567.2003.01575.x; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Yamaguchi Y, 1996, ONCOL RES, V8, P399	37	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e49339	10.1371/journal.pone.0049339	http://dx.doi.org/10.1371/journal.pone.0049339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372642	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500002
J	Wrench, AP; Gardner, CL; Gonzalez, CF; Lorca, GL				Wrench, Algevis P.; Gardner, Christopher L.; Gonzalez, Claudio F.; Lorca, Graciela L.			Identification of a Small Molecule That Modifies MglA/SspA Interaction and Impairs Intramacrophage Survival of Francisella tularensis	PLOS ONE			English	Article							STRINGENT STARVATION PROTEIN; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTORS; NOVICIDA; GENE; EXPRESSION; TULAREMIA; POLYMERASE; DISCOVERY	The transcription factors MglA and SspA of Francisella tularensis form a heterodimer complex and interact with the RNA polymerase to regulate the expression of the Francisella pathogenicity island (FPI) genes. These genes are essential for this pathogen's virulence and survival within host cells. In this study, we used a small molecule screening to identify quinacrine as a thermal stabilizing compound for F. tularensis SCHU S4 MglA and SspA. A bacterial two-hybrid system was used to analyze the in vivo effect of quinacrine on the heterodimer complex. The results show that quinacrine affects the interaction between MglA and SspA, indicated by decreased beta-galactosidase activity. Further in vitro analyses, using size exclusion chromatography, indicated that quinacrine does not disrupt the heterodimer formation, however, changes in the alpha helix content were confirmed by circular dichroism. Structure-guided site-directed mutagenesis experiments indicated that quinacrine makes contact with amino acid residues Y63 in MglA, and K97 in SspA, both located in the "cleft" of the interacting surfaces. In F. tularensis subsp. novicida, quinacrine decreased the transcription of the FPI genes, iglA, iglD, pdpD and pdpA. As a consequence, the intramacrophage survival capabilities of the bacteria were affected. These results support use of the MglA/SspA interacting surface, and quinacrine's chemical scaffold, for the design of high affinity molecules that will function as therapeutics for the treatment of Tularemia.	[Wrench, Algevis P.; Gardner, Christopher L.; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu		Gardner, Christopher/0000-0001-6416-8476	Institute of Food and Agricultural Sciences, University of Florida; University of Florida Open Access Publishing Fund	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); University of Florida Open Access Publishing Fund	This work was supported by a grant from the Institute of Food and Agricultural Sciences, University of Florida. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger JL, 1998, J BACTERIOL, V180, P793, DOI 10.1128/JB.180.4.793-800.1998; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Comer JE, 2006, J TOXICOL ENV HEAL A, V69, P1083, DOI 10.1080/15287390500360281; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DeReuse H, 1997, RES MICROBIOL, V148, P289, DOI 10.1016/S0923-2508(97)81585-9; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Hansen AM, 2005, J BIOL CHEM, V280, P17380, DOI 10.1074/jbc.M501444200; ISHIHAMA A, 1979, J MOL BIOL, V129, P517, DOI 10.1016/0022-2836(79)90466-2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; McRae S, 2010, J BIOL CHEM, V285, P5171, DOI 10.1074/jbc.M109.039511; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MILLER J H, 1972, P466; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Nishimura A, 2010, P NATL ACAD SCI US; Orzaz M, 2009, BIOORG MED CHEM LETT, V19, P1592, DOI 10.1016/j.bmcl.2009.02.020; Oyston PCF, 2009, EXPERT REV VACCINES, V8, P1575, DOI [10.1586/erv.09.114, 10.1586/ERV.09.114]; Pagliai FA, 2010, J BIOL CHEM, V285, P16921, DOI 10.1074/jbc.M110.111138; Pande SG, 2011, MOL MICROBIOL, V81, P1623, DOI 10.1111/j.1365-2958.2011.07796.x; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; REEH S, 1976, MOL GEN GENET, V149, P279, DOI 10.1007/BF00268529; Sambrook J., 2002, MOL CLONING LAB MANU; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Tran HNA, 2010, BIOORG MED CHEM LETT, V20, P1866, DOI 10.1016/j.bmcl.2010.01.149; TYERYAR FJ, 1969, J BACTERIOL, V100, P1112, DOI 10.1128/JB.100.2.1112-1113.1969; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whipple FW, 1998, NUCLEIC ACIDS RES, V26, P3700, DOI 10.1093/nar/26.16.3700; WILLIAMS MD, 1991, GENE, V109, P21, DOI 10.1016/0378-1119(91)90584-X; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xiang WK, 1998, J VIROL, V72, P6732, DOI 10.1128/JVI.72.8.6732-6741.1998	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54498	10.1371/journal.pone.0054498	http://dx.doi.org/10.1371/journal.pone.0054498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372736	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500080
J	Kennedy, PGE; Montague, P; Scott, F; Grinfeld, E; Ashrafi, GH; Breuer, J; Rowan, EG				Kennedy, Peter G. E.; Montague, Paul; Scott, Fiona; Grinfeld, Esther; Ashrafi, G. H.; Breuer, Judith; Rowan, Edward G.			Varicella-Zoster Viruses Associated with Post-Herpetic Neuralgia Induce Sodium Current Density Increases in the ND7-23 Nav-1.8 Neuroblastoma Cell Line	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXPRESSION; INFECTION; CHANNELS; NEURONS; LATENCY; PAIN; MODEL; GENE	Post-herpetic neuralgia (PHN) is the most significant complication of herpes zoster caused by reactivation of latent Varicella-Zoster virus (VZV). We undertook a heterologous infection in vitro study to determine whether PHN-associated VZV isolates induce changes in sodium ion channel currents known to be associated with neuropathic pain. Twenty VZV isolates were studied blind from 11 PHN and 9 non-PHN subjects. Viruses were propagated in the MeWo cell line from which cell-free virus was harvested and applied to the ND7/23-Nav1.8 rat DRG x mouse neuroblastoma hybrid cell line which showed constitutive expression of the exogenous Nav 1.8, and endogenous expression of Nav 1.6 and Nav 1.7 genes all encoding sodium ion channels the dysregulation of which is associated with a range of neuropathic pain syndromes. After 72 hrs all three classes of VZV gene transcripts were detected in the absence of infectious virus. Single cell sodium ion channel recording was performed after 72 hr by voltage-clamping. PHN-associated VZV significantly increased sodium current amplitude in the cell line when compared with non-PHN VZV, wild-type (Dumas) or vaccine VZV strains ((POka, Merck and GSK). These sodium current increases were unaffected by acyclovir pre-treatment but were abolished by exposure to Tetrodotoxin (TTX) which blocks the TTX-sensitive fast Nav 1.6 and Nav 1.7 channels but not the TTX-resistant slow Nav 1.8 channel. PHN-associated VZV sodium current increases were therefore mediated in part by the Nav 1.6 and Nav 1.7 sodium ion channels. An additional observation was a modest increase in message levels of both Nav1.6 and Nav1.7 mRNA but not Nav 1.8 in PHN virally infected cells.	[Kennedy, Peter G. E.; Montague, Paul; Grinfeld, Esther] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & life Sci, Glasgow, Lanark, Scotland; [Scott, Fiona; Breuer, Judith] UCL, Div Infect & Immun, London WC1E 6BT, England; [Ashrafi, G. H.] Kingston Univ London, Kingston Upon Thames, Surrey, England; [Rowan, Edward G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of London; University College London; Kingston University; University of Strathclyde	Kennedy, PGE (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & life Sci, Glasgow, Lanark, Scotland.	Peter.Kennedy@glasgow.ac.uk		Rowan, Edward/0000-0002-9960-3308; Breuer, Judith/0000-0001-8246-0534; Ashrafi, G. Hossein/0000-0002-4516-5111	Chief Scientist Office of Scottish Government; Wellcome Trust [081703]; University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre; Sanofi Pasteur MSD; MRC [G0700814] Funding Source: UKRI; Medical Research Council [G0700814] Funding Source: researchfish; Chief Scientist Office [CZB/4/737] Funding Source: researchfish	Chief Scientist Office of Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre; Sanofi Pasteur MSD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by a grant from The Chief Scientist Office of the Scottish Government. FS was supported by Wellcome Trust grant no 081703. JB receives funding from the University College London/University College London Hospitals National Institute for Health Research Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JB receives funding from Sanofi Pasteur MSD for viral genotyping of rashes following vaccination, however this funding was not for this specific study. PGEK has acted as an adviser on shingles vaccination to Sanofi Pasteur MSD. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashrafi GH, 2010, VIRUS GENES, V41, P192, DOI 10.1007/s11262-010-0515-2; BOURDONWOUTERS C, 1990, J NEUROSCI RES, V26, P90, DOI 10.1002/jnr.490260111; Bradley BM, 2003, J NEUROVIROL, V9, P194; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dabby R, 2012, CURR NEUROL NEUROSCI, V12, P76, DOI 10.1007/s11910-011-0233-8; Dalziel RG, 2004, BRAIN RES REV, V46, P234, DOI 10.1016/j.brainresrev.2004.07.008; Finnen RL, 2006, J VIROL, V80, P10325, DOI 10.1128/JVI.00939-06; Fleetwood-Walker SM, 1999, J GEN VIROL, V80, P2433, DOI 10.1099/0022-1317-80-9-2433; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Garry EM, 2005, PAIN, V118, P97, DOI 10.1016/j.pain.2005.08.003; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Hamza MA, 2007, NEUROSCI LETT, V413, P31, DOI 10.1016/j.neulet.2006.11.063; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Hasnie FS, 2007, NEUROSCIENCE, V144, P1495, DOI 10.1016/j.neuroscience.2006.11.029; KENNEDY PGE, 1994, VIROLOGY, V205, P558, DOI 10.1006/viro.1994.1679; Kennedy PGE, 2002, REV MED VIROL, V12, P327, DOI 10.1002/rmv.362; Kennedy PGE, 1998, P NATL ACAD SCI USA, V95, P4658, DOI 10.1073/pnas.95.8.4658; Kinchington PR, 2011, J NEUROVIROL, V17, P590, DOI 10.1007/s13365-011-0069-7; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; MAHALINGAM R, 1995, J NEUROVIROL, V1, P130, DOI 10.3109/13550289509111018; Markman JD, 2006, J PAIN, V7, pS38, DOI 10.1016/j.jpain.2005.09.008; McCarthy KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000640; Medhurst SJ, 2008, PAIN, V138, P61, DOI 10.1016/j.pain.2007.11.006; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Peng WP, 2003, J VIROL, V77, P10714, DOI 10.1128/JVI.77.19.10714-10718.2003; Quan D, 2006, ARCH NEUROL-CHICAGO, V63, P940, DOI 10.1001/archneur.63.7.noc60049; Quinlivan ML, 2011, J CLIN VIROL, V50, P130, DOI 10.1016/j.jcv.2010.10.014; Schunemann S, 1999, ACTA VIROL, V43, P337; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Storey N, 2002, J CELL BIOL, V158, P1251, DOI 10.1083/jcb.200204010; Szpara ML, 2010, J NEUROIMMUNE PHARM, V5, P418, DOI 10.1007/s11481-010-9212-0; VAFAI A, 1988, P NATL ACAD SCI USA, V85, P2767, DOI 10.1073/pnas.85.8.2767; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhou XP, 2003, J PHARMACOL EXP THER, V306, P498, DOI 10.1124/jpet.103.051086	38	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e51570	10.1371/journal.pone.0051570	http://dx.doi.org/10.1371/journal.pone.0051570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382806	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000314610600004
J	Shahab, U; Moinuddin; Ahmad, S; Dixit, K; Habib, S; Alam, K; Ali, A				Shahab, Uzma; Moinuddin; Ahmad, Saheem; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif			Genotoxic Effect of N-Hydroxy-4-Acetylaminobiphenyl on Human DNA: Implications in Bladder Cancer	PLOS ONE			English	Article							URINARY-BLADDER; ADDUCTS; 4-AMINOBIPHENYL-DNA; CELLS; IMMUNOGENICITY; QUANTITATION; METABOLITE; CHEMICALS; EXPOSURE; SMOKERS	Background: The interaction of environmental chemicals and their metabolites with biological macromolecules can result in cytotoxic and genotoxic effects. 4-Aminobiphenyl (4-ABP) and several other related arylamines have been shown to be causally involved in the induction of human urinary bladder cancers. The genotoxic and the carcinogenic effects of 4-ABP are exhibited only when it is metabolically converted to a reactive electrophile, the aryl nitrenium ions, which subsequently binds to DNA and induce lesions. Although several studies have reported the formation of 4-ABP-DNA adducts, no extensive work has been done to investigate the immunogenicity of 4-ABP-modified DNA and its possible involvement in the generation of antibodies in bladder cancer patients. Methodology/Principal Findings: Human DNA was modified by N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP), a reactive metabolite of 4-ABP. Structural perturbations in the N-OH-AABP modified DNA were assessed by ultraviolet, fluorescence, and circular dichroic spectroscopy as well as by agarose gel electrophoresis. Genotoxicity of N-OH-AABP modified DNA was ascertained by comet assay. High performance liquid chromatography (HPLC) analysis of native and modified DNA samples confirmed the formation of N-(deoxyguanosine-8-yl)-4-aminobiphenyl (dG-C8-4ABP) in the N-OH-AABP damaged DNA. The experimentally induced antibodies against N-OH-AABP-modified DNA exhibited much better recognition of the DNA isolated from bladder cancer patients as compared to the DNA obtained from healthy individuals in competitive binding ELISA. Conclusions/Significance: This work shows epitope sharing between the DNA isolated from bladder cancer patients and the N-OH-AABP-modified DNA implicating the role of 4-ABP metabolites in the DNA damage and neo-antigenic epitope generation that could lead to the induction of antibodies in bladder cancer patients.	[Shahab, Uzma; Moinuddin; Ahmad, Saheem; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Fac Med, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Moinuddin (corresponding author), Aligarh Muslim Univ, Fac Med, Dept Biochem, JN Med Coll, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	Shahab, Uzma/AAR-4332-2021; Ahmad, Saheem/R-7016-2017; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	ICMR grant [18/11/18/2008-ECD-I]; University (Aligarh Muslim University)	ICMR grant; University (Aligarh Muslim University)	This work was partly funded by the ICMR grant no. Immuno 18/11/18/2008-ECD-I (which now stands completed) and the funds from the University (Aligarh Muslim University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; ALATRASH J, 1995, CHEM RES TOXICOL, V8, P747, DOI 10.1021/tx00047a015; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; Beland FA, 1999, CHEM RES TOXICOL, V12, P68, DOI 10.1021/tx980172y; BELAND FA, 1983, ENVIRON HEALTH PERSP, V49, P125, DOI 10.2307/3429589; BRYANT MS, 1987, CANCER RES, V47, P602; Burger MS, 2001, ENVIRON MOL MUTAGEN, V38, P1, DOI 10.1002/em.1044; BUTLER MA, 1989, CANCER RES, V49, P25; Curigliano G, 1996, CARCINOGENESIS, V17, P911, DOI 10.1093/carcin/17.5.911; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; HATCHER JF, 1995, CARCINOGENESIS, V16, P295, DOI 10.1093/carcin/16.2.295; HAUGEN DA, 1982, ANAL CHEM, V54, P32, DOI 10.1021/ac00238a012; IARC, 1986, IARC SCI PUBLICATION, V38; KADLUBAR FF, 1985, ACS SYM SER, V283, P341; KADLUBAR FF, 1977, CANCER RES, V37, P805; KING C, 1995, FOOD CHEM TOXICOL, V33, P757, DOI 10.1016/0278-6915(95)00043-2; KING CM, 1974, CANCER RES, V34, P1503; LAI CC, 1985, CARCINOGENESIS, V6, P1037, DOI 10.1093/carcin/6.7.1037; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; MILLER JA, 1970, CANCER RES, V30, P559; Moinuddin, 2014, ENVIRON TOXICOL, V29, P568, DOI 10.1002/tox.21782; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Poirier MC, 1995, CARCINOGENESIS, V16, P2917, DOI 10.1093/carcin/16.12.2917; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; Schulte PA, 1988, CARCINOGENIC MUTAGEN, P23; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; STEINECK G, 1990, AM J IND MED, V17, P371, DOI 10.1002/ajim.4700170310; Swaminathan S, 2000, COMPREHENSIVE TXB GE, P289; TALASKA G, 1991, P NATL ACAD SCI USA, V88, P5350, DOI 10.1073/pnas.88.12.5350; Torino JL, 2001, CARCINOGENESIS, V22, P147, DOI 10.1093/carcin/22.1.147; VINEIS P, 1994, ENVIRON HEALTH PERSP, V102, P7, DOI 10.2307/3432143	32	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53205	10.1371/journal.pone.0053205	http://dx.doi.org/10.1371/journal.pone.0053205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382838	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600012
J	Wurpel, DJ; Beatson, SA; Totsika, M; Petty, NK; Schembri, MA				Wurpel, Daniel J.; Beatson, Scott A.; Totsika, Makrina; Petty, Nicola K.; Schembri, Mark A.			Chaperone-Usher Fimbriae of Escherichia coli	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL ADHESINS; PHASE VARIATION; COMMON PILUS; P-PILI; GENE; COMMENSAL; IDENTIFICATION; ADHERENCE; STRAINS	Chaperone-usher (CU) fimbriae are adhesive surface organelles common to many Gram-negative bacteria. Escherichia coli genomes contain a large variety of characterised and putative CU fimbrial operons, however, the classification and annotation of individual loci remains problematic. Here we describe a classification model based on usher phylogeny and genomic locus position to categorise the CU fimbrial types of E. coli. Using the BLASTp algorithm, an iterative usher protein search was performed to identify CU fimbrial operons from 35 E. coli (and one Escherichia fergusonnii) genomes representing different pathogenic and phylogenic lineages, as well as 132 Escherichia spp. plasmids. A total of 458 CU fimbrial operons were identified, which represent 38 distinct fimbrial types based on genomic locus position and usher phylogeny. The majority of fimbrial operon types occupied a specific locus position on the E. coli chromosome; exceptions were associated with mobile genetic elements. A group of core-associated E. coli CU fimbriae were defined and include the Type 1, Yad, Yeh, Yfc, Mat, F9 and Ybg fimbriae. These genes were present as intact or disrupted operons at the same genetic locus in almost all genomes examined. Evaluation of the distribution and prevalence of CU fimbrial types among different pathogenic and phylogenic groups provides an overview of group specific fimbrial profiles and insight into the ancestry and evolution of CU fimbriae in E. coli.	[Wurpel, Daniel J.; Beatson, Scott A.; Totsika, Makrina; Petty, Nicola K.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	University of Queensland	Beatson, SA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	s.beatson@uq.edu.au; m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Totsika, Makrina/A-8993-2011	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Totsika, Makrina/0000-0003-2468-0293; Petty, Nicola/0000-0001-6528-9886	Australian National Health and Medical Research Council [631654, APP1012076]; Australian Research Council (ARC) [FT100100662]; ARC Australian Research [DP0881247]; ARC Discovery Early Career [DE130101169]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC Australian Research(Australian Research Council); ARC Discovery Early Career(Australian Research Council)	This work was supported by grants from the Australian National Health and Medical Research Council (631654 and APP1012076). MAS is the recipient of an Australian Research Council (ARC) Future Fellowship (FT100100662). SAB is the recipient of an ARC Australian Research Fellowship (DP0881247). MT is the recipient of an ARC Discovery Early Career Researcher Award(DE130101169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Backhed F, 2002, J BIOL CHEM, V277, P18198, DOI 10.1074/jbc.M111640200; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; Bergsten G, 2004, J INFECT DIS, V189, P1734, DOI 10.1086/383278; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HEDGES SR, 1995, TRENDS MICROBIOL, V3, P266, DOI 10.1016/S0966-842X(00)88941-6; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Holden N, 2007, INFECT IMMUN, V75, P3325, DOI 10.1128/IAI.01989-06; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Khan AS, 2000, INFECT IMMUN, V68, P3541, DOI 10.1128/IAI.68.6.3541-3547.2000; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1986, INFECT IMMUN, V54, P322, DOI 10.1128/IAI.54.2.322-327.1986; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; KYOGASHIMA M, 1989, ARCH BIOCHEM BIOPHYS, V270, P391, DOI 10.1016/0003-9861(89)90042-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEBOUGUENEC C, 1993, INFECT IMMUN, V61, P5106, DOI 10.1128/IAI.61.12.5106-5114.1993; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lugering A, 2003, MICROBIOL-SGM, V149, P1387, DOI 10.1099/mic.0.26266-0; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mu XQ, 2006, P NATL ACAD SCI USA, V103, P9861, DOI 10.1073/pnas.0509620103; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; ORSKOV I, 1990, CURR TOP MICROBIOL, V151, P71; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455; PARKKINEN J, 1986, INFECT IMMUN, V54, P37, DOI 10.1128/IAI.54.1.37-42.1986; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Roberts JA, 2004, J UROLOGY, V171, P1682, DOI 10.1097/01.ju.0000116123.05160.43; Sakellaris H, 1996, MOL MICROBIOL, V21, P529, DOI 10.1111/j.1365-2958.1996.tb02562.x; Sakellaris H, 1999, P NATL ACAD SCI USA, V96, P12828, DOI 10.1073/pnas.96.22.12828; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Salih O, 2008, J MOL BIOL, V379, P174, DOI 10.1016/j.jmb.2008.03.056; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; SAVARINO SJ, 1994, J BACTERIOL, V176, P4949, DOI 10.1128/jb.176.16.4949-4957.1994; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Spurbeck RR, 2011, INFECT IMMUN, V79, P4753, DOI 10.1128/IAI.05621-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2008, MOL MICROBIOL, V67, P996, DOI 10.1111/j.1365-2958.2007.06098.x; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Verger D, 2007, PLOS PATHOG, V3, P674, DOI 10.1371/journal.ppat.0030073; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038596; Zavialov A, 2003, ACTA CRYSTALLOGR D, V59, P359, DOI 10.1107/S0907444902021054; Zavialov AV, 2007, MOL MICROBIOL, V64, P153, DOI 10.1111/j.1365-2958.2007.05644.x; Zavialvo AV, 2005, BIOCHEM J, V389, P685, DOI 10.1042/BJ20050426; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zhaxybayeva O, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-402; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	91	111	114	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52835	10.1371/journal.pone.0052835	http://dx.doi.org/10.1371/journal.pone.0052835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382825	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800013
J	Li, ZQ; Cheng, DJ; Mon, H; Zhu, L; Xu, J; Tatsuke, T; Lee, JM; Xia, QY; Kusakabe, T				Li, Zhiqing; Cheng, Daojun; Mon, Hiroaki; Zhu, Li; Xu, Jian; Tatsuke, Tsuneyuki; Lee, Jae Man; Xia, Qingyou; Kusakabe, Takahiro			Cell Cycle-Dependent Recruitment of Polycomb Proteins to the ASNS Promoter Counteracts C/ebp-Mediated Transcriptional Activation in Bombyx mori	PLOS ONE			English	Article							ASPARAGINE SYNTHETASE GENE; H3 LYSINE-27 METHYLATION; AMINO-ACID DEPRIVATION; DNA METHYLATION; DROSOPHILA; SILKWORM; CANCER; COMPLEX; BINDING; EXPRESSION	Epigenetic modifiers and transcription factors contribute to developmentally programmed gene expression. Here, we establish a functional link between epigenetic regulation by Polycomb group (PcG) proteins and transcriptional regulation by C/ebp that orchestrates the correct expression of Bombyx mori asparagine synthetase (BmASNS), a gene involved in the biosynthesis of asparagine. We show that the cis-regulatory elements of YY1-binding motifs and the CpG island present on the BmASNS promoter are required for the recruitment of PcG proteins and the subsequent deposition of the epigenetic repression mark H3K27me3. RNAi-mediated knockdown of PcG genes leads to derepression of the BmASNS gene via the recruitment of activators, including BmC/ebp, to the promoter. Intriguingly, we find that PcG proteins and BmC/ebp can dynamically modulate the transcriptional output of the BmASNS target in a cell cycle-dependent manner. It will be essential to suppress BmASNS expression by PcG proteins at the G2/M phase of the cell cycle in the presence of BmC/ebp activator. Thus, our results provide a novel insight into the molecular mechanism underlying the recruitment and regulation of the PcG system at a discrete gene locus in Bombyx mori.	[Li, Zhiqing; Mon, Hiroaki; Zhu, Li; Xu, Jian; Tatsuke, Tsuneyuki; Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan; [Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Kyushu University; Southwest University - China	Kusakabe, T (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan.	kusakabe@agr.kyushu-u.ac.jp	Tatsuke, Tsuneyuki/I-3714-2019; Zhu, Li/S-7517-2018; Xu, Jian/G-6684-2015	Tatsuke, Tsuneyuki/0000-0003-2322-4528; Zhu, Li/0000-0002-4919-1894; Xu, Jian/0000-0003-1816-4129; Li, Zhiqing/0000-0001-8323-3245	Japan Society for the Promotion of Science [22248004, 23580077]; National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) No. 22248004 and 23580077 from the Japan Society for the Promotion of Science to TK and JML, and also by grants from the National Basic Research Program of China (No. 2012CB114600) and the National Hi-Tech Research and Development Program of China (No. 2011AA100306) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Bruhat A, 2002, J BIOL CHEM, V277, P48107, DOI 10.1074/jbc.M206149200; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; GRECO A, 1989, MOL CELL BIOL, V9, P2350, DOI 10.1128/MCB.9.6.2350; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034330; Li ZQ, 2012, MOL BIOL REP, V39, P5575, DOI 10.1007/s11033-011-1362-5; Lorenzi PL, 2008, MOL CANCER THER, V7, P3123, DOI 10.1158/1535-7163.MCT-08-0589; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Mitsunobu H, 2012, INSECT MOL BIOL, V21, P9, DOI 10.1111/j.1365-2583.2011.01115.x; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Mon H, 2003, BIOCHEM BIOPH RES CO, V312, P684, DOI 10.1016/j.bbrc.2003.10.169; Mon H, 2012, J INSECT SC IN PRESS; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhou D, 2011, BBA-GENE REGUL MECH, V1809, P549, DOI 10.1016/j.bbagrm.2011.07.003	39	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e52320	10.1371/journal.pone.0052320	http://dx.doi.org/10.1371/journal.pone.0052320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382816	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500004
J	Bidwell, GL; Perkins, E; Hughes, J; Khan, M; James, JR; Raucher, D				Bidwell, Gene L., III; Perkins, Eddie; Hughes, Joshua; Khan, Majid; James, Judy R.; Raucher, Drazen			Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; ELASTIN-LIKE POLYPEPTIDE; CANCER-CELL-PROLIFERATION; DRUG-DELIVERY; GLIOBLASTOMA-MULTIFORME; GENETIC ALTERATIONS; SOLID TUMORS; PEPTIDE; DIFFERENTIATION; ACCUMULATION	Treatment of glioblastoma is complicated by the tumors' high resistance to chemotherapy, poor penetration of drugs across the blood brain barrier, and damaging effects of chemotherapy and radiation to normal neural tissue. To overcome these limitations, a thermally responsive polypeptide was developed for targeted delivery of therapeutic peptides to brain tumors using focused hyperthermia. The peptide carrier is based on elastin-like polypeptide (ELP), which is a thermally responsive biopolymer that forms aggregates above a characteristic transition temperature. ELP was modified with cell penetrating peptides (CPPs) to enhance delivery to brain tumors and mediate uptake across the tumor cells' plasma membranes and with a peptide inhibitor of c-Myc (H1). In rats with intracerebral gliomas, brain tumor targeting of ELP following systemic administration was enhanced up to 5-fold by the use of CPPs. When the lead CPP-ELP-fused c-Myc inhibitor was combined with focused hyperthermia of the tumors, an additional 3 fold increase in tumor polypeptide levels was observed, and 80% reduction in tumor volume, delayed onset of tumor-associated neurological deficits, and at least doubled median survival time including complete regression in 80% of animals was achieved. This work demonstrates that a c-Myc inhibitory peptide can be effectively delivered to brain tumors.	[Bidwell, Gene L., III; Khan, Majid] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; [Bidwell, Gene L., III; Perkins, Eddie; Raucher, Drazen] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Perkins, Eddie; Hughes, Joshua] Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA; [Perkins, Eddie] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Khan, Majid; James, Judy R.] Univ Mississippi, Med Ctr, Dept Radiol, Jackson, MS 39216 USA; [Raucher, Drazen] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Raucher, D (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.	draucher@umc.edu	Raucher, Drazen/AAE-4540-2022	Khan, Majid/0000-0002-3807-1387; Hughes, Joshua/0000-0003-0362-302X; Bidwell, Gene/0000-0001-9104-150X	Department of Defense Breast Cancer Research Program fellowship [W81XWH-08-1-0647]; National Science Foundation [CBET-0931041]; National Institutes of Health (NIH) National Cancer Institute [R21 CA139589-01]; NIH from the MFGN INBRE Program of the National Center for Research Resources [RR016476]; NATIONAL CANCER INSTITUTE [R21CA139589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program fellowship(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH from the MFGN INBRE Program of the National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for these studies was provided by a Department of Defense Breast Cancer Research Program fellowship [W81XWH-08-1-0647] to GLB, National Science Foundation grant [CBET-0931041] to DR, and National Institutes of Health (NIH) National Cancer Institute grant [R21 CA139589-01] to DR. The authors thank the Mississippi Functional Genomics Network (MFGN) Genomics Facility, which is supported by NIH Grant # RR016476 from the MFGN INBRE Program of the National Center for Research Resources, for access to and assistance with slide scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bidwell GL, 2012, CANCER LETT, V319, P136, DOI 10.1016/j.canlet.2011.12.042; Bidwell GL, 2010, ADV DRUG DELIVER REV, V62, P1486, DOI 10.1016/j.addr.2010.05.003; Bidwell GL, 2010, PEPTIDES, V31, P834, DOI 10.1016/j.peptides.2010.02.007; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Bidwell GL, 2006, BIOCHEM PHARMACOL, V71, P248, DOI 10.1016/j.bcp.2005.10.041; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1; DRAEGER LJ, 1994, J BIOL CHEM, V269, P1785; Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444; Gorin F, 2004, ACTA NEUROPATHOL, V107, P235, DOI 10.1007/s00401-003-0803-1; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Hou Lewis C, 2006, Neurosurg Focus, V20, pE5; Jolesz FA, 2008, J MAGN RESON IMAGING, V27, P391, DOI 10.1002/jmri.21261; Jolesz FA, 2009, ANNU REV MED, V60, P417, DOI 10.1146/annurev.med.60.041707.170303; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Lefranc F, 2006, EXPERT REV ANTICANC, V6, P719, DOI 10.1586/14737140.6.5.719; Lipka E, 1996, J CONTROL RELEASE, V39, P121, DOI 10.1016/0168-3659(95)00145-X; Liu WE, 2006, J CONTROL RELEASE, V116, P170, DOI 10.1016/j.jconrel.2006.06.026; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marquet F, 2009, PHYS MED BIOL, V54, P2597, DOI 10.1088/0031-9155/54/9/001; Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jconrel.2005.08.007; Massodi I, 2010, INT J CANCER, V126, P533, DOI 10.1002/ijc.24725; Massodi I, 2009, MOLECULES, V14, P1999, DOI 10.3390/molecules14061999; Meyer DE, 2001, CANCER RES, V61, P1548; ORIAN JM, 1992, BRIT J CANCER, V66, P106, DOI 10.1038/bjc.1992.225; Panicker SP, 2010, ONCOTARGET, V1, P289; Partanen A, 2012, INT J HYPERTHER, V28, P320, DOI 10.3109/02656736.2012.680173; Paul I, 2012, ONCOGENE; Pourquier P, 1998, BIOCHEM PHARMACOL, V55, P1963, DOI 10.1016/S0006-2952(98)00006-9; Raucher D, 2009, EXPERT OPIN DRUG DEL, V6, P1049, DOI 10.1517/17425240903158909; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Talmadge JE, 1998, ADV DRUG DELIVER REV, V33, P241, DOI 10.1016/S0169-409X(98)00032-5; Thuroff S, 2003, J ENDOUROL, V17, P673, DOI 10.1089/089277903322518699; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang X, 2002, CHINESE MED J-PEKING, V115, P1332; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	42	80	83	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55104	10.1371/journal.pone.0055104	http://dx.doi.org/10.1371/journal.pone.0055104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372821	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400063
J	Ventura, T; Manor, R; Aflalo, ED; Chalifa-Caspi, V; Weil, S; Sharabi, O; Sagi, A				Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Chalifa-Caspi, Vered; Weil, Simy; Sharabi, Omri; Sagi, Amir			Post-Embryonic Transcriptomes of the Prawn Macrobrachium rosenbergii: Multigenic Succession through Metamorphosis	PLOS ONE			English	Article							METHYL FARNESOATE; LIFE-CYCLE; MICROARRAY ANALYSIS; GENE-EXPRESSION; HEDGEHOG; LARVAL; GENOMICS; ANNOTATION; BLAST2GO; TOOL	Like many metazoans, the freshwater prawn Macrobrachium rosenbergii begins its post-embryonic life with a set of morphologically distinct planktonic larval stages, followed by a benthic post-larval stage during which the maturing organism differs from the larvae both ecologically and physiologically. Understanding of the molecular basis underlying morphogenesis in crustaceans is limited to the observation that methyl farnesoate, the non-epoxidated form of the insect juvenile hormone, acts as the active crustacean juvenoid. Molt steroids were also linked to morphogenesis and several other molecular pathways, such as Hedgehog and Wnt, are known to underlie morphogenesis in all metazoans examined and, as such, are thought to do the same in crustaceans. Using next generation sequencing, we deep-sequenced the transcriptomes of several larval and post-larval stages. De novo assembly, followed by bioinformatics analysis, revealed that many novel transcripts are over-expressed in either larvae-or post-larvae-stage prawn, shedding light on the molecular basis underlying M. rosenbergii metamorphosis. Fast larval molting rates and periodic morphological changes were reflected in over-expression of transcripts annotated to the cell cycle, DNA replication and morphogenic pathways (i.e., Hedgehog and Wnt). Further characterization of transcripts assigned to morphogenic pathways by real-time RT-PCR reconfirmed their over-expression in larvae, albeit with a more complex expression pattern when examined in the individual developmental stages. The expression level of an orthologue of cytochrome P450, 15A1, known to epoxidize methyl farnesoate in insects, was increased in the late larval and early post-larval stages, in accordance with the role of methyl farnesoate in crustacean metamorphosis. This study exemplifies the applicability of a high-throughput sequencing approach for studying complex traits, including metamorphosis, providing new insight into this unexplored area of crustacean research.	[Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Weil, Simy; Sharabi, Omri; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ventura, Tomer; Manor, Rivka; Aflalo, Eliahu D.; Chalifa-Caspi, Vered; Weil, Simy; Sharabi, Omri; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Ventura, T./H-9832-2019	Ventura, T./0000-0002-0777-2367; Sagi, Amir/0000-0002-4229-1059; Chalifa-Caspi, Vered/0000-0001-6030-5816; Aflalo, Eli/0000-0003-1385-2387	Tiran, Ltd. through BGNegev; National Institute for Biotechnology in the Negev (NIBN); Wolfson Family Charitable Trust	Tiran, Ltd. through BGNegev; National Institute for Biotechnology in the Negev (NIBN); Wolfson Family Charitable Trust	This study was funded by grants from Tiran, Ltd. through BGNegev and the National Institute for Biotechnology in the Negev (NIBN) and the Wolfson Family Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 1998, BIOL BULL, V195, P112, DOI 10.2307/1542818; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; FAO, 2009, MACR ROS SPEC FACT S; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Guerrero FD, 2009, J MED ENTOMOL, V46, P257, DOI 10.1603/033.046.0210; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Koutsos AC, 2007, P NATL ACAD SCI USA, V104, P11304, DOI 10.1073/pnas.0703988104; Laufer H, 2001, AM ZOOL, V41, P442, DOI 10.1668/0003-1569(2001)041[0442:UCLFMF]2.0.CO;2; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lemos D, 2002, AQUACULTURE, V214, P363, DOI 10.1016/S0044-8486(02)00253-3; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Medina M, 2009, MOL ECOL, V18, P763, DOI 10.1111/j.1365-294X.2008.04079.x; MOHLER J, 1988, GENETICS, V120, P1061; Retaux S, 2010, INTEGR COMP BIOL, V50, P98, DOI 10.1093/icb/icq032; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; SAGI A, 1991, COMP BIOCHEM PHYS B, V99, P879, DOI 10.1016/0305-0491(91)90157-9; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; UNO Y, 1969, Journal of the Tokyo University of Fisheries, V55, P179; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wong YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033323; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	38	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55322	10.1371/journal.pone.0055322	http://dx.doi.org/10.1371/journal.pone.0055322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372848	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400088
J	De Vylder, J; Aelterman, J; Lepez, T; Vandewoestyne, M; Douterloigne, K; Deforce, D; Philips, W				De Vylder, Jonas; Aelterman, Jan; Lepez, Trees; Vandewoestyne, Mado; Douterloigne, Koen; Deforce, Dieter; Philips, Wilfried			A Novel Dictionary Based Computer Vision Method for the Detection of Cell Nuclei	PLOS ONE			English	Article							ACTIVE CONTOUR MODEL; IMAGE SEGMENTATION; SHAPE PRIOR; SOFTWARE; EXTRACTION; MICROSCOPY; TRACKING; CIRCLES; GAS	Cell nuclei detection in fluorescent microscopic images is an important and time consuming task in a wide range of biological applications. Blur, clutter, bleed through and partial occlusion of nuclei make individual nuclei detection a challenging task for automated image analysis. This paper proposes a novel and robust detection method based on the active contour framework. Improvement over conventional approaches is achieved by exploiting prior knowledge of the nucleus shape in order to better detect individual nuclei. This prior knowledge is defined using a dictionary based approach which can be formulated as the optimization of a convex energy function. The proposed method shows accurate detection results for dense clusters of nuclei, for example, an F-measure (a measure for detection accuracy) of 0.96 for the detection of cell nuclei in peripheral blood mononuclear cells, compared to an F-measure of 0.90 achieved by state-of-the-art nuclei detection methods.	[De Vylder, Jonas; Aelterman, Jan; Douterloigne, Koen; Philips, Wilfried] Univ Ghent, iMinds, Dept Telecommun & Informat Proc, B-9000 Ghent, Belgium; [Lepez, Trees; Vandewoestyne, Mado; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium	Ghent University; IMEC; Ghent University	De Vylder, J (corresponding author), Univ Ghent, iMinds, Dept Telecommun & Informat Proc, B-9000 Ghent, Belgium.	jonas.devylder@telin.ugent.be	Deforce, Dieter LD/J-4725-2013	Deforce, Dieter LD/0000-0002-0635-661X; Aelterman, Jan/0000-0002-5543-2631	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Research Foundation Flanders (FWO)	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO)	Jonas De Vylder and Trees Lepez are funded by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Mado Vandewoestyne is funded by Research Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P118, DOI 10.1109/MSP.2007.4286571; Bresson X, 2007, IEEE IMAGE PROC, P33; Chan T, 1999, LECT NOTES COMPUT SC, V1682, P141; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Charmi MA, 2008, PATTERN RECOGN LETT, V29, P897, DOI 10.1016/j.patrec.2008.01.011; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cloppet F, 2008, INT C PATT RECOG, P789; Cremers D, 2008, PROC CVPR IEEE, P810; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; De Vylder J, 2011, P SPIE PHOT W C IM M; De Vylder J, 2011, 5 IEEE INT C SIGN PR, P1; Gudla PR, 2008, CYTOM PART A, V73A, P451, DOI 10.1002/cyto.a.20550; Horvath P, 2009, PATTERN RECOGN, V42, P699, DOI 10.1016/j.patcog.2008.09.008; Hukkanen J, 2010, EUR SIGNAL PR CONF, P1219; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Klodt M, 2011, IEEE I CONF COMP VIS, P2236, DOI 10.1109/ICCV.2011.6126502; Lepez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029646; Li G, 2008, J MICROSC-OXFORD, V231, P47, DOI 10.1111/j.1365-2818.2008.02016.x; Liu X, 2012, 34 ANN INT IEEE EMBS, P2327; Merchant FA, 2002, HUM REPROD UPDATE, V8, P509, DOI 10.1093/humupd/8.6.509; Nemeth J, 2011, LECT NOTES COMPUT SC, V6915, P171, DOI 10.1007/978-3-642-23687-7_16; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pock T, 2010, SIAM J IMAGING SCI, V3, P1122, DOI 10.1137/090757617; Pound MP, 2012, PLANT CELL, V24, P1353, DOI 10.1105/tpc.112.096289; Quelhas P, 2010, IEEE T MED IMAGING, V29, P1463, DOI 10.1109/TMI.2010.2048253; Ruusuvuori P., 2008, P 16 EUR SIGN PROC C; Schoenemann T, 2007, IEEE I CONF COMP VIS, P1132; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P441, DOI 10.1007/s00414-009-0341-z; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P169, DOI 10.1007/s00414-008-0271-1	32	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54068	10.1371/journal.pone.0054068	http://dx.doi.org/10.1371/journal.pone.0054068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358886	Green Published, gold			2022-12-27	WOS:000314023600028
J	Mi, Y; Zhang, X; Zhang, F; Qi, JL; Gao, HX; Huang, DY; Li, L; Zhang, HL; Du, XN				Mi, Yao; Zhang, Xuan; Zhang, Fan; Qi, Jinlong; Gao, Haixia; Huang, Dongyang; Li, Li; Zhang, Hailin; Du, Xiaona			The Role of Potassium Channel Activation in Celecoxib-Induced Analgesic Action	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SENSORY NEURONS; NEUROPATHIC PAIN; K+ CHANNELS; INHIBITION; CURRENTS; PROTEIN; CYCLOOXYGENASE; IDENTIFICATION; NOCICEPTION	Background and Purpose: Celecoxib (CXB) is a widely prescribed COX-2 inhibitor used clinically to treat pain and inflammation. Recently, COX-2 independent mechanisms have been described to be the targets of CXB. For instance, ion channels such as the voltage-gated sodium channel, L-type calcium channel, Kv2.1, Kv1.5, Kv4.3 and HERG potassium channel were all reported to be inhibited by CXB. Our recent study revealed that CXB is a potent activator of Kv7/M channels. M currents expressed in dorsal root ganglia play an important role in nociception. Our study was aimed at establishing the role of COX-2 independent M current activation in the analgesic action of CXB. Methods and Results: We compared the effects of CXB and its two structural analogues, unmethylated CXB (UMC) and 2,5-dimethyl-CXB (DMC), on Kv7/M currents and pain behavior in animal models. UMC is a more potent inhibitor of COX-2 than CXB while DMC has no COX-2 inhibiting activity. We found that CXB, UMC and DMC concentration-dependently activated Kv7.2/7.3 channels expressed in HEK293 cells and the M-type current in dorsal root ganglia neurons, negatively shifted I-V curve of Kv7.2/7.3 channels, with a potency and efficiency inverse to their COX-2 inhibitory potential. Furthermore, CXB, UMC and DMC greatly reduced inflammatory pain behavior induced by bradykinin, mechanical pain behavior induced by stimulation with von Frey filaments and thermal pain behavior in the Hargreaves test. CXB and DMC also significantly attenuated hyperalgesia in chronic constriction injury neuropathic pain. Conclusion: CXB, DMC and UMC are openers of Kv7/M K+ channels with effects independent of COX-2 inhibition. The analgesic effects of CXBs on pain behaviors, especially those of DMC, suggest that activation of Kv7/M K+ channels may play an important role in the analgesic action of CXB. This study strengthens the notion that Kv7/M K+ channels are a potential target for pain treatment.	[Mi, Yao; Zhang, Xuan; Zhang, Fan; Gao, Haixia; Huang, Dongyang; Li, Li; Zhang, Hailin; Du, Xiaona] Minist Educ, Key Lab Neural & Vasc Biol, Dept Pharmacol, Shijiazhuang, Peoples R China; [Qi, Jinlong] Hebei Med Univ, Dept New Drug Dev, Shijiazhuang, Peoples R China	Hebei Medical University	Du, XN (corresponding author), Minist Educ, Key Lab Neural & Vasc Biol, Dept Pharmacol, Shijiazhuang, Peoples R China.	du_xiaona@yahoo.com	张, 凡/GRX-6695-2022	张, 凡/0000-0003-0458-6742	National Natural Science Foundation of China [30500112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30500112) (X.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2002, J BIOL CHEM, V277, P27613, DOI 10.1074/jbc.M201119200; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; CASSELL JF, 1987, BRIT J PHARMACOL, V91, P259, DOI 10.1111/j.1476-5381.1987.tb10279.x; Chuang HC, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-38; Du XN, 2011, BRIT J PHARMACOL, V164, P1722, DOI 10.1111/j.1476-5381.2011.01483.x; Franco L, 1999, PROSTAG OTH LIPID M, V58, P9, DOI 10.1016/S0090-6980(99)00020-9; Frolov RV, 2008, NEUROSCIENCE, V154, P1525, DOI 10.1016/j.neuroscience.2008.05.004; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026344; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Ke M, 2008, BRAIN RES, V1209, P57, DOI 10.1016/j.brainres.2008.02.096; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Lynch JJ, 2004, PAIN, V110, P56, DOI 10.1016/j.pain.2004.03.010; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2003, EXP NEUROL, V183, P581, DOI 10.1016/S0014-4886(03)00182-1; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Rodrigues-Filho R, 2004, BRAIN RES, V1018, P159, DOI 10.1016/j.brainres.2004.05.058; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; White WB, 2007, AM J CARDIOL, V99, P91, DOI 10.1016/j.amjcard.2006.07.069; Zhang Y, 2007, PHARMACOL RES, V56, P267, DOI 10.1016/j.phrs.2007.07.004	37	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54797	10.1371/journal.pone.0054797	http://dx.doi.org/10.1371/journal.pone.0054797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358696	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600113
J	Ramakrishna, S; Kim, YH; Kim, H				Ramakrishna, Suresh; Kim, Young-Hoon; Kim, Hyongbum			Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; TARGETED GENE KNOCKOUT; HOMOLOGOUS RECOMBINATION; PATHWAY; DISRUPTION; DROSOPHILA; MUTATIONS; CLEAVAGE; ENZYMES	Background: Zinc finger nucleases (ZFNs) are powerful tools for gene therapy and genetic engineering. The characterization of ZFN protein stability and the development of simple methods to improve ZFN function would facilitate the application of this promising technology. However, the factors that affect ZFN protein stability and function are not yet clear. Here, we determined the stability and half-life of two ZFN proteins and examined the effect of MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-Hl), a proteasome inhibitor, on ZFN-mediated gene modifications. Methodology/Principal Findings: ZFN proteins were expressed in 293T cells after transfection of ZFN-encoding plasmids. We studied two ZFN pairs: Z-224, which targets the CCR5 gene, and K-230, which targets a region 230 kbp upstream of CCR5. Western blotting after treatment with cycloheximide showed that the half-life of these ZFN proteins was around two hours. An immunoprecipitation assay revealed that the ZFN interacts with ubiquitin molecules and undergoes polyubiquitination in vivo. Western blotting showed that the addition of MG132, a proteasomal inhibitor, increased ZFN protein levels. Finally, a surrogate reporter assay and a T7E1 assay revealed that MG132 treatment enhanced ZFN-directed gene editing. Conclusions: To our knowledge, this is the first study to investigate ZFN protein stability and to show that a small molecule can increase ZFN activity. Our protein stability study should lay the foundation for further improvement of ZFN technology; as a first step, the use of the small molecule MG132 can enhance the efficiency of ZFN-mediated gene editing.	[Ramakrishna, Suresh; Kim, Young-Hoon; Kim, Hyongbum] Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Med, Seoul 133791, South Korea	Hanyang University	Kim, H (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Med, Seoul 133791, South Korea.	hkim1@hanyang.ac.kr	Kim, Hyongbum Henry/D-5804-2019; Ramakrishna, Suresh/AAX-4096-2021	Kim, Hyongbum Henry/0000-0002-4693-738X; 	Ministry of Education, Science and Technology of Korea [2012-0006105, 2012-0003376, 2012-0006735, 2012-0009337, 2012K001482]	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Ministry of Education, Science and Technology of Korea (2012-0006105, 2012-0003376, 2012-0006735, 2012-0009337, and 2012K001482). No additional funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Ellis B.L., 2012, GENE THER; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hanin M, 2003, CURR OPIN PLANT BIOL, V6, P157, DOI 10.1016/S1369-5266(03)00016-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Pan HZ, 2011, PROTEIN CELL, V2, P950, DOI 10.1007/s13238-011-1132-0; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramakrishna S, 2011, CELL MOL LIFE SCI, V68, P15, DOI 10.1007/s00018-010-0504-6; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	38	16	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54282	10.1371/journal.pone.0054282	http://dx.doi.org/10.1371/journal.pone.0054282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365657	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600045
J	Wilke, C; Synofzik, M; Lindner, A				Wilke, Carlo; Synofzik, Matthis; Lindner, Axel			Sensorimotor Recalibration Depends on Attribution of Sensory Prediction Errors to Internal Causes	PLOS ONE			English	Article							MOTOR ADAPTATION; PERCEPTION; SCHIZOPHRENIA; CONSEQUENCES; AGENCY; ABNORMALITIES; INFORMATION; AWARENESS; CORRELATE; DYNAMICS	Sensorimotor learning critically depends on error signals. Learning usually tries to minimise these error signals to guarantee optimal performance. Errors can, however, have both internal causes, resulting from one's sensorimotor system, and external causes, resulting from external disturbances. Does learning take into account the perceived cause of error information? Here, we investigated the recalibration of internal predictions about the sensory consequences of one's actions. Since these predictions underlie the distinction of self- and externally produced sensory events, we assumed them to be recalibrated only by prediction errors attributed to internal causes. When subjects were confronted with experimentally induced visual prediction errors about their pointing movements in virtual reality, they recalibrated the predicted visual consequences of their movements. Recalibration was not proportional to the externally generated prediction error, but correlated with the error component which subjects attributed to internal causes. We also revealed adaptation in subjects' motor performance which reflected their recalibrated sensory predictions. Thus, causal attribution of error information is essential for sensorimotor learning.	[Wilke, Carlo; Lindner, Axel] Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lindner, A (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	a.lindner@medizin.uni-tuebingen.de	Wilke, Carlo/AAJ-8207-2020	Wilke, Carlo/0000-0002-7250-8597; Lindner, Axel/0000-0002-8201-788X; Synofzik, Matthis/0000-0002-2280-7273	German Research Council (Werner Reichardt Centre for Integrative Neuroscience); Bernstein Center for Computational Neuroscience Tubingen [BMBF FKZ 01GQ1002]; Volkswagen Stiftung [VW II/85158]	German Research Council (Werner Reichardt Centre for Integrative Neuroscience); Bernstein Center for Computational Neuroscience Tubingen; Volkswagen Stiftung(Volkswagen)	This work was supported by grants from the German Research Council (Werner Reichardt Centre for Integrative Neuroscience), the Bernstein Center for Computational Neuroscience Tubingen (BMBF FKZ 01GQ1002) and the Volkswagen Stiftung (VW II/85158 to MS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bland AR, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00080; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Cressman EK, 2011, PROG BRAIN RES, V191, P91, DOI 10.1016/B978-0-444-53752-2.00011-4; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Farrer C, 2003, CONSCIOUS COGN, V12, P609, DOI 10.1016/S1053-8100(03)00047-3; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; HAITH A, 2008, UNIFYING SENSORY MOT; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lai EJ, 2003, EXP BRAIN RES, V153, P76, DOI 10.1007/s00221-003-1584-4; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nakanishi J, 2004, NEURAL NETWORKS, V17, P1453, DOI 10.1016/j.neunet.2004.05.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Preston C, 2010, CONSCIOUS COGN, V19, P986, DOI 10.1016/j.concog.2010.04.005; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reuschel J, 2011, EXP BRAIN RES, V209, P619, DOI 10.1007/s00221-011-2596-0; Reuschel J, 2010, EXP BRAIN RES, V201, P853, DOI 10.1007/s00221-009-2099-4; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Synofzik M, 2009, CONSCIOUS COGN, V18, P1065, DOI 10.1016/j.concog.2009.07.007; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Torres-Oviedo G, 2012, J NEUROPHYSIOL, V107, P346, DOI 10.1152/jn.00570.2011; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wilke C, 2012, CONSCIOUS COGN, V21, P18, DOI 10.1016/j.concog.2011.06.004; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	66	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54925	10.1371/journal.pone.0054925	http://dx.doi.org/10.1371/journal.pone.0054925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359818	gold, Green Published			2022-12-27	WOS:000314023600136
J	Bowman, H; Filetti, M; Janssen, D; Su, L; Alsufyani, A; Wyble, B				Bowman, Howard; Filetti, Marco; Janssen, Dirk; Su, Li; Alsufyani, Abdulmajeed; Wyble, Brad			Subliminal Salience Search Illustrated: EEG Identity and Deception Detection on the Fringe of Awareness	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; EVENT-RELATED POTENTIALS; COMPLEX TRIAL PROTOCOL; TERM CONCEPTUAL MEMORY; ATTENTIONAL BLINK; CONCEALED INFORMATION; TEMPORAL ATTENTION; WORKING-MEMORY; TESTS; P300	We propose a novel deception detection system based on Rapid Serial Visual Presentation (RSVP). One motivation for the new method is to present stimuli on the fringe of awareness, such that it is more difficult for deceivers to confound the deception test using countermeasures. The proposed system is able to detect identity deception (by using the first names of participants) with a 100% hit rate (at an alpha level of 0.05). To achieve this, we extended the classic Event-Related Potential (ERP) techniques (such as peak-to-peak) by applying Randomisation, a form of Monte Carlo resampling, which we used to detect deception at an individual level. In order to make the deployment of the system simple and rapid, we utilised data from three electrodes only: Fz, Cz and Pz. We then combined data from the three electrodes using Fisher's method so that each participant was assigned a single p-value, which represents the combined probability that a specific participant was being deceptive. We also present subliminal salience search as a general method to determine what participants find salient by detecting breakthrough into conscious awareness using EEG.	[Bowman, Howard; Filetti, Marco; Alsufyani, Abdulmajeed] Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England; [Janssen, Dirk] NHTV Breda Univ Appl Sci, Breda, Netherlands; [Su, Li] Univ Cambridge, Cambridge, England; [Wyble, Brad] Syracuse Univ, Coll Arts & Sci, Dept Psychol, Syracuse, NY USA	University of Kent; Breda University of Applied Sciences; University of Cambridge; Syracuse University	Bowman, H (corresponding author), Univ Kent, Sch Comp, CCNCS, Canterbury, Kent, England.	H.Bowman@kent.ac.uk	Alsufyani, abdulmajeed/AGG-9038-2022	Alsufyani, abdulmajeed/0000-0001-6110-3642; Su, Li/0000-0002-6347-3986	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	University of Kent; United Kingdom (UK) Engineering and Physical Sciences Research Council	One of the PhD students involved in this research was supported financially by the University of Kent (www.kent.ac.uk). Initial ideas that led to the approach presented here were developed under United Kingdom (UK) Engineering and Physical Sciences Research Council funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2010, IEEE ENG MED BIO, P2686, DOI 10.1109/IEMBS.2010.5626548; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Barnard PJ, 2005, VIS COGN, V12, P181, DOI 10.1080/13506280444000139; Barnard PJ, 2004, PSYCHOL SCI, V15, P179, DOI 10.1111/j.0956-7976.2004.01503006.x; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Battye G, 2003, CONNECTIONIST MODELL; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; BOTELLA J, 1992, PERCEPT PSYCHOPHYS, V52, P547, DOI 10.3758/BF03206716; Bowman H., 2011, HUMAN ATTENTION DIGI, P114, DOI DOI 10.1017/CB09780511974519.005; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Chennu S., 2011, 33 ANN C COGN SCI SO, V33, P2598; Chennu S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000576; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Craston P, 2009, J COGNITIVE NEUROSCI, V21, P550, DOI 10.1162/jocn.2009.21036; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; ELAAD E, 1992, J APPL PSYCHOL, V77, P757, DOI 10.1037/0021-9010.77.5.757; Farwell LA, 2001, J FORENSIC SCI, V46, P135; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Labkovsky E, 2012, APPL PSYCHOPHYS BIOF, V37, P1, DOI 10.1007/s10484-011-9171-0; Lan T, 2010, ESANN EUR S ART NEUR, P351; LAWRENCE DH, 1971, PERCEPT PSYCHOPHYS, V10, P85, DOI 10.3758/BF03214320; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Lykken D.T., 1998, TREMOR BLOOD USES AB; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Miller AR, 2002, J PSYCHOPHYSIOL, V16, P1, DOI 10.1027//0269-8803.16.1.1; Nieuwenhuis S, 2005, J EXP PSYCHOL GEN, V134, P291, DOI 10.1037/0096-3445.134.3.291; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; Potter MC, 2010, J EXP PSYCHOL HUMAN, V36, P1486, DOI 10.1037/a0018730; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; POTTER MC, 1993, MEM COGNITION, V21, P156, DOI 10.3758/BF03202727; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rosenfeld JP, 2007, BIOL PSYCHOL, V74, P396, DOI 10.1016/j.biopsycho.2006.10.002; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 2006, INT J PSYCHOPHYSIOL, V60, P251, DOI 10.1016/j.ijpsycho.2005.06.002; Rosenfeld JP, 2004, PSYCHOPHYSIOLOGY, V41, P205, DOI 10.1111/j.1469-8986.2004.00158.x; Shih SI, 2002, PSYCHOL REV, V109, P260, DOI 10.1037//0033-295X.109.2.260; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wyble B, 2006, ELECTROPHYSIOLOGICAL; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	57	24	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54258	10.1371/journal.pone.0054258	http://dx.doi.org/10.1371/journal.pone.0054258			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372697	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500049
J	Fratkin, JL; Sinn, DL; Patall, EA; Gosling, SD				Fratkin, Jamie L.; Sinn, David L.; Patall, Erika A.; Gosling, Samuel D.			Personality Consistency in Dogs: A Meta-Analysis	PLOS ONE			English	Article							GREAT TITS; EXPLORATORY-BEHAVIOR; AGGRESSIVE-BEHAVIOR; PUBLICATION BIAS; EARLY PREDICTION; CORTISOL-LEVELS; PARUS-MAJOR; EFFECT SIZE; TRAITS; GUIDE	Personality, or consistent individual differences in behavior, is well established in studies of dogs. Such consistency implies predictability of behavior, but some recent research suggests that predictability cannot be assumed. In addition, anecdotally, many dog experts believe that 'puppy tests' measuring behavior during the first year of a dog's life are not accurate indicators of subsequent adult behavior. Personality consistency in dogs is an important aspect of human-dog relationships (e. g., when selecting dogs suitable for substance-detection work or placement in a family). Here we perform the first comprehensive meta-analysis of studies reporting estimates of temporal consistency of dog personality. A thorough literature search identified 31 studies suitable for inclusion in our meta-analysis. Overall, we found evidence to suggest substantial consistency (r = 0.43). Furthermore, personality consistency was higher in older dogs, when behavioral assessment intervals were shorter, and when the measurement tool was exactly the same in both assessments. In puppies, aggression and submissiveness were the most consistent dimensions, while responsiveness to training, fearfulness, and sociability were the least consistent dimensions. In adult dogs, there were no dimension-based differences in consistency. There was no difference in personality consistency in dogs tested first as puppies and later as adults (e. g., 'puppy tests') versus dogs tested first as puppies and later again as puppies. Finally, there were no differences in consistency between working versus non-working dogs, between behavioral codings versus behavioral ratings, and between aggregate versus single measures. Implications for theory, practice, and future research are discussed.	[Fratkin, Jamie L.; Sinn, David L.; Gosling, Samuel D.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Sinn, David L.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Patall, Erika A.] Univ Texas Austin, Dept Educ Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Tasmania; University of Texas System; University of Texas Austin	Fratkin, JL (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	fratkijl@utexas.edu	Patall, Erika/AAM-5679-2020; Gosling, Sam/AAL-5718-2020	Gosling, Sam/0000-0001-8970-591X	US Department of Homeland Security [HSHQDC-10-C-00085]	US Department of Homeland Security(United States Department of Homeland Security (DHS))	Funding provided by the US Department of Homeland Security, Contract HSHQDC-10-C-00085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1941, LECT CONDITIONED REF; Arata S, 2010, J VET MED SCI, V72, P539, DOI 10.1292/jvms.09-0512; Barnett V, 1994, OUTLIERS STAT DATA A; Battaglia CL, 2009, J VET BEHAV, V4, P203, DOI 10.1016/j.jveb.2009.03.003; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Borenstein M., 2009, HDB RES SYNTHESIS ME, VVolume 2, P221, DOI DOI 10.7758/9781610441384; Borenstein M., 2005, COMPREHENSIVE META A; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Christensen E, 2007, APPL ANIM BEHAV SCI, V106, P85, DOI 10.1016/j.applanim.2006.07.002; Cooper H, 2009, HDB RES SYNTHESIS ME; Coren S., 1998, WHY WE LOVE DOGS WE; De Meester RH, 2008, J VET BEHAV, V3, P161, DOI 10.1016/j.jveb.2007.10.005; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; DRAPER TW, 1995, J GEN PSYCHOL, V122, P241, DOI 10.1080/00221309.1995.9921236; Duffy D. L., 2008, J VET BEHAV, V3, P186, DOI DOI 10.1016/j.jveb.2007.12.010; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; EPSTEIN S, 1983, J PERS, V51, P360, DOI 10.1111/j.1467-6494.1983.tb00338.x; Field AP, 2003, PSYCHOLOGIST, V16, P642; Fleeson W, 2004, CURR DIR PSYCHOL SCI, V13, P83, DOI 10.1111/j.0963-7214.2004.00280.x; Fleeson W, 2001, J PERS SOC PSYCHOL, V80, P1011, DOI 10.1037/0022-3514.80.6.1011; Galibert F, 2011, CR BIOL, V334, P190, DOI 10.1016/j.crvi.2010.12.011; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; GODDARD ME, 1984, APPL ANIM BEHAV SCI, V12, P253, DOI 10.1016/0168-1591(84)90118-7; Gosling SD, 2008, SOC PERSONAL PSYCHOL, V2, P985, DOI 10.1111/j.1751-9004.2008.00087.x; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gosling SD, 1998, J COMP PSYCHOL, V112, P107, DOI 10.1037/0735-7036.112.2.107; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; HEDGES LV, 1992, J EDUC STAT, V17, P279, DOI 10.2307/1165125; Hedges LV, 2014, STAT METHODS META AN; Hennessy MB, 1997, PHYSIOL BEHAV, V62, P485, DOI 10.1016/S0031-9384(97)80328-9; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Highfill L, 2010, ZOO BIOL, V29, P509, DOI 10.1002/zoo.20279; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; John O. P., 2007, HDB RES METHODS PERS, P461; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; King T, 2009, APPL ANIM BEHAV SCI, V120, P84, DOI 10.1016/j.applanim.2009.04.011; Koda N, 2001, BEHAV PROCESS, V53, P41, DOI 10.1016/S0376-6357(00)00146-7; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; MARTINEK Z, 1969, PHYSIOL BOHEMOSLOV, V18, P217; McCrae RR., 1999, HDB PERSONALITY THEO, V2nd, P139, DOI DOI 10.1016/S0191-8869(97)81000-8; McPherson JA, 1998, THESIS U SOUTHAMPTON; Miklosi A., 2009, DOG BEHAV EVOLUTION; Mizukoshi M, 2008, J VET BEHAV, V3, P193, DOI 10.1016/j.jveb.2008.05.002; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; O'Farrell V., 1995, THE DOMESTIC DOG; Paroz C, 2008, APPL ANIM BEHAV SCI, V115, P67, DOI 10.1016/j.applanim.2008.04.010; Pederson AK, 2005, J RES PERS, V39, P534, DOI 10.1016/j.jrp.2004.07.002; Pervin LA., 2005, PERSONALITY THEORY R, V9th; Pfaffenberger C, 1976, GUIDE DOGS BLIND THE; Pierantoni L, 2011, VET REC, P1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Rodel HG, 2011, BEHAV ECOL, V22, P1123, DOI 10.1093/beheco/arr100; Rodel HG, 2011, DEV PSYCHOBIOL, V53, P601, DOI 10.1002/dev.20522; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Scott JP., 1965, GENETICS SOCIAL BEHA; Segurson SA, 2005, JAVMA-J AM VET MED A, V227, P1755, DOI 10.2460/javma.2005.227.1755; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Sinn DL, 2001, J COMP PSYCHOL, V115, P351, DOI 10.1037//0735-7036.115.4.351; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Solomon MB, 2009, HORM BEHAV, V56, P423, DOI 10.1016/j.yhbeh.2009.07.011; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Stamps J, 2003, ANIM BEHAV, V66, P1, DOI 10.1006/anbe.2003.2180; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stephen J, 2006, THESIS BRUNEL U UK; Stephen J, 2007, APPL ANIM BEHAV SCI, V107, P88, DOI 10.1016/j.applanim.2006.09.012; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; van den Berg L, 2006, BEHAV GENET, V36, P882, DOI 10.1007/s10519-006-9089-0; Vazire S., 2007, HDB RES METHODS PERS, P190; Weiss E, 1997, APPL ANIM BEHAV SCI, V53, P297, DOI 10.1016/S0168-1591(96)01176-8; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Wingfield JC, 2003, ANIM BEHAV, V66, P807, DOI 10.1006/anbe.2003.2298; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Garamszegi LZ, 2012, EVOL ECOL, V26, P1213, DOI 10.1007/s10682-012-9589-8	104	96	96	3	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54907	10.1371/journal.pone.0054907	http://dx.doi.org/10.1371/journal.pone.0054907			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372787	Green Published, gold			2022-12-27	WOS:000314021500140
J	Heynen, SR; Meneau, I; Caprara, C; Samardzija, M; Imsand, C; Levine, EM; Grimm, C				Heynen, Severin Reinhard; Meneau, Isabelle; Caprara, Christian; Samardzija, Marijana; Imsand, Cornelia; Levine, Edward M.; Grimm, Christian			CDC42 Is Required for Tissue Lamination and Cell Survival in the Mouse Retina	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; OPTIC-NERVE; PHOTORECEPTOR DEGENERATION; NEUROTROPHIC FACTOR; MAMMALIAN RETINA; TRANSGENIC MICE; BETA-CATENIN; LIGHT DAMAGE; RHO-GTPASES; N-CADHERIN	The small GTPase CDC42 has pleiotropic functions during development and in the adult. These functions include intra-as well as intercellular tasks such as organization of the cytoskeleton and, at least in epithelial cells, formation of adherens junctions. To investigate CDC42 in the neuronal retina, we generated retina-specific Cdc42-knockdown mice (Cdc42-KD) and analyzed the ensuing consequences for the developing and postnatal retina. Lack of CDC42 affected organization of the developing retina as early as E17.5, prevented correct tissue lamination, and resulted in progressive retinal degeneration and severely reduced retinal function of the postnatal retina. Despite the disorganization of the retina, formation of the primary vascular plexus was not strongly affected. However, both deeper vascular plexi developed abnormally with no clear layering of the vessels. Retinas of Cdc42-KD mice showed increased expression of pro-survival, but also of pro-apoptotic and pro-inflammatory genes and exhibited prolonged Muller glia hypertrophy. Thus, functional CDC42 is important for correct tissue organization already during retinal development. Its absence leads to severe destabilization of the postnatal retina with strong degeneration and loss of retinal function.	[Heynen, Severin Reinhard; Meneau, Isabelle; Caprara, Christian; Samardzija, Marijana; Imsand, Cornelia; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, CH-8006 Zurich, Switzerland; [Heynen, Severin Reinhard; Caprara, Christian; Grimm, Christian] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland; [Levine, Edward M.] Univ Utah, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Grimm, Christian] Univ Zurich, Ctr Neurosci, CH-8006 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Utah System of Higher Education; University of Utah; University of Zurich	Grimm, C (corresponding author), Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, CH-8006 Zurich, Switzerland.	cgrimm@opht.uzh.ch	Levine, Edward/N-3878-2015; Samardzija, Marijana/B-9245-2008	Levine, Edward/0000-0003-1725-2805; Samardzija, Marijana/0000-0003-0991-4653; Grimm, Christian/0000-0001-9318-4352	University of Zurich; Swiss National Science Foundation (SNF) [3100A0-117760]; NATIONAL EYE INSTITUTE [P30EY014800, R01EY013760] Funding Source: NIH RePORTER	University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a cooperative ZIHP project (University of Zurich) and the Swiss National Science Foundation (SNF #3100A0-117760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Burgi S, 2009, MOL VIS, V15, P1631; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Caprara C, 2011, INVEST OPHTH VIS SCI, V52, P2109, DOI 10.1167/iovs.10-6222; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen TJ, 2006, J NEUROBIOL, V66, P103, DOI 10.1002/neu.20204; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Haruta M, 2009, P NATL ACAD SCI USA, V106, P9397, DOI 10.1073/pnas.0808940106; Heynen SR, 2011, MOL VIS, V17, P2934; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Lange C, 2010, J NEUROCHEM, V113, P1210, DOI 10.1111/j.1471-4159.2010.06686.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mitchell DC, 2007, MOL VIS, V13, P1144; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Randlett O, 2011, DEV NEUROBIOL, V71, P567, DOI 10.1002/dneu.20841; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Santos-Bredariol AS, 2002, J NEUROCYTOL, V31, P149, DOI 10.1023/A:1023997506760; Schnack C, 2008, NEUROSCIENCE, V154, P1450, DOI 10.1016/j.neuroscience.2008.02.049; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Stone J, 1995, NEUROSCIENCE, V5, P4738; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Vazquez-Chona FR, 2009, INVEST OPHTH VIS SCI, V50, P3996, DOI 10.1167/iovs.08-3189; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yokota Y, 2010, DEVELOPMENT, V137, P4101, DOI 10.1242/dev.048637; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhu XW, 2000, INT J DEV NEUROSCI, V18, P433, DOI 10.1016/S0736-5748(00)00010-1	59	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53806	10.1371/journal.pone.0053806	http://dx.doi.org/10.1371/journal.pone.0053806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372671	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314021500025
J	Pielarski, KN; van Stegen, B; Andreyeva, A; Nieweg, K; Jungling, K; Redies, C; Gottmann, K				Pielarski, Kim N.; van Stegen, Bernd; Andreyeva, Aksana; Nieweg, Katja; Juengling, Kay; Redies, Christoph; Gottmann, Kurt			Asymmetric N-Cadherin Expression Results in Synapse Dysfunction, Synapse Elimination, and Axon Retraction in Cultured Mouse Neurons	PLOS ONE			English	Article							REGULATES DENDRITIC SPINE; EMBRYONIC STEM-CELLS; BETA-CATENIN; ADHESION; DIFFERENTIATION; MECHANISMS; RECEPTOR; LOCALIZATION; SUPERFAMILY; CONNECTIONS	Synapse elimination and pruning of axon collaterals are crucial developmental events in the refinement of neuronal circuits. While a control of synapse formation by adhesion molecules is well established, the involvement of adhesion molecules in developmental synapse loss is poorly characterized. To investigate the consequences of mis-match expression of a homophilic synaptic adhesion molecule, we analysed an asymmetric, exclusively postsynaptic expression of N-cadherin. This was induced by transfecting individual neurons in cultures of N-cadherin knockout mouse neurons with a N-cadherin expression vector. 2 days after transfection, patch-clamp analysis of AMPA receptor-mediated miniature postsynaptic currents revealed an impaired synaptic function without a reduction in the number of presynaptic vesicle clusters. Longterm asymmetric expression of N-cadherin for 8 days subsequently led to synapse elimination as indicated by a loss of colocalization of presynaptic vesicles and postsynaptic PSD95 protein. We further studied long-term asymmetric N-cadherin expression by conditional, Cre-induced knockout of N-cadherin in individual neurons in cultures of N-cadherin expressing cortical mouse neurons. This resulted in a strong retraction of axonal processes in individual neurons that lacked N-cadherin protein. Moreover, an in vivo asymmetric expression of N-cadherin in the developmentally transient cortico-tectal projection was indicated by in-situ hybridization with layer V neurons lacking N-cadherin expression. Thus, mis-match expression of N-cadherin might contribute to selective synaptic connectivity.	[Pielarski, Kim N.; van Stegen, Bernd; Andreyeva, Aksana; Nieweg, Katja; Juengling, Kay; Gottmann, Kurt] Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany; [Redies, Christoph] Univ Jena, Sch Med, Jena Univ Hosp, Inst Anat 1, Jena, Germany	Heinrich Heine University Dusseldorf; Friedrich Schiller University of Jena	Gottmann, K (corresponding author), Univ Dusseldorf, Fac Med, Inst Neuro & Sensory Physiol, D-40225 Dusseldorf, Germany.	Kurt.Gottmann@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding from Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva A, 2012, BRAIN, V135, P2140, DOI 10.1093/brain/aws120; Baba K, 2007, BRAIN RES, V1140, P205, DOI 10.1016/j.brainres.2006.09.113; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Cork RJ, 1998, J COMP NEUROL, V394, P205; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DOHERTY P, 1991, J CELL SCI, P13; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiederling A, 2011, NEUROSCI LETT, V501, P167, DOI 10.1016/j.neulet.2011.07.009; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Huntley GW, 1999, J COMP NEUROL, V407, P453; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Jungling K, 2003, FASEB J, V17, P2100, DOI 10.1096/fj.03-0118fje; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Mohrmann R, 2003, NEUROSCIENCE, V117, P7, DOI 10.1016/S0306-4522(02)00835-7; Moore R, 1999, INT J DEV BIOL, V43, P831; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Mysore SP, 2008, FRONT NEUROSCI-SWITZ, V2, P168, DOI 10.3389/neuro.01.035.2008; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Obst-Pernberg K, 2001, NEUROSCIENCE, V106, P505, DOI 10.1016/S0306-4522(01)00292-5; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Piechotta K, 2006, CELL TISSUE RES, V326, P617, DOI 10.1007/s00441-006-0267-4; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; SIDDIQUI TJ, 2010, CURR OPIN NEUROBIOL, V21, P1; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugiura H, 2009, NEUROSCIENTIST, V15, P90, DOI 10.1177/1073858408324024; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	71	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54105	10.1371/journal.pone.0054105	http://dx.doi.org/10.1371/journal.pone.0054105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382872	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600024
J	Campbell, AD; Lawn, S; McGarry, LC; Welch, HC; Ozanne, BW; Norman, JC				Campbell, Andrew D.; Lawn, Samuel; McGarry, Lynn C.; Welch, Heidi C.; Ozanne, Bradford W.; Norman, Jim C.			P-Rex1 Cooperates with PDGFR beta to Drive Cellular Migration in 3D Microenvironments	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; HUMAN ONCOGENE; RHO-GTPASES; RAC; GROWTH; GENES; PERICYTES; MELANOMA; INVASION; PROTEIN	Expression of the Rac-guanine nucleotide exchange factor (RacGEF), P-Rex1 is a key determinant of progression to metastasis in a number of human cancers. In accordance with this proposed role in cancer cell invasion and metastasis, we find that ectopic expression of P-Rex1 in an immortalised human fibroblast cell line is sufficient to drive multiple migratory and invasive phenotypes. The invasive phenotype is greatly enhanced by the presence of a gradient of serum or platelet-derived growth factor, and is dependent upon the expression of functional PDGF receptor beta. Consistently, the invasiveness of WM852 melanoma cells, which endogenously express P-Rex1 and PDGFR beta, is opposed by siRNA of either of these proteins. Furthermore, the current model of P-Rex1 activation is advanced through demonstration of P-Rex1 and PDGFR beta as components of the same macromolecular complex. These data suggest that P-Rex1 has an influence on physiological migratory processes, such as invasion of cancer cells, both through effects upon classical Rac1-driven motility and a novel association with RTK signalling complexes.	[Campbell, Andrew D.; Lawn, Samuel; McGarry, Lynn C.; Ozanne, Bradford W.; Norman, Jim C.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Welch, Heidi C.] Babraham Inst, Cambridge, England	Beatson Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Norman, JC (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	j.norman@beatson.gla.ac.uk		Welch, Heidi/0000-0001-7865-7000; NORMAN, Jim/0000-0002-0098-3014	Cancer Research UK; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0411, BB/I02154X/1] Funding Source: researchfish; BBSRC [BB/I02154X/1, BBS/E/B/000C0411] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by generous support from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RODECK U, 1991, J INVEST DERMATOL, V97, P20, DOI 10.1111/1523-1747.ep12477822; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Scott LA, 2004, MOL CELL BIOL, V24, P1540, DOI 10.1128/MCB.24.4.1540-1559.2004; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shi H, 2000, CANCER RES, V71, P5067; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Weiner OD, 2002, CURR BIOL, V12, pR429, DOI 10.1016/S0960-9822(02)00917-X; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	39	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53982	10.1371/journal.pone.0053982	http://dx.doi.org/10.1371/journal.pone.0053982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382862	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000315563800028
J	Dion, C; Singh, K; Ozaki, T; Lesk, MR; Costantino, S				Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki; Lesk, Mark R.; Costantino, Santiago			Analysis of Pulsatile Retinal Movements by Spectral-Domain Low-Coherence Interferometry: Influence of Age and Glaucoma on the Pulse Wave	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; FREQUENCY-ANALYSIS; AMPLITUDE	Recent studies have shown that ocular hemodynamics and eye tissue biomechanical properties play an important role in the pathophysiology of glaucoma. Nevertheless, better, non-invasive methods to assess these characteristics in vivo are essential for a thorough understanding of degenerative mechanisms. Here, we propose to measure ocular tissue movements induced by cardiac pulsations and study the ocular pulse waveform as an indicator of tissue compliance. Using a novel, low-cost and non-invasive device based on spectral-domain low coherence interferometry (SD-LCI), we demonstrate the potential of this technique to differentiate ocular hemodynamic and biomechanical properties. We measured the axial movement of the retina driven by the pulsatile ocular blood flow in 11 young healthy individuals, 12 older healthy individuals and 15 older treated glaucoma patients using our custom-made SD-OCT apparatus. The cardiac pulse was simultaneously measured through the use of an oximeter to allow comparison. Spectral components up to the second harmonic were obtained and analyzed. For the different cohorts, we computed a few parameters that characterize the three groups of individuals by analyzing the movement of the retinal tissue at two locations, using this simple, low-cost interferometric device. Our pilot study indicates that spectral analysis of the fundus pulsation has potential for the study of ocular biomechanical and vascular properties, as well as for the study of ocular disease.	[Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki] Inst Natl Rech Sci Energie Mat & Telecommun, Varennes, PQ, Canada; [Dion, Carolyne; Singh, Kanwarpal; Ozaki, Tsuneyuki; Lesk, Mark R.; Costantino, Santiago] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Lesk, Mark R.; Costantino, Santiago] Univ Montreal, Fac Med, Dept Ophthalmol, Montreal, PQ H3C 3J7, Canada; [Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; Universite de Montreal; Universite de Montreal	Costantino, S (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	santiago.costantino@umontreal.ca	Singh, Kanwarpal/P-3789-2019; Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Singh, Kanwarpal/0000-0002-6884-8089; Ozaki, Tsuneyuki/0000-0001-8857-3900	Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec; Fonds Quebecois de la Recherchesur la Nature et les Technologies; Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; le Fonds de Recherche en Ophthalmologie de Universite de Montreal; Natural Sciences and Engineering Research Council of Canada	Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec; Fonds Quebecois de la Recherchesur la Nature et les Technologies(FQRNT); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); le Fonds de Recherche en Ophthalmologie de Universite de Montreal; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The study was supported by the Ministere du Developpement Economique de l'Innovation et de l'Exportation du Quebec, the Fonds Quebecois de la Recherchesur la Nature et les Technologies, the Canadian Institutes of Health Research, the Fonds de la Recherche en Sante du Quebec, le Fonds de Recherche en Ophthalmologie de Universite de Montreal and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolger C, 1999, VISION RES, V39, P1911, DOI 10.1016/S0042-6989(98)00322-8; BOSLEY TM, 1993, STROKE, V24, P6, DOI 10.1161/01.STR.24.1.6; Delori FC, 2007, J OPT SOC AM A, V24, P1250, DOI 10.1364/JOSAA.24.001250; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Dragostinoff N, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251049; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; FINDLAY JM, 1971, KYBERNETIK, V8, P207, DOI 10.1007/BF00288749; FINKELSTEIN SM, 1988, HYPERTENSION, V12, P380, DOI 10.1161/01.HYP.12.4.380; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garzozi HJ, 2001, ISRAEL MED ASSOC J, V3, P443; Hodapp E, 1993, CLIN DECISIONS GLAUC; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; JAMES CB, 1991, BRIT J OPHTHALMOL, V75, P466, DOI 10.1136/bjo.75.8.466; Kasprzak H, 2007, OPT PURA APL, V40, P7; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kerr J, 1998, AM J OPHTHALMOL, V126, P42, DOI 10.1016/S0002-9394(98)00074-9; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; KRAKAU CET, 1995, ACTA OPHTHALMOL SCAN, V73, P472; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Lesk MR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1568, DOI 10.1001/archopht.124.11.1568; Mangouritsas G, 2008, ACTA OPHTHALMOLOGICA; NICHOLS WW, 1977, CIRC RES, V40, P451, DOI 10.1161/01.RES.40.5.451; Nowak W, 2008, OPT APPL, V38, P469; Plumb RD, 2011, BRIT J DIABETES VASC, V11, P243; Schmidt KG, 1997, EYE, V11, P485, DOI 10.1038/eye.1997.131; Silver D M, 1994, Surv Ophthalmol, V38 Suppl, pS72, DOI 10.1016/0039-6257(94)90049-3; Singh K, 2012, INVESTIGATIVE OPHTHA; Singh K, EXPT EYE RES, V91, P63; Singh K, INVESTIGATIVE OPHTHA, V52, P8927; Witte S, 2009, OPT EXPRESS, V17, P11335, DOI 10.1364/OE.17.011335; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309	32	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54207	10.1371/journal.pone.0054207	http://dx.doi.org/10.1371/journal.pone.0054207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382879	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800037
J	Glessner, JT; Smith, AV; Panossian, S; Kim, CE; Takahashi, N; Thomas, KA; Wang, FX; Seidler, K; Harris, TB; Launer, LJ; Keating, B; Connolly, J; Sleiman, PMA; Buxbaum, JD; Grant, SFA; Gudnason, V; Hakonarson, H				Glessner, Joseph T.; Smith, Albert Vernon; Panossian, Saarene; Kim, Cecilia E.; Takahashi, Nagahide; Thomas, Kelly A.; Wang, Fengxiang; Seidler, Kallyn; Harris, Tamara B.; Launer, Lenore J.; Keating, Brendan; Connolly, John; Sleiman, Patrick M. A.; Buxbaum, Joseph D.; Grant, Struan F. A.; Gudnason, Vilmundur; Hakonarson, Hakon			Copy Number Variations in Alternative Splicing Gene Networks Impact Lifespan	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; COMMON VARIANTS; EXCEPTIONAL LONGEVITY; SEQUENCE VARIANTS; ASSOCIATION; GENOTYPE; RISK; AGE; INSIGHTS; PATHWAY	Longevity has a strong genetic component evidenced by family-based studies. Lipoprotein metabolism, FOXO proteins, and insulin/IGF-1 signaling pathways in model systems have shown polygenic variations predisposing to shorter lifespan. To test the hypothesis that rare variants could influence lifespan, we compared the rates of CNVs in healthy children (0-18 years of age) with individuals 67 years or older. CNVs at a significantly higher frequency in the pediatric cohort were considered risk variants impacting lifespan, while those enriched in the geriatric cohort were considered longevity protective variants. We performed a whole-genome CNV analysis on 7,313 children and 2,701 adults of European ancestry genotyped with 302,108 SNP probes. Positive findings were evaluated in an independent cohort of 2,079 pediatric and 4,692 geriatric subjects. We detected 8 deletions and 10 duplications that were enriched in the pediatric group (P = 3.33 x 10(-8)-1.6 x 10(-2) unadjusted), while only one duplication was enriched in the geriatric cohort (P = 6.3 x 10(-4)). Population stratification correction resulted in 5 deletions and 3 duplications remaining significant (P = 5.16 x 10(-5)-4.26 x 10(-2)) in the replication cohort. Three deletions and four duplications were significant combined (combined P = 3.7 x 10(-4)-3.9 x 10(-2)). All associated loci were experimentally validated using qPCR. Evaluation of these genes for pathway enrichment demonstrated similar to 50% are involved in alternative splicing (P = 0.0077 Benjamini and Hochberg corrected). We conclude that genetic variations disrupting RNA splicing could have long-term biological effects impacting lifespan.	[Glessner, Joseph T.; Panossian, Saarene; Kim, Cecilia E.; Thomas, Kelly A.; Wang, Fengxiang; Seidler, Kallyn; Keating, Brendan; Connolly, John; Sleiman, Patrick M. A.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Heart Prevent Clin, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, New York, NY USA; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icelandic Heart Association; Icelandic Heart Association; University of Iceland; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Buxbaum, Joseph D/G-6001-2010; Takahashi, Nagahide/AAR-6268-2020; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015	Takahashi, Nagahide/0000-0002-7711-0297; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Glessner, Joseph/0000-0001-5131-2811; Smith, Albert Vernon/0000-0003-1942-5845; Buxbaum, Joseph/0000-0001-8898-8313; Connolly, John/0000-0003-4396-1226	Institutional Development; Children's Hospital of Philadelphia; Cotswold Foundation; National Institutes of Health (NIH) [N01-AG12100]; National Institute on Aging (NIA); Althingi; NIA Intramural Research Program Laboratory of Neurogenetics; National Human Genome Research Institute (NHGRI) [U01HG004608]; National Institute for General Medical Sciences (NIGMS); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy [D1A RH00025]; Wisconsin Department of Commerce Technology Development [TDF FYO10718]; NIH [U01HG004438]; eMERGE Administrative Coordinating Center [U01HG004603]; National Center for Biotechnology Information (NCBI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004603, U01HG004438, U01HG004608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, N01AG012100, ZIAAG007270] Funding Source: NIH RePORTER	Institutional Development; Children's Hospital of Philadelphia; Cotswold Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi; NIA Intramural Research Program Laboratory of Neurogenetics; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy; Wisconsin Department of Commerce Technology Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); eMERGE Administrative Coordinating Center; National Center for Biotechnology Information (NCBI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia; by a Research Development Award from the Cotswold Foundation. The AGES-Reykjavik is funded by National Institutes of Health (NIH) contract number N01-AG12100, the National Institute on Aging (NIA) Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Genotyping was conducted at the NIA Intramural Research Program Laboratory of Neurogenetics. The replication cohort for the older person dataset used for the analyses was obtained from the database of Genotype and Phenotype (dbGaP) found at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1. Samples and associated phenotype data for the "GWAS on Cataract and HDL in the PMRP'' project were accessed via an authorized data access request by Hakon Hakonarson and Struan F.A. Grant. Funding support for the Personalized Medicine Research Project (PMRP) was provided through a cooperative agreement (U01HG004608) with the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute for General Medical Sciences (NIGMS) The samples used for PMRP analyses were obtained with funding from Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy grant number D1A RH00025, and Wisconsin Department of Commerce Technology Development Fund contract number TDF FYO10718. Funding support for genotyping, which was performed at Johns Hopkins University, was provided by the NIH (U01HG004438). Assistance with phenotype harmonization and genotype cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Newman AB, 2010, J GERONTOL A-BIOL, V65, P478, DOI 10.1093/gerona/glq028; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Sebastiani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008210; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53846	10.1371/journal.pone.0053846	http://dx.doi.org/10.1371/journal.pone.0053846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382853	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800025
J	Itariu, BK; Zeyda, M; Leitner, L; Marculescu, R; Stulnig, TM				Itariu, Bianca K.; Zeyda, Maximilian; Leitner, Lukas; Marculescu, Rodrig; Stulnig, Thomas M.			Treatment with n-3 Polyunsaturated Fatty Acids Overcomes the Inverse Association of Vitamin D Deficiency with Inflammation in Severely Obese Patients: A Randomized Controlled Trial	PLOS ONE			English	Article							PREVENTION; SUPPLEMENTATION; CANCER	Obesity affects the vitamin D status in humans. Vitamin D and long-chain n-3 polyunsaturated fatty acids (PUFA) provide benefit for the prevention of fractures and cardiovascular events, respectively, and both are involved in controlling inflammatory and immune responses. However, published epidemiological data suggest a potential interference of n-3 PUFA supplementation with vitamin D status. Therefore, we aimed to investigate in a randomized controlled clinical trial whether treatment with long chain n-3 PUFA affects vitamin D status in severely obese patients and potential interrelations of vitamin D and PUFA treatment with inflammatory parameters. Fifty-four severely obese (BMI >= 40 kg/m2) non-diabetic patients were treated for eight weeks with either 3.36 g/d EPA and DHA or the same amount of butter fat as control. Changes in serum 25-hydroxy-vitamin D [25(OH) D] concentrations, plasma fatty acid profiles and circulating inflammatory marker concentrations from baseline to end of treatment were assessed. At baseline 43/54 patients were vitamin D deficient (serum 25(OH) D concentration,50 nmol/l). Treatment with n-3 PUFA did not affect vitamin D status (P = 0.91). Serum 25(OH) D concentration correlated negatively with both IL-6 (P = 0.02) and hsCRP serum concentration (P = 0.03) at baseline. Strikingly, the negative correlations of 25(OH) D with IL-6 and hsCRP were lost after n-3 PUFA treatment. In conclusion, vitamin D status of severely obese patients remained unaffected by n-3 PUFA treatment. However, abrogation of the inverse association of 25(OH) D concentration with inflammatory markers indicated that n-3 PUFA treatment could compensate for some detrimental consequences of vitamin D deficiency.	[Itariu, Bianca K.; Zeyda, Maximilian; Leitner, Lukas; Stulnig, Thomas M.] Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, Vienna, Austria; [Itariu, Bianca K.; Zeyda, Maximilian; Leitner, Lukas; Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Marculescu, Rodrig] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Stulnig, TM (corresponding author), Med Univ Vienna, Dept Internal Med 3, Clin Div Endocrinol & Metab, Vienna, Austria.	thomas.stulnig@meduniwien.ac.at	Marculescu, Rodrig/B-6474-2016; Itariu, Bianca-Karla/AAD-6317-2019	Marculescu, Rodrig/0000-0003-1772-6695; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974; Itariu, Bianca/0000-0001-8100-1715	Austrian National Bank [12735]; European Community [201608]; Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development; Solvay Pharma, Austria	Austrian National Bank; European Community(European Commission); Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development; Solvay Pharma, Austria	This work was supported by the Austrian National Bank Project no. 12735; the European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no. 201608; the Federal Ministry of Economy, Family and Youth; and the National Foundation for Research, Technology and Development (all to TMS). Omacor (R) capsules were generously provided by Solvay Pharma, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare Solvay Pharma, Austria, as a commercial funder. The corresponding author had a consultancy agreement with a company that purchased Solvay Pharma. No other authors have any relevant declarations relating to employment, consultancy, patents, products in development or marketed products, etc.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; Bakker GCM, 2010, AM J CLIN NUTR, V91, P1044, DOI 10.3945/ajcn.2009.28822; Bellia A, 2013, INTERN EMERG MED, V8, P33, DOI 10.1007/s11739-011-0559-x; BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Carriere I, 2007, INT J VITAM NUTR RES, V77, P57, DOI 10.1024/0300-9831.77.1.57; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Grethen E, 2011, J CLIN ENDOCR METAB, V96, P1320, DOI 10.1210/jc.2010-2202; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Kannus P, 2005, ANN MED, V37, P303, DOI 10.1080/07853890510007197; Karakas M, 2013, J CLIN ENDOCR METAB, V98, P272, DOI 10.1210/jc.2012-2368; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Mertens PR, 2010, INT UROL NEPHROL, V42, P165, DOI 10.1007/s11255-009-9685-z; Naesgaard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043228; Niramitmahapanya S, 2011, J CLIN ENDOCR METAB, V96, P3170, DOI 10.1210/jc.2011-1518; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Pitroda AP, 2009, ENDOCRINE, V36, P218, DOI 10.1007/s12020-009-9231-x; Rousseau JH, 2009, J AM GERIATR SOC, V57, P1781, DOI 10.1111/j.1532-5415.2008.01870.x; Song X, 2012, EUR J CLIN NUTR, V66, P156, DOI 10.1038/ejcn.2011.145; Soni M, 2012, SCAND J CLIN LAB INV, V72, P79, DOI 10.3109/00365513.2012.681969; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758	33	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54634	10.1371/journal.pone.0054634	http://dx.doi.org/10.1371/journal.pone.0054634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372745	Green Submitted, gold, Green Published			2022-12-27	WOS:000315210400020
J	Verstraete, B; Janssens, S; Smets, E; Dessein, S				Verstraete, Brecht; Janssens, Steven; Smets, Erik; Dessein, Steven			Symbiotic beta-Proteobacteria beyond Legumes: Burkholderia in Rubiaceae	PLOS ONE			English	Article							ENDOSYMBIONTS; ENDOPHYTES; NODULATION; DIVERSITY	Symbiotic beta-proteobacteria not only occur in root nodules of legumes but are also found in leaves of certain Rubiaceae. The discovery of bacteria in plants formerly not implicated in endosymbiosis suggests a wider occurrence of plant-microbe interactions. Several beta-proteobacteria of the genus Burkholderia are detected in close association with tropical plants. This interaction has occurred three times independently, which suggest a recent and open plant-bacteria association. The presence or absence of Burkholderia endophytes is consistent on genus level and therefore implies a predictive value for the discovery of bacteria. Only a single Burkholderia species is found in association with a given plant species. However, the endophyte species are promiscuous and can be found in association with several plant species. Most of the endophytes are part of the plant-associated beneficial and environmental group, but others are closely related to B. glathei. This soil bacteria, together with related nodulating and non-nodulating endophytes, is therefore transferred to a newly defined and larger PBE group within the genus Burkholderia.	[Verstraete, Brecht; Janssens, Steven; Smets, Erik] Katholieke Univ Leuven, Louvain, Belgium; [Smets, Erik] Leiden Univ, Nat Biodivers Ctr, Leiden, Netherlands; [Dessein, Steven] Natl Bot Garden Belgium, Meise, Belgium	KU Leuven; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Verstraete, B (corresponding author), Katholieke Univ Leuven, Louvain, Belgium.	brecht.verstraete@bio.kuleuven.be	Smets, Erik F/A-9875-2011; Verstraete, Brecht/E-4141-2015; Dessein, Steven/I-9147-2014	Smets, Erik F/0000-0002-9416-983X; Verstraete, Brecht/0000-0001-9332-7798; Dessein, Steven/0000-0002-3179-4005	Research Foundation - Flanders (FWO) [G.0343.09N]; King Leopold-III Fund for Nature Exploration and Conservation; Agency for Innovation by Science and Technology (IWT) [91158]	Research Foundation - Flanders (FWO)(FWO); King Leopold-III Fund for Nature Exploration and Conservation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported financially by the Research Foundation - Flanders (FWO, G.0343.09N) and by the King Leopold-III Fund for Nature Exploration and Conservation. BV holds a PhD research grant from the Agency for Innovation by Science and Technology (IWT, no. 91158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollback J.P., 2006, SIMMAP VERSION 1 0 P; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; Carlier AL, 2012, ENVIRON MICROBIOL, V14, P2757, DOI 10.1111/j.1462-2920.2012.02763.x; Chen WM, 2003, J BACTERIOL, V185, P7266, DOI 10.1128/JB.185.24.7266-7272.2003; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Couvreur TLP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010473; Drummond A., 2011, GENEIOUS V5 5; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Lemaire B, 2012, FEMS MICROBIOL ECOL, V81, P364, DOI 10.1111/j.1574-6941.2012.01356.x; Lemaire B, 2012, APPL ENVIRON MICROB, V78, P284, DOI 10.1128/AEM.06130-11; Lemaire B, 2011, J MICROBIOL, V49, P935, DOI 10.1007/s12275-011-1163-5; Lemaire B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024430; Lemaire B, 2011, RES MICROBIOL, V162, P528, DOI 10.1016/j.resmic.2011.04.003; Lemaire B, 2012, INT J SYST EVOL MICR, V62, P202, DOI 10.1099/ijs.0.028019-0; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Van Oevelen S, 2004, INT J SYST EVOL MICR, V54, P2237, DOI 10.1099/ijs.0.63188-0; Van Oevelen S, 2002, INT J SYST EVOL MICR, V52, P2023, DOI [10.1099/ijs.0.02103-0, 10.1099/00207713-52-6-2023]; Van Oevelen Sandra, 2001, Systematics and Geography of Plants, V71, P557, DOI 10.2307/3668700; Verstraete B, BOT J LINN IN PRESS; Verstraete B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019265	29	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55260	10.1371/journal.pone.0055260	http://dx.doi.org/10.1371/journal.pone.0055260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372845	gold, Green Submitted, Green Published			2022-12-27	WOS:000315210400085
J	Cheng, LB; Li, SY; Xu, XY; Hussain, J; Yin, JJ; Zhang, Y; Li, LJ; Chen, XH				Cheng, Libao; Li, Shuanyan; Xu, Xiaoyong; Hussain, Javeed; Yin, Jingjing; Zhang, Yi; Li, Liangjun; Chen, Xuehao			Identification of Differentially Expressed Genes Relevant to Corm Formation in Sagittaria trifolia	PLOS ONE			English	Article							TUBER FORMATION; MALATE-DEHYDROGENASE; TRANSCRIPTIONAL REGULATION; ANTHER DEVELOPMENT; CARBON-DIOXIDE; ABSCISIC-ACID; POTATO; PROTEIN; TUBERIZATION; SUCROSE	Sagittaria trifolia is a good model of wetland plants to elucidate the formation of corm. However, few studies have been conducted to uncover the complexity of gene expression involved in corm formation. In this study, high-throughput tag-sequencing based on Solexa Genome Analyzer Platform was applied to monitor the changes in gene expression with three libraries of differentially expressed genes (DEGs) (C1 library: stolon stage, C2 library: initial swelling stage and C3 library: swelling stage) during corm formation in Sagittaria trifolia. Approximately 6.0 million tags were sequenced, and 5854021, 5983454, and 5761079 clean tags including 138319, 116804, and 101739 distinct tags were obtained after removal of low quality tags from each library, respectively. About 46% distinct tags were unambiguous tags mapping to the reference genes, and 33% were unambiguous tag-mapped genes. Totally, 20575, 19807, and 18438 were annotated in C1, C2, and C3 libraries, respectively, after mapping their functions in existing databases. In addition, we found that profiling of gene expression in C1/C2 and C2/C3 libraries were different among most of the selected 20 DEGs. Most DEGs in C1/C2 libraries were relevant to hormone synthesis and response; energy metabolism and stress response, while most of the genes in C2/C3 libraries were involved in carbohydrate metabolism. All up-regulated transcriptional factors and 16 important genes relevant to corm formation in three libraries were also identified. To further analyze the expression of 9 genes, from the results of tag-sequencing, qRT-PCR was applied. In summary, this study provides a comprehensive understanding of gene expression, during the formation of corm in Sagittaria trifolia.	[Cheng, Libao; Li, Shuanyan; Xu, Xiaoyong; Yin, Jingjing; Zhang, Yi; Li, Liangjun; Chen, Xuehao] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Hussain, Javeed] Huazhong Univ Sci & Technol, China UK HUST RRes Genet Engn & Genom Joint Lab, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Yangzhou University; Huazhong University of Science & Technology	Li, LJ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	ljli@yzu.edu.cn; xhchen@yzu.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [200903017-02]; China Postdoctoral Science Foundation [2012M511805]; Jiangsu Postdoctoral Science Foundation [1102144C]	Special Fund for Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (200903017-02), China Postdoctoral Science Foundation (2012M511805) and Jiangsu Postdoctoral Science Foundation (1102144C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH Z, 1980, PLANT CELL PHYSIOL, V21, P1343; Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Abeles F, 1992, ETHYLENE PLANT BIOL; ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Appeldoorn NJG, 1997, PLANTA, V202, P220, DOI 10.1007/s004250050122; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; BALAMANI V, 1986, PLANT PHYSIOL, V80, P856, DOI 10.1104/pp.80.4.856; BANFALVI Z, 1994, MOL GEN GENET, V245, P517, DOI 10.1007/BF00302265; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhat S. R., 1994, Indian Journal of Experimental Biology, V32, P340; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Burton W. G., 1992, The potato crop: the scientific basis for improvement., P608; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen H, 2004, PLANT J, V38, P276, DOI 10.1111/j.1365-313X.2004.02048.x; CUSHMAN JC, 1993, PHOTOSYNTH RES, V35, P15, DOI 10.1007/BF02185408; DELVALLEE I, 1988, J PLANT PHYSIOL, V132, P210, DOI 10.1016/S0176-1617(88)80163-9; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; ELANTABLY HM, 1967, PLANTA, V73, P74, DOI 10.1007/BF00419842; ERSHOW A G, 1990, Journal of Food Composition and Analysis, V3, P191, DOI 10.1016/0889-1575(90)90026-I; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Fernie AR, 2001, PLANT PHYSIOL, V127, P1459, DOI [10.1104/pp.127.4.1459, 10.1104/pp.010764]; GALIS I, 1995, J PLANT GROWTH REGUL, V14, P143, DOI 10.1007/BF00210916; Geigenberger P, 2004, PLANT CELL ENVIRON, V27, P655, DOI 10.1111/j.1365-3040.2004.01183.x; GEIGENBERGER P, 1994, PLANTA, V193, P486, DOI 10.1007/BF02411552; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Hameister S, 2007, J MOL EVOL, V65, P437, DOI 10.1007/s00239-007-9025-9; Han S. S., 1993, Korean Journal of Weed Science, V13, P138; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; HANNAPEL DJ, 1991, PHYSIOL PLANTARUM, V83, P568, DOI [10.1034/j.1399-3054.1991.830405.x, 10.1111/j.1399-3054.1991.tb02469.x]; HANNAPEL DJ, 1985, PLANT PHYSIOL, V78, P700, DOI 10.1104/pp.78.4.700; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hussey B, 1981, ANNAL BOT, P787; Inui H, 2010, FEBS LETT, V584, P2393, DOI 10.1016/j.febslet.2010.04.031; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jasik J, 2006, J PLANT GROWTH REGUL, V25, P45, DOI 10.1007/s00344-005-0048-4; Kim KJ, 2005, ACTA HORTIC, P661, DOI 10.17660/ActaHortic.2005.673.91; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Krizek BA, 2009, PLANT PHYSIOL, V150, P1916, DOI 10.1104/pp.109.141119; Mach J, 2011, PLANT CELL, V23, P4166, DOI 10.1105/tpc.111.231210; MacLeod RAF, 1999, INT J CANCER, V83, P555; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Menzel BM, 1980, ANN BOT, V46, P259; MINGOCASTEL AM, 1976, PLANT PHYSIOL, V57, P480, DOI 10.1104/pp.57.4.480; Nakamura T, 1998, PLANT PHYSIOL, V118, P451, DOI 10.1104/pp.118.2.451; NEUTEBOOM CE, 2002, PGRSAQ, V30, P77; PAIVA E, 1983, PLANT PHYSIOL, V71, P161, DOI 10.1104/pp.71.1.161; Park WM, 1983, PLANT MOL BIOL REP, V1, P61, DOI [10.1007/BF02680300, DOI 10.1007/BF02680300]; Pedersen O, 2009, PLANT J, V58, P147, DOI 10.1111/j.1365-313X.2008.03769.x; PERL A, 1991, PLANT SCI, V73, P87, DOI 10.1016/0168-9452(91)90129-V; Poovaiah BW, 1996, J PLANT PHYSIOL, V149, P553, DOI 10.1016/S0176-1617(96)80333-6; Porterfield MM, 1951, ECO BOT, V3, P3; Qi XH, 2011, GENOMICS, DOI [10.1016/j.ygeno2011.12.008, DOI 10.1016/J.YGENO2011.12.008]; Racusen D, 1985, FOOD IND, V9, P61; Rayirath UP, 2011, PLANT CELL TISS ORG, V105, P253, DOI 10.1007/s11240-010-9861-y; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Sahi Chandan, 2006, Functional & Integrative Genomics, V6, P263, DOI 10.1007/s10142-006-0032-5; SAWHNEY VK, 1986, J PLANT PHYSIOL, V125, P467, DOI 10.1016/S0176-1617(86)80009-8; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; SUGE H, 1975, PLANT CELL PHYSIOL, V16, P65, DOI 10.1093/oxfordjournals.pcp.a075128; Thimann KV, 1934, P R SOC LOND B-CONTA, V114, P317, DOI 10.1098/rspb.1934.0010; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; VANCANNEYT G, 1989, PLANT CELL, V1, P533, DOI 10.1105/tpc.1.5.533; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; VARTAPETIAN BB, 1970, AGROCHIMICA, V15, P1; VREUGDENHIL D, 1989, PHYSIOL PLANTARUM, V75, P525, DOI 10.1111/j.1399-3054.1989.tb05619.x; VREUGDENHIL D, 1994, PLANT GROWTH REGUL, V14, P257, DOI 10.1007/BF00024801; Wang FD, 2012, GENOMICS, DOI [10.1016/j.ygeno.02.005, DOI 10.1016/J.YGENO.02.005]; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Yamakawa S., 1981, Weed Research, Japan, V26, P118; Zheng XW, 2006, CHEM NAT COMPD+, V42, P520, DOI 10.1007/s10600-006-0203-6; Zhu Y, 2003, J BIOL CHEM, V278, P47803, DOI 10.1074/jbc.M302806200	87	13	13	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54573	10.1371/journal.pone.0054573	http://dx.doi.org/10.1371/journal.pone.0054573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359383	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600074
J	Furuhashi, T; Saito, C; Torii, K; Nishida, E; Yamazaki, S; Morita, A				Furuhashi, Takuya; Saito, Chiyo; Torii, Kan; Nishida, Emi; Yamazaki, Sayuri; Morita, Akimichi			Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis	PLOS ONE			English	Article							UVB INDUCES APOPTOSIS; INDUCED IMMUNOSUPPRESSION; CONTACT HYPERSENSITIVITY; SUPPRESSIVE FUNCTION; RECEPTOR EXPRESSION; DENDRITIC CELLS; ULTRAVIOLET; PHOTOTHERAPY; KERATINOCYTES; PATHOGENESIS	Background: Photo(chemo)therapy is widely used to treat psoriasis, the pathogenesis of which might be caused by an imbalance of Th17 cells/regulatory T cells (Treg). In the present study, we evaluated the effects of photo(chemo)therapy on the Th17/Treg balance and Treg function. Methods: Peripheral blood was obtained from psoriasis patients treated with bath-psoralen ultraviolet A (UVA, n = 50) or narrowband ultraviolet B (UVB, n = 18), and age-matched healthy volunteers (n = 20). CD3(+)CD4(+)IL-17A(+) or CD4(+)CD25(+)Foxp3(+)cells were analyzed to estimate Th17 or Treg number by fluorescence-activated cell sorting. Moreover, CD4(+) CD25(-) T cells from patients treated with PUVA(n = 14) were incubated in CFSE and activated with or without CD4(+)CD25(+)T cells, and the suppressive function of CD4(+) CD25(+)T cells were analyzed. Results: Photo(chemo)therapy significantly reduced Th17 levels from 5.66 +/- 3.15% to 2.96 +/- 2.89% in patients with increased Th17 (Th17/CD4>3.01% [mean+SD of controls]). In contrast, photo(chemo)therapy significantly increased Treg levels from 2.77 +/- 0.75 to 3.40 +/- 1.88% in patients with less than 4.07% Treg level, defined as the mean of controls. Furthermore, while Treg suppressed the CD4(+)CD25(-) T cell proliferation to a greater extent in controls (Treg Functional Ratio 94.4 +/- 4.28%) than in patients (70.3 +/- 25.1%), PUVA significantly increased Treg Functional Ratio to 88.1 +/- 6.47%. Th17 levels in severe patients (>30 PASI) were significantly higher as compared to controls. Th17 levels that were left after treatment in the patients not achieving PASI 50 (3.78 +/- 4.18%) were significantly higher than those in the patients achieving PASI 75 (1.83 +/- 1.87%). Treg levels in patients achieving PASI 90 (4.89 +/- 1.70%) were significantly higher than those in the patients not achieving PASI 90 (3.90 +/- 1.66%). Treg levels prior to treatment with Th17 high decreased group (5.16 +/- 2.20%) was significantly higher than that with Th17 high increased group (3.33 +/- 1.39%). Conclusion: These findings indicate that Treg is dysfunctional in psoriasis patients, and photochemotherapy restores those dysfunctional Treg. Photo(chemo)therapy resolved the Th17/Treg imbalance in patients with psoriasis.	[Furuhashi, Takuya; Saito, Chiyo; Torii, Kan; Nishida, Emi; Yamazaki, Sayuri; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan	Nagoya City University	Furuhashi, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi, Japan.	tmail@med.nagoya-cu.ac.jp		Nishida, Emi/0000-0001-6563-1274; Torii, Kan/0000-0003-1964-0529	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [23390088] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2012, TRENDS IMMUNOL, V33, P505, DOI 10.1016/j.it.2012.05.004; Aufiero BM, 2006, J PHOTOCH PHOTOBIO B, V82, P132, DOI 10.1016/j.jphotobiol.2005.08.011; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Brazzelli V, 2008, INT J IMMUNOPATH PH, V21, P481, DOI 10.1177/039463200802100232; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Furuhashi T, 2011, EXP DERMATOL, V20, P768, DOI 10.1111/j.1600-0625.2011.01316.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Krutmann J, 1999, J INVEST DERM SYMP P, V4, P70, DOI 10.1038/sj.jidsp.5640185; Krutmann J., 2007, FITZPATRICKS DERMATO, V7th ed, P2243; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lo YH, 2010, J DERMATOL SCI, V58, P225, DOI 10.1016/j.jdermsci.2010.03.018; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Meyer T, 2007, BRIT J DERMATOL, V157, P1, DOI 10.1111/j.1365-2133.2007.08264.x; Ozawa M, 1999, J EXP MED, V189, P711, DOI 10.1084/jem.189.4.711; Racz E, 2011, J INVEST DERMATOL, V131, P1547, DOI 10.1038/jid.2011.53; Saito C, 2009, J DERMATOL SCI, V53, P231, DOI 10.1016/j.jdermsci.2008.09.011; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Schwarz A, 2007, J IMMUNOL, V178, P877, DOI 10.4049/jimmunol.178.2.877; Schwarz A, 2011, J ALLERGY CLIN IMMUN, V128, P826, DOI 10.1016/j.jaci.2011.06.005; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shintani Y, 2008, PHOTODERMATOL PHOTO, V24, P32, DOI 10.1111/j.1600-0781.2008.00333.x; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Sweeney CM, 2011, ARCH DERMATOL RES, V303, P691, DOI 10.1007/s00403-011-1169-1; Tan ZY, 2009, INT J BIOCHEM CELL B, V41, P733, DOI 10.1016/j.biocel.2008.04.027; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Zhang L, 2010, CLIN IMMUNOL, V135, P108, DOI 10.1016/j.clim.2009.11.008	38	77	83	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54895	10.1371/journal.pone.0054895	http://dx.doi.org/10.1371/journal.pone.0054895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365685	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600132
J	Garza-Ramos, G; Mujica-Jimenez, C; Munoz-Clares, RA				Garza-Ramos, Georgina; Mujica-Jimenez, Carlos; Munoz-Clares, Rosario A.			Potassium and Ionic Strength Effects on the Conformational and Thermal Stability of Two Aldehyde Dehydrogenases Reveal Structural and Functional Roles of K+-Binding Sites	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MONOVALENT CATIONS; AMYLOID FIBRILS; PORCINE KIDNEY; BETAINE; PURIFICATION; ENZYME; ASSOCIATION; CLONING	Many aldehyde dehydrogenases (ALDHs) have potential potassium-binding sites of as yet unknown structural or functional roles. To explore possible K+-specific effects, we performed comparative structural studies on the tetrameric betaine aldehyde dehydrogenase from Pseudomonas aeruginosa (PaBADH) and on the dimeric BADH from spinach (SoBADH), whose activities are K+-dependent and K+-independent, respectively, although both enzymes contain potassium-binding sites. Size exclusion chromatography, dynamic light scattering, far- and near-UV circular dichroism, and extrinsic fluorescence results indicated that in the absence of K+ ions and at very low ionic strength, PaBADH remained tetrameric but its tertiary structure was significantly altered, accounting for its inactivation, whereas SoBADH formed tetramers that maintained the native tertiary structure. The recovery of PaBADH native tertiary-structure was hyperbolically dependent on KCl concentration, indicating potassium-specific structuring effects probably arising from binding to a central-cavity site present in PaBADH but not in SoBADH. K+ ions stabilized the native structure of both enzymes against thermal denaturation more than did tetraethylammonium (TEA(+)) ions. This indicated specific effects of potassium on both enzymes, particularly on PaBADH whose apparent T-m values showed hyperbolical dependence on potassium concentration, similar to that observed with the tertiary structure changes. Interestingly, we also found that thermal denaturation of both enzymes performed in low ionic-strength buffers led to formation of heat-resistant, inactive soluble aggregates that retain 80% secondary structure, have increased beta-sheet content and bind thioflavin T. These structured aggregates underwent further thermal-induced aggregation and precipitation when the concentrations of KCl or TEACl were raised. Given that PaBADH and SoBADH belong to different ALDH families and differ not only in amino acid composition but also in association state and surface electrostatic potential, the formation of this kind of beta-sheet pre-fibrillar aggregates, not described before for any ALDH enzyme, appear to be a property of the ALDH fold.	[Garza-Ramos, Georgina] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Mujica-Jimenez, Carlos; Munoz-Clares, Rosario A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munoz-Clares, RA (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico.	clares@unam.mx		Garza Ramos, Georgina/0000-0003-3496-9525; Munoz-Clares, Rosario A./0000-0002-0115-3565	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [59654]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors acknowledge the financial support of Consejo Nacional de Ciencia y Tecnologia (CONACYT grant 59654) to R.A.M.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTS GF, 1979, BIOCHEM J, V183, P633, DOI 10.1042/bj1830633; BLACK S, 1951, ARCH BIOCHEM BIOPHYS, V34, P86, DOI 10.1016/S0003-9861(51)80013-4; Boch J, 1997, ARCH MICROBIOL, V168, P282, DOI 10.1007/s002030050500; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; DEPREZ E, 1994, FEBS LETT, V347, P207, DOI 10.1016/0014-5793(94)00545-1; Diaz-Sanchez AG, 2012, PLANT PHYSIOL, V158, P1570, DOI 10.1104/pp.112.194514; DRAGOLOVICH J, 1994, J EXP ZOOL, V270, P417, DOI 10.1002/jez.1402700502; FALKENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1034, P253, DOI 10.1016/0304-4165(90)90046-Y; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Segura L, 2005, BIOCHIMIE, V87, P1056, DOI 10.1016/j.biochi.2005.06.007; Gonzalez-Segura L, 2013, CHEM-BIOL INTERACT, V202, P41, DOI 10.1016/j.cbi.2012.12.007; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guzman-Partida AM, 1998, COMP BIOCHEM PHYS B, V119, P485, DOI 10.1016/S0305-0491(98)00009-1; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; JACOBSON MK, 1974, BIOCHIM BIOPHYS ACTA, V350, P277, DOI 10.1016/0005-2744(74)90502-6; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Pujar NS, 1998, J CHROMATOGR A, V796, P229, DOI 10.1016/S0021-9673(97)01003-0; Rahuel-Clermont S, 2005, J BIOL CHEM, V280, P18590, DOI 10.1074/jbc.M414110200; Sedlak E, 2008, ARCH BIOCHEM BIOPHYS, V474, P128, DOI 10.1016/j.abb.2008.02.037; SORGER GJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P1, DOI 10.1016/S0926-6593(66)80139-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STEINMAN CR, 1968, J BIOL CHEM, V243, P730; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Valenzuela-Soto EM, 2006, ENZYMOL MOL BIOL CAR, V12, P104; Valenzuela-Soto EM, 2003, CHEM-BIOL INTERACT, V143, P139, DOI 10.1016/S0009-2797(02)00198-9; Velasco-Garcia R, 2006, ARCH MICROBIOL, V185, P14, DOI 10.1007/s00203-005-0054-8; Velasco-Garcia R, 1999, J BACTERIOL, V181, P1292; VONTIGER.RG, 1968, J BIOL CHEM, V243, P2691; VONTIGERSTROM RG, 1968, J BIOL CHEM, V243, P6495; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Wei BX, 2000, BIOCHEMISTRY-US, V39, P5295, DOI 10.1021/bi000028n; WERETILNYK EA, 1989, ARCH BIOCHEM BIOPHYS, V271, P56, DOI 10.1016/0003-9861(89)90255-5; Yamanaka Y, 2002, BIOCHEM BIOPH RES CO, V298, P632, DOI 10.1016/S0006-291X(02)02523-8; Zaldivar-Machorro VJ, 2011, BIOCHIMIE, V93, P286, DOI 10.1016/j.biochi.2010.09.022	41	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54899	10.1371/journal.pone.0054899	http://dx.doi.org/10.1371/journal.pone.0054899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365686	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600133
J	Hoek-van den Hil, EF; Keijer, J; Bunschoten, A; Vervoort, JJM; Stankova, B; Bekkenkamp, M; Herreman, L; Venema, D; Hollman, PCH; Tvrzicka, E; Rietjens, IMCM; van Schothorst, EM				Hoek-van den Hil, Elise F.; Keijer, Jaap; Bunschoten, Annelies; Vervoort, Jacques J. M.; Stankova, Barbora; Bekkenkamp, Melissa; Herreman, Laure; Venema, Dini; Hollman, Peter C. H.; Tvrzicka, Eva; Rietjens, Ivonne M. C. M.; van Schothorst, Evert M.			Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice	PLOS ONE			English	Article							FATTY-ACID; LIVER; METABOLISM; DISEASE; DIETARY; FLAVONOIDS; RISK; CAR; RAT; ACTIVATION	Elevated circulating lipid levels are known risk factors for cardiovascular diseases (CVD). In order to examine the effects of quercetin on lipid metabolism, mice received a mild-high-fat diet without (control) or with supplementation of 0.33% (w/w) quercetin for 12 weeks. Gas chromatography and H-1 nuclear magnetic resonance were used to quantitatively measure serum lipid profiles. Whole genome microarray analysis of liver tissue was used to identify possible mechanisms underlying altered circulating lipid levels. Body weight, energy intake and hepatic lipid accumulation did not differ significantly between the quercetin and the control group. In serum of quercetin-fed mice, triglycerides (TG) were decreased with 14% (p<0.001) and total poly unsaturated fatty acids (PUFA) were increased with 13% (p<0.01). Palmitic acid, oleic acid, and linoleic acid were all decreased by 9-15% (p<0.05) in quercetin-fed mice. Both palmitic acid and oleic acid can be oxidized by omega (omega)-oxidation. Gene expression profiling showed that quercetin increased hepatic lipid metabolism, especially omega-oxidation. At the gene level, this was reflected by the up-regulation of cytochrome P450 (Cyp) 4a10, Cyp4a14, Cyp4a31 and Acyl-CoA thioesterase 3 (Acot3). Two relevant regulators, cytochrome P450 oxidoreductase (Por, rate limiting for cytochrome P450s) and the transcription factor constitutive androstane receptor (Car; official symbol Nr1i3) were also upregulated in the quercetin-fed mice. We conclude that quercetin intake increased hepatic lipid omega-oxidation and lowered corresponding circulating lipid levels, which may contribute to potential beneficial effects on CVD.	[Hoek-van den Hil, Elise F.; Rietjens, Ivonne M. C. M.; van Schothorst, Evert M.] Wageningen Univ, Div Toxicol, NL-6700 AP Wageningen, Netherlands; [Hoek-van den Hil, Elise F.; Venema, Dini; Hollman, Peter C. H.] RIKILT Inst Food Safety, Wageningen, Netherlands; [Stankova, Barbora; Tvrzicka, Eva] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic; [Vervoort, Jacques J. M.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Charles University Prague; Wageningen University & Research	van Schothorst, EM (corresponding author), Wageningen Univ, Div Toxicol, NL-6700 AP Wageningen, Netherlands.	evert.vanschothorst@wur.nl	Hollman, Peter C.H./I-7446-2013; Tvrzicka, Eva/Q-6300-2016; Keijer, Jaap/J-8089-2013; Stankova, Barbora/L-7933-2016	Hollman, Peter C.H./0000-0002-7510-6809; Tvrzicka, Eva/0000-0003-0794-8454; Keijer, Jaap/0000-0002-9720-7491; Rietjens, Ivonne/0000-0003-1894-3544; van Schothorst, Evert/0000-0002-3036-5903; Hoek - van den Hil, Elise/0000-0002-2646-9136; Stankova, Barbora/0000-0002-6184-4878	graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG); RIKILT-instutute of food safety	graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG); RIKILT-instutute of food safety	The research is funded by the graduate school Voeding, Levensmiddelentechnologie, Agrobiotechnologie en Gezondheid (VLAG), and RIKILT-instutute of food safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Baskin-Bey ES, 2007, WORLD J GASTROENTERO, V13, P5635, DOI 10.3748/wjg.v13.i42.5635; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; CARLSON LA, 1985, CLIN CHIM ACTA, V149, P89, DOI 10.1016/0009-8981(85)90277-3; de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Fiorini RN, 2004, CLIN TRANSPLANT, V18, P700, DOI 10.1111/j.1399-0012.2004.00282.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harchaoui KEL, 2009, CURR CARDIOL REV, V5, P216, DOI 10.2174/157340309788970315; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hoch U, 2000, ARCH BIOCHEM BIOPHYS, V373, P63, DOI 10.1006/abbi.1999.1504; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoek-van den Hil EF, 2012, ANAL BIOANAL CHEM, V402, P1389, DOI 10.1007/s00216-011-5563-5; Hollman PCH, 2010, J NUTR, V140, P600, DOI 10.3945/jn.109.116632; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hunt MC, 2005, J LIPID RES, V46, P2029, DOI 10.1194/jlr.E500003-JLR200; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Jung CH, 2012, PHYTOTHER RES; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Lavoie JM, 2006, CELL MOL LIFE SCI, V63, P1393, DOI 10.1007/s00018-006-6600-y; Li LH, 2009, PHARM RES-DORDR, V26, P872, DOI 10.1007/s11095-008-9788-8; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Mutch DM, 2007, J PROTEOME RES, V6, P3976, DOI 10.1021/pr0700448; Mutch DM, 2006, AM J PHYSIOL-GASTR L, V291, pG63, DOI 10.1152/ajpgi.00565.2005; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; Tukiainen T, 2008, BIOCHEM BIOPH RES CO, V375, P356, DOI 10.1016/j.bbrc.2008.08.007; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136; VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Yao RQ, 2010, J AGR FOOD CHEM, V58, P2168, DOI 10.1021/jf903711q; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	43	58	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e51588	10.1371/journal.pone.0051588	http://dx.doi.org/10.1371/journal.pone.0051588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359794	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600003
J	Piyathilake, CJ; Badiga, S; Alvarez, RD; Partridge, EE; Johanning, GL				Piyathilake, Chandrika J.; Badiga, Suguna; Alvarez, Ronald D.; Partridge, Edward E.; Johanning, Gary L.			A Lower Degree of PBMC L1 Methylation Is Associated with Excess Body Weight and Higher HOMA-IR in the Presence of Lower Concentrations of Plasma Folate	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; LINE-1 METHYLATION; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; LOWER RISK; HYPOMETHYLATION; ELEMENTS; OBESITY; CANCER; LEVEL	Background: Identification of associations between global DNA methylation and excess body weight (EBW) and related diseases and their modifying factors are an unmet research need that may lead to decreasing DNA methylation-associated disease risks in humans. The purpose of the current study was to evaluate the following; 1) Association between the degree of peripheral blood mononuclear cell (PBMC) L1 methylation and folate, and indicators of EBW, 2) Association between the degree of PBMC L1 methylation and folate, and insulin resistance (IR) as indicated by a higher homeostasis model assessment (HOMA-IR). Methods: The study population consisted of 470 child-bearing age women diagnosed with abnormal pap. The degree of PBMC L1 methylation was assessed by pyrosequencing. Logistic regression models specified indicators of EBW (body mass index-BMI, body fat-BF and waist circumference-WC) or HOMA-IR as dependent variables and the degree of PBMC L1 methylation and circulating concentrations of folate as the independent predictor of primary interest. Results: Women with a lower degree of PBMC L1 methylation and lower plasma folate concentrations were significantly more likely to have higher BMI, % BF or WC (OR = 2.49, 95% CI: 1.41-4.47, P = 0.002; OR = 2.49, 95% CI: 1.40-4.51, P = 0.002 and OR = 1.98, 95% = 1.14-3.48 P = 0.0145, respectively) and higher HOMA-IR (OR = 1.78, 95% CI: 1.02-3.13, P = 0.041). Conclusion: Our results demonstrated that a lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR, especially in the presence of lower concentrations of plasma folate.	[Piyathilake, Chandrika J.; Badiga, Suguna] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Alvarez, Ronald D.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Partridge, Edward E.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Johanning, Gary L.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Smithville, TX USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	piyathic@uab.edu			National Cancer Institute; Fulbright Senior Scholar Research Grant;  [R01 CA105448]; NATIONAL CANCER INSTITUTE [R01CA105448] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fulbright Senior Scholar Research Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by R01 CA105448 funded by the National Cancer Institute and a Fulbright Senior Scholar Research Grant awarded to Piyathilake CJ administered via the Korean-American Educational Commission (2012, Chungbuk National University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2010, EPIGENETICS-US, V5; Bajos N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2573; Beeson W L, 2010, Int J Body Compos Res, V8, P45; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Cash HL, 2011, EPIGENETICS-US, V6, P1257, DOI 10.4161/epi.6.10.17728; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Chowdhury S, 2011, BIRTH DEFECTS RES A, V91, P69, DOI 10.1002/bdra.20761; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gallo MF, 2003, COCHRANE DB SYST REV; Green NS, 2002, J NUTR, V132, p2356S, DOI 10.1093/jn/132.8.2356S; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Holt VL, 2002, OBSTET GYNECOL, V99, P820, DOI 10.1016/S0029-7844(02)01939-7; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kim SJ, 2012, DIABETES METAB J, V36, P108, DOI 10.4093/dmj.2012.36.2.108; Kimmons Joel E, 2006, MedGenMed, V8, P59; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kulie T, 2011, J AM BOARD FAM MED, V24, P75, DOI 10.3122/jabfm.2011.01.100076; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lash MM, 2009, FERTIL STERIL, V91, P1712, DOI 10.1016/j.fertnstert.2008.02.141; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Mirabello L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-77; Mojtabai R, 2004, EUR J EPIDEMIOL, V19, P1029, DOI 10.1007/s10654-004-2253-z; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Pearce MS, 2012, INT J EPIDEMIOL, V41, P210, DOI 10.1093/ije/dys020; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Piyathilake CJ, 2011, NUTRITION, V27, P513, DOI 10.1016/j.nut.2010.08.018; Piyathilake CJ, 2009, CANCER PREV RES, V2, P658, DOI 10.1158/1940-6207.CAPR-08-0175; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Takanabe-Mori R, 2010, BIOCHEM BIOPH RES CO, V398, P576, DOI 10.1016/j.bbrc.2010.06.123; THAYER RE, 1993, GENE, V133, P273, DOI 10.1016/0378-1119(93)90651-I; Tinker SC, 2012, BIRTH DEFECTS RES A, V94, P749, DOI 10.1002/bdra.23024; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Warholm L, 2012, EUR J CONTRACEP REPR, V17, P245, DOI 10.3109/13625187.2012.692411; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048	58	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54544	10.1371/journal.pone.0054544	http://dx.doi.org/10.1371/journal.pone.0054544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358786	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600066
J	Quiroz-Martinez, B; Salgado-Maldonado, G				Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo			Patterns of Distribution of the Helminth Parasites of Freshwater Fishes of Mexico	PLOS ONE			English	Article							RIVER-BASIN; N. SP; DISTANCE DECAY; OSTEICHTHYES; NEMATODA; CICHLIDAE; BIOGEOGRAPHY; SIMILARITY; TELEOSTEI; RICHNESS	In order to draw patterns in helminth parasite composition and species richness in Mexican freshwater fishes we analyse a presence-absence matrix representing every species of adult helminth parasites of freshwater fishes from 23 Mexican hydrological basins. We examine the distributional patterns of the helminth parasites with regard to the main hydrological basins of the country, and in doing so we identify areas of high diversity and point out the biotic similarities and differences among drainage basins. Our dataset allows us to evaluate the relationships among drainage basins in terms of helminth diversity. This paper shows that the helminth fauna of freshwater fishes of Mexico can characterise hydrological basins the same way as fish families do, and that the basins of south-eastern Mexico are home to a rich, predominantly Neotropical, helminth fauna whereas the basins of the Mexican Highland Plateau and the Nearctic area of Mexico harbour a less diverse Nearctic fauna, following the same pattern of distribution of their fish host families. The composition of the helminth fauna of each particular basin depends on the structure of the fish community rather than on the limnological characteristics and geographical position of the basin itself. This work shows distance decay of similarity and a clear linkage between host and parasite distributions.	[Quiroz-Martinez, Benjamin; Salgado-Maldonado, Guillermo] Univ Nacl Autonoma Mexico, Inst Biol, Lab Helmintol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Salgado-Maldonado, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Lab Helmintol, Mexico City 04510, DF, Mexico.	gsalgado@ibiologia.unam.mx	Quiroz-Martinez, Benjamin/AAG-2856-2019; Salgado-Maldonado, Guillermo/AAB-4960-2021	Quiroz-Martinez, Benjamin/0000-0001-9791-7031; Salgado-Maldonado, Guillermo/0000-0002-0772-0938	Universidad Nacional Autonoma de Mexico (UNAM); Direccion General de Asuntos del Personal Academico [PAPIIT IN220810]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [174861]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Universidad Nacional Autonoma de Mexico (UNAM), Direccion General de Asuntos del Personal Academico, projects PAPIIT IN220810, and by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) through a postdoctoral fellowship grant (no. 174861) to B.Q.M., Programa de Posgrado en Ciencias Biologicas, Instituto de Biologia, UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Aguilar R, 2003, J BIOGEOGR, V30, P1861, DOI 10.1111/j.1365-2699.2003.00931.x; Aguilar-Aguilar R, 2005, REGIONALIZACION BIOG; Aguilar-Aguilar R, 2008, BIOL J LINN SOC, V94, P435, DOI 10.1111/j.1095-8312.2008.00994.x; BARBOUR CD, 1973, COPEIA, P533; Caspeta-Mandujano JM, 2010, HELMINTHOLOGIA, V47, P33, DOI 10.2478/s11687-010-0006-y; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; De Cserna Z., 1995, ENVIRON ENG GEOSCI, V1, P29, DOI DOI 10.2113/GSEEGEOSCI.I.1.29; de Leon GPP, 2002, COMP PARASITOL, V69, P10, DOI 10.1654/1525-2647(2002)069[0010:AEPOIF]2.0.CO;2; Dogiel VA, 1961, PARASITOLOGY FISHES, P1; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3, DOI [DOI 10.1007/BF02908211, 10.1007/BF02908211]; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Flores Crespo J., 2003, Tecnica Pecuaria en Mexico, V41, P175; Gopar-Merino L, 2005, J PARASITOL, V91, P909, DOI 10.1645/GE-411R.1; Gorley C.K., 2006, GETTING STARTED PRIM; Hudson P.F., 2005, RIVERS N AM, P1030, DOI [10.1016/B978-012088253-3/50026-2, DOI 10.1016/B978-012088253-3/50026-2]; Jimenez-Garcia MI, 2001, J PARASITOL, V87, P907, DOI 10.2307/3285151; Lopez-Jimenez S, 2001, GACETA SIGOLFO SISTE, V2001, P8; Luque JL, 2007, PARASITOLOGY, V134, P865, DOI 10.1017/S0031182007002272; Caspeta-Mandujano JM, 2009, J PARASITOL, V95, P392, DOI 10.1645/GE-1502.1; Mendez O, 2010, ZOOTAXA, P44; Mendoza-Franco EF, 2008, J PARASITOL, V94, P28, DOI 10.1645/GE-1241.1; Mendoza-Palmero CA, 2009, J PARASITOL, V95, P315, DOI 10.1645/GE-1761.1; Miller R.R., 1986, P487; MILLER R R, 1986, Anales de la Escuela Nacional de Ciencias Biologicas Mexico, V30, P121; Mittermeier R. A., 1999, BIODIVERSIDAD AMENAZ; Moravec F, 2007, FOLIA PARASIT, V54, P215, DOI 10.14411/fp.2007.029; Morrone Juan J., 2001, M&T Manuales y Tesis SEA, V3, P1; Morrone Juan J., 2002, Acta Zool. Mex, P83; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NORRIS S. M., 2005, FRESHWATER FISHES ME; Palmer MW, 2005, J VEG SCI, V16, P161, DOI 10.1111/j.1654-1103.2005.tb02351.x; Perez-Ponce de Leon G, 2005, J BIOGEOGR, V32, P645, DOI 10.1111/j.1365-2699.2005.01218.x; De Leon GPP, 2009, ZOOTAXA, P1; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Poulin R., 2007, EVOL ECOL, V2; Poulin R, 2011, PHILOS T R SOC B, V366, P2379, DOI 10.1098/rstb.2011.0048; Razo-Mendivil U, 2008, J PARASITOL, V94, P1371, DOI 10.1645/GE-1546.1; Rodriguez-Olarte D, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P243; Salgado-Maldonado G, 2005, PARASITOL RES, V96, P69, DOI 10.1007/s00436-005-1315-9; Salgado-Maldonado G, 2004, COMP PARASITOL, V71, P190, DOI 10.1654/4088; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P196; Salgado-Maldonado G, 2001, COMP PARASITOL, V68, P204; Salgado-Maldonado G, PARASITOLOG IN PRESS; Salgado-Maldonado G, 2008, ZOOTAXA, P29; Salgado-Maldonado G, 2003, BIOL INVASIONS, V5, P261, DOI 10.1023/A:1026189331093; Salgado-Maldonado G, 2006, ZOOTAXA, P1; Salgado-Maldonado G, 2012, J PARASITOL, V98, P404, DOI 10.1645/GE-2907.1; Salgado-Maldonado G, 2011, J PARASITOL, V97, P707, DOI 10.1645/GE-2662.1; Salgado-Maldonado G, 2011, PARASITOL RES, V108, P31, DOI 10.1007/s00436-010-2035-3; Salgado-Maldonado G, 2010, SYST PARASITOL, V75, P231, DOI 10.1007/s11230-009-9218-2; Salgado-Maldonado G, 2009, SYST PARASITOL, V73, P193, DOI 10.1007/s11230-009-9189-3; SALGADOMALDONAD.G, 2005, BIODIVERSIDAD ESTADO, P145; Schaefer S, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P259; Sedlock R.L., 1993, GEOLOGICAL SOC AM SP, V278, P1, DOI DOI 10.1130/SPE278-P1; Vidal-Martinez V.M., 2000, P227; WOOTTEN R, 1973, J ZOOL, V171, P323, DOI 10.1111/j.1469-7998.1973.tb05342.x	56	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54787	10.1371/journal.pone.0054787	http://dx.doi.org/10.1371/journal.pone.0054787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359347	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600109
J	Geng, Y; Chandrasekaran, S; Hsu, JW; Gidwani, M; Hughes, AD; King, MR				Geng, Yue; Chandrasekaran, Siddarth; Hsu, Jong-Wei; Gidwani, Mishka; Hughes, Andrew D.; King, Michael R.			Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; E-SELECTIN; MESENCHYMAL TRANSITION; EXPRESSION; METASTASIS; CHEMOTHERAPY; ENDOTHELIUM; RESISTANCE; APOPTOSIS; CAPTURE	Hematogeneous metastasis can occur via a cascade of circulating tumor cell adhesion events to the endothelial lining of the vasculature, i.e. the metastatic cascade. Interestingly, the pro-inflammatory cytokines IL-6 and TNF-alpha, which play an important role in potentiating the inflammatory cascade, are significantly elevated in metastatic breast cancer (BCa) patients. Despite their high metastatic potential, human breast carcinoma cells MDA-MB-231 lack interactions with E-selectin functionalized surfaces under physiological shear stresses. We hypothesized that human plasma, 3-D tumor spheroid culture, and cytokine-supplemented culture media could induce a phenotypic switch that allows BCa cells to interact with E-selectin coated surfaces under physiological flow. Flow cytometry, immunofluorescence imaging, and flow-based cell adhesion assay were utilized to investigate the phenotypic changes of MDA-MB-231 cells with various treatments. Our results indicate that plasma, IL-6, and TNF-alpha promote breast cancer cell growth as aggregates and induce adhesive recruitment of BCa cells on E-selectin coated surfaces under flow. 3-D tumor spheroid culture exhibits the most significant increases in the interactions between BCa and E-selectin coated surfaces by upregulating CD44V4 and sLe(x) expression. Furthermore, we show that IL-6 and TNF-alpha concentrations in blood may regulate the recruitment of BCa cells to the inflamed endothelium. Finally, we propose a mechanism that could explain the invasiveness of 'triple-negative' breast cancer cell line MDA-MB-231 via a positive feedback loop of IL-6 secretion and maintenance. Taken together, our results suggest that therapeutic approaches targeting cytokine receptors and adhesion molecules on cancer cells may potentially reduce metastatic load and improve current cancer treatments.	[Geng, Yue; Chandrasekaran, Siddarth; Hsu, Jong-Wei; Gidwani, Mishka; Hughes, Andrew D.; King, Michael R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	King, MR (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mike.king@cornell.edu		Gidwani, Mishka/0000-0002-8477-2539	National Institutes of Health [U54CA143876]; National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grant No. U54CA143876 to M. R. K. and a National Science Foundation graduate research fellowship to Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agastin S, 2011, BIOMICROFLUIDICS, V5; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Ben-Baruch A, HOST MICROENVIROMNEN; Berberoglu U, 2004, INT J BIOL MARKER, V19, P130, DOI 10.1177/172460080401900207; Chandrasekaran S, 2012, BIOMATERIALS, V33, P9037, DOI 10.1016/j.biomaterials.2012.08.052; Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davril M, 1999, GLYCOBIOLOGY, V9, P311, DOI 10.1093/glycob/9.3.311; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Geng Y, 2012, FRONT ONCOL, V2, P1, DOI 10.2389/fonc.2012.00076; Geng Y, 2012, ANN BIOMED ENG, V40, P790, DOI 10.1007/s10439-011-0463-6; Geng Y, 2010, CELL MOL BIOENG, V3, P361, DOI 10.1007/s12195-010-0145-8; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; Goetz DJ, 1996, INT J CANCER, V65, P192, DOI 10.1002/(SICI)1097-0215(19960117)65:2<192::AID-IJC11>3.0.CO;2-G; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Groux-Degroote S, 2008, BIOCHEM J, V410, P213, DOI 10.1042/BJ20070958; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hou Jian-Mei, 2010, Cancers (Basel), V2, P1236, DOI 10.3390/cancers2021236; Hughes AD, 2012, JOVE-J VIS EXP, DOI 10.3791/4248; Hughes AD, 2012, CLIN CHEM, V58, P846, DOI 10.1373/clinchem.2011.176669; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kozlowski L, 2003, Rocz Akad Med Bialymst, V48, P82; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lagow EL, 2002, J CELL BIOCHEM, V86, P759, DOI 10.1002/jcb.10261; Lee D, 2007, J BIOL CHEM, V282, P4812, DOI 10.1074/jbc.M609994200; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Luque-Ramirez M, 2010, HORM METAB RES, V42, P815, DOI 10.1055/s-0030-1262855; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muthukumaran N, 2006, MOL CANCER RES, V4, P511, DOI 10.1158/1541-7786.MCR-05-0232; Narita, 1996, Breast Cancer, V3, P19, DOI 10.1007/BF02966958; Pandit TS, 2009, INT J ONCOL, V35, P297, DOI 10.3892/ijo_00000340; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thorlacius H, 1997, CLIN IMMUNOL IMMUNOP, V83, P68, DOI 10.1006/clin.1996.4325; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494	47	57	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54959	10.1371/journal.pone.0054959	http://dx.doi.org/10.1371/journal.pone.0054959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372803	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500150
J	McCormack, T; Frings, O; Alexeyenko, A; Sonnhammer, ELL				McCormack, Theodore; Frings, Oliver; Alexeyenko, Andrey; Sonnhammer, Erik L. L.			Statistical Assessment of Crosstalk Enrichment between Gene Groups in Biological Networks	PLOS ONE			English	Article							PATHWAY; GENOME	Motivation: Analyzing groups of functionally coupled genes or proteins in the context of global interaction networks has become an important aspect of bioinformatic investigations. Assessing the statistical significance of crosstalk enrichment between or within groups of genes can be a valuable tool for functional annotation of experimental gene sets. Results: Here we present CrossTalkZ, a statistical method and software to assess the significance of crosstalk enrichment between pairs of gene or protein groups in large biological networks. We demonstrate that the standard z-score is generally an appropriate and unbiased statistic. We further evaluate the ability of four different methods to reliably recover crosstalk within known biological pathways. We conclude that the methods preserving the second-order topological network properties perform best. Finally, we show how CrossTalkZ can be used to annotate experimental gene sets using known pathway annotations and that its performance at this task is superior to gene enrichment analysis (GEA). Availability and Implementation: CrossTalkZ (available at http://sonnhammer.sbc.su.se/download/software/CrossTalkZ/) is implemented in C++, easy to use, fast, accepts various input file formats, and produces a number of statistics. These include z-score, p-value, false discovery rate, and a test of normality for the null distributions.	[McCormack, Theodore; Frings, Oliver; Alexeyenko, Andrey; Sonnhammer, Erik L. L.] Stockholm Bioinformat Ctr, Sci Life Lab, Solna, Sweden; [McCormack, Theodore; Frings, Oliver; Sonnhammer, Erik L. L.] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Alexeyenko, Andrey] Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Sonnhammer, Erik L. L.] Swedish eSci Res Ctr, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Swedish e-Science Research Centre (SeRC)	Sonnhammer, ELL (corresponding author), Stockholm Bioinformat Ctr, Sci Life Lab, Solna, Sweden.	Erik.Sonnhammer@sbc.su.se	Alexeyenko, Andrey/F-1924-2016	Alexeyenko, Andrey/0000-0001-8812-6481; Sonnhammer, Erik/0000-0002-9015-5588	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Alexeyenko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010465; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Annibale A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/48/485001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Deng Minghua, 2003, Pac Symp Biocomput, P140; Hong MG, 2010, J HUM GENET, V55, P707, DOI 10.1038/jhg.2010.92; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; LI L, 2005, THEORY SCALE FREE GR; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milenkovic T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005967; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R, 2004, ARXIVCONDMAT0312028V; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Newman M, 2003, ARXIVCONDMAT0303516V; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; Penrose M., 2003, OXFORD STUDIES PROBA; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taylor JR, 1997, INTRO ERROR ANAL STU, VSecond	36	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54945	10.1371/journal.pone.0054945	http://dx.doi.org/10.1371/journal.pone.0054945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372799	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500148
J	Ahmad, A; Ali, S; Ahmed, A; Ali, AS; Raz, A; Sakr, WA; Rahman, KMW				Ahmad, Aamir; Ali, Shadan; Ahmed, Alia; Ali, Azfur S.; Raz, Avraham; Sakr, Wael A.; Rahman, K. M. Wahidur			3, 3 '- diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; M1 TRANSCRIPTION FACTOR; PROSTATE-CANCER; PANCREATIC-CANCER; DOWN-REGULATION; TRASTUZUMAB RESISTANCE; MIR-200 FAMILY; MICRORNA EXPRESSION; GROWTH-INHIBITION; APOPTOSIS	Herceptin failure is a major clinical problem in breast cancer. A subset of breast cancer patients with high HER-2/neu levels eventually experience metastatic disease progression when treated with Herceptin as a single agent. Mechanistic details of development of this aggressive disease are not clear. Therefore, there is a dire need to better understand the mechanisms by which drug resistance develops and to design new combined treatments that benefit patients with aggressive breast cancer and have minimal toxicity. We hypothesized that 3, 3'-diindolylmethane (DIM), a non-toxic agent can be combined with Herceptin to treat breast cancers with high levels of HER-2/neu. Here, we evaluated the effects of Herceptin alone and in combination with DIM on cell viability, apoptosis and clonogenic assays in SKBR3 (HER-2/neu-expressing) and MDA-MB-468 (HER-2/neu negative) breast cancer cells. We found that DIM could enhance the effectiveness of Herceptin by significantly reducing cell viability, which was associated with apoptosis-induction and significant inhibition of colony formation, compared with single agent treatment. These results were consistent with the down-regulation of Akt and NF-kB p65. Mechanistic investigations revealed a significant upregulation of miR-200 and reduction of FoxM1 expression in DIM and Herceptin-treated breast cancer cells. We, therefore, transfected cells with pre-miR-200 or silenced FoxM1 in these cells for understanding the molecular mechanism involved. These results provide experimental evidence, for the first time, that DIM plus Herceptin therapy could be translated to the clinic as a therapeutic modality to improve treatment outcome of patients with breast cancer, particularly for the patients whose tumors express high levels of HER-2/neu.	[Ahmad, Aamir; Ahmed, Alia; Ali, Azfur S.; Raz, Avraham; Sakr, Wael A.; Rahman, K. M. Wahidur] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Ali, Shadan; Raz, Avraham] Wayne State Univ, Sch Med, Div Hematol Oncol, Karmanos Canc Inst, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Rahman, KMW (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	kmrahman@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; Shah, Alia/0000-0001-6441-3902	Department of Pathology, Wayne State University, Detroit, Michigan; National Institutes of Health-National Cancer Institute grant [R01CA51714]; Department of Defense grant [W81XWH-05-1-0505]; NATIONAL CANCER INSTITUTE [R01CA140314, P30CA022453, R01CA051714] Funding Source: NIH RePORTER	Department of Pathology, Wayne State University, Detroit, Michigan; National Institutes of Health-National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Department of Pathology, Wayne State University, Detroit, Michigan, National Institutes of Health-National Cancer Institute grant R01CA51714 (AR) and Department of Defense grant W81XWH-05-1-0505 (KMWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, INT J CANCER, V129, P1781, DOI 10.1002/ijc.25839; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Ali S, 2008, MOL CANCER THER, V7, P1708, DOI 10.1158/1535-7163.MCT-08-0354; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bedard PL, 2009, CURR CANCER DRUG TAR, V9, P148, DOI 10.2174/156800909787581024; BLOCK G, 1991, AM J CLIN NUTR, V53, pS356, DOI 10.1093/ajcn/53.1.356S; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hahn T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-471; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Khalili P, 2005, ONCOGENE, V24, P6657, DOI 10.1038/sj.onc.1208790; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Li YW, 2005, FRONT BIOSCI-LANDMRK, V10, P236, DOI 10.2741/1523; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; McGuire KP, 2006, J SURG RES, V132, P208, DOI 10.1016/j.jss.2006.02.008; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2012, CURR MED CHEM, V19, P1065, DOI 10.2174/092986712799320691; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Radisky DC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2885; Rahman KMW, 2006, MOL CANCER THER, V5, P2747, DOI 10.1158/1535-7163.MCT-06-0221; Rahman KMW, 2006, CANCER RES, V66, P4952, DOI 10.1158/0008-5472.CAN-05-3918; Rahman KMW, 2009, CANCER RES, V69, P4468, DOI 10.1158/0008-5472.CAN-08-4423; Rahman KM, 2007, MOL CANCER THER, V6, P1; Rahman KMW, 2005, CANCER RES, V65, P364; Rahman KMW, 2000, ONCOGENE, V19, P5764, DOI 10.1038/sj.onc.1203959; Rahman KMW, 2003, NUTR CANCER, V45, P101, DOI 10.1207/S15327914NC4501_12; Rahman KW, 2004, NUTR CANCER, V48, P84, DOI 10.1207/s15327914nc4801_12; Sato J, 2011, J HEPATO-BIL-PAN SCI, V18, P700, DOI 10.1007/s00534-011-0376-7; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Wang TTY, 2012, MOL CARCINOGEN, V51, P244, DOI 10.1002/mc.20774; Wang ZW, 2008, MOL CANCER THER, V7, P341, DOI 10.1158/1535-7163.MCT-07-0476; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wilken JA, 2010, ANN NY ACAD SCI, V1210, P53, DOI 10.1111/j.1749-6632.2010.05782.x	55	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54657	10.1371/journal.pone.0054657	http://dx.doi.org/10.1371/journal.pone.0054657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23372748	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100088
J	Singh, DP; Khattar, JIS; Kaur, M; Kaur, G; Gupta, M; Singh, Y				Singh, D. P.; Khattar, J. I. S.; Kaur, Mandeep; Kaur, Gurdeep; Gupta, Meenu; Singh, Yadvinder			Anilofos Tolerance and Its Mineralization by the Cyanobacterium Synechocystis sp Strain PUPCCC 64	PLOS ONE			English	Article							RICE FIELDS; PHOTOSYNTHETIC PIGMENTS; SUPEROXIDE-DISMUTASE; GREEN-ALGAE; GROWTH; PESTICIDES; HERBICIDES; RESISTANT; MOLINATE; STRESS	This study deals with anilofos tolerance and its mineralization by the common rice field cyanobacterium Synechocystis sp. strain PUPCCC 64. The organism tolerated anilofos up to 25 mg L-1. The herbicide caused inhibitory effects on photosynthetic pigments of the test organism in a dose-dependent manner. The organism exhibited 60, 89, 96, 85 and 79% decrease in chlorophyll a, carotenoids, phycocyanin, allophycocyanin and phycoerythrin, respectively, in 20 mg L-1 anilofos on day six. Activities of superoxide dismutase, catalase and peroxidase increased by 1.04 to 1.80 times over control cultures in presence of 20 mg L-1 anilofos. Glutathione content decreased by 26% while proline content was unaffected by 20 mg L-1 anilofos. The test organism showed intracellular uptake and metabolized the herbicide. Uptake of herbicide by test organism was fast during initial six hours followed by slow uptake until 120 hours. The organism exhibited maximum anilofos removal at 100 mg protein L-1, pH 8.0 and 30 degrees C. Its growth in phosphate deficient basal medium in the presence of anilofos (2.5 mg L-1) indicated that herbicide was used by the strain PUPCCC 64 as a source of phosphate.	[Singh, D. P.; Khattar, J. I. S.; Kaur, Mandeep; Kaur, Gurdeep; Gupta, Meenu; Singh, Yadvinder] Punjabi Univ, Dept Bot, Patiala, Punjab, India	Punjabi University	Singh, DP (corresponding author), Punjabi Univ, Dept Bot, Patiala, Punjab, India.	dp.khokhar@rediffmail.com	KHATTAR, JIS/D-9797-2011; Singh, Yadvinder/AAM-7656-2021	Singh, Yadvinder/0000-0002-5835-718X	Council of Scientific and Industrial Research (CSIR), New Delhi, India [(38)1152/07/EMR-II]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR), New Delhi, India (scheme no. (38)1152/07/EMR-II). The funders had no role in designing the experiment, collection of data, decision to publish and preparation of this manuscript.	ALLEN MB, 1955, PLANT PHYSIOL, V30, P366, DOI 10.1104/pp.30.4.366; Bagchi SN, 2003, PHOTOSYNTH RES, V75, P171, DOI 10.1023/A:1022836218176; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Broser M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215970; Caceres TP, 2008, CURR MICROBIOL, V57, P643, DOI 10.1007/s00284-008-9293-7; Chen WC, 2009, ECOTOX ENVIRON SAFE, V72, P120, DOI 10.1016/j.ecoenv.2008.03.013; Chen Z, 2007, AQUAT TOXICOL, V81, P256, DOI 10.1016/j.aquatox.2006.12.008; Clay J., 2004, WORLD AGR ENV COMMOD; Dowidar SMA, 2010, J GENET ENG BIOTECHN, p[8, 89]; EGASHIRA T, 1989, PLANT CELL PHYSIOL, V30, P1171, DOI 10.1093/oxfordjournals.pcp.a077860; Eladel HM, 1998, J APPL PHYCOL, V10, P547, DOI 10.1023/A:1008092826338; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Faria MS, 2007, ECOTOX ENVIRON SAFE, V67, P218, DOI 10.1016/j.ecoenv.2006.11.018; Fatma T, 2007, J APPL PHYCOL, V19, P625, DOI 10.1007/s10811-007-9195-2; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Funari Enzo, 1995, P3; GAHAGAN HE, 1968, PHYSIOL PLANTARUM, V21, P1270, DOI 10.1111/j.1399-3054.1968.tb07358.x; Galhano V, 2009, WATER AIR SOIL POLL, V197, P211, DOI 10.1007/s11270-008-9804-y; Galhano V, 2011, AQUAT TOXICOL, V101, P367, DOI 10.1016/j.aquatox.2010.11.011; Galhano V, 2010, ENVIRON TOXICOL, V25, P147, DOI 10.1002/tox.20486; Gonzalez-Barreiro O, 2006, ENVIRON POLLUT, V144, P266, DOI 10.1016/j.envpol.2005.12.014; Holm G., 1954, Acta Agriculturae Scandinavica, V4, P457; Janardhan G., 1999, Current Research - University of Agricultural Sciences (Bangalore), V28, P12; Kang HS, 2009, B ENVIRON CONTAM TOX, V82, P305, DOI 10.1007/s00128-008-9602-7; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kulshrestha G, 2000, PEST MANAG SCI, V56, P202, DOI 10.1002/(SICI)1526-4998(200002)56:2<202::AID-PS97>3.0.CO;2-C; Kumar D, 2010, APPL BIOCHEM BIOTECH, V160, P2475, DOI 10.1007/s12010-009-8710-0; Kumar S, 2008, SCI TOTAL ENVIRON, V403, P130, DOI 10.1016/j.scitotenv.2008.05.026; Leitao S, 2007, AQUAT ECOL, V41, P373, DOI 10.1007/s10452-007-9082-6; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lipok J, 2007, ENZYME MICROB TECH, V41, P286, DOI 10.1016/j.enzmictec.2007.02.004; [刘新 Liu Xin], 2003, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V9, P78; Lopez-Rodas V, 2007, EVOL ECOL, V21, P535, DOI 10.1007/s10682-006-9134-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZM, 2009, ECOTOX ENVIRON SAFE, V72, P136, DOI 10.1016/j.ecoenv.2008.01.009; Mallory-Smith CA, 2003, WEED TECHNOL, V17, P605, DOI 10.1614/0890-037X(2003)017[0605:RCOHBS]2.0.CO;2; Marchesan E, 2007, SCI AGR, V64, P131, DOI 10.1590/S0103-90162007000200005; Min H, 2001, J ENVIRON SCI HEAL B, V36, P581, DOI 10.1081/PFC-100106187; Moraes BS, 2009, PESTIC BIOCHEM PHYS, V95, P57, DOI 10.1016/j.pestbp.2009.06.006; Mostaffa FI, 2002, J ENV SCI HLTH, V36, P709; MYERS J, 1955, J GEN PHYSIOL, V39, P11, DOI 10.1085/jgp.39.1.11; Narusaka Y, 1998, PLANT CELL PHYSIOL, V39, P620, DOI 10.1093/oxfordjournals.pcp.a029413; Oettmeier W, 1999, CELL MOL LIFE SCI, V55, P1255, DOI 10.1007/s000180050370; ORUS MI, 1991, B ENVIRON CONTAM TOX, V47, P392, DOI 10.1007/BF01702200; PADHY RN, 1985, RESIDUE REV, V95, P1; Pereira T, 2000, ENVIRON TOXICOL, V15, P401, DOI 10.1002/1522-7278(2000)15:5<401::AID-TOX7>3.3.CO;2-8; Phong TK, 2009, B ENVIRON CONTAM TOX, V83, P794, DOI 10.1007/s00128-009-9810-9; Pingali P, 1995, IMPACT PESTICIDES FA; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2009, ECOTOXICOLOGY, V18, P537, DOI 10.1007/s10646-009-0311-8; Rai A. K., 2000, Journal of the Indian Society of Soil Science, V48, P57; Rao V.S., 2000, PRINCIPLES WEED SCI, V2nd ed.; Roberts T., 1998, METABOLIC PATHWAYS A; ROGER PA, 1992, PLANT SOIL, V141, P41, DOI 10.1007/BF00011309; SAFFERMAN RS, 1964, J BACTERIOL, V88, P771, DOI 10.1128/JB.88.3.771-775.1964; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Singh DP, 2010, RES J BIOTECHNOL, V5, P27; Singh DP, 2012, TOXICOL ENVIRON CHEM, V94, P1304, DOI 10.1080/02772248.2012.703203; Singh S, 2007, PLANT SOIL, V296, P95, DOI 10.1007/s11104-007-9293-6; Singh S, 2006, J BASIC MICROB, V46, P219, DOI 10.1002/jobm.200510074; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; SUBRAMANIAN G, 1994, INT BIODETER BIODEGR, V33, P129, DOI 10.1016/0964-8305(94)90032-9; Thengodkar RRM, 2010, BIODEGRADATION, V21, P637, DOI 10.1007/s10532-010-9331-6; TIWARI DN, 1991, APPL BIOCHEM BIOTECH, V28-9, P387, DOI 10.1007/BF02922618; Valiente EF, 2000, PLANT SOIL, V221, P107, DOI 10.1023/A:1004737422842; [王晓 Wang Xiao], 2006, [土壤学报, Acta Pedologica Sinica], V43, P648; Whitton B.A., 2000, ECOLOGY CYANOBACTERI, P1, DOI [10.1007/0-306-46855-7, DOI 10.1007/0-306-46855-7, DOI 10.1007/0-306-46855-7_1]; Xu GM, 2007, BIOTECHNOL LETT, V29, P1469, DOI 10.1007/s10529-007-9444-0; Yaduraju N. T., 2006, AGR ENVIRON, P192; Zimmermann K, 2006, BBA-BIOENERGETICS, V1757, P106, DOI 10.1016/j.bbabio.2005.12.002	73	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53445	10.1371/journal.pone.0053445	http://dx.doi.org/10.1371/journal.pone.0053445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382844	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600015
J	Laska, MJ; Nissen, KK; Nexo, BA				Laska, Magdalena Janina; Nissen, Kari Konstantin; Nexo, Bjorn Andersen			(Some) Cellular Mechanisms Influencing the Transcription of Human Endogenous Retrovirus, HERV-Fc1	PLOS ONE			English	Article							DNA METHYLATION; CPG METHYLATION; GENE-EXPRESSION; HUMAN GENOME; CELLS; INDUCTION; SEQUENCES; 5-AZA-2'-DEOXYCYTIDINE; 5-AZA-2-DEOXYCYTIDINE; METHYLTRANSFERASES	DNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. DNA methylation is considered an important mechanism for silencing of retroelements in the mammalian genome. However, the methylation of human endogenous retroviruses (HERVs) is not well investigated. The aim of this study was to investigate the transcriptional potential of HERV-Fc1 proviral 5'LTR in more detail, and examined the specific influence of CpG methylation on this LTR in number of cell lines. Specifically, the role of demethylating chemicals e.g. 5-aza-2' deoxycytidine and Trichostatin-A, in inducing or reactivating expression of HERV-Fc1 specific sequences and the mechanisms were investigated. In our present study, 5-aza-dC is shown to be a powerful inducer of HERV-Fc1, and at the same time it strongly inhibits methylation of DNA. Treatment with this demethylating agent 5-aza-dC, results in significantly increased levels of HERV-Fc1 expression in cells previously not expressing HERV-Fc1, or with a very low expression level. The extent of expression of HERV-Fc1 RNAs precisely correlates with the apparent extent of demethylation of the related DNA sequences. In conclusion, the results suggest that inhibition of DNA methylation/histone deacetylase can interfere with gene silencing mechanisms affecting HERV-Fc1 expression in human cells.	[Laska, Magdalena Janina; Nissen, Kari Konstantin; Nexo, Bjorn Andersen] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University	Laska, MJ (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	laska@hum-gen.au.dk		Laska, Magdalena Janina/0000-0001-5188-3446	Warwara Larsen Fonden [J.2008-7306]; LundbeckFonden [R44-A4331]	Warwara Larsen Fonden; LundbeckFonden(Lundbeckfonden)	This work was supported by grant J.2008-7306 from Warwara Larsen Fonden and grant R44-A4331 from LundbeckFonden (http://www.lundbeckfonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1974, P NATL ACAD SCI USA, V71, P3941, DOI 10.1073/pnas.71.10.3941; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Bartoli A, 2003, PHARMACOL RES, V48, P111, DOI 10.1016/S1043-6618(03)00079-3; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jern P, 2004, VIROLOGY, V327, P93, DOI 10.1016/j.virol.2004.06.023; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kjellman C, 1999, J GEN VIROL, V80, P2383, DOI 10.1099/0022-1317-80-9-2383; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Laska MJ, 2012, J VIROL, V86, P3713, DOI 10.1128/JVI.06723-11; Lavie L, 2005, J VIROL, V79, P876, DOI 10.1128/JVI.79.2.876-883.2005; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; McInerney JM, 2000, GENE THER, V7, P653, DOI 10.1038/sj.gt.3301155; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; MICHALOWSKY LA, 1987, MOL CELL BIOL, V7, P3076, DOI 10.1128/MCB.7.9.3076; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; NIWA O, 1981, P NATL ACAD SCI-BIOL, V78, P6290, DOI 10.1073/pnas.78.10.6290; Ogasawara H, 2003, CLIN EXP RHEUMATOL, V21, P733; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okada M, 2002, J RHEUMATOL, V29, P1678; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; Patzke S, 2002, VIROLOGY, V303, P164, DOI 10.1006/viro.2002.1615; RASCATI RJ, 1988, MUTAT RES, V208, P21, DOI 10.1016/0165-7992(88)90015-2; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Sekigawa I, 1997, Nihon Rinsho, V55, P1492; Stengel S, 2010, GENE CHROMOSOME CANC, V49, P401, DOI 10.1002/gcc.20751; Strissel PL, 2012, ONCOTARGET; SUTTER D, 1980, P NATL ACAD SCI-BIOL, V77, P253, DOI 10.1073/pnas.77.1.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Wentzensen N, 2007, INT J CANCER, V121, P1417, DOI 10.1002/ijc.22826; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YUNG RL, 1995, J IMMUNOL, V154, P3025	49	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53895	10.1371/journal.pone.0053895	http://dx.doi.org/10.1371/journal.pone.0053895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382858	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500007
J	Kuo, CY; Yen, MF; Chen, LS; Fann, CY; Chiu, YH; Chen, HH; Pan, SL				Kuo, Cheng-Ya; Yen, Ming-Fang; Chen, Li-Sheng; Fann, Ching-Yuan; Chiu, Yueh-Hsia; Chen, Hsiu-Hsi; Pan, Shin-Liang			Increased Risk of Hemorrhagic Stroke in Patients with Migraine: A Population-Based Cohort Study	PLOS ONE			English	Article							CEREBRAL VASOCONSTRICTION SYNDROME; INTRACEREBRAL HEMORRHAGE; HEALTH-INSURANCE; ISCHEMIC-STROKE; WOMEN; EPIDEMIOLOGY; FREQUENCY; SEX	Objective: Previous studies on the association between migraine and the risk of developing hemorrhagic stroke (HS) have generated inconsistent results. The aim of the present population-based, age- and sex- matched follow-up study was to investigate whether migraine is associated with an increased risk of HS. Method: A total of 20925 persons with at least two ambulatory visits in 2001 with the principal diagnosis of migraine were enrolled in the migraine group. The non-migraine group consisted of 104625, age- and sex- matched, randomly sampled subjects without migraine. The two-year HS-free survival rates for these 2 groups were estimated using the Kaplan-Meier method. Cox proportional hazards regression was used to estimate the effect of migraine on the occurrence of HS. Results: During the 2 year follow-up, 113 subjects in the migraine group (0.54%) and 255 in the non-migraine group (0.24%) developed HS. The crude hazard ratio (HR) for developing HS in the migraine group was 2.22 compared to the non-migraine group (95% confidence interval [CI]: 1.78-2.77, p<0.0001) and the adjusted HR was 2.13 (95% CI: 1.71-2.67, p<0.0001) after controlling for demographic characteristics and comorbid medical disorders. Conclusions: This population-based age- and sex- matched cohort study shows that migraine was linked to an increased risk of HS.	[Kuo, Cheng-Ya; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kuo, Cheng-Ya; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yen, Ming-Fang; Chen, Li-Sheng] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Tao Yuan, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Nan Kai University Technology; Chang Gung University; National Taiwan University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		PAN, SHIN-LIANG/0000-0001-6451-4666; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; Chen, Hsiu-Hsi/0000-0002-5799-6705	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health, Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Carter KN, 2005, J CLIN NEUROSCI, V12, P534, DOI 10.1016/j.jocn.2004.09.009; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Daneshtalab N, 2010, CARDIOVASC RES, V86, P160, DOI 10.1093/cvr/cvp395; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; Gerretsen P, 2009, CURR NEUROL NEUROSCI, V9, P108, DOI 10.1007/s11910-009-0018-5; Heckmann JG, 1998, CEPHALALGIA, V18, P133, DOI 10.1046/j.1468-2982.1998.1803133.x; KRALL JM, 1975, BIOMETRICS, V31, P49, DOI 10.2307/2529709; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Lipton RB, 2005, HEADACHE, V45, pS3, DOI 10.1111/j.1526-4610.2005.4501001.x; Mathew NT, 1999, CEPHALALGIA, V19, P17, DOI 10.1177/0333102499019S2504; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; SMEDA JS, 1992, CAN J PHYSIOL PHARM, V70, P552, DOI 10.1139/y92-070; Smeda JS, 2003, STROKE, V34, P1491, DOI 10.1161/01.STR.0000073797.91891.9E; Sochurkova D, 1999, NEUROEPIDEMIOLOGY, V18, P85, DOI 10.1159/000069411; Soo Y, 2010, CEPHALALGIA, V30, P42, DOI 10.1111/j.1468-2982.2009.01868.x; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55253	10.1371/journal.pone.0055253	http://dx.doi.org/10.1371/journal.pone.0055253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372843	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400083
J	Saleem, H; Tovey, SC; Rahman, T; Riley, AM; Potter, BVL; Taylor, CW				Saleem, Huma; Tovey, Stephen C.; Rahman, Taufiq; Riley, Andrew M.; Potter, Barry V. L.; Taylor, Colin W.			Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Analogues of IP3	PLOS ONE			English	Article							LIGAND-BINDING; TRISPHOSPHATE RECEPTOR; TYPE-1; PHOSPHATES; ACTIVATION; INSP(3); PROTEIN; DOMAIN; MOBILIZATION; INVOLVEMENT	Most animal cells express mixtures of the three subtypes of inositol 1,4,5-trisphosphate receptor (IP3R) encoded by vertebrate genomes. Activation of each subtype by different agonists has not hitherto been examined in cells expressing defined homogenous populations of IP3R. Here we measure Ca2+ release evoked by synthetic analogues of IP3 using a Ca2+ indicator within the lumen of the endoplasmic reticulum of permeabilized DT40 cells stably expressing single subtypes of mammalian IP3R. Phosphorylation of (1,4,5)IP3 to (1,3,4,5)IP4 reduced potency by similar to 100-fold. Relative to (1,4,5)IP3, the potencies of IP3 analogues modified at the 1-position (malachite green (1,4,5)IP3), 2-position (2-deoxy(1,4,5)IP3) or 3-position (3-deoxy(1,4,5)IP3, (1,3,4,5)IP4) were similar for each IP3R subtype. The potency of an analogue, (1,4,6)IP3, in which the orientations of the 2- and 3-hydroxyl groups were inverted, was also reduced similarly for all three IP3R subtypes. Most analogues of IP3 interact similarly with the three IP3R subtypes, but the decrease in potency accompanying removal of the 1-phosphate from (1,4,5) IP3 was least for IP(3)R3. Addition of a large chromophore (malachite green) to the 1-phosphate of (1,4,5)IP3 only modestly reduced potency suggesting that similar analogues could be used to measure (1,4,5)IP3 binding optically. These data provide the first structure-activity analyses of key IP3 analogues using homogenous populations of each mammalian IP3R subtype. They demonstrate broadly similar structure-activity relationships for all mammalian IP3R subtypes and establish the potential utility of (1,4,5)IP3 analogues with chromophores attached to the 1-position.	[Saleem, Huma; Tovey, Stephen C.; Rahman, Taufiq; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Riley, Andrew M.; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Cambridge; University of Bath	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	rahman, taufiq/E-9806-2013; Potter, Barry/AAX-4781-2020; Riley, Andrew M/F-3526-2013; rahman, taufiq/GON-8210-2022; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; Riley, Andrew M/0000-0001-9003-3540; rahman, taufiq/0000-0003-3830-5160; Taylor, Colin/0000-0001-7771-1044	Wellcome Trust [085295, 082837]; Biotechnology and Biological Sciences Research Council [BB/H009736/1]; Jameel Family Trust; BBSRC [BB/H009736/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Jameel Family Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust to CWT [085295], and BVLP and AMR [082837], and from Biotechnology and Biological Sciences Research Council to CWT [BB/H009736/1]. HS is supported by a research studentship from the Jameel Family Trust. TR was a research fellow of Pembroke College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Bird GSJ, 1996, J BIOL CHEM, V271, P6766, DOI 10.1074/jbc.271.12.6766; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BURGESS GM, 1985, BIOCHEM J, V232, P237, DOI 10.1042/bj2320237; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELISLE S, 1994, AM J PHYSIOL, V266, pC429, DOI 10.1152/ajpcell.1994.266.2.C429; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/s004410050345; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; HAGIWARA T, 1994, B CHEM SOC JPN, V67, P390, DOI 10.1246/bcsj.67.390; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Inoue T, 1999, BIOORG MED CHEM LETT, V9, P1697, DOI 10.1016/S0960-894X(99)00256-5; Inoue T, 2001, CHEM BIOL, V8, P9, DOI 10.1016/S1074-5521(00)00051-X; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; KOZIKOWSKI AP, 1993, J AM CHEM SOC, V115, P4429, DOI 10.1021/ja00064a002; LAMPE D, 1992, J CHEM SOC PERK T 1, P2899, DOI 10.1039/p19920002899; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Loomis-Husselbee JW, 1998, BIOCHEM J, V331, P947, DOI 10.1042/bj3310947; LU PJ, 1994, BIOCHEMISTRY-US, V33, P11586, DOI 10.1021/bi00204a021; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Marchant JS, 1997, BIOCHEM J, V321, P573, DOI 10.1042/bj3210573; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Merlino A, 2012, MEDCHEMCOMM, V3, P90, DOI 10.1039/c1md00223f; Mills SJ, 1996, J ORG CHEM, V61, P8980, DOI 10.1021/jo961280x; Nakanishi W, 2002, BIOORG MED CHEM LETT, V12, P911, DOI 10.1016/S0960-894X(02)00044-6; Nerou EP, 2001, BIOCHEM J, V355, P59, DOI 10.1042/bj3550059; Pantazaka E, 2011, J BIOL CHEM, V286, P23378, DOI 10.1074/jbc.M111.236372; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poinas A, 2005, CHEMBIOCHEM, V6, P1449, DOI 10.1002/cbic.200400443; POTTER BVL, 1995, ANGEW CHEM INT EDIT, V34, P1933, DOI 10.1002/anie.199519331; Rahman T. U., 2009, NATURE, V458, P655; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Riley AM, 1997, ANGEW CHEM INT EDIT, V36, P1472, DOI 10.1002/anie.199714721; Rossi AM, 2010, BRIT J PHARMACOL, V161, P1070, DOI 10.1111/j.1476-5381.2010.00947.x; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sureshan KM, 2012, J MED CHEM, V55, P1706, DOI 10.1021/jm201571p; Sureshan KM, 2009, CHEM COMMUN, P1204, DOI 10.1039/b819328b; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilcox RA, 1997, FEBS LETT, V402, P241, DOI 10.1016/S0014-5793(96)01540-2; Wilcox RA, 1998, TRENDS PHARMACOL SCI, V19, P467, DOI 10.1016/S0165-6147(98)01260-7; YAMAMOTOHINO M, 1995, NEUROREPORT, V6, P273, DOI 10.1097/00001756-199501000-00012; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129	57	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54877	10.1371/journal.pone.0054877	http://dx.doi.org/10.1371/journal.pone.0054877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372785	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400038
J	Ueda, K; Kawabata, R; Irie, T; Nakai, Y; Tohya, Y; Sakaguchi, T				Ueda, Kyoko; Kawabata, Ryoko; Irie, Takashi; Nakai, Yoshiaki; Tohya, Yukinobu; Sakaguchi, Takemasa			Inactivation of Pathogenic Viruses by Plant-Derived Tannins: Strong Effects of Extracts from Persimmon (Diospyros kaki) on a Broad Range of Viruses	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; GREEN TEA; INHIBITION; FRUITS; REPLICATION; POLYPHENOL; MEMBRANE; PROTEIN; BINDS; CD4	Tannins, plant-derived polyphenols and other related compounds, have been utilized for a long time in many fields such as the food industry and manufacturing. In this study, we investigated the anti-viral effects of tannins on 12 different viruses including both enveloped viruses (influenza virus H3N2, H5N3, herpes simplex virus-1, vesicular stomatitis virus, Sendai virus and Newcastle disease virus) and non-enveloped viruses (poliovirus, coxsachievirus, adenovirus, rotavirus, feline calicivirus and mouse norovirus). We found that extracts from persimmon (Diospyros kaki), which contains ca. 22% of persimmon tannin, reduced viral infectivity in more than 4-log scale against all of the viruses tested, showing strong anti-viral effects against a broad range of viruses. Other tannins derived from green tea, acacia and gallnuts were effective for some of the viruses, while the coffee extracts were not effective for any of the virus. We then investigated the mechanism of the antiviral effects of persimmon extracts by using mainly influenza virus. Persimmon extracts were effective within 30 seconds at a concentration of 0.25% and inhibited attachment of the virus to cells. Pretreatment of cells with the persimmon extracts before virus infection or post-treatment after virus infection did not inhibit virus replication. Protein aggregation seems to be a fundamental mechanism underlying the anti-viral effect of persimmon tannin, since viral proteins formed aggregates when purified virions were treated with the persimmon extracts and since the anti-viral effect was competitively inhibited by a non-specific protein, bovine serum albumin. Considering that persimmon tannin is a food supplement, it has a potential to be utilized as a safe and highly effective anti-viral reagent against pathogenic viruses.	[Ueda, Kyoko; Kawabata, Ryoko; Irie, Takashi; Sakaguchi, Takemasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan; [Nakai, Yoshiaki] Altan Corp, Tokyo, Japan; [Tohya, Yukinobu] Nihon Univ, Coll Biosource Sci, Dept Vet Med, Kanagawa, Japan	Hiroshima University; Nihon University	Sakaguchi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan.	tsaka@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	Hiroshima University; Altan Corporation	Hiroshima University; Altan Corporation	This work was supported by the basic research fund from Hiroshima University. It was also supported by the Altan Corporation as joint research to evaluate anti-viral activity of various reagents. However, the Altan Corporation was involved in the initial study design alone and not involved in any of the study design thereafter; collection, analysis, or interpretations presented in the paper.	Flint SJ, 2009, PRINCIPLES VIROLOGY, P82; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; FUKUCHI K, 1989, ANTIVIR RES, V11, P285, DOI 10.1016/0166-3542(89)90038-7; Green KY, 2006, FIELDS VIROLOGY, P949; Harrison SC, 2007, FIELDS VIROLOGY, P59; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2003, INT C HARMONIZATION; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07; ITO S, 1964, NATURE, V204, P475, DOI 10.1038/204475a0; Kawai K, 2003, J ALLERGY CLIN IMMUN, V112, P951, DOI 10.1016/S0091-6749(03)02007-4; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; KUZUYA M, 1993, J CLIN MICROBIOL, V31, P1308, DOI 10.1128/JCM.31.5.1308-1311.1993; Matsumoto K, 2011, PHYTOTHER RES, V25, P624, DOI 10.1002/ptr.3306; MATSUO T, 1978, AGR BIOL CHEM TOKYO, V42, P1637, DOI 10.1080/00021369.1978.10863225; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; NAKASHIMA H, 1992, ANTIVIR RES, V18, P91, DOI 10.1016/0166-3542(92)90008-S; Nakatsubo F, 2002, J WOOD SCI, V48, P414, DOI 10.1007/BF00770702; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Noma K, 1998, ARCH VIROL, V143, P1893, DOI 10.1007/s007050050428; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Sakaguchi T, 1999, VIROLOGY, V263, P230, DOI 10.1006/viro.1999.9960; Sakaguchi T, 2002, J VIROL, V76, P1682, DOI 10.1128/JVI.76.4.1682-1690.2002; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; WHITE T., 1957, Journal of the Science of Food and Agriculture, V8, P377, DOI 10.1002/jsfa.2740080702; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; WRIGHT PF, 2006, FIELDS VIROLOGY, P1692; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9	28	84	93	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55343	10.1371/journal.pone.0055343	http://dx.doi.org/10.1371/journal.pone.0055343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372851	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400091
J	Yu, D; Jin, C; Ramachandran, M; Xu, J; Nilsson, B; Korsgren, O; Le Blanc, K; Uhrbom, L; Forsberg-Nilsson, K; Westermark, B; Adamson, R; Maitland, N; Fan, XL; Essand, M				Yu, Di; Jin, Chuan; Ramachandran, Mohanraj; Xu, Jing; Nilsson, Berith; Korsgren, Olle; Le Blanc, Katarina; Uhrbom, Lene; Forsberg-Nilsson, Karin; Westermark, Bengt; Adamson, Rachel; Maitland, Norman; Fan, Xiaolong; Essand, Magnus			Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures	PLOS ONE			English	Article							VIVO GENE-TRANSFER; CANCER STEM-CELLS; ONCOLYTIC ADENOVIRUS; IN-VIVO; BINDING ABLATION; RECOMBINANT ADENOVIRUSES; RAPID GENERATION; PROSTATE-CANCER; TUMOR-CELLS; CAR-BINDING	Recombinant adenovirus serotype 5 (Ad5) vectors represent one of the most efficient gene delivery vectors in life sciences. However, Ad5 is dependent on expression of the coxsackievirus-adenovirus- receptor (CAR) on the surface of target cell for efficient transduction, which limits it's utility for certain cell types. Herein we present a new vector, Ad5PTDf35, which is an Ad5 vector having serotype 35 fiber-specificity and Tat-PTD hexon-modification. This vector shows dramatically increased transduction capacity of primary human cell cultures including T cells, monocytes, macrophages, dendritic cells, pancreatic islets and exocrine cells, mesenchymal stem cells and tumor initiating cells. Biodistribution in mice following systemic administration (tail-vein injection) show significantly reduced uptake in the liver and spleen of Ad5PTDf35 compared to unmodified Ad5. Therefore, replication-competent viruses with these modifications may be further developed as oncolytic agents for cancer therapy. User-friendly backbone plasmids containing these modifications were developed for compatibility to the AdEasy-system to facilitate the development of surface-modified adenoviruses for gene delivery to difficult-to-transduce cells in basic, pre-clinical and clinical research.	[Yu, Di; Jin, Chuan; Ramachandran, Mohanraj; Xu, Jing; Nilsson, Berith; Korsgren, Olle; Uhrbom, Lene; Forsberg-Nilsson, Karin; Westermark, Bengt; Essand, Magnus] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Le Blanc, Katarina] Karolinska Univ Hosp, Div Clin Immunol, Huddinge, Sweden; [Adamson, Rachel; Maitland, Norman] Univ York, YCR Canc Res Unit, Dept Biol, Heslington, England; [Fan, Xiaolong] Lund Univ, Rausing Lab, Lund, Sweden; [Fan, Xiaolong] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing, Peoples R China	Uppsala University; Karolinska Institutet; Karolinska University Hospital; University of York - UK; Lund University; Beijing Normal University	Essand, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	magnus.essand@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Le Blanc, Katarina/L-4631-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Essand, Magnus/0000-0002-9725-0422; Westermark, Bengt/0000-0001-7153-5545; Maitland, Norman/0000-0003-1607-9035; Yu, Di/0000-0002-8636-0351; Korsgren, Olle/0000-0002-8524-9547; Xu, Jing/0000-0002-9506-5514	The Swedish Cancer Society [10-0105, 10-0552]; Swedish Children Cancer Foundation [PROJ10/027]; Swedish Research Council [K2013-55X-22191-01-3]; Gunnar Nilsson's Cancer Foundation; Marcus and Marianne Wallenberg Foundation; Medical Research Council [G0900871] Funding Source: researchfish; MRC [G0900871] Funding Source: UKRI	The Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson's Cancer Foundation; Marcus and Marianne Wallenberg Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Swedish Cancer Society (10-0105 and 10-0552), the Swedish Children Cancer Foundation (PROJ10/027), the Swedish Research Council (K2013-55X-22191-01-3), Gunnar Nilsson's Cancer Foundation and the Marcus and Marianne Wallenberg Foundation supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WC, 2011, P NATL ACAD SCI USA, V108, P7499, DOI 10.1073/pnas.1017146108; Adamson RE, 2012, HUM GENE THER, V23, P218, DOI 10.1089/hum.2011.021; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bayo-Puxan N, 2009, HUM GENE THER, V20, P1214, DOI 10.1089/hum.2009.038; Bilbao G, 2002, AM J TRANSPLANT, V2, P237, DOI 10.1034/j.1600-6143.2002.20308.x; Brouwer E, 2007, CANCER GENE THER, V14, P211, DOI 10.1038/sj.cgt.7701010; Carlsson B, 2003, BRIT J HAEMATOL, V121, P428, DOI 10.1046/j.1365-2141.2003.04300.x; Coughlan L, 2012, MOL THER; Danielsson A, 2008, CANCER GENE THER, V15, P203, DOI 10.1038/sj.cgt.7701117; de Vrij J, 2008, GENE THER, V15, P978, DOI 10.1038/gt.2008.26; Di BY, 2012, J BIOTECHNOL, V157, P373, DOI 10.1016/j.jbiotec.2011.12.022; Einfeld DA, 2001, J VIROL, V75, P11284, DOI 10.1128/JVI.75.23.11284-11291.2001; Escutenaire S, 2011, ANN MED, V43, P151, DOI 10.3109/07853890.2010.538079; Flotte T, 2001, DIABETES, V50, P515, DOI 10.2337/diabetes.50.3.515; Forsberg O, 2008, BRIT J HAEMATOL, V141, P188, DOI 10.1111/j.1365-2141.2008.07026.x; Friberg AS, 2008, CELL TRANSPLANT, V17, P1305, DOI 10.3727/096368908787648100; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Koizumi N, 2003, J VIROL, V77, P13062, DOI 10.1128/JVI.77.24.13062-13072.2003; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Leissner P, 2001, GENE THER, V8, P49, DOI 10.1038/sj.gt.3301343; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magnusson MK, 2012, HUM GENE THER, V23, P70, DOI 10.1089/hum.2011.016; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016792; Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj.gt.3301701; Molnar C, 2012, CELL TRANSPLANT; Mui TS, 2010, CURR OPIN ORGAN TRAN; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Ni Choileain S, 2012, IMMUNOBIOLOGY, V217, P169, DOI 10.1016/j.imbio.2011.06.003; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Sakurai F, 2003, MOL THER, V8, P813, DOI 10.1016/S1525-0016(03)00243-0; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Yoshioka Y, 2008, LIFE SCI, V83, P747, DOI 10.1016/j.lfs.2008.09.022; Yu D, 2011, J VIROL, V85, P13114, DOI 10.1128/JVI.05759-11; Yun CO, 2005, HUM GENE THER, V16, P248, DOI 10.1089/hum.2005.16.248	49	18	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54952	10.1371/journal.pone.0054952	http://dx.doi.org/10.1371/journal.pone.0054952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372800	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400045
J	Angell, RL; Butlin, RK; Altringham, JD				Angell, Ruth L.; Butlin, Roger K.; Altringham, John D.			Sexual Segregation and Flexible Mating Patterns in Temperate Bats	PLOS ONE			English	Article							LONG-EARED BAT; PLECOTUS-AURITUS; SWARMING SITES; BECHSTEINS BAT; POPULATION-STRUCTURE; MYOTIS-BECHSTEINII; GENETIC-STRUCTURE; NATTERERS BATS; PHILOPATRY; BEHAVIOR	Social structure evolves from a trade-off between the costs and benefits of group-living, which are in turn dependent upon the distribution of key resources such as food and shelter. Males and females, or juveniles and adults, may have different priorities when selecting habitat due to differences in physiological or behavioural imperatives, leading to complex patterns in group composition. We studied social structure and mating behaviour in the insectivorous bat Myotis daubentonii along an altitudinal gradient, combining field studies with molecular genetics. With increasing altitude the proportion of males in summer roosts increased and only males were present in the highest roosts. With increasing altitude environmental temperature decreased, nightly variation in temperature increased, and bat foraging activity decreased, supporting the hypothesis that the harsher, high elevation sites cannot support breeding females. We found that offspring in female-dominated lowland roosts had a very high probability of being fathered by bats caught during autumn swarming at hibernation sites, in contrast to those in intermediate roosts, which had a high probability of being fathered by males sharing the nursery roost with the females. Whilst females normally appear to exclude males from nursery colonies, for those in marginal habitats, one explanation for the presence of males is that the thermoregulatory benefits to the females may outweigh disadvantages, such as competition for food, and give some males an opportunity to increase their breeding success. We suggest that the environment, and its effects on resource distribution, thus determine social structure, which in turn determines the mating pattern that has evolved.	[Angell, Ruth L.; Altringham, John D.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Butlin, Roger K.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; University of Sheffield	Altringham, JD (corresponding author), Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England.	j.d.altringham@leeds.ac.uk	Butlin, Roger K/F-7709-2013	Butlin, Roger K/0000-0003-4736-0954	Natural Environment Research Council (NERC) PhD Studentship; NERC; Natural Environment Research Council [NBAF010001, NE/J006300/1] Funding Source: researchfish; NERC [NE/J006300/1, NBAF010001] Funding Source: UKRI	Natural Environment Research Council (NERC) PhD Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RLA was supported by a Natural Environment Research Council (NERC) PhD Studentship (www.nerc.ac.uk). Molecular work was carried out at the NERC Biomolecular Analysis Facility (NBAF) at the University of Sheffield with additional funding from NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Altringham John D., 2005, P280; Angell RL, 2008, THESIS U LEEDS; Anthony E.L.P., 1988, P47; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Burland TM, 2001, MOL ECOL, V10, P1309, DOI 10.1046/j.1365-294X.2001.01273.x; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kerth G, 2004, ETHOLOGY, V110, P987, DOI 10.1111/j.1439-0310.2004.01040.x; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, BEHAV ECOL SOCIOBIOL, V52, P203, DOI 10.1007/s00265-002-0499-6; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Petri B, 1997, MOL ECOL, V6, P235, DOI 10.1046/j.1365-294X.1997.00176.x; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; RICHARDSON PW, 1994, J ZOOL, V233, P307, DOI 10.1111/j.1469-7998.1994.tb08590.x; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559	28	37	40	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54194	10.1371/journal.pone.0054194	http://dx.doi.org/10.1371/journal.pone.0054194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365652	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600037
J	Kaasinen, E; Aavikko, M; Vahteristo, P; Patama, T; Li, YL; Saarinen, S; Kilpivaara, O; Pitkanen, E; Knekt, P; Laaksonen, M; Artama, M; Lehtonen, R; Aaltonen, LA; Pukkala, E				Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Patama, Toni; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Knekt, Paul; Laaksonen, Maarit; Artama, Miia; Lehtonen, Rainer; Aaltonen, Lauri A.; Pukkala, Eero			Nationwide Registry-Based Analysis of Cancer Clustering Detects Strong Familial Occurrence of Kaposi Sarcoma	PLOS ONE			English	Article							CARCINOID-TUMORS; PREDISPOSITION; POPULATION; FINLAND; RISK; GENE; HERPESVIRUS; DEFICIENCY; MUTATIONS; DISCOVERY	Many cancer predisposition syndromes are rare or have incomplete penetrance, and traditional epidemiological tools are not well suited for their detection. Here we have used an approach that employs the entire population based data in the Finnish Cancer Registry (FCR) for analyzing familial aggregation of all types of cancer, in order to find evidence for previously unrecognized cancer susceptibility conditions. We performed a systematic clustering of 878,593 patients in FCR based on family name at birth, municipality of birth, and tumor type, diagnosed between years 1952 and 2011. We also estimated the familial occurrence of the tumor types using cluster score that reflects the proportion of patients belonging to the most significant clusters compared to all patients in Finland. The clustering effort identified 25,910 birth name-municipality based clusters representing 183 different tumor types characterized by topography and morphology. We produced information about familial occurrence of hundreds of tumor types, and many of the tumor types with high cluster score represented known cancer syndromes. Unexpectedly, Kaposi sarcoma (KS) also produced a very high score (cluster score 1.91, p-value<0.0001). We verified from population records that many of the KS patients forming the clusters were indeed close relatives, and identified one family with five affected individuals in two generations and several families with two first degree relatives. Our approach is unique in enabling systematic examination of a national epidemiological database to derive evidence of aberrant familial aggregation of all tumor types, both common and rare. It allowed effortless identification of families displaying features of both known as well as potentially novel cancer predisposition conditions, including striking familial aggregation of KS. Further work with high-throughput methods should elucidate the molecular basis of the potentially novel predisposition conditions found in this study.	[Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Fac Med, Genome Scale Biol Res Program, Helsinki, Finland; [Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Fac Med, Dept Med Genet, Helsinki, Finland; [Kaasinen, Eevi; Aavikko, Mervi; Vahteristo, Pia; Li, Yilong; Saarinen, Silva; Kilpivaara, Outi; Pitkanen, Esa; Lehtonen, Rainer; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Patama, Toni; Artama, Miia; Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; [Knekt, Paul; Laaksonen, Maarit] Natl Inst Hlth & Welf, Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Finnish Cancer Registry; Finland National Institute for Health & Welfare; Tampere University	Aaltonen, LA (corresponding author), Univ Helsinki, Fac Med, Genome Scale Biol Res Program, Helsinki, Finland.	lauri.aaltonen@helsinki.fi	Laaksonen, Maarit A/O-3467-2016; Aaltonen, Lauri/A-5375-2010; Pitkanen, Esa/H-2435-2018	Laaksonen, Maarit A/0000-0002-3676-0787; Aaltonen, Lauri/0000-0001-6839-4286; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Pitkanen, Esa/0000-0002-9818-6370; Kaasinen, Eevi/0000-0002-1333-8049	Academy of Finland Center of Excellence in Cancer Genetics Research [250345]; Postdoctoral Researcher's grants [21290, 137680]; European Research Council [268648 - NGG]; Cancer Society of Finland; Ida Montini Foundation; Paulo Foundation; Orion Pharmos Foundation; Sigrid Juselius Foundation	Academy of Finland Center of Excellence in Cancer Genetics Research(Academy of Finland); Postdoctoral Researcher's grants; European Research Council(European Research Council (ERC)European Commission); Cancer Society of Finland; Ida Montini Foundation; Paulo Foundation; Orion Pharmos Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Center of Excellence in Cancer Genetics Research (No 250345) and Postdoctoral Researcher's grants (No 21290 and 137680), European Research Council (No 268648 - NGG), Cancer Society of Finland, Ida Montini Foundation, Paulo Foundation, Orion Pharmos Foundation, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenthal DT, 2008, NEUROLOGY, V71, P1015, DOI 10.1212/01.wnl.0000326597.60605.27; Brown EE, 2006, CANCER EPIDEM BIOMAR, V15, P926, DOI 10.1158/1055-9965.EPI-05-0791; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Camcioglu Y, 2004, J PEDIATR-US, V144, P519, DOI 10.1016/j.jpeds.2003.11.012; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cottoni F, 1996, ACTA DERM-VENEREOL, V76, P59; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DIGIOVANNA JJ, 1981, AM J MED, V71, P779, DOI 10.1016/0002-9343(81)90364-8; Dorak MT, 2005, J MED VIROL, V76, P302, DOI 10.1002/jmv.20361; Dukers NHTM, 2003, AIDS, V17, P1717, DOI 10.1097/00002030-200308150-00001; Farge D, 1993, Eur J Med, V2, P339; Fata F, 2002, J CLIN ONCOL, V20, P1415, DOI 10.1200/JCO.2002.20.5.1415; Gazouli M, 2004, ANTICANCER RES, V24, P1311; Georgitsi M, 2007, P NATL ACAD SCI USA, V104, P4101, DOI 10.1073/pnas.0700004104; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldin LR, 2009, BRIT J HAEMATOL, V146, P91, DOI 10.1111/j.1365-2141.2009.07721.x; Guerini Franca Rosa, 2006, Cancer Genomics & Proteomics, V3, P191; Guttman-Yassky E, 2005, ARCH DERMATOL, V141, P1429, DOI 10.1001/archderm.141.11.1429; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Hale L R, 1998, Australas J Dermatol, V39, P241, DOI 10.1111/j.1440-0960.1998.tb01481.x; Hemminki K, 2010, BRIT J CANCER, V102, P1786, DOI 10.1038/sj.bjc.6605708; Hemminki K, 2001, INT J CANCER, V94, P444, DOI 10.1002/ijc.1473; Hiripi E, 2009, ANN ONCOL, V20, P950, DOI 10.1093/annonc/mdn706; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; KALOTERAKIS A, 1995, TISSUE ANTIGENS, V45, P117, DOI 10.1111/j.1399-0039.1995.tb02427.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Mancuso R, 2011, J GEN VIROL, V92, P744, DOI 10.1099/vir.0.027847-0; Matikainen MP, 2000, INT J CANCER, V88, P307, DOI 10.1002/1097-0215(20001015)88:2&lt;307::AID-IJC25&gt;3.0.CO;2-7; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pukkala E, 2010, SMALL AREA BASED MAP; Pukkala E, 2011, METHODS MOL BIOL, V675, P127, DOI 10.1007/978-1-59745-423-0_5; SAFAI B, 1985, ANN INTERN MED, V103, P744, DOI 10.7326/0003-4819-103-5-744; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Weissmann-Brenner A, 2004, CLIN ONCOL-UK, V16, P125, DOI 10.1016/S0936-6555(03)00249-8	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55209	10.1371/journal.pone.0055209	http://dx.doi.org/10.1371/journal.pone.0055209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365693	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600159
J	Kwon, WS; Park, YJ; Kim, YH; You, YA; Kim, IC; Pang, MG				Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Kim, In Cheul; Pang, Myung-Geol			Vasopressin Effectively Suppresses Male Fertility	PLOS ONE			English	Article							SPERM CAPACITATION; MOUSE SPERM; TYROSINE PHOSPHORYLATION; SPERMATOZOA; PROTEIN; IDENTIFICATION; OXYTOCIN; CALCIUM; FLUORESCENCE; EXPRESSION	Arginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility. However, very little is known about the involvement of VP in controlling mammalian reproductive process. The goal of this study was to confirm that effect of VP receptor (AVPR2) on sperm function in capacitation condition. Deamino [Cys 1, D-ArgS] vasopressin (dDAVP), an AVPR2 agonist that operates only on AVPR2, was used. Also, Mouse spermatozoa were incubated with various concentrations of dDAVP (10(-11)-10(-5) M) and sperm motility, capacitation status, Protein Kinase A activity (PKA), tyrosine phosphorylation, fertilization, and embryo development were assessed using computer-assisted sperm analysis, Combined Hoechst 33258/chlortetracycline fluorescence, Western blotting, and in vitro fertilization, respectively. AVPR2 was placed on the acrosome region and mid-piece in cauda epididymal spermatozoa, but the caput epididymal spermatozoa was mid-piece only. The high dDAVP treatment (10(-8) and 10(-5) M) significantly decreased sperm motility, intracellular pH and PKA substrates (approximately 55 and 22 kDa) and increased Ca2+ concentration. The highest concentration treatment significantly decreased PKA substrate (approximately 23 kDa) and tyrosine phosphorylation (approximately 30 kDa). VP detrimentally affected capacitation, acrosome reaction, and embryo development. Treatment with the lowest concentration (10(-11) M) was not significantly different. Our data have shown that VP stimulates ion transport across sperm membrane through interactions with AVPR2. VP has a detrimental effect in sperm function, fertilization, and embryonic development, suggesting its critical role in the acquisition of fertilizing ability of mouse spermatozoa. These research findings will enable further study to determine molecular mechanism associated with fertility in capacitation and fertilization. It is also an important pivotal precondition to the progress of diagnostic test to identify infertility and to apply male contraception.	[Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Sch Bioresource & Biosci, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kwon, Woo-Sung; Park, Yoo-Jin; Kim, Yun-Hee; You, Young-Ah; Pang, Myung-Geol] Chung Ang Univ, Sch Bioresource & Biosci, BET Res Inst, Anseong, Gyeonggi Do, South Korea; [Kim, In Cheul] Rural Dev Adm, Natl Inst Anim Sci, Cheonan, Chungcheongnam, South Korea	Chung Ang University; Chung Ang University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Pang, MG (corresponding author), Chung Ang Univ, Sch Bioresource & Biosci, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Pang, Myung-Geol/AAV-2014-2021; Kwon, Woo-Sung/J-6731-2019	Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; You, Younag-Ah/0000-0001-6714-7144	Cooperative Research Program for Agriculture Science & Technology Development [PJ907170]; Rural Development Administration, Republic of Korea	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ907170), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Assinder SJ, 2000, BIOL REPROD, V63, P448, DOI 10.1095/biolreprod63.2.448; Baker SS, 2004, J ANDROL, V25, P744; Baldi E, 1996, FRONT BIOSCI, V1, P189; BROTHERTON J, 1990, ANDROLOGIA, V22, P305; Fernandes S, 2002, ENDOCRINOLOGY, V143, P2759, DOI 10.1210/en.143.7.2759; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; FRASER LR, 1992, J REPROD FERTIL, V96, P363, DOI 10.1530/jrf.0.0960363; Greenhalgh JR, 2009, J ANDROL, V30, P548, DOI 10.2164/jandrol.108.006049; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagedorn TA, 2007, BIOL REPROD, V77, P416, DOI 10.1095/biolreprod.106.056762; Harris CC, 1998, J ENDOCRINOL, V156, P35, DOI 10.1677/joe.0.1560035; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; KASSON BG, 1985, J BIOL CHEM, V260, P5302; KIHLSTROM JE, 1974, J ENDOCRINOL, V60, P445, DOI 10.1677/joe.0.0600445; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Maxwell WMC, 1999, THERIOGENOLOGY, V52, P1353, DOI 10.1016/S0093-691X(99)00222-8; MEIDAN R, 1985, ENDOCRINOLOGY, V116, P416, DOI 10.1210/endo-116-1-416; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Nicholson HD, 1999, J REPROD FERTIL, V117, P299, DOI 10.1530/jrf.0.1170299; Oh SA, 2008, THESIS CHUNG ANG U S; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; PICKERING BT, 1989, ANN NY ACAD SCI, V564, P198, DOI 10.1111/j.1749-6632.1989.tb25898.x; Pinto FM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-71; PURI S, 1985, ARCH ANDROLOGY, V14, P263, DOI 10.3109/01485018508988309; QUINN P, 1982, J REPROD FERTIL, V66, P161; RATNASOORIYA WD, 1993, MED SCI RES, V21, P13; Romero F, 2007, FERTIL STERIL, V87, P1345, DOI 10.1016/j.fertnstert.2006.11.054; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; SLIWA L, 1994, ARCH ANDROLOGY, V33, P145; Tabuchi T, 2008, J REPROD DEVELOP, V54, P502, DOI 10.1262/jrd.20021; Tian Y, 2000, ENDOCRINOLOGY, V141, P307, DOI 10.1210/en.141.1.307; Tulsiani DR, 2007, IOC REPROD FERTIL S, V63, P237; Varisli O, 2009, J ANDROL, V30, P75, DOI 10.2164/jandrol.107.004333; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Xia JS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-119; ZANEVELD LJD, 1991, HUM REPROD, V6, P1265, DOI 10.1093/oxfordjournals.humrep.a137524	45	40	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54192	10.1371/journal.pone.0054192	http://dx.doi.org/10.1371/journal.pone.0054192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365651	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600036
J	Maksimov, M; Vaht, M; Harro, J; Bachmann, T				Maksimov, Margus; Vaht, Mariliis; Harro, Jaanus; Bachmann, Talis			Can Common Functional Gene Variants Affect Visual Discrimination in Metacontrast Masking?	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; POLYMORPHISM; BRAIN; AMYGDALA; STIMULUS; IMPACTS	Mechanisms of visual perception should be robustly fast and provide veridical information about environmental objects in order to facilitate survival and successful coping. Because species-specific brain mechanisms for fast vision must have evolved under heavy pressure for efficiency, it has been held that different human individuals see the physical world in the same way and produce psychophysical functions of visual discrimination that are qualitatively the same. For many years, this assumption has been implicitly accepted in vision research studying extremely fast, basic visual processes, including studies of visual masking. However, in recent studies of metacontrast masking surprisingly robust individual differences in the qualitative aspects of subjects' performance have been found. As the basic species-specific visual functions very likely are based on universal brain mechanisms of vision, these differences probably are the outcome of variability in ontogenetic development (i.e., formation of idiosyncrasic skills of perception). Such developmental differences can be brought about by variants of genes that are differentially expressed in the course of CNS development. The objective of this study was to assess whether visual discrimination in metacontrast masking is related to three widely studied genetic polymorphisms implicated in brain function and used here as independent variables. The findings suggest no main effects of BDNF Val66Met, NRG1/rs6994992, or 5-HTTLPR polymorphisms on metacontrast performance, but several notable interactions of genetic variables with gender, stage of the sequence of experimental trials, perceptual strategies, and target/mask shape congruence were found. Thus, basic behavioral functions of fast vision may be influenced by common genetic variability. Also, when left uncontrolled, genetic factors may seriously confound variables in vision research using masking, obscure clear theoretical interpretation, lead to unexplicable inter-regional differences and create problems of replicability of formerly successful experiments.	[Maksimov, Margus; Vaht, Mariliis; Harro, Jaanus; Bachmann, Talis] Univ Tartu, EE-50090 Tartu, Estonia	University of Tartu	Bachmann, T (corresponding author), Univ Tartu, Ulikooli 18, EE-50090 Tartu, Estonia.	talis.bachmann@ut.ee	Harro, Jaanus/W-4939-2017; Vaht, Mariliis/AAI-7521-2020	Harro, Jaanus/0000-0002-4484-2096; Vaht, Mariliis/0000-0002-5733-7056; Bachmann, Talis/0000-0001-9595-1594	Estonian Ministry of Science and Education [SF0180027s12]	Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia)	Our research was supported by Estonian Ministry of Science and Education through a targeted financing project SF0180027s12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2012, CONSCIOUS COGN, V21, P1222, DOI 10.1016/j.concog.2012.04.006; Albrecht T, 2010, CONSCIOUS COGN, V19, P656, DOI 10.1016/j.concog.2009.12.002; [Anonymous], VISUAL MASKING; Aru J, 2009, NEUROSCI LETT, V450, P351, DOI 10.1016/j.neulet.2008.11.063; Bachmann T, 1994, PSYCHOPHYSIOLOGY OF; Bachmann T, 2010, CONSCIOUS COGN, V19, P667, DOI 10.1016/j.concog.2010.01.012; Barnes A, 2012, NEUROIMAGE, V59, P2057, DOI 10.1016/j.neuroimage.2011.10.007; Beste C, 2011, NEUROPHARMACOLOGY, V60, P467, DOI 10.1016/j.neuropharm.2010.10.028; Everaerd D, 2012, NEUROPSYCHOPHARMACOL, V37, P1848, DOI 10.1038/npp.2012.32; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; HUNTLEY GW, 1992, DEV BRAIN RES, V70, P53, DOI 10.1016/0165-3806(92)90103-4; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; Koch C, 2004, THE QUEST FOR CONSCI; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Maksimov M, 2011, SCAND J PSYCHOL, V52, P524, DOI 10.1111/j.1467-9450.2011.00904.x; McIntosh AM, 2008, MOL PSYCHIATR, V13, P1054, DOI 10.1038/sj.mp.4002103; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Sprooten E, 2009, MOL PSYCHIATR, V14, P237, DOI 10.1038/mp.2008.136; Stottenberg SF, 2010, NEUROPHARMACOLOGY, V58, P423, DOI 10.1016/j.neuropharm.2009.09.010; Wei SM, 2012, J NEUROSCI, V32, P7074, DOI 10.1523/JNEUROSCI.5375-11.2012	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55287	10.1371/journal.pone.0055287	http://dx.doi.org/10.1371/journal.pone.0055287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359627	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600163
J	Mountzios, G; Kostopoulos, I; Kotoula, V; Sfakianaki, I; Fountzilas, E; Markou, K; Karasmanis, I; Leva, S; Angouridakis, N; Vlachtsis, K; Nikolaou, A; Konstantinidis, I; Fountzilas, G				Mountzios, Giannis; Kostopoulos, Ioannis; Kotoula, Vassiliki; Sfakianaki, Ioanna; Fountzilas, Elena; Markou, Konstantinos; Karasmanis, Ilias; Leva, Sofia; Angouridakis, Nikolaos; Vlachtsis, Konstantinos; Nikolaou, Angelos; Konstantinidis, Ioannis; Fountzilas, George			Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; LUNG-CANCER; BREAST-CANCER; NECK-CANCER; HEAD; CARCINOMA; ASSOCIATION; PROGNOSIS; PROMOTER; TISSUES	Introduction: Prognosis of patients with operable laryngeal cancer is highly variable and therefore potent prognostic biomarkers are warranted. The insulin-like growth factor receptor (IGFR) signaling pathway plays a critical role in laryngeal carcinogenesis and progression. Patients and Methods: We identified all patients with localized TNM stage I-III laryngeal cancer managed with potentially curative surgery between 1985 and 2008. Immunohistochemical (IHC) expression of IGF1R-alpha, IGF1R-beta and IGF2R was evaluated using the immunoreactive score (IRS) and mRNA levels of important effectors of the IGFR pathway were assessed, including IGF1R, IGF-binding protein 3 (IGFBP3), suppressor of cytokine signaling 2 (SOCS2) and members of the MAP-kinase (MAP2K1, MAPK9) and phosphatidyl-inositol-3 kinase (PIK3CA, PIK3R1) families. Cox-regression models were applied to assess the predictive value of biomarkers on disease-free survival (DFS) and overall survival (OS). Results: Among 289 eligible patients, 95.2% were current or ex smokers, 75.4% were alcohol abusers, 15.6% had node-positive disease and 32.2% had received post-operative irradiation. After a median follow-up of 74.5 months, median DFS was 94.5 months and median OS was 106.3 months. Using the median IRS as the pre-defined cut-off, patients whose tumors had increased IGF1R-alpha cytoplasm or membrane expression experienced marginally shorter DFS and significantly shorter OS compared to those whose tumors had low IGF1R-alpha expression (91.1 vs 106.2 months, p = 0.0538 and 100.3 vs 118.6 months, p = 0.0157, respectively). Increased mRNA levels of MAPK9 were associated with prolonged DFS (p = 0.0655) and OS (p = 0.0344). In multivariate analysis, IGF1R-alpha overexpression was associated with a 46.6% increase in the probability for relapse (p = 0.0374). Independent predictors for poor OS included node-positive disease (HR = 2.569, p < 0.0001), subglottic/transglottic localization (HR = 1.756, p = 0.0438) and IGF1R-alpha protein overexpression (HR = 1.475, p = 0.0504). Conclusion: IGF1R-alpha protein overexpression may serve as an independent predictor of relapse and survival in operable laryngeal cancer. Prospective evaluation of the IGF1R-alpha prognostic utility is warranted.	[Mountzios, Giannis] 251 AF Gen Hosp, Dept Med Oncol, Athens, Greece; [Kostopoulos, Ioannis; Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Hellenic Fdn Canc Res, Sch Med, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Sfakianaki, Ioanna; Fountzilas, Elena; Leva, Sofia; Fountzilas, George] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Med, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Markou, Konstantinos; Angouridakis, Nikolaos; Vlachtsis, Konstantinos] Aristotle Univ Thessaloniki, AHEPA Hosp, Dept Otorhinolaryngol 1, Sch Med, GR-54006 Thessaloniki, Greece; [Karasmanis, Ilias; Nikolaou, Angelos] G Papanikolaou Gen Hosp, ENT Dept, Thessaloniki, Greece; [Konstantinidis, Ioannis] Papageorgiou Hosp, ENT Dept, Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital; George Papanikolaou General Hospital of Thessaloniki; Papageorgiou Hospital	Mountzios, G (corresponding author), 251 AF Gen Hosp, Dept Med Oncol, Athens, Greece.	gmountzios@gmail.com	Vlachtsis, Konstantinos/AAD-1262-2021; Mountzios, Giannis/ABE-1197-2020; Fountzilas, George/ABF-2139-2020	Markou, Konstantinos/0000-0001-9891-5185; Fountzilas, George/0000-0001-8045-2186	Hellenic Cooperative Oncology Group [HE R_5G]	Hellenic Cooperative Oncology Group	This work was in part funded by the Hellenic Cooperative Oncology Group (HE R_5G research grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenschein G, 2011, J THORAC ONCOL, V6, pS1799, DOI 10.1097/01.JTO.0000407563.14653.0c; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; Chui X, 1996, BRIT J CANCER, V73, P1233, DOI 10.1038/bjc.1996.236; Chung CH, 2011, HEAD NECK-J SCI SPEC, V33, P1804, DOI 10.1002/hed.21478; Ciampolillo A, 2007, CURR PHARM DESIGN, V13, P729, DOI 10.2174/138161207780249209; Doyle SL, 2012, AM J GASTROENTEROL, V107, P196, DOI 10.1038/ajg.2011.417; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Fountzilas E, 2012, ANN ONCOL, V23, P2146, DOI 10.1093/annonc/mdr576; Friedrich RE, 2010, ANTICANCER RES, V30, P1641; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Grbesa I, 2006, CANCER LETT, V238, P224, DOI 10.1016/j.canlet.2005.07.003; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Jameson MJ, 2011, MOL CANCER THER, V10, P2124, DOI 10.1158/1535-7163.MCT-11-0294; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; KREBS DL, 2003, SCI STKE, pPE6; Lefebvre JL, 2012, CURR OPIN ONCOL, V24, P218, DOI 10.1097/CCO.0b013e3283523c95; LeRoith D, 2005, J CLIN INVEST, V115, P233, DOI 10.1172/JCI200524228; Li S, 2011, HEAD NECK-J SCI SPEC, V33, P368, DOI 10.1002/hed.21457; Liu SG, 2010, EUR J CANCER, V46, P1744, DOI 10.1016/j.ejca.2010.03.038; Malaguarnera R, 2011, J CLIN ENDOCR METAB, V96, P766, DOI 10.1210/jc.2010-1255; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Niu JG, 2011, HEAD NECK-J SCI SPEC, V33, P650, DOI 10.1002/hed.21514; Oh SH, 2012, CANCER SCI, V103, P1259, DOI 10.1111/j.1349-7006.2012.02301.x; Papadimitrakopoulou VA, 2006, CANCER LETT, V239, P136, DOI 10.1016/j.canlet.2005.08.009; Penteroudakis G, 2012, ORAL ONCOL, DOI 10,1016/j.oraloncology.2012.02.002; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Sun JM, 2011, ORAL ONCOL, V47, P714, DOI 10.1016/j.oraloncology.2011.06.007; Thomas L, 2012, CANCER TREAT REV, V38, P203, DOI 10.1016/j.ctrv.2011.05.010; Victory K, 2011, J DENT RES, V90, P347, DOI 10.1177/0022034510388037	33	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54048	10.1371/journal.pone.0054048	http://dx.doi.org/10.1371/journal.pone.0054048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365645	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600026
J	Pistohl, T; Schmidt, TSB; Ball, T; Schulze-Bonhage, A; Aertsen, A; Mehring, C				Pistohl, Tobias; Schmidt, Thomas Sebastian Benedikt; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten			Grasp Detection from Human ECoG during Natural Reach-to-Grasp Movements	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; HAND MOVEMENT; EEG; CORTEX; TRAJECTORIES; DIRECTION; ARM	Various movement parameters of grasping movements, like velocity or type of the grasp, have been successfully decoded from neural activity. However, the question of movement event detection from brain activity, that is, decoding the time at which an event occurred (e. g. movement onset), has been addressed less often. Yet, this may be a topic of key importance, as a brain-machine interface (BMI) that controls a grasping prosthesis could be realized by detecting the time of grasp, together with an optional decoding of which type of grasp to apply. We, therefore, studied the detection of time of grasps from human ECoG recordings during a sequence of natural and continuous reach-to-grasp movements. Using signals recorded from the motor cortex, a detector based on regularized linear discriminant analysis was able to retrieve the time-point of grasp with high reliability and only few false detections. Best performance was achieved using a combination of signal components from time and frequency domains. Sensitivity, measured by the amount of correct detections, and specificity, represented by the amount of false detections, depended strongly on the imposed restrictions on temporal precision of detection and on the delay between event detection and the time the event occurred. Including neural data from after the event into the decoding analysis, slightly increased accuracy, however, reasonable performance could also be obtained when grasping events were detected 125 ms in advance. In summary, our results provide a good basis for using detection of grasping movements from ECoG to control a grasping prosthesis.	[Pistohl, Tobias; Schmidt, Thomas Sebastian Benedikt; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Pistohl, Tobias; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Pistohl, Tobias] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Freiburg; University of Freiburg; Imperial College London; Imperial College London; Newcastle University - UK	Pistohl, T (corresponding author), Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	tobias.pistohl@ncl.ac.uk	Schmidt, Thomas/F-3022-2014; Schulze-Bonhage, Andreas/AAJ-3107-2020; Mehring, Carsten/R-8986-2019	Schmidt, Thomas/0000-0001-8587-4177; Mehring, Carsten/0000-0001-8125-5205	German Federal Ministry of Education and Research: BMBF [01GQ0420]; GoBio grant [0313891]	German Federal Ministry of Education and Research: BMBF(Federal Ministry of Education & Research (BMBF)); GoBio grant	This work was funded by the German Federal Ministry of Education and Research: BMBF grant 01GQ0420 to BCCN Freiburg and GoBio grant 0313891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bashashati Ali, 2007, Comput Intell Neurosci, P84386, DOI 10.1155/2007/84386; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Masic N, 1993, Artif Intell Med, V5, P503, DOI 10.1016/0933-3657(93)90040-A; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Parks T. W., 1987, DIGITAL FILTER DESIG; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; RUMEAU C, 1994, AM J NEURORADIOL, V15, P567; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Solis-Escalante T, 2008, J NEUROSCI METH, V175, P148, DOI 10.1016/j.jneumeth.2008.07.019; STEINMETZ H, 1989, ELECTROEN CLIN NEURO, V72, P499, DOI 10.1016/0013-4694(89)90227-7; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	21	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54658	10.1371/journal.pone.0054658	http://dx.doi.org/10.1371/journal.pone.0054658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359537	gold, Green Published			2022-12-27	WOS:000314023600087
J	Schuchman, EH; Ge, Y; Lai, A; Borisov, Y; Faillace, M; Eliyahu, E; He, XX; Iatridis, J; Vlassara, H; Striker, G; Simonaro, CM				Schuchman, Edward H.; Ge, Yi; Lai, Alon; Borisov, Yury; Faillace, Meghan; Eliyahu, Efrat; He, Xingxuan; Iatridis, James; Vlassara, Helen; Striker, Gary; Simonaro, Calogera M.			Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses	PLOS ONE			English	Article							JOINT DISEASE; BONE; PROLIFERATION; INVOLVEMENT; INHIBITOR; MECHANISM; SODIUM; INJURY; VI	Background: Pentosan polysulfate (PPS) is an FDA-approved, oral medication with anti-inflammatory and pro-chondrogenic properties. We have previously shown that animal models of the mucopolysaccharidoses (MPS) exhibit significant inflammatory disease, contributing to cartilage degeneration. Enzyme replacement therapy (ERT) only partly reduced inflammation, and anti-TNF-alpha antibody therapy significantly enhanced clinical and pathological outcomes. Here we describe the use of PPS for the treatment of MPS type VI rats. Methodology/Principal Findings: Treatment began during prenatal development and at 1 and 6 months of age. All animals were treated until they were 9 months old. Significant reductions in the serum and tissue levels of several inflammatory markers (e.g., TNF-alpha, MIP-1alpha and RANTES/CCL5) were observed, as was reduced expression of inflammatory markers in cultured articular chondrocytes. ADAMTS-5/aggrecanase-2 levels also were reduced in chondrocytes, consistent with an elevation of serum tissue inhibitor of metalloproteinase 1. Marked improvements in motility and grooming behavior occurred, along with a reduction in eye and nasal secretions and a lessening of the tracheal deformities. MicroCT and radiographic analyses further revealed that the treated MPS skulls were longer and thinner, and that the teeth malocclusions, misalignments and mineral densities were improved. MicroCT analysis of the femurs and vertebrae revealed improvements in trabecular bone mineral densities, number and spacing in a subset of treated MPS animals. Biomechanical assessments of PPS-treated spines showed partially restored torsional behaviors, suggesting increased spinal stability. No improvements were observed in cortical bone or femur length. The positive changes in the PPS-treated MPS VI rats occurred despite glycosaminoglycan accumulation in their tissues. Conclusions: Based on these findings we conclude that PPS could be a simple and effective therapy for MPS that might provide significant clinical benefits alone and in combination with other therapies.	[Schuchman, Edward H.; Ge, Yi; Lai, Alon; Borisov, Yury; Faillace, Meghan; Eliyahu, Efrat; He, Xingxuan; Iatridis, James; Vlassara, Helen; Striker, Gary; Simonaro, Calogera M.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Simonaro, CM (corresponding author), Mt Sinai Sch Med, New York, NY USA.	Calogera.simonaro@mssm.edu		Iatridis, James/0000-0002-2186-0590; Lai, Alon/0000-0002-0163-4588	National Institutes of Health [DK087185, AR056639, AR051146]; Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051146, R01AR056639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK096182, R01DK087185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants DK087185, AR056639 and AR051146, and a grant from the Mucopolysaccharidosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger JT, 2011, INT UROGYNECOL J, V22, P395, DOI 10.1007/s00192-010-1252-8; Barbir A, 2011, SPINE, V36, P607, DOI 10.1097/BRS.0b013e3181d9b58b; Beck M, 2010, J PEDIATR REHAB MED, V3, P39, DOI 10.3233/PRM-2010-0100; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022447; Fotopoulos VC, 2012, KNEE SURG SPORT TR A, V20, P1159, DOI 10.1007/s00167-011-1676-9; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Ghosh P, 2001, BEST PRACT RES CL RH, V15, P693, DOI 10.1053/berh.2001.0188; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Ho STB, 2009, GROWTH FACTORS, V27, P321, DOI 10.1080/08977190903137595; Honda H, 2012, NEUROPATHOLOGY, V32, P124, DOI 10.1111/j.1440-1789.2011.01245.x; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; Kumagai Kenji, 2010, BMC Clin Pharmacol, V10, P7, DOI 10.1186/1472-6904-10-7; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; Kwan C, 2012, AUST VET J, V90, P315, DOI 10.1111/j.1751-0813.2012.00959.x; Lupia E, 2012, LAB INVEST, V92, P236, DOI 10.1038/labinvest.2011.154; McIlwraith CW, 2012, AM J VET RES, V73, P628, DOI 10.2460/ajvr.73.5.628; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Miyata N, 2010, CLIN EXP HYPERTENS, V32, P511, DOI 10.3109/10641963.2010.496511; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Oussoren E, 2011, BBA-MOL BASIS DIS, V1812, P1542, DOI 10.1016/j.bbadis.2011.07.013; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Smit TH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-38; Takizawa M, 2008, FEBS LETT, V582, P2945, DOI 10.1016/j.febslet.2008.07.036; Tommasini SM, 2009, J BONE MINER RES, V24, P606, DOI [10.1359/jbmr.081224, 10.1359/JBMR.081224]; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; White KK, 2011, RHEUMATOLOGY, V50, pV26, DOI 10.1093/rheumatology/ker393; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Zhao JG, 2011, MED HYPOTHESES, V76, P610, DOI 10.1016/j.mehy.2011.01.016	39	72	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54459	10.1371/journal.pone.0054459	http://dx.doi.org/10.1371/journal.pone.0054459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365668	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600056
J	Vegran, F; Rebucci, M; Chevrier, S; Cadouot, M; Boidot, R; Lizard-Nacol, S				Vegran, Frederique; Rebucci, Magali; Chevrier, Sandy; Cadouot, Muriel; Boidot, Romain; Lizard-Nacol, Sarab			Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma	PLOS ONE			English	Article							GENE ALTERATIONS; PROGNOSTIC-SIGNIFICANCE; CANCER PATIENTS; TP53 MUTATIONS; POOR SURVIVAL; EXPRESSION; ASSOCIATION; PROLIFERATION; INFORMATION; INVASION	The presence of a TP53 gene mutation can influence tumour response to some treatments, especially in breast cancer. In this study, we analysed p53 mRNA expression, LOH at 17p13 and TP53 mutations from exons 2 to 11 in 206 patients with breast carcinoma and correlated the results with disease-free and overall survival. The observed mutations were classified according to their type and location in the three protein domains (transactivation domain, DNA binding domain, oligomerization domain) and correlated with disease-free and overall survival. In our population, neither p53 mRNA expression nor LOH correlated with outcome. Concerning TP53 mutations, 27% of tumours were mutated (53/197) and the presence of a mutation in the TP53 gene was associated with worse overall survival (p=0.0026) but not with disease-free survival (p=0.0697), with median survival of 80 months and 78 months, respectively. When alterations were segregated into mutation categories and locations, and related to survival, tumours harbouring mutations other than missense mutations in the DNA binding domain of P53 had the same survival profiles as wild-type tumours. Concerning missense mutations in the DNA binding domain, median disease-free and overall survival was 23 months and 35 months, respectively (p=0.0021 and p < 0.0001, respectively), compared with 78 and 80 months in mutated tumours overall. This work shows that disease-free and overall survival in patients with a frameshift mutation of TP53 or missense mutation in the oligomerization domain are the same as those in wild-type TP53 patients.	[Vegran, Frederique; Rebucci, Magali; Chevrier, Sandy; Cadouot, Muriel; Boidot, Romain; Lizard-Nacol, Sarab] Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc	Boidot, R (corresponding author), Ctr Georges Francois Leclerc, Mol Biol Unit, Dijon, France.	rboidot@cgfl.fr	VEGRAN, Frédérique/H-4792-2017; VEGRAN, Frederique/O-9986-2018	VEGRAN, Frederique/0000-0002-4377-1441	l'Association pour la Recherche contre le Cancer; Conseil Regional de Bourgogne; La Ligue contre le Cancer de Cote d'Or; La Ligue contre le Cancer de l'Yonne	l'Association pour la Recherche contre le Cancer; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); La Ligue contre le Cancer de Cote d'Or; La Ligue contre le Cancer de l'Yonne	FV was financially supported by l'Association pour la Recherche contre le Cancer. RB was financially supported by the Conseil Regional de Bourgogne, and by grants from La Ligue contre le Cancer de Cote d'Or and La Ligue contre le Cancer de l'Yonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN TI, 1993, BRIT J CANCER, V68, P540, DOI 10.1038/bjc.1993.383; Aramayo R, 2011, NUCLEIC ACIDS RES, V39, P8960, DOI 10.1093/nar/gkr386; Arnal M, 2000, BREAST CANCER RES TR, V61, P13, DOI 10.1023/A:1006449931921; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Berns EMJJ, 1998, BRIT J CANCER, V77, P1130, DOI 10.1038/bjc.1998.187; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Doyon G, 2009, J BIOL CHEM, V284, P25220, DOI 10.1074/jbc.M109.022632; ELLEDGE RM, 1993, BREAST CANCER RES TR, V26, P225, DOI 10.1007/BF00665800; Falette N, 1998, CANCER RES, V58, P1451; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Iacopetta B, 1998, CLIN CANCER RES, V4, P1597; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Kovach JS, 1996, P NATL ACAD SCI USA, V93, P1093, DOI 10.1073/pnas.93.3.1093; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levrero M, 2000, J CELL SCI, V113, P1661; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lu Z, 2011, EXP CELL RES, V317, P1935, DOI 10.1016/j.yexcr.2011.05.019; MERLO GR, 1992, AM J PATHOL, V140, P215; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Oshima T, 2008, ONCOL REP, V19, P953; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Powell B, 2000, CLIN CANCER RES, V6, P443; Sarkar C, 2003, CANCER GENET CYTOGEN, V144, P156, DOI 10.1016/S0165-4608(02)00937-8; SHIAO YH, 1995, CANCER RES, V55, P1485; Soong R, 1997, INT J CANCER, V74, P642, DOI 10.1002/(SICI)1097-0215(19971219)74:6<642::AID-IJC15>3.0.CO;2-7; THORLACIUS S, 1995, EUR J CANCER, V31A, P1856, DOI 10.1016/0959-8049(95)00399-4; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Vegran F, 2007, ONCOGENE, V26, P290, DOI 10.1038/sj.onc.1209784; Velculescu VE, 1996, CLIN CHEM, V42, P858; Wegran F, 2006, CLIN CANCER RES, V12, P5794, DOI 10.1158/1078-0432.CCR-06-0725; Yang X, 2003, CELL DEATH DIFFER, V10, P400, DOI 10.1038/cj.cdd.4401182	38	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55103	10.1371/journal.pone.0055103	http://dx.doi.org/10.1371/journal.pone.0055103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359294	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600152
J	Ye, JN; Chen, XS; Su, L; Liu, YL; Cai, QY; Zhan, XL; Xu, Y; Zhao, SF; Yao, ZX				Ye, Jian-Ning; Chen, Xing-Shu; Su, Le; Liu, Yun-Lai; Cai, Qi-Yan; Zhan, Xiao-Li; Xu, Yan; Zhao, Shi-Fu; Yao, Zhong-Xiang			Progesterone Alleviates Neural Behavioral Deficits and Demyelination with Reduced Degeneration of Oligodendroglial Cells in Cuprizone-Induced Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; MODEL; REMYELINATION; RAT; NEUROPROTECTION; DIFFERENTIATION; PROGENITORS; INCREASES	Demyelination occurs widely in neurodegenerative diseases. Progesterone has neuroprotective effects, is known to reduce the clinical scores and the inflammatory response. Progesterone also promotes remyelination in experimental autoimmune encephalomyelitis and cuprizone-induced demyelinating brain. However, it still remains unclear whether progesterone can alleviate neural behavioral deficits and demyelination with degeneration of oligodendroglial cells in cuprizone-induced mice. In this study, mice were fed with 0.2% cuprizone to induce demyelination, and treated with progesterone to test its potential protective effect on neural behavioral deficits, demyelination and degeneration of oligodendroglial cells. Our results showed noticeable alleviation of neural behavioral deficits following progesterone treatment as assessed by changes in average body weight, and activity during the open field and Rota-rod tests when compared with the vehicle treated cuprizone group. Progesterone treatment alleviated demyelination as shown by Luxol fast blue staining, MBP immunohistochemical staining, and electron microscopy. There was an obvious decrease in TUNEL and Caspase-3-positive apoptotic cells, and an increase in the number of oligodendroglial cells staining positive for PDGFR alpha, Olig2, Sox10 and CC-1 antibody in the brains of cuprizone-induced mice after progesterone administration. These results indicate that progesterone can alleviate neural behavioral deficits and demyelination against oligodendroglial cell degeneration in cuprizone-induced mice.	[Ye, Jian-Ning; Zhao, Shi-Fu] Third Mil Med Univ, Dept Neurol, Xin Qiao Hosp, Chongqing, Peoples R China; [Chen, Xing-Shu; Liu, Yun-Lai; Cai, Qi-Yan; Zhan, Xiao-Li; Yao, Zhong-Xiang] Third Mil Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China; [Xu, Yan; Yao, Zhong-Xiang] Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Zhao, SF (corresponding author), Third Mil Med Univ, Dept Neurol, Xin Qiao Hosp, Chongqing, Peoples R China.	shifuzhao@yahoo.com; yaozhx@yahoo.com		Yao, Zhong-xiang/0000-0002-3335-1961	National Natural Science Foundation of China [31100771]; Open Foundation of Key Laboratory; Ministry of Education [2011JSDC01]; Natural Science Foundation Project of ChongQing Science and Technology Commission [2011jjA10029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of Key Laboratory; Ministry of Education; Natural Science Foundation Project of ChongQing Science and Technology Commission(Natural Science Foundation of Chongqing)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31100771), Open Foundation of Key Laboratory, and Ministry of Education (Grant No. 2011JSDC01), and Natural Science Foundation Project of ChongQing Science and Technology Commission (Grant No. 2011jjA10029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Copray JCVM, 2005, NEUROPATH APPL NEURO, V31, P600, DOI 10.1111/j.1365-2990.2005.00656.x; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay L, 2008, NEUROIMMUNOMODULAT, V15, P76, DOI 10.1159/000135627; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; HERVEY E, 1967, J ENDOCRINOL, V37, P361, DOI 10.1677/joe.0.0370361; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; JungTestas I, 1996, CELL MOL NEUROBIOL, V16, P439, DOI 10.1007/BF02088110; Kipp M, 2011, INFLAMM RES, V60, P723, DOI 10.1007/s00011-011-0339-0; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koenig HL, 2000, REV REPROD, V5, P189; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Makinodan M, 2009, PROG NEURO-PSYCHOPH, V33, P978, DOI 10.1016/j.pnpbp.2009.05.006; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Paxinos G., 2001, MOUSE BRAIN STEREOTO; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Vukusic S, 2009, J NEUROL SCI, V286, P114, DOI 10.1016/j.jns.2009.08.056; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079	31	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54590	10.1371/journal.pone.0054590	http://dx.doi.org/10.1371/journal.pone.0054590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359803	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600077
J	Dandoy, P; Meunier, CF; Leroux, G; Voisin, V; Giordano, L; Caron, N; Michiels, C; Su, BL				Dandoy, Philippe; Meunier, Christophe F.; Leroux, Gregory; Voisin, Virginie; Giordano, Laetitia; Caron, Nathalie; Michiels, Carine; Su, Bao-Lian			A Hybrid Assembly by Encapsulation of Human Cells within Mineralised Beads for Cell Therapy	PLOS ONE			English	Article							BIOARTIFICIAL ORGANS; ANIMAL-CELLS; SILICA; MICROENCAPSULATION; CAPSULES; ALGINATE	Background: The design of new technologies for treatment of human disorders such as protein deficiencies is a complex and difficult task. Particularly, the construction of artificial organs, based on the immunoisolation of protein-secreting cells, requires the use of suitable materials which have to be biocompatible with the immunoisolated cells and avoid any inappropriate host response. Methodology/Principal Findings: This work investigates the in vivo behavior of mechanically resistant hybrid beads which can be considered as a model for artificial organ for cell therapy. This hybrid system was designed and fabricated via the encapsulation of living cells (HepG2) within alginate-silica composites. Two types of beads (alginate-silica hybrid (AS) or alginate/silica hybrid subsequently covered by an external layer of pure alginate (ASA)), with or without HepG2 cells, were implanted into several female Wistar rats. After four weeks, the potential inflammatory local response that might be due to the presence of materials was studied by histochemistry. The results showed that the performance of ASA beads was quite promising compared to AS beads, where less abnormal rat behaviour and less inflammatory cells in histological sections were observed in the case of ASA beads. Conclusions/Significance: The current study highlights that alginate-silica composite materials coated with an extra-alginate shell offer much promise in the development of robust implantation devices and artificial organs.	[Dandoy, Philippe; Meunier, Christophe F.; Leroux, Gregory; Su, Bao-Lian] Univ Namur FUNDP, Lab Inorgan Mat Chem CMI, Namur, Belgium; [Voisin, Virginie; Giordano, Laetitia; Caron, Nathalie] Univ Namur FUNDP, Lab Mol Physiol URPhyM NARILIS, Namur, Belgium; [Michiels, Carine] Univ Namur FUNDP, Lab Biochem & Cellular Biol URBC NARILIS, Namur, Belgium	University of Namur; University of Namur; University of Namur	Meunier, CF (corresponding author), Univ Namur FUNDP, Lab Inorgan Mat Chem CMI, Namur, Belgium.	christophe.meunier@fundp.ac.be		Su, Bao-Lian/0000-0001-8474-0652	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles); University of Namur (Rue de Bruxelles, 61 - B5000 Namur)	Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles)(Fonds de la Recherche Scientifique - FNRS); University of Namur (Rue de Bruxelles, 61 - B5000 Namur)	The funders are the Belgian FNRS (Fonds de la Recherche Scientifique - FNRS, Rue d'Egmont 5 - B1000 Bruxelles; http://www1.frs-fnrs.be/) and The University of Namur (Rue de Bruxelles, 61 - B5000 Namur; http://www.fundp.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Bartkowiak A, 1999, ANN NY ACAD SCI, V875, P135, DOI 10.1111/j.1749-6632.1999.tb08499.x; Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g; Boninsegna S, 2003, J SOL-GEL SCI TECHN, V26, P1151, DOI 10.1023/A:1020731429533; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Carturan G, 2004, J MATER CHEM, V14, P2087, DOI 10.1039/b401450b; CARTURAN G, 1989, J MOL CATAL, V57, pL13, DOI 10.1016/0304-5102(89)80121-X; Carturan G, 1997, P SOC PHOTO-OPT INS, V3136, P366, DOI 10.1117/12.279168; Coradin T, 2003, J SOL-GEL SCI TECHN, V26, P1165, DOI 10.1023/A:1020787514512; Dandoy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020983; Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9; Desimone MF, 2003, BIOTECHNOL LETT, V25, P671, DOI 10.1023/A:1023481304479; DeVos P, 1997, DIABETOLOGIA, V40, P262; Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Meunier CF, 2010, LANGMUIR, V26, P6568, DOI 10.1021/la9039286; Meunier CF, 2010, J COLLOID INTERF SCI, V342, P211, DOI 10.1016/j.jcis.2009.10.050; Morris PJ, 1996, TRENDS BIOTECHNOL, V14, P163, DOI 10.1016/0167-7799(96)10020-2; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; Nieto A, 2009, ACTA BIOMATER, V5, P3478, DOI 10.1016/j.actbio.2009.05.033; Orive G, 2003, TRENDS PHARMACOL SCI, V24, P207, DOI 10.1016/S0165-6147(03)00073-7; Perullini M, 2008, CHEM MATER, V20, P3015, DOI 10.1021/cm703075b; Perullini M, 2007, J BIOTECHNOL, V127, P542, DOI 10.1016/j.jbiotec.2006.07.024; Pope EJA, 1997, J SOL-GEL SCI TECHN, V8, P635, DOI 10.1007/BF02436914; Pressi G, 2003, J SOL-GEL SCI TECHN, V26, P1189, DOI 10.1023/A:1020704118146; Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043; Sakai S, 2002, BIOTECHNOL PROGR, V18, P401, DOI 10.1021/bp010147+; Sakai S, 2001, BIOMATERIALS, V22, P2827, DOI 10.1016/S0142-9612(01)00016-3	30	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54683	10.1371/journal.pone.0054683	http://dx.doi.org/10.1371/journal.pone.0054683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372752	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500105
J	Fernandez-Duque, E; Huck, M				Fernandez-Duque, Eduardo; Huck, Maren			Till Death (Or an Intruder) Do Us Part: Intrasexual-Competition in a Monogamous Primate	PLOS ONE			English	Article							OPERATIONAL SEX-RATIO; MONKEYS AOTUS-AZARAI; INFANT DEVELOPMENT; CANINE SIZE; SELECTION; FEMALE; DIMORPHISM; INTENSITY; EVOLUTION; AGGRESSION	Polygynous animals are often highly dimorphic, and show large sex-differences in the degree of intra-sexual competition and aggression, which is associated with biased operational sex ratios (OSR). For socially monogamous, sexually monomorphic species, this relationship is less clear. Among mammals, pair-living has sometimes been assumed to imply equal OSR and low frequency, low intensity intra-sexual competition; even when high rates of intra-sexual competition and selection, in both sexes, have been theoretically predicted and described for various taxa. Owl monkeys are one of a few socially monogamous primates. Using long-term demographic and morphological data from 18 groups, we show that male and female owl monkeys experience intense intra-sexual competition and aggression from solitary floaters. Pair-mates are regularly replaced by intruding floaters (27 female and 23 male replacements in 149 group-years), with negative effects on the reproductive success of both partners. Individuals with only one partner during their life produced 25% more offspring per decade of tenure than those with two or more partners. The termination of the pair-bond is initiated by the floater, and sometimes has fatal consequences for the expelled adult. The existence of floaters and the sporadic, but intense aggression between them and residents suggest that it can be misleading to assume an equal OSR in socially monogamous species based solely on group composition. Instead, we suggest that sexual selection models must assume not equal, but flexible, context-specific, OSR in monogamous species.	[Fernandez-Duque, Eduardo; Huck, Maren] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Fernandez-Duque, Eduardo] Consejo Nacl Invest Cient & Tecn, Ctr Ecol Aplicada Litoral, RA-1033 Buenos Aires, DF, Argentina	University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez-Duque, E (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	eduardof@sas.upenn.edu			Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society; National Science Foundation [BCS-0621020]; University of Pennsylvania Research Foundation; Zoological Society of San Diego; German Science Foundation [HU 1746-2/1]	Wenner-Gren Foundation; L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; Zoological Society of San Diego; German Science Foundation(German Research Foundation (DFG))	EFD acknowledges financial support from the Wenner-Gren Foundation, the L.S.B. Leakey Foundation, the National Geographic Society, the National Science Foundation (BCS-0621020), the University of Pennsylvania Research Foundation and the Zoological Society of San Diego, and MH from the German Science Foundation (HU 1746-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Crawley M.J., 2007, R BOOK; de Jong K, 2009, ANIM BEHAV, V78, P1229, DOI 10.1016/j.anbehav.2009.08.006; DIXSON AF, 1981, J ZOOL, V194, P25, DOI 10.1111/j.1469-7998.1981.tb04576.x; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fernandez-Duque E, 2003, INT J PRIMATOL, V24, P1113, DOI 10.1023/A:1026284430453; Fernandez-Duque E, 2009, BEHAVIOUR, V146, P583, DOI 10.1163/156853908X397925; Fernandez-Duque E., 2011, PRIMATES PERSPECTIVE, P139; Fernandez-Duque E, 2011, AM J PHYS ANTHROPOL, V146, P38, DOI 10.1002/ajpa.21541; Fitze PS, 2008, ECOL LETT, V11, P432, DOI 10.1111/j.1461-0248.2008.01158.x; Garcia-Navas V, 2011, BEHAV ECOL, V22, P932, DOI 10.1093/beheco/arr067; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Grant JWA, 2002, CAN J ZOOL, V80, P2242, DOI 10.1139/Z02-217; HESKE EJ, 1990, J MAMMAL, V71, P510, DOI 10.2307/1381789; Huck, 2013, BUILDING BABIES PRIM, P361, DOI DOI 10.1007/978-1-4614-4060-4_16; Huck M, 2012, BEHAV ECOL SOCIOBIOL, V66, P505, DOI 10.1007/s00265-011-1297-9; Huck M, 2011, INT J PRIMATOL, V32, P1133, DOI 10.1007/s10764-011-9530-y; Knell RJ, 2009, J ZOOL, V278, P83, DOI 10.1111/j.1469-7998.2009.00566.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Lawrence J. M., 2007, THESIS COLUMBIA U; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; MITANI JC, 1984, BEHAV ECOL SOCIOBIOL, V15, P225, DOI 10.1007/BF00292979; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Mulder MB, 2009, HUM NATURE-INT BIOS, V20, P130, DOI 10.1007/s12110-009-9060-x; PALOMBIT R, 1994, BEHAVIOUR, V128, P65, DOI 10.1163/156853994X00055; Juarez CP, 2011, INT J PRIMATOL, V32, P69, DOI 10.1007/s10764-010-9437-z; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Pusey A, 2008, INT J PRIMATOL, V29, P949, DOI 10.1007/s10764-008-9281-6; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodman PS, 2007, AM J PHYS ANTHROPOL, P201; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rotundo M, 2005, INT J PRIMATOL, V26, P1459, DOI 10.1007/s10764-005-5329-z; Sandell MI, 2007, BEHAV ECOL SOCIOBIOL, V62, P255, DOI 10.1007/s00265-007-0460-9; Setchell JM, 2003, ADV STUD BEHAV, V33, P87, DOI 10.1016/S0065-3454(03)33003-7; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Thoren S, 2006, AM J PHYS ANTHROPOL, V130, P50, DOI 10.1002/ajpa.20321; van de Pol M, 2006, BEHAV ECOL, V17, P982, DOI 10.1093/beheco/arl036; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; Wright P., 1981, ECOLOGY BEHAVIOUR NE, P211; Wright P.C., 1984, Monographs in Primatology, V4, P59; Zuur Alain F., 2009, P1	46	51	52	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53724	10.1371/journal.pone.0053724	http://dx.doi.org/10.1371/journal.pone.0053724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372665	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500020
J	Jean, JC; George, E; Kaestner, KH; Brown, LAS; Spira, A; Joyce-Brady, M				Jean, Jyh-Chang; George, Elizabeth; Kaestner, Klaus H.; Brown, Lou Ann Scism; Spira, Avrum; Joyce-Brady, Martin			Transcription Factor Klf4, Induced in the Lung by Oxygen at Birth, Regulates Perinatal Fibroblast and Myofibroblast Differentiation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; GAMMA-GLUTAMYL-TRANSFERASE; NF-KAPPA-B; GENE-EXPRESSION; RAT LUNG; ANTIOXIDANT ENZYMES; MOUSE LUNG; STRESS; MORPHOGENESIS; PROGRESSION	The fluid-filled lung exists in relative hypoxia in utero (similar to 25 mm Hg), but at birth fills with ambient air where the partial pressure of oxygen is >150 mm Hg. The impact of this change was studied in mouse lung with microarrays to analyze gene expression one day before, and 2, 6, 12 and 24 hours after birth into room air or 10% O-2. The expression levels of >150 genes, representing transcriptional regulation, structure, apoptosis and antioxidants were altered 2 hrs after birth in room air but blunted or absent with birth in 10% O-2. Kruppel-like factor 4 (Klf4), a regulator of cell growth arrest and differentiation, was the most significantly altered lung gene at birth. Its protein product was expressed in fibroblasts and airway epithelial cells. Klf4 mRNA was induced in lung fibroblasts exposed to hyperoxia and constitutive expression of Klf4 mRNA in Klf4-null fibroblasts induced mRNAs for p21(cip1/Waf1), smooth muscle actin, type 1 collagen, fibronectin and tenascin C. In Klf4 perinatal null lung, p21(cip1/Waf1) mRNA expression was deficient prior to birth and associated with ongoing cell proliferation after birth; connective tissue gene expression was deficient around birth and smooth muscle actin protein expression was absent from myofibroblasts at tips of developing alveoli; p53, p21(cip1/Waf1) and caspase-3 protein expression were widespread at birth suggesting excess apoptosis compared to normal lung. We propose that the changing oxygen environment at birth acts as a physiologic signal to induce lung Klf4 mRNA expression, which then regulates proliferation and apoptosis in fibroblasts and airway epithelial cells, and connective tissue gene expression and myofibroblast differentiation at the tips of developing alveoli.	[Jean, Jyh-Chang; George, Elizabeth; Spira, Avrum; Joyce-Brady, Martin] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [George, Elizabeth; Spira, Avrum] Boston Univ, Coll Engn, Bioinformat Program, Boston, MA 02215 USA; [Spira, Avrum] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA; [Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Brown, Lou Ann Scism] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Boston University; Boston University; Boston University; University of Pennsylvania; Emory University	Joyce-Brady, M (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	mjbrady@bu.edu		Spira, Avrum/0000-0003-1467-0489; Joyce-Brady, Martin/0000-0002-1898-6002; Jean, Jyh-Chang/0000-0002-6569-5910	National Institutes of Health [PO1-HL47049]; National Institutes of Health (USA) [5RO1 AA012197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was funded by National Institutes of Health PO1-HL47049 (MJB). Dr. Lou Ann Brown acknowledges her grant 5RO1 AA012197 from the National Institutes of Health (USA). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1985, EXP LUNG RES, V8, P261, DOI 10.3109/01902148509087808; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bonner AE, 2004, ONCOGENE, V23, P1166, DOI 10.1038/sj.onc.1207234; Bonner AE, 2003, J MED GENET, V40, P408, DOI 10.1136/jmg.40.6.408; Bretz F, 2005, METHOD INFORM MED, V44, P431; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; CHEN YW, 1993, PEDIATR RES, V34, P27, DOI 10.1203/00006450-199307000-00008; CLERCH LB, 1992, AM J PHYSIOL, V263, pL466, DOI 10.1152/ajplung.1992.263.4.L466; Das KC, 2001, AM J RESP CELL MOL, V25, P226, DOI 10.1165/ajrcmb.25.2.4314; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, P530; Foronjy R, 2001, RESPIR RES, V2, P348, DOI 10.1186/rr85; Frank L, 1996, BIOL NEONATE, V70, P116; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Haddad JJE, 2001, CYTOKINE, V13, P138, DOI 10.1006/cyto.2000.0789; Haddad JJE, 2000, BIOCHEM BIOPH RES CO, V271, P257, DOI 10.1006/bbrc.2000.2607; Haddad JJE, 2000, AM J PHYSIOL-LUNG C, V278, pL492, DOI 10.1152/ajplung.2000.278.3.L492; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jean JC, 1999, GENOMICS, V57, P201, DOI 10.1006/geno.1999.5761; Jean JC, 2002, AM J PHYSIOL-LUNG C, V283, pL766, DOI 10.1152/ajplung.00250.2000; Jean JC, 2002, AM J PHYSIOL-LUNG C, V282, pL75, DOI 10.1152/ajplung.2002.282.1.L75; Jean JC, 2008, J CELL BIOCHEM, V103, P1886, DOI 10.1002/jcb.21584; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; JoyceBrady M, 1996, J CLIN INVEST, V97, P1774, DOI 10.1172/JCI118605; Kaminski N, 2002, AM J RESP CELL MOL, V27, P125, DOI 10.1165/ajrcmb.27.2.f247; Katz JP, 2002, DEVELOPMENT, V129, P2619; KAUFFMAN SL, 1974, ANAT RECORD, V180, P63, DOI 10.1002/ar.1091800108; Klings ES, 2009, AM J PATHOL, V175, P2309, DOI 10.2353/ajpath.2009.081017; Land SC, 2005, ANTIOXID REDOX SIGN, V7, P92, DOI 10.1089/ars.2005.7.92; Landesberg LJ, 2001, AM J PHYSIOL-LUNG C, V281, pL1138, DOI 10.1152/ajplung.2001.281.5.L1138; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; Millien G, 2008, GENE EXPR PATTERNS, V8, P124, DOI 10.1016/j.modgep.2007.09.003; Millien G, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-35; NARDELL EA, 1982, J APPL PHYSIOL, V53, P140, DOI 10.1152/jappl.1982.53.1.140; Oakes S, 1997, AM J PHYSIOL, V272, P739; Oakes SM, 1997, AM J PHYSIOL-LUNG C, V272, pL739, DOI 10.1152/ajplung.1997.272.4.L739; OHARE KH, 1970, J MORPHOL, V132, P69, DOI 10.1002/jmor.1051320105; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schittny JC, 1998, AM J RESP CELL MOL, V18, P786, DOI 10.1165/ajrcmb.18.6.3031; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Toledano MB, 2009, MOL CELL, V34, P637, DOI 10.1016/j.molcel.2009.06.005; Wagner TE, 2003, J HISTOCHEM CYTOCHEM, V51, P1307, DOI 10.1177/002215540305101008; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	54	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54806	10.1371/journal.pone.0054806	http://dx.doi.org/10.1371/journal.pone.0054806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372771	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500129
J	Luzon-Toro, B; Fernandez, RM; Torroglosa, A; de Agustin, JC; Mendez-Vidal, C; Segura, DI; Antinolo, G; Borrego, S				Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Carlos de Agustin, Juan; Mendez-Vidal, Cristina; Isabel Segura, Dolores; Antinolo, Guillermo; Borrego, Salud			Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients	PLOS ONE			English	Article							CREST-DERIVED CELLS; RECEPTOR TYROSINE KINASE; DISEASE; RET; MIGRATION; LOCUS; PROLIFERATION; EXPRESSION; REPELLENT; SEMA3A	Hirschsprung disease (HSCR, OMIM 142623) is a developmental disorder characterized by the absence of ganglion cells along variable lengths of the distal gastrointestinal tract, which results in tonic contraction of the aganglionic colon segment and functional intestinal obstruction. The RET proto-oncogene is the major gene associated to HSCR with differential contributions of its rare and common, coding and noncoding mutations to the multifactorial nature of this pathology. In addition, many other genes have been described to be associated with this pathology, including the semaphorins class III genes SEMA3A (7p12.1) and SEMA3D (7q21.11) through SNP array analyses and by next-generation sequencing technologies. Semaphorins are guidance cues for developing neurons implicated in the axonal projections and in the determination of the migratory pathway for neural-crest derived neural precursors during enteric nervous system development. In addition, it has been described that increased SEMA3A expression may be a risk factor for HSCR through the upregulation of the gene in the aganglionic smooth muscle layer of the colon in HSCR patients. Here we present the results of a comprehensive analysis of SEMA3A and SEMA3D in a series of 200 Spanish HSCR patients by the mutational screening of its coding sequence, which has led to find a number of potentially deleterious variants. RET mutations have been also detected in some of those patients carrying SEMAs variants. We have evaluated the A131T-SEMA3A, S598G-SEMA3A and E198K-SEMA3D mutations using colon tissue sections of these patients by immunohistochemistry. All mutants presented increased protein expression in smooth muscle layer of ganglionic segments. Moreover, A131T-SEMA3A also maintained higher protein levels in the aganglionic muscle layers. These findings strongly suggest that these mutants have a pathogenic effect on the disease. Furthermore, because of their coexistence with RET mutations, our data substantiate the additive genetic model proposed for this rare disorder and further support the association of SEMAs genes with HSCR.	[Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Mendez-Vidal, Cristina; Antinolo, Guillermo; Borrego, Salud] Univ Seville, Consejo Super Invest Cient, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain; [Luzon-Toro, Berta; Fernandez, Raquel M.; Torroglosa, Ana; Mendez-Vidal, Cristina; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis, Seville, Spain; [Carlos de Agustin, Juan] Univ Hosp Virgen del Rocio, Dept Pediat Surg, Seville, Spain; [Isabel Segura, Dolores] Univ Hosp Virgen del Rocio, Dept Pathol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Borrego, S (corresponding author), Univ Seville, Consejo Super Invest Cient, Univ Hosp Virgen del Rocio, Inst Biomed Seville,Dept Genet Reprod & Fetal Med, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, MALFORMACIONES/H-7372-2016; IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; LUZON, BERTA/D-4884-2014; De Agustin, Juan/AAT-1824-2021; IBIS, GENETICA/P-3384-2015; Torroglosa, Ana/AAU-9812-2020; Méndez-Vidal, Cristina/F-1366-2015	De Agustin, Juan/0000-0002-2413-2871; Méndez-Vidal, Cristina/0000-0002-1282-1688; Torroglosa, Ana/0000-0003-1911-7906; Antinolo Gil, Guillermo/0000-0002-2113-074X	Instituto de Salud Carlos III (ISCIII), Spain [PI1001290]; Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia [CTS-7447]	Instituto de Salud Carlos III (ISCIII), Spain(Instituto de Salud Carlos III); Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia	This study was funded by the Instituto de Salud Carlos III (ISCIII), Spain (PI1001290) and Consejeria de Economia, Innovacion y Ciencia de la Junta de Andalucia (CTS-7447). The CIBER de Enfermedades Raras is an initiative of the ISCIII, Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2007, DEV BIOL, V305, P287, DOI 10.1016/j.ydbio.2007.02.020; Anderson RB, 2006, CELL TISSUE RES, V323, P11, DOI 10.1007/s00441-005-0047-6; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 2003, J Med Genet, V40, pe18, DOI 10.1136/jmg.40.3.e18; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Brooks AS, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038125; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2002, METABOLIC MOL BASES; Charoy C, 2012, NEURON, V75, P1051, DOI 10.1016/j.neuron.2012.08.021; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Gershon MD, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P499; Goshima Y, 2012, EXPERT OPIN THER TAR, V16, P933, DOI 10.1517/14728222.2012.710201; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Maden CH, 2012, DEV BIOL, V369, P277, DOI 10.1016/j.ydbio.2012.06.026; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023475; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Shepherd IT, 1999, DEV BIOL, V212, P42, DOI 10.1006/dbio.1999.9294; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Wang LL, 2012, BIRTH DEFECTS RES A, V94, P91, DOI 10.1002/bdra.22866; Wang LL, 2011, BIRTH DEFECTS RES A, V91, P842, DOI 10.1002/bdra.20837; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029	42	22	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54800	10.1371/journal.pone.0054800	http://dx.doi.org/10.1371/journal.pone.0054800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372769	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500128
J	Sonah, H; Bastien, M; Iquira, E; Tardivel, A; Legare, G; Boyle, B; Normandeau, E; Laroche, J; Larose, S; Jean, M; Belzile, F				Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Legare, Gaetan; Boyle, Brian; Normandeau, Eric; Laroche, Jerome; Larose, Stephane; Jean, Martine; Belzile, Francois			An Improved Genotyping by Sequencing (GBS) Approach Offering Increased Versatility and Efficiency of SNP Discovery and Genotyping	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME	Highly parallel SNP genotyping platforms have been developed for some important crop species, but these platforms typically carry a high cost per sample for first-time or small-scale users. In contrast, recently developed genotyping by sequencing (GBS) approaches offer a highly cost effective alternative for simultaneous SNP discovery and genotyping. In the present investigation, we have explored the use of GBS in soybean. In addition to developing a novel analysis pipeline to call SNPs and indels from the resulting sequence reads, we have devised a modified library preparation protocol to alter the degree of complexity reduction. We used a set of eight diverse soybean genotypes to conduct a pilot scale test of the protocol and pipeline. Using ApeKI for GBS library preparation and sequencing on an Illumina GAIIx machine, we obtained 5.5 M reads and these were processed using our pipeline. A total of 10,120 high quality SNPs were obtained and the distribution of these SNPs mirrored closely the distribution of gene-rich regions in the soybean genome. A total of 39.5% of the SNPs were present in genic regions and 52.5% of these were located in the coding sequence. Validation of over 400 genotypes at a set of randomly selected SNPs using Sanger sequencing showed a 98% success rate. We then explored the use of selective primers to achieve a greater complexity reduction during GBS library preparation. The number of SNP calls could be increased by almost 40% and their depth of coverage was more than doubled, thus opening the door to an increase in the throughput and a significant decrease in the per sample cost. The approach to obtain high quality SNPs developed here will be helpful for marker assisted genomics as well as assessment of available genetic resources for effective utilisation in a wide number of species.	[Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Jean, Martine; Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; [Sonah, Humira; Bastien, Maxime; Iquira, Elmer; Tardivel, Aurelie; Legare, Gaetan; Boyle, Brian; Normandeau, Eric; Laroche, Jerome; Larose, Stephane; Jean, Martine; Belzile, Francois] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Normandeau, Eric] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University	Belzile, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	francois.belzile@fsaa.ulaval.ca		Sonah, Humira/0000-0003-4796-6120; Belzile, Francois/0000-0001-6893-4529	Natural Sciences and Engineering Research Council of Canada; Semences Prograin Inc. [RDCPJ 382089-09]; Agriculture and AgriFood Canada; Canadian Field Crop Research Alliance [DIAP 5987]; Canadian International Development Agency (CGIAR-Canada Linkage Fund)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Semences Prograin Inc.; Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); Canadian Field Crop Research Alliance; Canadian International Development Agency (CGIAR-Canada Linkage Fund)(CGIAR)	Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada and Semences Prograin Inc. (Grant no. RDCPJ 382089-09), Agriculture and AgriFood Canada and the Canadian Field Crop Research Alliance (Grant no. DIAP 5987) and the Canadian International Development Agency (CGIAR-Canada Linkage Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Haun WJ, 2011, PLANT PHYSIOL, V155, P645, DOI 10.1104/pp.110.166736; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Semagn K, 2006, AFR J BIOTECHNOL, V5, P2540; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sonah H, 2011, BIOTECHNOL ADV, V29, P199, DOI 10.1016/j.biotechadv.2010.11.002; Varala K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024811; Zhu YL, 2003, GENETICS, V163, P1123	20	301	322	1	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54603	10.1371/journal.pone.0054603	http://dx.doi.org/10.1371/journal.pone.0054603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372741	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500095
J	Swartz, MD; Peterson, CB; Lupo, PJ; Wu, XF; Forman, MR; Spitz, MR; Hernandez, LM; Vannucci, M; Shete, S				Swartz, Michael D.; Peterson, Christine B.; Lupo, Philip J.; Wu, Xifeng; Forman, Michele R.; Spitz, Margaret R.; Hernandez, Ladia M.; Vannucci, Marina; Shete, Sanjay			Investigating Multiple Candidate Genes and Nutrients in the Folate Metabolism Pathway to Detect Genetic and Nutritional Risk Factors for Lung Cancer	PLOS ONE			English	Article							ONE-CARBON METABOLISM; DNA-REPAIR CAPACITY; VARIABLE SELECTION; BREAST-CANCER; B-VITAMINS; STOCHASTIC SEARCH; MODEL SELECTION; DIETARY-INTAKE; BETAINE INTAKE; POLYMORPHISMS	Purpose: Folate metabolism, with its importance to DNA repair, provides a promising region for genetic investigation of lung cancer risk. This project investigates genes (MTHFR, MTR, MTRR, CBS, SHMT1, TYMS), folate metabolism related nutrients (B vitamins, methionine, choline, and betaine) and their gene-nutrient interactions. Methods: We analyzed 115 tag single nucleotide polymorphisms (SNPs) and 15 nutrients from 1239 and 1692 non-Hispanic white, histologically-confirmed lung cancer cases and controls, respectively, using stochastic search variable selection (a Bayesian model averaging approach). Analyses were stratified by current, former, and never smoking status. Results: Rs6893114 in MTRR (odds ratio [OR] = 2.10; 95% credible interval [CI]: 1.20-3.48) and alcohol (drinkers vs. nondrinkers, OR = 0.48; 95% CI: 0.26-0.84) were associated with lung cancer risk in current smokers. Rs13170530 in MTRR (OR = 1.70; 95% CI: 1.10-2.87) and two SNP*nutrient interactions [betaine*rs2658161 (OR = 0.42; 95% CI: 0.19-0.88) and betaine*rs16948305 (OR = 0.54; 95% CI: 0.30-0.91)] were associated with lung cancer risk in former smokers. SNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 95% CI: 0.41-0.90; rs2924471; OR = 3.31; 95% CI: 1.66-6.59), and MTHFR (rs9651118; OR = 0.63; 95% CI: 0.43-0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62; 95% CI: 1.11-2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27-0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15-0.95) were associated with lung cancer risk in never smokers. Conclusions: This study identified possible nutrient and genetic factors related to folate metabolism associated with lung cancer risk, which could potentially lead to nutritional interventions tailored by smoking status to reduce lung cancer risk.	[Swartz, Michael D.] Univ Texas Sch Publ Hlth, Div Biostat, Houston, TX USA; [Peterson, Christine B.; Vannucci, Marina] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Lupo, Philip J.] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Swartz, Michael D.; Wu, Xifeng; Forman, Michele R.; Spitz, Margaret R.; Hernandez, Ladia M.; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Spitz, Margaret R.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Rice University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Swartz, MD (corresponding author), Univ Texas Sch Publ Hlth, Div Biostat, Houston, TX USA.	Michael.D.Swartz@uth.tmc.edu	Lupo, Philip/R-8314-2019; Vannucci, Marina/I-8439-2014; Swartz, Michael/AEX-2820-2022	Lupo, Philip/0000-0003-0978-5863; Vannucci, Marina/0000-0002-7360-5321; Peterson, Christine/0000-0003-3316-0468; Swartz, Michael/0000-0003-3953-8775	National Cancer Institute (NCI) [K07-CA 123109, R03 CA141998]; NCI [R01 CA55679]; NATIONAL CANCER INSTITUTE [P30CA016672, K07CA123109, T32CA096520, R03CA141998] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors would like to acknowledge the funding sources National Cancer Institute (NCI) award K07-CA 123109, and R03 CA141998 (MDS PI), NCI award R01 CA55679 (Lung Cancer Study, MRS PI). The funders had no role in study design, data collection and analysis, decision to publis or preaparation of this manuscript.	Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; American Cancer Society, 2010, CANC FACTS FIG 2010; Bagnardi V, 2011, ANN ONCOL; Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bassett JK, 2012, EUR J CLIN NUTR, V66, P182, DOI 10.1038/ejcn.2011.157; Benedetti A, 2006, CANCER CAUSE CONTROL, V17, P469, DOI 10.1007/s10552-005-0496-y; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965; Block G, 1994, DIETSYS VERSION 3 0, P10; Boccia S, 2009, CANCER LETT, V273, P55, DOI 10.1016/j.canlet.2008.07.026; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cho E, 2010, BRIT J CANCER, V102, P489, DOI 10.1038/sj.bjc.6605510; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; FORMAN MR, 1993, AM J CLIN NUTR, V58, P519, DOI 10.1093/ajcn/58.4.519; Fridley BL, 2009, GENET EPIDEMIOL, V33, P27, DOI 10.1002/gepi.20353; Gelman A., 2004, BAYESIAN DATA ANAL, VXXV; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kruschke JK, 2011, DOING BAYESIAN DATA, pxvii; Kwon S, 2007, BMC P, V1, pSX; Lee JE, 2010, CANCER EPIDEM BIOMAR, V19, P884, DOI 10.1158/1055-9965.EPI-09-1295; Liu HL, 2008, LUNG CANCER, V61, P21, DOI 10.1016/j.lungcan.2007.12.001; Mahabir S, 2008, CARCINOGENESIS, V29, P949, DOI 10.1093/carcin/bgn043; Mahabir S, 2007, CANCER EPIDEM BIOMAR, V16, P2756, DOI 10.1158/1055-9965.EPI-07-0324; Mahabir S, 2007, INT J CANCER, V120, P1108, DOI 10.1002/ijc.22451; Mao RF, 2008, J HUM GENET, V53, P340, DOI 10.1007/s10038-008-0262-6; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; NIEHS SNPS, 2010, NIEHS ENV GEN PROJ; Parle-McDermott A, 2006, MOL GENET METAB, V88, P290, DOI 10.1016/j.ymgme.2006.02.011; Piskac-Collier AL, 2011, GENE CHROMOSOME CANC, V50, P1, DOI 10.1002/gcc.20826; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohrmann S, 2006, AM J EPIDEMIOL, V164, P1103, DOI 10.1093/aje/kwj326; Sakoda LC, 2011, CANCER CAUSE CONTROL, V22, P449, DOI 10.1007/s10552-010-9716-1; Schumacher Fredrick R, 2007, BMC Proc, V1 Suppl 1, pS112; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shen M, 2005, LUNG CANC; Shi QL, 2005, PHARMACOGENET GENOM, V15, P547, DOI 10.1097/01.fpc.0000170916.96650.70; Shi QL, 2005, CARCINOGENESIS, V26, P649, DOI 10.1093/carcin/bgh351; Spiegelhalter DJ, 2007, WINBUGS 1 4 2; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Srivastava S, 2009, BMC P S7, V3, pS21; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Swartz MD, 2006, BIOMETRICS, V62, P495, DOI 10.1111/j.1541-0420.2005.00451.x; Swartz MD, 2004, THESIS RICE U HOUSTO; Swartz Michael D, 2007, BMC Proc, V1 Suppl 1, pS113; Swartz MD, 2007, GENET EPIDEMIOL, V31, pS96, DOI 10.1002/gepi.20285; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; Wang L, 2007, LUNG CANCER, V57, P143, DOI 10.1016/j.lungcan.2007.03.002; Wei QY, 2003, CANCER EPIDEM BIOMAR, V12, P963; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 1998, NUTR EPIDEMIOLOGY, pxiv; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Zeisel SH, 2003, J NUTR, V133, P1302; Zijno A, 2003, CARCINOGENESIS, V24, P1097, DOI 10.1093/carcin/bgg064	70	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53475	10.1371/journal.pone.0053475	http://dx.doi.org/10.1371/journal.pone.0053475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372658	Green Published, gold			2022-12-27	WOS:000314021500014
J	Zhao, GY; Cai, CK; Yang, TT; Qiu, XC; Liao, B; Li, W; Ji, ZW; Zhao, J; Zhao, HE; Guo, MJ; Ma, Q; Xiao, C; Fan, QY; Ma, BA				Zhao, Guangyi; Cai, Chengkui; Yang, Tongtao; Qiu, Xiuchun; Liao, Bo; Li, Wei; Ji, Zhenwei; Zhao, Jian; Zhao, Haien; Guo, Mingjun; Ma, Qiong; Xiao, Chun; Fan, Qingyu; Ma, Baoan			MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; PROSTATE-CANCER CELLS; MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; GASTRIC-CANCER; BREAST-CANCER; LUNG-CANCER; SMALL RNAS; CYCLIN D1; EXPRESSION	Background: MicroRNAs are short regulatory RNAs that negatively modulate protein expression at a post-transcriptional and/or translational level and are deeply involved in the pathogenesis of several types of cancers. Specifically, microRNA-221 (miR-221) is overexpressed in many human cancers, wherein accumulating evidence indicates that it functions as an oncogene. However, the function of miR-221 in human osteosarcoma has not been totally elucidated. In the present study, the effects of miR-221 on osteosarcoma and the possible mechanism by which miR-221 affected the survival, apoptosis, and cisplatin resistance of osteosarcoma were investigated. Methodology/Principal Findings: Real-time quantitative PCR analysis revealed miR-221 was significantly upregulated in osteosarcoma cell lines than in osteoblasts. Both human osteosarcoma cell lines SOSP-9607 and MG63 were transfected with miR-221 mimic or inhibitor to regulate miR-221 expression. The effects of miR-221 were then assessed by cell viability, cell cycle analysis, apoptosis assay, and cisplatin resistance assay. In both cells, upregulation of miR-221 induced cell survival and cisplatin resistance and reduced cell apoptosis. In addition, knockdown of miR-221 inhibited cell growth and cisplatin resistance and induced cell apoptosis. Potential target genes of miR-221 were predicted using bioinformatics. Moreover, luciferase reporter assay and western blot confirmed that PTEN was a direct target of miR-221. Furthermore, introduction of PTEN cDNA lacking 39-UTR or PI3K inhibitor LY294002 abrogated miR-221-induced cisplatin resistance. Finally, both miR-221 and PTEN expression levels in osteosarcoma samples were examined by using real-time quantitative PCR and immunohistochemistry. High miR-221 expression level and inverse correlation between miR-221 and PTEN levels were revealed in osteosarcoma tissues. Conclusions/Significance: These results for the first time demonstrate that upregulation of miR-221 induces the malignant phenotype of human osteosarcoma whereas knockdown of miR-221 reverses this phenotype, suggesting that miR-221 could be a potential target for osteosarcoma treatment.	[Zhao, Guangyi; Cai, Chengkui; Yang, Tongtao; Qiu, Xiuchun; Liao, Bo; Li, Wei; Ji, Zhenwei; Zhao, Jian; Zhao, Haien; Guo, Mingjun; Ma, Qiong; Xiao, Chun; Fan, Qingyu; Ma, Baoan] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Fan, QY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China.	bonetm@fmmu.edu.cn; gukemba@fmmu.edu.cn			National Natural Science Foundation of China [81072194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO. 81072194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2004, J BIOL CHEM, V279, P38710, DOI 10.1074/jbc.M403329200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cenni V, 2004, INT J ONCOL, V25, P1599; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dai HZ, 2012, CARCINOGENESIS, V33, P30, DOI 10.1093/carcin/bgr232; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; delPeso L, 1997, SCIENCE, V278, P687; Diaz-Montero CM, 2006, EUR J CANCER, V42, P1491, DOI 10.1016/j.ejca.2006.03.007; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hsieh TC, 2012, CARCINOGENESIS, V33, P670, DOI 10.1093/carcin/bgs016; Huang J, 2012, AUTOPHAGY, V8, P275, DOI 10.4161/auto.8.2.18940; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; Jin ML, 2001, LUNG CANCER-J IASLC, V34, P207, DOI 10.1016/S0169-5002(01)00225-2; Joaquin M, 2003, J BIOL CHEM, V278, P44255, DOI 10.1074/jbc.M308953200; Kim VN, 2005, MOL CELLS, V19, P1; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Lai VK, 2012, CELL CYCLE, V11, P767, DOI 10.4161/cc.11.4.19211; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Miwa S, 2011, INT J ONCOL, V39, P465, DOI 10.3892/ijo.2011.1051; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Sun Y, 2007, MOL CANCER THER, V6, P2477, DOI 10.1158/1535-7163.MCT-07-0186; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Wang Guowen, 2010, Mol Biol (Mosk), V44, P1010; Wu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014648; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamada KM, 2001, J CELL SCI, V114, P2375; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang YW, 2001, ONCOGENE, V20, P4138, DOI 10.1038/sj.onc.1204563; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3	62	188	203	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53906	10.1371/journal.pone.0053906	http://dx.doi.org/10.1371/journal.pone.0053906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372675	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500030
J	Baugh, L; Gallagher, LA; Patrapuvich, R; Clifton, MC; Gardberg, AS; Edwards, TE; Armour, B; Begley, DW; Dieterich, SH; Dranow, DM; Abendroth, J; Fairman, JW; Fox, D; Staker, BL; Phan, I; Gillespie, A; Choi, R; Nakazawa-Hewitt, S; Nguyen, MT; Napuli, A; Barrett, L; Buchko, GW; Stacy, R; Myler, PJ; Stewart, LJ; Manoil, C; Van Voorhis, WC				Baugh, Loren; Gallagher, Larry A.; Patrapuvich, Rapatbhorn; Clifton, Matthew C.; Gardberg, Anna S.; Edwards, Thomas E.; Armour, Brianna; Begley, Darren W.; Dieterich, Shellie H.; Dranow, David M.; Abendroth, Jan; Fairman, James W.; Fox, David, III; Staker, Bart L.; Phan, Isabelle; Gillespie, Angela; Choi, Ryan; Nakazawa-Hewitt, Steve; Mary Trang Nguyen; Napuli, Alberto; Barrett, Lynn; Buchko, Garry W.; Stacy, Robin; Myler, Peter J.; Stewart, Lance J.; Manoil, Colin; Van Voorhis, Wesley C.			Combining Functional and Structural Genomics to Sample the Essential Burkholderia Structome	PLOS ONE			English	Article							TRANSFER-RNA HYDROLASE; PEPTIDYL-TRANSFER-RNA; SYNTHASE-III FABH; ESSENTIAL GENES; THYMIDYLATE SYNTHASE; PLASMODIUM-FALCIPARUM; BACILLUS-SUBTILIS; IDENTIFICATION; PROTEINS; THAILANDENSIS	Background: The genus Burkholderia includes pathogenic gram-negative bacteria that cause melioidosis, glanders, and pulmonary infections of patients with cancer and cystic fibrosis. Drug resistance has made development of new antimicrobials critical. Many approaches to discovering new antimicrobials, such as structure-based drug design and whole cell phenotypic screens followed by lead refinement, require high-resolution structures of proteins essential to the parasite. Methodology/Principal Findings: We experimentally identified 406 putative essential genes in B. thailandensis, a low-virulence species phylogenetically similar to B. pseudomallei, the causative agent of melioidosis, using saturation-level transposon mutagenesis and next-generation sequencing (Tn-seq). We selected 315 protein products of these genes based on structure-determination criteria, such as excluding very large and/or integral membrane proteins, and entered them into the Seattle Structural Genomics Center for Infection Disease (SSGCID) structure determination pipeline. To maximize structural coverage of these targets, we applied an "ortholog rescue'' strategy for those producing insoluble or difficult to crystallize proteins, resulting in the addition of 387 orthologs (or paralogs) from seven other Burkholderia species into the SSGCID pipeline. This structural genomics approach yielded structures from 31 putative essential targets from B. thailandensis, and 25 orthologs from other Burkholderia species, yielding an overall structural coverage for 49 of the 406 essential gene families, with a total of 88 depositions into the Protein Data Bank. Of these, 25 proteins have properties of a potential antimicrobial drug target i.e., no close human homolog, part of an essential metabolic pathway, and a deep binding pocket. We describe the structures of several potential drug targets in detail. Conclusions/Significance: This collection of structures, solubility and experimental essentiality data provides a resource for development of drugs against infections and diseases caused by Burkholderia. All expression clones and proteins created in this study are freely available by request.	[Gillespie, Angela; Choi, Ryan; Nakazawa-Hewitt, Steve; Mary Trang Nguyen; Napuli, Alberto; Barrett, Lynn; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Gallagher, Larry A.; Patrapuvich, Rapatbhorn; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Clifton, Matthew C.; Gardberg, Anna S.; Edwards, Thomas E.; Armour, Brianna; Begley, Darren W.; Dieterich, Shellie H.; Dranow, David M.; Abendroth, Jan; Fairman, James W.; Fox, David, III; Staker, Bart L.; Stewart, Lance J.] Emerald BioStruct, Bainbridge Isl, WA USA; [Baugh, Loren; Phan, Isabelle; Stacy, Robin; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Buchko, Garry W.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Myler, Peter J.; Van Voorhis, Wesley C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Van Voorhis, Wesley C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle		wesley@uw.edu	Myler, Peter John/AAR-9535-2021; Buchko, Garry/G-6173-2015	Buchko, Garry/0000-0002-3639-1061; Myler, Peter/0000-0002-0056-0513; Edwards, Thomas/0000-0002-0474-8003; Staker, Bart/0000-0001-9570-5086	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200700057C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley DW, 2011, ACTA CRYSTALLOGR F, V67, P1070, DOI 10.1107/S1744309111029009; Begley Darren W., 2011, Journal of Structural and Functional Genomics, V12, P63, DOI 10.1007/s10969-011-9102-6; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bryan CM, 2011, ACTA CRYSTALLOGR F, V67, P1010, DOI 10.1107/S1744309111018367; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Castillo YP, 2008, MINI-REV MED CHEM, V8, P36; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen M S, 1978, Methods Enzymol, V51, P354; Choi R, 2011, ACTA CRYSTALLOGR F, V67, P998, DOI 10.1107/S1744309111017374; Chong Chan-Eng, 2006, In Silico Biology, V6, P341; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Costi PM, 1999, J MED CHEM, V42, P2112, DOI 10.1021/jm9900016; DANNEBERG PB, 1958, CANCER RES, V18, P329; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; de Bono JS, 2001, INVEST NEW DRUG, V19, P41, DOI 10.1023/A:1006404701008; Edwards TE, 2012, PROTEIN SCI, V21, P1093, DOI 10.1002/pro.2084; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackman AL, 1995, ANN ONCOL, V6, P871, DOI 10.1093/oxfordjournals.annonc.a059353; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2002, J MED MICROBIOL, V51, P533, DOI 10.1099/0022-1317-51-7-533; Mann T, 2010, INFECTION, V38, P187, DOI 10.1007/s15010-010-0017-0; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Menez J, 2002, MOL MICROBIOL, V45, P123, DOI 10.1046/j.1365-2958.2002.02992.x; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Tondi D, 2005, J MED CHEM, V48, P913, DOI 10.1021/jm0491445; Unger F. M., 1981, ADV CARBOHYD CHEM BI, V38, P323; Van Lanen SG, 2008, P NATL ACAD SCI USA, V105, P494, DOI 10.1073/pnas.0708750105; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; West TE, 2009, INFECT IMMUN, V77, P5612, DOI 10.1128/IAI.00618-09; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	53	91	5724	2	476	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53851	10.1371/journal.pone.0053851	http://dx.doi.org/10.1371/journal.pone.0053851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382856	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600020
J	Aure, MR; Steinfeld, I; Baumbusch, LO; Liestol, K; Lipson, D; Nyberg, S; Naume, B; Sahlberg, KK; Kristensen, VN; Borresen-Dale, AL; Lingjaerde, OC; Yakhini, Z				Aure, Miriam Ragle; Steinfeld, Israel; Baumbusch, Lars Oliver; Liestol, Knut; Lipson, Doron; Nyberg, Sandra; Naume, Bjorn; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian; Yakhini, Zohar			Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ISOLATED TUMOR-CELLS; BONE-MARROW; MOLECULAR SUBTYPES; ANALYSIS REVEALS; CARCINOMA; AMPLIFICATION; PATTERNS; PROTEIN; RAD21	Genomic copy number alterations are common in cancer. Finding the genes causally implicated in oncogenesis is challenging because the gain or loss of a chromosomal region may affect a few key driver genes and many passengers. Integrative analyses have opened new vistas for addressing this issue. One approach is to identify genes with frequent copy number alterations and corresponding changes in expression. Several methods also analyse effects of transcriptional changes on known pathways. Here, we propose a method that analyses in-cis correlated genes for evidence of in-trans association to biological processes, with no bias towards processes of a particular type or function. The method aims to identify cis-regulated genes for which the expression correlation to other genes provides further evidence of a network-perturbing role in cancer. The proposed unsupervised approach involves a sequence of statistical tests to systematically narrow down the list of relevant genes, based on integrative analysis of copy number and gene expression data. A novel adjustment method handles confounding effects of co-occurring copy number aberrations, potentially a large source of false positives in such studies. Applying the method to whole-genome copy number and expression data from 100 primary breast carcinomas, 6373 genes were identified as commonly aberrant, 578 were highly in-cis correlated, and 56 were in addition associated in-trans to biological processes. Among these in-trans process associated and cis-correlated (iPAC) genes, 28% have previously been reported as breast cancer associated, and 64% as cancer associated. By combining statistical evidence from three separate subanalyses that focus respectively on copy number, gene expression and the combination of the two, the proposed method identifies several known and novel cancer driver candidates. Validation in an independent data set supports the conclusion that the method identifies genes implicated in cancer.	[Aure, Miriam Ragle; Baumbusch, Lars Oliver; Nyberg, Sandra; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Aure, Miriam Ragle; Nyberg, Sandra; Sahlberg, Kristine Kleivi; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingjaerde, Ole Christian] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Steinfeld, Israel; Lipson, Doron; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, Lab Computat Biol, IL-32000 Haifa, Israel; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Dept Comp Sci, Biomed Informat Lab, Oslo, Norway; [Liestol, Knut; Lingjaerde, Ole Christian] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Radiumhosp, Dept Oncol, Div Canc Med & Radiotherapy, Oslo, Norway; [Kristensen, Vessela N.] Akershus Univ Hosp, Inst Clin Epidemiol & Mol Biol EpiGen, Akershus, Norway; [Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel	University of Oslo; University of Oslo; Technion Israel Institute of Technology; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Agilent Technologies	Lingjaerde, OC (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway.	ole@ifi.uio.no; zohar_yakhini@agilent.com		Liestol, Knut/0000-0002-7929-582X; Lingjaerde, Ole Christian/0000-0003-3565-4912; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Baumbusch, Lars O./0000-0003-1290-312X; Yakhini, Zohar/0000-0002-0420-5412	Norwegian Research Council [193387/V50]; Norwegian Cancer Society [138296-PR2008- 0108]; South-Eastern Norway Regional Health Authority [2011042]; K.G. Jebsen Center for Breast Cancer Research	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; K.G. Jebsen Center for Breast Cancer Research	(1) Norwegian Research Council (Grant no 193387/V50, Understanding breast cancer genomics); (2) Norwegian Cancer Society (Grant no 138296-R2008-0108, Exploring The Systems Biology of Breast Cancer); (3) South-Eastern Norway Regional Health Authority (Project no 2011042, OSBREAC: Towards personalized therapy for breast cancer); (4) K.G. Jebsen Center for Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atienza JM, 2005, MOL CANCER THER, V4, P361; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Byrne JA, 2005, INT J CANCER, V117, P1049, DOI 10.1002/ijc.21250; Chari R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-67; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Goh XY, 2011, GUT; Gomulkiewicz A, FOLIA HISTOCHEMICA C, V48, P242; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hyman E, 2002, CANCER RES, V62, P6240; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Jung Y, 2011, CLIN CANCER RES, V17, P700, DOI 10.1158/1078-0432.CCR-10-1300; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kristensen VN, 2011, P NATL ACAD SCI; Lambros MB, MOD PATHOL, V23, P1334; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lipson D, 2004, P WORKSH ALG BIOINF; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Matsuura T, 2002, J INORG BIOCHEM, V88, P183, DOI 10.1016/S0162-0134(01)00377-4; Namba R, 2004, MOL CANCER RES, V2, P453; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Naume B, 2001, CLIN CANCER RES, V7, P4122; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Olesen C, 2004, MOL REPROD DEV, V67, P116, DOI 10.1002/mrd.20007; Ostrakhovitch EA, 2006, FEBS LETT, V580, P1235, DOI 10.1016/j.febslet.2006.01.036; Ostrakhovitch EA, 2007, J CELL BIOCHEM, V102, P1571, DOI 10.1002/jcb.21381; Parris TZ, 2010, CLIN CANCER RES, V16, P3860, DOI 10.1158/1078-0432.CCR-10-0889; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shehata M, 2008, CLIN CANCER RES, V14, P5050, DOI 10.1158/1078-0432.CCR-07-4994; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigman V, 2011, BREAST CANC RES TREA, P1; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814	65	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53014	10.1371/journal.pone.0053014	http://dx.doi.org/10.1371/journal.pone.0053014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382830	Green Published, gold			2022-12-27	WOS:000315563800016
J	Goode, EL; DeRycke, M; Kalli, KR; Oberg, AL; Cunningham, JM; Maurer, MJ; Fridley, BL; Armasu, SM; Serie, DJ; Ramar, P; Goergen, K; Vierkant, RA; Rider, DN; Sicotte, H; Wang, C; Winterhoff, B; Phelan, CM; Schildkraut, JM; Weber, RP; Iversen, E; Berchuck, A; Sutphen, R; Birrer, MJ; Hampras, S; Preus, L; Gayther, SA; Ramus, SJ; Wentzensen, N; Yang, HP; Garcia-Closas, M; Song, HL; Tyrer, J; Pharoah, PPD; Konecny, G; Sellers, TA; Ness, RB; Sucheston, LE; Odunsi, K; Hartmann, LC; Moysich, KB; Knutson, KL				Goode, Ellen L.; DeRycke, Melissa; Kalli, Kimberly R.; Oberg, Ann L.; Cunningham, Julie M.; Maurer, Matthew J.; Fridley, Brooke L.; Armasu, Sebastian M.; Serie, Daniel J.; Ramar, Priya; Goergen, Krista; Vierkant, Robert A.; Rider, David N.; Sicotte, Hugues; Wang, Chen; Winterhoff, Boris; Phelan, Catherine M.; Schildkraut, Joellen M.; Weber, Rachel P.; Iversen, Ed; Berchuck, Andrew; Sutphen, Rebecca; Birrer, Michael J.; Hampras, Shalaka; Preus, Leah; Gayther, Simon A.; Ramus, Susan J.; Wentzensen, Nicolas; Yang, Hannah P.; Garcia-Closas, Montserrat; Song, Honglin; Tyrer, Jonathan; Pharoah, Paul P. D.; Konecny, Gottfried; Sellers, Thomas A.; Ness, Roberta B.; Sucheston, Lara E.; Odunsi, Kunle; Hartmann, Lynn C.; Moysich, Kirsten B.; Knutson, Keith L.			Inherited Variants in Regulatory T Cell Genes and Outcome of Ovarian Cancer	PLOS ONE			English	Article							TGF-BETA; MEDIATED SUPPRESSION; OX40 COSTIMULATION; IMMUNE SUPPRESSION; EXPRESSION; SURVIVAL; RECEPTOR; WOMEN; FOXP3; GITR	Although ovarian cancer is the most lethal of gynecologic malignancies, wide variation in outcome following conventional therapy continues to exist. The presence of tumor-infiltrating regulatory T cells (Tregs) has a role in outcome of this disease, and a growing body of data supports the existence of inherited prognostic factors. However, the role of inherited variants in genes encoding Treg-related immune molecules has not been fully explored. We analyzed expression quantitative trait loci (eQTL) and sequence-based tagging single nucleotide polymorphisms (tagSNPs) for 54 genes associated with Tregs in 3,662 invasive ovarian cancer cases. With adjustment for known prognostic factors, suggestive results were observed among rarer histological subtypes; poorer survival was associated with minor alleles at SNPs in RGS1 (clear cell, rs10921202, p = 2.7x10(-5)), LRRC32 and TNFRSF18/TNFRSF4 (mucinous, rs3781699, p = 4.5x10(-4), and rs3753348, p = 9.0x10(-4), respectively), and CD80 (endometrioid, rs13071247, p = 8.0x10(-4)). Fo0r the latter, correlative data support a CD80 rs13071247 genotype association with CD80 tumor RNA expression (p = 0.006). An additional eQTL SNP in CD80 was associated with shorter survival (rs7804190, p = 8.1x10(-4)) among all cases combined. As the products of these genes are known to affect induction, trafficking, or immunosuppressive function of Tregs, these results suggest the need for follow-up phenotypic studies.	[Goode, Ellen L.; DeRycke, Melissa; Oberg, Ann L.; Maurer, Matthew J.; Fridley, Brooke L.; Armasu, Sebastian M.; Serie, Daniel J.; Ramar, Priya; Goergen, Krista; Vierkant, Robert A.; Rider, David N.; Sicotte, Hugues; Wang, Chen] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Kalli, Kimberly R.; Hartmann, Lynn C.] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Dept Expt Pathol, Rochester, MN USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Hampras, Shalaka; Preus, Leah; Sucheston, Lara E.; Moysich, Kirsten B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Winterhoff, Boris] Mayo Clin, Dept Gynecol Oncol, Rochester, MN USA; [Schildkraut, Joellen M.; Berchuck, Andrew] Duke Univ, Duke Comprehens Canc Ctr, Durham, NC USA; [Weber, Rachel P.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Iversen, Ed] Duke Univ, Dept Stat Sci, Durham, NC USA; [Sutphen, Rebecca] Univ S Florida, Coll Med, Tampa, FL USA; [Birrer, Michael J.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gayther, Simon A.; Ramus, Susan J.] Univ So Calif, Los Angeles, CA USA; [Wentzensen, Nicolas; Yang, Hannah P.] NCI, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat] Inst Canc Res, Sutton, Surrey, England; [Song, Honglin; Tyrer, Jonathan; Pharoah, Paul P. D.] Univ Cambridge, Cambridge, England; [Konecny, Gottfried] Univ Calif Los Angeles, Dept Gynecol Oncol, Los Angeles, CA USA; [Phelan, Catherine M.; Sellers, Thomas A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Knutson, Keith L.] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Mayo Clinic; Duke University; Duke University; Duke University; State University System of Florida; University of South Florida; Harvard University; Brigham & Women's Hospital; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Institute of Cancer Research - UK; University of Cambridge; University of California System; University of California Los Angeles; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Mayo Clinic	Goode, EL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	egoode@mayo.edu	Ramus, Susan/AAG-8352-2019; Fridley, Brooke L/D-8315-2015; wang, chen/GWM-9481-2022; Wang, Chen/B-3244-2011; Wentzensen, Nicolas/AAG-8522-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Garcia-Closas, Montserrat/F-3871-2015; Pharoah, Paul/V-6658-2019; Vierkant, Robert/AAP-4927-2020	Ramus, Susan/0000-0003-0005-7798; Fridley, Brooke L/0000-0001-7739-7956; Wang, Chen/0000-0003-2638-3081; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Pharoah, Paul/0000-0001-8494-732X; Vierkant, Robert/0000-0001-6242-5221; Weber, Rachel/0000-0001-7119-7734; Maurer, Matthew/0000-0002-1867-0526	Mayo Clinic Ovarian Cancer SPORE [P50-CA136393]; National Cancer Institute GAME-ON Post-GWAS Initiative [U19-CA148112]; National Cancer Institute [R01-CA086888, R01-CA122443, R01-CA106414, R01-CA76016, R01-CA114343]; Cancer Research United Kingdom [A10119, A10124, A8339, A6187, A11306, A7058]; Medical Research Council [G0801875-89310]; Ovarian Cancer Research Fund; Mayo Foundation; Minnesota Ovarian Cancer Alliance; Roswell Park Cancer Institute Alliance Foundation; Fred C. and Katherine B. Andersen Foundation; The Francis Crick Institute [10124, 10119] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA114343, ZIACP010126, U19CA148112, R01CA106414, R25CA092049, R01CA122443, P50CA136393, R01CA076016, R01CA086888, R01CA149429] Funding Source: NIH RePORTER	Mayo Clinic Ovarian Cancer SPORE; National Cancer Institute GAME-ON Post-GWAS Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research United Kingdom(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ovarian Cancer Research Fund; Mayo Foundation; Minnesota Ovarian Cancer Alliance; Roswell Park Cancer Institute Alliance Foundation; Fred C. and Katherine B. Andersen Foundation; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The scientific development and funding for this project were supported in part by the Mayo Clinic Ovarian Cancer SPORE (P50-CA136393) to ELG, LCH, and KLK, the National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112), National Cancer Institute Research project grants (R01-CA086888, R01-CA122443, R01-CA106414, R01-CA76016, R01-CA114343), Cancer Research United Kingdom (A10119, A10124, A8339, A6187, A11306, A7058), the Medical Research Council (G0801875-89310), the Ovarian Cancer Research Fund, the Mayo Foundation, the Minnesota Ovarian Cancer Alliance, the Mayo Foundation, the Roswell Park Cancer Institute Alliance Foundation, and the Fred C. and Katherine B. Andersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fridley BL, 2012, CANCER EPIDEM BIOMAR, V21, P529, DOI 10.1158/1055-9965.EPI-11-0741; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HOSKINS WJ, 1992, GYNECOL ONCOL, V47, P159, DOI 10.1016/0090-8258(92)90100-W; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Johnson BA, 2010, GENES IMMUN, V11, P343, DOI 10.1038/gene.2009.81; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kitamura N, 2009, INT J CANCER, V125, P630, DOI 10.1002/ijc.24435; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Knutson Keith L, 2006, Future Oncol, V2, P379, DOI 10.2217/14796694.2.3.379; Knutson KL, 2006, J CLIN ONCOL, V24, P4254, DOI 10.1200/JCO.2006.05.9311; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maggi E, 2005, AUTOIMMUN REV, V4, P579, DOI 10.1016/j.autrev.2005.04.010; McGuire V, 2002, GYNECOL ONCOL, V84, P399, DOI 10.1006/gyno.2001.6536; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Probst-Kepper M, 2010, CURR MOL MED, V10, P533; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sicotte H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-129; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wahl SM, 2004, J LEUKOCYTE BIOL, V76, P15, DOI 10.1189/jlb.1103539; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; White KL, 2012, CANCER RES, V72, P1064, DOI 10.1158/0008-5472.CAN-11-3512; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53903	10.1371/journal.pone.0053903	http://dx.doi.org/10.1371/journal.pone.0053903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382860	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800026
J	Mishra, S; Triptahi, V; Singh, S; Phukan, UJ; Gupta, MM; Shanker, K; Shukla, RK				Mishra, Sonal; Triptahi, Vineeta; Singh, Seema; Phukan, Ujjal J.; Gupta, M. M.; Shanker, Karuna; Shukla, Rakesh Kumar			Wound Induced Tanscriptional Regulation of Benzylisoquinoline Pathway and Characterization of Wound Inducible PsWRKY Transcription Factor from Papaver somniferum	PLOS ONE			English	Article							BERBERINE BRIDGE ENZYME; INDOLE ALKALOID BIOSYNTHESIS; TYROSINE DOPA DECARBOXYLASE; OPIUM POPPY; MOLECULAR-CLONING; MORPHINE BIOSYNTHESIS; DIHYDROBENZOPHENANTHRIDINE OXIDASE; GENE TRANSCRIPT; EXPRESSION; ACCUMULATION	Wounding is required to be made in the walls of the green seed pod of Opium poppy prior exudation of latex. To withstand this kind of trauma plants regulate expression of some metabolites through an induced transcript level. 167 unique wound-inducible ESTs were identified by a repetitive round of cDNA subtraction after 5 hours of wounding in Papaver somniferum seedlings. Further repetitive reverse northern analysis of these ESTs revealed 80 transcripts showing more than two fold induction, validated through semi-quantitative RT-PCR & real time expression analysis. One of the major classified categories among identified ESTs belonged to benzylisoquinoline transcripts. Tissue specific metabolite analysis of benzylisoquinoline alkaloids (BIAs) in response to wounding revealed increased accumulation of narcotine and papaverine. Promoter analysis of seven transcripts of BIAs pathway showed the presence of W-box cis-element with the consensus sequence of TGAC, which is the proposed binding site for WRKY type transcription factors. One of the Wound inducible 'WRKY' EST isolated from our subtracted library was made full-length and named as 'PsWRKY'. Bacterially expressed PsWRKY interacted with the W-box element having consensus sequence TTGACT/C present in the promoter region of BIAs biosynthetic pathway genes. PsWRKY further activated the TYDC promoter in yeast and transiently in tobacco BY2 cells. Preferential expression of PsWRKY in straw and capsule and its interaction with consensus W-box element present in BIAs pathway gene transcripts suggest its possible involvement in the wound induced regulation of BIAs pathway.	[Mishra, Sonal; Singh, Seema; Phukan, Ujjal J.; Shukla, Rakesh Kumar] Cent Inst Med & Aromat Plants CSIR CIMAP, Div Biotechnol, Lucknow, Uttar Pradesh, India; [Gupta, M. M.; Shanker, Karuna] Cent Inst Med & Aromat Plants CSIR CIMAP, Div Analyt Chem, Lucknow, Uttar Pradesh, India; [Triptahi, Vineeta] CSIR Cent Drug Res Inst CSIR CDRI, Dept Bot, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Shukla, RK (corresponding author), Cent Inst Med & Aromat Plants CSIR CIMAP, Div Biotechnol, Lucknow, Uttar Pradesh, India.	rk.shukla@cimap.res.in	Phukan, Ujjal Jyoti/Y-9156-2019; Shanker, Karuna/D-3596-2009; Shanker, Karuna/E-6692-2010	Phukan, Ujjal Jyoti/0000-0001-9788-4938; Shanker, Karuna/0000-0003-0144-3623; Shanker, Karuna/0000-0003-0144-3623; Mishra, Dr. Sonal/0000-0003-0727-6520	Council of Scientific and Industrial Research (CSIR) [NWP08]; Department of Science and Technology Fast Track Project [SR/FT/LS-189/2009]; Department of Science and Technology, India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology Fast Track Project(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India)); Department of Science and Technology, India(Department of Science & Technology (India))	The authors acknowledge Council of Scientific and Industrial Research (CSIR) Network Project (NWP08), and Department of Science and Technology Fast Track Project (Number: SR/FT/LS-189/2009) from Department of Science and Technology, India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 1999, J PHYTOPATHOL, V147, P535, DOI 10.1111/j.1439-0434.1999.tb03861.x; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; Berger B, 2007, PLANT J, V50, P911, DOI 10.1111/j.1365-313X.2007.03088.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Facchini PJ, 1998, PLANT PHYSIOL, V118, P69, DOI 10.1104/pp.118.1.69; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Facchini PJ, 2003, PHYTOCHEMISTRY, V64, P177, DOI 10.1016/S0031-9422(03)00292-9; FACCHINI PJ, 1995, PLANT CELL, V7, P1811, DOI 10.1105/tpc.7.11.1811; FACCHINI PJ, 1994, J BIOL CHEM, V269, P26684; FUJIWARA H, 1993, PHYTOCHEMISTRY, V34, P949, DOI 10.1016/S0031-9422(00)90692-7; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Gupta MM, 1996, INDIAN J PHARM SCI, P161; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong SB, 2006, J BIOTECHNOL, V122, P28, DOI 10.1016/j.jbiotec.2005.08.008; Huang FC, 2000, PHYTOCHEMISTRY, V53, P555, DOI 10.1016/S0031-9422(99)00600-7; Ignatov A, 1996, PHYTOCHEMISTRY, V43, P1141, DOI 10.1016/S0031-9422(96)00540-7; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Lee LY, 2008, PLANT METHODS, P4; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu DH, 2007, J INTEGR PLANT BIOL, V49, P961, DOI 10.1111/j.1672-9072.2007.00457.x; Memelink J., 2007, Phytochemistry Reviews, V6, P353, DOI 10.1007/s11101-006-9051-z; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Morimoto S, 2001, J BIOL CHEM, V276, P38179; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; NESSLER CL, 1977, AM J BOT, V64, P541, DOI 10.2307/2442002; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; Park SU, 1999, PLANT MOL BIOL, V40, P121, DOI 10.1023/A:1026433112119; Pauw B, 2004, J BIOL CHEM, V279, P52940, DOI 10.1074/jbc.M404391200; PenaCortes H, 1996, PLANTA, V198, P447, DOI 10.1007/BF00620062; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; RUEFFER M, 1986, PLANT CELL REP, V5, P182, DOI 10.1007/BF00269113; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samanani N, 2005, PLANT CELL, V17, P915, DOI 10.1105/tpc.104.028654; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; Schmeller T, 1997, PHYTOCHEMISTRY, V44, P257, DOI 10.1016/S0031-9422(96)00545-6; SCHUMACHER HM, 1988, PLANT CELL REP, V7, P43, DOI 10.1007/BF00272975; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Shukla RK, 2009, FEBS J, V276, P5252, DOI 10.1111/j.1742-4658.2009.07219.x; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200; Zuyu Z, 2006, PLANT J, P592	63	56	59	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52784	10.1371/journal.pone.0052784	http://dx.doi.org/10.1371/journal.pone.0052784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382823	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800011
J	Liu, YM; Wang, HW; Wang, XY; Mu, LL; Kong, QF; Wang, DD; Wang, JH; Zhang, Y; Yang, JF; Zhou, MY; Wang, GY; Sun, B; Li, HL				Liu, Yumei; Wang, Hongwei; Wang, Xinyue; Mu, Lili; Kong, Qingfei; Wang, Dandan; Wang, Jinghua; Zhang, Yao; Yang, Jinfeng; Zhou, Mingyan; Wang, Guangyou; Sun, Bo; Li, Hulun			The Mechanism of Effective Electroacupuncture on T Cell Response in Rats with Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							BETA-ENDORPHIN CONCENTRATIONS; ENDOGENOUS OPIOIDS; IMMUNE-SYSTEM; PROLIFERATION; RECEPTORS; APOPTOSIS; PEPTIDES; PRETREATMENT; ACUPUNCTURE; STIMULATION	Previously, we demonstrated that electroacupuncture (EA) decreased lymphocyte infiltration into the spinal cords of rats presenting with experimental autoimmune encephalomyelitis (EAE), a disease model used in the study of multiple sclerosis (MS). The aim of this study was to characterize the effects of EA on the EAE. Female Lewis rats were divided into either CFA, EAE, EA, or injection with naloxone after electroacupuncture (NAL) groups. Electroacupuncture was administered every day for 21 days. To evaluate proliferation and apoptosis, lymphocytes from rats presenting with EAE were collected and cultured with beta-endorphin. Immunohistochemisty, flow cytometry and radio-immunity methods were applied to detect the expression of beta-endorphin. Results presented in this report demonstrate that the beneficial anti-inflammatory effects of EA on EAE were related to beta-endorphin production that balances the Thl/Th2 and Th17/Treg responses. These results suggest that b-endorphin could be an important component in the development of EA-based therapies used for the treatment of EAE.	[Liu, Yumei; Wang, Xinyue; Mu, Lili; Kong, Qingfei; Wang, Dandan; Wang, Jinghua; Zhang, Yao; Yang, Jinfeng; Zhou, Mingyan; Wang, Guangyou; Sun, Bo; Li, Hulun] Harbin Med Univ, Dept Neurobiol, Heilongjiang Prov Key Lab Neurobiol, Harbin, Peoples R China; [Wang, Hongwei] Harbin Med Univ, Dept Orthopaed, Affiliated Hosp 2, Harbin, Peoples R China; [Li, Hulun] Harbin Med Univ, Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Sun, B (corresponding author), Harbin Med Univ, Dept Neurobiol, Heilongjiang Prov Key Lab Neurobiol, Harbin, Peoples R China.	sunbo720@yahoo.com.cn; lihulun@yahoo.com.cn	Yang, Jinfeng/GSN-6506-2022; Kong, qingfei/HCI-0643-2022		National Nature Science Foundation of China [81100883]; Science and Technology Study project of the Education Department of Heilongjiang Province [11541114]; Harbin Medical University [HCXB2010001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Study project of the Education Department of Heilongjiang Province; Harbin Medical University	The study is financially supported by National Nature Science Foundation of China (81100883), the Science and Technology Study project of the Education Department of Heilongjiang Province (11541114) and the Harbin Medical University Innovation Fund for Postgraduates (HCXB2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Boranic Milivoj, 2009, Acta Medica Croatica, V63, P27; Cheng CH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep132; CRINE P, 1978, P NATL ACAD SCI USA, V75, P4719, DOI 10.1073/pnas.75.10.4719; Feng SF, 2010, NEUROSCI LETT, V478, P150, DOI 10.1016/j.neulet.2010.05.006; GARCIA I, 1992, LYMPHOKINE CYTOK RES, V11, P339; Gein SV, 2006, B EXP BIOL MED+, V142, P226, DOI 10.1007/s10517-006-0334-6; GILMAN SC, 1982, P NATL ACAD SCI-BIOL, V79, P4226, DOI 10.1073/pnas.79.13.4226; GILMORE W, 1989, IMMUNOPHARMACOLOGY, V17, P19, DOI 10.1016/0162-3109(89)90004-0; Gironi M, 2000, ARCH NEUROL-CHICAGO, V57, P1178, DOI 10.1001/archneur.57.8.1178; Gironi M, 2003, J NEUROL NEUROSUR PS, V74, P495, DOI 10.1136/jnnp.74.4.495; Gutstein HB, 2001, GOODMAN GILMANS PHAR, P569; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Kravetz RE, 2007, AM J GASTROENTEROL, V102, P2371, DOI 10.1111/j.1572-0241.2007.01473.x; Liu JL, 2010, CHIN J INTEGR MED, V16, P315, DOI 10.1007/s11655-010-0503-3; Liu YM, 2010, J NEUROIMMUNOL, V220, P25, DOI 10.1016/j.jneuroim.2009.12.005; Machelska H, 2011, CNS NEUROL DISORD-DR, V10, P559, DOI 10.2174/187152711796234952; MANFREDI B, 1993, J NEUROIMMUNOL, V44, P43, DOI 10.1016/0165-5728(93)90266-2; Morch H, 1995, AUTOIMMUNITY, V21, P161, DOI 10.3109/08916939509008013; Navolotskaya EV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P357, DOI 10.1023/A:1014844718799; Pan BH, 1996, BRAIN RES BULL, V40, P175, DOI 10.1016/0361-9230(96)00011-1; PANERAI AE, 1994, J NEUROIMMUNOL, V51, P169, DOI 10.1016/0165-5728(94)90078-7; PANERAI AE, 1995, J NEUROIMMUNOL, V58, P71, DOI 10.1016/0165-5728(94)00189-U; Panerai AE, 1997, IMMUNOL TODAY, V18, P317, DOI 10.1016/S0167-5699(97)01045-1; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; SACERDOTE P, 1991, PEPTIDES, V12, P1353, DOI 10.1016/0196-9781(91)90219-F; Sacerdote P, 1998, CLIN EXP IMMUNOL, V113, P465; Sacerdote P, 2000, BLOOD, V95, P2031, DOI 10.1182/blood.V95.6.2031; Shahabi NA, 1996, ENDOCRINOLOGY, V137, P3386, DOI 10.1210/en.137.8.3386; SHARP B, 1993, ENDOCRINOLOGY, V133, pA1921, DOI 10.1210/endo.133.5.8404637; Sharp BM, 2001, J IMMUNOL, V167, P1097, DOI 10.4049/jimmunol.167.2.1097; Singhal P, 2001, ADV EXP MED BIOL, V493, P127; Su TF, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-98; Tjen-A-Looi SC, 2004, AM J PHYSIOL-REG I, V287, pR852, DOI 10.1152/ajpregu.00262.2004; VANDENBERGH P, 1993, IMMUNOLOGY, V79, P18; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wollemann M, 2004, LIFE SCI, V75, P257, DOI 10.1016/j.lfs.2003.12.005; Wu HG, 2007, DIGEST DIS SCI, V52, P379, DOI 10.1007/s10620-006-9561-y; YOSHINO S, 1992, J RHEUMATOL, V19, P660; ZAGON IS, 1987, BRAIN RES, V412, P68, DOI 10.1016/0006-8993(87)91440-5; ZAGON IS, 1989, BRAIN RES, V480, P16, DOI 10.1016/0006-8993(89)91562-X; ZAGON IS, 1988, LIFE SCI, V43, P1313, DOI 10.1016/0024-3205(88)90586-3; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	46	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e51573	10.1371/journal.pone.0051573	http://dx.doi.org/10.1371/journal.pone.0051573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382807	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500003
J	Ruhs, A; Cemic, F; Braun, T; Kruger, M				Ruhs, Aaron; Cemic, Franz; Braun, Thomas; Krueger, Marcus			ResA(3) : A Web Tool for Resampling Analysis of Arbitrary Annotations	PLOS ONE			English	Article							MOUSE	Resampling algorithms provide an empirical, non-parametric approach to determine the statistical significance of annotations in different experimental settings. ResA(3) (Resampling Analysis of Arbitrary Annotations, short: ResA) is a novel tool to facilitate the analysis of enrichment and regulation of annotations deposited in various online resources such as KEGG, Gene Ontology and Pfam or any kind of classification. Results are presented in readily accessible navigable table views together with relevant information for statistical inference. The tool is able to analyze multiple types of annotations in a single run and includes a Gene Ontology annotation feature. We successfully tested ResA using a dataset obtained by measuring incorporation rates of stable isotopes into proteins in intact animals. ResA complements existing tools and will help to evaluate the increasing number of large-scale transcriptomics and proteomics datasets (resa.mpi-bn.mpg.de).	[Ruhs, Aaron; Braun, Thomas; Krueger, Marcus] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Cemic, Franz] Univ Appl Sci, Inst Biochem Engn & Analyt, Giessen, Germany	Max Planck Society	Ruhs, A (corresponding author), Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany.	Aaron.Ruhs@mpi-bn.mpg.de; marcus.krueger@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Cemic, Franz/0000-0002-8194-1210	Max-Planck-Society; Excellence Initiative 'Cardiopulmonary System'; University of Giessen-Marburg Lung Centre (UGMLC); Cell and Gene Therapy Centre (CGT); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK)	Max-Planck-Society(Max Planck Society); Excellence Initiative 'Cardiopulmonary System'; University of Giessen-Marburg Lung Centre (UGMLC); Cell and Gene Therapy Centre (CGT); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK)	This work was funded by the Max-Planck-Society and the Excellence Initiative 'Cardiopulmonary System', the University of Giessen-Marburg Lung Centre (UGMLC), and the Cell and Gene Therapy Centre (CGT) supported by the Hessisches Ministerium fur Wissenschaft und Kunst (HMWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowley, 1920, ELEMENTARY MANUAL ST; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	10	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e53743	10.1371/journal.pone.0053743	http://dx.doi.org/10.1371/journal.pone.0053743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382850	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500006
J	Shi, XL; Gupta, S; Lindquist, IE; Cameron, CT; Mudge, J; Rashotte, AM				Shi, Xiuling; Gupta, Sarika; Lindquist, Ingrid E.; Cameron, Connor T.; Mudge, Joann; Rashotte, Aaron M.			Transcriptome Analysis of Cytokinin Response in Tomato Leaves	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSFER-RNA; ETHYLENE BIOSYNTHESIS; MICROARRAY ANALYSIS; GENE-EXPRESSION; FAMILY; PROTEINS; BOUNDARIES; DOMAIN; FRUIT	Tomato is one of the most economically and agriculturally important Solanaceous species and vegetable crops, serving as a model for examination of fruit biology and compound leaf development. Cytokinin is a plant hormone linked to the control of leaf development and is known to regulate a wide range of genes including many transcription factors. Currently there is little known of the leaf transcriptome in tomato and how it might be regulated by cytokinin. We employ high throughput mRNA sequencing technology and bioinformatic methodologies to robustly analyze cytokinin regulated tomato leaf transcriptomes. Leaf samples of two ages, 13d and 35d were treated with cytokinin or the solvent vehicle control dimethyl sulfoxide (DMSO) for 2 h or 24 h, after which RNA was extracted for sequencing. To confirm the accuracy of RNA sequencing results, we performed qPCR analysis of select transcripts identified as cytokinin regulated by the RNA sequencing approach. The resulting data provide the first hormone transcriptome analysis of leaves in tomato. Specifically we identified several previously untested tomato orthologs of cytokinin-related genes as well as numerous novel cytokinin-regulated transcripts in tomato leaves. Principal component analysis of the data indicates that length of cytokinin treatment and plant age are the major factors responsible for changes in transcripts observed in this study. Two hour cytokinin treatment showed a more robust transcript response indicated by both greater fold change of induced transcripts and the induction of twice as many cytokinin-related genes involved in signaling, metabolism, and transport in young vs. older leaves. This difference in transcriptome response in younger vs. older leaves was also found to a lesser extent with an extended (24 h) cytokinin treatment. Overall data presented here provides a solid foundation for future study of cytokinin and cytokinin regulated genes involved in compound leaf development or other developmental processes in tomato.	[Shi, Xiuling; Gupta, Sarika; Rashotte, Aaron M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Lindquist, Ingrid E.; Cameron, Connor T.; Mudge, Joann] Natl Ctr Genome Resources, Santa Fe, NM USA	Auburn University System; Auburn University; National Center for Genome Resources (NCGR)	Rashotte, AM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	rashotte@auburn.edu		Rashotte, Aaron/0000-0001-5034-4395; Mudge, Joann/0000-0002-2972-1640	USDA-NRI [2008-35304-04457]; AAES-HATCH [370220-310007-2055, 103600-310010-2055]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER; EPSCoR [1158862] Funding Source: National Science Foundation	USDA-NRI(United States Department of Agriculture (USDA)); AAES-HATCH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by USDA-NRI grant 2008-35304-04457 and AAES-HATCH grants 370220-310007-2055 and 103600-310010-2055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Allen M, 2002, PHYSIOL PLANTARUM, V115, P56, DOI 10.1034/j.1399-3054.2002.1150106.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Brand A, 2007, PLANTA, V226, P941, DOI 10.1007/s00425-007-0540-0; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CHORY J, 1994, PLANT PHYSIOL, V104, P339, DOI 10.1104/pp.104.2.339; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Gillissen B, 2000, PLANT CELL, V12, P291, DOI 10.1105/tpc.12.2.291; Golovko A, 2002, PLANT MOL BIOL, V49, P161, DOI 10.1023/A:1014958816241; Gordon A, FASTX TOOLKIT UNPUB; Gray J, 1996, PLANT PHYSIOL, V110, P431, DOI 10.1104/pp.110.2.431; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Harris JM, 2010, PLANT SIGNAL BEHAV, V5, P1365, DOI 10.4161/psb.5.11.13165; Heyl A, 2008, PLANT PHYSIOL, V147, P1380, DOI 10.1104/pp.107.115436; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Jung KH, 2010, PLANT PHYSIOL, V152, P1674, DOI 10.1104/pp.109.152157; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kusnetsov V, 1998, MOL GEN GENET, V259, P21, DOI 10.1007/PL00008626; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lin WC, 2003, PLANT CELL, V15, P2241, DOI 10.1105/tpc.014969; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; MOFFATT B, 1991, PLANT PHYSIOL, V95, P900, DOI 10.1104/pp.95.3.900; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1269, DOI 10.1271/bbb.60681; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pischke MS, 2006, PLANT PHYSIOL, V140, P1255, DOI 10.1104/pp.105.076059; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Rashotte AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-74; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Schaff JE, 2007, PLANT PHYSIOL, V144, P1079, DOI 10.1104/pp.106.090241; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Shani E, 2010, PLANT CELL, V22, P3206, DOI 10.1105/tpc.110.078253; Shi XL, 2012, J EXP BOT, V63, P973, DOI 10.1093/jxb/err325; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Woo HH, 2003, PLANT PHYSIOL, V133, P538, DOI 10.1104/pp.103.026278; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Yendrek CR, 2010, PLANT J, V62, P100, DOI 10.1111/j.1365-313X.2010.04134.x; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044	90	31	31	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55090	10.1371/journal.pone.0055090	http://dx.doi.org/10.1371/journal.pone.0055090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372818	gold, Green Published, Green Submitted			2022-12-27	WOS:000315210400061
J	van den Akker, T; Beltman, J; Leyten, J; Mwagomba, B; Meguid, T; Stekelenburg, J; van Roosmalen, J				van den Akker, Thomas; Beltman, Jogchum; Leyten, Joey; Mwagomba, Beatrice; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos			The WHO Maternal Near Miss Approach: Consequences at Malawian District Level	PLOS ONE			English	Article							NETHERLANDS; CARE	Introduction: WHO proposes a set of organ-failure based criteria for maternal near miss. Our objective was to evaluate what implementation of these criteria would mean for the analysis of a cohort of 386 women in Thyolo District, Malawi, who sustained severe acute maternal morbidity according to disease-based criteria. Methods and Findings: A WHO Maternal Near Miss (MNM) Tool, created to compare disease-, intervention- and organfailure based criteria for maternal near miss, was completed for each woman, based on a review of all available medical records. Using disease-based criteria developed for the local setting, 341 (88%) of the 386 women fulfilled the WHO disease-based criteria provided by the WHO MNM Tool, 179 (46%) fulfilled the intervention-based criteria, and only 85 (22%) the suggested organ-failure based criteria. Conclusions: In this low-resource setting, application of these organ-failure based criteria that require relatively sophisticated laboratory and clinical monitoring underestimates the occurrence of maternal near miss. Therefore, these criteria and the suggested WHO approach may not be suited to compare maternal near miss across all settings.	[van den Akker, Thomas; Beltman, Jogchum; Mwagomba, Beatrice] Thyolo Dist Hlth Off, Minist Hlth, Thyolo, Malawi; [van den Akker, Thomas; van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Med Humanities, Amsterdam, Netherlands; [van den Akker, Thomas; Beltman, Jogchum; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos] Dutch Soc Obstet & Gynecol, Utrecht, Netherlands; [van den Akker, Thomas; Beltman, Jogchum; Meguid, Tarek; Stekelenburg, Jelle; van Roosmalen, Jos] Netherlands Soc Trop Med & Int Hlth, Utrecht, Netherlands; [Beltman, Jogchum; Leyten, Joey; van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Meguid, Tarek] Univ Pittsburgh, Sch Law, Pittsburgh, PA 15260 USA; [Meguid, Tarek] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Meguid, Tarek] Bottom Hosp, Dept Obstet & Gynecol, Lilongwe, Malawi; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical Center Leeuwarden	van den Akker, T (corresponding author), Thyolo Dist Hlth Off, Minist Hlth, Thyolo, Malawi.	thomas_vd_akker@hotmail.com	Stekelenburg, Jelle/B-3129-2017	Stekelenburg, Jelle/0000-0002-2732-6620	Thyolo District Health Office	Thyolo District Health Office	The study was self-funded by the Thyolo District Health Office. There were no external funders that had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker W, 2011, TROP MED INT HEALTH, V16, P1243, DOI 10.1111/j.1365-3156.2011.02832.x; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Cavagnero E, 2008, LANCET, V371, P1284, DOI 10.1016/S0140-6736(08)60563-2; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *NAT STAT OFF, 2005, MAL DEM HLTH SURV 20; Oladapo Olufemi T, 2005, Reprod Health, V2, P9, DOI 10.1186/1742-4755-2-9; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Republic of Malawi Ministry of Health National Health Sciences Research Committee, 2001, SUMM GUID WRIT RES P; Republic of Malawi National Research Committee of Malawi, 2002, PROC GUID COND RES M; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; van den Akker T, 2011, OBSTET GYNECOL, V118, P266, DOI 10.1097/AOG.0b013e3182254d03; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van den Akker T, 2009, INT J GYNECOL OBSTET, V107, P289, DOI 10.1016/j.ijgo.2009.09.005; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x	21	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54805	10.1371/journal.pone.0054805	http://dx.doi.org/10.1371/journal.pone.0054805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372770	Green Published, gold			2022-12-27	WOS:000315210400031
J	de la Puerta, ML; Trinidad, AG; Rodriguez, MD; de Pereda, JM; Crespo, MS; Bayon, Y; Alonso, A				Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Maria de Pereda, Jose; Sanchez Crespo, Mariano; Bayon, Yolanda; Alonso, Andres			The Autoimmunity Risk Variant LYP-W620 Cooperates with CSK in the Regulation of TCR Signaling	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; T-CELL; KINASE P50(CSK); PTP-PEST; DOMAIN; PHOSPHORYLATION; ACTIVATION; PREDICTION; SEQUENCE; PEP	The protein tyrosine phosphatase LYP, a key regulator of TCR signaling, presents a single nucleotide polymorphism, C1858T, associated with several autoimmune diseases such as type I diabetes, rheumatoid arthritis, and lupus. This polymorphism changes an R by a W in the P1 Pro rich motif of LYP, which binds to CSK SH3 domain, another negative regulator of TCR signaling. Based on the analysis of the mouse homologue, Pep, it was proposed that LYP and CSK bind constitutively to inhibit LCK and subsequently TCR signaling. The detailed study of LYP/CSK interaction, here presented, showed that LYP/CSK interaction was inducible upon TCR stimulation, and involved LYP P1 and P2 motifs, and CSK SH3 and SH2 domains. Abrogating LYP/CSK interaction did not preclude the regulation of TCR signaling by these proteins.	[Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Sanchez Crespo, Mariano; Bayon, Yolanda; Alonso, Andres] Univ Valladolid, IBGM, CSIC, Valladolid, Spain; [Maria de Pereda, Jose] Univ Salamanca, Ctr Invest Canc, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Alonso, A (corresponding author), Univ Valladolid, IBGM, CSIC, Valladolid, Spain.	andres@ibgm.uva.es	de Pereda, Jose M/F-1733-2010; de Pereda, Jose M/AAE-5226-2022; Alonso, Andrés/L-7523-2014; BAyón, Yolanda/L-7635-2014	de Pereda, Jose M/0000-0002-8912-6739; de Pereda, Jose M/0000-0002-8912-6739; Alonso, Andrés/0000-0001-8674-9378; BAyón, Yolanda/0000-0003-3089-5485; Sanchez Crespo, Mariano/0000-0002-6149-154X	Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-09724]; Fundacion Mutua Madrilena; Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III; Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain; European Social Fund through FEDER-FSE	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain(German Research Foundation (DFG)); European Social Fund through FEDER-FSE	This work was supported by a grant (SAF2009-09724) from Ministerio de Ciencia e Innovacion (MICINN, http://www.idi.mineco.gob.es/portal/site/MICINN), by Fundacion Mutua Madrilena (http://www.fundacionmutua.es), and by Red Cardiovascular (RECAVA) from Instituto de Salud Carlos III (http://www.recava.com). Y. Bayon has been under contract within the Ramon y Cajal Program of the Ministerio de Educacion y Ciencia of Spain, co-funded by the European Social Fund through FEDER-FSE (http://www.educacion.gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo J, 2008, J AUTOIMMUN, V31, P13, DOI 10.1016/j.jaut.2008.01.001; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Encinar JA, 2009, BIOINFORMATICS, V25, P2418, DOI 10.1093/bioinformatics/btp424; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gregoire C, 2007, EUR J IMMUNOL, V37, P3259, DOI 10.1002/eji.200737563; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Kingston Robert E, 2003, Curr Protoc Mol Biol, VChapter 9, DOI 10.1002/0471142727.mb0901s63; Lefvert AK, 2008, J NEUROIMMUNOL, V197, P110, DOI 10.1016/j.jneuroim.2008.04.004; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; de la Puerta ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004431; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wang B, 2001, MOL CELL BIOL, V21, P1077, DOI 10.1128/MCB.21.4.1077-1088.2001; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54569	10.1371/journal.pone.0054569	http://dx.doi.org/10.1371/journal.pone.0054569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359562	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600072
J	Neumann, M; Coskun, E; Fransecky, L; Mochmann, LH; Bartram, I; Sartangi, NF; Heesch, S; Gokbuget, N; Schwartz, S; Brandts, C; Schlee, C; Haas, R; Duhrsen, U; Griesshammer, M; Dohner, H; Ehninger, G; Burmeister, T; Blau, O; Thiel, E; Hoelzer, D; Hofmann, WK; Baldus, CD				Neumann, Martin; Coskun, Ebru; Fransecky, Lars; Mochmann, Liliana H.; Bartram, Isabelle; Sartangi, Nasrin Farhadi; Heesch, Sandra; Goekbuget, Nicola; Schwartz, Stefan; Brandts, Christian; Schlee, Cornelia; Haas, Rainer; Duehrsen, Ulrich; Griesshammer, Martin; Doehner, Hartmut; Ehninger, Gerhard; Burmeister, Thomas; Blau, Olga; Thiel, Eckhard; Hoelzer, Dieter; Hofmann, Wolf-Karsten; Baldus, Claudia D.			FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; C-KIT; PROGNOSTIC IMPLICATIONS; NORMAL CYTOGENETICS; GROUP-B; ACTIVATION; NOTCH1; CANCER	Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) has been identified as high-risk subgroup of acute T-lymphoblastic leukemia (T-ALL) with a high rate of FLT3-mutations in adults. To unravel the underlying pathomechanisms and the clinical course we assessed molecular alterations and clinical characteristics in a large cohort of ETP-ALL (n = 68) in comparison to non-ETP T-ALL adult patients. Interestingly, we found a high rate of FLT3-mutations in ETP-ALL samples (n = 24, 35%). Furthermore, FLT3 mutated ETP-ALL was characterized by a specific immunophenotype (CD2+/CD5-/CD13+/CD33-), a distinct gene expression pattern (aberrant expression of IGFBP7, WT1, GATA3) and mutational status (absence of NOTCH1 mutations and a low frequency, 21%, of clonal TCR rearrangements). The observed low GATA3 expression and high WT1 expression in combination with lack of NOTCH1 mutations and a low rate of TCR rearrangements point to a leukemic transformation at the pluripotent prothymocyte stage in FLT3 mutated ETP-ALL. The clinical outcome in ETP-ALL patients was poor, but encouraging in those patients with allogeneic stem cell transplantation (3-year OS: 74%). To further explore the efficacy of targeted therapies, we demonstrate that T-ALL cell lines transfected with FLT3 expression constructs were particularly sensitive to tyrosine kinase inhibitors. In conclusion, FLT3 mutated ETP-ALL defines a molecular distinct stem cell like leukemic subtype. These data warrant clinical studies with the implementation of FLT3 inhibitors in addition to early allogeneic stem cell transplantation for this high risk subgroup.	[Neumann, Martin; Coskun, Ebru; Fransecky, Lars; Mochmann, Liliana H.; Bartram, Isabelle; Sartangi, Nasrin Farhadi; Heesch, Sandra; Schwartz, Stefan; Schlee, Cornelia; Burmeister, Thomas; Blau, Olga; Thiel, Eckhard; Baldus, Claudia D.] Univ Hosp Berlin, Dept Hematol & Oncol, Charite, Berlin, Germany; [Goekbuget, Nicola; Brandts, Christian; Hoelzer, Dieter] Goethe Univ Hosp, Dept Med Hematol & Oncol 2, Frankfurt, Germany; [Haas, Rainer] Univ Dusseldorf, Dept Hematol & Oncol, D-40225 Dusseldorf, Germany; [Duehrsen, Ulrich] Univ Essen Gesamthsch, Dept Hematol & Oncol, Essen, Germany; [Griesshammer, Martin] Klinikum Minden, Dept Hematol & Oncol, Minden, Germany; [Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Ehninger, Gerhard] Univ Dresden, Dept Hematol & Oncol, Dresden, Germany; [Hofmann, Wolf-Karsten] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Heinrich Heine University Dusseldorf; University of Duisburg Essen; Ruhr University Bochum; Ulm University; Technische Universitat Dresden; Ruprecht Karls University Heidelberg	Baldus, CD (corresponding author), Univ Hosp Berlin, Dept Hematol & Oncol, Charite, Campus Benjamin Franklin, Berlin, Germany.	claudia.baldus@charite.de	Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536; Blau, Olga/0000-0002-4304-5079; Brandts, Christian H./0000-0003-1732-2535; Burmeister, Thomas/0000-0003-4843-2876; Schwartz, Stefan/0000-0001-8833-5793; Coskun, Ebru/0000-0001-5045-2003; Bartram, Isabelle/0000-0003-1035-8084	Berliner Krebsgesellschaft; Deutsche Krebshilfe	Berliner Krebsgesellschaft; Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by research funding from Berliner Krebsgesellschaft and Deutsche Krebshilfe to C.D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Asnafi V, 2009, BLOOD, V113, P3918, DOI 10.1182/blood-2008-10-184069; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Blom B, 1999, BLOOD, V93, P3033; Brandts CH, 2005, CANCER RES, V65, P9643, DOI 10.1158/0008-5472.CAN-05-0422; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; Bruggemann M, 2006, BLOOD, V107, P1116, DOI 10.1182/blood-2005-07-2708; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; Cascavilla N, 1998, HAEMATOLOGICA, V83, P392; Chillon MC, 2012, LEUKEMIA, V26, P2360, DOI 10.1038/leu.2012.161; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gokbuget Nicola, 2006, Hematology Am Soc Hematol Educ Program, P133; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; GUNJI Y, 1993, BLOOD, V82, P3283; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Heesch S, 2010, LEUKEMIA, V24, P1429, DOI 10.1038/leu.2010.130; Heesch S, 2010, HAEMATOL-HEMATOL J, V95, P942, DOI 10.3324/haematol.2009.016386; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Hoehn D, 2012, AM J CLIN PATHOL, V137, P213, DOI 10.1309/AJCPR3N3JMSYLPFG; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; IKEDA H, 1991, BLOOD, V78, P2962; Inukai T, 2012, BRIT J HAEMATOL, V156, P358, DOI 10.1111/j.1365-2141.2011.08955.x; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Neumann M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.49; Paganin M, 2010, BLOOD REV; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Paietta E, 2010, BEST PRACT RES CL HA, V23, P359, DOI 10.1016/j.beha.2010.08.001; Paschka P, 2008, J CLIN ONCOL, V26, P4595, DOI 10.1200/JCO.2007.15.2058; Pemmaraju N, 2011, CANCER-AM CANCER SOC, V117, P3293, DOI 10.1002/cncr.25908; Pratz KW, 2010, BLOOD, V115, P1425, DOI 10.1182/blood-2009-09-242859; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; REUSSBORST MA, 1994, LEUKEMIA, V8, P258; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Sanz M, 2009, CURR OPIN ONCOL, V21, P594, DOI 10.1097/CCO.0b013e32833118fd; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Vlierberghe P, 2005, BLOOD, V106, P4414, DOI 10.1182/blood-2005-06-2267; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	52	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53190	10.1371/journal.pone.0053190	http://dx.doi.org/10.1371/journal.pone.0053190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359050	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600011
J	Nishikimi, T; Okamoto, H; Nakamura, M; Ogawa, N; Horii, K; Nagata, K; Nakagawa, Y; Kinoshita, H; Yamada, C; Nakao, K; Minami, T; Kuwabara, Y; Kuwahara, K; Masuda, I; Kangawa, K; Minamino, N; Nakao, K				Nishikimi, Toshio; Okamoto, Hiroyuki; Nakamura, Masahiro; Ogawa, Naoko; Horii, Kazukiyo; Nagata, Kiyoshi; Nakagawa, Yasuaki; Kinoshita, Hideyuki; Yamada, Chinatsu; Nakao, Kazuhiro; Minami, Takeya; Kuwabara, Yoshihiro; Kuwahara, Koichiro; Masuda, Izuru; Kangawa, Kenji; Minamino, Naoto; Nakao, Kazuwa			Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MOLECULAR-FORMS; NT-PROBNP; PRECURSOR	Background: Recent studies have shown that in addition to brain (or B-type) natriuretic peptide (BNP) and the N-terminal proBNP fragment, levels of intact proBNP are also increased in heart failure. Moreover, present BNP immunoassays also measure proBNP, as the anti-BNP antibody cross-reacts with proBNP. It is important to know the exact levels of proBNP in heart failure, because elevation of the low-activity proBNP may be associated with the development of heart failure. Methodology/Principal Findings: We therefore established a two-step immunochemiluminescent assay for total BNP (BNP+proBNP) and proBNP using monoclonal antibodies and glycosylated proBNP as a standard. The assay enables measurement of plasma total BNP and proBNP within only 7 h, without prior extraction of the plasma. The detection limit was 0.4 pmol/L for a 50-mu l plasma sample. Within-run CVs ranged from 5.2%-8.0% in proBNP assay and from 7.0%-8.4% in total BNP assay, and between-run CVs ranged from 5.3-7.4% in proBNP assay and from 2.9%-9.5% in total BNP assay, respectively. The dilution curves for plasma samples showed good linearity (correlation coefficients = 0.998-1.00), and analytical recovery was 90-101%. The mean total BNP and proBNP in plasma from 116 healthy subjects were 1.4 +/- 1.2 pM and 1.0 +/- 0.7 pM, respectively, and were 80 +/- 129 pM and 42 +/- 70 pM in 32 heart failure patients. Plasma proBNP levels significantly correlate with age in normal subjects. Conclusions/Significance: Our immunochemiluminescent assay is sufficiently rapid and precise for routine determination of total BNP and proBNP in human plasma.	[Nishikimi, Toshio; Nakagawa, Yasuaki; Kinoshita, Hideyuki; Yamada, Chinatsu; Nakao, Kazuhiro; Minami, Takeya; Kuwabara, Yoshihiro; Kuwahara, Koichiro; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Okamoto, Hiroyuki; Nakamura, Masahiro; Ogawa, Naoko; Horii, Kazukiyo; Nagata, Kiyoshi] Shionogi & Co Ltd, Div Diagnost, Osaka 553, Japan; [Masuda, Izuru] Takeda Hosp, Medial Examinat Ctr, Kyoto, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovascular Ctr, Res Inst, Dept Biochem, Osaka, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovascular Ctr, Res Inst, Dept Mol Pharmacol, Osaka, Japan	Kyoto University; Shionogi & Company Limited	Nishikimi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	nishikim@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Kuwabara, Yoshihiro/0000-0003-4161-2970	Ministry of Education, Culture, Sports, Science and Technology of Japan [20590837, 23591041]; Japan Science and Technology Agency [232Z01 302F]; Suzuken Memorial Foundation; Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan; Grants-in-Aid for Scientific Research [24659386, 24591095, 21229013] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Suzuken Memorial Foundation; Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Scientific Research Grants-in-Aid 20590837 and 23591041 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Nishikimi); a grant (AS 232Z01 302F) from the Japan Science and Technology Agency (to T. Nishikimi); a grant from the Suzuken Memorial Foundation (to T. Nishikimi); and the Intramural Research Fund of National Cerebral and Cardiovascular Center of Japan (to N. Minamino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Hammerer-Lercher A, 2008, CLIN CHEM, V54, P858, DOI 10.1373/clinchem.2007.090266; Heublein DM, 2007, HYPERTENSION, V49, P1114, DOI 10.1161/HYPERTENSIONAHA.106.081083; ISHIKAWA E, 1983, J IMMUNOASSAY, V4, P209, DOI 10.1080/15321818308057011; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Liang FQ, 2007, J AM COLL CARDIOL, V49, P1071, DOI 10.1016/j.jacc.2006.10.063; Maisel AS, 2011, INT HEART J, V52, P253, DOI 10.1536/ihj.52.253; Menon Santosh G, 2009, Clin Cardiol, V32, pE36, DOI 10.1002/clc.20480; Minamino N, 2006, HDB BIOL ACTIVE PEPT, P1217, DOI 10.1016/B978-012369442-3/50168-9; Nishikimi T, 2010, HEART, V96, P432, DOI 10.1136/hrt.2009.178392; Nishikimi T, 2007, HYPERTENSION, V50, pE163, DOI 10.1161/HYPERTENSIONAHA.107.098350; Nishikimi T, 2012, HEART, V98, P152, DOI 10.1136/heartjnl-2011-300102; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Seferian KR, 2008, CLIN CHEM, V54, P866, DOI 10.1373/clinchem.2007.100040; Seferian KR, 2007, CLIN CHEM, V53, P866, DOI 10.1373/clinchem.2006.076141; Semenov AG, 2011, CLIN CHIM ACTA, V412, P850, DOI 10.1016/j.cca.2011.03.006; Tsuji T, 2004, U.S. Patent, P16, Patent No. [6677124, 6, 677, 124 B2]; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051	19	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53233	10.1371/journal.pone.0053233	http://dx.doi.org/10.1371/journal.pone.0053233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365636	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600013
J	Strnad, P; von Figura, G; Gruss, R; Jareis, KM; Stiehl, A; Kulaksiz, H				Strnad, Pavel; von Figura, Guido; Gruss, Regina; Jareis, Katja-Marlen; Stiehl, Adolf; Kulaksiz, Hasan			Oblique Bile Duct Predisposes to the Recurrence of Bile Duct Stones	PLOS ONE			English	Article							RISK-FACTORS; GALLSTONE DISEASE; MANAGEMENT; CHOLEDOCHOLITHIASIS; SPHINCTEROTOMY	Background and Study Aims: Bile stones represent a highly prevalent condition and abnormalities of the biliary tree predispose to stone recurrence due to development of biliary stasis. In our study, we assessed the importance of an altered bile duct course for stone formation. Patients and Methods: 1,307 patients with choledocholithiasis in the absence of any associated hepatobiliary disease who underwent endoscopic retrograde cholangiopancreatography (ERCP) between 2002 and 2009 were analysed. The angle enclosed between the horizontal portion of the common bile duct (CBD) and the horizontal plane was measured (angle alpha). Oblique common bile duct (OCBD) was defined as a CBD with angle alpha<45 degrees. Results: 103 patients (7.9%) were found to harbour OCBD and these were compared to 104 randomly selected control subjects. Compared to controls, OCBD patients were (i) significantly older (72613 vs. 67613, p < 0.00001); (ii) more frequently underwent a cholecystectomy (p = 0.02) and biliary surgery (p = 0.003) prior to the diagnosis and (iii) more often developed chronic pancreatitis (p = 0.04) as well as biliary fistulae (p = 0.03). Prior to and after ERCP, OCBD subjects displayed significantly elevated cholestatic parameters and angle a negatively correlated with common bile duct diameter (r = -0.29, p = 0.003). OCBD subjects more often required multiple back-to-back ERCP sessions to remove bile stones (p = 0.005) as well as more ERCPs later on due to recurrent stone formation (p < 0.05). Conclusion: OCBD defines a novel variant of the biliary tree, which is associated with chronic cholestasis, hampers an efficient stone removal and predisposes to recurrence of bile duct stones.	[Strnad, Pavel; von Figura, Guido; Gruss, Regina; Jareis, Katja-Marlen; Kulaksiz, Hasan] Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany; [Strnad, Pavel] Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany; [Strnad, Pavel] Univ Hosp Aachen, IZKF, Aachen, Germany; [Stiehl, Adolf] Univ Med Ctr Heidelberg, Dept Internal Med 1, Div Gastroenterol, Heidelberg, Germany; [Kulaksiz, Hasan] Hosp Waldshut Tiengen, Dept Internal Med 2, Waldshut Tiengen, Germany	Ulm University; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Ruprecht Karls University Heidelberg	Strnad, P (corresponding author), Univ Med Ctr Ulm, Dept Internal Med 1, Ulm, Germany.	pstrnad@ukaachen.de; Hasan.Kulaksiz@spital-waldshut.de			Emmy Noether program of the German Research Foundation [STR 1095/2-1]	Emmy Noether program of the German Research Foundation(German Research Foundation (DFG))	This work was supported by the Emmy Noether program of the German Research Foundation STR 1095/2-1 (P. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2003, GUT, V52, P116, DOI 10.1136/gut.52.1.116; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Chathadi Krishnavel V, 2003, Semin Gastrointest Dis, V14, P199; Cheon YK, 2006, EUR J GASTROEN HEPAT, V18, P461, DOI 10.1097/00042737-200605000-00001; Costamagna G, 2002, ENDOSCOPY, V34, P273, DOI 10.1055/s-2002-23632; Frossard JL, 2010, GASTROINTEST ENDOSC, V72, P808, DOI 10.1016/j.gie.2010.06.033; Geenen DJ, 1998, ENDOSCOPY, V30, P18, DOI 10.1055/s-2007-993722; Kim DI, 2001, GASTROINTEST ENDOSC, V54, P42, DOI 10.1067/mge.2001.115335; Lammert F, 2008, J HEPATOL, V48, pS124, DOI 10.1016/j.jhep.2008.01.012; Li ZF, 2007, HEPATOB PANCREAT DIS, V6, P67; MADDEN JL, 1973, SURG CLIN N AM, V53, P1095; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; RIZO RJ, 1995, RADIOGRAPHICS, V15, P49, DOI 10.1148/radiographics.15.1.7899613; SIEG A, 1986, DEUT MED WOCHENSCHR, V111, P1760, DOI 10.1055/s-2008-1068706; Tazuma S, 2006, BEST PRACT RES CL GA, V20, P1075, DOI 10.1016/j.bpg.2006.05.009; Williams EJ, 2008, GUT, V57, P1004, DOI 10.1136/gut.2007.121657	16	15	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54601	10.1371/journal.pone.0054601	http://dx.doi.org/10.1371/journal.pone.0054601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365676	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600078
J	Thomson, DW; Bracken, CP; Szubert, JM; Goodall, GJ				Thomson, Daniel W.; Bracken, Cameron P.; Szubert, Jan M.; Goodall, Gregory J.			On Measuring miRNAs after Transient Transfection of Mimics or Antisense Inhibitors	PLOS ONE			English	Article							ENDONUCLEOLYTIC CLEAVAGE; RNA; MICRORNAS; DEGRADOME; DELIVERY; SITES	The ability to alter microRNA (miRNA) abundance is crucial for studying miRNA function. To achieve this there is widespread use of both exogenous double-stranded miRNA mimics for transient over-expression, and single stranded antisense RNAs (antimiRs) for miRNA inhibition. The success of these manipulations is often assessed using qPCR, but this does not accurately report the level of functional miRNA. Here, we draw attention to this discrepancy, which is overlooked in many published reports. We measured the functionality of exogenous miRNA by comparing the total level of transfected miRNA in whole cell extracts to the level of miRNA bound to Argonaute following transfection and show that the supraphysiological levels of transfected miRNA frequently seen using qPCR do not represent the functional levels, because the majority of transfected RNA that is detected is vesicular and not accessible for loading into Argonaute as functionally active miRNAs. In the case of microRNA inhibition by transient transfection with antisense inhibitors, there is also the potential for discrepancy, because following cell lysis the abundant inhibitor levels from cellular vesicles can directly interfere with the PCR reaction used to measure miRNA level.	[Thomson, Daniel W.; Bracken, Cameron P.; Szubert, Jan M.; Goodall, Gregory J.] S Australia Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Thomson, Daniel W.; Bracken, Cameron P.; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), S Australia Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	greg.goodall@health.sa.gov.au		Bracken, Cameron/0000-0001-7722-625X; Thomson, Daniel/0000-0001-8890-4263; Goodall, Gregory/0000-0003-1294-0692	PhD scholarship from Adelaide University; National Breast Cancer Foundation Australia; National Health and Medical Research Council; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	PhD scholarship from Adelaide University; National Breast Cancer Foundation Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by a PhD scholarship from Adelaide University (to DWT), a fellowship from the National Breast Cancer Foundation Australia (to CPB) and by grants from the National Health and Medical Research Council (to GJG and CPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bracken CP, 2011, NUCLEIC ACIDS RES, V39, P5658, DOI 10.1093/nar/gkr110; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005	12	86	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55214	10.1371/journal.pone.0055214	http://dx.doi.org/10.1371/journal.pone.0055214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358900	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600160
J	Yang, Q; Du, J; Yao, X				Yang, Qing; Du, Jun; Yao, Xin			Significant Association of Glutathione S-Transferase T1 Null Genotype with Prostate Cancer Risk: A Meta-Analysis of 26,393 Subjects	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; P1 POLYMORPHISMS; CANDIDATE GENES; GSTT1; GSTM1; SUSCEPTIBILITY; GSTP1; M1; SMOKING; POPULATIONS	Background: Recent studies on the association between Glutathione S-transferase T1 (GSTT1) polymorphism and risk of prostate cancer showed inconclusive results. To clarify this possible association, we conducted a meta-analysis of published studies. Methods: Data were collected from the following electronic databases: Pubmed, Embase, and Chinese Biomedical Database (CBM). The odds ratio (OR) and its 95% confidence interval (95% CI) was used to assess the strength of the association. We summarized the data on the association between GSTT1 null genotype and risk of prostate cancer in the overall population, and performed subgroup analyses by ethnicity, adjusted ORs, and types of controls. Results: Ultimately, a total of 43 studies with a total of 26,393 subjects (9,934 cases and 16,459 controls) were eligible for meta-analysis. Overall, there was a significant association between GSTT1 null genotype and increased risk of prostate cancer (OR = 1.14, 95% CI 1.01-1.29, P = 0.034). Meta-analysis of adjusted ORs also showed a significant association between GSTT1 null genotype and increased risk of prostate cancer (OR = 1.34, 95% CI 1.09-1.64, P = 0.006). Similar results were found in the subgroup analyses by ethnicity and types of controls. Conclusion: This meta-analysis demonstrates that GSTT1 null genotype is associated with prostate cancer susceptibility, and GSTT1 null genotype contributes to increased risk of prostate cancer.	[Yang, Qing; Du, Jun; Yao, Xin] Tianjin Med Univ, Canc Hosp, Dept Genitourinary Oncol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University	Yang, Q (corresponding author), Tianjin Med Univ, Canc Hosp, Dept Genitourinary Oncol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	yangqing951@yahoo.cn						Agalliu I, 2006, PROSTATE, V66, P146, DOI 10.1002/pros.20305; Ashtiani ZO, 2011, PATHOL ONCOL RES, V17, P269, DOI 10.1007/s12253-010-9309-z; Autrup JLC, 1999, EUR J CANCER PREV, V8, P525, DOI 10.1097/00008469-199912000-00008; Beer TM, 2002, PROSTATE CANCER P D, V5, P22, DOI 10.1038/sj/pcan/4500549; Caceres DD, 2005, EUR J EPIDEMIOL, V20, P79, DOI 10.1007/s10654-004-1632-9; Catsburg C, 2012, CARCINOGENESIS; Chen XX, 2011, CYTOKINE, V56, P477, DOI 10.1016/j.cyto.2011.06.008; Choubey VK, 2012, PROSTATE; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Davydova N. A., 2008, Urologiya (Moscow), P26; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Figer A, 2003, ISRAEL MED ASSOC J, V5, P741; Gilligan T, 2010, CLIN PROSTATE CANC, V3, P98; Gsur A, 2001, INT J CANCER, V95, P152, DOI 10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Katoh T, 2008, PHARMACOGENOMICS, V9, P93, DOI 10.2217/14622416.9.1.93; Kelada SN, 2000, CANCER EPIDEM BIOMAR, V9, P1329; Kidd LR, 2003, EUR J CANCER PREV, V12, P317, DOI 10.1097/00008469-200308000-00012; Komiya Y, 2005, J CANCER RES CLIN, V131, P238, DOI 10.1007/s00432-004-0634-z; Kote-Jarai Z, 2001, PHARMACOGENETICS, V11, P325, DOI 10.1097/00008571-200106000-00007; Kumar V, 2011, DIS MARKERS, V30, P163, DOI [10.1155/2011/624961, 10.3233/DMA-2011-0774]; Kwon DD, 2011, KOREAN J UROL, V52, P247, DOI 10.4111/kju.2011.52.4.247; Lavender NA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-397; Lima MM, 2008, FOLIA BIOL-PRAGUE, V54, P102; Lindstrom S, 2006, PROSTATE, V66, P1729, DOI 10.1002/pros.20489; Mallick S, 2007, UROLOGY, V69, P1165, DOI 10.1016/j.urology.2007.02.039; MANTEL N, 1959, J NATL CANCER I, V22, P719; Medeiros R, 2004, PROSTATE, V58, P414, DOI 10.1002/pros.10348; Mittal R D, 2004, Indian J Cancer, V41, P115; Mittal Rama Devi, 2006, Asian Pac J Cancer Prev, V7, P444; Mo ZN, 2009, PROSTATE, V69, P662, DOI 10.1002/pros.20907; Murata M, 2001, CANCER LETT, V165, P171, DOI 10.1016/S0304-3835(01)00398-6; Nakazato H, 2003, ANTICANCER RES, V23, P2897; Nam RK, 2005, CLIN CANCER RES, V11, P8391, DOI 10.1158/1078-0432.CCR-05-1226; Nam RK, 2003, CANCER EPIDEM BIOMAR, V12, P1429; Nock NL, 2006, CANCER EPIDEM BIOMAR, V15, P756, DOI 10.1158/1055-9965.EPI-05-0826; Nock NL, 2009, CANCER CAUSE CONTROL, V20, P1915, DOI 10.1007/s10552-009-9385-0; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176; Rebbeck TR, 1999, CANCER EPIDEM BIOMAR, V8, P283; Rodrigues IS, 2011, UROL ONCOL-SEMIN ORI, V29, P654, DOI 10.1016/j.urolonc.2010.01.009; Safarinejad MR, 2011, PROSTATE CANCER P D, V14, P105, DOI 10.1038/pcan.2010.54; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Silig Y, 2006, CANCER INVEST, V24, P41, DOI 10.1080/07357900500449579; Sivonova M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-32; Souiden Y, 2010, CANCER EPIDEMIOL, V34, P598, DOI 10.1016/j.canep.2010.06.002; Srivastava DSL, 2005, BJU INT, V95, P170, DOI 10.1111/j.1464-410X.2005.05271.x; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P135, DOI 10.1158/1055-9965.EPI-09-0660; Steinhoff C, 2000, ARCH TOXICOL, V74, P521, DOI 10.1007/s002040000161; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Taioli E, 2011, CARCINOGENESIS, V32, P1361, DOI 10.1093/carcin/bgr119; Thakur H, 2011, MOL BIOL REP, V38, P1733, DOI 10.1007/s11033-010-0287-8; Van Hemelrijck M, 2012, NUTR CANCER, V64, P704, DOI 10.1080/01635581.2012.678548; Wang B, 2010, J HEPATOL, V53, P508, DOI 10.1016/j.jhep.2010.03.026; [王亚林 Wang Yalin], 2005, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V27, P1039; Xu DH, 2011, ASIAN PAC J CANCER P, V12, P2279; Yang J, 2006, FRONT BIOSCI-LANDMRK, V11, P2052; Ye Z, 2006, PLOS MED, V3, P524, DOI 10.1371/journal.pmed.0030091	67	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53700	10.1371/journal.pone.0053700	http://dx.doi.org/10.1371/journal.pone.0053700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365641	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600020
J	Ye, JR; Xin, RL; Yu, SQ; Bai, LS; Wang, WS; Wu, TC; Su, XL; Lu, HY; Pang, XH; Yan, H; Feng, X; He, X; Zeng, Y				Ye, Jingrong; Xin, Ruolei; Yu, Shuangqing; Bai, Lishi; Wang, Weishi; Wu, Tingchen; Su, Xueli; Lu, Hongyan; Pang, Xinghuo; Yan, Hong; Feng, Xia; He, Xiong; Zeng, Yi			Phylogenetic and Temporal Dynamics of Human Immunodeficiency Virus Type 1 CRF01_AE in China	PLOS ONE			English	Article							HIV-1; SUBTYPES; GUANGXI	To explore the epidemic history of HIV-1 CRF01_AE in China, 408 fragments of gag gene sequences of CRF01_AE sampled in 2002-2010 were determined from different geographical regions and risk populations in China. Phylogenetic analysis indicates that the CRF01_AE sequences can be grouped into four clusters, suggesting that at least four genetically independent CRF01_AE descendants are circulating in China, of which two were closely related to the isolates from Thailand and Vietnam. Cluster 1 has the most extensive distribution in China. In North China, cluster 1 and cluster 4 were mainly transmitted through homosexuality. The real substance of the recent HIV-1 epidemic in men who have sex with men(MSM) of North China is a rapid spread of CRF01_AE, or rather two distinctive natives CRF01_AE. The time of the most recent common ancestor (tMRCA) of four CRF01_AE clusters ranged from the years 1990.9 to 2003.8 in different regions of China. This is the first phylogenetic and temporal dynamics study of HIV-1 CRF01_AE in China.	[Ye, Jingrong; Xin, Ruolei; Bai, Lishi; Wu, Tingchen; Su, Xueli; Lu, Hongyan; Pang, Xinghuo; He, Xiong] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [Ye, Jingrong; Yan, Hong; Zeng, Yi] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Ye, Jingrong; Yu, Shuangqing; Feng, Xia; Zeng, Yi] China Ctr Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Weishi] Univ Toronto, Program Pharmacol & Toxicol, Toronto, ON, Canada	Beijing University of Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Toronto	Feng, X (corresponding author), China Ctr Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	fengxia621@126.com; hexiong200@sina.com; basketball197602@hotmail.com			China megaprojects in infectious diseases [2012ZX10001-005, 2012ZX10001-002]; College of Life Science and Bio-engineering, Beijing University of Technology; National Institute for Viral Disease Control and Prevention of China	China megaprojects in infectious diseases; College of Life Science and Bio-engineering, Beijing University of Technology; National Institute for Viral Disease Control and Prevention of China	This study was supported by China megaprojects in infectious diseases (2012ZX10001-005 and 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the entire laboratory members of Beijing Center for Disease Prevention and Control, College of Life Science and Bio-engineering, Beijing University of Technology and the National Institute for Viral Disease Control and Prevention of China for their support in carrying out this project.	Bontell I, 2012, INFECT GENET EVOL, V12, P448, DOI 10.1016/j.meegid.2011.04.034; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Cheng Chun-Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P720; CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025286, 10.1371/journal.pone.0018954]; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; MURPHY E, 1993, AIDS RES HUM RETROV, V9, P997, DOI 10.1089/aid.1993.9.997; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; The Ministry of Health of China, 2012, CHIN J AIDS STD, V18, P1; Xin RL, 2009, J GEN VIROL, V90, P1757, DOI 10.1099/vir.0.009290-0; Ye JR, 2012, AIDS RES HUM RETROV, V28, P119, DOI [10.1089/aid.2011.0012, 10.1089/AID.2011.0012]; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364	17	23	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54238	10.1371/journal.pone.0054238	http://dx.doi.org/10.1371/journal.pone.0054238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365653	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600040
J	Davis, KF; D'Odorico, P; Laio, F; Ridolfi, L				Davis, Kyle F.; D'Odorico, Paolo; Laio, Francesco; Ridolfi, Luca			Global Spatio-Temporal Patterns in Human Migration: A Complex Network Perspective	PLOS ONE			English	Article							INTERNATIONAL MIGRATION; ENVIRONMENTAL REFUGEES; REMITTANCES; DYNAMICS	Migration is a powerful adaptive strategy for humans to navigate hardship and pursue a better quality of life. As a universal vehicle facilitating exchanges of ideas, culture, money and goods, international migration is a major contributor to globalization. Consisting of countries linked by multiple connections of human movements, global migration constitutes a network. Despite the important role of human migration in connecting various communities in different parts of the world, the topology and behavior of the international migration network and its changes through time remain poorly understood. Here we show that the global human migration network became more interconnected during the latter half of the twentieth century and that migrant destination choice partly reflects colonial and postcolonial histories, language, religion, and distances. From 1960 to 2000 we found a steady increase in network transitivity (i.e. connectivity between nodes connected to the same node), a decrease in average path length and an upward shift in degree distribution, all of which strengthened the 'small-world' behavior of the migration network. Furthermore, we found that distinct groups of countries preferentially interact to form migration communities based largely on historical, cultural and economic factors.	[Davis, Kyle F.; D'Odorico, Paolo] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Laio, Francesco; Ridolfi, Luca] Politecn Torino, Dept Environm Land & Infrastruct Engn, Turin, Italy	University of Virginia; Polytechnic University of Turin	Davis, KF (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	kfd5zs@virginia.edu	D'Odorico, Paolo/A-5836-2008; Laio, Francesco/F-6203-2013	D'Odorico, Paolo/0000-0002-0007-5833; Laio, Francesco/0000-0003-3931-1482; RIDOLFI, Luca/0000-0003-2947-8641; Davis, Kyle/0000-0003-4504-1407	University of Virginia	University of Virginia	Research was funded by University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2005, WORLD DEV, V33, P1645, DOI 10.1016/j.worlddev.2005.05.004; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carr JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051247; Castles S, 2000, INT SOC SCI J, V52, P269, DOI 10.1111/1468-2451.00258; D'Odorico P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034007; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Hatton TJ, 2003, 200323 UNUWIDER; Henry S, 2003, APPL GEOGR, V23, P115, DOI 10.1016/j.apgeog.2002.08.001; Koser K, 2010, WORLD MIGRATION REPO; Laczko F., 2009, Migration, environment and climate change: assessing the evidence; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; LEE ES, 1966, DEMOGRAPHY, V3, P47, DOI 10.2307/2060063; McFalls JA, 2003, POPUL BULL, V58, P3; McNamara KE, 2007, POPUL ENVIRON, V29, P12, DOI 10.1007/s11111-007-0058-1; MYERS N, 1993, BIOSCIENCE, V43, P752, DOI 10.2307/1312319; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Parsons CR, 2007, INT MIGRATION EC DEV, P17, DOI [10.1596/1813-9450-4165, DOI 10.1596/1813-9450-4165]; Pedersen PJ, 2008, EUR ECON REV, V52, P1160, DOI 10.1016/j.euroecorev.2007.12.002; Perch-Nielsen S, 2008, CLIMATIC CHANGE, V91, P375, DOI 10.1007/s10584-008-9416-y; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Ratha D, 2007, 102 WORLD BANK, DOI [10.1596/978-0-8213-7072-8, DOI 10.1596/978-0-8213-7072-8]; SAHOTA GS, 1968, J POLIT ECON, V76, P218, DOI 10.1086/259395; Song CH, 2008, SENSORS-BASEL, V8, P5069, DOI 10.3390/s8085069; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; Taylor JE, 1999, INT MIGR, V37, P63, DOI 10.1111/1468-2435.00066; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; United Nations Development Program, 2009, OV BARR HUM MOB DEV; Vayrynen R, 2003, 200372 WIDER UNU; Waldorf B, 1996, ENVIRON PLANN A, V28, P631, DOI 10.1068/a280631; Walmsley TL, 2005, J ECON INTEGR, V20, P688, DOI 10.11130/jei.2005.20.4.688; Walmsley TL, 2007, 28 GTAP CTR GLOB TRA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	39	68	72	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e53723	10.1371/journal.pone.0053723	http://dx.doi.org/10.1371/journal.pone.0053723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077IQ	23372664	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500019
J	Hill, MS; Hill, AL; Lopez, J; Peterson, KJ; Pomponi, S; Diaz, MC; Thacker, RW; Adamska, M; Boury-Esnault, N; Cardenas, P; Chaves-Fonnegra, A; Danka, E; De Laine, BO; Formica, D; Hajdu, E; Lobo-Hajdu, G; Klontz, S; Morrow, CC; Patel, J; Picton, B; Pisani, D; Pohlmann, D; Redmond, NE; Reed, J; Richey, S; Riesgo, A; Rubin, E; Russell, Z; Rutzler, K; Sperling, EA; di Stefano, M; Tarver, JE; Collins, AG				Hill, Malcolm S.; Hill, April L.; Lopez, Jose; Peterson, Kevin J.; Pomponi, Shirley; Diaz, Maria C.; Thacker, Robert W.; Adamska, Maja; Boury-Esnault, Nicole; Cardenas, Paco; Chaves-Fonnegra, Andia; Danka, Elizabeth; De laine, Bre-Onna; Formica, Dawn; Hajdu, Eduardo; Lobo-Hajdu, Gisele; Klontz, Sarah; Morrow, Christine C.; Patel, Jignasa; Picton, Bernard; Pisani, Davide; Pohlmann, Deborah; Redmond, Niamh E.; Reed, John; Richey, Stacy; Riesgo, Ana; Rubin, Ewelina; Russell, Zach; Ruetzler, Klaus; Sperling, Erik A.; di Stefano, Michael; Tarver, James E.; Collins, Allen G.			Reconstruction of Family-Level Phylogenetic Relationships within Demospongiae (Porifera) Using Nuclear Encoded Housekeeping Genes	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; SPONGES PORIFERA; MARINE SPONGES; CALCAREOUS SPONGES; SEQUENCE ALIGNMENT; MOLECULAR CLOCKS; PHYLUM PORIFERA; FRESH-WATER; EVOLUTION; SYSTEMATICS	Background: Demosponges are challenging for phylogenetic systematics because of their plastic and relatively simple morphologies and many deep divergences between major clades. To improve understanding of the phylogenetic relationships within Demospongiae, we sequenced and analyzed seven nuclear housekeeping genes involved in a variety of cellular functions from a diverse group of sponges. Methodology/Principal Findings: We generated data from each of the four sponge classes (i.e., Calcarea, Demospongiae, Hexactinellida, and Homoscleromorpha), but focused on family-level relationships within demosponges. With data for 21 newly sampled families, our Maximum Likelihood and Bayesian-based approaches recovered previously phylogenetically defined taxa: Keratosa(p), Myxospongiae(p), Spongillida(p), Haploscleromorpha(p) (the marine haplosclerids) and Democlavia(p). We found conflicting results concerning the relationships of Keratosa(p) and Myxospongiae(p) to the remaining demosponges, but our results strongly supported a clade of Haploscleromorpha(p)+Spongillida(p)+Democlavia(p). In contrast to hypotheses based on mitochondrial genome and ribosomal data, nuclear housekeeping gene data suggested that freshwater sponges (Spongillida(p)) are sister to Haploscleromorpha(p) rather than part of Democlavia(p). Within Keratosa(p), we found equivocal results as to the monophyly of Dictyoceratida. Within Myxospongiae(p), Chondrosida and Verongida were monophyletic. A well-supported clade within Democlavia(p), Tetractinellida(p), composed of all sampled members of Astrophorina and Spirophorina (including the only lithistid in our analysis), was consistently revealed as the sister group to all other members of Democlavia(p). Within Tetractinellida(p), we did not recover monophyletic Astrophorina or Spirophorina. Our results also reaffirmed the monophyly of order Poecilosclerida (excluding Desmacellidae and Raspailiidae), and polyphyly of Hadromerida and Halichondrida. Conclusions/Significance: These results, using an independent nuclear gene set, confirmed many hypotheses based on ribosomal and/or mitochondrial genes, and they also identified clades with low statistical support or clades that conflicted with traditional morphological classification. Our results will serve as a basis for future exploration of these outstanding questions using more taxon- and gene-rich datasets.	[Hill, Malcolm S.; Hill, April L.; Danka, Elizabeth; De laine, Bre-Onna; Pohlmann, Deborah; Richey, Stacy; Russell, Zach; di Stefano, Michael] Univ Richmond, Gottwald Sci Ctr, Richmond, VA 23173 USA; [Lopez, Jose; Chaves-Fonnegra, Andia; Formica, Dawn; Patel, Jignasa; Rubin, Ewelina] Nova SE Univ, Oceanog Ctr, Dania, FL USA; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Pomponi, Shirley; Reed, John] Florida Atlantic Univ, Oceanog Inst, Harbor Branch, Ft Pierce, FL USA; [Diaz, Maria C.] Museo Marino de Margarita, Boca Del Rio, Nueva Esparta, Venezuela; [Thacker, Robert W.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Adamska, Maja] Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Boury-Esnault, Nicole] Univ Aix Marseille, CNRS, IMBE, UMR7263,Stn Marine Endoume, Marseille, France; [Cardenas, Paco] Uppsala Univ, Evolutionary Biol Ctr, Dept Systemat Biol, Uppsala, Sweden; [Hajdu, Eduardo] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Rio De Janeiro, Brazil; [Lobo-Hajdu, Gisele] Univ Estado Rio de Janeiro, IBRAG, Dept Genet, BR-20550011 Rio De Janeiro, Brazil; [Klontz, Sarah; Redmond, Niamh E.; Ruetzler, Klaus; Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Morrow, Christine C.] Queens Univ Belfast, Sch Biol Sci, MBC, Belfast, Antrim, North Ireland; [Picton, Bernard] Natl Museums No Ireland, Holywood, North Ireland; [Pisani, Davide; Tarver, James E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Pisani, Davide] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Riesgo, Ana] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sperling, Erik A.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Collins, Allen G.] Smithsonian Inst, Natl Museum Nat Hist, Natl Systemat Lab NOAAs Fisheries Serv, Washington, DC 20560 USA	University of Richmond; Nova Southeastern University; Dartmouth College; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Alabama System; University of Alabama Birmingham; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Uppsala University; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Smithsonian Institution; Smithsonian National Museum of Natural History; Queens University Belfast; University of Bristol; University of Bristol; Harvard University; Harvard University; Smithsonian Institution; Smithsonian National Museum of Natural History	Collins, AG (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	collinsa@si.edu	Lobo-Hajdu, Gisele/A-6709-2008; Peterson, Kevin J/A-2188-2009; Hill, Malcolm/B-6204-2015; Riesgo, Ana/E-3341-2014; Lopez, Jose V/F-8809-2011; Pisani, Davide/ABD-5225-2021; Adamska, Maja/M-4128-2014; Picton, Bernard/K-2482-2019; Adamska, Maja/L-3306-2015; Hajdu, Eduardo/C-3863-2009; Collins, Allen/A-7944-2008	Lobo-Hajdu, Gisele/0000-0001-7792-9609; Riesgo, Ana/0000-0002-7993-1523; Lopez, Jose V/0000-0002-1637-4125; Pisani, Davide/0000-0003-0949-6682; Adamska, Maja/0000-0002-4223-8450; Hajdu, Eduardo/0000-0002-8760-9403; Morrow, Christine/0000-0001-5686-8747; Collins, Allen/0000-0002-3664-9691; Chaves Fonnegra, Andia/0000-0002-6781-0089; Picton, Bernard/0000-0002-1500-2215; Danka, Elizabeth/0000-0001-5705-9466	National Science Foundation's Assembling the Tree of Life Program; DEB award [0829763, 0829783, 0829791, 0829986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; Direct For Biological Sciences [0829986, 0829763] Funding Source: National Science Foundation; Division Of Environmental Biology [0829791] Funding Source: National Science Foundation	National Science Foundation's Assembling the Tree of Life Program; DEB award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation's Assembling the Tree of Life Program (http://www.nsf.gov/funding/pgm_summ.jsp?pims_ id = 5129; DEB awards 0829763, 0829783, 0829791, and 0829986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Addis JS, 2005, ZOOL SCR, V34, P549, DOI 10.1111/j.1463-6409.2005.00211.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez B, 2000, ZOOL SCR, V29, P169, DOI 10.1046/j.1463-6409.2000.00029.x; [Anonymous], 2002, SYSTEMA PORIFERA GUI; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2000, HYDROBIOLOGIA, V420, P15, DOI 10.1023/A:1003996517083; Brain C, 2012, S AFR J SCI, V108, P658; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018318; CHOMBARD C, 1998, THESIS MUSEUM NATL H; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Cummins CA, 2011, SYST BIOL, V60, P833, DOI 10.1093/sysbio/syr064; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Paula TS, 2012, MOL PHYLOGENET EVOL, V62, P529, DOI 10.1016/j.ympev.2011.11.001; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Drummond A. J., 2006, GENEIOUS V1 2 1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ereskovsky AV, 2011, ZOOTAXA, P5, DOI 10.11646/zootaxa.2768.1.2; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1571, DOI 10.1017/S0025315407058201; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1563, DOI 10.1017/S0025315407058195; Erpenbeck D, 2012, MOL PHYLOGENET EVOL, V63, P809, DOI 10.1016/j.ympev.2012.02.024; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x; Ferrario F, 2010, ORG DIVERS EVOL, V10, P275, DOI 10.1007/s13127-010-0027-x; Fortunato S, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-14; Gazave E, 2010, MOL PHYLOGENET EVOL, V57, P35, DOI 10.1016/j.ympev.2010.05.028; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HAJDU E, 1994, SPONGES IN TIME AND SPACE, P123; Hajdu E, 1999, MEM QUEENSLAND MUS, V44, P225; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper JNA, 2002, SYSTEMA PORIFERA GUI, P169; Itskovich Valeria, 2007, V28, P383; Kelly-Borges Michelle, 1994, Molecular Marine Biology and Biotechnology, V3, P87; Kober KM, 2007, J MAR BIOL ASSOC UK, V87, P1585, DOI 10.1017/S0025315407058237; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; LAFAY B, 1992, BIOSYSTEMS, V28, P139, DOI 10.1016/0303-2647(92)90016-R; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Ma J, 2007, ACTA PALAEONTOLOGICA, V46, P480; Maldonado M., 2002, SYSTEMA PORIFERA GUI, P141, DOI DOI 10.1007/978-1-4615-0747-5_15; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; McCormack GP, 2002, J ZOOL SYST EVOL RES, V40, P237, DOI 10.1046/j.1439-0469.2002.00204.x; Milsom C., 2010, FOSSILS GLANCE; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Negandhi K, 2010, SYMBIOSIS, V51, P117, DOI 10.1007/s13199-010-0059-1; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pisani D, 2002, SYST BIOL, V51, P151, DOI 10.1080/106351502753475925; Pisera A., 2002, SYSTEMA PORIFERA GUI, P299, DOI DOI 10.1007/978-1-4615-0747-5_33; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Raleigh J, 2007, J MAR BIOL ASSOC UK, V87, P1577, DOI 10.1017/S0025315407058341; Rao JV, 2009, ENVIRON MONIT ASSESS, V156, P451, DOI 10.1007/s10661-008-0497-x; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Redmond NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024344; Reed John K., 1997, P1387; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; Ruetzler K., 2004, BOLL MUS IST BIOL UN, V68, P85; Rutzler K, 1990, 3 INT C BIOL SPONG, P344; Rutzler Klaus, 2000, Zoosystema, V22, P337; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Vacelet Jean, 2000, Zoosystema, V22, P313; Van Soest R.W.M., 2002, SYSTEMA PORIFERA GUI, P831; van Soest RWM, 2012, WORLD PORIFERA DATAB; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; West Lani, 1993, Molecular Marine Biology and Biotechnology, V2, P71; Worheide G, 2012, ADV MAR BIOL, V61, P1, DOI 10.1016/B978-0-12-387787-1.00007-6; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	89	37	38	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50437	10.1371/journal.pone.0050437	http://dx.doi.org/10.1371/journal.pone.0050437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372644	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500004
J	Verdugo, RA; Zeller, T; Rotival, M; Wild, PS; Munzel, T; Lackner, KJ; Weidmann, H; Ninio, E; Tregouet, DA; Cambien, F; Blankenberg, S; Tiret, L				Verdugo, Ricardo A.; Zeller, Tanja; Rotival, Maxime; Wild, Philipp S.; Muenzel, Thomas; Lackner, Karl J.; Weidmann, Henri; Ninio, Ewa; Tregouet, David-Alexandre; Cambien, Francois; Blankenberg, Stefan; Tiret, Laurence			Graphical Modeling of Gene Expression in Monocytes Suggests Molecular Mechanisms Explaining Increased Atherosclerosis in Smokers	PLOS ONE			English	Article							ENDOTHELIAL TRANSCRIPTIONAL PROFILES; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; 52 COUNTRIES; SMOKING; RISK; CORONARY; CELLS; LOCI	Smoking is a risk factor for atherosclerosis with reported widespread effects on gene expression in circulating blood cells. We hypothesized that a molecular signature mediating the relation between smoking and atherosclerosis may be found in the transcriptome of circulating monocytes. Genome-wide expression profiles and counts of atherosclerotic plaques in carotid arteries were collected in 248 smokers and 688 non-smokers from the general population. Patterns of co-expressed genes were identified by Independent Component Analysis (ICA) and network structure of the pattern-specific gene modules was inferred by the PC-algorithm. A likelihood-based causality test was implemented to select patterns that fit models containing a path "smoking -> gene expression -> plaques". Robustness of the causal inference was assessed by bootstrapping. At a FDR <= 0.10, 3,368 genes were associated to smoking or plaques, of which 93% were associated to smoking only. SASH1 showed the strongest association to smoking and PPARG the strongest association to plaques. Twenty-nine gene patterns were identified by ICA. Modules containing SASH1 and PPARG did not show evidence for the "smoking -> gene expression -> plaques" causality model. Conversely, three modules had good support for causal effects and exhibited a network topology consistent with gene expression mediating the relation between smoking and plaques. The network with the strongest support for causal effects was connected to plaques through SLC39A8, a gene with known association to HDL-cholesterol and cellular uptake of cadmium from tobacco, while smoking was directly connected to GAS6, a gene reported to have anti-inflammatory effects in atherosclerosis and to be up-regulated in the placenta of women smoking during pregnancy. Our analysis of the transcriptome of monocytes recovered genes relevant for association to smoking and atherosclerosis, and connected genes that before, were only studied in separate contexts. Inspection of correlation structure revealed candidates that would be missed by expression-phenotype association analysis alone.	[Verdugo, Ricardo A.; Rotival, Maxime; Weidmann, Henri; Ninio, Ewa; Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence] Univ Paris 06, INSERM, UMR S 937, Paris, France; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Muenzel, Thomas] Univ Med Ctr Mainz, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Thrombosis & Haemostasis, Mainz, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Verdugo, Ricardo A.] Univ Chile, Sch Med, Human Genet Program, Santiago, Chile; [Rotival, Maxime] Imperial Coll London, Hammersmith Hosp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Universidad de Chile; Imperial College London	Tiret, L (corresponding author), Univ Paris 06, INSERM, UMR S 937, Paris, France.	laurence.tiret@upmc.fr	Trégouët, David-Alexandre/P-9210-2019; Munzel, Thomas/A-2912-2014; Tregouet, David-Alexandre/E-3961-2016; Wild, Philipp S./M-2106-2019; Verdugo, Ricardo A/A-3970-2013; Cambien, Francois/AAP-9751-2020	Trégouët, David-Alexandre/0000-0001-9084-7800; Munzel, Thomas/0000-0001-5503-4150; Wild, Philipp/0000-0003-4413-9752; Verdugo, Ricardo/0000-0001-5668-5449; Zeller, Tanja/0000-0003-3379-2641; Rotival, Maxime/0000-0003-2519-8044	government of Rheinland-Pfalz [AZ 961-386261/733]; research programs "Wissen schafft Zukunft"; "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; Gutenberg Health Study; National Genome Network "NGFNplus" [A3 01GS0833]; Federal Ministry of Education and Research, Germany [BMBF 01KU0908A]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; Fondation pour la Recherche Medicale; Region Ile-de-France	government of Rheinland-Pfalz; research programs "Wissen schafft Zukunft"; "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; Gutenberg Health Study; National Genome Network "NGFNplus"; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France)	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation, contract number AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. Specifically, the research reported in this article was supported by the National Genome Network "NGFNplus" by the Federal Ministry of Education and Research, Germany (contract number project A3 01GS0833) and by a joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A) and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01) for the project CARDomics. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale and the Region Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2002, CAUSE CORRELATION BI; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruchova H, 2010, PLACENTA, V31, P186, DOI 10.1016/j.placenta.2009.12.016; Burridge KA, 2010, AM J PHYSIOL-HEART C, V299, pH837, DOI 10.1152/ajpheart.00002.2010; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Carey V, 2010, RBGL INTERFACE BOOST; Charlesworth JC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-29; Chickering D. M., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P87; Clauser S, 2012, THROMB HAEMOSTASIS, V107, P140, DOI 10.1160/TH11-05-0368; Conway DE, 2009, CARDIOVASC RES, V81, P669, DOI 10.1093/cvr/cvn360; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dumeaux V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000873; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gastaldelli A, 2010, CURR PHARM DESIGN, V16, P2526, DOI 10.2174/138161210792062858; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Lunceford JK, 2011, PHARM STAT, V10, P302, DOI 10.1002/pst.466; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marchini JL, 2010, FASTICA FASTICA ALGO; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; MCGILL HC, 1990, ADV EXP MED BIOL, V273, P9; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Murphy K.P., 1998, INFERENCE LEARNING H; Napolitano JR, 2012, AM J PHYSL LUNG CELL; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Neter J., 1996, APPL LINEAR STAT MOD; Norata GD, 2011, CURR OPIN LIPIDOL, V22, P410, DOI 10.1097/MOL.0b013e32834adac3; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 2010, SOCIOL METHODOL, V40, P75, DOI 10.1111/j.1467-9531.2010.01228.x; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Sales G, 2011, BIOINFORMATICS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spirtes P, 2001, CAUSATION PREDICTION; Spirtes P, 2010, J MACH LEARN RES, V11, P1643; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tjwa M, 2009, CURR OPIN LIPIDOL, V20, P386, DOI 10.1097/MOL.0b013e328330982e; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120; Yang Q, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S12; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang J, 2008, AM J PHYSIOL-HEART C, V295, pH1556, DOI 10.1152/ajpheart.00540.2008; Zhou YP, 2011, BIOL REPROD, V84, P1242, DOI 10.1095/biolreprod.110.087494	64	28	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e50888	10.1371/journal.pone.0050888	http://dx.doi.org/10.1371/journal.pone.0050888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372645	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500005
J	Bucciol, A; Houser, D; Piovesan, M				Bucciol, Alessandro; Houser, Daniel; Piovesan, Marco			Temptation at Work	PLOS ONE			English	Article							SELF-CONTROL; LIMITED RESOURCES; EGO DEPLETION	To encourage worker productivity, companies routinely adopt policies requiring employees to delay gratification. For example, offices might prohibit use of the internet for personal purposes during regular business hours. Recent work in social psychology, however, suggests that using willpower to delay gratification can negatively impact performance. We report data from an experiment where subjects in a Willpower Treatment are asked to resist the temptation to join others in watching a humorous video for 10 minutes. In relation to a baseline treatment that does not require willpower, we show that resisting this temptation detrimentally impacts economic productivity on a subsequent task.	[Bucciol, Alessandro] Univ Verona, Dept Econ, I-37100 Verona, Italy; [Houser, Daniel] George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA; [Piovesan, Marco] Univ Copenhagen, Inst Food & Resource Econ, Copenhagen, Denmark	University of Verona; George Mason University; University of Copenhagen	Houser, D (corresponding author), George Mason Univ, Interdisciplinary Ctr Econ Sci, Fairfax, VA 22030 USA.	dhouser@gmu.edu		Piovesan, Marco/0000-0002-5721-3053; Houser, Daniel/0000-0003-3583-8201; Bucciol, Alessandro/0000-0001-8163-7617	Centre for Experimental Economics (CEE); University of Copenhagen	Centre for Experimental Economics (CEE); University of Copenhagen	Financial support from the Centre for Experimental Economics (CEE) and the University of Copenhagen is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquist J, 2012, WIRES COGN SCI, V3, P419, DOI 10.1002/wcs.1173; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Baumeister RF, 2011, WILLPOWER REDISCOVER; Bucciol A, 2011, J ECON BEHAV ORGAN, V78, P126, DOI 10.1016/j.jebo.2010.12.013; Burger N, 2011, J ECON BEHAV ORGAN, V77, P393, DOI 10.1016/j.jebo.2010.11.010; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Greiner B, 2004, WORKING PAPER SERIES, V10; Houser D., 2008, CHECKING OUT TEMPTAT; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Malachowski D, 2007, WASTED TIME WORK STI; Miller EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038680; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Ozdenoren E, 2008, J EUROPEAN EC ASS, V10, P342; Vohs KD, 2012, J EXP SOC PSYCHOL, V48, P943, DOI 10.1016/j.jesp.2012.03.002; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250	16	14	14	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53713	10.1371/journal.pone.0053713	http://dx.doi.org/10.1371/journal.pone.0053713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382849	gold, Green Published			2022-12-27	WOS:000315563800024
J	Christensen, A; Borchers, S; Himmelbach, M				Christensen, Andrea; Borchers, Svenja; Himmelbach, Marc			Effects of Pictorial Cues on Reaching Depend on the Distinctiveness of Target Objects	PLOS ONE			English	Article							LEARNED PERCEPTUAL ASSOCIATIONS; FAMILIAR SIZE; DISTANCE; ILLUSION; PREHENSION; GRASP	There is an ongoing debate under what conditions learned object sizes influence visuomotor control under preserved stereovision. Using meaningful objects (matchboxes of locally well-known brands in the UK) a previous study has nicely shown that the recognition of these objects influences action programming by means of reach amplitude and grasp pre-shaping even under binocular vision. Using the same paradigm, we demonstrated that short-term learning of colour-size associations was not sufficient to induce any visuomotor effects under binocular viewing conditions. Now we used the same matchboxes, for which the familiarity effect was shown in the UK, with German participants who have never seen these objects before. We addressed the question whether simply a high degree of distinctness, or whether instead actual prior familiarity of these objects, are required to affect motor computations. We found that under monocular and binocular viewing conditions the learned size and location influenced the amplitude of the reaching component significantly. In contrast, the maximum grip aperture remained unaffected for binocular vision. We conclude that visual distinctness is sufficient to form reliable associations in short-term learning to influence reaching even for preserved stereovision. Grasp pre-shaping instead seems to be less susceptible to such perceptual effects.	[Christensen, Andrea; Borchers, Svenja; Himmelbach, Marc] Univ Tubingen, Div Neuropsychol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Christensen, Andrea; Borchers, Svenja; Himmelbach, Marc] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Christensen, Andrea] Univ Tubingen, Sect Computat Sensomotor, Hertie Inst Clin Brain Res, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Himmelbach, M (corresponding author), Univ Tubingen, Div Neuropsychol, Hertie Inst Clin Brain Res, Tubingen, Germany.	marc.himmelbach@uni-tuebingen.de		Himmelbach, Marc/0000-0002-7771-2968	European Union [ERC StG 211078, FP7-249858-TP3, FP7-ICT-248311]; Deutsche Forschungsgemeinschaft [GI 305/4-1]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the European Union (ERC StG 211078, FP7 Project TANGO (Grant FP7-249858-TP3), and AMARSi (Grant FP7-ICT-248311)) and the Deutsche Forschungsgemeinschaft Grant GI 305/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers S, 2011, NEUROPSYCHOLOGIA, V49, P556, DOI 10.1016/j.neuropsychologia.2010.12.018; Brenner E, 1996, EXP BRAIN RES, V111, P473; Coats R, 2008, EXP BRAIN RES, V189, P211, DOI 10.1007/s00221-008-1418-5; Dijkerman HC, 1996, EXP BRAIN RES, V112, P442; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GOGEL WC, 1969, Q J EXP PSYCHOL, V21, P239, DOI 10.1080/14640746908400218; GOGEL WC, 1971, PSYCHOL FORSCH, V35, P57, DOI 10.1007/BF00424475; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale MA, 2010, VISION RES; Haber RN, 2001, PERCEPT PSYCHOPHYS, V63, P1140, DOI 10.3758/BF03194530; Haffenden AM, 2002, EXP BRAIN RES, V147, P473, DOI 10.1007/s00221-002-1249-8; Haffenden AM, 2000, J COGNITIVE NEUROSCI, V12, P950, DOI 10.1162/08989290051137495; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; Jackson SR, 2000, J EXP PSYCHOL HUMAN, V26, P418, DOI 10.1037/0096-1523.26.1.418; JEANNEROD M, 1994, NEUROPSYCHOLOGIA, V32, P369, DOI 10.1016/0028-3932(94)90084-1; Kaufman L, 2006, SPATIAL VISION, V19, P439, DOI 10.1163/156856806778457377; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; Marotta JJ, 2001, J COGNITIVE NEUROSCI, V13, P8, DOI 10.1162/089892901564135; McIntosh RD, 2008, NEUROPSYCHOLOGIA, V46, P2441, DOI 10.1016/j.neuropsychologia.2008.03.003; Mon-Williams M, 2001, EXP BRAIN RES, V139, P127, DOI 10.1007/s002210000657; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parma V, 2011, EXP BRAIN RES, V212, P339, DOI 10.1007/s00221-011-2733-9; REDDING GM, 1985, COGNITIVE PSYCHOL, V17, P1, DOI 10.1016/0010-0285(85)90002-7; Westwood DA, 2000, EXP BRAIN RES, V134, P456, DOI 10.1007/s002210000489	25	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54230	10.1371/journal.pone.0054230	http://dx.doi.org/10.1371/journal.pone.0054230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382882	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800039
J	Touraine, S; Ea, HK; Bousson, V; Cohen-Solal, M; Laouisset, L; Chappard, C; Liote, F; Laredo, JD				Touraine, Sebastien; Ea, Hang Korng; Bousson, Valerie; Cohen-Solal, Martine; Laouisset, Liess; Chappard, Christine; Liote, Frederic; Laredo, Jean-Denis			Chondrocalcinosis of Femoro-Tibial and Proximal Tibio-Fibular Joints in Cadaveric Specimens: A High-Resolution CT Imaging Study of the Calcification Distribution	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; TIBIOFIBULAR JOINT; INORGANIC PYROPHOSPHATE; OSTEOARTHRITIS; KNEE; RADIOGRAPHY; PREVALENCE; DEPOSITION; CRYSTALS	Objectives: To analyze calcium deposits by computed tomography (CT) in femoro-tibial compartments and proximal tibio-fibular joints; to assess the relationship with CT-assessed osteoarthritis (OA). Methods: 68 (34 pairs) cadaveric knees (mean age of 84) were scanned at high resolution CT. Menisci and hyaline cartilage calcifications in the femoro-tibial and proximal tibio-fibular joints were analyzed. OA was CT-assessed by the Kellgren and Lawrence score. Gross appearance of OA was evaluated on 29 left knees after dissection and India ink staining of tibial plateaus. Results: In femoro-tibial joints, meniscal calcifications (MC) and hyaline cartilage calcifications (HCC) were detected in 23(34%) and 14(21%) knees respectively. Calcifications mainly involved the three meniscal segments and were mainly observed in all thirds of the femoro-tibial compartments. In proximal tibio-fibular joints, HCC were detected in 19(28%) knees. The association HCC-MC in femoro-tibial joints and between calcifications in femoro-tibial and proximal tibio-fibular joints was strong (p<0.0001). Femoro-tibial and proximal tibio-fibular CT-assessed OA were respectively found in 23(34%) and 19(28%) knees. HCC were significantly associated with femoro-tibial OA (p = 0.04) while MC were not (p = 0.34). OA macroscopic evaluation showed a mean surface of cartilage lesions of 35% (range 0.13-0.55). No significant difference was demonstrated regarding the CT-detection of MC, HCC or CT-assessed OA. Conclusions: This is the first study to report a strong association of chondrocalcinosis between femoro-tibial and tibio-fibular joints in addition to a strong association between MC and HCC in femoro-tibial compartments. No significant relationship between chondrocalcinosis and OA was demonstrated.	[Touraine, Sebastien; Bousson, Valerie; Laouisset, Liess; Chappard, Christine; Laredo, Jean-Denis] Univ Paris Diderot, CNRS UMR 7052, Lab B2OA, Hop Lariboisiere, Paris, France; [Ea, Hang Korng; Cohen-Solal, Martine; Liote, Frederic] Univ Paris Diderot, Inserm UMR 606, Hop Lariboisiere, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Touraine, S (corresponding author), Univ Paris Diderot, CNRS UMR 7052, Lab B2OA, Hop Lariboisiere, Paris, France.	sebastien.touraine@lrb.aphp.fr	Chappard, Christine/AAB-2613-2022; Liote, Frederic/AAD-6926-2020; Cohen-Solal, Martine/P-7808-2017; Ea, HK/P-5527-2016	Liote, Frederic/0000-0003-4419-0726; Cohen-Solal, Martine/0000-0002-8582-8258; Ea, HK/0000-0002-2393-7475				Abreu M, 2004, SKELETAL RADIOL, V33, P392, DOI 10.1007/s00256-004-0767-9; Bozkurt M, 2003, CLIN ORTHOP RELAT R, P136, DOI 10.1097/01.blo.0000030167.56585.2f; CHAN WP, 1991, AM J ROENTGENOL, V157, P799, DOI 10.2214/ajr.157.4.1892040; Cheung HS, 2006, ARTHRITIS RHEUM-US, V54, P2452, DOI 10.1002/art.22017; Dirim B, 2008, AM J ROENTGENOL, V191, pW44, DOI 10.2214/AJR.07.3406; Ea HK, 2011, P NATL ACAD SCI USA, V108, pE1361, DOI 10.1073/pnas.1114968108; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Espregueira-Mendes JD, 2006, KNEE SURG SPORT TR A, V14, P241, DOI 10.1007/s00167-005-0684-z; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Fuerst M, 2010, RHEUMATOL INT, V30, P623, DOI 10.1007/s00296-009-1032-2; Fuerst M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-166; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Liu YZ, 2009, OSTEOARTHR CARTILAGE, V17, P1333, DOI 10.1016/j.joca.2009.04.022; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McCarthy Geraldine M, 2009, Curr Rheumatol Rep, V11, P141; MITROVIC DR, 1983, ANN RHEUM DIS, V42, P19, DOI 10.1136/ard.42.Suppl_1.19; MITROVIC DR, 1988, J RHEUMATOL, V15, P633; Mitsuyama H, 2007, OSTEOARTHR CARTILAGE, V15, P559, DOI 10.1016/j.joca.2006.10.017; Neame RL, 2003, ANN RHEUM DIS, V62, P513, DOI 10.1136/ard.62.6.513; Nguyen C, 2009, REV RHUM, V76, P986; Nguyen C, 2011, J SYNCHROTRON RADIAT, V18, P475, DOI 10.1107/S0909049511006984; Nguyen C, 2010, ARTHRITIS RHEUM-US, V62, P2829, DOI 10.1002/art.27576; Ozcan O, 2009, KNEE, V16, P248, DOI 10.1016/j.knee.2008.12.013; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; RESNICK D, 1978, AM J ROENTGENOL, V131, P133, DOI 10.2214/ajr.131.1.133; Rosen F, 1997, ARTHRITIS RHEUM-US, V40, P1275, DOI 10.1002/art.12; ROSENTHAL AK, 1993, ARTHRITIS RHEUM, V36, P539, DOI 10.1002/art.1780360415; Rothschild B, 1996, J Clin Rheumatol, V2, P170, DOI 10.1097/00124743-199606000-00013; Rothschild Bruce, 1997, Comprehensive Therapy, V23, P327; Ru LB, 2005, JOINT BONE SPINE, V72, P295, DOI 10.1016/j.jbspin.2004.12.010; Suan JC, 2005, SKELETAL RADIOL, V34, P714, DOI 10.1007/s00256-005-0930-y; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thouverey C, 2009, OSTEOARTHR CARTILAGE, V17, P64, DOI 10.1016/j.joca.2008.05.020; Zhang W, 2011, ANN RHEUM DIS, V70, P571, DOI 10.1136/ard.2010.139360; ZITNAN D, 1963, ANN RHEUM DIS, V22, P142, DOI 10.1136/ard.22.3.142	37	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54955	10.1371/journal.pone.0054955	http://dx.doi.org/10.1371/journal.pone.0054955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372802	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400046
J	Goggs, R; Savage, JS; Mellor, H; Poole, AW				Goggs, Robert; Savage, Joshua S.; Mellor, Harry; Poole, Alastair W.			The Small GTPase Rif Is Dispensable for Platelet Filopodia Generation in Mice	PLOS ONE			English	Article							INTEGRIN ALPHA(IIB)BETA(3); RHO GTPASES; CDC42; ACTIVATION; MDIA1; INSIGHTS; COLLAGEN; KINASE; CELLS	Background: Formation of filopodia and other shape change events are vital for platelet hemostatic function. The mechanisms regulating filopodia formation by platelets are incompletely understood however. In particular the small GTPase responsible for initiating filopodia formation by platelets remains elusive. The canonical pathway involving Cdc42 is not essential for filopodia formation in mouse platelets. The small GTPase Rif (RhoF) provides an alternative route to filopodia generation in other cell types and is expressed in both human and mouse platelets. Hypothesis/Objective: We hypothesized that Rif might be responsible for generating filopodia by platelets and generated a novel knockout mouse model to investigate the functional role of Rif in platelets. Methodology/Principal Findings: Constitutive RhoF(-/-) mice are viable and have normal platelet, leukocyte and erythrocyte counts and indices. RhoF(-/-) platelets form filopodia and spread normally on various agonist surfaces in static conditions and under arterial shear. In addition, RhoF(-/-) platelets have normal actin dynamics, are able to activate and aggregate normally and secrete from alpha and dense granules in response to collagen related peptide and thrombin stimulation. Conclusions: The small GTPase Rif does not appear to be critical for platelet function in mice. Functional overlap between Rif and other small GTPases may be responsible for the non-essential role of Rif in platelets.	[Goggs, Robert; Savage, Joshua S.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Mellor, Harry] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol; University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Savage, Joshua/A-8738-2008	Savage, Joshua/0000-0003-0599-0245; Poole, Alastair/0000-0002-0868-297X; Goggs, Robert/0000-0001-7446-6987; Mellor, Harry/0000-0003-3894-0623	Wellcome Trust [WT090093MA]; British Heart Foundation [RG/05/083, RG/10/006/28299]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was funded by grant WT090093MA from the Wellcome Trust (www.wellcome.ac.uk/) awarded to RG, HM and AWP. JSS was supported by grant RG/05/083 awarded to AWP by the British Heart Foundation (www.bhf.org.uk/). Work in Prof. Alastair Poole's laboratory is also supported by a programme grant from the British Heart Foundation (Ref: RG/10/006/28299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022117; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; Eliautou S, 2009, THROMB HAEMOSTASIS, V102, P792, DOI 10.1160/TH09-06-0379; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hartwig JH, 2007, PLATELETS, 2ND EDITION, P75, DOI 10.1016/B978-012369367-9/50766-7; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jones ML, 2010, J THROMB HAEMOST, V8, P567, DOI 10.1111/j.1538-7836.2009.03719.x; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Pula G, 2008, PLATELETS, V19, P199, DOI 10.1080/09537100701777303; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; ROWLEY JW, 2011, BLOOD; Thomas SG, 2011, J THROMB HAEMOST, V9, P1648, DOI 10.1111/j.1538-7836.2011.04357.x; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958	31	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54663	10.1371/journal.pone.0054663	http://dx.doi.org/10.1371/journal.pone.0054663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359340	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600089
J	Pavoine, S; Blondel, J; Dufour, AB; Gasc, A; Bonsall, MB				Pavoine, Sandrine; Blondel, Jacques; Dufour, Anne B.; Gasc, Amandine; Bonsall, Michael B.			A New Technique for Analysing Interacting Factors Affecting Biodiversity Patterns: Crossed-DPCoA	PLOS ONE			English	Article							QUADRATIC ENTROPY; TAXONOMIC DISTINCTNESS; SPECIES-DIVERSITY; TRAIT DIVERSITY; COMMUNITIES; EVOLUTIONARY; RICHNESS; INDEXES	We developed an approach for analysing the effects of two crossed factors A and B on the functional, taxonomic or phylogenetic composition of communities. The methodology, known as crossed-DPCoA, defines a space where species, communities and the levels of the two factors are organised as a set of points. In this space, the Euclidean distance between two species-specific points is a measure of the (functional, taxonomic or phylogenetic) dissimilarity. The communities are positioned at the centroid of their constitutive species; and the levels of two factors at the centroid of the communities associated with them. We develop two versions for crossed-DPCoA, the first one moves the levels of factor B to the centre of the space and analyses the axes of highest variance in the coordinates of the levels of factor A. It is related to previous ordination approaches such as partial canonical correspondence analysis and partial non-symmetrical correspondence analysis. The second version projects all points on the orthogonal complement of the space generated by the principal axes of factor B. This second version should be preferred when there is an a priori suspicion that factor A and B are associated. We apply the two versions of crossed-DPCoA to analyse the phylogenetic composition of Central European and Mediterranean bird communities. Applying crossed-DPCoA on bird communities supports the hypothesis that allopatric speciation processes during the Quaternary occurred in open and patchily distributed landscapes, while the lack of geographic barriers to dispersal among forest habitats may explain the homogeneity of forest bird communities over the whole western Palaearctic. Generalizing several ordination analyses commonly used in ecology, crossed-DPCoA provides an approach for analysing the effects of crossed factors on functional, taxonomic and phylogenetic diversity, environmental and geographic structure of species niches, and more broadly the role of genetics on population structures.	[Pavoine, Sandrine; Gasc, Amandine] UPMC, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7204,CNRS, Paris, France; [Pavoine, Sandrine; Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Blondel, Jacques] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Dufour, Anne B.] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Gasc, Amandine] Museum Natl Hist Nat, CNRS, Dept Systemat & Evolut, UMR 7205, Paris, France; [Bonsall, Michael B.] Univ Oxford, St Peters Coll, Oxford, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Pavoine, S (corresponding author), UPMC, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7204,CNRS, Paris, France.	pavoine@mnhn.fr	Dufour, Anne-Béatrice/I-9475-2016	Dufour, Anne-Béatrice/0000-0002-9339-4293; Bonsall, Michael/0000-0003-0250-0423	national French MERT grant at the University of Lyon; European Commission (EIF-FP6, project OxPhyloDiv); Royal Society	national French MERT grant at the University of Lyon; European Commission (EIF-FP6, project OxPhyloDiv)(European Commission); Royal Society(Royal Society of London)	SP was first funded by a national French MERT grant (2002-2005) at the University of Lyon. SP and MBB would like to thank the European Commission (EIF-FP6, project OxPhyloDiv) and the Royal Society for supporting this collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; BLONDEL J, 1988, ECOLOGY, V69, P1899, DOI 10.2307/1941167; Blondel J, 1996, J EVOLUTION BIOL, V9, P871, DOI 10.1046/j.1420-9101.1996.9060871.x; Blondel J, 2000, VIE MILIEU, V50, P205; BLONDEL J, 1988, OECOLOGIA, V75, P83, DOI 10.1007/BF00378818; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J., 1995, BIOGEOGRAPHIE APPROC; Blondel J, 2008, J BIOGEOGR, V35, P509, DOI 10.1111/j.1365-2699.2007.01819.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Champely S, 2002, ENVIRON ECOL STAT, V9, P167, DOI 10.1023/A:1015170104476; Chessel D, 1987, REV STAT APPL, V35, P55; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; COX DR, 2000, THEORY DESIGN EXPT; Davis KE, 2008, THESIS U GLASGOW GLA; de Vienne DM, 2011, SYST BIOL, V60, P826, DOI 10.1093/sysbio/syr066; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Gusewell S, 2012, ECOL INDIC, V20, P134, DOI 10.1016/j.ecolind.2012.02.011; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Izsak J, 1995, ENVIRON ECOL STAT, V2, P213, DOI 10.1007/BF00456668; Lauro C, 1999, APPL STOCH MODEL D A, V15, P1; Lauro N, 1984, DATA ANAL INFORMATIC, P433; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; LIU ZJ, 1995, J STAT PLAN INFER, V43, P1, DOI 10.1016/0378-3758(94)00005-G; LYONS NI, 1981, AM NAT, V118, P438, DOI 10.1086/283836; Mayfield MM, 2009, AM NAT, V174, pE1, DOI 10.1086/599293; NAYAK TK, 1986, SANKHYA SER B, V48, P315; Nayak TK, 1983, THESIS U PITTSBURGH, P1; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; Pavoine S, 2005, ENVIRON ECOL STAT, V12, P125, DOI 10.1007/s10651-005-1037-2; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pavoine S, 2007, ECOLOGY, V88, P512, DOI 10.1890/05-1806; Pavoine S, 2010, ECOL MONOGR, V80, P485, DOI 10.1890/09-1290.1; Pavoine S, 2009, ECOL LETT, V12, P898, DOI [10.1111/j.1461-0248.2009.01348.x, 10.1111/j.1461-0248.2009.01344.x]; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Pavoine S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-156; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; POLLOCK DD, 1995, MOL BIOL EVOL, V12, P713; Pontier J, 1987, P 3 S DAT AN INS OUT, P49; Rao CR, 2010, SANKHYA SER A, V72, P70, DOI 10.1007/s13171-010-0016-3; Rao C. R., 1986, ENCY STAT SCI, V7, P614; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Rao CR, 1984, INEQUALITIES STAT PR, V5, P68, DOI DOI 10.1214/LNMS/1215465631; Ricotta C, 2005, ECOL MODEL, V183, P365, DOI 10.1016/j.ecolmodel.2004.08.020; SABATIER R, 1989, MULTIWAY DATA ANAL, P341; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Ter Braak CJF, 1987, UNIMODAL MODELS RELA, P83; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; YOCCOZ N, 1988, CR ACAD SCI III-VIE, V307, P189	62	13	13	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54530	10.1371/journal.pone.0054530	http://dx.doi.org/10.1371/journal.pone.0054530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359802	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600065
J	Pinchuk, IV; Morris, KT; Nofchissey, RA; Earley, RB; Wu, JY; Ma, TY; Beswick, EJ				Pinchuk, Irina V.; Morris, Katherine T.; Nofchissey, Robert A.; Earley, Rachel B.; Wu, Jeng-Yih; Ma, Thomas Y.; Beswick, Ellen J.			Stromal Cells Induce Th17 during Helicobacter pylori Infection and in the Gastric Tumor Microenvironment	PLOS ONE			English	Article							T-CELLS; UP-REGULATION; TGF-BETA; EXPRESSION; FIBROBLASTS; CANCER; IL-17; MYOFIBROBLASTS; GROWTH; DIFFERENTIATION	Gastric cancer is associated with chronic inflammation and Helicobacter pylori infection. Th17 cells are CD4(+) T cells associated with infections and inflammation; but their role and mechanism of induction during carcinogenesis is not understood. Gastric myofibroblasts/fibroblasts (GMF) are abundant class II MHC expressing cells that act as novel antigen presenting cells. Here we have demonstrated the accumulation of Th17 in H. pylori-infected human tissues and in the gastric tumor microenvironment. GMF isolated from human gastric cancer and H. pylori infected tissues co-cultured with CD4(+) T cells induced substantially higher levels of Th17 than GMF from normal tissues in an IL-6, TGF-beta, and IL-21 dependent manner. Th17 required interaction with class II MHC on GMF for activation and proliferation. These studies suggest that Th17 are induced during both H. pylori infection and gastric cancer in the inflammatory milieu of gastric stroma and may be an important link between inflammation and carcinogenesis.	[Pinchuk, Irina V.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Morris, Katherine T.] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Earley, Rachel B.; Beswick, Ellen J.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Wu, Jeng-Yih] Kaohsiung Med Univ, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Ma, Thomas Y.] Univ New Mexico, Dept Internal Med, Div Gastroenterol & Hepatol, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico; Kaohsiung Medical University; University of New Mexico	Beswick, EJ (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	ebeswick@salud.unm.edu	Pinchuk, Irina V/A-7227-2008	Pinchuk, Irina V/0000-0003-1505-5779	American Cancer Society [RSG-10-159-01-LIB]; National Institutes of Health [8UL1TR000041, 1U54RR02614]; The University of New Mexico Clinical and Translational Science Center; American Gastroenterological Association Research Scholar Award; The University of Texas Medical Branch Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071, UL1TR000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of New Mexico Clinical and Translational Science Center; American Gastroenterological Association Research Scholar Award; The University of Texas Medical Branch Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the American Cancer Society RSG-10-159-01-LIB, National Institutes of Health 8UL1TR000041, The University of New Mexico Clinical and Translational Science Center, American Gastroenterological Association Research Scholar Award, and National Institutes of Health 1U54RR02614 The University of Texas Medical Branch Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboyega PA, 2002, ARCH PATHOL LAB MED, V126, P829; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10; Caruso R, 2007, WORLD J GASTROENTERO, V13, P5547, DOI 10.3748/wjg.v13.i42.5547; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Ferraccioli G, 2011, DISCOV MED, V11, P413; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hendrix A, 2011, CLIN RES HEPATOL GAS, V35, P714, DOI 10.1016/j.clinre.2011.05.003; Howlader N, 2010, J NATL CANCER I, V102, P1584, DOI 10.1093/jnci/djq366; Iida T, 2011, ONCOL REP, V25, P1271, DOI 10.3892/or.2011.1201; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Liu T, 2012, INCREASED CIRCULATIN; Lossius A, 2011, J NEUROIMMUNOL, V240, P87, DOI 10.1016/j.jneuroim.2011.09.011; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Mojibian M, 2009, DIABETES, V58, P1789, DOI 10.2337/db08-1579; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Pinchuk IV, 2008, GASTROENTEROLOGY, V135, P1228, DOI 10.1053/j.gastro.2008.07.016; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; Rolig AS, 2011, P NATL ACAD SCI USA, V108, P19749, DOI 10.1073/pnas.1104598108; Schirmer C, 2010, BLOOD, V116, P1715, DOI 10.1182/blood-2010-01-263509; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Scotti C, 2010, HELICOBACTER, V15, P76, DOI 10.1111/j.1523-5378.2009.00733.x; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Suzuki Hidekazu, 2002, Keio J Med, V51 Suppl 2, P40; Tartour E, 1999, INTERLEUKIN 17 T CEL; Torpy Janet M, 2010, JAMA, V303, P1771, DOI 10.1001/jama.303.17.1771; Vogel JD, 2004, GASTROENTEROLOGY, V126, P63, DOI 10.1053/j.gastro.2003.10.046; Vykhovanets EV, 2011, INT J CLIN EXP PATHO, V4, P552; Wang L, 2010, IL 17 ENHANCES TUMOR; Wilke CM, 2011, TH17 CELLS CANC HELP; Yamada Y, 2012, PREVALENCE CLIN RELE; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015; Zhu X, 2008, IL 17 EXPRESSION BRE; Zhuang YA, 2011, IMMUNOBIOLOGY, V216, P200, DOI 10.1016/j.imbio.2010.05.005	45	38	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e53798	10.1371/journal.pone.0053798	http://dx.doi.org/10.1371/journal.pone.0053798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365642	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600022
J	Wiria, AE; Wammes, LJ; Hamid, F; Dekkers, OM; Prasetyani, MA; May, L; Kaisar, MMM; Verweij, JJ; Tamsma, JT; Partono, F; Sartono, E; Supali, T; Yazdanbakhsh, M; Smit, JWA				Wiria, Aprilianto Eddy; Wammes, Linda J.; Hamid, Firdaus; Dekkers, Olaf M.; Prasetyani, Margaretta A.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Tamsma, Jouke T.; Partono, Felix; Sartono, Erliyani; Supali, Taniawati; Yazdanbakhsh, Maria; Smit, Johannes W. A.			Relationship between Carotid Intima Media Thickness and Helminth Infections on Flores Island, Indonesia	PLOS ONE			English	Article							REGULATORY T-CELLS; CARDIOVASCULAR RISK-FACTORS; SCHISTOSOMA-JAPONICUM; NUTRITIONAL-STATUS; BLOOD-PRESSURE; CHILDREN; ATHEROSCLEROSIS; POPULATION; ASSOCIATION; ADOLESCENTS	Objective: To examine the association between helminth infections and atherosclerosis. Background: Chronic helminth infection, which can lead to poor nutritional status and anti-inflammatory response, might protect against the development of atherosclerosis. Methods: A cross-sectional study was performed in Flores, Indonesia, an area highly endemic for soil-transmitted helminths (STH). Stool samples from 675 participants aged 18-80 years were collected and screened for Trichuris trichiura by microscopy and for Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, and Strongyloides stercoralis by qPCR. We collected data on body mass index (BMI), waist to hip ratio (WHR), blood pressure, fasting blood glucose (FBG), lipid, high sensitive C-reactive protein (hs-CRP), total immunoglobulin-E (TIgE) and Escherichia coli lipopolysaccharide stimulated cytokines (tumor necrosis factor and interleukin-10). In a subset of 301 elderly adults (>= 40 years of age) carotid intima media thickness (cIMT) was measured. Results: Participants with any STH infection had lower BMI (kg/m2) (mean difference -0.66, 95%CI [-1.26, -0.06]), WHR (-0.01, [-0.02, -0.00]), total cholesterol (mmol/L) (-0.22, [-0.43, -0.01]) and LDL-cholesterol (mmol/L) (-0.20, [-0.39, -0.00]) than uninfected participants. After additional adjustment for BMI the association between helminth infection and total cholesterol (mean difference -0.17, 95%CI [-0.37, 0.03]) as well as LDL-cholesterol (-.15, [-0.33, 0.04]) was less pronounced. BMI, WHR, and total cholesterol were negatively associated with number species of helminth co-infections. Participants with high TIgE, an indicator of exposure to helminths, had lower FBG, TC, and HDL. The association between TIgE and TC and HDL remained significant after adjustment with BMI. No clear association was found between STH infection or TIgE and mean cIMT. Conclusions: This cross-sectional study presents evidence that helminth infections were negatively associated with risk factors for cardiovascular disease, an association at least partially mediated by an effect on BMI. The significance of this finding needs to be determined.	[Wiria, Aprilianto Eddy; Prasetyani, Margaretta A.; Kaisar, Maria M. M.; Partono, Felix; Supali, Taniawati] Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Wiria, Aprilianto Eddy; Wammes, Linda J.; Hamid, Firdaus; Prasetyani, Margaretta A.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Hamid, Firdaus] Hasanuddin Univ, Dept Microbiol, Fac Med, Makassar, Indonesia; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Dekkers, Olaf M.; Tamsma, Jouke T.; Smit, Johannes W. A.] Leiden Univ, Med Ctr, Dept Endocrinol & Gen Internal Med, Leiden, Netherlands; [Smit, Johannes W. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6525 ED Nijmegen, Netherlands	University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universitas Hasanuddin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Wiria, AE (corresponding author), Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.	a.e.wiria@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Smit, J.W.A./H-8091-2014; Wiria, Aprilianto Eddy/AAZ-2419-2021; Hamid, Firdaus/M-6862-2017	Yazdanbakhsh, Maria/0000-0002-7666-1441; Smit, J.W.A./0000-0003-1052-9314; Wiria, Aprilianto Eddy/0000-0002-6482-424X; Hamid, Firdaus/0000-0003-1788-0836; Verweij, Jaco J./0000-0001-8553-931X; Kaisar, Maria M. M./0000-0002-7515-7673; Dekkers, Olaf/0000-0002-1333-7580	Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436]; Prof. Dr. P.C. Flu Foundation	Royal Netherlands Academy of Arts and Science (KNAW); European Commission(European CommissionEuropean Commission Joint Research Centre); Prof. Dr. P.C. Flu Foundation	This study was funded by The Royal Netherlands Academy of Arts and Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts INCO-CT-2006-031714 and INCO-CT-2006-032436, and the Prof. Dr. P.C. Flu Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzi F, 2010, OBES REV, V11, P127, DOI 10.1111/j.1467-789X.2009.00605.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cooper PJ, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-33; Coutinho HM, 2006, AM J TROP MED HYG, V75, P720, DOI 10.4269/ajtmh.2006.75.720; Coutinho HM, 2006, J NUTR, V136, P183, DOI 10.1093/jn/136.1.183; Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GUPTA MC, 1977, LANCET, V2, P108; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338; Kallio K, 2010, CIRC-CARDIOVASC QUAL, V3, P196, DOI 10.1161/CIRCOUTCOMES.109.857771; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Lakka TA, 1999, HYPERTENSION, V34, P51, DOI 10.1161/01.HYP.34.1.51; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Meurs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024393; Moya MD, 2012, ATHEROSCLEROSIS, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032; Mwatha JK, 1998, J IMMUNOL, V160, P1992; Pasha SM, 2011, J HYPERTENS, V29, P2194, DOI 10.1097/HJH.0b013e32834bbba8; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ricci ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001383; SALONEN JT, 1993, CIRCULATION, V87, P56; Soliman EZ, 2010, J STROKE CEREBROVASC, V19, P58, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.008; Stanley RG, 2009, ATHEROSCLEROSIS, V207, P131, DOI 10.1016/j.atherosclerosis.2009.04.037; Touboul PJ, 2009, CEREBROVASC DIS, V27, P361, DOI 10.1159/000202013; Van Bortel LM, 1998, J HUM HYPERTENS, V12, P583, DOI 10.1038/sj.jhh.1000669; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Wammes LJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001655; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676; WIEDERMANN U, 1991, ZBL BAKT-INT J MED M, V275, P279; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Wiria AE, 2012, SEMIN IMMUNOPATHOL, V34, P889, DOI 10.1007/s00281-012-0358-0; World Heatlh Organization, 2010, PREVENTION OF CARDIO; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	37	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54855	10.1371/journal.pone.0054855	http://dx.doi.org/10.1371/journal.pone.0054855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365679	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600124
J	Buckingham, G; Goodale, MA				Buckingham, Gavin; Goodale, Melvyn A.			Size Matters: A Single Representation Underlies Our Perceptions of Heaviness in the Size-Weight Illusion	PLOS ONE			English	Article							OBJECTS	In the size-weight illusion (SWI), a small object feels heavier than an equally-weighted larger object. It is thought that this illusion is a consequence of the way that we internally represent objects' properties - lifters expect one object to outweigh the other, and the subsequent illusion reflects a contrast with their expectations. Similar internal representations are also thought to guide the application of fingertip forces when we grip and lift objects. To determine the nature of the representations underpinning how we lift objects and perceive their weights, we examined weight judgments in addition to the dynamics and magnitudes of the fingertip forces when individuals lifted small and large exemplars of metal and polystyrene cubes, all of which had been adjusted to have exactly the same mass. Prior to starting the experiment, subjects expected the density of the metal cubes to be higher than that of the polystyrene cubes. Their illusions, however, did not reflect their conscious expectations of heaviness; instead subjects experienced a SWI of the same magnitude regardless of the cubes' material. Nevertheless, they did report that the polystyrene cubes felt heavier than the metal ones (i. e. they experienced a material-weight illusion). Subjects persisted in lifting the large metal cube with more force than the small metal cube, but lifted the large polystyrene cube with roughly the same amount of force that they used to lift the small polystyrene cube. These findings suggest that our perceptual and sensorimotor representations are not only functionally independent from one another, but that the perceptual system represents a more single, simple size-weight relationship which appears to drive the SWI itself.	[Buckingham, Gavin; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario)	Buckingham, G (corresponding author), Univ Western Ontario, Dept Psychol, Brain & Mind Inst, London, ON, Canada.	gavin.buckingham.hwu@gmail.com	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Buckingham, Gavin/0000-0002-6950-5504	Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	G. Buckingham was funded with a Banting Postdoctoral Fellowship awarded from the Natural Sciences and Engineering Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugh LA, 2012, J NEUROPHYSIOL; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2011, ATTEN PERCEPT PSYCHO, V73, P36, DOI 10.3758/s13414-010-0007-4; Buckingham G, 2011, J VISION, V11, DOI 10.1167/11.1.4; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; DAVIS CM, 1976, PERCEPT PSYCHOPHYS, V20, P33, DOI 10.3758/BF03198701; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; Ernst MO, 2009, CURR BIOL, V19, pR23, DOI 10.1016/j.cub.2008.10.039; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; HARSHFIELD SP, 1970, PSYCHON SCI, V20, P365, DOI 10.3758/BF03335692; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	22	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54709	10.1371/journal.pone.0054709	http://dx.doi.org/10.1371/journal.pone.0054709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372759	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500114
J	Cal, AJ; Liu, DC; Mauleon, R; Hsing, YIC; Serraj, R				Cal, Andrew J.; Liu, Dongcheng; Mauleon, Ramil; Hsing, Yue-Ie Caroline; Serraj, Rachid			Transcriptome Profiling of Leaf Elongation Zone under Drought in Contrasting Rice Cultivars	PLOS ONE			English	Article							GENE-EXPRESSION; WATER DEFICITS; FLOWERING TIME; MAIZE; XYLOGLUCAN; PEROXIDASE; ARABIDOPSIS; INCREASE; ENZYMES; GROWTH	Inhibition of leaf elongation and expansion is one of the earliest responses of rice to water deficit. Despite this sensitivity, a great deal of genetic variation exists in the extant of leaf elongation rate (LER) reduction in response to declining soil moisture. We analyzed global gene expression in the leaf elongation zone under drought in two rice cultivars with disparate LER sensitivities to water stress. We found little overlap in gene regulation between the two varieties under moderate drought; however, the transcriptional response to severe drought was more conserved. In response to moderate drought, we found several genes related to secondary cell wall deposition that were down regulated in Moroberekan, an LER tolerant variety, but up-regulated in LER sensitive variety IR64.	[Cal, Andrew J.; Liu, Dongcheng; Mauleon, Ramil; Serraj, Rachid] Int Rice Res Inst, Los Banos, Philippines; [Hsing, Yue-Ie Caroline] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan	CGIAR; International Rice Research Institute (IRRI); Academia Sinica - Taiwan	Cal, AJ (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	andrew.j.cal@gmail.com	Mauleon, Ramil/AAW-1697-2020	Mauleon, Ramil/0000-0001-8512-144X	Academia Sinica; Bill and Melinda Gates Foundation	Academia Sinica(Academia Sinica - Taiwan); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would like to thank Bill Hardy for careful reading of the manuscript and G. Dimayuga, E. Mico, E. Arcillas, R. Torres, the drought physiology team at IRRI for technical support. Affymetrix GeneChip assays were performed by the Affymetrix Gene Expression Service Laboratory http://ipmb.sinica.edu.tw/affy/, supported by Academia Sinica.; This work was funded by the Bill and Melinda Gates Foundation project "Stress-Tolerant Rice for Africa and South Asia." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Bacon MA, 1998, PLANT PHYSIOL, V118, P1507, DOI 10.1104/pp.118.4.1507; Bacon MA, 1997, J EXP BOT, V48, P2075, DOI 10.1093/jxb/48.12.2075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; CUTLER JM, 1980, CROP SCI, V20, P314, DOI 10.2135/cropsci1980.0011183X002000030006x; de Souza IRP, 1998, PHYSIOL PLANTARUM, V104, P556, DOI 10.1034/j.1399-3054.1998.1040406.x; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Hazen Samuel P., 2005, Functional & Integrative Genomics, V5, P104, DOI 10.1007/s10142-004-0126-x; He H, 2009, ACTA PHYSIOL PLANT, V31, P749, DOI 10.1007/s11738-009-0287-2; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Parent B, 2010, PLANT CELL ENVIRON, V33, P1256, DOI 10.1111/j.1365-3040.2010.02145.x; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Penning BW, 2009, PLANT PHYSIOL, V151, P1703, DOI 10.1104/pp.109.136804; Price NJ, 2003, J BIOL CHEM, V278, P41389, DOI 10.1074/jbc.M304519200; Puckridge D, 1980, FIELD CROPS RES, V3, P303; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; SINCLAIR TR, 1986, AUST J PLANT PHYSIOL, V13, P329, DOI 10.1071/PP9860329; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; TANGUILIG VC, 1987, PLANT SOIL, V103, P155, DOI 10.1007/BF02370385; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Volkenburgh E, 1980, PLANTA, V148, P273; Wonprasaid S, 1996, FIELD CROP RES, V47, P267, DOI 10.1016/0378-4290(96)00013-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	33	18	18	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54537	10.1371/journal.pone.0054537	http://dx.doi.org/10.1371/journal.pone.0054537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372737	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500084
J	Hewitt, KM; Mannino, FL; Gonzalez, A; Chase, JH; Caporaso, JG; Knight, R; Kelley, ST				Hewitt, Krissi M.; Mannino, Frank L.; Gonzalez, Antonio; Chase, John H.; Caporaso, J. Gregory; Knight, Rob; Kelley, Scott T.			Bacterial Diversity in Two Neonatal Intensive Care Units (NICUs)	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; NOSOCOMIAL INFECTION-RATES; ENVIRONMENTAL CONTAMINATION; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK; ACQUISITION; PATTERNS; SURFACES; STATES	Infants in Neonatal Intensive Care Units (NICUs) are particularly susceptible to opportunistic infection. Infected infants have high mortality rates, and survivors often suffer life-long neurological disorders. The causes of many NICU infections go undiagnosed, and there is debate as to the importance of inanimate hospital environments (IHEs) in the spread of infections. We used culture-independent next-generation sequencing to survey bacterial diversity in two San Diego NICUs and to track the sources of microbes in these environments. Thirty IHE samples were collected from two Level-Three NICU facilities. We extracted DNA from these samples and amplified the bacterial small subunit (16S) ribosomal RNA gene sequence using 'universal' barcoded primers. The purified PCR products were pooled into a single reaction for pyrosequencing, and the data were analyzed using QIIME. On average, we detected 93+/-39 (mean +/- standard deviation) bacterial genera per sample in NICU IHEs. Many of the bacterial genera included known opportunistic pathogens, and many were skin-associated (e. g., Propionibacterium). In one NICU, we also detected fecal coliform bacteria (Enterobacteriales) in a high proportion of the surface samples. Comparison of these NICU-derived sequences to previously published high-throughput 16S rRNA amplicon studies of other indoor environments (offices, restrooms and healthcare facilities), as well as human-and soil-associated environments, found the majority of the NICU samples to be similar to typical building surface and air samples, with the notable exception of the IHEs which were dominated by Enterobacteriaceae. Our findings provide evidence that NICU IHEs harbor a high diversity of human-associated bacteria and demonstrate the potential utility of molecular methods for identifying and tracking bacterial diversity in NICUs.	[Hewitt, Krissi M.; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mannino, Frank L.] Univ San Diego, Med Ctr, San Diego, CA 92110 USA; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Chase, John H.; Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Comp Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	California State University System; San Diego State University; University of San Diego; University of Colorado System; University of Colorado Boulder; Northern Arizona University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Kelley, ST (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skelley@sciences.sdsu.edu	Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Knight, Rob/0000-0002-0975-9019	Alfred P. Sloan foundation; Howard Hughes Medical Institute	Alfred P. Sloan foundation(Alfred P. Sloan Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Part of the study was funded by the Alfred P. Sloan foundation, the Howard Hughes Medical Institute, and the rest through an independent fund owned by the P. I. Scott Kelley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gonzalez A, 2012, BIOINFORMATICS, V28, P436, DOI 10.1093/bioinformatics/btr685; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hota B, 2009, J HOSP INFECT, V71, P123, DOI 10.1016/j.jhin.2008.10.030; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; JARVIS WR, 1991, AM J MED, V91, pS185, DOI 10.1016/0002-9343(91)90367-7; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maragakis LL, 2004, JAMA-J AM MED ASSOC, V292, P3006, DOI 10.1001/jama.292.24.3006; Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905; Mayfield JL, 2000, CLIN INFECT DIS, V31, P995, DOI 10.1086/318149; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stover BH, 2001, AM J INFECT CONTROL, V29, P152, DOI 10.1067/mic.2001.115407; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Urrea M, 2003, AM J INFECT CONTROL, V31, P505, DOI 10.1016/S0196-6553(03)00077-4; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	35	91	92	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54703	10.1371/journal.pone.0054703	http://dx.doi.org/10.1371/journal.pone.0054703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372757	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500111
J	Ogiwara, K; Fujimori, C; Rajapakse, S; Takahashi, T				Ogiwara, Katsueki; Fujimori, Chika; Rajapakse, Sanath; Takahashi, Takayuki			Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MESSENGER RIBONUCLEIC-ACIDS; ACTIVE RECOMBINANT FSH; OOCYTE MATURATION; GONADOTROPIN RECEPTORS; GRANULOSA-CELLS; MOLECULAR CHARACTERIZATION; MATRIX METALLOPROTEINASES; ZEBRAFISH GONADOTROPINS; EXPRESSION PATTERNS	The molecular properties and roles of luteinizing hormone (Lh) and its receptor (Lhcgrbb) have not been studied for the medaka (Oryzias latipes), which is an excellent animal model for ovulation studies. Here, we characterized the medaka Lh/Lhcgrbb system, with attention to its involvement in the ovulatory process of this teleost fish. In the medaka ovary, follicle-stimulating hormone receptor mRNA was expressed in small and medium-sized follicles, while lhcgrbb mRNA was expressed in the follicle layers of all growing follicles. Experiments using HEK 293T cells expressing medaka Lhcgrbb in vitro revealed that gonadotropin from pregnant mare's serum and medaka recombinant Lh (rLh) bound to the fish Lhcgrbb. The fish gonadotropin subunits Gtha, Fshb, and Lhb were essentially expressed at fairly constant levels in the pituitary of the fish during a 24-h spawning cycle. Using medaka rLh, we developed a follicle culture system that allowed us to follow the whole process of oocyte maturation and ovulation in vitro. This follicle culture method enabled us to determine that the Lh surge for the preovulatory follicle occurred in vivo between 19 and 15 h before ovulation. The present study also showed that oocyte maturation and ovulation were delayed several hours in vitro compared with in vivo. Treatment of large follicles with medaka rLh in vitro significantly increased the expression of Mmp15, which was previously demonstrated to be crucial for ovulation in the fish. These findings demonstrate that Lh/Lhcgrbb is critically involved in the induction of oocyte maturation and ovulation.	[Ogiwara, Katsueki; Fujimori, Chika; Takahashi, Takayuki] Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 060, Japan; [Rajapakse, Sanath] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka	Hokkaido University; University of Peradeniya	Takahashi, T (corresponding author), Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 060, Japan.	ttakaha@sci.hokudai.ac.jp		Fujimori, Chika/0000-0003-0574-6277	Ministry of Education, Culture, Sports, Science and Technology of Japan [21370024, 24247010]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research (nos. 21370024 and 24247010 to TT) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bogerd J, 2005, GEN COMP ENDOCR, V142, P34, DOI 10.1016/j.ygcen.2004.12.008; Bogerd J, 2001, BIOL REPROD, V64, P1633, DOI 10.1095/biolreprod64.6.1633; Chaffin CL, 1999, BIOL REPROD, V61, P14, DOI 10.1095/biolreprod61.1.14; Chaffin CL, 1999, HUM REPROD, V14, P642, DOI 10.1093/humrep/14.3.642; Chaffin CL, 2000, MOL HUM REPROD, V6, P11, DOI 10.1093/molehr/6.1.11; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Crespo D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-34; Egami N., 1959, Journal of the Faculty of Science Tokyo University Zoology, V8, P539; Espey LL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P425; Fujimori C, 2012, MOL CELL ENDOCRINOL, V362, P76, DOI 10.1016/j.mce.2012.05.013; Fujimori C, 2011, MOL CELL ENDOCRINOL, V332, P67, DOI 10.1016/j.mce.2010.09.015; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; Gazourian L, 1997, GEN COMP ENDOCR, V108, P327, DOI 10.1006/gcen.1997.6981; Goetz FW, 1997, FISH PHYSIOL BIOCHEM, V17, P33, DOI 10.1023/A:1007765902327; GOETZ FW, 1993, BIOL REPROD, V48, P846, DOI 10.1095/biolreprod48.4.846; GOETZ FW, 1982, GEN COMP ENDOCR, V48, P154, DOI 10.1016/0016-6480(82)90012-0; Gordon WL, 1985, LUTEINIZING HORMONE, P173; Hagglund AC, 1999, ENDOCRINOLOGY, V140, P4351, DOI 10.1210/en.140.9.4351; Hazzard TM, 1999, MOL HUM REPROD, V5, P1115, DOI 10.1093/molehr/5.12.1115; Horiguchi M, 2008, ZOOL SCI, V25, P937, DOI 10.2108/zsj.25.937; Huang H, 2009, GEN COMP ENDOCR, V162, P192, DOI 10.1016/j.ygcen.2009.02.012; Ishikawa Y, 1997, NATURE, V386, P234, DOI 10.1038/386234a0; IWAMATSU T, 1978, J EXP ZOOL, V206, P355, DOI 10.1002/jez.1402060307; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; IWAMATSU T, 1988, ZOOL SCI, V5, P353; KAGAWA H, 1981, B JPN SOC SCI FISH, V47, P1119; Karigo T, 2012, ENDOCRINOLOGY, V153, P3394, DOI 10.1210/en.2011-2022; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kato Y, 2010, CELL TISSUE RES, V340, P595, DOI 10.1007/s00441-010-0969-5; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; KOBAYASHI M, 1986, B JPN SOC SCI FISH, V52, P1153; KOOS RD, 1995, BIOL REPROD, V52, P1426, DOI 10.1095/biolreprod52.6.1426; Kusakabe R, 1999, INT J DEV BIOL, V43, P541; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li S, 1993, Chin J Biotechnol, V9, P247; Lister AL, 2008, GEN COMP ENDOCR, V159, P46, DOI 10.1016/j.ygcen.2008.07.017; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Matsui H, 2000, EUR J BIOCHEM, V267, P4658, DOI 10.1046/j.1432-1327.2000.01513.x; MIWA S, 1994, BIOL REPROD, V50, P629, DOI 10.1095/biolreprod50.3.629; Moyle W.R., 1996, REPROD ENDOCRINOLOGY, P683; Nagahama Y, 1997, STEROIDS, V62, P190, DOI 10.1016/S0039-128X(96)00180-8; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nagahama Yoshitaka, 1994, P393; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Ogiwara K, 2007, P NATL ACAD SCI USA, V104, P7021, DOI 10.1073/pnas.0610447104; Ogiwara K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093880; Ogiwara K, 2010, ZOOL SCI, V27, P762, DOI 10.2108/zsj.27.762; OZATO K, 1994, DEV GROWTH DIFFER, V36, P437; PATINO R, 1990, BIOL REPROD, V43, P818, DOI 10.1095/biolreprod43.5.818; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PINTER J, 1995, BIOL REPROD, V52, P667, DOI 10.1095/biolreprod52.3.667; Pinter J, 1999, GEN COMP ENDOCR, V115, P200, DOI 10.1006/gcen.1999.7312; Raldua D, 2006, AM J PHYSIOL-REG I, V290, pR456, DOI 10.1152/ajpregu.00528.2005; Robinson EJ, 1943, BIOL BULL-US, V84, P115, DOI 10.2307/1538054; Rocha A, 2007, MOL CELL ENDOCRINOL, V272, P63, DOI 10.1016/j.mce.2007.04.007; Sambroni E, 2007, J ENDOCRINOL, V195, P213, DOI 10.1677/JOE-06-0122; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Sorbera LA, 2001, BIOL REPROD, V64, P382, DOI 10.1095/biolreprod64.1.382; THEOFAN G, 1981, COMP BIOCHEM PHYS A, V69, P557, DOI 10.1016/0300-9629(81)93019-X; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Ulloa-Aguirre A, 2011, REV ENDOCR METAB DIS, V12, P259, DOI 10.1007/s11154-011-9176-2; Vischer HF, 2003, BIOL REPROD, V68, P1324, DOI 10.1095/biolreprod.102.009985; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Wallis M., 1985, BIOCH POLYPEPTIDE HO, P147; Wong TT, 2004, ENDOCRINOLOGY, V145, P5210, DOI 10.1210/en.2004-0558; Wu FR, 2009, COMP BIOCHEM PHYS A, V153, P44, DOI 10.1016/j.cbpa.2008.12.013; Wu YS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095646; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	76	56	57	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54482	10.1371/journal.pone.0054482	http://dx.doi.org/10.1371/journal.pone.0054482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372734	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500078
J	Theocharatos, S; Wilkinson, DJ; Darling, S; Wilm, B; Kenny, SE; Edgar, D				Theocharatos, Sokratis; Wilkinson, David J.; Darling, Sarah; Wilm, Bettina; Kenny, Simon E.; Edgar, David			Regulation of Progenitor Cell Proliferation and Neuronal Differentiation in Enteric Nervous System Neurospheres	PLOS ONE			English	Article							CREST STEM-CELLS; HIRSCHSPRUNG DISEASE; FATE DETERMINATION; GLIAL-CELLS; NEUROGENESIS; GUT; GLIOGENESIS; TRANSPLANTATION; MAINTENANCE; MECHANISM	Enteric nervous system (ENS) progenitor cells isolated from mouse and human bowel can be cultured in vitro as neurospheres which are aggregates of the proliferating progenitor cells, together with neurons and glial cells derived from them. To investigate the factors regulating progenitor cell proliferation and differentiation, we first characterised cell proliferation in mouse ENS neurospheres by pulse chase experiments using thymidine analogs. We demonstrate rapid and continuous cell proliferation near the neurosphere periphery, after which postmitotic cells move away from the periphery to become distributed throughout the neurosphere. While many proliferating cells expressed glial markers, expression of the neuronal markers beta-tubulin III (Tuj1) and nitric oxide synthase was detected in increasing numbers of post-mitotic cells after a delay of several days. Treatment of both mouse and human neurospheres with the gamma-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) reduced expression of the transcription factors Hes1 and Hes5, demonstrating inhibition of Notch signaling. DAPT treatment also inhibited progenitor cell proliferation and increased the numbers of differentiating neurons expressing Tuj1 and nitric oxide synthase. To confirm that the cellular effects of DAPT treatment were due to inhibition of Notch signaling, siRNA knockdown of RBPj kappa, a key component of the canonical Notch signaling pathway, was demonstrated both to reduce proliferation and to increase neuronal differentiation in neurosphere cells. These observations indicate that Notch signaling promotes progenitor cell proliferation and inhibits neuronal differentiation in ENS neurospheres.	[Theocharatos, Sokratis; Wilkinson, David J.; Darling, Sarah; Wilm, Bettina; Edgar, David] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Kenny, Simon E.] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Edgar, D (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	dhedgar@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Kenny, Simon/0000-0002-5917-8554; Wilkinson, David/0000-0001-5165-8230	Children's Research Fund, Liverpool; Royal College of Surgeons of England; British Association of Paediatric Surgeons; Action Medical Research Clinical Research Training Fellowship; UK Medical Research Council [G0802548]; Medical Research Council [G0802548] Funding Source: researchfish; Action Medical Research [1795] Funding Source: researchfish; MRC [G0802548] Funding Source: UKRI	Children's Research Fund, Liverpool; Royal College of Surgeons of England; British Association of Paediatric Surgeons; Action Medical Research Clinical Research Training Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ST was supported by a grant to SEK and DE from the Children's Research Fund, Liverpool. DJW was supported by a Research Fellowship from the Royal College of Surgeons of England and British Association of Paediatric Surgeons, and an Action Medical Research Clinical Research Training Fellowship. The work was funded by the Project Grant G0802548 from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Becker L, 2012, AM J PHYSIOL-GASTR L, V302, pG958, DOI 10.1152/ajpgi.00511.2011; Binder E, 2010, GUT, V59, pA141, DOI 10.1136/gut.2009.209049g; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Jarvi K, 2010, ANN SURG, V252, P977, DOI 10.1097/SLA.0b013e3182018542; Jia HM, 2012, INT J COLORECTAL DIS, V27, P37, DOI 10.1007/s00384-011-1295-4; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mosher JT, 2007, DEV BIOL, V303, P1, DOI 10.1016/j.ydbio.2006.10.026; Ngan ESW, 2011, J CLIN INVEST, V121, P3467, DOI 10.1172/JCI43737; Okamura Y, 2008, DEVELOPMENT, V135, P3555, DOI 10.1242/dev.022319; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sander GR, 2003, J HISTOCHEM CYTOCHEM, V51, P969, DOI 10.1177/002215540305100712; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theocharatos S, 2008, EARLY HUM DEV, V84, P801, DOI 10.1016/j.earlhumdev.2008.09.007; Tsarovina K, 2008, MOL CELL NEUROSCI, V37, P20, DOI 10.1016/j.mcn.2007.08.010; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wilkinson DJ, 2012, SEMIN PEDIATR SURG, V21, P364, DOI 10.1053/j.sempedsurg.2012.07.010; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	33	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54809	10.1371/journal.pone.0054809	http://dx.doi.org/10.1371/journal.pone.0054809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372773	gold, Green Published, Green Submitted			2022-12-27	WOS:000314021500131
J	Stander, BA; Joubert, F; Tu, CK; Sippel, KH; McKenna, R; Joubert, AM				Stander, Barend Andre; Joubert, Fourie; Tu, Chingkuang; Sippel, Katherine H.; McKenna, Robert; Joubert, Annie Margaretha			Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM STRESS; CARBONIC-ANHYDRASE; OXIDATIVE STRESS; IN-VITRO; HYDROGEN-PEROXIDE; HEME OXYGENASE; PROTEIN; 2-METHOXYESTRADIOL; GROWTH	The aim of this study was to characterize the in vitro action of 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10) 16-tetraene (ESE-16) on non-tumorigenic MCF-12A, tumorigenic MCF-7 and metastatic MDA-MB-231 breast cancer cells. ESE-16 is able to inhibit the activity of a carbonic anhydrase II and a mimic of carbonic anhydrase IX in the nanomolar range. Gene and protein expression studies using various techniques including gene and antibody microarrays and various flow cytometry assays yielded valuable information about the mechanism of action of ESE-16. The JNK pathway was identified as an important pathway mediating the effects of ESE-16 while the p38 stress-induced pathway is more important in MDA-MB-231 cells exposed to ESE-16. Lysosomal rupture and iron metabolism was identified as important mediators of mitochondrial membrane depolarization. Abrogation of Bcl-2 phosphorylation status as a result of ESE-16 also plays a role in inducing mitochondrial membrane depolarization. The study provides a basis for future research projects to develop the newly synthesized compound into a clinically usable anticancer agent either alone or in combination with other agents. Keywords: Antimitotic, anticarbonic anhydrase IX, apoptosis, autophagy, cell cycle arrest, Bcl-2, JNK, p38, mitochondrial membrane depolarization, flow cytometry, gene expression and protein microarray, anticancer.	[Stander, Barend Andre] Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa; [Joubert, Fourie; Joubert, Annie Margaretha] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, Gauteng, South Africa; [Tu, Chingkuang] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Sippel, Katherine H.] Baylor Coll Med, Houston, TX 77030 USA; [McKenna, Robert] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Pretoria; University of Pretoria; State University System of Florida; University of Florida; Baylor College of Medicine; State University System of Florida; University of Florida	Stander, BA (corresponding author), Univ Pretoria, Dept Physiol, ZA-0002 Pretoria, Gauteng, South Africa.	standerandre@gmail.com	Joubert, Annie/AAU-4562-2021	Joubert, Annie/0000-0002-6931-7554; Joubert, Fourie/0000-0003-4998-7531	Medical Research Council of South Africa [AG374, AK076]; Cancer Association of South Africa [AK246]; National Research Foundation (NRF) [AL239]; Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa [AJ038, AN074]	Medical Research Council of South Africa(South African Medical Research Council); Cancer Association of South Africa; National Research Foundation (NRF); Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria; Struwig-Germeshuysen Cancer Research Trust of South Africa	This research was supported by grants from the Medical Research Council of South Africa (AG374, AK076), the Cancer Association of South Africa (AK246), National Research Foundation (NRF) (AL239), the Research Committee of the Faculty of Health Sciences (RESCOM) of University of Pretoria and the Struwig-Germeshuysen Cancer Research Trust of South Africa (AJ038, AN074). Flow cytometric analyses were performed at the Department of Pharmacology at the Faculty of Health Sciences (University of Pretoria, Pretoria, South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston GE, 2009, BIOORG MED CHEM LETT, V19, P6241, DOI 10.1016/j.bmcl.2009.08.020; Attalla H, 1996, BIOCHEM BIOPH RES CO, V228, P467, DOI 10.1006/bbrc.1996.1683; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Bresgen N, 2010, FREE RADICAL BIO MED, V48, P1347, DOI 10.1016/j.freeradbiomed.2010.02.019; Bughani Usha, 2009, Recent Pat Antiinfect Drug Discov, V4, P164; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Genis C, 2009, BIOCHEMISTRY-US, V48, P1322, DOI 10.1021/bi802035f; Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034; Guthrie H. David, 2008, V477, P89, DOI 10.1007/978-1-60327-517-0_8; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Hasan MR, 2006, EXP CELL RES, V312, P1950, DOI 10.1016/j.yexcr.2006.02.023; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kurokawa H, 1999, ONCOL REP, V6, P33; Kutuk O, 2008, CURR MOL MED, V8, P102; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Moser C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-206; Newman SP, 2006, CANCER RES, V66, P324, DOI 10.1158/0008-5472.CAN-05-2391; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pasquier E, 2010, MOL CANCER THER, V9, P1408, DOI 10.1158/1535-7163.MCT-09-0894; Pastorekova S, 2008, BJU INT, V101, P8, DOI 10.1111/j.1464-410X.2008.07642.x; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Ryter SW, 2000, AM J PHYSIOL-HEART C, V279, pH2889, DOI 10.1152/ajpheart.2000.279.6.H2889; Sadowski-Debbing K, 2002, ARCH IMMUNOL THER EX, V50, P19; Segel IH, 1975, ENZYME KINETICS BEHA; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sippel KH, 2011, LETT DRUG DES DISCOV, V8, P678; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Snoeks TJA, 2011, MOL CANCER THER, V10, P874, DOI 10.1158/1535-7163.MCT-10-0997; Stander A, 2011, CHEM BIOL DRUG DES, V77, P173, DOI 10.1111/j.1747-0285.2010.01064.x; Stander BA, 2010, J STEROID BIOCHEM, V119, P149, DOI 10.1016/j.jsbmb.2010.02.019; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Van Zijl C, 2008, CELL BIOCHEM FUNCT, V26, P632, DOI 10.1002/cbf.1489; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yan S, 2012, J CANCER RES CLIN, P1; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zhou Q, 2011, INVEST NEW DRUG, V29, P340, DOI 10.1007/s10637-009-9383-9; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0; Zoubine MN, 1999, INT J ONCOL, V15, P639	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53853	10.1371/journal.pone.0053853	http://dx.doi.org/10.1371/journal.pone.0053853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382857	Green Published, gold			2022-12-27	WOS:000314610600021
J	Brown, A; Lee, M				Brown, Amy; Lee, Michelle			Breastfeeding Is Associated with a Maternal Feeding Style Low in Control from Birth	PLOS ONE			English	Article							CHILDHOOD OBESITY; FED INFANTS; 1ST YEAR; CHILDREN; BOTTLE; OVERWEIGHT; DECISIONS	Background: The influence of maternal child-feeding style upon child weight and eating style for children over the age of twelve months is well established. However there is little empirical evidence examining maternal child-feeding style during milk feeding despite evidence that mothers who breastfeed exert lower levels of control over later diet. The aim of this paper was to examine variation in maternal child-feeding style during the first six months postpartum and to explore associations with mode of milk feeding and infant weight. Methods: The Child Feeding Questionnaire (CFQ) is frequently used to measure maternal child-feeding style in preschool children. 390 mothers with an infant aged 0-6 months completed an adapted version of the CFQ to measure maternal child-feeding style during milk feeding. Participants reported breastfeeding duration, infant weight and perceived size. Results: Principle components analysis of questionnaire items produced six factors; encouraging feeding, feeding to a routine, limiting intake, concern for weight, monitoring and perceived responsibility. Breastfeeding was associated with lower levels of control compared to formula feeding. Infant birth weight was significantly inversely associated with concern for weight, monitoring and encouraging feeding. Discussion: Formula feeding is associated with greater maternal control of child-feeding from birth whilst a lower birth weight is linked to concerns for infant weight and pressure to eat. As early maternal child-feeding relationships may impact negatively upon longer term child weight and eating style, identifying variations in maternal feeding style and understanding the factors that influence this is pertinent.	[Brown, Amy] Swansea Univ, Coll Human & Hlth Sci, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales; [Lee, Michelle] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Swansea, W Glam, Wales	Swansea University; Swansea University	Brown, A (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales.	a.e.brown@swansea.ac.uk	Brown, Amy/AAT-2339-2020	Brown, Amy/0000-0002-0438-0157	Economic and Social Research Council, UK	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Amy Brown was supported by a Postdoctoral fellowship from the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR LS, 1984, J AM DIET ASSOC, V84, P543; Anzman SL, 2009, J PEDIATR-US, V155, P651, DOI 10.1016/j.jpeds.2009.04.052; Arden MA, 2010, MATERN CHILD NUTR, V6, P159, DOI 10.1111/j.1740-8709.2009.00194.x; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Bartok CJ, 2009, INT J PEDIATR OBES, V4, P196, DOI 10.3109/17477160902763309; Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Blissett J, 2007, INT J OBESITY, V31, P1520, DOI 10.1038/sj.ijo.0803661; Bonuck KA, 2002, CLIN PEDIATR, V41, P603, DOI 10.1177/000992280204100808; Brown A, 2012, PEDIATR OBES, V7, P382, DOI 10.1111/j.2047-6310.2012.00071.x; Brown A, 2011, J HUM NUTR DIET, V24, P177, DOI 10.1111/j.1365-277X.2010.01145.x; Brown A, 2011, J ADV NURS, V67, P1993, DOI 10.1111/j.1365-2648.2011.05647.x; Daly S E, 1995, J Hum Lact, V11, P21, DOI 10.1177/089033449501100119; Dollberg S, 2001, J AM COLL NUTR, V20, P209, DOI 10.1080/07315724.2001.10719033; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Farrow C, 2006, APPETITE, V46, P49, DOI 10.1016/j.appet.2005.10.005; Farrow C, 2006, PEDIATRICS, V118, pE293, DOI 10.1542/peds.2005-2919; Farrow CV, 2008, PEDIATRICS, V121, pE164, DOI 10.1542/peds.2006-3437; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Grovslien AH, 2009, J HUM LACT, V25, P206, DOI 10.1177/0890334409333425; Hardyment C, 2007, DREAM BABIES; Health and Social Care Information Centre, 2012, INF FEED SURV 2010; HEINIG MJ, 1993, AM J CLIN NUTR, V58, P152, DOI 10.1093/ajcn/58.2.152; Kroller K, 2008, APPETITE, V51, P166, DOI 10.1016/j.appet.2008.01.012; Li RW, 2010, PEDIATRICS, V125, pE1386, DOI 10.1542/peds.2009-2549; Snethen JA, 2007, JOGNN-J OBST GYN NEO, V36, P501, DOI [10.1111/J.1552-6909.2007.00181.x, 10.1111/j.1552-6909.2007.00181.x]; Tabachnick B. G., 2006, USING MULTIVARIATE S; Taveras EM, 2004, PEDIATRICS, V114, pE577, DOI 10.1542/peds.2004-0801; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; TYSON J, 1992, PEDIATRICS, V89, P215; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Welsh Assembly Government, 2008, WELSH IND MULT DEPR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; WRIGHT P, 1980, BEHAV PROCESS, V5, P1, DOI 10.1016/0376-6357(80)90045-5	37	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54229	10.1371/journal.pone.0054229	http://dx.doi.org/10.1371/journal.pone.0054229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382881	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800038
J	Liu, HY; Pfleger, CM				Liu, Hsiu-Yu; Pfleger, Cathie M.			Mutation in E1, the Ubiquitin Activating Enzyme, Reduces Drosophila Lifespan and Results in Motor Impairment	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; GROWTH-FACTOR RECEPTOR; RNA-BINDING PROTEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; PROTEASOME SYSTEM; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; DEFECTIVE UBIQUITINATION	Neurodegenerative diseases cause tremendous suffering for those afflicted and their families. Many of these diseases involve accumulation of mis-folded or aggregated proteins thought to play a causal role in disease pathology. Ubiquitinated proteins are often found in these protein aggregates, and the aggregates themselves have been shown to inhibit the activity of the proteasome. These and other alterations in the Ubiquitin Pathway observed in neurodegenerative diseases have led to the question of whether impairment of the Ubiquitin Pathway on its own can increase mortality or if ongoing neurodegeneration alters Ubiquitin Pathway function as a side-effect. To address the role of the Ubiquitin Pathway in vivo, we studied loss-of-function mutations in the Drosophila Ubiquitin Activating Enzyme, Uba1 or E1, the most upstream enzyme in the Ubiquitin Pathway. Loss of only one functional copy of E1 caused a significant reduction in adult lifespan. Rare homozygous hypomorphic E1 mutants reached adulthood. These mutants exhibited further reduced lifespan and showed inappropriate Ras activation in the brain. Removing just one functional copy of Ras restored the lifespan of heterozygous E1 mutants to that of wild-type flies and increased the survival of homozygous E1 mutants. E1 homozygous mutants also showed severe motor impairment. Our findings suggest that processes that impair the Ubiquitin Pathway are sufficient to cause early mortality. Reduced lifespan and motor impairment are seen in the human disease X-linked Infantile Spinal Muscular Atrophy, which is associated with mutation in human E1 warranting further analysis of these mutants as a potential animal model for study of this disease.	[Liu, Hsiu-Yu; Pfleger, Cathie M.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Pfleger, CM (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	cathie.pfleger@mssm.edu			Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine [P50 AG005138-24]; National Institutes of Health (NIH), National Cancer Institute (NCI) [CA140451-01]; Sidney Kimmel Foundation for Cancer Research; NIH-NCI [5R24 CA095823-04]; National Science Foundation [DBI-9724504]; NIH [1 S10 RR0 9145-01]; NATIONAL CANCER INSTITUTE [R24CA095823, R01CA140451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER	Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine; National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Foundation for Cancer Research; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project received pilot funding from the Alzheimer's Disease Research Center (ADRC) at The Mount Sinai School of Medicine (P50 AG005138-24). This work was also supported by the National Institutes of Health (NIH), National Cancer Institute (NCI) (CA140451-01). CMP is a Kimmel Scholar and received funding from the Sidney Kimmel Foundation for Cancer Research. Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources grant (5R24 CA095823-04), National Science Foundation Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1 S10 RR0 9145-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arendt T, 2000, ANN NY ACAD SCI, V920, P249; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Dawson TM, 2006, J NEURAL TRANSM-SUPP, P209; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Dressman D, 2007, GENET MED, V9, P52, DOI 10.1097/GIM.0b013e31802d8353; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; GARTNER U, 1995, NEUROREPORT, V6, P1441; Gartner U, 1999, NEUROSCIENCE, V91, P1, DOI 10.1016/S0306-4522(99)00059-7; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KOBAYASHI H, 1995, HUM MOL GENET, V4, P1213, DOI 10.1093/hmg/4.7.1213; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McShea A, 1999, BRAIN RES, V815, P237, DOI 10.1016/S0006-8993(98)01135-4; Mei M, 2006, J NEUROCHEM, V99, P1377, DOI 10.1111/j.1471-4159.2006.04174.x; Metzger S, 2006, HUM GENET, V120, P285, DOI 10.1007/s00439-006-0221-2; Mitchell MJ, 1998, HUM MOL GENET, V7, P429, DOI 10.1093/hmg/7.3.429; Naarding P, 2001, EUR PSYCHIAT, V16, P439, DOI 10.1016/S0924-9338(01)00604-6; Nerelius C, 2009, FRONT BIOSCI-LANDMRK, V14, P1716, DOI 10.2741/3335; Neumann CJ, 1996, GENETICS, V142, P1147; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pfleger CM, 2007, FLY, V1, P95, DOI 10.4161/fly.4285; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rao SS, 2006, AM FAM PHYSICIAN, V74, P2046; Rezak M, 2007, DM-DIS MON, V53, P195, DOI 10.1016/j.disamonth.2007.05.001; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Smith MA, 2002, NEUROCHEM INT, V40, P527, DOI 10.1016/S0197-0186(01)00123-1; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; van Leeuwen FW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P319; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yan H, 2009, J CELL SCI, V122, P1461, DOI 10.1242/jcs.042267; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	78	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e32835	10.1371/journal.pone.0032835	http://dx.doi.org/10.1371/journal.pone.0032835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382794	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200044
J	Zhuo, C; Li, XQ; Zong, ZY; Zhong, NS				Zhuo, Chao; Li, Xiao-qiang; Zong, Zhi-yong; Zhong, Nan-shan			Epidemic Plasmid Carrying bla(CTX-M-15) in Klebsiella penumoniae in China	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; GENOTYPE DISTRIBUTION; INCF PLASMIDS; ENTEROBACTERIACEAE; DISSEMINATION; RESISTANCE; SEQUENCE; STRAINS; INFECTION	Objective: To investigate the local epidemiology of Klebsiella penumoniae carrying blaCTX-M-15 in southern China and to characterize the genetic environment of bla(CTX-M-15). Methods: PCR and DNA sequencing were used to detect and characterize the genetic contexts of bla(CTX-M-15). The clonal relatedness of isolates carrying bla(CTX-M-15) was determined by pulse-field gel electrophoresis. Conjugative plasmids carrying bla(CTX-M-15) were obtained by mating and were further subject to restriction analysis and replicon typing. Results: A total of 47 CTX-M-15 ESBL-producing isolates of K. pneumoniae were collected from nine hospitals in China from October 2007 to October 2008. Isolates were clustered into various clonal groups. The local spread of bla(CTX-M-15) was mainly mediated by one major conjugative plasmid as determined by S1-PFGE and restriction analysis. A 90-kb plasmid belonging to incompatible group FII was the major carrier of bla(CTX-M-15) in K. pneumoniae. Except bla(TEM-1), the resistance genes such as bla(SHV), bla(DHA-1), bla(OXA-1), qnrB, qnrS, aac(3)-II, and aac(69)-Ib were not found in the plasmid. In the comparing of conjugative gene sequence, it is 100% identical with the plasmid pKF3-94, which was found in K. pneumonia from Zhejiang province of china previously. Conclusions: bla(CTX-M-15) was prevalent in K. pneumonia of southern China. The dissemination of bla(CTX-M-15) appeared to be due to the horizontal transfer of a 90-kb epidemic plasmid.	[Zhuo, Chao; Li, Xiao-qiang; Zhong, Nan-shan] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zong, Zhi-yong] Sichuan Univ, Dept Infect Dis, West China Hosp, Chengdu 610064, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sichuan University	Zhuo, C (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chao_sheep@263.net		ZONG, ZHIYONG/0000-0002-7675-260X	Key Foundation of Guangdong province Bureau of Science and Technology [201002021, 2009A030301011]; Natural Science Foundation of China [81271881]	Key Foundation of Guangdong province Bureau of Science and Technology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by a grant (no. 201002021) from Special Fund for Health-Scientific Research in the Public Interest: Research & application for the prevention & control of nosocomial infections coursed by multi-drug resistant bacteria, and a grant (no. 2009A030301011) from the Key Foundation of Guangdong province Bureau of Science and Technology. Grant from the Natural Science Foundation of China (No. 81271881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CLSI, 2009, M100S19 CLSI S; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Huang XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040360; Jeong SH, 2005, J APPL MICROBIOL, V98, P921, DOI 10.1111/j.1365-2672.2004.02526.x; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Machado E, 2006, ANTIMICROB AGENTS CH, V50, P3220, DOI 10.1128/AAC.00473-06; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; SEIFERT H, 1995, J CLIN MICROBIOL, V33, P1402, DOI 10.1128/JCM.33.5.1402-1407.1995; Shi ZY, 1996, J CLIN MICROBIOL, V34, P2784, DOI 10.1128/JCM.34.11.2784-2790.1996; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; TAKAHASHI S, 1984, J CLIN MICROBIOL, V20, P608, DOI 10.1128/JCM.20.4.608-613.1984; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014; Zhao FQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010141; [卓超 ZHUO Chao], 2009, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V32, P1114	27	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52222	10.1371/journal.pone.0052222	http://dx.doi.org/10.1371/journal.pone.0052222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382815	Green Submitted, Green Published, gold			2022-12-27	WOS:000315483200024
J	Castilho, A; Neumann, L; Gattinger, P; Strasser, R; Vorauer-Uhl, K; Sterovsky, T; Altmann, F; Steinkellner, H				Castilho, Alexandra; Neumann, Laura; Gattinger, Pia; Strasser, Richard; Vorauer-Uhl, Karola; Sterovsky, Thomas; Altmann, Friedrich; Steinkellner, Herta			Generation of Biologically Active Multi-Sialylated Recombinant Human EPOFc in Plants	PLOS ONE			English	Article							HAMSTER OVARY CELLS; N-GLYCAN STRUCTURES; FC FUSION PROTEIN; HUMAN-ERYTHROPOIETIN; CHO-CELLS; NICOTIANA-BENTHAMIANA; MASS-SPECTROMETRY; TOBACCO PLANTS; SUGAR CHAINS; GLYCOSYLATION	Hyperglycosylated proteins are more stable, show increased serum half-life and less sensitivity to proteolysis compared to non-sialylated forms. This applies particularly to recombinant human erythropoietin (rhEPO). Recent progress in N-glycoengineering of non-mammalian expression hosts resulted in in vivo protein sialylation at great homogeneity. However the synthesis of multi-sialylated N-glycans is so far restricted to mammalian cells. Here we used a plant based expression system to accomplish multi-antennary protein sialylation. A human erythropoietin fusion protein (EPOFc) was transiently expressed in Nicotiana benthamiana Delta XTFT, a glycosylation mutant that lacks plant specific N-glycan residues. cDNA of the hormone was co-delivered into plants with the necessary genes for (i) branching (ii) beta 1,4-galactosylation as well as for the (iii) synthesis, transport and transfer of sialic acid. This resulted in the production of recombinant EPOFc carrying bi-tri-and tetra-sialylated complex N-glycans. The formation of this highly complex oligosaccharide structure required the coordinated expression of 11 human proteins acting in different subcellular compartments at different stages of the glycosylation pathway. In vitro receptor binding assays demonstrate the generation of biologically active molecules. We demonstrate the in planta synthesis of one of the most complex mammalian glycoforms pointing to an outstanding high degree of tolerance to changes in the glycosylation pathway in plants.	[Castilho, Alexandra; Gattinger, Pia; Strasser, Richard; Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Neumann, Laura; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria; [Vorauer-Uhl, Karola] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Sterovsky, Thomas] Polymun Sci GmbH, Klosterneuburg, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Steinkellner, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	herta.steinkellner@boku.ac.at	Steinkellner, Herta/N-4267-2016; Strasser, Richard/AAD-2916-2020; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Gattinger, Pia/0000-0001-6724-8543; Vorauer-Uhl, Karola/0000-0003-4217-8846; Altmann, Friedrich/0000-0002-0112-7877; Strasser, Richard/0000-0001-8764-6530	Laura Bassi Centres of Expertise [822757]; Wiener Wissenschafts- und Technologie fonds (WWTF) [L575-B13]; Wiener Forschungs- und Technologie fonds [L575-B13]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish	Laura Bassi Centres of Expertise; Wiener Wissenschafts- und Technologie fonds (WWTF); Wiener Forschungs- und Technologie fonds; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Laura Bassi Centres of Expertise (Grant Number 822757) and the Wiener Wissenschafts-, Forschungs- und Technologie fonds (WWTF) (Grant Number L575-B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2000, J IMMUNOL METHODS, V237, P95, DOI 10.1016/S0022-1759(00)00135-6; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Bork K, 2007, FEBS LETT, V581, P4195, DOI 10.1016/j.febslet.2007.07.060; Bragonzi A, 2000, BBA-GEN SUBJECTS, V1474, P273, DOI 10.1016/S0304-4165(00)00023-4; Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Conley AJ, 2009, PLANT BIOTECHNOL J, V7, P183, DOI 10.1111/j.1467-7652.2008.00389.x; Davies HM, 2010, PLANT BIOTECHNOL J, V8, P845, DOI 10.1111/j.1467-7652.2010.00550.x; Dirnberger D, 2001, EUR J BIOCHEM, V268, P4570, DOI 10.1046/j.1432-1327.2001.02384.x; DUBE S, 1988, J BIOL CHEM, V263, P17516; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; HOKKE CH, 1995, EUR J BIOCHEM, V228, P981, DOI 10.1111/j.1432-1033.1995.tb20350.x; Im SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024574; Kittur FS, 2012, PLANT CELL REP, V31, P1233, DOI 10.1007/s00299-012-1244-x; KOMATSU N, 1991, CANCER RES, V51, P341; Lombardi R, 2012, TRANSGENIC RES, V21, P1005, DOI 10.1007/s11248-012-9587-1; Loos A, 2012, ARCH BIOCH BIOPHYS; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; MATSUMOTO S, 1995, PLANT MOL BIOL, V27, P1163, DOI 10.1007/BF00020889; MORGAN WTJ, 1969, BRIT MED BULL, V25, P30, DOI 10.1093/oxfordjournals.bmb.a070666; Nagels B, 2012, J BIOTECHNOL, V160, P242, DOI 10.1016/j.jbiotec.2012.03.003; Pabst M, 2012, BIOL CHEM, V393, P719, DOI 10.1515/hsz-2012-0148; Parsons J, 2012, PLANT BIOTECHNOL J, V10, P851, DOI 10.1111/j.1467-7652.2012.00704.x; Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z; RECNY MA, 1987, J BIOL CHEM, V262, P17156; SASAKI H, 1988, BIOCHEMISTRY-US, V27, P8618, DOI 10.1021/bi00423a017; Schriebl K, 2006, PROTEIN EXPRES PURIF, V49, P265, DOI 10.1016/j.pep.2006.05.018; Shahrokh Z, 2011, MOL PHARMACEUT, V8, P286, DOI 10.1021/mp100353a; Skibeli V, 2001, BLOOD, V98, P3626, DOI 10.1182/blood.V98.13.3626; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; Taschwer M, 2012, J BIOTECHNOL, V157, P295, DOI 10.1016/j.jbiotec.2011.11.014; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Wang MD, 2002, BIOTECHNOL BIOENG, V77, P194, DOI 10.1002/bit.10144; Wang Z, 2011, BIOTECHNOL BIOENG, V108, P1634, DOI 10.1002/bit.23091; WASLEY LC, 1991, BLOOD, V77, P2624; Way JC, 2005, PROTEIN ENG DES SEL, V18, P111, DOI 10.1093/protein/gzi021; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Yuen CT, 2003, BRIT J HAEMATOL, V121, P511, DOI 10.1046/j.1365-2141.2003.04307.x	50	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54836	10.1371/journal.pone.0054836	http://dx.doi.org/10.1371/journal.pone.0054836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372778	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400033
J	Dai, M; Li, B; Hu, SJ; Xu, CH; Yang, B; Li, JB; Fu, F; Fei, Z; Dong, XZ				Dai, Meng; Li, Bing; Hu, Shijie; Xu, Canhua; Yang, Bin; Li, Jianbo; Fu, Feng; Fei, Zhou; Dong, Xiuzhen			In Vivo Imaging of Twist Drill Drainage for Subdural Hematoma: A Clinical Feasibility Study on Electrical Impedance Tomography for Measuring Intracranial Bleeding in Humans	PLOS ONE			English	Article							RECONSTRUCTION ALGORITHMS; SPONTANEOUS RESOLUTION; BRAIN-FUNCTION; HUMAN HEAD; EIT; HEMORRHAGE; QUANTIFICATION; VENTILATION; CRANIOSTOMY; ELECTRODES	Intracranial bleeding is one of the most severe medical emergencies in neurosurgery. Early detection or diagnosis would largely reduce the rate of disability and mortality, and improve the prognosis of the patients. Electrical Impedance Tomography (EIT) can non-invasively image the internal resistivity distribution within a human body using a ring of external electrodes, and is thus a promising technique to promptly detect the occurrence of intracranial bleedings because blood differs from other brain tissues in resistivity. However, so far there is no experimental study that has determined whether the intracranial resistivity changes in humans could be repeatedly detected and imaged by EIT. Hence, we for the first time attempt to clinically validate this by in vivo imaging the influx and efflux of irrigating fluid (5% dextrose in water, D5W) during the twist-drill drainage operation for the patients with subdural hematoma (SDH). In this study, six patients (four male, two female) with subacute or chronic SDH received the surgical operation in order to evacuate the hematoma around subdural region, and EIT measurements were performed simultaneously on each patient's head. The results showed that the resistivity significantly increased on the corresponding position of EIT images during the influx of D5W and gradually decreased back to baseline during the efflux. In the quantitative analysis, the average resistivity values demonstrated the similar results and had highly linear correlation (R-2 = 0.93 +/- 0.06) with the injected D5W volumes, as well as the area of the resistivity gain(R-2 = 0.94 +/- 0.05). In conclusion, it was clinically validated that intracranial resistivity changes in humans were detectable and quantifiable by the EIT method. After further technical improvements, EIT has the great potential of being a routine neuroimaging tool for early detection of intracranial bleedings.	[Dai, Meng; Xu, Canhua; Yang, Bin; Li, Jianbo; Fu, Feng; Dong, Xiuzhen] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Li, Bing; Hu, Shijie; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn; dongxiuzhen@fmmu.edu.cn		Yang, Bin/0000-0001-9687-5968	National Key Technology R&D Program of China [2011BAI08B13, 2012BAI20B02]; National Natural Science Foundation of China [51207161]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Key Technology R&D Program of China under grant NO. 2011BAI08B13, 2012BAI20B02, and by National Natural Science Foundation of China under grant NO. 51207161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2008, NEUROIMAGE, V43, P258, DOI 10.1016/j.neuroimage.2008.07.023; Bagshaw AP, 2003, NEUROIMAGE, V20, P752, DOI 10.1016/S1053-8119(03)00301-X; BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Bozkurt G, 2006, TURK NEUROSURG, V16, P19; CAMEL M, 1986, J NEUROSURG, V65, P183, DOI 10.3171/jns.1986.65.2.0183; Clay MT, 2002, IEEE T MED IMAGING, V21, P629, DOI 10.1109/TMI.2002.800572; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Dawodu S, 2009, TRAUMATIC BRAIN INJU; Drapkin J, 1991, BRIT J NEUROSURG, V5, P67; Fabrizi L, 2006, PHYSIOL MEAS, V27, pS163, DOI 10.1088/0967-3334/27/5/S14; Holder D. S, 2005, ELECT IMPEDANCE TOMO; Holder DS, 1996, PHYSIOL MEAS, V17, pA179, DOI 10.1088/0967-3334/17/4A/022; Horesh L, 2006, THESIS U COLL LONDON; Ji ZY, 2009, MED BIOL ENG COMPUT, V47, P1045, DOI 10.1007/s11517-009-0516-2; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lindgren S, 2007, INTENS CARE MED, V33, P172, DOI 10.1007/s00134-006-0425-x; Lionheart WRB, 2004, PHYSIOL MEAS, V25, P125, DOI 10.1088/0967-3334/25/1/021; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MARKWALDER TM, 1985, NEUROSURGERY, V16, P185, DOI 10.1227/00006123-198502000-00010; Murphy D, 1987, Clin Phys Physiol Meas, V8 Suppl A, P131, DOI 10.1088/0143-0815/8/4A/017; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Parlato C, 2000, SURG NEUROL, V53, P312, DOI 10.1016/S0090-3019(00)00200-7; Pulletz S, 2006, PHYSIOL MEAS, V27, pS115, DOI 10.1088/0967-3334/27/5/S10; Sadleir RJ, 2009, PHYSIOL MEAS, V30, P63, DOI 10.1088/0967-3334/30/1/005; Sadleir RJ, 2001, IEEE T BIO-MED ENG, V48, P484, DOI 10.1109/10.915715; Shi X, 2006, THESIS 4 MILITARY ME; Shi XT, 2005, P ANN INT IEEE EMBS, P1492, DOI 10.1109/IEMBS.2005.1616714; Shuai WJ, 2009, ANN BIOMED ENG, V37, P2373, DOI 10.1007/s10439-009-9778-y; Tang C, 2009, PHYSIOL MEAS, V30, P1293, DOI 10.1088/0967-3334/30/12/001; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698; Tizzard A, 2005, PHYSIOL MEAS, V26, pS251, DOI 10.1088/0967-3334/26/2/024; Tucker AS, 2011, PHYSIOL MEAS, V32, P151, DOI 10.1088/0967-3334/32/2/001; WINN HR, 2003, YOUMANS NEUROLOGICAL; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu SW, 2011, ANN BIOMED ENG, V39, P2059, DOI 10.1007/s10439-011-0302-9	36	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55020	10.1371/journal.pone.0055020	http://dx.doi.org/10.1371/journal.pone.0055020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372808	Green Submitted, Green Published, gold			2022-12-27	WOS:000315210400051
J	Agenant, M; Noordmans, HJ; Koomen, W; Bosch, JLHR				Agenant, Michelle; Noordmans, Herke-Jan; Koomen, Wim; Bosch, J. L. H. Ruud			Real-Time Bladder Lesion Registration and Navigation: A Phantom Study	PLOS ONE			English	Article							MATERIAL-FILLED BLADDER; VIRTUAL CYSTOSCOPY; CANCER; RECURRENCE; DIAGNOSIS	Background: Bladder cancer is the fourth most common malignancy in men, with a recurrence rate of 33-64%. Tumor documentation during cystoscopy of the bladder is suboptimal and might play a role in these high recurrence rates. Objective: In this project, a bladder registration and navigation system was developed to improve bladder tumor documentation and consequently increase reproducibility of the cystoscopy. Materials/Methods: The bladder registration and navigation system consists of a stereo-tracker that tracks the location of a newly developed target, which is attached to the endoscope during cystoscopy. With this information the urology registration and navigation software is able to register the 3D position of a lesion of interest. Simultaneously, the endoscopic image is captured in order to combine it with this 3D position. To enable navigation, navigational cues are displayed on the monitor, which subsequently direct the cystoscopist to the previously registered lesion. To test the system, a rigid and a flexible bladder phantom was developed. The system's robustness was tested by measuring the accuracy of registering and navigating the lesions. Different calibration procedures were compared. It was also tested whether system accuracy is limited by using a previously saved calibration, to avoid surgical delay due to calibration. Urological application was tested by comparing a rotational camera (fixed to the rotating endoscope) to a non-rotational camera (dangling by gravity) used in standard urologic practice. Finally, the influence of volume differences on registering and navigating was tested. Results/Conclusion: The bladder registration and navigation system has an acceptable accuracy for bladder lesion registration and navigation. Limitations for patient determinants included changes in bladder volume and bladder deformation. In vivo studies are required to measure the effect of these limitations and functionality in urological practice as a tool to increase reproducibility of the cystoscopy.	[Agenant, Michelle; Bosch, J. L. H. Ruud] Univ Med Ctr Utrecht UMCU, Dept Urol, Utrecht, Netherlands; [Noordmans, Herke-Jan] Univ Med Ctr Utrecht UMCU, Dept Med Technol & Clin Phys, Utrecht, Netherlands; [Koomen, Wim] Personal Space Technol PS Tech, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Agenant, M (corresponding author), Univ Med Ctr Utrecht UMCU, Dept Urol, Utrecht, Netherlands.	m.agenant@umcutrecht.nl	Noordmans, Herke Jan/AAN-8366-2020	Noordmans, Herke Jan/0000-0002-9913-4556	University Medical Centre Utrecht	University Medical Centre Utrecht	This work was supported by University Medical Centre Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avcu S, 2011, BRIT J RADIOL, V84, P875, DOI 10.1259/bjr/30591350; Babjuk M, 2011, EAU GUIDELINE NONMUS; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Behrens A, 2011, IEEE ENG MED BIO, P5376, DOI 10.1109/IEMBS.2011.6091330; Behrens A, 2011, COMPUT SCI-RES DEV, V26, P51, DOI 10.1007/s00450-010-0135-z; Behrens A, 2009, IEEE ENG MED BIO, P6990, DOI 10.1109/IEMBS.2009.5333854; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Cauberg ECC, 2011, INDIAN J UROLOGY, V27, P245; Dighe MK, 2011, J COMPUT ASSIST TOMO, V35, P411, DOI 10.1097/RCT.0b013e31821c2e9d; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Gulsen F, 2011, J INT MED RES, V39, P2264, DOI 10.1177/147323001103900623; HALL RR, 1994, BMJ-BRIT MED J, V308, P257, DOI 10.1136/bmj.308.6923.257; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Hernandez-Mier Y, 2010, COMPUT MED IMAG GRAP, V34, P579, DOI 10.1016/j.compmedimag.2010.02.002; Hung AJ, 2012, BJU INT, V109, P1398, DOI 10.1111/j.1464-410X.2011.10648.x; Kagadis GC, 2006, ASIAN J ANDROL, V8, P31, DOI 10.1111/j.1745-7262.2006.00096.x; Karabacak OR, 2011, CUAJ-CAN UROL ASSOC, V5, P34, DOI 10.5489/cuaj.10002; Kim JK, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790763; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Kishore TA, 2006, J UROLOGY, V175, P870, DOI 10.1016/S0022-5347(05)00345-9; Kivrak AS, 2009, CLIN RADIOL, V64, P30, DOI 10.1016/j.crad.2008.05.004; Li QY, 2012, EUR J RADIOL, V81, P2936, DOI 10.1016/j.ejrad.2011.12.024; Liu JJ, 2012, J UROLOGY, V188, P361, DOI 10.1016/j.juro.2012.03.127; Lotz HT, 2005, MED PHYS, V32, P2590, DOI 10.1118/1.1992207; Lotz HT, 2004, MED PHYS, V31, P1415, DOI 10.1118/1.1738961; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Palou J, 2009, UROLOGY, V73, P1313, DOI 10.1016/j.urology.2008.12.047; Peyromaure M, 2004, BJU INT, V93, P60, DOI 10.1111/j.1464-410X.2004.04556.x; Ramirez-Backhaus M, 2012, CURR UROL REP, V13, P109, DOI 10.1007/s11934-012-0234-4; Schwaibold HE, 2006, BJU INT, V97, P1199, DOI 10.1111/j.1464-410X.2006.06144.x; Seshamani S, 2006, LECT NOTES COMPUT SC, V4190, P355; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Song JH, 2001, RADIOLOGY, V218, P95, DOI 10.1148/radiology.218.1.r01ja4995; Sylvester RJ, 2008, EUR UROL, V53, P709, DOI 10.1016/j.eururo.2008.01.015; van Rhijn A, 2007, THESIS EINDHOVEN U T; Weibel T, 2010, P 2010 IEEE; Weizer AZ, 2011, WORLD J UROL, V29, P59, DOI 10.1007/s00345-010-0617-4; Yazgan C, 2004, CLIN IMAG, V28, P138, DOI 10.1016/S0899-7071(03)00117-7; Zhang Z., 1998, TECHNICAL REPORT	39	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54348	10.1371/journal.pone.0054348	http://dx.doi.org/10.1371/journal.pone.0054348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365663	Green Published, gold			2022-12-27	WOS:000314023600051
J	Cheung, MK; Lam, WY; Fung, WYW; Law, PTW; Au, CH; Nong, WY; Kam, KM; Kwan, HS; Tsui, SKW				Cheung, Man Kit; Lam, Wai Yip; Fung, Wendy Yin Wan; Law, Patrick Tik Wan; Au, Chun Hang; Nong, Wenyan; Kam, Kai Man; Kwan, Hoi Shan; Tsui, Stephen Kwok Wing			Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA Pyrosequencing	PLOS ONE			English	Article							CYSTIC-FIBROSIS; GUT MICROBIOME; DIVERSITY; INFECTION; DISEASE; HEALTH; STREPTOCOCCI; COMMUNITIES; PATHOGENS; BIOFILMS	Background: Tuberculosis (TB) remains a global threat in the 21st century. Traditional studies of the disease are focused on the single pathogen Mycobacterium tuberculosis. Recent studies have revealed associations of some diseases with an imbalance in the microbial community. Characterization of the TB microbiota could allow a better understanding of the disease. Methodology/Principal Findings: Here, the sputum microbiota in TB infection was examined by using 16S rRNA pyrosequencing. A total of 829,873 high-quality sequencing reads were generated from 22 TB and 14 control sputum samples. Firmicutes, Proteobacteria, Bacteroidetes, Actinobacteria, and Fusobacteria were the five major bacterial phyla recovered, which together composed over 98% of the microbial community. Proteobacteria and Bacteroidetes were more represented in the TB samples and Firmicutes was more predominant in the controls. Sixteen major bacterial genera were recovered. Streptococcus, Neisseria and Prevotella were the most predominant genera, which were dominated by several operational taxonomic units grouped at a 97% similarity level. Actinomyces, Fusobacterium, Leptotrichia, Prevotella, Streptococcus, and Veillonella were found in all TB samples, possibly representing the core genera in TB sputum microbiota. The less represented genera Mogibacterium, Moryella and Oribacterium were enriched statistically in the TB samples, while a genus belonging to the unclassified Lactobacillales was enriched in the controls. The diversity of microbiota was similar in the TB and control samples. Conclusions/Significance: The composition and diversity of sputum microbiota in TB infection was characterized for the first time by using high-throughput pyrosequencing. It lays the framework for examination of potential roles played by the diverse microbiota in TB pathogenesis and progression, and could ultimately facilitate advances in TB treatment.	[Cheung, Man Kit; Au, Chun Hang; Nong, Wenyan; Kwan, Hoi Shan] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Wai Yip; Fung, Wendy Yin Wan; Tsui, Stephen Kwok Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Law, Patrick Tik Wan] Chinese Univ Hong Kong, Core Facil Genome Sequencing Lab, Hong Kong, Hong Kong, Peoples R China; [Kam, Kai Man] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China; [Tsui, Stephen Kwok Wing] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Kwan, HS (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China.	hoishankwan@cuhk.edu.hk; kwtsui@cuhk.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015; KAM, Kai Man/K-4546-2012; Nong, Wenyan/E-3260-2010; Kwan, Hoi Shan/GOV-6863-2022; Cheung, Man Kit/M-6972-2019; Cheung, Man Kit/E-5696-2012	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; KAM, Kai Man/0000-0003-0579-0307; Nong, Wenyan/0000-0002-3277-716X; Cheung, Man Kit/0000-0002-2764-2113; Cheung, Man Kit/0000-0002-2764-2113; Kwan, Hoi Shan/0000-0002-7943-2513	Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government [09080442]	Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government (Ref. No. 09080442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Brigham KS, 2009, CURR OPIN PEDIATR, V21, P437, DOI 10.1097/MOP.0b013e32832c9668; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlier JP, 2007, INT J SYST EVOL MICR, V57, P725, DOI 10.1099/ijs.0.64705-0; Carlier JP, 2004, INT J SYST EVOL MICR, V54, P1611, DOI 10.1099/ijs.0.63060-0; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Geng JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034769; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Han XY, 2006, J CLIN MICROBIOL, V44, P160, DOI 10.1128/JCM.44.1.160-165.2006; Haraldsson G, 2005, ANAEROBE, V11, P285, DOI 10.1016/j.anaerobe.2005.02.004; HILL GB, 1987, J CLIN MICROBIOL, V25, P1540, DOI 10.1128/JCM.25.8.1540-1545.1987; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; JACOBS JA, 1994, CLIN ORTHOP RELAT R, P183; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Murdoch DA, 1999, ANAEROBE, V5, P555, DOI 10.1006/anae.1999.0197; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rabunal Ramon, 2009, J Med Case Rep, V3, P37, DOI 10.1186/1752-1947-3-37; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Shankar EM, 2007, J MED MICROBIOL, V56, P1709, DOI 10.1099/jmm.0.47497-0; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stop TB Partnership, 2011, THE GLOBAL PLAN TO S; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; You M, J PERIODONTAL RES IN; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109; Zhou FX, 2012, WORLD J GASTROENTERO, V18, P2344, DOI 10.3748/wjg.v18.i19.2344; Zhou YH, 2010, ACTA BIOCH BIOPH SIN, V42, P754, DOI 10.1093/abbs/gmq081	47	64	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54574	10.1371/journal.pone.0054574	http://dx.doi.org/10.1371/journal.pone.0054574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365674	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600075
J	Cui, YY; Yamada, S				Cui, Yuanyuan; Yamada, Soichiro			N-Cadherin Dependent Collective Cell Invasion of Prostate Cancer Cells Is Regulated by the N-Terminus of alpha-Catenin	PLOS ONE			English	Article							BETA-CATENIN; TUMOR-METASTASIS; PROGNOSTIC VALUE; OVARIAN-CANCER; ACTIN-BINDING; GAMMA-CATENIN; EXPRESSION; SURVIVAL; ADHESION; COMPLEX	Cancer cell invasion is the critical first step of metastasis, yet, little is known about how cancer cells invade and initiate metastasis in a complex extracellular matrix. Using a cell line from bone metastasis of prostate cancer (PC3), we analyzed how prostate cancer cells migrate in a physiologically relevant 3D Matrigel. We found that PC3 cells migrated more efficiently as multi-cellular clusters than isolated single cells, suggesting that the presence of cell-cell adhesion improves 3D cell migration. Perturbation of N-cadherin function by transfection of either the N-cadherin cytoplasmic domain or shRNA specific to N-cadherin abolished collective cell migration. Interestingly, PC3 cells do not express alpha-catenin, an actin binding protein in the cadherin complex. When the full-length alpha-catenin was re-introduced, the phenotype of PC3 cells reverted back to a more epithelial phenotype with a decreased cell migration rate in 3D Matrigel. Interestingly, we found that the N-terminal half of alpha-catenin was sufficient to suppress invasive phenotype. Taken together, these data suggest that the formation of N-cadherin junctions promotes 3D cell migration of prostate cancer cells, and this is partly due to an aberrant regulation of the N-cadherin complex in the absence of alpha-catenin.	[Cui, Yuanyuan; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019; Cui, Yuanyuan/G-1899-2015; Cui, Yuanyuan/G-1787-2017	Yamada, Soichiro/0000-0001-6413-0814; Cui, Yuanyuan/0000-0002-1455-5643	Beckman Young Investigator Award; Hellman Family New Faculty Award; NIH EUREKA [GM094798]; University of California Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798] Funding Source: NIH RePORTER	Beckman Young Investigator Award; Hellman Family New Faculty Award; NIH EUREKA; University of California Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Beckman Young Investigator Award, a Hellman Family New Faculty Award, a NIH EUREKA GM094798, and the funds from the University of California Cancer Research Coordinating Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 1999, BRIT J CANCER, V80, P477, DOI 10.1038/sj.bjc.6690381; Aaltomaa S, 2005, ANTICANCER RES, V25, P4707; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Carmona FJ, 2012, J PATHOL; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Chung S, 2012, ONCOGENE; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Gao P., 2012, ONCOGENE; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ishida E, 2004, PATHOL INT, V54, P918, DOI 10.1111/j.1440-1827.2004.01773.x; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; Jaggi M, 2006, PROSTATE, V66, P193, DOI 10.1002/pros.20334; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li G, 2001, CANCER RES, V61, P3819; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; MORTON RA, 1993, CANCER RES, V53, P3585; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Richmond PJM, 1997, CANCER RES, V57, P3189; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Shih W, 2012, J CELL SCI; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tamura D, 2008, INT J ONCOL, V33, P17; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tomita K, 2000, CANCER RES, V60, P3650; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wong AST, 1999, INT J CANCER, V81, P180; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	40	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55069	10.1371/journal.pone.0055069	http://dx.doi.org/10.1371/journal.pone.0055069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359820	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600148
J	Davis, MF; Peterson, AE; Julian, KG; Greene, WH; Price, LB; Nelson, K; Whitener, CJ; Silbergeld, EK				Davis, Meghan F.; Peterson, Amy E.; Julian, Kathleen G.; Greene, Wallace H.; Price, Lance B.; Nelson, Kenrad; Whitener, Cynthia J.; Silbergeld, Ellen K.			Household Risk Factors for Colonization with Multidrug-Resistant Staphylococcus aureus Isolates	PLOS ONE			English	Article							SINGLE-DISK METHOD; METHICILLIN-RESISTANT; COMPANION ANIMALS; UNITED-STATES; ANTIBIOTIC SUSCEPTIBILITY; NASAL COLONIZATION; MRSA STRAINS; COMMUNITY; TRANSMISSION; PREVALENCE	Antimicrobial resistance, particularly in pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), limits treatment options and increases healthcare costs. To understand patient risk factors, including household and animal contact, potentially associated with colonization with multidrug-resistant MRSA isolates, we performed a prospective study of case patients colonized with MRSA on admission to a rural tertiary care hospital. Patients were interviewed and antimicrobial resistance patterns were tested among isolates from admitted patients colonized with MRSA in 2009-10. Prevalence of resistance was compared by case-patient risk factors and length-of-stay outcome among 88 MRSA case patients. Results were compared to NHANES 2003-04. Overall prevalence of multidrug resistance (non-susceptibility to >= four antimicrobial classes) in MRSA nasal isolates was high (73%) and was associated with a 1.5-day increase in subsequent length of stay (p = 0.008). History of hospitalization within the past six months, but not antimicrobial use in the same time period, was associated with resistance patterns. Within a subset of working-age case patients without recent history of hospitalization, animal contact was potentially associated with multidrug resistance. History of hospitalization, older age, and small household size were associated with multidrug resistance in NHANES data. In conclusion, recent hospitalization of case patients was predictive of antimicrobial resistance in MRSA isolates, but novel risk factors associated with the household may be emerging in CA-MRSA case patients. Understanding drivers of antimicrobial resistance in MRSA isolates is important to hospital infection control efforts, relevant to patient outcomes and to indicators of the economic burden of antimicrobial resistance.	[Davis, Meghan F.; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Peterson, Amy E.; Nelson, Kenrad] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Julian, Kathleen G.; Greene, Wallace H.; Whitener, Cynthia J.] Penn State Hershey Med Ctr, Hershey, PA USA; [Price, Lance B.] Translat Genom Res Inst TGen N, Div Pathogen Genom, Phoenix, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Translational Genomics Research Institute	Davis, MF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	mdavis@jhsph.edu	Davis, Meghan F./C-1494-2013	Davis, Meghan F./0000-0002-3475-4578	Johns Hopkins Center for a Livable Future; Heinz Foundation; Sommer Scholarship	Johns Hopkins Center for a Livable Future; Heinz Foundation; Sommer Scholarship	Research was supported by grants from the Johns Hopkins Center for a Livable Future (http://www.jhsph.edu/clf/) and the Heinz Foundation (http://www.heinzfamily.org/aboutus/philanthropies_02.html). AEP and MFD were supported by Johns Hopkins Center for a Livable Future Predoctoral Fellowships. Additionally, MFD was supported by a Sommer Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; *AM SOC MICR, 1995, REP ASM TASK FORC AN; Appelbaum PC, 2007, INT J ANTIMICROB AG, V30, P398, DOI 10.1016/j.ijantimicag.2007.07.011; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; BARRY AL, 1970, AM J CLIN PATHOL, V53, P149; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bordon J, 2010, DIAGN MICR INFEC DIS, V67, P395, DOI 10.1016/j.diagmicrobio.2010.03.006; Bramble M, 2011, VECTOR-BORNE ZOONOT, V11, P617, DOI 10.1089/vbz.2010.0025; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2003, NAT HLTH NUTR EX SUR; Clinical Laboratory Standards Institute, 2010, 2009 S AUR CLSI BREA; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fiebelkorn KR, 2003, J CLIN MICROBIOL, V41, P4740, DOI 10.1128/JCM.41.10.4740-4744.2003; Freitas EAF, 2010, INFECT CONT HOSP EP, V31, P469, DOI 10.1086/651672; Garcia Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI DOI 10.1016/S1473-3099(11)70126-8; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Kosowska-Shick K, 2008, ANTIMICROB AGENTS CH, V52, P4510, DOI 10.1128/AAC.01073-08; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lucet JC, 2009, ARCH INTERN MED, V169, P1372, DOI 10.1001/archinternmed.2009.217; Millar BC, 2007, J HOSP INFECT, V67, P109, DOI 10.1016/j.jhin.2007.06.003; Miller R, 2010, EPIDEMIOL INFECT, V138, P655, DOI 10.1017/S0950268809991294; Milstone AM, 2010, EMERG INFECT DIS, V16, P647, DOI 10.3201/eid1604.090107; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Morris DO, 2006, VET DERMATOL, V17, P332, DOI 10.1111/j.1365-3164.2006.00536.x; Peterson AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038354; Popovich K, 2007, J CLIN MICROBIOL, V45, P2293, DOI 10.1128/JCM.00044-07; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Rankin S, 2005, VET MICROBIOL, V108, P145, DOI 10.1016/j.vetmic.2005.02.013; Smith Tara C., 2010, Reviews on Environmental Health, V25, P121; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Winston LG, 2009, ANTIMICROBIAL RESIST	44	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54733	10.1371/journal.pone.0054733	http://dx.doi.org/10.1371/journal.pone.0054733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359808	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600099
J	Jacobson, AL; Kennedy, GG				Jacobson, Alana L.; Kennedy, George G.			Specific Insect-Virus Interactions Are Responsible for Variation in Competency of Different Thrips tabaci Isolines to Transmit Different Tomato Spotted Wilt Virus Isolates	PLOS ONE			English	Article							FRANKLINIELLA-FUSCA; TOBACCO THRIPS; ONION THRIPS; THYSANOPTERA; POPULATIONS; TOSPOVIRUS; VECTOR; HOST; EPIDEMIOLOGY; TEMPERATURE	Local adaptation between sympatric host and parasite populations driven by vector genetics appears to be a factor that influences dynamics of disease epidemics and evolution of insect-vectored viruses. Although T. tabaci is the primary vector of Tomato spotted wilt virus (TSWV) in some areas of the world, it is not an important vector of this economically important plant virus in many areas where it occurs. Previous studies suggest that genetic variation of thrips populations, virus isolates, or both are important factors underlying the localized importance of this species as a vector of TSWV. This study was undertaken to quantify variation in transmissibility of TSWV isolates by T. tabaci, in the ability of T. tabaci to transmit isolates of TSWV, and to examine the possibility that genetic interactions and local adaptation contribute to the localized nature of this species as a vector of TSWV. Isofemale lines of Thrips tabaci from multiple locations were tested for their ability to transmit multiple TSWV isolates collected at the same and different locations as the thrips. Results revealed that the probability of an isofemale line transmitting TSWV varied among virus isolates, and the probability of an isolate being transmitted varied among isofemale lines. These results indicate that the interaction of T. tabaci and TSWV isolate genetic determinants underlie successful transmission of TSWV by T. tabaci. Further analysis revealed sympatric vector-virus pairing resulted in higher transmission than allopatric pairing, which suggests that local adaptation is occurring between T. tabaci and TSWV isolates.	[Jacobson, Alana L.; Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Kennedy, GG (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	george_kennedy@ncsu.edu			North Carolina Tobacco Commission	North Carolina Tobacco Commission	The sources of funding for this work were provided by the North Carolina Tobacco Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatzivassiliou EK, 2008, PLANT DIS, V92, P1012, DOI 10.1094/PDIS-92-7-1012; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Chatzivassiliou EK, 1998, RECENT PROGR TOSPOVI, P59; CULBREATH AK, 1991, PLANT DIS, V75, P483, DOI 10.1094/PD-75-0483; Eckel CS, 1996, ENTOMOL EXP APPL, V78, P19, DOI 10.1007/BF00304453; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Groves RL, 2001, PHYTOPATHOLOGY, V91, P891, DOI 10.1094/PHYTO.2001.91.9.891; Groves RL, 2003, J ECON ENTOMOL, V96, P1, DOI 10.1603/0022-0493-96.1.1; Groves RL, 2002, PLANT DIS, V86, P573, DOI 10.1094/PDIS.2002.86.6.573; Jenser G., 2006, Acta Phytopathologica et Entomologica Hungarica, V41, P297, DOI 10.1556/APhyt.41.2006.3-4.12; Jenser G, 2003, J APPL ENTOMOL, V127, P7, DOI 10.1046/j.1439-0418.2003.00704.x; KENDALL DM, 1990, SOUTHWEST ENTOMOL, V15, P80; King A. M. Q., 2012, VIRUS TAXONOMY, P737; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; LEMMETTY A, 1993, AGR SCI FINLAND, V2, P189, DOI 10.23986/afsci.72648; Morsello SC, 2008, ENVIRON ENTOMOL, V37, P79, DOI 10.1603/0046-225X(2008)37[79:TAPASP]2.0.CO;2; Morsello SC, 2009, ENTOMOL EXP APPL, V130, P138, DOI 10.1111/j.1570-7458.2008.00801.x; Moudy, 2007, AM J TROP MED HYG, V77, P1176; Nagata T, 2004, PLANT PATHOL, V53, P136, DOI 10.1111/j.0032-0862.2004.00984.x; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; PALIWAL YC, 1974, CAN J BOT, V52, P1177, DOI 10.1139/b74-151; PALIWAL YC, 1976, CAN J BOT, V54, P402, DOI 10.1139/b76-038; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Peters D, 1995, ACTA HORTIC, P29; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; Sakimura K, 1932, J ECON ENTOMOL, V25, P884, DOI 10.1093/jee/25.4.884; SHERWOOD JL, 2000, ENCY PLANT PATHOLOGY, P1034; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Tedeschi R, 2001, PHYTOPARASITICA, V29, P37, DOI 10.1007/BF02981812; TRJAPITZIN SV, 1995, NATO ADV SCI INST SE, V276, P237; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1995, PHYTOPATHOLOGY, V85, P1069, DOI 10.1094/Phyto-85-1069; Wilson CR, 1998, PLANT PATHOL, V47, P171, DOI 10.1046/j.1365-3059.1998.00227.x; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	40	24	26	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54567	10.1371/journal.pone.0054567	http://dx.doi.org/10.1371/journal.pone.0054567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23358707	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600071
J	Sun, YBY; Qu, XL; Zhang, XM; Caruana, G; Bertram, JF; Li, JH				Sun, Yu Bo Yang; Qu, Xinli; Zhang, Xueming; Caruana, Georgina; Bertram, John F.; Li, Jinhua			Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ADVANCED DIABETIC-NEPHROPATHY; NONDIABETIC RENAL-DISEASE; GLYCATION END-PRODUCTS; NF-KAPPA-B; RELAXING FACTOR; FILTRATION BARRIER; GENE-EXPRESSION; MICE LACKING; POLYMORPHISM	The role of podocytes in the development and progression of glomerular disease has been extensively investigated in the past decade. However, the importance of glomerular endothelial cells in the pathogenesis of proteinuria and glomerulosclerosis has been largely ignored. Recent studies have demonstrated that endothelial nitric oxide synthatase (eNOS) deficiency exacerbates renal injury in anti-GBM and remnant kidney models and accelerates diabetic kidney damage. Increasing evidence also demonstrates the importance of the glomerular endothelium in preventing proteinuria. We hypothesize that endothelial dysfunction can initiate and promote the development and progression of glomerulopathy. Administration of adriamycin (ADR) to C57BL/6 mice, normally an ADR resistant strain, with an eNOS deficiency induced overt proteinuria, severe glomerulosclerosis, interstitial fibrosis and inflammation. We also examined glomerular endothelial cell and podocyte injury in ADR-induced nephropathy in Balb/c mice, an ADR susceptible strain, by immunostaining, TUNEL and Western blotting. Interestingly, down-regulation of eNOS and the appearance of apoptotic glomerular endothelial cells occurred as early as 24 hours after ADR injection, whilst synaptopodin, a functional podocyte marker, was reduced 7 days after ADR injection and coincided with a significant increase in the number of apoptotic podocytes. Furthermore, conditioned media from mouse microvascular endothelial cells over-expressing GFP-eNOS protected podocytes from TNF-alpha-induced loss of synaptopodin. In conclusion, our study demonstrated that endothelial dysfunction and damage precedes podocyte injury in ADR-induced nephropathy. Glomerular endothelial cells may protect podocytes from inflammatory insult. Understanding the role of glomerular endothelial dysfunction in the development of kidney disease will facilitate in the design of novel strategies to treat kidney disease.	[Sun, Yu Bo Yang; Qu, Xinli; Zhang, Xueming; Caruana, Georgina; Bertram, John F.; Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Zhang, Xueming] Inner Mongolia Univ Sci & Technol, Baotou Med Coll, Baotou, Peoples R China	Monash University; Baotou Medical College; Inner Mongolia University of Science & Technology	Li, JH (corresponding author), Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic, Australia.	jinhua.li@monash.edu	Li, Jinhua/I-2741-2014; Bertram, John F/I-2588-2014	Bertram, John F/0000-0001-5863-6464; Sun, Yu Bo Yang/0000-0003-0863-2769; Li, Jinhua/0000-0003-4039-5759	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia; NHMRC Career Development Award	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Monash University Accelerating Programme and the National Health and Medical Research Council (NHMRC) of Australia. JL is the recipient of a NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVASTHI PS, 1980, J CLIN INVEST, V65, P121, DOI 10.1172/JCI109641; Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Davila-Esqueda ME, 2005, RENAL FAILURE, V27, P115, DOI 10.1081/JDI-200042728; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; FORSTERMANN U, 1989, EUR HEART J, V10, P36, DOI 10.1093/eurheartj/10.suppl_F.36; FORSTERMANN U, 1993, EUR HEART J, V14, P10; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Guzik TJ, 2007, CIRC RES, V101, P227, DOI 10.1161/CIRCRESAHA.107.158295; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Lafayette RA, 1998, KIDNEY INT, V54, P1240, DOI 10.1046/j.1523-1755.1998.00097.x; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Morita T, 1999, CLIN NEPHROL, V52, P203; MUNDEL P, 1995, HISTOCHEM CELL BIOL, V103, P75, DOI 10.1007/BF01464478; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sharma M, 2005, KIDNEY INT, V68, P2735, DOI 10.1111/j.1523-1755.2005.00744.x; Sharma M, 2009, AM J PHYSIOL-RENAL, V296, pF1386, DOI 10.1152/ajprenal.90369.2008; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shin YS, 2004, DIABETES RES CLIN PR, V65, P257, DOI 10.1016/j.diabres.2004.01.010; SHULTZ PJ, 1990, AM J PHYSIOL, V258, pF162, DOI 10.1152/ajprenal.1990.258.1.F162; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Slater SC, 2012, INT J BIOCHEM CELL B, V44, P1482, DOI 10.1016/j.biocel.2012.05.020; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Stehouwer CDA, 2004, NEPHROL DIAL TRANSPL, V19, P778, DOI 10.1093/ndt/gfh015; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Ueda S, 2010, J NEPHROL, V23, P377; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yao J, 1998, KIDNEY INT, V53, P598, DOI 10.1046/j.1523-1755.1998.00793.x; Zanchi A, 2000, KIDNEY INT, V57, P405, DOI 10.1046/j.1523-1755.2000.00860.x; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	51	73	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55027	10.1371/journal.pone.0055027	http://dx.doi.org/10.1371/journal.pone.0055027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359116	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600144
J	Weber, BS; Miyata, ST; Iwashkiw, JA; Mortensen, BL; Skaar, EP; Pukatzki, S; Feldman, MF				Weber, Brent S.; Miyata, Sarah T.; Iwashkiw, Jeremy A.; Mortensen, Brittany L.; Skaar, Eric P.; Pukatzki, Stefan; Feldman, Mario F.			Genomic and Functional Analysis of the Type VI Secretion System in Acinetobacter	PLOS ONE			English	Article							IRON ACQUISITION FUNCTIONS; PROTEIN SECRETION; BAUMANNII PATHOGENESIS; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; BURKHOLDERIA-CENOCEPACIA; INTESTINAL INFLAMMATION; GALLERIA-MELLONELLA; ESCHERICHIA-COLI	The genus Acinetobacter is comprised of a diverse group of species, several of which have raised interest due to potential applications in bioremediation and agricultural purposes. In this work, we show that many species within the genus Acinetobacter possess the genetic requirements to assemble a functional type VI secretion system (T6SS). This secretion system is widespread among Gram negative bacteria, and can be used for toxicity against other bacteria and eukaryotic cells. The most studied species within this genus is A. baumannii, an emerging nosocomial pathogen that has become a significant threat to healthcare systems worldwide. The ability of A. baumannii to develop multidrug resistance has severely reduced treatment options, and strains resistant to most clinically useful antibiotics are frequently being isolated. Despite the widespread dissemination of A. baumannii, little is known about the virulence factors this bacterium utilizes to cause infection. We determined that the T6SS is conserved and syntenic among A. baumannii strains, although expression and secretion of the hallmark protein Hcp varies between strains, and is dependent on TssM, a known structural protein required for T6SS function. Unlike other bacteria, A. baumannii ATCC 17978 does not appear to use its T6SS to kill Escherichia coli or other Acinetobacter species. Deletion of tssM does not affect virulence in several infection models, including mice, and did not alter biofilm formation. These results suggest that the T6SS fulfils an important but as-yet-unidentified role in the various lifestyles of the Acinetobacter spp.	[Weber, Brent S.; Iwashkiw, Jeremy A.; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada; [Miyata, Sarah T.; Pukatzki, Stefan] Univ Alberta, Heritage Med Res Ctr, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Mortensen, Brittany L.; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	University of Alberta; University of Alberta; Vanderbilt University	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976	University of Alberta; Alberta Glycomics Center; Alberta Innovates-Health Solutions; Canadian Institute for Health Research Operating Grant [MOP-84473]; Alberta Heritage Foundation for Medical Research Endowment Fund; Childhood Infections Research Program [1T32AI095202-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095202] Funding Source: NIH RePORTER	University of Alberta(University of Alberta); Alberta Glycomics Center; Alberta Innovates-Health Solutions; Canadian Institute for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research Endowment Fund; Childhood Infections Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the Feldman lab is supported by the University of Alberta and the Alberta Glycomics Center. MFF is a Alberta Heritage Foundation for Medical Research scholar and Canadian Institutes of Health Research new investigator. STM is the recipient of an Alberta Innovates-Health Solutions Graduate Studentship Award. Work in SUP's laboratory is supported by the Canadian Institute for Health Research Operating Grant MOP-84473 and Alberta Innovates-Health Solutions (funded by the Alberta Heritage Foundation for Medical Research Endowment Fund). EPS is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases. BLM was supported by the Childhood Infections Research Program training program (1T32AI095202-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Carr EL, 2003, INT J SYST EVOL MICR, V53, P953, DOI 10.1099/ijs.0.02486-0; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hood MI, 2012, INFECT IMMUN; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Houang ETS, 2001, J CLIN MICROBIOL, V39, P228, DOI 10.1128/JCM.39.1.228-234.2001; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; JUNI E, 1972, J BACTERIOL, V112, P917, DOI 10.1128/JB.112.2.917-931.1972; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mara K, 2012, RES MICROBIOL, V163, P161, DOI 10.1016/j.resmic.2011.12.002; March C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010033; Margetts MB, 2000, PROTEIN EXPRES PURIF, V18, P262, DOI 10.1006/prep.2000.1193; McConnell MJ, 2012, FEMS MICROBIOL REV; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rokhbakhsh-Zamin F, 2011, J MICROBIOL BIOTECHN, V21, P556, DOI 10.4014/jmb.1012.12006; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Rupper A, 2001, BBA-GEN SUBJECTS, V1525, P205, DOI 10.1016/S0304-4165(01)00106-4; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sahl JW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-291; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006; Vidal R, 1996, MICROBIOS, V86, P49; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	75	76	80	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55142	10.1371/journal.pone.0055142	http://dx.doi.org/10.1371/journal.pone.0055142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365692	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600157
J	Curtis, VF; Wang, H; Yang, PY; McLendon, RE; Li, XH; Zhou, QY; Wang, XF				Curtis, Valerie F.; Wang, Hui; Yang, Pengyuan; McLendon, Roger E.; Li, Xiaohan; Zhou, Qun-Yong; Wang, Xiao-Fan			A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; TEMOZOLOMIDE; PROKINETICINS; MACROPHAGES; RESISTANCE; RECEPTORS; SURVIVAL; BV8; MICROENVIRONMENT; REFRACTORINESS	Infiltration of myeloid cells in the tumor microenvironment is often associated with enhanced angiogenesis and tumor progression, resulting in poor prognosis in many types of cancer. The polypeptide chemokine PK2 (Bv8, PROK2) has been shown to regulate myeloid cell mobilization from the bone marrow, leading to activation of the angiogenic process, as well as accumulation of macrophages and neutrophils in the tumor site. Neutralizing antibodies against PK2 were shown to display potent anti-tumor efficacy, illustrating the potential of PK2-antagonists as therapeutic agents for the treatment of cancer. In this study we demonstrate the anti-tumor activity of a small molecule PK2 antagonist, PKRA7, in the context of glioblastoma and pancreatic cancer xenograft tumor models. For the highly vascularized glioblastoma, PKRA7 was associated with decreased blood vessel density and increased necrotic areas in the tumor mass. Consistent with the anti-angiogenic activity of PKRA7 in vivo, this compound effectively reduced PK2-induced microvascular endothelial cell branching in vitro. For the poorly vascularized pancreatic cancer, the primary anti-tumor effect of PKRA7 appears to be mediated by the blockage of myeloid cell migration/infiltration. At the molecular level, PKRA7 inhibits PK2-induced expression of certain pro-migratory chemokines and chemokine receptors in macrophages. Combining PKRA7 treatment with standard chemotherapeutic agents resulted in enhanced effects in xenograft models for both types of tumor. Taken together, our results indicate that the anti-tumor activity of PKRA7 can be mediated by two distinct mechanisms that are relevant to the pathological features of the specific type of cancer. This small molecule PK2 antagonist holds the promise to be further developed as an effective agent for combinational cancer therapy.	[Curtis, Valerie F.; Wang, Hui; Yang, Pengyuan; Wang, Xiao-Fan] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA; [McLendon, Roger E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Li, Xiaohan; Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	Duke University; Duke University; University of California System; University of California Irvine	Wang, XF (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA.	xiao.fan.wang@duke.edu			National Cancer Institute [CA151541]; National Institutes of Health [MH67753]; NATIONAL CANCER INSTITUTE [R01CA151541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067753] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This was supported by CA151541 to XFW from the National Cancer Institute (www.cancer.gov) and by MH67753 to QYZ from National Institutes of Health (www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cheng CL, 2005, MOL CANCER THER, V4, P1364, DOI 10.1158/1535-7163.MCT-05-0128; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Cummings TJ, 2001, ARCH PATHOL LAB MED, V125, P637; Damaraju VL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-121; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P141, DOI 10.1007/s002329900093; Dempke WCM, 2009, EUR J CANCER, V45, P1117, DOI 10.1016/j.ejca.2008.11.038; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Franchi S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-60; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Kim SY, 1996, J MEMBRANE BIOL, V152, P117, DOI 10.1007/s002329900091; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Martucci C, 2006, BRIT J PHARMACOL, V147, P225, DOI 10.1038/sj.bjp.0706467; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Patel VJ, 2000, CLIN CANCER RES, V6, P4154; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rich JN, 2005, CLIN CANCER RES, V11, P8145, DOI 10.1158/1078-0432.CCR-05-0319; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; Shojaei F, 2008, TRENDS CELL BIOL, V18, P372, DOI 10.1016/j.tcb.2008.06.003; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Shojaei F, 2008, P NATL ACAD SCI USA, V105, P2640, DOI 10.1073/pnas.0712185105; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Shojaei F, 2008, DRUG RESIST UPDATE, V11, P219, DOI 10.1016/j.drup.2008.09.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi Yutaka, 2011, Front Biosci (Elite Ed), V3, P541, DOI 10.2741/e268; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Urayama K, 2009, CARDIOVASC RES, V81, P28, DOI 10.1093/cvr/cvn251; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wen HT, 2007, EUR J IMMUNOL, V37, P2487, DOI 10.1002/eji.200737370; Wong BM, 2001, J LEUKOCYTE BIOL, V69, P959; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhou QY, 2006, MOL INTERV, V6, P330, DOI 10.1124/mi.6.6.6	51	40	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54916	10.1371/journal.pone.0054916	http://dx.doi.org/10.1371/journal.pone.0054916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372791	Green Published, gold			2022-12-27	WOS:000314021500143
J	Kang, BN; Ha, SG; Bahaie, NS; Hosseinkhani, MR; Ge, XN; Blumenthal, MN; Rao, SP; Sriramarao, P				Kang, Bit Na; Ha, Sung Gil; Bahaie, Nooshin S.; Hosseinkhani, M. Reza; Ge, Xiao Na; Blumenthal, Malcolm N.; Rao, Savita P.; Sriramarao, P.			Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; 5-HT2A RECEPTOR ANTAGONIST; INDUCED DOPAMINE RELEASE; CELL-MIGRATION; THROMBOXANE A(2); BONE-MARROW; RHO GTPASES; ACTIVATION; 5-HYDROXYTRYPTAMINE; ADHESION	Association of the neurotransmitter serotonin (5-HT) with the pathogenesis of allergic asthma is well recognized and its role as a chemoattractant for eosinophils (Eos) in vitro and in vivo has been previously demonstrated. Here we have examined the regulation of 5-HT-induced human and murine Eos trafficking and migration at a cellular and molecular level. Eos from allergic donors and bone marrow-derived murine Eos (BM-Eos) were found to predominantly express the 5-HT2A receptor. Exposure to 5-HT or 2,5-dimethoxy-4-iodoamphetamine (DOI), a 5-HT2A/C selective agonist, induced rolling of human Eos and AML14.3D10 human Eos-like cells on vascular cell adhesion molecule (VCAM)-1 under conditions of flow in vitro coupled with distinct cytoskeletal and cell shape changes as well as phosphorylation of MAPK. Blockade of 5-HT2A or of ROCK MAPK, PI3K, PKC and calmodulin, but not G(alpha i)-proteins, with specific inhibitors inhibited DOI-induced rolling, actin polymerization and changes in morphology of VCAM-1-adherent AML14.3D10 cells. More extensive studies with murine BM-Eos demonstrated the role of 5-HT in promoting rolling in vivo within inflamed post-capillary venules of the mouse cremaster microcirculation and confirmed that down-stream signaling of 5-HT2A activation involves ROCK, MAPK, PI3K, PKC and calmodulin similar to AML14.3D10 cells. DOI-induced migration of BM-Eos is also dependent on these signaling molecules and requires Ca2+. Further, activation of 5-HT2A with DOI led to an increase in intracellular Ca2+ levels in murine BM-Eos. Overall, these data demonstrate that 5-HT (or DOI)/5-HT2A interaction regulates Eos trafficking and migration by promoting actin polymerization associated with changes in cell shape/morphology that favor cellular trafficking and recruitment via activation of specific intracellular signaling molecules (ROCK, MAPK, PI3K and the PKC-calmodulin pathway).	[Kang, Bit Na; Ha, Sung Gil; Bahaie, Nooshin S.; Hosseinkhani, M. Reza; Ge, Xiao Na; Rao, Savita P.; Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, Lab Allerg Dis & Inflammat, St Paul, MN 55108 USA; [Blumenthal, Malcolm N.; Sriramarao, P.] Univ Minnesota, Dept Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sriramarao, P (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Lab Allerg Dis & Inflammat, St Paul, MN 55108 USA.	psrao@umn.edu		Rao, Srirama/0000-0001-9082-1029	National Institutes of Health [HL079304, AI35796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035796, R01AI035796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants HL079304 and AI35796 to P. Sriramarao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bahaie NS, 2012, J IMMUNOL, V188, P1479, DOI 10.4049/jimmunol.1102253; Bahaie NS, 2011, J BIOL CHEM, V286, P38231, DOI 10.1074/jbc.M111.279554; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Bayer H, 2007, AM J RESP CELL MOL, V36, P85, DOI 10.1165/rcmb.2006-0151OC; Boehme SA, 1999, J IMMUNOL, V163, P1611; Boehme SA, 2004, J IMMUNOL, V173, P3599, DOI 10.4049/jimmunol.173.6.3599; BOOIJNOORD H, 1969, SCAND J RESPIR DIS, V50, P301; Broide D, 2008, CELLULAR ADHESION IN, V1, P149; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; Delaney C, 2011, AM J PHYSIOL-LUNG C, V301, pL937, DOI 10.1152/ajplung.00198.2011; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Freire-Garabal M, 2003, BRIT J PHARMACOL, V139, P457, DOI 10.1038/sj.bjp.0705188; Gandullia E, 1966, Minerva Pediatr, V18, P2230; HELLSTRAND K, 1990, CELL IMMUNOL, V127, P199, DOI 10.1016/0008-8749(90)90125-B; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; ICHIKAWA J, 1995, BRAIN RES, V698, P204, DOI 10.1016/0006-8993(95)00865-N; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; IKEN K, 1995, CELL IMMUNOL, V163, P1, DOI 10.1006/cimm.1995.1092; Kang BN, 2012, AM J PHYSIOL-LUNG C, V302, pL1179, DOI 10.1152/ajplung.00005.2012; Kehne JH, 1996, NEUROPSYCHOPHARMACOL, V15, P116, DOI 10.1016/0893-133X(95)00160-F; Kitson SL, 2007, CURR PHARM DESIGN, V13, P2621, DOI 10.2174/138161207781663000; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Kuroki T, 2003, BRAIN RES, V972, P216, DOI 10.1016/S0006-8993(03)02516-2; Kurrasch-Orbaugh DM, 2003, J NEUROCHEM, V86, P980, DOI 10.1046/j.1471-4159.2003.01921.x; Kushnir-Sukhov NM, 2006, J IMMUNOL, V177, P6422, DOI 10.4049/jimmunol.177.9.6422; Lechin F, 1998, J CLIN PHARMACOL, V38, P918, DOI 10.1002/j.1552-4604.1998.tb04387.x; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lima C, 2007, CLIN EXP ALLERGY, V37, P723, DOI 10.1111/j.1365-2222.2007.02700.x; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; MAREK GJ, 1994, EUR J PHARMACOL, V259, P137, DOI 10.1016/0014-2999(94)90502-9; Marek GJ, 1996, J PHARMACOL EXP THER, V278, P1373; Matsusaka S, 2005, BIOCHEM BIOPH RES CO, V337, P916, DOI 10.1016/j.bbrc.2005.09.129; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Menard G, 2007, CLIN EXP IMMUNOL, V150, P340, DOI 10.1111/j.1365-2249.2007.03492.x; Miike S, 2000, J LEUKOCYTE BIOL, V67, P117, DOI 10.1002/jlb.67.1.117; Mikulski Z, 2010, AM J PHYSIOL-LUNG C, V299, pL272, DOI 10.1152/ajplung.00032.2010; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Pakala R, 1997, CIRCULATION, V96, P2280; Pakala R, 1998, J LAB CLIN MED, V131, P527, DOI 10.1016/S0022-2143(98)90061-0; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Sabroe I, 1999, J IMMUNOL, V162, P2946; Sasaki T, 1966, Arerugi, V15, P831; Sikora L, 2003, AM J PHYSIOL-LUNG C, V285, pL654, DOI 10.1152/ajplung.00448.2002; SORENSEN SM, 1993, J PHARMACOL EXP THER, V266, P684; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; VONDRA V, 1975, Casopis Lekaru Ceskych, V114, P401; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Zuberi RI, 2009, J IMMUNOL, V183, P3971, DOI 10.4049/jimmunol.0901604	68	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54840	10.1371/journal.pone.0054840	http://dx.doi.org/10.1371/journal.pone.0054840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372779	Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500135
J	Chen, PZ; Li, MA; Gu, XL; Liu, YL; Li, XG; Li, CL; Wang, Y; Xie, D; Wang, FD; Yu, C; Li, JQ; Chen, XL; Chu, RA; Zhu, JM; Ou, ZL; Wang, H				Chen, Peizhan; Li, Mian; Gu, Xiaoli; Liu, Yanling; Li, Xiaoguang; Li, Chenglin; Wang, Yuan; Xie, Dong; Wang, Fudi; Yu, Chen; Li, Jingquan; Chen, Xinlei; Chu, Ruiai; Zhu, Jianmin; Ou, Zhouluo; Wang, Hui			Higher Blood 25(OH) D Level May Reduce the Breast Cancer Risk: Evidence from a Chinese Population Based Case-Control Study and Meta-Analysis of the Observational Studies	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; VITAMIN-D-RECEPTOR; D INSUFFICIENCY; LUNG-CANCER; METABOLIC SYNDROME; COLORECTAL-CANCER; D SUPPLEMENTATION; MAMMARY-GLAND; BONE HEALTH; WOMEN	Experimental data suggest a protective effect of vitamin D on breast cancer; however, epidemiologic results remain inclusive. With a Chinese population-based case-control study and meta-analysis of the observational studies, we here systematically evaluated the association of blood 25(OH) D level and breast cancer risk. With 593 breast cancer cases and 580 cancer-free controls from Shanghai, China, we found that 80% of the normal women had severe vitamin D deficiency (less than 20 ng/mL) and 15.2% had mild deficiency (20 to 30 ng/mL) and only 4.8% of women had sufficient vitamin D level (>30 ng/mL) while the proportion was 96.1%, 3.2% and 0.7% respectively for the breast cancer patients. Compared to those with the lowest quartile of plasma 25(OH) D level, women with highest quartile 25(OH) D level showed a significant decreased breast cancer risk (Q4 vs. Q1: OR = 0.10, 95% CI = 0.06-0.15) and every 1 ng/ml increment of plasma 25(OH) D level led to a 16% lower odds of breast cancer (OR = 0.84, 95% CI = 0.81-0.87; P, 0.001). From the meta-analysis of the observational studies, we found that women with highest quantile of blood 25(OH) D level was associated with a significantly reduced breast cancer risk compared to those with lowest quantile of blood 25(OH) D level for the 11 nested case-control and retrospective studies (pooled OR = 0.86, 95% CI = 0.75-1.00) and 10 case-control studies (7 population based, OR = 0.35, 95% CI = 0.24-0.52; 3 hospital based, OR = 0.08, 95% CI = 0.02-0.33). These results suggest that vitamin D may have a chemo-preventive effect against breast cancer.	[Chen, Peizhan; Li, Mian; Liu, Yanling; Li, Xiaoguang; Li, Chenglin; Wang, Yuan; Xie, Dong; Wang, Fudi; Li, Jingquan; Chen, Xinlei; Chu, Ruiai; Wang, Hui] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China; [Gu, Xiaoli; Ou, Zhouluo] Fudan Univ, Shanghai Med Coll, Key Lab Breast Canc Shanghai, Dept Oncol,Canc Hosp,Breast Canc Inst, Shanghai 200433, Peoples R China; [Yu, Chen; Zhu, Jianmin] Shanghai Xuhui Cent Hosp, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zhu, JM (corresponding author), Shanghai Xuhui Cent Hosp, Shanghai, Peoples R China.	zhujm55@xh.sh.cn; ouzhouluo@yahoo.com.cn; huiwang@sibs.ac.cn	liu, yan/HCI-5542-2022; Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Xie, Dong/0000-0002-1150-8657	One Hundred Talents Program of the Chinese Academy of Sciences; National Nature Science Foundation of China [81125020, 91029715, 31070680, 31101261, 31070802]; Ministry of Science and Technology of China [2012BAK01B00, 2011BAK10B00, 2009CB919000]; Science and Technology Commission of Shanghai Municipality [10391902100]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001, 12DZ2260100]; Xuhui Central Hospital [CRC2011001, CRC2011004]; Director Foundation [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute for Nutritional Sciences; Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences; National Basic Research Program of China [81172506]	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Xuhui District of Shanghai Municipality; Xuhui Central Hospital; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute for Nutritional Sciences; Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation of China (81125020, 91029715, 31070680, 31101261 and 31070802), the Ministry of Science and Technology of China (2012BAK01B00, 2011BAK10B00 and 2009CB919000), the Science and Technology Commission of Shanghai Municipality (10391902100), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001), and Xuhui Central Hospital (CRC2011001 and CRC2011004), Director Foundation (20090101) and the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. And in part by the grants from the Science and Technology Commission of Shanghai Municipality (12DZ2260100), National Basic Research Program of China (81172506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Almquist M, 2010, INT J CANCER, V127, P2159, DOI 10.1002/ijc.25215; Amir E, 2012, BREAST CANCER RES TR, V133, P1077, DOI 10.1007/s10549-012-2012-x; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Boucher BJ, 2011, CURR DRUG TARGETS, V12, P61; Brewer LC, 2011, CURR DRUG TARGETS, V12, P54; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Crew KD, 2009, J CLIN ONCOL, V27, P2151, DOI 10.1200/JCO.2008.19.6162; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; Dawson-Hughes B, 1998, OSTEOPOROSIS INT, V8, pS30, DOI 10.1007/PL00022730; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donkena Krishna Vanaja, 2011, Adv Prev Med, V2011, P281863, DOI 10.4061/2011/281863; Drake MT, 2010, J CLIN ONCOL, V28, P4191, DOI 10.1200/JCO.2010.28.6674; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eliassen AH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2880; Engel P, 2010, CANCER EPIDEM BIOMAR, V19, P2341, DOI 10.1158/1055-9965.EPI-10-0264; Fedirko V, 2012, CANCER CAUSE CONTROL, V23, P1149, DOI 10.1007/s10552-012-9984-z; Freedman DM, 2008, CANCER EPIDEM BIOMAR, V17, P889, DOI 10.1158/1055-9965.EPI-07-2594; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hewison M, 2011, CLIN ENDOCRINOL OXF; Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P15, DOI 10.3928/02793695-20110111-02; Imtiaz Saba, 2012, Indian J Endocrinol Metab, V16, P409, DOI 10.4103/2230-8210.95684; Kim HJ, 2011, ANN SURG ONCOL, V18, P1830, DOI 10.1245/s10434-010-1465-6; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; OKANO T, 1978, J NUTR SCI VITAMINOL, V24, P47; Palmieri C, 2006, J CLIN PATHOL, V59, P1334, DOI 10.1136/jcp.2006.042747; Pazdiora P, 2011, ANTICANCER RES, V31, P3619; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Ramnath N, 2011, EXPERT REV RESP MED, V5, P305, DOI [10.1586/ERS.11.31, 10.1586/ers.11.31]; Rejnmark L, 2009, CANCER EPIDEM BIOMAR, V18, P2655, DOI 10.1158/1055-9965.EPI-09-0531; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Vashi PG, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-60; Veldhuis S, 2011, MENOPAUSE, V18, P319, DOI 10.1097/gme.0b013e3181f81ad5; Vrieling A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2920; Woo J, 2008, BRIT J NUTR, V99, P1330, DOI 10.1017/S0007114507844382; Yao S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017251; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2004, CARCINOGENESIS, V25, P2361, DOI 10.1093/carcin/bgh271	54	45	49	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e49312	10.1371/journal.pone.0049312	http://dx.doi.org/10.1371/journal.pone.0049312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382798	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800003
J	Kramer, S; Bannerman-Chukualim, B; Ellis, L; Boulden, EA; Kelly, S; Field, MC; Carrington, M				Kramer, Susanne; Bannerman-Chukualim, Bridget; Ellis, Louise; Boulden, Elizabeth A.; Kelly, Steve; Field, Mark C.; Carrington, Mark			Differential Localization of the Two T-brucei Poly(A) Binding Proteins to the Nucleus and RNP Granules Suggests Binding to Distinct mRNA Pools	PLOS ONE			English	Article							EUKARYOTIC TRANSLATION INITIATION; CYTOPLASMIC PROCESSING BODIES; P-BODY FORMATION; POLY(A)-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; STRESS GRANULES; GENE-EXPRESSION; MAXIMUM-LIKELIHOOD; MIXED MODELS	The number of paralogs of proteins involved in translation initiation is larger in trypanosomes than in yeasts or many metazoan and includes two poly(A) binding proteins, PABP1 and PABP2, and four eIF4E variants. In many cases, the paralogs are individually essential and are thus unlikely to have redundant functions although, as yet, distinct functions of different isoforms have not been determined. Here, trypanosome PABP1 and PABP2 have been further characterised. PABP1 and PABP2 diverged subsequent to the differentiation of the Kinetoplastae lineage, supporting the existence of specific aspects of translation initiation regulation. PABP1 and PABP2 exhibit major differences in intracellular localization and distribution on polysome fractionation under various conditions that interfere with mRNA metabolism. Most striking are differences in localization to the four known types of inducible RNP granules. Moreover, only PABP2 but not PABP1 can accumulate in the nucleus. Taken together, these observations indicate that PABP1 and PABP2 likely associate with distinct populations of mRNAs. The differences in localization to inducible RNP granules also apply to paralogs of components of the eIF4F complex: eIF4E1 showed similar localization pattern to PABP2, whereas the localisation of eIF4E4 and eIF4G3 resembled that of PABP1. The grouping of translation initiation as either colocalizing with PABP1 or with PABP2 can be used to complement interaction studies to further define the translation initiation complexes in kinetoplastids.	[Kramer, Susanne; Bannerman-Chukualim, Bridget; Ellis, Louise; Boulden, Elizabeth A.; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QW, England; [Kelly, Steve] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steve] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Cambridge; University of Cambridge; University of Oxford; University of Oxford	Carrington, M (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mc115@cam.ac.uk	Kelly, Steven/F-7237-2011; Carrington, Mark/N-3653-2019; Field, Mark/AAD-6455-2021; Carrington, Mark/N-4892-2018	Kelly, Steven/0000-0001-8583-5362; Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Field, Mark/0000-0002-4866-2885	Wellcome Trust [085956/Z/08/Z]; Deutsche Forschungsgemeinschaft [Kr4017/1-1]; BBSRC [BB/D020190/1]; Schumberger Foundation; Faculty for the Future (BBC); EAB a Nuffield Foundation Vacation Bursary.; Biotechnology and Biological Sciences Research Council [BB/D020190/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Schumberger Foundation; Faculty for the Future (BBC); EAB a Nuffield Foundation Vacation Bursary.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust (085956/Z/08/Z) (MC), the Deutsche Forschungsgemeinschaft (Kr4017/1-1) (SKr), the BBSRC (BB/D020190/1) (SKe) and the Schumberger Foundation, Faculty for the Future (BBC). LE received a BBSRC Ph.D. studentship and EAB a Nuffield Foundation Vacation Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Bag J, 2010, RNA BIOL, V7, P5, DOI 10.4161/rna.7.1.10256; Bates EJ, 2000, NUCLEIC ACIDS RES, V28, P1211, DOI 10.1093/nar/28.5.1211; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Belostotsky DA, 2003, GENETICS, V163, P311; BELOSTOTSKY DA, 1993, P NATL ACAD SCI USA, V90, P6686, DOI 10.1073/pnas.90.14.6686; Belostotsky DA, 1996, PLANT CELL, V8, P1261, DOI 10.1105/tpc.8.8.1261; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bravo J, 2005, MOL GENET GENOMICS, V272, P651, DOI 10.1007/s00438-004-1090-9; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brook M, 2012, BIOCHEM J, V441, P803, DOI 10.1042/BJ20111474; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; D'Orso I, 2002, J BIOL CHEM, V277, P50520, DOI 10.1074/jbc.M209092200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Friend K, 2012, BIOCHEM J, V445, P93, DOI 10.1042/BJ20120304; GONZALEZ CI, 2007, TRANSLATIONAL CONTRO, P719; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guerra N, 2011, FEBS LETT, V585, P193, DOI 10.1016/j.febslet.2010.11.042; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BS, 2005, EUKARYOT CELL, V4, P971, DOI 10.1128/EC.4.5.971-980.2005; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; HILSON P, 1993, PLANT PHYSIOL, V103, P525, DOI 10.1104/pp.103.2.525; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Hotchkiss TL, 1999, MOL BIOCHEM PARASIT, V98, P117, DOI 10.1016/S0166-6851(98)00156-X; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kramer S, 2012, J CELL SCI; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Liu Y, 1996, EMBO J, V15, P6750, DOI 10.1002/j.1460-2075.1996.tb01064.x; Marchetti MA, 2000, J CELL SCI, V113, P899; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mittra B, 2004, EUKARYOT CELL, V3, P1185, DOI 10.1128/EC.3.5.1185-1197.2004; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Palanivelu R, 2000, PLANT J, V22, P199, DOI 10.1046/j.1365-313x.2000.00720.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pitula J, 1998, EXP PARASITOL, V88, P157, DOI 10.1006/expr.1998.4211; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Sunter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035167; Tani T, 1996, MOL BIOL CELL, V7, P173, DOI 10.1091/mbc.7.1.173; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; Vazquez-Pianzola P, 2011, DEV BIOL, V357, P404, DOI 10.1016/j.ydbio.2011.07.009; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; WOODWARD R, 1990, J CELL SCI, V95, P49; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Yoffe Y, 2009, NUCLEIC ACIDS RES, V37, P3243, DOI 10.1093/nar/gkp190; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	86	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54004	10.1371/journal.pone.0054004	http://dx.doi.org/10.1371/journal.pone.0054004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382864	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800029
J	Pilli, E; Modi, A; Serpico, C; Achilli, A; Lancioni, H; Lippi, B; Bertoldi, F; Gelichi, S; Lari, M; Caramelli, D				Pilli, Elena; Modi, Alessandra; Serpico, Ciro; Achilli, Alessandro; Lancioni, Hovirag; Lippi, Barbara; Bertoldi, Francesca; Gelichi, Sauro; Lari, Martina; Caramelli, David			Monitoring DNA Contamination in Handled vs. Directly Excavated Ancient Human Skeletal Remains	PLOS ONE			English	Article							SEQUENCES; GENETICS; TEETH	Bones, teeth and hair are often the only physical evidence of human or animal presence at an archaeological site; they are also the most widely used sources of samples for ancient DNA (aDNA) analysis. Unfortunately, the DNA extracted from ancient samples, already scarce and highly degraded, is widely susceptible to exogenous contaminations that can affect the reliability of aDNA studies. We evaluated the molecular effects of sample handling on five human skeletons freshly excavated from a cemetery dated between the 11 to the 14th century. We collected specimens from several skeletal areas (teeth, ribs, femurs and ulnas) from each individual burial. We then divided the samples into two different sets: one labeled as "virgin samples'' (i.e. samples that were taken by archaeologists under contamination-controlled conditions and then immediately sent to the laboratory for genetic analyses), and the second called "lab samples''(i.e. samples that were handled without any particular precautions and subject to normal washing, handling and measuring procedures in the osteological lab). Our results show that genetic profiles from "lab samples'' are incomplete or ambiguous in the different skeletal areas while a different outcome is observed in the "virgin samples'' set. Generally, all specimens from different skeletal areas in the exception of teeth present incongruent results between "lab'' and "virgin'' samples. Therefore teeth are less prone to contamination than the other skeletal areas we analyzed and may be considered a material of choice for classical aDNA studies. In addition, we showed that bones can also be a good candidate for human aDNA analysis if they come directly from the excavation site and are accompanied by a clear taphonomic history.	[Pilli, Elena; Modi, Alessandra; Serpico, Ciro; Lippi, Barbara; Lari, Martina; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy; [Achilli, Alessandro; Lancioni, Hovirag] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Bertoldi, Francesca; Gelichi, Sauro] Univ Ca Foscari Venezia, Dipartimento Studi Umanistici, Venice, Italy	University of Florence; University of Perugia; Universita Ca Foscari Venezia	Lari, M (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Florence, Italy.	martina.lari@unifi.it	Achilli, Alessandro/I-9236-2012; Lari, Martina/A-4085-2009; Lancioni, Hovirag/F-9067-2014	Achilli, Alessandro/0000-0001-6871-3451; Lancioni, Hovirag/0000-0001-5514-1853; Caramelli, David/0000-0001-6468-1675; Pilli, Elena/0000-0002-3150-5082	MIUR [2008TE2B8S_002]; Progetti di ricerca fondamentale o di base Sardinia Region [CRP2_439]; FIRB [RBFR08U07M]	MIUR(Ministry of Education, Universities and Research (MIUR)); Progetti di ricerca fondamentale o di base Sardinia Region; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by MIUR grant #2008TE2B8S_002 and Progetti di ricerca fondamentale o di base Sardinia Region grant #CRP2_439 assigned to DC, and by FIRB grant #RBFR08U07M "Futuro in Ricerca'' assigned to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bouwman AS, 2006, AM J PHYS ANTHROPOL, V131, P428, DOI 10.1002/ajpa.20411; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2007, FORENSIC SCI INT, V173, P36, DOI 10.1016/j.forsciint.2007.01.020; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Cooper A, 2000, SCIENCE, V289, P1139; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Gilbert MTP, 2006, INT J OSTEOARCHAEOL, V16, P156, DOI 10.1002/oa.832; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Linderholm A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002316; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; RICHARDS M, 1993, WORLD ARCHAEOL, V25, P18, DOI 10.1080/00438243.1993.9980225; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Serre D, 2004, MOL BIOL EVOL, V21, P1463, DOI 10.1093/molbev/msh139; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wandeler P, 2003, MOL ECOL, V12, P1087, DOI 10.1046/j.1365-294X.2003.01807.x	28	35	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e52524	10.1371/journal.pone.0052524	http://dx.doi.org/10.1371/journal.pone.0052524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372650	gold, Green Published			2022-12-27	WOS:000315210400003
J	Habart, D; Cheli, Y; Nugent, DJ; Ruggeri, ZM; Kunicki, TJ				Habart, David; Cheli, Yann; Nugent, Diane J.; Ruggeri, Zaverio M.; Kunicki, Thomas J.			Conditional Knockout of Integrin alpha 2 beta 1 in Murine Megakaryocytes Leads to Reduced Mean Platelet Volume	PLOS ONE			English	Article							PROPLATELET FORMATION; GLYCOPROTEIN-VI; COLLAGEN; ADHESION; MOUSE; EXPRESSION; GENERATION; MODEL; GPVI	We have engineered a transgenic mouse on a C57BL/6 background that bears a floxed Itga2 gene. The crossing of this mouse strain to transgenic mice expressing Cre recombinase driven by the megakaryocyte (MK)-specific Pf4 promoter permits the conditional knockout of Itga2 in the MK/platelet lineage. Mice lacking MK alpha 2 beta 1 develop normally, are fertile, and like their systemic alpha 2 beta 1 knockout counterparts, exhibit defective adhesion to and aggregation induced by soluble type I collagen and a delayed onset to low dose fibrillar collagen-induced aggregation, results consistent with blockade or loss of platelet alpha 2 beta 1. At the same time, we observed a significant reduction in mean platelet volume, which is consistent with the reported role of alpha 2 beta 1 in MK maturation and proplatelet formation in vivo. This transgenic mouse strain bearing a floxed Itga2 gene will prove valuable to distinguish in vivo the temporal and spatial contributions of alpha 2 integrin in selected cell types.	[Habart, David; Cheli, Yann; Ruggeri, Zaverio M.; Kunicki, Thomas J.] Scripps Res Inst, Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA; [Nugent, Diane J.; Kunicki, Thomas J.] CHOC Childrens Hosp, Orange, CA USA	Scripps Research Institute	Kunicki, TJ (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Roon Res Ctr Arteriosclerosis & Thrombosis, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tkunicki@choc.org	Cheli, Yann/O-5783-2016; Habart, David/B-4291-2009	Cheli, Yann/0000-0001-9839-4332; 	NHLBI [R01 HL086904]; Roon Research Foundation; Ministry of Health, Czech Republic for development of research organization IKEM, Prague [00023001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086904, R01HL042846] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Roon Research Foundation; Ministry of Health, Czech Republic for development of research organization IKEM, Prague; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI (www.nhlbi.nih.gov) R01 HL086904 awarded to TJK, institutional support 00023001 from the Ministry of Health, Czech Republic for development of research organization IKEM, Prague awarded to DH, and a grant from the Roon Research Foundation awarded to ZMR. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; COLLER BS, 1989, BLOOD, V74, P182; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Kunicki TJ, 2012, ARTERIOSCL THROM VAS, V32, P147, DOI 10.1161/ATVBAHA.111.239392; KUNICKI TJ, 1988, J BIOL CHEM, V263, P4516; Kunicki TJ, 2011, HAEMATOLOGICA, V97, P692; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lundberg S, 2006, INFLAMM BOWEL DIS, V12, P172, DOI 10.1097/01.MIB.0000217765.96604.83; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Pallotta I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008359; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; TOPP KS, 1990, BLOOD, V76, P912; Trifiro E, 2009, BLOOD, V114, P1893, DOI 10.1182/blood-2009-03-209510; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Zou ZY, 2009, BLOOD, V113, P6428, DOI 10.1182/blood-2008-08-175356	32	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55094	10.1371/journal.pone.0055094	http://dx.doi.org/10.1371/journal.pone.0055094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359821	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600151
J	Li, JS; Lin, X; Chen, AP; Peterson, T; Ma, KP; Bertzky, M; Ciais, P; Kapos, V; Peng, CH; Poulter, B				Li, Junsheng; Lin, Xin; Chen, Anping; Peterson, Townsend; Ma, Keping; Bertzky, Monika; Ciais, Philippe; Kapos, Valerie; Peng, Changhui; Poulter, Benjamin			Global Priority Conservation Areas in the Face of 21st Century Climate Change	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; MOUNTAIN PASSES; PROTECTED AREAS; PROJECTIONS; ADAPTATION; RESPONSES; ECOSYSTEM; FORESTS; PRECIPITATION; DEFORESTATION	In an era when global biodiversity is increasingly impacted by rapidly changing climate, efforts to conserve global biodiversity may be compromised if we do not consider the uneven distribution of climate-induced threats. Here, via a novel application of an aggregate Regional Climate Change Index (RCCI) that combines changes in mean annual temperature and precipitation with changes in their interannual variability, we assess multi-dimensional climate changes across the "Global 200" ecoregions - a set of priority ecoregions designed to "achieve the goal of saving a broad diversity of the Earth's ecosystems" - over the 21 st century. Using an ensemble of 62 climate scenarios, our analyses show that, between 1991-2010 and 2081-2100, 96% of the ecoregions considered will be likely (more than 66% probability) to face moderate-to-pronounced climate changes, when compared to the magnitudes of change during the past five decades. Ecoregions at high northern latitudes are projected to experience most pronounced climate change, followed by those in the Mediterranean Basin, Amazon Basin, East Africa, and South Asia. Relatively modest RCCI signals are expected over ecoregions in Northwest South America, West Africa, and Southeast Asia, yet with considerable uncertainties. Although not indicative of climate-change impacts per se, the RCCI-based assessment can help policy-makers gain a quantitative and comprehensive overview of the unevenly distributed climate risks across the G200 ecoregions. Whether due to significant climate change signals or large uncertainties, the ecoregions highlighted in the assessment deserve special attention in more detailed impact assessments to inform effective conservation strategies under future climate change.	[Li, Junsheng; Lin, Xin] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Lin, Xin] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Chen, Anping] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Peterson, Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Ma, Keping] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Bertzky, Monika; Kapos, Valerie] United Nations Environm Programme World Conservat, Cambridge, England; [Ciais, Philippe; Poulter, Benjamin] CNRS, LSCE, UM, Commissariat Energie Atom & Energies Alternat CE, Gif Sur Yvette, France; [Ciais, Philippe; Poulter, Benjamin] Univ Versailles St Quentin Yvelines UVSQ, Gif Sur Yvette, France; [Kapos, Valerie] Univ Cambridge, Dept Zool, Cambridge, England; [Peng, Changhui] Univ Quebec, Dept Biol Sci, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada; [Peng, Changhui] NW A&F Univ, Coll Forestry, Lab Ecol Forecasting & Global Change, Yangling, Shaanxi, Peoples R China	Chinese Research Academy of Environmental Sciences; Beijing Normal University; Princeton University; University of Kansas; Chinese Academy of Sciences; Institute of Botany, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; University of Quebec; University of Quebec Montreal; Northwest A&F University - China	Li, JS (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	lijsh@craes.org.cn	Ciais, Philippe/A-6840-2011; Lin, Xin/GRJ-1583-2022; Chen, Anping/H-9960-2014; Poulter, Ben/ABB-5886-2021; Kapos, Valerie/G-3136-2010	Ciais, Philippe/0000-0001-8560-4943; Chen, Anping/0000-0003-2085-3863; Poulter, Ben/0000-0002-9493-8600; Kapos, Valerie/0000-0002-5739-8262; Lin, Xin/0000-0002-0605-6430	Environmental Protection Public Service Project of China [201209031]	Environmental Protection Public Service Project of China	This study was supported by the Environmental Protection Public Service Project of China (201209031) (URL:http://kjs.mep.gov.cn/gyxhykyzx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Baettig MB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028159; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Diffenbaugh NS, 2007, P NATL ACAD SCI USA, V104, P20195, DOI 10.1073/pnas.0706680105; Diffenbaugh NS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035075; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Giorgi F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024288; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Iwamura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015103; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jones RN, 2001, NAT HAZARDS, V23, P197, DOI 10.1023/A:1011148019213; Keeley JE, 1995, MEDITERRANEAN TYPE E, P122; Killengreen ST, 2007, BIOL CONSERV, V135, P459, DOI 10.1016/j.biocon.2006.10.039; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mouillot F, 2002, GLOBAL CHANGE BIOL, V8, P423, DOI 10.1046/j.1365-2486.2002.00494.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tebaldi C, 2005, J CLIMATE, V18, P1524, DOI 10.1175/JCLI3363.1; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; Usher MB, 2005, ARCTIC CLIMATE IMPAC, P540; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	54	184	188	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54839	10.1371/journal.pone.0054839	http://dx.doi.org/10.1371/journal.pone.0054839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359638	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600120
J	Tang, HX; Cai, WB; Wang, HJ; Zhang, Q; Qian, L; Shell, DF; Newman, IM; Yin, P				Tang, Hongxiu; Cai, Weibin; Wang, Hongjing; Zhang, Qing; Qian, Ling; Shell, Duane F.; Newman, Ian M.; Yin, Ping			The Association between Cultural Orientation and Drinking Behaviors among University Students in Wuhan, China	PLOS ONE			English	Article							ALCOHOL-USE; ADOLESCENTS; ACCULTURATION; ZIMBABWE; EXPECTANCIES; SAMPLE; DRUG	Objectives: This study examines the association between cultural orientation and drinking behaviors among university students. Cultural orientation is the measure of how the cultural values of individuals living in their own society are influenced by cultural values introduced from the outside. Methods: In 2011, a cross-sectional survey collected data from 1279 university students from six universities in central China. Participants used a likert scale to rank a series of statements reflecting cultural values from the previously validated Chinese Cultural Orientation Scale and answered questions about their drinking behaviors and socio-demographic characteristics. Results: Statistically significant differences in cultural orientation were observed for gender, hometown and type of university attendance. Traditional-oriented students were more likely to be occasional drinkers or nondrinkers, while marginal-oriented students, bicultural-oriented students and western-oriented students were more likely to be regular drinkers. Bicultural orientation (OR = 1.80, P<0.05) and marginal orientation (OR = 1.64, P<0.05) increased the likelihood of the student being regular drinking, compared to students with traditional orientations. Males (OR = 4.40, P<0.05) had a higher likelihood of regular drinking than females, graduate students (OR = 2.59, P<0.05) had a higher likelihood of regular drinking than undergraduates, students from urban areas (OR = 1.79, P<0.05) had a higher likelihood of regular drinking than those from towns/rural areas, and students attending key universities (OR = 0.48, P<0.05) had a lower likelihood of regular drinking than those attending general universities. Conclusions: Cultural orientation influences drinking behaviors. Traditional cultural orientation was associated with less drinking while western cultural orientation, marginal cultural orientation and bicultural orientation were associated with more drinking. The role of gender, hometown and university attendance is partially moderated through the influence of cultural orientation. The relationship between a traditional cultural orientation and alcohol drinking suggests that traditional Chinese cultural values should be examined for their role in possibly reducing alcohol-related risks through education and policy initiatives.	[Tang, Hongxiu; Cai, Weibin; Wang, Hongjing; Zhang, Qing; Yin, Ping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Qian, Ling] Chinese Hlth Educ Ctr, Beijing, Peoples R China; [Shell, Duane F.] Univ Nebraska, Nebraska Prevent Ctr Alcohol & Drug Abuse, Lincoln, NE USA; [Newman, Ian M.] Univ Nebraska, Dept Educ Psychol, Lincoln, NE 68588 USA	Huazhong University of Science & Technology; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	ping_y2000@163.com		Shell, Duane/0000-0001-9037-5815	cooperation fund of University of Nebraska-Lincoln; Huazhong University of Science and Technology	cooperation fund of University of Nebraska-Lincoln; Huazhong University of Science and Technology	This work was supported by a cooperation fund of University of Nebraska-Lincoln and Huazhong University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANCET, V371, P1551, DOI DOI 10.1016/S0140-6736(08)60663-7; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Eide AH, 1997, J ADOLESCENCE, V20, P511, DOI 10.1006/jado.1997.0106; Eide AH, 1996, ADDICTION, V91, P807; Eide AH, 1996, J CHILD ADOLES SUBST, V5, P15; Fosados R, 2007, ADDICT BEHAV, V32, P2990, DOI 10.1016/j.addbeh.2007.06.015; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Herman-Stahl M, 2003, AM INDIAN ALASKA NAT, V11, P46; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karam E, 2007, CURR OPIN PSYCHIATR, V20, P213; Kraus L, 2010, DRUG ALCOHOL DEPEN, V110, P15, DOI 10.1016/j.drugalcdep.2010.01.020; McAllister I, 2003, ALCOHOL CONSUMPTION; Newman I.M., 2004, CHIN J DRUG ABUS PRE, V10, P272; Qian L, 2007, ALCOHOL CHINA PRODUC; Schulte MT, 2009, CLIN PSYCHOL REV, V29, P535, DOI 10.1016/j.cpr.2009.06.003; Schwartz SJ, 2008, CULT DIVERS ETHN MIN, V14, P275, DOI 10.1037/a0012818; Shell DF, 2010, ADDICTION, V105, P1608, DOI 10.1111/j.1360-0443.2010.03006.x; Shell DF, 2009, ASIA-PAC J PUBLIC HE, V21, P433, DOI 10.1177/1010539509344345; Timberlake DS, 2007, ALCOHOL CLIN EXP RES, V31, P1020, DOI 10.1111/j.1530-0277.2007.00383.x; Wang ZX, 2009, ZHONG GUO XUE XIAO W, V30, P499; World Advertising Research Center Ltd, 2005, WORLD DRINK TRENDS 2; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2007, WHO EXP COMM PROBL R; World Health Organization (WHO), 2005, ALC GEND DRINK PROBL; Xue J.P., 2005, ZHONGGUO XING WEI YI, V14, P1019; Zhou XH, 2006, ALCOHOL, V39, P87, DOI 10.1016/j.alcohol.2006.07.003	27	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54796	10.1371/journal.pone.0054796	http://dx.doi.org/10.1371/journal.pone.0054796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	077JK	23359611	gold, Green Published			2022-12-27	WOS:000314023600112
J	Basith, S; Manavalan, B; Gosu, V; Choi, S				Basith, Shaherin; Manavalan, Balachandran; Gosu, Vijayakumar; Choi, Sangdun			Evolutionary, Structural and Functional Interplay of the I kappa B Family Members	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NORMAL-MODE CALCULATIONS; DNA-BINDING; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; NEGATIVE REGULATION; NUCLEAR-PROTEIN; ANKYRIN REPEAT; NETWORK MODEL; C-REL	A primary level of control for nuclear factor kappa B (NF-kappa B) is effected through its interactions with the inhibitor protein, inhibitor of kappa B (I kappa B). Several lines of evidence confirm the existence of multiple forms of I kappa B that appear to regulate NF-kappa B by distinct mechanisms. Therefore, we performed a comprehensive bioinformatics analysis to understand the evolutionary history and intrinsic functional diversity of IkB family members. Phylogenetic relationships were constructed to trace the evolution of the IkB family genes. Our phylogenetic analysis revealed 10 I kappa B subfamily members that clustered into 5 major clades. Since the ankyrin (ANK) domain appears to be more ancient than the Rel homology domain (RHD), our phylogenetic analysis suggests that some undefined ancestral set of ANK repeats acquired an RHD before any duplication and was later duplicated and then diverged into the different I kappa B subfamilies. Functional analysis identified several functionally divergent sites in the ANK repeat domains (ARDs) and revealed that this region has undergone strong purifying selection, suggesting its functional importance in I kappa B genes. Structural analysis showed that the major variations in the number of ANK repeats and high conformational changes in the finger loop ARD region contribute to the differing binding partner specificities, thereby leading to distinct I kappa B functions. In summary, our study has provided useful information about the phylogeny and structural and functional divergence of the I kappa B family. Additionally, we identified a number of amino acid sites that contribute to the predicted functional divergence of these proteins.	[Basith, Shaherin; Gosu, Vijayakumar; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Manavalan, Balachandran] Korea Inst Adv Study, Sch Computat Sci, Ctr In Silico Prot Sci, Seoul, South Korea	Ajou University; Korea Institute for Advanced Study (KIAS)	Choi, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Manavalan, Balachandran/Q-8279-2019	Manavalan, Balachandran/0000-0003-0697-9419; Gosu, Vijayakumar/0000-0001-6038-4104	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012016803]; Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources [KSC-2012-C3-28]; Priority Research Centers Program [NRF 2012-0006687]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources; Priority Research Centers Program	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012016803). This work was also partly supported by the Supercomputing Center/Korea Institute of Science and Technology Information with supercomputing resources (KSC-2012-C3-28) and the Priority Research Centers Program (NRF 2012-0006687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Basith S, 2011, EXPERT OPIN THER PAT, V21, P927, DOI 10.1517/13543776.2011.569494; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Finn R. D., 2008, NUCLEIC ACIDS RES, V38, pD211; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HARRISON RW, 1984, BIOPOLYMERS, V23, P2943, DOI 10.1002/bip.360231216; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huguet C, 1997, ONCOGENE, V15, P2965, DOI 10.1038/sj.onc.1201471; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Huxford T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000075; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Manavalan B, 2012, ENCY SIGNALING MOL, P892; Manavalan B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00041; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Manavalan B, 2011, J MOL RECOGNIT, V24, P597, DOI 10.1002/jmr.1085; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; McDowall J, 2011, METHODS MOL BIOL, V694, P37, DOI 10.1007/978-1-60761-977-2_3; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Wu ZH, 2009, BIOCHEM BIOPH RES CO, V387, P348, DOI 10.1016/j.bbrc.2009.07.023; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000	83	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54178	10.1371/journal.pone.0054178	http://dx.doi.org/10.1371/journal.pone.0054178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372681	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500035
J	Gong, H; Zhang, X; Cheng, BA; Sun, Y; Li, CZ; Li, T; Zheng, L; Huang, K				Gong, Hao; Zhang, Xin; Cheng, Biao; Sun, Yue; Li, Chuanzhou; Li, Ting; Zheng, Ling; Huang, Kun			Bisphenol A Accelerates Toxic Amyloid Formation of Human Islet Amyloid Polypeptide: A Possible Link between Bisphenol A Exposure and Type 2 Diabetes	PLOS ONE			English	Article							MEMBRANE DISRUPTION; MISFOLDING DISEASES; HUMAN HEALTH; PEPTIDE; PROTEIN; IAPP; BPA; AGGREGATION; MECHANISM; INSULIN	Bisphenol A (BPA) is a chemical compound widely used in manufacturing plastic products. Recent epidemiological studies suggest BPA exposure is positively associated with the incidence of type 2 diabetes mellitus (T2DM), however the mechanisms underlying this link remain unclear. Human islet amyloid polypeptide (hIAPP) is a hormone synthesized and secreted by the pancreatic beta-cells. Misfolding of hIAPP into toxic oligomers and mature fibrils can disrupt cell membrane and lead to beta-cell death, which is regarded as one of the causative factors of T2DM. To test whether there are any connections between BPA exposure and hIAPP misfolding, we investigated the effects of BPA on hIAPP aggregation using thioflavin-T based fluorescence, transmission electronic microscopy, circular dichroism, dynamic light scattering, size-exclusion chromatography, fluorescence-dye leakage assay in an artificial micelle system and the generation of reactive oxygen species in INS-1 cells. We demonstrated that BPA not only dose-dependently promotes the aggregation of hIAPP and enhances the membrane disruption effects of hIAPP, but also promotes the extent of hIAPP aggregation related oxidative stress. Taken together, our results suggest that BPA exposure increased T2DM risk may involve the exacerbated toxic aggregation of hIAPP.	[Gong, Hao; Zhang, Xin; Cheng, Biao; Li, Ting; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Sun, Yue; Li, Chuanzhou; Zheng, Ling] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Huang, Kun] Wuhan Inst Biotechnol, Ctr Biomed Res, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Zheng, L (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	lzheng217@hotmail.com; kunhuang2008@hotmail.com		Zheng, Ling/0000-0002-6545-4180; Li, Chuanzhou/0000-0003-0174-4215	National Basic Research Program of China [2009BC918304, 2012CB524901]; Natural Science Foundation of China [81222043, 30970607, 81172971, 81100687, 31271370]; Program for New Century Excellent Talents in University [NECT100623, NECT11-0170]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (2009BC918304 & 2012CB524901 to LZ), the Natural Science Foundation of China (Nos. 81222043, 30970607, 81172971 to KH; and Nos. 81100687 & 31271370 to LZ), the Program for New Century Excellent Talents in University (NECT100623 to LZ & NECT11-0170 to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Benachour N, 2009, TOXICOL APPL PHARM, V241, P322, DOI 10.1016/j.taap.2009.09.005; Bontempo P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-48; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Cheng B, 2012, PROTEINS IN PRESS; Cheng BA, 2012, BIOCHEM BIOPH RES CO, V419, P495, DOI 10.1016/j.bbrc.2012.02.042; Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cui W, 2009, FEBS J, V276, P3365, DOI 10.1111/j.1742-4658.2009.07061.x; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Law E, 2010, DIABETOLOGIA, V53, P1415, DOI 10.1007/s00125-010-1717-9; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Lee S, 2008, J NEUROSCI RES, V86, P2932, DOI 10.1002/jnr.21739; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lubick N, 2010, ENVIRON HEALTH PERSP, V118, pA116, DOI 10.1289/ehp.118-a116a; Manley S, 1997, DIABETES, V46, P1307; Mead MN, 2010, ENVIRON HEALTH PERSP, V118, pA399, DOI 10.1289/ehp.118-a399a; Melzer D, 2009, JAMA-J AM MED ASSOC, V301, P721; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Salamekh S, 2011, J MOL BIOL, V410, P294, DOI 10.1016/j.jmb.2011.05.015; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Zhang X, 2011, FEBS LETT, V585, P71, DOI 10.1016/j.febslet.2010.11.050; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	62	62	63	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54198	10.1371/journal.pone.0054198	http://dx.doi.org/10.1371/journal.pone.0054198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372685	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500039
J	Parrilla-Bel, J; Young, MT; Moreno-Azanza, M; Canudo, JI				Parrilla-Bel, Jara; Young, Mark T.; Moreno-Azanza, Miguel; Ignacio Canudo, Jose			The First Metriorhynchid Crocodylomorph from the Middle Jurassic of Spain, with Implications for Evolution of the Subclade Rhacheosaurini	PLOS ONE			English	Article							SALT-GLANDS; CRETACEOUS TRANSITION; THALATTOSUCHIA; GEOSAURUS; SKULL; CROCODYLIFORM; MESOEUCROCODYLIA; DAKOSAURUS; SYSTEM; MEXICO	Background: Marine deposits from the Callovian of Europe have yielded numerous species of metriorhynchid crocodylomorphs. While common in English and French Formations, metriorhynchids are poorly known from the Iberian Peninsula. Twenty years ago an incomplete, but beautifully preserved, skull was discovered from the Middle Callovian of Spain. It is currently the oldest and best preserved metriorhynchid specimen from the Iberian Peninsula. Until now it has never been properly described and its taxonomic affinities remained obscure. Methodology/Principal Findings: Here we present a comprehensive description for this specimen and in doing so we refer it to a new genus and species: Maledictosuchus riclaensis. This species is diagnosed by numerous autapomorphies, including: heterodont dentition; tightly interlocking occlusion; lachrymal anterior process excludes the jugal from the preorbital fenestra; orbits longer than supratemporal fenestrae; palatine has two non-midline and one midline anterior processes. Our phylogenetic analysis finds Maledictosuchus riclaensis to be the basal-most known member of Rhacheosaurini (the subclade of increasingly mesopelagic piscivores that includes Cricosaurus and Rhacheosaurus). Conclusions/Significance: Our description of Maledictosuchus riclaensis shows that the craniodental morphologies that underpinned the success of Rhacheosaurini in the Late Jurassic and Early Cretaceous, as a result of increasing marine specialization to adaptations for feeding on fast small-bodied prey (i.e. divided and retracted external nares; reorientation of the lateral processes of the frontal; elongate, tubular rostrum; procumbent and non-carinated dentition; high overall tooth count; and dorsolaterally inclined paroccipital processes), first appeared during the Middle Jurassic. Rhacheosaurins were curiously rare in the Middle Jurassic, as only one specimen of Maledictosuchus riclaensis is known (with no representatives discovered from the well-sampled Oxford Clay Formation of England). As such, the feeding/marine adaptations of Rhacheosaurini did not confer an immediate selective advantage upon the group, and it took until the Late Jurassic for this subclade to dominate in Western Europe.	[Parrilla-Bel, Jara; Moreno-Azanza, Miguel; Ignacio Canudo, Jose] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus, IUCA Inst Univ Invest Ciencias Ambientales Aragon, E-50009 Zaragoza, Spain; [Young, Mark T.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	University of Zaragoza; University of Edinburgh	Parrilla-Bel, J (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus, IUCA Inst Univ Invest Ciencias Ambientales Aragon, E-50009 Zaragoza, Spain.	jarapb@unizar.es	Parrilla-Bel, Jara/K-7671-2017; Young, Mark T/P-3469-2014; Moreno-Azanza, Miguel/G-9165-2017	Parrilla-Bel, Jara/0000-0002-2426-7450; Young, Mark T/0000-0002-7263-6505; Moreno-Azanza, Miguel/0000-0002-7210-1033; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Spanish Ministerio de Economia y Competitividad [CGL2010-16447]; European Regional Development Fund; Government of Aragon ("Grupos Consolidados"); Government of Aragon ("Direccion General de Patrimonio Cultural"); Government of Aragon [B105/10]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon ("Grupos Consolidados")(Gobierno de Aragon); Government of Aragon ("Direccion General de Patrimonio Cultural"); Government of Aragon(Gobierno de Aragon)	This paper forms part of the project CGL2010-16447, subsidized by the Spanish Ministerio de Economia y Competitividad, the European Regional Development Fund, and the Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"). JP-B is supported by a predoctoral research grant (B105/10) from the Government of Aragon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C. W., 1913, DESCRIPTIVE CATALO 2; [Anonymous], 2008, GEOTEMAS; [Anonymous], 2005, NATURALEZA ARAGONESA, V14, P95; Antunes MT, 1967, MEMORIAS SERVICOS GE, V13, P1; Aurell M., 2002, GEOLOGY SPAIN, P223; Bardet Nathalie, 1994, Historical Biology, V7, P313; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Buchy MC, 2008, NEUES JAHRB GEOL P-A, V249, P1, DOI 10.1127/0077-7749/2008/0249-0001; Buchy MC, 2006, CR PALEVOL, V5, P785, DOI 10.1016/j.crpv.2006.03.003; Buchy MC, ORYCTOS IN PRESS; BUFFETAUT E, 1987, SHORT HIST VERTEBRAT; Canudo JI, 2006, NEUES JAHRB GEOL P-A, V239, P77; Canudo JI, 1998, ARAGONIA, V1, P13; Canudo JI, 1997, CUADERNOS PALEONTOLO, V1, P14; Cariou E., 1988, P 2 INT S JUR STRAT, P395; Cau A, 2011, GONDWANA RES, V19, P550, DOI 10.1016/j.gr.2010.07.007; De Andrade MB, 2010, J VERTEBR PALEONTOL, V30, P1451, DOI 10.1080/02724634.2010.501442; de la Fuente MS., 2007, ASOCIACI N PALEONTOL, V11, P137; Fernandez M, 2000, LETHAIA, V33, P269; Fernandez M, 2008, NATURWISSENSCHAFTEN, V95, P79, DOI 10.1007/s00114-007-0296-1; Fernandez MS, 2011, J VERTEBR PALEONTOL, V31, P369, DOI 10.1080/02724634.2011.550361; Fernandez MS, 2009, J VERTEBR PALEONTOL, V29, P702, DOI 10.1671/039.029.0323; Ferreira OV., 1959, AN FAC CIEN PORTO, V41, P121; Fitzinger LI, 1843, SYSTEMA REPTILIUM, P20; Fraas E., 1902, PALAEONTOGRAPHICA, V49, P1; Fraas E, 1901, JAHRESHEFTE VEREINS, V57, P409; Frey E, 2002, CAN J EARTH SCI, V39, P1467, DOI 10.1139/E02-060; Gamez Vintaned JA, 2006, TESOROS FOSILES ARAG; Gandola R, 2006, J VERTEBR PALEONTOL, V26, P1009, DOI 10.1671/0272-4634(2006)26[1009:SGITFC]2.0.CO;2; Gasparini Z., 2008, REV GEOL CHILE, V35, P335; Gasparini Z. B, 1977, NEUES JB GEOLOGIE PA, V153, p341 ; Genera i Monells M, 2010, ORIGENES EVOLUCION E; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomez JJ, 2006, PALAEOGEOGR PALAEOCL, V236, P190, DOI 10.1016/j.palaeo.2005.11.008; Gomez J.J., 2004, GEOLOGIA ESPANA, P500; Grange DR, 1996, PALAEONTOLOGY, V39, P497; Hay O.P., 1930, 2 BIBLIO CATALOGUE F, V2; Hua S, 2000, GEOBIOS-LYON, V33, P467, DOI 10.1016/S0016-6995(00)80080-7; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Karl Hans-Volker, 2006, Studia Geologica Salmanticensia, V42, P49; Langston W. Jr., 1973, P263; Lendinez A, 1995, SERIE MAGNA EPILA HO; Lepage Yves, 2008, Bulletin de la Societe Geologique de Normandie et des Amis du Museum du Havre, V95, P5; Linan E, 2002, NATURALEZA ARAGONESA, V9, P16; Linan Eladio, 2010, P17; Linan Guijarro E, 2006, AQUARIA AGUA TERRITO, P18; Martinez R. D., 1995, NATURALIA PATAGONICA, V3, P93; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; Melendez G, 2000, CURSOS C, V128, P197; Melendez G, 2001, ENSENANZA CIENCIAS T, V9, P160; Melendez G, 1988, 3 C JUR ESP GUIA EXC, P265; Meyer CEH von, 1832, PALAOLOGICA GESCH ER; Meyer H.von., 1831, NOVA ACTA ACAD LEOPO, V15, P173; Ochev VG, 1981, PRIRODA, V5, P103; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Page KN, 2004, RIV ITAL PALEONTOL S, V110, P191, DOI 10.13130/2039-4942/6285; Parrilla-Bel J, 2011, VIAJANDO MUNDOS PRET, P241; Pereda Suberbiola X., 2012, BERNISSART DINOSAURS, P379; Perez Urresti I, 2005, CUADERNOS PALEONTOLO, V3, P50; Perez Urresti I, 2003, CUADERNOS PALEONTOLO, V2, P8; PHANSALKAR VG, 1994, CURR SCI INDIA, V67, P460; Pierce SE, 2009, J ANAT, V215, P555, DOI 10.1111/j.1469-7580.2009.01137.x; Pierce SE, 2009, PALAEONTOLOGY, V52, P1057, DOI 10.1111/j.1475-4983.2009.00904.x; Pol Diego, 2007, P116; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Puertolas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020011; Quesada Juan M., 1998, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V94, P101; Ramajo J, 2006, THESIS U ZARAGOZA ZA; Rieppel O., 1979, BURGERGEMEINDE BERN, V7, P277; Royo-Torres R, 2009, PALAEONTOLOGY, V52, P1009, DOI 10.1111/j.1475-4983.2009.00898.x; Ruiz-Omenaca J. I., 2007, 23 JORN SOC ESP PAL, P204; Ruiz-Omenaca JI, 2010, COMM 5 C JUR ESP, P193; Sender Palomar LM, 2010, NATURALEZA ARAGONESA, V25, P4; SEQUEIROS L, 1984, Estudios Geologicos (Madrid), V40, P411; Steel R., 1973, HDB PALAOHERPETOL 16; Vignaud P, 1995, THESIS U POITIERS PO; von Sommerring ST, 1816, DENKSCHRIFTEN KONIGL, V6, P37; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Young MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044985; Young MT, 2012, ANAT REC, V295, P1147, DOI 10.1002/ar.22491; Young MT, 2011, ZOOL J LINN SOC-LOND, V163, P1199, DOI 10.1111/j.1096-3642.2011.00734.x; Young MT, 2011, BIOL LETTERS, V7, P913, DOI 10.1098/rsbl.2011.0357; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Young MT, 2009, ZOOL J LINN SOC-LOND, V157, P551, DOI 10.1111/j.1096-3642.2009.00536.x; Young MT, J SYST PALA IN PRESS	85	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54275	10.1371/journal.pone.0054275	http://dx.doi.org/10.1371/journal.pone.0054275			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372699	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500051
J	Nasu, A; Ikeya, M; Yamamoto, T; Watanabe, A; Jin, YH; Matsumoto, Y; Hayakawa, K; Amano, N; Sato, S; Osafune, K; Aoyama, T; Nakamura, T; Kato, T; Toguchida, J				Nasu, Akira; Ikeya, Makoto; Yamamoto, Takuya; Watanabe, Akira; Jin, Yonghui; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Amano, Naoki; Sato, Shingo; Osafune, Kenji; Aoyama, Tomoki; Nakamura, Takashi; Kato, Tomohisa; Toguchida, Junya			Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EPIGENETIC MEMORY; DNA METHYLATION; SOMATIC-CELLS; GENERATION; EXPRESSION; GENE; EFFICIENT	Background: For regenerative therapy using induced pluripotent stem cell (iPSC) technology, cell type of origin to be reprogrammed should be chosen based on accessibility and reprogramming efficiency. Some studies report that iPSCs exhibited a preference for differentiation into their original cell lineages, while others did not. Therefore, the type of cell which is most appropriate as a source for iPSCs needs to be clarified. Methodology/Principal Findings: Genetically matched human iPSCs from different origins were generated using bone marrow stromal cells (BMSCs) and dermal fibroblasts (DFs) of the same donor, and global gene expression profile, DNA methylation status, and differentiation properties into the chondrogenic and osteogenic lineage of each clone were analyzed. Although genome-wide profiling of DNA methylation suggested tissue memory in iPSCs, genes expressed differentially in BMSCs and DFs were equally silenced in our bona fide iPSCs. After cell-autonomous and induced differentiation, each iPSC clone exhibited various differentiation properties, which did not correlate with cell-of-origin. Conclusions/Significance: The reprogramming process may remove the difference between DFs and BMSCs at least for chondrogenic and osteogenic differentiation. Qualified and genetically matched human iPSC clone sets established in this study are valuable resources for further basic study of clonal differences.	[Nasu, Akira; Jin, Yonghui; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Sato, Shingo; Aoyama, Tomoki; Kato, Tomohisa; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Nasu, Akira; Nakamura, Takashi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Nasu, Akira; Ikeya, Makoto; Matsumoto, Yoshihisa; Hayakawa, Kazuo; Osafune, Kenji; Kato, Tomohisa; Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Yamamoto, Takuya; Watanabe, Akira; Amano, Naoki] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan; [Matsumoto, Yoshihisa; Hayakawa, Kazuo] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Nagoya City University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Ikeya, Makoto/0000-0002-3930-8032; Sato, Shingo/0000-0002-6227-5910; Kato, Tomohisa/0000-0002-3047-9847	Ministry of Education, Culture, Sports, Science and Technology; Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [24659133] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leading Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, and the Leading Project for Realization of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kaneko S, 2010, CURR OPIN HEMATOL, V17, P271, DOI 10.1097/MOH.0b013e32833a25ee; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quattrocelli M, 2011, J PATHOL, V223, P593, DOI 10.1002/path.2845; Rizzi R., 2012, CELL DEATH DIFFER; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	47	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e53771	10.1371/journal.pone.0053771	http://dx.doi.org/10.1371/journal.pone.0053771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382851	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600018
J	Barh, D; Barve, N; Gupta, K; Chandra, S; Jain, N; Tiwari, S; Leon-Sicairos, N; Canizalez-Roman, A; dos Santos, AR; Hassan, SS; Almeida, S; Ramos, RTJ; de Abreu, VAC; Carneiro, AR; Soares, SD; Castro, TLD; Miyoshi, A; Silva, A; Kumar, A; Misra, AN; Blum, K; Braverman, ER; Azevedo, V				Barh, Debmalya; Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Jain, Neha; Tiwari, Sandeep; Leon-Sicairos, Nidia; Canizalez-Roman, Adrian; dos Santos, Anderson Rodrigues; Hassan, Syed Shah; Almeida, Sintia; Juca Ramos, Rommel Thiago; Carvalho de Abreu, Vinicius Augusto; Carneiro, Adriana Ribeiro; Soares, Siomar de Castro; de Paula Castro, Thiago Luiz; Miyoshi, Anderson; Silva, Artur; Kumar, Anil; Misra, Amarendra Narayan; Blum, Kenneth; Braverman, Eric R.; Azevedo, Vasco			Exoproteome and Secretome Derived Broad Spectrum Novel Drug and Vaccine Candidates in Vibrio cholerae Targeted by Piper betel Derived Compounds	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PROTEIN-STRUCTURE; ESSENTIAL GENES; TDR TARGETS; PREDICTION; IDENTIFICATION; BETLE; DATABASE; EXTRACT; PATHOGEN	Vibrio cholerae is the causal organism of the cholera epidemic, which is mostly prevalent in developing and underdeveloped countries. However, incidences of cholera in developed countries are also alarming. Because of the emergence of new drug-resistant strains, even though several generic drugs and vaccines have been developed over time, Vibrio infections remain a global health problem that appeals for the development of novel drugs and vaccines against the pathogen. Here, applying comparative proteomic and reverse vaccinology approaches to the exoproteome and secretome of the pathogen, we have identified three candidate targets (ompU, uppP and yajC) for most of the pathogenic Vibrio strains. Two targets (uppP and yajC) are novel to Vibrio, and two targets (uppP and ompU) can be used to develop both drugs and vaccines (dual targets) against broad spectrum Vibrio serotypes. Using our novel computational approach, we have identified three peptide vaccine candidates that have high potential to induce both B-and T-cell-mediated immune responses from our identified two dual targets. These two targets were modeled and subjected to virtual screening against natural compounds derived from Piper betel. Seven compounds were identified first time from Piper betel to be highly effective to render the function of these targets to identify them as emerging potential drugs against Vibrio. Our preliminary validation suggests that these identified peptide vaccines and betel compounds are highly effective against Vibrio cholerae. Currently we are exhaustively validating these targets, candidate peptide vaccines, and betel derived lead compounds against a number of Vibrio species.	[Barh, Debmalya; Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Jain, Neha; Tiwari, Sandeep; Blum, Kenneth] IIOAB, Ctr Genom & Appl Gene Technol, Purba Medinipur, W Bengal, India; [Barh, Debmalya; Misra, Amarendra Narayan] Fakir Mohan Univ, Sch Biotechnol, Dept Biosci & Biotechnol, Balasore, Orissa, India; [Barve, Neha; Gupta, Krishnakant; Chandra, Sudha; Kumar, Anil] Devi Ahilya Univ, Sch Biotechnol, Indore, Madhya Pradesh, India; [Leon-Sicairos, Nidia; Canizalez-Roman, Adrian] Autonomous Univ Sinaloa, Sch Med, Unit Res, Fracc Fresnos, Culiacan, Mexico; [dos Santos, Anderson Rodrigues; Hassan, Syed Shah; Almeida, Sintia; Carvalho de Abreu, Vinicius Augusto; Soares, Siomar de Castro; de Paula Castro, Thiago Luiz; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil; [Juca Ramos, Rommel Thiago; Carneiro, Adriana Ribeiro; Silva, Artur] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Misra, Amarendra Narayan] Cent Univ Jharkhand, Sch Nat Sci, Ctr Life Sci, Ranchi, Jharkhand State, India; [Blum, Kenneth] Univ Florida, Coll Med, Gainesville, FL USA; [Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Burlington, VT USA; [Braverman, Eric R.] Cornell Univ, Weill Cornell Coll Med, New York, NY 10021 USA	Fakir Mohan University; Devi Ahilya University; Universidad Autonoma de Sinaloa; Universidade Federal de Minas Gerais; Universidade Federal do Para; Central University of Jharkhand; State University System of Florida; University of Florida; University of Vermont; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Barh, D (corresponding author), IIOAB, Ctr Genom & Appl Gene Technol, Purba Medinipur, W Bengal, India.	dr.barh@gmail.com	de Paula Castro, Thiago Luiz/H-5135-2019; Braverman, Eric new/ABC-1152-2021; Azevedo, Vasco A.C/F-4315-2011; de Castro Soares, Siomar/I-2705-2012; Hassan, Syed Shah/AAQ-5460-2021; Silva, Artur/E-1474-2014; Kumar, Anil/K-2136-2019; Folador, Adriana R.C./H-6410-2016; Folador, Adriana Ribeiro Carneiro/R-2658-2019; Almeida, Sintia/K-1217-2012; Boothapati, Anil Kumar/HHS-1813-2022; Misra, Amarendra Narayan Narayan/AAH-3996-2021; Abreu, Vinicius AC/G-3694-2014; Barh, Debmalya/O-4246-2015; MISRA, AMARENDRA N./B-8378-2012; Canizalez-Roman, Adrian/B-7621-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; tiwari, Sandeep/K-9616-2015; dos Santos, Anderson Rodrigues/G-3020-2011; Ramos, Rommel Thiago Juca/L-9329-2013; Azevedo, Vasco/B-1556-2019; Leon-Sicairos, Nidia/AAA-4630-2022	de Paula Castro, Thiago Luiz/0000-0002-2869-5065; Azevedo, Vasco A.C/0000-0002-4775-2280; de Castro Soares, Siomar/0000-0001-7299-3724; Hassan, Syed Shah/0000-0003-1251-5215; Silva, Artur/0000-0002-4082-1132; Folador, Adriana R.C./0000-0003-1522-9871; Almeida, Sintia/0000-0003-0270-9059; Misra, Amarendra Narayan Narayan/0000-0002-5565-8411; Barh, Debmalya/0000-0002-2557-7768; MISRA, AMARENDRA N./0000-0002-5565-8411; Canizalez-Roman, Adrian/0000-0001-8605-0639; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; tiwari, Sandeep/0000-0002-8554-1660; dos Santos, Anderson Rodrigues/0000-0003-3418-0823; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Azevedo, Vasco/0000-0002-4775-2280; Leon-Sicairos, Nidia/0000-0003-1470-3383; Jain, Neha/0000-0003-4627-3349				Abadio AKR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-75; Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Al-Adhroey AH, 2011, MOLECULES, V16, P107, DOI 10.3390/molecules16010107; Ali I, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-7; Barh D, 2011, CHEM BIOL DRUG DES, V78, P73, DOI 10.1111/j.1747-0285.2011.01118.x; Barh D, 2010, BIOINFORMATION, V5, P77, DOI 10.6026/97320630005077; Barh D, 2011, DRUG DEVELOP RES, V72, P162, DOI 10.1002/ddr.20413; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; DALLO SF, 1988, J EXP MED, V167, P718, DOI 10.1084/jem.167.2.718; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Duffield M, 2010, MOL BIOSYST, V6, P2482, DOI 10.1039/c0mb00001a; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fazil MHUT, 2011, FUTURE MICROBIOL, V6, P1199, DOI [10.2217/FMB.11.93, 10.2217/fmb.11.93]; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Ganguly S, 2007, J PHARM PHARMACOL, V59, P711, DOI 10.1211/jpp.59.5.0012; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Georrge JJ, 2011, INDIAN J BIOTECHNOL, V10, P432; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Tran HD, 2012, J MED MICROBIOL, V61, P431, DOI 10.1099/jmm.0.034744-0; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kangueane P, 2005, BIOINFORMATION, V1, P21, DOI 10.6026/97320630001021; Kanjwani DG, 2008, SCAND J IMMUNOL, V67, P589, DOI 10.1111/j.1365-3083.2008.02110.x; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin May Young, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P15, DOI 10.2174/187153008783928398; Lin Y, 2010, BIOCHEM BIOPH RES CO, V396, P472, DOI 10.1016/j.bbrc.2010.04.119; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magarinos MP, 2012, NUCLEIC ACIDS RES, V40, pD1118, DOI 10.1093/nar/gkr1053; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Majumdar Biswajit, 2003, Indian Journal of Experimental Biology, V41, P311; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Reddy G. K., 2011, INT J PHARM STUDIES, V2, P48; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sarkar A, 2008, PARASITOL RES, V102, P1249, DOI 10.1007/s00436-008-0902-y; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shanmugam A, 2010, BIOINFORMATION, V4, P392, DOI 10.6026/97320630004392; SHIMADA T, 1977, JPN J MED SCI BIOL, V30, P275, DOI 10.7883/yoken1952.30.275; Siddique AK, 1996, TROP MED INT HEALTH, V1, P393, DOI 10.1046/j.1365-3156.1996.d01-54.x; SIDDIQUE AK, 1992, J DIARRHOEAL DIS RES, V10, P79; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh M, 2009, INT IMMUNOPHARMACOL, V9, P716, DOI 10.1016/j.intimp.2009.02.012; Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z; Sperandio V, 1996, INFECT IMMUN, V64, P5406, DOI 10.1128/IAI.64.12.5406-5409.1996; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Trakranrungsie N, 2008, RES VET SCI, V84, P80, DOI 10.1016/j.rvsc.2007.03.006; Umashankar V, 2007, BIOINFORMATION, V2, P62; Valentao P, 2010, J SEP SCI, V33, P3168, DOI 10.1002/jssc.201000429; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wirotesangthong M, 2008, INT IMMUNOPHARMACOL, V8, P453, DOI 10.1016/j.intimp.2007.11.005; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	82	61	61	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52773	10.1371/journal.pone.0052773	http://dx.doi.org/10.1371/journal.pone.0052773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382822	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800010
J	Patton, JL; Wei, YJ; Bajaj, P; Scheidt, RA				Patton, James L.; Wei, Yejun John; Bajaj, Preeti; Scheidt, Robert A.			Visuomotor Learning Enhanced by Augmenting Instantaneous Trajectory Error Feedback during Reaching	PLOS ONE			English	Article							INTERNAL-MODEL; ARM MOVEMENTS; ADAPTATION; REHABILITATION; COORDINATION; STROKE; FORCE	We studied reach adaptation to a 30 degrees visuomotor rotation to determine whether augmented error feedback can promote faster and more complete motor learning. Four groups of healthy adults reached with their unseen arm to visual targets surrounding a central starting point. A manipulandum tracked hand motion and projected a cursor onto a display immediately above the horizontal plane of movement. For one group, deviations from the ideal movement were amplified with a gain of 2 whereas another group experienced a gain of 3.1. The third group experienced an offset equal to the average error seen in the initial perturbations, while a fourth group served as controls. Learning in the gain 2 and offset groups was nearly twice as fast as controls. Moreover, the offset group averaged more reduction in error. Such error augmentation techniques may be useful for training novel visuomotor transformations as required of robotic teleoperators or in movement rehabilitation of the neurologically impaired.	[Patton, James L.] Univ Illinois, Chicago, IL 60607 USA; [Patton, James L.; Wei, Yejun John; Bajaj, Preeti; Scheidt, Robert A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Patton, James L.; Scheidt, Robert A.] Northwestern Univ, Dept Phys Med, Chicago, IL 60611 USA; [Patton, James L.; Scheidt, Robert A.] Northwestern Univ, Dept Rehabil, Chicago, IL 60611 USA; [Scheidt, Robert A.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Marquette University	Patton, JL (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	pattonj@uic.edu	Scheidt, Robert A/F-5047-2010	Scheidt, Robert A/0000-0002-2024-5051	American Heart Association [0330411Z]; National Institutes of Health (NIH) [R24 HD39627, 5 RO1 NS 35673, F32HD08658, R01HD053727]; Whitaker [RG010157]; NSF [BES0238442]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053727] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008658, R24HD039627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035673] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker; NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association 0330411Z, National Institutes of Health (NIH) R24 HD39627, NIH 5 RO1 NS 35673, NIH F32HD08658, Whitaker RG010157, NSF BES0238442, NIH R01HD053727, the summer internship in neural engineering (SINE) program at the Sensory Motor Performance Program at the Rehabilitation Institute of Chicago, and the Falk Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M, 2006, PATTERN RECOGNITION; Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Emken JL, 2005, IEEE T NEUR SYS REH, V13, P33, DOI 10.1109/TNSRE.2004.843173; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KAWATO M, 1990, ADVANCED NEURAL COMPUTERS, P365; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nudo RJ, 1999, REV NEUROL, V155, P713; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Patton JL, 2006, J REHABILIT IN PRESS, P43; Ravaioli E, 2005, EXP BRAIN RES, V160, P450, DOI 10.1007/s00221-004-2030-y; Robles-De-La-Torre G, 2001, NATURE, V412, P445, DOI 10.1038/35086588; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wei Y, 2005, REAL TIME HAPTIC GRA; Winstein CJ, 1999, NEUROPSYCHOLOGIA, V37, P975, DOI 10.1016/S0028-3932(98)00145-6; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e46466	10.1371/journal.pone.0046466	http://dx.doi.org/10.1371/journal.pone.0046466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382796	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800001
J	Shine, JM; Matar, E; Ward, PB; Bolitho, SJ; Pearson, M; Naismith, SL; Lewis, SJG				Shine, James M.; Matar, Elie; Ward, Philip B.; Bolitho, Samuel J.; Pearson, Mark; Naismith, Sharon L.; Lewis, Simon J. G.			Differential Neural Activation Patterns in Patients with Parkinson's Disease and Freezing of Gait in Response to Concurrent Cognitive and Motor Load	PLOS ONE			English	Article							BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; NUCLEUS-ACCUMBENS; CONTROL NETWORK; MRI; QUESTIONNAIRE; SUPPLEMENTARY	Freezing of gait is a devastating symptom of Parkinson's disease (PD) that is exacerbated by the processing of cognitive information whilst walking. To date, no studies have explored the neural correlates associated with increases in cognitive load whilst performing a motor task in patients with freezing. In this experiment, 14 PD patients with and 15 PD patients without freezing of gait underwent 3T fMRI while performing a virtual reality gait task. Directions to walk and stop were presented on the viewing screen as either direct cues or as more cognitively indirect pre-learned cues. Both groups showed a consistent pattern of BOLD response within the Cognitive Control Network during performance of the paradigm. However, a between group comparison revealed that those PD patients with freezing of gait were less able to recruit the bilateral anterior insula, ventral striatum and the pre-supplementary motor area, as well as the left subthalamic nucleus when responding to indirect cognitive cues whilst maintaining a motor output. These results suggest that PD patients with freezing of gait are unable to properly recruit specific cortical and subcortical regions within the Cognitive Control Network during the performance of simultaneous motor and cognitive functions.	[Shine, James M.; Matar, Elie; Bolitho, Samuel J.; Pearson, Mark; Naismith, Sharon L.; Lewis, Simon J. G.] Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Ward, Philip B.] South Western Sydney Local Hlth Dist, Schizophrenia Res Unit, Liverpool, NSW, Australia	University of Sydney; University of New South Wales Sydney	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia.	simon.lewis@sydney.edu.au	Ward, Philip/E-3959-2010; Lewis, Simon/R-9469-2016	Ward, Philip/0000-0002-5779-7722; Lewis, Simon/0000-0002-4093-7071; Naismith, Sharon/0000-0001-9076-2778; Matar, Elie/0000-0002-4994-0488; Shine, James/0000-0003-1762-5499	Michael J. Fox Foundation	Michael J. Fox Foundation	The study was funded in it's entirety by the Michael J. Fox Foundation (https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Bartels AL, 2008, MOVEMENT DISORD, V23, pS461, DOI 10.1002/mds.21912; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Brett M, 2002, P INT C FUNCT MAPP H; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Lieberman A, 2006, J NEUROL SCI, V248, P219, DOI 10.1016/j.jns.2006.05.023; Maidan I, 2010, MOVEMENT DISORD, V25, P2346, DOI 10.1002/mds.23280; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Mazaika P, 2007, P HUM BRAIN MAPP C; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monchi O, 2004, J NEUROSCI, V24, P702, DOI 10.1523/JNEUROSCI.4860-03.2004; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Naismith SL, 2010, MOVEMENT DISORD, V25, P1000, DOI 10.1002/mds.23005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Prodoehl J, 2008, NEUROIMAGE, V39, P956, DOI 10.1016/j.neuroimage.2007.09.027; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Seeley WW, J NEUROSCI, V27, P2349; Shine JM, 2011, J CLIN NEUROSCI, V18, P1154, DOI 10.1016/j.jocn.2011.02.007; Shine JM, 2011, J CLIN NEUROSCI, V18, P807, DOI 10.1016/j.jocn.2011.02.003; Shine JM, 2012, PARKINSONISM RELAT D; Shine JM, 2013, GAIT POSTUR IN PRESS; Shine JM, 2013, PARKINSONISM RELAT D; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tessitore A, 2012, AM J NEURORADIOL, V33, P1804, DOI 10.3174/ajnr.A3066; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zumer JM, 2010, NEUROIMAGE, V49, P1479, DOI 10.1016/j.neuroimage.2009.09.020	55	84	89	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e52602	10.1371/journal.pone.0052602	http://dx.doi.org/10.1371/journal.pone.0052602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382821	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800009
J	Stoneman, P; Sturgis, P; Allum, N; Sibley, E				Stoneman, Paul; Sturgis, Patrick; Allum, Nick; Sibley, Elissa			Incommensurable Worldviews? Is Public Use of Complementary and Alternative Medicines Incompatible with Support for Science and Conventional Medicine?	PLOS ONE			English	Article							CONTROLLED-TRIALS; HOMEOPATHY; ATTITUDES; POPULATION; THERAPIES; CARE	Proponents of controversial Complementary and Alternative Medicines, such as homeopathy, argue that these treatments can be used with great effect in addition to, and sometimes instead of, 'conventional' medicine. In doing so, they accept the idea that the scientific approach to the evaluation of treatment does not undermine use of and support for some of the more controversial CAM treatments. For those adhering to the scientific canon, however, such efficacy claims lack the requisite evidential basis from randomised controlled trials. It is not clear, however, whether such opposition characterises the views of the general public. In this paper we use data from the 2009 Wellcome Monitor survey to investigate public use of and beliefs about the efficacy of a prominent and controversial CAM within the United Kingdom, homeopathy. We proceed by using Latent Class Analysis to assess whether it is possible to identify a sub-group of the population who are at ease in combining support for science and conventional medicine with use of CAM treatments, and belief in the efficacy of homeopathy. Our results suggest that over 40% of the British public maintain positive evaluations of both homeopathy and conventional medicine simultaneously. Explanatory analyses reveal that simultaneous support for a controversial CAM treatment and conventional medicine is, in part, explained by a lack of scientific knowledge as well as concerns about the regulation of medical research.	[Stoneman, Paul] Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England; [Sturgis, Patrick] Univ Southampton, Natl Ctr Res Methods, Southampton, Hants, England; [Allum, Nick; Sibley, Elissa] Univ Essex, Dept Sociol, Colchester CO4 3SQ, Essex, England	University of Surrey; University of Southampton; University of Essex	Stoneman, P (corresponding author), Univ Surrey, Dept Sociol, Guildford GU2 5XH, Surrey, England.	p.stoneman@surrey.ac.uk			Wellcome Trust [EDU/28/4/20/SotonUni/DO18-1299]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust, as part of the 'Developing a novel segmentation of adults and young people in relation to biomedical science' project, grant reference number: EDU/28/4/20/SotonUni/DO18-1299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; [Anonymous], 1987, SAGE U PAPER SERIES; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bains SS, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-138; Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Berman BM, 2000, ALTERN THER HEALTH M, V6, P98; Beyerstein BL, 2001, ACAD MED, V76, P230, DOI 10.1097/00001888-200103000-00009; Blais R, 1997, CAN J PUBLIC HEALTH, V88, P159, DOI 10.1007/BF03403880; Boissel JP, 1996, CRITICAL LIT REV EFF, V1996, P195; Braun LA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-38; Butt S., 2009, WELLCOME TRUST MONIT; Callahan D., 2002, HAST CENT S; Caulfield Timothy, 2005, BMC Complement Altern Med, V5, P12, DOI 10.1186/1472-6882-5-12; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Conboy Lisa, 2007, Complement Ther Clin Pract, V13, P146, DOI 10.1016/j.ctcp.2006.12.003; Cucherat M, 2000, EUR J CLIN PHARMACOL, V56, P27, DOI 10.1007/s002280050716; Easthope G, 2000, SOC SCI MED, V51, P1555, DOI 10.1016/S0277-9536(00)00048-4; Ernst E, 2008, BRIT J CLIN PHARMACO, V65, P163, DOI 10.1111/j.1365-2125.2007.03007.x; Ernst E, 2002, BRIT J CLIN PHARMACO, V54, P577, DOI 10.1046/j.1365-2125.2002.01699.x; Ernst E, 1999, J MANIP PHYSIOL THER, V22, P87, DOI 10.1016/S0161-4754(99)70112-0; Ernst E, 2012, GUARDIAN NEWSPA 0403; Ernst E, 2007, J HEALTH PSYCHOL, V12, P868, DOI 10.1177/1359105307082448; Goldacre B, 2007, LANCET, V370, P1672, DOI 10.1016/S0140-6736(07)61706-1; Grossinger R, 1998, HOMEOPATHY GREAT RID; Hameen-Anttila KP, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-107; Hori S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-14; House of Commons (HoC) Report, 2010, 4 HOC; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; KISH L, 1962, J AM STAT ASSOC, V57, P92, DOI 10.2307/2282442; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; MacLennan AH, 2002, PREV MED, V35, P166, DOI 10.1006/pmed.2002.1057; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; Miller JD, 1998, PUBLIC UNDERST SCI, V7, P203, DOI 10.1088/0963-6625/7/3/001; Muth?n B., 2001, NEW DEV TECHNIQUES S, V2, P1, DOI DOI 10.4324/9781410601858-6; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nguyen LT, 2011, J GEN INTERN MED, V26, P399, DOI 10.1007/s11606-010-1542-3; O'Mathuna DP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002766.pub2; Pawluch D, 2000, SOC SCI MED, V51, P251, DOI 10.1016/S0277-9536(99)00450-5; Sehon S, 2010, J EVAL CLIN PRACT, V16, P276, DOI 10.1111/j.1365-2753.2010.01384.x; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Testerman J, 2004, COMPLEMENT HLTH PRAC, V9, P81, DOI [10.1177/1076167503261254, DOI 10.1177/1076167503261254]; Vermunt J. K., 1997, ADV QUANTITATIVE TEC, V8; Vincent C, 1997, COMPLEMENTARY MED RE; Walach H, 2009, J ALTERN COMPLEM MED, V15, P1139, DOI 10.1089/acm.2009.0423; YATES PM, 1993, SOCIOL HEALTH ILL, V15, P199, DOI 10.1111/1467-9566.ep11346886	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53174	10.1371/journal.pone.0053174	http://dx.doi.org/10.1371/journal.pone.0053174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382836	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800019
J	Galazis, N; Docheva, N; Nicolaides, KH; Atiomo, W				Galazis, Nicolas; Docheva, Nikolina; Nicolaides, Kypros H.; Atiomo, William			Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration	PLOS ONE			English	Review							AMNIOTIC-FLUID; EXPRESSION; DIAGNOSIS; ENZYMES; GLUCONEOGENESIS; IDENTIFICATION; APOLIPOPROTEIN; TRANSFERRIN; LIPOGENESIS; GLYCOLYSIS	Background: Preterm Birth (PTB) is a major cause of neonatal mortality and morbidity. Women with Polycystic Ovary Syndrome (PCOS) are at high risk of PTB. There is a need for research studies to investigate the mechanisms linking PCOS and PTB, to facilitate screening, and develop novel preventative strategies. Objective: To list all the proteomic biomarkers of PTB and integrate this list with the PCOS biomarker database to identify commonly expressed biomarkers of the two conditions. Search Strategy: A systematic review of PTB biomarkers and update of PCOS biomarker database. All eligible published studies on proteomic biomarkers for PTB and PCOS identified through various databases were evaluated. Selection Criteria: For the identification of the relevant studies, the following search terms were used: "proteomics", "proteomic", "preterm birth", "preterm labour", "proteomic biomarker" and "polycystic ovary syndrome". This search was restricted to humans only Data Collection and Analysis: A database on proteomic biomarkers for PTB was created while an already existing PCOS biomarker database was updated. The two databases were integrated and biomarkers that were co-expressed in both women with PCOS and PTB were identified and investigated. Results: A panel of six proteomic biomarkers was similarly differentially expressed in women with PTB and women with PCOS compared to their respective controls (normal age-matched women in the case of PCOS studies and women with term pregnancy in the case of PTB studies). These biomarkers include Pyruvate kinase M1/M2, Vimentin, Fructose bisphosphonate aldolase A, Heat shock protein beta-1, Peroxiredoxin-1 and Transferrin. Conclusions: These proteomic biomarkers (Pyruvate kinase M1/M2, Vimentin, Fructose bisphosphonate aldolase A, Heat shock protein beta-1, Peroxiredoxin-1 and Transferrin) can be potentially used to better understand the pathophysiological mechanisms linking PCOS and PTB. This would help to identify subgroups of women with PCOS at risk of PTB and hence the potential of developing preventative strategies.	[Galazis, Nicolas; Docheva, Nikolina; Atiomo, William] Univ Nottingham, Div Human Dev, Sch Clin Sci, Nottingham NG7 2RD, England; [Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr, London, England; [Nicolaides, Kypros H.] Univ Coll London Hosp, Dept Fetal Med, London, England	University of Nottingham; King's College Hospital NHS Foundation Trust; King's College Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London	Galazis, N (corresponding author), Univ Nottingham, Div Human Dev, Sch Clin Sci, Nottingham NG7 2RD, England.	ngalazis@gmail.com	Docheva, Nikolina/AAO-5786-2020; Atiomo, William U/C-7324-2009	Nicolaides, Kypros/0000-0003-1266-0711; Atiomo, William/0000-0002-5027-3504				Altieri P, 2010, EUR J OBSTET GYN R B, V149, P31, DOI 10.1016/j.ejogrb.2009.11.010; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Atiomo W, 2009, BJOG-INT J OBSTET GY, V116, P137, DOI 10.1111/j.1471-0528.2008.02041.x; Atiomo WU, 2009, EXPERT REV PROTEOMIC, V6, P469, DOI 10.1586/EPR.09.68; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baek KH, 2010, FERTIL STERIL, V94, pS197, DOI 10.1016/j.fertnstert.2010.07.766; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Briggs DA, 1999, MOL HUM REPROD, V5, P1107, DOI 10.1093/molehr/5.12.1107; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Bujold E, 2008, J MATERN-FETAL NEO M, V21, P697, DOI 10.1080/14767050802053289; Centre for Maternal and Child Enquiries (CMACE), 2010, PER MORT 2008 UK; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Choi DH, 2010, J PROTEOME RES, V9, P4329, DOI 10.1021/pr100008e; Ciocca DR, 1992, NATL CANC I, V85, P1558; Cobo T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.036; Cox MC, 2010, HAEMATOL-HEMATOL J, V95, P176; DIAMANT YZ, 1984, PLACENTA, V5, P55, DOI 10.1016/S0143-4004(84)80048-X; DIAMANT YZ, 1978, DIABETOLOGIA, V15, P481, DOI 10.1007/BF02342874; DIAMANT YZ, 1975, AM J OBSTET GYNECOL, V121, P58, DOI 10.1016/0002-9378(75)90975-8; Dudley JT, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P27; Dunaif A, 2001, ANNU REV MED, V52, P401, DOI 10.1146/annurev.med.52.1.401; Fushinobu S, 2011, NATURE, V478, P538, DOI 10.1038/nature10457; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Insenser M, 2010, J CLIN ENDOCR METAB, V95, P3863, DOI 10.1210/jc.2010-0220; KATSUMOTO T, 1990, BIOL CELL, V68, P139, DOI 10.1016/0248-4900(90)90299-I; Kjerulff LE, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.03.021; Kralova A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-27; Lindquist L, 1998, REV GENET, V22, P631; Ling J, 2011, GYNECOL ENDOCRINOL, V27, P63, DOI 10.3109/09513590.2010.487594; Ma YL, 2012, MOL BIOL REP, V39, P8483, DOI 10.1007/s11033-012-1702-0; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Mikola M, 2001, HUM REPROD, V16, P226, DOI 10.1093/humrep/16.2.226; Misiti S, 2010, J ENDOCRINOL INVEST, V33, P156, DOI [10.1007/BF03346575, 10.3275/6544]; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Parker LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011419; Peral B, 2009, EXPERT REV PROTEOMIC, V6, P353, DOI [10.1586/epr.09.53, 10.1586/EPR.09.53]; Pereira L, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.048; Ptolemy AS, 2010, SCAND J CLIN LAB INV, V70, P6, DOI 10.3109/00365513.2010.493354; Raptopoulou A, 2007, CRIT REV CL LAB SCI, V44, P339, DOI 10.1080/10408360701295623; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; Ruetschi U, 2005, J PROTEOME RES, V4, P2236, DOI 10.1021/pr050139e; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Santillan I, 2010, AM J REPROD IMMUN S1, V63, P52; Shafrir E, 1978, Ciba Found Symp, P161; Stella CL, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.034; Veenstra TD, 2011, EXPERT REV PROTEOMIC, V8, P681, DOI [10.1586/EPR.11.60, 10.1586/epr.11.60]; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023563; Webber M, 2010, J REPROD IMMUNOL, V86, P56, DOI 10.1016/j.jri.2010.06.119; Wild RA, 2002, HUM REPROD UPDATE, V8, P231, DOI 10.1093/humupd/8.3.231	55	17	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e53801	10.1371/journal.pone.0053801	http://dx.doi.org/10.1371/journal.pone.0053801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382852	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200050
J	Zehetleitner, M; Koch, AI; Goschy, H; Muller, HJ				Zehetleitner, Michael; Koch, Anja Isabel; Goschy, Harriet; Mueller, Hermann Joseph			Salience-Based Selection: Attentional Capture by Distractors Less Salient Than the Target	PLOS ONE			English	Article							VISUAL-SEARCH; CONNECTIONIST MODEL; DIFFUSION-MODEL; PARIETAL CORTEX; GUIDED SEARCH; STIMULUS; DRIVEN; MECHANISMS; MEMORY; TIME	Current accounts of attentional capture predict the most salient stimulus to be invariably selected first. However, existing salience and visual search models assume noise in the map computation or selection process. Consequently, they predict the first selection to be stochastically dependent on salience, implying that attention could even be captured first by the second most salient (instead of the most salient) stimulus in the field. Yet, capture by less salient distractors has not been reported and salience-based selection accounts claim that the distractor has to be more salient in order to capture attention. We tested this prediction using an empirical and modeling approach of the visual search distractor paradigm. For the empirical part, we manipulated salience of target and distractor parametrically and measured reaction time interference when a distractor was present compared to absent. Reaction time interference was strongly correlated with distractor salience relative to the target. Moreover, even distractors less salient than the target captured attention, as measured by reaction time interference and oculomotor capture. In the modeling part, we simulated first selection in the distractor paradigm using behavioral measures of salience and considering the time course of selection including noise. We were able to replicate the result pattern we obtained in the empirical part. We conclude that each salience value follows a specific selection time distribution and attentional capture occurs when the selection time distributions of target and distractor overlap. Hence, selection is stochastic in nature and attentional capture occurs with a certain probability depending on relative salience.	[Zehetleitner, Michael; Koch, Anja Isabel; Goschy, Harriet; Mueller, Hermann Joseph] Univ Munich, Dept Psychol, Munich, Germany; [Koch, Anja Isabel; Goschy, Harriet] Univ Munich, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Mueller, Hermann Joseph] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; University of Munich; University of London; Birkbeck University London	Zehetleitner, M (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	mzehetleitner@psy.lmu.de; Isabel.Koch@psy.lmu.de	Zehetleitner, Michael/AHE-2494-2022		German Research Foundation (DFG) [EC 142, MZ-887/3-1]; German-Israeli Foundation for Scientific Research and Development [1130-158.4]; LMU Graduate School of Systemic Neurosciences [GSC 82/1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); LMU Graduate School of Systemic Neurosciences	This research was supported by German Research Foundation (DFG, www.dfg.de/en/) grant EC 142 (Excellence Cluster "Cognition for Technical Systems"), DFG grant MZ-887/3-1, German-Israeli Foundation for Scientific Research and Development (www.gif.org.il) grant 1130-158.4, and a fellowship of the LMU Graduate School of Systemic Neurosciences (www.gsn.lmu.de), GSC 82/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Beck DM, 2005, NAT NEUROSCI, V8, P1110, DOI 10.1038/nn1501; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Gao DS, 2009, NEURAL COMPUT, V21, P239, DOI 10.1162/neco.2009.11-06-391; Geyer T, 2010, J VISION, V10, DOI 10.1167/10.2.3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Green DM, 1966, SIGNAL DETECTION THE; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2010, EXP BRAIN RES, V201, P789, DOI 10.1007/s00221-009-2094-9; Hodsoll J, 2009, CEREB CORTEX, V19, P106, DOI 10.1093/cercor/bhn070; HUMPHREYS GW, 1993, COGNITIVE PSYCHOL, V25, P43, DOI 10.1006/cogp.1993.1002; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P510, DOI 10.1037/0096-1523.9.4.510; Kiss M, 2012, J COGNITIVE NEUROSCI, V24, P749, DOI 10.1162/jocn_a_00127; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; Lavie N, 2006, VIS COGN, V14, P863, DOI 10.1080/13506280500195953; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Mueller HJ, 2009, J EXP PSYCHOL HUMAN, V35, P1, DOI 10.1037/0096-1523.35.1.1; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NOTHDURFT HC, 1993, SPATIAL VISION, V7, P341, DOI 10.1163/156856893X00487; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; PHAF RH, 1990, COGNITIVE PSYCHOL, V22, P273, DOI 10.1016/0010-0285(90)90006-P; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tollner T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016276; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Usher M, 1996, J COGNITIVE NEUROSCI, V8, P311, DOI 10.1162/jocn.1996.8.4.311; van Zoest W, 2005, VIS COGN, V12, P353, DOI 10.1080/13506280444000229; van Zoest W, 2008, Q J EXP PSYCHOL, V61, P1553, DOI 10.1080/17470210701595555; Vandekerckhove J, 2007, PSYCHON B REV, V14, P1011, DOI 10.3758/BF03193087; VANZANDT T, 1993, PERCEPT PSYCHOPHYS, V53, P563, DOI 10.3758/BF03205204; VERGHESE P, 1994, VISION RES, V34, P2453, DOI 10.1016/0042-6989(94)90289-5; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Zehetleitner M, 2008, FRONT BIOSCI-LANDMRK, V13, P5279, DOI 10.2741/3080; Zehetleitner M, 2012, J EXP PSYCHOL HUMAN, V38, P941, DOI 10.1037/a0027629; Zehetleitner M, 2012, ATTEN PERCEPT PSYCHO, V74, P879, DOI 10.3758/s13414-012-0287-y; Zehetleitner M, 2011, ATTEN PERCEPT PSYCHO, V73, P349, DOI 10.3758/s13414-010-0035-0; Zehetleitner M, 2010, J VISION, V10, DOI 10.1167/10.14.35; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1739, DOI 10.3758/APP.71.8.1739; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760	73	35	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e52595	10.1371/journal.pone.0052595	http://dx.doi.org/10.1371/journal.pone.0052595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093SF	23382820	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315211500005
J	Lauterbach, R; Wells, K; O'Hara, RB; Kalko, EKV; Renner, SC				Lauterbach, Ralf; Wells, Konstans; O'Hara, Robert B.; Kalko, Elisabeth K. V.; Renner, Swen C.			Variable Strength of Forest Stand Attributes and Weather Conditions on the Questing Activity of Ixodes ricinus Ticks over Years in Managed Forests	PLOS ONE			English	Article							LYME-DISEASE VECTOR; CLIMATE-CHANGE; POPULATION-DYNAMICS; SATURATION DEFICIT; RANGE EXPANSION; LOCAL CLIMATE; ABUNDANCE; ACARI; SCAPULARIS; IXODIDAE	Given the ever-increasing human impact through land use and climate change on the environment, we crucially need to achieve a better understanding of those factors that influence the questing activity of ixodid ticks, a major disease-transmitting vector in temperate forests. We investigated variation in the relative questing nymph densities of Ixodes ricinus in differently managed forest types for three years (2008-2010) in SW Germany by drag sampling. We used a hierarchical Bayesian modeling approach to examine the relative effects of habitat and weather and to consider possible nested structures of habitat and climate forces. The questing activity of nymphs was considerably larger in young forest successional stages of thicket compared with pole wood and timber stages. Questing nymph density increased markedly with milder winter temperatures. Generally, the relative strength of the various environmental forces on questing nymph density differed across years. In particular, winter temperature had a negative effect on tick activity across sites in 2008 in contrast to the overall effect of temperature across years. Our results suggest that forest management practices have important impacts on questing nymph density. Variable weather conditions, however, might override the effects of forest management practices on the fluctuations and dynamics of tick populations and activity over years, in particular, the preceding winter temperatures. Therefore, robust predictions and the detection of possible interactions and nested structures of habitat and climate forces can only be quantified through the collection of long-term data. Such data are particularly important with regard to future scenarios of forest management and climate warming.	[Lauterbach, Ralf; Wells, Konstans; Kalko, Elisabeth K. V.; Renner, Swen C.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Wells, Konstans; O'Hara, Robert B.] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Renner, Swen C.] Smithsonian Conservat Biol Inst, Front Royal, VA USA	Ulm University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Renner, SC (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	swen.renner@uni-ulm.de	Wells, Konstans/A-7232-2010; O'Hara, Bob/A-7499-2008	Wells, Konstans/0000-0003-0377-2463; O'Hara, Bob/0000-0001-9737-3724; /0000-0002-6893-4219	DFG [KA 1241/15-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (KA 1241/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauhus J, 2009, FOREST ECOL MANAG, V258, P525, DOI 10.1016/j.foreco.2009.01.053; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Daniel M, 1998, EXP APPL ACAROL, V22, P417, DOI 10.1023/A:1006030827216; Daniel Milan, 1994, P91; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Dobson ADM, 2011, TICKS TICK-BORNE DIS, V2, P67, DOI 10.1016/j.ttbdis.2011.03.002; Ecke F, 2002, J APPL ECOL, V39, P781, DOI 10.1046/j.1365-2664.2002.00759.x; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Estrada-Pena A, 2001, J MED ENTOMOL, V38, P361, DOI 10.1603/0022-2585-38.3.361; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Gelman A., 2007, DATA ANAL USING REGR; Gilbert L, 2012, ECOL APPL, V22, P658, DOI 10.1890/11-0458.1; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grimmond CSB, 2000, CLIM RES, V15, P137, DOI 10.3354/cr015137; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hubalek Z, 2006, MED VET ENTOMOL, V20, P166, DOI 10.1111/j.1365-2915.2006.00615.x; Hubalek Z, 2003, J VECTOR ECOL, V28, P159; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Lasch P, 2002, FOREST ECOL MANAG, V162, P73, DOI 10.1016/S0378-1127(02)00051-8; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Lohmus A, 2003, ECOGRAPHY, V26, P545, DOI 10.1034/j.1600-0587.1999.03575.x; Lubelczyk CB, 2004, ENVIRON ENTOMOL, V33, P900, DOI 10.1603/0046-225X-33.4.900; Malo AF, 2013, BEHAV ECOL, V24, P759, DOI 10.1093/beheco/ars202; Muller-Westermeier G., 1995, NUMERISCHES VERFAHRE; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2009, ECOLOGY, V90, P903, DOI 10.1890/08-0659.1; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Perret JL, 2003, J EXP BIOL, V206, P1809, DOI 10.1242/jeb.00345; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Renaud V, 2009, AGR FOREST METEOROL, V149, P873, DOI 10.1016/j.agrformet.2008.11.006; Rosa R, 2007, VECTOR-BORNE ZOONOT, V7, P285, DOI 10.1089/vbz.2006.0607; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Taylor AR, 2005, SOIL BIOL BIOCHEM, V37, P2117, DOI 10.1016/j.soilbio.2005.03.015; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wells K, 2011, BASIC APPL ECOL, V12, P97, DOI 10.1016/j.baae.2011.01.002; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	54	12	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55365	10.1371/journal.pone.0055365	http://dx.doi.org/10.1371/journal.pone.0055365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372852	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400092
J	Schwingel, M; Bastmeyer, M				Schwingel, Melanie; Bastmeyer, Martin			Force Mapping during the Formation and Maturation of Cell Adhesion Sites with Multiple Optical Tweezers	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; F-ACTIN FLOW; FLUORESCENT SPECKLE MICROSCOPY; NEURONAL GROWTH CONES; FOCAL ADHESIONS; EXTRACELLULAR-MATRIX; RETROGRADE FLOW; MIGRATING CELLS; IN-VIVO; MECHANICAL-PROPERTIES	Focal contacts act as mechanosensors allowing cells to respond to their biomechanical environment. Force transmission through newly formed contact sites is a highly dynamic process requiring a stable link between the intracellular cytoskeleton and the extracellular environment. To simultaneously investigate cellular traction forces in several individual maturing adhesion sites within the same cell, we established a custom-built multiple trap optical tweezers setup. Beads functionalized with fibronectin or RGD-peptides were placed onto the apical surface of a cell and trapped with a maximum force of 160 pN. Cells form adhesion contacts around the beads as demonstrated by vinculin accumulation and start to apply traction forces after 30 seconds. Force transmission was found to strongly depend on bead size, surface density of integrin ligands and bead location on the cell surface. Highest traction forces were measured for beads positioned on the leading edge. For mouse embryonic fibroblasts, traction forces acting on single beads are in the range of 80 pN after 5 minutes. If two beads were positioned parallel to the leading edge and with a center-to-center distance less than 10 mm, traction forces acting on single beads were reduced by 40%. This indicates a spatial and temporal coordination of force development in closely related adhesion sites. We also used our setup to compare traction forces, retrograde transport velocities, and migration velocities between two cell lines (mouse melanoma and fibroblasts) and primary chick fibroblasts. We find that maximal force development differs considerably between the three cell types with the primary cells being the strongest. In addition, we observe a linear relation between force and retrograde transport velocity: a high retrograde transport velocity is associated with strong cellular traction forces. In contrast, migration velocity is inversely related to traction forces and retrograde transport velocity.	[Schwingel, Melanie; Bastmeyer, Martin] KIT, Inst Zool, Karlsruhe, Germany; [Schwingel, Melanie; Bastmeyer, Martin] KIT, DFG Ctr Funct Nanostruct CFN, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology	Bastmeyer, M (corresponding author), KIT, Inst Zool, Karlsruhe, Germany.	bastmeyer@kit.edu	Bastmeyer, Martin/H-9342-2013	Bastmeyer, Martin/0000-0003-3471-8400	DFG Research Center for Functional Nanostructures, Karlsruhe, Germany	DFG Research Center for Functional Nanostructures, Karlsruhe, Germany(German Research Foundation (DFG))	This work was supported by the DFG Research Center for Functional Nanostructures, Karlsruhe, Germany (http://www.cfn.kit.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; ASHKIN A, 1989, P NATL ACAD SCI USA, V86, P7914, DOI 10.1073/pnas.86.20.7914; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bordeleau F, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3626864; Brenner MD, 2011, BIOPOLYMERS, V95, P332, DOI 10.1002/bip.21587; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Brownell WE, 2010, BIOPHYS J, V99, P845, DOI 10.1016/j.bpj.2010.05.025; Caspi A, 2001, BIOPHYS J, V81, P1990, DOI 10.1016/S0006-3495(01)75849-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coussen F, 2002, J CELL SCI, V115, P2581; Cramer, 1997, FRONT BIOSCI, V2, pd260, DOI DOI 10.2741/A189; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Diez G, 2011, BIOCHEM BIOPH RES CO, V406, P85, DOI 10.1016/j.bbrc.2011.01.115; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916; Fukui Y, 1999, J CELL SCI, V112, P877; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GRINNELL F, 1986, EXP CELL RES, V162, P449, DOI 10.1016/0014-4827(86)90349-6; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Gross SP, 2003, METHOD ENZYMOL, V361, P162; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hochmuth FM, 1996, BIOPHYS J, V70, P358, DOI DOI 10.1016/S0006-3495(96)79577-2); Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Icard-Arcizet D, 2008, BIOPHYS J, V94, P2906, DOI 10.1529/biophysj.107.118265; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; Lagunas A, 2011, NANOMEDICINE, V8, P432; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Laurent VM, 2002, J BIOMECH ENG-T ASME, V124, P408, DOI 10.1115/1.1485285; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Malmstrom J, 2010, NANO LETT, V10, P686, DOI 10.1021/nl903875r; Marg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011530; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mejean CO, 2009, OPT EXPRESS, V17, P6209, DOI 10.1364/OE.17.006209; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; ROHDE H, 1980, H-S Z PHYSIOL CHEM, V361, P1651, DOI 10.1515/bchm2.1980.361.2.1651; Rohrbach A, 2004, REV SCI INSTRUM, V75, P2197, DOI 10.1063/1.1753097; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sato S, 1996, OPT QUANT ELECTRON, V28, P1, DOI 10.1007/BF00578546; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Singer W, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011916; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; SVITKINA TM, 1986, J CELL SCI, V82, P235; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; VISSCHER K, 1991, CYTOMETRY, V12, P486, DOI 10.1002/cyto.990120604; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]	109	26	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54850	10.1371/journal.pone.0054850	http://dx.doi.org/10.1371/journal.pone.0054850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23372781	Green Published, gold			2022-12-27	WOS:000315210400034
J	Chama, L; Berens, DG; Downs, CT; Farwig, N				Chama, Lackson; Berens, Dana G.; Downs, Colleen T.; Farwig, Nina			Habitat Characteristics of Forest Fragments Determine Specialisation of Plant-Frugivore Networks in a Mosaic Forest Landscape	PLOS ONE			English	Article							SEED-DISPERSAL; SCALE; CONSERVATION; BIODIVERSITY; POLLINATION; CONSEQUENCES; PATTERNS; ECOLOGY	Plant-frugivore networks play a key role in the regeneration of sub-tropical forest ecosystems. However, information about the impact of habitat characteristics on plant-frugivore networks in fragmented forests is scarce. We investigated the importance of fruit abundance, fruiting plant species richness and canopy cover within habitat fragments for the structure and robustness of plant-frugivore networks in a mosaic forest landscape of South Africa. In total, 53 avian species were involved in fruit removal of 31 fleshy-fruiting plant species. Species specialisation was always higher for plants than for frugivores. Both species and network-level specialisation increased with increasing fruit abundance and decreased with increasing fruiting plant species richness and canopy cover within fragments. Interaction diversity was unaffected by fruit abundance and canopy cover, but increased slightly with increasing fruiting plant species richness. These findings suggest that especially the availability of resources is an important determinant of the structure of plant-frugivore networks in a fragmented forest landscape.	[Chama, Lackson; Berens, Dana G.; Farwig, Nina] Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany; [Downs, Colleen T.] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	Philipps University Marburg; University of Kwazulu Natal	Berens, DG (corresponding author), Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany.	dana.berens@staff.uni-marburg.de	Downs, Colleen T./A-7770-2010	Downs, Colleen T./0000-0001-8334-1510; Chama, Lackson/0000-0002-0094-9238	Robert Bosch Stiftung	Robert Bosch Stiftung	The study was funded by the Robert Bosch Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzures-Dadda A, 2007, ANIM CONSERV, V10, P69, DOI 10.1111/j.1469-1795.2006.00074.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Boon R., 2010, POOLEYS TREES E S AF; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; Dormann C.F., 2008, R NEWS, V8, P8; Estrada E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016103; FAO, 2009, FAOSTAT ONL STAT SER; Farwig N, 2006, OECOLOGIA, V147, P238, DOI 10.1007/s00442-005-0288-9; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garcia D, 2007, CONSERV BIOL, V21, P400, DOI 10.1111/j.1523-1739.2006.00593.x; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Herrera Carlos M., 2002, P185; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kankam BO, 2011, AFRICAN J ECOLOGY, V50, P21; Khamcha D, 2012, J TROP ECOL, V28, P1, DOI 10.1017/S026646741100054X; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Menke S, 2012, OIKOS, V121, P1553, DOI 10.1111/j.1600-0706.2011.20210.x; Mucina L., 2006, VEGETATION S AFRICA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Neuschulz EL, 2011, OIKOS, V120, P1371, DOI 10.1111/j.1600-0706.2011.19097.x; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; Mello MAR, 2011, OECOLOGIA, V167, P131, DOI 10.1007/s00442-011-1984-2; Saracco JF, 2004, OECOLOGIA, V139, P235, DOI 10.1007/s00442-004-1493-7; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Schleuning M, 2011, ECOLOGY, V92, P26, DOI 10.1890/09-1842.1; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Stouffer DB, 2012, SCIENCE, V335, P1489, DOI 10.1126/science.1216556; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; von Maltitz G, 2003, 2003017 ENVPC; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	52	17	17	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54956	10.1371/journal.pone.0054956	http://dx.doi.org/10.1371/journal.pone.0054956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365688	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600138
J	Hu, JP; Liu, M; Tang, DY; Chang, S				Hu, Jianping; Liu, Ming; Tang, Dianyong; Chang, Shan			Substrate Recognition and Motion Mode Analyses of PFV Integrase in Complex with Viral DNA via Coarse-Grained Models	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 INTEGRASE; BINDING MODES; IN-VITRO; DYNAMICS; INHIBITORS; IDENTIFICATION; PROTEINS; RESIDUES; PREDICTION	HIV-1 integrase (IN) is an important target in the development of drugs against the AIDS virus. Drug design based on the structure of IN was markedly hampered due to the lack of three-dimensional structure information of HIV-1 IN-viral DNA complex. The prototype foamy virus (PFV) IN has a highly functional and structural homology with HIV-1 IN. Recently, the X-ray crystal complex structure of PFV IN with its cognate viral DNA has been obtained. In this study, both Gaussian network model (GNM) and anisotropy network model (ANM) have been applied to comparatively investigate the motion modes of PFV DNA-free and DNA-bound IN. The results show that the motion mode of PFV IN has only a slight change after binding with DNA. The motion of this enzyme is in favor of association with DNA, and the binding ability is determined by its intrinsic structural topology. Molecular docking experiments were performed to gain the binding modes of a series of diketo acid (DKA) inhibitors with PFV IN obtained from ANM, from which the dependability of PFV IN-DNA used in the drug screen for strand transfer (ST) inhibitors was confirmed. It is also found that the functional groups of keto-enol, bis-diketo, tetrazole and azido play a key role in aiding the recognition of viral DNA, and thus finally increase the inhibition capability for the corresponding DKA inhibitor. Our study provides some theoretical information and helps to design anti-AIDS drug based on the structure of IN.	[Hu, Jianping; Tang, Dianyong] Leshan Normal Univ, Dept Chem & Life Sci, Leshan, Peoples R China; [Liu, Ming] Beijing Inst Biotechnol, Beijing, Peoples R China; [Chang, Shan] S China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China	Leshan Normal University; South China Agricultural University	Chang, S (corresponding author), S China Agr Univ, Coll Informat, Guangzhou, Guangdong, Peoples R China.	schang1982@yahoo.cn		tang, Dianyong/0000-0001-9389-870X; Chang, Shan/0000-0001-7169-9398	National Natural Science Foundation of China [11147175, 11247018, 31200990]; key Project of Chinese Ministry of Education [211159]; Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration [201003]; key project of Leshan Science and Technology Administration [2011SZD109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key Project of Chinese Ministry of Education(Ministry of Education, China); Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration; key project of Leshan Science and Technology Administration	This work was supported by the National Natural Science Foundation of China (11147175, 11247018, 31200990), the key Project of Chinese Ministry of Education (211159), the Scientific Special Fund of Sichuan Traditional Chinese Medicine Administration (201003), and the key project of Leshan Science and Technology Administration (2011SZD109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GOLD 3 1 1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Chow SA, 1997, METHODS, V12, P306, DOI 10.1006/meth.1997.0484; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Erman B, 2006, BIOPHYS J, V91, P3589, DOI 10.1529/biophysj.106.090803; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; Gordon CP, 2007, MED CHEM, V3, P199, DOI 10.2174/157340607780059558; Haliloglu T, 2005, BIOPHYS J, V88, P1552, DOI 10.1529/biophysj.104.051342; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hu JP, 2008, BIOPHYS CHEM, V132, P69, DOI 10.1016/j.bpc.2007.09.008; Hu JP, 2013, J BIOMOL STRUCT DYN, V31, P734, DOI 10.1080/07391102.2012.709458; Hu JP, 2010, CHINESE J CHEM, V28, P33, DOI 10.1002/cjoc.201090032; Huang M, 2011, J MOL GRAPH MODEL, V29, P956, DOI 10.1016/j.jmgm.2011.04.002; Kong R, 2006, BBA-PROTEINS PROTEOM, V1764, P766, DOI 10.1016/j.bbapap.2005.12.017; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Marchand C, 2003, MOL PHARMACOL, V64, P600, DOI 10.1124/mol.64.3.600; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Pais GCG, 2002, J MED CHEM, V45, P3184, DOI 10.1021/jm020037p; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Zhang XC, 2003, BIOORG MED CHEM LETT, V13, P1215, DOI 10.1016/S0960-894X(03)00059-3; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659; Zhuang LC, 2003, J MED CHEM, V46, P453, DOI 10.1021/jm025553u	36	8	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54929	10.1371/journal.pone.0054929	http://dx.doi.org/10.1371/journal.pone.0054929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365687	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600137
J	Busman-Sahay, K; Drake, L; Sitaram, A; Marks, M; Drake, JR				Busman-Sahay, Kathleen; Drake, Lisa; Sitaram, Anand; Marks, Michael; Drake, James R.			Cis and Trans Regulatory Mechanisms Control AP2-Mediated B Cell Receptor Endocytosis via Select Tyrosine-Based Motifs	PLOS ONE			English	Article							CLATHRIN-COATED VESICLES; ANTIGEN RECEPTOR; IG-ALPHA; STRUCTURAL EXPLANATION; STRUCTURE PREDICTION; T-CELLS; INTERNALIZATION; BETA; KINASE; REQUIREMENTS	Following antigen recognition, B cell receptor (BCR)-mediated endocytosis is the first step of antigen processing and presentation to CD4+ T cells, a crucial component of the initiation and control of the humoral immune response. Despite this, the molecular mechanism of BCR internalization is poorly understood. Recently, studies of activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) have shown that mutations within the BCR subunit CD79b leads to increased BCR surface expression, suggesting that CD79b may control BCR internalization. Adaptor protein 2 (AP2) is the major mediator of receptor endocytosis via clathrin-coated pits. The BCR contains five putative AP2-binding Yxxempty set motifs, including four that are present within two immunoreceptor tyrosine-based activation motifs (ITAMs). Using a combination of in vitro and in situ approaches, we establish that the sole mediator of AP2-dependent BCR internalization is the membrane proximal ITAM Yxxempty set motif in CD79b, which is a major target of mutation in ABC DLBCL. In addition, we establish that BCR internalization can be regulated at a minimum of two different levels: regulation of Yxxempty set AP2 binding in cis by downstream ITAM-embedded DCSM and QTAT regulatory elements and regulation in trans by the partner cytoplasmic domain of the CD79 heterodimer. Beyond establishing the basic rules governing BCR internalization, these results illustrate an underappreciated role for ITAM residues in controlling clathrin-dependent endocytosis and highlight the complex mechanisms that control the activity of AP2 binding motifs in this receptor system.	[Busman-Sahay, Kathleen; Drake, Lisa; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Sitaram, Anand; Marks, Michael] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sitaram, Anand; Marks, Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Albany Medical College; University of Pennsylvania; University of Pennsylvania	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	DrakeJ@mail.amc.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262	National Institutes of Health (NIH) [AI-065773]; NATIONAL EYE INSTITUTE [R01EY015625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI-065773 to J.R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNEROT C, 1995, IMMUNITY, V3, P335, DOI 10.1016/1074-7613(95)90118-3; Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Caballero A, 2006, EUR J IMMUNOL, V36, P3131, DOI 10.1002/eji.200636447; Cassard S, 1998, J IMMUNOL, V160, P1767; Cassard S, 1996, J BIOL CHEM, V271, P23786, DOI 10.1074/jbc.271.39.23786; CHESNUT RW, 1982, J IMMUNOL, V129, P2382; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; DAmbrosio D, 1996, EUR J IMMUNOL, V26, P1960, DOI 10.1002/eji.1830260842; Davis RE, NATURE, V463, P88; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Gondre-Lewis TA, 2001, J IMMUNOL, V166, P6657, DOI 10.4049/jimmunol.166.11.6657; GREY HM, 1982, J IMMUNOL, V129, P2389; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Jang C, 2010, IMMUNOL LETT, V134, P75, DOI 10.1016/j.imlet.2010.09.001; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim JH, 2007, INT IMMUNOL, V19, P1403, DOI 10.1093/intimm/dxm110; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Li C, 2002, INT IMMUNOL, V14, P1179, DOI 10.1093/intimm/dxf083; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; Putnam MA, 2003, J IMMUNOL, V170, P905, DOI 10.4049/jimmunol.170.2.905; SALAMERO J, 1995, EUR J IMMUNOL, V25, P2757, DOI 10.1002/eji.1830251007; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; Siemasko K, 1999, J IMMUNOL, V162, P6518; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54938	10.1371/journal.pone.0054938	http://dx.doi.org/10.1371/journal.pone.0054938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372794	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500147
J	Mayeur, C; Gratadoux, JJ; Bridonneau, C; Chegdani, F; Larroque, B; Kapel, N; Corcos, O; Thomas, M; Joly, F				Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Larroque, Beatrice; Kapel, Nathalie; Corcos, Olivier; Thomas, Muriel; Joly, Francisca			Faecal D/L Lactate Ratio Is a Metabolic Signature of Microbiota Imbalance in Patients with Short Bowel Syndrome	PLOS ONE			English	Article							BUTYRATE-PRODUCING BACTERIA; HUMAN GUT MICROBIOTA; D-LACTIC ACIDEMIA; LARGE-INTESTINE; ADULT PATIENTS; HUMAN FECES; PARENTERAL-NUTRITION; ACIDOSIS; COLON; ABSORPTION	Our objective was to understand the functional link between the composition of faecal microbiota and the clinical characteristics of adults with short bowel syndrome (SBS). Sixteen patients suffering from type II SBS were included in the study. They displayed a total oral intake of 2661 +/- 1005 Kcal/day with superior sugar absorption (83 +/- 12%) than protein (42 +/- 13%) or fat (39 +/- 26%). These patients displayed a marked dysbiosis in faecal microbiota, with a predominance of Lactobacillus/Leuconostoc group, while Clostridium and Bacteroides were under-represented. Each patient exhibited a diverse lactic acid bacteria composition (L. delbrueckii subsp. bulgaricus, L. crispatus, L. gasseri, L. johnsonii, L. reuteri, L. mucosae), displaying specific D and L-lactate production profiles in vitro. Of 16 patients, 9/16 (56%) accumulated lactates in their faecal samples, from 2 to 110 mM of D-lactate and from 2 to 80 mM of L-lactate. The presence of lactates in faeces (56% patients) was used to define the Lactate-accumulator group (LA), while absence of faecal lactates (44% patients) defines the Non lactate-accumulator group (NLA). The LA group had a lower plasma HCO3(-) concentration (17.1 +/- 2.8 mM) than the NLA group (22.8 +/- 4.6 mM), indicating that LA and NLA groups are clinically relevant sub-types. Two patients, belonging to the LA group and who particularly accumulated faecal D-lactate, were at risk of D-encephalopathic reactions. Furthermore, all patients of the NLA group and those accumulating preferentially L isoform in the LA group had never developed D-acidosis. The D/L faecal lactate ratio seems to be the most relevant index for a higher D-encephalopathy risk, rather than D-and L-lactate faecal concentrations per se. Testing criteria that take into account HCO3(-) value, total faecal lactate and the faecal D/L lactate ratio may become useful tools for identifying SBS patients at risk for D-encephalopathy.	[Kapel, Nathalie; Corcos, Olivier; Joly, Francisca] Hop Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy, France; [Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Thomas, Muriel] INRA, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France; [Mayeur, Camille; Gratadoux, Jean-Jacques; Bridonneau, Chantal; Chegdani, Fatima; Thomas, Muriel] AgroParisTech, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France; [Larroque, Beatrice] Hop Beaujon, Epidemiol & Clin Res Unit, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Thomas, M (corresponding author), INRA, MICALIS UMR1319, Commensal & Probiot Host Interact Lab, Jouy En Josas, France.	muriel.thomas@jouy.inra.fr; francisca.joly@bjn.aphp.fr	thomas, muriel/HDO-3887-2022; Chegdani, Fatima/AAW-9322-2021; Thomas, Muriel/D-9164-2015	Chegdani, Fatima/0000-0002-2473-0302; Corcos, Olivier/0000-0002-9034-7053; Thomas, Muriel/0000-0002-7608-3274	APHP (Assistance Publique - Hopitaux de Paris) grant; Ferring-SAS France laboratory grant	APHP (Assistance Publique - Hopitaux de Paris) grant; Ferring-SAS France laboratory grant	This work was supported by APHP (Assistance Publique - Hopitaux de Paris) and by Ferring-SAS France laboratory grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekara S, 2007, AM J PHYSIOL-ENDOC M, V293, pE558, DOI 10.1152/ajpendo.00063.2007; Achour L, 2007, EUR J CLIN NUTR, V61, P233, DOI 10.1038/sj.ejcn.1602496; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Belenguer A, 2011, FEMS MICROBIOL ECOL, V77, P107, DOI 10.1111/j.1574-6941.2011.01086.x; Bongaerts G, 2000, J PEDIATR GASTR NUTR, V30, P288, DOI 10.1097/00005176-200003000-00014; BONGAERTS G, 1995, CLIN CHEM, V41, P107; Bongaerts GPA, 1997, MICROB PATHOGENESIS, V22, P285, DOI 10.1006/mpat.1996.0122; Bourriaud C, 2005, J APPL MICROBIOL, V99, P201, DOI 10.1111/j.1365-2672.2005.02605.x; BRIET F, 1995, GASTROENTEROLOGY, V109, P1446, DOI 10.1016/0016-5085(95)90629-0; BUSTOS D, 1994, DIGEST DIS SCI, V39, P2315, DOI 10.1007/BF02087644; CUMMINGS JH, 1973, LANCET, V1, P344; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DEVRESE M, 1990, CLIN NUTR, V9, P23, DOI 10.1016/0261-5614(90)90069-5; DiBaise JK, 2006, CLIN GASTROENTEROL H, V4, P11, DOI 10.1016/j.cgh.2005.10.020; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Ewaschuk JB, 2002, J CHROMATOGR B, V781, P39, DOI 10.1016/S1570-0232(02)00500-7; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gerard P, 2008, J MOL MICROB BIOTECH, V14, P115, DOI 10.1159/000106090; HINO T, 1993, APPL ENVIRON MICROB, V59, P255, DOI 10.1128/AEM.59.1.255-259.1993; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; HOVE H, 1995, DIGEST DIS SCI, V40, P1372, DOI 10.1007/BF02065554; HOVE H, 1993, GUT, V34, P625, DOI 10.1136/gut.34.5.625; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; James PD, 2010, CAN MED ASSOC J, V182, P276, DOI 10.1503/cmaj.090009; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; Joly F, 2009, GASTROENTEROLOGY, V136, P824, DOI 10.1053/j.gastro.2008.10.084; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kapel N, 1999, CLIN CHEM LAB MED, V37, P29, DOI 10.1515/CCLM.1999.004; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Messing B, 2006, GASTROENTEROLOGY, V130, pS43, DOI 10.1053/j.gastro.2005.09.064; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MESSING B, 1995, GASTROENTEROLOGY, V108, P1005, DOI 10.1016/0016-5085(95)90196-5; Messing B, 2006, J CLIN GASTROENTEROL, V40, pS75, DOI 10.1097/01.mcg.0000212677.06549.80; MILLER DS, 1959, BRIT J NUTR, V13, P501, DOI 10.1079/BJN19590064; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Nielsen C, 2011, SCAND J CLIN LAB INV, V71, P507, DOI 10.3109/00365513.2011.590900; NORDGAARD I, 1994, LANCET, V343, P373, DOI 10.1016/S0140-6736(94)91220-3; Nordgaard I, 1996, AM J CLIN NUTR, V64, P222, DOI 10.1093/ajcn/64.2.222; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Uribarri J, 1998, MEDICINE, V77, P73, DOI 10.1097/00005792-199803000-00001; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	57	59	65	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54335	10.1371/journal.pone.0054335	http://dx.doi.org/10.1371/journal.pone.0054335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372709	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500060
J	Nausch, H; Huckauf, J; Koslowski, R; Meyer, U; Broer, I; Mikschofsky, H				Nausch, Henrik; Huckauf, Jana; Koslowski, Roswitha; Meyer, Udo; Broer, Inge; Mikschofsky, Heike			Recombinant Production of Human Interleukin 6 in Escherichia coli	PLOS ONE			English	Article							PROTEIN-PRODUCTION; GLUCOSE-UTILIZATION; EXPRESSION; SOLUBILITY; FUSION; GROWTH; OVEREXPRESSION; PURIFICATION; AGGREGATION; STRATEGIES	In this study, we compared basic expression approaches for the efficient expression of bioactive recombinant human interleukin-6 (IL6), as an example for a difficult-to-express protein. We tested these approaches in a laboratory scale in order to pioneer the commercial production of this protein in Escherichia coli (E. coli). Among the various strategies, which were tested under Research and Development (R&D) conditions, aggregation-prone IL6 was solubilized most effectively by co-expressing cytoplasmic chaperones. Expression of a Glutathion-S-Transferase (GST) fusion protein was not efficient to increase IL6 solubility. Alteration of the cultivation temperature significantly increased the solubility in both cases, whereas reduced concentrations of IPTG to induce expression of the T7lac-promotor only had a positive effect on chaperone-assisted expression. The biological activity was comparable to that of commercial IL6. Targeting the expressed protein to an oxidizing environment was not effective in the generation of soluble IL6. Taken together, the presence of chaperones and a lowered cultivation temperature seem effective to isolate large quantities of soluble IL6. This approach led to in vivo soluble, functional protein fractions and reduces purification and refolding requirements caused by downstream purification procedures. The final yield of soluble recombinant protein averaged approximately 2.6 mg IL6/liter of cell culture. These findings might be beneficial for the development of the large-scale production of IL6 under the conditions of current good manufacturing practice (cGMP).	[Nausch, Henrik; Huckauf, Jana; Broer, Inge; Mikschofsky, Heike] Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, D-18055 Rostock, Germany; [Koslowski, Roswitha; Meyer, Udo] Bioserv GmbH, Rostock, Germany	University of Rostock	Broer, I (corresponding author), Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, D-18055 Rostock, Germany.	inge.broer@uni-rostock.de		Nausch, Henrik/0000-0001-5393-3267	University of Rostock	University of Rostock	The first author appreciates the grant from the doctorate program of the University of Rostock. No additional external funding has been received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRAKENHOFF JPJ, 1987, J IMMUNOL, V139, P4116; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Cong YH, 2012, BIOCONJUGATE CHEM, V23, P248, DOI 10.1021/bc200530x; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; Ejima D, 1999, BIOTECHNOL BIOENG, V62, P301, DOI 10.1002/(SICI)1097-0290(19990205)62:3<301::AID-BIT6>3.3.CO;2-N; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Jeong KJ, 2001, PROTEIN EXPRES PURIF, V23, P311, DOI 10.1006/prep.2001.1508; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; Kim TW, 2005, BIOTECHNOL PROGR, V21, P524, DOI 10.1021/bp049645j; Lauber T, 2001, PROTEIN EXPRES PURIF, V22, P108, DOI 10.1006/prep.2001.1415; Lee EG, 2009, ENZYME MICROB TECH, V44, P254, DOI 10.1016/j.enzmictec.2008.12.014; Li YY, 2002, PROTEIN EXPRES PURIF, V25, P437, DOI 10.1016/S1046-5928(02)00028-1; Lobel L, 2002, PROTEIN EXPRES PURIF, V25, P124, DOI 10.1006/prep.2002.1618; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; MAY LT, 1991, J BIOL CHEM, V266, P9950; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Negrete A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-75; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Niiranen L, 2007, PROTEIN EXPRES PURIF, V52, P210, DOI 10.1016/j.pep.2006.09.005; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Phue JN, 2004, J BIOTECHNOL, V109, P21, DOI 10.1016/j.jbiotec.2003.10.038; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; Schlapschy M, 2006, PROTEIN ENG DES SEL, V19, P385, DOI 10.1093/protein/gzl018; Seo JH, 2003, BIOTECHNOL APPL BIOC, V37, P103; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Shiloach J, 1996, BIOTECHNOL BIOENG, V49, P421, DOI 10.1002/(SICI)1097-0290(19960220)49:4<421::AID-BIT9>3.0.CO;2-R; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Spiridonova VA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P424, DOI 10.1134/S0006297907040098; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; TONOUCHI N, 1988, J BIOCHEM-TOKYO, V104, P30, DOI 10.1093/oxfordjournals.jbchem.a122416; Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60; Venturi M, 2002, J MOL BIOL, V315, P1, DOI 10.1006/jmbi.2001.5221; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Waegeman H, 2012, BIOTECHNOL LETT, V34, P329, DOI 10.1007/s10529-011-0774-6; Waegeman H, 2011, J IND MICROBIOL BIOT, V38, P1891, DOI 10.1007/s10295-011-1034-4; Wu HP, 2009, INFLAMM RES, V58, P385, DOI 10.1007/s00011-009-0003-0; Xu YL, 2008, WORLD J MICROB BIOT, V24, P2827, DOI 10.1007/s11274-008-9813-4	51	26	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54933	10.1371/journal.pone.0054933	http://dx.doi.org/10.1371/journal.pone.0054933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372793	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500146
J	Noto, JM; Khizanishvili, T; Chaturvedi, R; Piazuelo, MB; Romero-Gallo, J; Delgado, AG; Khurana, SS; Sierra, JC; Krishna, US; Suarez, G; Powell, AE; Goldenring, JR; Coffey, RJ; Yang, VW; Correa, P; Mills, JC; Wilson, KT; Peek, RM				Noto, Jennifer M.; Khizanishvili, Tinatin; Chaturvedi, Rupesh; Piazuelo, M. Blanca; Romero-Gallo, Judith; Delgado, Alberto G.; Khurana, Shradha S.; Sierra, Johanna C.; Krishna, Uma S.; Suarez, Giovanni; Powell, Anne E.; Goldenring, James R.; Coffey, Robert J.; Yang, Vincent W.; Correa, Pelayo; Mills, Jason C.; Wilson, Keith T.; Peek, Richard M., Jr.			Helicobacter Pylori Promotes the Expression of Kruppel-Like Factor 5, a Mediator of Carcinogenesis, In Vitro and In Vivo	PLOS ONE			English	Article							BINDING-PROTEIN; SELF-RENEWAL; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; BETA-CATENIN; STEM; KLF5; LRIG1; PROLIFERATION; ACTIVATION	Helicobacter pylori is the strongest known risk factor for the development of gastric adenocarcinoma. H. pylori expresses a repertoire of virulence factors that increase gastric cancer risk, including the cag pathogenicity island and the vacuolating cytotoxin (VacA). One host element that promotes carcinogenesis within the gastrointestinal tract is Kruppel-like factor 5 (KLF5), a transcription factor that mediates key cellular functions. To define the role of KLF5 within the context of H. pylori-induced inflammation and injury, human gastric epithelial cells were co-cultured with the wild-type cag(+) H. pylori strain 60190. KLF5 expression was significantly upregulated following co-culture with H. pylori, but increased expression was independent of the cag island or VacA. To translate these findings into an in vivo model, C57BL/6 mice were challenged with the wild-type rodent-adapted cag(+) H. pylori strain PMSS1 or a PMSS1 cagE(-) isogenic mutant. Similar to findings in vitro, KLF5 staining was significantly enhanced in gastric epithelium of H. pylori-infected compared to uninfected mice and this was independent of the cag island. Flow cytometry revealed that the majority of KLF5(+) cells also stained positively for the stem cell marker, Lrig1, and KLF5(+)/Lrig1(+) cells were significantly increased in H. pylori-infected versus uninfected tissue. To extend these results into the natural niche of this pathogen, levels of KLF5 expression were assessed in human gastric biopsies isolated from patients with or without premalignant lesions. Levels of KLF5 expression increased in parallel with advancing stages of neoplastic progression, being significantly elevated in gastritis, intestinal metaplasia, and dysplasia compared to normal gastric tissue. These results indicate that H. pylori induces expression of KLF5 in gastric epithelial cells in vitro and in vivo, and that the degree of KLF5 expression parallels the severity of premalignant lesions in human gastric carcinogenesis.	[Noto, Jennifer M.; Khizanishvili, Tinatin; Chaturvedi, Rupesh; Piazuelo, M. Blanca; Romero-Gallo, Judith; Delgado, Alberto G.; Sierra, Johanna C.; Krishna, Uma S.; Suarez, Giovanni; Coffey, Robert J.; Correa, Pelayo; Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Med, St Louis, MO USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Khurana, Shradha S.; Mills, Jason C.] Washington Univ, Dept Dev Biol, St Louis, MO USA; [Powell, Anne E.; Goldenring, James R.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Goldenring, James R.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Yang, Vincent W.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wilson, Keith T.; Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Immunol, Nashville, TN USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Noto, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA.	jennifer.noto@vanderbilt.edu	Mills, Jason/AAA-6688-2021	Mills, Jason/0000-0002-0402-4662; Wilson, Keith/0000-0003-4421-1830; Zemper, Anne/0000-0001-8238-1406	National Institutes of Health (NIH) [F32CA153539, R01CA077955, R01DK058587, P30DK058404, P01CA116087, R01DK053620, P01CA028842]; Vanderbilt University Digestive Disease Research Cente [P30DK058404]; Office of Medical Research, Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA119925, R01CA046413, P01CA116087, P01CA028842, F32CA153539, T32CA113275, R01CA077955] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094989, P30DK058404, R01DK058587, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Cente; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health (NIH) grants: F32CA153539 (JMN); R01CA077955 (RMP), R01DK058587 (RMP), P30DK058404 (RMP), P01CA116087 (RMP and KTW), R01DK053620 (KTW), P01CA028842 (KTW and PC), the flow cytometry core of the Vanderbilt University Digestive Disease Research Center grant (P30DK058404), and a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (KTW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chanchevalap S, 2004, FEBS LETT, V578, P99, DOI 10.1016/j.febslet.2004.10.079; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kojima S, 1997, J BIOCHEM, V121, P389; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Nagy TA, 2011, GASTROENTEROLOGY, V141, P553, DOI 10.1053/j.gastro.2011.05.004; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi S, 2000, DEV DYNAM, V217, P421, DOI 10.1002/(SICI)1097-0177(200004)217:4<421::AID-DVDY9>3.0.CO;2-1; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038338; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235	49	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54344	10.1371/journal.pone.0054344	http://dx.doi.org/10.1371/journal.pone.0054344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372710	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500061
J	Takahashi, RH; Capetillo-Zarate, E; Lin, MT; Milner, TA; Gouras, GK				Takahashi, Reisuke H.; Capetillo-Zarate, Estibaliz; Lin, Michael T.; Milner, Teresa A.; Gouras, Gunnar K.			Accumulation of Intraneuronal beta-Amyloid 42 Peptides Is Associated with Early Changes in Microtubule-Associated Protein 2 in Neurites and Synapses	PLOS ONE			English	Article							INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; TRANSGENIC MICE; PRECURSOR-PROTEIN; PLAQUE-FORMATION; MOUSE MODEL; SELECTIVE VULNERABILITY; A-BETA-42 ACCUMULATION; COGNITIVE DEFICITS; SYNAPTIC PATHOLOGY	Pathologic aggregation of beta-amyloid (A beta) peptide and the axonal microtubule-associated protein tau protein are hallmarks of Alzheimer's disease (AD). Evidence supports that A beta peptide accumulation precedes microtubule-related pathology, although the link between A beta and tau remains unclear. We previously provided evidence for early co-localization of A beta 42 peptides and hyperphosphorylated tau within postsynaptic terminals of CA1 dendrites in the hippocampus of AD transgenic mice. Here, we explore the relation between A beta peptide accumulation and the dendritic, microtubule-associated protein 2 (MAP2) in the well-characterized amyloid precursor protein Swedish mutant transgenic mouse (Tg2576). We provide evidence that localized intraneuronal accumulation of A beta 42 peptides is spatially associated with reductions of MAP2 in dendrites and postsynaptic compartments of Tg2576 mice at early ages. Our data support that reduction in MAP2 begins at sites of A beta 42 monomer and low molecular weight oligomer (M/LMW) peptide accumulation. Cumulative evidence suggests that accumulation of M/LMW A beta 42 peptides occurs early, before high molecular weight oligomerization and plaque formation. Since synaptic alteration is the best pathologic correlate of cognitive dysfunction in AD, the spatial association of M/LMW A beta peptide accumulation with pathology of MAP2 within neuronal processes and synaptic compartments early in the disease process reinforces the importance of intraneuronal A beta accumulation in AD pathogenesis.	[Takahashi, Reisuke H.] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan; [Takahashi, Reisuke H.; Capetillo-Zarate, Estibaliz; Lin, Michael T.; Milner, Teresa A.; Gouras, Gunnar K.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Milner, Teresa A.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; [Gouras, Gunnar K.] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Tokyo Medical University; Cornell University; Rockefeller University; Lund University	Takahashi, RH (corresponding author), Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan.	takaharh@tokyo-med.ac.jp; gunnar.gouras@med.lu.se	Gouras, Gunnar/B-3021-2010; Capetillo-Zarate, Estibaliz/Z-5772-2019	Gouras, Gunnar/0000-0002-5500-6325; Capetillo-Zarate, Estibaliz/0000-0002-8416-0495	National Institutes of Health [HL18974, DA08259, NS045677, AG028174]; MultiPark; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG028174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MultiPark; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health grants HL18974, DA08259 (TAM), NS045677 and AG028174, and MultiPark (GKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Capetillo-Zarate E, 2011, AM J PATHOL, V179, P2551, DOI 10.1016/j.ajpath.2011.07.045; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; Funato H, 1999, AM J PATHOL, V155, P23, DOI 10.1016/S0002-9440(10)65094-8; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Milner TA, 1998, J COMP NEUROL, V395, P310; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Peters A., 1991, FINE STRUCTURE NERVO; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Shie FS, 2003, NEUROREPORT, V14, P123, DOI 10.1097/00001756-200301200-00023; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Upadhaya AR, 2012, J CELL MOL MED, V16, P287, DOI 10.1111/j.1582-4934.2011.01306.x; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	60	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e51965	10.1371/journal.pone.0051965	http://dx.doi.org/10.1371/journal.pone.0051965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23372648	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500008
J	Lin, YT; Wu, YH; Tseng, CK; Lin, CK; Chen, WC; Hsu, YC; Lee, JC				Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Hsu, Yao-Chin; Lee, Jin-Ching			Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; (-)-EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; RNA REPLICATION; CELL-CULTURE; INFECTION; EXPRESSION; CYCLOOXYGENASE-2; CATECHINS; SYSTEM	Chronic hepatitis C virus (HCV) infection is the leading risk factor for hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Green tea, in addition to being consumed as a healthy beverage, contains phenolic catechins that have been used as medicinal substances. In the present study, we illustrated that the epicatechin isomers (+)-epicatechin and (-)-epicatechin concentration-dependently inhibited HCV replication at nontoxic concentrations by using in vitro cell-based HCV replicon and JFH-1 infectious systems. In addition to significantly suppressing virus-induced cyclooxygenase-2 (COX-2) expression, our results revealed that the anti-HCV activity of the epicatechin isomers occurred through the down-regulation of COX-2. Furthermore, both the epicatechin isomers additively inhibited HCV replication in combination with either interferon-alpha or viral enzyme inhibitors [2'-C-methylcytidine (NM-107) or telaprevir]. They also had prominent anti-inflammatory effects by inhibiting the gene expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and inducible nitrite oxide synthase as well as the COX-2 in viral protein-expressing hepatoma Huh-7 cells. Collectively, (+)-epicatechin and (-)-epicatechin may serve as therapeutic supplements for treating HCV-related diseases.	[Lin, Ying-Ting; Wu, Yu-Hsuan; Tseng, Chin-Kai; Lin, Chun-Kuang; Chen, Wei-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Dept Biotechnol, Coll Life Sci, Kaohsiung, Taiwan; [Hsu, Yao-Chin] ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University	Hsu, YC (corresponding author), ChiMei Med Ctr, Dept Chinese Med, Tainan, Taiwan.	cmh7100@mail.chimei.org.tw; jclee@kmu.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	 [NSC 101-2113-M-037-010];  [NSC 101-2311-B-037-002-MY3];  [KMUER014];  [97CM-KMU-13]	; ; ; 	NSC 101-2113-M-037-010, NSC 101-2311-B-037-002-MY3 (http://web1.nsc.gov.tw/), KMUER014, 97CM-KMU-13 (http://www2.kmu.edu.tw/index.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Bassit Leda, 2008, Antiviral Chemistry & Chemotherapy, V19, P25; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chang LK, 2003, BIOCHEM BIOPH RES CO, V301, P1062, DOI 10.1016/S0006-291X(03)00067-6; Chen C, 2012, ARCH VIROL; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h; Dong-rui Ma, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P914; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gee J, 2008, UROL ONCOL-SEMIN ORI, V26, P641, DOI 10.1016/j.urolonc.2007.05.015; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Ho HY, 2009, J AGR FOOD CHEM, V57, P6140, DOI 10.1021/jf901128u; Hou DX, 2007, ARCH BIOCHEM BIOPHYS, V460, P67, DOI 10.1016/j.abb.2007.01.009; Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021; Isaacs CE, 2011, ANTIMICROB AGENTS CH, V55, P5646, DOI 10.1128/AAC.05531-11; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Jiang YF, 2011, CELL BIOL INT, V35, P1225, DOI 10.1042/CBI20110102; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Laurie SA, 2005, CANCER CHEMOTH PHARM, V55, P33, DOI 10.1007/s00280-004-0859-1; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2003, ANAL BIOCHEM, V316, P162, DOI 10.1016/S0003-2697(03)00053-8; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Lee JC, 2010, ANAL BIOCHEM, V403, P52, DOI 10.1016/j.ab.2010.04.004; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li Jianxiang, 2001, Zhonghua Yufang Yixue Zazhi, V35, P404; Li Shenwei, 2010, Antiviral Chemistry & Chemotherapy, V20, P239, DOI 10.3851/IMP1597; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Matthews Carolyn M, 2010, Proc (Bayl Univ Med Cent), V23, P142; Morinaga S, 2007, J GASTROEN HEPATOL, V22, P1249, DOI 10.1111/j.1440-1746.2006.04367.x; Nunez O, 2004, GUT, V53, P1665, DOI 10.1136/gut.2003.038364; Okamoto Mika, 2009, Antivir Chem Chemother, V20, P47, DOI 10.3851/IMP1372; Pan KL, 2009, ANTIMICROB AGENTS CH, V53, P4825, DOI 10.1128/AAC.00601-09; Park CM, 2010, FOOD CHEM TOXICOL, V48, P1255, DOI 10.1016/j.fct.2010.02.019; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Roh C, 2011, TALANTA, V85, P2639, DOI 10.1016/j.talanta.2011.08.035; Sakaki M, 2010, HEPATOL RES, V40, P1219, DOI 10.1111/j.1872-034X.2010.00727.x; Salloum S, 2012, TRANSL RES, V159, P421, DOI 10.1016/j.trsl.2011.12.007; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schaefer Martin, 2008, Curr Drug Abuse Rev, V1, P177; Shanafelt TD, 2012, CANCER; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tseng CK, 2011, ANAL BIOCHEM, V418, P50, DOI 10.1016/j.ab.2011.06.042; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Wohlfarth C, 2009, ACTA PHARMACOL SIN, V30, P25, DOI 10.1038/aps.2008.5; Wu KM, 2010, REGUL TOXICOL PHARM, V56, P1, DOI 10.1016/j.yrtph.2009.09.012; Zuo GY, 2007, ANTIVIR RES, V76, P86, DOI 10.1016/j.antiviral.2007.06.001	55	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54466	10.1371/journal.pone.0054466	http://dx.doi.org/10.1371/journal.pone.0054466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23365670	Green Submitted, Green Published, gold			2022-12-27	WOS:000314023600058
J	de Carvalho, AL; Nelson, BW; Bianchini, MC; Plagnol, D; Kuplich, TM; Daly, DC				de Carvalho, Anelena L.; Nelson, Bruce W.; Bianchini, Milton C.; Plagnol, Daniela; Kuplich, Tatiana M.; Daly, Douglas C.			Bamboo-Dominated Forests of the Southwest Amazon: Detection, Spatial Extent, Life Cycle Length and Flowering Waves	PLOS ONE			English	Article							TROPICAL FOREST; LONG	We map the extent, infer the life-cycle length and describe spatial and temporal patterns of flowering of sarmentose bamboos (Guadua spp) in upland forests of the southwest Amazon. We first examine the spectra and the spectral separation of forests with different bamboo life stages. False-color composites from orbital sensors going back to 1975 are capable of distinguishing life stages. These woody bamboos flower produce massive quantities of seeds and then die. Life stage is synchronized, forming a single cohort within each population. Bamboo dominates at least 161,500 km(2) of forest, coincident with an area of recent or ongoing tectonic uplift, rapid mechanical erosion and poorly drained soils rich in exchangeable cations. Each bamboo population is confined to a single spatially continuous patch or to a core patch with small outliers. Using spatial congruence between pairs of mature-stage maps from different years, we estimate an average life cycle of 27-28 y. It is now possible to predict exactly where and approximately when new bamboo mortality events will occur. We also map 74 bamboo populations that flowered between 2001 and 2008 over the entire domain of bamboo-dominated forest. Population size averaged 330 km(2). Flowering events of these populations are temporally and/or spatially separated, restricting or preventing gene exchange. Nonetheless, adjacent populations flower closer in time than expected by chance, forming flowering waves. This may be a consequence of allochronic divergence from fewer ancestral populations and suggests a long history of widespread bamboo in the southwest Amazon.	[de Carvalho, Anelena L.] Natl Inst Amazon Res, Grad Program Forest Sci, Cruzeiro Do Sul, Brazil; [Bianchini, Milton C.] Natl Inst Amazon Res, Grad Program Ecol, Inst Criminalist Amazonas IC, Dept Policia Tecn Cient DPTC Policia Civil Estado, Manaus, Amazonas, Brazil; [Nelson, Bruce W.; Plagnol, Daniela] Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil; [Kuplich, Tatiana M.] So Reg INPE CRS, Natl Inst Space Res, Santa Maria, RS, Brazil; [Daly, Douglas C.] New York Bot Garden, Bronx, NY 10458 USA	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Instituto Nacional de Pesquisas Espaciais (INPE); New York Botanical Garden	Nelson, BW (corresponding author), Natl Inst Amazon Res, Dept Ecol, Grad Program Ecol, Manaus, Amazonas, Brazil.	bnelsonbr@gmail.com	Kuplich, Tatiana/C-6429-2013; Kuplich, Tatiana M/U-1112-2018; Nelson, Bruce/G-4562-2013; Gomes de Carvalho, Andre Luiz/M-9503-2017; Fernandes, Daniel/D-7168-2013	Kuplich, Tatiana M/0000-0003-0657-4024; Nelson, Bruce/0000-0002-0488-6895; Gomes de Carvalho, Andre Luiz/0000-0002-2528-6274; Fernandes, Daniel/0000-0001-6155-6246	Brazilian National Research Council (CNPq) [52.3102/96]; National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Amazon Research (INPA); CNPq via the GEOMA environmental modelling network	CLASlite image-processing software was developed by the Carnegie Institution of Washington, with support from The Gordon and Betty Moore Foundation and The John D. and Catherine T. MacArthur Foundation. Petrobras provided a low-level helicopter flight over senescing Guadua sarcocarpa. Brazil's National Institute for Space Research (INPE) provided the aircraft and 150 km low-level flight over juvenile bamboo populations. Funding for this research was provided by the Brazilian National Research Council (CNPq) via grant 52.3102/96, by CNPq via the GEOMA environmental modelling network and by the National Institute for Amazon Research (INPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D, 1962, EVOLUTIONARY RELATIO; [Anonymous], J ED, DOI [DOI 10.1080/01619569509538834, DOI 10.1080/10106048809354132]; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Balee W., 1989, Advances in Economic Botany, V7, P1; Barlow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033373; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Deering DW, 1999, REMOTE SENS ENVIRON, V67, P205, DOI 10.1016/S0034-4257(98)00087-X; Espirito-Santo FB, 2003, DETECCAO DINAMICA FL, P649; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; GADGIL M, 1984, BIOTROPICA, V16, P161, DOI 10.2307/2388050; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Hill RA, 1999, INT J REMOTE SENS, V20, P1039, DOI 10.1080/014311699213082; IBGE EMBRAPA, 2001, MAP SOL BRAS; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; Kratter AW, 1997, BIOTROPICA, V29, P100, DOI 10.1111/j.1744-7429.1997.tb00011.x; LONDONO X, 1991, SYST BOT, V16, P630, DOI 10.2307/2418866; Mascarenhas Artur Fernando Silva, 2004, Acta Amaz., V34, P61, DOI 10.1590/S0044-59672004000100008; Nelson B., 1994, REMOTE SENSING REV, V10, P105, DOI [10.1080/02757259409532239, DOI 10.1080/02757259409532239]; NELSON BW, 2006, AN SEM NAC BAMB FAC, P49; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Regard V, 2009, GEOMORPHOLOGY, V107, P107, DOI 10.1016/j.geomorph.2008.12.003; Santos H.G., 2018, BRAZILIAN SOIL CLASS, V5th edition, DOI [10.1016/j.eja.2021.126308, DOI 10.1016/J.EJA.2021.126308]; SANTOS U D M, 1988, Acta Amazonica, V18, P145; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Silveira M., 1999, Ecotropica, V5, P213; SINGH A, 1987, INT J REMOTE SENS, V8, P971, DOI 10.1080/01431168708954741; Smith M, 2011, J TROP ECOL, V27, P59, DOI 10.1017/S026646741000057X; Toivonen T, 2006, REMOTE SENS ENVIRON, V100, P550, DOI 10.1016/j.rse.2005.11.006; Williams KS, 1995, ANNU REV ENTOMOL, V40, P36	35	84	92	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54852	10.1371/journal.pone.0054852	http://dx.doi.org/10.1371/journal.pone.0054852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23359438	gold, Green Published, Green Submitted			2022-12-27	WOS:000314023600123
J	Hoffer, ME; Balaban, C; Slade, MD; Tsao, JW; Hoffer, B				Hoffer, Michael E.; Balaban, Carey; Slade, Martin D.; Tsao, Jack W.; Hoffer, Barry			Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study	PLOS ONE			English	Article							TYMPANIC MEMBRANE; RAT MODEL; NOISE; ACETYLCYSTEINE; RELIABILITY; MECHANISMS; INDUCTION; PRESSURE; PROTECTS; EXPOSURE	Background: Mild traumatic brain injury (mTBI) secondary to blast exposure is the most common battlefield injury in Southwest Asia. There has been little prospective work in the combat setting to test the efficacy of new countermeasures. The goal of this study was to compare the efficacy of N-acetyl cysteine (NAC) versus placebo on the symptoms associated with blast exposure mTBI in a combat setting. Methods: This study was a randomized double blind, placebo-controlled study that was conducted on active duty service members at a forward deployed field hospital in Iraq. All symptomatic U. S. service members who were exposed to significant ordnance blast and who met the criteria for mTBI were offered participation in the study and 81 individuals agreed to participate. Individuals underwent a baseline evaluation and then were randomly assigned to receive either N-acetyl cysteine (NAC) or placebo for seven days. Each subject was re-evaluated at 3 and 7 days. Outcome measures were the presence of the following sequelae of mTBI: dizziness, hearing loss, headache, memory loss, sleep disturbances, and neurocognitive dysfunction. The resolution of these symptoms seven days after the blast exposure was the main outcome measure in this study. Logistic regression on the outcome of 'no day 7 symptoms' indicated that NAC treatment was significantly better than placebo (OR = 3.6, p = 0.006). Secondary analysis revealed subjects receiving NAC within 24 hours of blast had an 86% chance of symptom resolution with no reported side effects versus 42% for those seen early who received placebo. Conclusion: This study, conducted in an active theatre of war, demonstrates that NAC, a safe pharmaceutical countermeasure, has beneficial effects on the severity and resolution of sequelae of blast induced mTBI. This is the first demonstration of an effective short term countermeasure for mTBI. Further work on long term outcomes and the potential use of NAC in civilian mTBI is warranted.	[Hoffer, Michael E.] USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Balaban, Carey; Slade, Martin D.] Yale Univ, Dept Internal Med, New Haven, CT USA; [Tsao, Jack W.] USN, Bur Med & Surg, Wounded Ill & Injured Directorate M9, Washington, DC USA; [Hoffer, Barry] Case Western Reserve Univ, Dept Neurosurg, Cleveland, OH 44106 USA	United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; United States Department of Defense; United States Navy; Case Western Reserve University	Hoffer, ME (corresponding author), USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA.	Michael.hoffer@med.navy.mil	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844	Department of Defense	Department of Defense(United States Department of Defense)	Supported by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2011, OTOL NEUROTOL, V32, P1309, DOI 10.1097/MAO.0b013e31822e5bee; Balaban CD, 2012, BRAIN INJUR IN PRESS; Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; De Vries H, 1996, PHARMACOL REV, V49, P143; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; French L., 2009, CARE COMBAT AMPUTEE, P399; Gabaix X., 2008, FDN POSITIVE NORMATI, P292, DOI [10.1093/acprof:oso/9780195328318.003.0012, DOI 10.1093/ACPROF:OSO/9780195328318.003.0012]; GARTH RJN, 1994, J LARYNGOL OTOL, V108, P925, DOI 10.1017/S0022215100128555; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; James DJ, 1982, 0482 ARM WEAP RES ES; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Reitan RM, 1992, TRAIL MAKIGN TEST MA; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santangelo F, 2003, CURR MED CHEM, V10, P2599, DOI 10.2174/0929867033456567; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Strauss E., 1998, COMPENDIUM NEUROPSYC, P447; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 1998, COMPENDIUM NEUROPSYC, P481; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024	46	158	162	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54163	10.1371/journal.pone.0054163	http://dx.doi.org/10.1371/journal.pone.0054163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544123	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500034
J	Cao, Y; Zhou, XX; Huang, XY; Li, QL; Gao, LL; Jiang, LJ; Huang, M; Zhou, JF				Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng			Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis	PLOS ONE			English	Article							CELLS; TARGETS; ESCAPE	Background: T cell immunoglobulin mucin-3 (Tim-3) has been identified as a negative regulator of anti-tumor immunity. Recent studies highlight the important role of Tim-3 in the CD8(+) T cell exhaustion that takes place in both human and animal cancer models. However, the nature of Tim-3 expression in the tumor cell and the mechanism by which it inhibits anti-tumor immunity are unclear. This present study aims to determine Tim-3 is expressed in cervical cancer cells and to evaluate the role of Tim-3 in cervical cancer progression. Methodology: A total of 85 cervical tissue specimens including 43 human cervical cancer, 22 cervical intraepithelial neoplasia (CIN) and 20 chronic cervicitis were involved. Tim-3 expression in tumor cells was detected and was found to correlate with clinicopathological parameters. Meanwhile, expression of Tim-3 was assessed by RT-PCR, Western Blot and confocal microscopy in cervical cancer cell lines, HeLa and SiHa. The migration and invasion potential of Hela cells was evaluated after inhibiting Tim-3 expression by ADV-antisense Tim-3. Conclusions: We found that Tim-3 was expressed at a higher level in the clinical cervical cancer cells compared to the CIN and chronic cervicitis controls. We supported this finding by confirming the presence of Tim-3 mRNA and protein in the cervical cell lines. Tim-3 expression in tumor cells correlated with clinicopathological parameters. Patients with high expression of Tim-3 had a significant metastatic potential, advanced cancer grades and shorter overall survival than those with lower expression. Multivariate analysis showed that Tim-3 expression was an independent factor for predicting the prognosis of cervical cancer. Significantly, down-regulating the expression of Tim-3 protein inhibited migration and invasion of Hela cells. Our study suggests that the expression of Tim-3 in tumor cells may be an independent prognostic factor for patients with cervical cancer. Moreover, Tim-3 expression may promote metastatic potential in cervical cancers.	[Cao, Yang; Zhou, Xiaoxi; Huang, Xiaoyuan; Li, Qinlu; Gao, Lili; Jiang, Lijun; Huang, Mei; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Huang, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China.	huangmei@medmail.com.cn	Cao, Yang/HGD-6463-2022	Yu, Shiqiang/0000-0003-3519-0943	National Science Foundation of China [81001049]; National Science Fund for Distinguished Young Scholars of China [81025011]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This article was supported by National Science Foundation of China (No. 81001049) and National Science Fund for Distinguished Young Scholars of China (No. 81025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2012, NAT REV CANCER, V12, P453; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Ibrahim R, 2006, CANCER-AM CANCER SOC, V106, P1065, DOI 10.1002/cncr.21697; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; No JH, 2011, MOL CARCINOGEN, V50, P244, DOI 10.1002/mc.20657; Norde WJ, 2012, BLOOD, V120, P728, DOI 10.1182/blood-2012-02-412510; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Zhou JF, 2005, CLIN CANCER RES, V11, P8431, DOI 10.1158/1078-0432.CCR-05-1085; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425	19	106	126	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53834	10.1371/journal.pone.0053834	http://dx.doi.org/10.1371/journal.pone.0053834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086SQ	23335978	Green Published, Green Submitted, gold			2022-12-27	WOS:000314707700036
J	Gao, XM; Zhao, YJ; Yang, XJ; Sun, SC				Gao, Xianming; Zhao, Yujie; Yang, Xuejun; Sun, Shucun			Linking Trait Differences to Community Dynamics: Evidence from Eupatorium adenophorum and Co-Occurring Native Species during a Three-Year Succession	PLOS ONE			English	Article							ALIEN INVASIVE PLANTS; RESOURCE-USE; IMPACTS; LEAF; ECOLOGY; HERBIVORY; PHENOLOGY; DOMINANCE; FRAMEWORK; RESPONSES	Trait differences between invasive and native species are believed to be closely related to whether the former are successful. However, few studies have measured trait differences between invasive and native species directly under field conditions or during long term experiments. We examined the phenological pattern, plant height and biomass accumulation and allocation of Crofton weed (Eupatorium adenophorum Spreng.) and co-occurring native species in a community during a three-year succession. The phenological pattern of Crofton weed differed from that of co-occurring native species. Crofton weed had longer vegetative stage (when resources were more available), a higher biomass accumulation and a higher above/below-ground ratio compared to native species. Crofton weed was shorter than grasses and two forbs (Artemisia tangutica and Cynoglossum amabile) during its first year of growth, but was significantly taller than all other species during subsequent years. The dominance (calculated as the importance value) of Crofton weed was the highest among all other species and continually increased over time while the dominance of co-occurring native species decreased. This study provides direct field evidence that trait differences are important to plant invasion.	[Gao, Xianming; Zhao, Yujie; Yang, Xuejun] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhao, Yujie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, ECORES Lab, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Gao, XM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	xmgao@ibcas.ac.cn	Yang, Xuejun/B-4718-2014	Yang, Xuejun/0000-0002-8595-545X	National Basic Research and Development Program of China [2009CB112000]; key project of the Chinese Academy of Science [KSCX1-SW-13-03-06]; National Nature Science Foundation of China [30670333]	National Basic Research and Development Program of China(National Basic Research Program of China); key project of the Chinese Academy of Science(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Basic Research and Development Program of China (2009CB112000), the key project of the Chinese Academy of Science (KSCX1-SW-13-03-06) and National Nature Science Foundation of China (30670333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AC, 1979, P 7 AS PAC WEED SCI, P351; Augspurger CK, 2008, OECOLOGIA, V156, P281, DOI 10.1007/s00442-008-1000-7; Barney JN, 2009, PLANT ECOL, V202, P275, DOI 10.1007/s11258-008-9481-3; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Cadotte MW, 2002, ECOSCIENCE, V9, P397, DOI 10.1080/11956860.2002.11682727; Cleland EE, 2011, NEW PHYTOL, V189, P649, DOI 10.1111/j.1469-8137.2010.03607.x; Coleman HM, 2007, BIOL INVASIONS, V9, P65, DOI 10.1007/s10530-006-9008-6; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Cronk QCB, 1995, PLANT INVADERS THREA; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Field CB, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P617; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Harper J. L., 1977, Population biology of plants.; Hina Fatimah, 2009, Advances in Environmental Biology, V3, P150; Ishii H, 2010, ECOL RES, V25, P715, DOI 10.1007/s11284-009-0668-4; KLUGE RL, 1991, AGR ECOSYST ENVIRON, V37, P187, DOI 10.1016/0167-8809(91)90146-O; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kudo G, 1996, ECOL RES, V11, P283, DOI 10.1007/BF02347785; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Manea A, 2011, OECOLOGIA, V165, P735, DOI 10.1007/s00442-010-1765-3; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Page AL., 1982, CHEM MICROBIOLOGICAL, V15, P99, DOI DOI 10.2134/AGRONMONOGR9.2.2ED; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rejmanek M., 2005, INVASIVE ALIEN SPECI; Scharfy D, 2011, NEW PHYTOL, V189, P818, DOI 10.1111/j.1469-8137.2010.03531.x; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; SHARMA K C, 1977, Nepalese Journal of Agriculture, V12, P135; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tao ZG, 2002, SICHUAN ANIM VET SCI, V29, P25; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; van der Wal R, 2008, GLOBAL CHANGE BIOL, V14, P1428, DOI 10.1111/j.1365-2486.2008.01576.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Waser NM., 2006, PLANT POLLINATOR INT; Weigelt A, 2002, BASIC APPL ECOL, V3, P85, DOI 10.1078/1439-1791-00080; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilsey BJ, 2006, OECOLOGIA, V150, P300, DOI 10.1007/s00442-006-0515-z; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Zheng YL, 2009, PLANT ECOL, V203, P263, DOI 10.1007/s11258-008-9544-5; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	60	51	56	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e50247	10.1371/journal.pone.0050247	http://dx.doi.org/10.1371/journal.pone.0050247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23613942	gold, Green Published			2022-12-27	WOS:000314610600002
J	Li, DT; Wang, LW; Liu, X; Cui, DZ; Chen, TT; Zhang, H; Jiang, C; Xu, CY; Li, P; Li, S; Zhao, L; Chen, HB				Li, Detao; Wang, Liwen; Liu, Xu; Cui, Dezhou; Chen, Tingting; Zhang, Hua; Jiang, Chuan; Xu, Chunyan; Li, Peng; Li, Song; Zhao, Li; Chen, Huabang			Deep Sequencing of Maize Small RNAs Reveals a Diverse Set of MicroRNA in Dry and Imbibed Seeds	PLOS ONE			English	Article							GENE-REGULATION CASCADES; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; COMPUTATIONAL IDENTIFICATION; DISTINCT ROLES; ABSCISIC-ACID; AUXIN; GERMINATION	Seed germination plays a pivotal role during the life cycle of plants. As dry seeds imbibe water, the resumption of energy metabolism and cellular repair occur and miRNA-mediated gene expression regulation is involved in the reactivation events. This research was aimed at understanding the role of miRNA in the molecular control during seed imbibition process. Small RNA libraries constructed from dry and imbibed maize seed embryos were sequenced using the Illumina platform. Twenty-four conserved miRNA families were identified in both libraries. Sixteen of them showed significant expression differences between dry and imbibed seeds. Twelve miRNA families, miR156, miR159, miR164, miR166, miR167, miR168, miR169, miR172, miR319, miR393, miR394 and miR397, were significantly down-regulated; while four families, miR398, miR408, miR528 and miR529, were significantly up-regulated in imbibed seeds compared to that in dry seeds. Furthermore, putative novel maize miRNAs and their target genes were predicted. Target gene GO analysis was performed for novel miRNAs that were sequenced more than 50 times in the normalized libraries. The result showed that carbohydrate catabolic related genes were specifically enriched in the dry seed, while in imbibed seed target gene enrichment covered a broad range of functional categories including genes in amino acid biosynthesis, isomerase activity, ligase activity and others. The sequencing results were partially validated by quantitative RT-PCR for both conserved and novel miRNAs and the predicted target genes. Our data suggested that diverse and complex miRNAs are involved in the seed imbibition process. That miRNA are involved in plant hormone regulation may play important roles during the dry-imbibed seed transition.	[Li, Detao; Wang, Liwen; Liu, Xu; Cui, Dezhou; Chen, Tingting; Zhang, Hua; Jiang, Chuan; Xu, Chunyan; Li, Peng; Li, Song] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhao, Li; Chen, Huabang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China	Shandong Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhao, L (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	hbchen@genetics.ac.cn; zhaoli@genetics.ac.cn			National Science Foundation of China [31071424]; Shandong Pivotal Project for Elite Agricultural Variety Development	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Pivotal Project for Elite Agricultural Variety Development	This work was partially supported by the National Science Foundation of China (31071424) and by the Shandong Pivotal Project for Elite Agricultural Variety Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Banu NA, 2009, J PLANT PHYSIOL, V166, P146, DOI 10.1016/j.jplph.2008.03.002; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Freudenberg K, 1959, BIOCH WOOD, P121; Fu CX, 2012, PLANT BIOTECHNOLOGY, P1; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kimura M, 2010, PLANT MOL BIOL, V73, P119, DOI 10.1007/s11103-010-9603-x; Kinoshita N, 2010, PLANT CELL PHYSIOL, V51, P239, DOI 10.1093/pcp/pcp183; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Martin RC, 2005, SEED SCI RES, V15, P319, DOI 10.1079/SSR2005220; Martin RC, 2006, CAN J BOT, V84, P189, DOI 10.1139/B05-141; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Martin RC, 2010, SEED SCI RES, V20, P89, DOI 10.1017/S0960258510000073; Martin RC, 2010, SEED SCI RES, V20, P79, DOI 10.1017/S0960258510000085; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sreenivasulu N, 2010, INT REV CEL MOL BIO, V281, P49, DOI 10.1016/S1937-6448(10)81002-0; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yamagishi K, 2009, PLANT CELL PHYSIOL, V50, P330, DOI 10.1093/pcp/pcn201; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	93	83	92	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55107	10.1371/journal.pone.0055107	http://dx.doi.org/10.1371/journal.pone.0055107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23527173	Green Published, gold, Green Submitted			2022-12-27	WOS:000314023600154
J	Kumar, S; Kaur, G				Kumar, Sushil; Kaur, Gurcharan			Intermittent Fasting Dietary Restriction Regimen Negatively Influences Reproduction in Young Rats: A Study of Hypothalamo-Hypophysial-Gonadal Axis	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; CHRONIC FOOD RESTRICTION; NEURON-GLIAL PLASTICITY; NEUROPEPTIDE-Y; METABOLIC HORMONES; BODY-WEIGHT; SEXUAL DEVELOPMENT; ANOREXIA-NERVOSA; FEED RESTRICTION; ENERGY-BALANCE	Nutritional infertility is very common in societies where women fail to eat enough to match their energy expenditure and such females often present as clinical cases of anorexia nervosa. The cellular and molecular mechanisms that link energy balance and central regulation of reproduction are still not well understood. Peripheral hormones such as estradiol, testosterone and leptin, as well as neuropeptides like kisspeptin and neuropeptides Y (NPY) play a potential role in regulation of reproduction and energy balance with their primary target converging on the hypothalamic median eminence-arcuate region. The present study was aimed to explore the effects of negative energy state resulting from intermittent fasting dietary restriction (IF-DR) regimen on complete hypothalamo-hypophysial-gonadal axis in Wistar strain young female and male rats. Significant changes in body weight, blood glucose, estrous cyclicity and serum estradiol, testosterone and LH level indicated the negative role of IF-DR regimen on reproduction in these young animals. Further, it was elucidated whether serum level of metabolic hormone, leptin plays a mechanistic role in suppressing hypothalamo-hypophysial-gonadal (HPG) axis via energy regulators, kisspeptin and NPY in rats on IF-DR regimen. We also studied the effect of IF-DR regimen on structural remodeling of GnRH axon terminals in median eminence region of hypothalamus along with the glial cell marker, GFAP and neuronal plasticity marker, PSA-NCAM using immunostaining, Western blotting and RT-PCR. Together these data suggest that IF-DR regimen negatively influences reproduction in young animals due to its adverse effects on complete hypothalamus-hypophysial-gonadal axis and may explain underlying mechanism(s) to understand the clinical basis of nutritional infertility.	[Kumar, Sushil; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019	Kaushik, Nutan/0000-0002-3870-8093	Indo-French Centre for Promotion of Advanced Research (IFCPAR); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	Indo-French Centre for Promotion of Advanced Research (IFCPAR)(French National Research Agency (ANR)); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	The study was supported by a Grant from the Indo-French Centre for Promotion of Advanced Research (IFCPAR) and Indian Council of Medical Research (ICMR) under the National Task Force Program. Mr. Sushil Kumar is thankful to the IFCPAR, New Delhi for the research fellowship provided during this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; ALMOND GW, 1990, J ANIM SCI, V68, P1077, DOI 10.2527/1990.6841077x; Archer ZA, 2004, J ENDOCRINOL, V182, P409, DOI 10.1677/joe.0.1820409; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; Bojkowska K, 2008, HORM BEHAV, V53, P342, DOI 10.1016/j.yhbeh.2007.10.013; Bonfanti L, 2009, CELL ADHES MIGR, V3, P43, DOI 10.4161/cam.3.1.7258; Booth PJ, 1996, J ANIM SCI, V74, P840; Brito LFC, 2007, REPRODUCTION, V134, P171, DOI 10.1530/REP-06-0353; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P1, DOI 10.1016/j.domaniend.2006.04.001; CAMERON JL, 1991, J CLIN ENDOCR METAB, V73, P35, DOI 10.1210/jcem-73-1-35; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254-255, P127; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GUY J, 1988, REGUL PEPTIDES, V23, P209, DOI 10.1016/0167-0115(88)90028-6; Haas VK, 2009, AM J CLIN NUTR, V89, P1005, DOI 10.3945/ajcn.2008.26958; Henry BA, 2004, J NEUROENDOCRINOL, V16, P244, DOI 10.1111/j.0953-8194.2004.01157.x; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kaur G, 2002, BRAIN RES, V954, P21, DOI 10.1016/S0006-8993(02)03301-2; Kinzig KP, 2009, AM J PHYSIOL-ENDOC M, V296, pE282, DOI 10.1152/ajpendo.90523.2008; Kumar S, 2011, MOL CELL ENDO, DOI 10.1016; Langle SL, 2002, J PHYSIOL-PARIS, V96, P169, DOI 10.1016/S0928-4257(02)00003-7; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Martin B, 2008, AGEING RES REV, V7, P209, DOI 10.1016/j.arr.2008.01.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Miller KK, 2007, J CLIN ENDOCR METAB, V92, P1334, DOI 10.1210/jc.2006-2501; Nagatani S, 2001, J NEUROENDOCRINOL, V13, P371, DOI 10.1046/j.1365-2826.2001.00638.x; Narita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028136; Parkash J, 2005, J ENDOCRINOL, V186, P397, DOI 10.1677/joe.1.06156; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Parkash J, 2007, BRAIN RES BULL, V74, P317, DOI 10.1016/j.brainresbull.2007.07.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Prevot V, 1998, NEUROSCIENCE, V84, P177, DOI 10.1016/S0306-4522(97)00537-X; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Quesnel H, 1998, J ANIM SCI, V76, P856; Santos ZA, 2011, J NUTR SCI VITAMINOL, V55, P1; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2; Smith JT, 2008, ENDOCRINOLOGY, V149, P1951, DOI 10.1210/en.2007-1425; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022333; Sucajtys-Szulc E, 2008, NEUROSCI LETT, V433, P174, DOI 10.1016/j.neulet.2008.01.004; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; True C, 2011, J NEUROENDOCRINOL, V23, P1099, DOI 10.1111/j.1365-2826.2011.02144.x; VELDHUIS JD, 1993, J CLIN ENDOCR METAB, V76, P587, DOI 10.1210/jcem.76.3.8445014; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004; Wagenmaker ER, 2010, BIOL REPROD, V82, P1206, DOI 10.1095/biolreprod.109.078774; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	60	59	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52416	10.1371/journal.pone.0052416	http://dx.doi.org/10.1371/journal.pone.0052416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23409154	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200038
J	Wang, Y; Wang, H; Zhang, W; Shao, C; Xu, P; Shi, CH; Shi, JG; Li, YM; Fu, Q; Xue, W; Lei, YH; Gao, JY; Wang, JY; Gao, XP; Li, JQ; Yuan, JL; Zhang, YT				Wang, Yong; Wang, He; Zhang, Wei; Shao, Chen; Xu, Peng; Shi, Chang Hong; Shi, Jian Guo; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping; Li, Jin Qing; Yuan, Jian Lin; Zhang, Yun Tao			Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-kappa B/IKK Pathway-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; MAMMARY TUMORIGENESIS; B ACTIVATION; GROWTH; CYTOTOXICITY; REPLICATION; INHIBITION; EXPOSURE; BETA; NBS1	Bladder cancer is the most common malignant urological disease in China. Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years. Previous research has demonstrated that the isoflavone, genistein, can sensitize multiple cancer cell lines to HCPT treatment, such as prostate and cervical cancer. In this study, we investigated whether genistein could sensitize bladder cancer cell lines and bladder epithelial cell BDEC cells to HCPT treatment, and investigated the possible underlying molecular mechanisms. Genistein could significantly and dose-dependently sensitize multiple bladder cancer cell lines and BDEC cells to HCPT-induced apoptosis both in vitro and in vivo. Genistein and HCPT synergistically inhibited bladder cell growth and proliferation, and induced G2/M phase cell cycle arrest and apoptosis in TCCSUP bladder cancer cell and BDEC cell. Pretreatment with genistein sensitized BDEC and bladder cancer cell lines to HCPT-induced DNA damage by the synergistic activation of ataxia telangiectasia mutated (ATM) kinase. Genistein significantly attenuated the ability of HCPT to induce activation of the antiapoptotic NF-kappa B pathway both in vitro and in vivo in a bladder cancer xenograft model, and thus counteracted the antiapoptotic effect of the NF-kappa B pathway. This study indicates that genistein could act as a promising non-toxic agent to improve efficacy of HCPT bladder cancer chemotherapy.	[Wang, Yong; Wang, He; Zhang, Wei; Li, Yu Mei; Fu, Qiang; Xue, Wei; Lei, Yong Hua; Gao, Jing Yu; Wang, Juan Ying; Gao, Xiao Ping] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Shao, Chen; Yuan, Jian Lin; Zhang, Yun Tao] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Dept Med, Xian 710032, Shaanxi, Peoples R China; [Xu, Peng] Fourth Mil Med Univ, Tangdu Hosp, Training Dept, Xian 710032, Shaanxi, Peoples R China; [Shi, Chang Hong] Fourth Mil Med Univ, Dept Expt Anim, Xian 710032, Shaanxi, Peoples R China; [Shi, Jian Guo] Fourth Mil Med Univ, Dept Canc Res Inst, Xian 710032, Shaanxi, Peoples R China; [Li, Jin Qing] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhang, YT (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China.	lijinqing@yahoo.cn; jianliny@fmmu.edu.cn; jiangru@fmmu.edu.cn	Wang, Chuan-Yue/C-9369-2015; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; zhang, wei/0000-0001-8511-7360; Xu, Zhi-Qing David/0000-0002-0387-7559	National Natural Science Foundation of China [30901498, 30100185, 81250036, 30973000, 30872583, 81072116]; Natural Science Foundation of Shaan'xi Province, China [2009JQ4003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaan'xi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901498, No. 30100185, No. 81250036, No. 30973000, No. 30872583, No. 81072116) and the Natural Science Foundation of Shaan'xi Province, China (2009JQ4003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Cheon J, 2002, INT J UROL, V9, P445, DOI 10.1046/j.1442-2042.2002.00500.x; Choi EJ, 2004, LIFE SCI, V75, P499, DOI 10.1016/j.lfs.2004.01.010; Davis JN, 1999, NUTR CANCER, V35, P167, DOI 10.1207/S15327914NC352_11; Dheekollu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001257; Fu SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038465; Hilakivi-Clarke L, 1999, ONCOL REP, V6, P1089; Hilakivi-Clarke L, 1999, BRIT J CANCER, V80, P1682, DOI 10.1038/sj.bjc.6690584; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kakehi Y, 2010, JPN J CLIN ONCOL, V40, pi57, DOI 10.1093/jjco/hyq128; Kawakami K, 2011, BIOSCI BIOTECH BIOCH, V75, P650, DOI 10.1271/bbb.100738; Kim SH, 2009, ANN NY ACAD SCI, V1171, P495, DOI 10.1111/j.1749-6632.2009.04899.x; Kobayashi J, 2009, BIOCHEM BIOPH RES CO, V380, P752, DOI 10.1016/j.bbrc.2009.01.109; Kontos S, 2011, UROL INT, V87, P151, DOI 10.1159/000324262; Kumi-Diaka J, 2010, J MED FOOD, V13, P842, DOI 10.1089/jmf.2009.0199; Lavin MF, 2005, ADV EXP MED BIOL, V570, P457, DOI 10.1007/1-4020-3764-3_16; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Manoharan N, 2010, ASIAN PAC J CANCER P, V11, P73; Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026903; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Papazisis KT, 2006, CANCER LETT, V233, P255, DOI 10.1016/j.canlet.2005.03.022; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; TANIZAWA A, 1994, J NATL CANCER I, V86, P836, DOI 10.1093/jnci/86.11.836; Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040955; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Wang Yong, 2003, Ai Zheng, V22, P1272; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yee DS, 2011, UROLOGY, V78, P544, DOI 10.1016/j.urology.2011.02.042; [张思维 ZHANG Si-wei], 2009, [中华泌尿外科杂志, Chinese Journal of Urology], V30, P673; Zhou JR, 1998, CANCER RES, V58, P5231; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	33	172	181	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e50175	10.1371/journal.pone.0050175	http://dx.doi.org/10.1371/journal.pone.0050175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23741354	Green Published, Green Submitted, gold			2022-12-27	WOS:000314023600001
J	Wang, HLS; Yu, RJ; Wu, YT; Lee, WY; Lin, MF; Chen, CY; Shen, EY				Wang, Hsiao-Lan Sharon; Yu, Rongjun; Wu, Yu-Tzu; Lee, Wen-Yuan; Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao			The Changes of Cerebral Morphology Related to Aging in Taiwanese Population	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHITE-MATTER; PHYSICAL-ACTIVITY; CHILDREN-A; BRAIN; MR; VOLUME; ADULT; MECHANISMS; PATTERNS	A cross-sectional study with the 3-dimensional (3D) MRI reconstruction technique was conducted to investigate cerebral complexity changes related to age differences in native Taiwanese population. In our sample of 85 participants aged between 25 and 81, age was associated with gradual ventricular expansion. A nonlinear quadratic relationship between white matter volume and age was found overall in the brain. Widespread age-related reduction in white matter was detected from late adulthood onwards. However, no significant age-related changes in the cortex and whole brain volume were determined throughout adulthood. These findings provided information in describing brain structural complexity, which might in the future serve as an objective diagnostic index or as a predictive parameter for neurological diseases. Our method then may be used for cross-cultural longitudinal studies to evaluate the effect of disease, environment and aging on the brain.	[Wang, Hsiao-Lan Sharon] Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan; [Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wu, Yu-Tzu] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Lee, Wen-Yuan; Shen, Ein-Yiao] China Med Univ Hosp, Taipei Branch, Taipei, Taiwan; [Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Taiwan Normal University; South China Normal University; South China Normal University; University of Cambridge; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Shen, EY (corresponding author), China Med Univ Hosp, Taipei Branch, Taipei, Taiwan.	acupmoxi123@gmail.com	Chen, Chia-Yuan/N-7780-2014; Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Chen, Chun-Hong/0000-0002-5166-9017; Wang, Hui-Min/0000-0002-4692-4917; Ho, Mei-Ling/0000-0001-8064-8488; Wu, Yu-Tzu/0000-0002-0874-4448	National Science Council in Taiwan, NSC [99-2320-B-039-018-MY2]	National Science Council in Taiwan, NSC	This study was supported the National Science Council in Taiwan, NSC 99-2320-B-039-018-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Boss B J, 1991, SCI Nurs, V8, P42; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Free SL, 1996, CEREB CORTEX, V6, P830, DOI 10.1093/cercor/6.6.830; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hobbs F, 2000, CENSUS 2000 SPECIAL; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Maillet D, 2011, BRAIN RES, V1420, P68, DOI 10.1016/j.brainres.2011.08.071; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Shen EY, 2010, CHILD NERV SYST, V26, P1619, DOI 10.1007/s00381-010-1280-1; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang X, 1985, Popul Res, V2, P24; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Xu J, 2000, AM J NEURORADIOL, V21, P112	35	81	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55241	10.1371/journal.pone.0055241	http://dx.doi.org/10.1371/journal.pone.0055241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23762223	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600161
J	Lin, YC; Chen, JC; Morni, WZW; Putra, DF; Huang, CL; Li, CC; Hsieh, JF				Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang			Vaccination Enhances Early Immune Responses in White Shrimp Litopenaeus vannamei after Secondary Exposure to Vibrio alginolyticus	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; PROPHENOLOXIDASE-ACTIVATING SYSTEM; HOT-WATER EXTRACT; PENAEUS-MONODON; GRACILARIA-TENUISTIPITATA; RESISTANCE; HEMOCYTES; INNATE; CLASSIFICATION; CRUSTACEANS	Background: Recent work suggested that the presence of specific memory or some form of adaptive immunity occurs in insects and shrimp. Hypervariable pattern recognition molecules, known as Down syndrome cell adhesion molecules, are able to mount specific recognition, and immune priming in invertebrates. In the present study, we attempted to understand the immune response pattern of white shrimp Litopenaeus vannamei which received primary (PE) and secondary exposure (SE) to Vibrio alginolyticus. Methodology: Immune parameters and proliferation of haematopoietic tissues (HPTs) of shrimp which had received PE and SE to V. alginolyticus were measured. In the PE trial, the immune parameters and proliferation of HPTs of shrimp that received heat-killed V. alginolyticus (HVa) and formalin-inactivated V. alginolyticus (FVa) were measured. Mortality, immune parameters and proliferation of HPTs of 7-day-HVa-PE shrimp (shrimp that received primary exposure to HVa after 7 days) and 7-day-FVa-PE shrimp (shrimp that received primary exposure to FVa after 7 days) following SE to live V. alginolyticus (LVa) were measured. Phagocytic activity and clearance efficiency were examined for the 7 similar to 35-day-HVa-PE and FVa-PE shrimp. Results: HVa-receiving shrimp showed an earlier increase in the immune response on day 1, whereas FVa-receiving shrimp showed a late increase in the immune response on day 5. The 7-day-FVa-PE shrimp showed enhancement of immunity when encountering SE to LVa, whereas 7-day-HVa-PE shrimp showed a minor enhancement in immunity. 7-day-FVa-PE shrimp showed higher proliferation and an HPT mitotic index. Both phagocytic activity and clearance maintained higher for both HVa-PE and FVa-PE shrimp after 28 days. Conclusions: HVa-and FVa-receiving shrimp showed the bacteria agglutinated prior to being phagocytised. FVa functions as a vaccine, whereas HVa functions as an inducer and can be used as an immune adjuvant. A combined mixture of FVa and HVa can serve as a "vaccine component" to modulate the immunity of shrimp.	[Lin, Yong-Chin; Chen, Jiann-Chu; Morni, Wan Zabidii W.; Putra, Dedi Fazriansyah; Huang, Chien-Lun; Li, Chang-Che; Hsieh, Jen-Fang] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan	National Taiwan Ocean University	Chen, JC (corresponding author), Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Keelung, Taiwan.	jcchen@mail.ntou.edu.tw	Putra, Dedi Fazriansyah/E-3111-2017; Zabidii, Wan/AAB-3381-2020	Putra, Dedi Fazriansyah/0000-0003-2896-1949; Lee, Jin-Ching/0000-0003-0729-9589; Wu, Yu-Hsuan/0000-0002-2175-3867; Morni, Wan Zabidii Wan/0000-0002-5595-7964	National Science Council [NSC98-2313-B-019-002-MY3, NSC101-2313-B-019-002]; Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	National Science Council(Ministry of Science and Technology, Taiwan); Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University	This paper was supported by grants from the National Science Council (NSC98-2313-B-019-002-MY3 and NSC101-2313-B-019-002), and the Center for Marine Bioenvironmental and Biotechnology, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AO, 1999, AQUACULTURE, V178, P1, DOI 10.1016/S0044-8486(99)00131-3; Arala-Chaves M, 2000, AQUACULTURE, V191, P247, DOI 10.1016/S0044-8486(00)00430-0; BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W; BIAGINI G, 1995, NEUROSCI LETT, V190, P212, DOI 10.1016/0304-3940(95)11529-6; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; CHAN SM, 1988, BIOL BULL, V175, P185, DOI 10.2307/1541558; Chang CC, 2008, FISH SHELLFISH IMMUN, V25, P672, DOI 10.1016/j.fsi.2008.09.004; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P1, DOI 10.1016/j.fsi.2004.03.002; Chou PH, 2011, FISH SHELLFISH IMMUN, V30, P1109, DOI 10.1016/j.fsi.2011.02.009; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Eliss A. E., 1990, TECHNIQUES FISH IMMU, P101, DOI DOI 10.1016/S0145-305X(01)00038-6; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Hossain M. M. M., 2009, Journal of Biological Sciences, V9, P392, DOI 10.3923/jbs.2009.392.401; Hou WY, 2005, FISH SHELLFISH IMMUN, V19, P127, DOI 10.1016/j.fsi.2004.11.009; Humason G.L., 1979, ANIMAL TISSUE TECHNI, P661, DOI DOI 10.5962/BHL.TITLE.5890; ITAMI T, 1991, Journal of Aquatic Animal Health, V3, P151, DOI 10.1577/1548-8667(1991)003&lt;0151:SOLGTP&gt;2.3.CO;2; Itami T, 1989, J AQUAT ANIM HEALTH, V1, P234; Itami T, 1992, FISHERIES, V40, P139; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Kurtz J, 2004, MICROBES INFECT, V6, P1410, DOI 10.1016/j.micinf.2004.10.002; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; Li CC, 2010, FISH SHELLFISH IMMUN, V28, P121, DOI 10.1016/j.fsi.2009.10.003; Li CC, 2008, FISH SHELLFISH IMMUN, V25, P853, DOI 10.1016/j.fsi.2008.09.014; Lightner DV, 1998, AQUACULTURE, V164, P201, DOI 10.1016/S0044-8486(98)00187-2; Liu CH, 2004, DIS AQUAT ORGAN, V61, P169, DOI 10.3354/dao061169; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Namikoshi A, 2004, AQUACULTURE, V229, P25, DOI 10.1016/S0044-8486(03)00363-6; Pereira J. J., 2009, Tamilnadu Journal of Veterinary and Animal Sciences, V5, P246; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pope EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020960; Powell A, 2011, J INVERTEBR PATHOL, V107, P95, DOI 10.1016/j.jip.2011.02.006; Rodriguez J, 2000, AQUACULTURE, V191, P109, DOI 10.1016/S0044-8486(00)00421-X; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Sirirustananun N, 2011, FISH SHELLFISH IMMUN, V31, P848, DOI 10.1016/j.fsi.2011.07.025; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; Smith VJ, 2003, FISH SHELLFISH IMMUN, V15, P71, DOI 10.1016/S1050-4648(02)00140-7; SODERHALL K, 1979, CAN J MICROBIOL, V25, P406, DOI 10.1139/m79-062; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Tayag CM, 2010, FISH SHELLFISH IMMUN, V28, P764, DOI 10.1016/j.fsi.2010.01.023; Teunissen OSP, 1998, AQUACULTURE, V164, P359, DOI 10.1016/S0044-8486(98)00200-2; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Vaseeharan B, 2006, LETT APPL MICROBIOL, V43, P137, DOI 10.1111/j.1472-765X.2006.01941.x; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yeh ST, 2008, AQUACULTURE, V276, P22, DOI 10.1016/j.aquaculture.2008.01.034; Yeh ST, 2009, FISH SHELLFISH IMMUN, V26, P724, DOI 10.1016/j.fsi.2009.02.025; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003	60	138	142	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69722	10.1371/journal.pone.0069722	http://dx.doi.org/10.1371/journal.pone.0069722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23365670	Green Published, Green Submitted, gold			2022-12-27	WOS:000322132100079
J	Lee, BH; Gauna, AE; Perez, G; Park, YJ; Pauley, KM; Kawai, T; Cha, S				Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Pauley, Kaleb M.; Kawai, Toshihisa; Cha, Seunghee			Autoantibodies against Muscarinic Type 3 Receptor in Sjogren's Syndrome Inhibit Aquaporin 5 Trafficking	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; 2ND EXTRACELLULAR LOOP; SALIVARY ACINAR-CELLS; ACETYLCHOLINE-RECEPTOR; WATER CHANNEL; ABNORMAL DISTRIBUTION; SUBMANDIBULAR-GLANDS; MOUSE MODEL; HSG CELLS; NOD MICE	Sjogren's syndrome (SjS) is a chronic autoimmune disease that mainly targets the salivary and lacrimal glands. It has been controversial whether anti-muscarinic type 3 receptor (alpha-M3R) autoantibodies in patients with SjS inhibit intracellular trafficking of aquaporin-5 (AQP5), water transport protein, leading to secretory dysfunction. To address this issue, GFP-tagged human AQP5 was overexpressed in human salivary gland cells (HSG-hAQP5) and monitored AQP5 trafficking to the plasma membrane following carbachol (CCh, M3R agonist) stimulation. AQP5 trafficking was indeed mediated by M3R stimulation, shown in partial blockage of trafficking by M3R-antagonist 4-DAMP. HSG-hAQP5 pre-incubated with SjS plasma for 24 hours significantly reduced AQP5 trafficking with CCh, compared with HSG-hAQP5 pre-incubated with healthy control (HC) plasma. This inhibition was confirmed by monoclonal a-M3R antibody and pre-absorbed plasma. Interestingly, HSG-hAQP5 pre-incubated with SjS plasma showed no change in cell volume, compared to the cells incubated with HC plasma showing shrinkage by twenty percent after CCh-stimulation. Our findings clearly indicate that binding of anti-M3R autoantibodies to the receptor, which was verified by immunoprecipitation, suppresses AQP5 trafficking to the membrane and contribute to impaired fluid secretion in SjS. Our current study urges further investigations of clinical associations between SjS symptoms, such as degree of secretory dysfunction, cognitive impairment, and/or bladder irritation, and different profiles (titers, isotypes, and/or specificity) of anti-M3R autoantibodies in individuals with SjS.	[Lee, Byung Ha; Gauna, Adrienne E.; Perez, Geidys; Park, Yun-Jong; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA; [Pauley, Kaleb M.] Cedarville Univ, Coll Arts & Sci, Dept Sci & Math, Cedarville, OH USA; [Kawai, Toshihisa] Forsyth Inst, Dept Immunol, Cambridge, MA USA	State University System of Florida; University of Florida; Cedarville University; Harvard University; Forsyth Institute	Cha, S (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA.	scha@dental.ufl.edu		Williams, Adrienne/0000-0003-0247-1175	NIH/NIDCR [DE019644, DE 016705];  [UL1 RR029890];  [TL1 RR029889];  [T90 DE021990]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890, TL1RR029889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990, R01DE019644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016705] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. The funders had no role in study design, data c S.CHA was supported by NIH/NIDCR grants DE019644 and DE 016705. AE.GAUNA was supported by UL1 RR029890, TL1 RR029889, and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukas T, 2001, LANCET, V358, P1875, DOI 10.1016/S0140-6736(01)06900-8; Cavill D, 2004, SCAND J IMMUNOL, V59, P261, DOI 10.1111/j.0300-9475.2004.01395.x; Cha SH, 2006, J RHEUMATOL, V33, P296; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Dawson L, 2005, ARTHRITIS RHEUM-US, V52, P2984, DOI 10.1002/art.21347; FATHERAZI S, 1994, J MEMBRANE BIOL, V142, P181; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; ISHIKAWA T, 1994, PFLUG ARCH EUR J PHY, V427, P203, DOI 10.1007/BF00374525; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Katz J, 2008, CANCER LETT, V270, P87, DOI 10.1016/j.canlet.2008.04.051; Konttinen YT, 2005, J RHEUMATOL, V32, P1071; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Li JC, 2004, LAB INVEST, V84, P1430, DOI 10.1038/labinvest.3700173; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Marczinovits I, 2005, J AUTOIMMUN, V24, P47, DOI 10.1016/j.jaut.2004.11.005; Nagy K, 2007, ACTA PHYSIOL HUNG, V94, P301, DOI 10.1556/APhysiol.94.2007.4.2; Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Ohashi Y, 2008, CURR EYE RES, V33, P621, DOI 10.1080/02713680802262819; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Smith AJ, 2005, HUM IMMUNOL, V66, P411, DOI 10.1016/j.humimm.2005.01.020; Soyfoo MS, 2007, ARTHRITIS RHEUM-US, V56, P2566, DOI 10.1002/art.22826; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; Wellner RB, 2005, TISSUE ENG, V11, P1449, DOI 10.1089/ten.2005.11.1449; Yuan ZF, 2003, EUR J PHARMACOL, V464, P197, DOI 10.1016/S0014-2999(03)01375-X	43	59	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e53113	10.1371/journal.pone.0053113	http://dx.doi.org/10.1371/journal.pone.0053113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382834	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800018
J	Luo, JL; Li, WF; Qiu, J; Wei, DT; Liu, YJ; Zhang, QL				Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin			Neural Basis of Scientific Innovation Induced by Heuristic Prototype	PLOS ONE			English	Article							DIVERGENT THINKING; CREATIVE-THINKING; INSIGHT; EEG; MEMORY; RECOGNITION; PERFORMANCE; LOCUS; FMRI	A number of major inventions in history have been based on bionic imitation. Heuristics, by applying biological systems to the creation of artificial devices and machines, might be one of the most critical processes in scientific innovation. In particular, prototype heuristics propositions that innovation may engage automatic activation of a prototype such as a biological system to form novel associations between a prototype's function and problem-solving. We speculated that the cortical dissociation between the automatic activation and forming novel associations in innovation is critical point to heuristic creativity. In the present study, novel and old scientific innovations (NSI and OSI) were selected as experimental materials in using learning-testing paradigm to explore the neural basis of scientific innovation induced by heuristic prototype. College students were required to resolve NSI problems (to which they did not know the answers) and OSI problems (to which they knew the answers). From two fMRI experiments, our results showed that the subjects could resolve NSI when provided with heuristic prototypes. In Experiment 1, it was found that the lingual gyrus (LG; BA18) might be related to prototype heuristics in college students resolving NSI after learning a relative prototype. In Experiment 2, the LG (BA18) and precuneus (BA31) were significantly activated for NSI compared to OSI when college students learned all prototypes one day before the test. In addition, the mean beta-values of these brain regions of NSI were all correlated with the behavior accuracy of NSI. As our hypothesis indicated, the findings suggested that the LG might be involved in forming novel associations using heuristic information, while the precuneus might be involved in the automatic activation of heuristic prototype during scientific innovation.	[Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin] Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Junlong] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China	Southwest University - China; Shanghai Normal University	Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; qlzhang.swu@gmail.com	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [31170983, 30970892, 31200768, 31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [NSKD11007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31170983; 30970892; 31200768; 31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Program for Talents in Colleges and Universities in Chongqing, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (NSKD11007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; BLAGROVE M, 1994, PERS INDIV DIFFER, V16, P981, DOI 10.1016/0191-8869(94)90242-9; Blagrove M, 2000, PERS INDIV DIFFER, V28, P41, DOI 10.1016/S0191-8869(99)00078-1; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; Dickinson MH, 1999, P NATL ACAD SCI USA, V96, P14208, DOI 10.1073/pnas.96.25.14208; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; DOMINO G, 1970, J CONSULT CLIN PSYCH, V35, P48, DOI 10.1037/h0029624; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; Fink A, 2007, METHODS, V42, P68, DOI 10.1016/j.ymeth.2006.12.001; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Jausovec N, 2000, INT J PSYCHOPHYSIOL, V36, P73, DOI 10.1016/S0167-8760(99)00113-0; Jausovec N, 2000, BRAIN TOPOGR, V12, P229, DOI 10.1023/A:1023446024923; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Molle M, 1999, PSYCHOPHYSIOLOGY, V36, P95, DOI 10.1017/S0048577299961619; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Razoumnikova OM, 2000, COGNITIVE BRAIN RES, V10, P11, DOI 10.1016/S0926-6410(00)00017-3; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Vogel S, 2000, CATS PAWS CATAPULTS	34	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e49231	10.1371/journal.pone.0049231	http://dx.doi.org/10.1371/journal.pone.0049231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	24098501	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400001
J	Yao, XL; Fu, BJ; Lu, YH; Sun, FX; Wang, S; Liu, M				Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min			Comparison of Four Spatial Interpolation Methods for Estimating Soil Moisture in a Complex Terrain Catchment	PLOS ONE			English	Article							SEMIARID LOESS PLATEAU; LINEAR-REGRESSION; VARIABILITY; WATER; PREDICTION; SURFACE; MODEL; SCALE; SCATTEROMETER; INFORMATION	Many spatial interpolation methods perform well for gentle terrains when producing spatially continuous surfaces based on ground point data. However, few interpolation methods perform satisfactorily for complex terrains. Our objective in the present study was to analyze the suitability of several popular interpolation methods for complex terrains and propose an optimal method. A data set of 153 soil water profiles (1 m) from the semiarid hilly gully Loess Plateau of China was used, generated under a wide range of land use types, vegetation types and topographic positions. Four spatial interpolation methods, including ordinary kriging, inverse distance weighting, linear regression and regression kriging were used for modeling, randomly partitioning the data set into 2/3 for model fit and 1/3 for independent testing. The performance of each method was assessed quantitatively in terms of mean-absolute-percentage-error, root-mean-square-error, and goodness-of-prediction statistic. The results showed that the prediction accuracy differed significantly between each method in complex terrain. The ordinary kriging and inverse distance weighted methods performed poorly due to the poor spatial autocorrelation of soil moisture at small catchment scale with complex terrain, where the environmental impact factors were discontinuous in space. The linear regression model was much more suitable to the complex terrain than the former two distance-based methods, but the predicted soil moisture changed too sharply near the boundary of the land use types and junction of the sunny (southern) and shady (northern) slopes, which was inconsistent with reality because soil moisture should change gradually in short distance due to its mobility in soil. The most optimal interpolation method in this study for the complex terrain was the hybrid regression kriging, which produced a detailed, reasonable prediction map with better accuracy and prediction effectiveness.	[Yao, Xueling; Fu, Bojie; Lu, Yihe; Sun, Feixiang; Wang, Shuai; Liu, Min] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009; Wang, Shuai/B-2334-2017	Wang, Shuai/0000-0003-1595-9858; Feng, Haiyang/0000-0002-2169-2347; Shen, Wen-Hui/0000-0001-7988-6382	National Natural Science Foundation of China [40930528]; State Forestry Administration [201004058]; CAS/SAFEA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (No. 40930528), State Forestry Administration (No. 201004058) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergel C, 2008, HYDROL EARTH SYST SC, V12, P1323, DOI 10.5194/hess-12-1323-2008; Bai Tian-lu, 2009, Shengtaixue Zazhi, V28, P2508; Baskan O, 2009, CLAY MINER, V44, P181, DOI 10.1180/claymin.2009.044.2.181; Bi HX, 2008, J AM WATER RESOUR AS, V44, P1121, DOI 10.1111/j.1752-1688.2008.00236.x; Bi HX, 2009, INT J SEDIMENT RES, V24, P63, DOI 10.1016/S1001-6279(09)60016-0; Carre F, 2002, GEODERMA, V110, P241, DOI 10.1016/S0016-7061(02)00233-1; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Fritsch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020682; Gilbert B, 1997, LANDSCAPE URBAN PLAN, V37, P235, DOI 10.1016/S0169-2046(97)80007-2; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Kravchenko A, 1999, AGRON J, V91, P393, DOI 10.2134/agronj1999.00021962009100030007x; Lesch SM, 2008, GEODERMA, V148, P130, DOI 10.1016/j.geoderma.2008.09.014; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Lin GF, 2004, J HYDROL, V288, P288, DOI 10.1016/j.jhydrol.2003.10.008; Liu W, 2010, AGR WATER MANAGE, V97, P1133, DOI 10.1016/j.agwat.2010.01.001; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Minet J, 2011, HYDROL EARTH SYST SC, V15, P1323, DOI 10.5194/hess-15-1323-2011; Moran MS, 2004, CAN J REMOTE SENS, V30, P805, DOI 10.5589/m04-043; Perry MA, 2008, HYDROL EARTH SYST SC, V12, P39, DOI 10.5194/hess-12-39-2008; Qiu Y, 2003, CATENA, V54, P173, DOI 10.1016/S0341-8162(03)00064-X; Sigua GC, 2008, J SOIL SEDIMENT, V8, P193, DOI 10.1007/s11368-008-0003-7; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Sun W, 2012, J PLANT NUTR SOIL SC, V175, P212, DOI 10.1002/jpln.201100005; Tabari H, 2011, METEOROL ATMOS PHYS, V110, P135, DOI 10.1007/s00703-010-0110-z; Tischler M, 2007, ENVIRON MODELL SOFTW, V22, P891, DOI 10.1016/j.envsoft.2006.05.022; Toth E, 2008, CEREAL RES COMMUN, V36, P307; Tramblay Y, 2010, J HYDROL, V387, P176, DOI 10.1016/j.jhydrol.2010.04.006; Vanita Pandey, 2010, International Journal of Geosciences, V1, P87; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Wang M, 2012, PLOS ONE, V7; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 2009, J GEOGR SCI, V19, P707, DOI 10.1007/s11442-009-0707-7; Wu J, 2006, GEODERMA, V134, P187, DOI 10.1016/j.geoderma.2005.11.002; Yao XL, 2012, J SOIL SEDIMENT, V12, P694, DOI 10.1007/s11368-012-0481-5; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zeng C, 2011, ACTA AGR SCAND B-S P, V61, P1, DOI 10.1080/09064710903352589; Zhang CL, 2008, INT FED INFO PROC, V258, P719; Zhang CL, 2009, INT FED INFO PROC, V293, P285; Zhao PP, 2010, ACTA AGR SCAND B-S P, V60, P117, DOI 10.1080/09064710802676377; Zhu Q, 2010, PEDOSPHERE, V20, P594, DOI 10.1016/S1002-0160(10)60049-5; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433; Zribi M, 2003, REMOTE SENS ENVIRON, V86, P30, DOI 10.1016/S0034-4257(03)00065-8	48	126	136	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54660	10.1371/journal.pone.0054660	http://dx.doi.org/10.1371/journal.pone.0054660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23483879	Green Submitted, gold, Green Published			2022-12-27	WOS:000314021500101
J	Wang, XL; Falkner, B; Zhu, HD; Shi, HD; Su, SY; Xu, XJ; Sharma, AK; Dong, YB; Treiber, F; Gutin, B; Harshfield, G; Snieder, H				Wang, Xiaoling; Falkner, Bonita; Zhu, Haidong; Shi, Huidong; Su, Shaoyong; Xu, Xiaojing; Sharma, Ashok Kumar; Dong, Yanbin; Treiber, Frank; Gutin, Bernard; Harshfield, Gregory; Snieder, Harold			A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; DNA METHYLATION; MALE TWINS; HSULF-1; CANCER; GENE; VARIANTS; HEMODYNAMICS; INFLAMMATION	Objective: There is emerging evidence from animal studies suggesting a key role for methylation in the pathogenesis of essential hypertension. However, to date, very few studies have investigated the role of methylation in the development of human hypertension, and none has taken a genome-wide approach. Based on the recent studies that highlight the involvement of inflammation in the development of hypertension, we hypothesize that changes in DNA methylation of leukocytes are involved in the pathogenesis of hypertension. Method & Results: We conducted a genome-wide methylation analysis on 8 hypertensive cases and 8 normotensive age-matched controls aged 14-23 years and performed validation of the most significant CpG sites in 2 genes in an independent sample of 36 hypertensive cases and 60 normotensive controls aged 14-30 years. Validation of the CpG sites in the SULF1 gene was further conducted in a second replication sample of 36 hypertensive cases and 34 controls aged 15.8-40 years. A CpG site in the SULF1 gene showed higher methylation levels in cases than in healthy controls in the genome-wide step (p = 6.2 x 10(-5)), which was confirmed in the validation step (p = 0.011) for subjects <= 30 years old but was not significant for subjects of all ages combined (p = 0.095). Conclusion: The identification of a difference in a blood leukocyte DNA methylation site between hypertensive cases and normotensive controls suggests that changes in DNA methylation may play an important role in the pathogenesis of hypertension. The age dependency of the effect further suggests complexity of epigenetic regulation in this age-related disease.	[Wang, Xiaoling; Zhu, Haidong; Su, Shaoyong; Xu, Xiaojing; Dong, Yanbin; Gutin, Bernard; Harshfield, Gregory] Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Shi, Huidong] Georgia Hlth Sci Univ, Sch Med, Canc Res Ctr, Augusta, GA USA; [Sharma, Ashok Kumar] Georgia Hlth Sci Univ, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Treiber, Frank] Med Univ S Carolina, Coll Nursing, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Treiber, Frank] Med Univ S Carolina, Coll Med, Technol Applicat Ctr Healthful Lifestyles, Charleston, SC 29425 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands	University System of Georgia; Augusta University; Jefferson University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Medical University of South Carolina; Medical University of South Carolina; University of Groningen	Wang, XL (corresponding author), Georgia Hlth Sci Univ, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA.	xwang@georgiahealth.edu	xu, xiaojing/C-2759-2014; Falkner, Bonita/Y-8451-2019	Shi, Huidong/0000-0003-1137-3390; Sanfacon, Helene/0000-0003-3807-3590; Sharma, Ashok/0000-0001-9597-4374	National Institutes of Health [HL69999, HL56622, HL077230, HL64157, DK046107, HL092030]; NLHBI [HL105689]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104125, R01HL092030, P01HL069999, R01HL056622, R01HL105689, R01HL064157, R01HL077230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLHBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The participants in this study were recruited by several National Institutes of Health funded projects including HL69999, HL56622, HL077230, HL64157, DK046107 & HL092030. The current study is funded by the NLHBI HL105689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baty F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-422; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Cantarin MPM, 2010, CTS-CLIN TRANSL SCI, V3, P279, DOI 10.1111/j.1752-8062.2010.00242.x; CARMELLI D, 1994, J HYPERTENS, V12, P323; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; COLLETTO GMDD, 1993, GENET EPIDEMIOL, V10, P533, DOI 10.1002/gepi.1370100634; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Falkner B, 2012, J PEADIAT IN PRESS; Frey FJ, 2005, NEPHROL DIAL TRANSPL, V20, P868, DOI 10.1093/ndt/gfh746; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Ge DL, 2006, TWIN RES HUM GENET, V9, P965, DOI 10.1375/twin.9.6.965; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Groom A, 2011, ARCH DIS CHILD, V96, P863, DOI 10.1136/adc.2009.165712; Gutin B, 2007, OBESITY, V15, P1029, DOI 10.1038/oby.2007.602; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Kapur G, 2010, CLIN HYPERTENSION VA, P241; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kupper N, 2006, HYPERTENSION, V47, P948, DOI 10.1161/01.HYP.0000217521.79447.9a; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snieder H, 2002, AM J HYPERTENS, V15, P973, DOI 10.1016/S0895-7061(02)02991-6; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Wang X, 2010, CLIN HYPERTENSION VA, P241; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940; Zhang DY, 2009, KIDNEY INT, V75, P260, DOI 10.1038/ki.2008.475; Zhu HD, 2009, PEDIATR RES, V65, P443, DOI 10.1203/PDR.0b013e3181994b85	41	163	175	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53938	10.1371/journal.pone.0053938	http://dx.doi.org/10.1371/journal.pone.0053938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23325143	gold, Green Published, Green Submitted			2022-12-27	WOS:000313552400062
J	Luo, JF; Wang, Y; Tang, SS; Liang, JW; Lin, WT; Luo, LX				Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin			Isolation and Identification of Algicidal Compound from Streptomyces and Algicidal Mechanism to Microcystis aeruginosa	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; TOXIC DINOFLAGELLATE; BIOLOGICAL-ACTIVITY; RED-TIDE; CYANOBACTERIA; BACTERIUM; SAPONIN; METABOLITES; BLOOMS; FUNGUS	The biological control of cyanobacterial harmful algal blooms (cyanoHABs) is important to promote human health, environmental protection, and economic growth. Active algicidal compounds and algicidal mechanisms should be identified and investigated to control cyanoHABs. In this study, the algicidal actinobacterium Streptomyces sp. L74 was isolated from the soil of a nearby pond which located in the center lake of Guanghzou Higher Education Mega Center. Results showed that the algicidal activities of cyanoHABs are mainly achieved via an indirect attack by producing algicidal compounds. All active algicidal compounds are hydrophilic substances that are heat and pH stable. In the present study, an active compound (B3) was isolated and purified by high-performance liquid chromatography and identified as a type of triterpenoid saponin (2-hydroxy-12-oleanene-3, 28-O-D- glucopyranosyl) with a molecular formula of C42H70O13 as determined by infrared spectrometry, electrospray ionization mass spectrometry, and nuclear magnetic resonance. Active algicidal compounds from Streptomyces sp. L74 were shown to disrupt the antioxidant systems of Microcystis aeruginosa cells.	[Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Lin, WT (corresponding author), S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	weitie@21cn.com; btlxluo@scut.edu.cn	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [21076090, 21276099]; Specialized Research Found for the Doctoral Program of Higher Education of China [20120172120045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Found for the Doctoral Program of Higher Education of China	This work was supported by the National Natural Science Foundation of China (21076090 and 21276099) and the Specialized Research Found for the Doctoral Program of Higher Education of China (20120172120045)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H E, 1983, METHOD ENZYMATIC ANA, P273, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Aliyu AB, 2011, J MED PLANTS RES, V5, P6709, DOI 10.5897/JMPR10.708; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Arabski M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/286216; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; CIVELLO PM, 1995, J AGR FOOD CHEM, V43, P2596, DOI 10.1021/jf00058a008; DAFT MJ, 1975, FRESHWATER BIOL, V5, P577, DOI 10.1111/j.1365-2427.1975.tb00157.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gause GF, 2004, HDB MICROBIOLOGICAL, P704; Hasegawa H, 1996, PLANTA MED, V62, P453, DOI 10.1055/s-2006-957938; Isaka M, 2011, J NAT PROD, V74, P300, DOI 10.1021/np100873t; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakamura N, 2003, J BIOSCI BIOENG, V95, P179, DOI 10.1263/jbb.95.179; Noike M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042090; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Podolak Irma, 2007, Acta Pol Pharm, V64, P39; REDHEAD K, 1978, APPL ENVIRON MICROB, V35, P962, DOI 10.1128/AEM.35.5.962-969.1978; SAFFERMAN RS, 1963, SCIENCE, V140, P679, DOI 10.1126/science.140.3567.679; SAFFERMAN RS, 1962, APPL MICROBIOL, V10, P289, DOI 10.1128/AEM.10.4.289-292.1962; Sakata T, 2011, FISHERIES SCI, V77, P397, DOI 10.1007/s12562-011-0345-8; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; SHIGEMATSU N, 1992, J ANTIBIOT, V45, P704, DOI 10.7164/antibiotics.45.704; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Volk RB, 2005, J APPL PHYCOL, V17, P339, DOI 10.1007/s10811-005-7292-7; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yang JD, 2009, INT J MOL SCI, V10, P4157, DOI 10.3390/ijms10094157; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	44	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76444	10.1371/journal.pone.0076444	http://dx.doi.org/10.1371/journal.pone.0076444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098501	Green Published, Green Submitted, gold			2022-12-27	WOS:000325483600052
J	Yu, CC; Huang, SP; Lee, YC; Huang, CY; Liu, CC; Hour, TC; Huang, CN; You, BJ; Chang, TY; Huang, CH; Bao, BY				Yu, Chia-Cheng; Huang, Shu-Pin; Lee, Yung-Chin; Huang, Chao-Yuan; Liu, Chia-Chu; Hour, Tzyh-Chyuan; Huang, Chun-Nung; You, Bang-Jau; Chang, Ta-Yuan; Huang, Chun-Hsiung; Bao, Bo-Ying			Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer	PLOS ONE			English	Article							CAG REPEAT LENGTH; RECEPTOR GENE; ENDOCRINE-THERAPY; ANTIGEN NADIR; SURVIVAL; POLYMORPHISMS; TESTOSTERONE; LEVEL; RISK; TIME	Although most advanced prostate cancer patients respond to androgen-deprivation therapy (ADT), the efficacy is widely variable. We investigated whether the host genetic variations in sex hormone pathway genes are associated with the efficacy of ADT. A cohort of 645 patients with advanced prostate cancer treated with ADT was genotyped for 18 polymorphisms across 12 key genes involved in androgen and estrogen metabolism. We found that after adjusting for known risk factors in multivariate Cox regression models, AKR1C3 rs12529 and AR-CAG repeat length remained significantly associated with prostate cancer-specific mortality (PCSM) after ADT (P <= 0.041). Furthermore, individuals carrying two unfavorable genotypes at these loci presented a 13.7-fold increased risk of PCSM compared with individuals carrying zero (P<0.001). Our results identify two candidate molecular markers in key genes of androgen and estrogen pathways associated with PCSM after ADT, establishing the role of pharmacogenomics in this therapy.	[Yu, Chia-Cheng] Kaohsiung Vet Gen Hosp, Div Urol, Dept Surg, Kaohsiung, Taiwan; [Yu, Chia-Cheng] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Yu, Chia-Cheng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chun-Nung; Huang, Chun-Hsiung] Kaohsiung Med Univ, Dept Urol, Fac Med, Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [You, Bang-Jau] China Med Univ, Dept Chinese Med Resources, Taichung, Taiwan; [Chang, Ta-Yuan] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ, Dept Pharm, Taichung, Taiwan; [Bao, Bo-Ying] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bao, BY (corresponding author), China Med Univ, Dept Pharm, Taichung, Taiwan.	bao@mail.cmu.edu.tw	Chang, Ta-Yuan/P-3126-2015; LIU, CHIA CHU/T-2880-2019; Bao, Bo-Ying/D-1789-2012; Bao, Bo-Ying/H-4589-2019	Chang, Ta-Yuan/0000-0001-5664-4559; Bao, Bo-Ying/0000-0001-5510-6513; Bao, Bo-Ying/0000-0001-5510-6513; CHOW, LU-PING/0000-0002-4420-211X; LIN, CHUNG-WU/0000-0001-5042-0503; HUANG, CHAO-YUAN/0000-0002-9322-6062; YANG, JYH-CHIN/0000-0003-4219-0685; Wu, Ming-Shiang/0000-0002-1940-6428; Yu, Cheng-Ping/0000-0002-0693-5056; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council (NSC), Taiwan [NSC-98-2320-B-039-019-MY3, NSC-100-2314-B-039-009-MY3]; China Medical University [CMU98-N1-21, CMU98-C-12]; Kaohsiung Medical University Hospital [KMUH100-0R42]; Kaohsiung Veterans General Hospital [VGHKS97-048, VGHKS101-112]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital	This work was supported by the National Science Council (NSC), Taiwan (grant numbers: NSC-98-2320-B-039-019-MY3 and NSC-100-2314-B-039-009-MY3), China Medical University (grant number: CMU98-N1-21 and CMU98-C-12), Kaohsiung Medical University Hospital (grant number: KMUH100-0R42), and Kaohsiung Veterans General Hospital (grant number: VGHKS97-048 and VGHKS101-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2006, AM J CLIN ONCOL-CANC, V29, P14, DOI 10.1097/01.coc.0000195085.34162.88; Bao BY, 2012, INT J CANCER, V130, P876, DOI 10.1002/ijc.26091; Bao BY, 2011, CLIN CANCER RES, V17, P928, DOI 10.1158/1078-0432.CCR-10-2648; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y; Figueroa JD, 2008, CARCINOGENESIS, V29, P1955, DOI 10.1093/carcin/bgn163; GELLER J, 1984, J UROLOGY, V132, P693, DOI 10.1016/S0022-5347(17)49829-6; Gregory CW, 2001, CANCER RES, V61, P4315; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; Huang CN, 2012, J INTERN MED, V271, P499, DOI 10.1111/j.1365-2796.2011.02449.x; Huang CN, 2012, ANN ONCOL, V23, P707, DOI 10.1093/annonc/mdr264; Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219; Hussain M, 2006, J CLIN ONCOL, V24, P3984, DOI 10.1200/JCO.2006.06.4246; Imamoto T, 2001, ENDOCR J, V48, P573, DOI 10.1507/endocrj.48.573; Klotz L, 2005, PROSTATE CANCER P D, V8, P179, DOI 10.1038/sj.pcan.4500792; Kwak C, 2002, J UROLOGY, V168, P995, DOI 10.1016/S0022-5347(05)64559-4; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Lindstrom S, 2006, PROSTATE, V66, P1729, DOI 10.1002/pros.20489; Misra D, 2011, BJU INT, V108, P1086, DOI 10.1111/j.1464-410X.2010.10037.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Palmberg C, 2000, J UROLOGY, V164, P1992, DOI 10.1016/S0022-5347(05)66935-2; Pao JB, 2013, WORLD J UROL, V31, P281, DOI 10.1007/s00345-011-0813-x; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Shimbo M, 2005, EUR UROL, V47, P557, DOI 10.1016/j.eururo.2004.10.016; Sircar K, 2007, PROSTATE CANCER P D, V10, P360, DOI 10.1038/sj.pcan.4500967; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stewart AJ, 2005, J CLIN ONCOL, V23, P6556, DOI 10.1200/JCO.2005.20.966; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki H, 2002, PROSTATE, V51, P219, DOI 10.1002/pros.10080; Takeda H, 1996, CANCER, V77, P934, DOI 10.1002/(SICI)1097-0142(19960301)77:5<934::AID-CNCR20>3.3.CO;2-Q; Taplin ME, 1999, CANCER RES, V59, P2511; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	42	149	150	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54627	10.1371/journal.pone.0054627	http://dx.doi.org/10.1371/journal.pone.0054627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23460808	Green Submitted, gold, Green Published			2022-12-27	WOS:000314023600080
J	Yang, YL; Ji, C; Bi, ZG; Lu, CC; Wang, R; Gu, B; Cheng, L				Yang, Yan-li; Ji, Chao; Bi, Zhi-gang; Lu, Chun-cheng; Wang, Rong; Gu, Bing; Cheng, Lei			Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE ACTIVITY; AMPK ACTIVATION; DOWN-REGULATION; AKT INHIBITOR; IN-VITRO; CERAMIDE; GROWTH; HSP90; CONTRIBUTES	Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly improved, and the search for potential alternative therapies is encouraging. Here we demonstrate that deguelin administration causes a significant HNSCC cell death. Deguelin induces both cell apoptosis and autophagy by modulating multiple signaling pathways in cultured HNSCC cells. Deguelin inhibits Akt signaling, and down-regulates survivin and cyclin-dependent kinase 4 (Cdk4) expressions, by disrupting their association with heat shock protein-90 (Hsp-90). Deguelin induces ceramide production through de novo synthase pathway to promote HNSCC cell death. Importantly, increased ceramide level activates AMP-activated protein kinase (AMPK), which then directly phosphorylates Ulk1 and eventually leads to cell autophagy. We found that a low dose of deguelin sensitized HNSCC cells to 5-FU. Finally, using a nude mice Hep-2 xenograft model, we also showed a significant anti-tumor ability of deguelin in vivo. Together, we suggest that deguelin may represent a novel and effective chemo-agent against HNSCC.	[Yang, Yan-li; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Bi, Zhi-gang] Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Lu, Chun-cheng] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Rong] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Gu, Bing] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	eltonbibenqhospital@yahoo.com.cn; jspent@126.com	Cheng, Lei/AAT-2690-2021; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022	Cheng, Lei/0000-0001-6541-7702; Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation [810701297, 81101188, 30671894, 30972822, 30801016]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province [XK200719, XK200731, RC2007065, RC2011071]; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China [2010NJMUZ19]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China	This research was supported by grants from the National Natural Science Foundation (810701297, 81101188, 30671894, 30972822 and 30801016), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project of Jiangsu Province (XK200719, XK200731, RC2007065 and RC2011071), and the Science & Technology Development Foundation of Nanjing Medical University (2010NJMUZ19), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bozec A, 2009, EXPERT OPIN EMERG DR, V14, P299, DOI 10.1517/14728210902997947; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GERHAUSER C, 1995, NAT MED, V1, P260, DOI 10.1038/nm0395-260; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jang K.Y., 2012, CANC LETT; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Ji C, 2012, BIOCH BIOPHYS RES CO; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Ji C, 2010, INT J MOL MED, V26, P257, DOI 10.3892/ijmm_00000460; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Lippert BM, 2007, INT J CANCER, V121, P1169, DOI 10.1002/ijc.22941; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simmonds MA, 2003, CA-CANCER J CLIN, V53, P4, DOI 10.3322/canjclin.53.1.4; Sommer K, 2001, INT J ONCOL, V18, P1145; STELL PM, 1989, EUR J SURG ONCOL, V15, P407; STELL PM, 1991, HEAD NECK-J SCI SPEC, V13, P277, DOI 10.1002/hed.2880130403; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tripathi A, 2003, J CANCER RES CLIN, V129, P642, DOI 10.1007/s00432-003-0485-z; Udeani GO, 1997, CANCER RES, V57, P3424; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Yao C, 2012, CELL BIOCH BIOPHYS; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	66	286	295	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54736	10.1371/journal.pone.0054736	http://dx.doi.org/10.1371/journal.pone.0054736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23383172	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500119
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500075
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
